0001144204-14-015509.txt : 20140313 0001144204-14-015509.hdr.sgml : 20140313 20140313171711 ACCESSION NUMBER: 0001144204-14-015509 CONFORMED SUBMISSION TYPE: 10-KT PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20130630 FILED AS OF DATE: 20140313 DATE AS OF CHANGE: 20140313 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Healthcare Corp of America CENTRAL INDEX KEY: 0001514682 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-KT SEC ACT: 1934 Act SEC FILE NUMBER: 000-54527 FILM NUMBER: 14691869 BUSINESS ADDRESS: STREET 1: 66 FORD ROAD STREET 2: SUITE 230 CITY: DENVILLE STATE: NJ ZIP: 07834 BUSINESS PHONE: (973) 983-6300 MAIL ADDRESS: STREET 1: 66 FORD ROAD STREET 2: SUITE 230 CITY: DENVILLE STATE: NJ ZIP: 07834 FORMER COMPANY: FORMER CONFORMED NAME: Selway Capital Acquisition Corp. DATE OF NAME CHANGE: 20110307 10-KT 1 v370891_10kt.htm FORM 10-KT

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

¨ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended _______________

 

or

 

xTRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from January 1, 2013 to June 30, 2013

 

Commission file number: 000-54527

 

HEALTHCARE CORPORATION OF AMERICA

 (Exact name of registrant as specified in its charter)

 

Delaware   27- 4563770
(State or other jurisdiction of   (I.R.S. Employer Identification No.)
incorporation or organization)    
     
66 Ford Road, Suite 230    
Denville, NJ   07834
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code:   (973) 983-6300

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Name of each exchange on which registered: None.

 

Securities registered pursuant to Section 12(g) of the Act:  Common Stock, par value $0.0001 per share

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  ¨  No  x

 

Indicate by check mark if the registrant is required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes  x   No  ¨

 

Indicate by check mark whether the registrant (1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes   ¨  No  x

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer  ¨ Accelerated filer   ¨
   
Non-accelerated filer  ¨ Smaller reporting company  x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No  x

 

The aggregate market value of the voting and non-voting stock held by non-affiliates of the Registrant as of December 31, 2012, the last business day of the Registrant’s most recently completed second fiscal quarter for the period ended June 30, 2013, was approximately $20,400,000.

 

The number of shares outstanding of the Registrant’s common stock as of March 10, 2014 was 8,832,692.

 

DOCUMENTS INCORPORATED BY REFERENCE

 

None.

 

 
 

  

HEALTHCARE CORPORATION OF AMERICA

 

Transition Report on Form 10-K for the Period Ended June 30, 2013

 

    Page
     
part I   2
     
ITEM 1. BUSINESS 2
     
ITEM 1A.   RISK FACTORS 20
     
ITEM 1B.   UNRESOLVED STAFF COMMENTS 26
     
ITEM 2. PROPERTIES 26
     
ITEM 3. LEGAL PROCEEDINGS 26
     
ITEM 4. MINE SAFETY DISCLOSURES 26
     
part II   27
     
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 27
     
ITEM 6. SELECTED FINANCIAL DATA 28
     
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 28
     
ITEM 7A.   QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 36
     
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 36
     
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 36
     
ITEM 9A.   CONTROLS AND PROCEDURES 36
     
ITEM 9B.   OTHER INFORMATION 37
     
part III   38
     
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 38
     
ITEM 11. EXECUTIVE COMPENSATION 41
     
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 43
     
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 45
     
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES 45
     
part IV   47
     
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES 47

 

Report of Independent Registered Public Accounting Firms   F-1 to F-2
     
Consolidated Balance Sheets as of June 30, 2013 and December 31, 2012   F-3
     
Consolidated Statements of Operations for the Six Months Ended June 30, 2013 and Year Ended December 31, 2012   F-4
     
Consolidated Statements of Redeemable Securities and Stockholders’ Deficit for the Six Months Ended June 30, 2013 and Year Ended December 31, 2012   F-5
     
Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2013 and Year Ended December 31,2012   F-6 to F-7
     
Notes to Consolidated Financial Statements   F-8 to F-26

 

i
 

  

FORWARD LOOKING STATEMENTS

 

This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, or the Exchange Act. The statements contained in this report that are not purely historical are forward-looking statements. Our forward-looking statements include, but are not limited to, statements regarding our or our management’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipates,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.

 

The forward-looking statements contained in this report are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described under the heading “Risk Factors,” which include, among other things:

 

·changing principles of generally accepted accounting principles;
·market acceptance of our products;
·changes in government regulations related to the pharmaceutical industry;
·changes in government regulations related to healthcare, generally;
·fluctuations in customer demand;
·management of growth;
·general economic conditions;
·relationships with suppliers;
·overall economic conditions and local market conditions;
·our ability to keep information confidential;
·the volume of prescriptions for certain drugs or drugs generally; and
·retaining key customer relationships.

 

Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws and/or if and when management knows or has a reasonable basis on which to conclude that previously disclosed projections are no longer reasonably attainable.

 

1
 

  

part I 

 

ITEM 1.  BUSINESS

 

Introduction

 

Healthcare Corporation of America, a Delaware corporation (formerly known as Selway Capital Acquisition Corporation ) (the “Company”, “we,” “us,” or “our”), is a company that was organized under the laws of the State of Delaware on January 12, 2011 to acquire, through a merger, capital stock exchange, asset acquisition, stock purchase or similar acquisition transaction, one or more operating businesses. Although we were not limited to a particular geographic region or industry, we focused on acquiring operating businesses in the United States. Until the acquisition (the “Acquisition”) of Healthcare Corporation of America, a New Jersey corporation (“HCCA”), on April 10, 2013, we did not operate a business and our activities were limited to locating a business to acquire.

 

As a result of the closing of the Acquisition, we operate our business through our wholly owned subsidiary, HCCA. HCCA is a Pharmacy Benefit Manager, or PBM. HCCA’s mission is to reduce prescription drug costs for clients while improving the quality of care. HCCA administers prescription drug benefit programs for employers who contract with HCCA directly in order to provide this component of healthcare benefits to their employees. HCCA also is the PBM for health benefit companies who partner with HCCA in order to provide prescription drug benefits along with their core offering, other health benefits like medical insurance, to their clients. HCCA’s growing customer base includes commercial clients of various sizes and industries, business associations and trade groups, and local government entities, labor unions and charitable and non-profit organizations. HCCA’s business model is based on proactive benefit cost management. HCCA’s brand in the marketplace is Prescription Corporation of America, or PCA.

 

Our principal executive offices are located at 66 Ford Road, Suite 230, Denville, NJ 07834, and the telephone number at our principal executive office is 973-983-6300. We maintain a website at www.hca-pca.com. The information contained in, or that can be accessed through, our website is not part of, and is not incorporated into, this current report on Form 8-K or other filings we make with the SEC. We makes available free of charge on our website annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and any amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 as soon as reasonably practicable after we electronically file such material with, or we furnishes it to, the SEC.

 

Acquisition of HCCA

 

On January 25, 2013, an Agreement and Plan of Merger (the “Agreement”) was entered into by and among the Company, Selway Merger Sub, Inc., a New Jersey corporation and wholly owned subsidiary of the Company (“Merger Sub”), HCCA, Prescription Corporation of America (“PCA”), Gary Sekulski, as the representative of the stockholders of HCCA, and Edmundo Gonzalez, as our representative. On April 10, 2013 (the “Closing Date”), the Acquisition and other transactions contemplated by the Agreement closed.

 

Pursuant to the Agreement, Merger Sub merged with and into HCCA (the “Merger”), resulting in HCCA becoming a wholly owned subsidiary of the Company. PCA and PCA Benefits, Inc., a dormant entity, remain wholly owned subsidiaries of HCCA.

 

Holders of all of the issued and outstanding shares of common stock of HCCA immediately prior to the time of the Merger had each of their shares of common stock of HCCA converted into the right to receive: (i) a proportional amount of 5,200,000 shares of our Series C common stock and promissory notes with an aggregate face value of $7,500,000 (collectively, the “Closing Payment”); plus (ii) a proportional amount of up to 2,800,000 shares of our common stock, if any, (the “Earnout Payment Shares”) issuable upon the our achieving certain consolidated gross revenue thresholds as more fully described below. A portion of the Closing Payment (520,000 shares and promissory notes with an aggregate face value of $750,000) was being held in escrow for a period of 12 months following the Merger to satisfy indemnification obligations of the HCCA. Effective December 20, 2013, the escrowed portion of the Closing Payment, together with a portion of the shares issued to Chardan Capital Markets, LLC (an aggregate of 546,002 shares, and promissory notes with an aggregate face value of $750,000) were released from escrow and cancelled.

 

2
 

  

The Earnout Payment Shares , if any, will be issued as follows: (i) 1,400,000 shares if we achieve consolidated gross revenue of $150,000,000 for the twelve months ended March 31, 2014 or June 30, 2014; and (ii) 1,400,000 shares if we achieve consolidated gross revenue of $300,000,000 for the twelve months ended March 31, 2015 or June 30, 2015. In the event we do not achieve the first earnout threshold, but do achieve the second earnout threshold, then all of the Earnout Payment Shares shall be issued. If we consolidates, merge or transfer substantially all of our assets prior to June 30, 2015 at a valuation of at least $15.00 per share, then all of the Earnout Payment Shares not previously paid out shall be issued immediately prior to such transaction. If, prior to achieving either earnout threshold we acquire another business in exchange for our equity or debt securities, then any remaining earnout thresholds may be adjusted by the independent members of our board of directors in its sole discretion.

 

In connection with the Merger, certain members of HCCA’s management received promissory notes with an aggregate face value of $2,500,000 (the “Management Incentive Notes”), which notes are non-interest bearing and subordinated to all our senior debt in the event of a default under such senior debt. The Management Incentive Notes will be repaid from 6.25% of our free cash-flow (defined as in the notes) in excess of $2,000,000. We will be obligated to repay such notes if, among other events, there is a transaction that that results in a change of control.

 

In addition to the Management Incentive Notes, certain members of HCCA’s management received an aggregate of 1,500,000 shares of our common stock (the “Management Incentive Shares”), which shares were placed in escrow and subject to release in three installments through June 30, 2015. Subsequently, certain members of HCCA management agreed to cancel an aggregate of 750,000 shares pursuant to rescission agreements entered into in June 2013. Of the remaining Management Incentive Shares outstanding, 400,000 shares have vested but remain in escrow until June 30, 2014 and 350,000 shares will vest on June 30, 2015 and will remain in escrow until June 30, 2015.

 

In connection with a bridge financing (the “Bridge Financing”) completed by HCCA in September 2012, HCCA issued 59.25 units, each unit consisting of 10,000 preferred shares and a promissory note with a face value of $100,000. At the time of the Merger, holders of all of the issued and outstanding shares of preferred stock of HCCA, by virtue of the Merger, had each of their shares of preferred stock of HCCA converted into the right to receive a proportional amount of 592,500 shares of our Series C common stock and warrants to purchase 296,250 shares of our Series C common stock. In accordance with the terms of the promissory notes issued in the Bridge Financing, at the time of the Merger, notes in the aggregate amount of $3,159,591.78 (including principal and interest accrued to date) were converted into 315,959 shares of our Series C common stock and notes in the aggregate principal amount of $3,025,000 were repaid in full.

 

In connection with transactions contemplated by the Agreement, we also entered into a registration rights agreement to register all shares included in the Closing Payment, the Earnout Payment Shares, the shares underlying the Exchange Warrants (as defined below), and the shares issued as compensation for the Bridge Financing completed by HCCA in September 2012, pursuant to the terms of a Registration Rights Agreement entered into at the closing of the merger (all such securities issued in connection with the merger, the “Merger Securities”). The holders of the majority of the Merger Securities are entitled to make up to two demands that we register such securities at any time commencing six months following the consummation of the merger. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to our consummation of an acquisition transaction. We will bear the expenses incurred in connection with the filing of any such registration statements. In addition, holders who received shares as compensation for the Bridge Financing are entitled to liquidated damages because the registration statement was not effective by October 8, 2013, or, after effectiveness, if it ceases to be effective for more than 45 days in a 12-month period. Such damages are assessed for each 30-day period that the registration statement is not effective, in the amount of 1.0% of the aggregate purchase price paid by each holder in the Bridge Financing, provided however, that total liquidated damages may not exceed 10% of the aggregate purchase price. As of June 30, 2013 we had accrued the maximum penalty of $592,000.

 

3
 

  

In conjunction with the merger of Merger Sub into HCCA:

 

·we entered into exchange agreements with 3 beneficial holders of HCCA’s bridge loan who were also beneficial holders of greater than 5% of our Series A common stock. Pursuant to the exchange agreements, such holders converted an aggregate of 281,554 shares of our Series A common stock to our Series C common stock. In conjunction with the exchange, such holders were repaid bridge notes in the aggregate principal amount of $3,025,000.

 

·we entered into exchange agreements with 3 beneficial holders of greater than 5% of our Series A common stock. Pursuant to the exchange agreements, such holders converted an aggregate of 878,481 shares of our Series A common stock to our Series C common stock and received $3.53 per share of Series A common stock exchanged, or an aggregate of $3,101,037.93.

 

·An aggregate of $11,948,360.50 was released from our trust account, reflecting the number of shares of Series A common stock that were converted into Series C common stock, of which $232,007 was paid to the underwriters from our initial public offering.

 

·The placement warrants held by our founders were converted into the right to receive: (i) an aggregate of 100,000 shares of our common stock; and (ii) warrants to purchase an aggregate of 1,000,000 shares of our common stock at an exercise price of $10.00 per share (the “Exchange Warrants”). On November 22, 2013, our Board of Directors approved a change in the terms of the Exchange Warrants, pursuant to which (a) the term of the warrants was extended for three year, (b) the exercise price was reduced to $1.50 (the conversion price of the Notes issued on December 31, 2013 as described herein), (c) providing for a cashless exercise feature for 100% of the warrant shares, and (d) increased to $17.50 the price at which the Exchange Warrants must be exercised if the closing price for the our common stock exceeds such price per share for 20 trading days in any 30-trading-day period.

 

We paid Chardan Capital Markets LLC a cash fee comprised of five percent of all equity consideration issued in the merger (335,000 shares of common stock), plus promissory notes having an aggregate principal amount of five percent of all promissory notes issued in connection with the Merger ($500,000), on the same terms and conditions as the promissory notes issued in the Merger, in consideration of its services in connection with the Merger. A portion of the shares (26,002 shares) and notes ($50,000 principal amount) issued to Chardan pursuant to the Merger were cancelled in connection with the cancellation of the escrowed portion of the Merger consideration. We also paid Chardan Capital Markets LLC a cash fee of $414,750, plus warrants to purchase up to 92,500 shares of common stock, in consideration of its services in connection with the bridge financing.

 

Immediately following the transactions described above, none of our Series A Shares and Units were outstanding and there were 839,965 shares of our Series B Shares issued and outstanding, 8,953,494 shares of our Series C Shares issued and outstanding, 2,296,250 public warrants issued and outstanding, warrants to purchase 1,000,000 shares of our common stock owned by our pre-initial public offering stockholders, and unit purchase options exercisable for 100,000 shares of our common stock and warrants to purchase 100,000 shares of our common stock.

 

Tender Offer

 

As required by our Certificate of Incorporation, following the Merger, we filed a tender offer to all holders of our outstanding Series B Shares of common stock, par value $0.0001 per share (the “Series B Shares”), at a price of $10.30 per share in cash, without interest.

 

The Offer expired at 5:00 p.m., United States Eastern Time on the evening of Tuesday, August 13, 2013. Based on information provided by American Stock Transfer & Trust Company, LLC (the “Depositary”), pursuant to the terms of the Offer, 839,765 Shares were tendered for an aggregate purchase price of $8,649,579.50. The Company has accepted for redemption all of the Shares validly tendered and not withdrawn.

 

4
 

  

As specified in our Certificate of Incorporation, On August 20, 2013, all outstanding classes of our common stock consolidated into a single class of common stock, designated “common stock”.

 

Restatement of Financial Information

 

On May 9, 2013, we issued a Current Report on Form 8-K announcing that our Board of Directors, after consultation with, and upon recommendation from, our management, concluded the previously issued audited financial statements for the years ended December 31, 2011 and 2012 for HCCA, which we recently acquired and which is currently our wholly owned subsidiary, should no longer be relied upon and that disclosure should be made, and action should be taken, to prevent future reliance on such financial statements. For a description of the basis for the Board’s determination, please see our Current Report on Form 8-K dated May 9, 2013, which description is incorporated by reference herein.

 

Our officers discussed the foregoing matters with HCCA’s independent registered public accounting firm during the period, Thomas J. Harris, Certified Public Accountant. The Board of Directors authorized and directed that our officers take the appropriate and necessary actions to amend and restate the Current Report on Form 8-K (the “Original 8-K”), pursuant to which HCCA’s financial statements were filed with the SEC on May 16, 2013.

 

The restated financial statements also include certain reclassifications related to revenue and cost of sales for the fiscal years ended December 31, 2011 and 2012. We previously disclosed in our Current Reports on Form 8-K filed on March 25, 2013 and April 16, 2013 HCCA’s practice of recognizing revenue from rebates as well as from its mail-order pharmacy business. HCCA has reclassified these figures as decreases to cost of sales, with the exception of co-pays from members who order from its mail-order facility. There is no impact on gross profit, nor is there an impact on operating expenses related to this reclassification.

 

On September 16, 2013, the Board of Directors of the Company, after consultation with, and upon recommendation from, management of the Company, concluded that the previously issued and restated audited financial statements for the years ended December 31, 2011 and 2012 of HCCA, and the previously issued unaudited financial statements for the quarter ended March 31, 2013 of HCCA, should no longer be relied upon and that disclosure should be made, and action should be taken, to prevent future reliance on such financial statements. The Company reported this information in its Current Report on Form 8-K dated September 16, 2013.

 

Our officers discussed the foregoing matters with HCCA’s independent registered public accounting firm during the period, Thomas J. Harris, Certified Public Accountant. The Board of Directors authorized and directed that our officers take the appropriate and necessary actions to amend and restate the Original 8-K. As a result we reviewed our financial statements in an attempt to discover all the material errors and misstatements that were included therein. As part of this review we engaged external consultants to review and investigate our books and records and other related transactions and activities for 2012 and 2011.

 

On November 11, 2013, the Company issued a press release announcing that the Company had discovered additional issues that necessitated an in-depth analysis of the books and records of HCCA for 2011, 2012 and the three months ended March 31, 2013. As a result of this review our management concluded that it will be unable to complete our restated 2011 financial statements, due to lack of sufficient source documents and other information, and that, as a result of the analysis, management had decided to exclude the 2011 income statement from our Transition Report on Form 10-K, in which it would otherwise be required, and that we would adjust the financial statements for 2012 and the 6 months ended June 30, 2013 to reflect the correction of the errors that were discovered.

 

The errors requiring a restatement of HCCA’s financial statements resulted in material weaknesses in internal control over financial reporting which were noted in the amended filings. In order to help prevent similar accounting errors in the future, the Company has hired a new CFO effective as of June 3, 2013 and instituted new procedures and controls where all material schedules and related journal entries are reviewed by the CFO on a monthly basis. On January 7, 2014, the Company’s Board of Directors established an Audit Committee consisting of Mr. Thomas Rebar and Edmundo Gonzalez, with Mr. Rebar as Chairman. In addition, the Company is in the process of locating additional independent directors eligible to serve on the audit committee.

 

5
 

  

New Chief Executive Officer

 

On December 31, 2013, the Company appointed Natasha Giordano to serve as Chief Executive Officer, President and director of the Company, effective January 1, 2014. Also on December 31, 2013, Gary Sekulski resigned as Chief Executive Officer of the Company effective upon the appointment of his successor, Natasha Giordano. He will continue to serve as a director of the Company. In addition, Mr. Sekulski entered into a one year renewable consulting agreement whereby he will provide sales and marketing consulting services to the Company.

 

Change in Fiscal Year

 

On November 7, 2013, the Company determined to change its fiscal year end from June 30 to December 31. As a result of the change in fiscal year, the Company will file a transition report on Form 10-K for the six months ended December 31, 2013.

 

Debt Modification

 

On October 15, 2013, the Company received a notice of events of default (the “Notice”) from Partners For Growth III, L.P. (the “Lender”) pursuant to that certain Loan and Security Agreement dated as of July 17, 2013 (the “Loan Agreement”) by and among the Company, Healthcare Corporation of America, a New Jersey corporation and wholly owned subsidiary of the Company (“HCA”), Prescription Corporation of America, a New Jersey corporation and wholly owned subsidiary of HCA (“PCA”), and PCA Benefits, Inc., a New Jersey corporation and wholly owned subsidiary of HCA (“PCAB”; and collectively with the Company, HCA and PCA, the “Borrowers”). On December 31, 2013, the Company entered into a Forbearance, Waiver and Modification No. 1 to Loan Agreement with the Lender (the “Modification”) that is described in the Company’s Current Report on Form 8-K dated December 31, 2013.

 

Private Placement

 

On December 31, 2013, the Company entered into a securities purchase agreement (the “SPA”) with certain purchasers (each a “Purchaser” and collectively, the “Purchasers”) named therein and Chardan Capital Markets, LLC (“Agent”) as administrative and collateral agent. Pursuant to the SPA, the Company issued $2,112,500 of Junior Secured Convertible Term Notes (the “Notes”), which Notes are convertible into shares of the Company’s common stock at an initial fixed conversion price equal to $1.50 per share. The Purchasers of Notes also received warrants (the “Warrants”) to purchase one share for every $1.50 of Notes purchased by such Purchaser. The Company completed the initial closing of a private placement of Notes and Warrants under the SPA on December 31, 2013, and may continue to make subsequent placements under the SPA until it has placed an aggregate of $6,000,000 in Notes under the SPA or the date that is 30 days after the date of such initial closing (the private placements under the SPA are collectively referred to as the “Private Placement”).

 

In connection with the Private Placement the Company agreed to pay the Agent a fee representing 9% of the principal amount of the Notes plus the $500,000 additional loan from the Lender, less $250,000, or $2,362,500. The fee was paid in the form of additional Notes (with a pro rata number of warrants) in the amount of $212,625 (for total principal amount of Notes equal to $2,325,125).

 

In connection with the issuance of the Notes under the SPA, the Company issued warrants to purchase an aggregate of 1,550,083 shares of common stock (including warrants to purchase 141,750 shares issued to the Agent for its fees), at an exercise price of $3.00 per share (the “Exercise Price”), at any time on or prior to December 31, 2018 (the “Warrants”). The Warrants may also be exercised on a cashless basis.

 

The Company and its subsidiaries entered into a Master Security Agreement with the Agent pursuant to which the Company and its subsidiaries agreed to secure the payment of all obligations under the Notes by granting and pledging to the Agent a continuing security interest in all of the Company’s and its subsidiaries’ property now owned or at any time hereafter acquired by them.

 

6
 

  

Pursuant to a registration rights agreement entered into in connection with the Private Placement, the Company is required to file a registration statement covering all securities issued or issuable pursuant to the SPA (the “SPA Securities”) no later than ten business days following the filing with the Commission of the Company’s annual or quarterly report for the period ending December 31, 2013 (or, if the Company does not file a report for such period, the report for the period ending closest to December 31, 2013), but in no event later than April 14, 2014. The holders of SPA Securities are entitled to liquidated damages in the amount of 1% of the face value of the Notes for each 30 day period the company fails to comply with its obligations under the registration rights agreement. In the event the Company fails to timely make such liquidated damages payment, the such amounts shall accrue interest at a rate of 1.5% for every 30 day period such failure continues.

 

Going Concern

 

We continue generating substantial losses and expect to into the foreseeable future, while successfully completing various financings as described herein during 2012 and 2013. Nevertheless, as of the date of this report we have not yet established an ongoing source of revenues sufficient to cover our operating costs to allow us to continue as a going concern. Our ability to continue as a going concern is dependent on our obtaining additional adequate capital to fund operating losses until we become profitable and generate cash flows from our operations. If we are unable to obtain adequate capital, we could be forced to cease operations. We are contemplating conducting additional offering of our debt or equity securities to obtain additional operating capital. There are no assurances we will be successful and without sufficient financing it would be unlikely for us to continue as a going concern.

 

Products and Services

 

HCCA’s primary products and services consist of a variety of Pharmacy Benefit Management (PBM) products, in addition to mail-order pharmacy services. HCCA’s suite of PBM products provides flexible and cost-effective alternatives to traditional PBM offerings typically used by health plans, government agencies and employers. HCCA provides a broad range of pharmacy benefit management solutions to managed care organizations, self-insured employer groups, unions, third party healthcare plan administrators, and local government entities. HCCA’s PBM products include solutions for self-insured entities such as employers, townships, counties and unions, as well as smaller fully-funded entities that typically require a fixed cost structure. The majority of HCCA’s client base is currently in New Jersey, and HCCA plans to expand its services out of New Jersey.

 

HCCA started its business by focusing on the needs of the local government market in New Jersey. Recently, we have decided to de-emphasize our focus on the fixed fee local government PBM marketplace due to its lack of profitability. We estimate that this business line which accounted for approximately 67% of our revenues for the six months ending June 30, 2013, and which generated substantial operating losses, will decline in the months to come as annual renewable contracts may not renew due to our demand for substantial price increases as a condition for contract renewals.

 

HCCA believes that our growth to date has been the result of clients (we refer to employers contracting with HCCA as “clients” while the employees to whom HCCA provides services are referred to as “members” throughout this document) finding HCCA’s pricing model, and its resulting savings, more attractive than other options.

 

HCCA has started to expand its business geographically and has also added products to address attractive market segments. HCCA’s PBM products include:

 

·Fully-funded Programs: A fully-funded prescription benefit plan takes the risk of overpayment from the client and passes it to the PBM in exchange for a higher fixed monthly cost.

 

·Self-Insured Programs: Larger organizations can take the risk of total drug spending varying, and traditionally provide the drug benefit to their employees on a self-insured basis. Under self-insurance, HCCA seeks to pass on the cost of drugs, and it generates revenue via administrative fees and rebates.

 

·340B Basics: The federal drug-pricing program, 340B, requires drug manufacturers to sell outpatient drugs at a reduced cost to eligible healthcare centers, clinics and hospitals. The goal is to incentivize healthcare providers to expand medication access to low-income individuals, families and other vulnerable populations. HCCA’s new 340 Basics product is a compliance management solution that includes HCCA proprietary software as well as management processes and controls.

 

7
 

  

·Rx Savings Solutions: These affordable plans marketed under the “Savings Solutions” brand feature generic only or generic and preferred brand drug formularies, allowing HCCA to provide lower cost alternatives. At this point, this program is most often employed by smaller businesses that want to provide prescription drug benefits to their employees but cannot afford a traditional fully-funded or self-funded plan.

 

·Mail-Order Pharmacy: HCCA offers mail-order pharmacy services to its PBM members. HCCA’s mail-order pharmacy service gives members flexibility, privacy, and easy access to their maintenance medications while offering plan savings to the client because we are able to take advantage of lower purchase prices, allowing HCCA to pass along savings to its customers. Unlike other PBM providers who outsource their mail order pharmacy services, HCCA’s in-house pharmacy team operates its own mail-order pharmacy directly from HCCA’s headquarters in Denville, New Jersey. HCCA believes this allows it to provide a higher standard of service and to assert greater control over fulfilling claims for members, as well as lowering costs.

 

On January 1, 2012, HCCA entered into a Management Services Agreement with Argus Health Systems (“Argus”) a provider of claims processing and related services. Pursuant to this agreement, HCCA engaged Argus as its exclusive claims processing service provider. The parties agreed to comply with applicable laws, including with respect to maintaining patient information confidential, and have agreed to customary indemnification obligations. The agreement provides that payment of all services are due within 15 days of invoicing, subject to good faith disputes. The initial term for the agreement with Argus is from January 1, 2012 through January 1, 2015, which term automatically renews for additional one year periods unless notice of non-renewal is made prior to a renewal, and can be terminated prior to such date upon a material uncured breach by the other party.

 

The Industry

 

According to IMS Health, or IMS, approximately 4.4 billion pharmacy prescriptions were written and filled in the United States during 2011 — representing a retail value in excess of $417 billion. Based on the factors described below, HCCA expects drug utilization rates to continue to rise in the future. HCCA estimates that the current market opportunity for HCCA’s services in its industry is significant and growing due to the following factors:

 

·Aging population. According to the U.S. Census Bureau, the U.S. population is expected to age rapidly through 2030, when 19.5% of the population will be over the age of 65, compared to 12.0% in 2000. Older Americans require more medications than their younger counterparts — often 20 to 40 prescriptions annually, according to the Centers for Medicare and Medicaid Services (“CMS”). According to the Kaiser Family Foundation, or Kaiser, the number of prescriptions purchased in the U.S. increased 39% from 1999 to 2009, while the population only grew 9%. The increase in prescriptions due to an aging population is expected to drive demand for senior-focused clinical programs and benefit plans which will address the prescription drug needs of an aging population.

 

·Rising drug prices. According to IMS, the U.S. pharmaceutical market is expected to grow at a 3% to 6% annual compound rate. Retail prescription prices have increased on average 3.6% annually between 2000 and 2009, according to Kaiser, a rate which is higher than the average inflation rate during that same period of 2.5%.

 

·Health care reform. The health care reform law enacted in 2010 is estimated to provide drug coverage for an estimated 30-35 million people in the form of expanded Medicaid coverage, and this increases the PBM market by an estimated 20%, or $87.5 billion. In addition, the law may push more employers towards lower-cost prescription drug providers, which HCCA believes may create demand for PBM products.

 

  · 340B Basics: The federal drug-pricing program, 340B, requires drug manufacturers to sell outpatient drugs at a reduced cost to eligible healthcare centers, clinics and hospitals. The goal is to incentivize healthcare providers to expand medication access to low-income individuals, families and other vulnerable populations. HCCA’s new 340 Basics product is a compliance management solution that includes HCCA proprietary software as well as management processes and controls.

   

8
 

  

·Generic pipeline. According to IMS, the generic share of the overall prescription drug market has increased from 67% in 2007 to 80% in 2011. Also according to IMS, over the next five years, $64 billion in branded drugs will come off patent in the U.S., fueling growth in the availability of generic equivalents. HCCA believes that this presents an opportunity for client cost savings and margin expansion for us. Generic drugs provide both immediate cost savings to the client and higher percent margins for HCCA’s business, despite the lower revenue.

 

Competition

 

HCCA competes with numerous companies that provide the same or similar services. HCCA’s competitors range from large publicly traded companies to several small and privately-owned companies, which compete for a significant part of the market. The principal competitive factors are quality of service, scope of available services, and price. The ability to be competitive is influenced by HCCA’s ability to negotiate prices with pharmacies, drug manufacturers, and third party rebate administrators. Market share for PBM services in the United States is highly concentrated, with a few national firms, such as recently merged leaders SXC Health Solutions, Inc./Catalyst and Medco Health Solutions, Inc./Express Scripts, Inc., along with CVS Caremark Corporation, controlling a significant share of prescription volume. Much of the rest, however, is divided among a combination of small regional PBM’s and so-called “captive” PBM’s, or subsidiaries of larger healthcare or hospital organizations. All told, HCCA believes there are an estimated 40-50 PBM’s operating in the United States, from the large players down to the small regional ones.

 

In addition, the recent merger activity between Express Scripts, Inc. and Medco Health Solutions, Inc., and between SXC Health Solutions, Inc. and Catalyst Health Solutions, Inc. signals that there may be further consolidation of these larger firms. Most of HCCA’s competitors have been in existence for longer periods of time and are better established, and some of them also have broader public recognition and substantially greater financial and marketing resources. However, the constant move towards consolidation may have the effect of encouraging clients to seek an alternative to their incumbent plan, opening an opportunity for a flexible and client-focused alternative.

 

HCCA’s ability to attract and retain customers is substantially dependent on HCCA’s capability to provide competitive pricing, efficient and accurate claims management, client and member services and related reporting and clinical management services.

 

Competitive Strengths

 

We believe that the following competitive strengths are the keys to our success:

 

·Customer Service: HCCA places high level of importance on the quality of its customer support organization. We believe based on customers feedback that our customer support is one of our competitive strengthens compared to our competitors.

 

·Pharmacy Network: Through HCCA’s partner Argus, HCCA’s network features over 63,000 pharmacies nationwide, representing over 95% of pharmacies in the country. Argus processes claims on the level of the largest PBMs. Argus’ buying power allows HCCA to compete with much bigger PBMs, as it eliminates some of the larger PBMs’ price advantage when compared to HCCA. New clients of HCCA who are switching from larger PBMs experience a seamless transition to HCCA’s plan, as it is accepted at nearly all pharmacies nationwide. By exploiting its relationship with Argus, HCCA is able to deliver a higher degree of savings to its customers and gain greater appeal in the contracting process due to the availability of the large network.

 

·Price: HCCA’s partnership with Argus provides state-of-the-art electronic claims adjudication capabilities. Argus currently processes an aggregate of over 500 million pharmacy claims a year for a number of PBM providers. Due to this substantial market presence, it is generally able to negotiate drug prices far below that which PBMs of comparable size to HCCA would otherwise be able to. Further, there are no fixed costs associated with this network, as all payments are set up on a per-prescription processed basis. When added to HCCA’s retail mail-order pharmacy, which provides discounts for customers while keeping all revenue in-house, we believe HCCA’s network stands at a fairly equal footing with the largest PBMs in the market.

 

9
 

  

·Unique and Innovative Programs:

 

oPatient Empowerment Program (PEP): This voluntary clinical management program provides members with a cash incentive to try brand-to-generic substitutions and therapeutic brand alternatives. PEP provides a small but worthwhile cash payment for each switch from brand to generic.

 

oPrescription Savings Card: HCCA’s prescription savings card program is a promotional program that enables members and their families to realize savings of 15% to 75% on prescription drug purchases through Argus’ nationwide network of over 64,000 retail pharmacies and HCCA’s mail-order retail pharmacy.

 

Business Strategy

 

We seek to continue our growth as a lower-cost, high customer service prescription services provider in the United States. Broadly defined, our basic strategies are to expand HCCA’s customer base geographically and within the government sector, while at the same time pursuing unique new applications of HCCA’s knowledge and technology to higher margin businesses that can continue to diversify and expand its overall revenue stream. HCCA’s primary strategies by product line are:

 

Existing Programs

 

·Fully-Funded: Penetrate the private market sector as well as non profits while improving the profitability of our current customer contacts which are primarily in the government sector. Recently, we have decided to de-emphasize our focus on the fixed fee local government PBM marketplace due to its lack of profitability. We estimate that this business line which accounted for approximately 67% of our revenues for the six months ending June 30, 2013, and which generated substantial operating losses, will decline in the months to come as annual renewable contracts may not renew due to our demand for substantial price increases as a condition for contract renewals.

 

·Self-Funded: Within the self-funded product line, we intend to follow a similar strategy of expansion within and outside the region and aggressive growth targeting as with the fully-funded line. In general, self-funded clients are larger and we believe the role of the benefit consultant is very important. HCCA has established good working relationships with benefits consulting groups, and will continue to do so as a market strategy. HCCA’s direct sales force also targets clients directly, so that HCCA can directly participate in the bidding process and receive RFPs from potential clients.

 

·340B Basics: The federal drug-pricing program, 340B, requires drug manufacturers to sell outpatient drugs at a reduced cost to eligible healthcare centers, clinics and hospitals. The goal is to incentivize healthcare providers to expand medication access to low-income individuals, families and other vulnerable populations. HCCA’s new 340 Basics product is a compliance management solution that includes HCCA proprietary software as well as management processes and controls. It provides multiple channels with the operational framework to meet administrative and inventory control challenges relating to 340B compliance, maximize potential pharmacy savings and control costs. Since its launch in August 2013, HCCA signed up 7 new customers that are expected to go live by mid-2014.

 

·Partnerships with Healthcare Management Companies: In early 2012, HCCA executed its first agreement with a regional health benefits provider, for which it created a privately labeled PBM product. HCCA’s private-label product, which does not vary in terms from HCCA’s other products, is the companion drug benefit program for clients that elect to include a drug benefit with their health benefits purchase. Since April 2013, the regional health benefits provider no longer offers the private-label PMB product to new customers, though it does provide the product to customers who have previously selected the private-label product. HCCA believes it can create privately labeled PBM products for other health benefits providers in the future and it is exploring other opportunities with firms like these.

 

10
 

  

·Rx Savings Solutions: The Savings Solutions line offers an opportunity for growth and higher margins as compared to the core PBM product lines. HCCA will continue to move aggressively to apply the Savings Solutions’ generic-based model to larger customers.

 

Government Regulation

 

Various aspects of our business are governed by federal and state laws and regulations. Because sanctions may be imposed for violations of these laws, compliance is a significant operational requirement. We believe that we are in substantial compliance with all existing legal requirements material to the operation of our business. There are, however, significant uncertainties involving the application of many of these legal requirements to its business. In addition, at any given time, there are numerous proposed health care laws and regulations at the federal and state levels, many of which could harm its business, results of operations, and financial condition. We are unable to predict what additional federal or state legislation or regulatory initiatives may be enacted in the future relating to its business or the health care industry in general, or what effect any such legislation or regulations might have on us. We also cannot provide any assurance that federal or state governments will not impose additional restrictions or adopt interpretations of existing laws or regulations that could harm our business or financial performance.

 

Some of the state laws described below may be preempted in whole or in part by the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), which provides for comprehensive federal regulation of employee benefit plans. However, the scope of ERISA preemption is uncertain given the extensive and sometimes conflicting court rulings addressing the topic. We also provide services to certain clients, such as governmental entities, that are not subject to ERISA.

 

Federal Laws and Regulations Affecting Us

 

The following descriptions identify various federal laws and regulations that affect or may affect aspects of HCCA’s PBM business:

 

Legislation and Litigation Affecting Drug Prices

 

Average wholesale price (“AWP”) is a standard pricing metric published by third party data sources and currently used throughout the pharmacy benefits industry as the basis for determining drug pricing under contracts with clients, pharmacies, and pharmaceutical manufacturers. The calculation and reporting of AWP have been the subject of investigations by federal and state governments and litigation brought against pharmaceutical manufacturers, as well as data services that report AWP. We are not responsible for calculations, reports or payments of AWP; however, such investigations or lawsuits could impact our business because many of our customer contracts, pharmaceutical purchase agreements, retail network contracts and other agreements use AWP as a pricing benchmark. In March 2009, a federal district court gave final approval to settlement of class action lawsuits brought against First DataBank and Medi-Span, two primary sources of AWP reporting. Under the terms of the settlement, First DataBank and Medi-Span agreed, among other things, to reduce the reported AWP of certain prescription drugs by four percent effective September 26, 2009. First DataBank and Medi-Span also announced that they would discontinue publishing AWP within two years of the settlement. On September 3, 2009, a federal appeals court rejected challenges to the settlements, clearing the way for the AWP reductions to take effect.

 

Changes such as these, as well as any changes proposed by the federal government and the states regarding the reimbursement for drugs by Medicaid and Medicare, could impact our pricing to customers and other payors and could impact our ability to negotiate discounts with manufacturers, wholesalers, or retail pharmacies.

 

11
 

  

Federal Anti-Kickback/Fraud and Abuse Laws

 

The federal Anti-Kickback Statute (“AKS”) is a criminal law that prohibits, among other things, an individual or entity from knowingly or willfully paying or receiving, subject to certain statutory exceptions and regulatory safe harbors, any remuneration, directly or indirectly, intended to induce: (1) a referral for the furnishing of any item or service for which payment may be made in whole or in part under a federal health care program, including Medicare, Medicaid and the Tricare Program, or (2) the purchase, lease, order or the arranging for or recommending of the purchase, lease, or order of items or services for which payment may be made in whole or in part under federal health care programs. Penalties for violating the AKS may include imprisonment, criminal and civil fines, and exclusion from participation in the federally-funded health care programs.

 

The AKS has been interpreted broadly by courts, the U.S. Department of Health & Human Services (“HHS”), Office of Inspector General (“OIG”), the agency charged with the enforcement of the AKS, and other administrative bodies. Because of the statute’s broad scope and the limited statutory exceptions, the OIG has established certain regulatory safe harbors which, if fully met, should immunize the parties from liability under the AKS. For example, safe harbors exist for certain properly disclosed and reported discounts received from vendors, certain investment interests, certain properly disclosed payments made by vendors to group purchasing organizations, certain personal services arrangements, and certain discount and payment arrangements between PBMs and HMO risk contractors serving Medicaid and Medicare members. A practice that does not fall within an exception or a safe harbor is not necessarily unlawful, but may be subject to scrutiny and challenge. Some, though not all, court opinions interpreting the AKS have focused primarily on the law’s intent requirement and have held that an arrangement will violate the AKS if any one purpose of the arrangement is to induce referrals or purchases, even if the payments at issue are also intended for a legitimate purpose. Thus, a violation of the statute may occur even if only one purpose of a payment arrangement is to induce patient referrals or purchases of products or services that are reimbursed by federal health care programs. Among the practices that have been identified by the OIG as potentially improper under the statute are certain product conversion programs in which benefits are given by drug manufacturers to pharmacists or physicians for changing a prescription, or recommending or requesting such a change, from one drug to another. The AKS has been cited as a partial basis, along with state consumer protection laws discussed below, for investigations and multi-state settlements relating to financial incentives provided by drug manufacturers to retail pharmacies as well as to PBMs in connection with such programs.

 

In April 2003, the OIG published “Final OIG Compliance Program Guidance for Pharmaceutical Manufacturers” (the “Compliance Guidance”). The Compliance Guidance, which is directed toward pharmaceutical manufacturers, provides the OIG’s views on the fundamental elements of pharmaceutical manufacturer compliance programs. The Compliance Guidance also highlights several potentially risky arrangements for pharmaceutical manufacturers, including the provision of grants, “prebates” and “upfront payments” to PBMs to support disease management programs and therapeutic interchanges. In addition, the Compliance Guidance indicates that the provision of rebates or other payments to PBMs by pharmaceutical manufacturers may potentially trigger liability under the AKS if not properly structured and disclosed.

 

The Health Care Reform Laws made two important clarifications that significantly strengthen the government’s ability to enforce the AKS. First, the Health Care Reform Laws clarified that a person need not have actual knowledge of or specific intent to violate the AKS. Second, the Health Care Reform Laws made clear that a claim resulting from an AKS violation constitutes a false claim under the federal False Claims Act (“FCA”). The provision codifies what some federal district courts had already held and significantly heightens the civil penalties HCCA could face for any alleged AKS violation.

 

Additionally, it is a crime under the Public Contract Anti-Kickback Act, for any person to knowingly and willfully offer or provide any remuneration to a prime contractor to the United States, including a contractor servicing federally funded health programs, in order to obtain favorable treatment in a subcontract. Violators of this law also may be subject to civil monetary penalties.

 

We believe that we are in substantial compliance with the legal requirements imposed by such anti-kickback laws and regulations. However, we cannot assure you that we will not be subject to scrutiny or challenge under such laws or regulations. Any such challenge could harm HCCA’s business, results of operations, financial condition or cash flows.

 

12
 

  

Federal Statutes Prohibiting False Claims

 

The FCA imposes liability for knowingly making or causing to be made false claims to the government, including federal health care programs such as Medicare and Medicaid. For example, potential false claims include claims for services not rendered, or claims that misrepresent actual services rendered in order to obtain higher reimbursement. Private individuals may bring qui tam or whistleblower lawsuits against providers under the FCA, which authorizes the payment of a portion of any recovery to the individual bringing suit. Such actions are initially required to be filed under seal pending their review by the Department of Justice. Federal district courts have interpreted the FCA as applying to claims for reimbursement that violate the AKS or federal physician self-referral law (commonly referred to as the “Stark Law”) under certain circumstances. The Health Care Reform Laws expanded false claims liability by clarifying that an AKS violation can be a predicate for a false claim under the FCA and by adding a provision that imposes FCA liability on an individual or entity that fails to make a timely return of any overpayments received from Medicare or Medicaid. The FCA generally provides for the imposition of civil penalties and for treble damages, resulting in the possibility of substantial financial penalties for small billing errors that are replicated in a large number of claims, as each individual claim could be deemed to be a separate violation of the FCA. Criminal provisions that are similar to the FCA provide that a corporation may be fined if it is convicted of presenting to any federal agency a claim or making a statement that it knows to be false, fictitious or fraudulent to any federal agency.

 

ERISA Regulation

 

ERISA regulates certain aspects of employee pension and health benefit plans, including self-funded corporate health plans. We have agreements with self-funded corporate health plans to provide PBM services, and therefore, we are a service provider to ERISA plans. ERISA imposes duties on any person or entity that is a fiduciary with respect to the ERISA plan. We administer pharmacy benefits for ERISA plans in accordance with plan design choices made by the ERISA plan sponsors. We do not believe that the general conduct of our business subjects us to the fiduciary obligations set forth by ERISA, except to the extent we have specifically contracted with an ERISA plan sponsor to accept fiduciary responsibility for the limited purpose of addressing benefit claims and appeals. However, we cannot assure you that the U.S. Department of Labor, which is the agency that enforces ERISA, or a private litigant would not assert that the fiduciary obligations imposed by ERISA apply to certain aspects of our operations.

 

Numerous lawsuits have been filed against various PBMs by private litigants, including Plan participants on behalf of an ERISA plan and by ERISA Plan sponsors, alleging that the PBMs are ERISA fiduciaries and that, in such capacity, they allegedly violated ERISA fiduciary duties in connection with certain business practices related to their respective contracts with retail pharmacy networks and/or pharmaceutical manufacturers.

 

ERISA also imposes civil and criminal liability on service providers to health plans and certain other persons if certain forms of illegal remuneration are made or received. These provisions of ERISA are similar, but not identical, to the federal healthcare Anti-Kickback Statute discussed above. In particular, ERISA does not provide the statutory and regulatory safe harbor exceptions incorporated into the federal healthcare Anti-Kickback Statute. Like the health care anti-kickback laws, the corresponding provisions of ERISA are written broadly and their application to particular cases is often uncertain. We have implemented policies regarding, among other things, disclosure to health plan sponsors with respect to any commissions paid by or to us that might fall within the scope of such provisions and, accordingly, believes that we are in substantial compliance with any applicable provisions of ERISA. However, we cannot assure you that our policies in this regard would be found by the U.S. Department of Labor and potential private litigants to meet the requirements of ERISA.

 

In addition, the U.S. Department of Labor has recently issued several regulations that impose new fee disclosure rules on certain ERISA plans and their service providers. Those regulations do not currently apply to self-funded corporate health plans and their service providers, but the U.S. Department of Labor has held hearings to discuss extending them in the future. As a result, we are not yet able to assess the effect the regulations may have on its business.

 

13
 

  

FDA Regulation

 

The U.S. Food and Drug Administration (“FDA”) generally has authority to regulate drug promotional materials that are disseminated by or on behalf of a drug manufacturer. The FDA also may inspect facilities in connection with procedures implemented to effect recalls of prescription drugs.

 

In addition, the FDA has authority to require the submission and implementation of a risk evaluation and mitigation strategy, or REMS, if the FDA determines that that a REMS is necessary for the safe and effective marketing of a drug. To the extent we dispense products subject to REMS requirements or provide REMS services to a pharmaceutical manufacturer, we are subject to audit by the pharmaceutical manufacturer.

 

Antitrust Regulation

 

Various federal and state antitrust laws regulate trade and commerce with the objective of protecting the competitive process. Thus, Section One of the Sherman Act prohibits agreements that unreasonably restrain competition; Section Two of the Sherman Act prohibits monopolization and attempts to monopolize; Section Seven of the Clayton Act prohibits mergers and acquisitions which may substantially lessen competition; and the Robinson-Patman Act prohibits discriminating in price among different customers in certain circumstances. The interpretation of these broadly-worded statutes is left for the courts, and there is often uncertainty concerning the application of the antitrust laws to specific business practices. Successful plaintiffs in federal antitrust actions are always entitled to recover treble damages, as well as their attorneys’ fees. (In addition, virtually all states have antitrust statutes analogous to the Sherman Act, often including automatic treble damages and attorneys’ fees.)

 

Numerous retail pharmacies in the U.S. have filed lawsuits against pharmaceutical manufacturers, drug wholesalers, and PBMs challenging certain branded drug pricing practices under federal and state antitrust laws. The complaints alleged, in part, that the manufacturers gave, and the PBMs accepted, rebates and discounts on purchases of brand name prescription drugs, in violation of the Robinson-Patman Act, and that the manufacturers, drug wholesalers, and PBMs conspired in violation of the Sherman Act not to provide similar rebates and discounts to the plaintiff retail pharmacies. Although the Sherman Act allegations have been resolved, often with substantial settlements, certain Robinson-Patman Act claims continue to be litigated. The plaintiffs seek unspecified monetary damages, including trebled damages, injunctive relief against the alleged price discrimination, and attorneys’ fees.

 

We believe that we are in compliance with the legal requirements imposed by the antitrust laws. However, we cannot assure you that we will not be subject to scrutiny or challenge under such laws. Any such challenge could harm our business, results of operations, financial condition, or cash flows.

 

State Laws and Regulations Affecting Us

 

The following descriptions identify various state laws and regulations that affect or may affect aspects of our PBM business:

 

State Anti-Kickback/False Claims Laws

 

Many states have laws and/or regulations similar to the AKS and the FCA described above, while several others are currently considering passing or strengthening false claims laws. Such state laws are not necessarily limited to services or items for which government-funded health care program payments may be made. Such state laws may be broad enough to include improper payments made in connection with services or items that are paid by commercial payors. Penalties for violating these state anti-kickback and false claims laws may include, but are not limited to, injunction, imprisonment, criminal and civil fines and exclusion from participation in the state Medicaid programs. Additionally, under the Deficit Reduction Act of 2005, discussed in greater detail below, states are incentivized to pass broad false claims legislation similar to the FCA, and there has been activity in several states during the past several years to do so.

 

We believe that we are in substantial compliance with the legal requirements imposed by such laws and regulations. However, we cannot assure you that we will not be subject to scrutiny or challenge under such laws or regulations. Any such challenge could harm our business, results of operations, financial condition or cash flows.

 

14
 

  

State Consumer Protection Laws

 

Most states have enacted consumer protection and deceptive trade practices laws that generally prohibit payments and other broad categories of conduct deemed harmful to consumers. These statutes may be enforced by states and/or private litigants. Such laws have been and continue to be the basis for investigations, prosecutions, and settlements of PBMs, initiated by state prosecutors as well as by private litigants.

 

We believe that we are in substantial compliance with the legal requirements imposed by such laws and regulations. However, we cannot assure you that we will not be subject to scrutiny or challenge under one or more of these laws, or under similar consumer protection theories.

 

State Comprehensive PBM Regulation

 

Legislation directly regulating PBM activities in a comprehensive manner has been introduced in a number of states. In addition, legislation has been proposed in some states seeking to impose fiduciary obligations or disclosure requirements on PBMs. The District of Columbia has enacted a statute imposing fiduciary and disclosure obligations on PBMs. Similarly, both North Dakota and South Dakota have relatively comprehensive PBM laws that, among other things, increase financial transparency and regulate therapeutic interchange programs. Each state that enacts such legislation requires us to adapt our operations in that state, which could harm us.

 

Many states have licensure or registration laws governing certain types of ancillary health care organizations, including preferred provider organizations, third-party administrators, or TPAs, companies that provide utilization review services, and companies that engage in the practices of a pharmacy. The scope of these laws differs significantly from state to state, and the application of such laws to the activities of PBMs often is unclear.

 

In addition, certain quasi-regulatory organizations, including the National Association of Boards of Pharmacy and the National Association of Insurance Commissioners have issued model regulations or may propose future regulations concerning PBMs and/or PBM activities, and the National Committee for Quality Assurance, the Utilization Review Accreditation Commission, or other credentialing organizations may provide voluntary standards regarding PBM activities. In 2007, for example, the Utilization Review Accreditation Commission finalized PBM accreditation standards for PBMs serving the commercially insured market. While the actions of these quasi-regulatory organizations do not have the force of law, they may influence states to adopt their requirements or recommendations as well as influence customer requirements for PBM services. Moreover, any standards established by these organizations could also impact its health plan customers and/or the services we provide to them.

 

Network Access Legislation

 

A majority of states now have some form of legislation affecting our ability to limit access to a pharmacy provider network (“any willing provider” legislation), or removal of a network provider, (“due process” legislation). Such legislation may require us or our clients to admit any retail pharmacy willing to meet the plan’s price and other terms for network participation, or may provide that a provider may not be removed from a network except in compliance with certain procedures. These statutes have not materially affected our business.

 

State Legislation Affecting Plan or Benefit Design

 

Some states have enacted legislation that prohibits certain types of managed care plan sponsors from implementing certain restrictive design features, and many states have legislation regulating various aspects of managed care plans, including provisions relating to the pharmacy benefits. For example, some states, under so-called freedom of choice legislation, provide that members of the plan may not be required to use network providers, but must instead be provided with benefits even if they choose to use non-network providers. Other states have enacted legislation purporting to prohibit health plans from offering members financial incentives for use of mail service pharmacies. Legislation has been introduced in some states to prohibit or restrict therapeutic intervention, to require coverage of all FDA-approved drugs or to require coverage for off-label uses of drugs where those uses are recognized in peer-reviewed medical journals or reference compendia. Other states mandate coverage of certain benefits or conditions and require health plan coverage of specific drugs, if deemed medically necessary by the prescribing physician. Such legislation does not generally apply to us directly, but may apply to certain of our clients, such as HMOs and health insurers. If legislation were to become widely adopted, it could have the effect of limiting the economic benefits achievable through PBMs. This development could harm our business, results of operations, financial condition or cash flows.

 

15
 

  

State Regulation of Financial Risk Plans

 

Fee-for-service prescription drug plans (“PDPs”) are generally not subject to financial regulation by the states. However, if a PBM offers to provide prescription drug coverage on a capitated basis or otherwise accepts material financial risk in providing the benefit, laws in various states may regulate the plan. Such laws may require that the party at risk establish reserves or otherwise demonstrate financial responsibility. Laws that may apply in such cases include insurance laws, HMO laws or limited prepaid health service plan laws. Currently, we do not believe that our PBM business incurs financial risk of the type subject to such regulation. However, if we choose to become a regional PDP for the Medicare outpatient prescription drug benefit at some time in the future, we would need to comply with state laws governing risk-bearing entities in the states where we operate a PDP.

 

State Discount Drug Card Regulation

 

Numerous states have laws and/or regulations regulating the selling, marketing, promoting, advertising or distributing of commercial discount drug cards for cash purchases. Such laws and regulations provide, generally, that any person may bring an action for damages or seek an injunction for violations. We administer a limited commercial discount drug card program that we do not consider material to our business. We believe the administration of the commercial discount drug card program is in compliance with various state laws. However, we cannot assure you that the existence of such laws will not materially impact our ability to offer certain new commercial products and/or services in the future.

 

Combined Federal and State Laws, Regulations and Other Standards Affecting Us

 

Certain aspects of our PBM business are or may be affected by bodies of law that exist at both the federal and state levels and by other standard setting entities. Among these are the following:

 

Pharmacy Licensure and Regulation

 

We are subject to state and federal statutes and regulations governing the operation of mail service pharmacies and the dispensing of controlled substances. The practice of pharmacy is generally regulated at the state level by state boards of pharmacy. Each of our pharmacies must be licensed in the state in which we are located. Also, many of the states where we deliver pharmaceuticals, including controlled substances, have laws and regulations that require out-of-state mail service pharmacies, such as us, to register with that state’s board of pharmacy or similar regulatory body. Federal statutes and regulations govern the labeling, packaging, advertising and adulteration of prescription drugs and the dispensing of controlled substances. Federal controlled substance laws require us to register our pharmacies with the United States Drug Enforcement Administration and to comply with security, record keeping, inventory control and labeling standards in order to dispense controlled substances. We are also subject to certain federal and state laws affecting Internet-based pharmacies because we dispense prescription drugs pursuant to refill orders received through our Internet websites, among other methods. Several states have proposed new laws to regulate Internet-based pharmacies, and federal regulation of Internet-based pharmacies by the FDA or another federal agency has also been proposed. Other statutes and regulations may affect our mail service operations. For example, the Federal Trade Commission, or FTC, requires mail service sellers of goods generally to engage in truthful advertising, to stock a reasonable supply of the products to be sold, to fill mail service orders within thirty days and to provide clients with refunds when appropriate. In addition, the United States Postal Service has statutory authority to restrict the transmission of drugs and medicines through the mail. Our pharmacists are subject to state regulation of the profession of pharmacy and employees engaged in a professional practice must satisfy applicable state licensing requirements.

 

16
 

  

Privacy and Confidentiality Legislation

 

Our activities involve the receipt, use and disclosure of confidential health information, including disclosure of the confidential information to a customer’s health benefit plan, as permitted in accordance with applicable federal and state privacy laws. In addition, we use and discloses data that was identifying information removed for analytical and other purposes. Many state laws restrict the use and disclosure of confidential medical information, and similar new legislative and regulatory initiatives are underway at the state and federal level. To date, no such laws presently have adversely impacted our ability to provide our services, but we cannot assure you that federal or state governments will not enact such legislation, impose restrictions or adopt interpretations of existing laws that could harm our business, results of operations, financial condition or cash flows.

 

The Health Insurance Portability and Accountability Act of 1996 and the regulations issued thereunder (collectively “HIPAA”) impose extensive requirements on the way in which health plans, healthcare providers that engage in certain electronic financial and administrative transactions covered by HIPAA, and healthcare clearinghouses (known as “covered entities”) and the persons or entities that use or disclose protected health information, or PHI, to provide services to covered entities or to perform functions on their behalf (known as “business associates”), use, disclose and safeguard PHI, including requirements to protect the integrity, availability and confidentiality of electronic PHI. Many of these obligations were expanded under the Health Information Technology for Economic and Clinic Health Act (the “HITECH Act”), passed as part of the American Recovery and Reinvestment Act of 2009.

 

The final privacy regulations, which is referred to as the Privacy Rule, issued by the Office for Civil Rights (“OCR”) of HHS pursuant to HIPAA, give individuals the right to know how their PHI is used and disclosed, as well as the right to access, amend and obtain information concerning certain disclosures of PHI. Covered entities, such as pharmacies and health plans, are required to provide a written Notice of Privacy Practices to individuals that describes how the entity uses and discloses PHI, and how individuals may exercise their rights with respect to their PHI. For most uses and disclosures of PHI other than for treatment, payment, healthcare operations and certain public policy purposes, HIPAA generally requires that covered entities obtain a valid written individual authorization. In most cases, use or disclosure of PHI must be limited to the minimum necessary to achieve the purpose of the use or disclosure.

 

We are a covered entity under HIPAA in connection with our operation of a mail service pharmacy.

 

In connection with our other activities that require access to PHI, we are not considered a covered entity. However, our health plan clients and pharmacy customers are covered entities, and are required to enter into business associate agreements with vendors, such as PBMs, that perform a function or activity for the covered entity that involves the use or disclosure of individually identifiable health information. The business associate agreements mandated by the Privacy Rule create a contractual obligation for the business associate to perform its duties for the covered entity in compliance with the Privacy Rule. Effective February 17, 2010, the HITECH Act created a statutory obligation for us, when we acts as a business associate, to satisfy certain aspects of the Privacy Rule and the final HIPAA security regulations.

 

If we fail to comply with HIPAA or our policies and procedures are not sufficient to prevent the unauthorized disclosure of PHI, we could be subject to liability, fines and lawsuits under federal and state privacy laws, consumer protection statutes and other laws. Criminal penalties and civil sanctions may be imposed for failing to comply with HIPAA standards either as a covered entity or business associate, and these penalties and sanctions have significantly increased under the HITECH Act. In February 2011, OCR, the agency responsible for enforcing HIPAA and HITECH, issued the first civil monetary penalty ever imposed for a covered entity’s violation of the HIPAA Privacy Rule. Additionally, the HITECH Act requires OCR to conduct periodic compliance audits. Continued enforcement actions are likely to occur in the future. Furthermore, HITECH provides authority to state attorney generals to bring actions in federal court for violations of HIPAA on behalf of state residents harmed by such violations.

 

17
 

  

The final transactions and code sets regulation (the “Transaction Rule”) promulgated under HIPAA requires that all covered entities that engage in certain electronic transactions use standardized formats and code sets. We, in our role as a business associate of a covered entity, must conduct such transactions in accordance with the Transaction Rule. HHS promulgated a National Provider Identifiers, or NPI, Final Rule which requires health plans to utilize NPIs in all Standard Transactions. NPIs replaced National Association of Boards of Pharmacy numbers for pharmacies, Drug Enforcement Agency numbers for physicians and similar identifiers for other health care providers for purposes of identifying providers in connection with HIPAA standard transactions. We have undertaken the necessary arrangements to ensure that our standard transactions remain compliant with the Transaction Rule subsequent to the implementation of the NPI Final Rule.

 

The final security regulations (the “Security Rule”) issued pursuant to HIPAA mandate the use of administrative, physical, and technical safeguards to protect the confidentiality of electronic PHI. As with the other two rules issued pursuant to HIPAA, the Security Rule applies to covered entities, and certain aspects of the Security Rule also apply to business associates. We have made the necessary arrangements to ensure compliance with the Security Rule for all aspects of our business.

 

We must also comply with the “breach notification” regulations, which implement provisions of the HITECH Act. Under these regulations, covered entities must promptly notify affected individuals and the HHS Secretary in the case of a breach of “unsecured PHI,” as well as the media in cases where a breach affects more than 500 individuals. Breaches affecting fewer than 500 individuals must be reported to the HHS Secretary on an annual basis. The regulations also require business associates of covered entities to notify the covered entity of breaches at or by the business associate. We have taken and continue to take reasonable steps to reduce the amount of unsecured PHI we handle.

 

In addition, final regulations governing a covered entity’s obligation to provide are available upon individual request. A recently released proposed rule, if finalized, would require covered entities to develop systems to monitor which of their employees’ and business associates’ access an individual’s electronic PHI, at what time and date access occurs, and the action taken during the access session (e.g., modification, deletion, viewing). The proposed rule would also require information on access to electronic designated record sets held by business associates. The proposed regulations could impose significant burdens on covered entities and business associates that result from having to take reports generated for internal purposes and modify them for disclosure to patients or health plan enrollees.

 

While new and future legal interpretations could alter our assessment of our efforts to comply with provisions of HIPAA, the HITECH Act, and the Health Care Reform Laws that govern the privacy, security and standardization of health care information and transactions, we currently believe that compliance with these legal authorities should not harm our business operations.

 

Pursuant to HIPAA, state laws that are more protective of PHI are not pre-empted. Therefore, to the extent states continue to enact more protective legislation, we could be required to make significant changes to our business operations.

 

Independent of any regulatory restrictions, individual health plan clients could increase limitations on their use of medical information, which could prevent us from offering certain services.

 

The Health Care Reform Laws

 

On March 23, 2010, the President of the United States signed into law the most comprehensive change to America’s healthcare system in decades. The Health Care Reform Laws contain a variety of provisions that could have a significant impact on us and our customers. The Health Care Reform Laws provide the opportunity for significant expansion of our PBM activities. These potential benefits are the result of an expected increase in the number of individuals with health insurance and the potential increase in demand for pharmaceutical products and services.

 

18
 

  

However, the Health Care Reform Laws also present great uncertainty for us and potential risks to our operations and financial success. The Health Care Reform Laws contain many provisions intended to reduce the government’s healthcare costs through reimbursement reductions, alternative payment methods, and ongoing studies of healthcare reimbursement systems. For example, the Health Care Reform Laws establish the Independent Payment Advisory Board, or IPAB, which is designed to make proposals as early as 2014 to reduce the per capita rate of growth in Medicare spending in years when that growth exceeds established targets. Another potential source of reimbursement uncertainty is the newly established Center for Medicare and Medicaid Innovation, or CMMI, which is designed to test the cost-cutting efficacy of innovative payment service delivery systems through demonstration projects. These types of provisions could have a significant impact on our profitability and our customers, particularly because of the unpredictability of the proposals that could be generated by the IPAB and the CMMI.

 

The Health Care Reform Laws also require PBMs to disclose certain information, including discounts and rebates obtained from pharmaceutical manufacturers, to PDP or MA-PD plan sponsors or qualified health benefits plans offered through an exchange. In addition, the Health Care Reform Laws change the calculation of Medicaid rebates in a way that could increase or decrease pharmaceutical manufacturers’ incentive to provide discounts and rebates to PBMs. These changes could have a negative impact on our revenues or business model. Additionally, the Health Care Reform Laws expand existing fraud and abuse provisions and significantly increase the resources available to the federal government to pursue fraud and abuse issues, which could expose us to greater scrutiny and possibly significant financial liability. For example, the Health Care Reform Laws extend the treble damages available for violations of the FCA to violations relating to the state-based health insurance exchanges created by the Health Care Reform Laws. Moreover, the Health Care Reform Laws establish new civil monetary penalties: $15,000 daily for failure to grant timely access to the OIG for the purposes of audits or investigations and $50,000 for each false record or statement knowingly submitted or caused to be submitted for payment of items furnished under a federal health care program. As a result, we may be forced to expend greater resources on monitoring and compliance programs and legal fees. Similarly, its customers may be subject to greater scrutiny and financial liability, which could indirectly put pressure on its financial relationships with those customers.

 

Aside from particular provisions of the Health Care Reform Laws, there is significant uncertainty about the implementation of the Health Care Reform Laws, likely through hundreds of new regulations, guidance documents, and other policy statements that could result in significant changes to our business model and the healthcare economy as a whole.

 

Political developments also continue to contribute to the uncertainty surrounding implementation of the Health Care Reform Laws. The Health Care Reform Laws will likely play an important role in the November 2012 elections, results of which may affect the timing, manner, and predictability of the Health Care Reform Laws’ regulatory implementation. The resulting unpredictability creates significant uncertainty for us and our customers about the structure and regulatory environment of the healthcare market and future revenue sources.

 

Future Regulation

 

We are unable to predict accurately what, if any, additional federal or state legislation or regulatory initiatives may be enacted in the future relating to our businesses or the health care industry in general, or what effect any such legislation or regulations might have on us. For example, the federal government and several state governments have considered the Patients’ Bill of Rights and other similar legislation aimed primarily at improving quality of care provided to individuals in managed care plans. Some of the initiatives would provide greater access to drugs not included on health plan formularies, giving participants the right to sue their health plan for malpractice, and mandating an appeals or grievance process. We cannot assure you that federal or state governments will not impose additional restrictions, via a Patients’ Bill of Rights or otherwise, or adopt interpretations of existing laws that could harm our business, results of operations, financial condition or cash flows.

 

Employees

 

As of June 30, 2013, we had 56 employees, primarily located in Denville, New Jersey, who work full time for us. We have never had a work stoppage. Our personnel are not represented by any collective bargaining unit and are not unionized. We consider our relations with our personnel to be good. Our future success will depend, in part, on our ability to continue to attract, retain, and motivate highly qualified technical and managerial personnel, for whom competition is intense.

 

19
 

  

Customers

 

As of June 30, 2013 we had 64 customers. For the six months ended June 30, 2013 and for the year ended December 31, 2012 one customer accounted for 10% and 12% of our revenues respectively.

 

In addition one reseller’s customers accounted for 14% of our revenues for the six month period ended June 30, 2013 as well as 14% of our revenues for the year ended December 31, 2012.

 

As we currently expect our revenues to decline over the next 12 months, hence it is possible that our dependence on revenues derived from any specific customer or reseller will increase over the short term.

 

ITEM 1A.         RISK FACTORS

 

We have restated our financial statements in the past and may be required to do so in the future.

 

We have restated certain financial information in the past, including by issuing restated financial information for the year ended December 31, 2012 and the quarter ended March 31, 2013. The preparation of financial statements in accordance with U.S. GAAP involves making estimates, judgments, interpretations and assumptions that affect reported amounts of assets, liabilities, revenues, expenses and income. These estimates, judgments, interpretations and assumptions are often inherently imprecise or uncertain, and any necessary revisions to prior estimates, judgments, interpretations or assumptions could lead to further restatements. Any such restatement or correction may be highly time consuming, may require substantial attention from management and significant accounting costs, may result in adverse regulatory actions by the SEC and/or stockholder litigation, may cause us to fail to meet our reporting obligations and/or may cause investors to lose confidence in our reported financial information, leading to a decline in our stock price.

 

Due to our inability to prepare audited financial statements for the year ended December 31, 2011 for HCCA, our predecessor, we are not compliant with our SEC filing obligations and our shareholders are therefore not eligible to sell securities pursuant to Rule 144 and the Company cannot file registration statements for the sale of our securities with the SEC.

 

Due to significant deficiencies in HCCA’s record keeping in the year ended December 31, 2011, we have been unable to prepare audited financial statements for HCCA for such year. Therefore, our shareholders are not eligible to sell securities pursuant to Rule 144 and we cannot file registration statements for the sale of our securities with the SEC. The market for our securities will be extremely limited until our stockholders are able to sell securities pursuant to Rule 144 promulgated under the Securities Act of 1933, as amended, and we are able to file a registration statement with the SEC relating to the sale of our securities. In addition, because we are unable to satisfy our obligations to have a registration statement effective under the terms of certain registration rights agreements, we have accrued estimated liquidated damages of approximately $592,000.

 

We have not yet established an ongoing source of revenues sufficient to cover our operating costs to allow us to continue as a going concern.

 

We have been able to complete various financings as described herein during 2012 and 2013. Nevertheless, as of February 2014 we have not yet established an ongoing source of revenues sufficient to cover our operating costs to allow us to continue as a going concern. Our ability to continue as a going concern is dependent on our obtaining additional adequate capital to fund operating losses until we become profitable and generate cash flows from our operations. We are unable to obtain adequate capital, we could be forced to cease operations. We are contemplating conducting additional offering of its debt or equity securities to obtain additional operating capital. There are no assurances we will be successful and without sufficient financing it would be unlikely for us to continue as a going concern.

 

20
 

  

Our independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern, which may hinder our ability to obtain future financing.

 

Our independent registered public accounting firms stated that our financial statements for the fiscal periods ended June 30, 2013 and December 31, 2012 were prepared assuming that we would continue as a going concern, and that certain matters raise substantial doubt about our ability to continue as a going concern. Such doubts are based on our recurring net losses, accumulated deficit and deficiency in working capital. We continue to experience losses. Our ability to continue as a going concern is subject to our ability to generate a profit and/or obtain necessary funding from outside sources, including by the sale of common stock or other equity securities, or obtaining loans from financial institutions or other financing arrangements. Our continued losses and “going concern” audit report increase the difficulty of our meeting such goals and our efforts to continue as a going concern may not prove successful.

 

Our future growth is dependent on further market acceptance and increased market penetration of our products.

 

Our business model depends on our ability to sell our products and services. Achieving increased market acceptance of our products and services will require substantial sales and marketing efforts and the expenditure of significant financial and other resources to create awareness and demand by participants in the pharmaceutical supply chain. Additionally, payors, which may have invested substantial resources in other methods of conducting business and exchanging information, may be reluctant to purchase our products and services.

 

Recently, we have decided to de-emphasize our focus on the fixed fee local government PBM marketplace due to its lack of profitability. We estimate that this business line which accounted for approximately 67% of our revenues for the six months ending June 30, 2013, and which generated substantial operating losses, will decline in the months to come as annual renewable contracts may not renew due to our demand for substantial price increases as a condition for contract renewals.

 

We cannot be assured that payors will purchase our products and services, or to renew our contracts following our anticipated price increases. If we fail to achieve broad acceptance of our products and services by payors, and other healthcare industry participants, or if we fail to position our services as a preferred method for pharmaceutical healthcare delivery, our business, financial condition, and results of operations will be harmed.

 

Competition in our industry is intense and we compete against companies with greater resources than we have, which could limit our growth potential.

 

The PBM industry is very competitive. If we do not compete effectively, our business, results of operations, financial condition or cash flows could suffer. The industry is highly consolidated and dominated by a few large companies with significant resources, purchasing power, and other competitive advantages, which we do not have. A limited number of firms, including national PBM companies, such as SXC Health Solutions, Inc., Medco Health Solutions, Inc., Express Scripts, Inc. and CVS Caremark Corporation, control a significant share of prescription volume. Moreover, the recent merger activity between Express Scripts, Inc. and Medco Health Solutions, Inc., and between SXC Health Solutions, Inc. and Catalyst Health Solutions, Inc. may further increase the market share of our competitors. Our competitors also include drug retailers, physician practice management companies, and insurance companies/health maintenance organizations. We may also experience competition from other sources in the future. PBM companies compete primarily on the basis of price, service, reporting capabilities and clinical services. In most cases, our competitors are large, profitable, and well-established companies with substantially greater financial and marketing resources than we have. Our limited resources may make it more difficult for us to compete with the larger companies in our industry and limit our growth.

 

21
 

  

Pending litigation could have a material, adverse effect on our business, financial condition, liquidity, results of operations and cash flows.

 

From time to time we are engaged in lawsuits which may require significant management time and attention and legal expense, and may result in an unfavorable outcome, which could have a material, adverse effect on our business, financial condition, liquidity, results of operations and cash flows. Current estimates of loss regarding pending litigation are based on information that is then available to us and may not reflect any particular final outcome. The results of rulings, judgments or settlements of pending litigation may result in financial liability that is materially higher than what management has estimated at this time. We make no assurances that we will not be subject to liability with respect to current or future litigation. We maintain various forms of insurance coverage. However, substantial rulings, judgments or settlements could exceed the amount of insurance coverage or could be excluded under the terms of an existing insurance policy.

 

During 2012, we filed a lawsuit against our past adjudicator of claims for overcharges, over payment on claims, errors and misclassifications, and rebates owed from drug manufacturers claiming damages of over $5 million. Additionally, we have recorded an expense for the amount owed for claims payable. The adjudicator of claims filed a counterclaim for amounts it claims are owed to it by us. In August 2013, we settled the suit with the claims adjudicator. Under the terms of the settlement we agreed to pay the claims adjudicator $2.7 million over 15 months commencing in September 2013. This amount was recorded as a liability as of December 31, 2012, in accounts payable.

 

On August 14, 2012, we entered into an agreement with a shareholder to buy back 500,000 shares of common stock for $100,000. The agreement also called for the payment of $50,000 in legal fees. As of December 31, 2012, we had not received the 500,000 shares of common stock but had paid the settlement. We received these shares in February 2013. A stock redemption was recorded on December 31, 2012 in the amount of $100,000.

 

We are dependent on key customers, the loss of which could significantly harm our results of operations.

 

We generate a significant portion of our revenue from a small number of customers. Our largest customer, accounted for 12% of our 2012 revenues and 10% of our revenues for the 6 month ended June 30, 2013. In addition, one reseller’s customers accounted for approximately 14% of the Company’s revenue for the six month period ended June 30, 2013 as well as approximately 14% of the Company’s revenue for the year ended December 31, 2012.

 

Although we continually seek to diversify our customer base, we may be unable to offset the effects of an adverse change in one of our key customer relationships. For example, if our existing customers elect not to renew their contracts with us at the expiry of the current terms of those contracts, or require that we reduce the level of service offerings we provide, our recurring revenue base will be reduced, which could harm our results of operations. If the healthcare benefits industry or our customers in the healthcare benefits industry experience problems, they may curtail spending on our products and services and our business and financial results could be harmed.

 

Costs and uncertainty associated with competitive bidding for client contracts could significantly harm our results of operations.

 

Many of our clients put their contracts out for competitive bidding prior to expiration. Competitive bidding requires costly and time-consuming efforts on our behalf. We could lose clients if such clients cancel their agreements, if we fail to win a competitive bid at the time of contract renewal, if the financial condition of any of our private clients deteriorates or if our clients are acquired by, or acquire, companies with which we do not have contracts. We often compete against much larger companies or PBMs which are captive, that is, they are subsidiaries of large medical insurance or other health benefit companies. These may have more substantial buying power and may lower their prices to win business further than we can afford to.

 

Due to the term of our contracts with customers, if we are unable to renew those contracts at the same service levels previously provided, or at all, or replace any lost customers, our future business and results of operations would be harmed.

 

Our contracts with customers generally do not have terms longer than one year and, in some cases, are terminable by the customer on relatively short notice. Our larger customers generally seek bids from other PBM providers in advance of the expiration of their contracts. There is no guarantee that we will win contacts as they expire, and we must continue to provide savings and quality service at lower cost in order to retain business. At some point it may not be profitable for us to retain certain clients if competition undercuts it.

 

22
 

  

A substantial portion of our previous growth was due to our creation of a private label product with a healthcare management company. If this product does not increase revenue in future periods, our growth could be negatively impacted.

 

We created a private label product a for a healthcare management company, which resulted in a substantial amount of revenue for us. If business from this private label product does not generate increased revenue and if we are unable to secure new partnerships, our growth would be limited and our business, financial condition and results of operations could suffer .

 

If rebate payments that we receive from pharmaceutical manufacturers and rebate processing service providers decline, our business, results of operations, financial condition or cash flows could be negatively impacted.

 

We receive fees from a rebate clearing house aggregator based on the use of selected drugs by members of health plans sponsored by its clients, as well as fees for other programs and services. Because these fees are significant relative to the margins for our PBM business, we believe our business, results of operations, financial condition or cash flows could suffer if:

 

·the rebate aggregator loses relationships with one or more key pharmaceutical manufacturers;

 

·the rebate aggregator is unable to finalize rebate contracts with one or more key pharmaceutical manufacturers in the future, or is unable to negotiate interim arrangements;

 

·rebates decline due to failure of the rebate aggregator to meet market share or other thresholds;

 

·legal restrictions are imposed on the ability of pharmaceutical manufacturers to offer rebates or purchase our programs or services;

 

·pharmaceutical manufacturers choose not to offer rebates or purchase our programs or services; or

 

·rebates decline due to contract branded products losing their patents.

 

Government efforts to reduce health care costs and alter health care financing practices could lead to a decreased demand for our services or to reduced rebates from manufacturers.

 

The Health Care Reform Laws and other proposals considered by Congress related to health care, could impact PBMs directly (e.g. requiring disclosure of information about pricing and product switches), or indirectly (e.g. modifying reimbursement rates for pharmaceutical manufacturers participating in government programs). The Health Care Reform Laws and other health care related proposals may increase government involvement in healthcare and regulation of PBM, pharmacy services and managed care plans, or otherwise change the way that we do business. Some of these initiatives would, among other things, require that health plan members have greater access to drugs not included on a plan’s formulary and give health plan members the right to sue their health plans for malpractice when they have been denied care. Health plan sponsors may react to the Health Care Reform Laws or other health care related proposals and the uncertainty surrounding them by cutting back or delaying the purchase of our PBM services, and manufacturers may react by reducing rebates or reducing supplies of certain products. These proposals could lead to a decreased demand for our services or to reduced rebates from manufacturers. We cannot predict what effect, if any, these proposals may have on our businesses. PBMs have recently been subject to enhanced political scrutiny as certain U.S. Senators have criticized PBMs for entering into agreements with manufacturers to allegedly limit access to generic products and for allegedly contributing to over-utilization and off-label use of some antipsychotic drugs. This enhanced scrutiny may result in increased audits or examination of the PBM industry. Further, in the FY 2012 Workplan, the HHS Office of Inspector General, or OIG, has also indicated intent to focus on PBMs, with plans to review the rebates collected by Medicare Part D sponsors and PBMs and analyze whether there are any discrepancies between the rebate amounts negotiated between PBMs and manufacturers and the actual rebates paid. Other legislative or market-driven changes in the healthcare system that we cannot anticipate could also harm our business, financial condition and results of operations.

 

23
 

 

Prescription volumes may decline, and our net revenues and profitability may be negatively impacted, if the safety risk profiles of drugs increase or if drugs are withdrawn from the market, including as a result of manufacturing issues, or if prescription drugs transition to over-the-counter products.

 

We dispense significant volumes of brand-name and generic drugs from our mail-order pharmacy. When increased safety risk profiles or manufacturing issues of specific drugs or classes of drugs result in utilization decreases, physicians may cease writing or otherwise reduce the numbers of prescriptions for these drugs. Additionally, negative press regarding drugs with higher safety risk profiles may result in reduced global consumer demand for such drugs. On occasion, products are withdrawn by their manufacturers or transition to over-the-counter products. In cases where there are no acceptable prescription drug equivalents or alternatives for these prescription drugs, our volumes, net revenues, profitability and cash flows may decline.

 

Our operations are vulnerable to interruption by damage from a variety of sources, many of which are not within our control.

 

The success of our business depends in part on our ability to operate our systems without interruption. Our systems are vulnerable to, among other things, power loss and telecommunications failures, software and hardware errors, failures or crashes, computer viruses and similar disruptive problems, and fire, flood, and other natural disasters. Although we take precautions to guard against and minimize damage from these and other potential risks, including implementing disaster recovery systems and procedures, they are often unpredictable and beyond our control. Any significant interruptions in our services could damage our reputation in the marketplace and harm our business, financial condition and results of operations.

 

We are subject to a number of existing laws, regulations, and industry initiatives, non-compliance with which could harm our business, financial condition and results of operations.

 

We could suffer civil and/or criminal penalties, lose customers, and be required to pay substantial damages or make significant changes to its operations if we fail to comply with complex and rapidly evolving laws and regulations.

 

During the past several years, the U.S. health care industry has been subject to an increase in government regulation at both the federal and state levels. Numerous state and federal laws and regulations affect our business and operations. The categories include, but are not limited to:

 

·health care fraud and abuse laws and regulations, including, but not limited to, the federal Anti-kickback Statute, the federal
·Civil False Claims Act, and comparable state law counterparts, which prohibit certain types of payments and referrals as well as false claims made in connection with health benefit programs;
·privacy and confidentiality laws and regulations, including those under HIPAA and HITECH;
·ERISA and related regulations, which regulate many health care plans;
·potential regulation of the PBM industry by the FDA;
·Medicare prescription drug coverage laws and related regulations promulgated by CMS;
·consumer protection and unfair trade practice laws and regulations;
·various licensure laws, such as state insurance, managed care and third party administrator licensure laws;
·pharmacy laws and regulations;
·antitrust lawsuits challenging PBM pricing practices;
·state legislation regulating PBMs or imposing fiduciary status on PBMs;
·drug pricing legislation, including, but not limited to, “most favored nation” pricing and “unitary pricing” legislation;
·other Medicare and Medicaid reimbursement regulations promulgated by CMS;
·pending legislation regarding importation of drug products into the U.S.;

·legislation imposing benefit plan design restrictions, which limit how our customers can design their drug benefit plans;

 

24
 

  

·network pharmacy access laws, including, but not limited to, “any willing provider” and “due process” legislation, that affect aspects of our pharmacy network contracts; and
·formulary development and disclosure laws.

 

We devote significant operational and managerial resources to comply with these laws and regulations. Although we have not been notified, and are not otherwise aware, of any material claim of non-compliance, we cannot assure you that we are in compliance with all existing legal requirements material to our business. Different interpretations and enforcement policies of these laws and regulations could subject our current practices to allegations of impropriety or illegality, or could require us to make significant changes to our operations. In addition, we cannot predict the impact of future legislation and regulatory changes on our business or assure you that we will be able to obtain or maintain the regulatory approvals required to operate our business.

 

We cannot predict whether or when future healthcare reform initiatives by U.S. federal or state, Canadian or other foreign regulatory authorities will be proposed, enacted or implemented or what impact those initiatives may have on our business, financial condition or results of operations. Additionally, government regulation could alter the clinical workflow of physicians, hospitals, and other healthcare participants, thereby limiting the utility of our products and services to existing and potential customers and resulting in a negative impact on market acceptance of our products and services.

 

Our mail-order pharmacy is dependent on our relationships with a limited number of suppliers, and the loss of any of these relationships could significantly impact our ability to sustain and/or improve our financial performance.

 

We acquire a substantial percentage of our mail-order pharmacy prescription drug supply from a limited number of suppliers. Our agreements with these suppliers may be short-term and cancelable by either party without cause with a relatively short time-frame of prior notice. These agreements may limit our ability to provide services for competing drugs during the term of the agreement and allow the supplier to distribute through channels other than us. Further, certain of these agreements allow pricing and other terms of these relationships to be periodically adjusted for changing market conditions or required service levels. A termination or modification to any of these relationships could harm our business, financial condition and results of operations. If any products we distribute are in short supply for long periods of time, this could result in harm to our business, financial condition and results of operations.

 

If our security systems are breached, outsiders could gain access to information we are required to keep confidential, and we could be subject to liability and customers could be deterred from using our services.

 

Our business relies on using the Internet to transmit confidential information. However, the difficulty of securely transmitting confidential information over the Internet has been a significant barrier to engaging in sensitive communications over the Internet, and is an important concern of our existing and prospective customers. Publicized compromise of Internet security, including third-party misappropriation of patient information or other data, or a perception of any such security breach, may deter people from using the Internet for these purposes, which would result in an unwillingness to use our systems to conduct transactions that involve transmitting confidential healthcare information. Further, if we are unable to protect the physical and electronic security and privacy of our databases and transactions, we could be subject to potential liability and regulatory action, our reputation and customer relationships would be harmed, and our business, operations, and financial results may be harmed.

 

We are highly dependent on senior management and key employees. Competition for our employees is intense, and we may not be able to attract and retain the highly skilled employees that we need to support our business.

 

Our success largely depends on the skills, experience, and continued efforts of our management and other key personnel, and on our ability to continue to attract, motivate, and retain highly qualified individuals. Competition for senior management and other key personnel is intense, and the pool of suitable candidates is limited. If we lose the services of one or more of our key employees, we may not be able to find a suitable replacement and our business, financial condition and results of operations could be harmed.

 

25
 

  

Our ability to provide high-quality services to our customers also depends in large part upon the experience and expertise of our employees generally. We must attract and retain highly qualified personnel with a deep understanding of the healthcare and PBM industries. We compete with a number of companies for experienced personnel and many of these companies, including customers and competitors, have greater resources than we have and may be able to offer more attractive terms of employment. In addition, we invest significant time and expense in training our employees, which increases their value to customers and competitors who may seek to recruit them and increases the cost of replacing them. If we are unable to attract or retain qualified employees, the quality of our services could diminish and we may be unable to meet its business and financial goals.

 

If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud. As a result stockholders could lose confidence in our financial and other public reporting, which would harm our business and the trading price of our common stock.

 

Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures, are designed to prevent fraud. Our Chief Executive Officer and Chief Financial Officer have determined that there are material weaknesses in internal control over financial reporting. Any failure to implement required new or improved controls, or difficulties encountered in their implementation, could cause us to fail to meet our reporting obligations. In addition, any testing by us conducted in connection with Section 404 of the Sarbanes-Oxley Act, or the subsequent testing by our independent registered public accounting firm, may reveal deficiencies in our internal controls over financials reporting that are deemed to be material weaknesses or that may require prospective or retroactive changes to our consolidated financial statements or identify other areas for further attention.

 

Our principal stockholders and management own a significant percentage of our stock and will be able to exert significant control over matters subject to stockholder approval.

 

As of March 10, 2013, our executive officers and directors and their affiliates beneficially own approximately 33.1% of our voting stock. Therefore, our executive officers and directors and their affiliates will have the ability to influence us through this ownership position with respect to matters subject to stockholder approval. For example, assuming that there are no other changes to the number of shares outstanding, these stockholders, acting together, may take actions with respect to such shares that are not consistent with the interests of the other shareholders, including influencing the election of the directors and other corporate actions of HCCA such as:

 

·its merger with or into another company;

 

·a sale of substantially all of its assets; and

 

·amendments to its bylaws and certificate of incorporation.

 

In addition, this may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may believe are in your best interest as one of our stockholders.

 

ITEM 1B.        UNRESOLVED STAFF COMMENTS

 

Not applicable.

 

ITEM 2.           PROPERTIES

 

Our principal business operations are conducted from a 15,000 square foot leased office facility located at 66 Ford Road, Suite 230, Denville, NJ, 07834. This lease expires in February 28, 2017. Our mail-order pharmacy is also located at our headquarters in Denville, New Jersey. We believe these properties are adequate for our current operations.

 

ITEM 3.           LEGAL PROCEEDINGS

 

During 2012, we filed a lawsuit against our past adjudicator of claims for overcharges, over payment on claims, errors and misclassifications, and rebates owed from drug manufacturers claiming damages of over $5 million. Additionally, we have recorded an expense for the amount owed for claims payable. The adjudicator of claims filed a counterclaim for amounts it claims are owed to it by us. In August 2013, we settled the suit with the claims adjudicator. Under the terms of the settlement we agreed to pay the claims adjudicator $2.7 million over 15 months commencing in September 2013. This amount was recorded as a liability as of December 31, 2012, in accounts payable.

 

On August 14, 2012, we entered into an agreement with a shareholder to buy back 500,000 shares of common stock for $100,000. The agreement also called for the payment of $50,000 in legal fees. As of December 31, 2012, we had not received the 500,000 shares of common stock but had paid the settlement. We received these shares in February 2013. A stock redemption was recorded on December 31, 2012 in the amount of $100,000.

 

ITEM 4.           MINE SAFETY DISCLOSURES

 

Not Applicable.

 

26
 

  

part II

 

ITEM 5.           MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

Our common stock and warrants are each currently quoted on the OTC Market under the symbols HCCA and HCCW, respectively. The common stock commenced trading on September 9, 2013, after the outstanding shares of Series B common stock and Series C common stock were consolidated into a single class of common stock. The warrants commenced trading on December 16, 2011. The Series C common stock commenced trading on April 10, 2013 and the callable Series B common stock commenced trading on April 18, 2013 and both classes of common stock ceased trading on August 28, 2013. Our callable Series A common stock, which are no longer trading, commenced trading on December 16, 2011 and ceased trading on April 10, 2013 upon their exchange for either Series B or Series C Shares. Our units, which are no longer trading, commenced trading on November 8, 2011 and ceased trading on April 10, 2013 upon their mandatory separation.

 

The tables below sets forth the quarterly high and low bid quotations of our callable Series A common stock, callable Series B common stock, Series C common stock, common stock, warrants, and units as reported on the OTC Bulletin Board or the OTC Market LLC for the period from November 8, 2011 (the date on which our units were first quoted on the OTC Bulletin Board) through March 10, 2014. Such over the counter market quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actual transactions.

 

Securities Currently Traded:

 

   Common Stock   Warrants 
Quarter Ended  High   Low   High   Low 
December 31, 2011   n/a    n/a    0.75    0.10 
March 31, 2012   n/a    n/a    0.43    0.25 
June 30, 2012   n/a    n/a    0.51    0.28 
September 30, 2012   n/a    n/a    0.52    0.41 
December 31, 2012   n/a    n/a    0.83    0.52 
March 31, 2013   n/a    n/a    0.90    0.50 
June 30, 2013   n/a    n/a    2.15    0.90 
September 30, 2013   n/a    n/a    1.60    1.5 
December 31, 2013   6.00    2.30    0.07    0.07 
March 31, 2014 (through March 10)   1.52    1.45    0.07    0.07 

 

Securities Previously Traded:

 

   Callable Series A
Common Stock
   Callable Series B
Common Stock
   Series C
Common Stock
   Units 
Quarter Ended  High   Low   High   Low   High   Low   High   Low 
December 31, 2011   9.95    9.25    n/a    n/a    n/a    n/a    10.00    9.90 
March 31, 2012   9.60    9.60    n/a    n/a    n/a    n/a    9.91    9.90 
June 30, 2012   9.60    9.60    n/a    n/a    n/a    n/a    10.10    9.91 
September 30, 2012   9.95    9.60    n/a    n/a    n/a    n/a    10.20    9.97 
December 31, 2012   10.20    9.92    n/a    n/a    n/a    n/a    11.50    10.20 
March 31, 2013   10.20    10.00    n/a    n/a    n/a    n/a    10.80    10.50 
June 30, 2013   10.70(1)   10.22(1)   11.00(2)   9.00(2)   8.25(3)   7.20(3)   n/a(4)   n/a(4)
September 30, 2013   n/a    n/a    10.15    10.15    7.20    7.20    n/a    n/a 
December 31, 2013   n/a    n/a    n/a    n/a    n/a    n/a    n/a    n/a 
March 31, 2014 (through March 10)   n/a    n/a    n/a    n/a    n/a    n/a    n/a    n/a 

 

(1)Represents quotations through April 10, 2013, when our callable Series A common stock ceased trading.

 

(2)Represents quotations from April 18, 2013 when our callable Series B common stock commenced trading.

 

(3)Represents quotations from April 10, 2013 when our callable Series C common stock commenced trading.

 

27
 

 

(4)           Our units ceased trading on April 10, 2013 upon their mandatory separation into Series B common stock and warrants in conjunction with the Merger.

 

Holders of Record

 

At March 10, 2014, there were 8,832,692 shares of our common stock outstanding held by 126 stockholders of record. The number of record holders was determined from the records of our transfer agent and does not include beneficial owners of common stock whose shares are held in the names of various security brokers, dealers, and registered clearing agencies. Our transfer agent is American Stock Transfer & Trust Company.

 

Dividends

 

We have not previously paid any cash dividends on our common stock and do not anticipate or contemplate paying dividends on our common stock in the foreseeable future. We currently intend to utilize all available funds to develop our business. We can give no assurances that we will ever have excess funds available to pay dividends.

 

Securities Authorized for Issuance Under Equity Compensation Plans

 

None.

 

Recent Sales of Unregistered Securities

 

None that have not been previously reported.

 

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

 

None.

 

ITEM 6.         SELECTED FINANCIAL DATA

 

As a smaller reporting company we are not required to make disclosures under this Item.

 

ITEM 7.         MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Overview

 

We are a company that was organized under the laws of the State of Delaware on January 12, 2011 to acquire, through a merger, capital stock exchange, asset acquisition, stock purchase or similar acquisition transaction, one or more operating businesses. Although we were not limited to a particular geographic region or industry, we focused on acquiring operating businesses in the United States. Until the acquisition the Acquisition, we did not operate a business and our activities were limited to locating a business to acquire. As a result of the closing of the Acquisition, we operate our business through our wholly owned subsidiary, HCCA.

 

Our subsidiary, HCCA, is a Pharmacy Benefit Manager, or PBM. Its mission is to reduce prescription drug costs for clients while improving the quality of care. HCCA administers prescription drug benefits programs for employers who contract with HCCA directly in order to provide this component of healthcare benefits to their employees. It also is the PBM for healthcare management companies who partner with HCCA in order to provide prescription drug benefits along with their core offering, other health benefits products, to their clients.

 

Restatement and Reclassification

 

On May 9, 2013, we issued a Current Report on Form 8-K announcing that our Board of Directors, after consultation with, and upon recommendation from, our management, concluded the previously issued audited financial statements for the years ended December 31, 2011 and 2012 for HCCA, which we recently acquired and which is currently our wholly owned subsidiary, should no longer be relied upon and that disclosure should be made, and action should be taken, to prevent future reliance on such financial statements. For a description of the basis for the Board’s determination, please see our Current Report on Form 8-K dated May 9, 2013, which description is incorporated by reference herein.

 

28
 

  

Our officers discussed the foregoing matters with HCCA’s independent registered public accounting firm during the period, Thomas J. Harris, Certified Public Accountant. The Board of Directors authorized and directed that our officers take the appropriate and necessary actions to amend and restate the Current Report on Form 8-K (the “Original 8-K”), pursuant to which HCCA’s financial statements were filed with the SEC on May 16, 2013.

 

The restated financial statements also include certain reclassifications related to revenue and cost of sales for the fiscal years ended December 31, 2011 and 2012. We previously disclosed in our Current Reports on Form 8-K filed on March 25, 2013 and April 16, 2013 HCCA’s practice of recognizing revenue from rebates as well as from its mail-order pharmacy business. HCCA has reclassified these figures as decreases to cost of sales, with the exception of co-pays from members who order from its mail-order facility. There is no impact on gross profit, nor is there an impact on operating expenses related to this reclassification.

 

On September 16, 2013, the Board of Directors of the Company, after consultation with, and upon recommendation from, management of the Company, concluded that the previously issued and restated audited financial statements for the years ended December 31, 2011 and 2012 of HCCA, and the previously issued unaudited financial statements for the quarter ended March 31, 2013 of HCCA, should no longer be relied upon and that disclosure should be made, and action should be taken, to prevent future reliance on such financial statements. The Company reported this information in its Current Report on Form 8-K dated September 16, 2013.

 

Our officers discussed the foregoing matters with HCCA’s independent registered public accounting firm during the period, Thomas J. Harris, Certified Public Accountant. The Board of Directors authorized and directed that our officers take the appropriate and necessary actions to amend and restate the Original 8-K. As a result we reviewed our financial statements in an attempt to discover all the material errors and misstatements that were included therein. As part of this review we engaged external consultants to review and investigate our books and records and other related transactions and activities for 2012 and 2011.

 

On November 11, 2013, the Company issued a press release announcing that the Company had discovered additional issues that necessitated an in-depth analysis of the books and records of HCCA for 2011, 2012 and the three months ended March 31, 2013. As a result of this review our management concluded that it will be unable to complete our restated 2011 financial statements, due to lack of sufficient source documents and other information, and that, as a result of the analysis, management had decided to exclude the 2011 income statement from our Transition Report on Form 10-K, in which it would otherwise be required, and that we would adjust the financial statements for 2012 and the 6 months ended June 30, 2013 to reflect the correction of the errors that were discovered.

 

The errors requiring a restatement of HCCA’s financial statements resulted in material weaknesses in internal control over financial reporting which were noted in the amended filings. In order to help prevent similar accounting errors in the future, the Company has hired a new CFO effective as of June 3, 2013 and instituted new procedures and controls where all material schedules and related journal entries are reviewed by the CFO on a monthly basis. On January 7, 2014, the Company’s Board of Directors established an Audit Committee consisting of Mr. Thomas Rebar and Edmundo Gonzalez, with Mr. Rebar as Chairman. In addition, the Company is in the process of locating additional independent directors eligible to serve on the audit committee.

 

Acquisition of HCCA

 

On January 25, 2013, the Agreement was entered into by and among the Company, Merger Sub, HCCA, PCA, Gary Sekulski, as the representative of the stockholders of HCCA, and Edmundo Gonzalez, as our representative. On April 10, 2013 the Acquisition and other transactions contemplated by the Agreement closed. Pursuant to the Agreement, Merger Sub merged with and into HCCA, resulting in HCCA becoming our wholly owned subsidiary. PCA and PCA Benefits, Inc., a dormant entity, remain wholly owned subsidiaries of HCCA.

 

29
 

  

Changes in Fiscal Year

 

On April 22, 2013, the Company determined to change its fiscal year end from December 31 to June 30. As a result of the change in fiscal year, the Company’s next fiscal year end was June 30, 2013. Accordingly, the Company is filing this transition report on Form 10-K for the six months ended June 30, 2013. On November 7, 2013, the Company determined to change its fiscal year end from June 30 to December 31. As a result of the change in fiscal year, the Company will file a transition report on Form 10-K for the period ended December 31, 2013.

 

Results of Operations

 

SIX MONTHS ENDED JUNE 30, 2013 COMPARED TO SIX MONTHS ENDED JUNE 30, 2012

 

Revenue

 

HCCA’s revenue includes revenues earned on its fully funded and self- funded plans. Revenue for the six months ended June 30, 2013 was $24,328,860, an increase of $14,272,125, or 142% as compared to revenue of $10,056,735 for the first six months of 2012. The increase was primarily attributable to significant growth in HCCA’s core PBM business (Fully-Funded and Self-Funded). HCCA’s revenue is based on contracts that generally last for one year and are billed on a monthly basis. Revenue is recognized as the products and services are delivered to members (typically employees of the client). Recently, we have decided to de-emphasize our focus on the fixed fee local government PBM marketplace due to its lack of profitability. We estimate that the Fully-Funded business line which accounted for approximately 67% of our revenues for the six months ending June 30, 2013, and which generated substantial operating losses, will decline in the months to come as annual renewable contracts may not renew due to our demand for substantial price increases as a condition for contract renewals.

 

Cost of Revenue

 

Cost of revenue for the six months ended June 30, 2013 was $23,309,725, an increase of $13,679,360 or 142%, as compared to $9,630,365 for the six months ended June 30, 2012. The increase was primarily attributable to HCCA’s growth in its core business.

 

HCCA’s cost of revenue for its PBM business derives from the cost of claims related to its clients. All claims are adjudicated via the Argus system. Cost of claims includes the cost of drugs dispensed and charged by pharmacies servicing HCCA’s members and an administrative fee charged by Argus. The cost of claims relating to HCCA’s mail-order pharmacy, which directly services our members, exclusively comes from the cost of each individual drug as set by the manufacturer. HCCA’s mail-order pharmacy purchases drugs from various suppliers, who are mainly drug wholesalers.

 

Rebates received from pharmaceutical manufacturers are recorded as reduction of cost of revenues, and the portion of the rebate payable to customers is treated as reduction of revenues.

 

Gross Profit

 

HCCA’s gross profit increased from $426,370 in the six months ended June 30, 2012 to $1,019,135 in the six months ended June 30, 2013. Gross margin was 4.2% in the first six month of 2013 same as the first six months of 2012.

 

SG&A Costs

 

HCCA’s SG&A costs totaled $10,815,273 in the six months ended June 30, 2013 compared to $2,916,282 in the six months ended June 30, 2012, representing an increase of 271%. SG&A costs derive primarily from wages and stock based compensation costs, which represented 63% of SG&A in the six months ended June 30, 2013, as well from commissions on sales to brokers, professional fees and reinsurance costs relating to the fully funded programs that collectively amounted to 21% of SG&A costs.

 

30
 

  

The increase in SG&A costs is primarily attributable to; wages and related costs which increased by approximately $1.7 million reflecting the increase in the number of employees, stock and note based compensation expense which was zero in the first six months of 2012 and amounted to approximately $3.7 million in the six months ended June 30, 2013 (of which approximately $2.9 million vested immediately and was expensed on the day of the merger), Professional fees which increased by approximately $0.8 million due to legal claim against Data Rx Management, Inc., a former claims adjudicator as well as well public company costs and, a severance charge of $0.75 million recorded in June 2013 relating to a former officer of HCCA.

 

Interest Expense and Other Expense, net

 

Interest expense and other expenses, net for the six months ended June 30, 2013 totaled $4,270,154, compared to $5,551 for the six months ended June 30, 2012. For the first six months of 2013 HCCA recorded interest expenses amounting to approximately $3.9 million in connection with the bridge financing, which HCCA consummated on September 19, 2012. Of that amount approximately $2.2 million represented the value ascribed to the beneficial conversion feature of the notes issued in the bridge financing that converted into common stock upon the Merger as well as the accelerated accretion to the book value of all such notes on the date of the Merger to their face value of $5,925,000. In addition, HCCA incurred interest expense associated with incentive notes of $175,983, issued to employees and consultants in the Merger as well as capital leases and other debt.

  

31
 

 

Liquidity and Capital Resources

 

HCCA’s sources of liquidity have historically primarily consisted of cash provided from purchases of equity and debt securities of the company by investors.

 

Since its inception through June 30, 2013 HCCA incurred accumulated (deficit) of ($24,705,834) and it continued to generate losses since July 1, 2013.

 

We have generated substantial losses, while successfully completing various financings as described herein during 2012 and 2013. Nevertheless, as of the date of this report we have not yet established an ongoing source of revenues sufficient to cover our operating costs to allow us to continue as a going concern. Our ability to continue as a going concern is dependent on our obtaining additional adequate capital to fund operating losses until we become profitable and generate cash flows from our operations. If we are unable to obtain adequate capital, we could be forced to cease operations. We are contemplating conducting additional offering of our debt or equity securities to obtain additional operating capital. There are no assurances we will be successful and without sufficient financing it would be unlikely for us to continue as a going concern. In addition, our independent registered public accounting firm has issued a going concern opinion.

 

32
 

  

Net cash used in operating activities for the six months ended June 30, 2013 was $4.8 million. Net loss for the period was $14.1 million offset by non-cash adjustments for approximately $6.6 million stock and note based compensation, non-cash interest expense, depreciation and amortization expense, and the mark to market adjustment on the warrant liability. Net changes in working capital increased cash from operating activities by approximately $2.6 million, primarily due to an increase in accounts payable and accrued expenses of $2.6 million due in part to the timing of invoice payments and accruals for severance and registration right penalties.

 

Cash used in purchasing of property and equipment was $104,981.

 

For the six months ended June 30, 2013 cash provided by financing activities was $4.9 million. The Company’s net cash in–flow from the Merger was approximately $8.0 million of which $3.0 million was used on the date of the Merger to repay a portion of the Bridge Notes, originally issued in September 2012, that did not convert into shares of common stock. In addition the Company repaid capital leases of $125,508.

 

In connection with the Bridge Financing completed by HCCA in September 2012, HCCA issued 59.25 units, each unit consisting of 10,000 preferred shares and a promissory note with a face value of $100,000. At the time of the Merger, holders of all of the issued and outstanding shares of preferred stock of HCCA, by virtue of the Merger, had each of their shares of preferred stock of HCCA converted into the right to receive a proportional amount of 592,500 shares of Selway Series C common stock and warrants to purchase 296,250 shares of Selway Series C common stock. In accordance with the terms of the promissory notes issued in the Bridge Financing, at the time of the Merger, notes in the aggregate amount of $3,159,591.78 (including principal and interest accrued to date) were converted into 315,959 shares of Selway Series C common stock and notes in the aggregate principal amount of $3,025,000 were repaid in full.

 

In addition to the conversion of the Notes described at the completion of the Merger, HCCA received $4.9 million in cash, after expenses related to the transaction, including investment banking fees, legal and other costs. In connection with the Merger, on April 10, 2013, Selway entered into exchange agreements with 3 beneficial holders of greater than 5% of Selway’s Series A common stock. Pursuant to the exchange agreements, such holders converted an aggregate of 878,481 shares of Selway’s Series A common stock to Selway’s Series C common stock and received $3.53 per share of Series A common stock exchanged, or an aggregate of $3,101,037.93.

 

Subsequent to the closing of the Merger, on April 11, 2013, PCA and PCA Benefits, Inc. (together, the “Borrower”), the wholly-owned subsidiaries of HCCA, entered into a credit and security agreement, as amended, with a fund managed by Muneris Capital Group (“Muneris”) for a secured revolving credit facility with an initial aggregate credit limit of $2,000,000 (the “Muneris Facility”). The facility was terminated in September 2013 due to HCCA’s inability to meet certain financial covenants.

 

On July 17, 2013, the Company obtained a $5,000,000 loan (the “PFG Loan”) from Partners for Growth III, LP (“PFG”) for a term of five years, with HCCA, PCA and PCA Benefits, Inc. serving as guarantors. Interest on the PFG Loan is payable on a monthly basis at an annual rate of prime (as quoted by the Wall Street Journal or other nationally recognized rate quoting service reasonably acceptable to Lender) plus 5.25% per annum, provided that the interest rate will automatically be reduced to prime plus 3.25% if our revenues and EBITDA for the six months ending December 31, 2013 exceed $35.5 million and $(3.1 million), respectively. The principal amount of the PFG Loan and all other accrued and unpaid monetary obligations under the loan and security agreement shall be repaid on July 17, 2018, unless earlier amortized, converted, or prepaid.

 

The agreement governing the PFG Loan contains certain financial covenants, including the requirement to: (i) maintain a cash and cash equivalents balance of at least $2 million from July 17, 2013 to January 31, 2014 and at least $3 million from February 1, 2014 to July 17, 2018; and (ii) limit our principal borrowings under the Muneris Facility at any given time to no more than $5 million, unless our EBITDA exceeds $0 in three consecutive months, upon which any increase in the amount of indebtedness under the Muneris Facility may not result in principal borrowings under the facility to exceed $25,000,000 without PFG’s consent. The agreement also includes customary negative covenants and financial reporting requirements, as well as certain customary events of default that would render all outstanding amounts under the agreement immediately due and payable, including but not limited to: (i) our failure to pay amounts due within 3 business days after the due date; (ii) PFG ceasing to have a valid perfected first priority security interest in any material portion of the collateral; (iii) we or any current subsidiary undergoing a change in the ownership of 35% or more of the voting power of its then outstanding securities; (iv) we or any current subsidiary acquiring or disposing of any assets, except as relates to certain permitted investments, including but not limited the incorporation of certain new subsidiaries, provided however that PFG may elect to add such new subsidiaries as guarantors for the PFG Loan.

 

33
 

  

Pursuant to the terms of agreement governing the PFG Loan, we issued a senior convertible note to PFG, in the amount of $5,000,000, representing the principal amount of the PFG Loan. All amounts owing under the Note are convertible, at PFG’s option, into Selway Series C common stock at an initial rate of $8.00 per share. The Note is also subject to mandatory conversion by us in the event that certain conditions are met. Additionally, as part of consideration for the PFG Loan, we issued to PFG and its designees warrants to purchase an aggregate of 220,000 shares of Series C common stock, for $7.50 per share, at any time on or prior to July 17, 2018. In order to include a provision in the loan and security agreement allowing us to prepay the PFG Loan, we issued to PFG and its designees an aggregate of 625,000 warrants that are not exercisable unless and until we choose to prepay the PFG Loan in full. These warrants will become exercisable, for $8.00 per share, only upon our optional prepayment of the loan in full, and will expire on July 17, 2018.

 

For a more detailed description of the terms of the PFG Loan, please see our Current Report on Form 8-K dated July 23, 2013, which description is incorporated by reference herein.

 

On December 31, 2013, we entered into a Forbearance, Waiver and Modification No. 1 to the PFG Loan. Pursuant to the terms of the modification, we received an additional $500,000 in loan proceeds, the conversion price was reduced from $7.50 to $2.50, the number of shares issuable upon exercise of the warrants was increased from 220,000 to 555,000 shares, among other changes. For a more detailed description of the terms of the modification, please see our Current Report on Form 8-K dated January 3, 2014, which description is incorporated by reference herein.

 

On December 31, 2013, we entered into a securities purchase agreement (the “SPA”) with certain purchasers (each a “Purchaser” and collectively, the “Purchasers”) named therein and Chardan Capital Markets, LLC (“Agent”) as administrative and collateral agent. Pursuant to the SPA, we issued $2,112,500 of Junior Secured Convertible Term Notes (the “Notes”), which Notes are convertible into shares of the Company’s common stock at an initial fixed conversion price equal to $1.50 per share. The Purchasers of Notes also received warrants (the “Warrants”) to purchase one share for every $1.50 of Notes purchased by such Purchaser. We completed the initial closing of a private placement of Notes and Warrants under the SPA on December 31, 2013, and may continue to make subsequent placements under the SPA until it has placed an aggregate of $6,000,000 in Notes under the SPA or the date that is 30 days after the date of such initial closing. For a more detailed description of the terms of the SPA, the Notes and the Warrants, please see our Current Report on Form 8-K dated January 3, 2014, which description is incorporated by reference herein.

 

Off-Balance Sheet Arrangements

 

HCCA has no off-balance sheet arrangements.

 

Critical Accounting Policies and Estimates

 

The preparation of financial statements and related disclosures in conformity with generally accepted accounting principles in the United States, or GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following as our critical accounting policies:

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements including disclosure of contingent assets and liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period and accompanying notes. The Company's critical accounting policies are those that are both most important to the Company's financial condition and results of operations and require the most difficult, subjective or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of the uncertainty of factor surrounding the estimates or judgments used in the preparation of the financial statements, actual results could differ from these estimates.

 

34
 

  

Rebates Receivable

 

Pharmaceutical manufacturers offer rebates for selected brand drugs. We currently receive these rebates through a third party administrator. The rebates are considered earned when our members (employees of customers) order the drugs, Rebates earned are paid to us by the third party administrator quarterly. Rebates earned are recognized as a reduction to cost of revenue. The portion of the rebate payable to customers is simultaneously recognized as a reduction of revenue. Management evaluates rebates receivable at the end of every reporting period and adjusts the amount reflected on the accompanying balance sheet to net realizable value. An adjustment is also made to the rebate payable to customers to correspond with any adjustment that Management applies to rebates receivable. Management estimates the rebates receivable based on the estimated number of brands dispensed through the end of reporting date multiplied by the rebate per prescription as agreed with the third party administrator.

 

Revenue Recognition

 

The Company typically enters into annual renewable agreements with its customers to provide pharmacy benefit management on a fixed price or self-insured basis. The Company records revenues from all its current contracts with customers gross as the Company acts as principal based on the following factors: 1) the Company has a separate contractual relationship with its customers and with its claims adjudicator to whom the Company pays the costs of the prescription drugs consumed by its customers (the claims), 2) the Company through its claim adjudicator is responsible to validate and manage the claims, and 3) the Company bears the credit risk for the amount due from the customers. Revenues are recorded monthly as earned. The Company also operates a mail order pharmacy that services our plan members. All revenues and associated costs from dispensing drugs by our mail order pharmacy to our plan members, excluding the members' co-pay are eliminated as inter-company revenues. Some of the contracts contain terms whereby we make certain financial guarantees regarding prescription costs. Actual performance is compared to the guaranteed measure throughout the period and accruals are recorded as an offset to revenue if we fail to meet a financial guarantee.

 

Incentive Notes

 

Upon consummation of the merger, Holders of all of the issued and outstanding shares of common stock of HCCA immediately prior to the time of the Merger had each of their shares of common stock of HCCA converted into the right to receive: (i) a proportional amount of 5,200,000 shares of the Company's Series C common stock and promissory notes with an aggregate face value of $7,500,000 (collectively, the "Closing Payment").

  

In addition the Company issued to its management $2,500,000 of Management Incentive Notes and paid fees in connection with the transaction by issuing promissory notes having an aggregate principal amount of $500,000, which reflects five percent of all promissory notes issued in the transaction.

  

The above described notes with an aggregate face value of $10,500,000 have identical terms and conditions, are non-interest bearing and are subordinated to all senior debt of the Company in the event of a default under such senior debt. The notes will be repaid prorate from 75% of 25% of the Company's free cash-flow (defined as in the notes) in excess of $2,000,000. The Company will be obligated to repay such notes if, among other events, there is a transaction that results in a change of control of the Company.

 

The notes were recorded at their estimated present value, based on the estimated time of repayment discounted to the balance sheet date. The Company will continue to re-evaluate its estimates on a periodic basis and adjust the present value of the notes accordingly.

 

35
 

  

Recent Accounting Pronouncements:

 

Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on our financial statements.

 

ITEM 7A.         QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a smaller reporting company we are not required to make disclosures under this Item.

 

ITEM 8.            FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

Our financial statements and the notes thereto begin on page F-1 of this Transition Report.

 

ITEM 9.            CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

Dismissal of McGladrey LLP; Engagement of BDO USA LLP

 

On June 28, 2013, we dismissed McGladrey LLP (“McGladrey”) as our independent registered public accounting firm and engaged BDO USA LLP (“BDO”) as our new independent registered public accounting firm. The decision to dismiss McGladrey and to retain BDO was approved by the Company's Board of Directors.

 

Other than indicating that there was substantial doubt about our ability to continue as a going concern, McGladrey’s report on our consolidated financial statements for the fiscal years ended December 31, 2012 and 2011 did not contain an adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting principles. During our fiscal years ended December 31, 2012 and 2011 and through June 28, 2013, there were no disagreements with McGladrey on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure which, if not resolved to McGladrey’s satisfaction, would have caused them to make reference to the subject matter in connection with their report on our consolidated financial statements for such period.

 

Dismissal of Thomas J. Harris, Certified Public Accountant

 

On June 28, 2013, we dismissed Thomas J. Harris, Certified Public Accountant (“Harris”), as the accounting firm for HCCA. The decision to dismiss Harris was approved by our Board of Directors.

 

Harris’s report on HCCA's consolidated financial statements for the fiscal years ended December 31, 2012 and 2011 did not contain an adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting principles. During our fiscal years ended December 31, 2012 and 2011 and through June 28, 2013, there were no disagreements with Harris on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure which, if not resolved to Harris’s satisfaction, would have caused them to make reference to the subject matter in connection with their report on our consolidated financial statements for such period.

  

ITEM 9A.         CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures

 

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in reports filed or submitted under the Securities Exchange Act of 1934 ("Exchange Act") is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms. Disclosure controls include, without limitation, controls and procedures designed to ensure that information required to be disclosed under the Exchange Act is accumulated and communicated to management, including principal executive and financial officers, as appropriate, to allow timely decisions regarding required disclosure. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives.

 

Management carried out an evaluation, under the supervision of the Chief Executive Officer and Chief Financial Officer, of the effectiveness of disclosure controls and procedures as of June 30, 2013. Based upon that evaluation, management, including the Chief Executive Officer and Chief Financial Officer, concluded that the design and operation of disclosure controls and procedures were not effective as of June 30, 2013.

 

Management's Report on Internal Control over Financial Reporting

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in the Securities Exchange Act of 1934, as amended. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Management assessed the effectiveness of internal control over financial reporting as of June 30, 2013. In making this assessment, management used the criteria set forth by Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (1992). Based on its assessment using those criteria, our Chief Executive Officer and Chief Financial Officer concluded that internal control over financial reporting was not effective as of June 30, 2013 as a result of certain material weaknesses in our internal control over financial reporting. These material weaknesses related to our lack of a sufficient complement of personnel with an appropriate level of knowledge and experience in the application of U.S. generally accepted accounting principles, or GAAP, commensurate with our financial reporting requirements and the fact that policies and procedures with respect to the review, supervision, and monitoring of our accounting and reporting functions were either not designed and in place or not operating effectively. As a result, numerous adjustments to our financial statements, including the restatement of the financial statements for the year ended December 31, 2012 and the quarter ended March 31, 2013, were identified. Our independent registered public accounting firm did not perform an evaluation of our internal control over financial reporting as of June 30, 2013, in accordance with the provisions of the Sarbanes-Oxley Act.

 

36
 

  

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company's annual or interim financial statements will not be prevented or detected on a timely basis.

 

To remediate this material weakness, a Chief Financial Officer, with appropriate public company experience was hired in June 2013. Additionally, the Company is working on expanding its accounting and finance staff. The material weakness is not yet fully remediated.

 

Changes in Internal Control over Financial Reporting

 

A Chief Financial Officer, with appropriate public company experience was hired in June 2013. Additionally, the Company is working on expanding its accounting and finance staff.

 

ITEM 9B.          OTHER INFORMATION

 

None.

 

37
 

 

part III

 

ITEM 10.           DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

The following table sets forth information about our directors and executive officers as of March 10, 2014.

 

Name:   Age:   Ownership or Relationship:
Natasha Giordano   53   Chief Executive Officer, President and director
Yoram Bibring   56   Chief Financial Officer
Ann F. Saskowitz   60   VP Service Operations and Director
Ruth Ackerman   63   VP Administration
Scott Weeber   43   VP of Finance & Accounting and Treasurer
Mark Carlesimo   60   Vice President, General Counsel and Secretary
Yaron Eitan   57   Chairman of the Board of Directors
Thomas E. Durkin, III   60   Director
Edmundo Gonzalez   40   Director
Thomas Rebar   51   Director
Gary J. Sekulski   66   Director

 

Below is a summary of the business experience of each of the above-named executive officers and directors:

 

Natasha Giordano has been our Chief Executive Officer, President and a director since January 1, 2014. Ms. Giordano served as the Chief Executive Officer, President and Director of Xanodyne Pharmaceuticals, Inc. a branded specialty pharmaceutical company with development and commercial capabilities focused on pain management, from May 2010 to August 2012 and Chief Operating Officer since 2009. Prior to that, she served as President, Americas for Cegedim Dendrite (formerly Dendrite International Inc.) from 2007 to 2008 and as Senior Vice President of the Global Customer Business Unit of Cegedim Dendrite from 2004 to 2007. She had been with Cegedim Dendrite since 2000 and served as Group President for Global Business Unit for major customers, and Vice President of Global Sales. Earlier in her career, she worked nine years with Parke-Davis then owned by Warner Lambert in several sales and marketing positions including Strategic Alliance management and Sales Integration. Ms. Giordano holds a Bachelors of Science degree in nursing from Wagner College in New York.

 

Yoram Bibring has been our Chief Financial Officer since June 3, 2013. Prior to joining us, Mr. Bibring served at Fundtech Ltd, a global financial transactions software and service solutions company, as chief financial officer from September 2001 through May 2012, and as an outside consultant from May 2012 to December 2012. In his capacity as chief financial officer of Fundtech, Mr. Bibring also served as a director of various other subsidiaries of the Fundtech group. Prior to joining Fundtech, Mr. Bibring served from December 1998 until May 2001 as chief financial officer of ViryaNet Ltd., a provider of software solutions to the workforce management market located in Southborough, Massachusetts. From January 1990 until January 1998, Mr. Bibring was employed by Geotek Communications, a wireless communications service provider located in Montvale, New Jersey, where he served initially as chief financial officer and then as the president of its International Division. Mr. Bibring holds a BS in Accounting and Economics from Tel Aviv University and is a certified public accountant in the United States.

 

Ann Saskowitz has been our Vice President of Service Operations and a director since April 10, 2013 and has been HCCA’s Vice President of Service Operations and a director since 2010. She served as Director of Claim Policy Implementation at Horizon Blue Cross-Blue Shield of New Jersey from 1984 to 2009, in which capacity she developed and managed call center operations and led multi-million dollar business initiatives. She is also responsible for creating Horizon’s Claim Policy Implementation Department. She holds a BA in Journalism and American Studies from Seton Hall University.

 

38
 

  

Ruth Ackerman has been our Vice President of Administration since April 10, 2013 and has been HCCA’s Vice President of Administration since 2011. Previously, she created and managed the operations and service departments for health benefits broker agencies, which were divisions of major banks, including: Alliance Benefits Strategists from 2005 to 2010, and General Insurance Agency Marketplace at Bank of America from 1990 to 2005. She also worked at Madison Consulting Group from 1991 to 1998. Prior to those positions, she served as Director of Corporate Planning & Contract Development at Horizon Blue Cross-Blue Shield from 1980 to 1990. She holds a BA in English from Drew University. In January 2011, the U.S. Bankruptcy Court for the District of Massachusetts issued a final order discharging Ms. Ackerman and her husband of all debts accrued with respect to a Massachusetts inn formerly co-owned by the couple.

 

Scott Weeber has been our Vice President of Finance and Accounting and Treasurer since April 10, 2013 and has been HCCA’s Vice President of Finance and Accounting since January 2013. He has held various accounting and finance positions during his career. He worked as an Accountant/Auditor at Pannell Kerr Forster PC from 1991 to 1995. He worked as a controller for U.S. Bronze Powders from 1996 to 1999. He held various managerial finance positions at Kraft Foods from 2000 to 2008 and at Novartis from 2010 to 2012. He holds a BS in Accounting from Rutgers University and is a CPA licensed in the state of New Jersey.

 

Mark Carlesimo has been our Vice President, General Counsel and Secretary since June 3, 2013. Mr. Carlesimo has more than three decades of experience in corporate law with several publicly traded companies and since January 2012 has acted as outside counsel to various small and mid-cap companies. Mr. Carlesimo previously served as Executive Vice President, General Counsel and Secretary of ground transportation company Velocity Express Corp. (OTC: VEXQ) from 2006 to 2011. From 1997 to 2006, he served as Vice President, General Counsel and Secretary of CD&L Inc., which later became a subsidiary of Velocity Express Corp. From 1983 to 1997, he also served as Vice President of Legal Affairs of Cunard Line Limited. From 1980 to 1983 he served as staff counsel to Seatrain Lines, Inc. Mr. Carlesimo received a B.A. in Economics from Fordham University in 1975 and received his law degree from Fordham University School of Law in 1979. He is a member of the bar of the states of New York and New Jersey.

 

Yaron Eitan has been a director since June 21, 2013 and Chairman of the Board of Directors since January 1, 2014. Mr. Eitan was the Company’s President, Chief Executive Officer and a director from its inception until April 10, 2013, when the Company acquired Healthcare Corporation of America, a New Jersey corporation. Mr. Eitan was the Company’s Chairman from its inception until April 28, 2011. Mr. Eitan founded Selway Capital LLC, an investment management firm, in March 2009 and serves as managing partner of the firm and since June 2002 has served as partner of SCP Partners, a private equity investment firm with multiple funds under management, specializing in the telecommunications, defense and security, and education industries. Previously, he was the co-founder of Reshef Technologies, a specialty munitions company, from August 1984 to August 1987, the President of Patlex, an industrial and patent enforcement holding company, from October 1987 to February 1989, and founder and CEO of Geotek Communications, a wireless communications company, from March 1989 to May 1998. In 1998, Mr. Eitan founded Selway Partners, a technology-sector holding company. Selway Partners was sold to SCP Partners in 2002, at which time Mr. Eitan became one of the partners of SCP Partners. In April 2007, Mr. Eitan launched Vector Intersect Security Acquisition Corporation, a special purpose acquisition corporation, which acquired Cyalume Technologies Holdings, Inc. in December 2008. Following the acquisition, Mr. Eitan continues to serve as a director of Cyalume. Mr. Eitan served in the Israeli Defense Forces for six years, where he reached the rank of Major. He received his bachelor’s degree in economics from Haifa University and an M.B.A. from the Wharton School of Business at the University of Pennsylvania.

 

Thomas E. Durkin, III has been a director since April 10, 2013 and has represented HCCA as counsel since November 2012. He served as our Vice President, General Counsel and Secretary from April 10, 2013 until June 3, 2013. Mr. Durkin has been a partner to Durkin & Durkin LLP, a New Jersey based law firm, since 1978. Mr. Durkin was formerly president and director of American Technologies Group Inc. (OTC: ATGR), a structural steel fabrication company, from 2007 to 2012, and as a director of CD&L Inc., a same-day delivery services company, from 1999 until its sale to Velocity Express Corp. (OTC: VEXQ) in 2006. He also served as an executive vice-president and general counsel for Waste Services Inc. from 2001 to 2004 and area vice-president of corporate development and government affairs for Waste Management Inc. (NYSE: WM) from 1997 to 2000. Mr. Durkin graduated from Fordham University in 1975 and graduated Cum Laude from Seton Hall University School of Law in 1978. Mr. Durkin also provides certain management and business consulting services outside of the practice of law. Mr. Durkin is a member of the bar of the states of New York and New Jersey.

 

39
 

  

Edmundo Gonzalez has been a director since inception and our Chief Financial Officer from inception until April 10, 2013 and is currently a member of the newly formed audit committee of the Board of Directors. Mr. Gonzalez joined SCP Partners as a principal in 2007, and has worked on dozens of transactions with Yaron Eitan, our prior Chief Executive Officer, since that time, including investments in portfolio companies, acquisitions, mergers and sales. From May 2004 to September 2007, he served as Vice President of Sales and Marketing for Software Technology, Inc., an educational software company and portfolio company of SCP Partners. From October 1999 to April 2004, he held various positions including Chief Operating Officer at TestU, an online education company, which was sold to Software Technology, Inc. in 2004. Previously, Mr. Gonzalez served as a consultant at PricewaterhouseCoopers Management Consulting (now IBM Business Consulting) from September 1995 to September 1999, where he consulted to Fortune 500 clients in the media, telecom and publishing industries. Mr. Gonzalez graduated with a bachelor’s degree from Harvard University and received an M.B.A. from Columbia Business School.

 

Thomas Rebar has been a director since January 3, 2014 and is the Chair of the newly formed audit committee of the Board of Directors. Mr. Rebar is a Partner of SCP Partners and has been with SCP Partners since its inception in 1996. SCP Partners manages approximately $750 million on behalf of institutional investors focusing primarily on venture capital and related activities. He has over 25 years experience in venture capital, private equity, investment banking, mergers and acquisitions, and leveraged buyout financing. Mr. Rebar is a director of several companies, including Magnolia Broadband, DVTel, Inc., Pentech Financial Services, Inc., and Cyalume Technologies Holdings, Inc. (OTC-CYLU), where he is currently the Chair of the Audit Committee. Prior to joining SCP, Mr. Rebar was a Senior Vice President at Charterhouse Inc., the U.S. investment banking arm of Charterhouse PLC, a leading U.K. merchant bank, from 1989 to 1996. At Charterhouse, he was responsible for a broad range of domestic and cross-border transactions including representing companies in the purchase and sale of businesses, rendering fairness opinions and business valuations, assisting companies in raising debt capital, and the placement of private equity. Before joining Charterhouse, from 1987 to 1989, Mr. Rebar was a member of the corporate finance department at Bankers Trust Company in New York City. Mr. Rebar received his B.S. summa cum laude from the University of Scranton and his M.B.A. from New York University Graduate School of Business Administration.

 

Gary Sekulski has been a director since April 10, 2013 and was our Chairman, President and Chief Executive Officer from April 10, 2013 until December 31, 2013, and HCCA’s Chairman, President and CEO from 2008 until December 31, 2013. He served as president of Broadreach Medical Services from 2003 to 2007 and Gladstone Consulting Group from 1993 to 2000, and has held executive positions in Summit Health Administrators and Metropolitan Life Insurance Company. Gary had a significant role in developing many of the innovations currently used in the PBM industry, including being involved in creating the first card/mail-order prescription program while at MetLife. He holds a BS in Economics from Stony Brook University. Chapter 7 bankruptcy proceedings were initiated in New Jersey in May 2001 by Gladstone Consulting Group, Inc. and Gladstone Group Inc., companies affiliated with Mr. Sekulski, and were terminated in August 2007 and May 2012, respectively. A personal bankruptcy proceeding filed in New Jersey by Mr. Sekulski and his wife in January 2003 was discharged in March 2006.

 

Family Relationships

 

There are no family relationships between any of our directors and our executive officers.

 

Code of Ethics

 

On June 21, 2013, our board of directors adopted a code of ethics that applies to our directors, officers and employees are required to abide by the Company’s Code of Business Conduct to ensure that our business is conducted in a consistently legal and ethical manner. Our policies and procedures cover all major areas of professional conduct, including employee policies, conflicts of interest, protection of confidential information, and compliance with applicable laws and regulations. We will provide a copy of our code of ethics to any person, without charge, upon request. Requests for copies of our code of ethics should be sent in writing to Healthcare Corporation of America, 66 Ford Road, Suite 230, Denville, NJ, Tel: (973) 983-6300.

 

40
 

 

Officer and Director Qualifications

 

Our officers and board of directors are composed of a diverse group of leaders. Many of the current officers or directors have senior leadership experience in both public and private companies. In these positions, they have also gained experience in core management skills, such as strategic and financial planning, public company financial reporting, compliance, risk management, and leadership development. Most of our officers and directors also have experience serving on boards of directors and board committees of other public companies and private companies, and have an understanding of corporate governance practices and trends, which provides an understanding of different business processes, challenges, and strategies. Further, our officers and directors also have other experience that makes them valuable, such as prior experience with blank check companies, managing and investing assets or facilitating the consummation of business combinations.

 

Board Committees

 

On January 7, 2014, the Company’s Board of Directors established an Audit Committee consisting of Thomas Rebar and Edmundo Gonzalez, with Mr. Rebar as Chairman. The Board has determined that Mr. Rebar is an “audit committee financial expert” as such term is defined in the rules of the Securities and Exchange Commission.

 

Section 16(a) Beneficial Ownership Reporting Compliance

 

Section 16(a) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, requires our executive officers, directors and persons who beneficially own more than 10% of a registered class of our equity securities to file with the Securities and Exchange Commission initial reports of ownership and reports of changes in ownership of our common stock and other equity securities. These executive officers, directors, and greater than 10% beneficial owners are required by SEC regulation to furnish us with copies of all Section 16(a) forms filed by such reporting persons.

 

Natasha Giordano, our Chief Executive Officer, President and director, failed to timely file a Form 3 as required by section 16(a) of the Exchange Act following her becoming a reporting person. Except as set forth above, based solely on our review of such forms furnished to us and written representations from certain reporting persons, we believe that all filing requirements applicable to our executive officers, directors and greater than 10% beneficial owners were filed in a timely manner.

 

ITEM 11.       EXECUTIVE COMPENSATION

 

The following table (the “Summary Compensation Table”) sets forth all compensation awarded to, earned by or paid to our principal executive officer and its two most highly compensated executive officers other than our principal executive officer who were serving as executive officers as of June 30, 2013 (collectively, the “Named Executive Officers”). Compensation for period prior to April 10, 2013, includes compensation received from HCCA, which we acquired on such date. Other than as described in this report, we do not have any supplemental executive retirement plans, change in control agreements or company perks (e.g., company cars, country club memberships, etc.).

 

Summary Compensation Table

 

Name and
Principal Position (1)
  Period Ending  Salary
($)
   Bonus
($)
   Stock
Awards
($)
   Option-
Based
Awards
($)
   Other
($)
   Total ($) 
Gary Sekulski (2)  June 30, 2013   233,000    0    0    0    0    233,000 
Chief Executive Officer  December 31, 2012   383,000    0    0    0    0    383,000 
   December 31, 2011   217,346    0    0    0    0    217,346 
                                  
Ann F. Saskowitz  June 30, 2013   99,800    0    0    0    0    99,800 
Vice President  December 31, 2012   109,000    0    0    0    0    109,000 
Service Operations  December 31, 2011   69,000    0    0    0    0    69,000 
                                  
John Phelps (2)  June 30, 2013   90,000    0    0    0    0    90,000 
Vice President of Marketing  December 31, 2012   172,000    0    0    0    0    172,000 
Administration  December 31, 2011   157,000    0    0    0    0    157,000 

 

41
 

  

1.          Effective January 3, 2014, Natasha Giordano was appointed our Chief Executive Officer and President.

 

Ms. Giordano did not serve as an executive officer of our Company prior to such time. The Company entered into an employment agreement with Ms. Giordano dated December 3, 2013 and amended it on December 31, 2013. The agreement was not effective until certain conditions were met. Such conditions were satisfied on December 31, 2013. The agreement, as amended, provides for an employment term of three years, during which Ms. Giordano will receive an initial annual base salary of $420,000. Ms. Giordano will also be eligible for an annual bonus equal to up to 50% of her base salary based on the achievement of annual targets established by the Board. Upon effectiveness of her appointment, Ms. Giordano will be granted a ten-year option to acquire shares of common stock of the Company equal to 4.7% of the fully diluted equity of the Company. The option is not subject to the requirement that the company adopt an option plan, and will be exercisable for the greater of the conversion price of the notes issued in the Private Placement or the fair market value of the Company’s Common Stock on the date of issuance. Pursuant to the employment agreement, in the event that Ms. Giordano is terminated without cause or Ms. Giordano terminates employment for good reason prior to the end of the employment term, she will be entitled to: (i) all accrued obligations, including salary, expense reimbursement, etc.; (ii) a pro-rated bonus for the year of termination; (iii) one year’s salary; (iv) her targeted annual bonus for the twelve months following termination; (v) the automatic vesting of the option issued at the time of appointment; and (vi) health insurance benefits for the twelve months following termination. In the event of Ms. Giordano’s death during the employment term, her spouse or estate will be entitled to: (i) all accrued obligations, including salary, expense reimbursement, etc.; (ii) one year’s base salary; (iii) a pro-rated bonus for the year of death; and (iv) the automatic vesting of the option issued at the time of appointment.

 

Effective June 3, 2013, Yoran Bibring was appointed our Chief Financial Officer. Mr. Bibring did not serve as an executive officer of our Company prior to such time. Pursuant to an employment agreement with Mr. Bibring dated May 9, 2013, as amended, Mr. Bibring is to receive an annual base salary of $250,000 for a three year term and a one-time signing bonus of $18,500. Mr. Bibring will also be eligible for a $100,000 annual bonus based on the terms and conditions of our bonus plan for senior management, of which 50% may, at our discretion, be paid in registered shares of our common stock. We have agreed to issue to Mr. Bibring an option to purchase up to 200,000 shares of Common Stock, at an exercise price equal to the fair market value of the shares on the date of grant, upon our implementation of a fully approved and legally compliant employee stock compensation program. These options will vest over a three year period in monthly increments beginning November 1, 2013; provided, however, that the options will vest immediately upon the sale or transfer of all or substantially all of our assets or the sale of more than 50% of the shares of our capital stock entitled to vote generally for the election of our directors.

 

2.No longer employed by the Company.

 

Narrative to Summary Compensation Table

 

In 2012, HCCA entered into employment agreements with the four executive officers listed in the table below. The employment agreements provide for an employment term through September 14, 2015, the base salary indicated below and increases in the base salaries in the event that the conditions specified in the table below are met. Each of the agreements provides that the employee is entitled to receive bonuses determined by HCCA’s Board of Directors based on the performance of the employee and HCCA. Each of the employees may be terminated for cause at any time. In the event that the employee is terminated without cause prior to the end of the employment term, the employee will be entitled to receive such employee’s base salary through the end of the employment term. In the event of the death of an employee during the employment term, the employee’s spouse or estate will be paid an amount equal to one year’s base salary.

 

42
 

 

Name  Title  Base
Salary ($)
   Salary if specified
conditions (1) are
met ($)
   Salary if specified
conditions (2) are
met ($)
   Salary if specified
conditions (3) are
met ($)
 
Gary J. Sekulski  President and Chief Executive Officer   450,000    500,000    550,000    650,000 
Ann F. Saskowitz  VP Service Operations   150,000*   180,000*   210,000*   240,000*
John M. Phelps  VP Marketing and Strategic Planning   180,000    210,000    240,000    270,000 
Ruth Ackerman  VP Administration   150,000    180,000    210,000    240,000 

 

*On April 22, 2013, Ms. Saskowitz’s base salary was increased to $240,000 through the end of her employment term. All other terms under her employment agreement remain unchanged.
(1)Company sales for January 1, 2013 – June 30, 2013 were not equal to or in excess of $50 million, so no additional salary was paid.

(2)Company sales for April 1, 2013 – March 31, 2014 are equal to or in excess of $150 million.
(3)Company sales for April 1, 2014 – March 31, 2015 are equal to or in excess of $300 million.

 

We did not have a stock option plan or a restricted stock program in the transition period ended June 30, 2013 or the years ended 2012 and 2011. Key executives did not receive bonuses during these years.

 

The key executives of HCCA are also significant stockholders. As owner-managers, the key executives believe that much of the reward for their talent and efforts will be through the appreciation of their shares, which they purchased in previous years and/or in the process of forming HCCA.

 

Compensation of Directors

 

As of June 30, 2013, none of our directors has received any compensation from us other than compensation for service as an officer to us or HCCA if such director were also an officer. Although we plan to do so, we have not yet determined the compensation we will pay to our independent directors.

 

ITEM 12.      SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS

 

The following table sets forth as of March 10, 2014 the number of shares of our common stock beneficially owned by (i) each person who is known by us to be the beneficial owner of more than five percent of our common stock; (ii) each director; (iii) each of the named executive officers in the Summary Compensation Table; and (iv) all directors and executive officers as a group. As of March 10, 2014, we had 8,832,692 shares of common stock issued and outstanding.

 

Beneficial ownership includes voting or investment power with respect to the securities and takes into consideration options exercisable by a person within 60 days after the date of this report. Except as indicated below, and subject to applicable community property laws, the persons named in the table have sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them.

 

Name and Address of Stockholder (1)  Number of
shares
beneficially
owned
   Percentage
Ownership
(2)
 
Directors and Executive Officers          
Natasha Giordano (3)   147,190    1.6 
Yoram Bibring (4)   -    - 
Ann F. Saskowitz (5)   188,610    2.1%
Ruth V. Ackerman (6)   50,740    * 
Scott Weeber (7)   70,050    * 
Mark Carlesimo (8)   -    - 
Yaron Eitan (9)   1,600,000    16.3%
Thomas E. Durkin, III   1,170    * 
Edmundo Gonzalez (9)   1,600,000    16.3%
Thomas Rebar   -    - 
Gary Sekulski (10)   1,243,710    14.1%
Total Officers and Directors   3,301,470    33.1%
5% Stockholders          
Selway Capital Holdings LLC (9)   1,600,000    16.3%
Andrew Intrater (9)   1,600,000    16.3%
Doron Cohen (9)   1,600,000    16.3%
Jarret Fass (9)   1,600,000    16.3%
Yair Shamir (9)   1,600,000    16.3%
Andrew Kahn (11)   949,019    9.7%
Donald M. Campbell (11)   949,019    9.7%
Jason Georgatos (11)   949,019    9.7%
AQR Capital Management, LLC (12)   484,758    5.2%
Parkins Capital Management, Inc. (13)   618,833    6.6%
Victor Wexler (14)   744,126    8.4%

 

43
 

 

*Beneficially owns less than 1% of our common stock.
1.Unless otherwise indicated, the business address of each beneficial owner is 66 Ford Road, Suite 230, Denville, NJ 07834.
2.Percentages based on 8,832,692 shares of common stock outstanding as of March 10, 2014.
3.Ms. Giordano will be granted a ten year option to acquire shares of common stock of the Company equal to 4.7% of the fully diluted equity of the Company. The option is not subject to the requirement that the company adopt an option plan, and will be exercisable for the greater of the conversion price of the notes issued in the Private Placement or the fair market value of the Company’s common stock on the date of issuance. The options vests as follows: (b) 10% on January 31, 2014; and (b) 2.5% monthly commencing January 3, 2014. Accordingly, as of March 10, 2014, 17.5% of Ms. Giordano’s option has vested in an amount equal to 0.8225% of the fully diluted equity of the Company, or 147,190 shares. In the event Ms. Giordano is terminated without cause, Ms. Giordano terminates her employment for Good Reason, or in the event of death, Ms. Giordano or her estate will be entitled to automatic vesting of the ten year option.
4.We have agreed to issue to Mr. Bibring an option to purchase up to 200,000 shares of common stock, at an exercise price equal to the fair market value of the shares on the date of grant, upon our implementation of a fully approved and legally compliant employee stock compensation program. These options will vest over a three year period in monthly increments beginning November 1, 2013; provided, however, that the options will vest immediately upon the sale or transfer of all or substantially all of our assets or the sale of more than 50% of the shares of our capital stock entitled to vote generally for the election of our directors.
5.Includes 150,000 shares beneficially owned by Ms. Saskowitz that are subject to the terms of the Management Share Escrow Agreement and are to be held in escrow until June 30, 2015, unless earlier released in connection with an acquisition transaction.
6.Includes 25,000 shares beneficially owned by Ms. Ackerman that are subject to the terms of the Management Share Escrow Agreement and are to be held in escrow until June 30, 2015, unless earlier released in connection with an acquisition transaction.
7.Includes 52,500 shares beneficially owned by Mr. Weeber that are subject to the terms of the Management Share Escrow Agreement and are to be held in escrow until June 30, 2015, unless earlier released in connection with an acquisition transaction. We have agreed to issue to Mr. Weeber an option to purchase up to 200,000 shares of common stock, at an exercise price equal to the fair market value of the shares on the date of grant, upon our implementation of a fully approved and legally compliant employee stock compensation program. These options will vest over a three year period in monthly increments beginning April 30, 2013; provided, however, that the options will vest immediately upon the sale or transfer of all or substantially all of our assets or the sale of more than 50% of the shares of our capital stock entitled to vote generally for the election of our directors.
8.We have agreed to issue to Mr. Carlesimo an option to purchase up to 200,000 shares of common stock, at an exercise price equal to the fair market value of the shares on the date of grant, upon our implementation of a fully approved and legally compliant employee stock compensation program. These options will vest over a three year period in monthly increments beginning June 3, 2013; provided, however, that the options will vest immediately upon the sale or transfer of all or substantially all of our assets or the sale of more than 35% of the shares of our capital stock entitled to vote generally for the election of our directors.
9.Consists of 600,000 shares and warrants to purchase 1,000,000 shares of common stock held of record by Selway Capital Holdings LLC. Messrs. Eitan, Gonzalez, Cohen, Fass and Shamir, together with Selway Capital LLC and CN-SCH, LLC, share voting and dispositive power over the founders’ shares owned by Selway Capital Holdings. Selway Capital LLC is controlled by Messrs. Eitan and Gonzalez. The business address of Selway Capital LLC is 900 Third Avenue, 19th Floor, New York, NY 10022. CNSCH, LLC is wholly-owned by Bounty Investments, LLC. Mr. Andrew Intrater is the Chief Executive Officer of each of CN-SCH, LLC and Bounty Investments, LLC. The business address of each of Mr. Intrater, CN-SCH, LLC and Bounty Investments, LLC is 900 Third Avenue, 19th Floor, New York, NY 10022. Mr. Intrater has voting and dispositive power over the founders’ shares attributable to CN-SCH, LLC and Bounty Investments, LLC.

 

44
 

 

10.Includes 416,000 shares owned by the Gary Sekulski 2013 Grantor Trust and 185,900 shares owned by Morris Consulting, which entities Mr. Sekulski controls.

11.Based on a Form 13G/A filed with the Commission on February 14, 2014.

12.Based on a Form 13G/A filed with the Commission on February 10, 2014.

13.Based on a Form 13G filed with the Commission on February 10, 2014.

14.The Company believes that Mr. Wexler is the beneficial owner of 744,126 shares of the Company’s common stock; however, no Form 13D or Form 13G has been filed by Mr. Wexler, so the Company cannot confirm the exact number of shares beneficially owned by him.

 

The shares beneficially owned by Gary Sekulski, Ann F. Saskowitz, Ruth V. Ackerman, Scott Weeber, Thomas E. Durkin, III and Selway Capital Holdings LLC are subject to a voting agreement dated April 10, 2013, pursuant to which, for a two year period following the Merger, the applicable holder will vote all shares then-owned in favor of those persons nominated to our board of directors by: (i) Mr. Sekulski, the representative of the stockholders of HCCA before the merger, who will designate three persons, (ii) Edmundo Gonzalez, representative for our pre-Merger stockholders, who will designate one person; and (iii) such board designees, who will unanimously designate three persons to be independent directors.

 

We are not aware of any arrangement that may, at a subsequent date, result in a change of control of the company.

 

ITEM 13.        CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 

We or one of our subsidiaries may occasionally enter into transactions with certain “related parties.” Related parties include its executive officers, directors, nominees for directors, a beneficial owner of 5% or more of its common stock and immediate family members of these parties. We refer to transactions involving amounts in excess of $120,000 and in which the related party has a direct or indirect material interest as “related party transactions.”

 

Otis Fund, a company controlled by Victor Wexler, has a consulting agreement to provide marketing and sales services to HCCA. The contract expires on January 2, 2017. The annual fees related to these services are $360,000. The Otis Fund and Mr. Wexler’s wife collectively owned 5.1% of HCCA shares outstanding prior to the closing of the transactions contemplated by the Agreement.

 

Director Independence

 

Our Board of Directors has affirmatively determined that Messrs. Eitan, Gonzalez, Rebar are independent directors within the meaning of NASDAQ Marketplace Rule 5605(a)(2). Ms. Saskowitz does not meet the independence requirements under NASDAQ Marketplace Rule 5605(a)(2) because she is a current officer and Messrs. Sekulski and Durkin do not meet the independence requirements because each is a former officer.

 

ITEM 14.        PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

Public Accounting Fees

 

The following chart sets forth public accounting fees in connection with services rendered by BDO USA LLP, our independent registered public accounting firm since June 28, 2013.

 

    

Period ended June 30,

2013

 
Audit Fees   296,988 
Audit-Related Fees   - 
Tax Fees   5,000 
All Other Fees   - 

 

45
 

 

Audit fees were for professional services rendered by BDO USA LLP for the audit of our June 30, 2013 financial statements, and services that are normally provided by BDO USA LLP in connection with statutory and regulatory filings or engagements for that fiscal year.

 

Tax fees were for professional services provided by BDO USA LLP for certain tax matters, including an evaluation of the limitation of net operating loss carry forward.

 

BDO USA LLP did not bill any other fees for services rendered to us during the fiscal period ended June 30, 2013 for assurance and related services in connection with the audit of our financial statements.

 

Pre-Approval of Services

 

Since our audit committee has not yet been formed, the audit committee was not able to pre-approve all of the foregoing services, although any services rendered were approved by our board of directors.

 

46
 

 

part IV

 

ITEM 15.      EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 

(a)The following are filed with this report:

 

(1)The financial statements listed on the Financial Statements’ Table of Contents
(2)Not applicable

 

(b)Exhibits

 

The following exhibits are filed with this report. Exhibits which are incorporated herein by reference can be inspected and copied at the public reference facilities maintained by the SEC, 100 F Street, N.E., Room 1580, Washington D.C. 20549. Copies of such materials can also be obtained from the Public Reference Section of the SEC, 100 F Street, N.E., Washington, D.C. 20549, at prescribed rates.

 

Exhibit No.   Description
     
2.1   Agreement and Plan of Merger, dated January 25, 2013, by and among us, Selway Merger Sub, Inc., Healthcare Corporation of America, Prescription Corporation of America, Gary Sekulski, and Edmundo Gonzalez (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
3.1   Amended and Restated Certificate of Incorporation (Incorporated by reference to our Annual Report on Form 10-K for the fiscal year ended December 31, 2011, filed with the Securities and Exchange Commission on March 30, 2012).
     
3.2   By-laws (Incorporated by reference to our Registration Statement on Form S-1 (File No. 333-172714) filed with the Securities and Exchange Commission on March 10, 2011).
     
3.3   Certificate of Merger (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013)
     
3.4   Certificate of Amendment to Certificate of Incorporation dated September 27, 2013 (incorporated by reference to our Current Report on Form 8-K dated September 27, 2013)
     
4.1   Specimen common stock certificate
     
4.2   Form of Unit Purchase Option (Incorporated by reference to our Registration Statement on Form S-1 (File No. 333-172714) filed with the Securities and Exchange Commission on March 10, 2011).
     
4.3   Specimen Public Redeemable Warrant Certificate (Incorporated by reference to our Registration Statement on Form S-1 (File No. 333-172714) filed with the Securities and Exchange Commission on March 10, 2011).
     
4.4   Form of Sponsor Payment Warrant (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
4.5   Forbearance, Waiver and Modification No. 1 to Loan Agreement, dated December 31, 2013 (incorporated by reference to our Current Report on Form 8-K dated December 31, 2013).
     
4.6   Securities Purchase Agreement dated December 31, 2013 (incorporated by reference to our Current Report on Form 8-K dated December 31, 2013).
     
4.7   Form of Junior Secured Convertible Term Notes (incorporated by reference to our Current Report on Form 8-K dated December 31, 2013).

 

47
 

 

4.8   Form of Warrant (incorporated by reference to our Current Report on Form 8-K dated December 31, 2013).
     
4.9   Master Security Agreement (incorporated by reference to our Current Report on Form 8-K dated December 31, 2013).
     
4.10   Subsidiary Guarantee (incorporated by reference to our Current Report on Form 8-K dated December 31, 2013).
     
4.11   Registration Rights Agreement (incorporated by reference to our Current Report on Form 8-K dated December 31, 2013).
     
10.1   Voting Agreement, dated January 25, 2013, by and among us, Healthcare Corporation of America, and certain shareholders (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.2   Voting Agreement, dated April 10, 2013, by and among us and certain shareholders (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.3   Exchange Agreement, by and between us and certain shareholders (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.4   Exchange Agreement, by and between us and certain shareholders (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.5   Registration Rights Agreement, dated April 10, 2013, by and among us and Gary Sekulski, as representative of the stockholders of Healthcare Corporation of America (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.6   Closing Payment Escrow Agreement, dated April 10, 2013, by and among us, Selway Merger Sub, Inc., Healthcare Corporation of America, Gary Sekulski, Edmundo Gonzalez, and American Stock Transfer & Trust Company LLC, as escrow agent (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.7   Management Share Escrow Agreement, dated April 10, 2013, by and among us, Healthcare Corporation of America, certain key personnel signatories thereto, and American Stock Transfer & Trust Company LLC, as escrow agent (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.8   Marketing and Consulting Agreement, dated January 3, 2012, by and between Prescription Corporation of America and Otis Fund (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.9   Employment Agreement, dated September 15, 2012, by and between Healthcare Corporation of America and Ruth Ackerman (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.10   Employment Agreement, dated September 15, 2012, by and between Healthcare Corporation of America and Ann Saskowitz (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.11   Consulting Agreement, dated October 1, 2012, by and between Healthcare Corporation of America, its subsidiaries, Rx Services Inc., Nitin Khandwala, and Hemil Khandwala (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.12   Lease, dated October 23, 2009, by and between W.P. Properties, LLC and Healthcare Corporation of America, its affiliates and subsidiaries (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.13   Lease, dated October 20, 2011, by and between W.P. Properties, LLC and Prescription Corporation of America (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).

 

48
 

 

10.14   Lease Extensions, dated February 28, 2012 (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.15   Management Services Agreement, dated January 1, 2012, by and between HCCA and Argus Health Systems (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).†
     
10.16   Amended and Restated Employment Agreement, dated May 9, 2013, by and between us and Yoram Bibring (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.17   Form of Restricted Stock Agreement, dated April 10, 2013 (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.18   Rescission Agreement, dated June 25, 2013, by and between us and Gary Sekulski (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.19   Rescission Agreement, dated June 28, 2013, by and between us and Thomas E. Durkin, III (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.20   Securities Escrow Agreement between us, American Stock Transfer & Trust Company, LLC and the Founders (Incorporated by reference to our Registration Statement on Form S-1 (File No. 333-172714) filed with the Securities and Exchange Commission on March 10, 2011).
     
10.21   Registration Rights Agreement among us and the founders (Incorporated by reference to our Registration Statement on Form S-1 (File No. 333-172714) filed with the Securities and Exchange Commission on March 10, 2011).
     
10.22   Employment Agreement by and between the Company and Natasha Giordano (incorporated by reference to our Current Report on Form 8-K dated December 31, 2013).
     
10.23   Amendment No. 1 to the Employment Agreement between the Company and Natasha Giordano (incorporated by reference to our Current Report on Form 8-K dated December 31, 2013).
     
14.1   Code of Business Conduct and Ethics (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
21.1   List of Subsidiaries (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
31.1   Certification of Principal Executive Officer pursuant to Rule 13A-14(A)/15D-14(A) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
31.2   Certification of the Principal Financial Officer pursuant to Rule 13A-14(A)/15D-14(A) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
32   Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. 1350 (Section 906 of the Sarbanes-Oxley Act of 2002)
     
101.INS   XBRL Instance Document
     
101.SCH   XBRL Taxonomy Extension Schema Document
     
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document

 

 

† Confidential treatment has been requested with respect to certain portions of this exhibit.

 

49
 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  HEALTHCARE CORPORATION OF AMERICA
     
Dated: March 13, 2014 By: /s/ Natasha Giordano
  Name: Natasha Giordano
  Title: Chief Executive Officer and President

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Dated: March 13, 2014 By: /s/ Natasha Giordano
  Name: Natasha Giordano
  Title: Chief Executive Officer, President and Director (Principal Executive Officer)
     
Dated: March 13, 2014 By: /s/ Yoram Bibring
  Name: Yoram Bibring
  Title: Chief Financial Officer (Principal Accounting and Financial Officer)
     
Dated: March 13, 2014 By: /s/ Ann F. Saskowitz
  Name: Ann F. Saskowitz
  Title: VP Service Operations and Director
     
     
Dated: March 13, 2014 By: /s/ Yaron Eitan
  Name: Yaron Eitan
  Title: Director
     
Dated: March 13, 2014 By: /s/ Thomas E. Durkin, III
  Name: Thomas E. Durkin, III
  Title: Director
     
Dated: March 13, 2014 By: /s/ Edmundo Gonzalez
  Name: Edmundo Gonzalez
  Title: Director
     
Dated: March 13, 2014 By: /s/ Thomas Rebar
  Name: Thomas Rebar
  Title: Director
     
Dated: March 13, 2014 By: /s/ Gary Sekulski
  Name: Gary Sekulski
  Title: Director

 

50
 

  

EXHIBIT INDEX

 

Exhibit No.   Description
     
2.1   Agreement and Plan of Merger, dated January 25, 2013, by and among us, Selway Merger Sub, Inc., Healthcare Corporation of America, Prescription Corporation of America, Gary Sekulski, and Edmundo Gonzalez (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
3.1   Amended and Restated Certificate of Incorporation (Incorporated by reference to our Annual Report on Form 10-K for the fiscal year ended December 31, 2011, filed with the Securities and Exchange Commission on March 30, 2012).
     
3.2   By-laws (Incorporated by reference to our Registration Statement on Form S-1 (File No. 333-172714) filed with the Securities and Exchange Commission on March 10, 2011).
     
3.3   Certificate of Merger (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013)
     
3.4   Certificate of Amendment to Certificate of Incorporation dated September 27, 2013 (incorporated by reference to our Current Report on Form 8-K dated September 27, 2013)
     
4.1   Specimen common stock certificate
     
4.2   Form of Unit Purchase Option (Incorporated by reference to our Registration Statement on Form S-1 (File No. 333-172714) filed with the Securities and Exchange Commission on March 10, 2011).
     
4.3   Specimen Public Redeemable Warrant Certificate (Incorporated by reference to our Registration Statement on Form S-1 (File No. 333-172714) filed with the Securities and Exchange Commission on March 10, 2011).
     
4.4   Form of Sponsor Payment Warrant (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
4.5   Forbearance, Waiver and Modification No. 1 to Loan Agreement, dated December 31, 2013 (incorporated by reference to our Current Report on Form 8-K dated December 31, 2013).
     
4.6   Securities Purchase Agreement dated December 31, 2013 (incorporated by reference to our Current Report on Form 8-K dated December 31, 2013).
     
4.7   Form of Junior Secured Convertible Term Notes (incorporated by reference to our Current Report on Form 8-K dated December 31, 2013).

 

51
 

 

4.8   Form of Warrant (incorporated by reference to our Current Report on Form 8-K dated December 31, 2013).
     
4.9   Master Security Agreement (incorporated by reference to our Current Report on Form 8-K dated December 31, 2013).
     
4.10   Subsidiary Guarantee (incorporated by reference to our Current Report on Form 8-K dated December 31, 2013).
     
4.11   Registration Rights Agreement (incorporated by reference to our Current Report on Form 8-K dated December 31, 2013).
     
10.1   Voting Agreement, dated January 25, 2013, by and among us, Healthcare Corporation of America, and certain shareholders (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.2   Voting Agreement, dated April 10, 2013, by and among us and certain shareholders (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.3   Exchange Agreement, by and between us and certain shareholders (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.4   Exchange Agreement, by and between us and certain shareholders (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.5   Registration Rights Agreement, dated April 10, 2013, by and among us and Gary Sekulski, as representative of the stockholders of Healthcare Corporation of America (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.6   Closing Payment Escrow Agreement, dated April 10, 2013, by and among us, Selway Merger Sub, Inc., Healthcare Corporation of America, Gary Sekulski, Edmundo Gonzalez, and American Stock Transfer & Trust Company LLC, as escrow agent (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.7   Management Share Escrow Agreement, dated April 10, 2013, by and among us, Healthcare Corporation of America, certain key personnel signatories thereto, and American Stock Transfer & Trust Company LLC, as escrow agent (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.8   Marketing and Consulting Agreement, dated January 3, 2012, by and between Prescription Corporation of America and Otis Fund (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.9   Employment Agreement, dated September 15, 2012, by and between Healthcare Corporation of America and Ruth Ackerman (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.10   Employment Agreement, dated September 15, 2012, by and between Healthcare Corporation of America and Ann Saskowitz (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.11   Consulting Agreement, dated October 1, 2012, by and between Healthcare Corporation of America, its subsidiaries, Rx Services Inc., Nitin Khandwala, and Hemil Khandwala (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.12   Lease, dated October 23, 2009, by and between W.P. Properties, LLC and Healthcare Corporation of America, its affiliates and subsidiaries (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.13   Lease, dated October 20, 2011, by and between W.P. Properties, LLC and Prescription Corporation of America (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).

 

52
 

 

10.14   Lease Extensions, dated February 28, 2012 (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.15   Management Services Agreement, dated January 1, 2012, by and between HCCA and Argus Health Systems (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).†
     
10.16   Amended and Restated Employment Agreement, dated May 9, 2013, by and between us and Yoram Bibring (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.17   Form of Restricted Stock Agreement, dated April 10, 2013 (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.18   Rescission Agreement, dated June 25, 2013, by and between us and Gary Sekulski (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.19   Rescission Agreement, dated June 28, 2013, by and between us and Thomas E. Durkin, III (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
10.20   Securities Escrow Agreement between us, American Stock Transfer & Trust Company, LLC and the Founders (Incorporated by reference to our Registration Statement on Form S-1 (File No. 333-172714) filed with the Securities and Exchange Commission on March 10, 2011).
     
10.21   Registration Rights Agreement among us and the founders (Incorporated by reference to our Registration Statement on Form S-1 (File No. 333-172714) filed with the Securities and Exchange Commission on March 10, 2011).
     
10.22   Employment Agreement by and between the Company and Natasha Giordano (incorporated by reference to our Current Report on Form 8-K dated December 31, 2013).
     
10.23   Amendment No. 1 to the Employment Agreement between the Company and Natasha Giordano (incorporated by reference to our Current Report on Form 8-K dated December 31, 2013).
     
14.1   Code of Business Conduct and Ethics (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
21.1   List of Subsidiaries (incorporated by reference to our Current Report on Form 8-K dated January 25, 2013).
     
31.1   Certification of Principal Executive Officer pursuant to Rule 13A-14(A)/15D-14(A) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
31.2   Certification of the Principal Financial Officer pursuant to Rule 13A-14(A)/15D-14(A) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
32   Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. 1350 (Section 906 of the Sarbanes-Oxley Act of 2002)
     
101.INS   XBRL Instance Document
     
101.SCH   XBRL Taxonomy Extension Schema Document
     
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document

 

 

† Confidential treatment has been requested with respect to certain portions of this exhibit.

 

 

53
 

  

 

Healthcare Corporation of America

 

Consolidated Financial Statements

 

As of and for the periods ended June 30, 2013 and December 31, 2012

 

and

Report of Independent Registered Public Accounting Firm

 

 
 

 

HEALTHCARE CORPORATION OF AMERICA

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

    Page
     
Reports of Independent Registered Public Accounting Firms   F-1 to F-2
     
Consolidated Balance Sheets as of June 30, 2013 and December 31, 2012   F-3
     
Consolidated Statements of Operations for the Six Months Ended June 30, 2013 and Year Ended December 31, 2012   F-4
     
Consolidated Statements of Redeemable Securities and Stockholders’ Deficit for the Six Months Ended June 30, 2013 and Year Ended December 31, 2012   F-5
     
Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2013 and Year Ended December 31, 2012   F-6 to F-7
     
Notes to Consolidated Financial Statements   F-8 to F-26

 

 
 

 

Report of Independent Registered Public Accounting Firm

 

Board of Directors and Stockholders

Healthcare Corporation of America

Denville, NJ

 

We have audited the accompanying consolidated balance sheet of Healthcare Corporation of America as of June 30, 2013 and the related consolidated statements of operations, redeemable securities and stockholders’ deficit, and cash flows for the period January 1, 2013 to June 30, 2013. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audit.

 

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.

 

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Healthcare Corporation of America at June 30, 2013, and the results of its operations and its cash flows for the period January 1, 2013 to June 30, 2013, in conformity with accounting principles generally accepted in the United States of America.

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the consolidated financial statements, the Company has suffered recurring losses from operations and has significant working capital and stockholders’ deficiencies at June 30, 2013, that raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Woodbridge, NJ

March 13, 2014

 

F-1
 

 

THOMAS J. HARRIS

CERTIFIED PUBLIC ACCOUNTANT

3901 STONE WAY N., SUITE 202

SEATTLE, WA 98103

206.547.6050

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors

Healthcare Corporation of America & Subsidiaries

 

We have audited the accompanying balance sheet of Healthcare Corporation of America & Subsidiaries as of December 31, 2012 (Restated) and the related restated statements of operations, stockholders’ equity and cash flows for the year ended December 31, 2012 (Restated). Healthcare Corporation of America & Subsidiaries management is responsible for these financial statements. Our responsibility is to express an opinion on these financial statements based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Healthcare Corporation of America & Subsidiaries as of December 31, 2012 (Restated), and the restated results of its operations and cash flows for the period then ended in conformity with generally accepted accounting principles in the United States of America.

 

The accompanying financial statements have been prepared assuming the Company will continue as a going concern. As discussed in Note #2 to the financial statements, the company has had significant operating losses; a working capital deficiency and its need for new capital raise substantial doubt about its ability to continue as a going concern. Management’s plan in regard to these matters is also described in Note #2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

As discussed in Note 4 to the financial statements, the 2012 financial statements have been restated to correct a misstatement.

 

Seattle, Washington

February 28, 2013

May 15, 2013 as to Note 2 and Restatement

January 17, 2014 as to Note 4 Subsequent Restatement and Going Concern Paragraph Above

 

F-2
 

 

 

HEALTHCARE CORPORATION OF AMERICA

CONSOLIDATED BALANCE SHEETS

As of June 30, 2013 and December 31, 2012

 

   June 30, 2013   December 31, 2012 
Assets          
           
Current assets:          
Cash and cash equivalents  $1,792,026   $1,791,134 
Accounts receivable   1,251,579    1,126,846 
Inventory   442,945    544,004 
Rebates receivable   1,574,659    1,323,474 
Prepaid expenses and other current assets   322,638    619,271 
           
Total current assets   5,383,847    5,404,729 
           
Property and equipment, net   1,236,734    1,114,055 
Investment held in trust   8,652,482    - 
Deferred financing costs, net   548,394    - 
Software, net   262,142    - 
Other assets   443,251    83,686 
           
Total assets  $16,526,850   $6,602,470 
           
Liabilities, Redeemable Securities and Stockholders’ Deficit          
           
Current liabilities:          
Accounts payable  $5,214,355   $4,431,366 
Accrued expenses   2,428,033    568,528 
Deferred revenue   495,286    638,223 
Bridge notes   -    4,192,954 
Line of credit   534,343    - 
Current portion of capital leases   189,989    137,703 
Other current liabilities   162,387    - 
           
Total current liabilities   9,024,393    9,968,774 
           
Incentive Notes   2,771,514    - 
Capital leases, net of current portion   658,092    399,382 
Derivative liabilities   3,559,188    121,350 
Other liabilities   143,546    64,133 
           
Total liabilities   16,156,733    10,553,639 
           
Commitments and contingencies          
           
Redeemable securities:          
Redeemable common stock, $.001 par value;  839,965 shares issued and outstanding   8,651,639    - 
           
Total redeemable securities   8,651,639    - 
           
Stockholders’ deficit:          
Preferred stock, $.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding at June 30, 2013 and Preferred stock,  no par value; 592,500 shares authorized; 592,500 shares issued and  outstanding; liquidation preference of $1,481,250 at December 31, 2012   -    2,362,517 
Common stock, $.0001 par value; 30,000,000 shares authorized; 8,953,494  shares issued and outstanding at June 30, 2013 and Common stock, no par  value; 50,000,000 authorized; 40,000,009 shares issued and outstanding at          
December 31, 2012   895    4,175,856 
Additional paid-in capital   16,423,417    150,000 
Accumulated deficit   (24,705,834)   (10,639,542)
           
Total stockholders’ deficit   (8,281,522)   (3,951,169)
           
Total liabilities, redeemable securities and stockholders’ deficit  $16,526,850   $6,602,470 

 

The accompanying notes form an integral part of the financial statements.

 

F-3
 

 

HEALTHCARE CORPORATION OF AMERICA

CONSOLIDATED STATEMENTS OF OPERATIONS

For the Six Months Ended June 30, 2013 and the Year Ended December 31, 2012

 

   For the Six     
   Months Ended   For the Year Ended 
   June 30, 2013   December 31, 2012 
         
Sales  $24,328,860   $27,305,795 
Cost of sales   23,309,725    26,148,118 
           
Gross profit   1,019,135    1,157,677 
           
Operating expenses:          
Selling, general and administrative   10,815,273    7,603,458 
           
Loss from operations   (9,796,138)   (6,445,781)
           
Other income (expense):          
Interest expense   (4,332,317)   (1,130,184)
Change in fair value of derivative liabilities   62,163    - 
           
Total other income (expense)   (4,270,154)   (1,130,184)
           
Loss before provision for income taxes   (14,066,292)   (7,575,965)
           
Provision for income taxes   -    - 
           
Net loss  $(14,066,292)  $(7,575,965)
           
Less: Deemed dividend to preferred stockholders   (3,532,858)   - 
           
Net loss attributable to common stockholders  $(17,599,150)  $(7,575,965)
           
Earnings per share:          
Basic and diluted loss per share  $(2.57)  $(0.19)
           
Weighted average number of shares outstanding   6,851,819    38,939,909 

 

The accompanying notes form an integral part of the financial statements

 

F-4
 

 

HEALTHCARE CORPORATION OF AMERICA

CONSOLIDATED STATEMENTS OF REDEEMABLE SECURITIES AND STOCKHOLDERS’ DEFICIT

For the Six Months Ended June 30, 2013 and the Year Ended December 31, 2012

 

           Stockholders’ Deficit   Treasury     
   Redeemable Common Stock   Preferred Stock   Common Stock   Additional   Accumulated   Stock   Stockholders’ 
   Shares   Amount   Shares   Amount   Shares   Amount   Paid-In Capital   Deficit   Shares   Amount   Deficit 
                                             
Balance at January 1, 2012   -   $-    -   $2,362,517    37,879,809   $3,525,294   $-   $(3,063,577)   -   $-   $2,824,234 
Sale of common stock   -    -    -    -    2,120,200    650,562    -    -    -    -    650,562 
Issuance of warrants   -    -    -    -              250,000    -    -    -    250,000 
Redemption of common stock   -    -    -    -         -    (100,000)   -    -    -    (100,000)
Net loss   -    -    -    -    -    -    -    (7,575,965)   -    -    (7,575,965)
                                                        
Balance at December 31, 2012   -    -    -    2,362,517    40,000,009    4,175,856    150,000    (10,639,542)   -    -    (3,951,169)
Receipt of stock previously redeemed   -    -    -    -    -    -    100,000    -    (500,000)   (100,000)   - 
Stock based compensation   -    -    -    -    -    -    380,000    -    500,000    100,000    480,000 
Effect of recapitalization – reverse merger with Selway Capital                                                       
Acquisition Corp   -    -    -    (2,362,517)   (40,000,009)   (4,175,856)   4,175,856    -    -    -    (2,362,517)
Issue stock to stockholders   -    -    -    -    5,200,000    520    (520)   -    -    -     
Selway equity at closing   -    -    -    -    2,500,000    250    20,599,750    -    -    -    20,600,000 
Common stock issued upon conversion of bridge notes   -    -    -    -    315,959    32    3,159,592    -    -    -    3,159,624 
Common stock issued in conversion of redeemable preferred stock and 296,250 warrants   -    -    -    -    592,500    59    2,362,458    -    -    -    2,362,517 
Common stock issued as incentive shares   -    -    -    -    750,000    75    2,919,925    -    -    -    2,920,000 
Conversion of sponsor warrants into common stock   -    -    -    -    100,000    10    (10)   -    -    -     
Stock issued to underwriters   -    -    -    -    335,000    33    (33)   -    -    -     
Stock subject to redemption   839,965    8,651,639    -    -    (839,965)   (84)   (8,651,555)   -    -    -    (8,651,639)
Expenses of offering   -    -    -    -    -    -    (814,076)   -    -    -    (814,076)
Payments to Series A Holders   -    -    -    -    -    -    (3,101,038)   -    -    -    (3,101,038)
Assumed liabilities of Selway   -    -    -    -    -    -    (6,323,148)                  (6,323,148)
Recognition of contingent beneficial conversion feature on the convertible bridge notes   -    -    -    -    -    -    1,182,327                   1,182,327 
Stock based compensation   -    -    -    -    -    -    283,889    -    -    -    283,889 
Net loss   -    -    -    -    -    -    -    (14,066,292)   -    -    (14,066,292)
                                                        
Balance at June 30, 2013   839,965   $8,651,639    -   $-    8,953,494   $895   $16,423,417   $(24,705,834)   -   $-   $(8,281,522)

 

The accompanying notes form an integral part of the financial statements

 

F-5
 

 

HEALTHCARE CORPORATION OF AMERICA

CONSOLIDATED STATEMENTS OF CASH FLOWS

For the six months ended June 30, 2013 and the year ended December 31, 2012

 

   Six Months Ended   Year Ended 
   June 30, 2013   December 31, 2012 
         
Cash used in operating activities:          
Net loss  $(14,066,292)  $(7,575,965)
Adjustments to reconcile net loss to cash used in operating activities:          
Depreciation and amortization   156,664    205,997 
Non cash interest expense   2,443,296    - 
Stock-based compensation   3,683,889    - 
Note-based compensation   412,824    - 
Common stock issued as other expense   -    641,142 
Mark to market adjustment on warrant liability   (62,163)   - 
Changes in assets and liabilities:          
Accounts receivable   (124,733)   42,316 
Rebates receivable   (251,185)   (1,323,474)
Inventory   101,059    (258,296)
Prepaid expenses and other current assets   300,811   (603,338)
Other assets   21,555    - 
Accounts payable and accrued expenses   2,589,957    295,502 
Deferred revenues   (142,937)   638,223 
Other liabilities   153,070  - 
Deferred rent   -   16,486 
           
Total cash used in operating activities   (4,784,185)   (7,921,407)
           
Cash used in investing activities:          
Purchase of property and equipment   (104,981)   (495,768)
           
Total cash used in investing activities   (104,981)   (495,768)
           
Cash from financing activities:          
Proceeds from cash received at Merger   11,948,361    - 
Payment to Series A Holders   (3,101,038)   - 
Expense of offering   (814,076)   - 
Proceeds from sale of common stock   -    9,420 
Proceeds from (Payments of) notes payable   (3,025,000)   4,192,954 
Drawings on line of credit   534,343    - 
Debt costs   (527,024)   - 
Redeemable preferred stock   -    2,362,517 
Warrants (repaid)/ issued   -    371,350 
Redemption of common stock   -    (100,000)
Payments of capital leases    (125,508)   - 
Other   -    17,683 
           
Total cash provided by financing activities   4,890,058    6,853,924 
           
Net increase (decrease) in cash   892    (1,563,251)
           
Cash, beginning of period   1,791,134    3,354,385 
           
Cash, end of period  $1,792,026   $1,791,134 

 

(Continued)

 

The accompanying notes form an integral part of the financial statements

 

F-6
 

 

HEALTHCARE CORPORATION OF AMERICA

CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)

For the Six Months Ended June 30, 2013 and the Year Ended December 31, 2012

 

   Six Months Ended   Year Ended 
   June 30, 2013   December 31, 2012 
         
Supplemental disclosures:          
           
Interest  $(305,318)  $(852,276)
           
Income taxes  $-   $- 
           
Conversion of stockholders’ loans to equity  $2,306,501   $- 
           
Equipment purchases under capital leases  $436,504      
Deferred financing fees incurred but not paid   88,730      
Promissory notes and interest converted to common stock   3,159,624      
           
Assets received in reverse merger:          
Other receivable  $857      
Note receivable   3,554      
           
    4,411      
           
Liabilities assumed in reverse merger:          
Accounts payable   183,981      
Deferred underwriting fees   148,008      
Notes payable   1,977,570      
Warrant liability   4,018,000      
Common stock   -      
Additional paid-in capital   -      
Accumulated deficit   -      
           
    6,327,559      
           
Net liabilities assumed  $6,323,148      

 

The accompanying notes form an integral part of the financial statements

 

F-7
 

 

HEALTHCARE CORPORATION OF AMERICA

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

As of June 30, 2013 and December 31, 2012 and for the Six-Month Period and Year Then Ended

 

 

1.Description of Business

 

Selway Capital Acquisition Corporation (“SCAC” or “Selway”) was originally incorporated under the laws of Delaware on January 12, 2011 for the purpose of acquiring one or more operating businesses through merger or capital stock exchange. On January 25, 2013, an agreement and plan of merger (the “Merger”) was entered into between SCAC and Healthcare Corporation of America (“HCCA”). The Merger closed on April 10, 2013 with SCAC being the surviving entity upon the consummation of the Merger (see Note 3).

 

HCCA and its wholly-owned subsidiaries, Prescription Corporation of America Benefits (“PCA Benefits”) and Prescription Corporation of America (“PCA”), are engaged in providing benefits management and mail order pharmaceutical fulfillment services to companies primarily in the northeast United States.

 

On June 3, 2013, SCAC amended its articles of incorporation to change its name to Healthcare Corporation of America (collectively with its subsidiaries, the “Company”).

 

On April 22, 2013, the Company’s board of directors approved the change of its fiscal year end from December 31 to June 30.

 

On November 7, 2013, the board of directors approved the change of its fiscal year end back to December 31.

  

The accompanying historical consolidated financial statements represent the financial position and results of operations of HCCA through April 10, 2013 and the financial position and results of operations of the Company thereafter (see Note 3).

  

2.Liquidity and Financial Condition

 

The Company has a working capital deficit and a history of recurring losses and negative cash flows from operating activities. As of June 30, 2013 and December 31, 2012, the Company has a working capital deficit of $3,640,546 and $4,564,045, respectively and stockholders’ deficit of $8,281,522 and $3,951,169, respectively. During the six months ended June 30, 2013 and year ended December 31, 2012, the Company incurred net losses of $14,066,292 and $7,575,965, respectively, and negative cash flows from operating activities of $4,784,185 and $7,921,407, respectively. Collectively, these factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

The Company is currently making efforts to raise capital in the form of debt and/or equity. No assurance can be given that the debt and/or equity can be raised and if available it will be on terms acceptable to the Company.

 

The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.

 

3.The Merger

 

On January 25, 2013, an Agreement and Plan of Merger (the “Agreement”) was entered into by and among the Company, Selway Merger Sub, Inc., a New Jersey corporation and wholly owned subsidiary of the Company (“Merger Sub”), HCCA, PCA, and representatives of HCCA and the Company. On April 10, 2013 (the “Closing Date”), the Merger and other transactions contemplated by the Agreement closed.

 

Pursuant to the Agreement, Merger Sub merged with and into HCCA, resulting in HCCA becoming a wholly owned subsidiary of the Company. PCA and PCA Benefits, a dormant entity, remain wholly owned subsidiaries of HCCA.

  

F-8
 

  

HEALTHCARE CORPORATION OF AMERICA

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of June 30, 2013 and December 31, 2012 and for the Six-Month Period and Year Then Ended

  

3.The Merger (Continued)

 

Holders of all of the issued and outstanding shares of common stock of HCCA immediately prior to the time of the Merger had each of their shares of common stock of HCCA converted into the right to receive: (i) a proportional amount of 5,200,000 shares of the Company’s Series C common stock and promissory notes with an aggregate face value of $7,500,000 (collectively, the “Closing Payment”); plus (ii) a proportional amount of up to 2,800,000 shares of the Company’s common stock, if any, (the “Earn-out Payment Shares”) issuable upon the Company achieving certain consolidated gross revenue thresholds as more fully described below; plus (iii) the right to receive a proportional amount of the proceeds from the exercise of certain warrants being issued to Selway Capital Holdings, LLC, Selway’s sponsor, as more fully described below. A portion of the Closing Payment (520,000 shares and promissory notes with an aggregate face value of $750,000) was being held in escrow for a period of 12 months following the Merger to satisfy indemnification obligations of HCCA. Effective December 20, 2013, the escrowed portion of the Closing Payment, together with a portion of the shares issued to HCCA’s investment banking advisor (an aggregate of 546,002 shares, and promissory notes with an aggregate face value of $750,000) were released from escrow and cancelled.

 

The promissory notes included in the Closing Payment are non-interest bearing and subordinated to all senior debt of the combined company in the event of a default under such senior debt. The notes will be repaid from 18.5% of the Company’s free cash-flow (as defined) in excess of $2,000,000. The Company will be obligated to repay such notes if, among other events, there is a transaction that results in a change of control of the Company. The Company valued the notes at $1,977,570, which represented the present value of the estimated future cash flows to be generated by the combined companies discounted using an interest rate reflective of the uncertainty and credit risk of the notes.

  

Certain members of HCCA’s management received an aggregate of 1,500,000 shares of our common stock (the “Management Incentive Shares”), which shares were placed in escrow and subject to release in three installments through June 30, 2015. Subsequently, certain members of HCCA management agreed to cancel an aggregate of 750,000 shares pursuant to rescission agreements entered into June 2013. Of the remaining Management Incentive Shares outstanding, 400,000 shares have vested but remain in escrow until June 30, 2014 and 350,000 shares will vest on June 30, 2015 and will remain in escrow until June 30, 2015.

  

As part of the Merger, Selway’s net liabilities, consisting primarily of warrant liabilities, were assumed. As part of its Initial Public Offering, Selway issued 2,000,000 warrants, with an exercise price of $7.50 and an expiration date of November 6, 2016 (“Selway IPO Warrants”). These warrants are classified as liabilities based on certain anti-dilution features. The Selway IPO Warrants were recorded at $4,018,000 based on the closing price of the warrants on the date of Merger.

  

The Earn-out Payment Shares, if any, will be issued as follows: (i) 1,400,000 shares if the Company achieves consolidated gross revenue of $150,000,000 for the twelve months ended March 31, 2014 or June 30, 2014; and (ii) 1,400,000 shares if the Company achieves consolidated gross revenue of $300,000,000 for the twelve months ended March 31, 2015 or June 30, 2015. In the event the Company does not achieve the first earn-out threshold, but does achieve the second earn-out threshold, then all of the Earn-out Payment Shares shall be issued. If the Company consolidates, merges or transfers substantially all of its assets prior to June 30, 2015 at a valuation of at least $15.00 per share, then all of the Earn-out Payment Shares not previously paid out shall be issued immediately prior to such transaction. If, prior to achieving either earn-out threshold the Company acquires another business in exchange for its equity or debt securities, then any remaining earn-out thresholds may be adjusted by the independent members of the Company’s board of directors at their sole discretion. The Company estimates that it will not achieve any of the abovementioned revenue targets and, therefore, no provision has been made for the Earn-out Payment Shares.

  

The Agreement required 10% of the consideration, or 520,000 shares of the Company’s Series C common stock and promissory notes with a face value of $750,000 to be held in escrow for a period of one year. As a result of the investigation and subsequent restatement (see Note 4), in December 2013 these shares of stock and promissory notes were returned to the Company. Also in December 2013, the rights to additional proceeds from the exercise of certain warrants issued to Selway Capital Holdings, LLC as part of the merger were cancelled.

  

F-9
 

  

HEALTHCARE CORPORATION OF AMERICA

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of June 30, 2013 and December 31, 2012 and for the Six-Month Period and Year Then Ended

  

In connection with a bridge financing (the “Bridge Financing”) completed by HCCA in September 2012, HCCA issued 59.25 units, each unit consisted of 10,000 Convertible Preferred Shares, a warrant for 5,000 shares of common stock that, upon a merger with Selway, converted to warrants with the same terms as Selway IPO warrants and a Promissory Note with a face value of $100,000 (“Promissory Notes”). At the time of the Merger, holders of all of the issued and outstanding shares of preferred stock of HCCA, by virtue of the Merger, had each of their shares of Preferred Stock of HCCA converted into the right to receive a proportional amount of 592,500 shares of the Company’s Series C common stock and warrants to purchase 296,250 shares of the Company’s Series C common stock. If a Merger with Selway or equivalent, as defined in the Preferred Stockholder agreement, occurred before the maturity date of the promissory notes, the preferred stock converted on a 1 to 1 basis into Series C Common Stock of Selway. If such Merger did not occur, then at the maturity of the Promissory Notes, the Preferred Stock converted into 3.7% of common stock of HCCA on a fully diluted basis. Upon issuing the preferred stock, HCCA determined the contingent beneficial conversion feature to the holders of the Preferred Stock if the Merger with Selway occurred to be $3,532,858 and recorded that as a deemed dividend to the Preferred Stockholders upon the closing of the Merger.

  

The warrants issued in connection with the bridge loan were initially exercisable at $7.50 into shares of common stock of HCCA and expired on November 7, 2016. The warrants contained certain anti-dilution that caused them to be classified as liabilities. Upon completion of the Merger with Selway, the warrants became exercisable in Series C shares of Common Stock of Selway. The exercise price and expiration date remained the same.

  

The Promissory Notes bore interest at 8%, were convertible into 10,000 shares of Series C Common Stock if a transaction with Selway occurred and matured on the earlier of a transaction with Selway or September 12, 2013. HCCA allocated the value received from the sale of the units first to the estimated fair value of warrants. The residual value was then allocated to the preferred stock and promissory note based on their relative fair values. As a result of the allocation, HCCA recorded a debt discount of $2,445,242. The debt discount was amortized to interest expense over the term of the Promissory Note. HCCA recorded interest expense of $1,732,047, including $1,018,851 to recognize the unamortized debt discount at the transaction date in the period ending June 30, 2013. HCCA recorded interest expense of $713,196 related amortization of the debt discount in the year ended December 31, 2012. Upon issuing the promissory notes, HCCA determined the contingent beneficial conversion feature to the holders of the Promissory Notes, if they converted into shares of Selway and recorded additionally $1,182,327, as additional interest expense upon the conversion of the promissory notes. In accordance with the terms of the promissory notes issued in the Bridge Financing, at the time of the Merger, notes in the aggregate amount of $3,159,624 (including principal and interest accrued to date) were converted into 315,959 shares of the Company’s Series C common stock and notes in the aggregate principal amount of $3,025,000 were repaid in full. The promissory note included in the Bridge Financing was only convertible into shares of common stock if the transaction with Selway closed before the maturity of the note. At the issuance of the Bridge Financing, the Company determined that a contingent beneficial conversion feature existed representing the difference in the value of the underlying shares and the allocated value to the promissory note. Upon closing of the transaction, the Company recognized the contingent beneficial conversion feature and recorded $1,182,327 as additional interest expense in the period ended June 30, 2013.

  

In connection with the Bridge Financing, HCCA executed a registration rights agreement that required it to register the shares underlying the Bridge Financing if the transaction was completed. The agreement required HCCA to file a registration statement within 60 days of the completion of the transaction with Selway and have the registration statement declared effective within 120 days. The agreement requires damages of 1% per month of the Bridge Financing, capped at 10%, for each month the Company does not comply with the requirement. As a result of the restatements and investigation, the Company concludes that it is probable it will not file a registration statement and have declared within the period required and estimates that it will incur the maximum damages under the agreement. The Company recorded $592,500 to interest expense for the period ended June 30, 2013.

 

In conjunction with the merger of Merger Sub into HCCA:

 

·The Company entered into exchange agreements with three beneficial holders of HCCA’s bridge loan who were also beneficial holders of greater than 5% of the Company’s Series A common stock. Pursuant to the exchange agreements, such holders converted an aggregate of 281,554 shares of the Company’s Series A common stock to the Company’s Series C common stock. In conjunction with the exchange, such holders were repaid bridge notes in the aggregate principal amount of $3,025,000.

  

F-10
 

  

HEALTHCARE CORPORATION OF AMERICA

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of June 30, 2013 and December 31, 2012 and for the Six-Month Period and Year Then Ended

  

·The Company entered into exchange agreements with three beneficial holders of greater than 5% of the Company’s Series A common stock. Pursuant to the exchange agreements, such holders converted an aggregate of 878,481 shares of the Company’s Series A common stock to the Company’s Series C common stock and received $3.53 per share of Series A common stock exchanged, or an aggregate of $3,101,038.

 

·An aggregate of $11,948,361 was released from the Company’s trust account, reflecting the number of shares of the Company’s Series A common stock that were converted into the Company’s Series C common stock, of which $237,007 was paid to the underwriters from the Company’s initial public offering. The Company incurred other costs related to the transaction totaling $577,069 and recorded both these costs and the costs paid to the underwriters as a reduction to Additional Paid In Capital.

  

·The placement warrants held by the Company’s founders were converted into the right to receive: (i) an aggregate of 100,000 shares of common stock; and (ii) warrants to purchase an aggregate of 1,000,000 shares of common stock at an exercise price of $10.00 per share. The proceeds from the exercise of the exchange warrants will be paid: (i) 75% to the holders of all of the issued and outstanding shares of common stock of HCCA immediately prior to the time of the merger; and (ii) 25% to certain members of HCCA management. The exchange warrants are only exercisable for cash, may not be exercised on a cashless basis, and must be exercised if the closing price for the combined company’s common stock exceeds $12.00 per share for 20 trading days in any 30-trading-day period. On November 22, 2013, the Company cancelled these warrants and issued a new warrant to purchase 1 million shares of common stock. The replacement warrant was recorded to additional paid in capital. Per the terms of the warrant agreement, the warrant’s initial exercise price was $7.50 per share, subject to adjustment upon the first subsequent financing of the Company. This financing occurred on December 31, 2013 upon which the exercise price of this warrant was adjusted from $7.50 to $1.50. The new warrants do not include the provision to share the exercise proceeds with former shareholders of HCCA or management. The Company will record a charge in the quarter ended December 31, 2013 reflecting the value of the modification to the warrant.

 

Pursuant to an engagement letter entered into by HCCA with its investment banking adviser, 5% of all consideration received was owed to the adviser. Accordingly the Company issued 335,000 shares of common stock representing 5% of the common stock and incentive stock, as adjusted, received by HCCA and issued an incentive note of $500,000 representing 5% of the incentive notes issued to HCCA. The present value of the incentive note was recorded to additional paid in capital and is included in liabilities assumed.

  

The business combination of the Company and HCCA was accounted for as a reverse recapitalization of HCCA, since prior to the merger the Company was a shell corporation as defined under Rule 12b-2 of the Exchange Act. HCCA was treated as the accounting acquirer in this transaction due to the following factors:

  

1)HCCA’s management pre-closing remained as the management of the Company post-closing;

  

2)The members of the board of directors of HCCA pre-closing represent the majority of directors of the Company post- closing; and

  

3)The majority of shares of the Company post-closing were still owned by HCCA shareholders, who represented 60% of the Company’s shares outstanding immediately after closing, if all shares subject to conversion in our post-closing tender offer actually convert to Series C (non-redeemable) common shares, and 65% of the Company’s shares outstanding if all shares subject to conversion do not convert to Series C shares and opt to receive their pro rata cash in trust at the time of the post-closing tender offer. Estimates of HCCA’s ownership do not include shares underlying warrants held by public investors and the Company’s sponsors restricted incentive shares held by management. However, HCCA shareholders would still have 51% of the Company’s shares post-closing when including shares underlying warrants and restricted shares and assuming all redeemable shares convert to Series C shares, and 54% of the Company’s shares post-closing if all shares subject to conversion do not convert to Series C shares and opt to receive their pro rata cash in trust at the time of the post-closing tender offer.

  

F-11
 

  

HEALTHCARE CORPORATION OF AMERICA

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of June 30, 2013 and December 31, 2012 and for the Six-Month Period and Year Then Ended

  

4.Restatement

 

The financial statements for 2012 have been revised to correct material errors in accounting for the Company’s sales, accounts receivable, cost of sales, accounts payable, capital leases, accrued rent and accrued taxes. In accordance with applicable Generally Accepted Accounting Principles (GAAP), the Company calculated and recognized adjustments accordingly.

 

On March 25, 2013, the Company filed with the Securities and Exchange Commission (“SEC”) its audited financial statements for the years ended December 31, 2012 and 2011. Following the discovery of various material errors the Company informed the SEC on May 9, 2013 that these financial statements could not be relied upon, and on May 15, 2013 filed its restated audited financial statements for the above-mentioned periods (First Restatement Financial Statements).

 

On September 19, 2013 following the discovery by management of additional material errors and misstatements in the First Restatement Financial Statements, the Company informed the SEC that the previously restated financials could not be relied upon and that the Company would review its financial statements in an attempt to discover all the material errors and misstatements that were included therein.

 

As part of this review, the Company engaged external consultants to review and investigate its books and records and other related transactions and activities for 2012 and 2011. As a result of this review, management concluded that it will be unable to complete its restated 2011 financial statements, due to lack of sufficient source documents and other information. In addition, the Company discovered various additional material errors and misstatements in the 2012 financial statements which were corrected in these restated financial statements.

  

F-12
 

  

HEALTHCARE CORPORATION OF AMERICA

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of June 30, 2013 and December 31, 2012 and for the Six-Month Period and Year Then Ended

  

The following table represents the effects of the subsequent and first restated statements as of December 31, 2012:

 

   Subsequent   First     
   Restatement   Restated   Original 
   December 31, 2012   December 31, 2012   December 31, 2012 
             
Accounts receivable  $1,126,846   $572,637   $1,220,065 
                
Rebates receivable  $1,323,474   $1,323,474   $1,638,000 
                
Other receivables  $40,867  $40,867   $40,867 
                
Accounts payable  $4,431,366   $4,520,223   $1,514,857 
                
Accrued expenses  $568,528   $453,057   $453,057 
                
Note payable  $4,192,954   $4,947,613   $4,947,613 
                
Redeemable preferred stock  $2,362,517   $458,800   $458,800 
                
Warrant liability  $121,350   $518,587   $518,587 
                
Common stock  $4,175,856   $3,556,056   $3,556,056 
                
APIC  $150,000   $-   $- 
                
Sales  $27,305,795   $28,663,284   $38,401,140 
                
Cost of sales  $26,148,118   $24,068,906   $31,650,232 
                
General and administrative expenses  $7,603,458   $7,299,603   $7,299,603 
                
Interest expense  $(1,130,184)  $640,286   $640,286 
                
Accumulated deficit  $(10,639,542)  $(8,937,860)  $(4,970,540)
                
Loss per share  $(0.19)  $(0.09)  $(0.02)

 

5.Significant Accounting Policies

 

Basis of Presentation

 

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements including disclosure of contingent assets and liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period and accompanying notes. The Company’s critical accounting policies are those that are both most important to the Company’s financial condition and results of operations and require the most difficult, subjective or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of the uncertainty of factors surrounding the estimates or judgments used in the preparation of the financial statements, actual results could differ from these estimates.

  

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances have been eliminated in consolidation.

  

F-13
 

  

HEALTHCARE CORPORATION OF AMERICA

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of June 30, 2013 and December 31, 2012 and for the Six-Month Period and Year Then Ended

  

Accounts Receivable

 

Accounts receivable represent amounts owed to the Company for products sold and services rendered net of an allowance for doubtful accounts. The Company grants unsecured credit to its customers. The Company continuously monitors the payment performance of its customers to ensure collections and minimize losses. Management does not believe that significant credit risks exist. An allowance for doubtful accounts is based upon the credit profiles of specific customers, economic and industry trends and historic payment experience. There is no allowance for doubtful accounts at June 30, 2013 and December 31, 2012.

 

Inventory

 

Inventories consist of finished pharmaceutical products and are recorded at the lower of cost or market, with the cost determined on a first-in, first-out basis. The Company periodically reviews the composition of inventory in order to identify obsolete, slow-moving or otherwise non-saleable items. If non-saleable items are observed and there are no alternate uses for the inventory, the Company will record a write-down to net realizable value in the period that the decline in values is first recognized.

  

Rebates

  

Pharmaceutical manufacturers offer rebates for selected brand drugs. The Company currently receives these rebates through a third party administrator. The rebates are considered earned when members (employees of customers) order the drugs. Rebates earned are paid to the Company by the third party administrator quarterly. Rebates earned are recognized as a reduction to cost of revenue. The portion of the rebate payable to customers is simultaneously recognized as a reduction of revenue. Management evaluates rebates receivable at the end of every reporting period and adjusts the amount reflected on the accompanying balance sheet to net realizable value. An adjustment is also made to the rebate payable to customers to correspond with any adjustment that applies to rebates receivable.

 

Property and Equipment

 

Property and equipment are stated at cost less accumulated amortization and depreciation. Leasehold improvements are amortized using the straight-line method over the shorter of the term of the lease or the estimated useful lives of the assets. Furniture and fixtures are depreciated using the straight-line method over the estimated useful lives of the assets of 5 years. Computer equipment and software are depreciated using the straight-line method over the estimated useful lives of the assets, which range from 3 to 5 years.

 

Internal-Use Software Development Costs

 

The Company capitalizes certain costs associated with the purchase and/or development of internal-use software, including its website. Generally, external and internal costs incurred during the application development stage of a project are capitalized. The application development stage of a project generally includes software design and configuration, coding, testing and installation activities. Training and maintenance costs are expensed as incurred. Upgrades and enhancements are capitalized if it is probable that such expenditures will result in additional functionality. Capitalized software costs are amortized using the straight-line method over the estimated useful life of the asst, which approximates 3 years.

  

Long-Lived Assets

 

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. The Company assesses recoverability by determining whether the net book value of the related asset will be recovered through the projected undiscounted future cash flows of the asset. If the Company determines that the carrying value of the asset may not be recoverable, it measures any impairment based on the fair value of the asset as compared to its carrying value. During the six months ended June 30, 2013 and the year ended December 31, 2012, the Company did not record any impairment charges.

  

F-14
 

 

HEALTHCARE CORPORATION OF AMERICA

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of June 30, 2013 and December 31, 2012 and for the Six-Month Period and Year Then Ended

 

Investments Held in Trust

 

The Company applies the provisions of ASC Topic 320-10, Investment – Debt and Equity, to account for investments held in trust, which comprise only of held-to maturity securities. Held-to-maturity securities are those securities, which the Company has the ability and intent to hold until maturity. Held-to-maturity securities are recorded at amortized cost on the accompanying balance sheets and adjusted for any amortization or accretion of premiums or discounts.

 

Deferred Financing Costs

 

Costs relating to obtaining the line of credit in April 2013 and the Bridge Notes in September 2012 have been capitalized and amortized over the term of the related debt using the straight line method. Amortization of deferred financing costs charged to interest expense was $686,631 and $254,993 in the six months ended June 30, 2013 and for the year ended December 31, 2013, respectively. The unamortized balance was $548,394 and $552,380 at June 30, 2013 and December 31, 2012, respectively.

  

Derivative Financial Instruments

 

The Company applies the provisions of ASC Topic 815-40, Contracts in Entity’s Own Equity (“ASC Topic 815-40”), under which convertible instruments and warrants, which contain terms that protect holders from declines in the stock price (reset provisions), may not be exempt from derivative accounting treatment. As a result, such warrants are recorded as a liability and are revalued at fair value at the end of each reporting period. Furthermore, under derivative accounting, the warrants are initially recorded at their fair value. If the fair value of the warrants exceeds the face value of the related debt, the excess is recorded as a change in fair value in the statement of operations on the issuance date.

 

Debt Discounts

 

Debt discounts are amortized using the effective interest rate method over the term of the related debt. The result achieved using the straight-line method is not materially different than those which would result using the effective interest method.

 

Share-Based Payments

 

Share-based payments to employees are measured at the fair value of the award on the date of grant based on the estimated number of awards that are ultimately expected to vest. The compensation expense resulting from such awards is recorded over the vesting period of the award in selling, general and administrative expenses on the accompanying consolidated statements of operations.

 

Share-based payments to non-employees for services rendered are recorded at either the fair value of the services rendered, or the fair value of the awards, whichever is more readily determinable. The expense resulting from such awards is marked to market over the vesting period of the award in selling, general and administration expenses on the accompanying consolidated statements of operations.

  

F-15
 

 

HEALTHCARE CORPORATION OF AMERICA

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of June 30, 2013 and December 31, 2012 and for the Six-Month Period and Year Then Ended

  

Revenue Recognition

 

The Company typically enters into annual renewable agreements with its customers to provide pharmacy benefit management on a fixed price or self-insured basis. The Company records revenues from all its current contracts with customers gross as the Company acts as principal based on the following factors: 1) the Company has a separate contractual relationship with its customers and with its claims adjudicator to whom the Company pays the costs of the prescription drugs consumed by its customers (the claims), 2) the Company through its claim adjudicator is responsible to validate and manage the claims, and 3) the Company bears the credit risk for the amount due from the customers. Revenues are recorded monthly as earned. The Company also operates a mail order pharmacy that services plan members. All revenues and associated costs from dispensing drugs by the mail order pharmacy to our plan members, excluding the members’ co-pay are eliminated as inter-company revenues. Some of the contracts contain terms whereby the Company makes certain financial guarantees regarding prescription costs. Actual performance is compared to the guaranteed measure throughout the period and accruals are recorded as an offset to revenue if the Company fails to meet a financial guarantee.

  

Cost of Sales

 

Cost of sales includes claim payments for both fixed- price and self-insured programs, administrative fees paid for processing the claims to the claims adjudicator and, the cost of prescription drugs of the mail order pharmacy.

 

Advertising Expenses

 

Advertising expenses are expensed as incurred and included in selling, general and administrative expenses on the accompanying statements of operations. Advertising expenses were approximately $68,000 and $143,000 for the six months ended June 30, 2013 and year ended December 31, 2012, respectively.

 

Income Taxes

 

The Company accounts for income taxes using the liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. A valuation allowance is established when realization of net deferred tax assets is not considered more likely than not.

 

Uncertain income tax positions are determined based upon the likelihood of the positions being sustained upon examination by taxing authorities. The benefit of a tax position is recognized in the consolidated financial statements in the period during which management believes it is more likely than not that the position will not be sustained. Income tax positions taken are not offset or aggregated with other positions. Income tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of income tax benefit that is more than 50 percent likely of being realized if challenged by the applicable taxing authority. The portion of the benefits associated with income tax positions taken that exceeds the amount measured is reflected as income taxes payable.

 

The Company recognizes interest related to uncertain tax positions in interest expense. The Company recognizes penalties related to uncertain tax positions in income tax expense.

 

Fair Value Measurements

 

The Company applies recurring fair value measurements to its derivative instruments in accordance with ASC 820, Fair Value Measurements. In determining fair value, the Company uses a market approach and incorporates assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and/or the risks inherent in the inputs to the valuation techniques. These inputs can be readily observable, market corroborated or generally unobservable internally-developed inputs. Based upon the observability of the inputs used in these valuation techniques, the Company’s derivative instruments are classified as follows:

  

F-16
 

  

HEALTHCARE CORPORATION OF AMERICA

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of June 30, 2013 and December 31, 2012 and for the Six-Month Period and Year Then Ended

  

Level 1:The fair value of derivative instruments classified as Level 1 is determined by unadjusted quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.

 

Level 2:The fair value of derivative instruments classified as Level 2 is determined by quoted market prices for similar assets or liabilities in active markets, quoted market prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data.

 

Level 3:The fair value of derivative instruments classified as Level 3 is determined by internally-developed models and methodologies utilizing significant inputs that are generally less readily observable from objective sources.

 

The Company’s valuation methodology for warrants classified as derivative liabilities qualifies as a level 2 fair value measurement since it is determined using internally developed models and analysis.

 

At June 30, 2013 the Company had 2,000,000 warrants exercisable into its Class C shares that were issued in connection with Selway’s initial public offering (“Selway IPO Warrants”). These warrants are publicly traded and are classified as liabilities. Additionally, HCCA issued 296,250 warrants in connection with the Bridge Financing with identical terms as the Selway IPO Warrants. The Company has valued all of these warrants as June 30, 2013 based on the closing price of the Selway IPO Warrants. Because the market for the Selway IPO Warrants is not active, the valuation is classified as a Level 2 measurement. These warrants are exercisable at $7.50 a share and expire on November 7, 2016.

 

The table below presents the Company’s fair value hierarchy for those derivative instruments measured at fair value on a recurring basis as of June 30, 2013:

 

   Level 1   Level 2   Level 3   Total 
                 
Warrants  $-   $3,559,188   $-   $3,559,188 
                     
Total derivative liabilities  $-   $3,559,188   $-   $3,559,188 

  

The table below presents the Company’s fair value hierarchy for those derivative instruments measured at fair value on a recurring basis as of December 31, 2012:

 

   Level 1   Level 2   Level 3   Total 
                 
Warrants  $-   $121,350   $-   $121,350 
                     
Total derivative liabilities  $-   $121,350   $-   $121,350 

 

Fair Value of Financial Instruments

 

The fair values of cash and cash equivalents, accounts receivable, rebates receivable and accounts payable approximate their carrying values due to the short-term nature of the instruments. The fair values of long-term debt and revolving loans approximates their carrying value due to their variable interest rates. The fair value of investments held in trust is not materially different than its carrying value because of the short-term nature of the investments.

 

Risks and Concentrations

 

The Company utilizes the services of a single claims adjudicator. If there is an adverse situation in this relationship, the Company’s mail order pharmaceutical fulfillment services would be ineffective until a replacement claims adjudicator was obtained.

  

F-17
 

  

HEALTHCARE CORPORATION OF AMERICA

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of June 30, 2013 and December 31, 2012 and for the Six-Month Period and Year Then Ended

 

Approximately 12% of the Company’s 2012 revenues were derived from one customer. Revenues from this customer were 10% of our revenues for the six month period ended June 30, 2013. No amounts were due from this customer at June 30, 2013 or December 31, 2012. In addition, one of the reseller’s customers accounted for approximately 14% of the Company’s revenue for the six month period ended June 30, 2013 as well as approximately 14% of the Company’s revenue for the year ended December 31, 2012. Amounts due from this customer represented 32% and 46% of accounts receivable at June 30, 2013 and December 31, 2012, respectively.

 

Cash and Cash Equivalents

 

The Company considers all cash in bank, money market funds and certificates of deposit with an original maturity of less than three months to be cash equivalents. The Company maintains its cash and cash equivalents in one financial institution. Cash balances on hand at this financial institution may exceed the insurance coverage provided to the Company by the Federal Deposit Insurance Corporation at various times during the year.

  

Earnings (Loss) Per Share

 

Basic earnings (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted earnings (loss) per share are determined in the same manner as basic earnings (loss) per share, except that the number of shares is increased to include potentially dilutive securities using the treasury stock method. Because the Company incurred a net loss in all periods presented, all potentially dilutive securities were excluded from the computation of diluted loss per share because the effect of including them is anti-dilutive.

 

   Six Months Ended   Year Ended 
   June 30, 2013   December 31, 2012 
Basic and Diluted:          
Net loss  $(14,066,292)  $(7,575,965)
Less: Deemed dividend to preferred stockholders   (3,532,858)   - 
Net loss attributable to common stockholders  $(17,599,150)  $(7,575,965)
Weighted average shares   6,851,819    38,939,909 
Basic loss per common share  $(2.57)  $(0.19)

  

The following table summarizes the number of shares of common stock attributable to potentially dilutive securities outstanding for each of the periods which are excluded in the calculation of diluted loss per share:

   

   Six Months Ended   Year Ended 
   June 30, 2013   December 31, 2012 
Dilutive Potential Common Shares          
Warrants  $3,314,023   $1,585,833
Restricted stock awards   -    75,292 
Convertible notes payable   -   2,666,667 

  

Reclassification

 

Certain previously reported amounts have been reclassified to conform to the presentation used in the June 30, 2013 financial statements.

  

6.Property and Equipment

 

Property and equipment is as follows:

 

   June 30, 2013   December 31, 2012 
         
Furniture, fixtures and equipment  $1,606,404   $1,374,126 
Leasehold improvements   25,260    10,162 
    1,631,664    1,384,288 
Accumulated depreciation and amortization   (394,930)   (270,233)
           
Net property and equipment  $1,236,734   $1,114,055 

 

F-18
 

 

HEALTHCARE CORPORATION OF AMERICA

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of June 30, 2013 and December 31, 2012 and for the Six-Month Period and Year Then Ended

 

Amortization and depreciation is approximately $124,700 and $206,000 for the six months ended June 30, 2013 and 2012.

 

7.Software, net

 

Software, net is as follows:

 

   June 30, 2013   December 31, 2012 
         
Software costs  $294,109   $- 
Accumulated amortization   (31,967)   - 
           
Net software costs  $262,142   $- 

 

Amortization expense was approximately $32,000 for the six month period ended June 30, 2013.

 

8.Investments Held in Trust

 

Following the initial public offering (“IPO”) of Selway in November 2011, a total of $20.6 million was placed in a trust account maintained by American Stock Transfer & Trust Company, as trustee. None of the funds held in the trust were to be released from the trust account, other than interest income, net of taxes, until the earlier of (i) consummation of an acquisition and (ii) redemption of 100% of the public shares sold in the IPO if Selway failed to consummate an acquisition by May 14, 2013.

 

On April 10, 2013, Selway closed the acquisition of HCCA through the Merger (see Notes 1 and 3). At the time of the Merger, holders of 1,160,035 shares of redeemable common stock decided not to redeem their shares and accordingly approximately $11,948,000 was released from the escrow. As per the certificate of incorporation of Selway, the remaining balance of the trust account of approximately $8,652,000 was used to redeem the remaining 839,965 redeemable common shares through a tender offer which closed on August 15, 2013. The amount in trust can be invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940 having a maturity of 180 days or less. During the six months ended June 30, 2013, the United States government securities were in an account at Wells Fargo Bank, while the cash amount was in a JP Morgan Chase cash account. The United States government securities matured and the total trust balance of $8,652,482 was in cash.

 

The Company classified its United States Treasury and equivalent securities as held-to-maturity in accordance with FASB ASC 320, “Investments – Debt and Equity Securities.” Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheet and adjusted for the amortization or accretion of premiums or discounts.

 

9.Deferred Financing Costs

 

Deferred financing costs are as follows:

 

     
Balance January 1, 2013  $- 
Costs incurred for line of credit for the six months ended June 30, 2013   615,754 
Amortization for the six monthes ended June 30, 2013   (67,360)
      
Balance June 30, 2013  $548,394 

 

F-19
 

 

HEALTHCARE CORPORATION OF AMERICA

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of June 30, 2013 and December 31, 2012 and for the Six-Month Period and Year Then Ended

 

10.Accrued Expenses

 

Accrued expenses are as follows:

 

   June 30, 2013   December 31, 2012 
         
Accrued severence costs*  $750,000   $- 
Accrued rebates   364,196    77,329 
Accrued registration rights penalties**   592,000    - 
Accrued professional fees   290,777    50,000 
Accrued expenses other   431,060    441,199 
           
   $2,428,033   $568,528 

 

*Payable to a former executive of the Company.

 

**Estimated penalties relating to late registration of shares of common stock in connection with the bridge notes.

 

11.Line of Credit

 

On April 11, 2013, the wholly-owned subsidiaries of HCCA, entered into a credit and security agreement for a secured revolving credit facility with an initial aggregate credit limit of $5,000,000. The facility has a term of 3 years, through April 11, 2016, during which the loan proceeds are to be used solely for working capital. The facility was terminated in September 2013 due to the Company’s inability to meet certain financial covenants and all outstanding balances under the line were repaid. The outstanding amount on the line of credit as of June 30, 2013 was $534,343.

 

12.Bridge Notes

 

On September 12, 2012, the Company completed a bridge financing (the “Bridge Financing”) consisting of 59.25 units, each unit consisting of 10,000 preferred shares, 5,000 warrants and a promissory note with a face value of $100,000. At the time of the transaction, the value of the units was allocated as follows: Preferred Stock was recorded at a value of $2,362,517, the warrants were recorded as a warrant liability of $82,726 and the notes were recorded at a value of $3,479,757, reflecting a loan discount of $2,445,242. In addition, the Company incurred loan fees amounting to $673,229. The Company recorded interest expense associated with the amortization of the loan discount and the loan fees through the Merger date.

 

At the time of the Merger, holders of all of the issued and outstanding shares of preferred stock of HCCA, by virtue of the Merger, had each of their shares of preferred stock of HCCA converted into the right to receive a proportional amount of 592,500 shares of the Company’s Series C common stock and warrants to purchase 296,250 shares of the Company’s Series C common stock. In accordance with the terms of the promissory notes issued in the Bridge Financing, at the time of the Merger, notes in the aggregate amount of $3,159,592 (including principal and interest accrued to date) were converted into 315,959 shares of the Company’s Series C common stock and notes in the aggregate principal amount of $3,025,000 were repaid in full.

  

13.Long-Term Debt

 

Incentive Notes

 

Upon consummation of the merger (see Note 3), Holders of all of the issued and outstanding shares of common stock of HCCA immediately prior to the time of the Merger had each of their shares of common stock of HCCA converted into the right to receive a proportional amount of 5,200,000 shares of the Company’s Series C common stock and promissory notes with an aggregate face value of $7,500,000 (collectively, the “Closing Payment”).

 

In addition, the Company issued to its management $2,500,000 of Management Incentive Notes and paid fees in connection with the transaction by issuing promissory notes having an aggregate principal amount of $500,000, which reflects five percent of all promissory notes issued in the transaction.

 

The above described notes with an aggregate face value of $10,500,000 have identical terms and conditions, are non-interest bearing and are subordinated to all senior debt of the Company in the event of a default under such senior debt. The notes will be repaid from 25% of the Company’s free cash-flow (defined as in the notes) in excess of $2,000,000. The Company will be obligated to repay such notes if, among other events, there is a transaction that results in a change of control of the Company.

  

F-20
 

  

HEALTHCARE CORPORATION OF AMERICA

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of June 30, 2013 and December 31, 2012 and for the Six-Month Period and Year Then Ended

  

The notes were recorded at their estimated present value, based on the estimated time of repayment discounted to the balance sheet date. The Company will continue to re-evaluate its estimates on a periodic basis and adjust the present value of the notes accordingly. Of the Management Incentive Notes, $222,477, net of discount vested immediately and $395,514 is being recognized as management incentive compensation over the estimated payment periods.

  

   June 30, 2013 
     
Shareholder notes  $7,500,000 
Placement notes   500,000 
Management incentive notes   2,500,000 
      
    10,500,000 
Less debt discount   (7,728,486)
      
   $2,771,514 

 

Future maturities of the Incentive Notes based on the Company’s estimates are as follows:

 

June 30,    
     
2014  $- 
2015   - 
2016   399,000 
2017   1,789,000 
2018   3,622,000 
Thereafter   4,690,000 
      
   $10,500,000 

  

Capital Leases

 

The Company has entered into capital lease agreements for equipment, which expire at various dates through November 2019. The assets capitalized under these leases and associated accumulated depreciation at June 30, 2013 and December 31, 2012 are as follows:

 

   June 30, 2013   December 31, 2012 
         
Furniture and equipment  $1,007,735   $584,638 
Accumulated depreciation   (250,821)   (153,937)
           
   $756,914   $430,701 

 

F-21
 

 

HEALTHCARE CORPORATION OF AMERICA

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of June 30, 2013 and December 31, 2012 and for the Six-Month Period and Year Then Ended

 

Amortization of capital leases is included in depreciation expense.

 

Minimum future lease payments under capital lease obligations as of June 30, 2013 are as follows:

 

Year Ended June 30,     
      
2014  $256,257 
2015   242,040 
2016   209,938 
2017   158,814 
2018   106,617 
Thereafter   50,640 
      
Total future minimum lease payments   1,024,306 
Less amount representing interest   (176,225)
Present value of net minimum lease payments   848,081 
Less current portion   (189,989)
      
   $658,092 

 

14.Redeemable Securities

 

Redeemable common stockholders are entitled to redeem all or a portion of such shares in connection with the Company’s initial Business Transaction, as defined in the Company’s Certificate of Incorporation, and are entitled to share ratably in the trust account, including the deferred underwriting discounts and commissions and accrued but undistributed interest, net of (i) taxes payable, (ii) interest income earned on the trust account (approximately $10.30 per share) and (iii) a pro rata share of the trust account released to the Company for each Share converted to a Series C Share upon completion of a Business Transaction. As of June 30, 2013, there were 839,965 shares of Series B common stock outstanding which are subject to redemption. These shares were redeemed from the trust account on August 15, 2013

 

15.Stockholders’ Equity

 

The Company is authorized 30,000,000 shares of common stock, par value $.0001, which shares may, but are not required to, be designated as part of one of three series, callable Series A, callable Series B and Series C shares. The holders of all common shares shall possess all voting power and each share shall have one vote.

 

Series A – Holders of shares of Series A Common Stock are entitled to cause the Corporation to redeem all or a portion of their shares in connection with an acquisition transaction. If the holders of Series A Common Stock do not elect to have their shares redeemed, then they will automatically be converted to Series B Common Stock. As of June 30, 2013 there are no outstanding Series A Common Stock.

 

Series B – Holders of shares of Series B Common Stock have the same rights as Series A Common Stock, except Series B Common Stock cannot be issued until such time as all outstanding shares of Series A Common Stock are converted to Series B Common Stock. The holders of Series B Common Stock have the right to participate in a Post-Acquisition Tender Offer or Post-Acquisition Automatic Trust Liquidation. As of June 30, 2013 there are 839,965 shares of Series B Common Stock outstanding, which are accounted for as shares subject to redemption on the balance sheet.

 

Series C – Holders of shares of Series C Common Stock have the same rights as Series A Common Stock, except holders of Series C Common Stock are not entitled to (1) cause the Corporation to redeem all or a portion of such Series C Common Stock in connection with the Acquisition Transaction, (2) share ratably in the Trust Account or (3) participate in a Post-Acquisition Tender Offer or Post-Acquisition Automatic Trust Liquidation. As of June 30, 2013, there are 8,953,494 shares of Series C Common Stock outstanding.

  

F-22
 

  

HEALTHCARE CORPORATION OF AMERICA

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of June 30, 2013 and December 31, 2012 and for the Six-Month Period and Year Then Ended

  

The Series A Common Stock, Series B Common Stock and Series C Common Stock will be automatically consolidated into one series of Common Stock after the consummation of the Post-Acquisition Tender Offer or Post-Acquisition Automatic Trust Liquidation. The consolidation shall be on a one-for-one basis of the then outstanding shares of each series of common stock. Following the automatic consolidation, only one series of Common Stock will be authorized, which will be referred to as “Common Stock,” which occurred after June 30, 2013.

 

Prior to the merger the Company’s operations were conducted under the HCCA corporate entity (See Note 1). HCCA had authorized 50,000,000 shares of common stock, no par value. Upon the merger, every 7.6923 HCCA shares of common stock were exchanged into 1 share of the Company’s common stock.

 

During 2012, the Company issued 2,120,200 shares of common stock with a fair value range of $0.01 to $0.31. These shares are freely tradable.

 

During 2012, the Company settled a suit with a shareholder to repurchase 500,000 shares of its common stock. These shares were recorded as a stock redemption for $100,000 and the shares were received in February 2013. In February 2013, these shares were issued to employees in recognition of service performed and an expense of $480,000 was recorded representing the estimate fair value of the shares issued.

 

As part of the Merger, 750,000 restricted shares of stock were issued to certain members of management. The shares were valued at $7.30, the share price at the date of the merger. 400,000 shares vested immediately and the remaining vest through June 30, 2015. In the period ending June 30, 2013, the Company recorded an expense of $2,920,000 for the shares that vested on the date of the Merger and $283,889 for the shares that vest through June 30, 2015.

  

16.Income Taxes

 

There was no provision (benefit) for income taxes for the six months and year ended June 30, 2013 and December 31, 2012.

 

Deferred tax assets are as follows:

  

   June 30, 2013   December 31, 2012 
         
Loss carryforwards  $6,363,018   $2,064,222 
Intangible assets   81,000    44,000 
Accrued expenses   1,060,000    1,060,000 
Stock based compensation   209,904    - 
Fixed assets   7,409   (14,120)
Less valuation allowance   (7,721,331)   (3,154,102)
           
Total net deferred tax assets  $-   $- 

  

The valuation allowance was increased by $4,567,229 during the six months ended June 30, 2013 and $2,575,828 for the year ended December 31, 2012. The valuation allowance was increased due to uncertainties as to the Company’s ability to generate sufficient taxable income to utilize the net operating loss carry forwards and other deferred income tax items.

  

F-23
 

  

HEALTHCARE CORPORATION OF AMERICA

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of June 30, 2013 and December 31, 2012 and for the Six-Month Period and Year Then Ended

  

A reconciliation of income taxes at the U.S. federal statutory rate to the income expense is as follows:

  

   Six Months and Year Ended 
   June 30, 2013   December 31, 2012 
U.S. Federal statutory rate   (34.0)%   (34.0)%
State income taxes, net of federal benefit   (5.9)   (5.9)
Permanent differences   (0.20)   0.20 
Interest expense   7.90    - 
Change in valuation allowance   32.2%   39.7%
           
Effective tax rate   - %   - %

  

The Company’s ability to utilize the net operating loss carry forwards in future years may be significantly limited in accordance with the provisions of Section 382 of the Internal Revenue Code, because of the changes in ownership that have occurred. The Company’s NOL may be further limited should there be any further changes in ownership. As defined in Section 382 of the Internal Revenue Code, the Company who has undergone, or may undergo in the future, a greater than fifty percent ownership change as a result of financing initiatives. Consequently, there may be limitations on the amount of the Company’s NOLs which may be utilized to offset future taxable income in any one year.

  

At June 30, 2013, the Company had federal and state net operating loss carry forwards (“NOLs”) of approximately $15,900,000. The federal net operating loss carry forwards will begin to expire in the year 2035.

 

In July 2006, the Financial Accounting Standards Board (“FASB”) issued ASC 740-10, Uncertainty in Income Taxes, which defines the threshold for recognizing the benefits of tax-return positions in the financial statements as “more-likely-than-not” to be sustained by the taxing authorities. This statement also requires explicit disclosure requirements about a Company’s uncertainties related to their income tax position, including a detailed roll forward or tax benefits taken that do not qualify for financial statement recognition. The Company files income tax returns in the U.S. federal jurisdiction and New Jersey. The Company’s tax years open to examination for federal and state are from 2009. The Company has no amount recorded for any unrecognized tax benefits as of June 30, 2013 and December 31, 2012 nor did the Company record any amount for the implementation of ASC 740-10-25. The Company’s policy is to record estimated interest and penalty related to the underpayment of income taxes for unrecognized tax benefits as a component of its income tax provision. During the period ended June 30, 2013 and year ended December 31, 2012 the Company did not recognize any interest or penalties accrued for unrecognized tax benefits.

 

17.Commitments and Contingencies

 

Operating Leases

 

The Company has certain non-cancelable operating leases for facilities and equipment that expire over the next four years. Future minimum payments for non-cancelable operating leases are as follows as of June 30, 2013:

 

Minimum Rental Payments 
     
2014  $207,764 
2015   206,251 
2016   217,740 
2017   146,520 
      
   $778,275 

 

Rent expense for the six months ended June 30, 2013 and for the year ended December 31, 2012 was $96,468 and $186,733, respectively.

 

Employment Agreements

 

As of June 30, 2013, the Company had entered into employment agreements with senior officers and other members of management. The agreements specify aggregate guaranteed annual salaries of $2.4 million for each year of employment and extended through May 2017. The agreements allowed the Company to terminate these individuals for cause and not for cause. Depending on the terms of the individual contract upon termination without cause the Company would either be required to continue to pay salary through the original term of the contract or pay severance, typically one year of salary.

  

From September 2013 to January 2014, the Company terminated agreements representing $1 million in annual compensation. The Company made severance payments of $120,000 and in one case replaced an existing agreement with an annual consulting agreement that renews annually and permits the Company to terminate at any time with 90 days notice.

  

F-24
 

  

HEALTHCARE CORPORATION OF AMERICA

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of June 30, 2013 and December 31, 2012 and for the Six-Month Period and Year Then Ended

  

As of June 30, 2013, the Company entered into employment contracts or employment arrangement letters with certain members of management that among other things committed the Company to issuing approximately 650,000 stock options. Subsequent to June 30, 2013, the Company entered into additional arrangements committing to issue an additional 841,000 of stock options. The Company does not currently have a stock option plan and these stock options will be granted at the time the stock option plan is appropriately established.

  

Litigation

 

During 2012, the Company filed a lawsuit against its past adjudicator of claims for overcharges, over payment on claims, errors and misclassifications, and rebates owed from drug manufacturers claiming damages of over $5 million. Additionally, the Company has recorded an expense for the amount owed for claims payable. The adjudicator of claims filed a counterclaim for amounts it claims are owed to it by the Company.

  

In August 2013, the Company settled the suit with the claims adjudicator. Under the terms of the settlement the Company agreed to pay the claims adjudicator $2.7 million over 15 months commencing in September 2013. This amount was recorded as a liability as of December 31, 2012, in accounts payable.

 

On August 14, 2012, the Company entered into an agreement with a shareholder to buy back 500,000 shares of common stock for $100,000. The order also called upon the payment of $50,000 in legal fees. As of December 31, 2012, the Company had not received the 500,000 shares of common stock but had paid the settlement. The Company received these shares in February 2013. A stock redemption was recorded on December 31, 2012 in the amount of $100,000.

  

F-25
 

  

HEALTHCARE CORPORATION OF AMERICA

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of June 30, 2013 and December 31, 2012 and for the Six-Month Period and Year Then Ended

  

18.Selected Financial Data (unaudited)

 

   Six months ended 
   June 30, 2012 
     
Revenue  $10,056,735 
Gross profit  $426,730 
Loss before income taxes  $(2,490,381)
Net loss  $(2,495,461)
Basic and diluted net income per share  $(0.07)
Weighted average number of shares outstanding   37,897,909 

  

19.Related Party

 

Otis Fund, a company controlled by a former consultant, who owns in excess of 5% of the Company’s outstanding shares, has a consulting agreement to provide marketing and sales services to HCCA. The contract was due to expire on January 2, 2017; however the Company terminated the agreement for cause in September 2013. The annual fees related to these services were $360,000.

  

In September 2012, 2,068,200 shares were issued to two entities believed to be controlled by this former consultant of the Company. The Company is currently investigating the circumstances under which these shares were issued to the two entities. The Company recorded a charge in 2012 equal to the shares of $641,142 as general and administrative expense.

 

20.Subsequent Events

 

On July 15, 2013, the Company entered into a $5 million Loan agreement with Partners For Growth III LP (“PFG”). On October 15, 2013 PFG notified the Company of events of Default. On December 31, 2013, the Company and PFG entered into a forbearance waiver and modification agreement to the Loan agreement.

 

The Company issued a total of 555,000 warrants to PFG in connection with the loan agreement and the forbearance waiver and modification agreement.

 

On August 15, 2013, the Company completed the purchase, through a tender offer, of 839,965 Series B shares of Common Stock in consideration for approximately $8.65 million (see Notes 8 and 14). Upon the completion of the tender offer and pursuant to the Company’s certificate of incorporation, all three classes of common stock A, B and C were consolidated into one class of common stock.

 

On September 26, 2013, the Company terminated its line of credit.

 

On November 7, 2013, the Company’s Board of Directors decided to change the Company’s fiscal year end from June 30 to December 31.

 

On December 31, 2013, the Company entered into a securities purchase agreement (the “SPA”) with certain purchasers (each a “Purchaser” and collectively, the “Purchasers”) named therein and Chardan Capital Markets, LLC (“Agent”) as administrative and collateral agent. Pursuant to the SPA, the Company issued $2,112,500 of Junior Secured Convertible Term Notes (the “Notes”), which Notes are convertible into shares of the Company’s common stock at an initial fixed conversion price equal to $1.50 per share. The Purchasers of Notes also received warrants (the “Warrants”) to purchase one share for every $1.50 of Notes purchased by such Purchaser. The Company completed the initial closing of a private placement of Notes and Warrants under the SPA on December 31, 2013, and may continue to make subsequent placements under the SPA until it has placed an aggregate of $6,000,000 in Notes under the SPA or the date that is 30 days after the date of such initial closing (the private placements under the SPA are collectively referred to as the “Private Placement”).

 

In connection with the Private Placement the Company agreed to pay the Agent a fee representing 9% of the principal amount of the Notes plus the $500,000 additional loan from the Lender, less $250,000, or $2,362,500. The fee was paid in the form of additional Notes (with a pro rata number of warrants) in the amount of $212,625 (for total principal amount of Notes equal to $2,325,125).

 

In connection with the issuance of the Notes under the SPA, the Company issued warrants to purchase an aggregate of 1,550,083 shares of common stock (including warrants to purchase 141,750 shares issued to the Agent for its fees), at an exercise price of $3.00 per share (the “Exercise Price”), at any time on or prior to December 31, 2018 (the “Warrants”). The Warrants may also be exercised on a cashless basis.

 

The Company and its subsidiaries entered into a Master Security Agreement with the Agent pursuant to which the Company and its subsidiaries agreed to secure the payment of all obligations under the Notes by granting and pledging to the Agent a continuing security interest in all of the Company’s and its subsidiaries’ property now owned or at any time hereafter acquired by them.

 

F-26

 

EX-4.1 2 v370891_ex4-1.htm EXHIBIT 4.1

 

 

 

 
 

  

 

 

 

 

EX-31.1 3 v370891_ex31-1.htm EXHIBIT 31.1

 

EXHIBIT 31.1

 

CERTIFICATIONS PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 CERTIFICATION

 

I, Natasha Giordano, certify that:

 

1.I have reviewed this transition report on Form 10-K of Healthcare Corporation of America;

 

2.Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;
b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this annual report based on such evaluation; and
d)disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 13, 2014

 

  /s/ Natasha Giordano 
  Natasha Giordano
  Chief Executive Officer and President
  (Principal Executive Officer)

 

 

 

 

EX-31.2 4 v370891_ex31-2.htm EXHIBIT 31.2

 

EXHIBIT 31.2

 

CERTIFICATIONS PURSUANT TO

 SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 CERTIFICATION

 

I, Yoram Bibring, certify that:

 

1.I have reviewed this annual report on Form 10-K of Healthcare Corporation of America;

 

2.Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;
b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this annual report based on such evaluation; and
d)disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 13, 2014

 

  /s/ Yoram Bibring 
  Yoram Bibring
  Chief Financial Officer
  (Principal Financial and Accounting Officer)

 

 

 

EX-32 5 v370891_ex32.htm EXHIBIT 32

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

 18 U.S.C. SECTION 1350,

 AS ADOPTED PURSUANT TO

 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Healthcare Corporation of America (the “Company”) on Form 10-K for the period ending June 30, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, Natasha Giordano, Chief Executive Officer and President of the Company, and Yoram Bibring, Chief Financial Officer of the Company, certify that, to the best of her or his knowledge:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Pursuant to the rules and regulations of the Securities and Exchange Commission, this certification is being furnished and is not deemed filed.

 

Date: March 13, 2014 /s/ Natasha Giordano
  Natasha Giordano
  Chief Executive Officer and President
  (Principal Executive Officer)
   
Date: March 13, 2014 /s/ Yoram Bibring
  Yoram Bibring
  Chief Financial Officer
  (Principal Financial and Accounting Officer)

 

 

 

 

EX-101.INS 6 swca-20130630.xml XBRL INSTANCE DOCUMENT 0001514682 2012-01-01 2012-06-30 0001514682 2012-01-01 2012-12-31 0001514682 2013-01-01 2013-06-30 0001514682 2013-01-01 2013-12-31 0001514682 2013-02-28 0001514682 2014-03-10 0001514682 2013-04-01 2013-04-11 0001514682 2013-04-10 0001514682 2013-04-11 0001514682 2013-06-30 0001514682 2013-07-01 2013-12-31 0001514682 2012-08-01 2012-08-14 0001514682 2012-08-13 2012-09-12 0001514682 2012-09-01 2012-09-30 0001514682 2011-11-01 2011-11-30 0001514682 2012-12-31 0001514682 2013-12-31 0001514682 2011-12-31 0001514682 us-gaap:SubsequentEventMember 2013-07-01 2013-07-15 0001514682 us-gaap:WarrantMember 2013-01-01 2013-06-30 0001514682 swca:SeriesBCommonStocksMember 2013-06-30 0001514682 swca:SeriesCCommonStockMember 2013-06-30 0001514682 us-gaap:EmploymentContractsMember 2013-01-01 2013-06-30 0001514682 swca:LitigationMember 2012-01-01 2012-12-31 0001514682 swca:LitigationMember us-gaap:SubsequentEventMember 2013-08-01 2013-08-31 0001514682 swca:LitigationMember us-gaap:CommonStockMember 2012-08-01 2012-08-14 0001514682 swca:LitigationMember 2012-12-31 0001514682 swca:HealthcareCorporationOfAmericaMember 2013-06-30 0001514682 us-gaap:MinimumMember 2012-12-31 0001514682 us-gaap:MaximumMember 2012-12-31 0001514682 swca:HealthcareCorporationOfAmericaMember 2013-01-01 2013-06-30 0001514682 swca:RedeemableCommonStockMember 2011-12-31 0001514682 us-gaap:PreferredStockMember us-gaap:ShareholdersEquityMember 2011-12-31 0001514682 us-gaap:CommonStockMember us-gaap:ShareholdersEquityMember 2011-12-31 0001514682 us-gaap:AdditionalPaidInCapitalMember us-gaap:ShareholdersEquityMember 2011-12-31 0001514682 us-gaap:RetainedEarningsMember us-gaap:ShareholdersEquityMember 2011-12-31 0001514682 us-gaap:TreasuryStockMember 2011-12-31 0001514682 swca:RedeemableCommonStockMember 2012-01-01 2012-12-31 0001514682 us-gaap:PreferredStockMember us-gaap:ShareholdersEquityMember 2012-01-01 2012-12-31 0001514682 us-gaap:CommonStockMember us-gaap:ShareholdersEquityMember 2012-01-01 2012-12-31 0001514682 us-gaap:AdditionalPaidInCapitalMember us-gaap:ShareholdersEquityMember 2012-01-01 2012-12-31 0001514682 us-gaap:RetainedEarningsMember us-gaap:ShareholdersEquityMember 2012-01-01 2012-12-31 0001514682 us-gaap:TreasuryStockMember 2012-01-01 2012-12-31 0001514682 swca:RedeemableCommonStockMember 2013-01-01 2013-06-30 0001514682 us-gaap:PreferredStockMember us-gaap:ShareholdersEquityMember 2013-01-01 2013-06-30 0001514682 us-gaap:CommonStockMember us-gaap:ShareholdersEquityMember 2013-01-01 2013-06-30 0001514682 us-gaap:AdditionalPaidInCapitalMember us-gaap:ShareholdersEquityMember 2013-01-01 2013-06-30 0001514682 us-gaap:RetainedEarningsMember us-gaap:ShareholdersEquityMember 2013-01-01 2013-06-30 0001514682 us-gaap:TreasuryStockMember 2013-01-01 2013-06-30 0001514682 swca:RedeemableCommonStockMember 2012-12-31 0001514682 us-gaap:PreferredStockMember us-gaap:ShareholdersEquityMember 2012-12-31 0001514682 us-gaap:CommonStockMember us-gaap:ShareholdersEquityMember 2012-12-31 0001514682 us-gaap:AdditionalPaidInCapitalMember us-gaap:ShareholdersEquityMember 2012-12-31 0001514682 us-gaap:RetainedEarningsMember us-gaap:ShareholdersEquityMember 2012-12-31 0001514682 us-gaap:TreasuryStockMember 2012-12-31 0001514682 swca:RedeemableCommonStockMember 2013-06-30 0001514682 us-gaap:PreferredStockMember us-gaap:ShareholdersEquityMember 2013-06-30 0001514682 us-gaap:CommonStockMember us-gaap:ShareholdersEquityMember 2013-06-30 0001514682 us-gaap:AdditionalPaidInCapitalMember us-gaap:ShareholdersEquityMember 2013-06-30 0001514682 us-gaap:RetainedEarningsMember us-gaap:ShareholdersEquityMember 2013-06-30 0001514682 us-gaap:TreasuryStockMember 2013-06-30 0001514682 us-gaap:AccountsPayableMember 2013-01-01 2013-06-30 0001514682 swca:DeferredUnderwritingFeesMember 2013-01-01 2013-06-30 0001514682 us-gaap:NotesPayableOtherPayablesMember 2013-01-01 2013-06-30 0001514682 swca:WarrantLiabilityMember 2013-01-01 2013-06-30 0001514682 us-gaap:CommonStockMember 2013-01-01 2013-06-30 0001514682 us-gaap:AdditionalPaidInCapitalMember 2013-01-01 2013-06-30 0001514682 us-gaap:RetainedEarningsMember 2013-01-01 2013-06-30 0001514682 swca:WarrantLiabilityMember 2013-06-30 0001514682 us-gaap:FairValueInputsLevel1Member swca:WarrantLiabilityMember 2013-06-30 0001514682 us-gaap:FairValueInputsLevel2Member swca:WarrantLiabilityMember 2013-06-30 0001514682 us-gaap:FairValueInputsLevel3Member swca:WarrantLiabilityMember 2013-06-30 0001514682 us-gaap:FairValueInputsLevel1Member 2013-06-30 0001514682 us-gaap:FairValueInputsLevel2Member 2013-06-30 0001514682 us-gaap:FairValueInputsLevel3Member 2013-06-30 0001514682 us-gaap:FairValueInputsLevel1Member swca:WarrantLiabilityMember 2012-12-31 0001514682 us-gaap:FairValueInputsLevel2Member swca:WarrantLiabilityMember 2012-12-31 0001514682 swca:WarrantLiabilityMember 2012-12-31 0001514682 us-gaap:FairValueInputsLevel1Member 2012-12-31 0001514682 us-gaap:FairValueInputsLevel2Member 2012-12-31 0001514682 swca:ManagementIncentiveNotesMember 2013-01-01 2013-06-30 0001514682 swca:SeriesCCommonStockMember 2013-01-01 2013-06-30 0001514682 us-gaap:SeniorDebtObligationsMember 2013-06-30 0001514682 swca:ShareholderNotesMember 2013-06-30 0001514682 swca:PlacementNotesMember 2013-06-30 0001514682 swca:ManagementIncentiveNotesMember 2013-06-30 0001514682 swca:HealthcareCorporationOfAmericaMember swca:BridgeFinancingMember 2012-08-13 2012-09-12 0001514682 swca:BridgeFinancingMember 2012-09-12 0001514682 swca:SeriesCCommonStockMember 2012-09-12 0001514682 swca:HealthcareCorporationOfAmericaMember 2012-08-13 2012-09-12 0001514682 swca:HealthcareCorporationOfAmericaMember swca:BridgeFinancingMember 2012-09-12 0001514682 swca:HealthcareCorporationOfAmericaMember swca:SeriesCCommonStockMember 2012-08-13 2012-09-12 0001514682 swca:SeriesCCommonStockMember swca:BridgeFinancingMember 2012-08-13 2012-09-12 0001514682 swca:FirstRestatedMember 2012-12-31 0001514682 swca:OriginalMember 2012-12-31 0001514682 swca:FirstRestatedMember 2012-01-01 2012-12-31 0001514682 swca:OriginalMember 2012-01-01 2012-12-31 0001514682 us-gaap:FurnitureAndFixturesMember 2013-01-01 2013-06-30 0001514682 swca:ComputerEquipmentAndSoftwareMember us-gaap:MinimumMember 2013-01-01 2013-06-30 0001514682 swca:ComputerEquipmentAndSoftwareMember us-gaap:MaximumMember 2013-01-01 2013-06-30 0001514682 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2013-01-01 2013-06-30 0001514682 swca:HealthcareCorporationOfAmericaMember 2013-01-01 2013-06-30 0001514682 swca:HealthcareCorporationOfAmericaMember swca:EscrowMember swca:PromissoryNoteMember 2013-06-30 0001514682 swca:HealthcareCorporationOfAmericaMember swca:EarnoutPaymentSharesMember 2013-01-01 2013-06-30 0001514682 swca:HealthcareCorporationOfAmericaMember swca:ChardanCapitalMarketsLlcMember 2013-01-01 2013-06-30 0001514682 swca:HealthcareCorporationOfAmericaMember us-gaap:NotesPayableOtherPayablesMember 2013-01-01 2013-06-30 0001514682 swca:ManagementIncentiveSharesMember 2013-01-01 2013-06-30 0001514682 swca:ManagementIncentiveSharesMember swca:RescissionAgreementsMember 2013-01-01 2013-06-30 0001514682 swca:ManagementIncentiveSharesMember swca:June302014Member 2013-01-01 2013-06-30 0001514682 swca:ManagementIncentiveSharesMember swca:June302015Member 2013-01-01 2013-06-30 0001514682 swca:CriteriaMember 2013-06-30 0001514682 swca:HealthcareCorporationOfAmericaMember swca:EarnoutPaymentSharesMember swca:CriteriaOneMember 2013-01-01 2013-06-30 0001514682 us-gaap:SubsequentEventMember swca:SeriesBCommonStockMember 2013-08-01 2013-08-15 0001514682 swca:HealthcareCorporationOfAmericaMember swca:EarnoutPaymentSharesMember swca:CriteriaTwoMember 2013-01-01 2013-06-30 0001514682 swca:HealthcareCorporationOfAmericaMember swca:BridgeFinancingMember 2013-01-01 2013-06-30 0001514682 swca:HealthcareCorporationOfAmericaMember swca:BridgeFinancingMember 2013-06-30 0001514682 us-gaap:SubsequentEventMember 2013-08-01 2013-08-31 0001514682 us-gaap:BridgeLoanMember 2013-06-30 0001514682 us-gaap:BridgeLoanMember 2013-01-01 2013-06-30 0001514682 swca:SeriesCCommonStockMember 2013-06-30 0001514682 swca:SeriesCCommonStockMember 2013-01-01 2013-06-30 0001514682 swca:BridgeFinancingMember 2013-06-30 0001514682 swca:SeriesCCommonStockMember swca:BridgeFinancingMember 2013-01-01 2013-06-30 0001514682 swca:BridgeFinancingMember 2013-01-01 2013-06-30 0001514682 swca:SeriesCCommonStockMember us-gaap:BridgeLoanMember 2013-01-01 2013-06-30 0001514682 swca:SeriesCCommonStockMember us-gaap:BridgeLoanMember 2013-06-30 0001514682 swca:SeriesCommonStockMember 2013-06-30 0001514682 us-gaap:SubsequentEventMember 2013-06-30 0001514682 us-gaap:MaximumMember 2013-01-01 2013-06-30 0001514682 us-gaap:MinimumMember 2013-01-01 2013-06-30 0001514682 swca:IncentiveStockMember 2013-01-01 2013-06-30 0001514682 swca:HealthcareCorporationOfAmericaMember 2013-06-30 0001514682 us-gaap:SubsequentEventMember 2013-12-31 0001514682 us-gaap:SubsequentEventMember swca:PromissoryNoteMember 2013-12-31 0001514682 us-gaap:SubsequentEventMember 2013-01-01 2013-12-31 0001514682 us-gaap:SubsequentEventMember swca:PromissoryNoteMember 2013-01-01 2013-12-31 0001514682 swca:CustomerMember 2013-01-01 2013-06-30 0001514682 swca:CustomerMember 2012-01-01 2012-12-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares iso4217:USD swca:Warrant xbrli:pure 1792026 1791134 5383847 5404729 8652482 0 16526850 6602470 5214355 4431366 9024393 9968774 16156733 10553639 0 2362517 895 4175856 16423417 150000 -24705834 -10639542 -8281522 -3951169 16526850 6602470 0.0001 0 1000000 592500 0 0 592500 592500 0.0001 0 30000000 50000000 8953494 8953494 40000009 40000009 10815273 7603458 -9796138 -6445781 -2.57 -0.19 6851819 38939909 10-KT false 2013 FY SWCA 8832692 Healthcare Corp of America 0001514682 --12-31 No Yes No Smaller Reporting Company 20400000 4890058 6853924 892 -1563251 1791134 3354385 1792026 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div><b>1.</b></div> </td> <td style="TEXT-ALIGN: justify"> <div><b>Description of Business</b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Selway Capital Acquisition Corporation (&#8220;SCAC&#8221; or &#8220;Selway&#8221;) was originally incorporated under the laws of Delaware on January 12, 2011 for the purpose of acquiring one or more operating businesses through merger or capital stock exchange. On January 25, 2013, an agreement and plan of merger (the &#8220;Merger&#8221;) was entered into between SCAC and Healthcare Corporation of America (&#8220;HCCA&#8221;). The Merger closed on April 10, 2013 with SCAC being the surviving entity upon the consummation of the Merger (see Note 3).</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">HCCA and its wholly-owned subsidiaries, Prescription Corporation of America Benefits (&#8220;PCA Benefits&#8221;) and Prescription Corporation of America (&#8220;PCA&#8221;), are engaged in providing benefits management and mail order pharmaceutical fulfillment services to companies primarily in the northeast United States.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On June 3, 2013, SCAC amended its articles of incorporation to change its name to Healthcare Corporation of America (collectively with its subsidiaries, the &#8220;Company&#8221;).</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On April 22, 2013, the Company&#8217;s board of directors approved the change of its fiscal year end from December 31 to June 30.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.25in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">On November 7, 2013, the board of directors approved the change of its fiscal year end back to December 31.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.25in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0px; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The accompanying historical consolidated financial statements represent the financial position and results of operations of HCCA through April 10, 2013 and the financial position and results of operations of the Company thereafter<font style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> (see Note 3)</font>.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Cash and Cash Equivalents</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company considers all cash in bank, money market funds and certificates of deposit with an original&#160;maturity of less than three months to be cash equivalents. The Company maintains its cash and cash equivalents in one financial institution. Cash balances on hand at this financial institution may exceed the insurance coverage provided to the Company by the Federal Deposit Insurance Corporation at various times during the year.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Earnings (Loss) Per Share</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Basic earnings (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted earnings (loss) per share are determined in the same manner as basic earnings (loss) per share, except that the number of shares is increased to include potentially dilutive securities using the treasury stock method. Because the Company incurred a net loss in all periods presented, all potentially dilutive securities were excluded from the computation of diluted loss per share because the effect of including them is anti-dilutive.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 85%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>Six&#160;Months&#160;Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>Year&#160;Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>June&#160;30,&#160;2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="52%"> <div>Basic and Diluted:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Net loss</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(14,066,292)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(7,575,965)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Less: Deemed dividend to preferred stockholders</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(3,532,858)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Net loss attributable to common stockholders</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>(17,599,150)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>(7,575,965)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Weighted average shares</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>6,851,819</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>38,939,909</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Basic loss per common share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(2.57)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(0.19)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif ">&#160;</div><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The following table summarizes the number of shares of common stock attributable to potentially dilutive securities outstanding for each of the periods which are excluded in the calculation of diluted loss per share:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 85%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>Six&#160;Months&#160;Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>Year&#160;Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>June&#160;30,&#160;2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="52%"> <div>Dilutive Potential Common Shares</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>3,314,023</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>1,585,833</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Restricted stock awards</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>75,292</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Convertible notes payable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>2,666,667</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Fair Value of Financial Instruments</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The fair values of cash and cash equivalents, accounts receivable, rebates receivable and&#160;accounts payable approximate their carrying values due to the short-term nature of the instruments. The fair values of long-term debt and revolving loans approximates their carrying value due to their variable interest rates. The fair value of investments held in trust is not materially different than its carrying value because of the short-term nature of the investments.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="clear:both;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div><b>20.</b></div> </td> <td style="TEXT-ALIGN: justify"> <div><b>Subsequent Events</b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> On July 15, 2013, the Company entered into a $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5</font> million Loan agreement with Partners For Growth&#160;III LP (&#8220;PFG&#8221;). On October 15, 2013 PFG notified the Company of events of Default. On December 31, 2013, the Company and PFG entered into a forbearance waiver and modification agreement to the Loan agreement.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company issued a total of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 555,000</font> warrants to PFG in connection with the loan agreement and the forbearance waiver and modification agreement.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> On August 15, 2013, the Company completed the purchase, through a tender offer, of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 839,965</font> Series B shares of Common Stock in consideration for approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8.65</font> million (see Notes 8 and 14). Upon the completion of the tender offer and pursuant to the Company&#8217;s certificate of incorporation, all three classes of common stock A, B and C were consolidated into one class of common stock.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> On September 26, 2013, the Company terminated its line of credit.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> On November 7, 2013, the Company&#8217;s Board of Directors decided to change the Company&#8217;s fiscal year end from June 30 to December 31.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> On December 31, 2013, <font style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">the Company entered into a securities purchase agreement (the &#8220;SPA&#8221;) with certain purchasers (each a &#8220;Purchaser&#8221; and collectively, the &#8220;Purchasers&#8221;) named therein and Chardan Capital Markets, LLC (&#8220;Agent&#8221;) as administrative and collateral agent. Pursuant to the SPA,</font> the Company issued $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,112,500</font> of Junior Secured Convertible Term Notes <font style="FONT-SIZE: 10pt">(the &#8220;Notes&#8221;), which Notes are convertible into shares of the Company&#8217;s common stock at an initial fixed conversion price equal to $1.50 per share. The Purchasers of Notes also received warrants (the &#8220;Warrants&#8221;) to purchase one share for every $1.50 of Notes purchased by such Purchaser. The Company completed the initial closing of a private placement of Notes and Warrants under the SPA on December 31, 2013, and may continue to make subsequent placements under the SPA until it has placed an aggregate of $6,000,000 in Notes under the SPA or the date that is 30 days after the date of such initial closing (the private placements under the SPA are collectively referred to as the &#8220;Private Placement&#8221;).</font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">In connection with the Private Placement the Company agreed to pay the Agent a fee representing 9% of the principal amount of the Notes plus the $500,000 additional loan from the Lender, less $250,000, or $2,362,500. The fee was paid in the form of additional Notes (with a pro rata number of warrants) in the amount of $212,625 (for total principal amount of Notes equal to $2,325,125).</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">In connection with the issuance of the Notes under the SPA, the Company issued warrants to purchase an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,550,083</font> shares of common stock (including warrants to purchase 141,750 shares issued to the Agent for its fees), at an exercise price of $3.00 per share (the &#8220;Exercise Price&#8221;), at any time on or prior to December 31, 2018 (the &#8220;Warrants&#8221;). The Warrants may also be exercised on a cashless basis.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <font style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">The Company and its subsidiaries entered into a Master Security Agreement with the Agent pursuant to which the Company and its subsidiaries agreed to secure the payment of all obligations under the Notes by granting and pledging to the Agent a continuing security interest in all of the Company&#8217;s and its subsidiaries&#8217; property now owned or at any time hereafter acquired by them</font>.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Accounts Receivable</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Accounts receivable represent amounts owed to the Company for products sold and services rendered net of an allowance for doubtful accounts. The Company grants unsecured credit to its customers. The Company continuously monitors the payment performance of its customers to ensure collections and minimize losses. Management does not believe that significant credit risks exist. An allowance for doubtful accounts is based upon the credit profiles of specific customers, economic and industry trends and historic payment experience. There is no allowance for doubtful accounts at June 30, 2013 and December 31, 2012.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Inventory</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Inventories consist of finished pharmaceutical products and are recorded at the lower of cost or market, with the cost determined on a first-in, first-out basis. The Company periodically reviews the composition of inventory in order to identify obsolete, slow-moving or otherwise non-saleable items. If non-saleable items are observed and there are no alternate uses for the inventory, the Company will record a write-down to net realizable value in the period that the decline in values is first recognized.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Principles of Consolidation</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances have been eliminated in consolidation.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Property and Equipment</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Property and equipment are stated at cost less accumulated amortization and depreciation. Leasehold improvements are amortized using the straight-line method over the shorter of the term of the lease or the estimated useful lives of the assets. Furniture and fixtures are depreciated using the straight-line method over the estimated useful lives of the assets of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5</font> years. Computer equipment and software are depreciated using the straight-line method over the estimated useful lives of the assets, which range from <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3</font> to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5</font> years.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Long-Lived Assets</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. The Company assesses recoverability by determining whether the net book value of the related asset will be recovered through the projected undiscounted future cash flows of the asset. If the Company determines that the carrying value of the asset may not be recoverable, it measures any impairment based on the fair value of the asset as compared to its carrying value. During the six months ended June 30, 2013 and the year ended December 31, 2012, the Company did not record any impairment charges.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Investments Held in Trust</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company applies the provisions of ASC Topic 320-10, <i>Investment &#150; Debt and Equity</i>, to account for investments held in trust, which comprise only of held-to maturity securities. Held-to-maturity securities are those securities, which the Company has the ability and intent to hold until maturity. Held-to-maturity securities are recorded at amortized cost on the accompanying balance sheets and adjusted for any amortization or accretion of premiums or discounts.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Deferred Financing Costs</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Costs relating to obtaining the line of credit in April 2013 and the Bridge Notes in September 2012 have been capitalized and amortized over the term of the related debt using the straight line method. Amortization of deferred financing costs charged to interest expense was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">686,631</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">254,993</font> in the six months ended June 30, 2013 and for the year ended December 31, 2013, respectively. The unamortized balance was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">548,394</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">552,380</font> at June 30, 2013 and December 31, 2012, respectively.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Derivative Financial Instruments</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company applies the provisions of ASC Topic 815-40, <i>Contracts in Entity&#8217;s Own Equity</i> (&#8220;ASC Topic 815-40&#8221;), under which convertible instruments and warrants, which contain terms that protect holders from declines in the stock price (reset provisions), may not be exempt from derivative accounting treatment. As a result, such warrants are recorded as a liability and are revalued at fair value at the end of each reporting period. Furthermore, under derivative accounting, the warrants are initially recorded at their fair value. If the fair value of the warrants exceeds the face value of the related debt, the excess is recorded as a change in fair value in the statement of operations on the issuance date.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Debt Discounts</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Debt discounts are amortized using the effective interest rate method over the term of the related debt. The result achieved using the straight-line method is not materially different than those which would result using the effective interest method.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Revenue Recognition</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company typically enters into annual renewable agreements with its customers to provide pharmacy benefit management on a fixed price or self-insured basis. The Company records revenues from all its current contracts with customers gross as the Company acts as principal based on the following factors: 1) the Company has a separate contractual relationship with its customers and with its claims adjudicator to whom the Company pays the costs of the prescription drugs consumed by its customers (the claims), 2) the Company through its claim adjudicator is responsible to validate and manage the claims, and 3) the Company bears the credit risk for the amount due from the customers. Revenues are recorded monthly as earned. The Company also operates a mail order pharmacy that services plan members. All revenues and associated costs from dispensing drugs by the mail order pharmacy to our plan members, excluding the members&#8217; co-pay are eliminated as inter-company revenues. Some of the contracts contain terms whereby the Company&#160;makes certain financial guarantees regarding prescription costs. Actual performance is compared to the guaranteed measure throughout the period and accruals are recorded as an offset to revenue if the Company&#160;fails to meet a financial guarantee.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 1251579 1126846 442945 544004 1574659 1323474 322638 619271 1236734 1114055 548394 0 262142 443251 83686 0 2428033 568528 495286 638223 0 4192954 534343 0 189989 137703 162387 0 2771514 0 658092 399382 3559188 121350 143546 64133 8651639 0 8651639 0 5000000 555000 2017-01-02 360000 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div><strong>18.</strong></div> </td> <td style="TEXT-ALIGN: justify"> <div><strong><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Selected Financial Data (unaudited)</strong></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 0.5in; WIDTH: 60%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>Six&#160;months&#160;ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>June&#160;30,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Revenue</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>10,056,735</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Gross profit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>426,730</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Loss before income taxes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(2,490,381)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Net loss</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(2,495,461)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Basic and diluted net income per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(0.07)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Weighted average number of shares outstanding</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>37,897,909</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 10056735 426730 -2490381 -2495461 -0.07 37897909 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div><strong>17.</strong></div> </td> <td style="TEXT-ALIGN: justify"> <div><strong>Commitments and Contingencies</strong></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Operating Leases</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company has certain non-cancelable operating leases for facilities and equipment that expire over the next four years.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> Future minimum payments for non-cancelable operating leases are as follows as of June 30, 2013:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 50%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%" colspan="4"> <div>Minimum&#160;Rental&#160;Payments</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="37%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="37%"> <div>2014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>207,764</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="37%"> <div>2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>206,251</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="37%"> <div>2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>217,740</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="37%"> <div>2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>146,520</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="37%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="37%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>778,275</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="center">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Rent expense&#160;for the six months ended June 30, 2013 and for the year ended December 31, 2012 was $96,468 and $186,733, respectively.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Employment Agreements</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As of June 30, 2013, the Company had entered into employment agreements with senior officers and other members of management. The agreements specify aggregate guaranteed annual salaries of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.4</font> million for each year of employment and extended through May 2017. The agreements allowed the Company to terminate these individuals for cause and not for cause. Depending on the terms of the individual contract upon termination without cause the Company would either be required to continue to pay salary through the original term of the contract or pay severance, typically one year of salary.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">From September 2013 to January 2014, the Company terminated agreements representing $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1</font> million in annual compensation. The Company made severance payments of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">120,000</font> and in one case replaced an existing agreement with an annual consulting agreement that renews annually and permits the Company to terminate at any time with 90 days notice.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif ">&#160;</div><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As of June 30, 2013, the Company entered into employment contracts or employment arrangement letters with certain members of management that among other things committed the Company to issuing approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 650,000</font> stock options. Subsequent to June 30, 2013, the Company entered into additional arrangements committing to issue an additional <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 841,000</font> of stock options. The Company does not currently have a stock option plan and these stock options will be granted at the time the stock option plan is appropriately established.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Litigation</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">During 2012, the Company filed a lawsuit against its past adjudicator of claims for overcharges, over payment on claims, errors and misclassifications, and rebates owed from drug manufacturers claiming damages of over $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5</font> million.&#160;Additionally, the Company has recorded an expense for the amount owed for claims payable. The adjudicator of claims filed a counterclaim for amounts it claims are owed to it by the Company.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In August 2013, the Company settled the suit with the claims adjudicator. Under the terms of the settlement the Company agreed to pay the claims adjudicator $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.7</font> million over 15 months commencing in September 2013. This amount was recorded as a liability as of December 31, 2012<font style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">, in accounts payable.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On August 14, 2012, the Company entered into an agreement with a shareholder to buy back <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 500,000</font> shares of common stock for $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">100,000</font>. The order also called upon the payment of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">50,000</font> in legal fees. As of December 31, 2012, the Company had not received the <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 500,000</font> shares of common stock but had paid the settlement. The Company received these shares in February 2013. A stock redemption was recorded on December 31, 2012 in the amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">100,000</font>.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Property and equipment is as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0px:auto; WIDTH: 75%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>June&#160;30,&#160;2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Furniture, fixtures and equipment</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,606,404</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,374,126</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Leasehold improvements</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>25,260</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>10,162</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,631,664</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,384,288</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Accumulated depreciation and amortization</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(394,930)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(270,233)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Net property and equipment</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,236,734</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,114,055</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Future minimum payments for non-cancelable operating leases are as follows as of June 30, 2013:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 50%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%" colspan="4"> <div>Minimum&#160;Rental&#160;Payments</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="37%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="37%"> <div>2014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>207,764</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="37%"> <div>2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>206,251</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="37%"> <div>2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>217,740</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="37%"> <div>2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>146,520</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="37%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="37%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>778,275</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 1606404 1374126 25260 10162 1631664 1384288 394930 270233 207764 206251 217740 146520 778275 6363018 2064222 81000 44000 7409 -14120 7721331 3154102 0 0 -0.340 -0.340 -0.059 -0.059 -0.0020 0.0020 0.322 0.397 0 0 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div><b>15.</b></div> </td> <td style="TEXT-ALIGN: justify"> <div><b>Stockholders&#8217; Equity</b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company is authorized <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 30,000,000</font> shares of common stock, par value $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">.0001</font>, which shares may, but are not required to, be designated as part of one of three series, callable Series A, callable Series B and Series C shares. The holders of all common shares shall possess all voting power and each share shall have one vote.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Series A &#150; Holders of shares of Series A Common Stock are entitled to cause the Corporation to redeem all or a portion of their shares in connection with an acquisition transaction. If the holders of Series A Common Stock do not elect to have their shares redeemed, then they will automatically be converted to Series B Common Stock. As of June 30, 2013 there are no outstanding Series A Common Stock.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Series B &#150; Holders of shares of Series B Common Stock have the same rights as Series A Common Stock, except Series B Common Stock cannot be issued until such time as all outstanding shares of Series A Common Stock are converted to Series B Common Stock. The holders of Series B Common Stock have the right to participate in a Post-Acquisition Tender Offer or Post-Acquisition Automatic Trust Liquidation. As of June 30, 2013 there are <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">839,965</font> shares of Series B Common Stock outstanding, which are accounted for as shares subject to redemption on the balance sheet.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Series C &#150; Holders of shares of Series C Common Stock have the same rights as Series A Common Stock, except holders of Series C Common Stock are not entitled to (1) cause the Corporation to redeem all or a portion of such Series C Common Stock in connection with the Acquisition Transaction, (2) share ratably in the Trust Account or (3) participate in a Post-Acquisition Tender Offer or Post-Acquisition Automatic Trust Liquidation. As of June 30, 2013, there are <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 8,953,494</font> shares of Series C Common Stock outstanding.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif ">&#160;</div><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Series A Common Stock, Series B Common Stock and Series C Common Stock will be automatically consolidated into one series of Common Stock after the consummation of the Post-Acquisition Tender Offer or Post-Acquisition Automatic Trust Liquidation. The consolidation shall be on a one-for-one basis of the then outstanding shares of each series of common stock. Following the automatic consolidation, only one series of Common Stock will be authorized, which will be referred to as &#8220;Common Stock,&#8221; <font style="FONT-SIZE: 10pt">which occurred after June 30, 2013.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Prior to the merger the Company&#8217;s operations were conducted under the HCCA corporate entity (See Note 1). HCCA had authorized <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 50,000,000</font> shares of common stock, no par value. Upon the merger, every 7.6923 HCCA shares of common stock were exchanged into 1 share of the Company&#8217;s common stock.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">During 2012, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,120,200</font> shares of common stock with a fair value range of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.01</font> to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.31</font>. These shares are freely tradable.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">During 2012, the Company settled a suit with a shareholder to repurchase <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 500,000</font> shares of its common stock. These shares were recorded as a stock redemption for $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">100,000</font> and the shares were received in February 2013. In February 2013, these shares were issued to employees in recognition of service performed and an expense of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">480,000</font> was recorded representing the estimate fair value of the shares issued.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As part of the Merger, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 750,000</font> restricted shares of stock were issued to certain members of management. The shares were valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">7.30</font>, the share price at the date of the merger. <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 400,000</font> shares vested immediately and the remaining vest through June 30, 2015. In the period ending June 30, 2013, the Company recorded an expense of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,920,000</font> for the shares that vested on the date of the Merger and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">283,889</font> for the shares that vest through June 30, 2015.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 15900000 32000 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Software, net is as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 80%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>June&#160;30,&#160;2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Software costs</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>294,109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Accumulated amortization</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(31,967)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Net software costs</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>262,142</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 839965 8953494 1000000 650000 841000 50000 2400000 120000 5000000 2700000 500000 100000 500000 100000 294109 0 31967 0 24328860 27305795 23309725 26148118 1019135 1157677 4332317 1130184 62163 0 -4270154 -1130184 -14066292 -7575965 0 0 3532858 0 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div><b>2.</b></div> </td> <td style="TEXT-ALIGN: justify"> <div><b>Liquidity and Financial Condition</b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company has a working capital deficit and a history of recurring losses and negative cash flows from operating activities. As of June 30, 2013 and December 31, 2012, the Company has a working capital deficit of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,640,546</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4,564,045</font>, respectively and stockholders&#8217; deficit of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8,281,522</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,951,169</font>, respectively. During the six months ended June 30, 2013 and year ended December 31, 2012, the Company incurred net losses of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">14,066,292</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">7,575,965</font>, respectively, and negative cash flows from operating activities of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4,784,185</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">7,921,407</font>, respectively.&#160;Collectively, these factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company is currently making efforts to raise capital in the form of debt and/or equity. <font style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">No assurance can be given that the debt and/or equity can be raised and if available it will be on terms acceptable to the Company.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div><b>8.</b></div> </td> <td style="TEXT-ALIGN: justify"> <div><b>Investments Held in Trust</b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Following the initial public offering (&#8220;IPO&#8221;) of Selway in November 2011, a total of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">20.6</font> million was placed in a trust account maintained by American Stock Transfer &amp; Trust Company, as trustee. None of the funds held in the trust were to be released from the trust account, other than interest income, net of taxes, until the earlier of (i) consummation of an acquisition and (ii) redemption of 100% of the public shares sold in the IPO if Selway failed to consummate an acquisition by May 14, 2013.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">On April 10, 2013, Selway closed the acquisition of HCCA through the Merger (see Notes 1 and 3). At the time of the Merger, holders of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,160,035</font> shares of redeemable common stock decided not to redeem their shares and accordingly approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">11,948,000</font> was released from the escrow. As per the certificate of incorporation of Selway, the remaining balance of the trust account of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8,652,000</font> was used to redeem the remaining <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 839,965</font> redeemable common shares through a tender offer which closed on August 15, 2013. The amount in trust can be</font>&#160;invested only in United States &#8220;government securities&#8221; within the meaning of Section 2(a)(16) of the Investment Company Act of 1940 having a maturity of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 180</font> days or less. During the six months ended June 30, 2013, the United States government securities were in an account at Wells Fargo Bank, while the cash amount was in a JP Morgan Chase cash account. The United States government securities matured and the total trust balance of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8,652,482</font> was in cash.</div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company classified its United States Treasury and equivalent securities as held-to-maturity in accordance with FASB ASC 320, &#8220;Investments &#150; Debt and Equity Securities.&#8221; Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheet and adjusted for the amortization or accretion of premiums or discounts.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> -7575965 -14066292 -17599150 -7575965 500000 100000 480000 750000 7.30 400000 2920000 50000000 0.01 0.31 283889 0 Upon the merger, every 7.6923 HCCA shares of common stock were exchanged into 1 share of the Company's common stock. <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div><b>11.</b></div> </td> <td style="TEXT-ALIGN: justify"> <div><b>Line of Credit</b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On April 11, 2013,&#160;the wholly-owned subsidiaries of HCCA, entered into a credit and security agreement for a secured revolving credit facility with an initial aggregate credit limit of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5,000,000</font>. The facility has a term of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3</font> years, through April 11, 2016, during which the loan proceeds are to be used solely for working capital. The facility was terminated in September 2013 due to the Company&#8217;s inability to meet certain financial covenants and all outstanding balances under the line were repaid. The outstanding amount on the line of credit as of June 30, 2013 was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">534,343</font>.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 3640546 4564045 5000000 P3Y 534343 4784185 7921407 2824234 0 2362517 3525294 0 -3063577 0 0 0 37879809 0 10.30 650562 0 0 650562 0 0 0 0 0 2120200 0 250000 0 0 250000 0 0 -100000 0 0 0 -100000 0 0 0 0 0 0 -7575965 0 0 0 0 0 -14066292 0 0 2362517 4175856 150000 -10639542 0 8651639 0 895 16423417 -24705834 0 0 0 40000009 0 839965 0 8953494 0 0 0 0 0 100000 -100000 0 0 0 -500000 480000 0 0 0 380000 0 100000 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div><strong>9.</strong></div> </td> <td style="TEXT-ALIGN: justify"> <div><strong>Deferred Financing Costs</strong></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Deferred financing costs are as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size:10pt;" align="justify"><strong>&#160;</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 0.5in; WIDTH: 70%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Balance January 1, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Costs incurred for line of credit for the six months ended June 30, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>615,754</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Amortization for the six monthes ended June 30, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(67,360)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Balance June 30, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>548,394</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 0 0 0 500000 -2362517 0 -2362517 -4175856 4175856 0 0 0 0 -40000009 0 0 0 0 520 -520 0 0 0 0 5200000 0 20600000 0 0 250 20599750 0 0 0 0 2500000 0 3159624 0 0 32 3159592 0 0 0 0 315959 0 2362517 0 0 59 2362458 0 0 0 0 592500 0 2920000 0 0 75 2919925 0 0 0 0 750000 0 0 0 0 10 -10 0 0 0 0 100000 0 0 0 0 33 -33 0 0 0 0 335000 0 615754 -8651639 8651639 0 -84 -8651555 0 0 839965 0 -839965 0 1182327 0 0 0 1182327 -814076 0 0 0 -814076 0 0 -6323148 0 0 0 -6323148 -67360 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Deferred financing costs are as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size:10pt;" align="justify"><strong>&#160;</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 0.5in; WIDTH: 70%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Balance January 1, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Costs incurred for line of credit for the six months ended June 30, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>615,754</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Amortization for the six monthes ended June 30, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(67,360)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Balance June 30, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>548,394</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 156664 205997 3683889 0 412824 0 0 641142 -62163 0 0 0 399000 1789000 3622000 4690000 10500000 256257 242040 209938 158814 106617 50640 1024306 176225 848081 658092 4567229 2575828 2035 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 0.5in; WIDTH: 65%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>June&#160;30,&#160;2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Shareholder notes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>7,500,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Placement notes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>500,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Management incentive notes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>2,500,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>10,500,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Less debt discount</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(7,728,486)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>2,771,514</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Future maturities of the Incentive Notes based on the Company&#8217;s estimates are as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 50%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>June&#160;30,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>2014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>399,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,789,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>2018</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>3,622,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>Thereafter</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>4,690,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>10,500,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company has entered into capital lease agreements for equipment, which expire at various dates through <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">November 2019</font>. The assets capitalized under these leases and associated accumulated depreciation at June 30, 2013 and December&#160;31, 2012 are as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 90%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="61%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>June&#160;30,&#160;2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="61%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="61%"> <div>Furniture and equipment</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,007,735</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>584,638</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="61%"> <div>Accumulated depreciation</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(250,821)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(153,937)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="61%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="61%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>756,914</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>430,701</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Minimum future lease payments under capital lease obligations as of June 30, 2013 are as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0px:auto; WIDTH: 85%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; TEXT-DECORATION: underline" width="70%"> <div>Year Ended June 30,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>2014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>256,257</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>242,040</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>209,938</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>158,814</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>2018</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>106,617</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>Thereafter</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>50,640</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>Total future minimum lease payments</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,024,306</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>Less amount representing interest</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(176,225)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>Present value of net minimum lease payments</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>848,081</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>Less current portion</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(189,989)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>658,092</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> -305318 -852276 0 0 2306501 0 436504 857 3554 4411 6327559 183981 148008 1977570 4018000 0 0 0 6323148 1007735 584638 250821 153937 756914 430701 3559188 0 3559188 0 3559188 0 3559188 0 0 121350 121350 121350 0 121350 0.25 2000000 222477 395514 5200000 7500000 10500000 2019-11-30 7500000 500000 2500000 7728486 500000 0.05 -750000 0 -364196 -77329 290777 50000 431060 441199 2428033 568528 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div><b>12.</b></div> </td> <td style="TEXT-ALIGN: justify"> <div><b>Bridge Notes</b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On September 12, 2012, the Company completed a bridge financing (the &#8220;Bridge Financing&#8221;) consisting of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 59.25</font> units, each unit consisting of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10,000</font> preferred shares, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5,000</font> warrants and a promissory note with a face value of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">100,000</font>. At the time of the transaction, the value of the units was allocated as follows: Preferred Stock was recorded at a value of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,362,517</font>, the warrants were recorded as a warrant liability of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">82,726</font> and the notes were recorded at a value of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,479,757</font>, reflecting a loan discount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,445,242</font>. In addition, the Company incurred loan fees amounting to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">673,229</font>. The Company recorded interest expense associated with the amortization of the loan discount and the loan fees through the Merger date.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">At the time of the Merger, holders of all of the issued and outstanding shares of preferred stock of HCCA, by virtue of the Merger, had each of their shares of preferred stock of HCCA converted into the right to receive a proportional amount of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 592,500</font> shares of the Company&#8217;s Series C common stock and warrants to purchase <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 296,250</font> shares of the Company&#8217;s Series C common stock. In accordance with the terms of the promissory notes issued in the Bridge Financing, at the time of the Merger, notes in the aggregate amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,159,592</font> (including principal and interest accrued to date) were converted into <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 315,959</font> shares of the Company&#8217;s Series C common stock and notes in the aggregate principal amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,025,000</font> were repaid in full.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> -14066292 -7575965 5000 82726 3479757 673229 3025000 59.25 10000 100000 2362517 2445242 592500 296250 3159592 315959 572637 1220065 1323474 1638000 40867 40867 40867 4520223 1514857 453057 453057 4947613 4947613 458800 458800 518587 518587 3556056 3556056 0 0 28663284 38401140 24068906 31650232 7603458 7299603 7299603 -1130184 640286 640286 -8937860 -4970540 -0.09 -0.02 P5Y P3Y P5Y P3Y 254993 548394 552380 68000 143000 2000000 296250 7.50 2016-11-07 0 0 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The table below presents the Company&#8217;s fair value hierarchy for those derivative instruments measured at fair value on a recurring basis as of June 30, 2013:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 84%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;1</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;2</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;3</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,559,188</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,559,188</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>Total derivative liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,559,188</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,559,188</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.25in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>The table below presents the Company&#8217;s fair value hierarchy for those derivative instruments measured at fair value on a recurring basis as of December 31, 2012:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0px:auto; WIDTH: 84%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;1</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;2</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;3</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>121,350</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>121,350</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>Total derivative liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>121,350</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>121,350</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The following table summarizes the number of shares of common stock attributable to potentially dilutive securities outstanding for each of the periods which are excluded in the calculation of diluted loss per share:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 85%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>Six&#160;Months&#160;Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>Year&#160;Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>June&#160;30,&#160;2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="52%"> <div>Basic and Diluted:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Net loss</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(14,066,292)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(7,575,965)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Less: Deemed dividend to preferred stockholders</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(3,532,858)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Net loss attributable to common stockholders</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>(17,599,150)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>(7,575,965)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Weighted average shares</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>6,851,819</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>38,939,909</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Basic income (loss) per common share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(2.57)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(0.19)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Cost of Sales</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Cost of sales includes claim payments for both fixed- price and self-insured programs, administrative fees paid for processing the claims to the claims adjudicator and, the cost of prescription drugs of the mail order pharmacy.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Advertising Expenses</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Advertising expenses are expensed as incurred and included in selling, general and administrative expenses on the accompanying statements of operations. Advertising expenses were approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">68,000</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">143,000</font> for the six months ended June 30, 2013 and year ended December 31, 2012, respectively.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div><strong><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>13.</strong></div> </td> <td style="TEXT-ALIGN: justify"> <div><strong>Long-Term Debt</strong></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Incentive Notes</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Upon consummation of the merger <font style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">(see Note 3)</font>, Holders of all of the issued and outstanding shares of common stock of HCCA immediately prior to the time of the Merger had each of their shares of common stock of HCCA converted into the right to receive a proportional amount of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5,200,000</font> shares of the Company&#8217;s Series C common stock and promissory notes with an aggregate face value of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">7,500,000</font> (collectively, the &#8220;Closing Payment&#8221;).</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In addition, the Company issued to its management $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,500,000</font> of Management Incentive Notes and paid fees in connection with the transaction by issuing promissory notes having an aggregate principal amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">500,000</font>, which reflects <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> five</font> percent of all promissory notes issued in the transaction.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The above described notes with an aggregate face value of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">10,500,000</font> have identical terms and conditions, are non-interest bearing and are subordinated to all senior debt of the Company in the event of a default under such senior debt. The notes will be repaid&#160;from <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 25</font>% of the Company&#8217;s free cash-flow (defined as in the notes) in excess of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,000,000</font>. The Company will be obligated to repay such notes if, among other events, there is a transaction that results in a change of control of the Company.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0in; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The notes were recorded at their estimated present value, based on the estimated time of repayment discounted to the balance sheet date. The Company will continue to re-evaluate its estimates on a periodic basis and adjust the present value of the notes accordingly. Of the Management Incentive Notes, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">222,477</font>, net of discount vested immediately and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">395,514</font> is being recognized as management incentive compensation over the estimated payment periods.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 0.5in; WIDTH: 65%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>June&#160;30,&#160;2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Shareholder notes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>7,500,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Placement notes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>500,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Management incentive notes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>2,500,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>10,500,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Less debt discount</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(7,728,486)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>2,771,514</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Future maturities of the Incentive Notes based on the Company&#8217;s estimates are as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 50%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>June&#160;30,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>2014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>399,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,789,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>2018</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>3,622,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>Thereafter</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>4,690,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>10,500,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Capital Leases</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The Company has entered into capital lease agreements for equipment, which expire at various dates through <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">November 2019</font>. The assets capitalized under these leases and associated accumulated depreciation at June 30, 2013 and December&#160;31, 2012 are as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 90%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="61%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>June&#160;30,&#160;2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="61%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="61%"> <div>Furniture and equipment</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,007,735</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>584,638</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="61%"> <div>Accumulated depreciation</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(250,821)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(153,937)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="61%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="61%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>756,914</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>430,701</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0in; FONT: 10pt Times New Roman, Times, Serif"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Amortization of capital leases is included in depreciation expense.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Minimum future lease payments under capital lease obligations as of June 30, 2013 are as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0px:auto; WIDTH: 85%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; TEXT-DECORATION: underline" width="70%"> <div>Year Ended June 30,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>2014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>256,257</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>242,040</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>209,938</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>158,814</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>2018</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>106,617</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>Thereafter</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>50,640</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>Total future minimum lease payments</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,024,306</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>Less amount representing interest</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(176,225)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>Present value of net minimum lease payments</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>848,081</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>Less current portion</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(189,989)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>658,092</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>14.</b></div> </td> <td style="TEXT-ALIGN: justify"> <div><b>Redeemable Securities</b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Redeemable common stockholders are entitled to redeem all or a portion of such shares in connection with the Company&#8217;s initial Business Transaction, as defined <font style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">in the Company&#8217;s Certificate of Incorporation,</font> and are entitled to share ratably in the trust account, including the deferred underwriting discounts and commissions and accrued but undistributed interest, net of (i) taxes payable, (ii) interest income earned on the trust account (approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">10.30</font> per share) and (iii) a pro rata share of the trust account released to the Company for each Share converted to a Series C Share upon completion of a Business Transaction. As of June 30, 2013, there were <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 839,965</font> shares of Series B common stock outstanding which are subject to redemption. These shares were redeemed from the trust account on August 15, 2013</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Internal-Use Software Development Costs</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company capitalizes certain costs associated with the purchase and/or development of internal-use software, including its website. Generally, external and internal costs incurred during the application development stage of a project are capitalized. The application development stage of a project generally includes software design and configuration, coding, testing and installation activities. Training and maintenance costs are expensed as incurred. Upgrades and enhancements are capitalized if it is probable that such expenditures will result in additional functionality. Capitalized software costs are amortized using the straight-line method over the estimated useful life of the asst, which approximates <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3</font> years.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Fair Value Measurements</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company applies recurring fair value measurements to its derivative instruments in accordance with ASC 820, <i>Fair Value Measurements</i>. In determining fair value, the Company uses a market approach and incorporates assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and/or the risks inherent in the inputs to the valuation techniques. These inputs can be readily observable, market corroborated or generally unobservable internally-developed inputs. Based upon the observability of the inputs used in these valuation techniques, the Company&#8217;s derivative instruments are classified as follows:</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0in; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.5in"> <div><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> <td style="TEXT-ALIGN: left; WIDTH: 0.65in"> <div>Level 1:</div> </td> <td style="TEXT-ALIGN: justify"> <div>The fair value of derivative instruments classified as Level 1 is determined by unadjusted quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; TEXT-INDENT: -0.55in; MARGIN: 0pt 0px 0pt 1.05in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.5in"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.65in"> <div>Level 2:</div> </td> <td style="TEXT-ALIGN: justify"> <div>The fair value of derivative instruments classified as Level 2 is determined by quoted market prices for similar assets or liabilities in active markets, quoted market prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; TEXT-INDENT: -0.55in; MARGIN: 0pt 0px 0pt 1.05in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.5in"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.65in"> <div>Level 3:</div> </td> <td style="TEXT-ALIGN: justify"> <div>The fair value of derivative instruments classified as Level 3 is determined by internally-developed models and methodologies utilizing significant inputs that are generally less readily observable from objective sources.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; TEXT-INDENT: -0.55in; MARGIN: 0pt 0px 0pt 1.05in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company&#8217;s valuation methodology for warrants classified as derivative liabilities qualifies as a level 2 fair value measurement since it is determined using internally developed models and analysis.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">At June 30, 2013 the Company had <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,000,000</font> warrants exercisable into its Class C shares that were issued in connection with Selway&#8217;s initial public offering (&#8220;Selway IPO Warrants&#8221;). These warrants are publicly traded and are classified as liabilities. Additionally, HCCA issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 296,250</font> warrants in connection with the Bridge Financing with identical terms as the Selway IPO Warrants. The Company has valued all of these warrants as June 30, 2013 based on the closing price of the Selway IPO Warrants. Because the market for the Selway IPO Warrants is not active, the valuation is classified as a Level 2 measurement. These warrants are exercisable at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">7.50</font> a share and expire on <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">November 7, 2016</font>.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>The table below presents the Company&#8217;s fair value hierarchy for those derivative instruments measured at fair value on a recurring basis as of June 30, 2013:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 84%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;1</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;2</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;3</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,559,188</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,559,188</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>Total derivative liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,559,188</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,559,188</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.25in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>The table below presents the Company&#8217;s fair value hierarchy for those derivative instruments measured at fair value on a recurring basis as of December 31, 2012:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0px:auto; WIDTH: 84%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;1</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;2</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;3</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>121,350</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>121,350</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>Total derivative liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>121,350</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>121,350</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> The majority of shares of the Company post-closing were still owned by HCCA shareholders, who represented 60% of the Companys shares outstanding immediately after closing, if all shares subject to conversion in our post-closing tender offer actually convert to Series C (non-redeemable) common shares, and 65% of the Companys shares outstanding if all shares subject to conversion do not convert to Series C shares and opt to receive their pro rata cash in trust at the time of the post-closing tender offer. Estimates of HCCAs ownership do not include shares underlying warrants held by public investors and the Companys sponsors restricted incentive shares held by management. However, HCCA shareholders would still have 51% of the Companys shares post-closing when including shares underlying warrants and restricted shares and assuming all redeemable shares convert to Series C shares, and 54% of the Companys shares post-closing if all shares subject to conversion do not convert to Series C shares and opt to receive their pro rata cash in trust at the time of the post-closing tender offer. 5200000 7500000 2800000 546002 1977570 The notes will be repaid from 18.5% of the Companys free cash-flow (as defined) in excess of $2,000,000. 2000000 1500000 750000 400000 350000 7.50 2016-11-06 1400000 839965 8650000 1400000 15.00 59.25 10000 100000 (i) 1,400,000 shares if the Company achieves consolidated gross revenue of $150,000,000 for the twelve months ended March 31, 2014 or June 30, 2014 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div><strong><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>7.</strong></div> </td> <td style="TEXT-ALIGN: justify"> <div><strong>Software, net</strong></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Software, net is as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 80%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>June&#160;30,&#160;2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Software costs</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>294,109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Accumulated amortization</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(31,967)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Net software costs</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>262,142</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="center">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Amortization expense was approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">32,000</font> for the six month period ended June 30, 2013.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 0.1 300000000 150000000 (ii) 1,400,000 shares if the Company achieves consolidated gross revenue of $300,000,000 for the twelve months ended March 31, 2015 0.12 0.1 15 months 1732047 713196 1182327 592500 296250 3532858 7.50 2016-11-07 0.08 10000 3159624 592500 0.05 878481 237007 577069 315959 3025000 0.05 281554 3025000 3.53 3101038 11948361 100000 1000000 0.75 0.25 7.50 0.05 0.05 500000 0.05 1000000 7.50 1.50 335000 common stock exceeds $12.00 per share for 20 trading days in any 30-trading-day period. <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Basis of Presentation</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;).</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Use of Estimates</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements including disclosure of contingent assets and liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period and accompanying notes. The Company&#8217;s critical accounting policies are those that are both most important to the Company&#8217;s financial condition and results of operations and require the most difficult, subjective or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>uncertain. Because of the uncertainty of factors surrounding the estimates or judgments used in the preparation of the financial statements, actual results could differ from these estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Share-Based Payments</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Share-based payments to employees are measured at the fair value of the award on the date of grant based on the estimated number of awards that are ultimately expected to vest. The compensation expense resulting from such awards is recorded over the vesting period of the award in selling, general and administrative expenses on the accompanying consolidated statements of operations.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Share-based payments to non-employees for services rendered are recorded at either the fair value of the services rendered, or the fair value of the awards, whichever is more readily determinable. The expense resulting from such awards is&#160; <font style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">marked to market over the vesting period of the award in selling, general and administration</font> expenses on the accompanying consolidated statements of operations.&#160;</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Income Taxes</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company accounts for income taxes using the liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. A valuation allowance is established when realization of net deferred tax assets is not considered more likely than not.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif ">&#160;</div><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Uncertain income tax positions are determined based upon the likelihood of the positions being sustained upon examination by taxing authorities. The benefit of a tax position is recognized in the consolidated financial statements in the period during which management believes it is more likely than not that the position will not be sustained. Income tax positions taken are not offset or aggregated with other positions. Income tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of income tax benefit that is more than 50 percent likely of being realized if challenged by the applicable taxing authority. The portion of the benefits associated with income tax positions taken that exceeds the amount measured is reflected as income taxes payable.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company recognizes interest related to uncertain tax positions in interest expense. The Company recognizes penalties related to uncertain tax positions in income tax expense.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Reclassification</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.25in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">Certain previously reported amounts have been reclassified to conform to the presentation used in the June 30, 2013 financial statements.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 0 0 0.0790 0 2013-06-30 2443296 0 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Rebates</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Pharmaceutical manufacturers offer rebates for selected brand drugs. The Company&#160;currently receives these rebates through a third party administrator. The rebates are considered earned when members (employees of customers) order the drugs. Rebates earned are paid to the Company&#160;by the third party administrator quarterly. Rebates earned are recognized as a reduction to cost of revenue. The portion of the rebate payable to customers is simultaneously recognized as a reduction of revenue. Management evaluates rebates receivable at the end of every reporting period and adjusts the amount reflected on the accompanying balance sheet to net realizable value. An adjustment is also made to the rebate payable to customers to correspond with any adjustment that applies to rebates receivable.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 0.5in; WIDTH: 60%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>Six&#160;months&#160;ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>June&#160;30,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Revenue</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>10,056,735</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Gross profit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>426,730</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Loss before income taxes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(2,490,381)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Net loss</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(2,495,461)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Basic and diluted net income per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(0.07)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Weighted average number of shares outstanding</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>37,897,909</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 283889 0 0 0 283889 0 0 0 0 548394 2445242 1018851 0.037 0.001 0.001 839965 839965 839965 839965 1481250 0 0 0 -3101038 0 0 124733 -42316 251185 1323474 -101059 258296 -300811 603338 2589957 295502 -142937 638223 0 -16486 -4784185 -7921407 104981 495768 -104981 -495768 11948361 0 0 9420 -3025000 4192954 534343 0 -21555 0 153070 0 814076 0 527024 0 0 2362517 0 371350 0 -100000 125508 0 0 17683 3101038 0 88730 3314023 1585833 0 75292 2666667 0 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table summarizes the number of shares of common stock attributable to potentially dilutive securities outstanding for each of the periods which are excluded in the calculation of diluted loss per share:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 85%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>Six&#160;Months&#160;Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>Year&#160;Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>June&#160;30,&#160;2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="52%"> <div>Dilutive Potential Common Shares</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>3,314,023</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>1,585,833</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Restricted stock awards</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>75,292</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Convertible notes payable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>2,666,667</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 1060000 1060000 209904 0 0.32 0.46 2068200 641142 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div><b>19.</b></div> </td> <td style="TEXT-ALIGN: justify"> <div><b>Related Party</b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Otis Fund, a company controlled by a former consultant, who owns in excess of 5% of the Company&#8217;s outstanding shares, has a consulting agreement to provide marketing and sales services to HCCA. The contract was due to expire on <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> January 2, 2017</font>; <font style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">however the Company terminated the agreement for cause in September 2013.</font>&#160;The annual fees related to these services were $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">360,000</font>.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font>&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">In September 2012, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,068,200</font> shares were issued to two entities believed to be controlled by this former consultant of the Company. The Company is currently investigating the circumstances under which these shares were issued to the two entities. The Company recorded a charge in 2012 equal to the shares of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">641,142</font> as general and administrative&#160;expense.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 96468 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div><strong>5.</strong></div> </td> <td style="TEXT-ALIGN: justify"> <div><strong>Significant Accounting Policies</strong></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Basis of Presentation</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;).</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Use of Estimates</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements including disclosure of contingent assets and liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period and accompanying notes. The Company&#8217;s critical accounting policies are those that are both most important to the Company&#8217;s financial condition and results of operations and require the most difficult, subjective or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>uncertain. Because of the uncertainty of factors surrounding the estimates or judgments used in the preparation of the financial statements, actual results could differ from these estimates.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Principles of Consolidation</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances have been eliminated in consolidation.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif ">&#160;</div><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Accounts Receivable</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Accounts receivable represent amounts owed to the Company for products sold and services rendered net of an allowance for doubtful accounts. The Company grants unsecured credit to its customers. The Company continuously monitors the payment performance of its customers to ensure collections and minimize losses. Management does not believe that significant credit risks exist. An allowance for doubtful accounts is based upon the credit profiles of specific customers, economic and industry trends and historic payment experience. There is no allowance for doubtful accounts at June 30, 2013 and December 31, 2012.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Inventory</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Inventories consist of finished pharmaceutical products and are recorded at the lower of cost or market, with the cost determined on a first-in, first-out basis. The Company periodically reviews the composition of inventory in order to identify obsolete, slow-moving or otherwise non-saleable items. If non-saleable items are observed and there are no alternate uses for the inventory, the Company will record a write-down to net realizable value in the period that the decline in values is first recognized.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Rebates</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Pharmaceutical manufacturers offer rebates for selected brand drugs. The Company&#160;currently receives these rebates through a third party administrator. The rebates are considered earned when members (employees of customers) order the drugs. Rebates earned are paid to the Company&#160;by the third party administrator quarterly. Rebates earned are recognized as a reduction to cost of revenue. The portion of the rebate payable to customers is simultaneously recognized as a reduction of revenue. Management evaluates rebates receivable at the end of every reporting period and adjusts the amount reflected on the accompanying balance sheet to net realizable value. An adjustment is also made to the rebate payable to customers to correspond with any adjustment that applies to rebates receivable.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Property and Equipment</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Property and equipment are stated at cost less accumulated amortization and depreciation. Leasehold improvements are amortized using the straight-line method over the shorter of the term of the lease or the estimated useful lives of the assets. Furniture and fixtures are depreciated using the straight-line method over the estimated useful lives of the assets of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5</font> years. Computer equipment and software are depreciated using the straight-line method over the estimated useful lives of the assets, which range from <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3</font> to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5</font> years.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong>&#160;</strong> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Internal-Use Software Development Costs</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company capitalizes certain costs associated with the purchase and/or development of internal-use software, including its website. Generally, external and internal costs incurred during the application development stage of a project are capitalized. The application development stage of a project generally includes software design and configuration, coding, testing and installation activities. Training and maintenance costs are expensed as incurred. Upgrades and enhancements are capitalized if it is probable that such expenditures will result in additional functionality. Capitalized software costs are amortized using the straight-line method over the estimated useful life of the asst, which approximates <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3</font> years.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Long-Lived Assets</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. The Company assesses recoverability by determining whether the net book value of the related asset will be recovered through the projected undiscounted future cash flows of the asset. If the Company determines that the carrying value of the asset may not be recoverable, it measures any impairment based on the fair value of the asset as compared to its carrying value. During the six months ended June 30, 2013 and the year ended December 31, 2012, the Company did not record any impairment charges.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif ">&#160;</div><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Investments Held in Trust</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company applies the provisions of ASC Topic 320-10, <em>Investment &#150; Debt and Equity</em>, to account for investments held in trust, which comprise only of held-to maturity securities. Held-to-maturity securities are those securities, which the Company has the ability and intent to hold until maturity. Held-to-maturity securities are recorded at amortized cost on the accompanying balance sheets and adjusted for any amortization or accretion of premiums or discounts.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Deferred Financing Costs</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Costs relating to obtaining the line of credit in April 2013 and the Bridge Notes in September 2012 have been capitalized and amortized over the term of the related debt using the straight line method. Amortization of deferred financing costs charged to interest expense was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">686,631</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">254,993</font> in the six months ended June 30, 2013 and for the year ended December 31, 2013, respectively. The unamortized balance was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">548,394</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">552,380</font> at June 30, 2013 and December 31, 2012, respectively.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Derivative Financial Instruments</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company applies the provisions of ASC Topic 815-40, <em>Contracts in Entity&#8217;s Own Equity</em> (&#8220;ASC Topic 815-40&#8221;), under which convertible instruments and warrants, which contain terms that protect holders from declines in the stock price (reset provisions), may not be exempt from derivative accounting treatment. As a result, such warrants are recorded as a liability and are revalued at fair value at the end of each reporting period. Furthermore, under derivative accounting, the warrants are initially recorded at their fair value. If the fair value of the warrants exceeds the face value of the related debt, the excess is recorded as a change in fair value in the statement of operations on the issuance date.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Debt Discounts</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Debt discounts are amortized using the effective interest rate method over the term of the related debt. The result achieved using the straight-line method is not materially different than those which would result using the effective interest method.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Share-Based Payments</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Share-based payments to employees are measured at the fair value of the award on the date of grant based on the estimated number of awards that are ultimately expected to vest. The compensation expense resulting from such awards is recorded over the vesting period of the award in selling, general and administrative expenses on the accompanying consolidated statements of operations.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Share-based payments to non-employees for services rendered are recorded at either the fair value of the services rendered, or the fair value of the awards, whichever is more readily determinable. The expense resulting from such awards is&#160; <font style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">marked to market over the vesting period of the award in selling, general and administration</font> expenses on the accompanying consolidated statements of operations.&#160;</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif ">&#160;</div><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Revenue Recognition</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company typically enters into annual renewable agreements with its customers to provide pharmacy benefit management on a fixed price or self-insured basis. The Company records revenues from all its current contracts with customers gross as the Company acts as principal based on the following factors: 1) the Company has a separate contractual relationship with its customers and with its claims adjudicator to whom the Company pays the costs of the prescription drugs consumed by its customers (the claims), 2) the Company through its claim adjudicator is responsible to validate and manage the claims, and 3) the Company bears the credit risk for the amount due from the customers. Revenues are recorded monthly as earned. The Company also operates a mail order pharmacy that services plan members. All revenues and associated costs from dispensing drugs by the mail order pharmacy to our plan members, excluding the members&#8217; co-pay are eliminated as inter-company revenues. Some of the contracts contain terms whereby the Company&#160;makes certain financial guarantees regarding prescription costs. Actual performance is compared to the guaranteed measure throughout the period and accruals are recorded as an offset to revenue if the Company&#160;fails to meet a financial guarantee.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Cost of Sales</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Cost of sales includes claim payments for both fixed- price and self-insured programs, administrative fees paid for processing the claims to the claims adjudicator and, the cost of prescription drugs of the mail order pharmacy.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Advertising Expenses</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Advertising expenses are expensed as incurred and included in selling, general and administrative expenses on the accompanying statements of operations. Advertising expenses were approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">68,000</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">143,000</font> for the six months ended June 30, 2013 and year ended December 31, 2012, respectively.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Income Taxes</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company accounts for income taxes using the liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. A valuation allowance is established when realization of net deferred tax assets is not considered more likely than not.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Uncertain income tax positions are determined based upon the likelihood of the positions being sustained upon examination by taxing authorities. The benefit of a tax position is recognized in the consolidated financial statements in the period during which management believes it is more likely than not that the position will not be sustained. Income tax positions taken are not offset or aggregated with other positions. Income tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of income tax benefit that is more than 50 percent likely of being realized if challenged by the applicable taxing authority. The portion of the benefits associated with income tax positions taken that exceeds the amount measured is reflected as income taxes payable.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company recognizes interest related to uncertain tax positions in interest expense. The Company recognizes penalties related to uncertain tax positions in income tax expense.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Fair Value Measurements</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company applies recurring fair value measurements to its derivative instruments in accordance with ASC 820, <i>Fair Value Measurements</i>. In determining fair value, the Company uses a market approach and incorporates assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and/or the risks inherent in the inputs to the valuation techniques. These inputs can be readily observable, market corroborated or generally unobservable internally-developed inputs. Based upon the observability of the inputs used in these valuation techniques, the Company&#8217;s derivative instruments are classified as follows:</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif ">&#160;</div><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.5in"> <div><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> <td style="TEXT-ALIGN: left; WIDTH: 0.65in"> <div>Level 1:</div> </td> <td style="TEXT-ALIGN: justify"> <div>The fair value of derivative instruments classified as Level 1 is determined by unadjusted quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; TEXT-INDENT: -0.55in; MARGIN: 0pt 0px 0pt 1.05in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.5in"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.65in"> <div>Level 2:</div> </td> <td style="TEXT-ALIGN: justify"> <div>The fair value of derivative instruments classified as Level 2 is determined by quoted market prices for similar assets or liabilities in active markets, quoted market prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; TEXT-INDENT: -0.55in; MARGIN: 0pt 0px 0pt 1.05in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.5in"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.65in"> <div>Level 3:</div> </td> <td style="TEXT-ALIGN: justify"> <div>The fair value of derivative instruments classified as Level 3 is determined by internally-developed models and methodologies utilizing significant inputs that are generally less readily observable from objective sources.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; TEXT-INDENT: -0.55in; MARGIN: 0pt 0px 0pt 1.05in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company&#8217;s valuation methodology for warrants classified as derivative liabilities qualifies as a level 2 fair value measurement since it is determined using internally developed models and analysis.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">At June 30, 2013 the Company had <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,000,000</font> warrants exercisable into its Class C shares that were issued in connection with Selway&#8217;s initial public offering (&#8220;Selway IPO Warrants&#8221;). These warrants are publicly traded and are classified as liabilities. Additionally, HCCA issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 296,250</font> warrants in connection with the Bridge Financing with identical terms as the Selway IPO Warrants. The Company has valued all of these warrants as June 30, 2013 based on the closing price of the Selway IPO Warrants. Because the market for the Selway IPO Warrants is not active, the valuation is classified as a Level 2 measurement. These warrants are exercisable at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">7.50</font> a share and expire on <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">November 7, 2016</font>.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>The table below presents the Company&#8217;s fair value hierarchy for those derivative instruments measured at fair value on a recurring basis as of June 30, 2013:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 84%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;1</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;2</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;3</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,559,188</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,559,188</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>Total derivative liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,559,188</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,559,188</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.25in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>The table below presents the Company&#8217;s fair value hierarchy for those derivative instruments measured at fair value on a recurring basis as of December 31, 2012:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0px:auto; WIDTH: 84%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;1</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;2</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;3</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>121,350</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>121,350</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>Total derivative liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>121,350</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>121,350</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Fair Value of Financial Instruments</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The fair values of cash and cash equivalents, accounts receivable, rebates receivable and&#160;accounts payable approximate their carrying values due to the short-term nature of the instruments. The fair values of long-term debt and revolving loans approximates their carrying value due to their variable interest rates. The fair value of investments held in trust is not materially different than its carrying value because of the short-term nature of the investments.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Risks and Concentrations</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company utilizes the services of a single claims adjudicator. If there is an adverse situation in this relationship, the Company&#8217;s mail order pharmaceutical fulfillment services would be ineffective until a replacement claims adjudicator was obtained.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif ">&#160;</div><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 12</font>% of the Company&#8217;s 2012 revenues were derived from one customer. Revenues from this customer were <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font>% of our revenues for the six month period ended June 30, 2013.&#160;<font style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">No amounts were due from this customer at June 30, 2013 or December 31, 2012. In addition, one of the reseller&#8217;s customers accounted for approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 14</font>% of the Company&#8217;s revenue for the six month period ended June 30, 2013 as well as approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 14</font>% of the Company&#8217;s revenue for the year ended December 31, 2012. Amounts due from this customer represented <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 32</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 46</font>% of accounts receivable at June 30, 2013 and December 31, 2012, respectively.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt"> &#160;</font> &#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Cash and Cash Equivalents</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company considers all cash in bank, money market funds and certificates of deposit with an original&#160;maturity of less than three months to be cash equivalents. The Company maintains its cash and cash equivalents in one financial institution. Cash balances on hand at this financial institution may exceed the insurance coverage provided to the Company by the Federal Deposit Insurance Corporation at various times during the year.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Earnings (Loss) Per Share</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Basic earnings (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted earnings (loss) per share are determined in the same manner as basic earnings (loss) per share, except that the number of shares is increased to include potentially dilutive securities using the treasury stock method. Because the Company incurred a net loss in all periods presented, all potentially dilutive securities were excluded from the computation of diluted loss per share because the effect of including them is anti-dilutive.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 85%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>Six&#160;Months&#160;Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>Year&#160;Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>June&#160;30,&#160;2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="52%"> <div>Basic and Diluted:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Net loss</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(14,066,292)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(7,575,965)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Less: Deemed dividend to preferred stockholders</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(3,532,858)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Net loss attributable to common stockholders</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>(17,599,150)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>(7,575,965)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Weighted average shares</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>6,851,819</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>38,939,909</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Basic loss per common share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(2.57)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(0.19)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>The following table summarizes the number of shares of common stock attributable to potentially dilutive securities outstanding for each of the periods which are excluded in the calculation of diluted loss per share:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 85%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>Six&#160;Months&#160;Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>Year&#160;Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>June&#160;30,&#160;2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="52%"> <div>Dilutive Potential Common Shares</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>3,314,023</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>1,585,833</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Restricted stock awards</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>75,292</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Convertible notes payable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>2,666,667</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Reclassification</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.25in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">Certain previously reported amounts have been reclassified to conform to the presentation used in the June 30, 2013 financial statements.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 186733 1.50 6000000 0.09 500000 212625 2325125 141750 3.00 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div><strong><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>16.</strong></div> </td> <td style="TEXT-ALIGN: justify"> <div><strong>Income Taxes</strong></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">There was no provision (benefit) for income taxes for the six months and year ended June 30, 2013 and December 31, 2012.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Deferred tax assets are as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0px:auto; WIDTH: 84%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>June&#160;30,&#160;2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Loss carryforwards</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>6,363,018</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>2,064,222</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Intangible assets</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>81,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>44,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="55%"> <div>Accrued expenses</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="12%"> <div>1,060,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="12%"> <div>1,060,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="55%"> <div>Stock based compensation</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="12%"> <div>209,904</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Fixed assets</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>7,409</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(14,120)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Less valuation allowance</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(7,721,331)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(3,154,102)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Total net deferred tax assets</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The valuation allowance was increased by $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4,567,229</font> during the six months ended June 30, 2013 and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,575,828</font> for the year ended December 31, 2012. The valuation allowance was increased due to uncertainties as to the Company&#8217;s ability to generate sufficient taxable income to utilize the net operating loss carry forwards and other deferred income tax items.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif ">&#160;</div><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>A reconciliation of income taxes at the U.S. federal statutory rate to the income expense is as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 82%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="28%" colspan="4"> <div>Six&#160;Months&#160;and&#160;Year&#160;Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>June&#160;30,&#160;2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>U.S. Federal statutory rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>(34.0)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>(34.0)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>State income taxes, net of federal benefit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(5.9)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(5.9)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Permanent differences</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(0.20)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>0.20</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Interest expense</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>7.90</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Change in valuation allowance</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>32.2</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>39.7</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Effective tax rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company&#8217;s ability to utilize the net operating loss carry forwards in future years may be significantly limited in accordance with the provisions of Section 382 of the Internal Revenue Code, because of the changes in ownership that have occurred. The Company&#8217;s NOL may be further limited should there be any further changes in ownership. As defined in Section 382 of the Internal Revenue Code, the Company who has undergone, or may undergo in the future, a greater than fifty percent ownership change as a result of financing initiatives. Consequently, there may be limitations on the amount of the Company&#8217;s NOLs which may be utilized to offset future taxable income in any one year.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">At June 30, 2013, the Company had federal and state net operating loss carry forwards (&#8220;NOLs&#8221;) of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">15,900,000</font>. The federal net operating loss carry forwards will begin to expire in the year <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2035</font>.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font>&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">In July 2006, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASC 740-10, <i>Uncertainty in Income Taxes</i>, which defines the threshold for recognizing the benefits of tax-return positions in the financial statements as &#8220;more-likely-than-not&#8221; to be sustained by the taxing authorities. This statement also requires explicit disclosure requirements about a Company&#8217;s uncertainties related to their income tax position, including a detailed roll forward or tax benefits taken that do not qualify for financial statement recognition.&#160;The Company files income tax returns in the U.S. federal jurisdiction and New Jersey. The Company&#8217;s tax years open to examination for federal and state are from 2009. The Company has no amount recorded for any unrecognized tax benefits as of June 30, 2013 and December 31, 2012 nor did the Company record any amount for the implementation of ASC 740-10-25. The Company&#8217;s policy is to record estimated interest and penalty related to the underpayment of income taxes for unrecognized tax benefits as a component of its income tax provision. During the period ended June 30, 2013 and year ended December 31, 2012 the Company did not recognize any interest or penalties accrued for unrecognized tax benefits.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> In connection with the Private Placement the Company agreed to pay the Agent a fee representing 9% of the principal amount of the Notes plus the $500,000 additional loan from the Lender, less $250,000, or $2,362,500. <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Deferred tax assets are as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0px:auto; WIDTH: 84%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>June&#160;30,&#160;2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Loss carryforwards</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>6,363,018</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>2,064,222</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Intangible assets</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>81,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>44,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="55%"> <div>Accrued expenses</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="12%"> <div>1,060,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="12%"> <div>1,060,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="55%"> <div>Stock based compensation</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="12%"> <div>209,904</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Fixed assets</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>7,409</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(14,120)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Less valuation allowance</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(7,721,331)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(3,154,102)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Total net deferred tax assets</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">A reconciliation of income taxes at the U.S. federal statutory rate to the income expense is as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 82%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="28%" colspan="4"> <div>Six&#160;Months&#160;and&#160;Year&#160;Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>June&#160;30,&#160;2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>U.S. Federal statutory rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>(34.0)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>(34.0)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>State income taxes, net of federal benefit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(5.9)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>(5.9)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Permanent differences</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(0.20)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>0.20</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Interest expense</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>7.90</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Change in valuation allowance</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>32.2</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>39.7</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Effective tax rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> -592000 0 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Risks and Concentrations</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company utilizes the services of a single claims adjudicator. If there is an adverse situation in this relationship, the Company&#8217;s mail order pharmaceutical fulfillment services would be ineffective until a replacement claims adjudicator was obtained.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif ">&#160;</div><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 12</font>% of the Company&#8217;s 2012 revenues were derived from one customer. Revenues from this customer were <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font>% of our revenues for the six month period ended June 30, 2013.&#160;<font style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">No amounts were due from this customer at June 30, 2013 or December 31, 2012. In addition, one of the reseller&#8217;s customers accounted for approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 14</font>% of the Company&#8217;s revenue for the six month period ended June 30, 2013 as well as approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 14</font>% of the Company&#8217;s revenue for the year ended December 31, 2012. Amounts due from this customer represented <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 32</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 46</font>% of accounts receivable at June 30, 2013 and December 31, 2012, respectively.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 20600000 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div><strong>10.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></strong></div> </td> <td style="TEXT-ALIGN: justify"> <div><strong>Accrued Expenses</strong></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Accrued expenses are as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0px:auto; WIDTH: 85%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>June&#160;30,&#160;2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Accrued severence costs*</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>750,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Accrued rebates</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>364,196</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>77,329</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Accrued registration rights penalties**</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>592,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Accrued professional fees</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>290,777</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>50,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Accrued expenses other</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>431,060</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>441,199</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>2,428,033</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>568,528</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif; font-size:10pt;"> &#160;&#160;</div> <table style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; TABLE-LAYOUT: fixed; FONT-SIZE: 10pt; dtth: tableHanging" cellspacing="0" cellpadding="0" width="100%"> <tr style="PADDING-BOTTOM: 0pt; VERTICAL-ALIGN: top; PADDING-TOP: 0in"> <td style="WIDTH: 0in; WORD-WRAP: break-word; VERTICAL-ALIGN: top"> </td> <td style="WIDTH: 0.4in; WORD-WRAP: break-word; VERTICAL-ALIGN: top"> <div><font style="FONT-SIZE: 10pt">*</font></div> </td> <td style="WORD-WRAP: break-word; VERTICAL-ALIGN: top"> <div><font style="FONT-SIZE: 10pt">Payable to a former executive of the Company.</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.4in; MARGIN: 0in 0in 0pt 0.4in"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <table style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; TABLE-LAYOUT: fixed; FONT-SIZE: 10pt; dtth: tableHanging" cellspacing="0" cellpadding="0" width="100%"> <tr style="PADDING-BOTTOM: 0pt; VERTICAL-ALIGN: top; PADDING-TOP: 0in"> <td style="WIDTH: 0in; WORD-WRAP: break-word; VERTICAL-ALIGN: top"> </td> <td style="WIDTH: 0.4in; WORD-WRAP: break-word; VERTICAL-ALIGN: top"> <div><font style="FONT-SIZE: 10pt">**</font></div> </td> <td style="WORD-WRAP: break-word; VERTICAL-ALIGN: top"> <div><font style="FONT-SIZE: 10pt">Estimated penalties relating to late registration of shares of common stock in connection with the bridge notes.</font></div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 1160035 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Accrued expenses are as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0px:auto; WIDTH: 85%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>June&#160;30,&#160;2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Accrued severence costs*</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>750,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Accrued rebates</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>364,196</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>77,329</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Accrued registration rights penalties**</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>592,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Accrued professional fees</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>290,777</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>50,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Accrued expenses other</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>431,060</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>441,199</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>2,428,033</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>568,528</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif; font-size:10pt;"> &#160;&#160;</div> <table style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; TABLE-LAYOUT: fixed; FONT-SIZE: 10pt; dtth: tableHanging" cellspacing="0" cellpadding="0" width="100%"> <tr style="PADDING-BOTTOM: 0pt; VERTICAL-ALIGN: top; PADDING-TOP: 0in"> <td style="WIDTH: 0in; WORD-WRAP: break-word; VERTICAL-ALIGN: top"> </td> <td style="WIDTH: 0.4in; WORD-WRAP: break-word; VERTICAL-ALIGN: top"> <div><font style="FONT-SIZE: 10pt">*</font></div> </td> <td style="WORD-WRAP: break-word; VERTICAL-ALIGN: top"> <div><font style="FONT-SIZE: 10pt">Payable to a former executive of the Company.</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.4in; MARGIN: 0in 0in 0pt 0.4in"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <table style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; TABLE-LAYOUT: fixed; FONT-SIZE: 10pt; dtth: tableHanging" cellspacing="0" cellpadding="0" width="100%"> <tr style="PADDING-BOTTOM: 0pt; VERTICAL-ALIGN: top; PADDING-TOP: 0in"> <td style="WIDTH: 0in; WORD-WRAP: break-word; VERTICAL-ALIGN: top"> </td> <td style="WIDTH: 0.4in; WORD-WRAP: break-word; VERTICAL-ALIGN: top"> <div><font style="FONT-SIZE: 10pt">**</font></div> </td> <td style="WORD-WRAP: break-word; VERTICAL-ALIGN: top"> <div><font style="FONT-SIZE: 10pt">Estimated penalties relating to late registration of shares of common stock in connection with the bridge notes.</font></div> </td> </tr> </table> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 11948000 8652000 839965 0.14 0.14 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div><b>3.</b></div> </td> <td style="TEXT-ALIGN: justify"> <div><b>The Merger</b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On January 25, 2013, an Agreement and Plan of Merger (the &#8220;Agreement&#8221;) was entered into by and among the Company, Selway Merger Sub, Inc., a New Jersey corporation and wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;), HCCA, PCA, and representatives of HCCA and the Company. On April 10, 2013 (the &#8220;Closing Date&#8221;), the Merger and other transactions contemplated by the Agreement closed.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Pursuant to the Agreement, Merger Sub merged with and into HCCA, resulting in HCCA becoming a wholly owned subsidiary of the Company. PCA and PCA Benefits, a dormant entity, remain wholly owned subsidiaries of HCCA.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif ">&#160;</div><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Holders of all of the issued and outstanding shares of common stock of HCCA immediately prior to the time of the Merger had each of their shares of common stock of HCCA converted into the right to receive: (i) a proportional amount of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5,200,000</font> shares of the Company&#8217;s Series C common stock and promissory notes with an aggregate face value of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">7,500,000</font> (collectively, the &#8220;Closing Payment&#8221;); plus (ii) a proportional amount of up to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,800,000</font> shares of the Company&#8217;s common stock, if any, (the &#8220;Earn-out Payment Shares&#8221;) issuable upon the Company achieving certain consolidated gross revenue thresholds as more fully described below; plus (iii) the right to receive a proportional amount of the proceeds from the exercise of certain warrants being issued to Selway Capital Holdings, LLC, Selway&#8217;s sponsor, as more fully described below. A portion of the Closing Payment (520,000 shares and promissory notes with an aggregate face value of $750,000) was being held in escrow for a period of 12 months following the Merger to satisfy indemnification obligations of HCCA. Effective December 20, 2013, the escrowed portion of the Closing Payment, together with a portion of the shares issued to <font style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">HCCA&#8217;s investment banking advisor</font> (an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 546,002</font> shares, and promissory notes with an aggregate face value of $750,000) were released from escrow and cancelled.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The promissory notes included in the Closing Payment are non-interest bearing and subordinated to all senior debt of the combined company in the event of a default under such senior debt. <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The notes will be repaid from 18.5% of the Company&#8217;s free cash-flow (as defined) in excess of $2,000,000.</font> The Company will be obligated to repay such notes if, among other events, there is a transaction that results in a change of control of the Company. The Company valued the notes at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,977,570</font>, which represented the present value of the estimated future cash flows to be generated by the combined companies discounted using an interest rate reflective of the uncertainty and credit risk of the notes.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Certain members of HCCA&#8217;s management received an aggregate of 1,500,000 shares of our common stock (the &#8220;Management Incentive Shares&#8221;), which shares were placed in escrow and subject to release in three installments through June 30, 2015.</font></font></font> Subsequently, certain members of HCCA management agreed to cancel an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 750,000</font> shares pursuant to rescission agreements entered into June 2013. Of the remaining Management Incentive Shares outstanding, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 400,000</font> shares have vested but remain in escrow until June 30, 2014 and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 350,000</font> shares will vest on June 30, 2015 and will remain in escrow until June 30, 2015.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As part of the Merger, Selway&#8217;s net liabilities, consisting primarily of warrant liabilities, were assumed. As part of its Initial Public Offering, Selway issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,000,000</font> warrants, with an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">7.50</font> and an expiration date of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">November 6, 2016</font> (&#8220;Selway IPO Warrants&#8221;). These warrants are classified as liabilities based on certain anti-dilution features. The Selway IPO Warrants were recorded at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4,018,000</font> based on the closing price of the warrants on the date of Merger.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Earn-out Payment Shares, if any, will be issued as follows: <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">(i) 1,400,000 shares if the Company achieves consolidated gross revenue of $150,000,000 for the twelve months ended March 31, 2014 or June 30, 2014</font>; and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">(ii) 1,400,000 shares if the Company achieves consolidated gross revenue of $300,000,000 for the twelve months ended March 31, 2015</font> or June 30, 2015. In the event the Company does not achieve the first earn-out threshold, but does achieve the second earn-out threshold, then all of the Earn-out Payment Shares shall be issued. If the Company consolidates, merges or transfers substantially all of its assets prior to June 30, 2015 at a valuation of at least $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">15.00</font> per share, then all of the Earn-out Payment Shares not previously paid out shall be issued immediately prior to such transaction. If, prior to achieving either earn-out threshold the Company acquires another business in exchange for its equity or debt securities, then any remaining earn-out thresholds may be adjusted by the independent members of the Company&#8217;s board of directors at their sole discretion. <font style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">The Company estimates that it will not achieve any of the abovementioned revenue targets and, therefore, n</font>o provision has been made for the Earn-out Payment Shares.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Agreement required <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font>% of the consideration, or 520,000 shares of the Company&#8217;s Series C common stock and promissory notes with a face value of $750,000 to be held in escrow for a period of one year. As a result of the investigation and subsequent restatement (see Note 4), in December 2013 these shares of stock and promissory notes were returned to the Company. Also in December 2013, the rights to additional proceeds from the exercise of certain warrants issued to Selway Capital Holdings, LLC as part of the merger were cancelled.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif ">&#160;</div><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In connection with a bridge financing (the &#8220;Bridge Financing&#8221;) completed by HCCA in September 2012, HCCA issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 59.25</font> units, each unit consisted of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10,000</font> Convertible Preferred Shares, a warrant for 5,000 shares of common stock that, upon a merger with Selway, converted to warrants with the same terms as Selway IPO warrants and a Promissory Note with a face value of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">100,000</font><font style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> (&#8220;Promissory Notes&#8221;).</font> At the time of the Merger, holders of all of the issued and outstanding shares of preferred stock of HCCA, by virtue of the Merger, had each of their shares of Preferred Stock of HCCA converted into the right to receive a proportional amount of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 592,500</font> shares of the Company&#8217;s Series C common stock and warrants to purchase <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 296,250</font> shares of the Company&#8217;s Series C common stock. If a Merger with Selway or equivalent, as defined in the Preferred Stockholder agreement, occurred before the maturity date of the promissory notes, the preferred stock converted on a 1 to 1 basis into Series C Common Stock of Selway. If such Merger did not occur, then at the maturity of the Promissory Notes, the Preferred Stock converted into <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3.7</font>% of common stock of HCCA on a fully diluted basis. Upon issuing the preferred stock, HCCA determined the contingent beneficial conversion feature to the holders of the Preferred Stock if the Merger with Selway occurred to be $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,532,858</font> and recorded that as a deemed dividend to the Preferred Stockholders upon the closing of the Merger.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The warrants issued in connection with the bridge loan were initially exercisable at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">7.50</font> into shares of common stock of HCCA and expired on <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">November 7, 2016</font>. The warrants contained certain anti-dilution that caused them to be classified as liabilities. Upon completion of the Merger with Selway, the warrants became exercisable in Series C shares of Common Stock of Selway. The exercise price and expiration date remained the same.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Promissory Notes bore interest at <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 8</font>%, were convertible into <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10,000</font> shares of Series C Common Stock if a transaction with Selway occurred and matured on the earlier of a transaction with Selway or September 12, 2013. HCCA allocated the value received from the sale of the units first to the estimated fair value of warrants. The residual value was then allocated to the preferred stock and promissory note based on their relative fair values. As a result of the allocation, HCCA recorded a debt discount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,445,242</font>. The debt discount was amortized to interest expense over the term of the Promissory Note. HCCA recorded interest expense of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,732,047</font>, including $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,018,851</font> to recognize the unamortized debt discount at the transaction date in the period ending June 30, 2013. HCCA recorded interest expense of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">713,196</font> related amortization of the debt discount in the year ended December 31, 2012. Upon issuing the promissory notes, HCCA determined the contingent beneficial conversion feature to the holders of the Promissory Notes, if they converted into shares of Selway and recorded additionally $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,182,327</font>, as additional interest expense upon the conversion of the promissory notes. In accordance with the terms of the promissory notes issued in the Bridge Financing, at the time of the Merger, notes in the aggregate amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,159,624</font> (including principal and interest accrued to date) were converted into <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 315,959</font> shares of the Company&#8217;s Series C common stock and notes in the aggregate principal amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,025,000</font> were repaid in full. The promissory note included in the Bridge Financing was only convertible into shares of common stock if the transaction with Selway closed before the maturity of the note. At the issuance of the Bridge Financing, the Company determined that a contingent beneficial conversion feature existed representing the difference in the value of the underlying shares and the allocated value to the promissory note. Upon closing of the transaction, the Company recognized the contingent beneficial conversion feature and recorded $1,182,327 as additional interest expense in the period ended June 30, 2013.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In connection with the Bridge Financing, HCCA executed a registration rights agreement that required it to register the shares underlying the Bridge Financing if the transaction was completed. The agreement required HCCA to file a registration statement within 60 days of the completion of the transaction with Selway and have the registration statement declared effective within 120 days. The agreement requires damages of 1% per month of the Bridge Financing, capped at 10%, for each month the Company does not comply with the requirement. As a result of the restatements and investigation, the Company concludes that it is probable it will not file a registration statement and have declared within the period required and estimates that it will incur the maximum damages under the agreement. The Company recorded $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">592,500</font> to interest expense for the period ended June 30, 2013.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In conjunction with the merger of Merger Sub into HCCA:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.5in"></td> <td style="WIDTH: 0.25in"> <div><font style="FONT-FAMILY:Symbol">&#183;</font></div> </td> <td style="TEXT-ALIGN: justify"> <div>The Company entered into exchange agreements with three beneficial holders of HCCA&#8217;s bridge loan who were also beneficial holders of greater than <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5</font>% of the Company&#8217;s Series A common stock. Pursuant to the exchange agreements, such holders converted an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 281,554</font> shares of the Company&#8217;s Series A common stock to the Company&#8217;s Series C common stock. In conjunction with the exchange, such holders were repaid bridge notes in the aggregate principal amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,025,000</font>.</div> </td> </tr> </table> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif ">&#160;</div><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.5in"></td> <td style="WIDTH: 0.25in"> <div><font style="FONT-FAMILY:Symbol">&#183;</font></div> </td> <td style="TEXT-ALIGN: justify"> <div>The Company entered into exchange agreements with three beneficial holders of greater than <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5</font>% of the Company&#8217;s Series A common stock. Pursuant to the exchange agreements, such holders converted an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 878,481</font> shares of the Company&#8217;s Series A common stock to the Company&#8217;s Series C common stock and received $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3.53</font> per share of Series A common stock exchanged, or an aggregate of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,101,038</font>.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;</div> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.5in"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.25in"> <div><font style="FONT-FAMILY:Symbol">&#183;</font></div> </td> <td style="TEXT-ALIGN: justify"> <div>An aggregate of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">11,948,361</font> was released from the Company&#8217;s trust account, reflecting the number of shares of the Company&#8217;s Series A common stock that were converted into the Company&#8217;s Series C common stock, of which $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">237,007</font> was paid to the underwriters from the Company&#8217;s initial public offering. The Company incurred other costs related to the transaction totaling $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">577,069</font> and recorded both these costs and the costs paid to the underwriters as a reduction to Additional Paid In Capital.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.5in"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.25in"> <div><font style="FONT-FAMILY:Symbol">&#183;</font></div> </td> <td style="TEXT-ALIGN: justify"> <div>The placement warrants held by the Company&#8217;s founders were converted into the right to receive: (i) an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 100,000</font> shares of common stock; and (ii) warrants to purchase an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,000,000</font> shares of common stock at an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">10.00</font> per share. The proceeds from the exercise of the exchange warrants will be paid: (i) <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 75</font>% to the holders of all of the issued and outstanding shares of common stock of HCCA immediately prior to the time of the merger; and (ii) <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 25</font>% to certain members of HCCA management. The exchange warrants are only exercisable for cash, may not be exercised on a cashless basis, and must be exercised if the closing price for the combined company&#8217;s <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">common stock exceeds $12.00 per share for 20 trading days in any 30-trading-day period.</font> On November 22, 2013, the Company cancelled these warrants and issued a new warrant to purchase <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1</font> million shares of common stock. The replacement warrant was recorded to additional paid in capital. Per the terms of the warrant agreement, the warrant&#8217;s initial exercise price was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">7.50</font> per share, subject to adjustment upon the first subsequent financing of the Company. This financing occurred on December 31, 2013 upon which the exercise price of this warrant was adjusted from $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">7.50</font> to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.50</font>. The new warrants do not include the provision to share the exercise proceeds with former shareholders of HCCA or management. The Company will record a charge in the quarter ended December 31, 2013 reflecting the value of the modification to the warrant.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif" align="justify">Pursuant to an engagement letter entered into by HCCA with its investment banking adviser, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5</font>% of all consideration received was owed to the adviser. Accordingly the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 335,000</font> shares of common stock representing <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5</font>% of the common stock and incentive stock, as adjusted, received by HCCA and issued an incentive note of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">500,000</font> representing <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5</font>% of the incentive notes issued to HCCA. The present value of the incentive note was recorded to additional paid in capital and is included in liabilities assumed.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif" align="justify">The business combination of the Company and HCCA was accounted for as a reverse recapitalization of HCCA, since prior to the merger the Company was a shell corporation as defined under Rule 12b-2 of the Exchange Act. HCCA was treated as the accounting acquirer in this transaction due to the following factors:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 1in"></td> <td style="WIDTH: 0.3in"> <div>1)</div> </td> <td style="TEXT-ALIGN: justify"> <div>HCCA&#8217;s management pre-closing remained as the management of the Company post-closing;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;&#160;</div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 1in"></td> <td style="WIDTH: 0.3in"> <div>2)</div> </td> <td style="TEXT-ALIGN: justify"> <div>The members of the board of directors of HCCA pre-closing represent the majority of directors of the Company post- closing; and</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;&#160;</div> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 1in"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.3in"> <div>3)</div> </td> <td style="TEXT-ALIGN: justify"> <div><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>The majority of shares of the Company post-closing were still owned by HCCA shareholders, who represented 60% of the Company&#8217;s shares outstanding immediately after closing, if all shares subject to conversion in our post-closing tender offer actually convert to Series C (non-redeemable) common shares, and 65% of the Company&#8217;s shares outstanding if all shares subject to conversion do not convert to Series C shares and opt to receive their pro rata cash in trust at the time of the post-closing tender offer. Estimates of HCCA&#8217;s ownership do not include shares underlying warrants held by public investors and the Company&#8217;s sponsors restricted incentive shares held by management. However, HCCA shareholders would still have 51% of the Company&#8217;s shares post-closing when including shares underlying warrants and restricted shares and assuming all redeemable shares convert to Series C shares, and 54% of the Company&#8217;s shares post-closing if all shares subject to conversion do not convert to Series C shares and opt to receive their pro rata cash in trust at the time of the post-closing tender offer.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </td> </tr> </table> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div><strong>4.</strong></div> </td> <td style="TEXT-ALIGN: justify"> <div><strong>Restatement</strong></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The financial statements for 2012&#160;have been revised to correct material errors in accounting for the Company&#8217;s sales, accounts receivable, cost of sales, accounts payable, capital leases, accrued rent and accrued taxes. In accordance with applicable Generally Accepted Accounting Principles (GAAP), the Company calculated and recognized adjustments accordingly.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On March 25, 2013, the Company filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) its audited financial statements for the years ended December 31, 2012 and 2011. Following the discovery of various material errors the Company informed the SEC on May 9, 2013 that these financial statements could not be relied upon, and on May 15, 2013 filed its restated audited financial statements for the above-mentioned periods (First Restatement Financial Statements).</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On September 19, 2013 following the discovery by management of additional material errors and misstatements in the First Restatement Financial Statements, the Company informed the SEC that the previously restated financials could not be relied upon and that the Company would review its financial statements in an attempt to discover all the material errors and misstatements that were included therein.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As part of this review, the Company engaged external consultants to review and investigate its books and records and other related transactions and activities for 2012 and 2011. As a result of this review, management concluded that it will be unable to complete its restated 2011 financial statements, due to lack of sufficient source documents and other information. In addition, the Company discovered various additional material errors and misstatements in the 2012 financial statements which were corrected in these restated financial statements.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif ">&#160;</div><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table represents the effects of the subsequent and first restated statements as of December 31, 2012:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Subsequent</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>First</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Restatement</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Restated</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Original</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Accounts receivable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,126,846</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>572,637</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,220,065</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Rebates receivable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,323,474</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,323,474</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,638,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Other receivables</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>40,867</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>40,867</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>40,867</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Accounts payable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>4,431,366</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>4,520,223</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,514,857</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Accrued expenses</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>568,528</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>453,057</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>453,057</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Note payable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>4,192,954</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>4,947,613</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>4,947,613</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Redeemable preferred stock</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>2,362,517</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>458,800</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>458,800</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Warrant liability</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>121,350</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>518,587</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>518,587</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Common stock</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>4,175,856</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>3,556,056</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>3,556,056</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>APIC</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>150,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Sales</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>27,305,795</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>28,663,284</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>38,401,140</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Cost of sales</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>26,148,118</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>24,068,906</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>31,650,232</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>General and administrative expenses</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>7,603,458</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>7,299,603</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>7,299,603</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Interest expense</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(1,130,184)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>640,286</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>640,286</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Accumulated deficit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(10,639,542)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(8,937,860)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(4,970,540)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Loss per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(0.19)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(0.09)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(0.02)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 124700 206000 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The following table represents the effects of the subsequent and first restated statements as of December 31, 2012:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Subsequent</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>First</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Restatement</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Restated</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Original</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Accounts receivable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,126,846</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>572,637</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,220,065</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Rebates receivable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,323,474</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,323,474</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,638,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Other receivables</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>40,867</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>40,867</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>40,867</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Accounts payable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>4,431,366</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>4,520,223</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,514,857</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Accrued expenses</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>568,528</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>453,057</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>453,057</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Note payable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>4,192,954</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>4,947,613</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>4,947,613</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Redeemable preferred stock</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>2,362,517</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>458,800</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>458,800</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Warrant liability</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>121,350</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>518,587</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>518,587</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Common stock</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>4,175,856</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>3,556,056</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>3,556,056</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>APIC</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>150,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Sales</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>27,305,795</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>28,663,284</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>38,401,140</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Cost of sales</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>26,148,118</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>24,068,906</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>31,650,232</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>General and administrative expenses</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>7,603,458</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>7,299,603</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>7,299,603</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Interest expense</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(1,130,184)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>640,286</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>640,286</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Accumulated deficit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(10,639,542)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(8,937,860)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(4,970,540)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Loss per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(0.19)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(0.09)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(0.02)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 2112500 1550083 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div><strong>6.</strong></div> </td> <td style="TEXT-ALIGN: justify"> <div><strong>Property and Equipment</strong></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Property and equipment is as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0px:auto; WIDTH: 75%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>June&#160;30,&#160;2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>December&#160;31,&#160;2012</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Furniture, fixtures and equipment</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,606,404</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,374,126</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Leasehold improvements</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>25,260</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>10,162</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,631,664</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,384,288</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Accumulated depreciation and amortization</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(394,930)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(270,233)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Net property and equipment</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,236,734</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,114,055</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif ">&#160;</div><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="left">Amortization and depreciation is approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">124,700</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">206,000</font> for the six months ended June 30, 2013 and 2012.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> Certain members of HCCAs management received an aggregate of 1,500,000 shares of our common stock (the Management Incentive Shares), which shares were placed in escrow and subject to release in three installments through June 30, 2015. Payable to a former executive of the Company. Estimated penalties relating to late registration of shares of common stock in connection with the bridge notes. EX-101.SCH 7 swca-20130630.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 102 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 103 - Statement - CONSOLIDATED BALANCE SHEETS [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 105 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT AND REDEEMABLE SECURITIES link:presentationLink link:definitionLink link:calculationLink 106 - Disclosure - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT AND REDEEMABLE SECURITIES [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 107 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 108 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 109 - Disclosure - Description of Business link:presentationLink link:definitionLink link:calculationLink 110 - Disclosure - Liquidity and Financial Condition link:presentationLink link:definitionLink link:calculationLink 111 - Disclosure - The Merger link:presentationLink link:definitionLink link:calculationLink 112 - Disclosure - Restatement link:presentationLink link:definitionLink link:calculationLink 113 - Disclosure - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 114 - Disclosure - Property and Equipment link:presentationLink link:definitionLink link:calculationLink 115 - Disclosure - Software, net link:presentationLink link:definitionLink link:calculationLink 116 - Disclosure - Investments Held in Trust link:presentationLink link:definitionLink link:calculationLink 117 - Disclosure - Deferred Financing Costs link:presentationLink link:definitionLink link:calculationLink 118 - Disclosure - Accrued Expenses link:presentationLink link:definitionLink link:calculationLink 119 - Disclosure - Line of Credit link:presentationLink link:definitionLink link:calculationLink 120 - Disclosure - Bridge Notes link:presentationLink link:definitionLink link:calculationLink 121 - Disclosure - Long-Term Debt link:presentationLink link:definitionLink link:calculationLink 122 - Disclosure - Redeemable Securities link:presentationLink link:definitionLink link:calculationLink 123 - Disclosure - Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 124 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 125 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 126 - Disclosure - Selected Financial Data (unaudited) link:presentationLink link:definitionLink link:calculationLink 127 - Disclosure - Related Party link:presentationLink link:definitionLink link:calculationLink 128 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 129 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 130 - Disclosure - Restatement (Tables) link:presentationLink link:definitionLink link:calculationLink 131 - Disclosure - Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 132 - Disclosure - Property and Equipment (Tables) link:presentationLink link:definitionLink link:calculationLink 133 - Disclosure - Software, net (Tables) link:presentationLink link:definitionLink link:calculationLink 134 - Disclosure - Deferred Financing Costs (Tables) link:presentationLink link:definitionLink link:calculationLink 135 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:definitionLink link:calculationLink 136 - Disclosure - Long-Term Debt (Tables) link:presentationLink link:definitionLink link:calculationLink 137 - Disclosure - Income Taxes (Tables) link:presentationLink link:definitionLink link:calculationLink 138 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 139 - Disclosure - Selected Financial Data (unaudited) (Tables) link:presentationLink link:definitionLink link:calculationLink 140 - Disclosure - Liquidity and Financial Condition (Details Textual) link:presentationLink link:definitionLink link:calculationLink 141 - Disclosure - The Merger (Details Textual) link:presentationLink link:definitionLink link:calculationLink 142 - Disclosure - Restatement (Details) link:presentationLink link:definitionLink link:calculationLink 143 - Disclosure - Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 144 - Disclosure - Significant Accounting Policies (Details 1) link:presentationLink link:definitionLink link:calculationLink 145 - Disclosure - Significant Accounting Policies (Details 2) link:presentationLink link:definitionLink link:calculationLink 146 - Disclosure - Significant Accounting Policies (Details Textual) link:presentationLink link:definitionLink link:calculationLink 147 - Disclosure - Property and Equipment (Details) link:presentationLink link:definitionLink link:calculationLink 148 - Disclosure - Property and Equipment (Details Textual) link:presentationLink link:definitionLink link:calculationLink 149 - Disclosure - Software, net (Details) link:presentationLink link:definitionLink link:calculationLink 150 - Disclosure - Software, net (Details Textual) link:presentationLink link:definitionLink link:calculationLink 151 - Disclosure - Investments Held in Trust (Details Textual) link:presentationLink link:definitionLink link:calculationLink 152 - Disclosure - Deferred Financing Costs (Details) link:presentationLink link:definitionLink link:calculationLink 153 - Disclosure - Accured Expenses (Details) link:presentationLink link:definitionLink link:calculationLink 154 - Disclosure - Line of Credit (Details Texual) link:presentationLink link:definitionLink link:calculationLink 155 - Disclosure - Bridge Notes (Details Textual) link:presentationLink link:definitionLink link:calculationLink 156 - Disclosure - Long-Term Debt (Details) link:presentationLink link:definitionLink link:calculationLink 157 - Disclosure - Long-Term Debt (Details 1) link:presentationLink link:definitionLink link:calculationLink 158 - Disclosure - Long-Term Debt (Details 2) link:presentationLink link:definitionLink link:calculationLink 159 - Disclosure - Long-Term Debt (Details 3) link:presentationLink link:definitionLink link:calculationLink 160 - Disclosure - Long-Term Debt (Details Textual) link:presentationLink link:definitionLink link:calculationLink 161 - Disclosure - Redeemable Securities (Details Textual) link:presentationLink link:definitionLink link:calculationLink 162 - Disclosure - Stockholders' Equity (Details Textual) link:presentationLink link:definitionLink link:calculationLink 163 - Disclosure - Income Taxes (Details) link:presentationLink link:definitionLink link:calculationLink 164 - Disclosure - Income Taxes (Details 1) link:presentationLink link:definitionLink link:calculationLink 165 - Disclosure - Income Taxes (Details Textual) link:presentationLink link:definitionLink link:calculationLink 166 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 167 - Disclosure - Commitments and Contingencies (Details Textual) link:presentationLink link:definitionLink link:calculationLink 168 - Disclosure - Selected Financial Data (unaudited) (Details) link:presentationLink link:definitionLink link:calculationLink 169 - Disclosure - Related Party (Details Textual) link:presentationLink link:definitionLink link:calculationLink 170 - Disclosure - Subsequent Events (Details Textual) link:presentationLink link:definitionLink link:calculationLink 171 - Disclosure - OFFERING AND BUSINESS OPERATIONS link:presentationLink link:definitionLink link:calculationLink 172 - Disclosure - COMMON STOCK AND WARRANTS link:presentationLink link:definitionLink link:calculationLink 173 - Disclosure - PREFERRED STOCK link:presentationLink link:definitionLink link:calculationLink 174 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Tables) link:presentationLink link:definitionLink link:calculationLink 175 - Disclosure - INVESTMENT HELD IN TRUST (Tables) link:presentationLink link:definitionLink link:calculationLink 176 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) link:presentationLink link:definitionLink link:calculationLink 177 - Disclosure - OFFERING AND BUSINESS OPERATIONS (Details Textual) link:presentationLink link:definitionLink link:calculationLink 178 - Disclosure - INVESTMENT HELD IN TRUST (Details) link:presentationLink link:definitionLink link:calculationLink 179 - Disclosure - COMMON STOCK AND WARRANTS (Details Textual) link:presentationLink link:definitionLink link:calculationLink 180 - Disclosure - PREFERRED STOCK (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 swca-20130630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 swca-20130630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 swca-20130630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 11 swca-20130630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 12 image_001.gif GRAPHIC begin 644 image_001.gif M1TE&.#EA^@`Q`&<``"'_"TU33T9&24-%.2XP#P````-S0DE4!P<'QYH)@P`A M_PM-4T]&1DE#13DN,!<````+;7-/4$U33T9&24-%.2XP0CRD]0`A_PM-4T]& M1DE#13DN,!@````,8VU04$I#;7`P-S$R`````T@`<[P`+`````#Z`#$`AP`` M````,P``9@``F0``S```_P`K```K,P`K9@`KF0`KS``K_P!5``!5,P!59@!5 MF0!5S`!5_P"```"`,P"`9@"`F0"`S`"`_P"J``"J,P"J9@"JF0"JS`"J_P#5 M``#5,P#59@#5F0#5S`#5_P#_``#_,P#_9@#_F0#_S`#__S,``#,`,S,`9C,` MF3,`S#,`_S,K`#,K,S,K9C,KF3,KS#,K_S-5`#-5,S-59C-5F3-5S#-5_S.` M`#.`,S.`9C.`F3.`S#.`_S.J`#.J,S.J9C.JF3.JS#.J_S/5`#/5,S/59C/5 MF3/5S#/5_S/_`#/_,S/_9C/_F3/_S#/__V8``&8`,V8`9F8`F68`S&8`_V8K M`&8K,V8K9F8KF68KS&8K_V95`&95,V959F95F695S&95_V:``&:`,V:`9F:` MF6:`S&:`_V:J`&:J,V:J9F:JF6:JS&:J_V;5`&;5,V;59F;5F6;5S&;5_V;_ M`&;_,V;_9F;_F6;_S&;__YD``)D`,YD`9ID`F9D`S)D`_YDK`)DK,YDK9IDK MF9DKS)DK_YE5`)E5,YE59IE5F9E5S)E5_YF``)F`,YF`9IF`F9F`S)F`_YFJ M`)FJ,YFJ9IFJF9FJS)FJ_YG5`)G5,YG59IG5F9G5S)G5_YG_`)G_,YG_9IG_ MF9G_S)G__\P``,P`,\P`9LP`F/($.*'$FR MI,F3*%.JY`C@QLJ7,&/*M"@&`(!,,W/JW"F36,L5Q'@*/8ASJ%&+-NL5/2I4 MF4TQ3*,^]!DC:@P`/#/9M*E,*DB7)&]@9>H40%>=-6/4A.JUH\VE(6U&K3E6 MITUH^^2VW5B69,V@4)A=A4"I(T MW(8#J?4B9/_%@%=7/D7FE(LE)E23C!3=$,-^]>257';J6=3:DPEI)2%(&FX5 MX#Y=$795>@`&)U9C7!7)D$T<8I2605="%-MW"YF7T(P,D4@076*(M>)_Y(EA MH),#!6GF0GW1*:6A`VF%H614IM8F0C+B=M!51!IDY7IW/I4CGS;=<&-"EB5F MY:`+U62`97!.U.95<0)@P)QE-O]$5Z4$5:C0AZFFMEY:ZBF#77IV.OECC:1. MJEZL%2$;**(&C9>0C)@F-)Y-BQ*D;$%@-DKL/C)2&6&C@#I)JU?!-O36HP]1 M>I`![A6427J2$@1A2X2A42ZWU%X5[T#;+JMEN]8"L&AL]&62X+B*XKN"3G\B MY*RJ-PELT:B,3LLIE5ENE:NC4+'***TW=ELME*E.2Y3&"$$();@H,09:PP+- MRW*5KJ5(45E+04-,MA>W.6TFX@FTY,F:YE7IC7!E"32:"+4)8-,)[IL:SIPE M="^;FZ'+97D36:GUF3<-U&V8DRB3"8.RV@(_U MR^^36JW_8*?7C0(NM4,X$D1@C1G9*<42\1B81Q>E!I6QZ.#%8%!IS MP\UF8OYM%1R`Y6UIL6MGB<'NN/Q*_EA-H*)L;-$.E;VWYX>CW"V)1<>CK0K.652SIY!F8;`WT#UOIT?T\1XZ"YMY8$+`0U;E"8592BE/#7T2(*VP[.MU9%M^WC< M/H:S%.9\SF)+`F)QFB.&`14&18L[X$+@-SQ884M']R%/W4HBOD3R*3J)$T@! ML?*_O6$'?$-\2I_<1)'-7$63#!'+U8HU,6KQ26V8T0I]T#`O#2)'`-AT?2F.,VI3G?*4Z8$!``[ ` end GRAPHIC 13 image_001.jpg GRAPHIC begin 644 image_001.jpg M_]C_X``02D9)1@`!`@$!+`$L``#_X1D117AI9@``34T`*@````@`!P$2``,` M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q M``(````<````<@$R``(````4````CH=I``0````!````I````-``+<;````G M$``MQL```"<0061O8F4@4&AO=&]S:&]P($-3,R!7:6YD;W=S`#(P,30Z,#,Z M,3,@,38Z-3$Z,S4``````Z`!``,````!``$``*`"``0````!```#-*`#``0` M```!```!U0`````````&`0,``P````$`!@```1H`!0````$```$>`1L`!0`` M``$```$F`2@``P````$``@```@$`!`````$```$N`@(`!`````$``!?;```` M`````$@````!````2`````'_V/_@`!!*1DE&``$"``!(`$@``/_M``Q!9&]B M95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\, M#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P, M#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`7`"@`P$B``(1`0,1`?_=``0` M"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$` M`````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$% M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F M]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B M$P4R@9$4H;%"(\%2T?`S)&+A7U5F9VAI:FML;6YO8G-T=7 M9W>'EZ>WQ__:``P#`0`"$0,1`#\`]$ZKU*W#?575Z>ZUECQZDZEAK:UC`SW; MG^LLJSZTYK'^EZ-7J#1PDS,;M&3N1/K8[:[#U(!]28\)J617]I-M=MWZQ?:U MH:'`'4;6M9HYVZQ]GTK'?X/]!_IU/CA$Q!('5K9TN%HQ:VB[TFO-DB-ILW[66/L?[=O M\VSZ:O5X^#A=/:_J,56-&ZUK7N)DG:W:RL[G.^BW]&H?;OJTUYK]?4`^[=;M MT&Z&V?0<[^3_`-;2]'2!/B$U,;Y`/`N?7]<7O(9NH#G.#`\AVR=VS=]/U/3T M_<_ZVKU/7KW-Q[0\18^8 M/&YCG;F?VDYZ54^T.=+:V<-!.YQ^C[WS]'9^ZFF4/W:71CDWXQ+R:C>L9]DM MII9=:W0U@.;K_*=[GUL_.]]/J?R%O94YXJ:YS&[G#AHF#[K'N9L M]I_PFQ;1`(((D'D%4;^EUO>U]4`#1U3I+"V0[V:_HG>W^I_(3A*/6*PQGTE; ME7?6PTO=6_T7D`.FHEP@@NV^[T]UFYOT?_!$O^<^8:2^JK'O(8VR*[>`X[=I M;;Z3]W]E:S\#IU;0ZUH8#I+G=_BXK-=G?58!KC=S,`->2`--Q:&>QCOS/](G MC@.T"6,C(-\@'X,'_6;)KLV/90'>JVGTP_<\DAON'I[J]FYW^DW[/\&E_P`Z MQ@JR:H.H:2=H<=1]&VJW^;_`$/Z7U?W_P!+0C$0.\:KNME+)&B)7?;5W\+K M&1?E546UUL%N^&AQ+QM&^7-KM=>2ZQS+"XDCQ$<;OS2 MNE<^P5O>"/;N@1^[/FH\@`-#LS8I&4;)O5AG97V3&.0?HL[:H_6(/^U8#F/M9Z9M>[T8W;6ACGNEY#/:U3^KV2P45XQ#O4LJ9>#R-NRJO MWN;]%^\*7_)BF`5[QO\`EH&ADULOZAEOMQOV@YMPK#G6BKTJMH^A6YS?\)ZK M/T?\Y_.*Q5T[IS\-E=N.RDOK`LI-@9CX4HPD":A&6_JONWZJ,7$ZKAG%BHWFP7;';B\!NY@>S<[=[MWZ17NH9_4 ML6]K<;IS\VDM!-M=C&D.)=+/2M+/HM8WW[O\(H]'Z5TW%K;D8KAD6/8&NR0[ M<'03N+(E_.?I/YOU9NZKU<-W?LJP$.>#7ZC'.<&MJ=6YCJRZMOJ>K;] M-W_:;T_YRVI:5F3CU.VVVL8[0PYP!@Z#E1^W843]HJCQWM_O35[F_MGJWOCH MUYV;O\)6)VC=M;NK'<+.D6LV,>XD6UD$M:Y M]=;/SG>JYOI_16A]LP^/7KUG\]O;Z7=+[9B3'KUSX;A.FGBDISOVIUII9/1W MN#F!YV75>TEU@?2[>6?I64MQ[/\`1;[O2]7]"GJZMU5SZFV=(NK;:6!SO4K= ML#G;+'V;7?X!OZ5_\C^;_P`)Z6@S+Q7O%;+JW/=]%H<"3WT;/DC)*@XD-#P=K+-"/5 M2TL_`PLQC?M;"X5F6EI<'"?;HZOW[7+#_P":F)$MR7[W$^H33.X'Z/MC]S^< M_P`'8_W^FI8R%`&1C3#*$N(D0$[ZWJMG=.P,7$LR:&>G?3[JKFO.YI<[W.9[ MOW7V/]-OTUM=0Q<:[&-]E;;+65PVTCW05GX/U=Z7C6[WN?>6V[J6N:X-;(/M ML:/9:[?^KEEC^J,+K&6$B_VL:`6-#PRO<\?Z;:_Z3O\`!+9ZCD.J=3)VU![R\R=0 MYMU306MGV[W,65T,O?U2A_J7&OT;&-:\-V2QSFO;6:W?X/V?SC/\)_85_JQM M9;6]C]FI&XCVB3;NGVO^DWV)9OF^B<'R?5/U4$]/R0.?;$&/\*>X1>EV66_: M++-'OMDM'`AE;6^WZ7T6_G*ED%YZ1>'L]-@]%M1D?0+J_P!)N_2_0L=9]/\` MT:M=&_F[QMVD6:@1^ZWX_P#24;*__]'L?KBTNKQPP$V;;3[9W;?T7J[=OYNW M^<_D+0^KN.:NFT7%VX7TT.:V(V@5,;MG\[W*M]8PYV3T]K:WO#W6,?Z;@P[7 M!C7,+G_H_P!)_P"JOTBT.B_\CX6L_H*]=/W6_N^U2D_JHCQ88C]=(^"?)MLJ MKW5-#W3HTF)_M*K]NS]/U9G`F;1H?D%9ROHM^/\`!5X_!1AD)U6;FYQ+=V.Q M@/TSZ@.WY#^<1?M5O@W\?[T(I(TBRE^U6^#?N/\`>E]JM\&_ZO!L8VYEA+RVV['MV.R*K6#]`SU/\%=^KV*H_*RF^UV^#?N/]ZYEG[5R,W*IO=FO?0RAKA@64UUM>ZEE MEVF0^KZ5KG/]JNNKRIZGT+7>EZ/ M_;B0R7^B=Z^Q4^5X2+RP^6,Y&/KX1DX.#2/K_P`K^X[/VNWP;]Q_O2^UV^#? MN/\`>N5SNH]4=?^Z_)OP[7 M-PV]/R'T`:3:RO'RFY']AF955_(?78A[L==#H:7#X?F/!ZH^N/N?I>D&,9QX MO3\TN/\`\;R/16W.N866!I:>8+A_TFN:Y"=546M86"&DD0YX,GF8?[N/SEB9 M@S<+IN;DA_4*7LJ`8_*LIL:"7L&ZIN/9:[U=JM86?==U)F)>YK,BBB]N70PZ M>HQ^+Z.0UIC]'?3=ZM'_`!GI?X-.&071!!T_YWI6'E9G]'U\']]U\:JI]@!;&QH#8<_\UXL;R_]]6,K'^T5>G(!#FN#B-T;2'LMM-;:'/:][FEDOJ=#SPWZ3==JB9G__2[3ZV.%8QK"UMFUMH:Q\QN<*V-?.O M\W.]:G1/^1L'_P`+U< MBB.CX(X(QZ@03/#&]U)+^;CYL,?YZ?E_WJ3->RNMKWF&@ZF">?;^;[E2^W8L MP7.F2-6/&H@N_,_E+2MNHJ@W/;7N,-+R!)\MR&W.P7`EM]3@!)AS3I&_Q_=3 M+92&A]OQ-L[W1$ZL>/+]Q3KOJMGTR3`!,M56QPU,% MKI']6?Y34%U],@G/K#2=P!]/5L?FG]W^4E:N%JY73L'+>++V$V!AJWL>^IQK M<=QJ>_'?4ZRK=_@[$6K&QJ7NLIK;6Y[&5D-T&RK=Z+&L^@QM?J/^@@'J&0"0 M1M`W;7&S&AX!&UP]^YOJM=[/_!$AG9A/IN::W`#W&S&ESB6_H]F[_C/=_P`$ MAI=T+[KC/(8\!G+A&G#Q'@KYOE5=TGI]U]F0]KQ;=M]1U=UM6[8-C-[:+:V. MVL]J5_2^G7O-EM4N]H>UGT&9+:WM;D[?\`NQZJ@>J93@TBL,!)XNQ7 M2`)\0B,ZA>70X!C0YC38;<36OWF3^ZD5H%/,?5-P?U!GL#75-N:YPGWASM[/Y/Z) MWJ?]NKK7N:*7-)`+R\-![GWN@?V6KF/JS0*<^D;=ECZ;+;)L#B[>_P#1'TFE MVSTJV?G?Z57\&=NV&N)V`N8:YV_FV^]^U_P#UM2YSHS[;J3H-/SO=])4,K9 M^RZBP.-?V9H8'!HT-E&WU&-_.;_P?Z-7NC:U7./)M,R23HUK>7?#][_R"B9R M-!XC]K__T^X^LCJF6X;[17%7JV!UK2YLL#"VO;+6[K'[-G_@?O6AT8STC",S M./49`@:L;^:LSZUM=8VBEKFLGY?]ZDS7N;0YK6O<7@M!8W=$CZ3F[F(#<&][=QO<);[`[> M'-)`V[]E[=VW\Y7U3R;MCGS2_)>(%=+8B".7.L[F/5'^;.2[:AV&Z[TL?WAC-2^)-AK#/:_W-]-KGO2 M8VP^I66MWO<[96)!K:!^C>UWN:S=MW>S_"V_\&DIG]@N!!%Y\"";2._;[2E] M@OVAIN!YW']*"9`;S]I]OT=RMU/+ZVOJWVU8S65.+++W MBL6`26B'66O9,M]7T:[/2W^SU4E,#BVA^QV6T6/'T9L!T^B6-^T_^=HM6!!+ MKK'/=.FU]K0!X;?6>J`Z7B!S<9U=?J6-#W-\VBC:ZMSB20UQLK]%SG^]_IVT6['O_`,#Z7OL_G$E-DX-! M`$V:1KZMDZ#;]+U-R+76VINQI<1_*<7'_.L+G)W[]CO3C?'MW<3VW0JC;.J" MMH=4QSZVR\AXBQP9]%GM_1;K?WO_`$9^B2FZDJUG[0#V&OTW-VD/!):-QX1[L[&]O\VXP?Z[+O_22 M+D%PQCO(W>V2!I,A0MKWYM;@"?2+7DSQ+,FO_OZ2GG?JRZI^=18T5;W4/K?Z M8+7`U.#=UON+/TK'L_[;_1_HUI9.)<[J3KO=75<[T]S8EP;6ZQQ^B7,_24^D M[U/\'^C65]4V/KS&;B(O9:YH#Y(%;FU_I&?RG.]G]1=4[^8L/]?\KE+G^=AY M?^;^KBY&-)V M?ZO53JS37B[*I:RNIP:T']VVD,^EN;[6_GV*_A,97=F,8`UHM;#6P`)JI/`^ MC[O'T@>EM8UK?4BOWL][6?Z-='=]GEOK[)UV[X_M;=R"[]D M[?=]GVSWV1*E!'"+%CS#!($SEPRH^4OZKA5_6?JCW-:ZBFK=])UCBP-]H?MW M6;6[_=]!.?K+8Z"[[,ZUM0M#?TP[QLW^G^Y^DW[/^&_FUM._8^F[[-_)G9^" M?_(^XQ]FW;=?H3MC_J-J7%#]S\5<.3]_\'G;?K#FU6/8W#986>T.KR;'@Z>H M=KZP[W?OJP/K'=1O?:REA`9IZ]EP.\G@L994W8WW_O\`I_R%LC]C0[;]FC\Z M-G_24/\`('IG^B>G(G^;B?S4N+'^Y^*>#+^_^#1K^L.4;F,LII])SWL=97:7 M'V@[8I=6RW])_P"I%9^UXO5\9U3'BC)K<'5AX!A[3[7;9;ZU+_YJ[9_@WV5_ MHD?_`")ZG_:7U/\`K>Z(_P#(J9_9>T[O0VS[IV1/FFR,#L*71$QO*_,-079[ M"T'$R`Y@@LKLI?62W1OIWW.JM])VSW^KZ-G_``2>BRGI=%N1G6-.3=J:ZR7P MUH<644[MK[=OZ6U]NRO?;9=;^AK_`$=9O\AQ_P!I8_ZVI,_8^OI_9O/;L_@F MBNMKSQ=*#GW_`%BO!+L:BNRH5&USK+=A$'Z/T';]T_X-0=]9;/4?56VA[V6- MK(+WL'N;NW;WU;/8\>G[_P`_]'_.+1?^PMX]3[+OUC=Z<]MW*1_8]WI_HW?36J/V'LT^R[/^MPG'[' M]L?9N3L^AS.NU'BQ_N5]4"&7_.7]'"N^M'4"QH^RT6,>P//IW.)&H`:_:QME M7N_TFQ$I^LF61Z]]>/1N:XN:7O>\"O=M:ZJMI])[G._PGI_N+9'[&DQ]FGO] M"?FDW]CP[;]FC7=&R(_.W)<4/W/Q1P9/WS]CA?5XM'4Z6,MJ+3B@EE=9KG7G M+45H MNP@".AO7^7S./UX5LK!/M;Z5D@`3]/&.FK/W5?QG$Y&6"2=MC8![#TJCIK^\ MIY'V3;^M>GM@_P`YMC;+=WT_S=VQ$;Z>Y^R-T_I(B=T-^G_*V;%$.K/+:/E_ MW4G_V?_M'B90:&]T;W-H;W`@,RXP`#A"24T$!```````!QP"```"AK\`.$)) M300E```````0@KAC-=,!(33Q3^2*3U!K+#A"24T$+P``````2O__`0!(```` M2```````````````T`(``$`"`````````````!@#``!D`@````'``P``L`0` M``$`#R7!E M96YU;0````I%4VQI8V54>7!E`````$EM9R`````&8F]U;F1S3V)J8P````$` M``````!28W0Q````!`````!4;W`@;&]N9P``````````3&5F=&QO;F<````` M`````$)T;VUL;VYG```!U0````!29VAT;&]N9P```S0````#=7)L5$585``` M``$```````!N=6QL5$585`````$```````!-'1415A4`````0``````"6AOD%L:6=N````!V1E9F%U;'0````)=F5R=$%L:6=N96YU;0````]%4VQI8V56 M97)T06QI9VX````'9&5F875L=`````MB9T-O;&]R5'EP965N=6T````115-L M:6-E0D=#;VQO)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=7 M9W>'EZ>WQ]?G]Q$``@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*! MD12AL4(CP5+1\#,D8N%R@I)#4Q5C+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B7 MI[?'_]H`#`,!``(1`Q$`/P#T3JO4K<-]5=7I[K66/'J3J6&MK6,#/=N?ZRRK M/K3FL?Z7HU>H-'"3,QNT9.Y$^MCMKL/4@'U)CPFI9%?VDVUVW?K%]K6AH<`= M1M:UFCG;K'V?2L=_@_T'^G4^.$3$$@=6MER2$R`2*IT7_6S)87-<,9CV5-M+ M'ES2[<>*G3Z?YO\`A75^]2_YRY[2X6C%K:+O2:\V2(VFS?M98^Q_MV_S;/IJ M]7CX.%T]K^HQ58T;K6M>XF2=K=K*SN<[Z+?T:A]N^K37FOU]0#[MUNW0;H;9 M]!SOY/\`UM+T=($^(34QOD`\"Y]?UQ>\AFZ@.O)<9_5 M^H8X/VS&;1!,.#B6$`3_`#CO2:QRC9UZ]E3GBIKG,;N<.&B8/NL>YFSVG_"; M%M$`@@B0>051OZ76][7U0`-'5.DL+9#O9K^B=[?ZG\A.$H]8K#&?25N5=];# M2]U;_1>0`Z:B7"""[;[O3W6;F_1_\$2_YSYAI+ZJL>\AC;(KMX#CMVEMOI/W M?V5K/P.G5M#K6A@.DN=W^+BLUV=]5@&N-W,P`UY(`TW%H9[&._,_TB>.`[0) M8R,@WR`?@P?]9LFNS8]E`=ZK:?3#]SR2&^X>GNKV;G?Z3?L_P:7_`#IR6D[L M>LQIH\^//N;]%RNX]?0\P6,QWML()86R1)(WS63])KO]-2N?LQLHW-Q[&"K) MJ@ZAI)VAQU'T;:K?YO\`0_I?5_?_`$M",1`[QJNZV4LD:(E=]M7?PNL9%^55 M1;76P6[X:'$O&T;YYF_P!T5EM.O^G^@C?5S'QGX5>2:V&Z&.%@'=]53W;9_-][MJC] M8@_[5@.8^UGIFU[O1C=M:&.>Z7D,]K5/ZO9+!17C$.]2RIEX/(V[*J_>YOT7 M[PI?\F*8!7O&_P"6@:&36R_J&6^W&_:#FW"L.=:*O2JVCZ%;G-_PGJL_1_SG M\XK%73NG/PV5VX[*2^L"RDV!SFG;#JO4:_8_;^^Q6^L](Z7DUV9&2YN-;MVC M*)V@=F^HUQ;59_H_TGYBQOV#]67@AO4ZC0!&P65&#$?3GR_K_P`M$2B=YF/A M2C"0)J$9;^J^[?JHQ<3JN&<6*C>;!=L=N+P&[F![-SMWNW?I%>ZAG]2Q;VMQ MNG/S:2T$VUV,:0XETL]*TL^BUC??N_PBCT?I73<6MN1BN&18]@:[)#MP=!.X MLASJZ_=_HUIJ.9!.ANNI9,<2`;`%FZ'1Q?VSUH-)8UEU;G$QOV/G8U MC_HM^EZ7\Y^D_F_5F[JO5PW=^RK`0YX-?J,W^]-7N;^V>K>^.C7G9N_ MPE8G:-VUNYS=WN_1_P"C_P!'8^KU+*YU]5ZL=PLZ1:S8Q[B1;602UKGUUL_. M=ZKF^G]%:'VS#X]>O6?SV]OI=TOMF),>O7/AN$Z:>*2G._:G6FED]'>X.8'G M9=5[276!]+MY9^E92W'L_P!%ON]+U?T*>KJW57/J;9TBZMMI8'.]2MVP.=LL M?9M=_@&_I7_R/YO_``GI:#,O%>\5LNK<]WT6AP)/?1L^2,DIP^KTTY75K_Q6S_A$U?2^G5@[*6PYQ>9<3J=#^=Y+2S\# M"S&-^UL+A69:6EP<)]NCJ_?MJV=T[`Q<2S)H9Z=]/NJN:\[FESO-;O>Y]Y;;NI:YK@UL@^VQH]EK MMSGV;W_]#TUH]3R*ZZACD.-F3+*H$C=_*=^:A*5D`$R\51C0D91$;'RAY_ZN M66/ZHPNL982+_:QH!8T/#*]SQ_IMK_I._P`$MGJ.0ZIU,G;4'O+S)U#FW5-! M:V?;O^ MV2T<"&5M;[?I?1;^STV#T6U&1]`NK_`$F[]+]"QUGT_P#1JUT; M^;O&W:19J!'[K?C_`-)1LK__T>Q^N+2ZO'#`39MM/MG=M_1>KMV_F[?YS^0M M#ZNXYJZ;1<7;A?30YK8C:!4QNV?SO\/=8Q_IN##M<&-W8[(JM8/T#/4_P5WZO8JC\K)R,N*K\W(:,7&LH?A! MM;'/L%NZZZJ[V5>JYC7;'_0_/49R`&J.]-O'RDIQ$OF]IQ79CJF:N_19=K/](BY?5[[K\F_#M9A_NX_.6)F#-PNF MYN2']0I>RH!C\JRFQH)>P;JFX]EKO5VJUA9]UW4F8E[FLR**+VY=##IZC'XO MHY#6F/T=]-WJT?\`&>E_@TX9!=$$'3_G>E8>5EP&<)QG`<5F)O\`FX1R2EZ? MT?7P?WW7QJJGV`%L;&@-AS_S7BQO+_WU8RL?[15Z<@$.:X.(W1M(=Q_50<0_ MI3_5_B%<3CH6N-1J\=]52#U&3,$V^D#NT'^%]/=^;_-;_P#K:VNJ4V/LIVN; M7O>YK'.&Z2T7W/:YG_%L]G[EGZ19GU?#V]0QZRVTUMH<]KWN:62]SB_TVU#_ M``G_``G^C_1KH;+#Z5C?3FY)@L,LB8G^=G37_HHW M1MGI7%@+1ZIT//#?I-UVJ)F?_]+M/K8X5C&L+6V;6VAK'S&YPK8U\Z_S<[UJ M=$_Y&P?_``O5QQ]!JSOK-4VZW#I<&O%HM8&.>&>XAGIV>[V_HGMWK1Z*(Z/@ MC@C'J!!,\,;W4DOYN/FPQ_GI^7_>I,U[*ZVO>8:#J8)Y]OYON5+[=BS!XPTO($GRW(;<[!<"6WU.`$F'-.D;_']U,ME(:' MV_$VSO=$3JQX\OW%.N^JV?3),`$RUS?I?1^FUO@K5N7BN$5Y5;'#4P6ND?U9 M_E-077TR"<^L-)W`'T]6Q^:?W?Y25JX6KE=.PQ[ZG&MQW&I[ M\=]3K*MW^#L1:L;&I>ZRFMM;GL960W0;*MWHL:SZ#&U^H_Z"`>H9`)!&T#=M M<;,:'@$;7#W[F^JUWL_\$2&=F$^FYIK<`/<;,:7.);^CV;O^,]W_``2&EW0O MNN,\ACP&"OF^55W2>GW7V9#VO%MVWU'5W6U;M@V,WMHMK8[:SVI7 M]+Z=>\V6U2YS6LLA[VA[6?09DMK>UN3M_P"['JJ!ZIE.#2*PP$GB[%=(`GQ" M(SJ%Y=#@&-#F--AMQRV'ES?5]IW^W9]#_"^HE4?W1KX+AES"JRS](X8^N7IC M^[']V/I7=@8+KO7-3?5]1EVZ3].MGH5/V@[?T=7L46]+ZJ6G"."/^+"7"T_V/T[996]C M[*[F[+&V7W6`MEK_`*-MS]ON8WZ*LFC'.4,PM'VGTS3ZLZ^F7"ST_P!WZ;=R ML59.$P`VYE-DB&R:VR1NW.]J)]KZ>7A@NI+R0`W'1Y-:_>9/[J16@4\Q]4W!_4&>P-=4VYKG"?>'.WL_D_HG>I_VZ MNM>YHIZ!_9:N8^K-`ISZ1MV6/ILMLFP.+M[_`-$?2:7;/2K9 M^=_I5=SKS3U=[P9V[8:XG8"YAKG;^;;[W[7_`/6U+G-S8N6%8]>Z?/R6V]++ MY-+LBNNQHD2!ZC-S7/\`H_X9K-RM=&+W8SBXR-[MNI.@T_.]WTE0RMG[+J+` MXU_9FA@<&C0V4;?48W\YO_!_HU>Z-K5K8'6M+FRP,+:]LM;NL?LV?^!^]:'1C/2,(S,X]1D" M!JQOYJS/K6UUC:*6N:QSF7/!YM#FM:]Q>"T%C=T2/I.;N8@-P;WMW&]PEOL#MXWWN4;,L<+(<=;_;X#U08D MGZ7VE)N%D22;Q[N8]4?YLY+MJ'8;KO2Q_>&,U+XDV&L,]K_])C;#ZE M9:W>]SME8D&MH'Z-[7>YK-VW=[/\+;_P:2F?V"X$$7GP()M([]OM*7V"_:&F MX'G*Q8!) M:(=9:]DRWU?1KL]+?[/524P.+:'['9;18\?1FP'3Z)8W[3_YVBU8$$NNL<]T MZ;7VM`'AM]9ZH#I>('-QG5U^I8T/^VUMGJ.]OTK_5ML_P!+_-JS MTFRQKK\-[S:*-KJW.))#7&ROT7.?[W^G;1;L>_\`P/I>^S^<24V3@T$`39I& MOJV3H-OTO4W(M=;:F[&EQ'\IQW=Q/;="J-LZH*VAU3' M/K;+R'B+'!GT6>W]%NM_>_\`1GZ)*;J2K6?M`/8:_3_\`F&I*;*IY'NSL;V_S;C!_KLN_])(N07#& M.\C=[9(&DR%"VO?FUN`)](M>3/$LR:_^_I*>=^K+JGYU%C15O=0^M_I@M<#4 MX-W6^XL_2L>S_MO]'^C6EDXESNI.N]U=5SO3W-B7!M;K''Z)+LJEK*ZG!K0?W;:0SZ6YOM;^?8K^$QE=V8Q@#6BUL-;``FJD\#Z/N]RB M[M@[1\O^ZD__U.[^L#@W*Z?-K:QO>=KF>I,!FNR'?0_TG^!_G51Q^NY-.'35 MC/Q7,KKSWM9_HUT=WV>6^OLG7;OC^UMW(+OV3M]WV? M;/?9$J4$<(L6/,,$@3.7#*CY2_JN%7]9^J/=M^L.;58]C<-EA9[0ZO)L>#IZAVOK#O M=^^K`^L=U&]]K*6$!FGKV7`[R>"QEE3=C??^_P"G_(6R/V-#MOV:/SHV?])0 M_P`@>F?Z)ZQUE=I*,FMP=6'@&'M/M=MEOK4O_FKMG^#?97^B1_\` M(GJ?]I?4_P"M[HC_`,BIG]E[3N]#;/NG9$^:;(P.PI=$3&\K\PU!=GL+0<3( M#F""RNRE]9+=&^G?ET6Y&=8TY-VIKK)?#6AQ91 M3NVOMV_I;7V[*]]MEUOZ&O\`1UF_R''_`&EC_K:DS]CZ^G]F\]NS^":*ZVO/ M%TH.??\`6*\$NQJ*[*A4;7.LMV$0?H_0=OW3_@U!WUEL]1]5;:'O98VL@O>P M>YN[=O?5L]CQZ?O_`#_T?\XM%_["WCU/LN_6-WISVWG]+9OW;?1]'_P)6V_6 M;(+VUV#&8]]CJQ#K'@;6AV[?75L=[W>G^C=]-:H_8>S3[+L_ZW"+'^Y7U0(9?\Y?T<*[ZT=0+&C[+18Q[`\^G[_2; M$2GZR99'KWUX]&YKBYI>][P*]VUKJJVGTGN<[_">G^XMD?L:3'V:>_T)^:3? MV/#MOV:-=T;(C\[=SF_IO M3W?I/]$_]'_PBZ@L8=2T3\$"C]G;Q]G]'?'M]/;.WRV?FJRAE)XM16B["`(Z M&]?Y?,X_7A6RL$^UOI62`!/T\8Z:L_=5_&<3D98))VV-@'L/2J.FO[RGD?9- MOZUZ>V#_`#FV-LMW?3_-W;$1OI[G[(W3^DB)W0WZ?\K9L40ZL\MH^7_=2?_9 M`#A"24T$(0``````50````$!````#P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\` MG)E4WI.5&-Z:V,Y9"(_/B`\>#IX;7!M971A('AM;&YS.G@] M(F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835`@0V]R92`T+C$M M8S`S-B`T-BXR-S8W,C`L($UO;B!&96(@,3D@,C`P-R`R,CHT,#HP."`@("`@ M("`@(CX@/')D9CI21$8@>&UL;G,Z&UL;G,Z>&%P/2)H='1P.B\O;G,N861O8F4N8V]M+WAA M<"\Q+C`O(B!X;6QN&UL;G,Z>&%P34T](FAT='`Z+R]N&%P+S$N,"]M;2\B('AM;&YS.G1I9F8](FAT='`Z+R]N&EF/2)H='1P.B\O;G,N861O8F4N8V]M M+V5X:68O,2XP+R(@>&%P.D-R96%T941A=&4](C(P,30M,#,M,3-4,38Z-3`Z M,S,M,#0Z,#`B('AA<#I-;V1I9GE$871E/2(R,#$T+3`S+3$S5#$V.C4Q.C,U M+3`T.C`P(B!X87`Z365T861A=&%$871E/2(R,#$T+3`S+3$S5#$V.C4Q.C,U M+3`T.C`P(B!X87`Z0W)E871O&EF.DYA=&EV941I9V5S=#TB,S8X-C0L M-#`Y-C`L-#`Y-C$L,S'0`````0V]P>7)I9VAT("AC*2`Q M.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY``!D97-C`````````!)S4D=" M($E%0S8Q.38V+3(N,0``````````````$G-21T(@245#-C$Y-C8M,BXQ```` M```````````````````````````````````````````````````````````` M``!865H@````````\U$``0````$6S%A96B``````````````````````6%E: M(````````&^B```X]0```Y!865H@````````8ID``+>%```8VEA96B`````` M```DH```#X0``+;/9&5S8P`````````6245#(&AT='`Z+R]W=W`&,`:`!M`'(`=P!\`($`A@"+`)``E0":`)\`I`"I`*X` ML@"W`+P`P0#&`,L`T`#5`-L`X`#E`.L`\`#V`/L!`0$'`0T!$P$9`1\!)0$K M`3(!.`$^`44!3`%2`5D!8`%G`6X!=0%\`8,!BP&2`9H!H0&I`;$!N0'!`$!Z0'R`?H"`P(,`A0"'0(F`B\".`)!`DL"5`)=`F<"<0)Z`H0"C@*8 M`J("K`*V`L$"RP+5`N`"ZP+U`P`#"P,6`R$#+0,X`T,#3P-:`V8#<@-^`XH# ME@.B`ZX#N@/'`],#X`/L`_D$!@03!"`$+00[!$@$501C!'$$?@2,!)H$J`2V M!,0$TP3A!/`$_@4-!1P%*P4Z!4D%6`5G!7<%A@66!:8%M07%!=4%Y07V!@8& M%@8G!C<&2`99!FH&>P:,!IT&KP;`!M$&XP;U!P<'&09 M!ZP'OP?2!^4'^`@+"!\(,@A&"%H(;@B"")8(J@B^"-((YPC["1`))0DZ"4\) M9`EY"8\)I`FZ"<\)Y0G["A$*)PH]"E0*:@J!"I@*K@K%"MP*\PL+"R(+.0M1 M"VD+@`N8"[`+R`OA"_D,$@PJ#$,,7`QU#(X,IPS`#-D,\PT-#28-0`U:#70- MC@VI#<,-W@WX#A,.+@Y)#F0.?PZ;#K8.T@[N#PD/)0]!#UX/>@^6#[,/SP_L M$`D0)A!#$&$0?A";$+D0UQ#U$1,1,1%/$6T1C!&J$)%ZX7TA?W&!L80!AE&(H8 MKQC5&/H9(!E%&6L9D1FW&=T:!!HJ&E$:=QJ>&L4:[!L4&SL;8QN*&[(;VAP" M'"H<4AQ['*,0!YJ'I0>OA[I'Q,?/A]I'Y0? MOQ_J(!4@02!L()@@Q"#P(1PA2"%U(:$ASB'[(B--@U$S5--8Y",$)R0K5"]T,Z0WU#P$0#1$=$BD3.11)%546:1=Y&(D9G1JM& M\$25^!8+UA]6,M9&EEI6;A:!UI6 M6J9:]5M%6Y5;Y5PU7(9O5\/7V%?LV`%8%=@JF#\84]A MHF'U8DEBG&+P8T-CEV/K9$!DE&3I93UEDF7G9CUFDF;H9SUGDV?I:#]HEFCL M:4-IFFGQ:DAJGVKW:T]KIVO_;%=LKVT(;6!MN6X2;FMNQ&\>;WAOT7`K<(9P MX'$Z<95Q\')+%V/G:;=OAW5G>S>!%X;GC, M>2IYB7GG>D9ZI7L$>V-[PGPA?(%\X7U!?:%^`7YB?L)_(W^$?^6`1X"H@0J! M:X'-@C""DH+T@U>#NH0=A("$XX5'A:N&#H9RAM>'.X>?B`2(:8C.B3.)F8G^ MBF2*RHLPBY:+_(QCC,J-,8V8C?^.9H[.CS:/GI`&D&Z0UI$_D:B2$9)ZDN.3 M39.VE""4BI3TE5^5R98TEI^7"I=UE^"83)BXF229D)G\FFB:U9M"FZ^<')R) MG/>=9)W2GD">KI\=GXN?^J!IH-BA1Z&VHB:BEJ,&HW:CYJ16I,>E.*6IIAJF MBZ;]IVZGX*A2J,2I-ZFIJARJCZL"JW6KZ:QK_UP'#`[,%GP>/"7\+;PUC#U,11Q,[%2\7( MQD;&P\=!Q[_(/%$XIZ#+H MO.E&Z=#J6^KEZW#K^^R&[1'MG.XH[K3O0._,\%CPY?%R\?_RC/,9\Z?T-/3" M]5#UWO9M]OOWBO@9^*CY./G'^E?ZY_MW_`?\F/TI_;K^2_[<_VW____N``Y! M9&]B90!D0`````'_VP"$``$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$"`@("`@("`@("`@,#`P,#`P,#`P,!`0$!`0$!`0$! M`0("`0("`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#`__``!$(`=4#-`,!$0`"$0$#$0'_W0`$`&?_Q`&B````!@(# M`0`````````````'"`8%!`D#"@(!``L!```&`P$!`0````````````8%!`,' M`@@!"0`*"Q```@$#!`$#`P(#`P,"!@EU`0(#!!$%$@8A!Q,B``@Q%$$R(Q4) M44(6820S%U)Q@1ABD25#H;'P)C1R"AG!T34GX5,V@O&2HD147J%AH>( MB8J4E9:7F)F:I*6FIZBIJK2UMK>XN;K$Q<;'R,G*U-76U]C9VN3EYN?HZ>KT M]?;W^/GZ$0`"`0,"!`0#!00$!`8&!6T!`@,1!"$2!3$&`"(305$',F$4<0A" M@2.1%5*A8A8S";$DP=%#$A:.SP]/C\RD:E*2TQ-3D])6EM<75Y?4H1U=F.':&EJ:VQM;F M]F=WAY>GM\?7Y_=(6&AXB)BHN,C8Z/@Y25EI>8F9J;G)V>GY*CI*6FIZBIJJ MNLK:ZOK_V@`,`P$``A$#$0`_`-_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7_T-_CW[KW7O?NO=>]^Z]U[W[KW7O?JCUZ]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]PX]<2R@@%E!/T!(!/^L/?NM5'"N>O:T'U=187/J'` M_K]?I[]UZH]>N)FB`N98P+VN74"Y-@+DVO?WZA].O5'KUB-91J;&KI@0+D&> M($#^O+?3W;2QX*>J^(@XN/V]=??47_*Y2_\`G1%_T?[]H?\`A/[.O&2,<7'[ M1UW][1_\K=-_U/B_Z/\`?M#_`,)_9U[Q(_XQ^T==_>4G_*U3_P#4^+_H[W[0 M_P#"?V=>\2/^,?M'7ONZ3_E:I_\`J='_`-'>_:&_A/7O$3^,?MZ\*NE/TJ:< M_GB:/Z?\E>_:6_A/6PZ'@X_;UW]U3?\`*Q!_U.C_`.CO?M+?PGKVM/XQ^WKW MW5-_RL0?]3H_^CO?M#_PG]G6O$C_`-^#]HZ[^YI_^.\/_4U/^CO>M+?PGK>M M/XQ^WKWW$'_'>'_J8G_1WO>AOX3U[6G\8_;UWYX/^.T7_4Q/^*^]:6'%3UX. MAX,/V]#]#_K'W MKK?7?OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>]5`XGKW M7O>Z]>Z][]U[KWOW7NO>_5Z]U[W[KW7O>JCUZ]U[WOKW7O?NO=>]^Z]U[W[K MW7O?NO=>]ZJ/7KW7O?JCUZ]U[WOKW7O?NO=<4=9`64W`9T/!'JC8HPL0#PRG M_`^_=>ZY>_=>Z][]U[KWOW7NO>]5'KU[KWO?7NO>_=>Z][]U[KWOW7NO>_=> MZ][]U[KWOW7NO>_=>Z]ZZN#^1[WU[KOWJH]>O=>][Z]UZX]^Z]U[WJH]>O=>]^J/7KW M7O>^O=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=<#) M&)%B+H)61I%C+*)&1"BNZI?441I%!-K`L/Z^_=>ZY^_=>Z][]U[KWOW7NO>_ M=>Z][]U[KWOW7NO_T=_CW[KW7O?NO=5G?S&^Q^X.O-L['7H63&2=L;VWILKK MO:-#F'>;&S9#>6>GHXGKJ.6M@QU)2^:C3RU\\;+2TZR&_)7V/_;_`&S:MRO[ MT[VTB[7;V[SR%#1M,8%0#I))H<`<33J*?=/=-]VNPV\\M!#O5S*6*AW`=C[:S*SP0U&64OD:.":IU0:/'['NS[%RE<[SM]CS!MCQ6& MY!VMM$K>)%H/:ERS=@D<#7V84E5(->HPWOF#G>TV#=-SY>)&K M12^)35):J`7,:$Z`6!+`%NVAZP]M;A_F)]5=-=C]O9_N#I3$ M0D5LTCR:V574*%J-#,5J0=1&H4'2`ZA[G^2V9RF>KNZ.QMK[+VYM&DRNY-ZT MFT^N,%..OMF[>CAGRTV_]QUT:6=I9&50@+:--"2W8.8.:YYKC^L M>\06]O"K22B&WC)MXT'=XSM4:JE42.)69I&6/4&)H(V3^0?:FY)II-C]>4M% MA,.8:?5OC&Y+=F\\GZ=%?4;ECV]VGL'KO`[AGJ()*>3#;?Q];)C:B)Z:IK!+ M&9)"^VY>VBW"K>;CKN),]C!(Q4T`CU02R.M*$2R%=2G4BTH.CN7F??;MVEV_ M:`D$:@UE0RRL/,RA;B&%'-"#%$K&-NUW)U=,%)\L,U529'![FR^;Z&WMAX/L ML?EMH8%NR]I9>F:J%"F8W%U)V3E&["H:0UE1$PK]O[GS4#TOA84*-50+(X.5 M+10MQ!`E]8.02)',+J:96.>+]$M@]DL2DY.N@/22/GR[=Y+.ZN&V[=$4Z6BC M^HB<5*AGMIZS:214/;S28I5!J"]!SG>X^ZLSN&KHJCYE?%BHIJ>HR%/2UE7U MIVODLY+B5JX,KCJ.LP"_&ZL!D%"Z+,(G8B&42JWTD8[L]IY>BACD@Y-W3*Y5 M;B`#5\+T;ZL8K4@FE<>H'1+?;]S)+*Z/S_M%=6";>X+%*ZE!0635)&&"\0#0 M^?7&?>.[JJMHZRE^6FSZ'&H*I:VJK/BQOX;>#TM1!/))3M3]5KDOX50XZ6*% MRU)Y=DJ;EN#3Q3'G6T\.N M3^ZY@@.#VL+<$**Y)7%<],7;G;?R5VEB=JG(;[ZX[$Z\W_7Y6JVYOS9.T.M< MUMO.5&+J:ALK@8J^KV)#7[8W92X+(4:3T&4QU+EZ01KK`&IPIVG9^5;UKDP[ M3<1;G`GZD,KRK(IIAS^H0Z,X(#HQ7!!ITUOG,'.NWP68EWBTN-HN68Q3PQ1/ M&X'&.OAADEC4@E'57J00".C9S[BSV,H]X_9TN\<3ALCW/\A>LA4C8.Q<;UBN M*VW#VM@=NT&U?M^J\;+/5;2QV!HYS7SYRKDFRD/CD?EX2#X+"VEEM&F%NQ%E M:34\5FE+/X#R&1?')`TV&V:"!5"N#=,`Q M)[2!-0F@!T@J2<`5X`7?;SFWE]+(?UDNUN9F9F4BS6J@+W@M;DZ:U4L`5!J2 M>T]*WKOM'M;L++;!Q]3WUV=3XC^!,.^B69`**2P!^F&3I.>^E:BG#I"-VCW?N*?+U-#VO MEZ''Q522RU64V[T''%MO$3U8YVN'CWJ98$^(LMD`BUHH M9C`*L:UK05`H!7B93LIL?A?CQMON_']F=ZCR[L@V_O*?95'\>=QXW$TF;VZF MX,!N<8>NZV,BT=524,PCH*6<2R22HWCTN(V#&TI+<\R76Q?NRP)*:HQ+]5&U M5?2T883`D@FAU<*&N17H8[P\-IRG:\S)N^YK6;3(8?I)%4,FM9&7P`=+`8"F MO#A6G1.WS?=\=#19C;_>/8&_L)DGGBAR6!VEU&8:3)T;U=//ALS$O6,E7MW) MX=XU%;3U#/+/4"550)$)",5M^71+-;W6Q6MM.E#I9[@5'"HK/I`?#*M0-4\33CTM<1F>P=NX^#.]R]X; M\V7@OO(8Z=:C;'6*;KW32/12Y%_[K;4CZXI9:O(-3AI4UU+4RTD'DDE431,4 MDEKM]W(;;8^7+*XN`#4ZIM*'&783D`5('K4@>1Z,(+W=K11<8&CO][L[ZWAO-^O?II9%4LGT]=+L0#&P@*M6@(%35<@DU"I7?VZ M^R=I8'-L_;N]4EP6?RN+IJBHHNG,-][!!55]1/DL9!ENNZ['1U4V,IH%@IYH MV,IB8/([F+4]86.U7/ MR^!JJCX^8G2M>1Y9)`(C([BGFCX>,+(4[[=[=MUW<0) ML%L(M*:6*7C**UU5/C?8*XR0>'1YRY:[OO-G%=2\SW)F620.ADLU;`72`/!K MQU'@:A:#YJ;=-#B]B["S];F.^.RQ7ON>3;^WLO5;*^/+-BJRAQ\F6SE/N.>/ MJJ2*;^%4)A\2)%225)>6Q>5$A""TE?<-SBABY@9:ZKRM)!18[+8FGDFZGJ:LT%+EJ@S>6#[RK<2P MQ@+J*>RZYW);.6_AN>5K99TDI4R75`I)TM_N0`"`*9TCUZ-;';9+Y-NDLN;K MIX)8@U!%::M0%&3_`''((+9JI9AP%.'0"=];:[OZ;VKM_(U78^](MP9;<>U-@5^PQV"UC& MFAJ]MVZ034A2#YD:2&4W6F([&WAO;K*GQ/R#RAV!N_$S9G1V]/'33BDC$GA70&9&3V@W*XVJTL=R#\N0_O"-J( M&DNJ#4RA&91/QHPJ-6/,9'2[9X=XO]PVM1S3,NVRJSN5BM-1$:,TBJQ@.`5( M5M`##(X$=(?8.\OD1O.*OW-M[MO?V/P.'S]#CZFBK=O?'#;U-3[0K\A+!MRA MEW;6=4IBA5S4-,T\",]'Y9Y!'&BC@+;ZTY>L0EI<;';&[DBJ&5KER'`[NP3: MB*TKAJ`9.>B[:;[FGN\LKMP;3P]7E]L]5Q9#& M[9JJ>LGIZ[P,LE3*\;)4)3LTGL++<;:)[^%.7[<:+=YUD1IQ)&D:OK(5I2I; M`921V@$$%J`#62VW62VVNX?FR[)>\CMWB=;5HY9)6C,8+)`&"48JU#DE3J"] M"\,=UG#L[$;TI=[Y'+1U>-VI*NW:#HSI>B[%R];NNLS^"P.1V-MREZ]RU/NM MMQ;EP<]+1XV&>&:.6EE$DXT.`6B?=!=OM[6`4J7'B&YN#&H0*S"1S(-&E&#% MJ9!J!T;>%M"6$6Y1[HS1E8Z1"TM1*_B%UC,*>$?%,DB,JQU%-)!:HZ4D/4'8 MM/2X[9W.:.BV5CY$=`/PQZM;#S#NRUX:`.C).7MY`B MNMPWH6EJP%(%MK1IQXE>S?O'?9+FR/,4EK<6U#*LEO:1*E22NDZ9!*' M"LPD0A5`*OH8Z>A>K>E.Y=T]A;3VGUU\E,K_`'6W5UUD>P:#>^4ZEZ5JLK3T M.,SM!@_,FUWVGA:C)T.9&6I)\=)]O%#,&>62=458I"U-RV:.PFO;WEA/'CN% MB*"XN`IU(S?'K:C+I(.?D!Y@[;8^8KO=K.QV_FMA8S6KS"5K:UU`*ZH?T_#7 M4KA@5;YU)Q0@SNC%_,+>,'9;?'SY)]5Y?!]?SUT,.0WQL/JK<)WSNS$8BI@Q M>+V1+U[#C8Z')Y3+8'(8ZJBKQ/%25T+NW]5^:[1K>U#:3-#;L)9%4T2/PJ M48E61@V%84R:T&K;75_=48RU%V%\EH\KDJC;E'D,=N;9/0VP.S@1(Y"@)C<,S,[ ML=5%5>U0-1!/5=W=G\S[!=9;OW'M'$9_?W<4VSJ^;$;IW=A-N]2;4VE1[CPL M='A2CJU.5II(:*&-4C@6J*-,\E[#[77.[V$&X7%I:V2 MRC4D;2W#R,K$LK,%9=%%TC2P+'B:<.HCY@]W8-GW"7;+>]N]P:)M+R)%:Q1* MZ@!@A96$NIM7>I5`*`:CDIC8_P#,3[:[5J1'UM\;/DKON*KDF\-3MO&]493: M<593R1SUE/5[F/5U%@J):6BA,G$ M/+B^/`>''=1J3ZZI98WJO\`I"#\^I/VAN>KP">Y MVY]OX5\66SE8*?416\D=&'K(&'RZ7&Z,SN>@RN1J4^0^S\75P4-+-B<>-K]= M;D---&AGK*7+T>U-J;BGEDCK)W@=H4*FG4.QAF8JA=;16LT21_U7E9-1JPEG M7C@4+NB@_F17UZ,;M[J&221N;(HYBHTIX5NU"!4ZE2.0X/F"*C..@CP?8^_* M3+UD^]_DAB=QNF02EKR/4CB0L<-!G@"[4\ST1V^Y[M%I4*?!#4.ATE5;7I+%3;-X6HSW\$0(K0@$_D7?/V]'B\P23Z4 MM]HN)S6FH:A^9$<8`^P?SX]2JS(]GYJJIIZ?H//QT,4=:[3U^X^W<.KRK!.( MZ22JFW]@,973SS*KQ3NBI)'*JA%W/D'D9H:[<6 M&Z[1ZB6"A@7+R=95.42"EDC:\U<O2DK=P_*K;OA2GVELW M32T4-'6Q+EMJI*,4Y`2&@DQ6ZL`(TJ)4$(A;[>K6%2\%2TBB-FA;\JMF2ZEH MS8-'(U>K51L^F2#^(`=+?K.(J#97Q[V9V7C:1F M81P13UN`[;Z^RU132RAE\L=.QN.`?K[.+?E2PM@J7>Q)RYD:S-33QK&&=!Y#44GB?)^7Y=*78W>G;&:Q=+!OCY-=5S M9]*ZLH5J\!U,VS,1_$::GED@E;&]F5^-AIZ.4KHD:+-9".$W_<=@`2^^VBPM MIF:QY5N/`X]\[2'37^*&HX_\+7HQV_F'<[F,)N/.5H;C(&FW2$5S2JSA?L[9 M6'G7RZ5&Z]S_`"APV*I\[L;/8?LD15,-+-3T.*V!MQHLE4QQS20T^8K,AE=E M3QU$EC"\V7@1E9-7C+:?:>UCY8FF^GW"T^E^9:=_/.`PDQ3/Z9/H#TKO;KG* M&'ZC:KA+P8P!;QG/#N(:+SQ65012NGHDW:/\RKY,]-0)7;^Z#^3&'PZ5,HK- MQP]2].[@VE2TE/Y!4U;[QV9OO=.T888JA/&YFK82C,">`?8ZVGVZY7WO2-OY MBVIY6%0AFN4E)/EX7+F\+!YN+6S>-16F9HVDCK7 MC5QCSZ#/$_SD-M;HW!'19G?6[MF8*C-4N1W[FNHMA[HPV!A+1+,*[;^Q=^5F MY*KRR.T,OAAEGI05J%AFC!0G-S[+;E:0-+:[?!<3&E(EFGC+^H5Y8PH-.%2` MU*`@]$=M[_;9>74<5WN=S:VP^.9[>"14\NY(92Y%?B*@E`:Z6I3JT6MRG=&/ MP^V-SX7Y,==`;NR>.:*2M^/F0J=N8G"9/,XS%T%3G-VTW9<,6.K\YB,G'48I MVHEIJ^9T50(&^X$21?N6>2YM9>6IS)$&J!=Z79U4DA8S":JK`JX!+``TJ<=3 M3*W,,$-I=PD[G=[_+"FAI)MO] M[]69G[+?._-H[LHI>D8XLG04&WZW,U.VMP4%'!VX138ZJV?MRJR6:GK)`,=Y M842)KMI>M8>5IS(D_+\Z$P(Z'ZDT9C0.I)A-3K.F-5!)\STS=W?.L8C:UYCL MW"74TMP[+^2O3^ZNJN]4* MTNZ<=TS#6/1B/8V>W]35V$R%#VC+B<_APY?@ M3?;:\Y;N(=ULA4HUPP_T58B&4P@AE9UJ*U.<#I>9.:9I^6YK+FZRFV7<:@2+ M:(6!$+S@HPF961DC>C>1`!K7`<;E[WS.UJFN?<'RBV2,;Y\!18K,X_HK*5\T ME;NP9M-L8;);17%RQ*? MC)'U(`TQE2[!]!70JL'9FI1#K76.BNZYA-G+)'<\XPA0(Z-])5M4NL(CQZ@P M=FC9$50U9%*.4;IWV;NKY)9RFJ-[[Z[;V%UQUE7?:8?:DVYNET_OAG^[K$ MEYL'-%K-;58'7;,`Q`PJRK*%#^H*,!YT\HG7VXNU]\Y/<5!N'MRCZ\R.T=P8 M#8NXL+O+I:BH=U1[ZW%6TV/VU@J+;V([?S%#+B=QTTT=1B\F*^1,I3-YX8_& MDSQNWL>WV2V[6^W&>&:-I$>.X+(545SV3[!ZJP>]I]U-@-P;YD;;6%R<=0T:XRAR-3+3U,C32 M:B0I-Y-HVJ&':5NM@9[J5[@NQN"JHL4S1!-21C401\;*`1PXU!1^_P#=I9MW M>TYH5+*".U\-?IE=W,]NLQ>CRG2#7X$)*DYZ`C/_`"K^4.W\U1XG(=FP4F-H MII:S*44_4L4&YOX/I^X>3'?=YB#[^;'4U-4HRRR*SM+`RB72;FMML'+MW;M+ M'M!9B.TB=RM:T[@HJ!4C@/PGU'0;NN;N<+69+>;>P(5:K5MU#E:$G35Z5`4G M)R&7'JOM[]Y_)7;6],FF)[^Q.2V1%M&AWEM6KAZGP4^;W%AZ_&+EL70N*C=* M4E)E9+K#(\E/XI6`T-ZP/:6TVOEJYMXA)RZRWOB:''U$FE&5M+&NFA7B10G` MKTOO=[YNM;^=(N:E>P$/BQGZ9=;J4UJI'B&CG`RM*GAT'_0GRC^;_>=3V)!@ MMY;?>HV;_!A18*/I++8W=&37+51IJNOJJ'<531QQF@:GMHI4J(GDK(P%`27Q MFN_\OHBHQ!ELE4424=0Y@\4I:&:/61[#'@1](_P`9 M>F17'F2`#44SQ'0VDO.:(9[H7_-8A@ABUG5:)J`!"D'@O<6%"2".!'078+NW MY1[RVG!N;$_(SKQ7_O-4;:R&*FZSQN1R^.F_BRR8^6>@P63GCJ15[CV;S;9RM:7JVL_+-P`T2NI,[*#5>X588TOZ^7#C7H/V^^?FZ&>S;+R5N=U;V3;0 MWU#ZZA;M@5TACG4F*Z0!QI6M.BWF#F+W&V:SNK_]\@V<84AFM*A]148TRBM- M1)R*Z:5Z#/;?SH^2FY-F4>7@W_@*3.56;K:*2*LZ]H8&HZ*AHXQ%F8,J2(Q,;GDKEF"]\$[>YB\,,0L[G))JH8HM:#2=6D#O MH`:&A;9^Y'.%S9(PW55EUE,VZ\,:68!W`KW"FKBA-0".E3OCY=?*##;\K]C8 M'LS&YFMP]2,3D:M^HJ8RMG*>CHY\U%2TE)O2G1<0DD4_CG=C-"#>:*,1L"BL M>5^69[.*\N=H*1,"0HN6KI)(4ZM%*G&.)X#I9N/.7.%ON-QMMCO7BRI@DVR@ MZ](9@$$BU49R"3\-?.AGMK=J=^5O4V]=^[M[GR.`SFP,;#G\PE!TUC,QA:K; M\LU%_$Z[%4I7U$5#`!:-Q"D])O"_./YN;HR MM)CMN[UZ]0R12UF7?*;'J:#^%4U'*(LE/3567WQB\,:6DE6.G!FD35/("QB0 MFZB7DSD6WC>2;;;DBNE`LQ)9J`C`C)(XUH*BE*$])[;W#]Q;N1(;;<[Q^WF^3-/OZ#:,N-P=)1=<]:;FVU M#D]W3XVLR];A:"JK>U4>OIZ&@IX9A/3>$.SNJ_<1-"6"MYM.U6N];=LZ\L?3 MB:K$S3JY"`TU$"(E$K6M`2?IOAK@YKZ5Z`UQSYS[ M!(%>=4CU`=\=P#G\-/K/B(K3%*\2/,3]P_([Y'83+U*X;L_;>?Q,FU*'>6WW MI<3W%)F*4;]2((&#:>TFV&I3Q!XC@5Z-[SF[FVVN)%CW>)[?P%E7].?7I9-7>!>$* MZTH5I3S#=-/47R?^:W<&5W+BMM;LVY456+H,;6Q4K=:=^4>0KONLJN/CIUQM M=WI`L4D;4T',,Q1VJ$$C1ZYPCV[\K1%NYJ&MV7-G*BN:DQM)!2U0H#$J M'RE&8D][RYM\31K9;)XMNX%"C6Y(J3Y5P>V7..Y.DZ7_, M!BO83$N@K/\`K.[*'%?J!H+EB$"JP4+7NZ#S#_S`OEY5=C;CZ@ZUV7C-_5VW M-V[RVXDE=4]D5-?2XG:>7KX*K<^[-V93>:8K%XZ#%4JM4U,C04<,MV\BZUC! MO+[?XR6Z2P1.:>&07D12$C18BS,6)HHJU*8Q7HHA]SN>I=TO=B MV7:DN9HKB5`6,V%C=@9)9&E(50H!+,54&O#ATJ:WYK?)>GGIJ++]^_"V+)34 M43L,7VIV558?'57AJJ.JIJ[:9I(`RL8VLQ0#DSEHN M3;[#O+PAN+6\-6'&JK(%D&I>!,?$5SP!F_N%S9&`+GF3E^.0C_E(F(4Y%#)' MKB)#`?Z(*@\1QZR[?^6?S2>FED?=7P[WI'5XZHK*+<^$^7F!PNW'JX!4118Z M+'U_=%3DT$,D8^XE?QA@&9;6"G&AC`%23-/'1032@:B]OF#[5AP+QS4<&2VEO? M-Y'<7I+(Y=['.AW"&[2S%5#I,[/4X5FCEMXH MY*-VE5EC9Z?IABRU=]__`#2^2FR:K!-LRIZV[:HMP;;H-Q;?:AWYV'M.LWWC MJP:8\CU]2Y^@JZ#/2465I:FAR&)>JASE%60O22THJ$\;;V[D[EJ_65+X7ME( MDA1R4BD6-AFDNCN0%*.KZ#&RD,&H:A_=.?N;]M:U_=SV6X":,2(!++$98SI! M:$.0'TL2C1EEE5PRE*CH/=C?/O\`F#=Z;LKJRE^UHEN9F4<@TW7V\]O-@N5@WC MFR2.ZO,]HT^P\G))`MRD#E90C)( MWDP@?F#\X>])>SH\KMJ@Z?\`]$&[EZWWI4=A]EU6%H(. MQ9$JOL]I4,U+U1N%JFL*TBM6U;%**D%3#(S!)%'MCF+E#D3E]=K>.YDO%O(1 M-'X4.H^#C5(0;I,9[5`U-0BF.GN6.>O9M]W#<+7F.TFM;NVG>%X MG=9%-(TD61&$,>#J[64LK*:@D9ZMH]QEU-/7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW51G0M;V-C_`.9OWEL_?&=[0W#@*?8W:>ZN ML:SL:OW'-M6BVAN++_&Z6LV_TXLVR]O86>AP&XDJ8\ZC5N02E63%I1.S'(.W MNO=6Y^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_TM_CW[KW7O?NO=4C?SM\ MUN+;/1&W]S[7RS;=W!MK?O66=VYN.GG:.MP>?QVZJN:BR=*SH:.GEH"/-Y*A MC3%$=)E,9(,Q^R\$%QS'#N+FSY4M;V MRN3#>07EN\<@(!1U=M+`MV]I-37%*UQT(O0N`[>J:?%4_?3_`!SK-XY+K/"X M]]Z=)X&O_N[O+:E;&^ABK))@JFCD99`WS# M=;,DTPV+]XIMR7#,([EE+1N.W5&?C0XIIA!RS8[[+;VZ\SC:VW-[ M14,EJK!)(6&HK*#^F]0=0DB&E23Q5NBX_(JHP-9W/LW"8WY%T'376U*F:RW; MO7>W\=OW<&^MYX_<.+K*+KK*4U-UGLW>U/L;"4+UYRF%HLZ\!KYS#D(Z4KX& M45\LPR_NJ_N).7#=[J61;>5VB2*/PV!E%9I$,C'3X;M'JT+5"14CH)@(W)MWK+=.>V]T MS\>9-S5?3%5O#`Y_<&Z,I1YG&9:MCP-'+0[;VOA:?>F-QNZ=SX+JQJK(YJIK MJG&::[=60P\7BK5QL\K'$,VZ007&^1V#*Q*"D<0\0"1TM_U9I'959KAH1W*A/0 M&;MW'O#?>;SE/U)MS';=VUL6-=H8G&J]/64II\7]M)CJ;$0Y[(*F)I:`XN"" M,:C4M212U'C2"J6!!!9V^VV5M!)O%QXEQ+^I4'3QH"6*\2U6;/`E0260,`U> MS;CN5Y='9;18K&WK$JD!U9E9=(`9L*M`#0G5I)^%R.DG!O+^],=%LCL[9]'! MN"CR-:$VQ-%]]_$*"CB?%YG<./**^X,=D[2ZTH:4KI8?A^8Z1?O)KCP]LWBR"S`$F)A6NGMU1N*N` M15"16H);BS$P*\]`QY=ZG`[8\LM)3YN6>A-9N3>-1E8'B?Q[A!&Q0%]*1!0=:9(&IB1D'R&G^&I9> M3ER.2L=NYG4L=(,DK.<-\)8!`&%"II7/\6.UW!UH@?:=1UU@,90FNI,?BJG- M;4V[#24],M;#B"K9/"U5+)A\O_N!P@ADU,"M'#.TT,DDDM%1H=T5'N([]C.$ M8G0[$CMJ#I:H8`NX*D$9H05[6VEUL\M+4[:BVX8`%HU&"0#1EHRLVF+N6F*T M(-640,'M"ICW;O7K)&FCVCVYLK-;EII,N96JG[)Z]PFXNS.M)[14\<=5N3;N MY=B9#!&K"0UE1@\_44\\<[QQU7M%+>(UM:[@:"_L[A$:FD_H2%89@2*`(Z3* M^G($D0<4X`QLK"5+J\VT%I-OO[=G77Q,]O&\\%`#_:(]N\18A2T4Q4DO3H>] MQQ4M?0YCWHD;O3+4])LQJ#9467KLI":YJZ MM>FS7W+U@6-2[E($(;&%XKN.,6ML0MC8E=+*)G-;1>\-,H`H"%JA%"2*#/0I MO=$]M)>-=78KNFYA]:GZ>/%XVF(B$DT)U-^I4^8)QT1KX^]B/NS;<>5[(HLK MNK&8ZAHJ1Z.KR#;=R._,55255.V,9EZ*G9%EI\=E*FMK@TD-( MS5*UXYYFVY[6Z:+:PDX-<%T]5?"G=NW>N-VT0/2=96[KRU1A M8ZK+9C,8+<&6P];&NXFJZK+F"5:2L@

*5R!'44X`\JF)(AWD\ZVUWNEG,? MK8Q"H<@`,BD=F%\U(!QZ'[>IUY>3V^O[+:+ZV'T,OU$FA2S,CLKTD)+4-&KY MX`<>1IT4/Y??"_=&T>O-X5NP[KMXW%&AEDMS#WJPC9E( M9Z&H#,%!Q7-:$=`+G[V_O[':;Z3:9$GLHKH3_ILK,J,I"'2`2JU8&O;PJ&\^ M@H^(G36\,CLBKS-?NNGWAUUV)A-U;'WKUUMVJU[CI-OPYC$C*;@V_CZ.K?&[ MAS>W)<7BNY]NGFFNQ<;/=+)!-"K'6$1EU/$!5&>*B2!%.H(`0 M&J5Z+9\A^CMV?&GLG+5VP-QY_(8;`95L8TNVZG^!Y45.5K*[<%3A<_KJL;)4 M3]CSP8K:>*K$\TM5BZZI=WBG0Q$2KJ3:IY9(D=E[&97!;5*5D`*_VI58T<5JCO4BB@ MCI\1_B3D.\JZH[:[QWQONMV]3XBIW30UDK93,;OW_08)LQYMUP+DGBRF#P6] M8ZN"GHHD^VKJS(U\IIXVB1F`>YOYO398FVK9+&`73.J,<(D1DH/#[*!FC(8^ M:J%`8FHZ$W(O(LO,DK;YS)>S_2^$9%J#)).B`MXG<2420%5&%=RQ*C#$9?EC MU'V%NC.5_9.],]0U61W)O(;=P'7U#4Y3+9/9<%)##/B<)3B&FFP[4^,QF!Q$ M+T='DH/!4T[+-.AG5@YRAO-A:6\6TV%L?#BB\1Y&"JLA-068DAQJ9I-)<$%2 MM!CIOGC8]SOI[C?+^X4R33^$D*EB\*T&E`7VTV2VG35LF?I::B6LI:97K M)FEDADDC>662SD&6X>X<0JRHWAL0JAZ.0`Q)!.,5R!T/^3^ M0FL[;99.8[N*V6TB,K1R.OBH&9B@,8)90"0.\DE2022:]+GLS=WQ+V)LO;\& MU.L*#MJMJMR[MI)<_P!DS9"&MDS-$U5E,WF*#&4V0\]?@*FK(CE5(ZB,4TL" MMJ\7C*"PM^:[^^N/JMQ:UTPH=$7`J#14)TT#\?S'SZ-]VN.2-LVJUELMH2\U M32`-,6KJH2S*BM4I0TR/A..JA/D+NB6GWI'18.HD=]P1T>`6A_W(;CQ.Q=V; MJ2:2FVW-3X',8_=E#%N;`BBK::JI9*MZ^DJ'2MFI:*.HEJYY+#92LBST`4-XBQRO6BG0P= M0P`(92VH$:BBJQ(V;WS]=F-R[GZ-Q=1F,A68+'X3-PG,PQUN:H.Q-HX_'P;I MQ633&X^3.-D]]XW#U4RC'8)Z:MK*#'3P2.DTDGLAVJUM[6WL]_G"K"6*,$-% M:&1SX905T@Q$@]\JD!BI4Z0"(-XNKFZO;OEQ&D=T5)%+=Q$T2J)@V`Q\51(, M0E6958$`DA_P6^,G3=>=K]0[+W5C:O/=?]7;@^\K,;D3ETR^5Q57A\EV+E_N MMM-D-TSXJDPN&S%)2BGIL%E9X:(18PFJJXR$LUB#N>T[MN5NRV]Q=(`&6A12 MKK$*.%346T%JEXQJU.P"D]*[*_ECVS=]BV^Y7ZZWM)"S*5H\H>)[A@8P6TA1 M(%`6)VTGP6=F%<'QOW[AL_M3)[TWV-P;FDDBQ@QF&J?V3 MM;L--RP9K$5&VJO+9&AJXZX[73)T=,^+GI\!MVKH:=S"E;3I4&K>2<3JLD4P MYY6YGL[O="]S1+J:V*$-J"JU07TL:TU5.2&H0``!U&/._)=_MVR>';$26%O= MJ^I2C,R`$1ZE)7"X.E2*\6)!-8/Q,ZQ[`Q>T>M=^3RX:NZTW'WGU#1Y+"T,] M6E?CYV"*Z M[A'8SD.0*%7@=W4,I-:EG)J!^WJG)NT[S#MVS;D[H^SS;A;#PP>Y3%TNU-H[5[NPW7>.["[.AI<[USTUALO70;=P>T-@[.W) MD]J]F=C5M9!)5U].G:&Y]K5.*Q%/CAJFQ.'\YFABJ*MZB][L`FN[O9+F]:#; M2ZSW+*`[O(\2O#$H-!^@D@DV'%U[MEL?FJ[;%% M7U`@VQE,I@A?"[.VANBBQQPF[\-ORACR-+1+/][4TN6QM1&[3Q2(?85W;EJV MM'^AVK1-N>\[88+(Q2-% M7M1W33ICC=@`Z3`E4#*65T>I*@5#CX6[.W3E\!DMT[LZ]W9U!LO>FZ>\OX/L MZ;,5^/WAUYTVNYJVJZN_AE5]O!4XG.=:R9/*8[!55+'))]KBXOL=4!A(,N">\O-MGL M-NN9KL(A;3)%;!R8*-FCP'Q$C8<41=-5IUQW)UO!N^ESG;?66[*S/8G`YSLW M;/\`IIZ[DA%1/1;&A;%;H+8_#19*AW)0UM)@O'/!!35D+5")$:4K!!+35MKV M:PEBVC<+81O(D,@@EX:I:,F6(*:2U5)8$5U5))!M=;9#N<4^^[/>&2WC>XC- MS%2I6`%7!"A@P=0:K0J3VT%*A?=>;9^0TFXYZS?_`&MLS9YQG6795+L7)22[ MBV!3Y/:^YX]F_P`0W)C]PS[JW#]O2X.IP=&U'-AM<./JJLU2T\J&&.-!=7?+ M[6PAL-IG96NH6E!*2$.A/,UQDFB+30DSY@M;/\` MK-NS65\US8W),GB2J"42BT!TU[80'B`4T/AK2HH>B[8-PO/ZI;(M]8BUOK0* MBPPLP623N.JC$=TK&.8D@D"5P3J)'0:_(;X.9/N?M#![Q[]^2QV#TML_;\6) MV7LGK=:W#9_35)+.%9$5>V*-0":B):/W21U=W)!P.BCFKVWGYDW M>TON9.M[$@W7F$VUIYI$1&M*>?AE<ORTPI\CZ&D^X^0F]ZJBBQV$P&P'AA$6'A>-3GHZ'/&2:*"CI_:** M*UBM8Q4**`,`034*PDD4_P"E0>@T]"+B_B;V#NNIBKM[;HWAG*DUNJ>JK5IL M;3QK&TI>2GJMU5F2RZ03).8XHEPXC58[D"X7VE?F>SMSHL;"&-:#U/\`)`%- M/7Q#^7'I?#R7N-X=>Y7LTC$^?#/HTC%QG/\`9C[.ACVK\(]AXLK4Y6CQ=;6! MU@+Y&?.9^;^&0R&:.F2>FKMHXV.H:H],-$H/ST=#MM[X_[!VW52U>/I!3RO2M1 M0KCL9MW"_84KMJDAQ]9AL+0YF!9#^HO5R.?KJOS[)9]VOKFOC3%LURS&OY%J M?RIT)+;8-NM*""%5']%57'VA=7YZJ_/I>1]?;26DIJ&?%'(4M')YJ>++5V2S M`27D>0_Q2LJR[`,;:KV!L+#VD^IFJ2'ICR`'^`=&`L;4<8R?M)/^$]/$&VMN M4J".EP&$IHU``2#%4,*`#@`+'`JBP/MLR2'C(Q_,].):VT=-%NB_8H'^3ISB MI*6!=$--!"GUTQ0QQK?Z?I10/H/=&);XB3T\%48"BG4CWJ@'6^O6][\J>77N ML4E/!,")H8I0PTD21I("/K8A@01?WX8R./6B`W$`]-4VVMNU"/%/@,+/&[B1 MXYL50R(\@D$H=T>!E9Q*H:YYU"_U]N++*OPRL/L)Z9:VMG!#VZ$'U4'_`"=, M`ZUV-$LR4.VZ#$K.C),N"^XP*NK1"$@KA9Z``B(!018@#@CVY]7=8_6)H?.C M?MU`])SMEB?AME7_`$M5_P".D=('=?QUZWW?0P4&5H)*J"E_S"Y>#$;LTC4& M\;G>F*W)(\3%?4-0+#\^U=OO&X6K^)!.5D]5++_QQD/\^B^]Y;VN^B:*XA#H M?)@C_P`I$?H"MV_`OJC/MGIJ'%8;'RYHK,11TV>W.QW$=PL5M&ID- M334AX>J-I_XP?LZ+;N#^7O6;2F;-]>Y[?N(RM/21RQ56%RV'W`(:F&%HY54Q MG8F?CDD&D0R4T%1(@0>@GGV?0^X#W$?@;A:0R0L?,,ISGA^HOVZ@/F1T&+CV MN%FWB[9>W*S`<=2R8_9"X_*O#\ND-5;=^6_6U64J*W#]A0PM4&"/-S24FZJB MCRA\1>AJ-U1[0WS2K6F9H9X*7)51AD$7C9U#%E@NN3]S6A@>UBT=F[>^.';,]92_* M7XET6(W)DD@GR.YL5MBKV[N:&)J&6AJZA:O'ML;?^3DFIJ=9)34YS+IYZ=@( MF%A[$NU7G,>RF.3E+G!F@7A&9`R^5,'Q(P/*GAHWS&.@EO5KRCO9E@YTY)5+ MEA4RK$R/P(:A7PY2?.OB2@^ASTANIOAUM[';[V&_1?RR[-W/U=@\)D=CY_X] M=M;OS^[MOX_KCL(1X?=%+L&D=-L[EVIFL%54-)E<&T&V\M3PY2DI&:H"IK]F M.\<\75SMM^G,'*%K%N>F%31[:WE!3X22JB$L"M M"90D0C8>$-Q[=8[Q=65I),8=ON74AA0Z(Y'0L%IC7$3)IKGAP/0H?<]QV&VO M[V*`7.ZV<ESE>I?EKA>G_C]'4T^PYXLAM/P]DX*B7+TNQJ#:T-%LG:N)V9392LQ.VGHWR#P;9J?MP[ M.S5(2C>N4GWCF"0&X$$L\=`8D#CP6)7Q#)J=S)17F!TZIEU:<:>E)V3GFUV# MEN-HK=[F&"4-29V0BX4!_"6/0D:Q@LD!0L4A8IJ[J]!7L'H'?F'AW!W7V[E9 MZRFP]7NW<>W<'OG51;7QVYLSEFHEQ6)H(JK(5&VTV.J)*7.;&I\BFWKA'@=OY;L'K7&Y?%T$=1/1Q M4\.11+H*AY&+.4[_`&?;I[N:\G6,R$'Q2ID*:HY`DKJ!5E25XW;2"2030Z`. MCWG;;-_W>+;K&SM&F5%8-"A\-9"DT)E@C=CHC:6W2:--;*HU+D!C5\[@^46] M<3LK:V8Z2ZVK*W<>^MJS[FW#M.ODIK&2,N-3LY MH%J&IX@)6O2K?><-PM]OV^;EK9]=]=0M(T;%6-LT>D".3PSHC6)=;2*I0-X9 M42&HJT]*=V;EW_G]C]L=D[:PV![/Z7GA.>SNWFKCMG?'1M=)68O=E:<7429* M<;XZF&9JV@BW;;P"[1U\.:T(TRL4);]6V+:XS M6HB,@2@D:I*=Z2?(.HVI78OK;$Y*@Z^VYU%\=\WV!N7'Y&DV]%6U,'4&T,BH MR^9_"8N#<.X=N4^[=L0[7R&XZR:NQ.W&&VC2Y^IIZJMQE-32 M3P8J"@2HIVK:^G-;$\GDU,D:).9]WVO:-RM[AC'%,T+ZU0`%EU#3A21\0-** MO9P'$E=R;L._[_M-W;PK++%XJ!'D+%58JPPW=E9'&T>=I-J87$XS'T]%*\DF5R^TL=F:O*;.R)%7 MD3FJ$9F.*2:IDJ=FT&1W6*+(4]&:85$-'`RH((FDH:26>HCDWEFWO]WNIH-Y M02R!0ZCMTFAH31R%)J>!8US168#J%N:KO:MHV^&ZY?,L$;2/$Q.LL,!E`,6J M3(`6H44%&+QJ&/2&VWVYN#(=5;`PG9&9K]\GN7%[OV]N3+9.NK-ZY''[6RF8 MJEZYW3'N3:;8W&;JP-7F,+`U/D8UQ&.JL?*U%3$PTB/(9OLULN[7\FWQ");) MHW5:")&=5_5C*25,;A6HR=[`@,PU.1T61;]W*@D$' MO"N<$*RZ8]#5T%:N`3493\K$;'##MTR^'>W5XK:05*CPRT0.H$JP:;4E"XPC M$8(`0'5?=W:'9^=R&Q^QMQ9[<5)MFIW-/N';JRY?/P8*JVWCLS+7[.`J(\?L MU\P(<3)1+A!+4Y:B2)XZJ("FI\HQGN^P;1M$%I>[=;K&\@3PY#H76KTI)3ND MT'5J\0A8V!J&R(^BO:N8=[W:ZGV[=+N2=5UF1&UNL;)\48P$\0`%?#JSK0!E M%/$:RGI/HOX;]P[4W1_8B.8.;=IOK;Z^"*XMP9`FC42P%*U-2"B`<*>AP. MI=V3E?D;?["\EVZXFM;@K$SE]/:QK2@"@AW-236O$9)/3A\F/AUV+MF;M#LW MK>FGW)+N/KFMK*#.;2K\A)44&?6CQB[MII73<6%2HH]Q4^&K%D<3P-*V1DU2 M7#*]>6^<-OF7:=NOV$;17*C2ZKI9=3:*DJ:%"P(%#A?+!%^;>0-T@_?F[[6O MBB:T)61"Q*2:5U$!64E7HQ:AH2U3J`(->WQ#P'>6%W!FZS9V/GSN$VS"E#NS M:%9E94BWOLO=5%5S9[;_`/!,I48['Y:NW5CMO21Q7_R9JVJ+":1C&/8_YQGV M*6W@BOI:&>I24+7PY8R`KZE%0J%N[%0O$=1;R%;\R6]U&"BR0EQ^K# M+4M&43)P8! M#DJG8>-SN(W`$;=$3YS/LF0)YH\U11Q/%"L<%U^R^X\9V1M.>IQV,IHIZNLP.9@BC,<$/E0VW&ZY7Y+B>^2PU7LGPKJ9I30 M$BID8A%:-UU.<+(K<3CH/[;:VRW^C;8_B;0$A5M6D@"-`99!<(2D: MU+12"G;4]&W^0VU^WMI==T75/3LAH.D^@1(VYMZXWP?\J]M:_K2K*(Q-,6/C2JK,&= M%D`C&H<$TKP/3!\2OC#WMV_UYF8,-393+8:7=FWL;A_XIE,NN,V]6T&,D7-3 MY'(9&EIJ"KHTQK44,XHU:J\D$FN1N5.:-^V:X2!'>V\>-8]9;0*`JS:FH&"J5U474S+EB:4LOW M_P#%CX[[/PN[:SM3LO*9/$[>VSAJ./9'7];'3Y.':^*:CQV+^\R;4LHRU0_] MUS%+!(LL3B&>`!GF)]QI8&!H74:&M=)K^?F>JP/D)N+:6P]K1;AZ?.9V'L MO-9>7:5?0UL51Y*.)VGFJ$@W%M7'56Z*6ASLZ?;2R1XZHEA2=8WFHZ62:6&3 MN64GO[A[3?46XN1&T@I3O([::78`MZ#6M:4HQ"CJ'>:[BRVNTBOMAD:VLVD\ M,ZJE@"-0[HT+*IX4\)BI.2@:O0P=&;GJJ'8E'DZOOK&[=FWKM+XQ_==?U--C M=X8?LNLSM'UU+/53;AH-PXIJ/-Y27),V*JZ7'B"I\:.OEA_;!-OEHO[T$";% M))#;RWFB3,;1!6E%"FEU*I2K(6KD9\^C_8;]UVB66;F%8IKF"PU0,HD$KMX! MJ)/$4AWKV,$H:'RQTV=M[.S55F,IT7L^GK\-'OO<%5WEW)54J4E54;IS>Y6W:'/U==/1T.4VYUKU;@L//B\#/\`<)-N/<354U/(*:*6-S;+^$6T>^7` M\26");6W&0$1%1&*Z0Q#RS-)KE6C"*(`,-1#,;U9S/-+RU8R&.*YG:[NFP3( M[N\JJ]2H\*&%8?#B8$-+<$D'0"`\FSG26*IJO`9RGJJD[<3,SQ5:;E[$G>IQ M`I\YNJAFF?!3OM^.++34\%#)+2AF%-75,H21765S`0[]%2$8L!3ILCZTZ M?WG+D:C`]AYK'15=20)$[*Q,&1ILIC,[A<0TU;+O'$C(1539/&-(LU/-,\*Y M"KL[U*M*WEW/?+(11W>TQN0"03`2.$C`45@"%J!D'X4%-..K)M7+E^DSV>[R M1D'21]0N2KJGQ2*:5&HC(Q)(`0:L9E7N_JOH"F@R^W,1E,AN1/O\'C"=<[6YBGQJQTL MD$=''69*F6*>AJFJ:PQ-!&8V9N.7]JGB=MAO$;%>9-OD7:9CI>I)4`G/BZR,?`'9*%6U$#30="EA*+95#4; MV^.V_=Q;=VQ@X-TX7>'3VYNQY'P&V*"+>4>-7.87=&8K,;A%V(^^:*@HZJDD ME7&4\>\,%*B+2MDXGF*S->/]'S#MEG+)-X313I#1F8H25,8#.9`CEE8=S&"3 M\7AX-XH;"+Z_E?=KZ**+QTEM99S2,)*%#!WTH(C*@1HR=""Y@.HJ9:L>'X_) MV!M'N6;J?%=C;#WSTK4;7S&]LYVOLC?&PLMN#)[]Q&?;!X27=6%V;N7,;V>7 M/=6U-%2Y?(9`5-'!D,:E;'4*PJ?N@5O_`-#-M+[K+M\]OO@F6-+>2*4(L)0, M?#:150!9PQ11I)5RA!&FDBR/RWE@WU\5JT," M1">1&;Z>*,]JHJJQ)K4DZ22?-14]"G?-LV^TL[V/]US7L4UP\WTT>1ZJQ/6U2E9_%= MA8+9VQL+!1[1S,^0>2MJJ_"-5,C2.Q5M7[0CA\<:#7W1VC;]IL]J;;K[ZI+J MW$[S8"RN\SUD4*``K<0./KFO0!]F=WW/=]PW;]Z;<;22TNFMD@(:L*10)2)B MU2S*2036@X+1:#J^OW"/61W7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW5"G0L6P^D?YF'SN[1JZ3<&(V5M;KS=>1WGOW<>1W%D6FRE M8.CMR2X+=^]=Z[JJ-CXW&+.\B;"HZ.>"OGCES%/D%IJ>AQ:O[JQ-:`#/5L7Q MA^2NQ/EAUO4=N]8&6JZ]J]UYW`;2SLYG@FW/C,$:2GDS[XBNHL?E=O\`W&1D MGA6CK(EJ%6`2'TR)[]U7AT8GW[KW7O?NO=>]^Z]U[W[KW7O?NO=?_]/?X]^Z M]U[W[KW5)?\`/`CQT?QEGKLK!355%39K9\LD,\$M0RFGSM5*'\*+4(\4BN8V MO"UM?UL;>YB]E6;^MD<:/I9H95K4+\2@8+4%?3(_;U`/WA`/ZG%FC#()HC2A M/!R<`ONS&J.HMS?N8_/Y3XWY:KZFFQ$>6Q\IZPV M=O):+%;TW+NW+5[R4=.,#0S8G$45?DXX:^I,T3_9"5MKV3E6YW+<=M5+RUIV M+>()]5&(GF3NC5(UR1*WB.VFJKIRX%.])1V)%$4^U*_;N7WK\J6(TG,$)M;< M-2NKN@BD(;^$L[N["E68U.>C#;Y+6:\YQ:2T2YG6[N6CU@%:+`A&53X;-Y,6I@@Y(7@PQ48Z*-\ANS4^.&&V1U\N(QVU MLC5]?X_>6^DJ=A;DWSFMW9C,TLVLIHB M%8B*G&'+>SRDY4M-MV M8Q1P.;=9)AX+2-(SKJ+*44MH6H+L2#W*H'`!EQ^]>B.[L-M[=$4M=DZ[%T!Q MFVXXL?G=U[.>CDC@GII*'/82&IRM,]+64:+)15`M`9M2NTBE`JFM-\V*ZN+1 M2!J!+U*QOYGN1B`:_A=:@C'`])8[OECF&U@N&615CHJ`*\B`4`PZ`LIX:T;@ M:$>?2#H/D%T7U%N"FV)M&GVA2Y6MJ*JB4;HW/M[;.:DJJR!EK9\G4-D\UFX* MBLJ*&."$964%Y)Y)`C!UU&$G+G,&\(VXWSW#1A`0%C=J`$THH`4@5XH#B@KQ MZ*H^:>7-EG3;]OCMUD=LZWC0DL%J2>]E)(_T33\7V="_V`^T-X='5/86.7*) MD$GQF'%/F5@R59BMRU590X[)X;&Y,M05,]!)55LR6 MQ2\M-^CV^6C"CL2O!D(-"U0XK09#>I!KQZ/MSDL-TY:?=4U)*650KG51]5&1 M>Y3I!RI%:4JE,U>]_5]1L'L;IC?U!B*J;-;9JYMSX#;E-CJ7''-U^%W+MS<% M3LW^,S898(VWGMK^)4-''IAIWEJ4\[Q+(S.UM_A7>V[Q9-*A28:"[,2%5XVC M#A`68&.32YRQ[>T>72S-'O[L7Y"Y;`4$6&_B76U+M;<-)O_<55M6KV[-@H M\SL_L6D7/*NZ,%EZO'Y2"M!HD,],T!W7*7VN=OW^+M7$69%5I366`D@J76HH%8EM#H.`UT94.*4Z:MV]J[SCQ.+[SZ^W+D] MI=J[2H,/L;=E;MN#+"OW/M?#1?PS:N96;`4'WN>RU/25L6.KZ*"I@I@HC2:* M+QZ9G++;;$2OR_N%M%-M,[M+&'T`)(1J=*N0%%!J1N-?A)ZK=[MNGA)S)MUY M)!O-O$L,K1E@7C%%BD(C^)M)1'`&D``,N.K#?C+\U^D:I5[)W#U_3X[.[=QN MUZ#O>@VCD,=39G&;^AK*FDHNQ=Q[!IA-MN'(5#T\U325V%EI,NJ3345?$^F$ M3`#FCD?>XF;;8-P\2U+.;34"4:+BT*2D!Z*3W*X*8#(<]2CR;[C\NR>#NT^U M^'?:$6\"L-8E&%G>$$I4Y*R(%;+*XX=!5V7NFN[!W[M&MWAV-LC+=O[XEWCB MMK5VTJ==G+W)@]GUU95;6W`^/\LF-CW5-M:HIOO*?$UTE(*RCK8YJ>!V@A*_ M:X18V5]!:[;<+LUN(F?O3<+.XOMVM MFWVZ\58GC_26YCC)$4A!8H)#'H!$;T$BE"`Q"]&$^/W<,O75)D:S;^_>M),9 M0;[QFUOD;NC-&IWKNFC_`(=&U;E^KNO:?;7VV&I\MEIJNBP<597531T\T%7. ME&Z4T;N0;WM)O[A+6;;;K6]N7LT2D:%G/;--J!;2`&D*J`2-(+*&Z%/+>^G: M+:6XM]RLQ#'O*C0]7DJ3$08\Y/;E!O)XPL7\.HZS,S$&HF M=$CIO9IRGR9N-S=HF[W?C;4IUR*VI8Y9:44:^#-ZV5`.T=U>BGGCW!VRV MVUVV&P%OO3`+$PHTD,)/<=&3&)?PF-3(U"Q.G'5?6-RN\:/:E;A\_E6]HT-S<3/ON M[/&9&RTC1DUB56(1B2.Z0/I*_"6J"`H=WYK%Y#?.VNML?DY\[L+K7'5&/>OI M8_)#NFLP$U;NK?VZ*FEKXWI?XCD:^BDD2&.DRLXEIVBD\(D6I4NM(VAV^XW7 M0B[A>.#D?`'[(THM0`"0?PT'J*J3&^F2;<;'95E)L;%"N,ZS'WR2'6!4FA`" M^)D#()#=%FZ^WG)NKO/<78^\H'RE5@<%N/<696FG3'8;>_6]%23P=6;>W)42 MXZK&'R&S=W0XO5MF@@J9*$4/W^<%3D<84J!/NEI]'L-MMEFX5961$U*"T4[' M_&)(U)`*2)K'C,5)+Z(BJ.:!;:K\7O,$^[7RERB/(P0Z4FA0?H(Y"G04D$7Z M:HVD+KF#R195B92>BP69WG7Y"H?<6\LEK<32TG]T)\YCZH5U8&VM3-]QXT.F%[B#;8QJM+>/QG"FA=Z:8?U= M!5U['9OJ$C;"_P",E0!TL,DGTES?RSA+J>0P1L4-`I(:=EA5M<;5=`AMFD4E MF/T@8FC[MG-/)#;@JK,9'50%5I<);W.T;NL0,,Y*S*VET=THLJ@*/#5I`QK!! M')&(W+42;3<-M',]UM5R'B@N)FAG8C6\SEBL M:(!VR1P5C9F6LL/<'+H4#'YZWR6Y-T[*[)^/$T\\6[V0J**;/8"FE,4U+45*T5?3ZIXJ:JT0&/-R2*UO-MWX*#;2A M8)@-50KFL3U%,UH`6"ZE/:67/4F;3)<7NV[SRJ:_5PZKB"JJ>Y`PFC(;R(JQ M"%PK*-0#8Z0VX.\>SX*/;_R0ZTWPVWMTX2@V?UOV72X6/<.5PNX(XGPE+@LK M38/&[5W(VZ),U*/X#DJ&2*B\4<-._A/+R+K38]OU7'+FZV0DMW=Y8&+(&C)! M+*9-:4I_:(U6\P>B^^YBW@1V_-FS;B8K^-8X+A`'9)%%%#:`CZC4:)%TI2@) M]>K".K^].G>RMF["W)C,%5;=S@[.Z5C[&QV/SV,P6U=L]M)OO:.;JMR[LV_# M*])@R;QM-Y>VESK*O$;VGJMN;CQG7>Q^OMFT=:]I(^\MRYS;N2JZ+:V=S-5CJ?;N:VUU' M%54U`M-+BL+496+Q54\M1'XV-;&&PO\`;-X2=O\`=\\Y=&2KS?3*K*"RJ.]7 MGT%M0:01G4@"GHEW1]WVG<=B>!"=A6W6.17!B@:[9U9@C/3PG6WUZ2"D9D72 M[5%"OJO?ORL[>S^X9_B'V?@$^+6P*#']=[]W)4TN(WMNC;^?H,/-E,MB^I/M ML:V9W3F*7![VI:/'U]34U%'C\M11R1R5%+`8JE&EARUM-G&>;-MG_K+<$RPJ MI\.-D+:5,^KX%U1EBH`8J2#1C@QEW3G7?KVY'(F\P?U-ME$,[LOBS*X34ZV^ MG+N%D"ZB=(<:E9D%"G,M\<]Q_''IC/X[I[<>\-C=P[QZEW/BVQU#F\*(LWO; M>E)N2FQM+FLMNJGDV_15=3/DL7"N2D%((&I(ZF28"TBJXN8K;F+?;:?>X(I] MD@NH6+%6JD4;(3H"]Y`HYH=7Q4`Z13\IS\J\NSVW+]S+;[W/82KX:LFEI9ED M"B1G.@',8#'3\(9FJ*?[*"7;6%F,40>/[F19&\M]\.U[Q>7=SR_M]Q;Q MS.3))*X0R9!%(U!<+7-)9",`TJHHDY=;=MCLK"RYFW>UNY;>,"."&,RB$_#5 MIG=8M5.U?!BP"5UL&-3$[6VOWSN_)TU13RY/9T%524ZXVOJ8ZRAS\.$JH*@- MC]O;?Q5-+O2&FK(*)3/-34=%%*Z`/.5%P'Y[K9;*,QL%F93D*>PL.!=CV&GD M"3_I3T)K:TYFW&X,JL]N'X,X(D"D<$1/U14<31?]-T/VR?@K%.$K-SS9"NJ) MH*B.KK=U9.KB25ZNFB_RFGVUM[*/F9?"S-[AI)?3=X;&P*;KFV324M0J( M3P0#_CQ``_)#]O0EV_D",D2W\DDCD9+LP&1Y(K%O]ZD!]5]3C[6^/NP=M4II M!1R3TLD315&,HA#M[!5&M5C?[K$;?CQXRJF-=(.1EKI`I-W))/L-S[M>7!U. M_=ZDER/S;A_M0O0TM>7]OMD5?"%*9``1?V+D_P"V9NACQN'Q6'@6FQ&-H,73 M*%5:;'4=/0TZJJA4`AI8XH[(HL..![+F=W.IW9C\R3_AZ.8XHH5T11A4]`*# M]@ZG.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N MO>_=>Z][]U[KWOW7NO>_=>ZP5--35D+T]7!#4T\@M)!411S0R#^CQ2JR./\` M7'O8)4U4D'Y=595<%6`*GR.>@PS_`$QL+/4LM&V*&.IYFF>2BH13R8266HE@ MGDGGVODZ?([5J)_-3HXDDH6D1@2K*2;JX=PNH&5TD)8<"2:C[&'V^V7`=K1/"8^49TCCP\-BT?R[=`'I3@3;>'0WR`ZWSLF0PN4DWO4014F'I M,)F8V8)EVIN&>*DW#!`/*E+_"JW(2TQK&2(*'`(GM=\V/<(%A MGMQ#6I+*1AR`"P9?@)Q\852,GUZ!U_RYS7M5RT]IMVM6W2SVY[?:;F6,*H99FBU`D=RZ#)#AF-8E%2:MP'0 M6];=&=T?(CKK+[`^3&\9]_\`;G5\]+0=;-M[L:*/JS9F.I/#O?9>?V13;/H7 MQ>],YN6;#00U63R%;)E:.!8ON`E3%*BG^Y\P[)R[N-I?\IV(M]HN@3,6B_QB M0M6.59#(28PBNQTHH1^"FA!)#LW+','->UW>U\X;B]QOEH1],$N/\6B"TEAD MB6)2LOB-&HU2,70?$`10&>]OV2^NMR MW6W;88[R&2:8F2&^$7BQ^-:IX4824$$QQN"DCKVD:J'J'!G*+N/N*M@;:K4' MQWJ<'N+:.7S'77\!S>+V=_&CMF'J[=?=>0AI*S=-+Y]YT%?2TV'IZJE6GI8X M*C*4=-%1&27TEM%M.RJPN]7,:NCJ)@ZERA?ZB*W&H(1H,99V!JU5C8ENFDNW MWO?Y8_H2O+#QO$Y@*.(E<1_3RW3`-(/U-:K$I/9W2*`I/2]Z4ZKAVKU-F8,) M3Y/=59D^UI\)'BMI8J#-9BLQ.X<#FL9'B5RF0R./'\!J,/DL@M94!_`M)&(D M/D322W>=S%YO5O*Q6&$6H8M)4*'#*U=*@GB$T^8)SCHUY>V1;#8;N.*$SS_6 M,FF,!F*LCI0,Y`TE6<-FA44&0.@LZ,J>HNK^H,WC>\-YTE'1;#Z3Z7V;V7%1 MYK)G"Y3+===-=:;>R,,V\*?(TU'NK9]9OS!?POSX5WDS-<"BU+TPUN:;XNZ; MKO<5<=$_+;;)L^PSV_,-ZH6TV^T2 M<`L59H(+="/%^%XWF7PZH2)"2`2,]%JZV^3O:^^,W%VU5Y?';%Z+ZR2N7:77 MNQJ;";0V-7[OW'2P8FA\55M_<^0H-R1[/AJHLED9,DDF0J(*C[>28N;$1;CR MUMMC%^ZE1Y]\NM&N234SI&OV7+,L M8H8=*1/)(I"BJ2%7T`AF##4QQ\61#S?8>]MN]00XRIW/.N]>[*>AW4)?/44< M.V-@;9W+_!5%9#]E-DLW1[RW?0-DUJ!'3QOCF"SS*A9G40_XG9= MH`6A:9EU8H=*Z$P0:T)(_P!X;@^[WMLSK/;\L&/SN#QDNW<'5202Y;'[V[(W/]L=]]);TV]5 M9FFBW?N&HH<=CZ2DV^)/X'$E/3R;BJZVDJ:18I`Y>@$>W7VYSQ$I*P=U':T< M$6KPKJ-@I:-D*W3?NC:X\5!=ECAHD<8TUG"2O2-F M@\=&CFR5/NO&9'^(MM:BP>OAD,-4TFFK1LD*J!1/$5,T M2';68R6Q.W-D;^P4\%7)V/2TFX<9@7I,*N#CKL2*BC[XR^1;&9O+;6WQ+@=S MT.3@IL;59`9_$S++)BZIXJ=*&=?L]O'N.S;AML\9!M"4=R7U4/\`N,%U(K1D MH4U$(8V``D103($6]7,NU[U8[M8RZUO!XFFBZ2RU^K9M#,D@$@?PD9PZ5;P7 MH!&3?[(WGMS!;WJMCRYLY7J3NW`XN/$[GBER>11*;/\`\#W#U1O[*+&M#N3[ M?;4U334[:_X@N-`E:I:FD\E(H-O;&>]VQ;P1:-UL68O'50U4'ASQ+0%>X5/; M36::5.&(UVODEO*:A7HK,`:B0+E796JJO<'=_ MQ[1<7:75U80S;+N,:@L5-8G-"KU`!&O7I]`P&2<=.' MF+?;:S.W6M]/;[[MDK.%5\21BJO%I8T+1D!LUU*:Z=)Z--\4?DKTKVCBJKL7 M<]%%MCN:'(04_9=9L#;%!CMO[[Z[ACI5I\MF,GCF20)\T\L;WM,L>W6D_C;*PK")&U%)1\2JPJR`B@"R8<5'Q4H.> M2^;.7]XCDWJ[@$&_@TN#!'198L%7=:*LK!B:O&VJ%BK%2M1T,'H[)PV_Y*&@SNT-V[8SZTR5&\MO[W5J%ZB@DK M*:I_BU)&4IWE<^RC;-K?;;>T,B2F6769X"A_2>)JH\;)4^&\9U#5H=2AH2#T M=[YOD>\75XJ-;B"+P_IK@2+699C1H94?_1!.-!TB1'$B*=)U=!/U14Y7J&M= M\;U-C<_F=I)-NO8W4N*R^TNJ\%7;FBBI-J4>YMU5,^*QV)QV*$M#2TIG:ER6 M:DI<9.8!(,;)3QF>ZF#=TC63P/I:1E4TKX=.A[[Z[?^+^)VIN M?=.[,BN:EVSMFBCW)@MI"L&RZS=F'I8LAM+9F'K88:++[EV-A,IQ#C*.CB6I M@U559=^Y M.AL[K<-PD$KQ1!9$CU>$TJ`%(T*A6>)6K@+D5:3-.JL,+\H.X-_E>U,]GZ;: MFQ>O:3,8OKW9VPLA@MK==5&Y=P00T4%532;>R];C!BMAXW+TTF3GRN.CJFJ9 M(1-4*R,IE6XY6V;;U&S6EN9+^Z(>:652\XC4ZM)5U#5E(('AL%IE<9ZA>VYN MW[UP1O.QO-PJ[ M$X`ME=M&O55V+L2U0``M,^716>_,M/-NW8?7&W9:"DJL7%58#`[F-'49[$;V M[`SPQ]3V-TMN3`KD\G2;\W/3PQ8JG&',IPJ>&%LY5U=/4T<<`LV&"."UW'=Y MD=@X#LF$=(5KX%Q&]!X:'N8OB4FO@@4D/0.YAEGENMKV>V"K-'^FKU+K+.Y4 MSVTB]^MZ^&!'J\$44S.X956SCKZ#.UFSZ7!]2]A;;IJ*FZA^.H_T993;=+F* MWMML5\5+EL;DDQE%N5]J/DH(##`KX^?7.DUQ'[W-8#:>7=HL9Q2 MY0`NI_#(PEE=205U%!)X98,U&6@IGK4.X#>>:]\OX0C6HZ"/K+";=Q.Q^R^Q-\4M#6UN.W#N)\@=Q4:UL=9-4YF'QP4U M+7TS-?40+!)*)*R>)5$<<OOE7_?OJNKJ\+/@:3%9JBPV)&X<8U;FA#N+&4HA?$;B,&-J:BEJ M8'D3*F,TY?\`=E5][MLFX\KG;MS$,L;B1699(VC-#1.VH`*C4M5;O&JH'7MH MWZPYQ;=]CF:%H7A<(T<@DHRC6NNA.EV"-0@Z6"D'B>C#T%#U=O\`ZQZ]W=OW M;")3T$+WEJ:J23)R275"L9D M#[/N^W;EN5E80QG;)'UAW(T@D!JZ2?B`-#2G;T)(XMAW;9MJW#=;B8;S''X3 MQQ@EF`'AY(![2`./XP/,=)SM#%=<;/ZZV1OOJZDS.V]Z#<.8S&T)X-L;PH9\M08O);7R-!N*1,9F8!HIZFFJ*B&9)(Y&TO[-<[E=[M=6& MZ.DEF5"R!5HK(X*O&0"0RLI+(2#I=59:$#JN]6NS[?M%ANFQPRQ7@D)CU$$J M\=)(Y5)TLA1ZHXU'6C%&!!Z'G>';_:WQ<[F[)K.UJ:J[HV?F8=Y;K^,?66SL M7C-G;XQ%!M_>>7AJMD87*4SIB=RPX?%0*9:.N6'*:X$:C^^,QC0BL]HVKF?: M-KCVL"QNXS''>3R,TD1UHM)64*'CJU07%4_BIQZ$>X;[O?)>_P"ZOO1.X6,G MB2V%O&BQ2KX@(2:>*28NDLAD:B3V$OMOW>\YJW;;K*2VM)]TED2 M-VULH:&.H9ZFO&H/Y`GK87]P/UD[U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]UKK0TNSL]\TOY@N?V!W3T,:_=O1_:R]X;,W-MSN#K M+L#8O6>,VSL#:,6^YLC'TY1+3U6UL-SRR;KH>O]CY#KJ/#)O&F3*[;K_=:Z][]U[KWOW7N MO>_=>Z][]U[K_]3?X]^Z]U[W[KW557\S38%1V5B>M-M3'#IMBDW5M[>V^J[< M2H=M;&(+76\LR>&D:4![FJ=/E45)`%1#GNQMK;NNS63L@L5F2:=GIH2&!Q( M\CU([$T@R4-2I(&2`:HMK[LW'4K18#H".DV-M6OJ<_0[G[CW[EEQ7;.?K*RJ MJZK=N7_B,$U6_6F1W+)+4551MK;38[*8J)/!ELVM6II$'MW':QJ;G>C]1N-% M\*WC'Z*4%$721614POBS!E<@F*)DI)U$=C<3R/\`1\NL;+;F)\6[E;3=2ZF+ M2D,#^B7X^#`4>).V696!3IQZBW+LWI;<&5Q_3^S=X]MP5N+B6IR,"C*;7PM% M1-6XJ&CR%8]!4Y*':1AGE=Y*(55-4RQR/&6,J2E/NT%_N<22;Q>P6@U\":.Q MH"2`*5;`&0"!Y"E.E6Q7NV;%<-!R_MT]_($(8JM(XUJ5"U8%?#8DFB-0G.F=W]?]H0[2H:/;5=6;QQ>WLKN+;F4JLIM[*4$&=?9`PV2RCM0 MYVHS#5#0%8YJ>@L4+.5+^P-S+:I>;K;7NVF4M(`C,J.*,IT^)J`RNFA/`GT\ MNI2Y)W":QV*\VW>E@4PL9$C9XR61AJ\/0Q)#$UI@TJ/S*-V=E^OMR[O[N[[V MMFYNMYJ*E^._5F1Q&Z<]0;-W%M;)[FH=T"+K++9>LRAIDS%1D\=0P3TU#6U% M//-#"JR31:XP*]KCOH+/9MANX?'@+W8[*X^EE"65NZ2,L;1EUD;P&)8J&+!0VECJH*$CHA6ZOA3T=N3L[=N M_N.H*_<='7K09[.;DEIJ#`3;,Q]150:\E24L] M+2V?S4\].G[`D"RY_P!]M=NM-NA2":0$)%.\7C7`3\*)J9@Y`-$9E8YH0>/4 M;WWMYR[/N-]NW23P;8OC4ST"%%;BZAAD$HRK10JLAM;I*3XN]N M[_VO%U]E/C?MWKC>E'7TG7V*P:;,_O%30U6/Q>'FKZ:E:7-9ZKWQE*"FCEFE M:JFJY*:4.RZ9/:.&?>_ZV;%874ERG,DEU$5$K-KT,VICI)[$$:M51V@5!IGI M^6UV(RYL)%119%J.?(4>XZ#$&HFGIQ*Z/4K M^V5C,:DFZ#J*,UHDHZA:Z"6I,,BERJ<)9W]M/>;!N M,X5`Q(>FNNH:M+8&`0=/H0*GIV62]L+RUL.9MKA;6RJ&0'25"D+J2NIL@C6" M#J_#QZ446RI=D=Q[HVCA6*I\4J,WYO-LAN9J+=6\B>$RJ03(;B-0@I MCPY5UEX_@_3,FD$5Z5G;6L=_O+:`L+"[AD\:-V!58Q:RL7J2&$L$GA!9:ZT$ MWA:B'`Z%&3^51\&,J]/E\OOSNE\\J8U)JVE[)W'%)3Y&@Q,..7*8R:/:D4U' ME6Q\8IY,E!XJJJ"A9':P4-Q^ZO.T*/##MMJ+=JU!M@:@MJ*MW`%=6='`>72] M_9SV]N##-/O5X;A:4(N'J"%5:@@5K10-0()I7IYJ/Y>WQ!V?GX]Z8[N/Y*8W MP=V5A@JI8:M]52:7:D5)64-(K,(J>4-!31'1"L:E0&1[A&"V7GGG*X\!SM%HHB960I'"-+I4!D MJK!30]U/BIFO1=%[=0" M-W?/O/%VQ:?;K=V+A_[.V'VOM];#3;[K<1KH*8ENQVD MU*_VO"HK3A7('0A;J^"'P5WYMBCVCO7M/=FXL#!E,;N-,37]S;S:EI-P8JAA MQ]#F,5(VZ_XACJV*F@0-+'*DDA+M(6=V8EMKS]SIM]X]]8;4D=T49"PMT%4; MX@1X=&!\JB@\NCFZ]LO;Z_M%LK[>I);<2"32UTVGQ`*!E'B]K`8-/SR.GC%_ M!?X*X3:&#V%ANU]^X?9^VUE3"8#$]P;CQ]%0B)Q))))XUZ2^:_ET_P`O#++4^Z(\C3XJF>)6BHXY4HH7%XXE-S[46_N5S_;1110[?$L*" M@5;6/2..=/A4)->YC5B.)Z12^T_MI/*T\^[3O.3EVNY*TH!35XM=(`%%KH%! M1>EBWP@^$,F9HMPR=O\`8[YJ@J\;6TF1_P!+^Y?N(ZG#^'^%.5.3,,G\/^W3 MQ!D8+IM]/:)>>N;U@>V&SQ>`P8$&T4BC?%Q0G/GFGRZ7M[<\AM.MR=_G^I!4 M@BZ:H*_"0/$H"/(@!OGU#I/@?\%L=455?1]I]IPULSUTM371=Q;L.0K6R&F> MHU59R#5-5:52T"EB*:4L80A9B;-SYSBZ1Q':XR@I0&V4`%10$#10&F#C(P>J MCVPY"C\4KO=V&"+9\63J5'W:XH48JT'CF\D?H]M0>Y'/%L_C060%P::F-N"9* M"B^)5#XFFITZZZ3D4Z4S>T_MO<0BWFW>5KHUUZ-.H4! MJ`.I]5\"_A!+CAA4[,[`J:#7D9(H*_L_:A@JZ:&*, M01ND8BCLJC3PVO/O-HG\?]T)XN`3].H-:U%1H[LYJ017KD5G?Y?'P6R.7Q^YLOV#V#7Y[#Y*++XO*2=E]EUM9B, MY&@@.T,_-7,L]DUA+LUHUN5``:.+&D@@BE"IJ*DJ07/Q MZL47V7)'*,%\NYQ\Q7B72LU6$UQ4^("'!PRE2#158$1KA*9ZG;>_EK?%8X#. M87%=P]_8_;V[L/78[-T']^<]2'(T64R4>9DAJZW-['FS-0U)60QR4+33O/C] M/^2M$)'#UN/;B-T*MX0.4&D8$@3(P_;1_P`0-.GK?VPY1%O= M01[]N8M)D96`F8!E8U(U-"6I7X34,OX2*]9MH_R\/CMTGEMI;VV#V7W%6Y#; M^Y^O*.DVWG\W2U>WL]2C>&R:2HQ^[*&HZ_QTFXQ6TV/A455?4/6@K(J3J)9T MDWN'N!S%O$%W9;CMUBL4DA\.3^S/BD1C)JJ`*:U*U"D6V[VVY6V6YL MK[;=XOC*DT2Z'E!20&:.HE7P1XE1^)B7I50P!(,GL?,YZIZAWAF<+N"MIMRX MSJ'>$L6+W+-3TNV8\P-BYFAV?7[?VUF,1$HI*#<]9CYX:A\K'302Q!(:9$,0 MC+]GMH3O=C#/&IMC=1\,L%\16<,<@U16!&DFA))/2G>KVYCV7<;FVF;ZQ+.7 M$C`)J$3+$40YQ(R%350&"@`4%`SZ_P!R;'^0N'ZQV#OZ6J7']#YWG-S;; MQ/7'8*X^AI*>CR,L>3V_D*;;F\AM_&)1?<;>%/FHH('>$QS&21BH7]\=HM=H MG2SN+*-M:-,C-+%J-2M5=2R%B6TR:H]7'!IT;FRVX;[>[Y;R;C:[E*AAD2V= M5MYZ!55NY&"R!5"ZH],H6FFA'3MCOCOO7O;<&/Q-?20[-V!M.2*FI]F;7I4R MU6F1Q\<6/PS9;*3UU/C\;B]LX2D$%.NX*J?-U=2#,U"(XJ9!5M]M-IMY9(=4 MNX3$UD>@%#\0H!DL<_IT0#M#DUZ`110& M8F1CGPU%.C_=8?$;8^QV%?44='#7O$B,V.:6LS,8UR2R0OO:OA@R\$(DE)1< M/3X)$!L4<^H@Z]WZ\O`59V*5\\+^2`T_WK4>I#VSE';[`B30!+3B"2__`#E; MN_)!&/EY]&EP^W\)M^G>FPN+HL;%*[2S_:P(DE3,Y+//5SV,]74.22TDK.[' MZGV3.[R$&1JG_5P'ET*(;>&!2L,2J#QH.)]2>)/S/3Q[KT]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW42MH*')4[TF1HZ2OI)2IDIJRG MAJJ>0HP9"\,Z/&Q1E!%QP1[VK%3J4D-ZCJKHDBE74,OH14?SZ+KV-\7^O-_H MKU%#3^>'SBGCRD-1E(Z2*J2EAJJ?#Y5*RCW7MN&6GI`BQ4&1AHE+%GII>%]F M]CO=Y8M^G(=)XT-*D>97*-_ME)/J.@YNG*VV;F/U(5)_I"N#Q"L*2)7^@X'J MK#'1",_\7]U=#92LWEM6JS!HS3R+/3U.3JY_''+4T;U])3[\Q5-BZB''UL;E MX)ZJ'#U^.K*2.>'S&2>0BU.8X=XMTLKY%J#6HP*^N@U.JN2%+*P-#2@'4>S\ MG7?+ER=PVV1RIK@GRS5?$4#LTFBE@KAE!!))/2HP&1ZN[9W5L.7?]3NJNW-U MA38?+[=V7E^RA0[$JLS@ZRKK\)E\[L2EDQ>-W[D]AU=`U1C:[.+42P3S"1C- M)`)42/+N.UVU_!9+$+>ZJK.(1XFEA1T20@M&KJ:.J4!&.!ITNA;:-]O-ON-Q M>5KRST,L33MX1=#J1Y(05$S1L-4;R5*L2'&5>$QO:F8R]`D./RV+K:-9:#%]A/CP8A'5SP(URZQI==S7%9"7Q MI+=O&U(10U(9H%#4I6FIH0?0'HMY(GW/Z58(+R,6^B92672#''%J7;VT\QCL)BX-SQ4&+I:S.1T M[=?5^5^VR^%H:#_(*FJEQS0(O^2H9)@ZR#G2XY8GNK:#:+>5G)[Y:LQ0DG3\ M>CM9F[E`>O%C0403^W4'.=O97,_,D\$4-:1Q:`H?2%+CL\2C1A1H9BE/PT.7 M.+^6!ME=JX#9W^GO+18C;K>Y$[7LU\=CB,[JBT:>X<*J<`-<[$@^8;9QN#,C=T=NRJR,&!4 M>"`"Q4>(::G!8,3J-9\W\IK:E9C]R8FL^2&]*S&[RJ*2IW11OCNN*-,I)0Y- MLQ30TCXGJ3&S;7H!E!'/-285L;25DT2R5,4SO,TK7$MO,W*]LIA8M M&%EN`(V((+H/%(1C4ZF4`M7)P.F[?V,L8(981SE^3W9^6PAHX\*F.J%V)20U&W\;G,INBBQ M!4MQIJU:1P`JQ+_`#_`/8;=B-V?_LTW M8DN]WRM#6USOBMA''564@IZ&GJHYZ6LZ`R,62I,FL,GGBKA6QZ9V6)HK`A*G MN#=?N_\`=G]4[4V84J!KGK2I(-1HQ$GEHOMI9("LDS:[]VM^O;=;>;E: MQ:(``@+*`:<&(%R!X@XA^.K/1-9>RG+ME=VWDY?C M7#5X';=+S7,]E<$ED(A(#'@\9%E6.131E=*,"./4[9O\` M+=V!MC(;VSU%\N>\]Q;JWCCJ#;^7["WKG=G[RWQ%AZ>DJ*&CVS1YS<'2DF0H M<'303&1(Z>:)#4NSLH;EJWWN9?W264#-ZX@&+>MB+-E6GI=@T51ELG4TCI'/]Z)Z2=(H M@]-^VH#EC[M7FVK*L7*=L'D(UG5*=5."T9V``XB@!!_%TFW#V3L-R^G$_.EY MX40(0`0=M:9!$:DL0*,6U!AQ7A3.G\J;%T.S=M[,H/DANK(8G;!RWV/W&WNK M:/(5M5G9L@ICV''3U];5T^0\!9((KQ00_[L5G=I?=65KZYOY>6XA/*$ M!_4F*KH%`5!-KY3>FZM[T'RMW6F\L]5X M[)35 M.Q]5VGG:6H[#II=S[QQY:.ESU)B*#K1,9A**KJIL/1Y<5N0,4]9,C@YV[Z^% M9%L*!P4,`0JYT5."3J+>?2_;[F."YDV[8-E-Q?A!5R::FTU!<\'-`'4`*B@= MN:#IZQ/0G8FV>@NU4WS!AMJUDM=MO9`KQMVL%*"-V)(&%P0,GB*@`4 MJ]#RON]IRMOJ;GH@G8K(FIU9@Y=%4`X+5HQ('K0L6!Z*MUE\?^@MS?'[8F2S MW4FSIY,UL7`Y/=_:N2JZ+:6_Y]]4M6,9V1D,SVU)78/>>-W/D>QX,C3/4')U M*"HBA@$>AA$PJWKF/F*SYAW&*WW>Y\*.9EBA%7B\*FJ)1;T:,J(0K4\,5%6) M\^@;L/*G+5[RQM,UWL\#%X$,T[$),)0=$[&XJKZVN`PRS>2A:8"5R/P9JJ;= M%'/V)\ANZNS^D[HY>$Z[PNS.ROC)W-N+$;0VS@\/ MVYE>FLQ6X&EIMH4D^RI>N]\[^GVG7IA:!8,A_W6)3J8D#`8UH.A[;[3!9;ORA MO=W:00JE\]L2@$0\(V\LABH@.HQF'4J4+DL4Q4CJT7L2BZ_V)\7JW.=,=523 MU/8=-B*J:"IV/-B-Y_PS<%53U68SF>57:%'5 MT]QM8RW=[S`D.\;D/#@+"OB!DJE1I5@Q4J3BH)4@4J1U+FY0[?M_*4USR[M% M9[E5(K#IEHYU%W0J'4@=P4@,I(J`>JONW]S=4=@[6VW@LE7YKK_<6W-NY[%/ M@^S,%EL#@=TB?"T6"W7C3DYJ.EK-RX/=DH:0O#-'JJ"I@*NCL)#VJ/=MNFO+ MF**.Y@D9"&A96="#52`"=#)PH5(IQ%*=1#O=WL>\6NVVGBO:3P(X*3HR*P(` M?N(&L.?,,K!O.HJ47N'*;B.V*'&][/6;VI]S8FDI]I][];4LF\.R=MTN)I*6 MIV_G]S8'&S14W=U!@VCI)Y*Q*;`;Y2GFI&'\4J9Y*>-39^`]T&V9$@GUG7:R MG1#)JJ"JEJFW+]PR[VU=5?"4=)KR6X2U6/F,RW$#1A4O8AKFC"`%6D1:"Z53 MH8=D=VH"G]9FIT?7^65UEB>M]Z]XTL;X22LW?N#;':5%5;2JI:S:.;IM\==; M;K,ANW;-?!%#CLAMK>.3DFRM`BEFH*>N2D9(98'C`2]P]SGW.TV`NKB."&2$ MB3XQX<[!4<<0Z*0C$_$5+"H(/0\]I]GAVF_W]$E1GGFCN`T9U12"6WC+2HU` M"DK`L@%=(.DT8$=7)^XNZG7KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO MW7NO>_=>Z][]U[K6WQFYNOJ;Y>?S1^]<33YJNKJOXV=@8V+/;>I=IY/;`P&/ MPO6FTLNF6VAGJ/*UF<[$VQN;"U?W-/5UDN*J:.G$"T$>FIUB".@]UJ3XVZM7]^ZIU[W[KW7O?NO=>]^Z]U[W[KW M7__5W^/?NO=>]^Z]U5+_`#/15G9&4:B6M$\?5=5554L#TXI4VY0?(7XX5^[5 MJ4K7BQY!PM,SSM4210IC8ZPO)&FMQ)'M\5%RHD*Z#<@*#6OB&TNU0BE3AB*` M`G7IH":=0Y[LA_HI2A9?\2.HBE!&+VQ:6M2!3PPVHL0H746(6O5'N[(YZSHO M#5E$S5-/%&(MTT.(C$,E15X[<`K.PZBJD\=#N=1`T%+)X*^*#$BFCIC4!X?M MD,I6/Z._,/@=O@+Y(U1_I4^)`"*@%27J2%`:M((O5>XY>MGC569``Z)@U$GZ MNG`8_A[2JJ10M4*@*MQU=EH.A)3L/,3F7&1;7W!E5Q-=B?X_2*:]:+\]W4.Z=L;XQ^(W"N`ZWJIZ"+KC,[7VG-,F*K=H9G;U4LN0RT<9K9,L7CJYX M@(B1%S(ES"FSG;+AK39+B"/2\)90TX!$ZR..X.K#MC)IHH5!J0`_RL;:2;=_ MWE917N_0SR!DF`E:."H,3QHW:8RARY&O736U-/2Z[RW^<[UUV_\`'K>'Q+Z/ M@^*L&QH>X^JLWUKD,OU5N7>/:?6&'DW!E,3V!O3:M;)B<+VWF>MX-RU6%IJO M%U6.K*RAC41Y'S/[3\NV1CW#9N8-NYNO3S:9Q!.LZB=([>=A&&CCY/+MN_6XMU+L)9(RRI<-#XS1) M)&4:10H60$GHKG<^POEG\@]B=30]@;,^7F-^).X]I];[AZ_WELKJ'J_MO/;@ MPN8QI-'NGO"JZNW3M.I[%SV&Q[0FAGKHZ"LFI@)9,?#5M>07;'>TN$^NZ=_9F;#8C:?8F>SDF>H]\;[ZAQ=)5[BR6V9L_)1T<4 MCY..@Q6FG@KY46)IS$%O>;]SGS9O?-T6YS;;S`4?Z6WA`=I(5&@Q17!TJ)/# MJQ["TAU%5)('4Y7%MRWR!R3R]R4=G@W3ECQ5-WOE@CW%N/!4XVSMO`MM&KW2V M/VGAL3X:R2;&8"27Q7IP9JF9XT1(9G:5+9P2[LW[ML+06NV1#X$+%Y&U!-4C MM72KL!4\`*8Z=W&6SVN*+>]TN!>;_<4_4?$<2&,R:8E2E60$D"E2>C'=%_#? M*=F;!SN2[1HZ#^(=K8K#97LZ7^*R+79#^(C'[]V]UCC)DQ&1HSM';DN5IJS< M-=I$^X]S1GTI08ZCCTEE2T=EAJH(!%4><@D49BI6$"GAPG/Z MKL>A)L7(IW?:KE]W4/+>QJ9VULK$&DB6X(##PU#*\[#^VG`&(XD'0N1_RQ.@ M(I0\>S,*`8]+/YZ)959%5$T:-IJH#*6+,+-J/^V0'W'YB-2;YJ_9_P!#='?^ MM1RP0*[9%6GK_P!"#_)UD?\`EJ=,TU/X,7MO$QH[U+2Q5=WU M_2!Z%_1&2650W/MO_7`WMVU3W;D^H`!QP_%U[_6KY?CTB&RC"YP6)&?D5IU( M3^7;UJ1HK-E]52=JB)?M) ME$4AB>%=`&#M^W%(P4MJ87O>X!#H]PM[6I&Y7%?M/_0?3)]J^7R!_NGL_P#> M1_T!U#QW\LGHS'T]9"G7.Q;5DM34R(T]=/&U5)&5@GO-AR\;P:W5"A'C1K*/ M=Y?-VG9)*V4PM*H#14[*,8-=#Y!=D//^/MO_`%Q^9*.OUS4(IY_]!8/V M=/+[2\HK0_NQ:ZJ\12O#S3A\NG1/Y9_QE"*K=<;=9A]CW!YC`I^\9J_Z=O^@NO+[4-!XO,Z MZ=40O"C$8ICXM8]0L?3?CWX>X?,HI_NRE_:W_076A[4\I*I";5'7\O\`H`], MO_#:/2E-25<5%UMUU435]1-YFR<;5'VE*A1J'^&U!VW+/2S(^IF%BBMRM^1[ M=7W#W[4A;=+D!0.#-D^=>_/29O:O8M,P3:K0F3!U"N/*G8:'[!U@IOY;?5U) M#'!3]<=7K'%3/2*"U6S&FDT^6)V_NOZQ+H&HD7-O?G]P-Y=F<[C<:B0/H#OMLP M,'4%>8R0"=)4F_ML\\[H6#&^N#3RKC_CW3W^MEM>AD&V6@J1GSQZ?I4_:#TX MQ?`/9L51]TF+P<$BTTM(L5-DU2C\4T9BD8T,NRY:,3A&.B7QF2,@%6!`(8;G M7=&C\,W!*U!RH)P:C.JO^?I4/;G;@5(B44!%`Y"T(H0!X=/Y"G4/$?R^.O=L M9?![EPN"VOB,MM7.XK=.&R%/-BH#CLQ@Z^GR=%7KHZ]1`8YZ1-9XU(+$V`MJ M;G;=KB">VN+MVAE1D8:1E6&DCXO,&G3=O[:;19W%O=V]K&D\,BR(0QPR,&4_ M!Y$#H`?D7M[KK;]$_7DV>VIA:'L!:O:VYJWKG;.T*?.XS;,].N8KY<;GH^N5 MJ5J_N<0C+X#-K0$7UE=)ELB'F MJUVB*%MLN+B.-+FD3F!8A(B'N.ES#7BHII-?F#U$H>GZK$W'A8JC#[@WM`^2\M1O:@42P5.2SN9@H5E4O!&`ZTB[EW M7PH8MRNUE:_<,/U/AC930JF*>&>(6-2?4USUZ'9FN[RZV"Q>$;1$R.!"`6N% MD74KR5-3(N:R2.%KA5_#T=GICX<;*ZZA^ZR=%1?>3P/3U=-C9GJ@`ZF^]=7Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][ M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NN+HLBLCJKHZE71@&5E8%65E-PR ML#8@\'W[KW&H/#HNG8OQKV)O2FJOLL7C\=-/*]:V-E@E_@[M"@#L5%!6N:5R,X8'T8'Y$=!S<^6M MOW!6/@J&R:4[:^M1W(?*J$5QJ#``=5V;\Z<[&Z4DJ(L?7X%=J[PW#MG;VX\+ MV?#0YW8=;%N#+T^%J,YFA:@Q&^L3AA7FI<>+$YV)(D$%/!8SD7V>YV>YL/$5 MA=1(SJT1*R`J"P5>)C8THHJR&IJ3PZCC<=CW/8FK;31BRED2-TG`:&CD)J<& M@E5:ZF;LE!`"KDGI,]69_J'9?9>Y^@=I[WAJ^LE;([AI221B">"R'G*_M((H8X5$:5!+(7))8FK%Z]U3D_9T=W'MY87E MS+*UT3/(%(59%0:54+1%15[0`!D$UJ:^74AOY;VRI9)G;,;L@26.)1!'N.H, M<3QY!-S[='/U^`@\*$D<3H&?Y4_EU0^U-@^LF>8`^7B MG'YTZETW\N#KZ!X&EKMV5:PL"Z2[QST9J!K+E97I\S$?5CS]N) MU42(5X4C3'[5/5U]J=L73628T_X2LWJT,Z-HHXM\ MYBGAII65AY86CR'ELKL&",S(+6M;CW[^O^Y:``L.KU\)/^@:?RZVWM5M98L' MG'R$S_\`%_SZPT_\M_8%.RR#,[]E8"S"3?.2$;@_UC2H&D_D6/!]V?W`W!U* M&&'/F(EK_@Z\/:K;EK_C%P1Z&9O^@>G5/Y?FU(XT2//;U0H'&L;I=Y'9R-3R M-(Q!-AQ90%_`'M+_`%TN2:F"'_>!_F_R]/CVRV]5"AI13S\0D_SH/Y#IN;^7 MEMF&J>OAS^_*Z8^%A15N^JN*@EDBX1V2!+Q"&VH`7#L3J!''M0W/=S)&L1M8 M%4>8C!-/3_9X_/IC_6OM8Y'>.XN2#Y&9J5]:?*G#@:YZP?[(#2ZGJCG=Z/.D MEX*)^P9?LB%EB192RXE71S"SRZ2'`=0H-FU+HM?ZVFJ;^7W&0&2IW'*R3,M/$>Q9J=**E1H9U6CDCP+-$M1 M*A5X[$",D7;5PH3GG33_`!>+_G'Q/^]>73+>VK'6!+,06Q6?@*CT2I/RZEP? M`C[:H7Q3;@-/')-(''8U3%-.VF1DDTK@R*:>2=]>H%]#$FQ_-OZ\(RG5#&'_ M`.:9_P"@^K+[;NKD@R$>OCFI^?PX_+KNE^`T<3/1U#&7S5"=B5;O(DTT M09&T8JG9D%/3QZP3^XR#E?=9N=D9:)%$1C!B_P`NIO\`!UZ+VYE#J[O*KYJ1 M/7'EQ3J4?@'3S5-)/4YW=S+358*PG>T\D(IF):0Z6IA,$+(G[*21\?1Q8ZDX MYVE1)%BMX`2./AY'\Z?M!Z4+[=!W5I[BX8`\/&IC\EK^P@_/J+5_RY\-5I#$ M^^.R(XZ1XUIVIM[Y"D>:"4AZHU)IZQ#)(KDZ;W+?6X/MV/G^[C-19VQ-/.(, M/\`Z:D]K[:;1XEU<]H\IF7CDUHQ..HLG\M[`1EC3[V[0U>&,I(W8>X6*S+4H MSE%&X(`'DIP5.K4@!X`:Q#@]PKMJ:[2UI7_?*4_/M/G]G5?]:RT1M<=U=U`Q M^NYS^;#_`#=<\+\'\_MJ*M&`S79E'4U4)C^Y;M*OD=Y%G22,U#/N)I)Z6-"^ MF$L`"PL1:QK<\WQ79C-R+9@#P\``#]BC^77K;D*[L_%-M)=K(PX_4?.O\?3F M?A;V'-3R4\W;G:@6>&-)"-W5Z3Q^LR21Q5-+O6DFC.HV,B%&*\"P`]IOZTV2 M3"9=JM&93BL2D?L:(CIX\B[S)$4DWZZ[AFCD?D"LH;]A'0)]O?!W>6$V+%+A MLMN/=&X<)N"?+;,R^;SD4N:@S.Y9J*'([(S>YLEE-RYRIVKV!N&GHIJ6NF>: M3;>X5BJM$F-JLE![.MNYTM9[W_&K>*.VD0+(B+12$J5F55"*LD2D@A0!)$2N M)%1@1;W[?7UMM2?2W M[S,MY9CZ7=K8A:A>V5GXU0$#%"IXZ"#2BTZ$./"X#Y5;EJ?4O9&WMQ MX/=^\:3'[FKZ#K_=.$V]@,CE\ABL[OS:%=M[=VR<;NS;K25-5'05DPQ^3^TD M,PCJ-%2A6]GY4MHK8007VV2Q,D9*`RQL[*%98I`5D9&H%+CNCU8J!0X-C:\[ M7D]V+BXV_=(95:8"1DMY5168AI8R'A61:AM#,5D`.JAZ3^WNIOC%\HOCO\E/ MY?O5'7?8?70FGG["INY]Z;TD[)Z8Z_[YR]1MG>$.P(.R-[UV.["FS-;N6BIY MLYA(\95S4XKJJH+!YE9E<^\X>[7MM.P`B,$:>!<2VRAXC(8HU,> MC02L5.;>6.;/;+8K&ZM4+F9;EY?'MHKIO#?PEGC._?D+\9\UN;XKIV'#\B-O[,S^X=H9#/=.=5]J]V[@Z"R>+ MQ^8QE=E.N6.:$M.;4L M#MMS*BR!+F:"V2[5BI`G"F4QD@&LD::V!HR^PY\ML"AQ.`VWNW?F,V5E,R=MQ5V2J* M_'STRM53&MFGC!G.%A=3[EO6^;GS+;6.ZVL*V-M#:6^J.;PU\26$+*2SI$SI M'XI555PV.T`CWDV_V^+:]CY6Y,[F0\NW*JKK'R.+J::?$34\/GJ'#_;@IY-VR#>-P79MSM8I M+'P'DN)!#'&8`(RRR:HT12==%"N"&U$`8KTNYYW2ZVFP_?>VWDT-_P".D=M& M;B:47!,E&CTS2.WP5;4K`J0O&M.E6[]T5&*;.S M;,V[MU,@C=9WWK;9&WU?$<*P\60!?TXQ4EG(4$JY\-3G5PST@>MYJ MC(=3[XIY(#0;8P\&_L?%'/*N(PZ4=!A5&-R-+EHWHZE=P;=S><1:6;%,TG(U MQ"6:%O9AN*1INUBR(C7DC1D_BJ3(=0P"&#(#KUD@`<0*@E^SN6V._C-?HT$E M*T50`I`(;MTLCG'A48.PJI-*6K_RPLCEY\!B\?6)4TF&Q.9^0-#MG&&&9J.B MP8RW1^;:FII7&C'0X_>NZ-P1)2?M>.1IHUIZ7P-2P`'W"$'C&0$&[>.V+GS+ M?XRHKZDQ1Q,3YU!J:U,I>T;7`@BB;4+.*2]6(4P%U6;E5H!I`F>72H``JX`& MF@N&]QCU.?7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW5`E'V7N'>?R*_F@[*Z[R7QJEZNVIT9VA!C\KMK;O7VUMP0[N39NP9=\8;=V MZMKY':>_J@TV0R.7_BF>KLM-CDR=1#H:FDQT\#^ZN%*LE?/HXW\HZLIJSX6[ M+:F?(`0YW.4\U%F>I]E=+9K%R)#C'CQ^6V1L7(9#%FJ2DDBD3)U!CK?XVZLU]^ZIU[W[KW7O?NO=>]^Z]U[W[KW7_UM_CW[KW7O?NO=5= M_P`S/?N-ZOV+M[>FX:1,OLTY7`;.[%VX-:R;CZP[!W1CME]D88RI+3F%:G9^ MKKV3;^8GV_E:NOBB>@H:;:V^<'+!FHJ:DDCJ2L]I4 MJA)53I*E]*MY#MN\PJJNZH"1BFI=2KP!UH]5+'&#I90%4P/91&QN=UY>GGUF M%I:%@&+"-M#UH*JDB!9%"'50KJ5B2>G'I7$P;*[)K-C8C,9<[8IZ/#YW+[)Z"MOM\,_N*-PM[NEA86L[R%.!1VE2.#R)\SFO8"1P'25[FW-OOY- M_*CJK^7]U;M?=FY-B;;[,VC)W1#3XBIW/-4[EJ(%QV6W+N"%X.[7T<>YS6;_`$HKI.@9"+P!EN'0 M`X/:5I0UZ0\QW&X\V\Z[/[:;1M\S[4EU&;HA2^ISVF4TR(K9')TDTPY/Q`@] MVZ*SO?X.?"#!['W#CMJ;\[TZ'Q&V^K*+%'<.V\DUOL-_(]PS%0LJA;822%:A M@/U$85-?,^?4D7EQS/[=\@P[==VMO-S!MZ)`JAC)$?$O'2,,`5)HDBD+C\(/ M"G0;9G;ORP[WZZW!M/>5)U1M;;FZL>HAKWQF-FF,`J3"R2K<+TNN3MDW&&[L9+J6\A?Q(Q M."(,S#BB.U"0*XIT2O;<]B4VL;@NK5UQK)<2F,+44=D1@ M!P-:CHT-/B%ZLZMW9MS?.0PF5IMX0.N#P>(R%:^#V_1T>W:;#1?835T-!D,M M%39/!*:JJA61Y*:E,[(!&S$+/.^[[Y;75BK+)`=3:2HJRY)[B`&%0QVWO([@Z&R\^6W#% M58W8F4J\UA,YEL?04<-=@=OYBFV]##3T];&M!+1U>*>>@D>K^V_9B;PU%H`) M5U_:K:;]$J6[!IU5&4=Q#.FHFN,FFH9(J<@5P6[==R7O+A,\P_Q9V93PJL;Z M%7-5((JIU4X'221FZ3^7-NG)YOH_"XG(AI?[N8J';B5\U5]Q59-^O=S[TZ9I M\C4JRHT4U?MWJW&3R655-3),+:E>H@F_7#HM`Y\0CT\:..X('V/,_P"1 M'4Y>V%S)<`\EJ&_P!M'!$3_2U'JPCV#NI*Z][]U[KWOW7N MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][] MU[KQX]^Z]U6I\@-\;EW3OR?^Y5-GLE3[=I7HJ:3#-)+CBM$TE0U154U34G'S MRU65+2%TB8M1P4I#CR,/8PV:SMH[8M>E0S$?#^9/IU&W,>YWJ3EJ,J&ND>GG4Y[E-?/TZ/1M+8FTMB4M71;2P5!@Z;(5C9"O6CC?RUU< M8(:85=;4S22U-5.E+3QQ*9';1$BHME`'L,3W$]RR/<2L[**"O`#Y`#'Y=#FR MV^SVY)([.W6-6;4U!EC2E6.2<``>GETK?;/2WKWOW7NO>_=>Z][]U[KWOW7N MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][] MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO M>_=>Z][]U[IHSV!PNY\/DMO[AQE%F<)F*26@RF+R-/'545=23#3)!402AD=" M.1^5-B""`?=XI)()4GAF9X(;J&2WN(U>!P05(J"#\NB0]N_" M+J"7:60J>N]N4^Q:G&4-95UE%@$TTF:A2(RU4E;#4_=&LR/BB_7+Y&FC7Q70 ME9$$NW\S[A%.BW4GC1F@&KRXCRX#/ET!=XY#V66!Y=OMOIY0*D1XU`4]:YH* M9\L8Z)GUS4;RZ\WQ@,I4XVIRV,VS546<@RU+DXY,/C<]A:V'(8G+T<%?C MZVG;7%44M3&)(G!_LM8V939D8%2`01[C.1'@=XIAID4T(ZG.">*YACN('#1. M*@@U_P!7H?GT[>Z].]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T53YC]CU'5O2NY=Y1T"Y&DVOB=Q[X MR=.:F6FFEAZ\VSF-[8>DIC""TSY+>.$Q=-+&2%:EFFN&MI80@JMW??X^'*R5%']SC-OXNMBZO@S%*B4IQIJH*:FKAQV909N/HA2QG?Y+S<&TPZ/TS75H6E(V M6@.I0?EJR?/H3;?!,O*ZV6UQ"29G'BAE`#-J!D1BVD(U"!0M3AZY)]LJH^27 MQ[VEMW83].8CL#;N+J,_E-HU^X=T;@ZGW!4+N/M MW!)3MDX*RDFK88HQ*@92/8RW(\L\RWDVYMO36L[+&'58Q.BZ$6/](!XY%6BU MT%=*$FA/$@+;I>;N4[*UVH74&/ZR&Z(MPY?*]MX/K:&'"5&)S\U/ MB*3,9*HS&ZZ2/Q5$4A%3$K1S.CI)[!V^XJWK[:_ M\(SF!R1@KAE=LY"OR`VS6&DCFIJ5X8I**2,4MVF;F:SLN?>5H^?-AE62[MI+ MEM("KKMO&JH,%S&H,HH`1J M=:R`\3KSW`]'(^0^XZ5Z9H';#U.6J:'(9JDQ"QXW%[4Q-)'2U^/Q%+V%O7(01Z/V:62&9FT5B5%1 M3R*-ODFNI+K<;QS^G1=0I16?/B$DC48HU+#!(.:(`"$FZ11V<=IMFWP@&X-1 MEAK$8"K&`N%\25P.VBBI+:SJ7JYK^7G58V@JMV];;7K_`.)[3Z4S6>ZDI\G# M&D%-G-TX#';3SG9FZ(H1&/\`)MS]L;ES]72JDDL45$T$:%5146->>5>4V>Y7 M*D7%[&D]":E8V++`OK5+=(U:N=6JO4T>V4\:3;EM-HP-C8226U:4URIX3W$E M*`4DN'E9--1I(`P.K4_<>]3#U[W[KW18.JNO?[W]=[2W/G-_=LSY?.XF+)9& M6G[,W914[U53)*\G@HZ7(14U+"";)'&JHB@`"P]^Z]T('^AK%?\`/<]O_P#H MU=Y__73W[KW7O]#6*_Y[GM__`-&KO/\`^NGOW7ND#VKL*+9'5_9&],1O?M-\ MKM'8.\-SXQ,AV?O:HH'R&`V]DM*/)[-PNX:C>_;`K60A1K)"_D_ M7W[KW2]-C8\GN3;.,S->F/II ML]7S4]"M56.(D>>9DCL#(Y&H^Z]TINMJ2OP'$$`$F_NO=&"]^Z]U1#C6ZM MV]\F_P"93M3K[J[I/9W;&S^F>Q=W9?<':6].X.Q=N[QVWOO;>Q-X[BJ]^X;- M;CQ/6NQ>N]Z9!&I,MB\+74M;CH,=#/.H@:)&]UL9(%>C2?RI\+M67X\Y'L7! M=';`Z.R._MUS"NQO7_7F9ZOH]RX;;>-H:';F:R6T\UV#V?/#-"E54P4E2F8J M8JS')!.JP"7[>+W6V`#$`]6=>_=5Z][]U[KWOW7NO>_=>Z][]U[K_]??X]^Z M]U[W[KW5.7\[",5?Q*K,6:I*1\ANW8L4$WVGW;P2OO'#4OW87QN==/\`=`1@ M%09'%R.")0]I*Q\UQ3A*A(Y"030'L/\`F/4%^_:K-R=);%A5YH@*BH'ZBC_# M0]52[JRL&2^67R)KZZOEKJ6FR^Z=CXK'PRTPD^XPN6VUU5+DXTFW'(:5ZBLV M!5S-+!C:=VEIE`K(9F2)I#5`G+&P*D965Q'(^$AR+;DR M-+O,;6@D6KI+1X+"Y1L%0XG$9#!@=3QZIU.[+%!+M MEE-(OTRE!)334:F7620M0"%(S2M13'!)LAF:#=]QABD-XXE:(U:A$:.44!GH MQ&H&@U<,^506Z5WW0;-S^\J7<6R-S[BDW=O#:FZY_OFW&_M]L:WOXE:WADC=)2P M;^V9VD%$<.&#!6X,I`H",]!_EW>$V^?=DN[.:1+F>*17B$9!`A5%C8NZ&-HV M0NFH%6!(8AC3JU/HGY"]H=CT?R2^/--U]B^HS]A;OFWIBLYWCOG= M';FX]P;#J]S/5;7JJO!P5VP-F;;RN36+[C)-15L,(>L57$?N-]YV+:-J'+F_ M_O%KZ"*[/FKEB'9UL;JY MM42*0RQM=RM>VQC1U4N(R53B>Q][96CH9*NNBK*O`5+_")2VA:":AHQQF.>;9] M_N9UYR6;QI78D%*]2L-502P4F,I(,76G%5D(C>*DR=8M9635%$CSR4E,J^1)9 MBD0?VF*S<;CN]Q"KIXPH/4M5L\1A=*BI]?MZ$>]S;BLFT;'!*D+&` M`!4AA5@S5`).#Q[2QY_9'4&PYJ&7?61SF\<]6P)5UE!7S9C/Y$S21G)Q5==M MZCR%+44R4E?C9JJJ-;7S01U%I39::AIHU5M?[S>QRIMZQP6R$C4`JH."D!R" M"2&`[$X<>+'I-=;5L6W/%)N,DD\\D=2I\1G.:U*`U51I/]H_D*?"J@1.O>N. MW.W6QN/V)@*+:6RL]**.HW!6X6BFPE5+CI*3+XJIKH<,:W`[NBP4TM%2TVU- MGP5:25U,XFK:6D2&>C0;C=[7M0FEOK]IKX`$H"0V:@GO`9&.DZIIB-(^%-9( M)EM.W[]S&T$.W[>EOMS,0TC*"*C2RBJLRRJO:!!;J=1!K*H1'%_'QDZ5Q_3& MP,;AJ;'U^/FBP^)P4$&9K*/([B3"X6?+Y"GJ-TY#&_[C*S=>X=P[DRN;RAI? M\EBR&6F@A9XH4D>%=]W1]VOY;IJ=SLQH*+J8**(#D(BJL:UR0FHY:G627*^Q M1;%MT5I&C*J(J*&-6"KJ(+,,,[L[R,1@%]`J$J3(^R;H3=>]^Z]TB=X=B;/V M'''+NG.4.(62/S`UE3!2QI!YXJ;[BHJ*J6"DI86J)EC5I9$\CG2FI@0%%O:7 M-T=-O"SGY"OD3@#)-!7`P,G'2.ZO[.Q&J[N4C6E:L0HXTR30#)`J2!4TZ>,# MN;";EIDJL/71U*/!!4^-@\-2D%4GDIIY*698YU@J4YCDT^.0)&5/((LG]E+H=F&@Z;.+D7`O[,(=GW.X5 MFAL9&4'B!J_X[7^=#\NBBYYDV6T94N-PC1SY,0I_XU3I0[7[9Z]WE'3R;>W1 MC*X54?D@_?$2RCS>#1%-)IIYI?*0-".S\@VL0?:>XLKRU8K<6SHP\B*']G$? MGTKM=VVZ]"FVNT8$5X_.G'@W66U,U0;>RNXH?XMD MYOMZ&DID,\E9.*FGI)(J!`5DRTT,U2!)'1BHD32P*@J1[,;?:K^YADN(K9C" MGQ'R7%:FE:#[:=%%SONU6D\=M/=J)W^%:Y8@THHQJ/R6O0I8[(T.6H:3)8VJ MAK:"NIXJJCJZ:198*BGF0/%+%(I(974^T#`J[(V''$=&DG M4WWKJ_7O?NO=>]^Z]U[W[KW0+;YZ_P![[NWO@ZJ+>:4/6:8B7';HV;$N0I*O M,2S2URUP:NH:F**LH,SC:M*:6*54DI3`LL$@+R(YA:W5M!;R!K>MYJJK\0/3 M!\PC&."")52. M%50"@``%`/+IT````X`X`'T`]ZZ=Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_ M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_= M>Z][]U[KWOW7NO>_=>ZZ(#`A@"""""+@@\$$'@@CW[KQ%10\.H%-B<714,>, MH\;04F-BA^WBQU-24\%#%3V*^".DBC6GCA*FVD*%M^/>V9F8NS$N36M37]O3 M:111J$2-52G```?LZ`*KZ8W11=K;?W9LK>B;/Z]HZFER&>V!C8,A%19&L2+= M4F8%#CX*^+;U(=UY/-4$]?4/2O/;&*L6AIIG(70N=)Q'V@ M%B28T?0>R88`'0DZ][WU[KWOW7NO>_=>ZPU%1!203U55-%3TU-%)/45$\B0P M000H9)9II9&6.***-2S,Q`4`DFWO8!8A5!+$T`'$D\`/F>JLRHK.[`(`22<` M`<23Y#H$\3\C.I\QF*K#09^HII:3[!FK;$47W68RE)'`B22RU^/PU/D*O'Q)'(IUSI&MF'//M9!M] M[1-%!^PL0#T67.\[;9N8I[I?&'X15V'VJ@8CUR.DA#\FNE:BKFHX M=Y1RR0Q0S%H,3FZJ.1)8S(1`:3'3O+)`.)4"ZHR;,![4ML>[HH9K!@M?,H/\ M+5SY4&?+I".:MA:01KN`+?Z5O^@<'U!X>?0O8#=Q[Z`*S$ MUU-7P*SHL@CD>FDD\,P1P3&^EUOR![+I8I8&,5M,:DG_5Q]!\SUN::*!#),X5!_Q?VG[!GI%[0[>V#OG)SX?;N9DG MR,/WC1T]9C,KC!7Q8YZ>.OFQ-1D:*FI6J M^)/%2/&00:5X5`)*U\M0%?+HOLMZV[<)6@MIR917!5EU4XE2P`:GGI)(\P.A M+]HNC7KWOW7NB^_)?JX=M]69_:K4U?D*>LQF=QV6PV*EIX,IG-N;BV]E=L[@ MQV(FJYJ>CBSL./RYK<:9G2%LE1TZ2,D;.P-]CW)]JW*UO(W"RHZLK'@KHP=2 MV/AJH5OZ+$Y(IT'.:-H7>MIN+-XV=&5E95H&9'1HW"DT&L*Q=*X+JH."3UKC MU@JNJ%S6P^P-K#<.T;!O[L>^.PO7])NNMVC@MD[TVMW#FZ^MQ>Y<-0X/< M6S:.N\E+C*VIS5%)+34Z-/*QD$>\;9M6_66U72)K M=0"CEED9,LJQD`M117H,\N;UNW+5]O%I%LT][?27RW$3@JL(7M^8?=5+O'MS%[P[=V;LS`4V_>O M,YU]%B^P]O[ZVUL_L+%X2IHZ2?:6^<6U12+DL148^2$"-Y)40`%[-LT&Y[GS M)N'+F]KL^S>%;F."623PY5E+1/"\D3&I#QL`VEPYR0`321]_WV?;]HY4VWFC M8/WWOWC70DN(XXS-$T&B>.6..5%XPRHS(3'III^*@ZJ7^0W9V!['JMH8;8#[ MTS^?K>S]C;T2?=W6V^-LXK:<6T(LPV[\KN++;TQ-+396HS.UZB?'?8T.0R+U M&0REPIC5%B8D*D@#EW"TI2E>H6Y MHWC;=W6QM=J6YEO6OH9=4L$T8B":_%,CR`+J,=4TH6U?/H=,[39;,=4=9[O# MU]9DMI8_;N1%=&U91P4=!!1U])05T]$V!W3GZZ+<,&$AE0PB./\`R4-X0T M2ICR#BKH(XJ:N8M538JC7TV6K<)*9D]K;D[5O]HJ:YA#)0@J2"8)5P5U`U(I M19*CB5X=&%U=Z-]Y7N92R1"YA)6AII6>!S@Z6RK<6B4\:-2M;'?Y0=#F*)_D M+C,RE;/D=K_(KNG;N4R-=!50355732;*@$S?=U-2*@R2T4P\L)\+Z;CZW(,] MSF0KL+(5\.3;[9E`(X41',L&Y7:,S5R085KDFM:>@ M^SJ[_P!Q3U/_`%[W[KW01="?\R;ZZ_\`#:H_][D]^Z]T+OOW7NO>_=>Z!SY$ MQ^;X_=Z1?\=>G>S8OTQM_G-E9M/TS/'"QY^CLJG\D#GW[KW2DV@I'5NUT/U& MP,(IX4ZY[5_[*'[F_\`$:=%?^[GNSW[KW0Y^_=>ZI#Q79O4 MF<^9?\PSI[+;#P_7F\MJ]"]G[HK>]8\OV;NC:=#LS=6S>L:3>F2JNC]XX<[! M&[9I*#%U.Y*[;K34^X:7`8Z&<23+(%]U:FDJ3T.G\G_:?6^Q_ASCMK=4=RU? M>^S,5V+O=*#L"NVQO+:-36&IDQM8*8X?>^C)1TCTM1%5TKTL4&,:DJXA21B% M5)]UYCJ8GH_?=&^*[K+J3LCL7&TN,KJ[8VR]P[L@HLSDL=AL95G`XRHR;T]9 MEZT!4@=`U\*?DTWRTZ#V]VY5[779F=G MR.4V]N?;<6;VWGJ;&;APSP_?0T=7MS<6XC%2Z*J/1'7M25_]MZ=(GB>3W7B* M$CHV7OW6NO>_=>Z][]U[K__0W^/?NO=>]^Z]U3]_.4RTN"^.-%E8XO.V.W=L M;)10R/&E-]QC.QMF5L4U5Y8I4^WB\)#\QG2Q`D2Y/N3/:U$FY@D@=@%,$@)H M2:/'(N,C/IQSQ!ZA#WPF:VY=28"M'0TK0'3-$=ZRF[#W9F-_[&J'7)28G=&.[)R.7[QZ]FCDV.R%@IYS@ZNKEK*. M6FBJEE\:RC^2LVR['=F.BP1+')0BJ^$BVTP\FJCQU*ZZ!7!TD5(BMT%MS+S' M:I<:_J9VGB)KH=;B1[N*GQJ2Z345A$WP,OB=HJ%6T=L]F;!R/\*H=L4VXJ!< ME'/05U378_;F4Q]?39(TTU-4XVL,,6*R4+H],:E%GQTNNGJ%O2FF\!E<76T; MA"IENFCDT`,`NM2*<01D@X;2:,`2/B!U!ZSM=XVR>2"*T5H6-L47ESM<,2!M3D=TA0D@DNJ4K6I6M-+#B0:]'3W_`+?VOU_V M;4?(*>LVG4=U=O;5P76W3^3EQ1DST>XMR8:@QFYZ^1<5(M]AS2TD.42.G2G: MH^Y&N=;`^P=:7EY?[2G+X$J;/;3&2==780I;0.']K0E,DX&!U(6XVMIMF[R< MU*\#[_=PK%;D*=99E17D(!%8<%P5`)+U+9Z`S>7;FZMGRT]'WKM7&Y3*T_AP M.V-_83'[9SM#_#H*>NJ%23(Q9JNHJ"BHSC?,L5*_HL$=0+LQQ:[99WW=L%X5 M0C5)&6*D$^F`37@:BGS\N@Y>[QN&W-HYGLM4H`6.8+&P/H&U,=-*5%#^$8Z! MSK[*X'>6_MU]K9NFK(-H8["5M/B*F')25D>0Q-%2)-GLK+EI:*IR7WU)1P/" M32KXZFJK/%!.K3I%ECJ_6;:[&VVJ&6MX9`6730@DT2@!-5+'AY`$E3AE#^V2 M1[ON-[O5S%HM$@HK%M0T*27[V`(/;0TRQ-%)H(V,?\*OCE%WYO;-=A;VHF=Z M[<>2A6@R;2YG;L-)@X\3ELF]3M[/T\4&Z\=M"GW'AL/C*:O@DQ,F1RO>(]*!P):@1\@Q\21PATBB5QH,I=GC)AH=@G:6PML;+IHHL+C_`/*T MHX*&7,9":3)9VKIJ:*&**&JRU8TE8]/&D":(%9*>(*!'&B@`0G/=3W#,9'[2 M:T&!7UH,5^9R?,GK)6SL+:RCC2%.Y5IJ)U,1Z:CFGHHHH_"`.EE[3]+.@^RW M:O7F"R-5B!`J/3_)T72[MML$KPS7B+,O$$Y&*\/LZ;YNZ>KJ>&:HGWEBX8*>!JJHFE M2MCCAI8]9>HE=J4+'`OC:[L0OI//!]W&V;@Q54M'+$T&*U/I0<3\NF7WW:$5 MF>_C"J*FM10?F.M:+YY=[9SY%_('^YM+CL=2;6ZHRLV&:BR$T>5Q^Z^Q\O3[ M;J8*Z3#M25V/IJ/8>TZF3%XVLRQ@AJZ_+Y&HO!2S0H^0/(^RVFP\OK>/,3?W MJAL=ICA77VEJ@ZY9%UN%!TJD8!+D@8I^Y/,ESS/S&=O2W'T5B[)0]ZRW#:*, M%TL*0HWAHS4+L[L-"T(C=-[[[>^)N7;*=32IO#:F,RLU-NOHW;^[\)FZ?;-1 M1U,466@V70XY\IE^NMT9!JBDAJ:*HI6VO-(B_P`0ACGFIZR%_<]OV3FNVC3= MG\#<"E4NVC8,X/#Q:A5F4'5W*WC*#V%@"A9V#==_Y+E\3:5\;;EAVK@Z/<=#B M:C-9KPLM73=I[JVI6PY.EVA7QU,*T6)VU6PT\L[THR537?=22PI]EY6VSEVU MB$-O%>;N&)D9T+:4_#X$4@H76A+O,M2OP!:"KO,//&\\V7<[RW,UAL9C'A*K M@%V%0PN9(\K'4:5BMW:O^B,X/158L?L[!E=MY/;N,Q63CR9ARM%DMOX/,9** MJADDI:V>IGFI\HV:RWDDI94F4-%4I)&T2"C$*1B8SWLR_41WC2J4`4JSBO\` M1H"H52*CRH,5U5'00";?;?XO)9JDVLED9$)!-:-5@Q<@\"#1CP73GKDE$,96 MC(3`[\SAU-Y<14T\\5510 MU+3JHAIZD^CG\1/I]RA2_613H@F(=!D`%F)UH`&S#)*JJT21J89"&!&HD?`W1[]J?S/>]?\`1I7]5T^PLQO#M&ND M-!L;>$1Q%!LG,XJ::)^U(L/)3>:AP]#3K3XN":.*&-51@! MQ:[C:6ZVD-E&((5`$4:`JH742QH3WEJE79JEB:UX=1GN.V;E*;N^W68SW#,? M%E9U9C)I&A5(4B-12L<8"HBT6H`IU?9\!OG+A]R].46)[VRF.V/NO:.2JMD9 M.LR7WS0;AW)@L+M?.9K,8RI1*HST>XJ/>%)D?'-XZFCJYJJE<2K`E1)"G.G) MLMKO#G8XVGM)D\50M#H1G=-)S_H;(R5J0RA'J-5.LC?;GW#M[S88(N8)%MKZ M%S"Q;51W1$D+@YQ(CK)W4(?Q$H0JL3UGY:?'%9!$W;FU5E;5IB:2N61M()8+ M&:(.Q4*20!<`$_CV$3RQOR@D[9)C[/\`/U(3O>_=>Z][ M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][] MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7ND]N;=>W=FXPYG<^6I<-C!4TU']W M5>30U562B&EIT6)))))9Y#9552?J?H#[=@@EN95@@0M*02`/ED_LZ37=W;6, M)N+N4)""!4UXDT`Q7B>@W_V8OHXM2JG9NUYC6TQJZ3[:L>J$\*SM3N(VIX95 M,\M=7K#JJ;( M[?I]^G=F=Q?9]%N&HK\AV:*NHVOOA]^;IFCR55N"FWM40TE5FZO=V9Q3":GC MDGCK$UTABF@O:>-WW,PSRV?THDVAE&F&@>,0Q@#1X>=`B4U!(`4T(->L7MDV MGQK>+\NHNJ]U=2;IP M61F[%2FJJ;9.\Z004G7-;-44T=3A8\W-C_!F=MM)BJB*HK<5MHU6(KI>,=DL M)1N\<84C]M]CW;<+;=[2^3]V$CQ(>YIQ2FK0#5'!;"/*0ZJ?U$D85Z'_`/KN M@;?D7RVE MWO%[+=H^DD2'2D$A)*KX*@1Q1M_H1*@O76]6"CIMRM-U9DX)UR6R=G4\%&JP MQ#(X'&8CF0BF)-+`F6S&.LCQ>7KI"M0])'$YEO.VMSGL%Q9A1]5`7EB8G MO9-)9XZDEN[2LB!L:D48!Z(^6=Y;D/F:RO5%+.Y$<4J#M19->A):4T@`N8WT M@,(G=B6:,(=J+&?)#IRLQ5)D,AOS;>'JI*2.;)8VJR<4DV(K0QIZ_&U,\*M3 MRSXW(1R4\C(2ADC-C;WC>^S;DCL@M790<$"@(X@T\JBA_/K+^#F79I88Y7OX MTJJ(J2F@3)PB:>IF>..***) MRLCL\DRJ+"UV`]IWV^]C^.U<"E>!_P`/2V/>-JE&J._B(J!\0XGACCT)/U'^ M!]HQZ]&702]B=)=>]EP9%=Q8''2U66I8Z/*U+8O$U\.;I:>%XJ.DW-A\Q09' M`[JHJ`OJIXLC2U(IW`:$QMZO9C9;M?[<\;VL[J4-5HQ!4^91@0R,?,J17@0> MB?*BIT1L-356)B!%-&S%(R\;(0KE5"3>N_*/;^^NM.WJ M9\95[9EQ\$.2R5)'X,8<=GZ&GR.UHLE29D)4QFAH-P2T<57*()*2O6E1HJ:1 MEIZ\RL;,W&W[KLEPS+=*31?Q:D+!R-(-J*[!S),U-6UZTL=#D3%-$].[1U..\LQ0`??1.HD]A^ZV?=OHWAWB\\': ME4E!J4!Z&H`%1@BI"M_O)X=">QW_`&)-RCN.7MN-QO3N!*WAL3&?A9F(#4): M@U)7!'<*5Z-/2=:["[\[%#65^>K*;%MAZE,WC\ M>N$R,JX7KIHA44H,K@QJ&WW;<=HVN\Y=2Z(VZ>19HM(4$M M33EAW`)J+:*T+$-2O0UCV?;^8MYVWFF2T3]ZVRM!=!BS`!&U*"CT$ADTJNL@ M,$!4G%>B'[J[=VOOW.[@W7C_`(Y;;WSB=LYRHQ;[GQ>'VSB<2*3F!X9I(]6@ZR:`!M!9CEJ M<:"GY#J.+W>[/<)[BXCY1CN;>*73K58U4,S%0]%`"H6IAN&":EAT"_9>Y=Z= MF8[-[

C1%Q\<6)+4OWV0,,^-H_-55V1-ED MC6EDD@-MLLMOVN=+NXW6&1T^$)DDTJ*-D!B0#K8A50Y#:J,1;ON.[[U:SVUM MM-Q!;N!K9\"H)4%0*'MJP$<8)D<&A%.QLS&WK[G^//4>WJ+%-5UV[L=%'MX0 M+CZC$/G=[[!VK@:B:CPK5V'AJ:N3(K4P.T`J*F"%52JB1Z=*=79W3:-\WF=V M\%58EZE@VA)I&`KW4`P2#ISPI6K-[:Z[KES9H`AG>=1I4:2"TL,:N0`5J:DJ MIHQ"T#$Z1U<=_+%R6,S^?^7.Z,,99L=N;Y4]P9>CKVD26#(T4^0Q0HZJC9*R MKO324X#*;1:@UP@')BSG[4D?*\$@`>/;(`10BATOQJ!G]O4U>U$B3W/.ES$Q M:&;>;IE-<$:TI3)\NK_=>Z!OY%AF^/G>JK;4W3?9RKJ9$74=DYL#4\A"(MSR6(`^IX]^Z]TI-H M7_T6;7N!?_1_A+@,I%_[NTW`8'21_B#;W[KW2(^+2NGQD^.:R$,Z]$=1*[*Z M2*S+U_MX,PDC+1N"1]5)4_@V]^Z]UDVK_P!E#]S?^(TZ*_\`=SW9[]U[H<_? MNO=:W$V_<#U__,E_F4;BW5E]][>V[D?COOS&9G>=',F1PG4U)@^K^G*A=ZY+ M<%)/D<_E\=FII8:>BQ&/QE5+LK(04_FAE&XH9(O>O3Q_T+H[7\F3+Y2J^(M' MA*S!;EIZ'![FR`QVZ0Q6>IH M243-'3^ZI)\;=';^8M$V0^*WR#IDVYM[=C'J7>LZX#=>X%VIM^M- M)A*JK\F1W*V?VFN#6@\'W,=3_%L3XI85;[ZCM]S%[JH%2`>'1;?Y7>3&:Z%W MME!O&N[.^Y[GW*C=L[FSL&8[*[,:BVCL2@&>[4I:;LGM:';N[\''2K@*>@&6 M73@Z\10D=62>_=:Z][]U[KWOW7NO_]'?X]^Z]U[W[KW54'\V MC9V;W_T=0[8P$6WWK9\=VM\MNI:B;[N.*+;F[=YTN#DCR+_=50EJQC]T?(^EDR6J=6TTU4(UAC"EB MC^DM&Z6@.R\?GWW#_!ZW$Q5>8I-NFBA MHABHJ M7Y0X/;%=3=@=;G>^-JYA_$Z3!XV@GR>%QLM%-%55VTFOD#QZ7QCG"&QF.X; M8+F(C*J%+(NG+$0RSE6`U=KHM&(JP..DOBZ7=G;,$NU-I==/MG9,==4TVX=Q MYW^\^0PTU+CY;;7.]]TOB,9#44M'%4/$NTL;]SF\_/\`M+'+'/+'[4LMMM#" M\O;]9+FH\-%*:@3ES'&&;C3,L@\.,=S4H#TP#>;VDFV[?M9CL]?ZCNLFD!?@ M\20A"549\"&LDQI'0AR#>]\5.B,=TEL"CH(J2>GKJBCI>",M!34Y$2VC1"OW#E*?'PR&1*:)O)/6U\T4+U$E-C<=2QSU^2JE M@C9_%!'(^D$VL"?;D44D[:(D+4X^@_U''26ZO+:R3Q+F4*N:>9-,FBBI:GH` M>M:3YW[KZH[(^1F/WWA^Z>N8MK8W$UE#NK!X:KKNR>S\DLM#E7GPFW.NM@TV M:#YJ&;QZAE,CA(HI(B*BHBBB=DR"Y%M-WL>7[NW?9KKQV8/&6I#"-.GODDD9 M#II_`LA(/:"2*XH>X]SLVX7<-L@F88ECCO&D2E3^FC>&A<::H[ M.%-5.GR(!$&RNHO(MMW:[ACQX'QNU*[*T5=2;87,T,$-/ M2ODJ$28ZF2.676H()-Y^C1-EVRU9H;!O#@U,PU!"=#%G(8:RAU,2K`.Q(%.C M79A=23[[N]S:B?<09+IHU0E"X&L`1ZE8(&`"]P/AKG-!T3K`X[L&; MDR>+['J\G%2UV\]68AHMEU65WAM_*5N7RN8W;%BJG;V+JJW)LO;-=E<;2X;$Y2 M*FIJAJ.AJYHC$\@"0W,MXEBEQKG6-G%:EQ$K:`7R5;PY'5"TCQDE=4BJW4CR M+;V^W2[QV-Q_P*DKJO;=+TIM[- MJYFDQU+*T\E.\1II)$YW.WG>3P(+J*X\"21R(GB!\`$Z48W$BS22@CPV73J8 M!01GHS399+>WA6XDLIK9;B")*SI<,OU+*FMU%M$T$<+!A+'(6T`5(((/2ORW M0>7P_8^UMMY?&X+L3%9+8_;&\MMX7KC=NW-P;7V]L;JO,X?'[GJ*&DQ_6VP- ME[;%35U=)6T,#91:S(B.)(W2=)DD+5WF%]OO+Q99+=&*AM4T MDA`"LK,$(7C3(/2QN6KJ'=;"RD@CNE>"ZDB2WD0HL5LX5V'Z,**:L&0&0,Q: MA;B.B\;YP>Y,1MW'XOKMZ:3%5>>W=MOL=9ZDQYO=>&Q&.\-?U[@-T4;U&+S* MT\M3246X,?MROR>5IJFL61DE5#2RB+;9K62XDDW%:NL4;04^"-F.)G0C4"0K M&-I41*`Y%:]!?=([V*!(=HH87EFCN3J`>4`"L"2*VF@9D$RQ.[C545H00T^) M&TH*_<5;UBN.SV=V[N""1L_+O&')8VAI>P>L]JY!\+@L!@&>!MDY?<^%D,0I M,H,OFIZ"L>"K>*K$)5;SE-((%WEI$2XC-5\,`UBFDRSOG6J-J6J:8PP!4LIZ M+^0K>%ICLB0O);SC)DU`"6"(E-"$`1LRT;0^J1E)#!7QTJ,-CMQ[,K=V_P`/ MP&2W;L7>N2P&;W!@,5NBAV;G]N[QVA2NVW]P[.R+[,RM/CK87./BLICZK"SP M93'QTTKSP3TL(]MK=P7D%DTEPL6X0*ZHS(75HI"-<QM@9JH:H^]^VEEQ5=65=.55C15L M1D#/E[B,F.*^LIQ0U0+)"Q%2.R1IY5!Q4!]*G_?BGIF*#;92)9;"^MI!7]4O M%.H-*D-"D4#M05KH9F7CX;>5O7\OOY3]'=6["V[T7G=]_>[LS>Y,S482IJMK M[^VA+N>N\6-@S,6#P_8FT-H9'.Y*FR2N\U%BQD*X!RXIPBL5B'GCE_>MPO)] MXAL2;>.,!@KQR>&M6(UM$\F@4\W"CYGJ=O;+FOE_9=MM>6[C<:WGJ:>9`\4 MT$T3-'+%(A!#`D$>XJ*LI*LI##R/$=3NCI(BR1N&C85!'`CU'4KWKJW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>N!]>/Q_L??NO<./58_\QGM+K?/_'7L'K:+ MLC9NV8MOOQMDTT$9)*HC,U",'2H-`<$:@`>HK]S=VVZ;EC\D`E:48)J*^?6MMMO;/2^,P>'VYGNR.T=]9[(NT6=R?0>' MV'EMFXVIS62J#2Q8C=G;3=>5>Z<\(:R(S)A83CJ>`AFR$DK+&N24]UO$DD\\ M6V6=O;#X?JWG$K4IEDMFE$:4^$R'6YX1@`GK$VUM.7HXK6"?=;VZO#76;$1& M%X:[:D/8 MFYJ3!46[(-A[)QM%UW6O0[4V1MO(;GJ\FTM?ELID\G7R0,32TU,L4C'U(687 MN[WL#W0ADCCCM_%\*,R:/%>X\#2=5]T8O(YK;4T6V\3U-38[!5.5[&V[518J M*>HBV%L\XZC[%WGM/<5:G@DH$IRHK)&K))?N(:C[I[?;FUMI)=VV&=8[D>*T M]658G!/%6\**B MSRQ2M0%`@4DEV8N*L97L#J&?`5^QLYA.O^UZ2;LW)]E[>KXOX-LB;#4^/ZLP M[P;_`*GL,5&[,U-M&CVSDJ=(\Z^7QQW.XVS? M2Q1/4-)J+S-2-8J1KXA<$&/0V.YF-".A?N&QR6TVVS1;1>![R26(C3#HT6ZA M9FN*ROX:QL*2F1!J(1`M0:*/'?%;M:+E$'*&Z_5[E967+9M[NVE MMX_%,X;6\Q#)-;&1&B\/(U%*%"""`1TA\CU#UW_!VSO8.T>R<'M[9_96\<#O M//1KM_>^TLMOCJ9\U0[[Q.4SNR\UNW$8K'8:N2%:C*Y>"FIQ00DU4X:!RBM= MRW#ZB.+;KZUEGEM5:)*-$PCG`*,JRA&8E2:(IW)O"DDEPVSWJL) MU?6[6K*>+9T^&Q.\-HYK;TN-R4<.9V96XJNJ-NU1_C$G\6K6K\C`QI9*W_@* M+MM@VM8KJWM7(EFT/,L@_4#&-UD[25EJ-8"QC0G8U'"@`@/=YMTDN;6>^B)B M@!6W,3#PC&LL9C*LH:(Z2CDR:FK=R8//T M%>CKD8JZES-#EZG;IW7CA4T&)R!7<$RPY%?V*9'K3(9H1Y!$H5Y9D_=6Z[A$ MERDD4#JP`I5E;N*FC$?I@E"AES.IWW:=NNYK22*>Y1UO7VY-K8;=65::KJ<1/35:T&1KR(ZJ>G2)4%ME<7-A!%MUAN5E) M8J@5#.US'*B#X4D6-)4=D4`!T*@J!50U>@K>P6>YW$^Y[AMM[#?O(6E%N+62 M"21LM)$\LD3QJ[%F,3!B&)TG2!T*GQ@H>E=B?(OKSLNI[EJL+A-HU%?6UFU> MW<1NWK?L>NSJ/D(A2S4V#QN[^K]TX*EHLFCPS0[E,)E99)XJ:1%!*>9Y]ZON M7MRVI-G5IYU4:X'CF@*AJZE+%)HV.GN!BU>7`X-^5X=DL>9MGW:;?6CM("S> M'PBEK MJ"M6HHPZ1/5T%=C*NOQ&8I()W$4TU%4U,4$Y\4K)+=/>+FX;1N.TRM;[A:O% M(IH0010^0(8!@2,@,`2,BHSUFGM',&S[[")]JOHYHR*U5@00*5*E258"H!*D MA3VFAQT,'LOZ.>@!^1W5>-[4ZXS.)J\7/E*B+%Y:F6GHA&(W'7XO%;MZVJWU5D=/K2OP61FJ*2L MI()4E6HG;PY]XACWK:+Y:J`K*59I%*];>3`Y[&72B,K`AO#\1HTFA?XM(!DA:L;A?K,3LG,]C^6GH6;'Y%=SXGJ3$;DQF-I5Q4,2^66KK"E3`H\=XW\J"^VGQV6 M3F#!X@M@PVW?);4:.5MF`PNIUB>=L?$76W60+ MBA+%S0U%"%'0U1[IS?8>!J.X>GFITAVVY&U;C&S[<'U0LX421DBM' M#$4XU&2K_$NH="(7]SO%N-_V:X$>Z^`4N8T9S%*M=-58`D>0;4H>,=C4/0:[ MZS^6Z4Z=V#M+!T^03=F9J9K*BGQE9N*LDQ=;493#X[6^:S.:W51T^ M-VY21X^3,94TJP)$LDH:1;M\*[WNUU<2$FV%$H"`Q"+J/>Q`543OE8L%4&O` M&A5N,\FP;!MVWP+6_DJY)5B`7.B@1!5W>0".!0"[E0H%2*Q<=TK\LJK'T^XQ M48W9&.=\=)%C]PG&S[\H\D\%,F;I:K"]8[7[TSU!2Q+-D*4T-3!CJFC\@6H* M3))[6+?\L1M].P\:95-&0-X?XOA:9[93^$ZAK!`)7!!Z2G9>=)0ER9!;PN0Q M#A3-7%:I;QW3+3N'AO1E[0RA@U0ZR/5':O56=IMS=;=:]N=M=R9%),3C^VLC MUMN/!;%ZPFKS._-OXO)"[2&@:6F"3/LF[[1<1W MNT;;=WO,#@J+IK>1(82P*-*BR2>-+.R$K'+)HCA&HQQ!B"++/Y0/6&YNJ.NM M]8/=^T,QLS)YC?&:S=%C\O@$P-J/O[1MFX17UF\, MTEP[@,K+4:8031B14M6I!SQX4/5S'N-^IMZ][]U[H(NA/^9-]=?^&U1_[W)[ M]U[H7??NO=%2W/\`-/X^[8^2.S?B.=T9/<'?^\Y"8]B;6VUG1 MS.^,_!1)MK:>/DVUCY*N):JL6JJ(@###)<>_=>Z$[Y".(^@^[Y&74L?4/93E M?-%3:@FS,TQ7[B:.:&"X'ZW1U3ZD$"WOW7NE%M$@]7[8:VE3L+"G3Y%>P.WJ M8V\JJJ-8?V@H!^MO?NO=(OXQ2++\;/CW*JA%DZ/ZHD5!40U84/L/`L%%73PT M]/5!0;>1(T1_J%`('OW7NN.U?^RA^YO_`!&G17_NY[L]^Z]T.?OW7NM?[:.R M.E\_\[OF]\BL'W/U]VM-@NB^X:FGZ3WYU]V7UYLWKK<>.V_MK8._\EO#<^2V MQ0[0W'MO<=/MI\?N&O67(35E`\,BT[)1Q2+[IPMJ\,`4/1[?Y7&9RVXOB9MS M.YGI[&=(UF6W%F*S^Z>-P/8.W?OXFH\1&NY9J#LS<&[MTR4^4:(ICIFRV0@E MPT%&8GB7_):?W57!#&IJ>C"?,'9N>[!^+W>^RMKX)MR[DW'UKN7&X+#1[H39 M4U1E9*)GH9J?=4N:VW#A*K'U"+4Q329&@B\D2J]3`A:5?=:4T8'H'_Y;_7^X MNJ_BWMCK[=V%W?@-S[7SN?H,YC]W]GX3M21ZYY*:K.5P>4P/8W:5-MO`YZ&H M2O7"29:23'553.`#&\]^Z]U__TM_CW[KW7O?N MO=5[_P`PBOI\'LKK+=!SM/M3)[7[9V3F=O[DKMD1;_Q<&??+T^`Q&*RV`_O% MMNI^VRU;GT$=0)9(:>HB1ID\=R!KR,'DW#<[HS]RY%@L]DNA<"&XAOHG1S%XRAM80*R>)&=+E^-2!2IH.J@MY]N8 M+IK.["SN[^[JVEJANG/=^[5H,!T?G,[2;A*Q87'YO93'#42R14J3.Y6:1+#9IM]:^3;]M4IX(MVU70734L$4%HA0C6I<#R!+4`- M(@W#>H-A:QEO]^*L)S>J!9ZPP!74W;/D$QL%K458::URA=H?*#I_)[AH\7BO MDU/!/UWW;4=NTS6YY5WE+1;B38S2;;Q;TCF61M.IAXFA8RZH&;2W;34%4D$@$ MFM.<>7Y;A8K?F@>+:;F;NLELT:ZF"DQ%WE$;.54%!4XU%1Z+&/+;`W;F-J8W M=V^.Q:_+;\SV7P/4&Z]M]+YFEQM3M>7;3=NUNSMV9?=&^*/#[^H:?+TF4S>! MW'19K$U^*R55D:"FFJJ24P1(FCO=OMKAK>W@-O;1J\\.QE7CMW[8R6 MU=BXC$9'*TFT:ZLEP,35^YZC,9S<==17H(JBBI998W#TVX2[IRQ?[A'2.U1D MC$*FH8@H^J5V"EU&OLB")$K=]&;/0H@V>'8^<-NV?29+QTDE:=L,JD/&4@C4 MLL;-HH]PSO.R'0&C&.KWZC8^SLM0X^#(;8P50E#CQ18\G%T<XF%S<([,L[U)J2J M<9))`[(S0-&S*S`D@F]I+RYD5D:8A#Q``4'[=(%?SZK%MEA%(DR6RF5>!-6( M^8U$T/S'0A^TW2_KQ^A]^^SCU[K6@^87"^]L2R*W=14.F0:-+'Q)&\1(Y`K,@CJ`ID;K%#GO?KSF_F M.[Y^1=49+AE!BB7PWEA9E60RDMJ\)`03Z`^+M=W%DMJ[;P MRG;$>PJ,TFYL[15%)]KB]I4536?W7SN"H,.U&*C,5E&_V%/C]6/=ZF>G:*ID M6&K,)OS'S)^YOJ;J61Y3.Q>-6U:O%;3XBLS<%!KW]P[2-()%2+E;E23F3Z:U MM52);6,)(Z:"JQ*6,3HJTU.0*!`R992&(!(L]H?AGM?'44@PW9.1VR^6HZ.F M48CJO9E;7T54/LJZMKJQ]Q[TW)@LI)DY:*16402I!!43B!D5GF,:'G.1I8Y+ MC;!,R&E3/*H8<`O:JL`HI3(!H#3RZF"+V_ABBD2WWIH@X_#;0,RFN22\DBU; M(8$$@$BM<]);(_`^AS.W=P[6JODCN_[+DGDITFEC:1UFD4)SM!'=6UVO+4;2Q/J35=7+!3C*@F MJGCD$')%:8Z23^W,DUM.W,_%B>M-];O[2WYG]SQ9/#RFES^VL/M_;&U,5B\5493%FF?/;5 MF9$CGQ@K/[9[AL^XJ?%&BQQJBZDTAD8FI4*&(322 M#T;S"_$7:.5RN3WCOS=^X]S[TW-5XO);[KJ+!X/&[1W1F=KTF4Q6V,M7[*VO ME-L[)K=P;?\`XS6J]6<9-E:TS>.HJ)"I`";\V7$$<5I9V\<=I%J$8)8R*'*F M0>(RNX#:%.D,$4UTJ*]#E>1K6XFFOMRO9IK^;2TI"HL$&2)674QU> M&9'!&M\5+W@OB=UU25U;7U>Y,T97GGDIIL1U?U%@8:,'&U,:H<=MF+[K-_N( MDQ^X^XDEEB`^@8JW-SAN)11%&*T`.J>=R<^KG'V#R\^KVW(FU"9Y)II`:DC3 M!:H.'F$6K#_3$Y%:>?7.H^(O7,N.JZ*FWID%Q%?034X@CZCZU3/J&H5B7[C= MN&FP^X\G#3SS23>.HJ)?(TI\A9!J]M'FN]K&\EF#*K5_MI2A-3PC8,BX-,#I MS^HFW%)`NXN(G4@5M[?Q0",CQ5*NPK4TJ:8))H"`T[<^/O:TO5G:VPNCM[8F MND[#ZQ[$V''%VIMC$9FEQ6>[(JJ;,;MW=CH5JLAD:;,9[,4]/6U MT;KMO+]]&5NK6:("X0$)).P>212*LK,P#%G:5@X!3```(]:?`^EW'M[JOL;> MG:._MH]V;4V'UGL3<-;LZ#:.Y:;;>^-@=?X39&6JL9G=TT,&?R&2_O/BCD*F MHD5:Y\M;=+"UVJ";:);B615D,B:HY96D`(1M*@HP0*.T)04 M''H.;1[8B[M-HW6]W>XAWZ*VAB=HO#8++#"L+-5UU%Q(I=B:MXE34\.C+1?% MS,UU309/*?(CM&"H6H6:I$/6'2&)7-55-7O+33[ABH*."#)4TN)5\?+2(B4U M135!#P"9&=`Z>9K+3)'%RY;Z34#]:Y.D$4[:M@US4U((&?+H5CDN_:2*6?FN M[U`FI\"T&K.-9"C4"HTE,!@Q!7T3V[_B/D*C`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`]#YK([3H_XENS-0?:8 M;%K/4TLN6J\AFMN[.PF$CJ:62GJ((,YO/>N)IJV2.>"=,6]689%F$;*,^1=C MM=^W^VM;R4I:+5G:@(5%5Y'8UQVQQOIKC64U#22#''N;S+=N7J>;<>Z]H]J;XGW'7[BW]L2OVOV]D M=P34;_WM]-8 MW.T62Q+!:S+);I%D&I-8Y&4=TJ@,7E3!X+);9S6 MZJO"T%1*M3!EMQULN\]F2XRNR<)^^FPSHB8L-3K(XJ0\2@/>^>[N2X>&S9Y; M;6*D.JAB.*K^FX*J7(T,M)W544F/QC2)286NZ`Z^S^*%O-3EMX M56;"TN5:>MBBKJN8R2U4].[.E0(F+4YP46TLA5[/SO<&]-P5^`J\-F9L+E-E;/PV#R<^#S%%70P35^,WK555-M2.&DTP8 MZH,]#3RHTB1ZEE`,K?GN9((MOM-GAB$@9=:RR.ZAE8$T:,`N:@%@:G\^B*[] ML[47,N\7N^SRM#H:C0Q1HQ22H`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`0QA+LVI]2.\H76P!)B$<@/!Q0]%MWQT3VOVEW!28C?FV=E];C>>RL] MB-_=_;0:*F7L+?N1WOUQFMA557T_%)AZ:BWAMS:&V<[0+D\1F&96AM):GPH1',LO^,:M11W:,Z&10"!@@#H);ERY MO6[[_;VNZ6=O:I<0.DUY#0>+,98&@U6^$5XXUD42([%@6J5J:B!LWX%S[`V_ M1X*D[_VIE<)039:LHZ3.MD# M5%4TL3.`67O.MM>W#71Y?E6Y(7N6[TEJ?QT@R3GAIP0!D='-A[:3[9:):Q\R MP/:C5B2RU@%A@H#/V`8Q4@LI)X]/"_$/T:2N.)/'IQ^1KI([6*3>[*XA`I)6R\-M.#3].Y15U/5CJUM M7S'`EX[$^+E;T_V%M7=VF7R&`434W7]9@3EAR!V@!Z` MT!!Z"6[\G'8=VL+N>IL05:)T!4NZ4(B<5)!4@'B28Q7)!4`_U[49KX5]J],; MIV)4;A?"]OYB"?M<+05-1LNGWKO7=@VUMK(4HQ4<./DW%M[/RT=!N:MA>(97 M!Y22C(DFH*>>G.+PQ\Z[3O5O?&(SV$1^F-0)3'%&SNIKW:)%U/$IJ$D34*!Z M$DV[ZCV^W7EZ\VUYA:7SUN1I8PK+*X2-A0!=:,56=L>)')X="ZJZ;3>V<]1[ MJVY@=S8\.*#<.&Q>;HED`$BTN5H8*^G60"X$BQ5`#?XCWCI+$T$LL+D%T=E- M/D2/\G67=I<)=VMM=QBDV^E'0/;QZ+Z[WO'7Q97%R00Y6O M.4RE)120MBLADVBDA?)U.!R-/D,`V5D$FIZM:5:J1PK-(Q46,+;=+ZUH89R" M!0'@0O\`#J%&I\JT].B>[V+;;TMXT`H6U$8*EJ4)*L"M2!DTK\^G>AZDV+0T M,>/.*GKJ6&E:BIH,CD\E54U#3.@C:+$T#52X["`H+`T4-.5M<$$`^V7O;ER6 M,F3QP,_::5;_`&Q/3T>T6$:>&(:I0BA)H`?("M%_(#JE;?V(QN?[GCV1MW^, M[5[@WAB,SO.AW]AQD)Z;>=5MFJH*1EW3B=K5N*W3CM[8VES^-I*?<>,CRL^; M@C$6;QU$2-(H(N$?2&Z*]VGO[:'5. M=FK:CM_:-5\B*?(TD.,Q677N:F392O3';^X.QY,E6=-C-;BW=5X"6NV_@ZN# M$8G'[:>NJ*F&2>M2"6E/]MV^ZW2TTIMTZ;`RL2X6$EPM6$:I]0%1`X61QK=Y M-(4@)@A3=MPL=DO':;>K>3F8,J!&:>D0([IF?Z9FDF="T,3!$6'4[JQE^$,M MT]\=(_P;>5#N/9_Q>PN1[LW)UE4;)R0VAN[%YB@R.W9.L<5DZW$03_&BKFP] M=N'([>G%2C,]'/7Y9HZI4E,RL=VNT;Z6MTL]SWB2.Q@F\55((H?%(X7M"%5E M`T_ACJM10]$]YO\`L8BNUO;#9(I=PDMS"2KJRL#`KD`V&I-9CAWG-V M$F/H>N<2^'RE/#F,7U%A]UXS94&638W7.%DR.2&=Z^Z[QL&\=Q1X45M33T]+ M*_B<3/):546,N?()8?H!-/?4M>UU\E MY+N?AQ6<>AR&2U#B%6\.W4EM44(\1RNH@)4<3\0ZMS]Q]U,?7O?NO=!%T)_S M)OKK_P`-JC_WN3W[KW0N^_=>ZI0[EWWG*[^9QUEUCG<+M;*)BNR>L=X]>]E; M@V;55>4ZWVI-U'N^CW)U%MIYNDG_W&2T] M;[K=#0-Y=6F?(IVB^/O>LJ&SQ=.=G2(;D6=-E9ME-P"19A_0^_=:Z4>T&+=6 M;7])LS=^T(MD;C[.W=N5J/:N[M\XC:.`["W#E\=D:FLSHD MJJ1,OLW*XQZ]X;Y:-2*-O=.,U=%#D='W_E?P;&B^)NV9NO*#*XW;E?N+<%?% M29K(;;KLC%4U'V0GCJH]G=3=*;7QM5#XUCGIJ'`PPQSHY,U0[/*WNJM6IU#/ M0J_/2:BI_AK\D)\I#E*C$0]5[DDS4.%R.&Q>4;"+`IS1I*G<>-S.WI'3%B9F MIZ^DJ:.K0&":)XY&4^ZTM=0IQZ*G_)JW!L[/_$S,#KNC:#8>'[O,YN*MSW^BC:VT-NY+(T.\LSDL='6STAKJNBH8)))&C,07W7F MKJ->/5LGOW6NO>_=>Z][]U[K_]/?X]^Z]U[W[KW55?\`-YDK*7XO4V0QZXUJ MZ@[6Z1J*7^*T\D]%Y$[FV#-HJQ"RS?8O]N/,BL@=5&J2,`R+(7MDJ2IFCY4@FC"^(E[;$:N&+F$Y.,4!K4@4XD#JDCK MK:V;^6TL6,KIJ6E7;FRUW)DJC$RTTBTFU\-D9LS5XK&P5=%73_=;EJA#4UH5 M*ZDJ4E6MC1I*:`K*%_+#RFC/:EB)I-()K\955J:'.D%@.#"K+PKU!6T6LW.S MI'@MC?Q1YMGYJ;`9?;\"_W:VU MNC^'Y_;&(RBY1,KF\O45^-I)5K-[XS)RR9NF%2M70NJUD4L4.-#1(,=MYBO_ M``7%Y`);>8][QU$K+0(%`8T$9%(R5TM\+!B]"0+NG*^WI-&+.[,4L"]B24>- M7KJ9RP2OBZOU%#@I\08>&KCI[^*>S-\;5^6_Q^IZIJ#(X5MY[\JLIN*HR,.1 MW%G=Q5O4?9L#S8&BI,KF#MGK6+(Q2M3X>K>FKJ#*+-'/$IT1Q[YJW';=PY.Y MCD2)DNS;P!8U4B-(EG@.F1B%\2XI@RKJ#Q:3J-22_P`G;=N&W\\\KPLR-;?5 MSEFJ"[N;:Y!,:@DI!YF-M+))J4J*=7Q_(DU.6^9(*NEZX[.I*%*A:N MK,LT.>W0T,M-5.S4V,"/5D%&5D*DZ`"7/N#]F7PN0MRD*DQ&[CU8%`-"KNZ>W@AM]/%';_`%M`]Q8> M)^WJ>D^!*\:#K+[UU;KWOW7NNFMI:XN+&X_J+?3_`&/OW7N&>M4_Y;]7;KZA M^0FZ-M382*NPO8^%Q[;#JMP5XQF*W#NK:6QMN['W1LIJN%OM:')[JVGL_`93 M&3JD24AK79DE2DR`AR0Y1OK7=.6[.Z28K5Y4FIQ*HTDBN!W-I M'#MKAUSSLU_L_-5[:>!JM[Z-3$6-`TL4$<3P`C\GEJJZ'=.VLC3ST% M=321N*>KBEBABCI_$C@;W#CNXM_BMMP0K7AR*59"*%EH6J MU3U*/M9)8W'+5U>[8P:VFFC8$J`XI#0QR4R)$8,KBM%:H2BT'1FF[UZ.H=J; MBWUFNW>M\5L[8FZZKKO>6ZJ_?&`I=N;4[#AR>-P-;L;<^5DRTN-PF[(8QTQ;\^2/Q\Z MJWWM7JWM;O/I_K?LS?"1Q;-V'OGLG;&SMW[I:OK$I:1L9M_+Y*CK*R(SMXJ= M[LTL[L$93ZI-LR*:%AJ/`=4AAG<.XA8Q*,FF,_YOS_,$'H0-S]A=9[)S&S-J M;V[%V9L?=G9.?FVIU[MS<.Y,1B<[V#NC'TB&MQ&QL!D&-0TLM.3 M*C((FF-+-'52PE/TUXU'I_E\_V\?D//N2&-8Z$`N+AA#J2H$:""9X4$L@1HHY(I MI/"(/&5MZ!'RT/OP8G5JX];JJ!%7*FO\NNC*R&GIM$462`:HAY M"8HF#!!^A/2C@'P;!P?+K=17AG_57J+]OHIW20,(Y*9'J$?6)AIG>IE@@GAF M@#1S1R$6:13>,,-=Q*OA6JM7-?\`57IF156-U))%"?0GY`U'V_E@&E>J@/D) MOC!8/O/N;:-;7UT>0W'O3<6^)<()GEHMH;"P.!ZYQF;WCN"EE-&L0RV0E3#8 MRF8-][F3'/Y8H*#(PF5MCL)[S8-OO%`%O'&L.JF9)7>1A"E*UTK^JYQICHM" M9$Z@SF7<+:TYDWJTDD8SO.TQCQIBA58@96)X5(,48:NJ3OU!(Y03U_RIMD[I MBV5OOMW=.):@D[;W7N#>>$>H5Z=Z;:N9_N]@MG8R@H#?[3'U&R=AXO+(LC-* MM/E:="2RN2%O MJ?@-\?-Q?)7NG&;UR_7^V,_LO;>1HNOL/CL[N=Z_?FZL5L_"O2XS*YK;]%+2 MQY7+Q-4,U4C1PAF57(TGW5E740!U$^4'S9ZE^)>1^,F+[,Q6^,A4_*_O[8_Q MQZV.TJJ<+5[M>OS>(.+VU%'1O]Q4P"KF0VTPM?CW6PA;5G MAT<'W[JG7O?NO=%,W+\RNJ=J?,#:_P`*,K0;R_TL;L^/.[/DSC\Q38:BJ-C4 M_7>S-W4VR\S35N63*_QE-SG*U:O!218^6.6`%O*K>@^ZMI.G5Y5Z`;>'\V+X MA[=Z!^,WRK+/?NM=>]^Z]U[W[KW7O?NO M=>]^Z]T5/YG?-#H/X$=$[A^0WR+W/4[>V-A*R@PN.Q^'H3F=W;TW7F&E3";, MV1MY)H)<]N?+M!(T4/DBBCABEGFDB@BDD3W5D1G-%&>B8?#/^=-\7/F1WB/C M3!U_\COC?WSD=K3[VV;UI\I>I:CJK-]C;6HJ>6KR.4V,XS&ZVR%?.O5O?OW5.O>_=>Z][]U[KWOW7NO7_WCZ_X>_=> MZ][]U[H"-P?)?I?:_P`ANO/BKG-WM1][=J;`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`NR*:5KU31TENC$[L[ MHZ;BJ*P(N\=R=;;PV154M?%5;?[`VC@^S-A+N#"-2ULM-3MN;KW+U=)45,;_ M`+TV-DIZF*G-5]S!3RYN]K-:;/NX5.RW6:*4<&BDDAE*.2`3HE`(4B@#G26I M0F!]CO(+O?MHC9QXMS);RQ&M4DB2XA62-02.^&M75L^&/$50U5%\+G[EJVK1 MOL8*>&3P2F2G)C\E07=VE>H6HEJF,MIF:1"=36=O)KG@<8`3RK_+_-C'62Q) M93*`00/S%?\`+0T)\\^N>4<[T[O.3"9Q+(L-5*S3&$-(X:9E/AB22)O04*0_ ME`SNS4S>;*CC3T_U?ZO\/5XY*4)`)K@FM/RIFM?L'SJ:=8)9X*MGB"QRT[4T M1?\`:$U+;(,(*,R*=)C5U&DM/I*0;TE3\O]7G_J]<`BM"WB*&+# MY_*OJ.&?L`)QDU4N$],8PSSM'5+"D$ACJ(XF$LJE7$A^Z9FAG*TWF4*T2_1C M,VE94H#2B`>7']O_`!7^JG2D*HJ3I_/\L^@.#@?EQZY"-Y)9IY5J757CCABI MR\'G>DE,0:**I-$*<2^AO2L:*YOY!<2/;\`6F:_ZAU0TUR.U=(&`?]6/+^1^ M?46I4NTT:I*L#"2(22:T6*8Q$.=$-3%&OJ32?VZ926T%]1$4VP:$$<13_5_J MK^?5-'B-_9E5H>/"OGP/F>/\R,$S*.GABCD*JGFFDDJ//6>D"IGAD4+XU34- M>DQ`I&%`31>2YB%6!-*<.MQ45F``,GD3Y_\`%>9H/F23U#J0E9&5,0=(8170 M32Q1SB*?G0ZO-+$K>1(M0"GQV4%990&>/8-*`8\ORZJP$I;T`KGU'E^>:'B! MPX=<*2FJ*6D>61H(Q'!3OI-!C\C7K'44IF6>ECC*>204[:1XB0=-2 MDIDAGC83"/Y_,GB/\/G6G01=ZXJ3- M=,[RQR/-+CDW#UQ.]'`&(I,O_?W;M))DHI9J.ABQM2M`:F*>:.2F5Z**6-WT M"44QQL,W@[O;R*=,GAS"I\QX3FGSS2@R=5"`32H>YKB:78[B,IK@\:W.D5%" M)E!.:4JNJIQVA@32M*E[UHZ>22:BH\Q08$R8.=X(ZRNI6QKE9:JOAB66(K<[8NY;A>JB2V-M* MH7MU"XGC9(TS\3:G'BBND4E`HL9ZA.6Y7>6V;;-O9WMK^ZAD+9[K6WD2227^ M@I"?HT&IM43&ID7K:&Z[P57MC8.RMN9!TER."VKM_$Y&6,62;(4&*I*:NE46 M4!9:N-V'`%C[QSN'$EQ<2+\#2,1]A/67&VP/:[=86K_''"BG[54`\*CC\STL MO;/2WKWOW7NO>]'KW5'4%/#DOG!U5CZBJ6&).KMUU+(*\Q.DC=I=-M'.ZHL, ME(CFA6,?O'RWMI`)URM'*T/)5Z\9JWU,8(TGAX5QY\#Z\/+J`TB+^X=@KC3& M;*4AJCCX]OP\P/S\^J>_G6>YY/E]V'2=12]H1');>PE+EJKK.HRL>6VW4Q[M M[$GIJ=J;+S,.:Q.X*@T4J8'.8C<, M>0QE!M/)XN;.14<1>HFEJ)I\EDGI4JIS%">7G-?TJ*NR6SR11U<23(%9*DZU M=2"95(!@S:!)1F`#'7\!#-@Z375QJ6.HU-:CN-) M?;O7^BL_U<(958E08R#(CJAP7JFGAI`':`ND]6U_R;,U%GZ+Y.95<=4XJ2K[ MHQ?EHJC)5>7,;Q=*]0V:.KKX:;(10S0NK^&IAIYHW9@T8/J:/?=*UEM7Y9CD MD#TLV`(4+_Q(N`105&"*`U-10UZEOV.N(;DK4:BP_W&M:&I`-6% M"<"AQ3'5X'N+.I^Z][]U[H(NA/\`F3?77_AM4?\`OJP>W_`.=='7XS8O;P[`S6X=B89=TXZOV55=3Y#:.X M^H>HJ?<3Y:GRG6.6W3AZ[^&[-D)^TW#1GS[?A6,(N1J%F]TZ?[)/M_S]7??( MEQ%\?N])6U6CZ=[-D.ES$UDV5FV.F0`F-N.&'(//OW372DV@P;JW:[Z1'Q=E$WQG^.\RZM,O1G4LJZY&F>TFP<`PURL% M:5K'EB`6//OW7NN6U?\`LH?N;_Q&G17_`+N>[/?NO=#G[]U[J@;:-'T%L[YG M_P`QOJC8W3FX,1V-5_&GMO?O9/8O8O8.VLAM'>4F\,?M+)UZ2;/P5-@M\X+; M6??,4[RY!,U3),E)*H$=0IEA]U85#*?GTS_#'?V]^EOY-VY>S.M]V8&CW)A, MO-71=@SC&2I@=N)NC8^TM\;RU=VITSUGF\QLG9E-DJC!Q//2;9K(\?04YJZQ MVJ)Y_=6DRYZ$SIKO?M#=WP;^>79.%WY3[IWSM3?.[,?MCM?.[MZLVIN_<DV)O#*;/7;.?WUW/OG<.R(L;AMNU./VIFV[_P"J^G.S M]L5--B*ZFJH,96X1(EH:N"J@FFBJE;W[K1XG/1X/?NM=>]^Z]U[W[KW7_]3? MX]^Z]U[W[KW57_\`->H,OE?CC0XS!R4JY2O[.ZEHJ2.LFH:2G::I[-VE&9Y: M[(214E&M+3F1M;LJ`D$D%0?8^]N#$N_W3S!C&MC<$TR:"&3@/.O40^\PGDY9 MMXKJT_B%G,/UWW+CZPY;I#>_\4K*S8E>N/R%+ MA]RU>W-TRJ=QPX"LR]-A*3(8N5H7$%(E1-5S^`ND>A53V,>9H9;[:G1;:]A" M`29&I-2G!:A)4_.@&>/4;\DW5KMO,$,C7NWW!=C$Q!T/H=>Y5)HKC!.D5)'# MX2>FCYP[+VUU9W9GIR#I65&'IJ:6*2-TC2* M6NE4,]9)84;O?S3\MQ&KZCW&NU!S[?;JBU(:XCJ*\>U M*8\\]3!OI3_75V@XJ+:8U/E0RDY\L#J\FGX@@'_-F/\`Z$7W$[?$?MZGY/@3 M[!UF]ZZMU[W[KW7CP+_T]^Z]U2=_,D[JV1N_,XWH3#8#;.>W'(T6:W3O/+@. MO4>U]GYB>IS'::R056.G3+[-JL;DZ7!*M3&TM;!F'F#4%!64F1ECV^V>[@CD MYBFGD2S4&-(U-#ZN^V=])%RO;VT3WC,KO, MPJ+5(F+-=8*U:$JZP@'+B;4-*T<'_P"5-LKI.W,WNH08'_2W\D][]R;> MZ]:*MII-L;=WKMQ,K@\)44$\ZB'+?PBGBKZN@\$LM#]ZB-''-Y"3'W4O[6]W MW9[>UJYL]MBMGEX^+)&^EW!`R`U4#?BTUKT6>S5C<6.Q;]K\Q7=O9S>+_)[HZ.3*8'ME=QKM_%8V/,R8J1J&:@K)DBIZB)RKRQ*D3,DB MK-I(TZ_\OKU/EK+`T]DI#>/X(TGRII-,>O'HWV\=T_R^-D=L?SJ,'_,_Q&TL MKVSOCOM*G;VU-UT./K>]^S/BI5=:;8QGQZPOQ.6KGQFX:G)/-]_2TYVU6P54 M>:4"?P2(+WUP`N)&[Z\/.GR^?56%V8K'Z4TCH:D<`P-26'\-/\O1=?YF>[^P M^Y_D/N7/=(]%_(_L*B_E2_&CH?VGB,7N&FZ3^1T^XM@?('=DWR0S.3W M[39.EEHOC[U[1X'+Q4ZY#+)52U#RQQ.A#-SL2SJB:E4`C.2:@FGY>?6[-/TV MUS!?%8JWH5RH(]03G[*'RZVRNJ>U=L]S=6=9=T;/K(Z_;?;>P-H]A;:J\7IJ M:%L'O[!4&XL=44,TM/)5.8?NTC564DM$8Y(@4*0+=)=05RO'Y_GY5^SHG($; MO&^)`=/R^7S_`&YXG@"0OTM)^5.M$T:C`AO]7V^GSQG@#U$GE+-(HTM50SB!YU!J&BCCO.S,WW* MRI&BU`;2S#46#!%!5Y+57@/AZT`3D\?]7S_U<*D=9VC-"Z3)JE%-I0K%(?VR M3&6^XA2$F.*)4``5$`;]M4U-XI-5#8\NJ-J3O&0//YGC_J_/CVF#1?Q.=(D# M$1#RR,L=XUD-/IC`>-J2+R*ZRN;%8PFC2(7"F*-QRE>[CU2(S.0210?E7_8' ME7AY"@T]^1'7V0V MS\V?D9O#.4^*RVU.[L7M/&8*EW/!756WCV5T+28/>M;TUN^CH9Z6JDVKVEUY MD9MP4]!&]''F12U$<3&6G*R3?R]N`N.2>7[6`%+W;YY&W`62PW**)$62I0W-GX^V.]>FL3F,'C:7`5N)FK\5EL!#,LDM#78_)UV,R2R_LTWD>E MS5!4T[2I&L-0(5GB5(9HD6%N:]EN=BW>6UN)6D5E5EIZNC--,;%ZI9-.I>/=.*5.O2M#3H@79E)\S?F/O M/^8C\N=KX;Y`Q_(SH#YH[\ZXZ4^0U/\`/7J'XV_'[XC83JK>>#Q6T.LMS]-= MH;[V545-#G<-"8ZJNF:*GRM76QE6DF2K2;W5RJA42F"*_/HP_P#,ERF8^5_: M'R_W[18SY<]R]S_$7X<=,;D[,W+M'Y4;2^-GQ"^`?9^4Z0'8N4S77]/M/<.1 MW-\A-U[KS-/6UIBHEEIZZ7_(:6IDA,%7![JB`*.ZE&./7T_+HS_04V:^6GRH M_E])W5N[>>7S?>G_``F_WU0]C;XP&YV.CL13?R)_Y6-3M;?/8^W-R?)/\` MFW]0ON#<<>\*_-2]=9ZEW_WUU3BLWU'BLF\V,V!-B\1C*?(_;4J"&;-J];(# M+*WOWE3IRH626O`)_FZ,YV)N+L_^4Y\@?YXG2_Q*[7[TS&R^M?YPJ' ML_LS<_:N?VAW!O\`WCM':>X.U<7F-RR9"HBSF#Q^^LCDWG,=Y7@C,[,D$937 MKUH`2"'4!D]'%^*?QK^-_P`!=T?$3Y+[?_FB]L[,WE\@/A!V3W#WATIVIO'- M=]R?)]*3HY>R=V=Q;*I\IN*/'[5K>GJ,V^J.S,&7 MPUI7CU5K\8:_?G6/RR_E%?)OJ"G^:.U=H?,CY8UNT-S?(KY3?*K$;UWE\X]@ M[K>HILIE<]\8MG9O.;:ZQVYB<=DB89*J>1X9ZBF6)7=$J!KK9`*E6IJ4>7^? MSZ&WJ[#]P[-^+G\XC^9MA^_OD)G^XOAI\I/GWU'\8NN/[]Y3(]6]74O8&;QN MV]]=H5.UJFFRE?GMR;6PG835^++5$5'AHL%"(HO&9`-]>(%4CI@BO^K]G0@? MRO>G/E)T7\O_`.7?V[L#9G>76O6?R1ZTS/\`LT%?\A?YA'1G=])\L,?NOK*D MW/@NYNL.FI.R4["I\I@MW>*MGBI*"NKL;CIHXI%C:.L\_NO-I=2/-?E_AZL@ M_GZ5VV]M_)/^2/OCMEUH_C[M7^8%1S=H9G+E4V5A].J14_4'XBIIT?7Y@=T?`S$_*7X[8/>&VMI=H?S M`\%U?WWV7\.8<7MC/;KW/M>EVYUYEL[N>MK=T;6IZG&[,VYNBBPS4\;966." MO*RI`KN6!]U5=6EJ'M\^M36#:V7V=_*;Z5_GF;?^6_R`R/\`,?WK\E-O9/<. M2K>Z\OD]C[CRFX/D%E=E9OH2?J!*_P#N]_=V+8],*ML/]N'6D5U$249C2/73 MQ`U>%I&D"OSX>O5MO3_QYR7R[_GQ?S&*/LGO7Y`;)^.&RM@]R9OJ7;G46"R_2=9V)F. M]Y-O4&1QB92>IW9&M5-5U7^3".;PRS,HIO#[JF(TCTJ,DUKGTZ)A@=^?(?\` MF!8__A.CL;MKY(]Z;$RWRDZG^;/5_<_8W6&]LCM'?F^-A;(SM?M2+(U5:OGQ MU3N[=.P=GBADS=32U-7')73UD1\\FH^ZT0B^.5'^KY=*'^95UCMW/]D?.+;O M257\X^\I?Y;OQBZJZXH.V]P?*S;WQX^.OP6KM@].4N1P%7@:+`9&+L'Y%=J[ MSQ^*^[R6JAAFK\U4RT894>*HI_=:B("J*+D^G1I>JNE<3WI_-6_DF=U]E]A] MT9?L?MW^6/M?Y)[VR\?;.Z\=%E^S>EMK=+SX6./&TU:M/3;5WG4&:IW9AHK4 M6Y9Y&EK$"3'^E_GZ)9MCN3M[L#X<](_&[=/R![2Z^ZL^8'\_OY$_ M'OOOM3']AYS&;SQW36/S>,K:#KO#[_RV1FFVE@,Q5Z8UA2:.!5@":&A,T4GC MQZV`$D:BU[U/YS_P+^-W=O<.XOC/@_P"4EN/Y-X_;.\.U M]Q;\S_Q^[W>KAVNN-VOO6MR,^Y-KU&Y-N9'^)M3>>"H<2P2\B&.0^_/JP[EC MD90&U4^73%\?^B\I\6.[O^$ZOR8V1\@ODMNKL[YX4S;;^2![)[DW3O3:F[-I M571&!W)B=I4&U,M538S%;?VTN;-+1P`2`"F@J"?ND:9_=:8AQ*"H&D5%.KB? M^%`W9V_<'U5\*OC]@>S-T=*]8_,+YR].?'[Y`=K;+SLVTMS[?ZDSTE=D,[B, M9O&.2"/:Z[@:C7SU!DC+P4SQ-JADF1O=4A4$NU*D+4=5.=C_`!JV_P#&3Y5? MS&?Y8O3O;_R#W/\`$#=G\J/=/RPW1LK-=X;RW/N'I7NWJ[.R9C;28;>G\1FS MNVNOY2 M?Q*RV%RF[LE4=L[$H^V=PQ;IW3E=RTF(W#N*FIL778?9E+DYI8MH[*IHL#$] M)AZ,)1TLLLSHNJ5R?=4F_M''H>M2;Y[=]8#Y?=S?SA.\\;T]\H>Q]Z4V^^EN MI_A'W5T[TSN'L/I7JO&_"S?`SN]=P;N['ID6+8B[GK,7-DI32K+XJ:O::8*C M:G]T^@&E%)&GS_/TZN,[[[+C_F;_`"D_D.0KVYV_UUU9\U/B5\J,AW+1]&]G MYCK_`">8J\]O5>*J9XH4K8*<5$,$L#2,1[CTT%" M"1J9!''Y]5&;NZDWWU/_`"V^\_EG@?E7\LZOM7^7Y_-+W)\5/BQ!6]X;J79> MQ.J]I]T[7H)8J_:D52*+<6:W#/N6JEK*BJ=QXA'21JE&I@;W$5Z=U*2%*BA7 MTZ-Q\W<#\BOG;_,(_F>X6MV!\F^P)/AYANM]I_':IZI^;?7/Q(Z^^+<%9U54 M[IH^]]V[;[(W-M4;VHMW[F;^+U.1IY!3TN/CE@DG771O%[K6I8T4Z13[*]"G M@^H>^?Y@'SP^!GQM^5GR([BV`N]_Y-VU-\?*"'X[]X8.IH>XMS]:]_;IP]/5 M4N_]C97>?7^4Q^^,I2XO+9/*XEJA\C#`:0RK%))&ONJ501.5'$_GT%7RZ^3' M?G74G\]C;NR^Z^P>OZ'?7\SGX/\`QKJM_P!+O#-QOTET]VKMC,T_8&0V?5U- M<\.P\?6T5"*6IEH7H0$JV(D5])]^/6PJGPQY::]'JWITC\6?Y36)_F$;;ZS_ M`)H?R,VIL6J^#&+WSN_XW4&;'=?R$ZCS6>WOAMG8#Y,=3[OWAN:APV,W#OBL MW.N&I*!Z:@B:MRL=8:I8X*;P^Z;S*02!3AC'13_Y86&[3^,O\WWX:]7878_R M/^.G6?R>^'/:V^=]=3?(/Y7P?)+>O^-]8##5=;M/JK<.X,OAX M134-.[52_;58(@CD>)_=..%,)(I533_5Z];O?OW2;KWOW7N@7[][*V5U;UEN M37E>#'&"@Q==FLG7Y">)7J*;&8/#XRHKZF6(&=(:8^`-. M8D8QVG;[K=-PM[2R5FN"RT"\:DA5`\JLQ"CRJWR#WK25576X.A*0T=335LIBD6GJJJHRB-.7^ M5.9[3<+IKR=MK-BK8(:4+),0E>YH[./"RMEJ@U[E`PR1AS/SGRM=[79K9VJ[ MJE\P-0R1%X(JN."RWTM6DB6@5O$-.UV?8[64(LS0%)[U8A#'(=:-45? M[Q@78;`]?\W7M!#E& MXEJX6K:F.98WAC1?/.XGB@D9HE?[F)()94)\B MFTJ*7:610K0>I0,*"O\`J_U?X*$FK@"51P6KZ^8^SCGUJ23P):@(PS*/"E2Z MU/G\L#!*>&)S6:8UE1HXIR3`9))#(\RM$`&+>4`)4#07)J<`=:DU:-1KJ+?* MA&#Y<<>8[2*9(`(Y5#PP1Q1)&T%*E>9YO'^RJ0&1I9C"QIJ:.F8A@)&/B];` MF4LUI?#4:GSIULF/2@)HE?LP?F*$?;@^8J:@R*%8XQ(T1,VL23),TA,843>" MKC'A:)9V(*`2*NM2;$D,86I5JT-.GTTU=5\R?\V*?\7Y<,=-X1"ZR,I@BH8Y MIHVC1D0I5+XV2/52P^6.>.[:P=1D73Y)/5'&[W4QQ_U'_5_L`])0J#77`0DC MC3S!X?S\QD#31D6;-$###)":>4RQ_NS2U$SR00",M#-"UU?RR0TZRZVE#*5U M--(H$\5`P!917_9^=>GE1G,U1' M&K1A143BWEABB64N=;7A)!N9H]0F??''^K_5_J^7389]+2+3`R<<./R%!_M1 MYDBI;J*TM)+`9!3>6HAEJ)%64R1J@24!JB#[=`$.@A/+Z;%]/F4EHY-\&X]N M/]6?\`QTRQJ&9DK)4^H\^/E]F:&O&C$@E(^>6S]Z[S^$_P`H]B[&R\N%W?NC M9^TZ+;V1HJHXALMD:G>..U[9BK(_!!2T^]L9JP\LSR(A6J"2NR!DIAAR!>V6 MV\Z`["Z=WGN3;4$/^DWKOK3!;)W)7-5T2 M[(I=B[;7"Y/K;,8J=31X?*[/WAM+(9.>=Q"<=JWN>RWF MRAF9EM+F:25,'Q?$DUI.I&2&1UC"@D)4'X9'Z"'(.]\O6^Y[#>SVJJUY:P)" MYJ/!,4>AK5AP#HZM(QQJTG\4*=;'P8,+@W']1]#_`*Q_(]P4"#PZR@Z[][Z] MU[W[KW7O>CU[JDV&HG'S/Z@A:FJ*R).K=YR01JLD42HW:_4(EBCDD5XIGUR& M=R%(54(O>^F3X5_Y".Y,I4'ZB+B?/PKC_)CJ!V+?UZVT."0+.:@H>'CVWGPX MUZJM^6W76_-X_*_LZNP^5I,3LLX_`XS^4@IZ=*F9D70"KE!SAN>ZVUG<23R):6R@Z(RJO)4=M&--*:L`Z/M- M>EO(>S[3?;I9VEM!)>WOB@/,6>*$)\0*+4-(54,1K`XX\ZF#^=6QSN[M"FHM MG=?;?EP^P]MX;8^W\CNW<>-PB2T^T*VIC3*8V+,Y;#4U178ZJJO#4IXF/V\X ME,WC*K[#_)MQ#:[>S7>XR#Q69V$88GOIQ*BHH!7CQQ3H5^X]M/>;RJV&S1F. MWC2)#+($%(Z]P5W"D'6001D4KQZ-M_*/I,EC$^2.+RVUYMH5>.[;QU#'B9:> MGI8?M*?J?K`T22*1U<,2/W-,#?U;>"Y\9#: ML2:DFIGG!!)-2335G(!`/#H4^RJSQCFF.>R^G<7H[*!0`+>U(H%[0`"`-/:> M(QU<_P"XNZGCKWOW7N@BZ$_YDWUU_P"&U1_[W)[]U[HA?RCWACML_+KK"IK] MH;-J?%0=/XZ+L'/[&V/E)=OUV?[6R>-PNTY:_<.R]P;VS>7W7/-4M@&P>8VS M186OII9*NIJ:FHHZ*?W7NBO]W;!FI_YR70^^:_K_`+=DILYEL+C\3V/G^M]B M[2Z%Q4N&ZASTTE!@.VNO]K5?8_8^\,M)3R428[>^4IZ6BR#QP4$)I@CCW5R0 M4`\^C:[GZ3W+F<#\G>[8?FYWMVKL?[KOR;;G2M+4]44O3FV:';VSR,1FE>=,Y0U]/:*BD9WHWFJ/=4ZL"VG;_1GMG]M8Q_<7#? MM+Y"B#^[]-^VI9FETK]!`Z!#XWU M=%A/Y)&Z$W)DJS:])+F:A*EJX*ONMN2LA(Z''XE9?;M/\`RQ/E5LBL MWIL_LG9'3E+V;L*E[%RGKSV-R"X;<%)DU>NK(X(V7W7F(=Q3SZ,W_*&K\IE?B3-ENPV\\A7Y7,=I8O%M0_PJ/T<204L%/ M3P^ZJP`8@<.K1O?NJ]>]^Z]U[W[KW7__U=_CW[KW7O?NO=50_P`W_'M7_&&( M++X6_P!(O5%(&U&%M-;VGLORG[A2'BC$=,0ZBXD4Z2&'I,D>USK'S'*634OT MD^/LADI_,]0S[WJ3RE&5:C_56],TXSQ9KGX:5X'[/+K7OW)N3#=84O7\D>V* MC<^9S6!GW?ESE\Q/:DH4W!#C,/-MVA%)ICR:#`UPB$]17.S5%/$:>"!I9C,U MC:3;P^XGZ[PH%0'$ZJT!QMOKN#9%VYVV[Q;F1/%9FX:E`ST:3O#Y,;Q[L7K)$Z9[RZVSMVIF#%3/BZBKI,K%BJ^@%7C9(LQ2U5,AAJ#&[,P=V;ENTVO>K_:-R M`43UGMIT["A!"L!QH5)#!2"I'$5Z&6_F*<>KP8/\`,0W^OBC_`.A![B1OB/V]3Y'\"?8.LOO7 M5^O>_=>Z\;6-_I^?];W[C@]>ZUB")-4;.&0P MQL%K6FGZD2!Q0DR%BXPQZ,A\2=UPX3=VX]GYM:]9]RU&WZC'[DJDWV M^.R&!CV;5X]ZRK%;0[NQC:MOY".2IIJJHHQ2%XY):%%#O-UFTEK;74+`^&&[ M`IU&(OJ\2H&"C`B1,$:M61JZ%W(NY10W]S874;*TS*5D+J4$X1E,1J=1\2,_ MHR95B@C)!*`V!Y'8^S8<#FJ*NV#MK^!9C,?Q[.X^JV7B9L)G=Q3S4^1DR^>Q MTN(2CS6:JZFEAF^[JDDF>6%9"RNJ2-'"T,P]%CZ*&AQ6)Q&-BQ='BZ"-H(H<7C<504R4U%0T_VH18*<+%<*%1M M-T<`8%>VB_ETRTB/JK+60FM3DY(IZ'B,-EEII7G>='LL-$HJX2 M4J*F5H&JI@HGEJ?NH)'C9&&DH`O&FLL(SI%O60A:TOO";RX>O7A<1&@\4:CY?Y.N% M-'7UMTO2U@CDIZMW@IM4!HA^T'JHEB0M$;\!+`P'VI5`(TD\/V M9Z\@DUR+WTXC!X&E*8X5-`*T]!FG3G2XW)4T=%,F,R)2:ETB:+&UL/C"STT: ME$CHD589&LOI/)11IE`!A:,L;:N]?VC_`#]/^$Z`:8FX^AX\">'[>N"8V>K% M15&AK&%/5K!4RRPU=*L;S5&AHX"BI4*[S0JH!L))%!+LH$ZW9A15U`8KQ'54 MAD:LB1G2"030T&VNII6\)8T9F9JA44`]S$@44`5SQI09('53^]>Q=M]J;C M[AW?GX*_&[#DBQ&Z3+E1D:[?^Z39BHBG%7!0XV:7<"[0Z@AGF&(H*BO@I6/VTR3)Y@::JCE32%9(X2GW( MB,%OL45P/\<$/E6@3Q9RHJV:9JOD5(-3YBGV;G%U/S#<6]39/-4$Z15_"MPY MHF`21D8TL&``X"Z7W%'4\=>]^Z]T`'R:^+W1_P`Q.H\QT5\B=ECL#JW/Y;;> M!(X'J M+WA\4NB/D=6=(U_<>R6W=5_'3MC;'>'3\O\`>'#;FY2FW\QB MTS1QT55(/M:\55')JO)$Q`M[KU2.!Z)5W;_)'_EI_(?Y`Y'Y*=K?':DSW86X M\SC]R[]QE)O/?.#ZZ[/W-B#`V+W'V5UKA=PT.S=XY>E-,A>2JI&6K(/W*SZF MO[J_B/IT5QTH.[OY.'\O#Y$]V;N[[[:Z'.?WKV%M7&;3[$Q>.[`[&VGL'L"E MP&+I\)MC+;SZ^VENK";3W!N/:F*I(8L973TK343P0S1D5$,,J>ZT'8`@'H;^ MK/Y?7Q,Z8W;U'OGK[K&;%[IZ+^/V0^+/5^5R&]=^;B;;?0V3ST>Y*KK]J;<. MYLI1YBB&4AC,=571U-?%#&L*3K$`GOW6JGUZ`_8?\F[^7AUKL>'K/:'1E7CN MOL=\F-G_`"\V]M"3LWM2LPVU.]M@X^;&;2W/MF.JWG+48K%8BGJ92,.LC8F6 M21FEIW-K>ZLSLQJ3FG1D,C\'OBSF>[>Y_D/G>I,/G^U?D+T]1=`]RYG/Y+<& M:PV_.H:!((H=DY;9>3RU5LQ,<\5,B2R0T$51,EP\C`F_NJU.,]%>^+O\ES^7 M1\0=W;XWOT]T1JW!OG:6Y^NJB;L'>N]>S:/;766\U:/='6VRL;OC.YJ@VQL[ M.0R/'5001^:>&1XGE:)V0^ZLTC/\1Z3O4W\C+^6=TIN7KG>FQ.A\W!N[IWLF MB[0ZAW%F>Y.Y\_D.K\SBZ^3*8S`[(7+;]JJ/#;$H\C*TYPBQ-CJF9O)4QS.` MP]UXNQ`!/1S^IOA=\9ND=C]W]:=>=6XO'[!^1_8'9'9_=>T\UD\_N_"[]WCV M[214'8U=E:/=N5S:0X_=-%"L4]!3^&@6.ZQPH&-_=5J:UKGHK_Q2_DU_R\/A M;V_/WKT'T4<'V73T>8Q.SLYNC?._.P(NKL!N#SC-;>ZLQN]=Q9R@V-B\E%4/ M%*:.-:@P.T7E$3R(WNMEV8`'HZ/R-^-71GRWZDW+T7\B^M]O]J=6;L%(^7VM MN!*E(UK,=4+5XS+XK)XZHHLQ@<[BZI!)35U#44]7`U]$@#,#[JM2.!Z)_P#! M_P#E"_`S^7IN?ZV78@"O^?]O1YM@?$[H7JSO?O7Y,[#V-_!.[?DE1[+HNY-X_WAW/7C>$'7 M>)DPNSHS@LGF:S;F%.(QLABU8^DI3->\I=N??NJU.,XZH>_EI?R`/COM+ICI MG?7SQ^,6V*WY9]8]J=K;MF2E['RV?V=GJ2;M_=6Z^I/7VWMV8K:>BFABJ8BM5%'.ONK"1U72IQ7I<9O^5O\)]P9CXA[DR/5N7;< M_P`%/[L4OQDW-'V5V6F?V'@-GY+'97`;0K\H=VM5;TVE1U.'I%-#FSD(W@IU MA-XBZ/[KP=@&%<'K'E/Y5/P*S7QR[&^)^6Z!P^2Z+[2[9W/WMNG:60W-O;(5 MD7<.[JZ/)YGL/;6Z:[V*O9O?6X-U;WWON?LOM+;-91UM`^&W%V M5DL\^\*;'P4F0F6&''U5%%"TAD11*2Y]U9I':E3PZ&V7X!_$^>+X@PR]7:X_ M@'[-ZNW9]G-D]NY9ZVDDI\CC*A:S$YS"9C%5-#FMOY_ M$5:"2FK:*H@J(B6`;0[JWNO*Q4U4YZ*S\7_Y3'P4^(6P>XNO^F^H:J"#Y`[2 MR&P^Z-X;PWMO3>W9/8.S])]!=5_'7I/9'QWZ9V[4;(ZEZXVJNRMD[ZKQX](?X^?#?XW?%OHRM^-O2' M6=!M+IK*U6]*[-[1JLON'=+;@KNQ*BKJ-Z5NX<[NW+YS<6=J\^:UTFDJJN5A M#IB4K&B*ONMU/KT#'3?\K?X.]`9/XW9CJCIJ7;-?\1E[=C^/$LG879NCW--52OXLBM8E&\K-3"$L??NO%F-:L>O9_P#E;_!K M='1O:/QOSO2HKNFNY^^\SFZ;=T.X,8:G. MXFGG^QI*J#'+X]"P!"RGW7JGC7I"?+#^3C_+U^:O:.,[E[^Z-DSO8M/A<5M? M<.?VMOS?_7LG8NTL(($Q.U>S(-D;DP5/OG"4$%,D,:URR3+3J(O)XU1%]UL. MR\#_`)>C*;5^$OQ?V+W;L+Y#;,ZHQ.U>T^KN@Z/XO]?9;`9+/XO![3Z(QV43 M,X_KS$;*H\K%LNGQE#D(E>&;^'FKC50@E">GW[K532E<=(+/_P`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` M.X'+$!I`$I7.?,"A.<9K7`\JUKUF4QPJ]94--+!'H5C',LJ6!6!ZB`E)&IY9 M*@%C()"G!+U#*HFCUD@>7#_BNMFF:'L%1\LX!K@_+'[:@$Y6KXJQJI%$0!EGDUX9334G_5_JIUMYD?Q`A4 MC'`^N1^S!'[<<3YY+RPAJ>0HJ5$KRF*2D>61(=2.ET6B=`9$2(!I;>92 MPBFWY-0^?R_+KV-<:D@KZY^P_/[:5^9P*QJ?RPSA#X96>.I-/"[/YVEF8PPH M$@\ACB6%?"9$21F)93(W,2^(JM0/2OR_U>G5:^%(5J*FOR)^7V9'\JL<%8,% M1242F21(H8V@IP'+PP"<56F%I8M<1#+_`).5,HDG1PMC4N$U16^(MIR0?+-/ MVM?\OV<`>L%5E*9 MHQ/!(E-'+52P!UJED9U&J0/#(D9BJ95DYDT-Y$5Q^[&S?N61BV M?(??.*P'6DN,K(Q49G?N2V]1X48^6G.:@CV[NRBS.RLIOWKS?F M)VI@),S60Y+<%=O;9+TNY=QUDN-@Q462WHF5,*)!-+!/34HJ95\DE2E9*.SR M&\\<`.=K6&:)I&I4(L,M5!!)T1A>+`4KQPNF(-YC^D:S=FC7=I+B">.-,U=I M82)"#I&N37I(74'TDTJS:MHKJ6KJ:_K#KZMK)9)ZBJV9MJ=JB:_FJ4EP]&\- M5-J"GS5,)5WN!ZF/`^GO'&\`%W&MO\)ZRXV@N=KVXR"C^!'_QT="%[3=& M/7O?NO=>]Z/7NJ1MM.LGSZZRI)#53"/J/< M+;BG&N#GADM\AU4I\R(>JA\N.UA`@@*QZ69W[I%U)12JZ6<*69Q0NN"!T M8#X/_(R;8>`[=[^SE!0]8]"[.Q-5LSK#9.,Q$.:WSNKM+/4M>HERFXJJ-,A7 M93:6WZ3),^J6GI?[KS"I6A+>FG>!_9T=MW;E^QLW/@M:%E4A28Z`L1JH0-8U:>&!7.2>@I M^]=JYFO[IP;I+K2[AGT2JY`#%>+:*J&/=6H7`%!2X?\`DZ4C4>,^0<$LT]14 M0]FX))YZ@5-VF;I?J-WC@^],E6M+2Z_#&KR2,B1"/65C4+&WNHP=]@=5508' MP`!_Q(N`X\,]33['1&*/F57E9Y!]^Z]T$70G_,F^NO\`PVJ/_>Y/?NO=`'WU\@MY;([PZHZ7VSLS9%=C^Q9L M/-N#L6N[9VUA=T]>X/\`BM<^1WR(V3_,KR&PJ7>&`W!\8,[O[8W5&>P^:Q-`^;V# MV1V#TQL?=F%V[MVEB[1QN[ZT0*` MUSU6W7Y7I+;/?_.<_F&[!S&5I.]ZY;5_[*'[F_\1IT5_[N>[/?NO=#G[]U[K7E MQ.%Z_P`3\V_YCV'S4.R=P[;J?COVSD=X;1[%W)N_.X3*8?8F&Z:WQBH=[8%Z M7+]@;7V5297?^4^ZKZJLR..S]',8=LT5'#BZZ&?W5JZBHI3H3NG\COSL+^5E MW!1]:]/[*V+VG/G*[`XWK7H3!;^^WBW=)6;#F6N@QNS>]=H[DAR=5!6I6T]5 M0[^IJ2'#_9U-5.L2U5`/=><48BM>A<^/(V.M1#,SXG,YS.9:.$RK4YR9 MY4$'NMM0L-'\NA?_`)9V\]K[VZ*WI7;-V;U)LW;^,[LWQB:>+I/!X+9FQ<_6 M#%;5RF8W!%UOMSLWMW%]:YN7,92>DR&*7-SM)5T;U[)$:W0/=4-:YX]6(^_= M>Z][]U[KWOW7NO_6W^/?NO=>]^Z]U7K_`#$-SXS9G7_66Z,WBJ;+X7$]Y=,? MQJER$T4.*?"Y#L[:>*RRY+[FKHJ1Z=:"N>4B1_4L+*+ZBK#7D>V:[O=WMTD* MR-MUQ2G'4(9"NFF:U`'Y]1C[G745E8[%=31*\2[E:U#?#I:XC5]5<4"DG\O+ MJD[LT]#?(G>3VOA:;=-=DM^]<=@4=?F*$[:H*;?M!0T\ M5#)7R5XJJ*2;'Y''U57.I@EU)K65MI_??+T1W(J-QV9X@[-'2.6,Z:-6,FK4 M`((5E-!W"IT]05OD?+O--R-I1GVK?HIFC192TL,R%ZIIE4`)J.5+1L"6HI`& MHV4_'?JW#=3PR[_WACMM]2';VQL'LKL_=-;3XG;FS8@#SF MW\YGZ:FJ\3N0&IFAJ3+3SMI:H@$>;WN4^ZNMC82RW:/.SPH"7DKJ)&E:%E95 M[7B&/,9H>I8Y7V6TV5)=PO[."Q,<"Q7#,H6(=BJP9JZ)$9@&CFS0EE:E6'59 M.9Z5PO7G\P3X^9B+;E)L7)9#LCL'"Y?:.+A=,!DFK>H.\-S/O'9]1CA'3T>2 MS\^7J:G)T@1!3_9]P]O.8X&F,T"6L#*Y/H?N.7+;:_=+EJXC@$%P]Y%W]] MH_Y28SY<=$?^K_#U)F\QI+[I6"2?"UK,#]FJ7'RQU=W!_F(?^64?_0@]Q*>) MZGU/@3[!UE]ZZMU[W[KW71%P1_46]^Z]U4!\VOB?V73;QS'R"^.E)BWW_E=K MY#:62I*JJK,2(*?-U%?-)FZ#*8ZFJWV]NS;V3S5?D,)FS!+%2U65KH:TPT\T M-722?R;S+M7TT'+_`#&[_N])EE#`!B&4!::25#QN`JR1ZM1THR5(*M"//_*& M]1WMUS1RFJ'=7@:(JQ*X*72:%Y%DHK*RTV[HZ_[[Q6W]GG>G M3W94^&VC0UNX?S9SFSJ?=."H9]QR4RU,%1C:MH(8 MF!E>(T[A)9MKO8YY[SZ'?+7Q+A]"!Y5CJI`TC]01DZ*Z2KC+8H:Y@>YVWF6W MMK%=PY?O2EJAD=D@>10:U+!HO$4:J:M2-VC-01AZQWR\VY6Y"'^]G8>^Z/$Y M#!T\M#5]?_(SLK';ABRLU?BE-N/9^;H-L=J_*W$[SVMMO<6XQN7)_(_?\` MGZ#.TE%%6YAH2QD=#*::CD@B>DH6EH9:F,24\RK$L1?](8+NV>\VC:G MM)940HMI"A0FB:@2#Q-"0Q`)!)85-3"7<%N-NNDM-[WF.]@@DE$CWTT@=5&O M2]"!@$@%5J!10IH*$FV]\LNQ<%62U>7[<[^WM@\?A*L9S&8/N7M:DJZ2"OVC MNN096@DS^X?O8VMT97:^-WCN?M?L^6OWK M4YRFQF,H:+)YS'9F';W\>:NQMZ&GIJ<)C4K_`+J4R+]Q,Z"WYEUYSEO_P!+XMGNVZQ64,[HLDEQ.QD+ M@*%+J^AGUXCT@*I9:ZJ$D==L]L;BV#B\*W:GYNQ\IB<7_%-A-\B^R*3: MVPDEIQ0*,QN.AW5B#F=UYF6/S5D1F"8>M=8!'(WE\1+<;1!N,MPNV;58Q;6K M-HE^DBU2_B("E6`13A2`I<5)ICH16>^S[9#`=XWW<9MV95UP&^G$<``T@EE8 M:Y&'@D[6[8[>V?ML=A=;?(;OO=77F1SDC;DFW+W;OHU/4]93XV MMBP&T\KEHMVB3,8#?+87/2P M4FXZK,;UR9PJU^XLA1QU.9Q\.2IYZ6CUSQK3QS"H63\O6;6]-OV?:VMYGF-? M`CK'I*]R%$!?L5QX;!2I8^="$%OS;N,%PG[TWC=EF@BBJHGE'C%ED[7+3=I\ M5HV\5%?6BFNE59F?.C>W^PNP^RMF[.W)\C^ZL=CMP9">+.5\N]NP:S)2R2X# M)UNXWHJ*GSF6?:]109C&5*4-+D4-$D$B2TM3,C01^V^8-DV_:]MO=P@Y.DCBE%`QCBDII:8N`]%M=T]NR16EC)(U0:6,`8'U1 MD4,M!PUUHPJ0P-.A1)O5FEV)9MPW"&-2--=QN2",45E9R'/%F$>DE<`@BI2V M_.U=Z=EYN@VSM/<^X]TY6NRWWT>PMB;JW5NS`YO&TTM,\U9N/`YK>.4@H]NX M;&))6RRY%$QD;4ZF=HRVL+=NVJTVV":XO;:**)4(,LD:(ZD^4;+&IUFH4*E7 M8-C%>B_=-WW#=YHK.RFGGF+%_!AED='4"M95D=QX=`Q8R4C!6I-2.A8ZPZ4^ M4N_LGLV7J:@.)RV/FS>)W#V57YC9V]=OTF+J&JJ`;1J=O;.WME:C>E=!A:S( M4\D-XCUJ\YDBDC$99D\,QPR-XK(I<`-IBS@J1C82 M^)/QKV[\7^I\5L#"(&J?W*W+53%):B2NK)Y\A6B>K4!JRIJ@OSCRW!S5L%_LTPJ)4(^+36HX:J&AX,IH=+JK4QUKG; MBV7\E>H MRMX;OAB:NJJ;*PUV-;*QI/CZZI3Q32SY;WG+.[VZW=AO$:3SSA[B.:54>@KI M59'*1RHC4"E&1PM5=<=8MW5ISCLTKV.Y;#-+!;6S16[P1LZUJNIVB0/)&\BU M+*VM*T9)&!!"LZ=^27^C*2?8N*S.]-D&LJ*2MR6VI]S]D]:[HQ&9S>&%1)EX MMGYNJQ=-4X]:.F:"EFJ,0*66IIC$S*T`!9W;E=KR2.[\"&=<`.$AG5E!RID3 M64I7*ZPV0:4->E&S\W#:E?;X[B>V:4EB@DGMW1V'Q!'*JU=/QE&44TDU`'2Q MC[^?+/BLOA_E5\IJN@<2WP-)V;@YJ:2BR^)QF,#U6:RCY>7+5&*R=.*]R\-/ M3T[ULE+)&?&&9`=CDB1HKGE7:U-?B:W8,""6^%=-`P[#EC1=0-3TN7F7Q9() MX><=Y9=)[![<93Y_=:_WFQ&,DR-5C\G4Y6E^WGV^ST53):>MRDYI:2*GC-+25-46IY#W8 M=AV3<[2Z^HY5L/J5F*$K'1'(4&BGXQ4%:*HU%F(9@H#`.KR,%`52%)JI9\3\\NWJ*GVGE\EWU\A*?.I/@<3 MN;9^3GIJ?;V1-J9[Z.#8]O\(*[K*`24T:`8BOP%M9;7(&*BM`O9W-Q^Y>\)'832\R[I]02 MJR15HCZB[>,'/>J^&$"0Z2[')8594=.N/DI\S^PU]O8[:V+HJ;? M.[*W.8:HQNU9$.*K\?D*W$PP4.0;<&^*`5GV5)2M+&M+40SR)&U+5*K>Y[#R M?M\%O,FPV\DTK?IQA35\$,`V1HC[2SX.L$5H0.G=IYHY_P!WN+F`\TWL$,*` M2RLX(B."NM<'Q)*D+&IX$'-#T-57W?V-O>*?;W7?R]^3&SMV_P`-:;;U;N_= M6ULY1[XDQ\T"\4$HTLBN)@FDE=(1 M"CL056E5`/<#T6&;YK?(ZG;=E!OSMGN!HZ+&YW&G'5V=R>(RFW=RE:#^'O25 ME5C:-HLMCJC(>>FH\I!'!E*"%]`E*3S1"D=[^0AF+JX**VDBD8%-51"3)-FI8(8M0+H!JV1\@.U M\AL##;OW;\D.W2N;S&XZ?%T&U=YXNNQ^"@P)^P?*U-56=>D9VM;-+/":-<=3 M2P5$"B224NZ*'[[8=KAW.:QL^7[(Z`I8R1.&;4=5%`D)`T4(8MD>7GT(MMYE MWB;:;6^O^:=Q4RNRHL4JE5*=NJ1C%I)U<5"BAXD<.GW;ORSWUM3!8^FJOD'W M+OS(1Y""KJP-V;OS.0=:?&?=T<:9%5F10KN?9S-M MEC86:6ENEO;2"3Q$1I8H])8C3((G844J`22F4-,\.@['N^Y[GN#W=PUS>*\? MA22K%-*755),9E13J8,3I4/VN*D+0]'%^,?Q3[J^1.^^H-W]T[1KMG[4Z@\F M2QM=GAX-_96HKJB;*4$6XX:6FHZ#!C:4U7,,)BF0Y*DJYHZNI2D@HJ>"N"/, M?,VQ[#:;O:;+>1W%U>=KZ*F%0,$1DY.L`&5JA"`44L6++('*?)O,',M]L5[S M!8/;[?8U9"^)W).H>(!V)X9)$*9=7TR,%6-4;8TIZ>&E@AI::)(*>GBC@@AC M4+'##$@CBBC4<*D:*``.`![@HDDDL2223GYYZR<55151%`0"@`P`!P`'EUF] MZZWU[W[KW7O>CU[JD_#S0M\]>IJ-*NB>D@ZKW9.:%52')1Y-NR.DRM55M$3+ M-!+%(BQW;19+:?J?-:T)\CY?8.JT^\^E<)VC\\^P:C>>1R)V=A-N[8QV^/W) MF^QXJS9D:T<.O!8_+QUBSU>3AJS4T\M+3".DDGT202;LN^W6T\@;2EBM+QY) MF#GA$8RA$E:Y84TJE*,&:II4&'^8N7K/>O=#>9MQD_Q*..%6C`):?Q#-^B*? M`&'["QD/]V]A]6T>1VYCFH,C-4"HUB6C4/%:1]SO]^YF@2':X%CV MT#4]P^H)H44JJBA,8H&!9?3O8ANH@V?:.5>4;FXGWR667=F)$5I&`\NMF)(= M])59&#%64-YDZ5!'5T?P>W7M+='9WR;AV/AY\%MK:>_=J;+H<=4U#5-6E3@. MF^JGRTV1+QQ5%-E),EDI%J(JA4G\J,Q6Q'N+.<+:XMMKY8:[EUW$L$DA-"/B MN+D+2I.*+44ZG3D"]M;S>>;ULK;P;6&YBB"UK0I:VNJIIQJ2VSN>MW#M.NI9]B[&R/7]-78S(SU%#CJC*9JDFCGJZB&I48^= MDJ/=>Z"7?O>\]+_-CZXZ9BZMZ`&179=)(G;V\.E?O>]SMW*[3SF2FV?U;V=B M.R*W+'%M5I6S5]5D<'B,90TRSTL29&5Y9HO=6TD*&\NEQ\L.JOEEOBFWEN&J MKOCULOJC9S[WW=ELSLJH[+7NK?76.WM@;]I\9UYN29J#'[B\'QH M^.\(U6AZ,ZEB&N^NT>PL`OKU$MJXYN;W]^Z]UWM7_LH?N;_Q&G17_NY[L]^Z M]T.?OW7NJ,MO=]=H;[^4W\R+'0=]U^4Z2V-T9V;1[$VE05FQML[LVKNS9^Q= MAT>?RFS:;*U5%64F'V3G*VN%+G:Z>*CGRV1G^[\,45.[^Z_'F9] MM_R:JU,+C*GHR&?=>U8,!CL'BN_=NU^^I-S=K]=R5NT-N8G;.[\[WU!G>^LS ME:O:T2R[U=`D%++%4/[K4GQMGH2?COE=]XS^6W\H<)N',[JG[NV M5)O+`=GP[Z[*[]V#VI0[HR&Q]G9BI_O'NSN;?9W'UKNGW MTIZ^AGQ\Z323!?=>P6&CHP'\I#+#(_&?=%#1X_\`@F`VQW+NC;&WL!/O6GW] MD<+'C-I;#?=4&2W'39G/I7_Q+L6IS>0HYS53/7XRLI:TR3?<^>7W56KJ.KCU M:-[]UKKWOW7NO>_=>Z__U]_CW[KW7O?NO=54_P`W@+_LL,R.J*XTW MVL=?'40X[LC;&0J`]!/)#!6E8J7B-W`8$CGZ>Y(]KO\`E9)!6@-I,*@Z2*Q2 M#CY<>/4-^]Q4--E;![/J*ZFH-XX#?<76 MF5W)'/@\769*CIBU1L^?&;TW#5TV)Q.5P%9AJV*GAAJ!DQ1.4HEJ8DC\,^;( M-=[N.TQH[VEN%2]CN%@+ MKH4E2"T-)'8*N@AJ*IUZ*!0P%%.9UY\F>Q-X]<[HPN5DJOXGD'I^ONUMHYG" MUU!M;LNGW9!FJ.&IS6S=XXW!28>GS."T0Y:>JQ5!%DJMFKX(I8Y*AHP?NG+> MVV.Z0RVV+8#Q8'5U9X2I%5\2,N#0FJ*&8HA"%JK3H;[7S7NNZ;==6UV29B?` MNHV#+%':781[(_P"?4E;LJ-[J;;5: MR?32T.13OE_*G5V5.+00"UK0QBP^@]"\#Z>XD;XF^WJ>4^!/L'6;WKJW7O?N MO=>]^Z]U[W[KW5,?S5^)O?'<7>%+O/JS$X?!TF!@IY\?NJU5CMP?QPX^2FAR MN,R>&+UGDPRUCO3ES`\55&'5B/(OHR.)`ZLI^$@T%.!'0+;V_]R7474^ZO-.!7PV*M M&Q%>UT>(QNIH"RL,^H.17#F$'0G>O:&R=OT6WJ+&[8WS)-1[2,"TV)IMB;YQ M.%W-B\9%C,M5/2Y':V-CW=)18W[I)I"E*L*M9"?8_P!*\Q\O;5?W%T[2R6]& M$T`S,6>$%" M/U"NHR2#2P(04`.,#(27/+VS27NX;B^XQ1[&P=U@32DVEP?T@Q5(H\C3K:M5 MI4,<$2,!OS>.=KJ2BZ]%$E/)A:;:^T=NG*4]9M?9^(VG5460QR+3YNOR=+05 MV+RU*E549;()41TU9.9ZAM*R("BYV^UM8]>Y1MK#N\CZ2KR,]:_#1B'4813\ M.%K05-;7<[J]E,6SA6@\-$CB#!DC5#5!WU5'4FK.W!M3M45HC#MFCQ^8R$6- MVZF]\S1F2GS&Z-U2YJDQ.0?&Z6J%PFU\)/A_+%C,S9XZG*3^2FFDAIA!#X"G MLR^K>2&!I[HP(2"J)I+*&X:Y'#CX0#I7!%&!-027?0Q)+NLO4RYC9F8Q5/% M0?>3SP5=,'J8T25JP8U*>HKX_&TM`TD\T:*S<3I+;L;RX[==8YE`256[O,&I MS@/7210-0#J]G`\$_P#NOME%4"R02'Q(76BDD`@&M.XQ@!ZBL=6(7ICW#N+" M=AYJDZX[(WGE%SLN>H]S[$SV/RBTV0VCN*"F2=<5_!'E>.?8M-7X^KCCII)( MY\;70^>E,=9).LJB"UFVJ,;CMEG&(U@*S(:GQ1_&7`J)2"#48D!(;MH>F+F[ MMMZG&U[O?OXAEUPNK`?3R5^`@_Z""M-+4,9H(\E@*MK\#NK<^4K=K4>4K*`TF6CQ\T5/]Q'',R2 M%',.Z[/R]%R_;;W62QF229HP`R.P=(H/%C[0Z1HLI4.6375@&IT(>4MGYAYJ MEYENN75\.\BEBA$Q)5XQX;S7!AK MVEO_`#F_=Y;0R.1IZK([=W)W=O#=-!D=#B"**OPN[Z_-453%1R"*HC:5)HTE MIUF6.-U%R"'W"Y*LKU;[;]NA@NT'8T=M%&5(\P\;*PJ*J:$54D>?0GN?:SW% MW"S:QW+A=\_'/HW)=>;_`(&B MRQ[`W;N&E8U%-4+)CMP5W\4IU3[6HJ(H_MWJ&0@:;LI-N?<0O;?EZ_Y8Y=_=>XYN/J)7)J#7Q'+^7I6E>)I4]'Q]A+ MH?=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%3^:6Q-V=@_'3LG; MO7..JJKL?)8)Z/9=3C*B?&96BS+31S48=KNMQ8?NU)*R`@,I6A!!0@AOL(Z!G/^V[ANG*F\6FSQ%MV>*D1!TD- M4$'6,J/4CJE>C^(_S>SF)HJ;?^'Q6\)J+'Y+(4,G8FSL!VQF<'EU!CVDBDD:!7*N\NOS;R5!)(]GJB5G`(@DEMPR^3L M(&C4E22#K5GH0`U!00*O(_N'-;11W\45PP#,#<)#=-&YXJC3Q3.JFBZ=.E,- M45R2P?)3H#??2VWMJ;W[6ZXV-LS*8/L/:>#P>\=H[9QVSY]T[5WIA][XG*8O M?.!V%M7"[4KZ[;&\L5@:C%Y/^$?30\31,&B>9FD0/$TJNH<+1-0%:U"'-/+>Z[!;66Y[]LUM;SQ3Q*)H5 MCB$L1I8JBLJGVSA<_"V>J'AJ/L*C)FFJ)E@*:55;65XNQ[H\EP MMPVV2(P(0!B)M(*L``':.JA::E4$`D9KTDO;`\Q;5'].ULN[PS1D&0E0;<$A MD)-8E9V_2X23/;6(EFV^]^JYD:%4U1G4D06JGPV8?J2-W M%G`!0M0%F8L5;6[@S'8V-GW3FEFVA@<_DQFZZKV_#]UN'LW?F(IH,5F9YJ!' MH\/$,90T*T[9"HDDHL?43IX)*I:^:)R^."#;WBBMV$TT:E5#D^'!"V4TL#74 M:ZM*@%@.XJ4!Z,IGEW*&:>:/Z>T+!G9,RW$X%&8C"X`"ZWJJD@HK:Z=)UJC; ME/D\-4P[1SVRIL92&`;VGS^-W#396+G[R7+88T6UZO<&/H(Z8LT^-2"T0D$( MG\$>I1$+G1*'N8YT)S'1DQ3&EPTB@DFE'J2?0GI%*UJLD+_1S6[1@_K:EE/& MM672C-I^+].@`J,@="?5;\W%MS(9"HJ=H[S=K8R MGI<#AZS)TE7!54.0Q\U%4O%+7)_#TK9:>2*)$JJ3R$LCVNSN?`5+R1;)`?#C M#F-XG:K.%:HT,*5T,&TU#9#TZ.9=WN;)Y)I+.*3<'`,TC1K*D\2T"E@=55(X ML-)8C3C17H!]V=)Y_?5*V\^B,SA=][-W)F-UYK([6S60VO5C#5>0CPSU6V*C M"9',8O"]A8ZBR&$C9I,=-#+11QZH7I*M)OOQ!;[W'MY:RWY&@O840"15<%@I M8Z]0!*,:G)7O)(8L"-(8O-AN;S1N'+$RS6,KR.T,CQ#PW.FD="0)E#**E:!2 M@H`?B5/3'QYBKK'W5D]P M9>HIQNB2J,%"E114:121(JU!TH4&QVEW=WTV\;@I/CDMI*A:(FH`'3I'P@%G M()XDT'1CS#>6=EM5KLMA*!]*`-0)?5*RKJ:KAZ:FKI0$*30+5NC.UOQK[QH? M[R8;JWXVK2;&HZO+8K8T6=ZHZ1WM5YS`[;RE5A\1E-V[[W_USO[>6XEQ&SC442**6.-$BK MX:@5PH/&IZ&4:;:LC)%6WLYO$2,E5DDEN(I)9'EIXC%FIJ:B MA5%.G[H3XL_*@_*;H_?O9W76ZJ;K_9^7QE+7X2ODH:C96`Q\&*W90T4&W.N< M)@<+LK;*'+[D26;^#8^AAO$M3(SS-.73[]S-RJ.6MWV_;-PMVOY(V(903*[L M\3-JE8M(^$--;LZ;IM=TNW0RKJ1F01(@250$@B"QH- M4@)"(%J-5*DGK:7CCCB18XT2-$%D1%5$47^BJH``_P!;WC;QI4U^?67X```5 M0`.N?OW6^O>_=>Z][]U[KWOQZ]U1]#48['_S`>M*NFHWHZI=@5.!JUG,`KA# MF.QNA#3)5RR0QF=/+622(%-XXG4`!F!:4FCD/)&Z(S5!FB(H:\([NM!7R\Z_ MEU!$$D:>XNUD1Z?\7E!)6AJ9;.@+4S6O`5IBO1'>PNQ:O;'STWQLO"[8W#F< M[D:#;6Z-X9&GR";5PNRNKZ?+;ZI),W7YP8O)UU5F=P;DR%#1T,4=-/44U.\] M12M!.TYV[6=M!(\\HB>1@0BQ6Z:PSZ]+$NTCQHJZ30:BFER&7O/_+-ND^JLAB- MAY6MH-G[0W%493.X.',3C<78W9^_YJO/Y3KDIY*F2JGR.9IX MJQ8:6CIYX5:)BFM.59.8-TCEOHPUS)$H5M(TQPQ@*$AA106I0"B(>X=FT\2Q,D@)%!4=$FZVJ\[DLCV'WSNC M0PTTDL M+Q3I4B-XAYO`BMXMOY>M;4)!+4,>PT2&E%U+HD6K$:TD5)!W`IY&.MF,T\VY M\Q7UR6O4:J`ZU)>>NHZ6#J:*I*.C21FJ$,6H5NN_DNR5,F"^0LF2E@?)U7/=T`P,#@//USU.WL(6:VYE>4_K/?LQXBO^+V?=DL<\IW%L> M,QS9#>J3]F;8CA7!R_Z.,Y38,O+@*9VGJLU2@PXJMC2.)JB*8^ZN%JK'TZ:L MWA:/>7\R#@][2_FN;'WUG>X? MB-3[?Q%+VY7[I[9Z-K<&]9OXL)NRCE?.0(WV5+MVIH*J?%TKS05KU#/3^ZIT>3XOTS M47QH^/%&\D$KTO1O4U,\M,TCTTC0;"P$;/3O+:5H7*W4MZBMK\^_=>Z[VK_V M4/W-_P"(TZ*_]W/=GOW7NAS]^Z]UKR;I[/J^F>P_YF.-/0G3N5W7MKICMK=, MV^^K^H5ZP[8W_'NJ?K\5XWEN7*[R[DEI8LGC-Z4_AKU!G,S_`"C\OUELGJ[$]N5V0[%Q?W'5-%7T&PHMS;;Q M'9G7E5O6BVQN;<$_7LNTM\S[/P]?D<;FY\G#5X_<[1UE+61>.FC@]UZ3+GHR MG5FWZ_H/^71W?7]L?$2'8&\J#9^\-U]L=;]@]LX/MZB[KWH-D86#.;YW!V3D M.S>RVO][U#0U6%V?O.?#[3V0%W-%MK)YK<6]^Z]U__]#?X]^Z]U[W[KW56?\` M-JI9JWXV4-)1T9R%?5=J=/T-#0^&"I%545W9>V((H6IJJEKZ:9&F*%M<$H"@ M^D_3W(OMDZ1\P7#N^E!9SU/H!%)_JK4?:.H?]ZD=^5[-4BUNU];*%XU)FCIB MA''UZU^9=A;P[9WOM/XX[*7(8^GVWE-6YMP;:I\K6&CW56I18??$^=+[=RF/ MW+M?;>-<1,:BM2A9X+E1#(FB:X=QLMIVV^YBOQ&TLRT1'*KV#N31W@QNYIP4 MU[:9!KC9)M6Y;YN5ARMMH8Q1-622,.P\1J+)K'AE9$0'S<5HS.0"*6C;*^$^ M+QNPZVFZ>FP?9-;LW^(IU[U=BLQ0[XM^35=%09+<^YM^3XN/:U%MW#9"D MCJ\E)AZ3(TM*:*6CH(IZH&+W&U[SC//?>)N^JV:8`RS,I9DB`8JBQ@ZF9JT& MLJ[`AG(45$QV/M[;6^V/%L9CO%@U"*W1PB23L5#R--\"HM`S^&)%2A1`S$CH M!YD-G':*8D("@%[NW)9U2JDC MM5:LQ4#C4GH+O9V5GSSL4B640W&6\9)G4EP!'8W*JL3R:756TL[Z40%FPM%! M)Q>]ZF)/GCL>F6819&MV;V138P2^JFDJ6S&^&3R0^>%9'UJ%3R:HR6TD`LI] MA;;5U^W]ZQ0F$3QDD8IV1^?0YWU@GNEMBF4"5K:737S[Y?G_`+'5WD`(@A!- MR(HP3:UR$'-AP+^XD;XC]O4^1_V:5XT'^#K+[UU?KWOW7NO>_=>Z][]U[KWO MW7NO>_=>ZJ+_`)BWP?S/=\VR]^]4;?VQ4;[VW79&`KGFMO* MD>DD1(:L"0Q>13I8JM58CY+]I;N/<8=WYJ$):$J884%43SJ^I0TD@HM*J$C( MU1ZG[E-A\E_Y=NQ.Y:BMW1M+*9/9.]ZFDI:6HSF,JHIJ_*4E!-][%BMR)G8, MMB.Q=OU$\2Q/C,_%.P@D>&ER&/A)4A?EOGW<=CC6TN(XY[`-J".#I5C@LFDJ MT3@$D/&U*Y:-ST->;/;';.8))+VU=K;;2H(H-+>$[(0&HQ`TV;]??`/I+9G4>Y.KZO!469AWK3U3;NJ\K3IEX]PUM M;`L<\^Z8JN.!-Y2+I"I+61QFE50<>F.*Q^..;_G3?+W=;;=!&%)41@ M'`C%3H'J!\9_M->:R[M/MSR_MNR7FS/;++%(?1FH5_P!# M\,4`J>[7_E?][[2K\E@.MOJUBDF45-08_-,D,3"(>:.8)^9-YOMSE;LED+!020N*!03DA5`5:@8`-!6G M4\\E]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UU8?[XGWJ@ M]!UJGV_MZ!?O;IG9_=NPLSM3=FW<7N.*;'5D-)0Y6.-J2J:;PS/CJII5=$I* MVHHX6$EA+25$4-5`T533P2QFFT;I<[/?07MK.T3HP.I>(]3CT%:@U!%0P*D@ MD?,&Q6/,&W3V%];+-&RD!6X&OX36O$@4/%6"NM'52-:[!_R\?EGBMQIL#"8/ M;DU-#7C'4_9F:R`HTRFVH\V6EK,UMC"XV#=<.Y4VW!XJ^$BBIJNNJ'TY1X=- M6V1%Q[@^XF_7.^#=8+IXHDJL<2LWAI&34H$8LK*>)UJQ8Y-#2DZ6/M1R]!R^^ MT7,"S74E&>9U4RO*!36TJA9%;T\-DT`Z5J*EJXNS/Y=?R,V'E:^+;F1Q7:.S MHFIX,/'O.H.+S>&Q-%%%1X+%XO-;;VGD-LY88-?N`M96TNVJB>*K<3PLR154 M8]VSW!Y.\L<",2G1)&B@:55TC:-M-#WE89#7NKI5@F*OX??)-J2BFJ]@;?DKC2B''5 M,78^+22;)@8MZ+[W+XF'.[B:CBFQ:LBTV-=*8U'[<1,;66+S=RLDDVC<)5@# M9_2:ND@BBJ2JZC7S;\^D(Y'YME$`DVV!IR*BDZ!=0SDA6:E>*JN:F@R1T/G0 M?\JO?N4R6+JOD3N[$Y'9.,RE/EJ;K7;%+EZ/`25CX]Z7(T^9SF:AQVZ-U8-$ M6*@@PHH^^Z%IHE'+UBR7K*4,\A5FTU&DI&I9(WXDR M:GDK0+I`%!-R[[,W\KQ-S-N"-MZNK"WC#*A.FC*[N%D=."+"`D950S%B6#+/ MY:_RRZ@5G^D/XR1XC;68AIZ*#+[)IJ>/;&S]Q^!T23*UV,VCB8\=MS6)_=>Z][T>!Z]U1GNJ&&E_F+]G,$-1"LOGA%MG>[C:<@6<)2*;:W9VT, MIU(R."TR,A5PRJ=&"10U*G((,O[7:KSW*W&5EF@W.)(U+*PTR1RHX$3JVI-! M:,R,S!3JP'7!`J4GPV'8O4N&W-O[#R]:/OEI]N9KKW>$\77':'7?;6'W)G<& MF>VEG'K9_MJB9IDG- M#+"45RCK2II6C*4JCKE10CHW3D+]\;!:W6X6ILS.=$D4U(9X;A7*!XV[D-2O M:0Y$D;&C-@]5EX?J7Y@O!RY/:L&MS:"C`DZOUKK.0#GC3-*\3U.GL?9 MSV2\T6UW"8[M+Y@RT"Z2+>SJ"%P37B?.G5W/N(>I^Z][]U[H(NA/^9-]=?\` MAM4?^]R>_=>ZKK^5&V\;DOF+UIO"?=F5QF:V<_5%)AMCX?H3$9:OWM'/V7@Z MAWF[YPT%%V!B,5&V6F9L3)7OA(H\=5RU%+-Y3;W6ZD`BN.BW]I9W8>X_YU75 MF`3=79>-WGUY6T-?4[5[`[/PE=T1G7KNE,;3H_7'4-=C8\A@^PGQF_Z>HH&;Q/7F MQ-PYK:&W*S:.W-X;7H-HU!S^8_O"D]9&\E?)CR<[CA72TSPT7OW370.=_P"> MZSV?\9_A%V!W3VU\LNB.I]H]'8S);VWI\=][;_V%U5%!5]1;5H\1B>]]W=;Y M%]W;7Q=/G)8*G#91*2>""2FJ$J9HX97$GNM@%B`./1\?CIE*+.;JR6;QM;/D ML=F/C;\4LK09&JW7/ORIKZ+(4?;572UM1OFJ5*G>D]5!*KOEI%5\BS&H8`R' MW[K1P2.C<^_=>ZH]S&:G[,^3_P#,5Z2[7W+W%7=-U/1F[LU3U&+SO9]1D^N< M3AMH=525$^RMH;=[#?8F)@DR4U5D=HUE#MV'/[AK:7+4\U08Z26.J]UL5J*< M>@XZ@DZWG_E"=@'I[LC?._MJ[E["VS015/\`='=N*S6ZLGN[L[JK$UG3F+Q- M'WUF=QFB[/&33;F2J(-_Q+1U>ZVU0QJ<]#!\(]F;TWG\!_DI MC^N-H[GP6`[6R&_:OXY=7G<6YN@\)M_;6;ZKVAAZ+#]7;RS>\/D5O/JS9^Y] M\TF2RM/6O3*^&KZW30PKGHRG\L#JCL_I;XUU_7W;6QZ[K?< M^)[7[`>EV95#:^0I,5M^IJ,<^&JL5O3:^4R@[,I]P4X.2JMP9$P9:MR=95)5 M0H\/J]U5C4D]6*^_=:Z][]U[KWOW7NO_T=_CW[KW7O?NO=5[?S#,Y@ML["ZR MW%NK'#);9P7=W469RM.*BJI7DDQF_L%4XJ`5%`'KH4ER:QEFB5F`3^E[C;D: M*XN+W=K>T:EQ)83J.'XHG!XXK3A\^HR]S[BVM=OV*ZO$#6T6Y6S$9R5F1E&, MTU`$X\NJ+ODE\@JNMIZ'KCJO;.,ZXVAG:2CW)E-M=<4M)ALGOK*/N%:6E&3K M:VNKLOG8*.2.".GCKDGA$LR()(DJ`XE[EOEQ0[[CND_U-S&VD/,2ZQ@`$D`" MBTXFGD,`TZQ_YOYJ=E@V;9;1+.TF4R%(%",[:B*LQ)9@:<6[0Q`QK'1G>I?E M+2X/JW-]Q;VQF7ZWZXVSB<=L_"46P'J*K<.]-Z/MK*5.*IL)#F0HQ[`2H*1A1($/PD@L7I3HB72O M=&9[:^8_Q\J(,-6X[96&W;V!0X/;=)HK*7`'%]3=G"KBW+FVEISF-Z;VQ]?B MJZ*NJ5>K5Z;)4D*TM(C0*/=ZV"#9^2N8U-PK7KI"S-P9]=Q#0HIU$11T="!1 M22CDDT(C;E_F&?F#G_E67P&3;HYYU114B/3:W-!(QHK2R!HVUM5@5E5=*U'5 MKO?V`R^1^>6V<[CJ7"K3;*ZN[(W)F\SGJN/%46V,)/O?/823<-?EZR-Z&@P5 M-79.`5(:TE398XF4ZI$C+:9X1[>W-LS/XT]Y&JJHJ7811MH"\20`2*<*U/$= M3'S!!.WNA97<5NA6WLIG9G.D(C3.AV) MR.Q>U=GX-*N/-9SJ/*U61_NTV'BA;-R97'5[Y8N[:[BL[B":VN9*%5F727#&BZ3@=Q(45[22.X=238\ZVEU8S;A;3 MV]W8Q&CO;L6\.F6+*:FBJ"[`=P520K=&&Z7[PV#WOMA]T[!R\&1HX)UIZVG5 MP:JBDE4RTCSQ$)-%%74X\L7D2-RMPRJP903;GM5]L]R;2_@*34X'^8_(X-"< MUZ$&Q;_MW,5F+[;9P\-:'Y'_``YXBH&/+H8/9=T=]>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO<>O>_=>Z][]U[KWOW7NO>_=>Z][]U M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO> M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[ MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_ M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_= M>Z][]U[KWOW7NDYNS=>"V3M_);FW'7PX[$XJG>HJ9Y65;A02D,(=D$E1,PLB MW`OR2`"0[!!-=31V]NA:9C@`$_X.DUY>6]A;37=U($@1223\O(5XD^0Z`X?) MK:N5Q8R&S\)E-U,CRTU4D66VCC'F.SND1[)#*GXFU(%4@T(+ M:B#GS74O]+JM+=-6*S^8!U/D7I,OB*^JV7B]>)S%'%25'V=)VQ\:\=_$J2>" M-Z?)XVJK8IX%F@GEBU4[!@KD@2!;U_J5O"@JR"=1J6M*F.\8*0>#`&H%`:'- M<=1+=DCW'V;6C)*;>I1@O`3V*:E('<-0920S"JXZKD^77R!JND?YAW8F,;`S M[OV;DMK]&3;RPR144F3HZJOHLWC]L3[.S%3.(,!N>LJ9ZV2=IX9H:B#'4\#" M-&>:.4.4^6DW[VYVZ6.X$5^ES=B)JFFD,CR>(@R\8`4"E"K.2"ZJ"BP$V8V=N:BSU*T=1CY3[?<)':[Q%)XBB3(9-3#6A4^1!#"C!AQT^ M1ZA^0FU:+N_KZ#;4N;V;1;S_`(M)F,%4;(F;)33;;W320/G:,4>`D2*H@;+2 MMY*97:))1*I'_,_*:V,";IL%T;.^\0)-X9&EA)VC4FK20S?"P04##4>!ZBWE M'G87TXV/FJP7<=M\(M`)0=:&(A^R327':V09#4J=(XCJZ[X*97KO<'8'R(WA MUEBZK%;:WUV!B\XU'42S5D=)GJ'I7HC'[EI8*V9Y9I$7).H/E(:1U9@+<+$/ M.:;A#MG+5EN,FJXMX&48IV&XNRM?MXCY=3W[>3;;=;MS9?;5%HL;BY1^)/?] M)9:P*^AP?7JS/W'_`%+/7O?NO=!%T)_S)OKK_P`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`CKT+ M.BS&ABD4'QO[A:PO;S:=N3<+=X]+0-"N3XD+N(2UPH\NP>$'\M3#TZR'WBRL M-[WJ3:KI):K.LSB@\*>.,S!;9VXFLA\4H*5T*1P/59%5F=[Y[Y"?(W/]*;0V M=@^DLMDJKXT=P]>9:@H:I?2AH9+$-C#R]RS:[[?2R[TD?UMO*KD*$D*R-"TLKE:$"C$?"RFBU M.8D6YW*?FKFV\Y;L8(=@=_H+J!D#%I(T>)9EB@`8:2:J:@LK`%J#%AW\L+9= M7LS9F:Q.+FJ)=GX2@H-LT<]:U*U=DJK;O@V[35E:<7,^*3*0/@*Y*V-?(\$K M+"&$4<>H`^XMZ+W<(YIM(O'JY"@A55ZN`M"W! M%A'^F*FK,8PL8+9/O>_=>Z][]U[KWOW7NO$@`DF MP'))X``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`5N+I]N56[JG)Q4^9_A])MBCI\K52YRMK6Q MBTU'C9(,'6-#)*R+4?;N(M9%O?NO=+1.].GVQ.+SK=C;5AQ69PN\-Q8VJJLI M#1^?"]>TT59ONN:"K\-33)L^FG1LDLJ))17M*JGCW[KW2;J_E)\=Z*+;T\_< M6Q##NNHR%-MZ2GS<%8F3DP^5W!@\R\)H_/HI<+E]J9.GK9WT0T:LCHJC(;4EFAW4U-7M1BBJ<=M>2G< M9*M21J*@TDSRQCW[KW2J7OOIUNQ:GJ3^_P#@D['I)\72S[2F>I@R2U.G8^R]KYF'%T^;J,3G-QXO'9&EPE9#N.>DS-71U%2E128FKCVAE/%4 MR*L,C8^=58M$P'NO9].FG#?('I+<6X<=M3`]I;*S.XLOX!C<7C,[1UL]6]7A MZ?<-!#$U/))#]QE<'4BKHXRPDK*=)7@$BPRE/=>Z9JOY/_'^BR"XF7M7:DV6 MDS<^WJ?%8^JGRF3K,I2T]75524&/QE/5UF0HZ:+'U'DJX$DI(W@E1I`\;J/= M>Z?,9WUU#E][9KKG'[ZQ,N]]O5SXS,[%^172&X<+N? M+Q.9K/OZV7&TE'CL[EJ;;^'EJ\CD:>EQU-+D=Q528V*%Y5F;)!J31]PCQK[K MW7#;7RI^/N\<[C-L;7[.PFAR_:.U::OP>6I\#D,?%6/6 MY`9NHJWQXQ%'0T$-35Y3(TV1C:FJ8:5)I*2I4Q3".0:??NO=9-Q?(WH[:5=D M\;NCLK;>`KL-MFDWCE:?+3U%$]#MZOI9JZAK*@STZ(D]914\DT5+?[MXD9Q$ M5!/OW7NGN'NOJ>7:6Y-^3;_VWB]G;.@2JW?N+/UZ;;QFU:>2CI\BDVY)\^,; M_`HWH*N*8&J$0,4J-^EE)]U[J"_?_24=1E:27M78L53@8WFS<,FX\;&^'@BK M-_T$]1DP\Z_8TU/6=5[D26272D1P=;J(%/(1[KW3%DOE'\>\3DLAAZ_MG:,. M2QM/AJB>D2MDJ7J!N&BVUD\)3XIJ6">/-Y#)XO>.)JH:6B,]2U+D:>;Q^.5& M/NO=#1A_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[HH MO:'RK?K3L-M@MU/O+<2G.;9PL6X\3+"^'T[BVUG-PR9*L:&DJVQM'C),-]FX MF*22SS*47QV8^Z]TCG&>.CS.=J?V((V"?N<#4>/?NO=.&1^8N0QN3Q6,EZ+[`J!DD1FR=#/ M35>+AEKMI5.\\+10SQT?GJJ^OQ$"I+'XD6FJYD@9VD)`]UL"M<]-D'S:JFRN M+Q%=T)V9BJO(93&8BH7(((OX155N=K\'6/F(QCFFQD&-DI$D)J%B:=9;Q*RH M[CW6]/:6KTHMV?+C([4;=9GZ-[$K(]N9[=V%Q5/#%*F7WZFUMQ_W8.1V#C&Q M3#<5,]3_`);5:)5%%B5:IO*1XC[JO4+/_,>IV]M/';EKNE=]TU=58JHKZK:5 M>TU%N:.JI]];HV//CL?C_P"#3G(28IMK/D,B\AIA14-;2/:1IPH]UM1J-*]0 M]W_,S,;3@W)5_P"R_=EY>'!5U+C\;3XVERE5E-ZSY.@W9-A_[E8^BVU6_P`8 MBR&5VF]$96DA@@>IB>614UE?=:Z<:#YDTN4W!N?#4G4^]Z3&XFAR&7V[O+/1 MSX;9^Z,/0;OZPV@^3?+28JHDP,2R]F1UTD=1$T\>.H9IPCK?1[KW2?G^;N1` MK&HOCSVKD5QU7O&/(K2TLLDU#C]FXK!9.HS53##BIO%C,V_=>ZK:_F6X6MW-U9M';BT6>K,3EMSU*9-L11'(4E M)/#0()+IV4/''5:^M[%JUYL5K:!6,4D_=05%-)R1P)4#4H/'30X)ZIX_O9OKKCI[XJ;`[-V3 M557Q2Z/S6S*/NS6#Z[VLLM--_",M3P MT]/EJ>&&LCJ)*:6CJI5%OM^Z[KS9N.S7BCFF]69[:-T$+0`&-G8%T=&E8:N^ M-M16I%`:B#VO=RV;9.2-KWNQ9N2=O>$7K-IX'.5.5VME=\X3=?0VTZG+U^>J>IMFY3L;IN/NC;= M)D\E)/51;"W!OP82MPN-$CPXF5JB*/2K&-(XO-^OM]VJ_NI[<+/'&8[J0*B" M>18YOIVTH%!E2/Q%D<+5P5+>1,N6G+-ARSN^W6=O/KLI)TDLHRSN;:(R6PN4 M5F+'P))?">)":(0P49H*TOFM7;CPGRL[4_BO4=%V1UI38_K7)Y:JK>MZK<&. MQDE?MF''Y/*4N?QN"R&6Q%?M^!J66]+4HVI9)F,!19/H@]P'O(. M(`71HP%*TP#J:H8`@0?@CUGU+EL]OCJC;N]L'G.K>S^O&Q5)T3V+AG.AQ^36?(3/1Y,U&3D5;*512OGS=-X2WL+^\L&3=[2 MXU?5PD:9(V;]0.M#I%2#0=IP:GHR]LMKV&>ZW'9[/=4EV>\M:?1SUUQ2JI$3 M1N--2*,`]`_$:5&.@H[#Z4KNE=S;HQ6!Z2R-)N6NIZG'9'>45-N?IGE<^0-4)),[DPV[>OWW;64ESO<;6\9#*A*1C M4JZ5+`TJR\00*<*U`Z)]TY??ERXO+>TY0,K2`2R%0T@=M!0&B,>(8GBU M`":]60_RD-M9[9]+V[B]W8?(8?<>2[,WAG/X?DIXUK,?C)MB?'S[2CJBK*66>*)%:F=O$S.VH^P+[IW%M>-L]^Z]T$70G_ M`#)OKK_PVJ/_`'N3W[KW1,?D-U7VAN?Y*[3S.W-D[NR6RC5]6U^XJS&;DKZ+ M:>?I,+O.@JLMC+R=%-B\;DY)I,?/3_88'P'[B7()'3^Z]T37?[Y MG'?SA&P.KZS:69>L9=J=D[GZ7V]G-HXW;&SZ+Y4;5S&=Q\ M.-HZO(P;B'6^7P^-J-S9J*;;^/\;T_7.\MO0].[A^0.3V$NX]Q;BI.U=F;G MQE/6XS(K.5QE.M8%C9JNK]UH*2I:HIT9OS;0;Y([!DSN;V_6[AI]K]I^S<=M:@J,;4;CR5?032[;JI:9HLZ=;!@4]U7H M8MI_%'H_Y,_'3XG9KM?`[LK,CM/H'J^FV]5[.[6[2ZNJZ*DK\'UAO)J6JJNJ M-Z;-.8AI-V;!PN3I15-.E)D,93U%.(Y$#>_=>R#4<>C`]=XJEP/=_:&#H9,A M-187J'X]XFCFRV5R>=RLM+CJ_N>CIY,GF\U5U^9S.0>*$&:KJYYZFHD)DED= MV9C[KW1A??NO=:\>/W%7[A_F`_S2NE%R65P.TLQ\< M=UWO7^5-V1%UUVAV)UMMC<7\?JMR=T_*[?.2V+F]NB)]K?WHW/G^Q>D]R=UMRP[OZ,ZHZPV[)N?=V4P=)038&CVQU1N/9(W=O['Y##PQFKW% MN,[@J*KQIDA7_E$0[B7XQ;IK=\56&J^QLMWEV#D>Q7Q>+P M&&KH-U/C]KT[T.[<9LS)5VP:;>N-P]-1T^3&!CI<:U3&6T35!GK:KW532IH* M#JTSW[K77O?NO=>]^Z]U_]/?X]^Z]U[W[KW55W\W"2EC^-F,^]F>"D;M7J-* MF2&&CGJC"_8>WU>&ECR`^S2:J5O$LKD"%W5P0R@B1O;!7;F&X\--3_1ST%2! M7PGH30@T!R0,D"E#PZAWWJT#E:V\1B(_K;>M`"=/BJ&H&Q4@T%?/JK3X-[UV M!E/D)A"Q>WZ[>.*W-D\]38FOJ,CC-OY*O&)CQD<-)2Y+%QYG#RP^ M)9DC6HJ_*8I$X0;`\3W""5I%1E12<%@"U?,D%?4T]*=1%[;[IM<_ M-"2K:L;>.%I?$9@I)"DA0!2JAE8YP:@BM17/WE\C<[OKLC/Y+K_8-+!O3(9& MJFI-ST=++NW.XWQU#X_(U6T\36M5XC#5%342+%%,R4M5/+5IJ$1+7WLW+EO9 M[?;+N>Y$6$:BL=1&&8^3D4+"@)_VI&:=;YDYNN-RW:]?:MIC&X2.0)J:Y%`U M*XB!J$:E`#P+,HP&Z++U)/N"J^473VZMZ=A[>WGNX[][4:OQS[WI=VYO$YV# MHCM67N'FKL6E=3O5I":?(M!/0X]$I]#5$=0D(IWJ2U3E;>+;;[!H++P+ M>C"(QK)_C-OI(+T8H:<5KJ<,X[64=!#8%NYN=-@N=QW))[_ZBYU*9?$='^DN M2RD(2H=:FH-"$TJ156I(A72 MIUZX%JIU"M-(..%=-1Y]3QO5Q;ISS>V,P<++M\CAU+J8VCGDTN"A%&#,"K8( M57`.:=`IM[JS:O9W:,NX^S,UEJ?[[K+>;I/(=Q=T@N0%*2N$901< M-%/##.45XV!-M(3&ZL=:D]7I[)V1MCKW;M!M;:.(I<-AL=%'%#2TL,408Q0P MTRR2^&.-&=:>GCC0!52.&-(T58T1%A^YNI[V>2YN)"TSFI/S.3_.M3YFI-2: M]9`V5C:;;;1V=E"L=N@````&!3RQP_9P``QTK?;'2OKWOW7NO>_=>Z][]U[K M#40154$U-.GD@J(9()HR2`\4R-'(A*D,-2,1P0??NO=53XK^69NC$]:[$ZUB M^6W8%1B_CENKK#W\D+K??\`+4Y;#<5;V M=N.FV[LRB;L3=6^,]\D-^;YRM?B:.B@QN)P&;[0[]H\Y!AZ=/MZ)MFXJ$22' MSS/[JRR,HH.'4_+?R0^FMQ[US.Z-R=R=E9/#[DR>Y,EG]H08[;V.QE=4;PWG MO#<&Y:V&J@A>KH\W7[7W1!M]:U;R1T&,@;2SW'OW5O%?Y=+]?Y3F#WM7[;S/ MR(^0&\^[\[M/$[3V'A,JNQMD]W1\1?C=\4(NY\I+3_'/; M]7MW&=F[QZRV+O/>V9ER6'JL14[_`,/EF3![CZR[?Q353UF*S^W,K0"FKG9J MJEKH=,">ZKK.K7^+H4=_?R]L/NZH[!W#BNY=]8+L#<&[_B_V/L#?.4Q>"WA7 M[![%^*F";`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`E2"./62G^"G3.(V-@]@;3J-S[. MQ%+U5_H2WC7X*?!'<'9_64P&2K9*NNQ>UJ:#[_'FAK*:&2: M.FDA5U$?NO$U))Z8A_+N^/Z8K:&%IIM_T..V+C>OSMV'';PJZ!Z?>O5>+.)Z M][-JY:6&*3);NVK3.S4T-09,-Y')>A<6`]UO4::?+I3Y#X6=?5LLTT6YMU4D MU3U%B.EZBM-+M"ORZ;5P5/NN''56.S.3VQ69'$Y4/N^HDF\$BTL[11AX"NM7 M]U7K/GOA;UGN/&M#D-P[Y7/Y+)]M9#=>[Z6OP4&:W?#WIA\;MSM#%Y6C_N\^ MWJ&ASFW,+0T5,]!14E5C8J&%J>9)/*\ONO=)&G_E^=38;=$&[=H;N[)V9D$P M65V]4TN$R6V9L764FXJ3=^/W3D?LLQM3)K2;AW/C]W%*VNA*2R28^EG`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`1Y'I\QOPZV'B>Q-@]HTNYMUU.[N MOT[)BQ];F8-IYM:Y>V.TF[=WE/4#([:EFQV1JMSS2Q0U./>DEBHI#'=F`<>Z MUU'SWPJZMW;EMO5&\,MNS=6VMF[[W#V#LO8F7DVVVV-N9C=VYZO>6Z*5#2;; MI?6?NGX;]?][-NZEWCN;>5/MW M>0V[5Y+:N)?;$>&BS^T<)D-O[;W#3R9#;.1RIJ<909%V^UDJ7H)ID1I8'"E6 M]UX$KD=-V7^%6Q=R[;W)L/=&\=Z9;K7>V1VID=[=>4`VQM#`;E&S*+"X_"8N M6MV7MW`;DQ.#--MVA^YI*"NIDJ6@]1"R2J_NO`E34<>D%!_+5Z`2JIZJHS': M-4XFRJY,Q[U?#39_%YS`[*V]E\%F*S;M!A\@^-K*7:-5-J@F@JHZSC:N`BVKMO";;@ MJ#508/&TF+IYS1X_'ZZ>CB6""U#BJ:BQM(J1(%$<$,42@650./?NM=/_`+]U M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z+]F_E!TUMW,]G MXC+9W/4]/TSCZ:M[+W3'L/?E7L+:]75QX&HCVW/OZCVW4;0R&\HJ'=%!4S8: MCK*C)T]-4K++"BABONO=)?U\[0[9J=R[IS6=K=W=B;*;&[,ZM[1WS M4X_,]2U^U\9V5-EX]H;.S38O";,K-Z8P5N0FT4:I4^19&CCE>/W7NN&XOF=T M=M//]Q;;W!+V9C\CT1CL!DNPY6Z2[@GQ<$6[LS0[?V=2[7S%-LF;%[\RF[\M MD%BQ=)A)%W'M_.X3*TDD-135=+%(I`8`HRL?=: MZ2,'R5Z>R,.^AM[<.3W?ENN)]STNZ=I[,VAN_=F]X)]F[RKNO]QIB]EX+!5V MYMPKC]WXRIHM=!2U*2O`[1ET4M[]U[I#R_-3HJ#;.T]Z5$O:$&TMV;GR>RVW M%-T9W-'BMF;LPO8"]697;_:-4VQ0O5F2H=^$X^1-P?PX!E:4$PJ9![K9!!H> MIF=^8W1NU*GMFDWC7[^V7-TOLGG^O\`=?9N\QG_`.Z>RL149[<4NV-J[EWMF:7#T5GKZ^GV MSM#%YK<62@QU-JGJ/MJ64PT\;RL`B,P]U[H*-T_+;I#9V\=D[&S.:W2^7WYB M>M\YB:[#]:]C;AVMB\5W!NNIV-U=6;QWC@MK9':VQX]];PI)<=C_`.+5=&9: ME""%`U>_=>Z&3?>]<;U[MFOW7E\5N_-4..:D27';$V3NSL/<\YK*N"CC-!M/ M9.'SNX\BD4DX:5H*600Q!I'*HK,/=>`KCJ'UEV5L_M_8V`[&V%D*O)[5W)%6 M28ZIR&&S.W_=>Z0/9W6NT^W-E9O86]<;%E=OYZDFI*RFE5'&BH@FI9; M"161DFIJB2*5""LL,CQL"K$>U=A?76VW<%[92E+B-@P(]0:C\P0"/0@$9'1= MNNUV6]6%SMNX0A[252K`^8(H?VC!]02.J+^^/C1B]N[HR%+NW>>7[=V-TYF) M<_!M3LWL[>U735^;K-N[>S\J[FV?MCIR#=?;.U\!B_M9#!F^S)XZ>,"&MJ85 MJ=$LO;'S-(UJ7L[2&TW&[3PS+##&"$#,ITR/<&.!V(/]G:*S"I`-.L?>9.48 M8;UCN%]->[=82:Q'<3RLI-$DH\26OB7*1C00LMZ54T5G3603`;9[.W#F.W.N M-K;B_CCYO<6Y,9F=R9K(UM!14^=R.QNYNC,,,!2[-HMBU>XIJ6&AAD MD3'U`JFDEJ:B:2JE#ESM<:;/NE[;M'X,2!`H7(\6&Y.HL1R[NQ"AC#LHJ*2(V#U+NS.:P_ES/VS#\ MW=]Y?K?/;NQ;4^+ZFAGI,%N[PP9JK_N/EZP05>S,H\&)6BJL?#)1U]L+O+:N3WKL:@[=Z[ MDW[7#!U)I,9C*V+)9-\O195,=78BEK9IYL#4/6RQRS2%=+*+*S^R+E';[ZXM M);6ZM(+B2UG\(!CW$$+0@D-BK"GR->A)SWN>VP7T-[97=S;+>6WC$H1H!#-4 M$`KFB&M3@C)\^C%_REJVEKI>RGI_=>Z*1W+O7LC`_)S')3;7V'O7I?'P=88?LC,[I++D^LJOL+>N% MH=I0XRD%)4Y++?Q?=FW**LA2@BGBBKO!+6-"D*2)[JPTT:ISY=)+>NP,U6_. M7&;Y@[I^/V/BQG8/7,ZIEMR^+Y`[/P-%UA5;>RGQUP&S?X=+C*[9O:V5WQ%N M*HK)\E2U0JDQLR^ZKU6CNOW]PX2EW1U)#L_O/LNAVE2[9V-CZN&`1E\SU8#_$M\;5^5VR,UM[?G5U#@]U]?=5[%W/UUG:%YNX] MV8',;3Q4L-7UO'!5+CJOJ_:.3H9*VKJ-&F@J:C+NI74%G]U3JP+XTL'^.70# MA:5`_2G5;!*+[/[-0VQ<$0*3^'?[C_M@#^WX/V=-M'IM[]U[K!M7_LH?N;_Q M&G17_NY[L]^Z]T.?OW7NM=R'.`ZBC[+WIBL MOU16[@P7771M-D=KYWKG=FWMM5-;E\&M=0>3S;AJ<)245=++34E4AR*4_NK: MJE:\!T*_4?1W:W6O\KWM?:79_5'978W8\?94W:^+Z\^/6&^.>PNS]V9S`]A; M`WYMJIV;M';N>WY\=]MU-#NC;*U#T:R5--D,;1O/+1_>5CTI]ULM1]2]1/B? ME3V1\$/GKV)W-MRNQFX.R>PNZ9>Y-@]T8)-S;FPXV;UIM#K`4?:FTMZ;#^%6 MU\C4;AV)L>@R?VB4^WJ*IQ]=`9ZV20RDTQT:;^4]M#*["^*;;1ST M57BL_B.S][ON'9E12XNCINO-QYES<1#0]S=[9#^"4F=R]15TS9+.)7 M/'6:OM*:G-.K>ZJQ!8D=68^_=5Z][]U[KWOW7NO_U-_CW[KW7O?NO=5Y%]LI?!WZ\E+E5%C<`FE:`Q.":?(5XXI6O40^\T?C!)`I\Z4S3JC[Y#8C&?';KG8N_.O:&HVK5R9/+1[YI\1739F"2GP>7 M.0QM,697YFW&^L-RG\50BE"VE3W M@@G4``3K`TU`H":M@:L>.;+6'E#:]MO]KMW@9F990AU$"-Q0,*N!J0D]K-6@ M[#;R=4F4MHRJL2L\,C:%(`U'0&8&34P&E: MJ(WQDZQI-G?)OI'<#]B[.W3O29>R,/7?W4Q^=IZ^#!T/Q[["R6W:'<4V3QM/ M@*FIQ\>>26'(05E56Y^5*BJF:98'G!7S/NL]_P`J[_;?NRX@M%$#?J:-.HWD M53&`2ZJ62F@@"*H7&K3T;\G['#MG./+MPN[V]Q=5G1O#5]0`L9"HD:@CU:2" M'#,\IU'(R+S/EAOEL%\B]P]=;>VQN3%1J5F49%'-/,D=\CR1[G-=3WMI$;N,C2U!7M1,J.(JC1JQXDHM>``L1]@O MJ3NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z] M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7 MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][ M]U[KWOW7NO>_=>Z][]U[HBVZOAOFZ"W( M?`;M2HVOLRCQGR@QV"WYC?D/O'Y*;R[%Q_1&+_B=5V!N[<.)R,TO55+)V*U5 MU=2Q[7I7:F\/DW4=A=XXO( M]7_(_&]6XF386WNJJG;&Y-H4/4FZZ#<&W(D[&@[-KJG-/7XW[^BKI8\;CYV: MKCJ*=Z9Z<)+[JQ-0!3AT_ M-W]<=@;JZ[SGR`P>W*7\]U9E>N\MV#AL7!B.RN:W(_Z7*SM2IWEUCM1NZWI.I]]9*:J6"KRZV6%00*=/>QOY=^V-MTWQ6DW!V-E M&""1T17:W\O MOM/`Q]04F7^6%;O2DVAM[H3`=L5NZ>HZ?(;H[2B^.GR$W7\A.OVV[N%^QB.M M*5,KNC^#3P/39X?PBC@2)HG4N?=>)!)(%!T;#Y7=`5_R4ZH7K;';QQFRZB/> MNQ=X-6Y_9\W8&ULS#LS?%'X:F#^)4XL0QU:=)]U MKH1^F>NTZFZMV/UQ&FSD&T,%38A_]'VQXNMMF/-$TDL\^W]BPYO5 MI/MSD*QM;,S2NS$^_=>Z$WW[KW7O?NO=>]^Z]T47Y"=7[*JRLR MN.2::HRV5I\5E4VHL>\<#C\CC(JG^$U8?=VT<-(5EA(G^U6)M2.Z.(=FO[F) M9;97_P`7(I32"0'K&Y4T)!\.23AP)U>5>@=S+MMAJ@OVA_QC6*G4P4^'25`P MKI*^+''4$4--/GT07I'>^/RW:6UNG]S5.2?M?8V>Q78$5;D]L3C'YWK+>O>F MT,_B-Q;:W3)]O]U!/C,G@,?EJ80S(,Y!*WECDI)8R--\VV:+:[O>+7PQL\J> M$560$I-%;NC(\0R,K*\;XJAP*/7J.^7=T@EWBTV"\24[W`XF#-$0KV\ES&Z- M'*<'#0I*@U?J`DD%2O51_P`]^MV+W%GY'2@H\ M#!V3B(,KO'MK/;N@D?&9VGSM#N"J_N!M'.Y*24-00Y!(L9GU:F%1/!G#54)J M=IV7>_%^@N8X9*%F\`D16R)\:Z"%\205!#%>^/431HM+D$F\ MY\_VYKU,_M!9KM\^^VJJP'UP^G,!NC=-30X3_`$;]DP8? M:%=FMK39BJEH<;#FU!Y:169U;^'">I>55]U[JMOMO8/V' M\[3KS=F]=GY3:^W=Y9C:7 MK7Y.T=;V+_HM[#PVPZKY:T6-RV>S'6&T.SY]BQ]/[C[(JL--NS)9Y:?+R9.' M*4C4Y66JDJ8H_=5IVEJ]68[2AIWZSVI4&*)I8^O<3'%.8T,L<,^WZ%I8XY"@ M9(Y3"A8"P8J+C@>_=5Z1OQ=:)OC/\=VA96A;HSJ5HF4H5:([!P!C93''#&5* M6MI11_0#Z>_=>ZY;5_[*'[F_\1IT5_[N>[/?NO=#G[]U[J@2HZFZUWC\G/YF M?9NXMZ=+]K8[.]&]D1X?:&VM[]*]_P"X-LT6W.N]D;:R=9N?H?,XO^*TFXL# MG]N5=+34.0K(\6C324]1(SY*1:?W5^)0::?Y>D?TAD\]M'^33NW-50AZ;SF) M[1V5D]GR[?J=K9+:V+SW^FSJ2IV0]/V#OK,]2[:WELK7W7G`#$#ATKO@-GL53_RTOD#V'V76[@^4^RL[_#I6GAGG@O[K MQ.M@.'5AW\OOMDH.V:FAW`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`U(]"G7VGJP3X(=7Y/:FS?[S[FR%/G-W9>FRV3W5G MZ+^'G&9?>78FY*GL#=U;B/L#44\6-DCJ<6$B@J):>(J8%-X#[CSG/=(KV_\` M!M8?#M(J(BFM1'$HC0-7)8T_=>Z][]U[KWOW7NO'Z>_'ACCU[[>@\4IZ#KA M'V'NN\*-44Q"2205$DE%$A;QZHQ-Z8]"MP"_"KK86`],;^^FB_A_F>O"_N36 MCCCZ#KK_`$E;EDJ($CD5#*LP:%L=^MC%J22`&G%0(4>(J&D4!F9A8NOB79M( M@*D8^WK?[QFU!=7\NLX[!W1*GDBGIU0!@6>BC5&=Y`87C5EUM3E8WN59SI#$ M$V+1^^FA!(*Y^WK?UURRU1A6A\A\J?Y>L2]C;D=Y84KZ`20EO*LM)3I($4DF M9")M!BM*J@VLS*`&*MY3KZ6.@.@T/SZU]?<=WZJU'R'Y=81V+NM0ZS5=.IB" MB\>/B\LAB0+*7B9+7>29";%54V!9!I,F_I83P4_MZT+Z[I5I%I\A_J_EUC3L M_<,A@CAJ#4&7@R1XRF.EW+4ME)>*.7[>:,L_Z?4Q'!`B/C:1`9&?MZ]]?5#FX2IMH M:D!<_;U<7\Y4'6/V=1&[$WHL>II:.YTM$4I8.5,J3N\Z1K5`+]NK!41M1C-] M7!E2WTT!X`_MZ:^NOE4LS*1]F?\`5_J^0S/V7N2"2.&6JI?,\;2")J*%2R1H M$+^/5'*WKF1W"@Z05N54JTGOI8BI-#^WJS7]VI`J#7[/]7^S0<2.HY[+W?(1 M&)*6GD>GC=3]DNCRR`QI$DT\83674G]+&Y&I$)6.30M8O3'V]:_>%T6TB@-/ M3S\_Y=26['W143F&FJZ$+%&[RRP44=2'87M:56EBAC=UTK<,_JN5)!0;-I$! M4J?V]6;<+EB?#9*#Y5ZX)V!O*2.J8U=&SQ%2IIJ***!%EEU@6E@KV9888R.' M9F4W(!-TK]-$/PGK0O[HUH02..*?ZO\`)Y]=-VAN<0G0U)(=#LM0M)&8[1Z4 MD,C^5:="COJY9/TD'2G[A]]-#QH?LZV-QN"O$!OR/7*B['W2["*6KI&:1FAC M,M)2`B8:J90YBDBBXJ!) MQ-V9N]G$D38XTS747A1)6D$H@D$2E9+"GDX(8F4V-HB]HVV;.$#-0W5/WESAP@6GD#,=3`DV1SQ% M8V45%[2/S_U#]G6_K[PLP5EJ.((^6*>?[>I"=E[OE:C=9,/`\.O579VXQ%(L593) M5#6SZ<6DU+2+#(8I3/*T\<8T?J`,@+6L='U;?TD(-&'\^K2;A<#20V"<]HQ^ M?^7KA)V#N^,,7RE+&D=.L9E>AI!&\S%8HGNT*R?>/+($*:$4RVTQC_--KZ:$ M\$/'US_FI_/UZTU_=*V7%*>@I^?G7^1\NLDG9.Z)(IGI:ND'4R#4&*@L%=AXAXVL0H-.:>IZT-RG*LX?M'R'7?\`I-W(@D66 MJHBS24PC9:*%`@:.25R`T\EHG5=1+7]"^AF&J1=_20]IH:4SGIWZ^X"MD:OL MZQU/8^\H%0?<8_7%&\,X;'H6-2GD'FR-UA9"?L(=,8"O54;A%F2T=0"RM"TP1OTG1&ID( M4Z;@'7TL/D2>M#<;SS``'[?F>`%/V?.G6$]C[ME2:>.:ACC1'M$M"BRZ'TZ9 MU^ZD7]V%_3H(*MJ)!+*8A[Z:$%>T\?7KPW"Z9692.'"E#G-?D?D<=8U0BCBC@:5F0'[8S-([HA"B,L#&"59SZE\;6`<6-.O?O"]*@J% MJ?7_`"]8&[-W5"IFEEHC&L$TH"4<,B,0HFAD=C4TX\+)*NH*ZB-`2TI4&7W8 M641H!7C_`,7UX[E2.DFQGE`DDBDJZ7Q MTQB6`W)8R0++XRNNPD4%W52R`@MH6D(!8U(ZV=PNR2%T@CU]/+AUD'9VYR(V M`QTJF!6"2-@R6-AR?4-'O7TD`R=7\NK-N%W10OAU\\' MKJ#LS=@Q`*)+@:KLQ*)[Z6$@$$]5%_ M>"M0I'D1_LYZZ?LS=:7;QT:QK$9FDDQ\BQJW^<2F:5)WC$[Q%G"*7+1QDAK7 MD]^%I`:48UZT=QO0115I\Q_F_P`'GY=8&[5W.L"/(F-A,DIT_MH]2OCC2::& M6&*HJ%#K"P8!0QE@G"FHM(>&HUZU^\;PT*A:?S_`,W6 M"3MCDHH6BET?Y!Y9)R\C>%X3JG!J(PI0Q1I.YM=D5]4:W%E&!ZG[>' M6FW*Y#9(51\JU^?[/\OSZ[7MO=#K$4&.8NE5(K"@G:FG];-30I44\]4!*4*` M",3.R:B%8JS1^-C$,U;^73?[WN>!"_D#^7^KCUW3]M;E=5:I?&)>0JWBI$NB MZ`5(C^^G,I\C`,$9F`920L=IGT;&,5R>K)NER_\`"#Y_ZC7[>/`@\"">23%$RU;TWC-,MF=24,0D@JIVU`Q-8*K MN6X8(UH?=?HH^-32G5CN-V"HHF6I_FI]OS^76=^T]U@HY&)1'=U$7VK)( M:8PXK*HAQHL0J3.;-9=6I8_"SB(KGKS;C=%]*A:?S_S?YZ&G`TQ)VKNIXFD* MT2K^\T3?9%_N!$!,/$D$U02AA-C;6]@6`*^L;^CB!TFI/5!N=TP)!4$<13CZ M4IG/YU\NL/\`I3WBJ!G-`H_;;NK2LH@A\DU*&FDCD1N/(UN"L=T>3WT4 M5>#?M'51NMV0VD(2,X!X?Y?+^7J.LQ[5W4$15.,=Y6B56%&0RR%O"]*XDJHD M22-I"2?VM7[26:S@U4`-/]7KU4;I=Z`W;QID? MYO\`5Y<2!URINU=VL^J2+'M":9)U\M!/3.&+W0,6E\213@E06=7&GA6];1U- ME%04)&?6O^#JZ[E=`DN%*4KP(/VY\OM^?6.L[:W-3"92^/$JL(T"T"F*,AD4 M^>2;(00J[>34%>2)F6UAI_=;8L8\'-.M-NEP*TIDXX?G7[//S&*TZYMV=O%F MJ8A/B(Y(Y24!HK,*9T186(FJHP);L2PD$1UE0%TZ3)Y;.`T)#4^WKQW*]UE: M1U\N/#_5_P`6.([7MC<[/2E&Q!CGDJ4G#4=5_D@IM4<@+*X82+/$(],HC.N0 M@@N%A]Z-E#4_%^T=67<;PY(337T/E_J\^N=1VONJ/6T<6(*JD+A9:2:.T6II M)ZN64UC!*BB)01=F*(5`(9E)<>%C$:Y;C\NM-NERI M!(0+I^?$]=3]L;CC]6BCC$LL=/"DF/GU*00)*B19):[4SK&LD22 M/&)`7(34S11ZF_U02.39L8_4]>7%C%6G=_+_`%?ZOSZ;DW:Z%2/#`&#Q M.?\`-_L\2I4SAVKGF@9BN-#1BSR?;NBN+(WW$0^YF00R:^"[*@52=1%W6OT4 M=::C_J]>G!NL_A:V45X0_PQWB'@\7V,ZD3P0DSRU,[U$%(F MLN)%&N.)D`TR&,^4[^ACX5/K_L=:&ZW"K60*"0:?EQ)/\_D,\.NV[3W22`C8 MH@Z(7!HI/+"0X62JT&J!<,`VEG6*'D$L+!9/?10^K?RZV-QOCY1TKZ$?\7]H MQUFG[8W$LRQQP8V/U2%1/3SHDJ(1=EF220Z%8".^@`F0$'7:$[%@A&I22/\` M5_J_;Z'KTNZRHP4@`_/_`%.OT_=>Z][]U[KWOW7NO>_=>Z*E\R=J9S=_2V M6Q.!R,^*J:FKBH)\A1S>"NHHLO3U6+HZS&S"&H$.2I\W549@=E*(_J/T'L_Y M;N8K7=(I9D#(,T/`T()!^174#3/00YVL;B_V.>&VE9)":57B`RL`1@\&*G@: M4Z(!T3G.Z^R?D'MFM[9^/-/U3-L&BS6"H]^Q[ZJ]R;:WYD,[VUTSO.;^#[)G M$-;L&3+TN&J\U1^9!]R:AEM:F:*$:[U!L>W[!=Q;5S`+KZEXW\(Q%9(@L5Q' M0R<)`NI4-"=-`>)-8WY>4SRX39/> MFS=]5B1XW$[IW=D5IL343RU6,K-H;9IEIIICD620[N(=ANQ#+O%A+:W:$4"A MI)$%"P$$>@]')O]B9HMFW2&YLW%""RQI(03K\6*9B MNF69@8I.X200+WDR:>C5],]G[$VU6T&)JJ_`QYC=%<<9,.I.L,=CL.J1QXN+ M'SUE5%3;0S&XLEA(YJ7S/!24M,M11LM*E7/)]S[">\[)?W$V4**G2!7L9R@*^(0% M34,!C4K<#\`Y,+-VGWA)M_.Q[EQ;=D]L>+-0J8X*N4;2^*0G2&!IIWI8:-_V M%B+$H([?XF*^>O%_=>PB>`QR"VA[3QIXM[0UP#4>@'V=3A[;B`;WS&]O<>+# M]5/W#A7P=NJ`,\*4R3]O5LON,^IFZ][]U[H(NA/^9-]=?^&U1_[W)[]U[HC7 MR1R*8WY/[9QM7O.EV]0;DR'Q]:7J&NHFDQ7R'J*?LO(4]+D\EO":LCIM@U74 MM3%'74L$7@._R6[$V?LK;/>F-P MWQMZN[AJMI=G9_,;YW/UIWGU'T[W'G\M6[BSU?E(<7L;%QV5^,G<-%2MO\` M6LJ.BL!62;*Z%CW?FJ79M5@334-7BEGQT_9M?7U-;0[AI)<,N+A3[3+J?=6U M&JD\!UFZ>IMV[$_E@]AX@]C]+;PV[@^Q.FWZBW#UIC=[=Y'>>XJWLKJC*4'3 M^^.M9NN?C;4YMNSMRU./P6/H*<4$,V%W%"M14100_Z\Q#,2.'0W?'/6)6@GC'NM@$,O0D_P`G,10_$*JQ\/W$<6)[ MF[/Q<=-D=Y8+M'/0PTE;CEI:K_=:?XFZM6]^ZKU[W[KW7O?NO=?_6W^/?NO=>]^Z]U63_`#0(JJ7JCK7[ M&D3(UT7??2%934%1'%4T,G\/[.VO7S55;0RPU2U=/C8J4SNIAD'C1ENA8-[D M'V[9/WGNJR.4C.VW0U#B"87``/J3@?/J*/=K4-JV-HU#2C<[0A3P-+B,DD>8 M49/RZI_^2D/5^V*#;V1S6,ZZZMS.^QN'<2;G3:62WI]AMW!QU<^[=RS;;K*S M/X&E79U%++`]1-3N\$-+&B0F..J=90Y6?=;N6Y@A-U=6\12-D$B1U9C6.,L% M5CXA()6N26.H$BL(&-0U4X!!I8` ME214^UNVZ;)T(R=9A)\=V5 MO1JJ9\ACK8ZBH*5V:G:*DB4>/=[.UO)!?[<;&2M%FTLH1@H37!/&0'K%'3!T MNS/4$U)CA++?([B!MIW-;]PH+0!Q(64MJ9;B"124`GE).I#HC1&#`Z5"G^/^ ML*:DV)3[,W54YGLDU#P564;`;EQ5#TIWGN,M-LS(M<6L=#(C+J5%5 M80Q0^(\?B@T<$F7*MQ;?UQV`+MOTU\7G)(8Z746MXY_3=6,;M([W!0.NA)A$ M:M'0;D.ZNH>LM_4%;0[QV1M[/4N6#C*QU>/B0Y16EBE,>4DIO!+D8O+3QOHF M9U#QHP&I01B79[GN%F\VA^&F,5X?E]G#K.:YV?:]Q@:.]L8Y%<= MU1\7#XJ4KG(KP.>/2RV_M_"[5PV-V[MW&4>'P>(I(J'&8R@A6"EHZ6$62**- M?ZDEF8W9V)9B6))3RS2SRR33R%Y6-23DDG_5@>72ZVMK>SMXK6UB$=O&M%4< M`/\`5Q/$G)Z>?;?3_7O?NO=>]^Z]U[W[KW7O?NO=%QWBLB[GRUD\3ZS402+3 M-IT?8A7E9@JHS:Q<%HV+'Z,XU)[-+?\`L4-:]!Z]/^,R]I!_EPXUZJ=^1B=G M;1W?\H-V=<=A=[FHVM\:.M>QNM]OR]@;MDV/C^Q][=I=I[:W"N)VVV'W#ADI MOX!MK&!:&..NAQ<423I3JSEO=F0C51C6G[>K0!";=F"A2 MWOD[M[N/M:@RF2R/4E!A*.GEH(^NX]Q]^[6VU0S_`!=[YW&V[6I(NN-O9C/& MCW[@\?7UE+38J:2&3'T\R?>.5B:Y9W[4%&)QZ$FN/\GY]5A2`(K,*D?%Z@!@ M":?ZN'2TV'VQVEF/BY\D]Q;8W#NS-[OZ[S]#2;5W3MW<@[_PE/A:K;FQZW?6 M;Z:W]N'KKK_!ZZRV[-W8^GW(L=;5)-2U$,.?>;'1U$* M0?8PTSV8H>)K_J\STXJC]6L::M(H`*^8XYX@=2<9NGN2L[*AR>*WIVKD.I=P M_*[J7HR/=.-[FW+NK%0=4]@?'#KNKJ3MO:$VWZ!^,]G?G7B7R&2WCN;=>8HZ'K#-]L[?Z<3'FNH-R3;4@BI<5 MCIH:J"&62KGBAK&6HD4$;[]*YI4^?^H=6A$#S2*P"J`AP/7B>/#Y?+I1?)?= M/?/2F9V7MY]W[ZVEB&%A+_+[XK[.,M5\A M-.HG8/?6_-I?Z,\GM'M3.[FV>VRY.VZO#UU/UIV?N; MI_*[1^3^YEVS%%15'7N;CVT^!\D53!4EJN.H@\["BA#WC_5CU/5D`J7EB&ER M1GRX8('PBG`YSQZ-7\A<3NS"=T+6;:W_`-W8K'3_`!A^3.^I=M;2WMN2/9C= M@=;Q=1X[K:VV*-:G'35CTV* MLC2F21W@EJ*CR1-#*[Q>(JCHWH$10DD6"?^`X) M!ZAIY5=XRCU44<2/#$\<<2BG!4/33S*LJRNX2\IUN7TD*I`TQ[)JM*YKUL"H M)8U!_+KG*DDH$(B]#0)(KE'G7]<=2-!=9@\SA?Z^I4N+@>5:^1/^K_4.O,`2 MJ4%..?*G^?\`U>HBG72H&I0B/:I_,QQD,I&A+^)]<#4<`>G*,P`IW4J?EZ_G\NN+TR00E*"E+SS/'').R"4PP,/ M$R+=E2"%_!HX736`*B6VN.VD?Q]49G!4)'4#T_U4_P!GU(5AG:69HZ>F(AC` M:2;]MI$TERDY#7,!)8QW9BT():Y^@F]T^%C]G3@)[,-7=2$5Z6(F&>4'^K]O^HU MR+%53+-&&2%))'7]T:HX="?;K-2(D"Q3Z'.D!54,'9;&PA]Z-,9KU4H>ZGG_ M`*O]7^8"F.]-3R1@EZCPB1WD$:QO(YC996J#$)VB5P@_&I@HL9%XCLS$X(ZT M@"+HH:4R3_A/^KTXU-.*DU$0:G:,RRH:^F9Y/4:68I.&4A#:4QMJC]4;2,!J MD)O.M!7\AU8N*`@U)%1_DZRJ$C8W=%2$1I%530Z&U!P9)[.\>@+Y0PLL;+>^ MI39WMQJ0<^G5J]Q%,5X]8(F$K"&FHY*@H1W"M/\`5_JQGSH)JO2RRQRDH*AX?#%30S-4 M12@J%`:)YY(T=(T!;4I9ET*"R@QK4E@H'X:]7`%0:4-*?ZO]7R\AUP6,1ZWF M5"T:R>5&0O&Q,YDF^X1FGB6*1/UW+73GR.H\JZX\>'6U&FF>`_RUZCU7E,E9 M$@6.(3QLLC1E5E1)"6C\GVJ7A6`&0DD@+R7C)%07`PTC.>M:B7DJE!6H_P!7 M^K-?0$Y4CIYJB$^0!U1YC+#:(ZHE5)4B:>>GIBB1F,*42ZZ[71B%DJ,*1_JI MZ]>*Z@!6C9/^Q\P,=8!(9$T0)I+J\>A47ROJB\8A#-%4:T\2JFN-)"H)4*+& M%?4`H/\`5_D_U?MZU0NH/`_ZO/\`U'U^?5+4)5AY7ABBF:`P2I)$3/)-#Y4@ M5:A?N2SPQ1*3=91=2&\@%UVXTT7B.(]!_P`7Y?D<<.JQ.KT[`)*4.,FGS^7F M*?*IXF5.(RLODCCE2I\=9-$R>B>59"ZQ``$R!(V:2QX)]5Q?S>]4K]HQTXU= M)'E@_P`_\W4=>K$X(4XIBGKZ=<'5XZN&*-(Y'0QQHZ/X8YD*2M&'4^N2F$$2J"JS M`D$"*RZ(]KGN_EUI^S2-`R?R'^$_LZSJ]+!*!2O$M1-HC\]HS#+')($\3NKR M1J\$;B[>O]K4QX42I4:AD@T'6R=)&D@.?YC_`%?YNN%11J0GF"U"I!XY)?54 M:3!4">%6FF21O,C.D@<,QL`RZ?\`.OM375CKU*$&@';3!I^P\//B:?MZA`-C MUD=0D\E/5:9O$LH"ZHHTN5\"R.84FUR@!5U\+&A;0VS1B%R,=-*K1!B#4UX` MT'Y_,>8Q\@#4'+)36ECF1E9HYYP8WD<0K:3T-$HK.!%"#'I17X]"PJ;TXW4@ M4*_GUXH6*$-4?*OG\C_J\L"E(LE1(8S)"SU$4D=4:B27RRNY%C%`M7.)XS4^ M1P2I64.$(2-P#XO$:NTX/51^G1T:HK0^G^H>OGQ)XGIPL2L:S0,B%JEEIU8K M"LLTU(S"&)5,21SHHD9'/K*ZR+'S&ND5'?\`+]G3RX5ZK1:D_M_U?GU&BECJ MVD(1(EB>&CJ:EHUD5HE0$01RZ:=5DCDD'`TF.0\(FL&;;*0*5K_J_P!7^KA1 M:!F=35CY#_+_`*AC-,FO`LM'&LLL%552P2I%(L+>(0PN[LB5DZRQ$(Y98_&F M@L[:$A%_MS>N=./\_P#J_9U73I`?)<>5/\)_R"I^1X=>6&2JAX6-IJB"=!,: M7Q24J$Q+'`L9HFI:AYZ6,AB`S/XA>"128XO`Y/H/Y];D0NJXR?EPSPID5/Y^ MF1UGUQF2.:`U<\0@F-O)XQ4*TLCHLD3@(^I8W-Q+&KBS$,`DD5,Z&\CU8@`^ M)EA0GUK_`*O]G/7>0IHI9(XF5RX-'I'I1(RDOW%,VIY(6BTAU98V>)B1J!Y# M2;C)(IY"O3<_!_`C2TYEB M4UM)`,*ZUU.%ZJ(R>+T_P"+!^7^>F<9'6&B M*1KHD:%QJFA\1"+*B5LDDJS3*]EU3Z;_`.94-HN3(`'CVW>G"/3,)&*>)(XY1(CS5,49:IAM<:HM+DE9"2*AM% M_,#'3?A:Q0FI'YU\^-VEP6(F\*FK`=:>H500Q`/'CCU\J`+49 M1Q-'[@1CR_U#K9<58$"M>!_PG_5\J^?6&6GF$E0JZD=:M6UV*0G2U1+'=C3T M_+)9F%E-['S@D3/X''SZ:96UM2M#CY#Y\.'^3.36N:E>-0D<4,H21IT\Y%F# M4I\;2K"[I42";[G@JG&HJS(S".31I75J\NGDP%4?/_B_SZ\T<=DIZ>,22B.5 M('J)R*/1(MB'01S(`OZ2R12V4!0>6A'A3S%!U[00LF:L?7_5_JX`4QU&FEDB M+S*L&GGEO"-:2QN5M=))SI6[2V!:+P%%R?/IIV*'2H-*8 M\JG_`&.`-?\`;`]25F#5*R1Z*F6*=H`9U80-,OJO^TR&7Q1>OU&0#2&9T_S_ M`+V8POD"2N]^Z]U[W[KW7O?NO=1*ZAI,G15>.KX(ZJBKJ::DJZ>4$QST]1& MT4T3V(;2\;$<$$?CWM696#*:,.JNBR(R.*J10]!#L_X_]8[(R55E\)AZLY&K MR=-F)JROS&4KZF3(49!I9IYZBK:6M%+8>%:@S+"/\V%NVI=<;G>7*JDLM5`I MP'G_`(*^=./GT3VFP;992-);P$.7#Y)/'EUJG_,2+K:J^3_;=/N. MD[%SVY)9]CPU.!V<,#AS/AZ'JG"+1T&-S]=39W(56=JZ;,5M9@XA011IO2CP MH2H6<1^\I.4VW4L+^=# MM?\`6[?_`*E+F6[+Q!DB,:DA;<:0&8,VO2S/"0E!=+"`2^D$+L%C>V=T4HR. MV:G9?7>PJ6GR&0JJBHBQZ[!K*ZHPE+2YO/3S[TJLE+OK;^9QU)@,OBWJIZDO MAJN>EIH(:JC-.3":?8[:0K<"XN]S8Z:`DSJ`Q9%7P0%B>KRQR"G]H(V;P2NL6T]8*TH25(\0*`K``-I9N&<=69_R^(8H>S>[O#@<9ME9N MS.X*B3#8;'8S'8NFGGVW\5VF>@3$RS4U92SOZXZIB)JE"'D&HEFCKGHL=IY> M+7#2GZ6#N8EB0)+T9)]*4IFE*5ZF#VR0)N?,^FW2(->SG2BJJJ3%8?"!D@\0 M2:D4/5N'N,NIHZ][]U[H(NA/^9-]=?\`AM4?^]R>_=>Z(7W+L7<=;\_^L-XR MT';U%M.@QFUQ3YK9G1>V^P]LON!),A`&W+V%F.G-XUNTMLUM(YQ]5#2YS'5& M-F89%'I0[32>Z]TE=W[&W7B_YC$7?N^8=U;9VO3[XV+T!U5GU^1F>P.&W9MO M>O6&S-T93;M-\?L=T]NS'[CQ5=VG1U0J:RHW+A8Y:S&AR(_MBU5[KW0V=V?! MSXOXW']Y_(VIZQH=U]]+UYW1G=O]L]G[@WCVCNCK^NW+LC<5+7P]956^\UNK M_15@H:&K>FAQ^V(,;2T](S110@,P;W7NCH[06W5VUUU*UM@X5=8$@1O]^[3# M4%=!*%/UL5#6^HOQ[]U[I$_%Z+[?XS_'>#RI/X.B^I(?/$)A'-XM@[?3RQBI MB@J`DFFX\B(]CZE!N![KW7>U?^RA^YO_`!&G17_NY[L]^Z]T.?OW7NM=GL'! MQ;@^>/SC;XW=I=I[D^4VT^CM\[ADZ>RNQ,ACMA;[?-=:[(V7A-B5^X]]=PXS MK'L+;^RZNC`8(P3TN-A]1[IZM_D]=E=8 MU'46QJ!J2IJX-S;.GW+LSNBD38E=O':LW9N]Z&GKNT=P;(RW9&W-LOE\Q@<% M/N>.C7-8^A@5X%*4Z>ZT]-1H<="#\&-DX2N^#?R;ZMQ51N+9W74^_.P-J[1[ M(H-J=1[1^1>?Q.X=C[,7,;W[7V3)!O[8^([3QNZ\C7X_'R9_%K-6[?QV,JJG M&)'(@E]U9F[E;CCH\GPC^.>T_BIUENKIG:6Y-\;M@Q/8V5S^7S_8%3LVKSU? MFMT[=VMEJB3S[&VKLS!FF^UEAX&/AD$IDY*:/?NJ$U)/KT] M^Z]U_]??X]^Z]U[W[KW54O\`-VJHL?\`'7:^2>DDKGI>[.DTAI*>M3'5=1)5 M=F;=@C@@K9:>LBIUEG*"0F&8Z>%1F(4R5[5J\O,=U`K*-5A]>A.5[2=E)*7]L<&A_MD^1]!7!QU3MA(*/YAU>+H'V[_`Y-I]=K-30XU/XK M64&T,'G5T=9:22J@FE=W/)"2W"3^*9YR"2 M2NIG10J@9I12#6N:`BC`,(*@)Y]>&&2!H/I[7-`&*JDA)=AVZNXD4TTI742I M*DF.[_CA78?*46/V#O7&Y7[)L;FJ7;^7II=FYC+;VJ)Y2#410E>H^O^5&M96BVC<0X5U.AB(G>4G2LKRZM+!:Z?#!/Z9*UU`$+/XV MUO>>(^0_4&S.Q9MYUVV8:GM"O,.5KZM=F;3RT?Q][1JJ;K[:E!5QT<6XL%20 M9!JW&[CHT<5=)*U.7?QR3.CYL7EYN5M_OMHCA2[18`,`R.!=0_JN0>UR1WQD M8(#4[@`:\HS_=>Z][]U[KWOW7NO>_& MM#3CU[HN6[8#4[JR2O'(B/(L0.I%:1C#&J.KA9R(F<#ZJ=7Z3<`K$:6X_1C^ MRO1#A4]7D8B&9'%;&$0"F$C$R* MP9M+?I8$7$K^)!)`X=-`4*FO`?Y:]27K)[F%_O)/V6\HAK84$LZ`^")*EO%) M$(6EL_,8\AO="1Y-$D@$>OIY?\7UL$U<$#(S\S_Q76/S%)+??2QS$``1-*DY MBC,2-Y&$85X)FF]+)<:T9+$$PCU3QIUZBGM!&/EU(F,E5/*PK@ZAC'+'3M>9 MH)%5OW*ATEB>EG90-(8F\;7N+"/0KC&.G"`02&SZ>?\`Q74)FDIY4EBDDB:6 M2/5X_,SSL(ED$GG9I4*2_J(#773^NUIDN,BA'3)(&AR.T^O'AZ^GR\LFIZR0 M-.(&DIDA,"%FD14,C25<01@ZW4G7<,@U&:F>(-#TZ*TX`T]?7J. MV5JHJ6KD>JJJM9E:&H\2O&L!J>)4BD.A`I1`J,5:Z6O^RUV`)4`9_P!7 M^K_57JM2HU,Q()^S)\OS\L=<7LS4PDG*ZH!4?LP%GED@4M3K3/3SE:B401HW MDTR.WJ]+?I37`GY=5:I(5FHQ\Q^W]OS\\]9C,R1:IIY:",N2H>2=6J9*D+XF M94J"D;((?(-98,J:O45$L>JD<.KH*J7#T_,@]2C%]O12RU6)?'&-36C^A(87#M4'(6G5RJF-C7'$BF/RIY]1?)KJ%FI'"R.(0@ MCDC%0D\$926-X7CA:+Q)(!QI(=F4HK76;=,4/`=5+:G%/B/7)%6&\#4\74E(8VJ525`/% M96C658K,(TE>)YH7BDA60S#381@ZA<1EOW-5Q\^M@!6HPP#C[:5SZ_+A3Y]1 MYHEG\]('J]1J`B.YC=IE4&$,ACF],:1ZE,2H5=259&!,#6%5(/D1UHK4]Q\_ M]7^K_)3KN*1XHE>H1RP"1O8K`"6E95DE=Z54\J@!K,NJ1``%DM:/6"33AUO" M@_9_Q7\^N`F+I(LE6*6!(&!$C`0>)BDHJ)6+J\@!-N0O/J.H`3)L`@BOG_J_ MU?ZAUZA%#^*G7"!)4TPZ6@>*BC>CE^W0)H\2B;3(9(9?&#$`X#TX611PMQ+) MXE0QJ:_+_5_L]>[N%#7U\OV>?V"G61K5-9]P4=E6I5X(A#+(\;L&34)G4&!6 M@9H[V0-<+6.O$:8V"@:N/^KS_P!6>L5./%&B2/IF ME622=T1%CF),C1RM9R7/B01^15FU``$RZ?1MJ_#Y=;`TD:N)/'R`/"OR`Q7C MU(%IEC=*N2>*1*:2I\207G5:=&^W6$?O'!J MKU6@_;Y_ZO\`.>H51-&NA(9"%D2$1QRP7UNGBE6-2[QF2"-I+S5HX[+I>?28D;QV6) MO58#QF\+>Q6C<>G*"H)&>'6%6_;&B?5&5FC15.D)/))ILFN&K:4ETT@,);&X M"$+XX_-0$8^WK0#"H4^>/MZS)410Q:KP/(93$TDTKM++,+-&IF_?FJ(@(B2$ MU,/U'4+3"AJ#G_4.O5.DT^*N3ZD>O^3T\NO2U/W4L]R@@5A3P0-.(UE95,CA M!"8CY8S*LHU.02MVTW\TEJ`%1P]3_J_GUXM7);'"G^KS].HGVR00A:/R22U/ MED5A*ZQND&JF9G254*-1QL4>)4M'(A`B0MI>Y)J2W`?Y>JZ4!/AD$MY^6#_J M'66F@FCDE$\C1$,VJ`$3(6AFD42Q%%=V>2EATJ(V&I>/"MO`E68$#UZVBZ1G M_4?^*ZXUAA:1F\04M+)222@QO!)#&.(99(ISXX9I)4&AQ,2I),;A=47AJP`< M4'^K_9X=;)U`U^&I!]/S\J9X'/G2G6**)&EGJ/%"I2JBB!+A&,)C:=(%43R$ MP)E$3R2!ITEDJ)*> M-T@=?&)4+R!2DS)4"0B90\/E'KU$1QDL\VA_1QU<4(H'!/G3U_R=F9Z02 M+&N/1I)%96DU,OK:F%+#'.`8XHY#9$=8V0C28E.J`^U!35\GJCH:43%3GJ#I M)DM:2M% M)J"*OV_\`%=8#!$NHQ5I237(#($9J6.(2RR1Q%D,3 M1L?.5$1*H'`&E-3)-LO0G5PZJJ*K=OQ?Y/\`4?\`!Z]=P)/3^#RL2DAF5::( M2Q1HK54B0)+)+"6UDRJIC#H/2RK#8>%-D@@L./50DM`&(T#B.`^P<*?R\_.G M6&6+6?4Q^V\4D$:2+H0E9(S")T%.X1W5&0&,@2(P_;F"WAV":`US_J_U4_GU M;O)+5JA'V?M%*U^=?RX=9(U*P".%8%`,$%##&IIY(S^[/)2.S5,1@$FE6%A' MKC*F]_WFTW%J\//K2M51H^#@/\)^>?0Y_;UR&NM:>F:(NL$QACG1=$O^#[/G\SUG$$'YGAUEIX]4<59.RU,C2F2$F-PJ%(3,YCHK+.OW>AT_W]O^;]G' MYT%.I,%HGAUQK/-+"9K)/$DYF>66%%TAW`,AA"J[@@!1F4.*DBH_U#A^>/G4]<(X+^)4$<`GAFDCA#H\<.O2[&5HTEM(KQ7,A+ M:P-8>11>+RM4FIQU:C*J@?%_+]O`?G^60.LL<"1"&2G02,DTH3RR:5;4S"-M1=3_`)0*U+'23CK81=6IE!-//U\\=8Y9!60P1@0P MR112D/'(FHO"HEE%03)IDEB:0:'](1C8/$S`2;44U>G59&;@A`I7AQH/Y#]G M'S'49*FK11)-3WI)6\T@IZ*H M%;4Q*GZE$X+>@G0-$?AE2/,?X>K&4"AJ<_*G^'T_9^WKJ>J,@EEA.E9O&:@J M84`6!$FJ:9F<2"5C'&1XU>8M8MK6WFB\%-`"!UIF!7!-3Z^=`_=>Z][]U[KWOW7 MNO>_=>Z][]U[K2O^:?9G9&)^87MJ:.JP^WMR;WR6]-Y]>[RV M^T&1P^;ZSKHY]P9:3;.W**-*>3[^KH'JLM6S5[O6"@Q$TIHN\[/ML3C9+*&X MBTG5)'&(HI4D+*R3X1?$>K&J*^E%$=$US*"AMBWC=)DDY@O)K>35VQR2M++! M(A5@\&DL3$@"K1V34Y+U?1$Q.EMW-8;XC46[L3EL9E13]F[,PLT-=L>GI,%5 MPX'6^]=LYS"8YXY9_P"$8+&X\TE,)ZB2JQB*J)(U13SU=8"[F.ZYR-C+;2`R M6TO<)#4-)18G4D84ESJ)H2]:GBJJ/;2>VY`&YQWD3:;RWPT*Z:(M9D?.3H44 M0!AH"KDN'=[)/Y3FW`U.:L=,=@*FF",8(K7^(\>KNO]^Z]T$70G_,F M^NO_``VJ/_>Y/?NO="[[]U[JA7NW';5R'\W'I_9^,\TNS]Z[8Q.\L#0]* MX;"_)R/,Y7JK#8[9U9D^YMR]7;UK=YX2ER?86$:*/![DVJU'AZB6DD@JVBEE M'NK5732G?U<7\@V9>@^[V54=EZA[*94D%0R.PV9FBJ.M&R5;(Q%B(B)"/TD- M;W[JO2CVB3_HPVP2J@_W#PI*J)0H/]WJ:ZA9"9@H_H3J_KS[]U[I%?&-F?XV M?'QW6-'?I#JAG2):M(T9MB8$LL:5[R5R(I-@)F:4#]9+7]^Z]UQVK_V4/W-_ MXC3HK_W<]V>_=>Z'/W[KW5)E;N/Y![Q[[^>C=A[\DAZ+7XP=V[>V-UGAIOC# MO#=NWZW"X3;-'7U>/P&Q=_9CM/*YJ@%962BEW!%1T3')4L%1]O-)&I]U?M)4 M`?;T`W55920?R5-UR[LQTV*IL%NW9"T.1VO2X:';L^3Q';_557M+=HR.^,)W MKM?-=?XS<:4DNZ*F;"9JBBI*+*4RXZ8T^B3W6G`#$#AT/GPPWEU]US_*WW7N MOHSM#'[C@VSM>KE*]M;%V)@:+J[?%3M;:T=7UYN^'JGI[K6BW<<%6UT3?QBO MP=35U;5*/5L:=/#%[KVG2PU<.C=?R\^S-^=H]2;ZR_8V\.OM[;BQG;&0H1E. MN,%!@L+0XK.;`ZZW_B,!.M)@MOTN4EPE!O5(*6K\+U,N+6D%9(:Y:I5]UHTJ M:<.C[>_=:Z][]U[KWOW7NO_0W^/?NO=>]^Z]U55_-OJHZ2"A?R&2KJ*[?6(HHJ:-898II0ZU#LR(=QDW6 MG=5!6[EZ\:2#+8?);`S#[$SN(R\>'V[F)88:PS;,VY4YQL95;5;(F"6LBI*9 MHR"JL$:211ES'/\`O+994M]S96C<2J)%9=;CX:,0`:BI%3FOF>H[Y,MOW5S# M%)<;+5)(V@8Q,KF-7`U%D5F*T8:20%*GY5Z#;Y?[&Z8V3VKG=E[EVMG-ARS; MCJ:3;.9IIX\MM)DDIIZILIN:"FBQBX7^.XN*=#4TLU;6P?=H3::+QJ;\H7&] MWVUQ7MI=13A8ZNI['!!IV&IU9H34`44^71'S_9GMH;QQW=O4^X*ROQ&YMM5NX>U%DW!M[-I48RIRAZ)[ MAIY\D]%]ABZUOO*HF5$GC;R/E7E8DTT&@0WR\M;[`D$D-SX$)TLF=/U% MOI6OP]HP6!KVT&&;H*-<]Z.#GZ2Z)8C!H2#0$"M36NE M"-R"+_-K_L?][]XHGCUG6GPCK)[UU?KWOW7NO>_=>Z][]U[KWOW7NO'Z>_$5 M%.O=%NWAY9,WE2VN6%@@DL6"%;F0H!+[>P#\ MNDH:1EQ0'YUZP2S!Z1W26=E34I62-8M)9)`G"!OHM[,VHWL#=&] M3B!U8!<5)ZQ34E5)YGC:>19TIT$3$R-&RF4J$$.I2_BLO"#7:S:E411[%#\1 MZH5H2PK3Y]<9)T@GO'JGD9HY&9733+#%&TDB>(*T4A4FPD+G6J+>2RAD\.&. MJD&H/_%I"2QQO%"4@*H"\)?'Y\.O!@R$_/_B_V=1!511VB=O/%52Z*=2-957"D*@0 MJTB?M"^GTO\`5@8P1%[R8^?5"^@^5#C\O/K'45,,$:QQR*U*U8R33I,TM4Y6 M"0GQN:J)T8R*LI"E]7#VT@SKL5)-!W4_U?ZO^*ZJSZ%'\-<_(>O^#_-2I7KS M02(]+.$%QHJ=*O&4K'N8BL0\?V\CT\B,P$@))U`(6_=]2HJ#BO7E!R&&.)^1 M\A^S/7.HDBC%*AEC1@3%%.ZPQ5D=2K2"&1`D*WJ:H/I<&ZN3H(%S"U?XCZ]6 M8U\,'RX?ZOLZP132MY!''++Z:E]-[ZKJWGB9G-0D12XNK7)T$(K:2D6Z#&>J MZBH>;R1Q_MQQUD31R&JIY)A'*;-%)$WC:.05#,MD+Z MAHNH92TL5M(*UKP/E_/K0+`J3@,!Q^PD4^W^=,5-:2X$,9AI8GD61HE2;5&L MOA<1@PRI3M3QQP`0!39BFGAET!@[ZKP/D/3_`#];KJ8+0BG&O#Y8_P!5.H]2 ME3Y##!5*L8\$--531)YF\=J61)(X9A3O*)6(5$BC".VCQM?Q2;4K357NZJ1( MATK\`''SK_@ZCI'''H1J3S:E:%=*,@A$B,%L/'(ZK((RLETTNA\91C^RM\`- MG)ZV:XKYC/\`(_ZO\F*YDD\@@D=(A3(T@DGT&":`E%)-03$L4@J6`.I@+K&F MD2`ZXZ:0%KY_X?\`-]G7B:$5^$G/E3_/]O`>?4D&.%VJ+."#HEC@=HX6CB5' M]-1(\?VLBARY/!+LS,VD+-[J?Y]6!-5(/GZ'_4.L=,2]34LTJAYGCAIJ.)ZM M7B6,.D(D-1+XZ832N`L=XM9D%K$@R[9:$>E.O#6P+.!QX=2`J33-XX(9):2F M5XHT@$DQEDM3M$Z`*2TD2L%<*64I8#26A&P2*@?"33K974R!FZT9]+5K3R MX$?+B?RI3SJ``.-3/#(9O$];4(T+QR,DO@:,A-?DTO/YDA30`'U(6$BS,Y4> M5-K@=PH.KE@I(T$CUJ/\'7*&C#0)4A%6..(/3:FO3HBH9$%W6(@P*00XLX^I M=-7D:M:$CRZV,BOEU@D77/#+(5=XTFJF50J>4Q-'3QN\#24Z*"CLIM&0I)'[ M>K1)[%&%>J,N0P)QGCYCACJ;JIXZ)QI2J01U#B".GDDDJ)'1;5)8T'6S04.G2M/,_+_*?+_B^L^N`L"8W,1M^_2QB0 M&9=7V[JT;1R&42E6\@?5&O[@8!1*U,U(/'KRZ30^77&6DBB*DJC-32%Q!,SQ ML%5XOT%BJ`("==[LNI;^,M9]@D=;Q7_5_JX]1JC5*9%4B6*\T\CHG`!2/3&( M@T\I,*^C4()02"BA1:#W9>T@'%.FR"&(_"<_ZO\`BOMI@GPA$5.7CJ?+YEDA MB\@$GD26"35'J$-69XYP+L3Y1Z>$<*!'IC4_+JS4*E:\1Q_+\_\`+C/7,PS5 MLLTI$-.I>!9'#-J>16$RFG4$1Q>+U2*'_/J/%IVUCK57-#0#A_J_U?E44)P5 M,AII(V@B-C/':H%T8,ILZL5J8?'J$I-KVU-<(I]' MY_ZOG^'I/`M53M(WVPEC*Q*8Y8V\IU1+'&LL20I,JW0QD!Q^DQQDF)O,.RGS MZN/B7'EG_)^T?GCRR.I$(BADDO(LE0TRQ%Y9$>[S*\4;B?U!FDB30"@"Z000 M2/$E6)-*CK:J$)H:-R342&5@P9M;R M"X&HAQ:1=D@HN<]>J2YJ,$?MZXSQO6:HYH8/MYJHQ5;N6TF!?%.6IO!.[),* MA]1/DCLUV"A7\TG@0I^(Z_+[?SZJR,XHP&D\?L^5#Q_/AP\J\D@:C22.G8V, MG^3NJ(\<<0D9!$M/(L/@>..158>E%:X6-;Z9;:ABIS3K8B5`QK@_L_,8'^0> M5#6N)P:IVE"*D@IY*>G84H,-)#')&LA;PA/&[M&$`=1J8A#"2#`M5(44ZV36 MA`):OY<,_,'RS7T`!J#E>:1XGIVF8K-9%DJ(%J):>*0H]5Y(Y)R)IY$6P6^E M@+!)%5M&PM:GJA8DD'%<"OD,']OEZ>N,]=S!U$[3,%IS%&M-&KO2J'9D\!CE MD]+M5.MVC#%DTZKG_.&BUJ*"IZ<)-2#\/KPI_G&*DCA3.!489(6G@G#O)(LR M10M,K0HYACFFE:0`/0S"*D:HNRD7A!NJJ6U37K1UI3_9].J."ZD'`_R>9_+_ M`"^@5NNUIIXEAK&DB@J5=80!$D"Q4ZLIAA,"R1R222T\:F]HTUMS$"33O:H+ ME!PZ\J$#76AIY_ZL_P"K[.O&-9IW-0T05Z=*>?RN7#!;HJ6\95_,JFX&FX4+ MHDMHBKKH!0=;XLQ?@`/Y?ZO\_F!DJ8Z>F9)I2]0C-#"RPLL3()Y&?S2&42`F M1U9I&6PLINT@`>/PJPIP\^MG#U-23B@'Y\?]7[*`8U0M,K%HX4I)`I2F\4?F M2,,]+]QK"/'(TG.D-'9W!U%2)6WE<`9.>FUIK#`]HQ7U_P!G_5GAUP4Q>?[/2G`8JIY(HYGAF7Q@4S14D<+RR22!:99*XR-4P'[?QI=3Y3R MK%WD55$&QQ"TP1Q^76I&(6I-,T\_\'G\O/Y\>G`0PQ5/GUKY%EB:-A,9(BL- M-#,S3`Q%8&:%O(-3ZF!OK'$PHU0H%.WK87O+>>/G]M/3[/4YKCK!3J]43,BG MS&KJ91YRX1&=75JDB*-$U>)3Z@0+N2)079I;/4#AY=6X#MSG_5_J_;4U)\\$ M#>,0&0.[S6A)/[03QJ[TXCIO(C,K:':UP'*`@_L/4,P`QCILQ@L6+&I_V/L^ M7'KN`RS2J&IHI5A/E=Y#9"0#)#41R/+*:A@6U*8Q(&*Z"Q*LL=B%4$`\>M#6 M^G4E/G_J_P!D?S`QHM&9'HI9#&56.H9E@EG6:L,T4@>'6U9%XIC'K=KNT9#$ M2-H$J;%=(('6UP61\)Y>=3]N?V4KYU)ZCT[CRQAYF53,_C@DNLI>%'E?AEJ'J&@UQJT0>ZF&21H&IG>JB$DD3!WG,)XU53/<:#;U1ZU`?%Z M]:;73Y4^7'R'G_E_/J+3F2&HBC*S+^Y4RH%E1$.HV_RJ,SCR*I7TWD=CY-95 M=(G&V(I4=4C9R:%.VG^K_5^TUZG`!#$8>9%-2(0M08Y!(DQ584G=I4.I6L%) M%@P],1-GH`3@XZL2M5(.?*G[/LXXS05I4C'3EB&8YC$M#3O^_7T:*9X((YZ> MG2="4,DFCPKI+:E-M/J3QW_9:LA`CD&K@IZ]^Z]U[W[KW7O?NO=>]^Z]UJ0][[>[RW+\M_D+!UAB M=TRX".;KFER6?Q%=B\!B,37UW4^V14OD-QY',8VEQRTV.@URFKT0^66@9)$9 M)"V4NRR[!;@NL=Y=G[5V%F]Z[I[&WMD\ MQ2T>X*SJ+["+8.U8<.3/7I6;QFS=-4;QQL<_C2)J"ADBIZ>B,:*\4)/LJYIW M_=[7:YKN"TCMK)4JOC?VCECC3&$_3P::6-:DG%>CODWE?8[S>;;;KJ[FN]S= MJ.;<'P8@H!),C/\`J`8&I25!4K0A>A\^;G5='OKO6+^XO6N^=T_Z/]KX7KJF MJ,?CKX)%QF-J8%K<-)#2)0+)+,T=)5R2R+'`?$$119P2XPQ": M8RY8!LM6F34&IU+YT!/'H0>X>RQW_,*_NS:[B62W@2`,J,4HJD8(&DD?"?*K M`<">C$_RKXS3UO8="^"EVU48S?';&)J\%-2RTLV,J<;MKXJT9IIS4`5595+! M#&9ZB8F::VB8-6M09+VA]*'R`P/+'0H]F2X.\QO; M&)X[F960KI*LL5@""/7S)XDGJZCW$G4]]>]^Z]T$70G_`#)OKK_PVJ/_`'N3 MW[KW0N^_=>ZJ;WK\']Y;B_F;[1^7L76O4M;U[@]O8RFKMTUV\-K4W:8WECT-0ZLVOJ!U#K_"7 M!!#:O[N4UQI/(-_Q[]U[I$?%KR_[+)\=/.&$_P#H)ZC\P=2KB7^X&W_('5O4 MK![W!Y!]^Z]UDVK_`-E#]S?^(TZ*_P#=SW9[]U[H<_?NO=41;HH?B5B-\_S( M.OMB[&[TVGV9C.H.X\[\AMR[3W[35F[]X8?+XGKW?>0RG5B]HYC-=/&IS&,W M1)!6+FY,;-CHJ986IGHZI91[K8K44X]*SIW?6-ZB_E?Y;?WQ;RV_.E,5MS?& MS\IM7W)\IC=NU?9W6\.[9<_M#KZFQ;9G;F7VE55]!B<1A@N>RWDBI\ M8PKJBDM[K;$EC49Z&BC[AW5\A_@1\F]R;D[+Z5WSG*/;W9FVYZK9W3&^NK\1 MM(8O:5!6S;5[0ZD^3VXLCN/;.Z(EJVJ9SG$HZ=,96TE6M*\>EY_=;`*LM<=0 MOY/=5@6I\130R4,T<$ZTU-1IPZM6]^ZKU[W[KW7O?NO M=?_1W^/?NO=>]^Z]U5?_`#:JJ2#X^;;BIZJ>BK'[:ZPG@JZ:6"FFI8X=X8R& M:ICJZ@B&C>'[M=,QL8V(92&`/N2/;",/O]R64,OTHJHH_`%*G)U$T!%2,=9[BUV%[9Y6G-Y/"S`)0%$+`"4NWXRP;S`HM M20>C4_)CY$9GL;J3JWMG`-3;]V+B,91=9=R[7([#>=SVJXU6MZS&:V=&;PI$PI MC*>:JYJRFA*Y!IT+><.:Y-TV'9M^@*W>VQ(+:[CD5#/'(:LLHD!.EWC!"N-0 M!!!`)Z*AT/7]59GO/J3+[-S\>/W#5Y3?R9CK_3;6+S\4%5+]W$T,4\41B\T<@]B/FF/>[?EO?K>_MC);+%'IF33X9'U4( MJ02'765JHH?7@14&\M3;)=Z+DM-KMW#:P?H)F`#`%',88JQ!\Q7N M!`W/XOT#_8_[V?>)1XGK/!/A'63WKJ_7O?NO=>]^Z]U[W[KW7O?NO=>]^Z\> M!Z+9NQT&Y,\L;+-42SJDE.2`#1^.%'T,9"HF5Z>ZCU:@K7`"`1&L.88:<`.@ M]=FLUP`.+?;CSIZ?SKY],%'I\C^82S%BTDB54L;M=H5\PE)!:,*DTBE4(L75S<`.KD@3"Q##'X>M5'"N>L M\C>2K@%1#+)/&[U/C#F+QAI8X1Y*6.4-/X7G4*Q5$4L2Q34#+JO:VG'5@JJR MLPU'B,X^5?L\NNJ=]%/(T,J7>*98:.:1&>R.RA@9%'VTHJ5=)0XTE@$`6QB; MQ].FU>H[6R1P].L<"U$B2U50&A:.""!:=%TN+W:\!BAE#:1>X9G)TZ`#8Q1Z MJ":=6"]I>N<=9)):F$0H5CG5I)C#-H\S-3!!H5C%+XX&#$,BVO->8*98_8 MX]:X'_!\NH\+2Q6:611.D)$1=7225%F*H\``K M3U_P=25T^=HI-+2HTAC:2-9!)`MS*89H_+>>;4R`:B?'<6(!A'O('AU[4I++ M3N'[/R^?^3K!22HZR120S4M,TT,:+4>F`B0EG2.$54T\8?0"`8]!!/+`:XO$ M4`((ZV#57U+C@/\`"?Y=9&B1RZ.K25/D29)ZIP\WE5V5`$F#LZ10KJ_4M@%; M6!^^?`FE/+KVD,&!%6)'GZ?M\L?YNL;)5%B2\8?]I2%D+1HQN@A>$O3D2JDF MJ-E$:ZV'"_67PX4ZJX.HD'\Z?Y/\G[:BH..-J:0STU,2DE.U/+:;3#-YU1UC M3QQ^J.>HCJT[6`-*9^W[/3APR/6HJ#U3:I)E_;E\ M$4"D7:-1K\058&I)$9UAD4N6<("610!(+I'X@@*3_J_/_53KR/J)`4T%/]5# MG_/URDC>25I86CB+!M4D^MD*S1JLOA8R12&GF^VCOZBI*%KM998_!JJ!3(ZL M0`>)S_+[/]7'K)!64T*""H;[-PKC5(C6B#71&ED1HZB5(9>0X*L05TZ2RR/L M(U:KENM,R1I1B%7U\A\\9^>/+S!I6G3Y6?SG_C7\;LWENO-FT.7[Y[)P%1]E MFZ7:&0QN+V#@LS23M%D,-EM\S1U\>1K\9(IU1XJ@J8XIU,,DL3++$(0YU]^> M4>5+JXVVR23NGWW:/[J/[P_O_`+'MG.?, MUY:\E\CW:"6"6_BEEOYXF%5EAV^-HF6)P0T;W,UOK4AUB*$5KE7_`(42=EQU MR21?%[K!PJRHV1CQ45"LTB@@/]B0H(724!4Q3_P`%'N7C MEAR?;?2$_#X\FO\`WK3IK_M*?*N>L^(?[BCDK]VJEU]XO>3O6CXTVVU6#7Z^ M$9C+I'\/CU/\0&.CO?''^>K\<.W<[1;6[?VSN/X_9_(3M38S<65S4.].N)Y* MLT\<=!E,[1XW"Y3;0DJG;]^IH7HPBAIZE"0R2)RE]XGE+?9X+#>[.3;+J0@! MV(D@J<9D`5T%?XD*CU&>L.OO`?W/'O\`>T^T;AS5[; MZA4!9O!LY)IHKIM(PD-P)GX)$QH#>)'-CZ^EI*ZCK*2>BK(*:HI*^"<3TE5! M50)605L%7!/+2U5'44S^6.=6;R1%9!(%TS^Y^U!P&5@RD5!&0?0@^8\P1UR2 MDCEB>6"6-HYTIML=M9;K[(] MATVY.P*+8Z8/%;BI-JO3S5N(W!FY\I+75>&RQEB2'"-$8X8$+22@DQK_`)P! M^XG/=O[>[';;W=;8]W')?65WW./NJ;K]\'W/WGV MRV?G:WV"ZL]EFW#QYK5[I'6&XMX#%X:30E235E[5P<;R7("EVAV!'J,<(L+W%R;`)=#"?_!1[8&K_`%,N*?\`/2G_ M`%IZZ:C^XHYX*LO_``2.TU^6S7'_`'LNL:_\**MEJM,!\7=WAH4='<=LXB[H MYOXTU;#;QJOZ;G47')_I[\OWH]KKGDV>E?\`E)C/_6$?X1UM_P"XGYYTC1]Y M':M0'GLTXS^6X?X0>C#=7_SZ/B'V)E*7#=A;:[-Z=J*ZLBA3,;CQF(W;LBG2 M218T2NK=JR2YVE@D)O)(V-=$^KRJ;SH+MC^\;R+N5Q#;[A:W>WZR`'D"R1BI MI5G1BRCU)2@&3CJ`/=+^YN^]/R1ME[NW)^\.2-PKHZFH(8`^8[3W5V? MS!OYBV$^!QZG&;ZJS/:5'V>=\3T4F/W=%MF/#3[1EVJ)(Y&KL#F/XA%.^XGM M&%B,316)L2@C/W,]T+7VU__OJR^Y$>R^Y5KR^.719%O'LY;OQ_K3'M?$0A6%@FFVQ'XA5%"@W7\6"6C$5G[TFU5SR92VDG_`*4US_WLNN/_`$$3;%U*O^RJ[K$15O,Z=MXI M9798&AIU\;["EI7$(<\NC$VY!-BNC]Z3:N(Y,N*_\],?_6GK?_)B?GDJB_\` M!'[2"/,;-_Z")=BA(D7XN;U00N\BB/M_$PB1V=95$XBV$JS1I* MTA`L.&N;O>3W[_@I=J_Z8N>O_/3'_P!:>M'^XFYZK_XDEM5/^E-<#_!N(ZN7 M^'/R3QWR\^/FW_D!0[1J]AT6Y,KO#$QX7(YZ/<>2QD6UL]78J2?^*4E)ATD2 MKDA\H1H8?%?2MQI:6>^1N;H.>>6[#F6#;VMHIGD7PV8.1X;E#W!5!J5K\/GF MIZY.?>E^[YN'W7?>OF?V5W7FB'>;S;;>SE-W%"]NL@O+9+D*(I)IF4H)`A/B M$&E10=&;CB<@U&H1PI3BF6<*@E0A?6%@2$6\J(`#I`9N/$/\P!@[5[?/K'MM M,98D]HQ_JI_J]:FA%3ORD_G-_$WXYYO*[,VHN;[W[!PE3)1U^-Z_K<53[.Q6 M1@!AJJ+*=@SM78^9D<,LT6.@R3Q2KXYF!70D*VH/$*'*\"*]=+?NX_W5_P!Y3W^VW;^:MZMK?DODBYH\4^Z1R&\N M(S0K+!ML>F81,#J5[B2U$@H4U*0QK,K_`/A1)V.:27!X4F!(QCR.C\:OYY_QO M[9SE!M+N39N4^/6>R]3#1X_==;EX=V]=M4UCJ=&8W'34&#RNU8I*]F;[B>B- M&GFUS5$(665I"Y5^\5RGOD-/)1U&/EIPU/D*:5"B2I5*X8&(*D@:ZJI/ MA,_AE8*R,&0@$$$$$'(((J"",@@T(X'KD9)#-;RS0W,+Q7<;%'1U*.C*2K*Z M,%9'5@592H*L""`13HMGS&^2^-^(_P`>-T]YY+:=?O+&[5S&U,,-L8_+4>!E MR)W-FJ?;LCQY"KI,G%"*!:POH-(3)IL5**Z1!'GKFV+D;EN]YEGL6N8H7C7P MU<(3XCA*ABK`4)KPSPQQZR"^ZO\`=\OOO1^]?+?LMM?-,6RWNX6MY,MU+`US M&@L[9[@J84EA9BX30")`%XT-*=`Y\!/G7A/G5LOLO?&,ZTR'6\'76Y<+M?[/ M*[NH=T5>4J,[A9\L9Z.H&,P8IO#]FRLKQOJ4(VIR&\13[:^XT/N/8;A?VVU/ M:);S",AI%DU5757M1*8('G4^G4C_`'U/N;;O]S+F_DSE/>N?K;F&;>=OENUD MAM)+00K',(?#9'GG#DGN#*5QA@3W%^^=/S/QWP>ZDVYVID=@5_8--F^Q,?L8 M8/'Y^DVW/1U.0PFY,\N4DJ:O!952M(N`L$$2-))4K)J_W9*J]Q^?;;VXV:UW MFYVM[M);E80J.(R"5=]19E84HA%*5J1Y`]$GW-ONH[M]\;W0WOVSV;GBVV&Y MLMEFW%IYK9[I62*XM;?PECCEA(2_O`[3S;S'MO+;DE00(U/<1I&3DCK+[[R? M]T7S_P#=^]FN<_>"'W>L-_M]CACGFLX=MFMI3;&5(YI5D:[G%(%M7-OC" M;1P&TZ'-4^#J\SDLY2Y"MJGBR,]#F_M(L;C,/-5R?M6D(47)=)F!//W/%C[? M\OOOUW:FRP/ M0/?*QY]YDM^7HN6YK:9XI'$C3JX'AJ6(*K&M:TH/3Y]99?>S_NN.9ONG>S6Z M>\6Z^\EAO=G:WUI;FTBVV6V=S=S+`'$KWDP`C+!R-!U4/`T/5E'R"[HIOCET M9V5WED-KUFYZ/KK:E3N&OVO3Y&/%3Y-?XA1TZTU/D&Q]7%02HU8W[STY0A;` MABL;RKS9OZ+VZ] MHK#>8]MN>8MP%H+F2-IE@+1N_B-$K(7IHH0'0FOQ@#-%9_X4/[&5$CA^+&ZP MD,6F)6[8Q'ZV=I96ET[#\FVRH*\G7'_93'_UI].G!_<3\\:7!^\CM53P_W33_ M`,Z[@3^PCKC'_P`*'MA0U,L\?Q;WHLJ[.QV?O3;8<'DV>G_`#TQ_P#6GIO_`),3\]5)'WDMI`)S_NEN.'_X\3MX40H M<5MG!O'*D>:NLCR,#=U&C5ZY']M/>&S]Q]QW#:X-CEM)+>W\4LTJ2!AK5*`! M%(-6!^P'AUAI]]3^[IYD^YER1RCSQNONM8[_`&^[[N;!8(K":U:-OIIKGQ=3 MW4X=:0%2M`065@::@QGOFA\IL7\->BA6A82+XIF8.J!@BLBB_G[G&+D3EJXW^XL&N4BFC30KA"= M;4KJ(;`^SK'3[J'W<=R^]9[R;;[/;7S=#LE[=6%W="ZE@>ZC46J*S)X4N.H MB\.XYL;7)C<5XZG!6II9H'CFJ#2,TPD:.&3P!'VZ]X]F]Q+Z\VM-N>QW*--: M))(LGC+^+055.Y.+`UJ#4#!ID']\S^[B]S/N?IH)RT[5;E5J&!#0@"IF, M-1(E1YFB""1Y`9+:>&7BI69%((`IY=$K\EVON/I[^^U7OK'5, M5-/@,9D*@HS*6T>%6A*UIJJ!YUSUU:PN-LBY6MMZ_ M=XVZ992ES##*+?ZKZQDU()])D\"C,NH*HQU(:X@" M4/ADELYGFE5BLEH0"J$N5M>VD>:.Y(T@>?3+!BX->RG#C3/KYX]?7S%>IM'! M'!$7G?RS.TD5E=(R8C)(XU2/4">=8&>YLRF/4"`MP[-.232F.KJ`*]Q)&/E^ MS-?M)QP&.H%J=9+5#P14\5.T6E`(FBBEJT5`K-2E<'TX_YR/S/D0H<\;5K_>'#HRPI-/E<7%/.)#(3)YXE58G+4D<: M/!$59C*K-8J8V.J(4D7])S\CU>"4FY@0IC6O#[?]7_%U`.%[)>A7U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]UI_P#RQ&%C^4G>`WMVGB=L;%Q^\>H*"HVW M/N"M?*9:JR75FRJR.KPG75#+6UF?05YZ'NT`8!H:#X'?(':>U-I]M=O8/;FT-B]*]>[%;:/7NZ=TRO MDNU]X]AYNG7*XNFR@CN>[+S#-=7D&_WZL,,$FTQ6\'AQ"WAQZ'Q+VO#YU/Y]2[[)W5S>)O$]Y-XEP M;F<%LY`BV^ASYTH*]7<>X?ZR!Z][]U[H(NA/^9-]=?\`AM4?^]R>_=>Z%WW[ MKW7O?NO=`W\BFT?'WO5RBR:.F^SFT,I97T[)S9T,JD,RM:Q`()]^Z]TI=GF_ M5FUFL!?8&$.D`A1?;M*;`?6W^'OW7ND/\6G$GQD^.D@18A)T5U'((T4HD8?8 M&WV"(K,S*J@V`))`_/OW7NLFU?\`LH?N;_Q&G17_`+N>[/?NO=#G[]U[K7=Z MXHL?7_,[^:5O2/>^W=UUC=']RTF$FQFRNL(8%PS[-ZR2;^/[T^\QFW:W([:R M>+?$/CLUCJ1O%2>;*UM:&65?=.$`&*@ZY]'XO`47\EC?:?WFW;NV+`ST.YL1 M7X#K+LO=._MH[MV_N/KW<^T:C9FS^D^S]S]IYK>6!W+1469PM?C<[3BEK98* MD+#B*<`^ZT_QGH3_`(+8[?&Z?Y>7RES?9=;35/:/9.X^R\CNG<^?V?O?=F[\ ME/\`Z-]G[@9<8IT9#^491/%\3'S#5M#F(MY=I[YWM0[BH,9UWMB'<.(W.F&R.$KGZ_ZL MW3O'976LE!AW@QW\$IJYFA6B6=TB:H*#W5#0DT&.K0/?NM=>]^Z]U[W[KW7_ MTM_CW[KW7O?NO=5O?S&,OM?$;9Z;DWKBX,OM1^Y^N5W%03L(DJL34;TV]B9X M'J/%4LD9GRL4A01.':-;VTCV/>0X)[B7?A:RE+I;&;01QU>&Q'YFA`ZBGW2G MM+>'EUK^$261OX?$4^:&6-#QQC4#U3AW!UGTC\@<]-C.GM_5VQ^SMD5.?V@O M4?="8+:^4R=?C*R-\8FV]R1RU6$KZJDR>5C1J(3XV>8/$%=G8,\J;'O6\LE!P;6@-0*`U:C4-3@=0EO^Q[#S-.%V'<9+?=H&:+Z>ZTQ MYK4")J:7J3322N"HRV.CS?$_X\;7_@6=P=3LO![6GEQ--M#L#9>^:*?(XR'< MM-@:.E2MWCMG<3U\>(WEAGR#Q?9S,DU`A1%62&**19.OM[EW3V_WL3GQ:P6[K*N0 M4%Q;HL<@'!TH#KX/2IH<=0W#R]#LWN'M36L?@1+)=HT+54K*UI*IXGK.-/AZY^]=7Z][]U[KWOW7NO>_=>Z][]U[ MKWOQ%01U[HM>\HVFW%7QNI>G6M_7!99U=_"75O\`/LT4L<2+);241`0%_4AM M;XBC]:=!^Z)-Q*H]>DHDVB=?&D_W!:%955U,:QL=*14J'Q*L*1R?N$FUWN2+ MZI7/(4..DBG))^/S_P`G69X9))(&9(R34>)&#-)XYZA)A`M3%&8S!-*(Y`I` M6S*$]!?Q2>X:LXI7\NK,M74/@U`'VTQU+C!<^-V0(ID>I5A"C^F)*01#RQ/, MZ&6`@1.7-PRA3I\:>\@>MCB5KCJ/HB,0$D+,'U-(P":%F0B%2Z,D[^.1H]6E MM10#4"X4/'[/'KU/V=8&BDDGC0H53PNYG:<^:.2-HG\A,DWIE1`7'IO>SAAQ M*_JTSU4J6KCMIG^5.N1'E27[>GUF'Q&>0QZU:2)C+`)'`9R8RU]*JEBQMH=M M,FB0H`)QUH@,)*+FN?\`)]OY=&GC]"W M4JP]`'!B][\OD!U81A=.H#43Q^9\NNYS&RE:6K2$)4I)XR"]5,)(Q"4@=2L3 M.D,08EP4NA"ZBH\/A3SX=>88!0YZ[EF6%(A.4OXUE9C3@"HC)'C>,+.D;K(R M']/J`%RQ!\H]FG6ZBE*YZ:YI$JJ[]QQ''3QF)H)#5TXE>I*210-4(T2RL+:E M52)(Q*"2FI6FL`0K`#CTTQ&H,6H%_P`)'"OK3('&A^?3JTD3QO`P>Z1B2?R) M(DBH@DD4^:(1A7FG<)XVT!EDTD$$Q/2F*^73^-(!-.FAI(]-7-5/'%XY:;0E M0X?]J<_;J53[J4Z*L,40VU-:WJL8TO2I0+D'INJ$,6.5_P`/6>IJPJ&*69@& M::1#9YJ5JE8E9HZFJ0R:'\,J*H8J674ZZPADC\JDDZ>`_;UJ4]J@\001Z5'J M>`_/SSY=<_#4>2229*>)!'&:2601RE6\47W/K+H952H4M=/#P.=)_>>N-(QG M_9ZMWAVI0#R_9_/[:#[.LCSQ22RJC1QEHD:2!'FC5)%0?;C^QX5:52I5T76S MFY5VTRZ_#^?_`!?7M62`<,!7_)3[>NVCB@D)J$DJSYM<;![R@D^'Q#3K18C< MACZ@5_;"M69!$R@A6U*"29-&J+?;04K7JP4U8D]OD/,>M>NA)(U5++(5D95^\=A M,F@I5N\[FF5S$Z221Q:S<@ZKDF_[P\*:<=:),DI[>ZE?VGJO#^:EWCN;H7X0 M]N[PV=EJO&;ISK;=Z_VUEZ-IH:_#5>^:U<1ENBPJP-"GC.$9@?(A2:'R)KY8S6_N[_:'8 MO>[[X'M/R=S3:)<OLPTHVY4[@?$0YW);@W+0C]OQ[!R\D"P)L5DL-/A$$0%/LT<.OGAD]V/=:XO? MWG<>Z7,LNZ!@?&?=+\REE^%B_P!1JU#Y$]:__P#.*_ER=.;;Z6K/EAT-LS;_ M`%IE]EY+#TW:>T=J4L6%V;N/;>=R%-AJ?=>*P-/)+BL-N#&9S)TJS1T12&MH MIWF(D>$S2XV^^GM3L-KL-QS?R[8I:W5LZ^/'&`L;KG?-CWJWG&UWEXYEO+2[MHFG-M)=-^I-; M7%O'+H\9I'BFCC",4D8*8[^1+WYN'M?XQ;OZDW3D*[)Y+HK[*.OS&W\?'+.!,T.W\[A M+'I"?O.UD6.YE"J*`W,4L$LE*!IO%D-6D:L?_A0+#/3_``[ZV28N[2_(O`3M M98X4@=^O.P0U.\:^%I633=697=1<$1BRE/\`>5_Y4;;/^EG'_P!6I>C7^Y.# M?\%9SG6A_P"03=_:/\?V_B,_X<^G03^5M[Y`2^WC MEZSNKSZZ=='05(K09IG'0O_O6?O$>_/MG][F[Y7]N_>+F/8^7/ZL[ M9,+:RO9K>#Q9&NA))X:$+K>B:FI4Z5].K54_E\?!94I63XA_'ZS3(\2+U[AZ MU:R%-*GQR!)Y&,L(,@0/9E)(8M>5)D_UN>0*&G)NV\/]\)_FIUS?'WR/O:5[ MOO)\Z4KY;ICG]WC_>.^^:^^O)O MM![U\[7',O)',]T+*&XO=#7EA>RJ?I62X54>6">8);R12Z])D26-ETNKIG_A M/U\@=R;IV)VY\==R9*MKL1U;5X7L/KQZF0SQX/$[LK,E0;IVY1_OI-!CSGHH M*^",*T4<]75,"C2V=)]VCF:ZOMJW[E>ZDUQV;)-#4_"DI(D4#^$.`P'D7/EP M//[[?V.V'E;GWVI]\MCM5AO>8TN-OW$*M!+*(K^])\ M/)!]?J?Y>#\OF?,_YQ[_`'$M3=_>:5N`38_Y_O/Y_+T_V#G?RW/A1\2.R_@S M\>M][\^.'36^M\[CVMN*LS&Y]Q[/H*_*97(4V_=W4%/_`!G(R+53U$D6/HTA MULK>)(Q9&\81!_[6\J[AN/*UA->RV[%Y'A5F8^+(*DD5.`!^76)' MW^?O-_>/Y(^^#[Z\I\E^^G-6U]C_ M`/UN.0,?\@W;?^<"?YNL0U^^5][0`T^\ESGD?]'2X_R-UT?Y>7P95#?XA="2 M,S5$DC+UYB2L4-,8P\NM94$:LQ"MJT*"/3IN7?Q]N?;_`!_R#=M_YP)_FZT/ MOD_>U(.O[R7.G_>^9K_`'KFBXC19;N\F:>= MTC4)&KRR$L1'&`B`G"B@ZHS_`)W/SFW'TIM/`_%CJC--M_??9VWI,_V?N/!5 M)AR.WNMZB6HQ6/VIB*R&*GJ,;4[TJ:2I%5+'XW7&4_A%EJ2(\??O`^X]UR]: M6_*6RW)BW.\BUSN#0I`VI-"GB'E(:I%&5!@]X/77O^Z)^YSL7N[S1O7W@O>WIBJ'GESN=S./F6I3 M'U)%)14\L?EBEG+&G+?:3V.VE=ML>9.<;47%Y<('BMG!\.)&RIE7&N1E-=)[ M5!H03P&?]X-_>A>XESSUS/[*?=TY@;9^6MFN6M+_`'BW*&\O;N)BL\5E,0XM M[2"1?"-Q&!//(KE'CATM)>N/C]T-#BJ/"T_3/2E/BHHDCFI*+K'9M-CXX$M` M*>>G3!(OA%*B.4U%`C6U$WE;(U-AV"&-K:+8;)8*4T^!%3'RT=<9;SW6]V+S M<1NUW[K\SONI;5XQW6_,NJI.'^HU#B<@U\J^75'/\U+^55UE5=5[D^0_QHV+ MB^N]\]>4>1W'V)UOL^BF@VKO+9].SU6:S.%PD""DP.Y]K4Z25C+2QT])7T7D M3Q+4+3B3'CWD]E]FFV>^YGY3V];?0>Y6W^YW+'L7[]\V^^D)%O%-(]I#XELS'(BU!7 MBKYA&9605.E20.T85_WRWW7>7^2N8>6_O+\E;?%;0\P7WT.]0Q`(K7WA/);; M@%%`'N(X7@NFH%>6."1CXLCECR?SJ'$G\O3MP22O*Z;KZ@,;L@C8R/OW$B;5 M>H#V9472K*2RH"-84F`=>_\`CVMWI?\`A]M_U?3_`%?ZLXM?W28)^_3[8EN( MVO>O^[;-_J_P\.B=?\)YE9NE_D:;GQIVKLQW;5=8M.SQ]%_YUF[_P"TT="3_/XBCI?A MYUW31TI@3_9B-OS"XC4ZY=B]CS3%A&L7D!GE>SM'K`_406USKOO,FO(^T5X_ MO2/^4,_^KC_L`3^Y&4K]ZOGJ@[/ZBW?'U_>6VU-X=1[-Z)^46 MW:B0QUO9^Z:;"3B*9(L1O;INOV3N:*FFJJ6>.0??T6YJ.:-=44K".;3PNKWB M5%8WVP;?RKSI9RD,]Y+I/\$UJ\;`5_I*ZGSKG[.OH9W/FOEKW7YN]^/NT1D2*GW5C*;(ST<-2]IJ/^'S+)2F)XXV8(Z:7*-%%TRV;=8M\ MVK;-YMB/I[NW25?LD4-3[020?LZ^)#W`Y)W+VQY\YW]N]Y6N[[!NMU83T(/? M:S/%J_VX4.!Z,*8Z$:41).K5DR)(\(27[*EWMVG74FG(3T=5/'2C^[G7V.@K]>I8U2OGLQU-(^(WOO=3\U\]Y2-!0?&\$=`VE22;_R2HDI_YA>U*:%O*D6P^X88'E]) ME%/M2N,3N!+"`Y$08#D!A]!8,(]^[Z`GNC:*I[!;W0'V",]9=_WN5S)>?<7W MRZN8U$TF\;(S`5H"UW$Q`\Z`F@SULW_S*A?X$_*FR>`CJ2N?[7R!E"_W@P,4 MLD3'6S(A;GTKRV@.`K1KEK[M'_F&W.A_Y8'YN_?FRVMX(OIM'C1J^G49M6 MG5PK1:T]!7KLG_?,^\7NU[33_=Z_UKO^7OKQO7U/[ONY;7Q_!_=O@^+X9 M&OP_$DT:OAUM3CUL`4_\O;X,M32UDOQ#Z%6,H\T;C8V%>F9/#XTC$AD41WC1 M969'9`KDB4W,XR<_UN/;[4`.3-M/_-A/\W7#S_@R?O;Z26^\GSF!\MUN#Q^U MA3]H^9ZZ;X`_!&<)X?B1T+'#,)`9HNO\2')A$ M:P]M_;X&AY,VW_G`G^;KW_!D_>R(#+]Y/G:M:8W>Y_Z"I_D^=.A.ZG^+WQ]Z M,S>7W%U)TGUQU5FLKBX\'7Y79VV*3"9/(X@5E-D3C:JIIJ:-77[U89'4>1#- M'CPDVVCEGEK8)99=AV"UM)I5TNT4:H64&M#3RKGJ/?<+WQ]ZO=BPLML]T MO=7?N8-KLY_&@BO[N6Y2*4HT;2QK(2%25J7(YZ))9;U/C>?Q+I9E61G\7JOI'AB[[P2#_6ROCYB\MOYL>LZ M_P"Z!=C]]WE,*`5/+V\5^5(8_P#**?ZAUJ)=99SMCI#+==?)/88R>`?;78%5 M2[0WG3`-0?WPVI18;+YC;U859@Z5.#W%`E32S+XZRAJY([.GE480[)<;YRY/ MM/.6VJR+#=E8Y?PF6-5=XFIPU(XJ#34I:AP:?4![H;)[8>].W<__`'=.V/DIVW9M">>J1Y7FQ^27RPN;M+1305&I1*DT MG27DWFS;^<^7K#F/;0%CF%)$K4Q2K3Q(S\E8]I--2T8"AZ^++[QGL+S;]VOW MCYO]GN<59[G;90UM!7#L59"'`9@-*:M$HJ#4=:\*C_#U!MR*VT\8/X& M'_&2/\-.M(SXN,O_``\CMEF19`?F/V0/&YUK(7WAO-5C8KY/)K9@.`^J_"O^ MD\^.4Z?Z_4&?^6_/_P!79?LZ^NO[P&H_W3^Z8JW^M/MG[?HK'[:_SK\^MVBG M$LM3.8&U7(68!%J8VBB2H6>%6DC(,LT%P%4R'0IL"1JBZ"R5QZ=?(PI!+MY^ M?R_V?E\OEUS1T@B$:M9(9K:GA.1(Y@EE9`1<$N`0C_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NM0#Y(_&=>U_P"8 M%W=D,_F9=N=?4TW5F,RTF,EH*S>.[FH.J=G5\>R=N00I556+FR,M=-]QDZQ( M,=%"ZA#45*)`6N:'VCV^V..UMTFW%DN"H:HBC!G=/$D;@<4HBU8FI.E<] M8.OZ4Z4V+@,;DZ7K_8F3AJ:_,;VWAC\/1Y_<^X:G(?QWR_Y1#3;? MPV/425^;K)JI5B@>J431KL/-NXG<+QXYOK=XN9"AFF%`L:,S*JD%:``F5V-% MC55/!21+7,G(VV)MEC;3P?N_ERVAU"&!CJ,TJHKNU0U34"*.(5:=F8`*6`Z) MGTKU%UKTY.F[?D9O&GP`S6$H]M;:ZJQ&$?=':25.]*OS54E5MO%Y7'4^UY\C MBZ)U23(T-+4U-3+(#'),A\@RWO>=SWM/I.7K0R:'+R3,Q6`"*M*.0Q7=CV?EZ1-PYJO5C9XU2*V51)BZY^+465RDAQK-2&;(9.@>4Z/ MJ[R!K,MO<3\YF]7;>7VOI1)>91M]^Z]T$7R!?Q]#=VOJC31U'V0^N41F)-.S/?NO=*+:1_XQCMDW0_[\/"FZA/&?\`?OTQNH7]O1_2W%O\/?NO=(OXRN)/ MC?\`'UP\<@?I'JEA)"(UB<-L3`D/$L/[*Q.#=0GI`/''OW7NL>U?^RA^YO\` MQ&G17_NY[L]^Z]T.?OW7NM<7Y"X/MO:W:'\S7L'K?L+IK([3S75W8N+W]M+8 M7:^X,CW'UKD:+KSJ&IP.[\GT!C^M(I7SLL=!-#N6NJ=QU-%D,#E*">)8HZ.: MAK?=63XE^WH4?BGO?<_4/\J'=F[NB<3N7:.Z^OM]FK7!;HV7NE-X5E#%OC8] M7NC!4V#J]M=F;DI\SN_8M=-1X3(56)R4%$E92530+10J4]UN3XST+?QIS7;_ M`,B?@U\J<3WWVYNKZRWC MO':6,[*S>=CVU1T6*J MEJ:[(U,=*R4T,<,7NM$$&AX]'M]^ZUU[W[KW7O?NO=?_T]_CW[KW7O?NO=5) M?S>DG?HK;LE/,D$M'O?86162>*JDI+4G:O7'D%\WZNI8/;2J``"23!-0`'!J12GSQGJ$??$.=AL&3XUN(B,D?\2; M8<5J12M<`G'`]:]':M3DZ[`;0[:PM364&^\+NJ@V=DH,)'D:W<>8_NQBH:S9 M>[DVW_$J3;TF7P,-#6)/42TLQIO'`9J598_W)TV/3>Y,%NW&8O=6!WSMJOZN[1V750PYO;M4]?C,Q2P9C`9^G%= M+),?MI:K[:.=%PM5X9M>MG$=C/'*LFH%U<=D@J[EB[=U*`;8R? MI_V+?[V?>,YZS)3X1US]^ZOU[W[KW7O?NO=>]^Z]U[W[KW7O?NO'@>BR[O,4 M6XLS)(_E>"H:5XVFC!%,OC5?]7^HX]2!4],C,DSHRPEDJS-YY-+0/KJ`TBJTMXY)4@+CQ/PZ7)O&YTS.< M,=)@0:Z10W]6` M!(<6E][(H!GCTXIP1Z8KZ]8UF)B3S4TM+]T/#4TZK$\FJ$^5S-":AE5I6*EE M5U"J2UE/,FN)(KUK5P4*<^GRZXHPI?&Q:6EFC?13K+)XHT4H&5(IEC1HU9IR M46P*1RJH52WA?QSQ`(_U?ZO7JHJAJ'[OMJ/R/&G\O0=<;2R+JM5W&J2G)E16 MHPSK"DDGEDC:2-74GG3I(411^K3'6LGB3\O*GS'K7Y_E3K@]4JAD@=9 M-2)$C!$:I\:*-4,BM$`7,4-F<&0OP=3`:X]T&/3JN::017AQ_P`/^K^52/+3 MQ&1G84\9$99JA_N3?]M#X;HJ_;B3R!R@8:F&MF'$CZZ<"`,=34P.N2&!DC"_ M;O41S2N'E2:)TB64P"FA,R:T>43`*5MI$EFM?QO[N4FO#JH57!93GB<>0\O] M7KZGJ,88Y'G^XUQF"9`_D9OW'TJ&>-:=VD>&4J57@ZN$*D:H??CP`ZT*ZCG] MO^3Y?/\`*GF>O,HBFA`5F8ZE2:X4QFUU0R22)6>>%VL."!"64LJGQ^K0CK38 M!/J1_J_U>G4N)A#"XEB\+LL1O4L9(8S3HSZ$61M"-3T[!DD?BS%M:C][WK\0 M(/#IXD:6&G)ZBA'E9M<:^E@)&6I`D%DN]*AC,`_:DD+ZT6-KR,Q:_P#G-U`' M'/315BP.G'J?/Y#[/R^=1CKMF:,C3*H6&%2\(B2&2;3((?+,$>)Y4U`Z1H0: MB>.#"VP0`<=>7B1Y@&1O$D#R1L&66U1$\?BBHE):. M=F!&D,2HM(VC7@!UNH5"Y;-:5_XKT_XOS/13_G'\;X?EU\:.S>CTR&-PNXMP MXNBRFQ\EE0TF-Q>]MO96FRVVJBLJX$J)J*@GJ*0T%7*J-+!3U\A2,L3#*$.? M>5VYSY0WCEQ'"S3(K1L>`EC8/'7^B2-+'T-?+K(;[J'OO)]VO[PGMS[Q^!)- MM6W7#Q7L,8J\MA=1O;W0CK0&5(W\6%#0--$BD@$]:A_Q<^7OR3_E5]N;]Z[W M=UF:FAKFH]R;8S5-%4I25DU!+(E-D88Z['UU*Z-I MFBTGWA1RESSS?[,[ON>RWNT5@D93-;S52K+VB6*05I48!`9&7RP*?3?]X;[K M7W?/[RGVYY']P^5_<01[C:0R#;MYL-%QIBFH\UE>VLC(6"R!6>%V@N;>4,`R M:G5KY^I_Y[OPYWW!31]BT79'2N=F1#5Q[CP!WSM:*H*QETH\[LD2Y*:%2Q16 MJ,33>1(QY"2RA,CMD^\3R%N:(FZ?4[?<@9U)XL=?0/%4T^90=<9/<_\`N=/O M81>VO?#B5P.*QWG,BBLIU,;Q%F92G MF$O[1S#RYS-#XFQ[O:WL9&1&RN1\FC/>*'^)1FG7/3W!]GO>/V1W*"U]S?;O M?N6[\M^E)=6\UNKMD$P7('@R5R*PS-YBO0T46-HL:M+%CZ"@QE'3Q2#[>EHZ M>B2F63Q+"C#'I31?;T"2,`I16427_;:_D.$5$!$<:@<,`#A]G4:33W%U+X]U M=2RRY[G=G.:>;$^8-?F?4=49?\*!I4;X>];-$B11S?(W!E!'*)(Y?#U]V'`7 MC*B%2-<3'20Q1-("Q\HF/GWEO^5%VO\`Z6 M2KO_`+3]O^7^4?GY"'_(GIW;X(8B:`%ZH=U=FK&"98A$&I=JJ9(Y(F)DDC(U M:=)!XL&L0AC]W/4?;;*'1^\)\_E%_L]`G^^4>(??5NJ.OBCE/::K7/Q7IK^> M*>M/EU?GC9N7^3M MZVKZ^)]ZOK=H4A5@SZ9:J[L!72BIJR:$D@`9J.DG]VW]UGW)]X_O&>VO/K\J M7]O[6\L[M%N-WN4L3Q6SS6?ZUM:0/(%\>:6Y$.M8M8CB#LY7M#$-_P"$[_4& MXJ>G^07=^1I:BDVMG5VOUCMR>2.18LY78>HJMS;M:GUO"L\&'6JQ<;21ZBLM M05U`AD:-?NP[)=0P\S\P2Q%;2016\;$?$REGDTGS`[03PKCRZS7_`+\?W0V3 M=-V]B_9_;[I9-[L&O-VO$4U:*.>-;6S#C\+2E;EPI_`@;\2@MO\`PHO:-I/B M4R'R'Q]UHTEPQ+0S]:4[B1PY!E#PE6LBBZVN2"D5/O2_!R/ZUNO^L/\`L_M_ M:O\`[B8GZO[S1%*:-CX'Y[G_`*N'0]_R]?YDGPEZ=^%O1G5O:O=-#MO?NTMN MYC&[AV[/M#?E>U!4R[XW1F*:*:MP^VLIC:J"7&Y")]4VONK MR#L/(G+.T;IS&D.XP0LLB%)B5/BR-3$9'`C@3]O4%_?=^X?][7W9^]9[U>X7 M(7LU=[CR?NFXV\EKZ,5TUI3HYR_S>/Y>*1I M'_LQ>*#*Y:9XMA]J,K:!KC50=GI)+8MIU&S![E3QY2.?]>OVPJ?^17'_`,XY MO^M?6*X_NS?OR@`'V"O*_P#/=M?^2]/\Z=>A_FZ_RZ13LK?(NA]4L@E#[#[6 MCF=!-)=EDI]H1.-1=O&PLP4A@4Y4Z_UZ_;#C_6N/_G'-_P!:^K?\FSOOR4I_ MK`WU?^>W:_\`MNK_`"ZL)V]NC%;LVMMG_V;6^];;>3VMS$2I,4]M*T,T9*ED8QR(R MU4E33!((/6DQ\NHJSY,_S<=W;*R,=1EZ/Z]J8: M>*)\=C)ISI5M+2,1K/+8"\ZA^;/?&\V^5B89-VBM@#D".-DC(`]**33U) MZ^LW[L@M_N__`-USRWSC9K%%N-GR%N&^-(%'==7<-U?HS^;E7DBBJ:DJB@F@ MZW;H8XH:JHIL>JXVEA:&GC9Y+PPXX4D(HJ>&D%9**BD2(,-`*7L'*M9:@]`R M0@6-5[%PH&*`8'[``/RIU\C$XN'8W,O=(S&I9B`6)]26)8_,^:Z2>-HH4996&@`O"VF6-U97&I"""#G!XU'H:_/J\-Q>6\\%Q;3O%=12*Z,AT, MKHP9&1QW*Z,`RD$%2`0:TZ8MI['V1UO0SXC8>Q-C['Q$+TX:AV?MK;^VH-:H M:>"`18C'XVFK-2+XU9E;2=27DNT4:*RVW;=MB6+;=O@@CI2D<:)C_:@8Z/N8 MN<^<.<+V7W=Q=.,UH&GDD([L]N*DTJ:JE;?\`.J5U_EY= MKM/,X=]V=4%8(W!A\DV_L'/*9&1E1I/&B<`N&`!_L9\>V_ MZOKUT#_ND1_X'5[9,2<[5O6/2NW3?YNB@_\`">-=?1OR54MXR.U-F,DIU%4# M;.R'E)TS1&/3&M[DH&(%W73J0$_=A_Y5OF0?\OZ']L0ZR<_ORQJ]Y_9$:J'^ MK%W_`-IHZ$7^?TL*?#KKM*>"6&%/D-MH:7FUHK-U_P!B$Q1J3"[+$VJS-$&% MS?3J)D,/O,KIY%V?S/[T3/\`S9G_`-7'H#_W)5/^"MY[`Q_R!;O'_4QVO_.? MY]5N]/\`1,/>'\D7MK(TM-#/NGH[OC>'<.W)FDJ/-#0X7`;+HM\4@BIIZC4E M9LVKJIE\L,49FI$`+'U+&VS\NMO_`-W3@ MZS9]T?><>SW]\AR+%N-XL7+G-/)>W;%=:B`H:[GO)+)R3@4OH8(ZD@!97\R. MK,/Y&'>2=B?$K.=69&>HK=S]![UK,51_/YT#!U'E2G#SP+_OD M_9J/D'[SVV^YMA8A-EYTVA)6*J`OU^WZ;6[6@H-3PFSE9CW.SN6)\KK(GLY%/SI[D\X>X=U'^C$LI2 MHK22?4D:@G^"!6\O3A7KZ$_[QW2/IX?5;I+"PXAZ2C-#T4#^2))X_YB&TI+*Q_N)W)I5T,B%SM+(:-2*^E_ M418$L"U@`QL"!?8$$^Z-M_S0NO\`JV>LJ/[VG'W$=ZQG][;%_P!I4/6SE_,S M6HF^`ORMJ-4R0OU66+PI$U/-)'G<$'@E0PS>*2+6Q8(;HNC]RP(ART]V?^G: M\Y"G_$,^O\:=?/U_=_\`_B:?W;R33_D21_\`5B?UX=:\W\E3Y;_'3XM'Y$OW MYV32]?'>2]8G:RU.W=RYX9@X`[[DRH4[=P68:D%&^3IK^5H]1E&E6(UQ8S>P M'.O+')PYK/,F[+:FX^G\*JR-KT>+KIH5@*:EXTK7'7<'^]Q^[-[Y_>)F]A3[ M,>W\^^#:!N_U9CGM8?!^I_=W@:OJ9H=7B>#+31JIH[J5'5ZG_#N'\NZ41)/\ MCZ"1E>=X_+L/M#P1>0-?6(]H$D$5)%BSDE22P9?*V17^O7[8%C_R*X_^<5+V'L_"YP[9RV2BP MF:PT6.S2X['Y&3%U]'N+%XNJD5**L@=/%!+&WDL&-VC`SY8MOY3]XN3I-EY@O+);N&& M26WF+V[220B35;RRH/U8I%HQ#`K4"A!ZKR_GE6'P#W%(LXE$W;O5K$^;RK(6 MJ,R7>)ON=?CEDA+@.9^!9;JH,49?>"/_`##2^S_Q,MO^/GK.+^Z"7_P-SE0C MRY?W?_JS']M,Y\NB`_RM/C#L3Y=?RU/D=TUO=:>FJLIW]E,ML/OSH$FYEH MY.)BE6&+0_V`X;S*$CK-W^\F^\-S;]U[[_7L/[N)`V/#N(XG/:".BC?RU/DUO3^7I\O]R_'[OB6OVEU[N[=?^CGM MG#Y)ZB*EV'OR@J6QVV>Q((JD4W@IJ6:98*NH_:6;#5?G:Y@@*@[VHYOOO;'G M2^Y6YE'A;9<3^#.&X13#MCG!_@X:F&#&P8.U/&*27^WRJ)+O;91Q$X"F2&-AJBO('@H#-(1NATR)'5RJE/Y&F M:G!+2QD:BRQM,VJ-D550A#I!U*>%!8Q/G4@/\`7WA/G_6";_JY-_L=?75]X"O_`":< MW,?^N+E8XV$59*@I099"\T,B,JZ9D^YIY"D!D MIPY*F1D$:2,6`XE-@:-4K4=4()7L?AQIFOI\N'"OSXUQA8E&\<%7)&D<.B"1 M0H^TJ(W1J1I*>57#M$TZ!H;1JM]"HA?QR:^(5\Z_R_U?[/5R!BAH*?S/`_;_ M`,4/GZ:6$1Q4[JL!%1%3.0-$$FI6HS%`L*Z59KA/4J,]]"JW-/[WIH"3GKQ) M(H#^?7"B>-\WB`[RB*#,TC`4YFI8P@J8GB"23O&H!*,25GC$@53=U`>*KU\% MCYZ3UI&_7B.K\8I3TJ//_-C\P0#I^R/H6]>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=:PN_=Q;1V=\_^YZ'$U&:RO9^5GV-E,G6;=PU']ET/LC:G36W*ZF[ M)W36;BDFV?!6;PSM7#BL7&(:B>&$U=4*>6=(;Y%VEO?7_M[L\CK&FVQB10'8 MUN9)+EP84"T>D2@R.00,+FAIUB7>7>W6'N3OJ0M*^\RF(DHH*VD45K$_C2%Z MIJE9EB04)4%C@T/0D;G^9=-U+UIC=KU66WCO&/;U=69.DRNZR4\-35R5U?M3&XNEJ3/*N$HPN)Q\D5/101+X]"*UY)?=MR,Q@ACDD`5A& M/#MK:!:*":?&7X5D-6>I8D]&-W[A1[%LT(WC7-U:IK8*"A44D9 M249930`A%90#7)!$-[?>R[MN&X\S7#`RK.`-))_6EK\`T+(CQ"M4+9.GRJ#> MW_*$>.OV?V9F?!"'R';7:,PJ:?(5.5BJW;;G0L5;7_Q*K@HY*^3+UE*:AY%@ MBC#'2JZ0&:!O=BBW^SVX8D1V$0-0%_T6Z--()TT!I0]9'^QU&V[?9ROQ;A-G M)K^G:U;40*ZB*XK]O5T'N)NIXZ][]U[H(NA!;IOKJ_'^_:HC_MS(1_MQ[]U[ MH7??NO=>]^Z]T#WR&M_H![RNKN/]#_9=TCC6:1Q_/ M?NO=*3:"G_1?M=0CAO[A810A0+(#_=ZF`0Q@6#WXT@6OQ[]U[I$_&"W^RT_' MFR/&#T;U,0DD*4\B`["P!"R4\8"0.OT**`%/``M[]U[KVU1_SD/W-_CUGT41 M_B/XUW:+C_"X]^Z]T.?OW7NM;W"]C8GK[^:-_-%W3N"O-7L[:OQ8S&?W+A8* MS$=ES4LU/MCI>@,U?M"EQGBJL+54$<>C!Y&4#'/]ZU1^Q5-*?=7TD:*')Z-9 M\0.[>W-K_!+L#L#9GQ^Z'QF9V=F'FV5U_P!";8[Y7';@S.4SE%_'J'=_65%U M-ENSJ/=5%@V-JR;UW"<%C-I1 MTT&`%`E%A88I:"GH_DC\I::EC!B,7B3K!O?NM=> M]^Z]U[W[KW7_U-_CW[KW7O?NO=5-_P`W"!*WHO#8MJD4SYK=6R<-!KDE2&IE MR';'6]D?C['96Y_'-&!Q)K]3:TX`GR/`'K7UWKA\WN\)H8V"Z=:'PAFJR*#3QR``DB:2!\*J*DFWGN_84M)45VP]DUL M._NUNT.Q\)!C3%B*/^-9X4%'B\;5U='/%2Y+*NN`QM1+454D+.Q6.;SG,[I? M1HX6"UFP))%\*"*(DG4=*ABQH>Y5J[`!:]2]8>W;;/MLTT;-<7MOEHHF$MS- M*-(*IJ:F@$B@=_TU+%O3HN%7L39>V/EIUWD3MS,P=GP5NZMJ5J;DW/0[H38N MWL+\=^V)LO@]L56&E&W*%MP9RLFK<@E!!XY((J"(SM,E2TQ\UW?W').[Q&X3 M]UZ4([7,-&;5WMH6BJ6H02^*:>@T+';X.?]F?Z:0;MXC1L'=9!$HLKK M6J%#X8UN'_=>Z][]U[KWOW7NO>_=>Z+1NM:?\`O'EDM$9TJZBH1'52=.BTDD@E6F6X M:H4J5?Z$$D%O)(:PU,*'Y#H.W97QY5/F2.F6GB55!D2\J1)&(_(Y5&T:4N@D M0Q:5]`34.1P%),;N],K4J-0[AY?X.L$#2)5>."F?1'`KR.]C$#.TZJ-7GDDE M=54`KPK?HLQ5HH]^1)/6HQH<*HP!7\^LDD3C3+(K2/'$XAB_=:)V2,Z391+H M64V?U:F.DZ=5M2>#&E.K/11PR3UBF6HEE#5)5X58R1E(/*4=61HA#$KQJBS" M1F"2*"&`?4+"5M4X_P"K[>M,7)4MP/GCUQ_*O4JHF:-:GQDT\:B-C)!!)/4F M'5_E&F#QKXVC\B:E5`4O-.MF@U4_L_P#5_J/7*593XF!>..*J M^WA0A472LX@>2`JJTK1/"RD$!"U_H3^S[T&!K3CULC4%T\!_JK7J(D25E3H4 MB*E>324FC@6ZR(7BAE9$96_;C-SJ9++<(]AXKFBJ2>/5`K%B*C'E_L]<]"JS MW>$A2TK&GED\8?T.FDARB-'(=08&Q`N21:85'EU:BDTKGKTT0AMI>5&ENOGD MU,9(U6P`J=*-*5J:ERM@@75;4"=4N^-:#AULKH(4'N_;_/KBW#RU?CCD"/3Z MA2M)Y$>*=H9',4JD+XDL92#R^M0NH^*37`!?+/\`J_;U4AF)E:E13AQ_9Z4\ MQGB!@FN%72?RS$J)S$X10%DA+HT:3^"3R5`1SK"_I9BE[Z@FB/9P0/\`5Y]: M7N!:G=FOY?ZA_@\L1IG@A@>I1H)YGITJ#(9=4RQ2(9%^X1Y13V549G=208PC M:K+Y8_5ZJ.WO_P"+I\QP_9\LXZD.X$5JJ;QQ/3D.NEXTAJ*8F?542K&@B3[5 M`Y5F"@697C9A(W@#7`Z<\0!>XT)X?[/I^?V=29W2"6GCC=XQ-/Y72F5-2L!? MUQ-&NH0/,IF%BWJ8<,PCFUY'K9-&I^$\?\G7'3!!)XG,GDG1PSE_6X1@I$44 M/"1*Z%5U:N`4TWO$OOMZT=->WC3CZ_EY=-WD7RK2P",P/#%-(*9TDCD1Q:.I M\A9RK^)&;47*E2WJETGQ7&D@5K4=4`_F17[*BO\`*O4E=-'H".B2TT$/GFF< MRTZM#>0FN@+L55!^X9"Y/A4$RBWE%2*FGEUYB`01@`"I/\Q_L^77<-8LDH57 M60R22R1PH&="8G6.1F&L-%]N9PR.;*KA0Q5F_=V:FE3Y=:61!0(U?Y]BMG_BOG^7#`X`=`GW/\>.E?D-B:7;W=?5FR.Q\+0TM5'C1N+#B3.XB6J=E MEDP&XJ66GSV$C8*"OV`6J'N#^07\3=Y?S(ZR=YIHKT&X9J?=/B@5@" MBY8CPJ+%O7+[A??/NW\E;@&?9[R[L)LT`/C1U\JJ]&`KC#_EUTU]L/[Z#[SG M)WTUI[A1XFV^\*X!*RVQ:W)(J>ZTXGC3A2]\K?Y5ORS^!E)%W MAMG=-)OC9&SZ^AK'[2ZHK,]MS=6P*IY:6&CRVX!.;?9[G3V[C/,5E=K<6$#!C/;LR20YP[H:,HX=P+J":$]=7/N] M?WB_W9OOF7@]G>ZL=P[26AMYQJBN)-()$,T,$C:3X M:OU>9_*!_F"[R^7^R=U=5]R5T&7[HZBQV/RT>ZFBHZ>7L/8E=4KBJ?)Y/'TY MIXAN7;>4ECIZV:*..&JBJJ=SIF:;SY$^R/N9=\[[=?;5ODH;F&S56,@H#-$> MW6PH!K5J*].-0WF>N.W]Y]]R#E[[K7.'+?/OMC:F#VEYEFEB2TJ\@VW<(E$A MMXW:K&UGBU26P=F=&CEBJ$6,%%_\*`7B;X;]9K%3B`_[,1MR>?\`:EBM/4]> M]BLT`U2-'XX!%I5`6\84J.%M&7_>5QR+M?=7_=G'Y_\`"I?]7^K(S_N3C7[U MG.BA2*HY MHWUQ2*G;_84VJ-T367C&RBW@;4`Q:RVL3Z/5[%__``/?N;_T?[/[/J)_^M?6 M/1_O>_N1D:A[4/[HVS_MMKT-/3/_``GJW4^:P^4^1'?6VZ?;YJI'RNWN MI,;D\QF,@E/,%-*-U;LIL)28TU2C2TJXZK>+D:0P'L0[%]V2Y-S#/S1S)&8* M@O';J[.V>'BR:0HIQ(0GT%<]1%[J_P!]_LT6TWVV>Q'LQ=C=)]<[5ZRZUVU1[,V)LK&IA\#M^B\U M4GVPJ)X\C--,ZR9#-9:NR-1+/5U$[?=5%1,[.&D=H?>5&T[5MVQ;=:;1M-JL M.W0+I1%X`<22>+,QRS&I)))/7!SW!]P.=;K_K#_`):]=T_[B/]U_:+E7E/E*YY9V2_BAMY+JUO7N&22RMK M@^*\6X11L0\S`%84[=(()!8FJA_X3]_#LQ?Y3V+\B8Y]E+7@E_? MZ]@,@9;,?T`A@;HI4L*_^!GY'Q_NVW/_`)R0_P#6GK'X_R_P!VF?MZ\W_"?OX>.RI!V#\BB6A23C<_7['4TA#_`*^M(A''"HL2WJ+7 M!4,-!\/NT5ZN8V3LW$; M"V'M+K[%S5%9C-A;3VMLRCJ&)-TWC<[J^G6(,L:RWD\EQ*L:EG8(KR,(P6=@M!J8U)TRNRYIND MOYTU=E0/@]QQS`!G#7^L@_5@7 MNS#9/?V66?")OZ/G^&216!\L4>O7U=\AQCW0_ND;#:]G-9[GVHNK,`5)\:RL MI[>10,DDRVS+05-33K=FK:N.%FI9W15IY93KDJ8R(A&;P-*\CEI6@9-9`!_P`/[1_/ MK--`M8LU31U&A9@@@\T=53WA55U1HJH)`9630$5&))TM9085UZ5&?EQZ<.@J M[JX51ZUI]I/ITW4.3Q.5@>HQV0H?IY];O+6YM98X-PLYK>Y9=06 M16C8K_$`X!*D4(-""#48SU5=_.BD,O\`+Q[9G28^.;=W5#`>J]3%_I!Q+JQ! MTJ(U,BE66X<`'5+<2M#GO^*>UN]5'=X]M_U>7KI!_=)T_P"#K]LJ_%^Z]Z_[ MMLW^K]E?+HI/_">.9TZ1^1\:1H[2=M;)`:365C#;/R"-(B)I)D34#JU)I)'J M!M[!7W8J?U9YF)_Y3D_ZM#K)K^_,+?Z]7L<%H3_5F[QY_P"YPX_Y'6(H]Q_R_MS[< MRU*E7A=P=Q]IX+,T^D-][B<]M+96-R&/J"IEFCIJNB$R%M"*-1%W)(5=]WJ& M*X]MI+:X4-;R7URK*>!1EC5A^88]!S^^'W/E]<$TFX_L:.*F=UD1HLN3&X#B3W$/M3+)[?>\>[U1!-$(DB$6U,9+3-(H)#5L;%F+^26=O?3F1>7O;[O6LI_*B^`737SD/>2]N;A[$V\>MT MZ_\`[NR;$RNW<9'5S;J7>CY"++'/;(WLU[9[) M[B?UC_?-U'X1M[FW*ZOJ7UZM=:+0+D]7#1_\`"?WX>32M$G8OR(4( M55YGW'U]XED9%X+#KT_M(Q-R=+$_4+Z?).G_``,_(FD']Z[I4_\`#(?^M'7+ M4_WV_P!ZP.H_J+R*%\_\3W'%?G^]?\W7O^@?WX=!G/\`I'^09194BM_>C82\ MF=XY"TK]:*BQQA`+D!BQ/IUZ8CH?=HY$IG=-TK_S4A_ZT=6/]]O]ZFM%Y&Y' MI6G^X6X_][7JQ;X?_#?JKX5=?;EZRZSRV],_MS<^[JC?554[^J\/E,L4ERS:FNT<E^]/[@?>XYZV;G_`-R-IVJSW>PVM;"-+".:*(PK M<33AG$]Q<,9"\S"H95":10MJ/1/_`.>C&Z?`+YJ#'TTA.Y=@4H^RQ>]I$CACCFRNR'"T]9(%$KXF6)I M51*2/6B^\'[=?O6P_KSM<).X6L86Y51_:0"H67_315`?_A=#P0]'?]T)]\3_ M`%ON<&^[!SYN:IRAS!`QH*W*]"U_)3 M^;]3W_U+'\<=_9E*SMKH_%XZ';M3D:O7DM\=0T]33T&.JF,Y+UF3Z_>6+'54 MA\KO0RTC,LK>17/O8#W$3F39DY9W6XKOE@@$9)S+;@@*:GBT9(1LUII/K2+/ M[VO[GD_L?[DW/O5R1M9'M;S?<2MYM_PK*MS$!01! MJ0_C#9OYR&W-3Z0?F1V26DC+267^^6\RQ41U$C3W7Z*'E\GZ;2WTMCWRF1_K M\P'\7[_G_P"KDW^6G77_`.\&3_R:>W<@C_IT^V9_Z@[#_)_J/6[*L=)20G4T MFE;NS,)(&E29T,$A3@01OI)\:O#;]5CQ-[Z"#7J!`SU\C+**57V?ZN/ MRZ]JJ5,!6.:!8I%D,Q6%ECC`@F:X22GE@CIXYW!61(6N+%1_NRI)(.HU7K2= MI6@(!]?V_*GSKYY.:UX5918)(IH)I*>0I&\:A)4FY6!6,8*K345#7,=(VJ0D;HMJ@)*9$=M2) M,)0BQ:TC6%9^``4`*W6\JAD39)X@=:.D`(IP_K\_6M>/SK4>1%2CC@XJ6DRV M)HA"]/(*S'13`ROZ(Z?(LRR:8Y%%.6D90&*^:0`L9G`\R-2G4LM"#VG_``?Y MNMPJ%FME9"&,G^`_Y_,\>CG>R/H8=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=:Q/9/5=)G?YA7=6[-F;BW-@NQHAMG`[EVG!BTW#MSM_9M/TOLC+;.VT,/ M-6XIDR^&WM3*)*JCKJ.L6DK'T->$K+D7MVZRV_M[L]I=6TW1.^*=,-GLMGX1ACF:VHW52_WJV5_%*' M<.T*;<&X(J$57\2IUJJ6BAQ5/2X*BJ"HI*3SE?)(>Z75K[#)+N.U3*M':RBKFH)\2YR.'D-!49`IU_=>Z()L7H?I=\5,>+AJYYI(Z(5,'?&,@J#`IL72F@5CR(U''OW7NE9_LKV[ M/^>NZD_]$]OW_P"Z&]^Z]U[_`&5[=G_/7=2?^B>W[_\`=#>_=>Z2>_>B=R[$ MV-O/?%3GNK,M3;-VIN'==1BJ3J'?,=7DH=NXBLR\N/I9)OD(T*5-8E&8XV8% M0[`D$>_=>ZQ3]';EI]@3;^.HM\"L,$>%.:_AJS?[,)X!5& M,>(-;1KYM;W[KW3KMCX\[GW-MK;VXX-R=4T,.X,'B_=>Z$+HG;5?L;LOMO9F2CV-65-%MCJG/#<&TMI M9O:E9D(<[5]E4B8S,19O?&^9*R'$/@6DI6CGA5/NY04N;GW7NC4^_=>ZU_\` MKNXNR:[K+>_3_9.UFQ?6F=RFU.N*S<% M7@\?-OW;65W?A,//B\I'+'MY9,<:V?344<AL_EX8?9=9_*X^1NVL)C]][(ZOJ]U=WR8VA MI,%M?/;YVU@MX8S&[IW3+AZLY.I?6G5@/\MFDZ#I?C;`WQHW=O'L7J6MWMN.OPO9>\L7MW#OV)75% M+A_XMNK;='M_`[7D;:C^>_=:Z] M[]U[KWOW7NO_U=_CW[KW7O?NO=5X?S`9=IP[=Z[J]\U4E#M/$[^Z^S6:J8)J M2GJ?!B.W>LLG34U)/7QR4<557U]%%3H7`#&73<:O8ZY'6Z,^YK9*#=O;2JH( MJ#J@F4UIZ`EOE2OEU%ON2;'3LS[DU+*.YA=C4`]EU;.*$^I`7YUIY]4E]_=] M[3ZS=,5T#LNCZ\R6Z(,GF=];WH7RF9[/STE=42T5!3P[[J*'&1'#U.-HZAI: M/"5M+7UR1Z9:>0E"9:Y>Y=NMS8R;W?-<1P$*D=56%.!/Z8)-0Q`)<%5Q0]0/ MS/S1:;3$UMROMJV)HTM&W5]5CLMG&@:1J2,TDBOX<2*E>UBGB2R?&Z@$Z0Q/5??7/=U!O[ MY;]08;:T68AV/)G.WH\3]_%4S;EW#E=N]0=J8/=>9["JJ.:NQ=-D*$YC'U>+ MIX98Z&FH,Y-'^]4J\S#_`';87VWDCF&:_=&W#PX*^:HK3P&)800"0P5@[4K5 M/P\.HTV3F2+=/<'EN"QCD7;O&NM-::I&2VN`\DP!(#C4K*!0!7IDZCUN?#Z> M\11_EZSOZ[][Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%&GG5JT M/31R>2$4TC0P++(Z1"G,KN\NI76]RQU,"09C>$?XO`:_AZ#EP:75P2JE=7G_ M`*AU",4RRQ3I4LY$3U#L0$!E?72+!&()"VB,1L560>3U!%33>(WK13CSZH!3 M/RK3_5_GKZ`]9GG2U.\FJ42IJ M2/V]I:R6C:::2,:9PY":P\/7E75J<,3@8/^JN.HTNFJCF\;&2!#+RCL51KQU$GW'CD1H2VI7'K! M93JU#_.MX=M,=:;O6@'EUT(8XW6=:98I)-4<#2QRL==+^U&M,BJY197.F.WC M%WY*.Q$NO45ZLN""1Y=2E2/R21R!OV5IWCC*PQ!HY9X]0D*1ZG29+A1:1ARH M!`:+W[RX];.'`"X`'\SY_P"'J/4+X%EBA$2QO.+K%()(U$BR.ZT\:5,UY8U5 M18>12+\D+:+W^'K1`%:'[>NM>MY?2LDCZS`Q9I34&58A"YCJ]1#1K!JN&:^K MU-Z5F71KZ]:_HD9/4%LDT2TZ*STA/@IID,!DB;P2"5);#[9(8*=4+!Y+`."R MZ"Z^794G(`)!KTVKZ1I#-2E.!ICIRB>%/'-5(\]C*T+EWCE58K'@-IIW29.# M=7&AC'Z2_B;9R!U96(H"*U)S_@_;Y>76#49D9GDENKB26)6C5SJBN]-:%)85 M@N^A=+.?1Z0RAT3?H:=;T_$#@UK_`+'4:HUS:Z6"3[2:621F;S1"J6"1`[ZJ MO3K(:.%22'NRC4')M-'X&E*C'6F(8D#!_P!7^K^?$=2S3ROY7^Z!1JF"5S') M&C1AS;3K6-)@)%<*RZE>Y##0;3-[SI3K01B"P>H'K3^5/]7EY]1H:J;RQK`T MH5V:+QQRR:S1CRQ+JBC4RJL.7WC[+=OZM;/O.VW5Q';V]R4G$;LH*RJ-#L`0#I9= M-2#0N*<<]B/[FK>O;>Y][_VB\W3>MECFVUKRVM[AEFL)7:Y@A,R, M5>6"<3:4IK6V=F!""@L?R9_EGM+N_P"+.U^G*S(I\;5Q4%9I644L]/9M,+0!!#[&+YI]P]NV)U]J.; MIDO+2YBB(M(+MHU2[L795"0R^*C7$,9H)(IJQEBCJEQ`,:CQU4L(22/RGQD& M265Y%GDD"F?3`D=39BX8!0=1(LLIFLU%*'->N9G80PUU%/*F4K< MDA4HD@6)9)9%C6,LX3Y^W;;-DY.YCOMX*?2&TDCT-_HCR*41%'FQ=/(W,!S>^=U;=F MPF.#K$P:=Z/;-;/I#*Q2&WJU"-\5?NR;;=2\U;UN84BQAL#&S>1>21"J_,T1 MC3B*`XK7KO3_`'X7.>R6'L1[79-RYK6ZB2JZQ;V5G34B*TL$:."+$2$.%% MM87]J4?O*BG(VV@L%O[DYJ?>JYS2ASR3=_E_C^W_X>A"_D1V_ MV0Z".1;0S=R=FLSB.[(_V.TXT<_M1HZ:@+ZC(`R`DZ5/B,/NZU_UN(SJX7]S M_P!8N@9_?()7[Z=\QX?U4VD?\:O/\O5Q]2/'*D9L4BRJTU7]LS@,B":,(&`:31$ M\,D4DJ!$<)>)M0E7T"-R?"/`Y'KUI]5'-#0'C_Q=/\/6LM_PHR9O)\2$9)4( MI^YV!E+%G1INM=!/*QNP'U=5.K_5L-/O$K[T1[>213_E*_ZP_P#%]?03_<3? M[E_>8J!\&Q^OKN?K_L?9U;+_`"IM"?R[_BY)$IEE7:>Z:EY8YM;TJQ=C[N5E MD#FT%/ITL5UJGJ#V4_N":?9P_P#,,N3\4_Q9Q]OZTN>N:/\`>0#5]^+[PQ!K M7=[8_P#=+L!3^5>K!*?6\,KO.L\DDL9UI*VEWBE+>-8WDIVC>.)U0\*L;!C: M,FSR92E,4ZPF4$ZGUDFH`]?LR>N55+&:F2)G>29J%TCG:)F6=9-452GW<43Q M^59F$:1&Y4M9%L#$/4/IUMCG)J?SZ]#$)9&BE2&TOB\DE0)JA2BQ3JQBAC2I M5Y]**GJ5_(+_`*U33'K((/E3JH:H:,TJ3\_\W^'K4Y_GV_&G-;6[CV=\L=LX MQX]K=CXW%;,WMDZ%75L3V3M*E>/;]?D#]Q,T+[FVA20+3RK:-Y<5(2SLR2S8 M:?>0Y3N+#?-NYTL486MTB1RL/PSQ5T,3Y:XPH'E6,BM<#Z1?[E_W\V[FGVRY MS^[/S->I^^-ENI[[;XI#_;[9>MJNHHP<-]/>O*\@'=HNU-*"O5XW\O/YJ;%^ M9/0^!W%29*AI>Y-EXC'X?M[8457%%DZ+<5)"(EW90XZKJ6J*W:>[:F!JVGK! MJ$$TLE+-,LT3239$>VG/MCS[L%K=13QC>HHPMU$/C6111I-/^^WPRL*C)!-0 M1UQ^^^U]T[FW[J'N[S!LE[M%Q_K:7][+-LE^5)@GM96,D=JTP`07=HI\"6%@ MLC",3*K1R!NCV3!17U`D,<5/2K%*D`7391)]NU5KO;S0HV@HJKI#<6(:(R,, MH*<2?]0ZPW8HK9(U>0Q]E?MKC_BNBC_.CYB;.^&/0VZ]^9C,8I]_93%U.*ZA MV?)5I_%MW;NDI#!050H!-'/+@,%4U,=3DZE%\$4$*Q%FDD2!`+[@\[;=R)R_ M=;K>R@7S(RV\>-4DI!TT7CI0T9VI0`<:D#K*/[HWW9.[^P^WW+^W3-R MM%=12[S>A3X%CMZN#/KD^$7-P@:&TB^*25@U/#21EUPOY''4W8O9WRFW)W35 MYS=%+L'J[%Y;.;NDIHBJ&8(:: M-F'[BM[Q>^[KLNZ;KSC?P66:8,%4@&C^^W_`-W7ECVQL*2)&==_Q)]KM[_P":]M_U?7KEA_=)#_P.KVT/KMF]?]VV;HH__">!=71WR4)5 MG5.UMD.8P"WD<;4K!#ICM^XTY/^K0ZR:_O MR_\`I]7L=4]O]6;O'J?K1\_+[/SZ$O\`X4`M&?AYU\%5HG7Y$[9#HS(?U;![ M("J"C!F$?VY'K!/X`72RQKOO,:OZC[1Z?O2/_JS-_GZ!/]R4H/WJN>6KDR6.J\/DJU95^UDDR>W:C'Z` MA=*@8^1V+ZO+-&'WBMIN>7^;>7.>-N)668)WCRGMB"AJ,U9-/^\'\LX/[G3W M`VGW7^[_`.]'W7N;G26SVYYW6%CW/M>^1RI<(H."L5R)V9J4!NHP:5%8/SS[ M7@_F2?+GX.]`]?U4QVMF-B=>[CSP59P^)S?==#B^P-_F>.">HBOM#85%3J#J M_9E297F-WE]L^Y&\I[I\]^WG+6W/JL98()'H?A:Z"RS5IP,<2@'AI:H-*=+/ MN7^W%S]PG[J_WO\`WKYPMU'--ENVZ65GXH7]>'8Y)]OVT`-I.F\W&20TK^HC M(R_$O6U?!CZ7&[>7%8>A%!C<+@4QV*IA>..CQN/QAQV.A19HY&DDI*&-(C&J M/8>D6+-&^8[PQ6]KX-NH6W2+2H_A55HH_(`#KYP8[R]W/>$O]QD,VX7%V)9G M;C)-+-XDKY'%G9CPKFOG3K3+_DDZF_F([6])9GV/W$/VPVI"^UZX:D(BJ=/U MMSP0=-VOI;`O[O\`_P!/2MO^:%U_U;/7U>?WM9T_<0WH4K7==B_[2H>MF[^9 MFD'^R"?*P,PGE'5\RR.(ECT2)N'`$.()@[O%--3V'^<=;+)>R"6'+3W:K_K: M\Y8[?HS\_P`:?+'\NOG[_N_6)^^E]W#U',<=?+C!/\Q_L]4]_P#"H$8A>"/RP")*B>2-9B\9EH8XT"L MOD70P),9+<1EBL^6P/D/]7V'_57KY]&&H,S+CTXDT]0,?Z7)/R'6*IL'9DFE M;[A8S)3O"WF150NNA/MIWGD57"M^VX`/C1`08AX9%//JV":+6N/+_)\NI%.Z M21O`B0)(LJTZNM?55(8Z:K4 MGUZJ"_GFJ\GP"W+4RR0M,G;W6-*RQK'>WW.4ED4`.\B$2%3K+$N#SKNKF$?O M!_\`3L[\BN;JW_X^>NGW]T$*??UV>[^HT7_`'=-P\^KTZJCH,IB\EBL_3X^MQ>5HZG#Y3'9"E2? M&UN.RE$V+JJ"KHJA135E+D*&I:"2.2)1*DIC,:ZFA;(R2*.5&CE0/&RD,IR" M"*$$>A%0?4=<:K6[N;&[M-QLKMX=Q@F62*5&*O%)&P:.2-L%71@&5A0@@'K2 MK^7?2V_OY5/SCVEV;TS45]%LF7.MV/TY725%7)22X#[^2FW=U+N&OL#DX\73 MU$N*KHGUO4XJKADD!>5K8&UONBJ-SY#8+MF]JH'C1W'AUL-YM@_`S/&+J M.E5BNHIH6JJ]P=_!G>L'8O\`-2Z?[%IJ"7%TV_/DIN'>L.,EF:LGQL&Z\GN3 M.I023ZM=9+1)7^,L23*5N0;V)-[?[A'NWO1LV[01,D-SN\DJJ>*B1I'`-,54 M&AZD?[W_`"?=^W_]VK[D<@[A>QSWNR>WEO822Q@JDKVD5I;M(BGN57,995.0 M&H2>MY.I61UIVGF:%53R_=+!XXE'E'@J/"!"8WU"\EY8=+%OH;2'HBI/'C3R MZ^.R2N(S@>I^7I3_`"T]`".I%5%(D+4RA;0R+!KC>*9661%A(>"GJ%"2H')L MH@"L;!+L(Y=#XAU<#MHP%.`X'_5_J/#J%3QB=#]PR(Z>9Y99I"L21B1X%1U> MFC#^4.J*I6,$^@!U!A]WH`=0I3TZ\JD*H8:N/'\_Y^0'Y=K0OI0DQZ(U5B*53J_0T8NOD4ZX]&A.2-/^'KPI57!);4,D4(X'_)3_ M`(OK)MVA6GSVW2$9)8_=>Z][]U[H",-WK39 M;O#.=(3=?]@8>NQ&'KI:&+;TDRX+*-6>3(R,VX533'&S(T M$OD"`(6]U[H=_?NO=(_?V[XMA;0S6[9\7D[8]];3P^ZHL7D<*F5CJB,?E$C6 MHB:CKJK'O-!+"[P5V+K9*0ST57&3%64B0>_=>ZU.ODOW=@NKOYC??D> MX<;#58BIS'3%6=Q81$H]_;/R62ZDV!@,(F)\5?C%W9B=Q29&>IJZ.J:9:;'X M>L:G\`-;A][==8EMP?PWL3:V'Q-=08N@HY%[#VEN#/4.2Q&=@ MBA2.CK3#7%?%,K1MRSL%_M]Y(MM;"+W02WESXVTS1*1-`I?3.BJZHH%&2>*1T>.4#25.'!DHZN MGK)\754R24YD-2T;$/K.4[H6MK)(\8K\WLO-;YWYNZEK\E5+65CY3*X/HUMMFQ-N,*QW4=O%%I`(%%>YH:'^+XJX!K4`=3I[?&PCW MGF:+:9FDV^2YEE#,:G4T=I45_HFJYR*4)KU:%[CSJ7.O>_=>Z"+H3_F3?77_ M`(;5'_O]JN7P-SS;0FWK1IN7#IC,4^-QU#@J.DK,S)+,])[J^K*T7AT83H#![4Z M9_EEY_\`O4O4_P`\-@UF_<1FMS8+K/:>>[?V1N+:>]NR=A0[JI8]AIMS>FY- MP5?6]-DJO,1XEL75UU/%CX()0T\3U!]UX]SYQU@^'$,7:O\`+^^1FS]H=.U' MQ$IO1>2V;EI=S;]Z=Z^WCNNLW5L)^M.MYMX)U_O?=M;L>#*8W#Z MZ_';;@DII'J$!'NMGM85-:='9^"74UH.PY\ M+UM0Y?;FTY(]JTNY^V,1A.QM[FKFBDS#Y+*0!T?*FBA/VU)`J^ZH34D]'8]^ MZUU[W[KW7O?NO=?_UM_CW[KW7O?NO=58_P`U3%5N;Z9Q.)Q4<4V4K]U]<0T% M//4BDAJJQ>[>IIH*628S0*%J/$RV+$&_Z)"`C23[:RI!NT\TK%8EAF)(%2!] M-<5-/.G'J&O>&%[G:;6"&,-*TL(`)H"?J[7%?*O^'JF7&=79[?$V%VWF^A]Q MY_+8NJ@I,9N2E@W!LEL?CSDL?E$3.;AGEQ^(%!0YK&(T9GJ7IFCJ'^WJ-2Q" M*4WW*WV]+JXMM]CCAD6I5O#DU$`BB+EJE222.['RS",.QW.Z-;6UURU+-/$> MU@DD0'<#5Y&`%%8#35J5X"IH#0?,#H[:VQ>M^C^M\ANK&=:[7V9MJIW3V!UQ MLK%/7[RWMV%FL?38>)SN2:'(T=%6TNT9DI4R->U=+CX9G*PRI*&)#R=OE]=[ MKO&ZP6CW5_/*(XII#2**,'5\.#3Q.[0M-5`"12G0JY]Y:L=NVCE_9)[Z.TVZ MWB,LUO&*RSRL`@!?(IX9T^(U:=Q`)/10^E&K:3N/XY4.WNH)-B]1Y3>&]:7% M5N+P\%'D\E5Y#HSN&BI1W;4Q%7,:POL?- M,MWO/U&]);H22U1I%S!B-`:)I-*8H$J/*O0,Y6\00:=;@:WMS]?>*_6;@Z[]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7C]/?NO=%;W!)2P[KW(PK:F&?[FLEF,<9O"L:0J$@C0P/(TB5-_,&-B?& M##5]/`?PT'0:N#']7=*Q(R:X\O]7GY?F:MS>1X7?PR&-*.YTOKD1Z>( MT\#V@2H1I)D6VD*2Y&DJY4QJYPH/GU5FH@)^&F?RX?RZX4U+ICDJED`J&EE( M6&$!I0PN6&G[H+.D*KZFY98Q96"AHO&E0!PZ\!I&M>-?\G61'#14TTDVL21D M2-%(HHJB)RLU1.D4Z\^/6UJ0"WQ=926NT$<:IXG9I2 MKO43EO&'>=0DL4-/%3Q:>1I8ZKW!:S^Z]WLP4`=8::6>4@`-=`_W+*IU*K,Q MUQ:AK+0@$,H"L?4ME_S(]CJJDU`!P3G_`"?SZS51F0RQT\<3M-*9(M/ULNF0 MQH!*_B*+"`SZI`;D#6JE4]Y_/JS!F)/SKTV3^<4\,=;5*3(@E1=3K>-OMR(](E:-BLU M[TTDK-'(%1T$GU0GR2:XY/6T(2H^W^?'KM8*593>I:53H5S'3:V2*\C.*ED% MD4@L(@+:9&"7!O&_J\<=6JAT5)H#PZR3>4P+#')&::_B30J%-+1K&$T@,)W< M`(`%8#Z6X,:>%,GKQ+4P<#KBC0HDDOJ'[4HY6..Y9O*A'T M;T^2/WF!UY5!#-FO$]<3Y9JZG`III):>(E)UIXG>2HNDH)@!DC2-70.Q;])( M.H:5D/N`J#_Q77FKXBD>0Q]O_%?ZN'6-O)2:4U5#K+.WC01@`/\`11%')()#KB57$A M:'7)"3*]E7TO;18)^J+W4_+IU0B$@$G&.L#(])431#1(#I6>1RLJNS`+>9X! M.7LB`,2TG"#5J`M#NNI0:XZKH;(;)_R'K$U+3PF66.,)/(B3QD,'=Y`AF)>> M1@\K:8+@F5.!<%3:4>J3CJI55J%`&.LY"M&JJ(-#2%&4I.&J69XY4F5"!S#( M$*\QM"S*+@DE_?B/K_FZUVJJ_P"K)ZAPTT:(*F=98:U:F><-21>:5YW,U/&L MM/$:B.*:>-&42:-2`%"%UF%]ZL`4J/\`5GK7ATJZFA/'Y_;_`)_\YJE=_P#7 M^U^TMA;OZZW]M6@W!L[>6-J\!N+"9B&1L;7T.2'A-/)/11_>1U4301U,,\;" M6EG1)(B6C"Q([^PL=UL[K;=SMEFV^>,I(A'Q*>/I\B#44.:CCT(>4.;>9>0. M:N7N>.3-WFV[FK:KR.YM;F(D-%,A.G(KJ!RKHRE'C9D<%&*]:J_?W\D7Y6=' M[Z/8/PWW56=BX3&5;9/;*XW=-+USW5LZ>62:'[)*BHR6&Q.:DI:.3_@9CJ^* M::)F!IE`+-AQS3[!BAJJ'H,:E*DX[1GKZ._ M9'^]I^[O[Q+:-SF@$5XTEF=QV.^IAI#$L=9!HB,`DBW'-L7.332H3Y`[U M+DS6EN9+/[1)S+]X[:P;)K3='6)/";TXU)^?0M/LM_#D&T^O@&FE!I6(+3M`KU'QO\O;^:E\Z]W87,?)7+;QV MIMV.8)!NOOS<)HZ+!QRF&"ICVKUECJALA#DID95,<./Q\,KC3+.K>ZQ^V7O+ M[BW<,W-UQ/#:I3ONWIH'GHMTS4UQV+7UZW????\`[MS[F_*^Y;?]W39]KW+? M9<&UV"V+-X4QF-37XKBX<5[(CULY_$'XD=8?#+IVFZGZT%=7>6I. M;W?O;)0TT6X=[[FK85HYMPY!H()Z2FAIZ2,04%#&TL5)3#QWFE>;R99\EX'WI_=#$M0L2S-)-*P#32LS:54(BDZ_G*?'SNOY-?&G8.R.C MM@Y?L/=6,[DP&Y:O;^+K<+134&WZ39>]<95Y5OXWD*"FCIQDP?W@^:.B^V?CO\1X.O.Y]DUVP=ZP]G;WW%+@LE+BZK(0XS()M88NN-3A:O(T1IJU M8)20\VM!$KZD&ET7>R?+N]_V#VU^+R9M#$'M<1Z3VL1G2>&?7H*_W MF_O#[;>^GWI[GGSVGYI@WGE)N7-NMQ!KDRQTFCC>J!T)JM,X/5HTL M!9RYC$221RQLS2(=>A1(2$,4O*:-'<2&?Z?Z_QM/@0 MRTT>+'741EA3JMW8'3/\]SIO96W^O^O<)WSLG8NUZ6HI=N[>Q>[.N(,3AZ2H MK:O*3PTPFW#+X89*^KEF(9K>1[CG3[B?;-@^\9L]A;[5M4&Y0;?$"$C22`*H M))-.[S))_/K/WGGW6_N:_N>N?K_`)1W3FS<9%>YNKBSW1I9G5%C4N?` M`)"(B"@P%`\NE;'B?^%!DMH8J[Y$WIXD/B3=O6T3TZNH:.-T7-HT,YO98VM) MJ)4#42/:TV'WG!W&3=L_\.A_Z"Z"HYA_N/""HL.1_L%ANG^2#J0=L?\`"A5& M/[_R,=GUI==X]:U`?A0RJR9Z0$$$(+'D`H.`0-?1?>:`IXNZT_YJP_\`076Q MOW]Q^PQ8D5`<[33@B70Y)N!(C*8\@O:.'GR'8=T7W"-Q^]C M=GP_&*,WA^&@P4)QJK_A'7(W^\%O/NFWONCR7+]T&#:DY#&PTO!M\5Q#$;X7 M4WQK;MOJ[8??>P=U=3]J;:I-T;(WQCS19''UPF@6> M*&0UE+DL55K,U109O'5R"HHZI-$D-2@(8W\SR%O6S;9S!M5YLV[VJS[?.FEU M/\F4\5=3W*PR"/RZQ!]MO]Q?;[?IMLYRVN;Q+>XCXC/?&Z'ME@ MF0F*>)P5DC=D-"58:J_>'\FWYC_&CL!^Q?B%NO*=@8;&5<^1VQD=I;N@V%W5 MM6ACE>H%-F:.:MV]299J6.%%>HQE0PJSI+4D)<1>\/\`?/8?GWE39K2R2FF009_P#T>5SN2UT$HJ"=#$!@I]ISS']Y&UC:P:SW0N/Q_1JS M@'^&41']H/0@@]D_[ES>6'-EONO(0MA5C".8;B&,E:DZK([@A!X5'A`T`%*" MG67KO^5!_,$^7G8T._OE7FL_U[CMS7=.=;F6VMV(+RW#AYJ<2(X@W;PI M0Z54D8ZMSU_>5_6?KZ2"3+[LW M+6I(RU^;SRTL;R'4D4,$<<,0CIXHC'F)RORWLO*>S6VR;':B.RB)-3EW<@!G MD;\3-05/`4`%``.OG-][O>GW%^\#[C[[[I^Z>]M>0O+&X5V-[M:<'>\6Q[KS)[?;MLVQV37 M&Z230%8U*@D)*K-EB!@"O'K(_P#NX_=3D#V7^]MR%[B>Y_,L6T?QHZP[QP/?77.7ZWRNZM][ M:SFWZ3*5F!KI\IC,=MRIH:BJ@&'RU?%%%#5U'C+R."&)4:?4)`M["*R*Q4ZE$8!-5+#!QQX]3O\`WLOW@/9[[PWNE[3;[[.\\0;Y MLNW;# MPGWA^<.;_=[G^6KCE*XM(YYDFD62X>]L)4A401ROJ\.*5R2H4`4U5P'?^ M4=T#VUT#\2ZWKKNC9-7L3>_^F'=^Z:7`Y6NQ%;5#"Y#"[5I:/*K_``>LS%(] M/D)<541J4/ETQ:@X70\2[V2Y>WKE7DC]V;_8/;7_`-=,VAM)-&":3VDBAH:9 M_P!D,_WGOO+[;^^_WGSSQ[2\VP;SRG_5K;[;ZF)9D7QH9+MI8Z31QO5!*FJB MCC0'C01_YHOQDR_RQ^).\MF;&PG\6[+VOF<-V1UMBX'I))\WG,/4S4F0Q%+6 MU%3BZ"GJ,OM/-UT2R2Z%214UL4(>19[O)NT,B30+BI=3I9 M020!KC9ADTK0]!#^[T^\-M7W:OO/XD]B?:[F+ESF'VDBM_"@#E22TAH[C2S`:$!7U[ZCAUT&_O4_OR>S'O)[3T?L3SW#O M5M?[Q]9NDL$)'BT%(F9W*V(D(55NO)B]Y2R@^'*H%05(I]HX#\^N$EN MP6[M7;!21&]:*K@D_LKCCZ#K5S_E0?!#Y<="?-K;O9GTL75 M;CR>5VK54D&2S.V:ZBQT$2XG-Y>IGJ*FHFT)XT*L;W;2&!Q`]GO;?G?EKG^W MWC?=@EMMM\&X'B,4(JRD*.UV-22/Y]?1)_>,??,^[%[T?='W/VZ]K_=FRWCG M-]QVJ1;6*&[1REM<1-,P:6WCCI&H)-6%?PUJ*WN_//KG=W:GP_\`D#L+8FWY M]W;NWMU]-0;8V[!]BF4KLY-F,15P4<+U=?!0EH4@U^>25PP02"UA,N1WN+M6 MX;WR-S1M&U6QEW">V*QH"`6;4IH"U`,#S(_R=<:_N<\[VOWH_8[W`YXWF M.PY0VO?([BZNI`Q2"(0S+J8(&\.MAY%]]N5 MOJOZN[3?V?CZ=?AR0C7IU::]YK34U/M/7T:>[OWIO[J;W]?8C[Q\\\M/X7C>&%MEIXG@Q:CFN@4X=#K4;2_X4#RK/+4#Y%RB&:(3'^\_ M7;L98HU>"$(F9+3^,2$)&H8!V<`:RX]B+Z3[SG^_MV_YS0_]!=0R=Y_N.?B_ M=O(XIZ6.ZC_K".I<6VO^%"56M08IOD7,L4Y%2?[W=;>B9)(X"DI;."P5T$>D M^FRE+65@-?2?>:Q^KNO_`#EA^W^+\^MC??[CP@$;?R21_P`\6Z_]:>CI_P`O M_`_S>L?\IME5OR[?N%NDQA=ZON,;PW+LBKV]-DO[IY=-K-DX<%D:W(R`9]*9 MHF5#9HXV)\:"T@^V5M[VQ\VV;<\2[@>7Q%+K$LD;)JT$("%8FNHBG_%]8E?? M5T]XC?6'TS65K?0W`@%U&;JCS1*@0P!Q)4Y&.-.CK? MS9>E.UOD/\.,KUSTWL^KW_OVHW[U_DUP&&JL?!-4XK#UN3J\A705F;J\?2S0 MX\U0UZI4EO*"`RL"TA>\^P[QS+R)=[3L6WO<[@UU"RHM`:*U2>X@4`^?6(?] MVK[N^W/LE]ZOEWW`]U>9X=GY1AV314+O MY,OQJ[E^-'0/96T>^]@YOK/=&X.YYL[C\3DYL)63U^WQLG:^/BR,DF&K:N-X M8LC%/$D4U8I64-:--1%03>PW+&_\I\J;MM_,.VO:WLE^9%5BI)0Q1+J&DL*5 M4CUQU)G]Z[[Z>TGW@/??V_YM]G^=8-[Y>L^4TM)IHHYHU2X%_>RF,B>*)B?# MEC:JJ5HP%>(ZMY1I@0*N:D%(="WUEJ=)9*C28DD&F29Y6E,2CCCT!"I\(F]B MN"!W='Q$VC\ROC[N;JW)B&DW;3O/NCJ_=U8C-4 M[5[!I*:I3%2+)())6V_N&F1L?D8DD9&I9?(-4D,,E.!_<+DNVY]Y9OMCF(6\ M`\2W8W_[J7OCRS[G[2)9M@<_2;K:*:?5[ M=*R^,H'`S6Y"W-L6X2QA,+(]=;KX&?RV_F[U!\S_`(^]A]C?'W=&V]D;'[)Q MV8W/N.7.[,J*+%8REBK8FR+"@W+55L]*CLK@Q1,6C96L%8-[Q4]M_:KW`V/G M[EG=-UY;EBVZWNJO(6C*@!6%<.32O#'IUWJ^^C]_;[I/NK]TWWIY'Y%]Y;/< M.<-VV!X;:U2WO4EEF=X6$?ZELJ*P"FM6`%"*];?U14SU(B,+&2I>HAB$=Y$# M+-4*RRR(6A>*H5GD96(B99&XTEAY,X@=)K7KY=6);[?]7^KR^T'(X0-#$K1R MDT=@758XWAIY$633"OJ43$(S",C2!*Y4!?K`=LK<01U13@:\4S_FIP_R=1II MZFMD3R4K@3&1A4:C,@9'$3T[P5$"QMJCD#$L%OI0+Y%U*EU``!)/5M9:F.)& M?]7^KS^WC/43P12+`U/(8Q**C44C,7B$D9E:#STS:)@H?EP%71^ZZGRI4!30 M$9ZKJ(!8_"/\V?\`5Z4\FU!TQ%14?W@PYFE1H%R>+2&%HO+.E2]0H21BHJ#H M*K95,0T@:N&(=Z2`:)0N#I/5XG'C6[L*QZQ3[?+^?^KU.%[)>A5U[W[KW7O? MNO=(JFZZV70[WK>QZ'`4E%O;*8I<'EMP4;U%-59C$Q212TM%EXH9DI*EI!4TJU+BBEJXHXZH-3-*I]U[K-\7T*]`]7R/#DX MIJW;@R=2V:QTF(RU769:NK,G6Y+(8J2648ZJRM75O5/"FB&,S:8HXXPD:^Z] MUJL_+W.;$R/RI^0F-WKL/';HIQ.N-W[*KMV;&D.YH-M]H;/[+VA1187$;8?:_EEC M;-O@1403RPR-B1-.CO&66-8R7G;>#8W.U[T8)+7=X91',!&S030NQ+.).!56 MRJGO`/'/0@]O=E7/0 M3GMK3EB2ZMXK2Z3HH+M)%1I/D>J:B"`2M(QU?;RH=!`="2'"L"ON(?=95%Q;B.0/'H@S M\QXX-/48X^?4[>R`D$>XM-&5E,EQ4'B*FW(KW-G.<_D.KNO<0=9!]>]^Z]T$ M70G_`#)OKK_PVJ/_`'N3W[KW0N^_=>Z][]U[H'?D0RI\?^\W>^A>GNS&>RHY MT+LO-EK)(#&YTC@-Z3]#Q[]U[J+D&7_9_=>Z5W5)!ZNZV(^AV#LXBZJG!V[CB/2OI7C\#@>_=>Z16U?^RA^YO\` MQ&G17_NY[L]^Z]T.?OW7NJ)\C\@Z7L?Y>_,C:O77772,&&V-TYW9LSN+O/;< MV"ZL[3JAM?KS#+C:3LGL.3%9S>4.T-C;CJ$H(,W1UM')'-(\U/BZN'$S3Q>X M]7"D,E?/H.?AEN;=_4'\G+>F[^J'J>F=PX3>&0SS3;DR'777^Z]E;:K=Z[%D M[(R$K=[1#8&U=X'9%7E*G;U3NMZ^#)R3XW)57G:O\'OW6WIXAU<.C,?$+Y$] M@;__`)>G;/>_<6Y-Q=W[JQK;VR>=3_2)\>8<=Y,!@<-45FWMD97HC&Q8K86W M,+4!V2BW!!5[LAG6:2:.=)J.%O=>=1J`7HU_P3[LK?D#U9N_L?);3?:E96=G MYO%:'W[3=A'+T..VYM(XBOFRU)AL!3X_)T6)J8<=D:)*.1O M=4(()!X]'7]^ZUU[W[KW7O?NO=?_U]_CW[KW7O?NO=53?S8S"G1,#5%0U'$V MXNO(A6I'632T4TO<_5J4E92P8^:"NJJ^GK?&::&)@TT^E;,"4:2O;1G&[3&, M5<12FF,_XM<5!K@`BM3Z5ZAGWDTKLL4DKZ(Q+#W4)T_XU:D,`,U#`4IYTZK3 M^*6X-L[O[JV+MS*;EW9V!MQ82AQT>2S4.(&V,O6Y2JJV>; M`5$,M:^J66J*0O&;@H.>:;.ZL=GOIULX;>8D(%`TO4D"M<<`P(&,?SBWDNXM M+SF&QLI;VXN;4`REW[D.FK:*-4T!5@6!%214`=9?D[W=MW=W8FKJG,[ MUB8U&).\6AW9M[;+DT[3UN(V>)5J8^4_QWW!VAF\VQRO9.[IJ##5=8N&I\9E9^C>TI(J M-=F?LQI14]`T45.N/IHM-"M)7\K.S,(-U&QQ@[L#[_/SSR?<;W=R$M=R40G3I)MK@@".H[?)0$&E=#U;6:;@ MZ_0?[[_8?[#WBSUFT,@?9UW[]UOKWOW7NO>_=>Z][]U[KWOW7NO'Z>_$5!'7 MNBP;GDA;=.>4F7743U"1M&:'40U1'EE$,;3AFA5DDCCU2N_(61H3,T-/#JE<@TZRZ0"U4[01R>!E9DC#T_HDBE5EF:0(J^!0US=FTEF+A%:+7 M5@*]U>&>L$C%JB5ZE"M*T-J43%8V\@,VN?[@.)ZC]]OU*R,+`Z@3Y6WFBT.> MM`C4[2+V?Y_\W6'2NHQ$&654T>FG="M$7+OY)HE!/BEE;26(9=8M];2^R".F M]-105+'_``?[`Z<&,865EIZB2>1U_P`D2G25*B8N%J)_*C"**G@@71R'DTWL M`08A4`X-13IT]HP"7X`#_5PI6O7&+Q,L<-(SR.@:.6E\:D/Y+ZIF5$DD"-'& M0BB-T9`6]2@"/>:D'JPH1VDDGK!.%%.BNP(TS2QJ?W`'9K+Y&9X9-20TPFU, M[(5.HV/[H]Y]-L#H"G#$9^77)O/31R.'EF6"":5GUP1RL"QBA58Y5IEDB629 M1(B,'6,W-.L2!8Y'65B9\A`0JT\TRR1T[()9J2I2"56J)H MZKQ@&RM%I"6!;QR>9:TIZ]5^(%JY(_8/]7G\B/(TXZI:C[=0\:T[R0QO3R!Z MGQE))8%8,T*2-?%H24NUU(4,6*('CV3J```QUXFAU'5J;\Z?;_J^ MP#KN*4A%23PQLB+*&2/R3RK)(`S,8I1+`(DJ#)/7 M,/'612O2?LQQS.D`\DI9IU:*-RS3B&"]T\=M"DZRJA7)5_'''CU[#K4<:X^? M7!X):XO+6!E"TLP/`C4$>.G,+1NY@348_&%:-R`Q4*;F+W[A2GKU4KJPQH*$ M=5L$#/^K_ M`%?R/6-(WUQ-)5U5,A(59(WB>2,A'G95:6;0)*E`KL=3NB_N`BPF&P1G%>MC M5Y-0?YLCJ7'41HGVM-45"!X6>G^ZFD:#7*Q$D;5=P[U`$9;66B(L-0C+JTFN M%*#'^`=><*:ALM3%>!_XKCUQ!:-(8G2FULA71XPK:X@83H`B0"%%`C5B`=19 M2H/[+^`4944'7@[!0A.2/V]85@0M(M0\$I],4\20B>DF6,:&AA$A$TT%2$(9 M6N?&-%F`,:^K@4!'50H-2S"M1\QC/RX]:6[5*+Y9UU M%:B=#'$QEL+ZPEPQ`,J650003U8L(W4T&?\`50?;_J^7&DAE<.]1]W3O,R3M M',F@T:I'J,CEPT]Y7M)I=UTW#G2WK;1IP!J.JJ#5FH06/[/]7^JE2.LBRKXH MX&DB*6E$DP;5+Z[EP(S''.SPA@K%%4AM2C0;1-KSKZ]79@4"`^7^K_5ZXXCK MA5K%H:J.N5Y2DLT8#R21^&)0%C1"9:AI1&X)5)+@F(K(28AM14D5QUXJ:*?, M_P"K\_M&/SZDU$TK:$656%1*J^:2/S,(S^6.JTRS(`+WDYLVIU4LFA4<>'7F M[:+ZGJ/(]-',HC8>:"*012RP,P5U_=N\_C6-C)*A8IY@3H#%CQ/[]3SI@]4) M'`&M/]7^K\O(CK@S25,:SS3/$A5Y)(XRQBA=*:,J9%DD@F5X'8%D'A92#^AV M(;5`"?V=:%6`+$\:D?/T_+_5Z##XZ>GO4>-K+YT5U@53(3I242!%EE-HE9%$ M0!5AI"_[I][I6HZ\`*ZAP''_`%?+KGX5:1&_MI"SOI>)6TR,/+3PSQ"1IHI8 MDC(4F[Z2`'"%$]CTZWBM5(IZ^?[>H\Z1`*L0>#RR":%C,G@$?C6H\1*?M,$U M:V8.IE'J))'F]^^9/7BA!9EXG_)_J_U&I,QP(W$JQZT12(6%.\D,L]G=AJFD M:3SJ_P"Y=](UV+:6(=O9X#K8-*.1\L_ZOV>O7%,*V&=6HX_P!7ETR\2H5`4`C`I\LTX_E]G^\G M#1@3?Y5&7>">6IC.F5)9/`+B&4$JD=0)8(05)\FI1JNR`2+IJBBTH`/R^RG5 MD"E2X:I)X8X>O_%4'IZF87=6=O++*"J1(TCO.J:EL#,-+^)*=HPY<2,0@UEE M_P`\WJU`%.KGS'''\NHTZ))05$L47\*%J$]-@+H&DT7_`"^G^K\J&AZE?<4DG@OI9)XXHZ:DDG%2"(M5-*HC M4L'/E,C)\QQ_GQZCK!$LL3M4"K_=:02TT1$9 M,BF>F:!?)*KE01'Y428N%O\`0'Q7U8H5_;UL&F`17Y=>@J%G<(E6(_)!,YBA MC5FF#B>8-22W<%28PYL9+M8EF%I/=2#W&G6M0)'=4G_5_J_;PZGBHDI8)BRF M+7&9))3$L9NU/*B^1@:8KI23R,%D"J;LQ0D/)4Y(/3@8A2!QKTW)`1^F:0FJ M@BEEDC-)%)XZ6>2)?'(2T[IY7":%*D%K60^AG:U9<4H>F0O0"JGAABI_IXM$S".`QNVF<^@QJ&\9CCL0 M`=1/'U\NJLH92H(QG'G_`),^H.?F"RAQEA(D>?4+@U7V\D,A$#Z*::1QINSN M7"%E_P`X=`U`-I#QM"@4+Y&GY=.$FC4&16GSIUQBC,D+2K'($B19)?+).KA9 M?(TC5$>H.B1-9EU,I77=@IM(U=*'JA"ZL5J/V?+_`(H9]*5:O$15 M$[3([?Y^4I)'>.(1EF*:!$\5#J]">KN](FKFGY_P"H?,5^P\.H4#JR M34X@EB542IA\4+#P4]1/&D$LB3&141H5=45;"6VE495:-+%0"!45\_ETT'-# M5",`C_5Y'S(S]IX]9R[M4Q5EM<;Q^*$SP,6*&0L*U#,U7?^K^?!>JQZCU2)I$J>"+S_;Z_"8PKR54L(J*>,HVM M9)"Q70H!!6XE?2*,5X_Y_+IQZU)4Y`'Y4X?ZO\/`\9(H1YX-9EA(3S*C_;F3 M0ZWU^*:*:-Y'E(.A4*GBRLVF38J#JICJU*@!\U_+_5]G4$XUZF2%YP9O#(LO MJE9WC'^K'^KTJR]9)2 M89B97@B%/"'ED'V_VS"J+H/,TS.K"7Q,QT@J=`!>703%X_!2O5ZBH8'M'Y4/ M^7[1^?E3C]KIAF,DO[K431/4K+]LC/<2&8>&LIW28.VLLC#2H!:46$PT*ZN& M*]5HN07I4'_#6OEY_,>I()+')A97J<]B:4TX$<.3PQDI_P!R6:F9:R%`5\B2 M>5(YD4?YH:O*6%F(\NY:>'(=7D?\'5H96::)/#%=2X_/[/\`,?512I.;[(NA M9U[W[KW7O?NO=>]^Z]U[W[KW0.]_Y'.8CJ#>V4VYCH\IEJ''T]1'22UNX,>@ MHX\C1G+UGW6U)(=R+)C5XA&I&HGW[KW2.^(E4E=\>MA5BRO*U3 M/O2:=I,KN+-.*N3?^Z6K8GR&[8*?ZU;/D/V% MV7@_DQ\A,#M^F_C6R\]E.LJ*?:F>PD>?V37U5+TGU9))22T$LNJ4U!J31O*L ME/IGR7DD*Q4DD@RVY?V_;)>7>7;B63PKP"+7FKFJWLXQ)8NUO^FZ!HB5M+75CXM)K3C@OQHO2V^+^\NL]B=Q[?[(% M5G]BY?%Y/"Y*IP&VZ+^/;?W"C5<4U?+@AEO/DL5+N*G2DKIXH*:J6)*EHTD0 MV<(N:;7<;O9IMN'A36SH5#OV.N!0$@C5I^$$T#4K2M>C/DN_V;;][M=X1I;> M=75BJ4='&H,:*P+*#AJ`'2'`KCHQWS(W#1;'[1H(R18 MQ1+:XM[#7NPJQR621V_A*(K?M]*>./RJ`"1ZGH9^R()BW)FG$C>-<5(IQ+05 M&/0XZNU]P]U/_7O?NO=!%T)_S)OKK_PVJ/\`WN3W[KW0N^_=>Z][]U[H(OD" MT"]#=VM5()*9>H^R&J(VDBA62`;-S)FC::>.:&%7CN"[HRJ#<@@6]^Z]U%KF MI_\`9>:QVC!I?]#%0S1>6(`T_P#<=R8_.8O`!X^-931^=-N/?NO=*OJPQGK' MKDPIXX3L/:!B36LFB/\`N_C_`!KY$2-)-*V&I54'Z@`>_=>Z1&U?^RA^YO\` MQ&G17_NY[L]^Z]T.?OW7NML?Y@_\Q3!8>@%-L_>?Q![KSW7\3;!_ MOMFMW#)3T61H6C["-+N3=7B_@;R)22PR4U(LA^/?5ZYKYU=SUFW<# MM/(XC>>Z-A]AX^ERV.B;'Y*#&4$%115Z2P4_=:D(+D@XZ-[\;^T^J\[\* M?EYWAU#VCN'-[CR>X-\[B[8[A^*=\-1I2+1F6LI9F,KS>ZJ:BE>C#?RU-_P"\NS/C_GMV;ORVR\\* MGMS?%#M[,]>]>5W7&T:S$XJ'"8_)4V#Q^0V5L"?<&*P6\J?*XVDRYQ^NMHZ* M+RSU$R2RM[K75A'OW7NO>_=>Z][]U[K_T-_CW[KW7O?NO=5;_P`UW&4^8^/M M)CI:>NKI*GL#J#_(,44&4J*>F[JZXK9#1M44M?1JT$U+'(1+!(K!;&R%O MU\SV_,$\RN$5;:?N/`$V]P/(@\"1Q\^H=]Z(5N.7+>W":W>YMQI'%A]5;F@K M45-,5'5+_:U+A/B]L/JK>VPJ&N@3=M)N8Y!,UEI!18:AV9(-Q5&-@JYZ2"*> MOK\5G:O[RMJZ8T"X:+S&6:'1%52GM'U/-E_N5G>NC+"4((''7V@@`TIJ10J@ MZM6-(R5@S>8K7DC:MFOK%67QUEKK()_3JQ5F*ZM81C4L`I4`AB`H8HM=W/W% MW5DLOMKJ[9U5MF6@J1A]U5_6N.J9MS[5RV&RAR&(W[/DZW(BMR'6>7CK(LKD MJ:2I"SU38W#R5`99IY1NFQ;+L$:76\7JSM(H:,7!_3D4BC14532=6'A!Z4`$ MDVG*A01+O^^\QRO;;-MKP(ATR&V4F2,JP=9@S-5H&!\9D8YI%"&IJ+*OXF]5 M;HVG\H_CYNS=NX-IR;@S79NZ\978W";RH:Z;-PTO3&],L=UUVS::JBR5%V;7 M2[EIZ[=&0J*<4G^74J0:5G#3HN<=UL[[D_FBRL8I_I(K5&#/&U!6XB7PUEII M,("E8@#4E&)`Q0QY"V:\V[GGE&\O[B%KN:\="$E4EM-K*VMX0Q=9:,IE9@!1 MDX%JG=V'T]X=9\^L^_3KOW[KW7O?NO=>]^Z]U[W[KW7O?NO=>/T]^Z]QQT6; M=DJOG&KT1T\P=T\DU2C)*898Q'I+`L)(V)/52=!)U50#RZQI(4&IR:728X4AGCCIWCUZ%:-5=X1(CSL9(2%5PD MB@Z"29?=:)`*D>9IUQ@GDJZIU97C%A&_[,ATQ&/P.JS1@23Q)-=M++'(5N@T M@&+WLBB].$EJ"N0.L2,D>D222S*J-(SU$6N=%J"8XZB8I`B,&CB*W!`;1I&L M@>.I)(-*`^730[?5O\WK]G62>8CSU`9_L8XC4*&,5/!50JBQ13K]S)-:*R,1 M>1O4&))LLJ>'D,:_]5>K,:*&0]AX_/TZS-+X#3>5HA',\!H_;]A!_GU@ M134+3T[)&M54I`3)(SO$\TS`H0D4KU3"FCI1(`-0^AU-HUQ[/K\^JUH53SIU MF="YA\-+-&*J8O#)'$P$[F67QR1)HTRL9+^0LS,&!((-I6]7SKU<)@:E.?/_ M`#=8XV%,[(B790S/&6+-&D:F-'6!UB-0D4[KI`*'2?H&)67W$#.#TVI`+*HZ MR)2UDM/*9*22%>8:@4TT;(B"&,)3JT-G>9[NME:0K^DJ!^S[]45H6SY=61&T M.S+Y&I'E3Y<37A@'YTZZDF@IA!2P0.*A89HQ&DWW3".4^D";553.X1=3:G96 M>X"MH9D]QZUJ50-*5IY=>,4K2--41&$15*R0RSWD2!76P1Y(XF37#"_DOR!8 MN;6$R[^SK6E@-3C2*U_+_8ZZ1]2_L3F,DLB:%U))$8V01!HY8FII6)#AM2-= M;677=_9I0CK7Q#6"*\*^H^7^?R].L%"LBP0R25+&6-F"1NRQ^+QNT#W"R2:Y M-;$//5#X68 M456SM&CL?4;G2Z@1KZIJ.MLK4;4017`\OSZQQT\=/5L1,KA:6:&.1JB1"&2, MS3(PJ6IU8@ACK!:_C;0_F1U:0$5U'X3U'6EDC=YFC:/1'`&F M56DD8J31Q/Z*=HR^D:!Z1Y?H$/,/O8->'6M/=GB.I,2"3UQO9U<2@K:JIP]/ M=&-0XE<>&KEDX$A;2+&\@7T:ZNJH:FGS'^#UZQ2L%UQSF.J*G[<%5LBE46I< M2EHW&N2-M1=FU$$'78"8;H#2O5&)!/IUR=#'-2Q1EUU16\05OM`LJ"[-+>G$ M;0*EHRH0`C\:]4F@:AL>?5Z-K7N\OD/\/IUSDBI*)::&$)K69H(8W:$I-%.Z MT\:02%HD0R-<($BTQH5"_F$[%22/EU5@B`8XG_",?ZO3J))(YGAF$"QK&4IF M;3&4:&5P(PC>I$21R4U7;4?PYLL>\"O5=1)&3CY_Y.NK:*5/7<4J1,9'A$KL%58(H MC*4E9B`YC:*5!:(,"P6PM8*W$2:SUY2%!'4/B6650Z4:12)41LOC-/*/%([) M4K(CQ>-;R%I%4F0!;,X6Z6%*C%?7JA\];Z5Q3_5\^IZ3>...".:6LGE9$TR* M#+*L;:X!X3H0(&_S8)!9+.6-_.U?.OEU;4Y`"G)(ZQR0U*0>:8I/'&5(ELZ$ MV8JK&GUJ(I/+)?2VD@WX0_J\/(=69:(U<@=9'_;F$K/35,T:>(!Y%+A8T%YU MB6%J:QFD$(%C>Y72+&'WJ@(I0@?R^SJY9M0?4":>>3]M#BG328&CF+5`TS-( M7I8_'(8Z66:)9Y&CCB2TD56LAU-K81!-(&FZ16)^+T\^DY&DA1Q\OD?\W7)J MADBAIZ=IYXUB\LM5"%?S2!6DLU2U945#221N)`&=AQK+&WF]^K4DGCUIPU%[ MCCU_U?ZCUS@9J>2621F:.:DB:.43`2(B.0ZDV+<1O?5K/ZB6,9(DEW0,J@?$ M.MZPKUIQ'\O]7\NN$T32/2N\LSI*J2BE>%3')2TLP0B"E#)+YXYF57<%3&0/ M2ES$_JTJM.O%=15Z^0\O]6>I*2FGC9V!),BRA`(B'X6&%3X`Y\H$8B8@2%P` M+6'B35`2"1PZL%;2[?/_`%>7[<=1%\R*GW2&0JTD+&(EWU12R&,E%$J3B.G4 M:258G@G6%\D>V(KCAUH5XD=W7<1:"%X8IE:)$D5GMY*J50D+H'D\CL9KLK:S MJ:Y]3`$2OYJ$_/KRT`JHQG_5_EZY`/&\?W4[JC`T_P`^LF@M+//2T\-I2R6J-4L-6@$,=&*@ M4Q8*H4%58*XN-(T'5![VI-5!.!UXK5G<*"QXUZQ4C)#`)>$:H2&-FJXM-;/K M5_#$SO#5JLU.$(-C.K)&;@A2L5CW,1Y#KVFG#CYG%3^?^P>LLO^3_5^?7.0 MI&M0@1=O6M1",B@=8XHI)GF M$DL<$32QN)7685-P4ABABBC].@L+("!<2&/0`3%)HGX?SZUQ9A04QZUZE"KD MIZM6C\54DOHA*&"2-*F!52>.913K(2XA>+4&>0DNTR>2&1H;?I+$*0P9@]A)'NN*` M=W50@!)IG_9K^RO^3Y]9U:>*8REA$\?B1;/XE9%:1BT4[NA]8EO8L2#9B5U" M5ZGT/5UJ?PTZYI.M*(IZCRQ0RU*P/43+?RKYTIF:)28G],[D#A'+,0J@MIEL M14LH(UTZJI^&@(6O48O1U*^$F-J)U:";RJ4#:SH$*I%H^W4>%H=*D&QTD?6/ MWZKL5\FZW32"O%/V4^0\AUSIIU`@6(VD2&=$@CC]*HP@\1D+0RLDQTV%S^Y& M"=#A`T>FXMUY-5%KD_L_(@YK\_Y=)`.6H3CKH)&)`\:/960NBR22!$#/Y%C@3R,1, MCBSJJ&_!'J:&2QU#M)ZTQ%:+BF?VL,VE`%2JD\-*&D-.IAB+T] M0LD#-K$93Q`QE`JZ0Y4@%E4Q+X'5@^?#K3::,#P`'^4CK,ZLL4,:12JD\K`J MHAGB57C1_&K:%<2636UY'#>0MZ[>:*G`GUZV?P@\"?\`-3^8Z;9HA/(DS25* M>"G1)BCQH$,ZQR?=1>&>)(K:[RR!H7C-V$BW$I<&*C\1/3;)J9#7M&?VYK\C MYUX\/(GITPC0KG<3>!&63,4;QW`D5I9*^"FIVC4QQ>26,,Q\GB])8BY8F.;4 ME?"85SI/^R/]7[//J]OH6XCI'G57[<@`CAP^P_Z;RZ.5[(NA9U[W[KW7O?NO M=>]^Z]U[W[KW5#6UN]NR]Y4W\Q#86[^Z=S;LIM@9W*UFRMFY+:.U<;BNKJ"7 MMBNQ&WJ/^_\`_'#V?N;!3)00KD'R6WH,70XY97I:ZI`8+[J[@#33JU[XGXV; M#_'?JS$U$-73SXS`U%#-3U;5<@II:7,9*!Z;'5%?_`#I8;Y-S=OM_MRS-%&\`0!PL:-]+;UE( M#:I'4T`A*-X@H*'X&"C;WR#WEMFHDP_:O7^.W'6T^1S>*J>OQ]5/BJS*2XV6OIYB,E'%12F5[RU97@DEVC<&C MB\,$*'6>**-:C4[:V_4;M5U#T60KD(2W1':=H6:16H3H:"69S4)' M&M!V*>]28RQ4-K&I0G1R<;DJ'Y=YG(Q5.=7:DFS]D92OG@EHGW7IVBF3BVUC M,3M^KK(E6;$5BUZ5RH\:4]3CYHZNFAGAE\8!C(>3XHQ'`9O&F50U='?367(& M5(^`C.DU5Z-3HY)WEN!"T$#L%/<-"N8U1<4*D_J#AJ4U6JU'5J_\` M*DPJ[>J^S<0)JFH>FWUW9)-/5TGV,\LU;NKKJOE]^Z]T$70G_,F^NO_#:H_P#>Y/?NO="[[]U[KWOW7N@>^0ZJ_0'> M2.0$?I[LQ7)=8@$;9>:#$RNKI&`I_45(7ZD'Z>_=>Z(=W1\N]Q]:YSKOXYP= M3P93!]E=.[8Q^.WG6[OR&.R&:J-S[0W2F<7:6-HMD9G:_=>Z'/W[KW5"$F'Z-B_F'_-[>.U>T]^Y_O#97 MQV[2WCG.N<9A^SNLMK4M6>ONN-O4V.W/V'0=N[7ZUWE_=2@6.?#0KBE-X]M=Q?RB^X-^=V[V[7[IHZW.;>QNZ=NT7 M:--A=V;>V%LSM7;-1VO6;![UP9Z,W;-C*;KR2>>GDS6>R,@?%R^7-Y6CK&:3 MW6W`#$#AT(O\M;M8MB[<@FR786R<#O+=V&[@VYGLGB^B. ML)>UY#NMNW,[C=P["',U62R4=!@C/43E?X>HC%75^Z;(H2.K%??NM=>]^Z]U[W[KW7__1W^/?NO=> M]^Z]U6E_,_FQ]+T=@ZK)93'X*F@[5Z3,F&&:1L925E65-4L M>A(XW+S:%92A:P^]NO%;>;R.)"[FSGHHID_3S^N/]CJ)O=\QIL%E))*L:B\M MN\UHO^-6^8ZQPV?Z_JLW0^:J6H M.W\K1Y+<%=B:;-1K#3O20TM4D=,3#'*D@C$E;%R[OQ2#<([<1F44[92D@!P3 MJ!"J2/)C3/$<>H=YEYGY?:6?:1=^,(V!!>!9(0ZFOP$LT@#8!"@@9`8XZ)IO M7*[YW%_!\;7[]V3MSKV.;&4F(R6.JXJ/:5/'_&:R&B;:>SMD219"GJ:3*8_" MYBMI3BZ,T>%W!45#+3T98QC:RCVZ#QYH+.>7=.XD9+@L!4/)+@JRM)$K!F!D MB4KJ)%8\W&XW.]%M;/N5O#LQTZ&#+X9`)*Z(HZ][]U[KWOW7NO>_=>Z][]U[KH_0_ZQ]^Z]T6#<5-!2;ES+ M"60K/79&00U%2\L4TTTJ/+&'G:M(C!=M,5],:(P2,*FB$U@_L8OL'#'0;N:" MYF&)K_A_PQ.I-C8?IW<6\*/M_*9/&XSF%2LK-,]M6%-,MP'3?AU#NL M@TJ2#YYP/+YU_/HO.=_F+=(Q;.V-NW`0T^Z:S>_5V-[8GPE!V#L&FGV/BLCV M?TGU32[:[&R+;GDQ&Q,NN:[OQ\\]35L*2&EQU>S.&412[#@_#4U\A3/^KAUO MZ=ZU:BR+6I(/`"M/S&>ARSOR7CVMU!3=N9'8V/KVSF^]G[#PNVMK=K];[JPU M5E^P-_8+K3#UTW:%-DI-@4>*HLSFRU?-)42O0PTLJE69?"F@P*AJT7CU;PJ3 M^$6&H@G&:8\_+C\^@7/SPV[/G]M;(QG7U/\`WFW''W#+44.Z.Z>G]C;4H,OT M_O38>S-PX+;F_0_S@FO\^A&KOE/CS:'J/9&:[*QV;[5QT>T9S?BCTPI4P5LSM0WE@8^VG M3!C8L4_T0]U!7%GRSK>N:_;FW-X]-;NVOOW=&=V+C=K;&SN].KL71 MY?#[YK]UT5)N3(;^&Y:_:6)7:U5M*2#-4%0\=5CJNMHX4:<54;S:U(0:`X'G MY_9_JSUOZ61_!99%-:B@R0?.OR^?ETG,1\[-OY]MP9'!=.[ZRVW.L^NQV3VG MG<1N7KFJI]E8*C[%[9ZRW#-AT_CK47:F)P>7Z7S-0,E@)ZF@JL7X9Z?R!FH_ M==0*CT/3GTYU@,X$E2%%#D@`DGT!J`OSXXZ$7M[Y9]2=+[A[/VWO7)TE%EMA M=`Q_(B'^(;JVMA1OO`S97?F*BV=L=,YFL6^5W.U1U[,K+&OB=:^C!+*^F.X- M:>0QGRSTT(BS$*1K9J4XT(IQH/4],.Y/F'MC;^(R^^JKK7L#_11BLUO78]-V M1]QM1L/D>PMCT^X%EP$6VSN63<5-@,UNW;-;M[&;BFIQCZC.)&KF.FDBKA34 M*,:5%?+^?5A`[O'&74.1_P`4?\PIGSQTJ-\?(>JVU6;"P^V>IMY=DU^_.I]T M]V2T^&S^S\+5[:V'M:LZ^3,*@SE7B(<[N5XNR*&U6T@/I&":YXGT%/+)^?0>K\XMI9?/;RI=M;6&4%1(_=7&,$5TC-?7^=!Y]+OJCY6;1[!P>^LCG\)/U MN_5O6&V>W-YP'=6U.P<72=?[VPVY]P8_(S[JZ_R>K-;-'X:!JL<#R_;Z>E.D+O3YRXCK/"[;K M]_=2;[V5G-]1]?9#KS`[QW9UIMR#=^VNR-^[)Z^:NS&Y:W=%?M;8-?LC.[_Q M#;DQ>1G6IH*.OCEC:K(D-/=B%!-"13RZHD98Z%92:YSP%#^W(XX'RZ-/LS*6*)T8RL M0%CTJK(`;A"X26Q`I\6>FQ52`5-3GY#Y'_)^=:8KP!)CAD\K11O4!*=1(\DS MM&QI)5*F$@L\JE1J0D&ZZ2MH?>C0$^O6UR"?+J7+X_MY-315B6,*12E98/"H M>5[?MLC)-)J8K=S,H(LXYCUYBAH>K$`IW"M?V?F//[#CINBQYBJ8I[.R5TU' M5@/44DH2**$.*F[U"$AHT#A6DE(;U#3_`)Y=ZJBGICJA3O5C_1QY4IQ_9_Q5 M:$3!+$T(\$Q#16\,@>9560SS`L6A9AJBB%P&>VIC?2W+ZX'AU;`K3AUZ&*.D MIH'BM5&$R3+3^21O)X))*>0QR0^2HG,;@J05#6LJ(MS"VR0S&OV=7%**X-0, M_P"3K%+#]R:6"NC"M)13QSPS1.]/4Z6+R:H'=DJY'0!;`,&7@K(`RCV:DJ>F MVTL$1A44."/G7\^NS(ACC262],E1H>"JF+K*)H9I@AAAK6CDCF929%#M:P:Q M%IHM4H21\75`&:F?TQY'S]"/0?+AUFJ0LUU-T;Q&H$'Y=6048#R()/R_S_9_/KB\OH`D@8K)$R-'#'%] MDB5$3QJLJ21QZ$*WB`".6;T*I'[0]3AD4Z\6J0*5ZQ>9)WG@,X,2HIG?R3*1 M(\4@@B<('+M(T=C;6"HN=:W,?J4TGSZJ7PIFHSUMA20*K]E?]1ZY3`3/((9I#(;N M(F9B[*J^4#6?"8V36%`9D9#RS(3>3W#RZM0'X3U@BC:*)$!*^%HTLOC">(I- MX(EBCC+.(Y0JB,1QKZM((%X#XFM>M%:E:^1ZXTT-XJF>H*RL\D,2M=V9'=M* M2(>(HQ-&=`"AQ:Z$2"R1[\P/+J@!&IL5K2@_S_Y/+S)Q3J:5(Z241+XU@>64 M+4*1!$HF=IU+.ZZZ9].J5B-+$,X=E/W'O7KU>@I\^N773J%$D"I!) M)(\)A=XY5CAG7TR+4K`I6"66'458A095TZ%8A&W7*D_\7U4(37.#Y^A\OSI^ M771CGB=3XT#1B)(V2+29I$BG#&I5J:2\S%RGHT:E15Y%X%T0"./7M4AJ=/`? MZO\`5_EJ`WQ/]S5+!35'K8^1G1XZ=")],DW[;F1IJ>9XR&*^8VY]0T%-GS)' M7@,A4;/^K_9_U#J4*X+Y'5;R3TU0D):19*LD0 M7$8#E+&,%6@%AA@Q'38(`.?^+_XO'RX'KNG"M4P2A6232S$M)9FD%.3,)%ED M5*A)DBTH@\S+I^C!;1Z8#23Y$];!.M:BAI_Q?[.L,SO41,HI9EJ)6:2Z-#_# M2K2/,TTTCM/_`)PP!E0-(0EV))"RBPI2A(TT_.O7M1R`#6H_V?V=2?(*:-JF M-9@X2S,`0D,KN"D?D15-RCNRJ%9D`+7C8ZY:Z34`XKU8L55C2O\`J_/U].&> MH\,T@DGG!D_;`B6-'C#-)"KQ>6/QJCESY"C+K(-AZ8R6B>W=IH10=4(*ZJ9- M<_E_J_S"M:Y*<1TR"%T+(ZRU,4FA:A$J1]P!2Q/&]9,S>==.E?*JJ`H3QCPQ MZ8ZB/7K:]IH0:4_GZ?ZJ_+%`/1T=0U)&QO"TL#!XI%#MY2J@DQF.9A33QEK^ M0N5)%A*`'CT<$TZT%J!0]O\`A\Z_9_JX8,R6\6N*)&-J=(7(9OV_.\%0[^1E MNCV35>Z,19B>?,^NKAB`0!6OY=89%)CF$@<^*C"K`429#P*A9W66G0Q>(2_H MLC+I](37IF\,9'K_`)*=5(!QPQP_.M>L=04>JAIU1VUB19!(D@C%.%=HXU%A M'$';2"@#`*=(6Q,/O8!H3Y=>)RH'G_JQZ]N]%=4M3$SSM3ND1AB*S,'$97AF#1I&FBY*@7)8D"5/8H33NZV%?4H#$U\OE_L=>J)99JK13T@GJH8Q4* M[HZN0TDY""I:,!`%N0SR@Z6&JVI7DV`*$DTZ\2=5`M3_`*OEC[?Y=F,+R M`2F.]0L(:J,<(FJHS&@^V942%8'D41H%"(Y<+INQBDT?EUH$J7KPKYXS\OE_ M,GY$5XRU8JZF-*2GA0B6HCA4P/&JQ1P/!`R1:ZE1*7('J8&5239@"B^I058Y MZO1>VBC\A3K%%&T<#02UL\L,4$6I(%I(Y:C(,LI>20F6581^VK(E@I7U&211 MKC\"68FG$_RZK2@*U.!Y>OSZYLI:KECBE15I1"YE>6-7?[8>=J1R%,?F4D6) M5"01=E-ICKT/RZVM:`$CM/\`@]>O$)"BL8GCD$U(Z:09!'*%$?E:`F`I$"Q+ M!5B#*;\,Y23U"3UH85<\>'^3_5_EZQ1FFFD5XO&BK%,TD3";3$R2^!Y:8$"U MBLD:V5V=;H`0/%[W0_;U8@%4(XUS^7IZ?(\>L-9,U/3J8IXC21I+4RH888S/ M&1<,[SPJ-#U!8*-01D+'4X]4>QQ((RV.J,"%PU`#7U^?Y_X?YUA.13?YYY5I M$$41DATT\=0K0FMEJ5K#4-+&JQ:B;R(4P*_(^?^#JE*``UU#@!G MCGC6GR\J'&K\7666#*8I6JR\LF:I'\7,T$<35*^"..0T MX%'$OD?TC2'.E2UF,$M9B=#XQI/^#IVWS-&1_&/\/#-/V8.,J.).9[(NA3U[ MW[KW7O?NO=>]^Z]U[W[KW6N)L>;[/>?\Q'&8.M[2?<*XNNVQN;=F=FRF\-A9 M.KW)WC3XYK::&DI:J&C-335)-1"E$91[J[DG344QU< M]\-)II?C-U1'418J&6@Q&7PY3"8"HVMC"F$W/G,/%)3X&I>:3'&:*A5Y%62: M-Y69XY98V61O=4ZU*_EWCMAGY(]P+E]YY?:F[LKGMCU<%,NW:.MVCD=MT75' M56`R!W)EL)DX-\X^MR\V:BPL%0M'4?;8+*9QX$D"S"+,GE.2_'+>THFW+-8A M9A77ID#MV MC<,482J[ZA&&"L$C>5@#7H*HG&V\#D=U"3,4T7\-CG>:%:05F-I)DGD!#S/J`G,NW;QN;&Z5;RYB@+$,P M2/)+:I!%535L!B0&;'`4I('*6Z[-M5+9YK&VDGTAE0RR)I&DK$9B6PH8]H;2 MA##/$V[_`,M\UE7O'NBLJ*J/(_;]B]O8R6MIZFGJJ-7H\SUM34U)0S032":A MIJ6C$<+61A'&!)'%)JB2*^?Q&MMM"("M;2U:A%#PG))'D22*Y\\=39[4>(;[ MF%I'#L+RZ4D&HP\(`!\Q@T-/+RZMR]QEU-O7O?NO=!%T)_S)OKK_`,-JC_WN M3W[KW0N^_=>Z][]U[H'/D4GD^/O>L>K3Y.G.SDU<>G7LK-KJYN++>_OW7NJ) M_DMM&EW#\T^L:LIL+`4N&^/72[93<>X&6%!N_,X#8.4IZ)*GK+>F M\$CV[)DMNTS38W)09*FH7D^[HXYX&]U8,5KCCU?YU0-/5O6RDW(V#LX7XYMM MW'"_%AS[]U7I#[;.GY!=UGZ6ZPZ--_Z6R_=I_P`/?ORK_/\`EY]:/`]%:^!& M_>Y-^9KY"5'>O\,BW]A]Y[=Q=31T6W^P-IS#"KC:W#\JOYF6[=^UU5N7IO:/1/=^"K,#U!N&&O[.KJC)X'J M3![[R.V=F[RQ.W MA,H*SK#%?RD]YT]`W<]=L_:^]M@XJCF[?3K+KW>6'S^&[,7 M*5<."I\SBMV4N2,\LU3$)6]UYB3IJ*8ZL.^,VS-M[%P._P##X.LR6>RE3V$V M6WCO;-]E97M?.[YW+5[(V53Q9O,;ORV,PTLM3CMM4>.Q,5+#30T]+2XV%$46 M/OW5>C*^_=>Z][]U[KWOW7NO_]+?X]^Z]U[W[KW5;/\`,[%(O1NW9:O'MEX1 MW%T6LN*%`V56O'^FC8+14TV-BC>:KII)U43*IC<0ZRLD3`2H._;[Q/WS>B.3 M0WT-SFNFG^+3Y!]14T^>.HJ]VR@V/;#)#XD?[PM*K354?5P8(\Q6A/G3AU33 MW?UEU7BX%W338#9.S9-S5LPVU7]I[BGK=EI1+''32YC)[Y2V+=MW=TM?J)YFC6I6!0)2:,:*Y)"EF(IV,S<5H17J M#>8]EV2`"^6&*&2=BJ-,31YF14[DZ MRK:AZ!MI8..@RNR\_@,I-25\6V]NK@:W;>:V7E:C/9K#;?QT=(^*J4BHY:F- MDH::[C2.3EYWD4!K+=5I21JK(KBJF1]:L)5*B65U8$,S*AJQ)Z!3CFGCXUU&T\A\LOCKE*3%YG'[E MK.PMUU+TU;D<9GMGR4]?UOVWDLYN;963D_AN>Q]7FMQ2U"8V":.OEFV"N'O( ML4,;*EYI6_BY)YEBDGC-J+>/3I#+)_:VZK'*M62BIW.1I"W/B``ECTKY*_=[ M>X'*DL$+I>&Z?5E7B8&&X=GB:BN`TA*Q@Z@]H(6KVCK=5;7I.@*6OP')5?U< MW(#$\2.L\>N?OW7NO>_=>Z][]U[KWOW7NO>_=>Z\?H??NO?9QZ*_N9HC MN',LQ)C&1J]6LNS)('0>*)[.0C^(%D`](47](_:-H/["+'X1T'+L+]1*0>#_ M`&_;^71-NQ?B?LG?U5OIH^PNU-IP=NY_=&=W]B\/4[-R&W-TTF[]A;%Z\SF, MRFSM\[%W;MJ6*##==T4V,RC4RY_%54M5)2UZ0U4B.Z$%-1'<#U3QC5$!P%P? MQ5'S'E_1\_/H9X>L]GU&0Z:FBCS6.'0X\[1;HZ0Q"?Y72S4LU--512P$NB1Z1**%KP`R../\`9SUM[AP6?BS,<'AD M4IZTICH8)NBL1N7K?&=<;VW%EM]T.(W_`++[/AJJS!=;X=\AD-E[XP6_,#@\ MC@=F[&V[LJOP,N9PD:U4`QJS54$LJM,[`O#L`*H%.WA\OV^76UD=FU:\@>7& MA]/,]!GD_AML4;]K-_[+WMNKKC<"R]GST])A=N]1Y_;6*C[4RG7.>W3!A]N; MZZYW;AL-0)N7JZBR---2>.JBJYZPF9DG+IH*M0:8ZN9R!X9:I\JU_P`_3]D? MBKL6K;/8?<&[NTR>0I*&OS-9A\1E/F*=I7C58*=Q&3&SK;B*:>'^K^7^7IL2NA1*]M=5?Z6*U^1H#]O M2/W)\3NN]Q4>2P-?O?M.JZUS6XMW[K@ZP_O+C'V1CM_;KQ>:H,KNW%SOMA]X MQK3Y#.UV:HL14YNHP%#GYS6Q4:LD3+4QY*`D?X/MZTMT5T2T4E:4-,X/#/'T M^SJ/4_%6:I?;2*_BE-.GB>KM.:2%HQI)J5R1\B"F,)T10XS$[AW7U[N M+L[`4\FR,%2Q#[?-Z9*VEED,9$LM/)8J"22//_4*]:\=@T:,7V[U[3[VQU#D:F';^-QLT> M[LKC-[UM+75HD=Y:>*%$$8BM%L18^$!2.'R/RZ;:=V(HU=+(VICHMRTN?W M#LS%-G\EF%R&7S%+CZ=):Q41ZCWY55B02>'^#_5_JX=6,[*M`%"Y/#C7!S^? MV>N.C8*E'1P4U/3T])B*.".,T-+0+34-)1TE.K^:.*BAAAI:%JI)"0JQJB,3 M^@E7DW0Y'33-J`;74X\_+J4D,3>(LP-*]WB%E)9EE:*&,2B6)[1RAE=0H#6* MA%4^*37R\^M+0D%B2N>'\OV=<9II"U3!"L<+R?LQ_2)HA2+)4LD#Q>.1 M(S<,C7T\J]S$NQ3'IUHC+=V3_J_U?Y!0#D)1##!,[2>+R!4C9H]9%0C)(K:6 M!5@?6;O*K6U<@>6+0%:BO5@=2J0<=>E2X$\`)65PQJ:=`BE"SMXC(QC(#1#4 MO*W&I@58>;WOC12<]:90N5:HJ/V>F?\`5ZGKSS^&GDD8LJ*`&BTK"L$=@T,Q M`C5EG>,N'4J+'0`%9B)?`5-!UJO:6/#_`%?ZO+[!UQ<-%#!]S*)C4M*M0Z0N MFAV;[*G=8Y_*DYDCD0!0/65("\^`>-"<"@'5CV`5R?/Y]9Y):.*6HB0(:A)) M87,JZRW[$AEIED$E2#*JEF**&)12WJ"^C0J:5&.O52K#S%?R_/A7Y>77"E95 MC63Q,JND;?O*TD@BBI6:[()TD@>+R(ZFQ!#%N>9_=C\1ZK4(E#G[/]7#]OS) M-2<-6T4,#57HC:GAC*5$EXGCY)BNT@@LJ7<:5$974`=.J[:'$*.%>JO326_% M3S_V>LDM2Z!@L2F0--7)Y1412.ZJU,E-&3$:9)I"VDE@2&?3IM>-O'!IU=JA MF*X`K\O\/7(35CN5C*QPQ^$0)+XF@FD:\,].L5UA"BZQP/ M7AJ.:4/[?Y?Y>/7?DTHP,PIF\HDJ)6=ZA%EIUF]'H?URWD0J2L@^KAG'[HUG MTKUM:$FK4ZC*9I85J8XX&F+`P5#TH9HY*E353,8R\&IW9R\S2/$5OIM/.(Q$9YS$!./N)]0T*9Y6N%@OJ97"6]=A%%XC(`XUZ\M:%B<4X?D/\`*"?S MZ[>PJ MA#J8@X\OE_J^W^50>9J`LBT\.M4>LD77Y54Q2,J111>4^$EXI208V50NK0=/ M^;;38J:\!U96)*9XD_D*8ZCP,NNDUQZ:J6&L,H`#+)+$DPA%HZJ:&2-H8@8T M\4LBJI4Q#2T4=J$*Q)KFG^K]O30*DC2M,'^6!Y^5,8X?R\]4U=&8D\H@K:9I M8W)4B1&4R!)"WW,!4E`S!1*LD8_3(@U+81_/ATZS!E%//_5_J\OL'7*1X*21 MP(W"R4T"R.*<)#"/*X9YIA!$RF-I-8(=]*DN56_E>@';\^M%Q4*0:X\L?M_U M?.F*Y8Z%8WG,\@JDG2"`1B80QZE%3$H:I#1.Y+LQ`5D"ZO0D;,3/MF^&G$=> M\-5XTH1G[:DU_G7[:GCUS29*,MZ_WC-,%:.[.=<*P(T89YS(UX=.G1?4ND*O M^97U"V.MK45U,"2>L$"H`2.)_+)-JGE:=$<%(9!9` M%C!"%AJ4R-(DD#A95DD270(V:VD\'6V@F-O2 M"*TZL7S0G'KUP:2/5/$E0((H(Q#*X+Q+3F%VJP)&BECD+HDP(Y5M%F#$*UQ9&8^2S"E M.M::@U-:_P"KY?ZO,<>L51(%44?FE@656&I""- M4!\O&I7K1HH"D5'^K[/\@X\.'6"EA\41C<0RPT[22ETGIY/,F0B8Q1'Q-(RR M1B#D*OC=#_;*GQV/=336O#KRAJ%7:M#^VM>[Q>C7YU4UC1M%#'3)&5JIE9"WAU$H2P9P\U0*`$\*=:!KJTC-8"*.6,FE$,2KXI4>4SF,FRVU%"?5X7W2N5Q3_`"]: M)-5!^T#[,4`\\&A^7&M1UP:H<5"YY1!$\RRJPGF2HE:.[!7*C6 MZ>"2-(7^ZE5F:[FXM^XRA9(ZC5\0/`].U!.DY)'\A_J^W[(!(.`1_J\NN*NR4G[4; MD4\<4/A6='804NG13+)H(+QS3QD>,1>)B?4-163?XU!Z;U!E-`00!4>><\1G MYXSPR*,IE;9DJ3G\6)XTB1]^Z]U[W[KW5"73>X\/A*_^8=N+:^XNP]M[OVK0=EX?LC=N1ZJF.ULKONL[ M;[`GVIO'K7L'#Q[BZXSDNV=CRXW'2[5Q\ZF?(PO/EZ".2=WE]U=@1IJ:XZN" M^..XZ_=W1?5VX\ID7R^0RFT<=+5Y*0[9UUDT0>F:5DV;C<1M:`GPV\5#3QT\ M-M"ZM.H^ZIUJ$_+3#[%/S'[GR^X]\YK$[A?[C+'=^)$/T8PSA1:0?`6 M*J&CU^*M.XEZ>0Z"O:>,WOG\CFH-F]/4`ZZQISL.Z**N,FX%J$HZ:&+)XW/; M^J'IYZ+`[5KXLGB\3D::3!P4^"SE).'MYGKW!M7&[AP6;VA0TV,JL71U4B[V MQM=##55M=/2B>=G@AR(IIG+",R)(0%O7-6]O%<6:R1@HA"NR.DC%]7^AT\A\ MR*^O4B;#RCR_#/;7C6\S1LREE5XVB0+IXR"O$>0`-,8.>K9OY6R[?^S[B;;6 M`H\#BE[5[+6EH:6MS5:<4S5.QVK<545&>JZK(U=9#6*PJ)2TD7GC80N8M-XU M]QFN&?9#K=/<8]37U[W[KW01="?\`,F^NO_#:H_\`>Y/?NO="[[]U M[JESNWNW'[:_FB]6]8BMQU7FMV_Z*<+C=M2_)3L7$J4DQ78^X,[GY.H\!V_@ MMBX+-T>WJ-YH:'-;2R_][HL?&()HY(KK[KW5HOR#AGJ>A.[J>E)%34=0]E0T MY#^,B>79F:CB(DL?':1AZK&WU]^Z]U2Y\I/DWV!L[Y6?';H7%9_#8_;^8Z@V MBQ6BH=RQX\97>VQ-\[5SV*[BR^.R]!]]5YO`R`;%ABH-U;%)!UEUU#-?S0[$VC%+=M9\D>W\>CW;^T=0//Y]^ZKT`V\,CF< M1O+Y9Y;;E+D:[<.+^.?7N1P-%AQ6'+UF9HJ7OZIQ=+BQCJ#*9`Y&HKHD2#P4 MM3-Y2NB*1K(46Y22Q;=?RP*QF6%RH6NHL%)`72&-:\*`FO`$XZ$O)=E8;CSC MRGM^ZW$,6US[G:QS/*4$21/.BR/(9'CC$:H27+R(FD'4ZK5@4[^53C<[B=I] MQ4^S]X87 M>^WY-^5^R:+'QTU=@J0P3XF@K:62"DJJG[^KQE5(W6'AI^ETM/B3L+LO>?\` M*![DV/U+MG>N>[%W%O;><&S-L=9?(OKC8V]LB:G<6SJJ+%X[Y28O;62V/6_; MX97@K:V7&RN*"&7`RQI+`0GNJR?&>C/_``FP?R@^+OP2[FR'R/VDV"[&V5D. MPMZ;T,?M#"5M#0MO?+=S[WVN*:>MHZU7E:?:6/DJR\K8NB2 M1IIO=>8ZV7HS_P#+^[RF^0_QUPW9.0H=Q87/U.7J,%NG;NY*_8M?4[?W)MW" MX'$Y2EI1L8HM'39.2G&3DCRD-+DFK*Z>44\-'+1H/=5(H2.CM>_=:Z][]U[K MWOW7NO_3W^/?NO=>]^Z]U5]_-?R\>W?CEC\]X\K--0]K=)-%%A%8Y6=G[FV# M#'3XXJI`K*B:9$3D$ZC:UKB0_;.+ZCF"XMSITM97/Q<,6\QSYTZB+WGF:WY8 MM9UU:DO;:FG)S=6_`4.>J4+&3^I4]U=7;EVFD1ET M5I4!-"`]I%&HU#B@4C20:PEN,?\`K@VUGMFWQJCVT$BMXF,5?Q'(&I*%05J# M5LUJ"*$YW/T-VAUMNNJS^R=Z5F4S:34NXLU6]?YK*X+L7<>7,L+8?!4<,E-' M70;$P>,Q=/B\I%!/75,F&-#6/'+E<93)4#.SYDVG=+6*VW6P5+R.RZWY;_`!ZV;VC%.F@KED3('(2TN3PK1R.TT_D2D9YNVK;(.3.9[[9VI;_2Q MK7Q7(F!N(#XD<>O0D1.2A74DE0`JT+*>2=YW>3GWE"QW:ID%Y-(WZ2`PTMIP M8YI"GBR34%0Y0?Z@_0^\0#@TZSZ!#`$<*=NM]> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW4&?&8ZI=I*B@HYY&8,SS4L$K,P5$#,SQL M20L2CG\*!^/>]3#@Q_:>JE(V-6C4GY@=8EPN(7].+QR_3Z45,/HYD'TB_$AU M?\&Y^OOQ9C@L?VG_`#]:\.,9$2U^P==+@\,JJJXK'*JD%5%%3``C60;"/D@R M,?\`78GZGW;Q)/-R?SZT(HA@1J!]@ZY'#8AG,AQE`9"P_U MTC^@]^#N/]$;]IZ\8HR"/#6A^0ZY_P`$P]K?PO'V#%P/LZ>VLR"8L/V^"95# M'_:@#[WXC_Q'K7@Q4IX:T^P=86VY@7(+8;&,P.H,:&FU!M3M<'QW!#2,>/R2 M?K[T9)#PD(ZWX452?"7/R'7,X#!D,IQ&-*O;4OV5/I:RLHN/':P5VX^G)_J? M?@[_`,9_;U[PX_\`?:T^P?YNL:[;V^I)7"8M26UG30TPNWHY-HQ<_MK]?]2/ MZ>_:Y/.0GK7@Q9_36GV=9FP6%>^O$XU]1+-KHJ9M1)5CJO&=5RBWO];#^@]^ M+N?QG]IZWX47G&O[!UP;;^";QZL/C#XG\D5Z*GM'(9/-K0>.ROYO7<U]N1*J1X+%*J@JH%!3>E2I0J"8[A=!(M^`2/R? M>_$EH?U6_;UX00`U$*_L'623;N!F.J7#8R1M+K=Z*G8E9?'Y%-X^5D\*ZA^= M(O\`3W4/(,"1J?;U;PHB:F):TIP'#KF,#A%%EQ&-`L%M]E3?0/Y`#^W_`,=/ M5_BW)Y][UOY.1UKP8?\`?2_LZQIMS;Z$%,)BE(6-.*"E'IB9WC4CQ6(1Y&(_ MH23]3[UKD_WZW[3UX0PBM(5S\A_FZXOMG;KQ-`^#Q3PO&(FB:@I6C:(1F$1E M3$046)BH'T"DC\^]ZY/]^M^WKW@PG_0E_9UW)MO;\UQ+A<7("'4J]#3,K+(% M$BLK1E65P@#`BQ`L??MM_XCUOP8J$>&*?9UQ;;F`9=+8;&%=`CT_94]@@0QJH' MCL`L9*C^@-O>O$D\G(Z]X,7^^E_8.N9P =+8C',OKX:CIVOY!I>]XR3J4V M/^T\?3W[7)_OPTZUX,/^^E_9UB;;6WGU:\+C&UZM>JB@.K6;N6NAN6_/]1Q] M/>_$D\I"#UXP0D4,2T^SKE_=S`:0O\&QA5550#14[657$@7U1G@.`W^N`?>M M*U/MZWX$%6/@K4T\AY.]VG17 M/]6`/X]^#R#_`$1CUOP8J4\)?V#KR[;V^I0KA<6#&08_\AI_2REV#"\?Z]4C M$GZDFYY]^\27SE:GV]5^G@_WTO[.N!VMMPQ-#_`\6(F4*46B@4:5C\2CTH"` MD?`_I^.?=A+*#B0]>-M`:UA7/RZ[DVQMV6_EPF+DNYD]=#3-^X8O`9.8SZS# MZ+_70;?0V]U\27_?K=>-M;M0F%>->'GUY-L;=C),>$QB%F=F*T<(U-(Q:0M9 M/5K8\W^O']![MXLA`!<]:^FM_P#?*_LZXKM7;2C2N!Q(4N9"!04P!D:5YVD/ M[?+O/*SDGDNQ8\\^_>++6OBMU[Z:#_?*_LZ]3[6VW2*R4V#QD"O^H14D*:CI MTW)502UOS]>3_4^_&60\7/6Q!"H(6,`=<'VEM>33KV_B#H?R)_D%.-$AB\&M M;1C2W@]'']CCZ>]>))Y.1UKZ:WJ#X*U!QCKF^U=MR(L;X/%NBL75&HX&4,T@ ME8A2EK,X!(^A^GT][$LH_P!$/7C;0'C$O'TZXC:>V1(\HP.*661E:204-.'= MD>212[!+M:25FY_)/O1EE/\`HC?MZ]]-!_OI>NXMJ;:A#"/!8M=?C+$T<#,3 M$Q>(ZW1F!C&)(Y)]^,DC4K(`:J1+D9ZYG;&WBK*<-CBK(8V4 MTL5C&4T%+:;!=!(_P!/]3[UKE_WZW[>M?36Y!'@K3KB^U=M.+/@<2PTL@!H* M;A'TAD7]OTJ50"PL+"WT]V$TH_T5NO?36_\`OE?V=>&U=M`$#!XP`_511PZ2 M/()2"NFQ5I`"1]#;GWX32CA(>O?36_\`OI>NO[J;:#B08'%+(%C76M%`KZ8F MD>,:E0&R/,[#_:F)^I][\:7_`'X?V]>^FM_]\K^SKO\`NMMLH(_X'B]`54"? M90:0B*R(MM%M*JY`_I<_U]U\26M?%;]O7OIK?_?*_LZQG:&UB0W]W\0&5&C4 MBAIP5C90C(I"`JA1;6%A;CZ$^[>/-_OUOV]>-K;&E8%Q\NN9VIMDL7.!Q18H MT>HT4!(C>43N@NG"O*JD@?72M^%%O>-+_OP]>^F@_P!]+^SK'_<_:Y##^!8W MUQQ1,?MDU-'"\DD2EK:O3)*Q^MR3S[]X\O\`OP]>^FM_]]+UFCVMMR(1B+!X MM%A5$B5:*G"1K&&"!$T:%T:C;BX))^I]Z,TIK65JGY]>%M;@*!"M!PQUW_=C M;QU`X?'G7^K53QM?]D4_&H'3^P-'%O3))_OP]>^FM_]\K^SK#_`'/V MK=3_`'=PX*1M"EL?3#3$YC+1+:,6C;PJ"/I90/I[MXTO^_#^WKWTUO\`[Y7] MG61=J[;33IP>,&@,J#[.&RAY!,X4:>-O"VMP`HA M6GV>O6)=G[621)4P&*26.YCD2BA5T+:BS*P4$.Q]_>C+*01XK?MZ] M]-;D@F%:CACKS[.VK(%#[>Q#:2S(30P:D=X9*=Y$;1J21X)G4L"&(=N?4;[\ M:7_?AZ]]-;_[Y7]G7<>T-KP@+#@<7$H26,+%211J$G\?E72BJOK$2C_6%OH3 M[]XTO^_#U[Z:W)KX2]O$D\I#ULV\!P8E_9UB&T-K@DK@<6FH$-XZ2*.]Q)\K'5];L3>_ M/NWC2_[\/[>M?36_E"O[.LB;5VU'&(DP6*6,$L$%#3E0Q0Q%@#&0&\9(O];$ M_P!?=3+*?]%;]O7A:VX%/!6GV=<#M':YU7P&)]3M(W^0TXU2.5+N;(+L^@7_ M`*@6^GOPEE&?%;KQM;JAIV_>6<5(E.I#>45 M`#ZOKJ`/X'NWC2_[\/[>MFV@/&(=8%V3M)'$B;=Q*2*R/Y$HXDD+Q^3QLSJ` MSM&TS,I))#'4.>??O&E_WX>M?30?[Z7]G70V1M`-&XVUA0\4AEC<8^F#I*87 M@,BN(]0D,,C+>]_4?ZGW[QI?]^'KWTUO_OI?V=9:;9^UJ.2&:DP&+IY:>19H M'AI(D:*5/'HDC(7TN@B4`_A18<7'O1EE8$&0T/7EM;='\185#^M,]*3VWT_U M[W[KW7O?NO=>]^Z]U[W[KW5$W6VY_C;19OYV[@P6MW/!OS84> M"V+@\YM?NG)8K$[%V6FP=TX"E@R>V]_5U%.#X<=N.>:L@JZJIJ:Q)8J;W6R2 M:5\NK2_B3EZUUJ&?-?MO(;%^77R%VYA-M]=5FYLID^O*_ M"Y7>F-R>:JY*&CZ9V#%7ST$D>8HL%C,[C),Y)3X?&O1U%3G6@:J%BG:'D<,%C5210G4O/OW"WV;:O< M/FVUM+6U:Z:2#0TBEF-+2$$CO`U#45B303(SGRH"%7]SOD/W4FW4SE5F=IX? M[XQ;#QNYZ'!;&BVUF,'545-5;`R&UL=C<3C,S@XF_;3)T^)K:2;/5&J*FIJ7 M&2T9-'O^6N7WN3;P)-.J_JM&7F+JXJ)5-0BNM.TNL14R@T`5"O1KNB,OB/C)M#L;8N_I,EM. MNRF/I#A*:*&K:HK*;;.9R6-CJ<6\"9WP8#^%/%344D"3&I$;/*M1454LT8/W MN.XYMW*QNK(1RI'(2U2!\:J2&..[S()H#330`=#+EZYAY.V[]^Z]U5-\O,=M;/ M?RTYMM;TFW?%M3/T/4]#NQMB9B?%;CI-EGM39[;TSC08[;^[<[G=M[9VQ]UD M,SC<=BLA7U^*IIX(8M<@9?=60D'M&>J_=T?,_O+X&?$[X28CJG:.RI.LMT]- M[RQE5D^TYL=M&IP^[SN6?$]:UU*M6=DT6/V_N;*;AH9Z#$ST5/E3CV%++"M? M=/?NMA058GB.C'=]T_?%7_-'^.N[,3!O*NZUV7_HQP.?S%!U+L&';FQLEV5C MMT8W,KCM[5YJ.RM\4^]<;'5XNLCI4BQV"I*RIKGF23$O#5^ZKVZ1_%U;5\B2 MX^/_`'F8P#(O3O9K1@WL7&RLV4!TD-8L/P0??NM=5,_)/;G55=\C?C'N$]\9 MK"]G8?IVF?>W3$?968Q-)7[*;I_MF'JR?';-QOV\M9C]X=MU42Y%)IIZ+(?P M>/7$IIYG;W6PU*T\^KB^J2QZNZV+@!CL'9Q8"]@W]W<=<"_-@??NM=!SC$R$ MG>/?4>)FHZ;*R=1]+IC*C(4M174%/D&R'>*T4U=14=;C:NLHXJDJTL451!)( M@*K(A(84D\0QR")@)=)H2"0#3!(!!(KQ`(/H1T_:O9QW-O)N,,LFWK(IE6)E M21HP076-W21$YO!/D,%7P12@C"K+*M!0]U59N+U:O63/WI^7N7>7.9>38.4^0[;8]@ MFVSQ(FADFE_>&I@3?N9["QEB,QJ1;_K6]N/T[7PX@%Z(AOKKSIS)?/3YL[MH M\)\DNN>QNLOCIW%V14=KYVEP&T>F\O-N3IS;.S-QQ83>.S<37]U9S$8+'RXZ MNQQ9M.*K*/(-CHY&E*>QQUC$C$=H&">DMTIO'J@?R:.W,+0Y3`4#8K,X+"[L MVS@\KU=GO]'^Z.P]]=?T.TZO;>)(Z(ZXZNJ,KDLO29G#9&NFI:3%96=L[6U% M74I61-[KTGQGH;/C!VKMGNO^67\G)=J5W;W;;[7VWGZ"O@^9GR$V#VCFJV/) M]&]>=F;;JLSW!UONG`;8PM*=E;LQV3JZ49K$5>%W`:N">LH)(S4Q>ZT%.I0P MX]&T_EA9F'<71&]<[#NI>P_XCW+N;R=G93,QY?L#L.2BVIL;'?QGM*./MGNL M8C>.$2D&"@I/XZVG`XC'2BEHQ+]M'[K3"C$=6.^_=:Z][]U[KWOW7NO_U-_C MW[KW7O?NO=5B?S7VG7XT4WVV.JG5=OQ&P&.ZM[7VM5;UVKG]K8K>N,S&QJ_%5<]7+@ MQ@\U'5TV.J3!)C:I*F:FJ,W4S5R5\ZK]W/>2G:14]C#F>Y?<=NN5M+B.1XBL MH84#!AIU4SYA<:10@`C'4=3;";QWCUU7U1JJ>@K\Y!1RP[BR-#6356)DAKX&6HV7` MD%#+D*7*5O@Q7W[4Q_R- M^-]7OK&YJHQ4_:&X*>&M+XC.;7@K:?ION#%/C\7G\?E,A34N*Q4]!440A6&, MR0F@"$1K(L@AWB[VA^5^:!:-&)/HEH/A<@W%M0LE,DJRM756NJM3P"VPV>\6 M_./)[;E'(T0O6!)*M'_N+<@(KJ2M`P9:%1VZ-)X];?,9!06``!(`'T`5B./I MQQ[QG84/'K-9:4%!04ZY^Z];Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z] M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z+U\L-_]@=6 M_''N#L#JG%IF^R-K;-K\CLO$R8Q\RN0W!Y(*>@I?X:E31BJ:66>RAY8XE:S2 M,(PQ]^Z]T5/,?)KO38N.RFS=UXA:/N!<5C-T8#:>=VS2Y;-5VUDV;V-G]TY. M:KZ]R5;LS*TV!R>TH(I)J&I"PAT@D'W%1"']UM14\:=/&\?F!GICO^7J?-[! MWED-L].=8=N;`VF\5;%+W#78O+=N5W>?6^W,^E1)#2[@?:^Q:*FH)TIZG^#9 M&KBEJH*B*7Q>_=:ZD]Z]I?+/K6GZRI=N8[#[GSF+ZFW=V5W'D MTL]L*3(8J63.;JQFZHMN/@LMEX**/!TV4S]9-#%**86:,^Z]T$.!^8G?^=V5 MMD=CX7_9KQ6W>C<%FL5M;=.^Z?$IFTRFQLEG(MW8[<>,HJILK51X^DK*1J>5U:HA] MUX+4$UZ!:G^8_P`DSE=M[.[,R^V>D4_AVT,MNCMRHZ?W+E]H/BM\;8^3F\MI MY+"T>3S@HZB6JCZUV[A?<&V>W^R=Z;%VWMQJ8?Q*::@VGB\A7UV+RU M#4P35>._B=+D)ZB*EQ];Y/=>`J":]!;3?*_Y.SOLQ]F3[4[8S68W%UWD.S=B MT?4>Z-JUW5+U=9OS(]A]%)F:W=/V51ON7;VV9*'$5E>RO29;&BIKHC1Y:CCA M]U7I<;Q^:G;F'ZB^.N^=L]/;ZW#DMZMM/L/M2HINK,WD*:'HFBP."S_9NX\! M@:;@'SGSD^2-#C]_1PU M6TY:S!;]C6@S6-V)-'MRHVY)_I7$6T,%EMUYW`T>*W]&VU,4\^V]Y#;F;J8H MJT4%1.U?C#'[K>G)%>EMD?F)WP]+WE61U&)VY5[6WGBL-M'%;CH-G8F:CVU6 M[UQN.>KR.#JT>.VXN0JXQ)4HC1$^ZT!4TKTU4OSF^0B M5>X6@VVNZIVZJ]'%V9\H-V;^^8N4ZWP&>P5?TDF`VU7[3S&+JMCQQ;IJLAM+.Y'. M)3IELU'OG<1HB>AI/"T50P=92/=5Z!_"_,;Y-OV=O7:.&ZWH>X MCC.Q,WB\;@=I4-%LZDI-LT5!WFT-)6;TWIF\2-J[DQ;[(PC5F+W%CJ.MJI%J MJC'35=#64AA]U[I`X;YY?*3==%M_%T74FY:.OWEUS\9,7MW/XSJ++TL-;WGG M<[TQ4_)#!8S)[XW1A]H+3X_:O;=7#A8LFU#0T%=M/(O45]6A\%O?NJ]#YMOY-=JYSHS9VZ-Q;IQ'7,N0[ MTS'6^].W\IL.AW9MO;FTL?MO-;@P^>RZN'KC&["P53%E\?B-M[6PVXMSUNS M<1FX*J/!;CS=5V?BGW8V13(TM.8)*7&4U4E%4S/54\['W7N@/C^6?;E9#M!* M[O#9>TL%N?!OG>P>Q*[XW[ZGQ71W8?\`=.KRU'T'7P56YJ:@RV;R64$K:*R2 M'+T<6%FHIA]YEL?)![KW0.[\^??S>Q&'S-!0=,X+;^\8\Y6;BI8\EU]O[+TN M+Z]3XA5V['PE7CZ>J@:HW9B/E$D%+,S52,^`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`DWNO*NJN>F7;/R[^3&X,1VG4T&UNNLGN#:' M4F\MV;:P=5L;LW;E)D9MBTFTJ_`]HU=?)F,Q55>Q_D#C\_D9ML8&GIQD*)\2 M(9,A5N:UJ+W7F&DTK7H3_D;WG\B.M^V\9=UYG![*H*7;U-@L5DUAR];$V2T4LRD>ZT,D#H M#^O?E5\P]Z[@V+29OJ[/[/GV[_H:VQW3CJ_KS!8C!8O>6\N_]Z];[FR.17-] MA5.\J;;N;Z\Q>'S>$&WX\X<<,FDN3D$&H+[KS"AH#4=/_>?RR^5776[>QNO. MO^I9^Q]W;.SU9#@(<-L'-U_]],3OZMH-]]6?W?3^\.*Q5H<:^B):M*>;W6NA*V?\`-O$93#8_K=K[_`,AU?FMR8P_<5N'K\UN&@P5$]8\;4T\]68D56E0K[KW31\=_D?W= MV!VEOC;'8]/18`;>Z^V_G,;MLTFT\345&8K^I>K=WY(2[3GS=1VS3FDW-NK( MQ--+2+C],0IPYF3U>ZLPI3->@@I/DE\R,!C.B:WLO'4FU,;VY6TM=)59BBZ= MVKN/&T2[3V-D,I%629#L/,;+I\(^9W!5'&4?W"[IJHH)4DI5,.IO=5Z%#J#Y M#?)S,47=.9["VX,-C\'U=V?OCK^7/[#=*6KRVU^P=Z;;VW)A<;UYG=X;PRFT MA@L/23U])E*&CW'4/+&]'32(\BI[KW2$Z_\`F1\FLQC^&@RG7N-W9 MV?2?W0QVWMJT>X.Y(]KY_/TPP^[,E1=J86'9546CJMM@-1U-)(M92P3K)"/= M6(H`:\>D]5_,SY;[NVMFJG;G2^]MF;AI-U=B[LV]BZCKG`QYK,=#R=>9/>/4 M6Y:RBWQO_%X>0RYC&56,S*TU4N8GFH_\FQ\+3!%]UZG;JKT._P`5?DYV)V/V M!V+B.Y,G@-OP8S<^4VOM+#TTFTL33Y*I_O3)B<#)CMN39>H[7QYR-!3AX7S= M)315HG$D/!0>_=5Z#C/?)WY*2U^Y\7LR?%;JWS5[DW!@ZSIS$];OB]S]+T^/ M^0&P^M]H2Y'>>YMQIM/-56]-D9^KJ8ZC)BEHJV9X\E1:<;252/[KW5EO7,V[ M*G8FU*C?=)58_>4^$H9=R4-<^"DK*/+R1!JNEJ9-L5-7MZ2>"0Z6:BEDIV(N MC$>_=>Z6GOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[J@G8>3RNZ>R_G9EZ:K["H\WM;%Y/ M:^9Q4V_^P>W,5UUN1OD'7UF"V_#M+ZLQ!I0=7`_&BJ2MZ/V'5(F:A:6DS!GI=PT4>/RU!6+N/,)78R>E MBBB58<96+)3P.3*TM/$CM-.S&:3W5>M5_OO(;]J?F/WGMWJW9]-GMTS;RZ^? M[J'9=)D*])XS.[+E/L$5FG M)6P7&Y7QBL_IGK60@:?JI@W:#4@G`4`U<@D$4I@_S3)N4GN#S1;;-MXDW`7$ M0#>&I.KZ.`KWD:054$LS9$88`KFH_?%[XSU&_NS,70]E[]I82Q134BQR%IEEUU*2EF<.\S%:4I3H2\H2`4C0^*8B5J6G?"DUH M"JCB!4UK7G\Y-G["S7>&9H\73;AW3@-M;>Q6TF9XR666245(B9WD6_W"TV<%RD,SN9!(QSERQ.DTI1>!^5 M1PZW[F[?ME[S"ZQ++-#'&D7AHOPE8U51K`8$DC@00":,#4UL&_E!TF+HNNNP M*7"T-73T,6_MY&5JVIJ:J>'(2U&WVKZ)JBM:6KJ)XJ@-YG9A:0:;>F_L$^Z; MW#[EMS73`R_21<*4(!E`((`Q3X?EU)?LH+4;5N7T2,(!>3CNK4-^CJ4ZB34& MM16@-:#JX[W%?4W]>]^Z]U3Q\\<=A%_E:9C>63VS+GJSKG;NP-ZXZNH]L;&W M56;,512+N*`X')O5X+[J$0-JNONKH"6`!H> MB8=Y=:]L]N_!GX5?(+H+9&%JL'U!L+-[RR78F-[*S?1&Y.L>O7SV/K=P=G]: M=(=0;F^,WQ^K*Z?KC#Y#*T-1D(J*OQ)$%)%B_P#+<@(O=:#4#+3CT93M+Y7= MK[?_`)B^V^B<)\G>K\/USFMS]%B;J'.)D8NWJNFW"O5+5]+M:BAV)78[-XK= M7\6=9IFS$'BARN0GLO\`"A?W6R!H4TSU9W\C-Z;2@ZA[PVD=T;;_`+X/TEVO MD:?:;YO'C<5124&Q,A4U=3'@DJAF)*2FAKX&ED2(A$GC)(UJ3[JGSZJ4^2.Z MNZ:7Y(=4X/;-/\J9MBS]&=/9"MGZ^26AZ-P^*BH-[Q;WFWUBJ"B2+LG#Y.DK MJ7'U;9/(TYVV:QZV.BKG6F>E]U8"M3(8F.>&LS$<,;(U53!@UC+&#K"2_:Y2PO6LXP]V(7**0"&<*=(()4 M&K4%"PKPJ./1]RK:['>\TFDEF_EJ].;AZ=QW=&-S/6>]=C46W0XVY-%F: M6'9^S>S^T=KXS#[?RA=J>H@J:6>K>NE^XCD>/[B4&22>/2'B=)%B%NOANBOX2`9/N;ORK^6O\PS;+;M[?V_ MM"CZ,W?F^KMTY#%;]WYA.OG1J:^7`_P_;U? MN3.[CI^N:+.Q-GU.V>LMY?"_#=O'*=: M['WGAM]5'7.\=R4V\>J,WC_=>Z][]U[K_U=_C MW[KW7O?NO=5;_P`VZNK,=\75KL?45=%74G9W3E31Y"A1):O'U<';&S'IJVGC M>2)6FI9;2"[*JZ"S,`/V*HW,[+*H:,V=P"#P(\"6H/R/#Y\.H@]Z9)(N5 M(Y(BPE6[MRI7B&^HAH0?(@^?5'^V=\XOJ3^![NRV^]S[=SV\*>KGP,&/CS]; ME)L9-/Y1D<]D,S68.#<%))5"68QTU37O5SXVME$:1H6:4Y+&7=FN;2WV^.2W M@IK+:*5H0JK16*XH,Z0-2@FIZ@FVW!=CCL[^XW*:*ZFU%-.HG22*M)4H""0Y M[?$-4+`4%2;#YD=][?[)ZOZ<[2KMI;:[9ZZR*4'7?;&9EPDV'[.ZY[#H?N5I M=Q5T%1!#C66OQ,TE7'1U<%/BI5I)HI9T+1GV&^5=CN;3=-WVCZN2TOU4RP#5 M6&6,@53YY(!*]P-"`:=#'GKF*UW79-CWTV<-[M3@07+:=,\$R%],GYJ6*A^Q M@""VE-N*JS^5VOELU'CMSXBN/0O95?]OF]@QP M4M.N2@P[TLE34TZR0>%J:H8AIV1!7S*;F#E7F./<]M6.Z6$*KHFJ,K]5$.R7 MB5U!J`YXJ,+T!^48[>[YQY2?;-X\:P:Z+-&6TR(WT<[=T7D:,*E<"@8TU];C M:J%%AP+L?]NQ)_WOWC(34]9N4`H!UR]ZZ]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7K?[[_6^G^V]^Z]U[W[KW7K?[[_`%N1_MC[]U[KH``6``']!P/?NO=> ML/Z#ZW^GY'T/^N/?NO=>L!]`!^?]O]??NO==^_=>ZK/WG_-0^.FQLAVI@,S% MF!O'JOYB]4_#&MV(N;V'%O?F-W;FV/GZN7JC!=X9GOJEQF5W-MB>&BGFVM&ABFBGE\4$@D]^ZTRE M*5Z#/;O\YKXR;LZ-^77?6`VGVQ6;9^'_`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`V5OSKO:F6 MS_=Z=T[VQW6_66R>MLCL+?6[=IIVUFM]YO'X^LVKF^]H]F?%/Y%["^0NP^S?C=UO/\`'/*5_2-;O#Z\J,W#J M1'_-UVW79/;/7V"^)'R:S/?^>^0_9'QGK^@8:CH>CW9@.P^L^E:+Y"9FIGWG M6]SP=29C;E=U5DH,A355!N"I?RN:>6..8:#[K9C8>E*5_+J%@_YQW7?:6#V? M5_&GXP_)KY);MRG3>X>]^QNN-A8OK#";MZ5V)MK?F\.L*J@WS)O?LK;NWLIO M[-[]Z[S]!A<%@:[+U>8&(FGIR8&BDD]UXHPX]0-W?SJ.EL5@]S=@]?="]_\` M<_2^P/CCTK\K.R>U]@_Z'*'';(Z=[QHMUY/;^3J=H;[[8V?OS/[@P5!LG*-E M<7BL=6U=+-1O#I:72A]UXQLO$=&,W[_,FZ/V+\N.IOAI_=_?^X>T.Y^H:OM7 M:&7Q6*Q5'LF*OJ\+O/<.P.K\_N+/9C$18/LKM3"];[AJ,'13JL4L>'G,TL/I MO[JNDZ=7ET`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`<_\5)_WL^_=>Z[]^Z]U[W[ MKW7O?NO=89J>GJ/%YX(9_!,E1#YHTD\4\5S'/%K#>.:.YTL+,+\'W[KW6:WT M_P`.1_A^./\`8'W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=4N]?='_`"!Z MFW9\J=R;PQ71^W]LY?`[D7X\XW'FMDWGB.L\G\@]S=B;]B[4Q51V5D<=ELSN M/);MEKL++CI/`D4M'254U).OV"^ZLVG&GJPWX@0PP?';KY8(J2&*5]X52B@Q MV2Q5'(:W?FZ*QZFFH MW>-0.SH-A],UN[MIX?.QYG-_W:VWGJANE^K*G/8RCIZ#)TF3W=6M3&.>IC6& MLJ:6E]'JB>*(Y-\LS[-'R_L"C;3/O7T[L&`ULE+F>C58%4`;MS16H#QKUA;S MA!O4O,W,CONHMN7?J(U.IM"NWTMN62@(,I89``+`%A32.C;?`#M[JKK78_>_ M8VW]N1X#9?4&Q\5C,#W!V)DJ*DKMU;^S%!4O+!B<;(_@QU)5X=$J/X:IGK4I MDC+%UD2-`ISQM6Z[AN&S;?=3A]RN9F9K>%:B*/5^(\:ZF(U?!4$#AT-/;7>M MFVG;.8]WM("FVV5NJ))Q,D]1D]M;,GEV+DXJ:JW!5T59/-L^3";7I\Q1XO/TA2JG2EKDT:'JVC4L MJ"2SV/;K&WM(+K93'<2@:6EI(IH@(`<,VEB#6A(%>T#/01ON9]UW">^N+/F) M)8(B2Z1#PZ$R4):+2@900!J`)(.JM!46O?REMU97?&R^R]W96;'R5&?4P^S-[-N&V[I>SR(SO=SY7S(*`F@51D\6'$UZN`]QAU- M?7O?NO=4M_S`.P>MMH_RV]H;:WWVALSK/.=@9OJ>CZV&\*#+9B7>F[MB[ZPO M:WMD5IH8TVUE429!)+#XD=A[JR:M7;QZ*WW/GMCU/ MQ3^&-/V]\2\;VQN/<70F>SFUH.V]^]C]:X7+ME=R[18]3X7$=(]1XG%[M[-[ M$VIE3EU7EI?=7/\`9+Z5Z"CM&CQ%/\\/DG71;;Z[A`I.^JN3?N+V3N?^)Y;.I\(J MV"7KENW)*H5>3[0P^,>?*U&T&`VS1X2HEKZ;_V,]OG9^%W1F>EJ=L1M?+;FP^,W'ECF-HUM%B4QF$K,A#E:V3*UU#-!3")&: M>:%T34Z,![IOH7^JF#]7];N`0&V%L]@"""`VWL<0"&)8&Q_))]^Z]T73LH;; MDSOS#I]X[JGV+M2K^,^Q:3T<`IRMRUN[,YL_8V9H9,EUQEZ/,;AVS@MZG%;^VL8J_P"URU7F M*C$UB5.+:K\U#/%&7;"\:_66:W,[-"XHDKM(R1D?I'6X#D2(-=&+%6U*352. MA3[L17ES<\MU\:UN-4326T=M'< MQ&&\6'PKF-WJFSV\]YY?O;^9]L;MSLGO'>NW,3\?^WL9L#`TF-DQ70>)PF.V M[UMD-T9+K6EVWV'B-O3$G>=.!YZ*GEAJ*:JHY,K4T MGGHK"KE/Y/.X8J3-TNWZV@W/@-VXW=,G;N$W=]QN+9_9G7F\ MC<6%R.,JZ/YI2=<[#W%+0]<])=;]5[.S&'SF#;HG%2=5TVS>O\9'293VL MC6R4U0^32)68'W7M9+*6\NC$?RAZ3;0^)C9[:J;83&;R[%S>ZBNULWMC,P>: MNVOLRC5\VFT^UNXL=B=US4F/B?)TTV5CR#5C/45=.E1/)+-[JK&K$CJT?W[K M77O?NO=>]^Z]U__6W^/?NO=>]^Z]T0KY^IM*7K[KBFW[3K5[*K^\>F,5N6D9 M83Y\=F.R]L8LG5//3QIX)ZM)-18%=.I;L`I%O)IN1N.X&SQ=BQN"A^:PR-^> M!_D\^HY]R!8MM^SIN2UV]MPMED']%KB)?Y$@U\N/5,?R#^.FQ.W11UGQ>W?C M>Q-W=<_WJV5OG8>Y4=AWZ\VVEGZJKDFQ=2T/FQ^1E=2TB M0I(%>9>9+Y;F.9IUCO(7+121BFF-B1IS561EH`P!HR@=#?DSDK:Y;2:W%LTV MW7,2"X24BC2H*@C"NKQL6)0D55ZYH.J]-L]"8GIWYY=>9[:E=3P;]\GTKVS/7#(U4=+%7YO:-3@HZ>##UCU,]7XY(X*A8S3D./KO MF)]Z]O=YM+H'ZOPK4Z@"(WB2XA4:03192Y+2"BK1214O3J,+#ENVV#W0VB[L MI0MFDUVIC+`R1R-:SL06`!:,H`(B22":&@`KMPC_`(D_[V?>-@ZS-SY]=^]] M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KHD"UR!_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KH$$7!! M!^A!N/\`;^_=>Z[]^Z]U[W[KW7O?NO=>]^Z]UZ]OKQ]!_M^!_MS[]U[JH'L' M^4%U'V#N'N+?V2S6T%[6[1^=O2OS/P_;-3TQM+)=C;!Q/4&7Z*RDG2.#WE49 M)=RMMG=0Z9GBFK(ZRE2G7.U!^SETL)_=.+(13TITD>G/Y4_9G0]1V:>MN_/C MK@ZS?;_)^JPW:4/P4VI'\E=KY#Y&9[L'=U%55/?4'T#P0ST$ M<>0Q^)@HW\*6>/W6F?4P)&!T"'_0/SLC:?7>^^M.I/E?W%M_;_9?Q4ZN^->[ M*;LS'CM^ECK>DNWMG]N=5[WVQ29'=&W&VSB=KUV+SM$-NPRM2/#N.9UGC>$" M7W5O%/FOGU9!-\4.\>P\E\>=Q?(3Y&[0[#W1\=?DU'\@-N5VP.AI.J\7F<,G M2O9G4O\`<#*8FM[:["ECJ#6]ESY7^+I4WTTZ4OVGJ,X]U2M-6G@1T`.\/Y0W M4.[]V;C['J\OL].U<]_,,Z^^=*=J3],[4K>PL?@-BYGK[*O\>XMXR9./+ZHZQ^>&?VQ\ M8^KX>[Y_C_T_B^D=N4NX-K5G:N/WE#LK`=M=CC>KJ^IHZ,5^0E2GTR>ZT7!-2F>BNXS_A/OL39W6^Y.L]A_++NM<#V-\+:CX=] MHT79M,O:6(SM'2[ZV]V7MC>VSL3D]QXD]?TNWMXCZV9*\5Z$[M/^1_U1EU[>P?0.Y^M^@.LNS>R?AWW%0]+Q?'[#;[ZDPW9'Q/ MW)O',UV3W#L6JWUMS"[VPW=&+W#08W/T4T=)JI>`SBMQ]?=);4ZMVWU%V)T!V/B^U]E]YYC855NK?%+V-VIG=WX"@C MSC35V/Q%1B89*.DHZ/SM,ONKB0`X3H.M]?R=?(;`]V]F]F]H M?$3-[Y7#]#X_9'4M7T?\1]][BW]A^A<;UO4]B[KR`HNQ\OO#*OG,U7YK(5%Z MM$AIUA@6)O=>\3&E10=3HOY(/QX.[]G8^JJ=LR_&G8/RK[:^3FU?C#2==MC= MD8I.W?CE@^E,QUS19*BWI&]!A,9OC#R;V@GIZ2)7R-;-3-3^,B7W[K?BG213 M-`*_9T+6_P#^6[N39W9=/V7\!N[]I?"FHROQUV]\7-Y[+I>A,!VCUZ_7&Q\[ MNOVZ=ZT^9KX(!BX8ZS&H$D,0P7WE'TWM:/XXXG:NV-A;+SW37W50Y M!4CR%.@K?EI4_,;87QJ/3^(I=\T&^X^RLUW3M MSKG+=[?WPJ)\IU!M'M[/U&9I*1=OP9B:$1T-1D9:=+M[JWB#)"]]./\`L=-G M0/\`)AV9T'VS\(>Y<+WGN;([K^)6-[?Q.]:*/9]'B=N_(.+?Z]SQ[#S&Y<3% MN.K7;&[>HJ/O+-4-#DHWKY:W&SM2RJB"'P>Z\TNK7VX/\NEI\B/Y9'9?:N\O MEI#U/\M\ATITE\]L9MO'_*OK2?J##]A[FJZG%;"QG4NZ\OTGV!D=X8*GZSR/ M9G5&#HL+E?XAA]Q14[0"LHUAF.D>ZTLE-/;D=#QT/_+=^-W2?<_:G?DW7766 M^.T]X=HXK?76W8&=ZMVN>Q.E=K8+H[K7H_$==;1W_5C*[F.(HL1L*IJ1-%-1 M7.8J(C#;4\GNM,Y:G16?EK_)PH/EQW%WYWUN;Y6]S;&[%[`H.A,9TE#L5/X7 ML7I6D^.N=P%9WON[Y+;YW10T/5U#58D[F[O?$OU[E*NCEW MU",I5]"_?;K7$R,8WJUW5.&,'@7R>ZMXV`-.!T:[8_\`+)W#UY\L>SODC@>R M?CQEJ#M3Y"9;O?)P;X^&6V=V=[[53/[1VWLW+[,V!\DI>U:#<&U:!<9MTM1U M$>'D^TDK:C]F02,#[JC.&I5>'199O^$_G2^#Z>VWUMU/V/B.H]SU_P`*_D#\ M/>^NR=J=08Z',?(C_3=MG9V+QG:>_<=#O6BADSO7NX]J29:DHY9JM:F;(3)] MQ#97]^ZN)?BJM:D?ET9;9W\MKNKJ/?NZ*?H?YJ9WJ'X]=K]M]<]Z]S=6[=Z> MV[4]B9GL3:>!V%A.P8NN^YZW=,DNPMF]ZCKJA;<5!483,5%/'45J8ZJI?NBR M>ZT9`WQ)GI$]9_R<:+K3O[K3Y6T?RN[CRG?6V/E/WA\C^P9J^$2=/;[Q?R&B MW#A.R^N<#T_49^KQW79R6R7VYBDS=/75M5HVK22-"VI4@]U[Q,,-`H1^SJZJ MX%KD]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=(_*;^VCA=QXK:>3S"4V?S7B^PHOM*^9&-3(\-(M77 M4]++C\;)7SQ,E.M3+$U0ZE8@Y!'OW7NJ'NGMBT_9WR"_F#XO:%+U!7;FBFQ^ MUX(XI.\:;=`'8>R*;L2NK5Q.=?$Y*2DR4T.&QE9#+3!Z@1MD$I M/=.2#X?LZN>^-6SLOL#H_8&U,[BX<'DL;09*:3"02UDHP]-EL]EFG1XH)9($C<^Z;ZU5NTOCAD^WOG1VU/G:W)[=Z[H- MU=._WJSCTM7ELC6/C>H^MX\;B^M<1643X_,;BK(ZS+4N9:GG,%+134\]9R(8 MIL)-ZY2N.8?M=L23= M0_'OIW'Y/=E73;AQ)W;EM^;CAP6(Q^2W+F:Y\GA+;9VWCL>=OXVIFBBK:V-Y M%HB(O%*(^Y?YKNI-U?XY&JM:FO5QOP+P^U,!N[Y!X+9`I?[ MK;?[*W/M_#R4L$--'(F%J\;C&_A,V[E@V*6] M+?4O9Q,U37X@Q'_&2*`8'`=3=[=0V=O>\R06`464=Y,B4%,*R*Q_WH&OF34G M/5E?L!]2KU[W[KW587R&[6VSU;\']B-N'H*+Y*5&]3LW8^#ZLS'6._.S=EY. MMW%F:?'5V2WU1]?]5=QY7$[>PF$J*JK+_P`$JI:Z:%*&E22JJ88V]U914_%3 MJJ;YJ4.V,QU=\#(,5LOJ#JG8^Q.G^Q^Q*CIG<:=B["VMF\=LS>&R*&+I7J+< M&^'Z([RW/V)'75);'=;24&VFS800USQP1Q4TONM@D*P`P>C6]O[T[(7^:[UI MUGM?N7*C;&Z_]#V]-W]5XQ.OOO\`96!P6,@R=*VZ*W+?(3;.Z=HX?=E=LRJH MZ/&)M/*UV0_C.6%+354H_;F$Z#B^\*G=?>T1C9SBMN8K_`&76>FV]T+7C%8FFQL-;F<71Y;=L>7EKOOY(-OR8^*)9 M$K*B7W7@3H84QT!'R@IL1B?GWU1NF/8O<55NB7I'I;'X;-8+`=79WJ.LPV:I MO[M[BBW3E]U]/;KWYM63%;0R.9JF?&;EQZTH!K4TZV+>K M61^LNNGB18XWV)M%HXT+E(T;;^/*HAD=Y"JJ;#4Q-OJ3[]U7HNG8F%W!N3<_ MRVV_M3;^V]U;DS?QSZYQ."VUO"-)MK9[+9&/OFDH,/N&&26".;$9">413HTL M2NC$-(BDN$.YQR3[;N$$,"R3/"X56^%B5("M4@4)I@D#YCB!3R-?V&U<[T M(.S-J8_;C;LW%A-P8&2?.S;MW>N.7$2T%-M3/[JK-W[XR69QFQL%3XZBI3/7 MM''D#D5I%-!]I)(&N3]KW/;(MP;'Y\Y+YZW+E!N3.8)[V*PM)X)OT?IK4N95=KJWMA:V:0O>S&>=Q'`-4' MTAG*W7CQI7%L'=>5S_SH_FL;TJ,)V-C^LZ#IK>?6>?J\+MO;NT]^XS,[)P'7 MN-RF?VYN3L>3&8UHTV_GJC*XB;^].)Q;T=*M348W3]C52#/K'BFDJ0:]A)-\[3FQ.PNVJ#J?HG%T6*P?:>P_]*>&Q&X.N]Q4 MN"H9>S,6*B:@GDRBSSYJL1X"CU05O=>8DL21GI7_`!JVJ^$_EV_-+;'R!_A7 M16.PF>K]O]D4'1_8>(WUN38>\-I=*=.X;MTXG*U&[\RFV-R;A[:Q67K<-1Y+ M)0&BQV1H9F:*G>.3W[JSBI6@\NK+?@SV%U]VET;'O;J_)]Q9G9N6W=N(8[+] MX[PQ&]-Z9"2C^QI*NHBR&*W7NV2@P/W$)6EI:N:GJAI>7P+#-#)+[IOHXOOW M7NO>_=>Z][]U[K__U]_CW[KW7O?NO=5:?S;IUI_C%%,ZBT'9O3M3Y7E6G2/[ M?MC9DWIJ2P:"HN@:)A8B15L0UO<;294W%)D26A MJ#(HU12E44N_B<&JX4T_4:IZM'P/S:Q'>/5V]Z;<<553X?L3;Z][]U[ MKWOW7NO>_=>Z][]U[KWOW7NJU>XL=\N,9\I]T9GJO<';/^C+*['ZIRL>#Q>, MZYS>RJVKV%LWY6YO<>S,#+O;%U%-M+-=@[YCV-C\K6-+#534M7"(JBG5//3> MZ]T@NM=Q_/S/X7&9C<&1[,QM;M/*XNK7`9GK;JNCE[.HMQ;[ZY@J:#,4$6U:HO0Q/53!H)&J/=;%*&HST7RLI_P"8CE<[U;VM7T_; M9W'L[:_+;^Y-X_'&NK-U;:Z_P#]%U944NYJNJP^;HL93RX' M,U--AJ6L^WGRL)AR55[JP*`9&>AWW7N_^8?AL%MO.0P;[RNZ2:HDR]%'23XB.CH\A2N:> M+(^Z\2E10=O0/=78#YR;2ZUV[1X7#=LSU_6VWMP4F*?L/;VUZ+<>U=R9C,YB MGWKCMGT^.Q.7I]_;7P_7!QU;MJLR])GJJKSLT\#M4E310>Z\"FHU';T;#=FY MOF.O07360H)NP:3LBN.]O[SUNTNO-@Y;=^3W#`G7$-#V+UI#B,KM*-= MB;JS66W?V#@=P9NLKZ/(8_-Q)%3RO0TE&U.J/[KU4U5IVTZ,#VQ_LW*YGXF[ MUVO0;LA[17IK<>$[`H]M;;VU7=9UW96X]W_'3*5>V.W%R8SE3LS9%;AL#N.6 M3(X:2.NHGI6CIZW4\4%7[KW;G'V=(`;P^?K46H3]NJIE#)*_4_48SO\`IY$/ M_,K)L73 M7N'33\FNK_D]5_([:V4Z>W;W5B=I[4VGMC.[7JMN8[8&5V1M_/;7Z'^:N"R. M/H\/N';5?A?XGO#=V;V90Y*.JI:CRI64II?MS#'-2^ZUBAQW=")U9G?G!N_< M/?>([`HZO;=-7=;[W_T>038?#X7![8WK6ND'5G]S]T4>&I*ZL6LP=1+4YI:N MOS\E%D(HP7QY4TLONMG304'=T$N.P'9'76P:B7X[]'?(#H.&K3K^B[=W%1I@ M^Q^R\[N^@V?V.^4J=G=8;_K-Y;4W5F!V*VVJ/<^]GB8[CQF0GDCG=,>,A2^Z MKTDI^SOY@&(WSU[MK=VZ=ZT78/9&0^0VX<-UCM3K+J/*;'HAU5G/CIM[8V#R MNXJO!56Y:#I/-U6_OW5AIS7CT)5%N+Y]U>0W#5_ M=]H?8[P]MX'?=;BNE>MVEC.O:[)X1M[93JS>V^:?&[9V?)A=X9&ASV&Q\%4M+@Q5TZSPU-%!*E65]U MX::&HST+>Q,Q\U\EN7;N5GW)V]4=>X'+HM^]7=1;8W7V5M+='>=%M;? MF0[8H,3M>CJ]LY39/6-5D*ZDAPR8%VI:2BK*B*21Y89O=>[:?TNG,)\P*#Y` M;MJ,`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`QL)OEF>K&Z8SFS.\JPY???86[G MWIN#:&T.,QPT3Q0^_= M6.FHH,="UUOW!\H]\?&;NGL.FFW'N;>&#[!3I;KV7:.$Z_J*G<&,ZCWE0]5= MI_('9XH,'N'&Y>BW_F:'.9^DH?L,I]M144,-%CYI6^VE]UHTJ:<.@[W#OCYW M[SZ@W!L"NVOW9MS?NY.M*R>+?&U-H["P&1PE9ANANV:/*K1YR,RX_&;ZW'WA MM[!M2PT]+;1D(I*00T4MX_=6JE108ZX;Z7K, M)UMU/NKLS8/\;[#^0M1M[:^U<%N#;L])F,/F9H]ES9LYD5]7145;-)!-CX'D M:A]U4TKCATX=LY+YM;?VC5[PDJNW:WLC==5V-M/`_P"BCJWK3<]'T5+5[WZH MPNV,G34$VS=R9_>?5PPU)FMP9))TK\QF5H:>DIIJ+4LJ^ZM5-0QV]=Q;T^?Z M;@W;1UL_91V%2Y#;\5;N'%]7;'J-]XSK=-RX>DP^[^MU]U[.#U MNYL+5P;BI\355%6M/3XZ6EI*&?W6F*XTCIA[+J5K5RDU/A&R,:*'Q[347NK'3B@ST)WC^>M M=CILYF=[;IV]G1%N_<=3LS9^PNJ,CMNDR>R]N]7KMO86)RV=VYE\WDMM;_W- MD=Q2U%5)4G(RPP+%2U-&(EDD]U7H$L_W?\^=G9^+&[EJAC,GV7W&.EMI8"MV MCMJ6BP.8WU_?^N3?&PLBVUL-6[LV!TMLS:5!EIA+'FS4BLD^YKJAA+3T?NK- MI_".C?\`R/[-^1&*DZYR?0FT]ZY_`[\VIC%7^%;,P^2J<#N;)=K=*525V\J? M<(@KML8^GZ?J]VF8S($CFC*:?O5I4;W5>B9=.=P_/#L?K#K7?E'GNU\YM[>F MSME[HPFY4ZAZ@ILSN#N3.8*@R$NQ\YB(\-28S$_$:NBJ$F_O33)%N%)Y)E&2 M2-(@?=;%*BO#HW.T:OY?T&VN^)<]FMRYW<.3ZCI=U]4OE-B]?B+9G9>1W;W7 MB9MI[ZT:>7#HONV.U/Y@9 MVG587(['[/;=&7P.6K]G[JRFR>O,G!0TF*VC\A8Z?(;HF@V]U^L>Z]TI]WG^8#L[<>!CVYOW>_8&`J>R\Q@YJC(]<] M30S'$[;KNM\7M)LM1;;V!2A]H=CXW);IR>:R)J\']C/0TD-)5T"@0UGNK#30 MZN/00=F2_P`P7*=8[^VAGLKWAE:'?'1]7DH\IL7J[IJ?>>.[=WEMSN##TO4% M)2)A:"DQ_6-(^'PCY#),K9JCJJR`G+TT-3(]/[KW;IX=W0T]3U7SQW%ON/;& M^L]NG8&T(>U<*,UD<;L78.3I<+LO#T'<>4_NGL_-Y[9L:U^S]U4&%VE25V3F M7.92DGK2(:BH]RC=N-K)9X(<="X2*D1*1\A[ MK6*<,]8NT-C?*(_([M3>6QMY=Q8W`X.DJ=V=?T5)A]C;DV57TR=:]1XU>O7DR\0TY17C\E+4T8JO+)[KPI45X=3]F3_`#AWUU]\L=O= MDTM=B]T5&!R5-UI0XRFQFWJ:ES%7G-^1UNU^M-Z45#LZIJ\97;"@PD=!DJJI MKI*')59FDRWE\]-1>Z\:5QPZ#C,4?>O7-#C(/AMT1V)TAUCD]\3-DL5FJ>+. MY7<6Y:';.SL=A#!U/N:GWA!UIUEEL@F2I<[5P5&WYLK7XX9'[^DCJ_OJ_P!U MKI+=F;"^;FZ,915N6W5W3N#,;SV1VI15&$QFW>M,9MKKO(2=ZX)-GR83'8W; MD'V.[]N]8*TN&S%?+6ULJ&>1W,GH7W7OMZ=-G#YH]4;8JL!MK:W;0I-F[7W: MFP-H[8V'TQ4X7?SX_%[]HY\IV-N7<@IWATP39K^8;%14&\8YNYXLM4[/JMI9X/MG9L[4VWML]Y=N3XC?F' MV=!UGEL?-VON?861V73U.K;L`J<-45LG\/HZNCE-'[JU8Z<#7HR_8/8_R>IN MQ>@]G8*JW1#NZOZ?VKO'?NU-K['V7D]AY+>+;OVOBM]Q]C;@RXRNX-E[;I-L MRYA\8N)JXFER,,:?<3.D5-5^ZIT5_N7M'Y_]+]7[@W1D-[]AY++;;ZBHMR9; M<-?U+TTNT*6AS/7'\4S>?1Z#!8](^[]K=[9*#;N(VT\DV+GVS"E15P5$S5&2 M7W6Q2HKPZ69WE_,B3/54-"F[IMMC:?9_^CNNR_7>Q'S6Y,33XOMJ39FZ.V\9 M2;1Q>-VUVU39"FVO]MBZ6NQ-!5JZ+)BY6GR`H?=7!C\P>EOL_+?)/KSY98+H MJ3>N?WAMCM'<.6[(W1N_/838,&>Q.S^E]F[#Q^ZMV5=!B,9CJ.CQ/?V[-WX; M`4D5#0TM-CI<'DY:40RNS-[JHTT->/4JOR?S^W)WIOC:!RN=V#U;7]CS8RAW M/MO9>P,RVT^L1N?"P[.SVQLON;:N0Q=;G=R[/CR4N>&1;7V_M;'3;IAV]USUX^U]K[/W!M;J&EW MCO+83P[%S.Y/ MXQVB33YWJC";9V?1]7=0T67S^W9ME9K*9C8\[1]']487=&*S>'W1MKKK8VVMS46?IY8:]-PX7:>&HLTWEEFJ? MOXAD8Y%%0LLJ3,K$.WU/NJ=#+[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][ M]U[HD7>^W-O[B^3_`,8Z?(8V&HK*6NRN9DJGW)5XZ58ML^7*KBBDB:.<(WA]U[HK7\O7.TU3\E/E[08^CK<9@\AO7>F4P]#A MMK4F(V6:S%]L;OQ6Y)&9[3GJ:BEJ\H"S M8;,$TNVL1F5VGF4QQN0=3(JEGTJU!I]33&"3>;.VYTW:T-Z/WX9@\8$33"%4 MMH&\65:@*KL=":G2IJ>`HPK;^^;5+UOU_B,?V362=@9;KW*TM;G^PM_X3$U. MX>TNP+5>8BI<)M/;]/AMIX&DQCU]5!BYJFFJ:7`XZ."0NU28VF1V/)LVX[C* M^WQ"W6=*)#$QTPQX7+N=;%Z5=5(:1R10+T9;A[@P[7M446YS?4S6KH9)Y45G MGF-7HL7:._=T?)3=,\]0<7DY,=LMJRK@KHJ/ M>N8%;N3!MALS15U1-N'$]>4\+3QTE?B34QR3H$65?')%*FX6-MLUC:E_*0E2KV!OW(0QU:09#?&_*Y#750JZF:2OW?45\]29/O M:_13U4U4984$LBQ0NJ:B5-H3]S5*;E:1$`,EO"N!2@$=`.`&/7SZR)]F6,FV MW\Q!!:XG.34YESQ)(S7'`=7!>XQZFSKWOW7NJ?/G1M3$;C_EE8S*5N"VSE\U ML;+]'[VV=7[SV=AM[;0VMN?#]L[3BI]R[SQV?67&XS8%#05E1'N3)M%,V.V] M-6U"Q2,@0^ZLNFO<,=$+[+Q78'DEJ)H9/=;#` M*P\ST,'>_8W7T'\X?J#;>X>P,)B]S[;EZIQ&V.I*7(]A[=W1O++[MQV'QL6[ MZJ"E[ACV]N[$X"AWA))28[^[E-21PX?*5%<,E+20-#[K9_LU^WI@[@ZB[>'\ MPKY$]QY'9F\FZDK.NN]-G4&](SU-N#^]F`WGB]X]C]4?>_&_>6(PDO7.$K&.Z,M6[[Q&5I,5'(F/D MQ;O"^4]U4%J@J]7];JMM*["V>%T_ITC;V.`T\MQ;Z5Q9IDIIV0 M&X1K6]U]U4.RKYLJ%D#$#@I M=0>&H<>@'^`_4F6Z>VWV+M_*UFP,G//NNCGDR>S][X??V=KPV,-5#4;^S6,V M-L>I;<.YVVCGS?.4MZVBTW2%/W>5=;NVEM(@P?3ILH9+V]5;965U`B M,**P*^$M*`AF_59O;;WQQS>VM^]'9CI;P)L'"[GP?7 ME+M[MC;VZ\G45'7.^]F1K*72FJZ1:RN=*Q*DR14CZQAUCNJD,A]>L/0%%C*? M^4;NE_\`1YG,S1TW96)SNY\=L#=NYZC>;#&]R=?9;=7;.T-R8C>N9SN%WOLJ MDHI]TXI*7)?;X^MQ<$:P?;1_;M[KTGQGI\^*N1W/N'X`?-/<.Z,3V%TUOG-P MU-?OK?OL?QAZ<3?F:W]5;DRM)_%,7U[N*&MVOC6HX,+%'MO`T MLU/$DW^52^ZV0P9S<.0Q\V7JGR^BHIFRXI85%)3TU_=5:NHUX M]6,^_=5Z][]U[KWOW7NO_]#?X]^Z]U[W[KW56O\`-MC,GQ@TB:GA+]C=30J] M910Y.DC,W9NU$\C8VH9(:VH4<0H3V`KS,RT/^XLYP=-:0R8KY M`^?''D>H>]ZU#&`WEO+%5F/SE)38:LKL7'CMH=>RYC:]30YK:^4B&7K9Y9_X>^,^TG@CJ MZ$01"26:-DNX5>\YBN9FBM4C>.(U74]&U22T<,C#M"@5#UU%'J<8Z[Y932Q6 M7+%M&'OI9$EF[7HK,-$419-,D9[]9)C\,51749I8AM?X/U?QYZTS6X-^R9*G MP.`HHMU=IYIZ&7>NXMS[D-/!AMM[*V5LG:FWX\U6&2OR]32XJJI,=Y\Q4U[/ M+3K$D21@>]YR',>Z6T-E&GU+_I0J&\-$6I9I)7D8KD4+)K"H%H&R:R59>WL_ M*VT7-SN6I+6(>+HTPP1QJ&:E2J.4U.[`L"!4!SE.N\-1?+#XM[RS= M7OVDW%CMZ5VV]A==[FQL.W:'K7$9+I/M"I["J\SBJ)JNIK-[;HRF*H:)3EJR MIJXL7B(ID6..ICAIU";A*.3><-KA6W:V-L))IT[S*ZW,`@"N:`(BECVC23(5 M.5-4TFUPKSQR-N%P]Q'&.&WD"H(5-I<&X9D45:220!=3FH2,-4AA39]'_ M`!)_WOW`?6577?OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NB_?(MMY4 M>U-M939?96Z.NJS_`$E]3;6KI=MXGK_+#*XKL'M?8NQ\M'5Q[\V7O&*&HH\/ MG*EJ-Z80%*APTGE50GOW7NB%X[YM]M[%BS>%[`P^/W><9W-\@\)L?<^.W;M? M;F9WCLWIWNGLSK:FPG8='D.O<7L[:%74#!8V`5U#4A)526JJ):(!HG]U[H;( M?E)E>S.BNLM_Q[MP_0E+O7NZIZNWOOVD^RW10[%H,&=X>9J')[_VUC=L45?N MK<&V:+!15];C\CBZ:?*AX6JAX9C[KW05M_,"R&PIZ?9T-'#\A8<=L?>FYJ'M MU)L?U3_I+7#T/=&W,;!MG<4VX<;@MK[BG^#0 MW+UG+D<]G*B?Y`YJEPM>F/H*+PK*)J62>&&2+W6P`30G'3K7?S&LA@MK)E9- MI]=U,S;9VLV+Q>Y.WWQO8U=N')X#KC.3U^YMGX7K&;'X+:6;I-]2OB\HE1'3 MU9HT)AITJT6G]UX\33ATQ0_S*MT8C=38_+=98+=&%W5N3;&6V@VV-Y4U'68; MK[H[%V1L^3+Y;=M!C_P"#0[FV[U=-`F`VSA-HY'=^8J\9NI=F=N-E-TT+[)K<;M/KC#X;=4B9+*+75U5214;U/VCQ M:@ONO4&FM<]-77ORZ[2WK_LP>N3KJC?NX\9V# M\A]E[OK]N[QEVM'3YOK[=T?3])/MK(Q8]6D6J`FC4R?M^ZKT7_=W\T:3/8I* M3KC;N!H*?L?K_LG=W4F_DW'-E:XX/&[#[1[+ZG[`R.S<]L_$T$V"[(V-UO'D MH*6.MJIJ=,O3++R&#>Z]T*VR?FAO3?';G1/7%#!MC"8WY]E[M7<.\L+5 M=G[JP]!U#WMONCR6W-C46R\123=>TN6V5CJ-\Y35,%0F1H:BD>%U2667W7NG M+Z!OKS^9?N:6>V>V`^[.Z,G@:E] MP[:V=6XC:&;W+G\9L;:M"M734V%S]5LVBP@EW!7RUD4L%',LX28C2?=6H--: MYZ%GISY_2]J]C=3[/R76FU<)5[UK=P;';U:9`*+)5,D!C/NJ]/^^?G1EMK;BW5@*3;'3RC&[UW/L[& M5FZN\9=M':C;+?L!:_)]X4J=>Y-NL*3?7^CYUVD4?)C,29.B5S!Y+^_=>Z8X MOYB#;@J]E;9V;UO@YNP][;CFP']R-V]BIM_-;+BJ=_=&;,P>3WWC,?M;/9G! MI7T?<[5WB-*S2G%-#`THF\T7NO=!RW\RC>.`W'74^X.K<#F<;G*W;.7VSC,# MO`4&1P6V:CJ'H7=N;V]D,MG<708O/[\S>[>VZMZW M0:0:YZQ;[_F4[LV]MDSY;J_![5GW)UAV1OK;5?@^T8,[G*>+;E#VID-N(:"N MZNRE#B,U5XGK(UE2ZV`*$DYZ=Z;^8SNO(]F576FS M^F>M:C+Y/&;EW93QUO=-90YC;M'MBF[[GRV/[7P&-ZLR5=M+>]13]"L$HHVK MP&RBAY@M([S>ZU0TK3'3SA_YDM5N7.5^'QG5&$VW3U6X8,+@]P]D]GT6T,%M MJF7,[QP\N9[CECVYEJ[K[%YZ79KI@JB&#)4^1J\C14S20M,']^ZUU(P?S&[+ MQFU?A?N'+-L+<];WS\:=M;^W/MW+;LQ>S,SN??.XE$[%W-+4R0TN&%\6&$K)7-'"P/NM@#NJW1EODAOSL?I?=>U<]L#=& MZKT'^(^?NZ]S93?.U]K]8]>Y;=.T-S/B$5NV\O2X.HQ>,VO\` M(O.9_(5ZLP`I0]!%O3^8IN>-9 MX.MMA8K;V"ZWWW@LKF=OXC+4N>W3O/J/%[4[8SV6P&#H*#9^5VGM_/[CK^NX MJ>&F6M_B5%'++%-'22!)S[K2@$T)IT:CX\?+[='?78,.SHNM=M8'#8K:VY\_ MO#=,/8XSB)4XO/T6"P=-L_&T&U_'FZ'(R54GWTU?58F?'RTKHL%0&1_?NM=% M.]<3N[XR9GMV;*]%;'D^/\`E:3L3$T>XLA5/=>(4-35CH5MJ_,+<G;F\<1L/&XC8V.ZR34D1:2.)HY-/NM'!-#T% M6,_F49?);>H=Z4W3>&KMJ?W86?*OCNSONLQ'O5]M?(G/MB:"GAV9/BWVM1/\ M>*I*K)2U<=1##DTE%&QII(Y/=:Z5&R/F+V?5[0K\U-@NK^R-P[E^:W^RY;6@ MV;V6T_76'VM-LC&;IFS6+WYC.OZC([NEQM+0UTJT[XJ*>>MF%&T\:1^?W[KW M2,PO\S.OSW7F4WW%U;L?;*8C`9G>(QNS-N;QAV#ALS!LS, M54_==3!N(1#!3T5-$T=)+/'4.MT3W6P">`STDM^?S"]X4E-F,#M;9^R(=Z;< MQ^WLG@]X=A[@7*`T]?V9UWMW?,U?C-G;3@IMM4F,VAO62,-75&+F=X8ZA(ZN MF+N/=>`!-">E)C/YF^XN!1C"3+3T8J,G';(,();^ZW05(+8ZPU_\`,"W7F-I;2I=G M[0ZZZYR,W:?5.R*ZKS/9&'J*3/X7<7>'5&PLS1=)X>/;%3'OS(46W]ZSQ92E MJOX-4XB1HB@G'=W\PC.=,=N?(K`=AXG;&Z.L^KNXC0Y/,X3F_]\[&QNU*JIGV)@:GL?)UD>4DKFGJ)4^UTI&(W3W7NA`[S M^3'R`VQLSXZYK;&U>O\`9&Z.X=L[=S>=V3NS4ZPQ^*K,TU M=A,[F*+?"UGV^YL31]CU.4R&T\5D]O82MW7L.DJNN)J0UW^35HGJ3KI$%-+J M]U[HI\_S;^077/8&Y-R;MP^]MR=;P]L?-#8V%I,W'TG1;`W=%TUV9F]M=>[? MZ_JMC0U/KMM?W&W)B=[;(I:CJ1F^[JIH)(VK M62>D#T9'?^.[(VIUN8:+M_++@(Q:ZKJLAUA0[ MF%/M',;.J)*+1B#'DTECC,E/<2M[JO5F=)5TM?2TU=0U-/6T59!%54E9231U M-+54T\:RP5%-40L\4\$T3!D=2592"#;W[KW4CW[KW7O?NO=>]^Z]U[W[KW6+ MPP^;[CQ1?<>+P^?QKYO#JU^+RVU^+7SIO:_/OW7NNJBFIZR"2FJX(:JFF73+ M3U$23P2K<'3)%*K1NMQ>Q!]^Z]UF]^Z]U&%'1BL?("DIA7R4T5')7""(5DE) M!+-/!2O4A?,]-#-42.B%M*L[$"Y-_=>ZD^_=>Z][]U[KWOW7NO>_=>Z][]U[ MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJ_N_-F8[<7S,^).;S+[3 MJ:K;3[VGVI$^)R.Z M]T4[^7_68O*?./Y?Y?'#JO"5V0ILZ-T;)Z\[-W9N'.8+-4'9M7005?86Q=SY MO)T>$W#EJ>GDK#5XJ&FI#-5U`(TRP*ONKNNG3]G5V1X!_/\`A[]U3K5DDZ\J MX_D]\F^UL%EJ2/&[FPFTZ;N':^KFR>R]T+N*@P^4FPVXMS;;R M&+RN/KMP\)CFBS&-I3DJEX:OR4TB&GUM7-\.R;G=07M5,3M#)WIMS*NQ'9FWI:?!X: MCVABMQX"7$4E3!1&HJ*]8XW-77S:;H.>8#%'?;7O0-)+H9Z+=^]:!'@2>.G-)1[LJ8:`1BJEGJA:A6,6=WL``&8`$P?[ MIOXF[V[T(!MX3FE]^Z]U3/\X>BSW=\#.KXZ_MSH[HS:6Q9\5NK?/9G=^V]RYNCP6V)L=E-O MU--LO+[=W_L1]E;QS53F(J.#+/\`Q&:".9TI(%JY(9XO=60D-@5/5??SA@VG MU9UI\".J\/OK!;BVO-TIOW:-+B.EOD'D-N;;S$."S^T#@]Z;8V9V'4]Q=W]A M0;4W@E#D*K(',96KCR^.I8J]F$CA_=77X'/5TNX^M=O]5=Y5/>.[_D+VW2#M MC=?5.!V;TG@RF$VKBMCO35NWJW$Y7*>`!Y([ M1O*_NFNB6][=B4.\/DM\E>K)N^),;GMM]<]D)BMB;:^4N],C4UN.I^A*K=C; M>S7QH/14?2-*M8):Z.HCRFZ)<]-34D]?3U"M&(J?W6Z&E:8Z*U\L,&RJS(;BVYN#:N_L?7[RZAV_FI.ETQE37TDV0H:?(-D>\%HZBMH*>KQ\ M];20U)5I(4G@>1`5$B$AA20.R.L3*)"IH2"0#Y$@$$BO$`@D8!''IV!K9)X6 MO8Y'LPXUJC!'9*C4$=D=48K4*S(X4T)5@*$A'\H_;-+A]@=HYN.#"4M9N/3+&K,5N'(];]8KMVHVQC=^9S>&`QM'4QK7Y M1J>JVF&R$&.CFE#R3UACI-5!\^GGI"JR6_\`^55EE^PM@Q;T[X<9L:HQW:_559L7$;TP_R1Z[Q+9;#3[FBQ_]Y%W#C*S!&GR=9:=L6L;1 M>Z\PTD@=#MT=A^H_C)_+_P"Y:;XX?)GKCN#;?7F%WE58/M/84_1^V:#`[JIM MK8G[+$9[/=$]6;[VW6[M-8::HEK:S;&?S52U=&'I:H&",^ZV2'85QT,O\N/> M?=F\N@LH?D9N[^*;=F%IMM9G:-3/A-L;DQ&U?[O1=.=*5F+ MQ<&WMP4E;0?>8_(U=50UT52^1G$ZQ0>ZJP`)`..C]>_=:Z][]U[KWOW7NO_1 MW^/?NO=>]^Z]T17YU8[!9?:G56/W14/2;-CQJ."T_P9ZJ`[T[&Z(^.^3R.3Z1V=B\OV1OJ;VM<8P:DUK7,+\Q[OR_RU+)/R[;)+N]T7E>XN"'95)R MX7\(Q\5"2`",@GH[GQP^3FW\WB:/6;BUF:WEMU:XF?3'% M"`V`0U1I%-*H00@&HEJM3(Z'_*O.-K=6JW<%VRV5N@::>Y)122"NDZFU>(\@ M*LYJBQKV`\>JRZ3Y%[4[>^_=>Z][]U[K MWOW7NO>_=>Z][]U[HJ'RE^1]3\>*#:]4.O3OQ=XT'85%MNE7,_PDU?:6UMHU M&\>MMDN6PV62!.PLCAZF@CK[%L=5+#((9PS!/=;`J0.@$VQ\T*[LJ'.577/4 MFQZH8S:6^]Y8;*[AWC4T^)R=3U_L+XZ[_P"Q<4:O#;'RM535]#N#ONLPS2I' M*&R>`G:4*9BD/NME2O$]-U-\V)MMQ8/8/8/1NU<'CMX]/]2;TV8=M;JCR77> M;RW:FY,C29'J">'*;.P,]!N3!=?QC/TZFB>FS5-39..(1&@=I?=5Z;L#\V\S MN3INI[NI.F=C9^CQE=AMI)A]JS=G;LS77&W=S;MK=N9S-[]CPW25=EDV7MW% M;?:JR8VY1YF,-"HE\5(C5L?NO=*;;WS=QVXNPNF<3-L#K6FQ_;^)V,:3?:[^ MK:S`;NS.X=S;@P57B^HNP9.MZ7K[L"LV56;>I*F;"5^:P>ZI5K%2+$I4P)#4 M>Z]T-?R$[^VET?N79.T\CU'N#>[[^Q5'D'J]M[9AS5)2X[:_;W2O75#B9,?1 M4==EDVOELU!MK*T]91Q5FWM]XC9F+K)VIY8XVIJ--' MD!ECCD]U[2=.KRZ0^/\`G+T+')BI.XL-/UEN:KK^W=P[VXLG%D$Q/FCW=F]H=;Y"MBIZ9)2B,**.>662!)_=5Z<=U?.#HC''.X>?%; M@QF^*#:]=NC*[8[$ZYWCM>JQ4*5N4VO+'NFE?;&4SU+3U\6#JH8JZ"AK,=4P M"%%J&%33++[KW371?/?XY_83OMO";UPJ4FW*^+;F:W+T[O\`VCLBOP^%PN_, M[AZ*@W+'M.JB.$RV.ZQW%)C8Z:*7RKB9=$7[M+]Q[JS*5I7I2]-_++H7MO*^HDW'@H&JX<#N'ZR8GYA?'*MSE721[?WMB,G-+ MN-L_7Y;IG=F'6BW/MS"=CUN9VQG:ZJP,3MO48+JK<)6DO+-)!1`7TU5)]Q[K MW33M/YH_'W=&]=MX7#[:S4.,K=E[FW;MK?3;/C&)H\U@LEW!A=_;)1Z.*HJ\ M;N3%TG1>:EGDCO1UT,,:PS2ZXM?NK:3IU>739AOG=\/$BV_D:*:LV_0KG,SM M/:>8R76>6VM0-!!3[0R>]LGM:NR>*QT=5M;`U&^,/%F*F@+Q)75:PLLDLZV!4@=-L/S;^/E%BLMDNQMKY?866P6^J_;6$QFX-D5,4FZ\MM??F M_=C82HV)D\ACZ"@SV3Q46RZ^HJA32E<2JS*)GC7RR>ZWH);3Y]+K>W<57E*S M8E)T%U?U_P!M9'=/3&X.W:"HWANENM\;-UA4/MU<;A,%E'V-NN7^*=B5V:@" M0UD-#CZ2*G>:MD4B*)_=5Z"/:?:?Q"Z>WIV#FL)LSL.#?NZ\S18NOJY=L=@= MCU6[L_5[TP^VLYL3JG*3U&YJ#-4.S>P>V8Z?+4F`E_A-!-DII-1I8)'@]UNI MH!Y=+/\`V=/XP5^(RM>N`WE7_P`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`BEB6247]U M[IB[>^4'POW]L^3#=E_Z1,=M[9U+F3L"$['W9E-E' M$YG;6XLU+U7G:>@PSRF/*O0Q+&KM4X\S^Z]TK<3\M_CMUWB=O1Y#9N=V#MB7 M+XSKS"U!ZVW#C9=F8;8G4>"[5HZ7LS'Y3#8[-[)IMA==9&;)U#2Q5-#AL;3L M\U1#-Y(4]U[IOS_SQ^/:.T8AK&I_=>Z6_;?RMZQZKGW_MS:.R M\KO7L#8RK30XG![4R%)M?(;^.-P.>+V;ONGSE51HLM4N' MJ)9(UD<21CW7ND?U9\S.N[-X[DP.$P&].P M=E2;WSV&V]LZ.EPF'I,9LB.JJ)Z5ZK[(5JT[$MXC/[KW2`WU\D_@9W1BL#-F M)-U[IP>(W!NW=BQ;"PG8U/BI\53;,R&^-R;ZWS1]?R4U+7]=[AVMBYIWGS:- M3UKJ(7C\LRQR>ZV"1D'/1Z^LMT]<=Q;,Q?9&TL-25&%W1BZW#Q5&4P%'2UU3 MB*#+5]+58J6JI<3C::I MFK:C)S5$%#2PSRY&KIXZ2JR$LT<2R25M32PI%)*29'C4*20`/?NO=14VOMJ* M+&01[=P<<.%EFGP\*8F@2+$SU+F6HFQD:TX2@EGD8L[1!"S&YN??NO=)K?/5 MFQ.QL'GMN;LP$%;BMU04%#NA**>JPU7N/$4%?!D/X!F\GAIZ#)9+;V0:$PUM M!+*U+6TDLM/.CPRR(WNO=+2IQN.K&I7K*"BJWH)1-0O4TL$[4,QZ9"""II8*Y**F6LAI:RH6KJZ:*J$0GC@JJ MI1+(@8*\@#,">??NO==/B,3(%63%XZ15EK9E5Z*F<+-DUF3)2J&B($N02ID$ M[?642,&OJ-_=>Z"G)_'WJ3,=A;:[/R.U?N-T;0Q%/A=NPG,YY-J8VEH:;)46 M-GAV)'DTV5_$L70YFK@IZHT'W$<505#_`+**"G@C2&""&-8H888E"1Q11(%2..-%`50``!8>_=>ZR>_=>Z][]U[KWOW M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z] M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[HI?=VY]];<[BZ-3:.7.'VW MF]Q46$[+EI=JTV0ER>/J\YB*;;>$RN\LCL[+X7:6.J:C)5?CBGRF/KLA/(L& M.5ZF0LONO=`I\.Y,72;QR M=/'5C8F:R.4R.S,=78K&8^OBJXGAIJ^E-+`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`MTT+(,K! MMB3)Y/'&2@J*@4C^=?=;#`(5ID]"5WM\B-^=7]A[1Z^?OWXX[=ZVW?TOU-L7 M_0IO7,;:W/\`(3>N\.SJMMF4N8Z@V7@-P[&W+M+;T4=4LF6S6-U8BX*DJ?J M"1[]U[H,:3"XS"S-.U7BLMU+TG09"F6IJJ-IZ2IRO=T<\:U5%/35E. M70VUQR(Z_4$'W22-98WC<55A3B1_,4(_(]/6]W<6,\-[:N%N8F#*2`U&&0=+ M`J?L((/F.B._RN.QL?G,;VCLO)28Y-WX[)8O<%/*D>;ASFZ=IU,$M)1;GW+2 MY3M'LBCQ6ZTG=8,MC**/$Q8RI98VAD,BN(]]O[^UDAW&Q#(+M7#8#`NE*!V! MEE`;R91ITG%//K,+[W?*>Z[;N/)O,/@W)V"6W>W77X1AM[A2':WMGCV[;VEM M2M7M;B4W+7,0+^(A4KT5G$9#I/(]K_S&>F*+X,YO=/D-U;\ M<=^]*;>V;]_BMP46(RS==8/PNU=U?R\?FS4 M[^R'0G8/8.(IMSM/'TQ5;(V=\9,KLO?73O7G8>TI>N\OE-MKD\7LK.=8[XI* MVHK-WKG2JHUHZ<>Z]5*B@[>CG_R\-@XCK#HW.;&Q5#B\5-@NT-V0 MYO%4/<5-WCD,=FIJ'`5-3!N/>J]6]1Y-,Z]/+%(U'7XN6K@IGA85,L$D*Q^Z MJ>)Z/A[]UKKWOW7NO>_=>Z__TM_CW[KW7O?NO=5D?S4J*OR/Q[Q%!BZ*?)5] M7VYTQ%3X^F*"HK3_`*3ML--30B1XXF>6G1AI9XU<'270'6L@>VTB1;_\J2S5KZV`5::F/U$>%KBI%:?/S''J MD:JVWM?MG*[3VUDMI]F93<^#1,,@V)D:^6KJJ*HR\572QY#;>8H1#2#"QU%=8-&1U-`,K4!6(9P2?,W'RR^-LW6_QUZGZEV9 M7;7ZBZ]JZ*;>_>.1W!F*[,;JW-NF3!?W=VSB(-I2Y/$5VY,Q5[<-:RXV>*@P MT,Y>2>:-X%#!CE7F,7O,&Y[O?"6ZOU_2ME50$52=;-XE"$"L%)<:G8&@!J>A MOSMRF=HY7V/9-N:"RVIM,MZTCEI7=5$:*(ZU9F35V]D:D5)&FG1+.C:WK6C^ M1WQUP&P-C?:4;=F[JJW["S4$F2WYN#Q]']D8N5:S*-EJC&;1QN;.VVGD2BA@ M2NGHJ<3JI6((,N9#NMI,N6';&K:*G1_::%)&`1N%^\6A_EZS:Z][W MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H.>Q^I]@]M0;-IM_X%<]#U_V M)M#M;:2M79&@.)WYL2N?([7SBMC:NC>J..JY&)IYC)33JQ26-T)7W[KW2#V= M\6NB^O\`&-A]G;'AP.-9>[E^TI,MG&B4?(K>5'O[M[0*C)3%!N?<^/@FC467 M'Q1+!1B"`"/W[KW7''J+(XRMBR$==0Y':&6+2+/'(LE6CO%5&:%WC;W7NDICOA?TIB]MMM"CG[83 M;=-D:',[:Q1[S[A:+8&:QF3KLMCPZ^AJ,E/$C8R2G1J.5J5U>F M8Q'W7NGBB^(W2&,S.-SV+PNZ*"NH),175<$78_8CX;=>X]O9JIW-MW>O8&`F MW3)A>PM]83Z]TNLWTEL7=%5UKE=U09C<.?Z MJI::GVSGZW<&;BR$SP9?9.XY:C/"BKZ:EW#)6;FZZPV1E%;'.K5="CV%V#>Z M]TE]F_%GI'K_`'GC=^[0VK683<6,.2FC:EW3NL8FNR64I:['S9W-[?;--@<] MN*GQ.2GH:>OK*:>JIZ)UAC=4CB">Z]TD\W\(?C/N3<-H863W7NN68 M^$WQTW'/CZC7IZ:3'[7ST5VKVY4YN;`9#<1PL24(R,]-)6+11I"L@10![KW M2"W%\+^HJW%;W?:U)7[=WQO*;[U=^9?.;PWCEL174XB_A`HGRF[*;+4F,VZ4 M9L5!15]#+AY9#-CIJ2H6.5/=;!H0>H6U_A!TS1=9?Z.=^45?V/\`Q+)[DW!N MS-Y;-;KI*CVLD\/;&4Q&9WIDJ[=^\,EN.JR6VFIY-H56*W1D,[4[BV]+ MLF>DAEPC4%33MB9H8Y*4Q,B%?=>Z<\-\=NH\%M#>.QJ+;=3)MWL'9U1L7>T& M1W#N/*9#<^WZY]W3Y7^,9O(Y6JS59F?W7D<[BMU46;I]P8[ M<-9FMU9)Y*Z&H2I>&NF@+F"1H_?NO=/^]OCIU-V!A-M;>W%@LL,9M/;57LG% M+A=Y;SVW6S[&R=/B*3-[(SN4V_G\;E-R[2W#2X&D3(T&0FJ:>M$"M*K.-7OW M7NF^D^+_`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`;>H,7/F4I5R>R.'KIL5N&C>OVWFLGNRM?(8R8R4%]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]TE=\[D;9VS=T[L2EBK3MK;^7SOVD\M=! M!4#%4$]CRFZMK[5W,C2T4"5(%1CJ&6&69K1)]3 M[KW5>_PIW-N+=_SQ^7;UV[KAIC:&4VO:-S;^OI/'^ MQ]V3XU^T=,S?V4M1^$_X.M,#NO;W3FX.\^XHMQ8O(;5WO)4=5U^)['H,A59" M@V]54WQLZVQV)CW1M=Q7'(TFUL9N$U,0IX:59)&CJ"9)*9D?+/9;G?K?EW8G MMIUEV\1RKX+*`6!NY2WAR"E-;)0LVJAQP8=8*WOA);LMP MC$A"+*!5$D7%A$K@JJE<9.1DYGQGZ#WMV_T?VITSOAER6W-CBI[*^/W96SJB MDS-1B:R@^TPN6VI_=;-T0RE+)7XG#45978F2]4E;!K5GCE1G!W,.^V>USN M8B&8&NAD",`0650SQFM":@YZ*'M[96T>C:_?U13;IR^X=U;GV]B]MTE3D=M4 M&WEVYMUJ^ER./#X^G2G^YI:6)8ZA[+43^+V+[S@-:;=M_+5QNLT5_))?SQB,50+X<99 M2P8G4QIIC50K*K:6S4]7>_RFZG(5>P-\3Y2:2HK9=X[X=YIZNBZFI7J!@OD)N3%?&'X;[.P,&T,QM7M+KGL#&;]V] MN/XE_*GY>Q5^1V#F*+"Y+#8I>L>WNX\?)B\;F7K*>IJ,_O//1Y&GCBK*"KJJ M8.%]U3I!_(O9G9,?\W+X[]A4U+O79_4]/7=98'-;HR6&W]E>K]XYO(8'S=W5W=G6'6-% MNO8NW]DX/97QFRV[:!ME=9IW?GLWGJ_*97;%%UQF6*E64L=O8ZY5D`1E)^A M7@_CCW[KW04-N*BVGW%\A-RY*.MEQV"Z>Z9RUV6>GZNXD$::F"+K MK.X=T5NYI,#O:AQNWIWG>C06=N`P-:'6&YMUT7\S;YB[,WO6X[.[>W[UUW5M'* M=^;=RT9SG0VQ,MM79&Z,9N[=U)7;;EV;#UW0'%S8W$2U^-_EI=B_'7XK1T?RMV]_IGVC+MZNW5FLOUKL_L MRAKNX>KMT[MKZ'L?:6[=R;JQ%#@<+!654NX>@QY2*EI']TTY)8 MDC/0[[`^+5?T3\&?D+U9MOX]_'CI#);DILW74VP)?D+V9W5U%G\;3;,VEM2C MGWGV;W'L[9VX-HT:[8VS'B(:>&D:APM'0TLM.X(*1^ZT*5%>'2W_`)8\^8;J MCN#'[DJ-CUNYL'WQ5XK<>1V1VAG>[TR69/3'2V4KJ[<7<.Y7J,-)B@Z_8>&+W7C2IIPZLD]^ZUU[W[KW7O?NO=?__3W^/?NO=>]^Z] MU5W_`#7ZLX_XZXK))4&AGQW;/3=92U_E6*.AJJ7L_:U32UL[-3U0>GHZN&.6 M2/0?-&C)QJN)%]LU#[[>(5!5K&X!!%:@PR`BGS!('H<]0_[T$IRWM\B2%)%W M"U(8$@J1<1D-4>AH?RZ([\4=^9SL?N#`; MO4>\-_9K<][VUK#:(T5O&ZL9)*AV93@A%/:IX9R?.F.F^>>9.7[ M[<[F\D6:]E4J(HR-$2:6!#2,!K9:GA6G'RZ*[U%V7V]O'Y'?':FS-+5;3ZR7 ML/,5F.V7MW;4.*V12PT/57;^.P-)2I%B_+CX,.8V@59:MWJ,G3U,J&1)PQ$^ M^;=LECROS.T0\;='M$K(\A:0DS6U3QTG4*'`H%*\&5@`CR_N^_;CS?R:ETO@ M[5]8[+$D82-:07.D?QC30A=1)-&([&4];:P_XK[QDZS/Z][]U[KWOW7NO>_= M>Z][]U[KWOW7NO>_=>ZJS^0'<6Z]J_)[?N"PW=NGR. MU/X5V[N/L3M/N+`]C8V7:&1PU3N7=BU^W=N4,-55T53%_`8(Q6"2GTO(WNO= M`O5?S,^SW<%)49^- M]G;MH-X=4QC(/EHL?620^2*7&4+QE9/=7*4TBHSU/B_F%=J[^ING:2FQ_7'5 MD^YNS^KZ"JKH[8VY4]_[BV#O6IZI;:F4W]MFHVYM3;NS$GW8?XED? MX91YY-%9$\44U1[JI%#3JX_`UYRN#PV4:IQM8]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=`]\@H8*GHWMNFJJ26O@JNN]W4KT$$6*GJ:_[G!UL"4-)%G* MN@PLE;5R2".`54\4'E9=;J.??NO=(GX=Y!,I\:^JJY*4T/W&&R#M1/EOX[+3 M-_'LM>.?,B&G7)U#?J>=4"2LQ925()]U[HC7P0W'N;%?*3Y&=4Y'L[K[.X'' M-V)NW$]6=>YOL;-8KK\UW>V[)SEY*?=*4FV]KY/=+[AE6OQ5!%(L%11!TF;R M3,_NK,0:4%.K=YS:"8\<12'GZ?H/U_P]V3XT^T=,R_V4O^E/^#K3S[0[)KMN M=R=F[>EZYZY[*Q']X.JZZBPU=228S,ID9?C_`-/P'%Q;OQM1%N"EIY17/3*L M6F()E:*)Y7(>*+*K:-M2?8MHGCW"ZMK@03$D,2A7ZBX%?#/:34*Q%,^&YI2A M.#V^[O): MW:'>.T-_R;4Q4CT)SNS-U8"65*>%Z&I^[H,'N>@>BAS].N*JXZF.KR&21I$0'<[V^YW&V/9W5@)'!)21"!45--2'X:E:$+@$$`TIT._;JXVBRW MV#2FR?7>Y\K7T2 M[ZP"[XVQCLAD(-KY**:II*B>NJ<-C*&NI*.6N\K0U=3,QD$6K]E]A5N=GQU7E*K?.^ZBHK,6]/)258GWGD)8)O) M2*E-+5?;LBSL@`:=7/L->Y:0Q;C910*ZQK;08;B/TA7CY5X?+H8^STDT^W[C M<3NK2/>&^WS=74=M]4[7[)H\YB6P.=Q;87;&:W9MS?>-ZLW')79"&5-P+MO M<$L$,3Q+2'RZT]U92`:D8Z6O4GPTR5;TW\:*3LS=?:?5?:W2_3^5V)7)U1W) M7M%2[KW)F-IY7=NXEW#C,%MS";QH\G5[284E+D<$,?3T.1>-:&&2.,Q^ZKT5 M3Y'5E-6?S&>HWP7Q\VG6-M/LWH/![W^669W7V9GH]E9//4-=58?JVJZUEZ\R M76>-WUO+$Y&FH\5F(;&WJ'U]^Z]U6UWMT%O/$ZHI*[&T]%40TU+6X&KAK:2MKY\I%54U'$U+[K8(% M:CJTGJAF;JWK5G_4VP-G,WY]1V[CB>;#\^_=:Z#[#T5'DN]^].LHZVCJLGWA!4TE723)+#54U3"Y22-U974E2"#;WIE5U9'4%"* M$4K4'B*>=?3SZLD\UJZ75M*T=Q&0R,I*LK+E64C(92`01D$5&>JR_P"4]@Y: MC=G=NX\-NO?=)MW`/0;+RO7VY]KKMK&YO*5`H;>)UN91#&WAE&0(KFM4FT^+*58JI!7L6APH% M.L[/OCW%M:;9[?;7<['MC[K=![M;ZWNFN)8D77'/MI M!R\[R^+0OU+V=OW;6SLO(N0BQ^/Q>WHC39W(4LV2JC%1Q12IU@F"2RU]>A#^ M$G8&]=H_RG\AN':&(W'V)EH.T,9LG%;&W7VYMSLS<^=VGNSL_KO8FXME8/N" MIWEL7:^X<]N';FX<@NW/%D,*F-K*RCQ8U5%&9*CW6Y/C/0K[";Y)YSX&_+7. M?(+IO.?'3?F5V]M^3%;-I\3B>UJI(]H?'#I7;6ZZ^EVS0]N;^I=P[*JNPML9 MJDIX*K-T=748*$35@6=Y:B7W6DH6`/#H5_Y2_P#')/CQONJS]'+CZNL[LSCT MM%'UM#U3AUQ5'USU?B<5D<)M*GW%N>*D&Y*'')ELF/N0\&>KZ^FD020.S>Z\ MP`8@=6B>_=5Z][]U[KWOW7NO_]3?X]^Z]U[W[KW57G\V""*K^.N&I9:R;'I+ MW)T;Y*RFIFK*FGC3MG:4KRPTD=50R5+@);0)4U7MS?29(]L&T']A)YT/4/>]2E^6;%`6!-_;#''^WC^8_P`/52&8CPOQ`Z_ZXWEM*>?*_P`? M3+8E:.N%+C!1T=!DZBASE"M3%XJ&NJ\AAJN2"-8ZBG:A2%ZB*.FBBFGCDE/& MYNO[^UOAX?A:6)!9OB`T]N2`&'&AJ:#4<#J%YA%R'M.T[A82B03AQ210*!:Z MP&KI!:-LFH*@5"A03T3W?WRIW!OS*YBEZSV71X+<%3F8:"'==3M7+;[S.V-P M8:LII:7:>\L-_"LHW]R\Y#BUS4V9I,525T6#AIDCB^[KS10C2PY0MMNB1]WO M_$@"5$?B"%7C.2R/J'ZO^AK$S%3(SM4H@=@1>\YW>XSRILFW>%>>(%\01F:2 M*16'9*I5J1'2':6-`?#1!IUN45T^/&VN]8?E-T%N3M!MX4E#EMT]B5\F`W3E MJ;(XG%Y>?ICM"BBWK@LA)79&3;]1O/[:35MM-%'MG'I!`A>P@I$W-<^PORES M/:;0(6,<,($B`JU!<0U1J`!]`_T5JM(VHGU93RA8\RKSERI=[MXP2:6=M#FJ MAFM9@)%J3H\0U_24*L2E0/,#=;A4K&@/!MR+WY)O]?S[Q%8@L:<*]9ZI\(ZR M^Z]6Z][]U[KWOW7NO>_=>Z][]U[KWOW7NL1@A:59VAB,Z*528QJ944_55DMK M53^0#8^_=>Z]X(;@^**X;6#H6X?6TI:]OU&1RU_ZDG\^_=>Z]X(+(OABTQ(8 MXE\:6CC(4&-!:R(0@%AQP/Z>_=>ZR*JHH50%4"P50``/Z`#@`>_=>Z[]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]T'O8O;75W4.`R6Z>U.Q-E==;4IHYIR?%$]1&&8%UO[KW15-S_S,?@[M'^\JYCO MO!F3:$/9TVX(L9MW>V:DH1TOV9L?I[M2)1B=LU@K*K8W8O9&%Q]=#`9)5^]$ MZJ]/'-+'[J_AO_#TJ*+^8!\.JS*5N'/>VU,;7XZKWG0URYZEW!MVDI:S8'?. M.^,.YZ6?)YS#8_&1U%/WWEJ7;-+&9M>2R%0GV8GB82>_=>T-2M.C3; M&/\`XMM+'SF,J:*JCU M:Z>KIY89`LD;J/=4Z?\`W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=(+M%E7KK>I?$TF=C_NUEQ+B*^JJJ*@R$#4,RU%/7 M5E%35M;341@+&5X8995C!*(S6'OW7N@I^(,M5-\<>KI:VHCJZJ3"5#S5,6;I MMR),[Y6O?RKG:/#X"FRGD#!O*E'3HQ/I73I)]U[HLOQ%[ZV01QZLGJ/\`@//_`,L9?J;#]#?G\>[Q_&GVCIJ7^RD_ MTI_P=:3?R1SG>NT.]^S\IL\[EK-CU-)UK24&$HMGRYC9=3F(^@.L&RVY.PMT M5'W&,EZLI;R09=(7I:VBE/WZ-%&LU1)F%RU;[%=\O[-'>B(7:^*6]:4),3K3Y/XF@GCS6Y-I3OFID M--E<]@LKE8J:MS$4V,H_X14TN5BCBQS(T-MTY4EDI':WRBW8KHCFU,RJ*@32 M,#54D"DJAU,&5HS60-5+M'-EG!();NQ8RJ"))82BAG.G]&.(X=D+#7("BZ2L M@"Q:>C?;JKZ[YMIGLQ0Y?&;178&R\ABXZS)56FBB2:8'6P3D4PVL\3RK<3@D"B_J2*S@^:T5-H9U\?D*ZC829^G%-115,$<$+9RI:H]U[JTGJPJ>L>N2 MKB13L/:!60%R'4[?Q]G!D5)"&'/J`/\`4`^_=>Z"AOX5_I=^1G\=IZZLPG^A M3J/^,4F,IO\0I\?18%)X^6>C#:%O7W7;$VR2--R-Q&(FD>*-%D+KX9=Y MRL*(&H6>9A$HJ9"$!/11?Y7&RJK9'7V_<;DMK;DVQE1GL%!5+G]K[SVW3UL- M%AIX*`;?'8&Q]G[LJL'04A$<2U7EK%.[U+^#X"/@K$%T@%][!WIN+N/OC^9Q\=NS.PLNVTMJ_'W.]=Y;1V"<54;EW'MS#M%F9<;2U>'@CC<).WNMR?&W0T]$;]K.L/Y M=WROWGU+LKKWIY=@[HW/D>O^T>A^D.T=@==]RR0;6Z_K?])VSNE^TIL]V0L$ M&4JI]K5:)499,E4X.:?&35"211K[KP4Z@K>?1^_@]E>X\UU=NG)]X;^DW[O" M?L.H@IY7ZT[1ZI&W<1C-B["Q`PB;7[@V3L#>9.0S5!6YJ2H;'BD:7+O%!(Z1 M>GW532IIPZ.9[]UKKWOW7NO>_=>Z_]7?X]^Z]U[W[KW5\>D4@KJRMIL91TLJ]F;>F23(9"K=((\9KB`J8V*^>$M&&4L"!][>L M%W3HL]V59]EVA4D"O\`O*UH20`#XZ&K$X"X M[OE7/54/R$WATI4U0ZXWC5]7[GIL/D*PXW';H@W!2[6R=='!62YK"T^[(LG$ M8:6IQ&'CQ5=)(9L5+%%,*I9H$CF$C\M66_(J[A80748DHIT:3)P[7"D9HS%D MR'!)*T->H;YLO>7+N5MIW2>SE:,EUUAQ'7(:,/J%"RJ$)`ZSQX== M^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZC5M; M1XVCJ\CD:NFH,?04T];75U;/%2T=%1TL3SU575U4[QP4U-301L\DCLJ(BDD@ M#W[KW198N^-U]HKX_C7LBDWKMZH@E:#N[>^2J-L=,S->N@CFVUHT MJZ12)\71TV!J89`T.8+`I[]U[IYKNHNU]U8SP;P^2&^<)D&RU#E2W3.UMA]? MXN".AGI:@8>G3>&"[4W')BJEZ=DJ!-E)))HY674HL%]U[I)U>Y^QN@M^]>83 M?.\,CVCTUV?N"CZ]H=\;EQ^W,=OWK7LO,1,NRJ'=57M?&;;P&Y]C=AY*!L32 MU,>-@R6-S]30PRFKIZYI:#W7NC;>_=>Z][]U[KWOW7NJKOD?\J=S4'4'>'>N M)W_D^K>LNMY=Q;?^/E'L_#8CZ\;*U&2CBH,Q@-TP2]09K=&"?#4\ M6.IH*BJQ='D_&W$UE#3O0;?Q^'3N MGL^@JG>>X_D1\<\6G8 M.Z=U8KY!].[?I5J^U$&RJ#97;^RMO4L5`F7[%VR=LUB;/WUA-N4Z5>2RV#.- MH,G]A&[T%155$4=!4^Z]T-.\^]=D[6Q^U9,-_$NRMP=@4$.5Z[V;UK#1[EW! MO7$SP052;AQLOWM)@,7LV.FJX7FSV3KJ'"0":)7JA)/`DGNO=)JBH/DQO1Y* MK.9_K_I/"5"8"HH\#M/&3=G[_HRDE1)N&CRF\MQ_PC8T$M7%X8X5IMOUR4S^ M0^><:"?=>Z@U'QYW4^5JL]3_`"C^2$&7EECGI%DR_5<^WJ*6*.I01#:7^B>+ M;M513&=3+'+`S-XETNC78^Z]U,Z`[0W7NRL[3ZP[+?!U':O1>\*#:>ZLQMFE MGQV`WE@=R;;Q6\]@[]QN&J:O(5&WI=P[9S"0Y#'/45"T>7HJQ(9)*;P2/[KW M1C??NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW2?W3NS:N MQ=OY+=F]MS;?V=M;"PQU&8W+NG,X[;VW\3!+/%2Q3Y+,Y:II,=0PR5,Z1JTL MB*9'50;D#W[KW'J@#OO^:5VQWAON#HKXA;"["Q]-F=R[GV+G\YC-NU,?>>4H M-J;GW+T-\I-M[-VWG:?&ITG\C_B5F-X[1[1Q.-W%'64V]-E"6>E:(77W[IX1 MA2"S#H/J;^4_V=V'MO*]D_S%/D_MKKQ]T;6W=C>R*#![@QN+H,!!T9G)?! MK^65'D=Z46]=Y=@=B;JR+]@8_=$$>[-XS9#=^:[\W9\>8.PJ/:N*ZYP>)IMT M9G?$)_=B@&+I MX9V($GNKZU_WV.AE^+/\VW*[4SU;TO\`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`!ED^(E$,0PY'6!_,TDZ@_P`MOG"T9>Z-R"I"C45F24!@1'$TKK6/,J@D*!4JGW"]^I-GO\`LL=QNNH: M9$%)`[$A3#)"2A`DD\.-@LH(C)/B'4!8Q\6<%L_K2DRF`V[08/KVNW]'A,3F M]E;_`-Y_QC>6.VI%'@5V\E06QT>/Q671<92O50U\XR+K1LUI1Y+@L-J+V<,<=LUTJ*T4 M\VN58UTF-:!0B@K0$-1ZH3(3IQ:'_+HAJH(>YHZLP^7_`$J]ENL<$HGCIH'W MWE&IZ(5*TE"E4:*$K%YEB5)M&M2ZL':.^?&UR;0PK0V5OQ%,^$,TJ:?8]^Z]T$70G_,F^NO\`PVJ/ M_>Y/?NO="[[]U[KWOW7N@B^0$R4W0W=E3(L;I3]1]D3NDHG,3I%L[,R,LHI6 M2I,;!;,(R)+?I(-O?NO=5E?)#=^XH=^]*;>-?0-UOE.O=DMN+&8;=GJR3P9G.7GBBD@@GJ,4:OW7NK5^K9!+ MUEUU*%1%DV+M&14C$@1%?`8]@J"9FF"*#8:R6M]>??NO=(7;!(^0G=)'!'67 M19!/T!_C'=OU]^X9IU5R0C$<:'HJ_P`2?F_#\E.W=P[`BH9:6##]6XC>M-.V MVJ'%I65;93'X_-3+7XOLCL&&%"VXQSO<[U-9.JSR M.8PL321AHYMOL&+5AF5YX?'MI"@,3A=)#@S/>?\P[>.X.X_C%-4;BZG M^0"4N-ZW[QS':F_>H,?)AME[2W#GLIUYL[$[>SVR<;51[&H*S<(H*3^/R96& MFI7JZMH:-U''6,9.4HM/\O0B_'3XNOO/^5[N'X\]/]M]!;[RF^:%Z;!=G9"E MKOD'TM'D%GVK-'69+9"Q=5AI\7C\.C1X95I$HQ]W9;=G4&>[KZVR^;J\_M'%8B7-UN\\KV)O M+>^V>PY-GS_`,,FF^ZI5$&0\7AD!+61R0DA M`C>1/;626+>-S>&4),-MO*,?*MO)G_-\^HF]WA$VR;,MQ$9(/WM8U4?B_P`: MB[?L(J#Y4K7'50/R&^,?5SUT^ZL1A\]/DLIN"KQFUL7O'L#!;1P]4*VDII,= M1TNXHYDR\N.6BTRQXZGC6ODEBD?S11",&3]@YMW81"RFDC,2("VB)Y6&G54: M0"I)X=U0`0H!ZA#FGDK9O&DOK:&4RRRLJ>)-'$A9E730_$0%_"M"675K`[22 M/?4>ZL%BMMP]I]7X)NM\ICLA%3P;?VX,%EDQ&4-)4')=6[XP>)S;MDJS'-MO M:RU=4FIA#333/H'NVM8W$MV=HW:1=S1_BD+-I4*5 M&F@H`#&VY1W\$=I'O>RPG:I$:@C0(VEAAK:5%*ZR/`M]=6#G74EM1"Z^)^VM MC?[.7\=]S83-9O)YK^^V^X%VYG,#+0Y':=%D.N^W8,WN&?<>$EFVMNN@S&>Q M#;52H$./%4^U$KTA!JE,I=SA<[B>1>9+>>&-8?!C.L/424FM]**C#6A529R* MM3Q2I-0:''(EMMG^N+RGN_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW6.66*"*2>>6.&&&-Y9II76.***-2\DDDCD(D:*"220`!S[]U[HE&S M<,WR^JJ[LGL.D-;\:6JX4Z/ZQJDR5%C>T\50RPRS=R=M86KBHFW!@]PY&G8; M5V[6Q28P854R=;#455=3Q8SW7NCL1QQPQQPPQI%%$BQQ11JJ1QQHH5(XT4!4 M1%``````]^Z]US]^Z]T3KY]S9:G^)_9TVW:JMHMT1U_6C;1J<82N5CWD.V=B M_P!T!B65D9]^Z]T5[YE[ZW?L/XZ;] MEZWGDINT-[MMOJ'JVJA+B?']B]R;IPW6&TLW&8WC9%VQE=U)E)7U!8X*)W;A M3[]U[JM/KW9V!^3W>VZ^ENKZ./,_'GXK[KZJZ0R79BY>ARVT\7TSUGU]U/V1 M5]'];5J3UK;NWWWSVG(E'V-F:98::GVGMN/%5-1)73)%%[K94@`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`WM%BWMO1G<>(RV'-=5ID9+ MTE=4U$T4?NMDEC4\>@_W+\3NM)WQ>;3$_)/I;>N9[&P&^]R=H4N+P78^[Z_, MU^Y-^=2G#-7;2EWI!@<]O"K[6:[+P-/5 MOLZ/<%+F=WTFS,<12SR[9K:6MR,KO3034+^ZUTL>X>F^GOGNFY=L2Y#8?3OS M+Z=W,NX]C=B;'R6$[(K\1GMEX-,'M'O;`X2OCVYC>S*3KV/M#*8_:>0W1BJR MGV5O22LFI(&K:%VE]U96*G'#HEO\M_Y;[Q^,'96+^"7R8PDG6V%J-XKU;TKC M,[G,E7T&S.P6H\77X?H+KO>6\\6>[?FYOC<=!D:S=_8?:D=#C=A8/,Y),=12 MK"\<4?NKOI(UCUZV/??NFNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_= M>Z(_\H?E/+L'>'7'QUZCJL7D/D%W5NO#[.Q^3KZ.IS6TNC\-GL5N3,IV5V?! MCU812UF*VGD5VM@YY::;=&6IC$KQ4%-D:RD]U[HXFV<-+MW;N$P51FLQN.HQ M.,HZ"HW!N"HBJLYFJBF@2.?*96>"&FIWKZZ53))XHHHE9B$14`4>Z]T^>_=> MZ#3N'M[8'0_7&Y^UNS\['M[9FTZ2"?(UIAFJZRJJZ^LIL7AL)AL;2I)6YC<. MX_=;`+$`<>F#X]=KY[N_J?;O:&?ZTSW4LNZJ MC.56(VAN;+8?,YH[7IL[D:':VY*NJP,M1BXX]X8"EI\K##%+,(H*M%\DEM;> MZT10T/'H:O?NO=>]^Z]TUYS-X?;.%S&Y-PY.APF`V_B\AF\YFXZR+.0=C;LWIE\9D]T[L.ZJ:MECQ.,IH=D97;&2BQT5-' M6XDYK[.OD_B$-724/NME2M*]6(^_=:Z+)\J/D?1_'38F*J<-MRJ['[F[,W!' MUS\?.F<14"FS?;':V3H*VOQF"^]:.:';NT<'CL?49;LDP29TT<)RZX63(QQ9"3$KD/(*9IU M68PZ2X#7'OW7NG?W[KW2&W)3=CR[KZ^GVGE=GT6R:3)9]^T<;G<+EJ_]^Z] MU[W[KW7O?NO=>]^Z]U'JS**6I,*)+,*>8Q122>*.241MXT>7Q3>-':P+:'L. M=)^GOW7NB6?!BOCJ^O=[0B:DDJZ+LC.19B"&'`T=3C=PRTF.GW%B9J/`4E)" MN.Q><>H@QL\ZQU-3C8X7>"DXIHO=>Z.W[]U[H-^X:,U_5?85(,;'F3-M#/@8 M>:J%%!EBF-J)%QE35E7%-25[((I7*L!&[7!^GOW7N@W^(]!#B?CYU]AX(J>! M<-%N##M34G\2:EI),7NG-T$E)!-F,GF,C5K2M3^-JB2M MMN8C#;&HGJ/MTW%3YO('.5!E>.!(`D\_NKNP.FG5L]00()R?H(9"?SP$:_'Y M]V3XT^T=,2_V4G^E/^#K2.^1NQ\;DODSW#NH;XP6SI%CZWF6IR]%7YN9SC^@ M>J\7M9Z#;KH:&K?'9/(3U-=$]1102//A#+(LO@;WF7RUN4UMRKL=D-OEF8"4 M]K!%S]UI,@]5E8XMN4N MUJRGV[MG+XDY_=V%GIXJ#+#+9&@HJN9JIYEF5V_L0/"W3=)K6.^9UHI16C#@ M:27+CQ)%8)!)K+H$C=QP%.F-NOF42[9LUK>-MR`DD2$2A6U.!'X9,43(6N(M M(5_%D6,C))Z,]T)\.]GTG8N)K:S=&^H<8(J#(97!9+`PX_>F)\-1,9MNR9"G MHSM]'JJ@24LE;3231(JN4C1E,+!3?.>;I]KDMX+*`RK4*U=4;<`&.HZ^&=)' MIT,^7?;NU&\V]Q/>7"QE1JC*Z94K7M)5?##`]NI2:5(IY=7-_P`L&+$Q;9[2 M7`K6QX<]F=E-CX,C6T61K88GW]EW=:BMQL,-%++)*S.R@>2-F*2_N*WN(O<= MY'O-M\;3XOTD!)4:03X0R!_E\^IT]HTA2UW98-?AB\N0`S!B!XQP6H*FO'`I MZ=6J^XUZF3KWOW7N@BZ$_P"9-]=?^&U1_P"]R>_=>Z%WW[KW7O?NO=`]\A]' M^@#O+RZ1'_H>[,\A<2%!'_I_GH8WCC.J5T94')!]M3S?3P M37%*Z%+4K3AGCY8'2[:[#]Z;GM^V>*4^HF2/4%+D:V"@A!EC4BBCCPZKY_E9 M5=96[B[&EKJ?"5,E1MZESR;NPV>W?N"3?DFZ,_49&KW;GYMR[BS^-H-TY5H8 MY*^GQ:8^$.5:6F1C':,O;VY>XN+T/X;$15+J78OJD)#.6=QK.=073\U'EF_] M\#:K;;=HY2\`W43_`%9B-M-%:Q"S%O;K&MK`+>TM9#:Q598#<&X)`;PYFHYZ M+G@]SYC.?.S^:%-MFLJ,;'M+H7LVBHL?)1=C[4SNSZVHVETI3[QS>U\1AHLQ M74&X]U4.WX\G%F]OTN3K=Q/38ES!0FGA2KE+K!;NU1ZORZ/%_)^D$GPXQ1:I MHIYAO_>'W$.$DQ4NU*!F3$R04>U&VWE]Q;2^P:B>*>N_A>1K8/XY-7F=HJ[[ MNGA]UJ3XST:3YMS1P?$3Y&RS9&?$P+U%O05.0I]LQ[P>GI7P]0E5Y-OS9C;L M5732T[,DTC9''BEA9IS54_B\R>ZTI`8$\.B^_P`JNNK!\68MIY.EZ]3*==;] MW!LFMR?5L.#KMEYU*/$[]-^8?M;(4N"S5+05^X!6K62UU'+25 MT0KJ.I>3W7F(+$CJR;W[JO7O?NO=>]^Z]U__U]_CW[KW7O?NO=5@?S4LU4;? MZ,VEF*>:2*2B[JZ/\(AIZ:JG\U7VEMFA1HH:P&EE<_=:51R`68&X(!]R)[9P MI<[[>0.M0UC<<308A<\?+(ZB+WCG:VY=L9E:C+?VN1DBMQ&*T]FR]=DLEOFOJHHHA4[?DQV#IOM_' M+)#!)%XY(HJ3(T5(K2QRY+_5":_GO],,LLWBC&ML!1&HR`]6.O`\BI)5V(@[ MFE6YW@V^#;4>:.&V\(U[0*LS2M0@E0`"IJP-A=<9NEJL)M>CK?LDHTS=3A:.AH<]3?=* MZ8RKGH_8TM[GE7>E%M);A;O01$C5B<`4)GEG4JTC"O\`9K(6,>*:E!ZCZYM> M;^6G>9+AC:Z]4C)2:/4S$I!%"X,:+4`"5HPJS=VH+7I?_#CM*FWG\M_C/M3/ M;`V;MK>])N[>NX\36X'!YS';I_NCC.B-^;.BJ-YM'EH-K8'<%)28.CQ>0VP, M11_P8TDT/M_)G-=Y!N,TVWF"-#J8&,RFZB8^$""Q3N++-J M)DU%7);4>C;V]WI+[GSDZRN=LMHK_P"HE96C0B01)9RQ_JE6"(_8JM#X:^&% MU*`"!UNNC_BO^]^\/.L^>O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=> MZ][]U[KWOW7NBH_->6>J^/6XMET]9-0/W!O#J7H>IJ:=A'.F%[R[8V5U5ND0 M3-%*L%0VU-V5PB?T$2:;.C6=?=>Z-%CL=08C'T&)Q=)3X_&8NCI<=CJ"DB2" MDHJ&B@2FI*.E@C`CAIZ:GC5$10`JJ`.![]U[J9[]U[IKPV;PNXL?%EMOY?%Y MW%3RU<$&3PU?29/'S34%9/CZZ&*MHI9Z:26BKZ66"50Q,Z]T4+M M/)CO?O?870VUY!6;6Z0WGLGO/Y"YV$05&+QV5VR9MS](=01U23-)#OS-;XI\ M7N^L@"$T&W\+%]SXQF<>9O=>Z.@S*BL[L%5069F(5551 M5^4E'N:*IH_C9L'._)7+QU+T"Y[:63QFV^E:"NAG,-6F8[OSNO:U?'CGBE2J MBVU#N;(TL\?BEI$=A[]UX@CB.B;]T]*]M=[_`"%^*'67R=WK@=V;&S6Y>R.Z M]Y_'CK;'U.*Z9@VETIM%<1@DW=N?+4\78W:F4/;7:FU*MEJI,-@:B&BEADP[ MJTAD]U8&@(ID]'US7QQV.V>P6[^O*W-]+;NVYMC$[(H,KU6V(P>(K]C[?DKY M]N[*W'L>OQ&5V)N#;.WJG*5#8^.;&_=8Q:B=:&HI5GF#^ZKTDD3+;9[QVU0Q5=6"NJ-?=;8U-0*#H89>L_EO@*RIRNVOD_M/>L445=)2[0[6Z+PD6 M.K99)YIJ.DDW5UAN+9.6PZPP,D(J10Y#3I\C4\Q/C/NM="#\>^Z#WAL.LS^2 MVQ-L7>VTMX[MZS[.V'/EJ3/_`-SNQ=B9:7#[BQ5'N"ABIZ7<&"K0L.1Q5>(: M9ZW$UU--+3TTKR4\7NO=%<^)W96+ZQ^#?66^*]:C<>DMG]H9_;./V?G8V5O;<>QLG/A-P38K!5.5P M>3K=MO5T4LU'2SFEGC$D:2!@/=>8`$@&HZ'GW[K77O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW54O\WCY3TGQU^.%'M;';ZQNPM_=X9V79VT\K4]R[4^/6?7 M'8BE7,[GJ.O.W>T]A[VZ,Q?8E-&:1,?A]YOB\1N&&>HI/NXV)8>ZLHR#3`Z# MOX"]"9OX4?"RNW_@]C0U/<'=.3QG8N=V?A=B0;"P^VJ3N^UM M_P#6F`W=@MH5'\`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`&3I7*4W847V^VDBV[\L.X=Y];[\S&S,=B=PU:"?$]4]7=3X;*Y^K MJ8WI[Z^4FS?D+NKI:+H[I"FV%60;V:BJS'9W>9S'8 M_:]+4YK:.Q):A=G]&2XK,]>;"QU-GLC3T=25K(MS8PFHC37&WNO4&FM<]'"Z M^V)\D<3O9MP]F_(/9^]MI2TV21NO-J]%T^PZ*FJZL4[8^6EW17=C;UW`\6(= M)`%E+FH1QK(9;GW5>@M^55'6]L]C?'SXK/0PUO7_`&KD]Z]F]]0S&\>5Z7Z/ M@VU4R;'FBTE9:#L+MC>^U,?DX7/CK-OC)TS`K,UO=>Z)Y\FOGOT1\`>QNJ?B M3T5A-H9GM'MKNJ/>_D/\!Z4V;VUO;XZ?/[CWONFCI, M_6X/;\%4DI:KW5@*@DMPZ--\:_F%F>T\'\J>T.X-N8+ICIGI M[N*IV?U[GMQUT^+S*J M%.5I*V-?=:(X=%AV?W9MS<'/?6#J]EX;X6]00[0Z)Z^W/-6)N3;/3. M]^M\#WMN[NG*[1JJ(93:78?R(JACL#%0?:')4%!M1,<_^6RY"E3W5M(JH!K7 MI]7^;ETUL;X\[:VCF@N,IHMA9[=N2 MCI(-O98;EW)B<+)'6TJ9(Y/()'#0S-9/?NM%H,3M/LC=`VM3]O8_([@Q69A3-;(8]P[)S^/ZHH>I=]=S9WL/(URT.Z:' M8>SJBEQ>*W?3=2#&5.YUV=V+N?(4^%VQ4Y2?$9+<64>1<;CZRFIZBJB]U[H? M=R_+7IO;/7/;?9==G9(<+U%OW/\`4V1@JJ6I2NW3VIAAC*2CV!L;'T4.1RF\ M-S;DW%F:;#XVAQU/55]9EG-)%`]0IC]^Z]0GAT#.S.^?GAV5L[;F>POPLZKZ MVR.Y<'CLJZ=K?+:CKZ3;,^0I*.IEHF%W0U;M5=J;:Z7ZGV76;)Z=VC%)EX]^Z]TW9AY8L1 ME)821-'CJYXBL#5+"5*:5HRM,EWJ"&`L@Y?Z#Z^_=>Z)9\$*#-8SKG<='FXF M^X&8VY5"NJ-FTNRLEF)J[8.U:O*YC+XS'YG.XT9*OSDM4SI!+$E.H$;00R"1 M![KW1Y/?NO=!GW/G9MK]2=E[DIJZ7&U&"V-NK+P9"!JE9Z*;'X2MJH:F`TA% M29X9(@R!""S@#\^_=>Z0GQ7W5N+?GQXZTW+NO<$NY-R9;`U:Y?Z`7X@[8Z\'8?;_8VS^E> MS=B9_=]7D,)O+M;?NXNL87[LK=E[XW7@J3<-9U[UYN^IFPF3H6IYEI:ZOVY@ MZJJQ4T`E,K@Z?=>Z/Y4$B"8@7(BD(%KW(1B!;\W/X]V3+J/F.FY?[*3_`$I_ MP=:2?RA[-VAM?Y`]XT>:ZO3>F\'J>NLU34-;NZOVY4T.W4Z`ZRFW9NW&X'$4 M-JS$[5I!32YJ*6LAK*I\;0PTR,M$U319E\J[9?WG+>PBUWEH+8K*O8@:K?52 MZ$+DU4NVKPSI(4.[U[R&P"YUW:RLN;.94N-E^IO?$B6)-G8O^Z&V-\8RDI*2+.=? M]FTU5E'J:?=5-13QUU=2Y+*?;2U%30XKSU$3U-6BZ>TY9V6>#][CQ;J,4/B, M9'B85TRQ472RUJ%"H=(!<@&@Z)[>\YNWFWG&ROHM)#_H2^%'/&*:X9=3EEDT MZ20\G2P>Z: MYJFNAI7XA\4E?5UU.)*Z8RULD]-HIH8P/S=8KONZVLFU6&J-596TTRI5644! MR/BTTR``IJ=74A:>AJY,CV=VF9JS'4C4%+5S4_9.X*62JCI)::DGA:H$`>0O&K M22EGM9@3%?N?";;]^Z]T#OR(02_'_`+SB-[2=.]FQG3DY<9B:S)G"TF1K4RO=I@HJC+BAR7\-BJ'] M)F^WF\8YT-]/=)#($8PJ#+3`)H"?MH:?L/3UNEI)<0QW]PT-DS`.ZIXA13Q8 M)J360,Z=2UX5'5?7\KIZZ3-;Y:LJ<;4G^[-+HD:OJ,AO4J=P5#'_`$E/5X#` MU,>[V9KRZQ.9!=_(P(+1IR";KQIQ=2HX$/80Q+A2]:2:E4A@3Y@UXU(ZS7^] MD=I;;.7CM-A/;GZXF:JHMH[FV%#MXCN+B,6M/A"E`I[="D$`L^*[/VOUU\Q? MYG&$WAN??&\\C-TWW!EJ#;6VN\MI=R MMJY>G#[L_B*I58N-*F`U<]-D)J>3NL)VHWA@'RZL>_EFR[9E^.-2-LP=G4,< M?8>XOXOBNX[;@K,;54U93TV.I@*V*I&3 MJ'DJZ^=S[JC"C$5KT-7S7RF3POQ(^1.5PNX,]M;*T74V\)J#/;8HE_AWM*IF MWA4;RS%;N'<%5N6IKY^PJG*8/<;?8Q9/;&2G[$['[.JJE\*\2I3U&+K:7"UE M$T%334D)FE:3W7G^)L>?5DGOW5>O>_=>Z][]U[K_T-_CW[KW7O?NO=53_P`U MRHIX.G=LM6X^NS5'#V!UG6_P7%2RQ9&JR-)V5M:3$5$)B&I(J/*>%Y9!8I&# MR!"]?,<0#3Y]0K[TO&FRV7CH[P?4VYTI\1/CQ MTI]AH?LKT27X#;5V/M+L3*;:SDFY]NC>VV<_U_@X,]BQ]L@R.B/$2)FGBQ,+ MI5O622TM.L$+ERH4H(UU"GGJYO+O;X9X_#E:&1)6*-F@)J-(..&>(%/GT!_; M6QL+3=I[6X>:)+F)X5#I05(J"&(_I=H[:XQ@`!GWYU!C]F=B9O;VS=]Y;';@ MVI6+08#'Y["R[>R^XI:>5JC,0;,SR4D&"K*ZAFI/OJ:",I/534B1QRDNRH9< MO[N]QM\4M[MX:TD5M3*VI5&""ZY:@-0:"BAV)Z*N:]A6RW>:ULMU(O(W4*K* M49R*]L3&BDD4/JQ51@=`MT#BMW[>^670T.X]IC:^5R.X.P,O/-6[0H:7,YO^ M&]*=OT^0%540CQG(I4Q5,2Y:IJJR&2)8H M5`$OZ:UN+]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=`9\D\'NG.]+;T.Q<=%E]\;;CPF_\` M9N)>AILC-EMS];;CP^_L-A\?3U8\"Y;,5NW%I*20LGAJ)D<.FG4/=>Z$'KW? M^T^T]D[:["V-EZ;.;5W9BH,MB,C3.C:HI=4=11U<:,[465Q=9%)2UM+):>DJ MX9()562-E'NO=(?O_O[KCXV=:YKLSLG)SPT-"C4>WMLX:DJ,UO?L7=M1!,^! MZ\ZWVECHZC.;UW[NJKA^WQV+H(9JF>0WTA%=U]UL`L0!UK]9G9?R'[/_`):- M'A]J5_:WQFZ\V)G>SMA=A] MK[LSZON-A!5[HF6@GEEDQC1"EK/=6&E20PZ,E\//DCLGX?U>X^G.T-V=NYSI M^BI.C8O]F4[(ZWAZUZ;A[6WSMKL%>Q\]%V/O=\#F]W[+WANO82M3[@R=?N7- M9#.5=0L]2]$:"LJ_=;T:LJ,=']E^:%+E,3N.HP70G=LUL=-N/9F0WQLZMV#L M#=W628K(UU1VQN#?F9IZK%=<;)ISB:D38_-0P[O^V:GGCP\]M]`]2]A]";DP/Q\GW;L*AWAD/A_O-UM\;P["WQOK=M318S:79.W-L2;2ZGP-9*6 MVY+/2T<)EJHTC,$DONM>0/KU8)7?+CI[[[.X;:/^D+M+<&`;PU6&ZLZI[%WI M'/5BI-')1TVZGJT>*AJMJ=2[#S>7Z\Q=='4MS/G=SU/VYT^3 M%3^J/W[KW0*9GH#KOX[_`"?^,/>U=GMW[IW7O&M[7^/F^>W^SMUU&X-UY_+] MQ8C;.Z]@X_,UTB8[;>V]M3;JZBCPV%P>%H<5A8,OFX8Z2B2>K=G]U[JR_P!^ MZ]U%KJZCQE%69+(U5/0X_'TM175U;5S)3TE'1TD+SU-555$I6."GIX8V=W8A M54$G@>_=>Z)?\!(ZC.=&YCN:JQ]7B&^3';W:_P`B<7C*Z$PU5+LGL3=E7_HL MEF4LS&;*=3XC!5LEPMI*EAI``]^Z]T[;(^)VQ>DZZGW7MS/[^SV`ZN3M3<73 M'5&6RF+?8?5V5[*K,UN'>$^V<=C,3B,IGF MIYYA)[KW63^7W)'5?!KXC9-%HUES_P`=^I=TU[4`M2U&6W7LO$;DS59'^Q3E MWKLME)IG8H"\CEC_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW M7NM=C^976[D[3^>?QXZ*AS&9P>V\I/U_LJOHZ#?7RRZKI=WXOL+WJ.(1X3<,M%F*9S402U5/'40LGNG4^"3HX_SOQ75':68Q MWQ]WGMS8T6;P>V]I9/H!)-OU>3AD-104U#)D*?W38)7@>CQ]18O"G[\S70P5^%AK15XE:56K3I-/# M[K70L2;1VI_>)=YR;?Q)W1!2-2KN#["$Y9*41/"4%4L9G)%,[1@\OXF*`Z21 M[]U[HM6W?FSTMO`;2_NDF^-PMO:NR]-M]:+:%;2K5T.%GVI!5YL5&7EQM(^- MOO7'>B.22LB>9X9H(IX9HH_=>Z%'8'R"ZM[/W'E=J[+S=9E5N?=>Z`CNG8^T]T[AR&S=^ALQLSN/9E5C*K;\FZ=R9'/RLTU/0QQB1D2:F]UX8ST!OQPP?0VY>K^\ M?C=U/OC>>4\&TWP6]=D=@TO;>!WUL'(;RP>XMI0U&XMP[DRN.WW_`!W)T6$2 M.IFQV5AJ8J['35-/-3RS!D]ULDDU/'HA/\CJ3)]9U?>/Q\R>QSLN:BIMO=@U M4%+TAU7T%BZS<\%1/M#=64&!?Y+_`"`^4_86;RE/#BQ5;@[#%'/X::GBA*%V MB]^Z]^Z]U[W[KW7O?NO=,FY-M[>WCM_-;3 MW9A,5N7:^X\96X7<&WL[04V5PNER.*RV,K8YJ/(8VOI96BF@E1XY8V M*L"I(]^Z]T"7R,Z&H>YOCYWKT[M=L+LG.=N=/;EZOI-R08J&*"B6LVWE\-MF M#,QT$457D-LX>;*NCT:L`*.:>.+09"??NO=`?\I_A)0_.+JOKC:7<6_^R.F< MCM+%YW(5FW^A=X80;8CWUN+:$NU(LK)7;JV%4U>>IMC05]:<)(M-BY8S6.[J M'T>/W6P2""./2(Q_\N#!UG?62[(['[8W+VEU3-TYUSU92=,[IP^.BI)SL?<^ M?W)6T>2RF&FQ>WL=U+N2>KQ)R&QL%@\+@LO-@*`Y9_=:XY/0P;TVS MG$^=GQPW(VWJ^;KW%?'#Y,[;H,Q1XVJJ,#@.RY(5%7MG=V$F`+4^:VKGZ>FKZ20::@W>N?S]/D\[4 M[R@J*F6;^,35,F2>>5Y&G:1V8^Z]TF8_B;\>8^S:GMX=:XY]ZU6X(MX2F?+[ MEJ-H+OB&03+V#3]:SYJ3K>D[&:H42ON&+$IFI)@)&JBX#>_=>Z?NS/C9\?.Z M,BN6[=Z2ZK[-R8Q$>`:NWUL3;>Z*F?!05=17TN&JY,SCJMJS%T60K)JBGIY= M<5/4322QJKNS'W6P2#4<>I1^._Q_:GVW2-T9TZU+LW)SYK:%,W66RC3[5S-3 M3P4E3EMMPG">/!Y.HI::.)YZ412O'&JEB%`'NO5.37CTKMQ=;]=[OR6W\SNW M86R]T9C:4TE1M7*[BVM@\WDMLU$OC$L^WZ[)T-358::01)J:F>-CI%SP/?NM M=;<&PZZHJJNCFGGJ MME9ZIDK<3([%L=5R--3F.1BQ]U[HMF^_@%\1>Q\XFZ-R]-XI-T0]E3=NTVY= MN9[=VSMPT/85=#EH,WN'%9K:6X,+DL++NE,]6MF(J.2G@RTM5)+5I-*Q?W[K M8)!J.C;XS&8["XV@P^'H*/%XG%4=-CL9C,?3Q4=!CZ"BA2FHZ*BI($C@IJ6E MIXU2.-%"HB@``#W[K74[W[KW7O?NO=>]^Z]U%KXUEH:R)Z<5:24M1&U*S^): ME7A=6IS)_NL3`Z=7XO?W[KW1*O@?G]L[GZPW'F-J[0I]H8Q-W1X):2GW74;M ML^V=K;2>8JJ?:SPU(<@Q.L@4CW7N@ M\^*&?AW3\?\`KO<4&-I\5_&:#)Y&>EILCN?+H];4YW*2Y"N?+;TR.7W9E)\E M7-)4/4Y"IFJJAI3(Y!;2/=>Z+U\/NCNQ^G.R>V*GW%VY39?;53%N'^(9*CQ#8R;(K1)$Y5X MZ7W7NK"955HI%?\`0T;J][6TE2&O?CZ>]J2&4CC7JK@,C*>!!ZTM_DE5;7Q? MRH[;3']>;=WIN7%[QZLJMM5M?C\GNVOCJ\?TKU5-M44^WJ27Q+%#4TR,E/!$ MT,K@5TU/)+2TSKE_RNEQ-R?L;2;M)#;-#-J576(4-Q.&U-455JE37/!00&(. M!7.,UO:<\\P)%LZ7%W#<6_ADH\C$BU@T`*M:9`[5Q7]1@Q4$&7Z"Z`[1[/[` MVQ)OO<6"VAFLO5?Q+9F$RM=2P;MKZJ.H&1M/MC'U=;C]J466GD7*@LL$MIQH MIG91&`]OO,.S[58WIVZWEFB"T>0`Z0M*?VA`\1AP!6HI@G%>A/RYRON^\[GM MYW2\@AG=F,<;%0Y8@',*-2)206HV=3&B\`'OYU=?;,'=-=BCNB)L+MG:6'VI M/@J#'539F:LI,%C*H^DQTK!)&DOM+R'?WR[(DR6Y M%R\S.'--/Q544X$!6R#C%""#3I;[E[3MS\RR127(-I'`B:`._M158@\0Q<8I MDUK4'A8W_)ZI,=2]([Q&,DJZBE_TI=F""IJ'Q[QR0S;H^^%FQ5L<]1/+6O42 MF)5YG`98W#11@+WZR,31K+_H;J$%0RJ81)_1)F78NT5::.WCE88#'@R)I`70Y%Q;BQ]^Z]T"6>VF-^]A_*/8IR= M1A1O3H'K+:9S%''Y:O$C<2]]8 M68D*>+$Z:AQ74I6HR,BM>(^T='W*V_#E;F?ESF=K);E=NO[>Z,+'2LOT\J2^ M&6TMI#Z-).EJ`UTGAT6;^7[38_$NVV\'W//VUMS#;-S51@L9D.JY.I!=1)"Y M5?!,+0AYBWA%=384FB@TTJ`!CK)_[S,EU>1KNFX^W)Y?W.?<(5E8;D-T3<6M M[!;=;];A8HE+SH@DG<`FXG>2=Z.[*"UP]M=M;H^?/S]ZNSF17'=<==?&3?6X M=@Y<=+]>[7J\'N6?:&R*6//XGLV?%Y#?NXLEB:?<62A:>L\V'GB8"..0JT44 MA]8BA2I0GSZ%W^2/MW$;3^#F+P&`P^&_MH9>?.25[9$2XS+5-&8ZQ0J4K!Z.G]UZ3XVZL#^3FU,QOKX\] MS[/P&*WGGLUN+KG=.+Q>`Z\W%M#:6]<_65.+J%AP.W-Q]@056Q<3DBT?RQJ+MO"_&"GVQW#MW?.R\MM#L/?>U]H[&['Q M]!3[LV7UQB5PFP.N=K[DH%QSFIH:O$4,N,AHJB*BBJ)#2,L?NO, M:L2.K"_?NM=>]^Z]U[W[KW7_T=_CW[KW7O?NO=56?S3L[F=L]:;(W!@:DTV5 MQ'8O6E70LT4,T`J7[*VM1+)51S`+)30)6-(RED5M`#,%N?VMM!>[E?6ER MM8'MI@WV>#(:?R^WTZACWDN;FTVS;KBT>DZW,&G`-&,\:@Y!&*^AQU3]M'M? M>6Q=T[+WAN3O.OQM?G*ZHJ-M8JOR\F[ZN:FH-PXW&4K9S$I09NEPF'SV4R"1 MR5;PTZBIHYC&RD1B24[S:K*^M;RRM=B5UC"@L`J`%E).EJJ78**D9(!&.)ZA M:PW;;<]JM;AENH)&_P`7D6FN)A0%7_B+E0N"M?/H9>Y6X;3= M0[-O5W:1M874*UNHG),2::05%1KFJ:021KXJE M'83;V+%]GY@9MN6'=PD(>H-6'U4"MW4HX5@0",9/G4`)\N_O%.8.6O#W+Q]@ MU3O$0P.AOHKDI5>*L58LX/F*\".MJH>\9%X#K,KKOWOKW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1`/D_M3"=53;=W#T^,AUQVW\ MB^W]M=54NX\9O'<^V>K:?>^Z<7G\Q!V%VAL;#Y.GP&Z,@E/M>2FB%/3T>8W# ME:BBQDF1IHZDU5/[KW0F]&?$/8_462QV_-W[JWS\@^]J;'5N.G[Y[OS$>Z]\ MT%'E9ZBJRF#V#1I34FVNJ]HS35DD8QN`HZ(34XC6LEK)4\S>Z]TV_#&IIX]M M=^;;@HX\?_='Y@?)V@EHXJ-Z*.,[H[0RW9<,Z1,B+(,C1[[BJC(ETD,Y8'D@ M>Z]T;BOQV/RM,U%E*&CR5&\E/,U)7TL%93--23QU5+*T%0DD1DIJJ%)(VM=) M$#"Q`/OW7NBM_,F$;DZEQO3R2Y&&3Y#=C;$Z1K'P];'09,;2W7EOXGVE)23R MQ3(7@ZBV_GY&0J=:(0>+^_=>Z-9%%%!%%!!%'#!#&D4,,2+'%%%&H2.**-`$ MCCC0`*H```L/?NO=$+Z$VIM;NS-_//);WP.,SVTNROD;F>ILE@IQ7&@S>T.G M>K>N>J\CC\KK>%ZA*W=&&S2SQQD4[1/HLUWU>Z]T?@````6`X`'``'T`'OW7 MNO>_=>Z0_9/76T^V=D;AZ]WOC?XIMOD@KL;7T[)4T%?3PU$+++&C#W7NBRX?(?,SI^MAVSFMH;6^5O7U*8J M?#=D8+=^"ZL[XCQ\0D/C[`V%N/&XKJ?=N;CB:.,Y;$9W`0ULD;2-BJ37Q[KW M2?WCM/Y'?*RA'778FQX?C3T!E6>/M+&#L#![U[K[0V7UG ML7=M")*;<.2I\UE,S5X^66AHHZ%I3D8_=>Z/51T=)CZ2EH*"EIZ&AH:>"CHJ M*C@BIJ2CI*:)8::EI::%4AIZ>GA141$4*B@```>_=>ZS,JNK(ZJZ.I5E8!E9 M6%F5E-PRL#8@_7W[KW168_BOMO8O6F2V%\?MU[YZ6EH<9DH^MQ1;YW[NK977 M>7FAJCAVQ?7FX]V5>WI-H86NG5X]O1BGQ*P(*>**&(*%]U[HTZ@A5#$%@`&( M&D$@]^Z]U[W[KW7O?NO=>]^Z]UKS]M4>[,= M_.KV+F8]N[[?9^2RO6N/R>:VMU5_,0;;TKMU=/28W^^':&W^Y-M_!UJ*CSLD M7[51MK*I$BF*L4Y)D<>Z=3X'ZL`[*JY1LW+I/+V+N_?.T^R:'<-)F/"D$U!29-,<9?V8IYI1'%[IKHVW2= M;%4[;W/2_P`;&:K<3VCVEC&J_[]9RO@P-;FXJ6B;!28_%U],8M MOR1B3;M,\6.+2"G$K^Z]T+TL:2Q212`E)8WCONZ:S%8_#=]8_MC#OJS>XYE?*Y.78=)N3;NPCO+Z$CX_;2^*LW9VU:SI+!]J=>[QFV M7V12S3M%N7`XO=>'Z([CH.GNP%WRF=:MH\UN_)[ZPU)][4S+_&6:JJJ@3?V*V=+E<-B.O=XUF6: M;"5U//7]@XW$J8JF;&T1@FIG2.O>58J1U?W7NJQ?Y9.X,Y5=B=I[7DW)N"KV M]@<7F$[.R."GAFJ\WN#)5F+R M4<\K!ON'0#W7NBF?R=)=FUWS#^5.6V1/LNMQ>0PV_:B6HV;2_P`K:HCB-5W2 MM31KD<[\*ZK_`&8&ODK(F>2-M[4T%/,5D>I'\24#W[IV7BOK3K9-]^Z:Z][] MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U M[KWOW7NO>_=>Z][]U[J+71)/15D,D?ECFI:B)XKJOE22)T:/4SQJ-:FURRCG MZCZ^_=>ZKZ_EJS5U3T9F):TD$86-@"MA[KW1A_?NO= M<7%T<<\JPX^OT/T_Q][7B/MZJ_P/]AZU)>R\WW-3_)OY+X3KVIK-LX!MS;&H MLAOC%8'&4V6Q2Y+I+J9JVNR?853@&+P5$S#QWEG7*7:+ M;93RURM<[B1+.89"L18E6(N)Z#P@P#*<$L5-*?(#K"S>[O?DYOYQL]JUQ6QN M8@TZJ`ZUM;:K/<%24*C"J&746]"W1P/Y>6].I-O8SNK>.VI,SV-F.FML5.=S MW9-724^(V3FMQ;EJY4CI\?7Y":+(97#P1T<=;_%LCX@8B\N@!5E(0]P;'>+B MXVBUNPMNMY(JQP`EI%10*,P44![@F@5(H*GH=>U>X;-:6^^7UDLMW+86[-)< M%=,3R2$]B,V>P]SYK<>Y<#B.L(\%`M-E,S0[+Q.QMUO@ M)L[EVCQL69S$,VXMQ02IE`\8G-1!4@`^'6-,<@DM=HL(+>"WN)KP7!!53*TB M%@BU)5#I3Y@4X`TST$]QW_=KB>ZN;6/;Q!J!=81#+I9GP&<:G\J%@:@D'AQM M)_E-909GJ?L;)+0X?#O5]V=O2U>'P<.G'45=)N>E>J%/-]S4^19)&+\$*`X" MJJJ%$9^Z$3P;MM\4CL["QMJ,QJ2N@Z?Y9'4N^RLRW&R[I,L2QJVXW?8H`"GQ M$U`4]#44&!Y$]6Q^XPZFKKWOW7N@BZ$_YDWUU_X;5'_OZBY`/\`[+E6@$>3 M_0G4@'2+:_[BOSI_3;5^/I[]U[I7=4:O]%O6VLW<;!V<&(L!J&W<=JX'`Y]^ MZ]T$\M7N"A[?^1%9M3'XG*[EI>F>G:G`XW/92?"83(9>"N[QEH*'+9FFHLE/ MBPL7O^D@GI]LU53E\YEW*-G*B.* M;PP>+08\Y)VN^VN[O%OM(FEA#$+(L@!UG.I0*NU29'(!D(7';UEC]Y#GKECG M;8-B'*0+[38[E)&LK6DEF[!X25C2.0DQV<*J!968++9(\B"2377HONP(]@I\ MQOYDG:\&S_`!]W73;O^,/;O7]/UUL''8/;^$Q=/BZ[RX<$QCR%3B8Z:7#5DD\4O7N8@V%FJW%[VBS'\`.VZ_'Q+7TN3E MS&A_L:2*:F`G>QO"6'Y]^ZTI((H.BP?RLMP;OWE\::S?.^-]YW?>>WGOV?,/ M+N/(M6Y;;-'0[!Z]VS1[7KZ0M(N$RE/#M_[S(4BO(/XE6U$VJ\Q`]UYOB-10 M]62>_=:Z][]U[KWOW7NO_]+?X]^Z]U[W[KW5=/S[P^WMRQ=.[7W9(8-M;C[0 MV!ALM4BG-6:1*[>F&CH:K[1%=ZH0Y44Y*!6]-R0%!8#SDF:XMOWS"R>5J\?!E<124F:?"UE309RLI MHITQ-/4QMYA]^ITZ);Y7YLC65MKW6S:SN9Y`R>)ITLK*`:&JZ@=*DJ7(I2J$ MD]01SAR9)X/[WV3<4W"RMXV1O"KK326TZE`;0:,P#:`:Y5A3H\71'Q!VWOCI M^NZOW//N'LCJK?2)O;%3BE38^Y=N;SR^V\F'RV(EIY*L-@)9LM4XW(-%$^2H M*V*".H+0Q64$[YS9=V6\1;O9A+?=8*1FA\16C1E`#8%'&E67\)`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`K*F/-4T>*E@R78OW-/.5J&-90K3B/5( M63W7NAOK.Q=@8^JJJ*OWOM*AJZ%:%ZZFK-Q8FEFHAE(X)L9]XD]6AI6R,-5$ M\`DTF9)%9`0P)]U[HJ_P_P!S8'9'QXV0O9.Z]E[;WYO#<'9&_=Y4%7O/;-5) M#O3LGL?='86?QU1E*6O-#D,AC*K=B4\S1LPC8(G'I7W[KW1G\GVCUIA*J"AS M/86R<3655$,E34V3W3A*&6?',,>17PI55L1DHR,O2?NBZ?Y5#S^['J]U[J;! MO_8M379#&TV\MKU.0Q!KAEJ*GSV+GJ<4<8)&R0R<454[T#8]8F,XF"&(*=5K M'W[KW3+'W'U)-`*J'L[8$],8X)?/#N_`RQ>.JR$F(I&+QU[*!69:%Z6&_P#G M:E3$EW!7W[KW4BK[8ZOH*@4==V+LBBK&AIIUHZO=.$IZQHJRICHJ1EI9JU*@ MFJK)DBC`6[R.%`)('OW7NGW#;PVIN*KK:#`;EP6:KL:`J@IIY)8`*JGDB)8"TL;(?4K`>Z]TH_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=:WW\V/KW'=2_,'HSYC1=J<[@-A[[K-[;;6K<9;,-F*'#T=)'5?PJM1F\?NF^C7=4=GTN9W M--_$:S)XB#LR2>LPFW-Y;EZ\I:_:W9FT*2KV[VCTOM3:V$Q^-W1EZK9TFSYL MWD\A439:&IDR$LU+5&B$21^Z]T99F52H9E4NVA`Q`+MI9M*@_J;2I-A^`??N MO=%QB^)'Q_BS57N`[&JJC*5V^\KV54S5V]=_Y"!]X9[,Q[@SU4HLUMC:U'B./T>_=>Z$2.:*8,T,L< MJI))"YC=7"RPN8Y8F*D@212*58?56!!Y]^Z]T1OY(=S[$VGM_L+?&\\[D?\` M1EM["U72U-)@,[TWEMM;@[)[)RLNU]RTU34[FC,NQ-[]54N(DI)FW#F,+MV2 M/,S0UBR.BO![K8%2!T&/4/:&\]D?&+M[Y,=L[9Q5#F,#UY69/!9;!==[R@R& MX:&EP#[@2*KV=UAF.YLAN>@H]T99:!DBK-M]E4DF3QXBII85"RN[>ZPL``H_`_`]^Z]US]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW21RF_]BX3(3XG,;QVQB\K31P33XROSN,I,A%%5 M-$M.[T<]2E0HF,Z:?3R'4_1A?W7NFV;M?JZGFGII^QMBP5%+5M0U,$V[,%'+ M35B2BG>FJ(WK@T,R5)\3*P!67T'U<>_=>ZQS=N]54YHA4]D[$IOXC3-6X\U. M[,%3K7T2UE'CFK:)IJY%JJ,9'(TU.94+1^>HBCOKD0-[KW4M.S^MI,A-B$[` MV4V6@J4HYL6-T83^(QU_=>Z7/O MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[J/5Z_M:GQF$/ M]O-H-0I:G#^-M)G57C9H0?U`,I*WY'U]^Z]T3KX6Y;;>:V;O6KPV+AQ>;IMX MPX?>_P##HQ#MZLW1A-L8#%3U>V((ZJO@I\`])21"DC6HG84PC9G?6)']U[HY MOOW7ND#VI5?8];;\KO&DWV>T=PU0AD>...4T^)JY0CM*RII)3D7!8<#DCW[K MW0:?$^>IK?C[UQE:RCCH:K.8W(9^IIXL%N?;"&HSF5GJ!M_>5%CMQXD5D MM6TPAJ(5TAQXVDCT2-[KW1B??NO==-^D_P"L?]Z]['$=:/`_9UIG]_=2]B]V M_-_O;9F&W?6878&-W;UYEMU'(,]1M+9X/4'4U.-PY#&4LD=5D*S?./J*W'T\ M,:O55%;@:=%M$"T>77+N[;7LW(G+M[<6"3;F8)%C%%UO6>>J!C4J(R%=N`T. MU#JQU@=S1L^[\P^X_-FUVM^\6U+/"TE=1CC/TMN!(0"`SRKK2-02[/$,4%>C MO]G?$Z7"=483X_\`6%?3XKK_`&MD5WEVAO7L$UV(E[`W>NRZ.FDVW)B-GXVK MH*V#8^TX7I*RKCE_AU/D99DF6>>)](&VSF]+C=[CF#=HO$W25?#ABBHPB363 MKU.009'J5'Q%0."XZDK>>1S;['!ROL]R(]J@D,L\T]5,TGA@:`D8(I#'16?$ M:NQ4]RL>B\_#;XS[CR6+WKOS)97%;/VME<53;9K=Z;SRVVMF86MK<_FJ>OFG MP>:R]5#,];CW@J*B00)121U<^F6"=V\H$W.G,EM')M]@EOXUZCLWAQAGE54! M^)5!4:J@G!&D&A'01Y!Y.NGAW/ZNKUMIN[Z%TN7M(C1@0=-9-%?M4`_9UD)[:V=CMR[ MY8;=,KVD5],H92"":0EZ?\W-7YUICJR#V`NI2Z][]U[H$L-TU5[>Q='A<+VM MV7C\3CHOM\?0Q5&T9(J.E5F,=/&]1M*:=HX@U@7=FM^??NO=.?\`HSS_`/S^ M+L[_`*F[+_\`L.]^Z]U[_1GG_P#G\79W_4W9?_V'>_=>Z;\MT]69[%Y+!YKM M3L;)X?,T%9BLMC:P[+EI,AC_=>ZD4/4N M3QE%1XW'=L]D46/Q]+3T-#1T[;+2"DHZ2)(*:F@3^YWHA@AC55'X4#W[KW63 M%]9;=VK)V%N7=6Y,GNZ'=^UL7A-WS]@38"?"+M3:T.Z)A1U=/#B<7BX\4:?= M-<:S[A7CDB?U^D'VW-X?A2^,%,6DZ@U-)%,UKBE.-<4X]*;-KY;NU;:S,-S$ MBF$Q:O%$NH>'X>CO\3731H[M5-.:=5%?R@J/%4.[.YX<1@]NX>D7!X&&A.V- MT]=;DQ&>@?WVWOI-BY`DO=PN;B1KJ8OX]ON,$ MBW!@B:Z+#<9)&1FN"^NSMM%M9Z5"KJF-$3B\QE*_YX_S.J78T&QLMO/8?Q][ M$GH.N=S;4W;OBG7(;LV1TU7TN:Q_5,&Z<'4;SI>X1M@T.Y%>;'4F7FPV*@P\ MI*YDO+?7/7204SQZ/A_*RW@-]_%+&;E?K_KKK6LK][;K_B6V^I-G-L[K?^)( M<<*NLVI%)NC=TN=IFD/AJJUJF/1D(*BC6&-*10?=><$,:G/1J/DQM786]N@N MU]K=H[@W-M7KO+[.R<.\=Q[,FR=/NO#8&%4JZZOV_483'Y7-4^5ACI[Q24=/ M+5HWJA`D"D>ZT"0:CCT'_P`0>Q>K>Q-G=AGIZN[3S>R]F]JY/9]/N?MK=G:^ M\,WN?(Q[+V+N;)9/"Y'NG)9+?E)MNBJ-S?PY*:]^Z]U__T]_CW[KW7O?NO=5+_P`V/-U^W^KMDY3&/'%7TW8?6QI) MY0S)2U+=C[:6FK7C26)Y(J&H*32!=1$:,VAP"ID[VRB2?<;^*1:H;6>HJ14> M!)BH\_3]G4+^\MQ):[;MJ6-^=@;ZZG[!V#\G=BU4V M'QFZMY5N(R^*S6YZ3`8+,]JX''QY?<-+G MHG18PQ>&*7-NL8=XL-PY7OP97C@!5D36PA9BJLBZ5`:&@4R,]%49)P>H&W;< M+_8]RVSG+;D\-)9RC)KTJUS&JO(KD.QT2U+".-5U.:`>0MNH?EEM;?/4>XT_&:FBK=W=9Y/!U5'CQ6S8SRNDN-@_O'A MPTC0:Y6C6)FY7O+/=+:7<(DO$A^*)R2D\(.FDV MMET/[X[4W;\=NWWJ]Y[%IA-48[-[0[1N-ER[O$\=Y;@1RD`%7*$.@8*6!;C3)'/O>V M[ES-R]"S4WV*1GE1HS$)5DL+G5+#Q#H'!C6 M"G_OO3K/4LL<$#8G/B6662FPM9!"B#%$M-44>XJ*6-!=W2H4@?6SB;'NKK(R MVA*K2O8JMYTU/C\?4"EKY9\9G89:&9J'`Y)%K*23%K64RO0[HQTBL\:JPK8@"2X'M MO]S[B9A`+>LIX`,IK4LN"&HX^@R<=.N"^0'2^Y\[B-L;>[(VOF-PYVHJ*3%8:@KON,A55% M+15>2EB^V2,R0$XZ@GGC\H02PPNZ:E4D4FV7=;>&6XGL)5@0`LQ%`*D`9^T@ M?GT_;\Q['=3VUM;;G$\\Q(10:EJ`L:?D":G&,=.NY>Y.K]G;@I]J[IWM@\%N M&KB>:DQ61G>GJ:I(Z.;(2?;:HO'.\=#3O*R(Q94%R+6]M6^V7]U'XUM:.\5: M5`J.('^$@=/76][38S_37FX113TK1C3%"?/Y*?V4X],.)^1/2F<\HQ/86%K3 M!%EYIEB3(*\*8+$+G\L)$DHD9):3".M44(#M"Z,H8.MW)=GW.$Z9;)U/;Q'\ M1*C/#+`C[>F(>9-BN-0AW.(D!C2IK1%U-@BIHN33RZP'Y*=$ADC/9NVA+([Q MB`S5/W`*23PZI*?[;S112S4TB1NRA)6C8(6*FUUV3=FRMA(5]:8\O/ABHKG% M17CU4\S;`OQ;K#7TKGS%:<:8-#3-#Z=39/D)TE"0L_9FTX';"IN)(JC)+!-) MA9,AG,4F0BAE5)98&R.VJ^'T@MKI)!;T^VUVC=&^"PE/?IPI/=133'R=3_MA MT[)S!LD7]IN<2]FO)IV5<:OLJC_[R?3INI?DU\?ZW[,TO;FR)_XED*W%8W1F M8#_$/29>;.6W*A=Y@U,Y4#5DLHJR@<20.('#%>/3S2]\].UE%49&F[$VU)04F8 MIL#459K"D$67K,'!N6EHFDDC1==1@:J*K1A=##*AOZUNPVU[@K(AM'ULI8`" MI(#:21=QB\-7"$DT`8J'`J:#X2#7@*BIZR+WMTP_G\?:6 MQ)/M5J&JC'N;%.*8TNC[J.H9*DB">G\JZXVM(FH7`][.T[H!7]W34_TC>?Y9 MZJ>8MB`8G=[>@X]ZXIZYZ5&"W_LC<^&J=Q[>W9M_,[?HP6JLYCLI256(@188 MZAI)D1L&OI(/M++;7$$O@30.LW\)!!XTX'/$'I=!?V5U" MUS;W<;VXXLK`KP!^(8X$'CY]9\9O?9N;EIH,/NO;F5FK&9:2+'9K'5LE4R4R M5CK3I3U$C3,E)(LI"W(C8,>"#[W);7,(+2V[JOS4CSIZ>O6H=PL;@JL%Y$[' MAI8'RKY'TZ!O>?QAZ]W[N3,9[<61WA/CL_NG:>^M"8*G0*REBSGW7NG? M?7P[ZP[$SO9&3W'EMZ28;M?&[3QN]=ETU?@(MM9!-E08&'`SP32;:FW/230' M;-#(X3)")Y(`2EF<-[KW6#$?#S9&*CJX7W]VGDJ?*9'=U3G(:S*[0IOX]A]^ MY3'Y[=^U,I/AMDXJI_@6;S^*IJN22G>GR4;1>*.K2FDFAD]U[I['Q3Z\JL5@ M<3N/,[RWC#@85HXYMQU^!>3)XJ+<_46YJ7#9BFP^W,/C:S&4HZ1P-`%6".2: MACG$SRSSO/[]U[J%M/XB=<;+BCH,+GM]'!OUIDNK\MA,AE<+D(MPXG*U&J2OCC?2A>)BI)]U[K&WP]ZMR=3G,KO/)[V[!W-N9 MNOFW#NK=&9QE-F,LO6F^3OW;TNWLUAVGG M9WKXJ7;U)CS!423T!HXRPIQ5.]2WNO="9UQT/L7J[/Y3=&VOXP^>S^.JL?N# M(9&MAJ#FGJ]T9G=SU]53P4=+24U7'EMP5>A:6.G@6*73XR0&'NO=#1[]U[KW MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JO3^97\4X/E M#\>JO^![?ILKVSU#D&[-ZER%!USTSV)V%1YW#T[/F,%U,._X:KJK9'8N]\+% M)B<;N3*03QX.>H6K6-FB'OW5E(#`GAT1G^6GW[MGY;?&^I^,/8F]$F[&ZXR6 M>I.J.Q(>R>P.TXMUTVV154&7CVA\AMY#KG.?*C>G4LN4?&=AY[95!C]FQ4^; MAQ-!4K"SE/=;?)+#X>K"OC'\?]Y]<[&W5U5N&`;;V#A=[9JJV)N;%YZKHNW= MWQG/TN1BW?G)]NUHVSU_1U6/HUQ0QF+\IRE!&:NJ%#+5U%`ONJLQ8U/27^16 MV=^[YIL+09C=S];=LXF*';/6.:BQ=/-U3NOL_=HSFZ<-/US5UU5E\_AM][?P M>P&IZ^NR]"*>&AK:BDHW3[V:H3W6NLN*[1^7>P]C;:Q\'4F?[TS&)S$]9NW= M&2J]AX2KR/7,6P$K\1)MNJVQN,83>&\\YOADIPU+`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`)CE0-=6_!Y]^Z]T$/2G0O7OQ_P M&1VSUQ29&@Q&5K:'*5U/D,@^0:;*4>$QF!ER9D>.,_?9.EQ,,E4_^[I[OQ<` M>Z]T,WOW7NDWO':^/WOM3<>S\M)/%B]T83*8#(24J4,E2E%EJ*:@JF@3)T61 MQ[3""=M(FIYH[_J1AQ[]U[I-]1=6[_=>ZZ;]+?ZQ_P!Z]['$ M=5?",?D>M:)LUB=M_+'LZLSN;VS75><[5@AV!UGNS)3XO'[LSNU_C[U3ERM]PI7[8Z[R='-#BL%G:F2OFV7MA,-E\9 MDMK9+`TN%PBUM578?(0K#X-,CR/(D,\IR[/;[%M$&U;>4&[7*_JS"AJB@"60 ML&#BI>FF1*DMCU6%HN8;GF#>;O?-P+-LEI(#%`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` MRJ\-5@PV6B<`TJO-H4^ZTM:B@ST!G\M'K).I?CME=I0QY**E?MKL/<5,F=VO MV!MS/J-T5=#G:M_=>Z__]3?X]^Z]U[W[KW52?\`-GQ]9D>K-EQT5:*&9=\; M/9)7ERU*DLR[BII:2!*W#4\]?354E9#'X3%ID\ND@\$&3_:Z1$W6^:1`RBWD MXZ>&@ZOBQP)K7%,=0G[U122;3M@C:C&XC`^+CXBD"JY&0*$9KU1QVUBLK'@> MMNCMJX>:OW34;A;?.77:^3R^WZDU^ZZ" NT]OYVIIY-JYF6NHJV<5>(JLG M25$\KH9W,L@2"8]EN(#>;EOE[)HLQ%X2:E5QI7^T9@"L@`HH$J*:`'0"!G'[ MF"UN5M=DY?L4+7S2>(U&=#W@^%&DC`Q&H9B8G*ZF(#'410_G7OQ0@^.716>R MO8^6H=K[)V_-3[NW]OC+0TV$VHN>-,,5BJ+8V%QM534SYH5.6-$K4$*U&4S, ML!I6)IX9F`-_S1)S%N\,6TPF2[D!CACCJS%`2Q,CL*A30M1Z"-`=1R>I*VWD M=>5M@NI]VE6&SB(EGD?L42:0J+''J(+=P2J$F60C0,=%FWAM;O;=/>W7'9_2 M`Q.-%2 M[9H'62XFF62L)MUHULL,: M1$S,X8N2`#ZA6\M.8[SF3;]SY>57N[:.9(!<(\5M!;O&5N#V,U3O2S462C1*R.CJHIJF$1M&)`WN6U\G?52VT4LDMAX:M M%(KP*=+95)%%JK1R#@ZU*Z@0"2"`*]MWCGPVD5PRQ0;AXC)/%)%<&C1_')"Q MOG66,@@JPH^D@D`$$@_W?\X_F=T3E*2/%ITYEME9OPU.TMTY[;_9N+Q.::_6_C.F2- M'B8J3DL`(*"(DX;4*U)"TKT'^8_VV2T,4LD5PJD#\+5N=0F' MXT"MI.FK=+6/YF_*?.;YV=L\YWI]MM;TJML?PK<,FR>UL8'H=T8K$PT]::>N M[S7%P93%QY"$U<$U6L-/!I42V$1*'^I?+,=GN%XJ7OCVX?4@EB8ZD9BTYMVBNHYZ?N%THJG#TE?4Q_=XVG[6^YHJ>3'44CU3F$ M/-#J^R%:RF+VL?D_EI+2UOH3?/%)X608!76J?YC?R)W'69S+X?;O3>W-S46 MSIM\8_'Y2E[&_ONVTZ7/XVGQF3R5;ANSLK_OV-[T67DJL)4T7W/YDBM; M&\3:-M5[KQ550DNH^'H1F[)G\1')<%8MH:%]W>T'8AO$FY7L;O`9TC)BU.BU+T.@4,>DZB<,11:XZ17ONAOB\Q/L M4>S64K"X$$D@$H1&8A4-,%DD8]FDEJ9*YR(NROF)VEV)O6FP7^ACXWU_]WJ/ M(Y=]TYFDW144F-P.SZG+9O'Y"DEJ:Z"N3$0Y[(N\,T(DHY:BO,L4NMV!0W_) M6R6%B;EMUW!?$=0$4Q5+-I!`*J`S4"UIE0H!&.EVW<^Y]074QHI!!+&E*TZ9O]GTW_`(S8N].SO]E[^-5%3;:J\9E\=7Q[ M0WRIRF_LU74]*OW>3QT637#U5$)V6>NHX\K/$L*>:-`T:.Y_439YMPM-J&^[ M@TLNI7&N,TC0$G^&N1VJQ6I^&O'JD7N%O$.VW^\2\O;4L5NRL#X,U2\C:/*?QC+X^EI:.):VL\]0ODD01LWM#9['RK=Q7EV_,=U#9VY5 M%)0/(YDK1$B2YU_"I9B:`"GJ.C2[YBYM@N++;UY1M)[R<-(RK)ICC6.G<\TE MH(ZEF154,QU-0D%2.EGL3YC=]Y[K"HEJ>GMJ[+IZRKR&'W;U5NC-Y['5&"RF MW\W_`'0S5'6(G1]-@L_M^"?')#'DL4:['SQK!$&C=U7VGW/E'EF#=/IUWB:= M`BLLT:(0RNNL$`W)=6H3J1]+*0:C'2W:N>^9YMJ,J;)!;$LP>WDD92I0B-JD M6NAE%``Z$J10\".@4W]_,)[6^/\`F1EJ+XO=;R5<(3)X'<^&W_)@]NY;9M1+ M6TM/O6FW/5=/4^,HZR6B1_NL96-'5TAC99@)8PQ-]MY!V7F",Q'F6\4`T=&A M5W5_X#&+BI6I[7':U:C'0=W/W.WCEB9;E.4+(T!,#M3*#;$F(W'C*?,;=K_`+ZL MZ4-%'+FDJ8X/M:J>ALT@\-3+9S&2GV\Y>&W7E^;^]$D*L6C-M%KJAHZD&Y'# MC50QIQ`Z$0]VN:#NEEMO[LLRMPRA9!GHI)*B6> M&&GHH-$BRU/D`52OM?RZT-M=G>+LV\A112VCJ6D(`6GU63D:`#5B=-`13I%) M[SV*C;VV,CN^:@S';^S\)F%PU!G,/BS692FW1T&^.PF-R<&?CJ,15U$R M4^5AI9DC;RJ-9KN7LYR_MDD*3;W.\;S+'J6`LNME<@*5N06*Z-,JJ*QEEU"E M2"W;/?CF;=4N&BV6"-XX#-I>Z57*!HUJ=5J%4-XFJ-B0)`K!36@Z4.Y_YKOR M%VWLZ/=G\-JZQIX(J]_;4VY5TTN*>@>:'=$^;^)=-2=93RT&2@JH8-UO MA*JKBEC6CBJYG6+V6VGM9L-S=BU;<98U[:MX6L4:M-`2\/C9!!\`RZ:$OH`K MTJO?>CF*ULUO([%)*ZNWQ]---,N6L@L-:X%P86;\"N2!UAE_FV=_4F'P^1J] MM9R@K-Q0Y(4&#W!O[9N!SF,&,.W(VS&?QU1\5GFPVU*S(YB>EI\H%JUE%&TG MVZ^51%L>T^Q-<7D0W:0Q0E0SK$S*=6HA5(O,R``%HR1352M5S[_7MYDCM+.X MEV<))-JHCSJCKITC4X:S)6,LVE9!JK2M`#C!E/YQW>&W>QTV#6[2HJN1-R3; M)S^9/;NS%PVRLH$^UP61W13O\9*++XK^^]=I7#HRNU>YD*0*(VB]OP>T&S7. MV?7Q;M."T(EC3Z8ZIEJ=0C+7>DF.GZAJ%3%3FO3%Q[]69_)\=:*HQ44U$&NV3-+&TH_R>6IA9)6*[CVOV2"Q%\^\3A-2KI$" MDZF-`!_C7VL%AXLUE,YF*;$T6%BR&XN M@,?CL;Y#5"1*FI\<,\<;M&S*I/M9'[6;)]=9V)W*9IY2]0+=F**BEBQ6.Z)( M`&:!22#,97,=H;9HL2V::2K2BPNWJQ_C@4W/)5+0RM)44MX*:P M\C%7C=Z[C[:\LV!C5MY+2-D*MNY;3CN8?6`I2HPP%:XX'JVV^\'-VYI*\>Q% M$CH&+7"!=9J=*$[?1\"I93I`I4Y'2HW1_,I^6&UZG:&WZ/X]93>G8^]FW!58 MGK;;7:NS_P")8_`;4^Q.(%K&Z6[/',K*&22)A>U(8&M"`5_$.'3UG[K\TW M>VIN,>U1Z->F16N462!@Q1DE5K%=)##!RK?A)H>@TW3_`#E^V-D9Z7"9_H<2 M3+)05:R8SMK"Y6E?;>1KLA!2[NI*B#HZCHJK:]11T_W$3I52U[JJQ_:B;R(% MMI[.[9?0"YAYC"QTIW6T@(D`_LF_QHE9*]N0%J?BH0>BB[]^-]VZ[:SNN6BT M@H:K4I^F MIL-$M13TTE3#*:@Q)#_P)-+(4CW7^LAT2%>[Z^V[2B[/\`5@%HE;^0+3DX[?;R[E'=22B824C:,1NBJT?ZFMAH->^E: M*37NT]"+D7W0O^?9-SF@VV6T$!M]%7636DDCI*?#\-"673VX[B!I.D-U8/UA MW1C,C4[WIZK(Y[/R;9KJ/$5F(VZ:CMA\)G:2&J.?P[[AV-M44;Y:@G$<591- M-5/1U*E/(K,84C^_VR6$V@:-8VD34-8\$E:X;0[5*GBK`+J%#2F>I-VK?H9O MKJN\GA2!&$9-P%>E6C\2-*:EX.I8Z3BM30"WA^V]A9G(08B/-28O,5/B6#$[ MDQ68VMD)III3#'20T^X\?BVGKVF!7P1ZYKC]-O9>]C=(I?P]4?JI#C'&NDF@ M'SIT=0;O8SN(O$:.:OPR*T9SPH'"UKY4K7H2?:3HRZ][]U[KWOW7NM>'^8?\ M+^S^DNW:OYW?%7-C`[C,N(R'8V3SVX\MCZ':-%L^GCS%'E^S^SXZDR78NXIXJ.KD:"?5![IY&4C2P_U?Y^C[?!W^9#U=\L M,/2[8W&:KK#NRAQ>R2S-/L_<7=&P= MDU>\\?L.JRM=NW![9JJ:?(1".1)W]U1D*]63.J2(R.JR1NK(Z.`R.K`JR,IN M&5@;$'Z^_=4Z*9WQ%TM\=>ML]W3D=J9?&8_9,_6,E/ANO<_D=GQ5U7M3(#9O M6&V4QF/SF#V['M:BK-U"FEQ[Q''24[@S4U1X8D'NM@5(%>HOQL@Z-[UZBV5V MQM[9V5RN+S.)AV_#3]J9O(=BYFDFZW[)S.9I:;(UNYLYNB++5^U.R:&HJ\=D MI7:NB>"!T>(10QQ>Z\10D=&_^GOW6NJ>/GG_`#1]H=)+FNFNAOXEV;WG5C>6 M"R+[`CQ.=RFRJG9VV\/N/L_#=<4>3HLMM+LOY9=6];;OH]^X7JK)-056\,'1 M3BGF9@(I/=71:G/#H,OY97P#W;@\WB?E=\H7Q6[>SH,MN_=O3L%129#*XW:V M8[0_C-7OWOWI^NWUC<;W9T'M?Y/;>W3'DL_TUG*BMQ6T=S_?3TB4[3I!3>ZL M[#X5&/\`5_JKU>I[]TUU[W[KW7O?B0.)Z]TC,CV#M#&5\V*FS,53E*82_=8W M$TU=G*^C>)(G,-;286EKYJ*HD6=/'',$>4NH0,6`+RV\[`-X=%.020H(^18B MM/.G#I#+N5E$[QM.#(O$*"Q'H"%!H3Y`Y/D.B_=W]\TFU,9M&HHJ_=^V\;G= MP5&'RU75;8?8U93Q'&5=723KNSMC"8_8FWH/NZ01N:]TDJ!($IV\H"L<[1M$ ME[-.A6-F5-0`8R>8']G$3(W&O:#2E6QT']\YBM[."V?Q9H8WDTDF/PCD&A\2 MX58D%13N8:B0%SCJNOY,_P`QSM#XPT^P<[F=G[IWG1[CW_O;952E$N%PL]=M M[`8O:%/MK*4&U4VON'-UFZ:G*")P2&<:W+ED+ZD%-"50'N.H`Y5NHIYQ]T]VY-AL)Y]NFG\6YFBXHI M*1B,*P30[&4L]7H/#&DT(UH"F9?YL_;$>9Q6W\=T;AL[FLVFTYZ.G@[DPQQ- M%C]Q*RU.0RN>H.HJJEIH\8\D"ZPIIZZ26]+(T0U^WQ[7;7X$L\V_ND4?B5/T MYU$Q_@"M*V'+R&XD\&@-RND++^)G6V8`#&::&!JK M4Z5]9_,[[GH=^[NV#6])[+HJG:&=S^-R&9E[L_W'QXG:U%-DL]N*JITZ0GR- M!2TF/1)HXO!.9D=CK7QM[2CVVVDV-GN"[Y,T)Q MV"^,5/A:W(19')5E5E>X*6JVGB]J8R415V[?](&$Z7RVR,U%1F.4?PW'UU5E M3)&(_M];HOM?O/M9LVQK,]US,650``+C?]^DBAM>5BCL"Q+7*F-8EIJE\5;1HV`R-",TE005!H.A:[)^=OR'ZYV'3; MVS'66+J\ME:G`X+976>T-_S;@W_V3O3<]3)18;:FU\2_QU'[KUB.)LA4O28V MG@B,LD@-T]E6T\F26<>XR>&BL\DS04BAB05:1V^L]*44`L2:4\^CK=/ M_3.^NQ-N46_<1BY:&3(X7>T,]2!&CR.'JJV M.`";S!6@TR*=RY,Y8V][22+<3=;7<#]*YBA8Q,:A61A]7KC=2?A=17%#4])] MI]P^;]T2_1]J6VW6V-);669!,E5+*RD6922-@,/&S4SJ`TU*([%_FB=V]9PT MLE1U+!N9EQN3Q4J*M7)F9\31115 M---'4S1S>E=8>VFR;KXGA[HT#)36&A;4@/!ROU9+*WEH#&M104KT5;G[PVZ/;.T=V8WK'9V6 MQV]<='ES?DL++<(MEMWC MN$U*!="H[F1E=OI2JNC*:@%JC@>H^]/YHG?NU.Q1UIE>O<-051R6+AI]Q8WL M>FK:;(4F:QU%E9)$HJGXYSST]5A*.N1TH)$CK:N]HQ(2![;M/;+9+G:1NJ[O M+0JQ*-;@$:25\KP:@Q%`P[1Y^?5]P]W^9MOW@[/-M4.H.@$BW`96#@$FGT/: M4!^$]S?A!)'0&[/_`)RW>._]_P`77>W-A5J9D95MNU-14]F;"?'S9QHIYJ8; M?DA^-50^X\'XJ9OOG;7H,V/O\`\P[CNJ;3;['2Y,C1YN(J%QJPM+/N4:>YAA*BOD2L M:?\`G$=RKM23<3=?8>6*GRN,I&EJ.QH:M&@RE-6SQASMSX\5\M:57&SE,C04 MU1MJ0Q2`9>T4C(D;V>VIKX68W:;()J(56E&"FH:Z%"-0)1],M*4C)QT8#WZW MP6$EV=CA8HU&K.3Q!8$%+,5%`0)%K"3CQ?1/8+^=7WGG=JQ[LDZ-3%X^2JPN M/-*W85%4Y6LKL[+E)*6GVBL?2J8_?OVN'Q$U;52XJ>HAID1T9B49O;UQ[*;+ M!>I8CF.1Y&#D$144!--==9]4=2P50R@DT]1TFM/O![]=637YY8C2%71,SDEB MQ:OA4@TRZ%4N^EL+\^F_??\`.F[NVS0T);J[&5^3R.T,1O,X?:7;F"JP]EMDO#(1O\L=NL[P MAY(#0R*%(3LN&(>34!&N=6@QGC[$VY,U5_>*/&34TL%% M2_&&JR-<6CS$4D2PQ:#"I$[TT]H2F'M5R[]//$DIMDX_*Y/(SSMCNBZ2$11P8*IBAECEC@$Z6F: MQ*HG/MCRX+2PN#N5R);GPM$8A&NLI4*!JN*U[JD<:`_;TJC]X^:?WCN-HNUV M[P6PE+2?4'0!"&+,=-H>WMH"#EB`,])CJK^;_P#)WMC(TV,PW1^S*9I5;(U. M9C[;KLYMFEVY#&DE5DH\OA.H*F:ORT;3)'#CHZ=6JW)"3!P8PMW;VFY8VB.2 M2?F&Y9U-`GTRK(6]-+7``7U?4:<:4K1!M'OES;O,ZPV_+MJL=-1D-T[1JGF2 MR6[$M7`334^HZ%O=W\Q'Y;[=V7%GST[B?J>FX=N[-P<=!0U%5+D\E,E,(*>?3J:)])):X\2)E)'Q#2U10YZ;MO.\BEV98-RMG`:%IRQ97! M,7';`PM)M//XI:BG\KYBIAH9(JG5"\C+((5EG[=F_F^][0;8V-NG^Y'5F0P&Z\6U9D9\/N?>.1R&&EI,Y8KK0U7*]/F[OY MH'R4VMVJO6L^T^JZ]ZG*8FDHOJ?KS8= M#E$S=9M&8C?>Z:RHJ-T4U!75;2[8HDI(WW5M;&5%.M/E:Y#3OBY;F6(H\;$\ MW#V@Y?L-O7UU(%.]-(U`@^"TJW%2`8ZU'1@GO-S>=L>[@L+=KA):: M7\=@T;`G4OAMK8*RD>.L9MC0TESTF\5_.7^3.4V4V[*G8/6]`]/D,#BQ04S; MDKURU;F*7(54M5L[(IV!28??&$Q<%`9:BHBJJ./Q2*8FF72[+Y?:#ER"^2T_ M>=RP9'>M$#*J_P"_%,),3D_"#J%*U(Z1Q^^G-\NWO>?NNU2171`M9'U.ZL1X M;"?3,H"U-"I-10$<6CLK^<3\NME4V,H*?:'16YMQ5>P=M;]S^!V_D>S::OP6 MW,PE149W=<577[BHW&R-D4,)7*Y&JAHY8*PA/!HCJ9:93M7M#RI>O.\FX7\5 MNMQ)$K.+>C.M`J55"#))74B@$:2*M4@%C=??#GBP\.&*QVZ:X:".5E4W(*HP M8LY+2C2D8`$A900Q(I120M\!_,G^8NY-X;=V-!0=0#+;HW-A=LK/35/]JO*[E3*]ERT%9@]GT>=,"QTJ[ MOJ(HZ:>Z$05/T-6N1E!/]D*HB MDZA0$,,GHP'N+S:)]X2>ZMDMK/Q6=_\`&:%(@U/]%8JSD*%:I5@U0/,H3I'^ M8U\ONWLI+`V(V+C<9C2E9N3+8_'H&\LD..Q.;BSU--N'=^2@6,4V, MFH<:))9&T5$B0RA#7?O;[E#942DURTSX1"L*LS4XL#&0J*2"T@9@5Q2O15R_ M[I<];Y.5:&VC@CH7?7.R*N,#3)5I&)"+&RIW5.K!'0T=G_+OYC;/V=1YG9\6 M)W?O+.\JW?M'@NO]IXS;=%7U8K:YO\NC MIT>!279$#VV\L\I7MZ\-R[PV<<9DDDUPFBCMI&@MR9'+T72!05))Q3H0[OSG MSW8[?'<686:_ED$44&B<$O\`$QED,X2-$C!?6S`,`-)XTK?ZIJ=[_P"S(=T= M_=[;L]V[NK,_A>V]E]D;%I(:[ M(QQU^/K8&**:3-X7;TY9V38-@GEGMK8^)"U%+7"S,ZR":.,*T,D, MK%$)1DT-56R:1?L\M]_6KF'F?F2WA@N;P%)ERHMVA2,Q^#)(SK.D\2J[CQ%8 M.N<`%C#]T_$OLKW7D4+/NO`;[3L*FVO/03;I5+(FC*EM(#-7^,U M%`#L%N9]KW;;%0G<8+KQ@N@H63PV#MI9VDU!P"Q*J%SV+E>KX?Y05E7R:B;_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z#KMW=FW-B]6]B[QWAA MI]Q;3VSLC=&$Q3LM.X""9G>,12RRJD,-(OAN0U8U:04JBEJ`U!_P`IJ@AQ._.]\929F'.8Y8H, MA@0 MB>2,?;@*EYN\*R:HT':="(&0RN`XT.]0Q4T!-%55*`(XZS>^^6\MQRS[W-[TFV-HSTV%F[0W]FGV5C- MM;&BSRTV>Z]QD%5-+/4SSVF59)9ZP#+5*XX=6(_"[&=@;:ZHKMF]L[YV+O\` M[*VQNK(0;HS76^W?12S-9#[KRFA!Z*W_*DV;O[8OQ7;!]G8#>NW=YMV M7O+(Y6CWOMFKVA4R_?4^$DIY<#@LCU=U/DZ?;$$"K2TLE50UE34-3R2R5DK. M8X?=>8U8D<.K*_?NM=>]^Z]U[W[KW7__U=_CW[KW7O?NO=$%^;N/H,S6]!XG M+5\&.Q-1WMUA79.KJX34TM/1[?RV1W+([P"2$F:5L,(4(;4/(2HU6]C+E*5H M%WV9%)E%A.J@&F7"K_EK^74=<_1)?PBG59_966 MZ+^/V^H\QL3[OL+N+N6[*W738_'XS$5DV9$Z_PG;N)J5C>NH8\/'/Y M*JCR*TL:0R>,$RCV/[!-ZYAL%MK]Q#L\>B)84J"X`X,Y':K5TX9226S2AZBG M=9N6N5=P^MVT-=U\'E-OX.>FS MT&\>NLC24V;KM^9C#Y2KWQOO>T%0^&I:;;.*S6,I(LAG5W;3PP8I*"FTTDM% M''!$8AY4CN]VVXMYY5,!BW!6TB)2`D49755R"2$,9J=1[@U2<]2QMV\V=Q:6 MS+=^/MFG49V0EY9PP0")645D$N$TKAUHJ]O1)/E-C.B?B7LO&X/$9BKVKMN> MMJ]^QNR-W5%?D!N7=NZ\EN/(U.6R>+QF3RE8V2R-14BD@KJQ@@4 MR`Q#3EB;?>;-PFNFA6:Y"@`A5B@AC%`D:!5"J2H"QI2I`J:T),>VV;A#8[I) M?.4L9#)%)`[&NF,I-!,M6U>&CCQ4.590RMI`IR^7%=U!N'"-UWV[CX]J=?\` M96X3F>ONP]F8VEJ*K:&Z<#2I55=/_#<5FJ>FRT.2Q4[U)S6$6.JJ\,[P3#RQ MAFMRB-VANEO]HD,NXVL966%V(\2-JJ#J(JM#^&3"L`0:=>Y[DV"ZMGVG?(O! MVN\DUPW$0!\*5*:JJ&SJ%"9(LLAH:%>BI8;^7]W/E>M=S;4;+87?.T,;)B-^ M]-=A;'W#D:VJEH]R+3U&X-J-LK<>4R6X*;%YA)EK(HZR1HX!')$$U3ZD%C>X M&U+NEK?&,PW+`Q3PO&-(T#LD+JJH64BG:*DZ6+=H'0('MCOEQM%W913QW%G' MIFM9HY"S,)"-<9CD9FTNM&JY(I50N:]!3W;U%N3`;IZQ[@FH\IB-XY#%2['[AEF%.5BJ4994>2-C/9MV@N;3==D M9Q)8!@T3`U"QR]RJ30M6-B:`BH[:U(%"+F#9KVTO-FY@:(IN+H4F4K2LT-%. ME:@:)4&6X'-*`Y(9_`Z3HOY`TT^4SE$FPMX;NR;Y"KS4\F`S^X(^V<&,3#M/ M:^U<3/C\KL7;>R:[>LEQU,D@+=2)B3&ZVL/+7,T)FE3]V2S$58Z)9%N$95CB0 M$-''%XN7!$3:-0T3H@`DS[/S&/W#NCJO+4]#C@I-K[GVU M5/2;BJ\,],V+VUUIM;>&-KJ['Y&MVC19?,1UP@;*YFN&37'+P$;H=# MNI`"0(Z51VMDFD9R@EF2>JR.'3:V4H:NH>>MPD<<+-&QY1;LLF]2220*NS[9$:*0H1 MTM`TA$NA6MV=W#,S1_3RJS:Y(P%H`MZ(Q^>SF]=P]Q9">FKLQM;;&Y_[L[LP M-+5U&-WEC>S(JBDFVOE,7EH:I=I;EVA!,E75UF06#=&0IXJ:.HCQF-6@=C7F M"2WM[.VV1$/TTLL?B1N>Z/P*$R*RY9)`--%)C#:M.MPW1)RS%<76X76^_%-# M!(8Y$0E9C/J4HP:HC>,DL7=1*R:4?PH0E34[6V#NFIV131;,PU1G=U=V91L/ MCZNECAS*3['P&>I,GDX:J`-3TTU;GJRIA8S96>JFI(H&,<[H@TA2ZO[+]X_X M_*L5K9+K*G`\1UI6I.HT%?A`%6S7/0SV_:MPCVIOW;")+S<6\-6TZJPQD,0= M(XL0/[0FH496N14[-^'?9%-#MW$]C9A.I>D^N,?B\A4[QW+DR,10M7;AI,1E]TY]9%Q.-%+DLIFLO5!9G*HJ21UO6V[T;NY2[G>6[=_$EC M!;3FI$9(H655KJ>H5%K3-:2WR[NW+JV5N]E:)!M\<7APNRJ6Q0>*HJRAY#F. M/27D;B0*#HFWR0BVWT93G%4O9FXZ+8NW\_0XF7?W8^]-Q;X[:[0W7!6Y&MW) MDH8L#509LT&/S53D7E>CI:/$4574-2@0BHCA0<)ODA>3;XWOY8ZF*!$BA MAC(`C&0$!*Z:`DR,JAJG23U''-R6W+L8A7=)5L89M(FN)&FN)Y1J:0]IUE=0 M:I"+&DC:1\2CH3?CK5[8W5-LS>U7O!Z/&=:TN=WQ@]SXW)IN#J3M#:68H/[L M;^ZTWQB-QQ5D&W<[0XV3'325,RTF6P+T"K*RT*,CD?,4,UDU_:QV9\29TB>- MAIFAD7OCEB*D:T)UCS637V]QZ/>5)K.]_=VXR;@?"MA)(LH;7;W$3+XCW1U7VOL?,UV8.\-K;GF@RF0 MP\&7@RVY<[-4X9Q%-2M5T=-3QTLL@2(2Q1LXFFYZV?\`>R74"K"]PI2>"10H M61<5(TJH%*CM)):AKBG01B]M]\_U]+@# M231:TH#_`&AA,SC-W[/[TI<54XZ;>M;EH-X8&"BJ<33OO_:56<3OJE@QDSU5 M-!BMQ[8H4F>IFDQ25E34SQ/4+$'4&&SWL)2-^Z,UKJUHY MI45I12!7B6;Y9SPWFW\Q1QT:V6B-VZ)$%6P`Q9U).:$>VMM,]7 M?(Q5> M^-EJ#B_NL?'68:MC>DIL>\BWE\N[\L^)%&6O;=0XA"I(J-$0TLLA(<.TH61- M:KKTR.LT=&9A&6WV3[1S9X,Q5=NN&*-*"Z-IF4K#%&"R-&L9>-]!?0IC5H9* MJBE=46VS=P;XR$]9-5 MUFS\G1TBO7PTN7Q]=2?<2H[.T@VH&.:27<-RF5"Q;Q%$DW;&GB4=G6%=(2.X MC9A0F&56IUZ%(I=W_P`9@6/;]L@9@E/#8QP@R2/X6J-8WFX&6V=%JWZRR+K8 M(CH7:&3S/9FX^Q1])D5-!.F6$Q:?%1M.JJ M/7$4194+DRLX:B%'+.VS7>Z7>ZS"+Q(HV?6JZDFUZA$Z!BM'1J$O(49P@6)5 M/P/AOVK MD,QMS;67@K>K^E^O\GAP$=;#EI>PUP$%6:>@ MQ_VE9YEFF1FC2*%5+]KYPVF!+NX2EWO-PVF.)5#%50FNOX-&H@,6!'D>C+=> M0]]FNK.TEUV7+MK$KS3NWAJTD@4ED'>91'4HB,IJ"PJ#QLS^/FW?CEB=F;=Q M>QQX7QM))AZK-T4&GC51+'W,%QS%->W4^X7#O=RL`Z*U6T$=D7B9.K234@40"M2>I;Y5MN48 M]LM(=MM47;X(V\*5Q1/%6FN81_"4+YHQ+NY*Z0*#HJ'?6)I>KTFQ.]ZK)9# M.JI?/--I*N:)TVN*]BM;4:YBL>H%HY;:1'UK5=/>C#6'#`]E"C$*O1YR=;2[ MJ^WR7UR0EN6D\,Z98KN%TT.`]>UU8QLA##O!5U!<]!K\CNC.C.P-O9/8F$IJ M3K/<*[P.Z.I=Y]G9.&KV$<576H=S]9U6:K<-(-E5U;FY:5)\+F&GQZ3EJNGE M`JG0F/+F^[_MES'N;GZFW$?AW$<0_5U#,;N7.6M MTM9=K@`M+XR^):RW!_2TD_J0ZRH,5>VL1^-_=^%ZSJLAN[:N M[\)O;I*IVO+B=[XW%193"=AX2"&*;9U?3Y+"TNV*&KJ]I9>GIX8SCHS)-B8Z M=Q*;:%/!S)LDFXA+&\B?;[]9`T;$AH6`_4U(S.0D@))JR8,;@-VTO:N-Q%`=G=Q MXO6!5HI*@U`I)!(II0MVC4FI5J"2&J1T3[H([;<(M[6V_W6[@KK M+$5(TE@8KB-A4D(-50P5FIA2E.A2_EU;"PW7$?R@SF^MQY)9$UV"ZVV?A9:O$[7V5G:*2',?Q_=K=E8W!4U6\:Y/$XY,E2022/3T=7(7>X M^YR;E+RK!8VJ!8X#)#&P&EII#1WD4U&E#%)(P)9&8QDT!*]'/M/MPVF+G&>_ MG;]258YY5/V-D;5WW18BHGW)!CYH*..EQ&3Q^-K8R MLU-&[$>XYVB&ZM]Z%WO%NEWMDKE)7:$.J.<>(\CH6`1B&:.NR^Y:+);1R.Y\]LC<69Q>U*)\=D<#XD?+?+ MS9-NJNR\BN7BQ5534%'O"JJI/O<=!DL;)D=O_P`<-;#235%%6C'9&DFG\:1T M=9C)61GI)5%&">9^5XXH?WIMZZ8W%='S#4<+Z:2R$`DDJX\QF1>3.=IIKC]R M;K+XDD9`$M#6C*&C+\:A@'4OV@-&V-)J+3@;B_N.^I<4E+5]];MVK#\J>ZME5T"+N/%_*#L;HW;TVQ- MO[BJLA-0;5PU;+'CZ2EUL_OW3BR$8/#HH>SODM_-)^(&6P6`[]V/2[@V3D-Y M]M_B!\1^LL3M+'UN49H\ MKOC)CRRU"F.-_=6/A$DU->E-#_/7V/N+KJGQG>R,+O+ M`;IP-.FX/@5O/Y\;JVYF(MT;>P:B/:O6>%Q>)JO-&QER.:$FA(*:1F]UIHC7 MMX=3MU_SLL1LK8F7P/07Q6I8\IMG9.0.Q=FY?=]-A<96;B3^7YL_Y_\`7NT, M?A-G[6R`:/=O7E?F\'3I33>;^)X-72-XJQ#'[KPCXE\#I$;IW3_-C^;&L>U@PFW.G-T;NK_C/ELOB\A5YFDW1WG\?>O-W/LK&=AA*#-UN MVJ.GIY(XPEC[JK2,:CRZM2]^Z;Z][]U[KWOW7NJ[_E)\G,OBJ'^YG5]93ID, MUGI=E/FX*AFK3D5QF8S6;R&/_A]1]_38+:NW=M92JJ)T59ZV>C\$#PH?N&&/ M+O+XNG-U?H1!&GB$<`5U*JK4CXG=T4#@-53Y#J-^;.;7M8?HMJ'WG@\CF=G;1B&,QQJGRF^]V4.+SVXYZ2*@DJJN@BBHF_P`GUB0;[GL,-E>V M2;E$8K&Y2!G;X5,;*LDE"0*1IJ2'56BMJ<`L*B--GWZ>]LMQDVN<37UI-<)& MF7=95)ABQ4ZI9"DTS)I)*!8M6ACJ%SJO,[2Z[V\*'MW+]G[Q[>WO55\M=M;? M/<&[\!NS:FUZ9)OLZ#/[(RF\L9MBBHL_1X]JN>-<;0X$35L>.>>JF"QN6;Q] M7?3R?NBWM8=EME4!XH$=&?%2LP1Y'()H"SF32I;`J0>;')8;?:PKOUQ>7',5 MV[,89;B19$CJP&N`O'&J,!4KH$19@F6HO1&?Y@?7F.W31]#U7660FPVQX.T] MS;>QV'SPJ(TV)0YC:U+4]M=`ULU:TV4HMBY7;VU(,GBZ"CDIJ6NPT]3C?NH\ M-%"\`]]O-Q-I+OZ[I#XEW](LA9*5D=7TP7*D``R!I#&[,"4<*VDNS`QO[H;/ M%>QWB\>-%<4$*O&&N;1JD:8F2$21J&TNCLA;PT5E#CIO$+5[KWCW M:F'B7&=>_;T>U,148FDJ(!NG)T";2Z>VFU-$FN3'TJ52U:U5-2Q338^FC1ZR MJT1.ZS>KEH[.SV9I_P!:YJTA#8"@ZYY%I0$D=K(25UDMH2I`+-@M7FW+<.88 M[6MO;BD::02SM^G;1$T!4*`)`X`8H`I=J=.W^@'M_=765!2=:[8S6:WAWU79 M_+[XW>,:N$P>U-H8N'5E)ZG=F4QV5K*.OWIG9JD5)^#(:O"S_X3])=3=8]=R[%J,7M3>&\:O+8^M[BW M-M.HCDV]7U-1_%WV5MY,M28>@H=WY^A%.0M-2$X^)3)6//*2K/&O.6][MNNX M+N!FFAM-/Z"2$EP.W6Y5B2@>N2E)N)MP;[=_P"&[?V_U)TK MU9BJ1]JX<028OS5.3R>,P25E/+G\A75E5D*FOJ9:>F5)%AA-^6&M-QCMX[G9 MUB$:K%Q=Y[J?4'--6`"P4B)0JJJ@,2*U)N<8KS;IKF:SWQIDE+RU"I';6MOH M*(:KQTJ6_4)9F9B5`-*!+TMN'(]M9+`[,3LS&[?RV3RF+_N9VYMK&XW<.!BW M5U]GI:Z@V3OC;%9(&K:&I6[R;>9;3;!O*Q3R%1#=(!(K20,Q$4 MRM0D4,D3`-&2C$`D5/1H?E9A_COE,)N3;>ZMHTNV]A=C4"X:FWIA):G);:VA MV+612Y'8&Z,]A\-2U]0-O96-XJFERN$D>%Z<2T59#H:(R!;EJ;F(3V]U97/B MW]L0WAM35)"#25%+'26!J"L@J/C0\>AMSE:\J36US9[A8B':[I=/BK\$*6IH\LL!B'DDD(D:^YUV=C'N:W!MM MXA=4D@FU++)&_P"+)?68^W2^H*4J.HFLO;K?HTEVCPDO-CFB9XKB`*\44J$@ M(,*T*.*ETTDK)0\2>D9O_JO=51U[MC=V2Q^8I]W=8/0]?UN0:BE:OKMH5>6+ M[)W!ELED*:3[AJ"@AJS7K[;:7S(RW]B?`9BN3$Q/A2MK#,:"J4<.1@Z M:"G1&NY<-F]@]J;0[GQDM'$T7>RRANVL1J`6FJ`84110TCP MP4D.NCL+J#6.]ZM9]JW>RWR,IX3E90H[$AHU)V=N&N0CND`T/KI(JOI*B+GL M"L.^\ILJ"GG?9'<-%BJW;L:P[CKG,6Y5P^Y>L]\9##[6K)-VYNJQTN4IZ>IT MY';N'I8JBL@DR-2K2)[*X+HR;;%?'MOK$GQ`2@H4JD\2M(`D>H*2M5EE+::* ME00;3VAAW.3;B2VW[@BM%36:B7OMY2L;:W*%\E6BC52PUN0R])&7`9W*3]?= M4PXG#12[YR^)W+G<_!1;9&)WCN_=L>%H-O8&MQTU2W5_<$6P<5"4Q]*./46<"GC0"1PI>/2\1"KJ!4F MJ*:"[D?;-D6WC$DS+*S$)2225$6-,5AN1$I[90\[51P.DYEMM1=P_(P_P MVIIY-N8G.4>.P>[J;,9#,T\,/4^*I:7=FS][UE=693*;JGST>#K*VEH*F:7' MPUV1^\R=37U595T14QWAV;EJEPE+F2.KQZ0IU7!)CEA`"A=!959@H8A`L>@` M-TEFLH]ZYJ'TP_Q6.4*CABZ@6R@21RLQ9I=80O\`$R*7UR&5G9.CC;(V=E,C MD=^]JU6%J*JMVO'1XWK[%B$21#>69SJT>*JIJ5T_AN1H\!A()YT$[YC[.II1 M'%*(EBC0%7UTD`V[:4E55EJ9&)_`HU%0?B4L32H*BC&M:FH\VZTDFEW7>IK8 MR2Q4$*5`H[,%1V'PN(UJP!#L#I"D4ITME^)WR%W+UW@,!MC$9*FINR6620?P%6)"#L4L<&I!IT9-R/S5+M5I:VELT8NRTT] MQ)J2*".,\#("H#2'O(`R*"E1T=OXEQ?'38>!2@V]BL9VSEL3NFNBW[OK&PP8 MS'[NWA7F?[:'&XEDQLV17;Z3R&;+5;10XNBJ9&2.7[@,`/S>W,=]=>/&L418GPD\ZFITAVX(M230=2'R,O*VWVB6]M$+V:*4B:5!199/*BD*6,:G,C MT"IJH*]=?)G;FR]KU65WMANTJ_>&%W=/6]F;GSF]LD8NO]BX3+TWV.Q-J=3[ M,VW1T-.M)+M+!U.-IEI8*_-9>*I>:)YOO)F][Y;N;JYT6LFUI'/&HA1(U/BR MNN9))W7F@E#3R22/2"&)P4B@MHT``)C4H MH4/)*K%Z$L2$!\<*;'=RXN'9]+VOE\'29G.XQ]L=A;*MD7VENW9&X),WL^BW M3LK<6-6FR^VLU78VIA7'5L?ARN/K7?'U#QS23A?S.DNS3_43;2K2)$VJ&3'B MQ2JJR%)$.&0$'4N4D4AA44Z*^4?IN8;8VD.\.B23*4GB[C%+"Q>)98G!U(Y4 M@1L-+H]4(UDDU?RMI_CL^U-Y4NY]@T5-UKOS%PX?+;HV5015U-M_DW\!UHKMI M+JOQP^(^UI_XYC-F;VV7#6FFH,OB M:[+-N';U)GYXFH:[%X_"P,*M(E,KJ)=0\O>?+".:*]>W:RWVV=5DC>@,T;T! M8:4"EDXH6)\#A8Q MG3F@-0.WQUIF8NOL-FLSC\SMSL'IO+[W,4V=MY/:/:NW.^\328,X[/5V!W/E\OF(JG'[1Z^H\+(T?8*5N/1,O5P;IWS MEJ>M%3D,9450:BR;QY:D?[TUZ2#L=Y!>[+>'(!WQKX1[2C1SOEO<6>^V?--LD8BE$;$NI6.`(U)JBKUDE9,O&Q*HY$B4? M6HP;KV2N*WW4X"EQ5=D]D=\#;&4Q5:*6OW5!14>^8EW%UQO"OVWAFY M<,F3I85RF;W''4ST*5T%*U+2!%[:8-PEM4@;]W;@J%20T@C$HU6\C)&Q\1U+"CRRJ=(<(*4/ M02TV!S^>2BSQ<(A.UN+2*SW'>+B/^S0A8]3J8HH2P.6/BQEY&+%(@ M\0)`>&F>B1K2XN;K:]DBD/A2LI)4H5DFG"')`,4NF,!5:71.:$BX.%+7@:#& M=I=XG<&/H-6R\!EFW9M2OPE)D,IBJ3%=90XS#5^R]X>2N>NW#2[F&&>.FDG, MF`Q63KRT*YG(UM=`BJ>679=@CMGEK?/&(W5Z!B\Q9A+$%`53"7&O365U7/@I MHZ2V\";SS$;H1:K%)#(C)4JJ0`*TV:7'(=S/6Y#:VS,AC<5]U)69C?(FCK]U)#)D4ES=/A,#D&DB4Y'-2TBU9I M?2@C0QMNFZ0J++:VN0UII#2`M^"/.C^%"S`:J*E=-:5->I-V?:KR5;_>TLZ7 M08QQ4%>^;!?42"VA&(52TI75W-2B@6\_\/.]LGUWM/;F&3/]<;7W)0U7:?LB>NJ,9!3Y"EJXZE(_M[JLC%UGS M;L<.Y7]W<1I/<(?`MX$_59F.6<`U!)K0.2I%.UAT=WO(O,VYAL+V%%LG+;@RF[.U MJRG&&H=U[XD%7N/.Y2(O64"8JCVOCJE/N\QEQ&PHXZ:&&`+)>$'EGK:/+;3K:K+5NT.S-F[@QE7!GL+O+!#)1+AZ^GA,F.R3STZD6WUSO&\C=]C;XINFMM4G7'7&,VSU[L+8&#GW M#T(KEMUW.>2YNIWTW(H?&#%@NM2M"'R"=7;)G56M>ASO.X'EZS3:-K@@M;" MW77:4-8&4*7T2!^TQX(!4ZHVTE*!:=5U=4;0Z*^2&^*_LC;5=2='=VXW=%%N M_<^&S=3FLIL7LF'*9*MDW9D%P5*M#O&AV[EZ@2QSQU;UU*36W1_VU]R#N]UO MW+-BNW72F_V9XC&CK19H2B@("Q!1B!2E*$`8IFL4['8\M"X#L?$*K42*M:A@W:VHU)\K/\`^7UU[0=:;D[WVGCI?]MMK7:;SF*SCN(Y(X[VY`TTX,T3CAC`8#[1U9][CCJ6^ MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZPU"H]/.CQQRH\,JO%*H> M*1&1@T^>[&R MG5U2D>SZ"#;>`ZUVYE]KR[/H8LP,;/A-U8S-XG#U\>2:EQ-',B21O)3.\U.' M:&*!FC_D_<-RW&\N9]QEMF(@`00HZ:0'H5<.JL&P#2IIY8IUEM]X7E7DSE#E MO9-LY1V_>8W.YN;B:_G@N%N6-OXB36LD$LJ-$&EFC9@P$@6*4@2/(J$_^//9 MW9_:W;OSRP7=6=TSIU5\FQUGEI<5U^W4^1VU'FL/L/>^9V__`+].?*=FXO;, M>T]N8VID27,8S'PTA@R*25U:3-('6)O:"FGHX'\G'&S8SX-;#AD&02%]P[G: MABJ]O4&W:(45-44N.@K=NQ4>Y=SS93;.=^Q.2HZRJDI*B5*PI]E211Q0K[KT MF7;HX?RW_O,/C1W7+LS+;VP6[*;8.:K=NYCKG$5&?WICLO0Q+6455A,)1Y#% M5F6DBG@!FIX:B.66F\BH2Q"GW512HKPZ*U_*USW96X^CNQ\CVUN;?>Z-[KW? MF*"MJNP,)5;:S%'B\9UIU7C]NTB[;KL]N&MP$]5M^FIJ[*4_=>Z_];?X]^Z]U[W[KW55?\`-.RM9A^O>KZV MC=Z=J;M_8-3)6PN\"=[?;-DDC#:QN$)J"`<%L"H(K2IR",<#PZI,[+@W-W'E, M=/L2/)4V_L1_#MO[TP^Y,UC8JW=.%26>NQE=L6JAQ^.BGR-*F.-$JULKUM-4 MM#44\D<-9.DTP[6UELJSINA4V+:I(R@;M;`9)%J:*:ZZJ!J`TMY$8][S]5O[ MV[;7$S;A&!'(K,*R)EE:)J+J84""K!D(U1D:F4F3Z?ZYWI\?NH]P_(O>U7CX M*W:N$S&$ZFPF7RR9;(XCM7(XZL3^\?V>W\;5XN.*BDK,S)`BF+)-4FC0Q2.Z M$A[=]SM.8=UMM@LXCX;NKW+`:080P/AZC1B<*!Y4)X`=##8]ION4]BGYKW(J M7@CDCM4J'*W+(=3Z4!3M)D9>!)*TU$ZB5#>?4O<';>XZOLCY&=L4.W]QYB=< MC!@]W8ZIS>],A14E1GL3!!A=H8&@CP&W=K[AQ&+HJR%*D1F:/S/XON"@E&5A MO.R[-;P[;RWM!EM5%"\9`C#41FUNY+-(NI@W&C%*L%U#H%;CL?,6_74VZ\U[ M^(KE^X)(&>8J-::8XE&A(I-*,*Z:A6(&JAZ=.J7[[^*F3?L7IW?]-O[9N=I\ M''N3<^'II(\7_!#0_>5>6WAL?,;>-3AMT;OWQNZMRLU;1EXZ.FJ13^4QI(43 M[L=@YMC_`'5NVW&VW%&8HKGNU5(I'(K'5'%%$L85N+9*UI2^R?UEY'G_`'KR M_N:W6UR(@ED4'24TUK)&P[7EDE9RX.%8@-IKT8[Y,=*;SWS!M#?O4E=6[OZF M['H&WALC:F.W%3UC;5I\K50PYK&U.$R]=5X1,%B,@\, M%WIC*3(8-Z.AI-U9_<)QRRC%&IQ,=5A\+GH&:821"*H@,310^-U5/S#MEAOD M&^WTZC.I%*5:I-3YK>4]\W+ERXY=VZ6X`N1&%G6JE5\ M5VH!IQ^F'KJ+"G:&5#@#?O[YL56Z]H[;Q^^.L-M]EUAS61VG59-H\O#E*6&E MC:DKJG'2XB6F^\EK*N,K*9+0M2HMUQY($%SRMMQV.*\83-$6;6'!`(UC33XBIJ<"E,&N27[A^- M^=^6>;E[+Q>[,7MO$5%'6X.DILU4X/!93;%)1S2TDN!P]>DV(WPE M>FEHQC;92K,5!8.32A8$21AB`I8D=M!I" MD5(!N.59.=[@;I9W4:6SJT:ZF5"@2M0IK'(5!^M+F]@-U=&.VA1W16J5WY-)N(86G7 M"T&2KZO#9"MJI9ZVIVEC:7`1Y2N&?J&D%11U=>[VEKZB:KE+1*;V\7FCPY]J MOU1K==-06(`(QI$C%RN.T:@@X*J@4*2QL_ZE&>#?]KD=;BC`#PQ5E;)JBA0V M>ZB,YJ"Y+='2V[\UI<-MG9NV>IM@8;K+;V-AW!G*^BR%8^8W5_"MJTM2ARM)4+BGPU/DX9G)PYI:ND`BJ%22HJX&: M6G2591(FSV^U_610=P(/"M!YTZB??+S>.;;*%H+B M>:[6Z,CQ51GTN"5*J2&JNEE3.7(-5!/0@=/XCL;X]=:Y'Y&]SYZJI\)UF:[; MO276UY\KAJ/-12SXJG176O_YV7,?-%P=[WS<88->5\6JDI5A2*% M%[8]2I*:JH'?DT)*IZMWUWG\2YJO)[=FVSV)UY59+1D)\?5MG.OD6#&TV/S= M?64^9CJCL;<'8>5WK4N\M7#3:L)!#$2XGC0)MWLN7>79O2F?P6/WUU+335$>X<;MFFW#D:>EQ^&&W!2 M93/XO*8F3'QX^H\U-4314T-1)')$'#P!WEB^V8M&%`+J0!H9F!P&*LA* ME1_^,O?_`&'TYO#IK8M743TN0S>UL;@-V4L58F3IJ+)[RJLHVUI'F?/;HIX< MK!AJK"S3P5594)1R>50J!#&@6YDV3;=TM=ZW"W75'',6C/`E4TZQ32A(UZJ, M%R*>O0JY0YEW?8KSEW:)B=;VZK*H((#2EO#))=Z$#34$X:HP13H2.V/FYUMO M39.!H>X^EJ+=.8CS^2V\FOQZW?WWN"AWOU7AJNLQ-7C,SL3`9^KR^ MU\3)MRDQ:M453KFMZ45?6U%/D*3*/-.E+3(E;4Q_93>*=:6NIQ_8X8\[M[$Y_.U,-;/$U7-/>B@L=4\^I+RQ=K?RFTUQFU@C+!#0@^)J)9ETA M79%!3X0.X\*=&7.%E+ML7UPC=;RYE5#(#2@@TBBE6UH'8AP3(?@6M06U.5+\ M?MV;EZ\WCD=@XNG?>O=.#VMG:7$;;S%'A\K6[TPVZ\?5[@?#XJJP^9VG1G>F M1P$V1#9:BKZ>222NI273QH^SS-9VVY64&X2$V=D\BAF77^DZ$(7.I'[`V@B- MD(`5@%(KU0\L7UWM-]+M<%;N^2-Z*WAZI(Y09`HH\9\73K'B*ZZBZ=RG2'CI M?:TGQG&1P?"LR^W,-6555B*K<=#05#O7 M2A8WG:GA-3*U2ZT=*QOMV_,[V[[3=1NT(\-6+`K3R5R0"JFG8M3IJ56H[B]R M_:17-=F4M-F=WT^$PD5?+EHL=6A:B+#TM=B\/4?;A(RPIS3H55RL7L M$R\G74UY=?O;<`\CE59(B0I+%5!(_$VIABOJ3@$]21![@V4%E8KL6V%8T1F5 M[A0T@5`6)4YTJR*=)(J,+0U'5<'?_:?$^8WABL?-4Y MBNH(*_!9.MP==AL$E=7ULV/2@IGBB>*)V2H]R7RYM6S;%N!MY M)([ M6.K%(1\;!JE:R#0ATGN).HBE"8\OR;WLVSOS/O4L_P"[-N6EO#+I4/<$AHU* M"C'PF\60ZL(`I09)Z*)OZC^0WRBS4O9&]3M#;&U6BK*3:M-F\S0[/VQC,(N0 MJ)48OW=:-+-<@ M@RZ4,LC,%!1W*C2NF-GCTJ1I98J**L"!]R7FKG2Z;=+WP(+,@B/4RPQJI8ZT M0.=1+N$D#,#K5I:L:*0)'0W<_;'PUW'_`'>WGB,5N3KS<%-D\?%BY'I]V[0F MASU#C8-UYS;F[=J5E52T.2WSG=T+0QX^H_X%1TD8.0+QK3<+59-LEU8.EXM+4 M\2194)`:8N0J-@Z`=`JK$:_E#@>X<3D]GIE=XJ>`K,02R2XNI;K979GM9"-9DBD4%0TBZ3J M4*J.7-<9-`#T=+X^_)OMSKZHZ;Z\W;7U=?-NSK["X+*XC=HRE>^(SE53YJ?` M5\N+JX(:B22KQT.)%/"Z*9A7H?)XUX!?,'+FU7J[UN%H%"Q7#.K(``R`J'&H M8P2V14"AZD'E;FW>MNEY=VR_ULLMHD;I)J8HW>R$JW=JT::UH34<<=3.W^_O MCWVGL7;C;QZO?'9:1LKC=MG957@DI3E*FD6@>@@QM?#2?=9G,P5RT\S4@8K" M9C(P1;^_;1R]O^V7=T]AN8>"B%A)JK2M5)(^'211:FGIQZOOO-'*N]6%HFZ; M+IG+NL?A%=.HX84(R6KWZ02!Q)Z*MMQ]S[DVQ6;7&8J<1AMP_(3:=%MIML?> M&3&X;+=6P[=VKF\;%BQ5Y>JR3UN-R3^5:>&H3(51DBA1EBJ0*9VM[:\6\$"/ M/'8R,_BGM8I-J=6!H*49`030J!7&.@7:_4W5A)9"=D@FW5%B\+)53;F.-D*@ MDM5)!J*_&V`&`/0\[SNW,?NS9'0^*P]#NNHA[;VI%FX M<`VV^M,!N'?N'6?K_";RW=O*GRV4:%4JT;[?+<[O>[\MQ#9J@E M_P`9AU!1'`CS!C"LKR"25AB1D;!X=!UO.B[MVIV7L?%]F8K=_96\]MI59WKS M>.PMOYC([/R5-N'K:AV[NW,3[@GQ:83:'7E7N>LEJZC%&KQ]3B:FEFF0TD:O M%(:[<^R7.U7<]A=Q6ME+1)XI64/5)V>,".I>20(0@<*RN"*@DU!/N:\Q6>[V M$&\6TU]>Q5>&:)':,B2!(Y&\72$BA,@U&)F4QL"P8**%`]4T.:WIN'Y@;CVK M2#<-'T_UIU#@*?="C(T>`K^[-A[J[`[J*2GSB"= M`:EH_9AN9BMHN3[6[58IK^[N&,9H6^EECBME8BM?[0)2M#6,T^&O11LD4]TW M/5U:5DBVZRME$@+!7NX99;EP#0J28O$#::@B4:@-5""@AH-F[WW3+74]+2U#U6*:FVQV%EZ18:;9YQ."R<549JW4'QCI5TC5: M))2P@G=>2-HW)TOMLN2CL3XL*4)H`W?"#7Q%++0A:4>JM3B9`V/W-WO;%EVW M=[(-'&*1S/JP2RTCG(Q&41M56J6CT/'KJ56U*?Y.=6TYRJ&HW+4'#;@V9MZM MFH]H;BK*%I-_9J+!;8R]-E*;'R8N?!5]5)YFG$P:*C`J'0121-)&*['N++$V MF,!D=A5T!_34,X*UU!A6E*4+54&H-)G;FC:E>5"924DB0TCN_?NO=<6575D=5='4JZ,`RLK"S M*RFX96!L0?K[]U[H/RMM94U#Y;;-3LK*M. M:[&3F9LGLVLFQ-06N9L9*]*]X&9#ZO6]3>IZ<,-UOUWMQZ:3;VPMEX*2B.*- M')AMK8/%O2'!8&/:V#-,U#0P-`<-MB),=2:+?;T"BGCTQ`)[]CKU3ZGI:>_= M:Z][T"#6AZ]U[WOKW1?,Y\F.L<#N/*;4K'W1+FL1NF'9]4E%M+.ST,F(JL8U&LJK+)4^)J45`4!ZUJ`BLP)_VQ@:,,--FGMKG=.:MKA2#ZF+;;5X@QIXBV\RS3@>7<6'D254,00N M`#O%M/9['R?NLMQ<-92[K>PR.H&J+ZF)K:W)P,40@DTH7(QJ'2(Z>R/:^`[] MQD.?ZMSM!VQOO`;4VEN/>-%C*Q^H=R=:X#>.X`B&!UF])M%QL$IBWB$[1!(TJ1FGU"3,J!5>%B2S1=R(% M4C.M=1J>B_E^3?;7F5%NM@E&^7420R3`,+:2!99"\D4Z@!%E++)(6<=J-&QS MIZ-C7;]W?O/XZY3)[W@[WVCWOU#WYL/I[-XZHW=15.Z-VY3-8S#OOK8NQVV) MC*.',=3;VH4I,U1858I)<1)_NJD>EUD*P[=:VF_1Q67T4VQ7FVRW"GPCIB16 M;PY)1*W;/&08VD!&L&E#72!O<;I=WW+$L^X?7P`4TBID12%TZA4\2.B7=C/#97^W7\+I%#?VP42!_$!TR,7*/4D>$[C5JTL M%`P.CD_'_L+XD[!V/O==F87,;[RT>T4@FCCI5F6-%F5Y`/OMAS/=7EJ+YUA0HY4(6)$8J'J-((Q@U'^#J2 M.6=VY.V_:[\;?&]Q+XL7B&1513*0-!4U/I6H)Z1ORY^5_86Z,'WOL;8U-N+" MKL_:5=@9]NXF$B3*I'%CQO:&"/&9;#5DM338F@R34T<%3+I2-XI'0M((S3E' MEK;K>ZV*^OY8RL\X;4Q&"-1C^(,.YM.HL`/0'HHYXYQW.[L^9MLVR*53;P%= M`!JU-/B@%&4U"AZ!22/,KGHFOQ,QO?&:HBY(Y-U]W;FK((MI04 MVV=MUOV69-959*B:N6=L+ALO0O*CZZBF>DCG\XM5L,>;)=B@F2Y^GAN-\U:+ M9*F34[U84%:4#-&P!&"'*T)T]1_R-%S)/!-9_57%MRW_`&EU)B,>'&:,&.FN M465>TU:J*U1W$NW=W?G>/R^SM7M_K+;^%V3UKL%Z9,!2I(FT]F8W^Z=#CY^O MFF@RTE=ZY(YX_(8[G+RYSI!/97\\B M7:U855HY:D223,FI0I1W.E8\]@6H&G!9LZ\S\%C;=P;FWWV_T=B^W.KLAN#*=1=AU$^1WMM#'X;'Y& MGZ[[7P-;]=[GOW+=OO6TW,C;!>MJGB5 M580W$?<%52C/$C`"1:54%Q@DD=0_CMW9VUT#U_2Y=,CN;;A_OSX,)A\F^?J# MGL3A:'&S[LK*C#9/)UB3TKY:F0OX'?6E9)+,*=D:E@2QNXZW'IA:^OCDHLG M#)!0XVJH8IHYTJ#(4,:HZA@`#MG)6Y:MNO-GO_#:34"'&I0R`U`IDU(\J`'S M'4F[U[B;0T>\6._[3XL$91AI_3=DD92A89``5@"#7S%"<=5A=F]?Y7Y,UW\- MZ3V)#5[5V'N>#,/MW.XR6K;"9;-T.*6#X+RRKMONX%+JXBTZ@::@IX4%2,47!H:`5#!6$1;KMD_-[&/ES:Z MV]M<:@K_`(#*HHQ8Z%R:N#I[*E@"I8%\SG4F\MC]7T=9NQJG/[OZPV9-A=OU M=!'C:^CP.X=T[ES%)B*Z6JI\/_='^([3PV9B3&-C'2T7P[*[G5G!-&<*JLR\2U)'4L:LQ8$ENXDE3<[%?[5L*2;B@DO[*W M910!M#R,X4L=)0-'&RJ-*JH*@)V=H1W2W56;W11[6W^(L'2;AV_C]R=;9?+U M^8GQE/N$9S:6;@ZPK34XN+'YRKJ-F+')0L)5J:N/&0TDOBO3AV7;UNJ64]YM ML[%[>4K.J@`Z:.OC`5J%64$FE11M0J:GHLY>VB6\@M-SBC47$*O`[,2-0>-Q M`Y*%2S1L-`^(&/34$*"(/5_279OQUW5!OWM#9$V/P.6P<6V,K4YK#U>/R&XL M5)IJ(J+(Y/#T&!VWE\G30"*7&*U&K&I+P0K,9,G7,[N^][5S)8?NO:[W5/'+ MK0`ZDC\P0C,[`8(D[B*A3V@(O5=DV#=N4[N/5!0<,2WM?/.Q6UM+'MFUL;EI%2LU'%0K:-`QYBIS@D,>/17OD=WOV[\@8 MNVMNX7/UL^9HL=/2;>V3C*NEQKOB]J[CAH-PT='C)\ABZ".LS-#1SQI'&]<\ MJ$,D-C;V*.6]BVKE^;9[J6-1"S!FE-2`9$;15J,S!"1Y#/$CH&4RN4_@34GCIZ.F@DILG%%)&H33[-^9]VY M=CC63;S%=\PRCP;"2?:FQ.NMI9B2/9]77R4.V MMA8C(TJ82+9F>AGQD3_W]S&WI\?24+FCHFECQX>F95DJ/$#7:['ESD2-;8^+ M<;O*!X@4&20A@=:YIX8;46[B!J%NB1`I3PY M,9D=-"KV`G15:`$KTS=5[1[K^,.ZJ;?G3^5V]NS%XR/`4F1BV1+!N#"RQS9[ M`XO8V%WELA:/'5IP^Q=H;:HH9,LT&F#)Q5%=#(WF64/;I=]CT]54=P['P==35< M.W>T<10QYO-S4^UY4%'1P;ICIJ/+TCQ0)2Q5N1BD-+,T?(#VN/;>7-]EVC5ZC5`]`M649*5*N2=5%(#"O4A[X^\] MNU@'J2M"J`%M.#1GTD4U'CTAY:WO?>4MKMI;HR*WUM4C[E+1J%#A@S%J:J$* M50E>XK45Z/IV_P#-[!UTW8_7_:?3479>W]NY:DR5%D**>EV]6M3Y"MHLIMVN MD>%VJZK+X.DR%*[(E*3%/30R%U?U*`]IY-N&6RO-MW589I(V!!J1VBA7(H-6 M>)\R.I.WSW!M-6Y;=N^R&[@AG732B,`P#HV#4L@8"H%#2H]>J_MS];[6^4.W M(*'J3:%1+0;(JWW0FVLKNO$1&@W!N:):"`UV>[$QC?PW/8E,;1ZO!JR=#01S MS43<5$=0.=KW>XY3NY3NMR#+.`I<`Y136FF%A522Q-2`S4##@>HRW398.=;9 M(]DL&$-O5M)=!I$WJN^X; M=:(BZ6#Z'ED?]0'+.Z!P@>/X:@@`*``PZFV!4;TH*+L;;=/;>.9PVZ>H\E+E M*/)U%%E*/=>V,\NT,W7[HH$HO[R;3P&'QF5RV,@QPGCR==0U-$D&N*C,4&J/(-;KOECS+`MKL=V MKD,71%U`*Q!#-XG\QM3*Y3L*DP%-N3MJH&=:JJII M<;1Q9/'5%5'0?;55'CEII&1VA@\L<>IW.M_-#4BOKU*>V\_;+;VG@;'L\D>NZ"B6>C9;2-:UI33C#4%0,\>BV]Z][ M=Q?(G%][8?!Y+,29BAW!BL;@]ETU;@!/D\%AL_3X^7#4E/*QHYJK+UR4DAD6 MDKI$T3R"DDC72XGV'9MHY=GV&XG1/`:-B9>ZB.T=0Q/F%JP`)4:J#4#T#^9> M8M]YJMN8[2UF8SK*H6+M)=$D"E0`:#6=-=.IJ`G01TC/C'L/L#:&`WGO'M2H MWYMSH#K"ECWYO#96ZW;:,V\!+`@@BA8.S,Y\@_FWFL+V!O_,[ M9VSLGS9BGV?D]TM2;5VE#4T])M>KS&3VG@(J.NEW-5YO:^2GQ4U92P2)+7QT M:K.$T1J*=MM^7N1DEVZRCEN-R)0R:/U&((>BNY*A0)-#Z2`0I8@$Y(0WN]YH M]Q+I-WW&XAM]L&L1:SX4890A+HE&:0O$6C9P"H<1@$&H$SKQOD1\/,Q)VCU= M7;1W]M;'_P`._CU9UY)_?+;<<)>?,R9+>6-GQM#F\'1;*V-MBDH,=5F'4<@U M;=M7F0[W(\MVO`2%$M(W'PJ`C`LK&25V8K4]I':0`W5MG/-G(

ZL0%+^"6E7)+%W1@K*(H455:@J23J`:A-3WYMK?G;O3>W^Q]BY/.;K MZ`[-6/=&=V;@ZR;<`V?VGB64;YHEP*U=9%05!W%4U%?C4IT-/]U.L24GJTD+ M;'<6&Q;Q/MFYI'#S#:GPUF(T:X#\)+B@-%&EBP!-/C'0RYEMMUY@V&UW?:9) MKCE:\`D,"?J&.Y4_JKH[L%VU(149'8034I'7NUMT_'_*;ASF[8:[";FW7M_( M8G8&QL@E?/D7QO\`>`U>?RM748;*_94V0Q^2QTO@GEIWS%1,YGE\<3:8Q9N- MW9\PPPVEDNJWAE#2S+0*#H.D*&!-&#T8`E5P*UZ!.V6U]RQ-[*S%5HEGK]_=BRFH">%A'2;D MQF.AIHX8Y&@6GAAI55#8LP4-J(/N%?]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW3=F)M"F^^XA!D1/K+2U M01WLT9:%4&F>.(+<6;:;V]$`LB5C3;E98MO#M'$95DU]`/U?F:'<_?7RE;_1 M33=3]0T7Q6^W.KL'U?U-L7%Y2F>7 MY3ZP0``9*'HX/\E>A^Q^"&R8I?LGKFW9NT5U M1%DZ;*Y:J6DEH,=A9]S5$&;RTD><_NQ14">.:GQ$BT:4]L=21F-6]UZ3XVZ/ M)\JH:VJ^./=%'0;!W=VE-7]?;@Q\O7NP=T;DV7OC=M!D*1J+*8?:.ZMGY'$; MJP6Y*C&3S&BJ,=54U8M0%\4B.0P]U4"I`K3HHG\J7`0[.Z"[$V10];]@=2X? M:O?&ZDQ.P^UX]OKV3@QNW8_6_8V(HQ(%'`J0P!HP(!%0?RX]`_F[EJ3F6&P@ MCO'MV@G28.H#'5&3VE25JKAF5LC&#@]5Y1?RD\WA:NCKL+W;5"+'UJU-!@:; MK'95'B**"&%UI\?"DF>>9L;&20L3R/I+W!&D6'[>Y]K<+*D^Q@%UH6\>4G-* MXTTJ:9Q3Y=1:GLG+:-`UKS$YCC8$)]-"H%*TSXFKSQ4FG1F\G\;/DI6[/P6Q MZ+M;!X;#X.JJ:R.IH>KMFU&7JZFHIWI14OD,MNW(-15E/!(1'/2K!,++ZK"Q M#J[]RTMW-=OM#R2.`*&XE`QG@J*?RK3Y="Z3ECF[Z&VV^WWE(H(ZT*VT!)J* M9U.U17P05M0L\T<=Y]K;*D46PP"%373KDI3-!330<3ZY-?3H'3^S-_ M8Y_&=:%O"CU5/$U\6N:+PIP^VL[;_\`*][1XTIV:,"Q]M77N1MEY;FVNN7%: M.E!2X>OEYF(^@)/$G->GK3VBWNPN!=6?-C)+JJ:VT>DUKC2)A@5H%X`8ICH8 MY?AEWQ6]9X;J?)[_`.J*G;FW*W,56WJS&]%P[W>Z<3A98X MY92_[M),TDCWD+$%B3Q\V[+%N,NYP[9=">15#![K6#3U+6[,?R84'#H0?U#Y MADVN#:9]ULS;PEC&RV81EU>5([E5-/\`C5<]%MQ?\LOO':FX:+=%#V72[CS= M+#)5TM35=:;9^UQ^5/WU-257\-K^[XL?4Y#%QSQO3L\3PQQQ+&+W<$2S>XNT M7ML]I+MYBMS2H$\@+4I6I6V)`8"A%1GNX]!*+VEW^PN(KN'=_&N%J03;0T4F MM#I-V`2M<'T[>DOD?Y67Q>1PN4WLWVF8J()DZ0VIAJ"KJ*[RAZJHIMI][XFED?RRRRHK*45:AX65H0D:(= MP]P.7]R:=[G:'\60`%A=2,104IWVA\A35\7GQZ,-O]J>:-L-D;/?DT0EJ*UI M&%R=7^AWB8KP7*C`I0``4LG\-OEAG=K;AV7GNWMJY;`[A>CJ)H:CI^FC2AKZ M"KHYX:W%QT_R,B7'^2@I%H7B@6&.2!I!('$A'LK@YJY6M[RWOH=HD2:.O_$E MC4$$4/\`B6:$Z@3Z4Z/)N2.>+FSNK&XW^%H)=)/^+`$$&M12\Q454@<0?D.F M6/XQ_+JCI,101U6WVI,5@QMQXZ?I7K>D%;CH:V.IIVBEIOEK2U>*JD*2`M2M M%')'4,C1Z51(_#F+E1OJ':.7Q'?7W74ATFE*'_$J-C&?3IH\I\\Q^%'%/:^" MD?AT6TB74M:U!_>"E2F#7.ZQ1D!J5M8G'=I\C?L:@BM2ER-! M4O#(H+2&%F421W]IKGW*V&\M);:ZVB?4YJ2MPAR"".-LO`@$#AC/2BV]H.9; M*\BN;;>[;0G!3`144((Q=-D@G/''Q"O3!2_RN>_Z#*"KQW8VV8<<)%:+%2=; M9"9((8/N/M:?[UN_UD8TGWLH@D\9=$=H[^/2BO2>Z&Q2PB)MIN=5,MXR5)Q4 MXMZ9ID<"<\>DZ>SG,EO.SQ[M;>$6KI\%\+_"";K@,4ID``#'1EMV?'#Y(5.Q MMJ=JJG>4T.YJFB?'G<-]T?(-9!E8:.:>$:2D8@J M9(P-.G2'[/F'EE;VYW&>6[:290K*9EB[0,[BJL/D:)HJBK$$DU+ MKA$IC!\84!)>^XW+-ZC+/M\]:@ZHIE#:J?%7P`0Q(6NO/[K_'3;Z;-7(+L_-[ M6INU-OS80Y&1YZD/A[9BBKX*F65_,)II)FUN5E0M?V$HN9-@AW"?,IJ8L1I+."#4D M@GSP>B];-_EM?([:VZ,;NJHSW3&3R&$DJ:K!"+&]D8V/&9&8U\E+7J6BR3SR M435K/XF)IY9WDD="[HT1U><_;#*KBC5:,EE[:BH1:`Z1P\A]M0KM M_M9S78WEO>//8RRQ&J524!6H_=37FFNH!QJJ3G31#YO^6-\A,MMRMP>1RG6E M=D*^H6IK:]2W+UJ3IETD_(JRM0U-14G MA0^?2BZS_E^_*KKO";2P!R?4.2Q^VFK4JX\5M7LS;*9FDKZV6NGIIH(\5Y:4+21.5H,$?IK3.2!1:^72O9 M_;CG':;>RM1-9M!$6)"PSIJU$FA_5(-*T#$:J=";GOAU\P]V;"R6R*O*=$.* MG*X'<%'5YK:N\I(Z#*X3-R5=.:%#@JJKI8QMV44)8U+U(GA643:"\+DUKS#R MM:WL-VL-]H"LI`>(FC+I->X`T/[=)82/MNIG1PS13=K(U M>PA6*ZE[&.21\NECD_B]\KL2VTI=I;>^/5%#A,?'CZNC3)]I1R3-35,U:E1_ M$FV3E:^JDK_/+'5FJ\ZNKZ8DC41)$S!O'+$AN1=7.XDLQ8'3`>."*>*HX4IC M_+57+RQSG']+]%8;2@2/21JN5%0VH$$0%N)-1CCZ`=%?[#^`?S@[27;;Y:L^ M/:P[>CSDD\.5S7R&EJ,RF>@HG\%0:3$8@T_V[4Y\L2*?,\TY:TK"1!7M7//) M.U1W*Q1[D!)HJR"S`!2OX6+U!J.)!%.@5N_MQ[A;X+=KA]JT1:NUC?%FUD$] MP5=-`",*:ZO*G7L!\+OE?MS=.W\U5[3ZKRF*QNT*_:M=AD_TRU#YG$9:AK*2 MKI*W)R=4R5,/\`TUT^;IZ%?$M/$NNH/MX33S21LRA" M'\@OJ6S<]C6;BZ)^0.Y.L]H=?TW173]95;8W!EMR5.7[&K.X-STV:W% MF,%+C:C-5.+I.D,'0"951$"3Q5$`!Y0R`/["=MO^R6FY7EZV[7JQ3QA*0+`A M558,!4SL4R%KA[EPTC+H+T^F48&,U% M*=%&W7_+M^;V\LU39S-93JZJKDHVQ[U:UW8SQ/0YN.7.:?W-8;5;;):V[VJ,D9BGNV3034*0]H6H*^3&E M*<.`#;0^,WRHVUO;';\R?7NRMRY;!/\`Q+$PU;?)2D^[SU'BI,9AY\YDJ7XZ MK65&$H_*9'HH1$KLJDLQ#%CVZYDY4N;.6QCO;J*"0!6HEJ>PM5@!]4%KDT)X M>707L>3N=+7<8MQN;"UFGC[E[K[^T"T4L38UT@BM%(KYDCI+2?#OY0UNU:S; M-;M7#44DN07(4.:VW4_(K#93'"K\@RM&LLOQJR-.U&&D$M-%##3Q!X46570D M>U@YOY62[CN1=3E50KI9+9P8DWGF;:+BXCNM MLO768REF\2.T"A"@!41K))')4J`58**9K4"@@V#D_F&TMYK/=K!7MQ%I30]Z M69_$+!C(\4^1>9VW78S:M9-7XMEW+1]3P9E\SB:ZHEEHJVF$#12:9-+.7:0LEWC8+BPVJ MR66XC-L799%-JK@R#2P"&;2%*\5)SZB@H<1;#S/:;ANM_P#3V\QNM"R12)>- M&RQY0F06XM-LX.NR%%5PC[6JK*3]\K']U2N5LUK/F;;8;I?%G=TCH/AMU+*!0 M#Q/%=E!&"%)H*Z6S7KU]RAO$UM+X-LBO*2U*W3*CL:EO"$**U#4@LHJN!VA/N$X_ M$YS+U:I/7U]54>*IDC(,9\?LOGYAVZY]0"LPTX#:B&%.KWG*V_7R0J\RI( MLJ.2S7$@(0HVD#PX])9HU[J,5H"N>+'D>M?EAAIMP5&*W-41RY+G\07X_P`5>DMQLO.MN]ZUG?J%>X#Q+HN)!#&23)&: MQGQ0]>UFKX?X:=8,AMGYE-45U31;VGH(Z@N])C?]`>_\M'0^26I:*D?(2;8I MIJR*A(CC$OCBDG13(P4OI%X[KDT(BR;:[.!0M]0BUH!F@9N)J:5Q6GEUZ6T] MPWDE:/=ECC:I51:.^GC1=112:8%:9X]3Z#:/S$JXZJ6I[*J*"M>*#P0Q?&W> M/V;?;A#+)/45N*:HC>H"2Z8E5]#2+ZB!8LR7?*2D!-I)7U-T*_R-.G8K'G]T M!DWH*^D5'T;\:9-2/Y=9Z/;?RZ7S+D.QGV];6QYY5'#[TQ>F*6;?YNIDFV/ ME/-4--2=E;K2A`@+4]9\:]QP52N\L$1IXW7%S"<%O)^]H58TTNRA;@5-URSI M6NUC7ZBZ!]?+'RQ4].M8\ZF4Z-Y;P:<#9.#Y8!J?GD@>1^7334;"^;-2\\&/ M[*AQZ>5XXFEZ2W+(9$J#/(SDS[9AIZ:J,3QNL^N:&&8,C0N+#W9+[D]!63:Y M&_YO@9I\FKIKQ&D'T(Z9DVKW`<:(-VB45\[=Z`5XY'Q4_I::_AZ3E?\`&[YA M5<$\U9W!52U:U!@IH(NK**:BJ,4TWE=:A6V4M;25D\VEW*2RHI3CAN%L7,W+ M":479B%ID^*PS_O>0/GQ\QTBGY1YVD`=]]!?56@MTH5]/@J"?/./+J-D?CC\ M@(MR19.E7(9/$ION#,)25^.[,IGDZ^I8Z"L@ZXS&-PIF<10B.5%IHE5NXW; M9YH+>W\8+$J`-F*2I'`T8)0UX4-!G&>O025G5J31%2Q-02/ M%!4@Y!342%R`.G7=?QX^1>]Y6KLY)2)FH*'(TM%EJ&7O""5#E$HCD(LC3U5! MD:/-XVMKL53F2GF36:*%*>.:&$^,)[/?-EVYBD"R/;EU8BD`)TU`TL"&4@$Y M!I7-"<]*KWE3F'=/U)'1;D1%02;DK5M);6AJCU*BN*Z0!4#'2ERW6_RRS.3R ME-5+M7"[/W)M1=D;HZYV;M#L''[-RN%GR>0W!FTD:FJ3 M@TZ>EV?G&ZNYTFDA3;YH?"D@2*40E:L[.K.KE9&=V[P.U=(&5!Z151\4^V<5 MM3/XJCQHR0RT5&]6LE;V[AWJ:VGI6BK*VJ@V_L/,4F3K:BK=G2K&,CJ9(0B2 M:G42!]>9MHFN8)YQ(C(333'`U/3+2AL#RUE1]G21^3-[M+.X@MUC>.4#4"]R MM33-1'$RGR[M"L?MZ"_.?'/Y,9#B.XY/YOFN]IG22!$M[CQBH6Z*EF-6.;8DL>`8Y`) M'#I@[Z^,G>&^=H83;76NSCMVJGW+N3*;[P&8VS\EFVQDQ+AS1[6S>.[4I=L5 M'9TF4Q=55U0;&ICJ?&O#.%:5A"34VV'F79;&]GN=SG>2/PHUC=3:B1*&KCP" MW@D-058OJQ49)Z8YGY+YAW*QM[39K:.%S-*\R,MYX;54^$XN/#:<.AJ"@14( M:F56A"?:WQ`^7.V-D;>VE1[=VPT6#R5;F:BER%)\CLSCJVLGKJ1Z)$DROQXJ MLG#0XW'4J0)2B1E#%WC>)7=&.KGF[E"ZO[J[DEG'B)I!5+92!0^2W84DG):A MSQ!Z(;7D/GBWV^RL%CMS'"VJC_6/J)\M36A<`#%`1_1*BG2WWK\9/E5N3=^Y M=SX[8FS<73;DW!/G,EC9*;Y%5U3VX-U2JC%:9!..EVYA%I6C$5()/=0UXU,YM/JWY*Q]*;SZJS'2FP-T#L"AEQNX,O MN'L+O7%.^.K)**2LIHJ>H^/*YQ!4TM!$K!JSQB10#'H'B(9N=SY;&]6FZ0[O M=1>`U5"6]NV:&AH+K1@GR'\^A?9[+S6NP;AL\NPVR7=R;;VVD4,5+%5XV& M/IRFK)ZC"S]PN3[0F9_WA->O\_E\?, M?965CR6#K=A8ZL_A]1BIVQ..[JB202U49DIC54_3WD;"5:5$L-2/3)44TK$, MK1*Q677N+R=>PE+BWN6[PRZOIP5IJTT_7PP[2#QJ.DMK[5<\[7(DEE<6BOH* MMI6Z-=6DL/\`<>A0Y4@C(`]!T:O8/2/?NQ^O]S[#_P!`/6=.^[)L+DLMF-D5 M_?VTX8MRX@9*GFS&%P\_1V=QV'IJZDK1"8*:.$>-02S.%("6X;[LMY?65ZF\ M7)\#4JK(MLU$)!"DK."Q!!()J<^G0VVWEGF/;]KOMM_<%F$N-+.8FNXQXJU! M8(ULR@."`P%.'#HK^;^#?R[W)DII\MC]FU5%-4TLRT[T/?:UE-2T[*L]#2Y& MHZ@;/[: M\[W4CM<&V9"PP1=DA<=H;P!08IB@^72]S7\O_P"8^?W-N[>%33=-T\^\ED@C MQV/W#V_1+BL<<+1XW&DR/U4:B3-8XTS3&HJUJ0\TGJ2ZBZ&W]P>4[6WL;:!+ M\>!G4RP$LQ))H!/0(?1:&G2ZY]KN>;^[OK^9=N7QS\"O<(54(%6K?3DLPI4Z MM0KTV;$_EP?+W9.-RM"F1ZE5,J:>H!I\QW]E:RBJZ&/)12@U.;P%=0U4&0@R M31HL=+2B%5)&J1Y)6EJL6T#5-;52]?-/D:Z',Z*F,REH8XHDC2)"-?L,?OKE*2.(/> M7JSJX?6K0?$&K109NVJU7`'$GH8+L//$1-!C*7%*4.2PAJYU9[B M0`!3->DG@/BY\Q*/;%)M&EVST!0UHS,V6.<7#=O8ZGJYZB"NBG7*JVU97"&* M6+3XIH8S*)2Z,LD:0K[CF3D^6]GOGO-P*%-(37;L1FN/U`..:&OV]%]IRCSW M!8PV$=EM@<2ERQCN5#$BA+'PR02,5'3#V=\#/G!V9M[(;7EW#\?<%@\G68VK MCAIZKN>KFHI<=#3Z]"IBL?`D534TS2A="K'YY(U],K74[5SUR9MDR7/TFYR7 M2AAJ)M16H(_B;UIQ/23>?;?W#WBV:T:]VN.U9E.FEXP&DCA4#TKP&?V])W!_ MRQOD_MW"XS%XO?/4N$I\;G:'/24N-V]V7G4^X5*:.J3&U.YJ^KKPRO3M+"[S M)!"\\O\`DSAR`[)[EMLU*B*4C4?0AXS3SI2@-2!T M9G:/QB^1>T.J]W]:+L_ICH ML+BZ!#'1X#";$WI@L7B<4H^U&#P&*QU3%B,+3-22SC0*>96>J\?-D&2:*'1' M3PPJ("3YF82@(7.]\O3WEM=&_O-$*%55YEDHI-=()MJZ?MJ?0CS&]ER]S5:[ M=?6+[?8DW#*S,EN\=7%07(%Y0M0^@'R/D5ZN_EV_(?+9V+*Y;.[8K<='7FLJ M<".ILA2PY&"04\%7C)JR/OV62&CR%,DBU'A6)Y3,;DQCPL(TY\Y:AMO`@CG5 M]--7C`TI4@A?I.(:A%20.@@_MGS//=&:XEA,&H-H%NP#>15B+RM"N#0`D8-? M.3N[^7[\E]Z9G>.?R^XMKP3[T2H@R>/PO460Q%)1T$6.HJ+%T&!,'R"^XQ/\ M/./BD5S+(DLR!BBKWWMQ MS??S;C.]W!&US4$+:L%`T@)I`O*KHH"*=8>NOY8OR!V#AJS&T_86UIZ6OS&' MSK0)U!5UDT,^/@R]$8D;)_)&G,\ZT.1CB)JI)X=,3,%+2S&;>[>Y'+VYR12M MM-R)$1U!\:.E#I(H!:8%02:`'^5/;/[0\S[3:M:IO-J8F>-J?32&A6HI4W@K MVT&212HIDDF`B^,_RVH6RM'+F\-E<;F,5E,-/34'2FSHJ2&GJZ&HI8*SSYWY M635M1E/O?'62SR1.9I%4*M/JE'L.-S!RHPB9+*X296#:C<5-0?Z-F!0BHIY5 M\^A4O*G/"BX23<+:2*2-D*BUIAAQJUV3J!IFOD.'2&Q_Q&^6>+P6*PE)DL5& M<9DJ[*RU[]"[`DK\E6U\:125-?,/F/>*:&F18Z1N=H+.WM(Y[8+&Q:OTBU8MQJ?KSD#%<9 MSQZ#W?O\OCY*=C8W(82NW)/C,97Y$9GQS=,[-R]319"%JJ<3XJLR7S!JSBZE MIJ@F.6"*.1)`-3E'F$AEM_/?+>VRQSQV,K3!"M1<%*@BG=ILN[\^D&Y>V?-V MZ6\MI->1K;-*'TFV5Z$?PDWYI\Z+GKO9?\LWOW;>*V]C<%OFDV]5[!>*EJ4KL;DZF*"AI/E#D4C%35T+`*\E1%&D[*%8*I]N7GN1L%]TMK>WM=R@BEB<.':WU9!!I07C# MRH`U5%20-0'2GR?\M#Y`Y/=.5W,G96S,2XO+L5I#:G:;F0HH4%KE3A>'_$;RZ4S^T? M-,][/>KO5M"TDC.0EL10M\7_`!*K4TX]#[C/B1WW@^DLQTQ!5]?YRBSBXT9S M.[FZBH-QUN9.*=?X9KQN0^2]'C`:'0KDRW#L@N'!T>PZW-&RR;U%NYBN$T5T MHEP$TZA0]RVOF/ET+H>2^8K?E^;8XWLW\2A=Y+!?G0U!].BN;\ M_EF_([=F9_C&8[.J<^]/*T6,H\3T_P!=8+#X>B@I$BQE'B,%+\EZ;#TN-Q-0 M5GIH6IVT5$*L1I`!%NW^Y.P65NT-OLRQELLS7,C.W<2=3"R)J:!:U^$D=`G= M?:3FS<)EFGWUI=.%5;>)$0!2%"I]:J@(34`#B*]8=F?RZ/E!UYEJ?([3WA7T M"TYAJ&0]:]*>MIJG'O\I!BY,;DZ^&.JJH?"%DJ4.G3&=/O=][A&:H$(E(2DBB$GJL&`/L-MS#RZ;Z/<#42`QVL<>EJ`$@+N`4<*]H`KT`53_*^[JW9+.NZM MW8.>EEJ3+4TV8ZHPD\&2IV@L:&5Z/Y.92=J,RZ3*"$:9TO(7!!`BC]S-JM!6 MSM)%-!\%PPIPX`V0%OQNH]Q;2R^6*>WC,;KH73K:0A44Y9S'%5F9C4!<4XTZE# MD'E*\Y4BEM;E@Z'6VL*J#4[@Z0@DEHJJHH2U37A4='\]@?J1^O>_=>Z][]U[ MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z07:6)WMG^M]^X/K?/TFU=_YC9VY,9LO MCWE:[V.PYGYT.L>Q>S=V[QZ[V)U;MC>V*P9Q.R]FY_`[LJZ?=] M%38ZEWQN[<6Z<+L7KW^,5O8F0HDR`CDHIVIYDFF::-JTTE,%.6MFW&PW#<;V MYLH+:TF10L495FUBGB2.ZQQZC*W=2AH=1J"Y'4Y^]'N%RAS5RMRCL&R#QJ/)9'(;P>C[`Q?9D&=SE53X^"MW%3[IQG7'6$G\/R4E):BH*J M@J:K%T,<-&:RHCAC*^ZTYU,2.'0_?(S;O8&[NB.VMK]5"F/8VX=A[AP^S6JM MT9G9,<6>R%!+3450F[=OJ^7V]54SR>2"JA5C%,JEE9-0/NM"E17AT#7P1Z@W MSTOT6FV^T]IT^W>T\ING(YWL3.1]G[B[9K.RMPIB,!MNE['S.YMS.]=1YO.; M;VY04]1CH=-#0M1Z*5(Z?QQK[KQI4TX='.]^ZUU[W[KW7O?NO=?_T-_CW[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW75A_0?[;W[KU3Z]>L/Z#W[KW7=A_3WJ@].O4Z][]I!X@=>Z][UI7 M^$=>ZZL/K8?[;W88%!PZ]UZP_H/?NO=>L/Z#_;>_=;J?7KOWJ@].M=>]^H/3 MKW7O>^O==6!^H'^V'OW7JGKK2O\`J5_VP]ZH`"*8Z]UW8?T'^V]^TKPH*=>Z M]8?T'OU!Z=>IUZP_H/\`;>_4'IUX8X==V][X<.O==6']!_MO?JGKW7=A_3W[ MKU!UZP_I[UI7^$=>ZZL/Z#_;>_:5_A'7NO6']!_MO>P`.`Z]UZP_H/>J#TZ] MUZP_H/\`;>]G/'KW7M*_ZD?[8>_=>Z]8?T'^V]^Z]3KNP]^Z]0==6!^H'^V' MOW7N'#KVE3]0/]L/?NO#'#KUA_0>_=>Z]8?T'OW6J#TZ]8?T'OW7J#TZ]8?T M'OW7J#TZ[L/Z>_=;ZZL/Z#_;>]$`\1U[KUA_0>_:5'`#KW7M*_ZD?[8>]U/7 MN'#KVE?II%OZ6'O0`'`4Z]UZP^EA_MO>^O'/'KUA_0>_=:H/3KUA_0?[;W[K MU!Z==V'OW6Z#KUA_3W[KU!Z==6']!_MO?NM4'IUZP_H/]M[W4^O6^O:5_P!2 M/]L/?JGUZ]U[2O\`0?[8>ZT'IU[KVD?T'^V'OU!Z=>Z[][Z]UU8'Z@&WTX]^ MZ]U[2/Z#_;#WZ@Z]U[2!^!_MA[]U[KOWJ@].O=>][IU[KWOU!Z=>Z][U0>G7 MNO>]T'7NNK#^@_VWOW7NO:0?J`;?3@>]``N_?J#TZUU[WZ@Z]UZWOW7NNK# M^@]ZH/3KW7?O?7J#TZ][]UJ@].O>_=>H/3KWOW7J#TZ][]UOKWOU!U[KWOW7 MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][ M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z_]'?X]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ 1Z]U[W[KW7O?NO=>]^Z]U_]D_ ` end GRAPHIC 14 image_002.jpg GRAPHIC begin 644 image_002.jpg M_]C_X``02D9)1@`!`@$`R`#(``#_X0T>17AI9@``34T`*@````@`!P$2``,` M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q M``(````<````<@$R``(````4````CH=I``0````!````I````-``'H2````G M$``>A(```"<0061O8F4@4&AO=&]S:&]P($-3,R!7:6YD;W=S`#(P,30Z,#,Z M,3,@,38Z-3$Z-3<``````Z`!``,````!``$``*`"``0````!```#-*`#``0` M```!```%FP`````````&`0,``P````$`!@```1H`!0````$```$>`1L`!0`` M``$```$F`2@``P````$``@```@$`!`````$```$N`@(`!`````$```OH```` M`````$@````!````2`````'_V/_@`!!*1DE&``$"``!(`$@``/_M``Q!9&]B M95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\, M#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P, M#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`H`!;`P$B``(1`0,1`?_=``0` M!O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$` M`````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$% M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F M]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B M$P4R@9$4H;%"(\%2T?`S)&+A7U5F9VAI:FML;6YO8G-T=7 M9W>'EZ>WQ__:``P#`0`"$0,1`#\`]5225!V?E;G!M+6PZ-MEC`X"`6[]CW_2 MZS4!S7""9+ZW&9]7:[VN]SO;_P"K%O%?`),,)EU6QK====U?]E28,UC`UK*6AHAK07`#73\WZ/II$]0VZ"G='!+ MHF/ZO[R2FPT0(B/@G4*_5]WJ[>?;MGZ/\J?SE-)3_]'U1P):0.2-$,U@ZFMI M,09U_P"^HBAM_D,^_P#\Q24MZ3-?T3->>/\`R*0KVCV,:W4$QIQ\&I]O\AOW M_P#F*A]G9,QWG^<='W)*2R_]T??_`+$I?^Z/O_V(7V=DS''_``CTWV9D1!_[ M<>DI-+_W1]_^Q*7_`+H^_P#V(7V=G@?^W'I?9V>'_@CTE)9?^Z/O_P!B4O\` MW1]_^Q0;6&B`T$?RG%Q_SG`I]O\`(;]__F*2F8GN(_%.HM$=@/@I)*?_TO5# MQXJMOR8'ZJV>_O'_`)%671!GB.W/X*I55CV2]K\@08A[K6<;7:,MV)*9%^2/ M^TH.I_/;P._'YR0?D_\`<5HY_/;Y^20QJ1_A;3\;'^,_O)?9:/\`26\1_./_ M`/))*6-F4`",1I,21O'/A]%2<_(&[;BM=''O`G\$_P!CJ()%EON@SZK^PC3W M)?8JYGU+>VGJ/C3^TDIB7Y$Z8H(TUWMX^Y(/R9(^RMCL=[?[E+[%7_I+?^W7 M_P#DDG85;C/J7#R%KP/^J24O4;GSZE#:@.)(=.I_=4RPP=&`QH2)`_(AG#K, M^^T3X6/'_?D3[/5Z?I/;ZC8VG?[I'\O=]-)2J66M:?5QOK/ M;=G"I[*&U.M?4[]&F>Y'3?739L_=%[@QI>9(:).T%Q^36RYR$YCFG@NTWM;NX67T_ MZQ'*S<;&MJ%3,G"JRA;NT%E@=;]FX_T-=MK/^)L5%_UI=D"L>EBT,MMO:RS- ML-;-E;:+*7'V.VVY%65OV)>["KM<.0Y@R,>#4#B.L?E/%+_U'-Z#[?C@2=PC M3Z)F>4OM^.`2=PB9EI'$?^260>LX]'V#[37BV498M];*QG!]-899510[U'-& M^MUN173;_HK?^#6ETN^O)KOL%+*C7?=C^WN*;'4AQT'TMB(G$F@=6/)RV6$> M.4?39'%?42E#_N&S3D5W@ED^W0R(Y$HJ8`#A.G,+_]3U0D`$G@:JH.J8Y[/U M\AW&[Q5Q#]"C_1M_S0DIP6T;K:&6Y;[L;$N%]37U[L@$;G,J?FON>YU6ONVT M>K93^BLM]/U-Y^DU].Z7B54,8'W5,%;\@5M8Y^OY\$N^E_+6QZ%/^C;X\!+T MJOW&_<$T0B#=:LT^9RRB8&7I)!(`C&R.+]W^^Y/3^EY@P*<+(R:8LDSNP0;C"6DH\$A\O[KGCIEEUE M=F=97?MHOQ[6,K-;'MO=2[Z+K;MNUF/L^E^DWJ?2.F_LS#^R^L_(_266>K9] M,^H]UGZ1WY]GN]]G^$5U).$0#?5BEGR2@8$^@F^$`"-CB/\`ZDFI)))%C?_5 M]522224I))))2DDDDE*22224I))))2DDDDE/_];U5))))2DDDDE*22224I)) M))2DDDDE*22224__U_54DD`W7&Q[*ZPX5D`ESMNI`?QM=^\DI.DL]_4[V6%C ML*[0EN\06DC]T_2V_P!E!9U^M^W90\[W;6Z@21]+G]S\])3K)+/Q^J6Y);Z6 M+86/G;:2!7I/Y_TNW[B,[*R&W5T&EN^T.?\`ME0.78.12._\Z>!'_`_RDE-M)56Y=K@"T4D.C;%IUGZ/^!4K M+LFMCK'U,VM$NAY)@0UK&G;R&_1#M??RMRW'NLLWLR;:FQ'IL%9$PX;_TM5C]WN_?_`#$, MX628C/O;`C1M&IU]VN/YI*:N)FX#;'"JZ@V7&0**RUSB![MT>HZUVCD]F;2[ MJ-&U^YU;;6/:&G<''TG-;LV;_P`W=]%678>2X0,Z]O/#:/\`OV.4YP\B1^NW M0#);MI@C]S^824TZ`^UHVV@-(_.?4=O[BIY#<+8;JGOMH#@ M"^EK2*P&R\O>^ME5=7NWV;5LG#R2V!G7@SH0VGB(V_T?^TF.%DF?U^_G0[:) M'.G]'24YM/[(#AZ]U=A,15`V._=LV>C[['>[>_\`XQ6']1Z;]E?1CW5M:6PQ MC=![_H_F#Z:MNP\D\9U[=>S:?^_8Y5M)2"K.PKGM95D56/?JUK7M),?NAI1T MDDE/_]G_[1(R4&AO=&]S:&]P(#,N,``X0DE-!`0```````<<`@```H:^`#A" M24T$)0``````$*4T?;PS^1'(B4$$>)X`0^LX0DE-!"\``````$K__P$`2``` M`$@``````````````-`"``!``@`````````````8`P``9`(````!P`,``+`$ M```!``\G`0!J`'``9P``````````L#A"24T#[0``````$`#(`````0`!`,@` M```!``$X0DE-!"8```````X`````````````/X```#A"24T$#0``````!``` M`!XX0DE-!!D```````0````>.$))30/S```````)```````````!`#A"24T$ M"@```````0``.$))32<0```````*``$``````````CA"24T#]0``````2``O M9F8``0!L9F8`!@```````0`O9F8``0"AF9H`!@```````0`R`````0!:```` M!@```````0`U`````0`M````!@```````3A"24T#^```````<```________ M_____________________P/H`````/____________________________\# MZ`````#_____________________________`^@`````________________ M_____________P/H```X0DE-!`@``````!`````!```"0````D``````.$)) M300>```````$`````#A"24T$&@`````#50````8`````````````!9L```,T M````$`!I`&T`80!G`&4`7P`P`#``,0!?`%``80!G`&4`7P`R`````0`````` M```````````````````!``````````````,T```%FP`````````````````` M```!`````````````````````````!`````!````````;G5L;`````(````& M8F]U;F1S3V)J8P````$```````!28W0Q````!`````!4;W`@;&]N9P`````` M````3&5F=&QO;F<``````````$)T;VUL;VYG```%FP````!29VAT;&]N9P`` M`S0````&7!E`````$YO;F4````)=&]P3W5T/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C=' M5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B$P4R M@9$4H;%"(\%2T?`S)&+A7U5F9VAI:FML;6YO8G-T=79W>' MEZ>WQ__:``P#`0`"$0,1`#\`]5225!V?E;G!M+6PZ-MEC`X"`6[]CW_2ZS4!S7""9+ZW&9]7:[VN]SO;_P"K%O% M?`),,)EU6QK====U?]E28,UC`UK*6AHAK07`#73\WZ/II$]0VZ"G='!+HF/Z MO[R2FPT0(B/@G4*_5]WJ[>?;MGZ/\J?SE-)3_]'U1P):0.2-$,U@ZFMI,09U M_P"^HBAM_D,^_P#\Q24MZ3-?T3->>/\`R*0KVCV,:W4$QIQ\&I]O\AOW_P#F M*A]G9,QWG^<='W)*2R_]T??_`+$I?^Z/O_V(7V=DS''_``CTWV9D1!_[<>DI M-+_W1]_^Q*7_`+H^_P#V(7V=G@?^W'I?9V>'_@CTE)9?^Z/O_P!B4O\`W1]_ M^Q0;6&B`T$?RG%Q_SG`I]O\`(;]__F*2F8GN(_%.HM$=@/@I)*?_TO5#QXJM MOR8'ZJV>_O'_`)%671!GB.W/X*I55CV2]K\@08A[K6<;7:,MV)*9%^2/^TH. MI_/;P._'YR0?D_\`<5HY_/;Y^20QJ1_A;3\;'^,_O)?9:/\`26\1_./_`/)) M*6-F4`",1I,21O'/A]%2<_(&[;BM=''O`G\$_P!CJ()%EON@SZK^PC3W)?8J MYGU+>VGJ/C3^TDIB7Y$Z8H(TUWMX^Y(/R9(^RMCL=[?[E+[%7_I+?^W7_P#D MDG85;C/J7#R%KP/^J24O4;GSZE#:@.)(=.I_=4RPP=&`QH2)`_(AG#K,^^T3 MX6/'_?D3[/5Z?I/;ZC8VG?[I'\O=]-)2J66M:?5QOK/;=G" MI[*&U.M?4[]&F>Y'3?739L_=%[@QI>9(:).T%Q^36RYR$YCFG@NTWM;NX67T_ZQ'* MS<;&MJ%3,G"JRA;NT%E@=;]FX_T-=MK/^)L5%_UI=D"L>EBT,MMO:RS-L-;- ME;:+*7'V.VVY%65OV)>["KM<.0Y@R,>#4#B.L?E/%+_U'-Z#[?C@2=PC3Z)F M>4OM^.`2=PB9EI'$?^260>LX]'V#[37BV498M];*QG!]-899510[U'-&^MUN M173;_HK?^#6ETN^O)KOL%+*C7?=C^WN*;'4AQT'TMB(G$F@=6/)RV6$>.4?3 M9'%?42E#_N&S3D5W@ED^W0R(Y$HJ8`#A.G,+_]3U0D`$G@:JH.J8Y[/U\AW& M[Q5Q#]"C_1M_S0DIP6T;K:&6Y;[L;$N%]37U[L@$;G,J?FON>YU6ONVT>K93 M^BLM]/U-Y^DU].Z7B54,8'W5,%;\@5M8Y^OY\$N^E_+6QZ%/^C;X\!+TJOW& M_<$T0B#=:LT^9RRB8&7I)!(`C&R.+]W^^Y/3^EY@P*<+(R:8LDSNP0;C"6DH\$A\O[KGCIEEUE=F=9 M7?MHOQ[6,K-;'MO=2[Z+K;MNUF/L^E^DWJ?2.F_LS#^R^L_(_266>K9],^H] MUGZ1WY]GN]]G^$5U).$0#?5BEGR2@8$^@F^$`"-CB/\`ZDFI)))%C?_5]522 M224I))))2DDDDE*22224I))))2DDDDE/_];U5))))2DDDDE*22224I))))2D MDDDE*22224__U_54DD`W7&Q[*ZPX5D`ESMNI`?QM=^\DI.DL]_4[V6%CL*[0 MEN\06DC]T_2V_P!E!9U^M^W90\[W;6Z@21]+G]S\])3K)+/Q^J6Y);Z6+86/ MG;:2!7I/Y_TNW[B,[*R&W5T&EN^T.?\`ME0.78.12._\Z>!'_`_RDE-M)56Y=K@"T4D.C;%IUGZ/^!4K+LFM MCK'U,VM$NAY)@0UK&G;R&_1#M??RMRW'NLLWLR;:FQ'IL%9$PX;_TM5C]WN_?_`#$,X628 MC/O;`C1M&IU]VN/YI*:N)FX#;'"JZ@V7&0**RUSB![MT>HZUVCD]F;2[J-&U M^YU;;6/:&G<''TG-;LV;_P`W=]%678>2X0,Z]O/#:/\`OV.4YP\B1^NW0#); MMI@C]S^824TZ`^UHVV@-(_.?4=O[BIY#<+8;JGOMH#@"^EK M2*P&R\O>^ME5=7NWV;5LG#R2V!G7@SH0VGB(V_T?^TF.%DF?U^_G0[:)'.G] M'24YM/[(#AZ]U=A,15`V._=LV>C[['>[>_\`XQ6']1Z;]E?1CW5M:6PQC=![ M_H_F#Z:MNP\D\9U[=>S:?^_8Y5M)2"K.PKGM95D56/?JUK7M),?NAI1TDDE/ M_]DX0DE-!"$``````%4````!`0````\`00!D`&\`8@!E`"``4`!H`&\`=`!O M`',`:`!O`'`````3`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P`"`` M0P!3`#,````!`#A"24T$!@``````!P`(`````0$`_^$.PFAT='`Z+R]N&%P+S$N,"\`/#]X<&%C:V5T(&)E9VEN/2+ON[\B(&ED/2)7 M-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX@/'@Z>&UP;65T82!X;6QN#IX;7!T:STB061O8F4@6$U0($-O&UL;G,Z9&,](FAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT M&EF+S$N,"\B('AA<#I#&%P.DUE=&%D871A1&%T93TB,C`Q-"TP,RTQ,U0Q-CHU,3HU M-RTP-#HP,"(@>&%P.D-R96%T;W)4;V]L/2)!9&]B92!0:&]T;W-H;W`@0U,S M(%=I;F1O=W,B(&1C.F9O3TB(B!X87!-33I);G-T86YC94E$ M/2)U=6ED.C@U0S%#,#1#1C%!044S,3$Y0C-#0D,W-3&EF.D-O;&]R4W!A8V4](C$B(&5X:68Z3F%T:79E1&EG97-T/2(S-C@V M-"PT,#DV,"PT,#DV,2PS-S$R,2PS-S$R,BPT,#DV,BPT,#DV,RPS-S4Q,"PT M,#DV-"PS-C@V-RPS-C@V."PS,S0S-"PS,S0S-RPS-#@U,"PS-#@U,BPS-#@U M-2PS-#@U-BPS-S,W-RPS-S,W."PS-S,W.2PS-S,X,"PS-S,X,2PS-S,X,BPS M-S,X,RPS-S,X-"PS-S,X-2PS-S,X-BPS-S,Y-BPT,30X,RPT,30X-"PT,30X M-BPT,30X-RPT,30X."PT,30Y,BPT,30Y,RPT,30Y-2PT,3&UP;65T83X@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`\/WAP86-K970@96YD/2)W(C\^_^(,6$E#0U]04D]&24Q% M``$!```,2$QI;F\"$```;6YT`",`*``M`#(`-P`[ M`$``10!*`$\`5`!9`%X`8P!H`&T`<@!W`'P`@0"&`(L`D`"5`)H`GP"D`*D` MK@"R`+<`O`#!`,8`RP#0`-4`VP#@`.4`ZP#P`/8`^P$!`0& M!YD'K`>_!]('Y0?X"`L('P@R"$8(6@AN"(((E@BJ"+X(T@CG"/L)$`DE"3H) M3PED"7D)CPFD";H)SPGE"?L*$0HG"CT*5`IJ"H$*F`JN"L4*W`KS"PL+(@LY M"U$+:0N`"Y@+L`O("^$+^0P2#"H,0PQ<#'4,C@RG#,`,V0SS#0T-)@U`#5H- M=`V.#:D-PPW>#?@.$PXN#DD.9`Y_#IL.M@[2#NX/"0\E#T$/7@]Z#Y8/LP_/ M#^P0"1`F$$,081!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@<2)A)%$F02 MA!*C$L,2XQ,#$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA3P%1(5-!56 M%7@5FQ6]%>`6`Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_<8&QA`&&48 MBABO&-48^AD@&449:QF1&;<9W1H$&BH:41IW&IX:Q1KL&Q0;.QMC&XH;LAO: M'`(<*AQ2''LP>%AY`'FH>E!Z^'ND?$Q\^'VD? ME!^_'^H@%2!!(&P@F"#$(/`A'"%((74AH2'.(?LB)R)5(H(BKR+=(PHC."-F M(Y0CPB/P)!\D321\)*LDVB4))3@E:"67)<`^(#Y@/J`^X#\A/V$_HC_B0"-`9$"F M0.=!*4%J0:Q![D(P0G)"M4+W0SI#?4/`1`-$1T2*1,Y%$D5519I%WD8B1F=& MJT;P1S5'>T?`2`5(2TB12-=)'4EC2:E)\$HW2GU*Q$L,2U-+FDOB3"I,%W)7AI>;%Z]7P]?85^S8`5@5V"J8/QA M3V&B8?5B26*<8O!C0V.78^MD0&249.EE/6629>=F/6:29NAG/6>39^EH/VB6 M:.QI0VF::?%J2&J?:O=K3VNG:_]L5VRO;0AM8&VY;A)N:V[$;QYO>&_1<"MP MAG#@<3IQE7'P,QY*GF)>>=Z1GJE>P1[8WO"?"%\@7SA?4%]H7X!?F)^PG\C?X1_Y8!'@*B! M"H%K@%JX8.AG*&UX<[AY^(!(AIB,Z),XF9 MB?Z*9(K*BS"+EHO\C&.,RHTQC9B-_XYFCLZ/-H^>D`:0;I#6D3^1J)(1DGJ2 MXY--D[:4()2*E/257Y7)EC26GY<*EW67X)A,F+B9))F0F?R::)K5FT*;KYP< MG(F<]YUDG=*>0)ZNGQV?BY_ZH&F@V*%'H;:B)J*6HP:C=J/FI%:DQZ4XI:FF M&J:+IOVG;J?@J%*HQ*DWJ:FJ'*J/JP*K=:OIK%RLT*U$K;BN+:ZAKQ:OB[`` ML'6PZK%@L=:R2[+"LSBSKK0EM)RU$[6*M@&V>;;PMVBWX+A9N-&Y2KG"NCNZ MM;LNNZ>\(;R;O16]C[X*OH2^_[]ZO_7`<,#LP6?!X\)?PMO#6,/4Q%'$SL5+ MQHM\IWZ_@-N"]X43AS.)3XMOC8^/KY'/D_.6$Y@WFENV<[BCNM.]`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`NP07XNQ%PO/YMS[]U[KG[]U[KBSJOZF`_2.?QJ.E;_ZYX'O MW7NN7OW7NO>_=>ZXEU4JI(#-?2/RVD7-@/Z>_=>Z\SHBZV8!1R6/T%_IS[]U M[KE[]U[KWOW7NN"NC$A6!(+`V_JILP_V%Q?W[KW77E34%U_=>ZZU"^G\_P"L;?UM M?Z7_`,/?NO==^_=>Z][]U[KWOW7NO>_=>ZZ)`!)-@`22?H`.23[]U[KH.I74 M&&G3JO\`C21<-_K?X^_=>Z\KJVK20=+%6M^&'U!]^Z]UTSJOZB?H3P&/`-C] M![]U[KD&#ZXJRN-2D,I^C#D'_6/OW7NN7OW7NO>_ M=>ZXJZ-^E@>2.#_J39K?ZWY]^Z]UQ\J:@NKU,6"BQY*?J`_VQ]^Z]US!#`," M""`01R"#R"#[]U[KOW[KW7O?NO=>]^Z]UP,B!M!/JL3:Q)L/J>/]A[]U[KM6 M5Q=3<7(O_B#8CW[KW7;,%!9B`!]2>!SQ[]U[K@LT;:-+@ZP"E@?4K"ZL/\"! M]??NO=9/?NO=>]^Z]UXD`$G@#DG_``'OW7NN(9674+Z>>;$7`_(!^O\`@??N MO=<3+&`2S:547+,&50+7/J86]^Z]UR5E<74W'X(^A_UC^??NO=]^Z M]UQ9T0J&=5+7T@D`MI&HZ0?K8]^Z] MU[W[KW7`NJFQ)OZ?H&/ZC8?0>_=>ZY^_=>Z][]U[KB6`(!^I_P`"?\+FWT_V M/OW7NN7OW7NO>_=>ZX/(B6U$B_TLK-^0O]D'\D#W[KW7DD1RP5KE"%<6(*L5 M#6(/YL1[]U[KG[]U[KWOW7NN(=2=(8:M.JWYTDV#6_IQ]??NO=WD2^L MQV#`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`K=G\P7Y,UV)/;U9-U.-T=,?&O MYG[?AAFVQEG;#?*KXL?$?&;Z[PR.9CQF7.+DQHWO7+B)L32U.2CI8,?+3K6P MU_W0C]U[HW.^/E!\S>L>W\W\;=R=O=*9"OWS%\9=V8OY(S=+U.U-L?';;/R! M/:.'R]#N#8F2W=-2YB"++]=8W$[6KLCF:9WK<_#!6I6F",5'NO='5_E_=V=@ M]Z]*[SW'V7OK8G9VXMF?(SY(=/4O8'6VWHMK[0W?MSJ'N#*[`VUGZ,KVKW;\C<]\D_CKT[7?+KJ/$U&R?D;N';^WOEKB^O<=0=8[QB[#^%.^ M]_Y?K'/]7C=[8+(Y[;TM%CI*8S9HHM/DL?4O0-5Q">H]U[IZ^_JNFK.E-A9W;M1W!NI M]B=,X//Y##]]=8[PSO4&-P>WND>QNR4I(*+ZF9[Y4_*_8W9%;L36Q)]N/\9OF_MW=?4U/M?%3]>=O;R^.'SPV%\?H-_25VRMWS M!Z]T;'Y(?S!ODGU5A/D)W%M??W4B MTFP^X^_?C?M3XDY#94%9VIA9>L-A[AS6!^0.5W0Z5.ZOEU\U>K*3LS9N<[(Z"[&WUN/XW?%WOWK7<1V-CNF\7L M.O[S[M'2>\MB8FFWIN^;#9ZLB0?Q#94>>W#C(ZW*M%CZ/-\` M?D)NSY`]+MF.P=T4&?WYMC??86P=Q)-LFEZUW;!5;%SJX>IBWELG&9;/8F') M02,(ZFJVOGLIA:A3%/1US>5H8O=>Z+]_,:^5GR:^.FYMK[-Z'AVOF=S?(#KS M-[7Z#P^5VI%EZR#Y"=?;[PVY-QT=95Y+(XS'UE+DM@5V?KXL;/705"R8.6:F M$ZFH$/NO=$CP?R7^37>_?79_R1Z9[MV'LC8S?"/LON_JW$U&P,IV3MW-]2=7 M]]UF!VECWI)\WAJ+^(;A?"9J;([DBIZ@BDK*1,;(]/"D\WNO="AU1_-`[\[- M^2/6F/.PGQ/5VZ>P^DNC\QL;^%=04F-ER_;71^![AR'9F&[`W!V'2[SJ*BA? M-234.(I.NYZ2JPE))4K4//(U12^Z]T*OPQ^5_P`L=][I^#^8[N[`ZIWMM#YM M]"]N[]BVAL_J;)=?9/JW_K7:E-T3_+\VG\A>E1OAL=CCE>XZ]T3#L^ MRMW;'VSL?Y-Y[KCK39.TMN;GP.YY_COU[6;J&"Q_:^T=T5.X,7O2-\;-4;KV MYO?:&&QM/"*^'%9>KFI:3[OW7NE3U]\^OE)G^N^P-GYBMV[C]Z4?=/QMZ_3Y M`[YV)T[C]O=8[*^2F1RE/4[JW3U?TWVEO;%2I@QC::+"U.3W50I7-F<8U13R MBGG^]]U[HVO\K_.;KW#LGY;#>O:^*[IS>'^^V9>Q-N0O0;8S%/A<+MZBB M3;F#&2R]/C(82&CGQ]%724\-6*GQK%K\X,4:MJ4J[6]U[JO[K'Y(?)SXT;)JNVL MIV-MWO?K+Z-;_+C^:/=WR.W#OC:O;>-6O#=6]7][;:W+'A M.F=L18?&]JU^3I(]@4N`ZH['W_-5XF..@6JP&>R\F/JZN(5:3P2/3Z_?NO=( M7M_Y`]Z;<^:V\>F.E]P=;;#R?8OR!^)/3]=O/=6RTJ`8J2+P1@:Q5I5HQM[KW1:M[?S'?F'LJDHXL[V#TU#C^C-V M=Z;,[CWUMCK3";DR.^ZKIKY-YGHW'=@]C='5V\Z'=&V=D5V-Q,=7ELKU[%NK M(TM>U?'%C!#!1Q57NO=#5VA\[^\L!M'Y&]X;>^17QQV['L_:_P`_-O=?_$+> MVQF/;&'W)\/L!NE,3V)+N;&YYJW)///MREW'E,-78:AIC@\G$\%3'(D$M7[K MW09;I^1WRIZN[RR_6%=\@.B]N=@]A=K_``O,OO`XZ*II:O;6*Q>`F?)(TKR6K!6R2J@]U[H#^_OE+\I*S=>U]X;E[ MKV+D=J8'J#Y,[*DV+2[)J,5UC\BI^E?GQU=TMAN^<)38?=+54,^6H,RF3I$H M:VHCH7H,A!3RS464FC@]U[H\&Z/G!W[@-[[KWI%V#U7-MK_9FNZOBIC_`(FQ M;.@F[=V;1=9X71QF7W7N MA0^%'R*^46\NS>@]L=]=A=6=D83Y,?`;;?R[Q*;%ZMKNLZOK3=N*J]D8'=&U M:*:IW!F_XQBY=XT.*^& M^9Z^WSL?J3`[13KMOEYW'NWIRMQ]7L_>.]J+$96BVTVU5JL369W=F,^\K:Z* MBKJC0HDD]U[HZOP6[][)^1?1V9R_8U"N.WILOLS?W461W!/1=>Q-NU]E24\, M>[Z_;76&Z-WX7&5VNH-#E,33;AJDBKJ:H`$",D$7NO=4<]>_)3Y+_'+J?<\. M)^2&!W!OC,[Y_F`_)CL?=>>ZBVODJW-4?3/R-W5U+11[SS/V7D^*%-\BVJNJ]^T&7ERIR>7DR#R;6I1MIJ*IQ6.:2>19* MIJB'W7NAS_EP_,;O3Y$;B[`VEW#COXG]GUUU;W3MW=J8/I?:,6/Q_;59F(H= M@TNWNH^Q^Q7J,;30XR&JP>=R\^/J:Z&2I62"1Z;R'W7NFWY<_+WO'K3L7OU- MG[[ZUZQV_P#$[I_K?MM.KNP=GIG=V?,JHW_%FZJIVCL+.'+44^(@^XPJ;6PU M1B\?6U,N=J)TJHTIXJ=9_=>Z6?\`*TV]V%!U?\HMS=A=GY'L;?.]?FW\KX:W M<>9VW482MQ,NP^SZ[JS&XQL+-F,I3Q4]+!A8!38ZB:GIZ2(+1QI((?N9O=>Z MJ8^-_8_S0;>'N[^H_C5\N-][ARN^>KJC=T65H>E_Y@78N$QFP! MM.FW9%08@5E+@JF!J^3SU=#C:J@Q]&HAQR2R^Z]T97,?-CY"28'L7='4YV)L MC.=B]\],R9=,'0;.W;V@F`W#_+:ZY^0E=C>L-B]X;SVIMS=.3BR63^RK(ESV M-FAPT9JJ:AKJV*9Y/=>ZLFI/EUF:3^7H/F;_``_#=BY2@^+==WR:'9^"W9MK M$;OR>,V(^Z33XC;&[E3,XVGFEC(EI*\&HIDUJSNT>MO=>ZKZ[7^U_D=U+\G]_=H=@8*DH.UOC]T_UG49?I7#5/567[/EVIN#9&_\`LW";-KYL M]%B%J-KU=3O-*Q\:Z5^P/E3\N?EA7TT6T^QMB_'?;]-_+] MVS\AMRXJDZTVYVSN+,=B;VWQV7UA2YK:^[GOC'M+._(Q:JIS/R!_E=T7:V^\9@,]DL]W51[]^ M'%#W`N'["K:7=5.)GH_H[YF=J;DZQ^// M\)[PZ"^,F+Z[^,OP#[%W7MCMG:-;E,)\AJ[Y34$43;3V1N/(;@.9PU#!40-M MK"UM%1Y:JDS52R5'W*TP@D]U[HJ??G\P?Y5;NZ?[MP^#^0V`VS#VQ\5OEYW' MUEO7!=9[#V/FNO*?X[?P+,15W40H=^Y#=]5C,UC\U5XV'.;TV[@Z.KFOY@7R#VO\N,3U#`AWOU]UQV5\=_CQO:M@V7TCMG"=R[A[GV M=MG/Y+NK![HSO9M'N+%@?W@>KP>!P6RLO254>/JZ=:^>61GQ_NO=7693 MU\EN#$5N#K!18O)U\51/DT_@ODQ]-,[_`'F2H5F*0QRQ%:F2*.1D57(1V72? M=>ZUGZ/Y@_+'O[.=!]>[K[:V5MOLVM^3?P^[$P5;A=@XVNZ_QF![:PF^Z?(M ML?<_4&^LKBNP=BL<;)#@OX_D<)G7J*>*KS&$BI9H/?NO="YO_P"?GRRV[3Y_ MK1.X=A8[?G1>X/E'0;XWYBNF.OTI^RL!\=)L9X]];RH.V]^[3VYM/#5+9./' MUM+@LSELL:MHI8*.&D\CK[KW6;X[=\;M[M^8?1?95?G*[&4O;/R9ZSW?5;2P M^Z\U5[3H*3?/\CFE[0K=KXRDJ)52?'09>IDKHHI(+&H053(*@%Q[KW1L?FEN MSL3`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`K/DU@*?O'N;J"+H/L?=/\R3:&W=NML.BZ_GV7+\,_DUA>I-BU.0[0RN< MJ(\E793&9"OGK*8T=,A2F62)+QSNWNO=%.?^;)\FYMC?'S>.-PV+S4D/Q2Z" M^2_93X+:_35)LONJI[QW5GMM+M7%[G[0[*VI6[?HJ=,+#'0UVW,1N"1Z^O@2 M>,1QQ4M?[KW0\Y#O3N_LSY:_#_);T[NZ[VUM6K_F#_)'J&E^*&#V]#@^SL!A M>F>E.X]M[7W9O#=,>Y)Z[,09RBQN.W+5T%5@(J*-:_%3TXC,,-14>Z]TH_P":!\BNT=W?$[?&2W1U/M_J M?MW&_&#`;APFR=L[<[/Q$N]^\Z],-FJ7L_)8C=J;SV=4UU140)LFIPFUMP8* M662G.7RM+2?>U%+[KW1U/YHV>[9VX/B#/UWWQ/TOMO/=^=@;5[%H(,#09&/L M#$S?$[L7=V-V_DOJ:&O0?<8VGBF]U[HFO57R]^4? MQA^.'4QWCNW8O>,6Y_Y76QODSL8R]?YW:8ZGK]D?Z,>K:RNW_N#^/9K*;GP< M4.])=U[KRLQAK88,74M3*WW(CA]U[H,QVX\++C$R M^_\`KF@I-E9"7=6/^TH<50;9P^/I)<53UDE7E*MI97:&2&E;W3XC6H'K_FZ' M/I;N'Y&=6=C5NZ!V=M/=/3G9_P#-I^1_QBJ>JMS<\L,N&J,2T-#@:;#Q40HY%A-I8_,?=,=##_,3W+V_@.]_B!3;0[UJNNN MO-U8'Y>4>_\`84&*CCA[(J=L_'+*;HQE'/G!74\D4P$)CH%2EF>GGTUL*F6( M(?=>Z)WM[YK?*WXH?''XZXK=.^-M=ZU/<'P4^-O877]=BNKZ7$;BZDS^?WYU M3\?:G*YBJWMO:DI=V4MM^2YZMK-QY[#(:NCCCGK:>FK9&IO=>Z7%)_,Q^0^P M>LE[$[-IJ:MP^(3Y4?'*GGJ]I]7T6XM^?*W9'6N`[8^-]34X7JC>>\YM_8K&;+W3MK96$[C^5VP,-1[:QU;F]W?##=28KK+XF9 M@S8#/RXZ*FJ-RY+);BS6LMW9V#U)U-GJZOV=NKXG[S^0]2LW373'9NZ\/C<[C M*K!4=/`:G.J]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U__U=_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=!MV[VQLG MH_KW/=I=D9=]O['VLV(;<>>&.K\I!A:+,9RFP$>5R,&-222*BIYJJ.6NK&40 MTM.LM34-'!#)(ONO=%7?>Q-[0GK[?KUN,S M7QBZZ7M+N^NI<=%CWGK,5A,1+3R',T:2T5143TU'2S3551%$_NO=`+OC^;#U MELBHIZZ'KSM7>V"S'<_0G46,PVU^F/D%3=JX&/NZAR%;1[NWMUIG-G05D$$L M=`U1MVCH343Y>%XO%XIIHHG]U[KEUC\__B5W+U+0=I[PZAWCLJ#N'?6\/[X; M6W1\<.Q-T92DI^B-^?Z/Z3NGN?\`AFV9%QNV\:UMJX3=>8S_<.P>F>T7WA\:MU[OZAE[ARFU<) MN'J+;?9_:F5VW5;1_B60H\YAJ;:YRF3)>HGAHJ9A,R1'W7NC$]W_`"3Z=^+E M'M3#[R3=C/N#'9EMJ[)ZJZHW_P!K;I&W-E4]*NY]PQ;'ZEQ63KJ/`X**KQ\> M0RDE(E'2&II8F=7FB0^Z]T`\O:_P)R.VHK8XLQ!N[;;4U3MI!32FK"^0212!?=>Z0G6 M/RLZ-[&^#V1^;VW>D\)U5MW(X#?6.S.$[>ZVW#M)TQ.7[2FI=WX[/RXG;<^7 MKL3FLO5564JC0X:I@K:RHEDF5Y?N)1[KW2BZZ^0WP%AW1MSXK]<;.VYM7'4/ M=6_.N]H[5I/C)O#8'0T?R(Z4W#D,WN39>U]W2;;I-EC=^/K\+5YN@3'UC54P MI7K:1I&173W7N@[[H^5?Q^ZD^56;^-F_/CYMS'=<[=Z$WCWYW!V]G.F-SU^W MX:CO/L&BZYJ-N;:I<)M.NP^6DW55U4L>[*ZHS,0J9"*:2.MJ(ZM(?=>Z"+^: M'W?U\F+WUTOM6CBINSL/USV#NWM/<5'MC9]6]-M?I3XZ[N^3.P>KMZ[=[,VW MGMM[VVON:GQ>;QE5A,C#/38Z2J;(Q1Q9".`^_=>Z.EU2_2OP-^+NQ!(-S+@= MT92#/-0;5V%DMX[Y[&[<[AFJ-^;@IMD]3=/8@/+5UM9/75,&$VQ@X:.AHJ=E MIZ:GI*4A/=>Z!OO\`+9IMFUO;>P-X;[S^_L?COAAN;>';>'W/ MU]2?W>[6WGWSUMCMH5&Y<%+M^/()09[+;HH86IXZN*&24K5*']U[IVS/97\L MRGJT^-^Y.L.G8^N<.V]]STCY7XP0R?$ZCW!C]FU?9V_J'&=GU&V_[@?WA_@, M5=F*[6Z+Q&W^NOQ>[%ZBZ%P&XNL>B]X M?([==9O&HAV+48G);MV_D]E4=+N3;\-)4YW'U#R2FF>NQ_V9]U[HS.Y_DO\` M`GL_?>0Z4[,VGMO?.XMV]F=>]';[JMZ?&C>^ZNIJCN*BVQC^P^I>O=[]L;KV MQ)MF6ND7<=+)M"'*Y!9'JZMH*0)6R-$WNO=<]J]T?R^^V^V=H=$XKKS:FY]S M9K.=Q9SK&;/?%;.TO5FZ=Q;)C%%W=N'JOM//[:AVQE:BFE'V&;K\+D9FJ9%\ M9DF"AO?NO=(S8W7N/O#$ M]_\`W6#P/2FQ\O1[9J,KN?[Z9(,?1;>H*FM7+(]1]O3R04%:8_=>Z,]C.QOB MIVOTEO7NRMPFS)NJ<3L;=6PNTY^R^M#@,SMC9O7M;6+OOJGM;8>^,3#D\?3X M61*HUNVZ+1@OEM\!NI,AM?]Z=>]I18'LJ7.=G[=P6Q_CS1;2HLW-A<]4;-SLM%D:#$M0M5XNKA62.H6 MM<1 MUYT+LOKS$YKL7I7:^Z*2C@CQV].D-D?%[8WREK*_!1X7`-A:/;LE/OR0UN)R M>3IJ/[>'[RF-3/424\/NO=2\3\MO@3#N"A[)V_U7N:+MK:U-@NJ=EX_%_"3N M&B^265V+E,+5[AVU3]2;/7:$>[,EL@X_&5]3'78>F?#QT])-JDC$=C[KW23V ME_,*^'^%[?78T.QX=M]9=8]2]6;OZL[7VGTCOW*X#K/"=R;HW9UYOK;_`&$N MW-LM3]54F&R^S$PN53.U5`'K#/3UD5.6^2>2V?L7I?N[-]#=@=G92JP&V\M5;;VM64F,HY] MRY6L6GQM/]W'1U%1-8%_=>Z&/MK,]0=$=@](=C[>Z5ZKRF[OE!V]M7X][P[6 MH,/M3#;K?8.0ZJS^_J;)Y?>F.H&K,WC:6#:E%308VIJA3&G:-P0M/&GOW7N@ M;V5\H_Y=^.Z_W1L+";"Q'674&XL50;BRVV=Q_$S>G4?4W;VR.SM]87K7(=E[ M5P^Y]KX[#[LVK/E=R8!,[N*A6KHJ>FRE'5Y"=*2HBF/NO=*[;7S1^!O1>U\M MMK8\VWNK=L;=[+[DZRJ]G[&Z5S^TZ:3L/H?*8C9?8M'A-G;6P\)KBV1RFWMO M8>MHJ62'*Y"OQ./QKU4U;21/[KW0Y],97XT]R=9[MRVP>O_3+]49K!4&SL;)7P];=F]:;\Q.-K:*EHJ',-64F,RU"M.E'D//`G@J];^Z] MT"65^?7PHWGU?V[GMW9K,575.R^N1V!O>E[)Z0[+H,!V#T1GZ[^[X[#V#MC= MN$C_`+\[0KI9TIEK\#2Y"DE66(>H30B3W7NE;N/N;XI=,]!=?]S[BZZK>N^H M?[^[9'7.W&^-6\L1O/"=H]B;HJ-@;5KZ]U@Z.[R^'V/W-N7K_J+9E-T]59N7,]B[AKI/C_NCH78N[-UX^B& M;["CJ-[Y/!8?"9;=VWXT==X8LULN2QLD%5'D(XY:.JCB]U[I`;7^7QC[0V;7[U&_-P3=-]/=C[)WEOC;M",ICJV7,U M6)Q&>HJF2&*DJJBTT5)-+J]U[I&[X^0WP[@^1%7U_N_J3JC-8KH'`=V]T;H[ M*RW5-+F=R=:]_;.WYUI#E<1U_MR?`U%?7[AW#-V+A:].U(MQU&WZG',\^,HLM!X,G`98J(R>"94]U[I,=Q=K?!WN_:7Q-W= MWI'MR;^/0=2?*G>,77G1V\>VNIZ[84^P-T=3[*R'R+W1E=J+_!>OC_>;,?P? M)[UI,8H:CJ'"P)!6(GNO="Q4_+K^6AN6;;VVMW8G8M!MGJ?%=V8S8>Y.R_C) MN?;O3NS?]ER.1P?=.R^L.QMZ;:@VXE9MVCVU7U-9B,%6&5L;0O4PQ24T&I/= M>Z&'J[M/X?=R;ZR'9&"Z]I\3W-GZC'],;DR/:/QHW1UIWQ44.X-JUF[\%MG> M<6_MN4.XH]NY7$8JIFQ]5D'7$U,=.88I7E"1GW7NCE878VR<)/@Z M9=U=.]4[ZW1M'>^]^N-B;PWGU]639#K_`'=NG9^V\_N?85=4O&]16;(S^5I9 M:O$RR-#$SRX^:)V9$8L652/=>Z=(NM]@01T$4&R]J01XG=65WWBDAV[AXUQ> M^,ZU9)FMYXX+`/!EJM\CD'JLG':IF:JJ3)*QGEU^Z]U`WQU'U?V;!C*7LGKS M9'85+A:J>NP]-OG:6WMW4^*KJO%S8.MKL;!N&FJ4IYIZ&IJ*.>6$*TD$LD+D MQNRGW7NI&:ZNZXW*FXTW'L39VX%WCMNCV;O`9S:^"RR[LV;CY*N;'[0W,E?3 MR+7XN"2OKI(,?5!X(WJ)V1`99"WNO=..U=B[-V+MW#;0V/M;;^RMI[=H$Q>W M]K[0P^.VSMS!8R,@Q8_#X+"104E-"A`*1PPJJ\V`N;^Z]TD,MT+TCGFVPV>HR%91"*:IE MDDDG>1W9C[KW76&Z#Z/V[N3"[SV_T_U?@=Y;;VC3=?[['ZY MHL]FJK6]^MM@[OWAUW639+KW=NZ-F[;W#N;8.2J6C>HR6RL[F:6>JQ M51(T,+/-0RQ.QC0DDJ+>Z]TJ<+MK`;+-N)N=FYS:V7R.U\338#;60R>WEB58T@2-1&L*J$"^FUN/?NO=!`/B[\;5V%D.JH^@>E8>KM(NJ=@)U[F=PRU8KY<[E]E#'?PRIK6G"SFKFI6E\@#APW/OW7NA-QNQ] MHXC(G+XO;>"QV5_@.+VJ,C08;%T-Z1^V>A.D=F4=+CMH=0=7[6Q]%F:'<='0;4GV%M*;)=9T/VOV7V77N0DHS-A(?"!$(<6\"!`$50HM[]U[II3XV?'V&M MW#DZ?I'J&FRF[9S];%CA)6U64Q]144&2 MJ*II'JJ::6GG:2&1T/NO=.5#T'T?C-R[.WECNGNK:#=G7>VH=F=?[FH^N]FT MNX=B[/IJ84=+M/9N=@H5J\7C(H0(8J"AFB@5`$6,*`/?NO=/VQ.M-G=:;5HM MF;)Q,>W]O8^MS>2I:"@(@CAR&X]PUFZ\Y5QK&`J&IR%?65+HBA`9"$55`4>Z M]TG=N_'WHK:%17U>T^FNJMKU.4WI'V1DI]N==;,P4N0[$BCEBCW]7OBJ&$S9 MM5GJ%3+2EJM1+*%F`D<-[KW63.=!]';GKL7DMR=.]6;AR&#W;D=_8:MSG7FS MLQ5XG?>7ITI,KO;&5.1HI9*?+U,4<<53DX66IE1$625E50/=>Z=-O=.]2[2F MP\^UNL.O-MS;>FIZG`2X#9.VG^J0;^_=>Z>MU[$V=OO;N8VA MO?;."WCM+<-+)0;@VKNK#XW<.VL[037\U!F\#EXIJ2K@<&S0U,+J>.+B_OW7 MND1D?CQT+E\9L#"9;I;J?*X/J>MHLCU9@\GUQLS(8;K*OQBQICJWKS%UE"\& M#F@$47AEQ:0.NA;'TK;W7NE9'UKU_"E&D.S-K1?P[=>1W[0-'M[#(:+?F9>J MDS&^:0+!:/,UC5U::K*(!4RFHG,DK>:35[KW2+Q7QM^/F#V3N7K/#='=/XKK M7>>0J$O8>(P.=V'M/,X3%[_GR51F:C?..Q.3 MHY8(,S)65=56296*-:IIII96F+R.6]U[K#4]`]&ULNP9ZWI[JVNJ.IY))>JJ MFLZ]V?55'6$DJ")VZ[FFHF;">D!?]QIAX`'T'OW7NL\G1?3,O80[FJ:FF@455HXII8TLCLI]U[I[W[ MU?UQVI08G%=F;"V7V%BL%GL?NG"XO?.U-O;OQV)W/B"QQ&X\91;CIJF.GKZ0 MNYIJR%5FCU-H<7/OW7NDO2_'CH>@W1MC>]#TSU30[RV1!F:796[*'KC95%N? M9U+N2OK,KN*FVIN*EH4K<Z]TL=[]=[#[+ MQ5+@NP]F[4WU@Z+*X[.T>%WEMO![JQ%-GK:E:LV7C3#` M/!B)OL:+RXR+33-X(;Q7BCT^Z]T'D/Q:^-5-L.FZKI_C]TG!U?1[AAW=1]:P M]4=?Q=>T>[*:H%53;II=D)CABTR4Z*S8^2QDN7IH8!4,E1$M3[]U<2,.'1\$ZUZ^$=.O]R=I@4^ZZC?\`&V\*HA MW]622SUF^X46"R9J62HG>3*J!5,TCDRDNU_=4ZR;IZWV!OE,)'O;9>U=XIMG M-1[DVV-U[>Q&XSMW<,5#+C(<[@6S,,QHJQ*:HJ*=*FF*2+'+(@8*[`^Z]TW5 MO4/5F1QL.'K>NMCU6*IMF5/7%+C:C:6WJB@I>NZS[7[OK^GHIZ9HEP4OV5&) M<.$^S?P0ZH3XDT^Z]T`>^OAQUMO3)?'K!4"T_7_2GQTWYCNT=O=#;`V1U]MK MKC/]A;1J(\IU?G*U:+&BJH8-MUQJ*^DH<3)2P5%2ZO5"401K[]U[HW%114E7 M234-5!%44=3'+#4TT\:3P5$$X*SP3Q3!E='#%75@002#[]U[I#8OJ7K'!Q+# M@]@;,PJ)LS&= M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_6W^/?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T&W<77>'[=ZI[%ZKW`U1'A M.R-E;HV+E:FC>2.MH:'=F$GP4^2H)8;,E13+/YZ>12&21%=65E##W7NJE\#_ M`"DGP_7O:NRSW6:K(]P_"W<_QVW=G3UA244>1[Y[+5H>X_E/D,P.TML]N4FV-U[H[I^'/=&V M8LSUS5[LP&#R_P`2X)*27;^X:2DS6-J:^#/PU-0HFIZJE:DD\;@U(5XW]U[H MH6\OY+$.](Z6GRW:VP]P*E%W#UO)/OGI#<>??'=*=E]T;B[RP]+@J+$[XQE` MV\<-D=UYS'OF\<_CMT2TIVIC M]P;=FI,QBLGBH*S$Y&/(/`5FJ8:ZBJXV@^W]U[HGNR/Y7&Y.H\'MWJ3J?OO& M8CXZ83Y#_&+Y.5>R=T]03[H[/S?87Q[R.QZBOQ,O:D>XJ+'TN'SR;'H*HQP; M8-315L\[)4S4>BB7W7NAGQGP4W'%\"=U?!_+]LT&0I*\[CQ&U.Q:3KJHQE7A M]GY'LT[]P&.W'MILU5ID,E21.U'65M+54L-2;3)34P!C/NO=*'&?"6HQ]-UI M2KV()O\`1Y_,`[D^<))VG+&N3A[=RV_LL>MOW*\^$T+[X*G++J\IH[FDC^X( MC]U[K+\GO@W3_(S?':&ZJWL2MVO3]E?&G:_0U-1T.VTRDJ<2(X'EA1Q'61/(&B]U[HKV_OY7_:G[Z.C\E_C!G>^?C]MCI7#[^CVI5[;KMB9%JC.;>SV>V!OR/9..-,^ MT>TMF[5S>WLMD=OUSLM7/18[<>/G6JIZ1S4/%%)#/[KW1/.M_P"6GW?TAF=W M[RZ5^5.R=@;^WWD>Y*#,[CI?C%056#V_L+NC=..[!JJ/K[8W]ZEH1DI?N)O=>Z$&O_EZ]@YG;_:W1V7^2^6?XE=L93O/ M=NY^M:#JS;]'VWF]X_(!Z<:WX*]J]AYBK[![\[YVKOWN5]S?$Z/%;IV)TW7]=;4Q76'Q5 M^1]#\C8=MML^KW+FY)Z#;O+^6=V/V MWC<]UCMSY"[>V-\>)^P/DOV[MWK^;H^LS_8&)[*^4G3_`&)L3?=1D^SZK==- M!6X:DS79.7W%CJ!,'!/=?L):UXA')%[KW0YT_P`%JF';F[MN/V4X.Z_G)T%\ MR361;181T471LG7U1)@=DX_:/=]+NC,0=E4[ M:*J?&5F-V_AA18AX!FVES+*C>Z]T:_M_X*;UW[\A-[_(#9_S>\NLL''U_/ANP>P=I MT?7M+G.JMJUU;F&P\&WL+B<+18>GJZZLF84:3U57454\\Q]U[JKS/?RU/DET MWW/\:^S.D^P^I*3=3=I=7;;S[;&^+.XJ+JGK'!=/],]UI@^P=U83/]CY+<&8 MH,LV_9MO9C[[_=^Z>CJ[>>T-T]H?(SY-;1[0[`QVU]G0;IQ@V_D:JW M_@]L/X508&FW?65S^2MQ=!LE]J/<&>R]5 M4U=/G_//O2/%4^3H:7QXZ!+K/\`E1=J];8GLOK;_9G=GYOHOO78 ML/4O=^R#\;#AMS9WJR'MOL7M2OPVP-RX'>$-%M[(UT/8N2P$E2,15TT%+`D] M-2156AU]U[J;VW_)]Q/9--M^HC[`V=49_&9'Y48ZMGW_`-4[GWIM^FZ_^3GR M.R_R)^WVOM_;V\-O>'<>V*G+RXZ@K\I5Y+&UL89J_$R`QQI[KW1]]^_%JBW- MMCXI[/VSN.?9V"^+?:&Q=ZX""DP$4U3E<'L?IW<746+V_1^%Z>FQTJT^;CK( MZE87BB>F$0IRL@"^Z]T1+8O\J'[(>\,CM[<]+W7V%V3F]Y9BOK]\T.:VW2Y:OK*6.BQSSR2MC<=B9"''NO= M*+9_\J6#9F`[(PU!VO@DJ!C3=E[;['J^R7SF'PL.\]L;&VAM7L_&'&9GK/JC%;OS^Y\_B":&G-/2T_NO=%GW%_+;[/[%Z_R^Q>W?DEAMX3;>Z`_V5SHG/[< MZ8?9\VR>LLEO+:V[-S[F[+H?[P5T>Y-S94;+VY2U-70-AL="*=WIL;":B4#W M7NCX?(WHH]Z8#K?!0;B.W&V#\A.A^^6G?&S9<9-NE>S:#L0[<5/N(/`,D:`4 M?W&IQ`)/)X)`-)]U[JN_9W\I/8^RNYM[=FU5?M/=VSLIF/DANW`[038V?P/: M>2S?R9QFY<=OG;>ZNYT<57+!4(E96U(A83>Z]T6 M+ICXJ?*OY&[WVYO'=M?NKIK$?&[IOIOK[H:H[I^-J;&S6WNS^E^Z,/VGM##; MYV;@]\90[_QL5#B(*'=&Z,#F-O8VMF,1P4,=JLQ^Z]T:>'^6+V16[F[TWYN; MY1UC[^[RVSWEC,KN'8G5M7U[!A*[N?*=3Y*2EQN/I=RUM2,+2Q=9'$9"ABRD M5=78_*SH,E2U<7WDGNO=-FS/Y7?8&S'W!F<)W3UCA-SY#N/XD]XX#'[/^.>7 MVUUCM/N22JGJJV*1*>/W7 MNE#A_P"6GOO9/5V%ZCZY^06/VQM'>GQ7ZH^)7R=DR_3IW7G^Q^O>J,#DMF8C M62I]U[I=1_P`N>*DZ4Z/Z M3QO:$F*Q/2/:'RN[`QN17KO"[GBK<7\E-J]H[4Q.UGVOOJHRF)J4V[3]D(&; M,4V1I\DN-:*IID6M8Q>Z]TMOA_\`#_L?XG8GZL2A+&*,NI1M"ZE/U!M^?K[]U[K)[]U[KWOW7NO>_=>Z][]U[KWOW7N MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][] MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO> M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K_]??X]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UT2`"20``2238`#D MDD^_=>ZZUH/JR_2_ZA]`+D^_=>Z]K0_VE_!_4/H38'_;^_=>Z]K2Y74NH6N- M0N+G2+C_`%P1[]U[KQ90;%E!XX)%^?IQ[]U[KNX!"DBYN0+BY`^I`_PO[]U[ MKQ('U('T^I'YX'OW7NO*RL+JP87M=2"+CZCCW[KW7?OW7NO>_=>Z][]U[KWO MW7NO>_=>Z][]U[KWOW7NO>_=>ZZU"]KB_P#2XO\`[;W[KW7?OW7NO>_=>Z][ M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][] MU[KWOW7NO>_=>Z][]U[KWOW7NN)91P64'CZD#Z\#Z_U]^Z]U[6GTU++JOZF5 M?SR0/S;\^_=>Z\64?5E'%^2/I_7W[KW7BZ#ZLH_/+#Z#ZGW[KW7@Z'@,I/UX M8'W[KW77D2U]:6_KJ%OZ?7W[KW7>M.?6O&J_J'&GAK_ZWY]^Z]UX,K?I96M< M&Q!L0;$#?W[KW7?OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_ M=>Z][]U[KHLH-BR@FU@2`3]^Z]U[W[KW71('U('^O[]U[ MKOW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_T-_C MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW39FHJ MZ;%9"+&5-/19*2DG3'UM71/DJ2BK6C(I:RKQL4L#5$43Z7D@6>,R*"@D0G4/ M=>ZHUWS\DOGSU+LS^8UO?=/='QHWC1_!3:E5-18W#_%+?>T).P-QY7XS8/O# M!Y_(UTW9^6^SH\=5YM::JQT-/-+60TQ"55(\X*>Z]UAW#\ZNYL5\T>L.N]K9+K;;,/Q`[OZ`VOMW>.[=^TVT<7E^P,KN_>.6;+8J9ZM4 MEIL;]O-#XWG+2`B+W[KW1ON@?F5GN\>]=@;%CVM0[,Q5=\9^T=[]F;(S-/#+ MOWKOY!]1=Z8GJ#?77&3RE%524S4]!55->J,D1%6AI*^"4T]1'Y/=>ZC;G[=^ M9/W-R8. M'9VWHZ;/XG#1Y7^&YBI:H>KK#2^""&&7W7NL='W%\QOD#OOLK`=&R]"='TG0 M-;L39'8-+V[L[=7=E5OGNWZ]T"737\RG?';ORNZ%Z_R6R=I;3Z.[;^-$N6W/6U<^0JMU M=??*K'=I]A[-R.T1N>1X,?7;G M1C/Y$U=-*)M.^0V_NGLO9FWLW0I5TZU=*]9BLM6PSQ"2)TEC+QC4C!A<$'W[JG0/? M)_Y?8GXU)LT+U;OGM6?>-'GLK#/M;HK)*[L'O7<^T]OS9 M"=:J.3'X&@R=1E*N%*FJAHVI*2JGB]U=5U>=.@;ZX_F<=,=O]O;1ZMZRV=V3 MO#%[NPW6F6C[#H:':--0X5NV^N,=VSL@YCK"OS,>_CBI<'E\;/6[KI-ISX&A MFE>FK,E!+2U0A]UYDTTZX]^_S`9/CE\HFZI[$ZNR=!T7B_BOO7Y`[B[P_CVR M*:GI\]M_L3";!P6T5=74+$ M?S.>O=Q[>V4^T^G^T-\]H;R[GRG0C](]?[EZ#WQO/;'8E)TEE_D#BH\]N[;. M]:G9K8S([Z\RZ0#Z])OUG3QZ:WUF.N^X=O5]/V-NW$C=V9VUDMOYG^(XC MKML_4B"*EFB21,KBOO?=4Z6&%_F5;0S^[,;@L9T!W\^UMQ=V]K?&S9O:,^/Z MRIMB[V[VZO3.5$.P<$DVYAF(4ST6W\@,5F9ZVVANW;6 MVZG=(W#O"*NJ<)725.*V5C,SEL?'$9LC0TD-11-4^ZLZ!<@]&P^5WS$P7Q.W M'AAJ$KR]Y*O'_;J*KW3?0B]'?*.G[FWQVIUGE>INS^F.Q.HO[E93<&S>U* M3:'\0RVQNSFR2];=@;=RFP,SG<=+0Y1\+EZ9Z26KCKJ*HI)8JREA)C,GNO=` MU/\`S%]BT,&Z=V9'IGO2'I3&T6Y%Z_\`D#B\!LW=/6/=F[-M;WI.MAUWUU'M M;/5F;@S&:S]8F*VJNX\3C*?-2I(U!/+'I9O=>Z164_F=4.'WCA^H*GXD_)F; MY#U,6\QMK[/VWB=Y'?>?WA4[YBVI/@\ECZCP_P`UOJV;9F1WH.C?D*M/D=K]#=B=08!]N[#7=7?75OR1 M[7Q/2O5G8>P,0VX@N/IZS/9JAA?&;KGQ&32%_N#1^/GW[KW3UMS^9WUY5YM: M#L3I?NCH_;F.WIO?J+>_8G9HZJ?8_7G>G7G7.3[CW3U/N*LV-NC,U=3+!M/$ M5F:_C^(HZS`V44;91:[53I[KW6"?^9YL[#8*GR6]?CK\D-C;@W*.G"G%)F=P87^/X+/U..S&,BK:5JNAC,\ M8/NO=&I^.WR/H?D%CM_QR]<=@]0[YZF[(K>K.SNLNSX=L+N?:FZ(=K8O?6+> M/*[&R>;PF2H\C@\YA\I15F,RL\9CJ1'(8ZB.6%?=>Z,C[]U[KWOW7NO>_=>Z M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z*?VGW%NO:7RM^+'2^+ MI\*^T^Y]G?([/;LJJRAFGSM)6=28K;-=MM,%6K,L4$^\;\8?C9U]2 M;EK]];)B:O,57G\*E5_&LG3O$5K\?1U-+20Q5;TX?W7NA=QWSG[.S';D&SL/ M!UQD]HU_S`^2G1V(S&.QU35OD>N>JO@ZOR5V'G*'*P5[P/5U>5>**IK$0P38 M]@L,4;E9_?NO=,G\N+YC=E?*^+K+<>[/E)T;V+5;GZ*V[VIO?I#KWX?]Q]49 M_:68W)@,75U%)3]P[QWGEL364^'KJTT4BP8PM6KIDC:)%)/NO="OW3\G>ZJ_ M>'R,;K7LKICH'J'XBY?9&S>SNQNU>E>R>^LUO'L;>VQ,)V2=OX;9FPMP[;GQ M6'H<5N?`)+DPZ*/V%_-`[4INE-\]F;.K>@8X=N_#W MHSNE=V82CWMVGUMCNRM^_+S-_&[M#)XY9YMNY?+;?Q\&)J*RBQ%124&26=6I MZDK.&B7W7NA[VCWY\CNS>AN]>RNG/F;\=>SLWU-1U.XH\K_LB?8V?DL!N_LFGJ:NJRKI0/39.CJ@E%'#*LE/4M5)X?=>Z-!\8M[=\[C^* M.`[K[TWMUUO?>F^NH]L]T8&'KOJO-=88/:=+N'K&DW='M&OQV8W3N6;)S4U5 M-,#D%JJ421E5%/&RZS[KW593?S4^^W_EW?'GNV/9W51^6V^^PNM=I]J;/%-F MVZ\P&TXY\)OGLCL+`8;[IZ1/QE[Q^1D>^_D/D?E=\F/B]2=3_'_O#)?'J23&=+9+I&?=VY)N MIMG=GX+=+;WWGV1G*/'&^Y:BA.$^QJ'F%.DR5:ZFC7W7NK%MC]H]9]FTV0K. MMNQ-B]A4>)J8J/*56Q]W;?W938VLGA^X@I,A/@:BH6&5X_6D_=>ZXF1!]70?7ZL!].#]?]<>_=>Z[UI<#4MVY4:A<_P"M[]U[ MKVM;VU+?^EQ?GZ<>_=>Z[U+]=0MP/J/S]/\`>_?NO==%E%R64`10A965C8Z!<'6P^BK_`%N;#CW[KW5=^\.V M?E+W!WSVWU;\8]S=*]883XW4&QL?O_/=Q=;;L[3J^R.S>R-GTW9.!V5MZBVO MN?;`P>'H,)5X]\EFW>OGFJ*[QT]&HH)&J/=>ZE0?/.CV=UCW3G^Z^M,QMOLO MXO[,Z*RG?^S=C9?";PV_3;P[EP5+7M@^M-U5511#*T=!4S21M5UT%$6C"MHU MZE7W7NB\=R_S;J+`=1_*G>_27Q\[&[(S?Q\V[V+D,'75>6ZO&SMQY+JK>J]? M[];>=!C=T?W@V=#CZ\5%12T>\L7AZ_,T=-4SX.FK_"Z#W3WA"N3T8^D_F![5 MEWQB=NY3IKMW;FQ)>Q=N=%[M[PRIZVK.K>OOD9N.GI$CZ.W+/M_<59EIJZER ME=2[9K,]B\55X"/..<8,J\R2:?=,]%/WU_-(W!ENP>C$V=U)V!U[T5W!L>JW MOLSMOL;8FSMRT_<>#S/R)ZBJ4@>AJ_=/>%7SST+O8_\V3J/J7,]G4&_.GNYL'C-@8CNBOP61>?J"HS M_8^1Z'V3D.P]Y[>PO5$.ZSO3!U%5A\1D\A@ZK>6W<-19"".GE@JM&0QYJ?=: M$=?/HU_0WRCH^ZM^]J]79GJ3M?I/L3JG';'W/D-H]L4&S8J_/]>]F39>EV!V M!@J_86:SU`:7(U&!S-+)CZFKAR%'-2.E92PEX]7NFNC2ZEX&I;GD"XY']1[] MU[KK6@M=E%S8>HUK>VI;VO:XO;^MO? MNO=>+H"`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`RN;P63&'2#%U&5VCE<555%-3TPED::GBG7W7NFS=/P6VX-R3 M;BZ.[N[K^*:Y[;FT=F[^V_T16=<0;;WWMG8VWQM#:HJ,3V5MW<:XC+T.(6GQ M5/N';S4&1%+3TL4E1)]M3F/W7ND5OO\`E@_'_=VT\WLO`9C?_6F$K^C^F.A\ M$NQ\MB8Z_9^WND>R\YV?M_<^%RFX**OJ)L[D*S<65I\QD,A+4&JCF>1D%3)) M._NKJY7AT:WICH/9W1M5V[/LZKR\D'<'95'V9EL=DIJ.6@V[78WJ?:_3F.P& MV(Z>&-X\=!BMIXYHXZJ2>7S/,3,49(X_=:9M5.I.Y_CC\?=[YROW/O3HSIO= M^Y/5N_9-^[WZTW=U=A]W;2Q.5V5CNM,N:K8^_(Z!=U8"CQW9NW]P4 MF'K)3C*+[7<>`IZ+,TD8FIZ:OCIJF>)_=65M/0!;`_E9]4[$W7\<,_4]R=U; MVQ'Q9Q^Q8NL=K[VFZNRC8[-]<["CZSVGE:7?U/MJ#=F*HSAX:>/)[8P.?H,# MDZD35E=BYZBMKVJ?=>9M6:=##\FO@;U5\J]UX[<_8FZ-]8^FBZFW=TUG]M[= MDV<<#NG;&X-YX/LK!5^1CW-B,G+#D=O[FVWA\WBYJ26**26G$&0@K:-WIV]U MY6T\.F#J'^7MUGU-5=7YB'?F]-S[KZR[MSG?'\>J,#U)L>EW1NW-])9KH2/% M9/9/4>V]N[?H,72X/-5$\%+A,51.]9M704[X_E+]*[T3>- M/'VYW3M.E[-P/R!VAV8VW3U#79C<^S/D-V?N_MCVT\Q7;56CR6]L MW3Q5NTI\;5UM']K!EI\@:.FDB]U7H<-D?!#KK9NS^J]J?W^[%W">K?E#N'Y: MT.?RM1M&#*[D[,W3'N$9JBS\.%Q5+1#%22;DKI$I:"DIG31"JRA48/[JRMIK M\\=`+6?RENILEM?K#KK,]Y]ZYWK#JS<$>8Q6PL^W3V8I3B,-V?5=J;$P^$W' M7[3?,[7J<+6UUJO=.5OE**K'WM*VTZ$8]M/B3RSF2*4 ME-'NJ="U@>DMN;?[M[4[VH\QG)=S]N;*Z@V+GL7//0G`X_&],9#Z?]C?R_=F[<[6HN^MY=P]M=O=XR;?[(VON;LW?(ZVQ^4W9MWL#;&& MVC08&IP?7^W\+B:"@P%'ADDP]'BJ"FB^ZK,C6U8JJJMEE/NO=-\?\MSI^'%] M/XJ'>O9BP=+=,?%7I';,C9+;CRY#;7Q'[MP/>^P4I,GNO=*C._`7IS=8R]'NG+[JW%@=Q?*3??RJW!MK*382HPV; MW#V+TAE.A-R;!R%/]GJ?;LN%S%6_@#"I,Y5C4Z`4;W7ND/B/Y;6Q/+MVOW]W MCWKV_G-@Y3H^'JCZ-SUMTKMSK+>?>.]\+ELQ7Y#OSL_&]J[GI*SV+ZJVWU)'0;=^UABDCI&Q^V**H=)WED^XDJ")!&R1Q^Z]T,@=#P&4\V MX8'D_=>Z]J6]M2WOIM<7U6O;_`%_?NO=]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=%L[^^->*[QR?76\\9V%O_`*;[;ZBK]QU76O;G M6C[4J-S;:H-[XJ/`[]V[48#L'%YS;^3QV8HX:=:BERN'J!%/3TM93F&JIHI5 M]U[H,^O_`(&]5]?9CI_GQ\-(TM2)#)1T.'IJ"AI$6*E@I4HX8X%]U[H/>J?Y7OQ]Z4CV[CNN\ MYV1B-M[1[Q[T[SVOM>HSF'R.)V_D>^>F*GHS,["Q+56/,\6VL'A:GQ[9QWE+ MT*PTU/YI:2!(/?NO='3Z6ZLPO1W3W5?2VVLCF,KMSJ/K?8_6&WLGGYJ>HSE? M@]@[8I=J8BMS$]%%!`]7+3TDM? MD)W9\?=Q[PQ^!Q7;V,ZH'5U9MKMVFVP$I-OY+<>&[0VUN-,?EZ.@#XJ+-8)J M&L>B,4$\LPI*0P>Z]T"6'_E6]$;?VADME8C?7+W%N=\ M7L_Y6YCY?4>3J]SYS'SUE7DJG<>TZ^KH?`*ZEH=RX>;"UE11-4I(BS)'.S1LZ,NH#4K" MX/NO=)'9G3F"V1TMM7H_&9/*U.W-H]78+JC'Y6N^Q?-SX+;^SHMET>0K)((8 MX6K&IH5D=TA6,R%K1A#H'NO=$;B_E1]$0X:KP2;Z[9^PJ_COT;\=?&G,9II*;&4ZTU+32&627W7NALV_\&>L M-N=JXCMJEW)O:KS>&[T[\[^AQ61JL'58*IW7\ANO(NMMWX:MI10K))BZ6BB$ MM!3^42+,29IIH[1^_=>ZV-EX/;R]$X^OV[79['[+Z_CW7W=LOY:++RY3/%&@DJLI#35K.'BTGW7NEEU9\*L/U]N/8F;W5W?W;W7B^FQDH. MAMI]J9+8E1A.GJ/([:;9228NKV;@6H83Z'1$]U[I58+HO8NQ9\5_HDPFV.F<;%NA-R M;MPO66PM@[9QW8L,.W:S`T^$W>M-C=;0Q/4P5L=51/3UBR4L,0J12O403^Z] MU@AZLWW'C*6A?Y!=F3UD&V=G82;-/M_J%Z7SV>WG-'%MI:9:_/T;C M#9.&.!:**E428^DHZPFI/NO=/]+L+0J8'J(9O=>Z#+,XNKV5!C ML3N;Y-;NQV1BV%MR6;+9?&]/460K:?JK<4.=[$[&K(1MQ*6*7/TM;287<'CA MBH:6GD@;%TV/KY14-[KW3SUT8=_Q4&]]J]\[KW=MV//=A/48J7!;$Q\%]R5$ M51M_:N8I9,#29:C_`+JQC3B8YGAJYXIO)E'R&J)Q[KW7.MV=N3;V-QU/F?D+ MO:GU8SJ+;/\`>#+XGI^E;([DVONCSYW*20C!0T_\3WY'+'AGC5\.N,JB]0WNO=-M1UCO*:"KB MA[Q["HY:B@[5I*>KI\#U4:B@J=_Y-*[9F3IEJ-O21F;9,2M1[?62-HZF)BV; MCRTP64>Z]T#W8/Q!3=F_*GLG8_?'[-V[>VWM/N?(=3IU?#_IMP.T:.HH M=MR;M3?&V\V,;E:&&LK8*;.;9_AEZ]T"._/Y6W3VZ,7N/9 M^R^T>Z>ENK-[]?\`4_7N_NJ>M,IL.7;&]<;T8::FZPK,OF>P/S%/'DX6=ZY)JAFG;W7NHVZ_Y5_4&_=R][;FWUVIW)NJM[JZF[9Z6HJK M(S=9P[DZYV/W/DJ;,[LHL9V%0;;AW)N9J2IH:`;>7?V7ST6'IX%I:"*&!I$; MW3GB?+I>X_\`E^;2AWKBL]FNYNWMR[#3L3;7>V[^DJ^/K''=8=A_)';=+1O_ M`*<-RT^WMNT>5BJJW+8^DW17;=QN4I=OR9Q/XFN+29Y-?NF^@ZJ_Y6'7&2W) ML_(93OCOW([,ZJQ^/VYTAU1-4=3T^PNF=EXON_87?%%LW:"X_:L.4JJ2+(]= MX/%Q2YO)5U1'BS)1QS*5@EA]T[XI].D;V'_)UZ7[%BW5BJWNSOC![3S^\>[= MZ8S:.`7I>DI,)D?D1LC/;$[53([GGV?+N+<35%)N/)?PRLW1FLC58U/!34<\ M5)"(#[K0D(Z/A4_'G'1]N[_[KV[OS>>U-Z]C;,Z&Z^S;XN+:=?C*?:?0^_=P M[YH<;CZ'<6,K1&V=3<^5Q.9G9FD%(T;4+457&*GW[IOI2576F]9XZI(.\^P* M(STO:4$$L&`ZMEEH)M^9):W9E92-5X"0:]DP@T>WUE5TJ8V9LXF7ETR+[KW4 MA>N=W#(05A[HWXU)#N/9^:DQ)PG67V-1BMN;;.$SNTI9?X#]Q]EGJH_Q7(RK M.*N*H_;H:FDI/\G]^Z]T&F^*RDV5`N*W=\H,[LZJS-!V=A\57Y>'IV@J(:_L MC>V+PFP,[!%D\":?S;,K&DR%'C=Q5F*KL\U74 M5$=6:N!HJ&L@H+4;>Z]TH3UEO:7!46/'?W8PR$&PMZ[2GW(NWNHQE,AN7[=S)D MES&+['&QVQ?7KQ3[%H]JC8]=M6)FP_W@P]7F?]SU55I5#(ID66"&L@QC+0M[ MKW7I.K-[O@:7$COOL=ZC;,5VY\S5TM1B^U*BF?;9H!F<4D M$T%'21T:XF1:B4U6-J'6!XO=>Z4HV1N49D9$]I;P.-&]J?]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__2W^/? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=-^5QT& M8QE?BJHRBER5)/0U7@GGI9FIJJ,PU"15-*\Z]UK6= MP?'OK_IKJS^=+NGKK*]Q8WZ,S\6>Z^S]S_`,P5_CUW'N;)3=N_'SX<]@;9[8Q=-%DMO[4[#EA^ M0>W:;I_Y'8G:DU54TA7=^V`*IJA))&HJ_P#B^)CE(HWU>Z]T!G:NRMS=F?/+ MYI1R]&U?>^$V)NWX^XC!5F3_`)B?;_Q1H.OX,C\>-M9W)X3#=;;(=J&LBFEJ M)^V-A9J"H"[>PNX]P[@KMN9]H(E"YBIV_DDEA9JLO[ MKW1T^V_BQU/O+YQ_#]-P5';9A[IZ5^2&^^SL/B?D7\B=KX#=.[^L\7U=1;*S M+;9VMNNBQ]']@F2R%Z?'TL$$S5$KSQR2-K]^Z]U=#'$*=9&N&+69F(TDZ(P@ MUMS_`$^OOW7NB@]I_+?.]9;XS>RZ+X??,3M2FPT>.=-\=5=?]/!Y//[MQ=5*U.9/MJCR4,869'52Z@.?=>Z`'YQ?)3NCK[=O4>Q.E=R;;V3 MG]U]?=D=H[C&;ZBH>VMQXO:>Q#AZ>OR^;I=W;VZ[VS@MO4D^4@ILKF*K=$]: M*N6DIZ7&2P25-93>Z]T4OIC^8]\A>U>W/C5F=P0=4;-Z1[XI_CGM^GPV`VY) MV'A(]W]U_'?!=U5FW=T=S[6W++FMF[PCJ\O-1[?VWG^OOX7D:"''5$F=@DRH M$/NO=++YU_)OOKXK?+:JWWM[?J[CZ?VU\%]\[TI_CPFRYL@N9[`K/D#LSJ?% M;TK\S)N7&PR'%S;D@RE5,8*?PXFCR-&U3$M8:VC]U[IMV!\SOF!V)_HHZ=HI M=G["[8W-\N,W\=-V]F=K=&8S&PR;;C^&VZ/DC2YV+H;8?9V>_A&=QU=CJ&A- M'6;O,=73>*J:GBCK"D7NO=`QO[^9;\KML];[LW!2[AZ?7>/QFZW^2V].[Z'; MW3-3DMK=@/\`&WO7?W3=%GMS;D[)W_M6CZ^Q&\O[@3_P:DP]3NK*I5S9%'I% MBH<=_%_=>Z'G9OR]^7>ZLOU[OF3=?1,'5_;'SF[X^$FWMD4_4^Y:G=VU:+"K MO+_1QV_7]@2;I2GRM5CI]L019#!1X2C@R-'*7^ZHZB[#W7NBA=*_.KYE]<=& M_&#+;\[>ZZ[,VY+L79N[.V>U\UUM)O/,5+=G=_;EZVQ>&[OI]N;W?=6QL'1T MV)@@Q&^<9M7<<5=4O6)64=!%B':H]U[JRGYHYKN#'_,3X5;9ZD[[V'T57[CZ MF^9V1S&4[:P&2WSL/.TVTINL,G2T,^P*'I>EKJC(.U!1R9*:&, MER5]U[HO?77\P7Y([]S'3W7&6P&T-F=N?*)_A9V/TQMZ?:-;/C,'TGV+@LKF M_E:];%65T=372X.FV+NJLQ%8ZJ(8C]U[I^[R^;WRJZ*[#WU\9,I4[6[.[:RW8G2^*Z^[6ZH^ M/JUL.UL1W)UIV/V?+AZ-E%\W]RT/\L[<7S6S76=15[NVQU]OK+5>Q,?\`PJ>FR^X-F[UKNOQFA3X; M-9*FI\76U%(,U-2#/SM244CP2UK20O-[]U[HHFS?G!\O]X_W+ZA$.T=F=L93 MY>;`Z$RO9_;/1V,P>+K-A=F_''>W=TL\?0W779VY)J+.XF3;%&M(U7NU8*ZD MGI)V@1)Y2/=>Z*QW!\M/E_/O.BK]Z]O]:5V#Z]V;\I.J=]]9[7V+OK96S^V= MZ_'W^8?U?\?Z?MBEEQ.]X\GB MS_G?\O<#O;?N%VX^WT:#<>3S,2RXNFQD%1C%IJ5)J]?O)H#3M[KW0(]R_+_`.2&]MP_'GMM][X3 M:_6O8GQ6VUNS/?&^MQ]>,1EM]0_/[J[I>OWW0[WZYWKK9V3,+EL**>IJ4I:$ M38VLDKX:^H:/W7NC`0_S+>_I.V^WSCNN\+3]=TF4^8VR.ML9V?@]G]1;+VYO M7XF87=J=R[*H\EBY^J6Z]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T4+N3JOHQ&V]X]5=RX3N'%XW<44;"=]>P>O.W^N0[!PVW8LCN:OQ3[>DF<5V(I2U-50T-)+3"B\]7[KW34_Q-W5D>S- MU[KR`ZR.%R/8'578%)32T5=E\_ELEUGV]M[L!:_+UE?C4GIJBGH<55T=-'45 MV4CAJIHGQ/\``Z+[JCJ/=>Z-K\>,!F-M]4X>BSN)FV]D,AN'L/=8VW/]KYML M8_?78N6WOAMK2"A)A#8RCR%/0,L-D4PE55``H]U[H;/?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T1CY#=%97M[?XQE5C MUK-E;RV9LG;>=R4YE6GVY2=?=X8WL/=&.UJ':&?<>*EE@H9HXBGW>.A6J_;, M4D7NO=`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`=2L2`>Z]TL??NO=>]^Z]T%_972W4O<1 MVN>U.L>NNR3LG-C!44VA_I=B!; MW[KW22V_\6_CKM/=>V-_;7Z)Z6VWOS9.VSL[9V]=O]5;'PFZMI[3>:>67;&V M-PXVBCJ\?CV^ZJ`:*DF2*TL@TV=@?=>ZE;@V3T?V1OZEHMX;+JBBBGKA334\C3"%@/=> MZ9=I=4_&_K"MZ^ZMV'U[TQL&IV@-U]D=8]>;7VILK;%1MPQTW]S]X[YV5MC$ M0TXI7\><3'9/*4L2MHK_`+:9]-3I/NO=8=Z?'+XQY:;;&0WYTIT-F)\5N#=, MFT:O>/6W7M?4XC65&>W7O+:-D=I/7[]U[I1=H_' M?I#O&'$4W=74/5?;]+M^2HEP-/VAUYM7?\>%>MJZ2OKGQ*;JIJI:9IYJ"ADE M:!5+FGA+ZFC4CW7ND/!\:\:_RAI/E#NG=$NYLOLSJK-]/=-;-;;&V<5B.K=N M;]RV#S/9]?29FGA:OKZ[,U.W,,(I))8THZ>.>FAC=*EBONO=+K=W4?27>D&V M\[OS8'5W;-+@:C,56TLANO:NU.P:7#396+^$YV3;U?EXJM:Z]USWS\?NE>SJ3=E#V1U/UAV!1;\@V_2[WH=[=?;5W;1;PI-I35,^ MTZ3=%)N*FJDKH\6U;5MCUJ`PIVFF,.CRR:O=>ZG9&?JO96'V_P!2U9ZZVKA, MSM_.X/:_7\Z[=P6'R&U-K85:C<&)P6SI5CIIX(L/M M2".'%Y:NP.969:L".IFQ]>C1R/35`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`5T>,K\;6X[;N"ZJRVWL-O"GW;E(9 MC'BZZ*7<^*>*CK?&[Q-++PD+D>Z]TMY^T^O*?:]%OB7?.R8MEY*-IL=NZ?>& MW8=KU\,<S-\=3[PJ=[5^/V;!3;JZ[K:'&[IDH)L]-"E1 M0PU&2H(5K481L\\:W#.H;W7ND7VU\T>F^E,OBL#OV3<5%F=S=Q;`Z,V1BZ'$ MQ9&OWYOWL7!4VZ,4FTZ>&<&>@H<=4&KS%?+XXZ18I`VLF(2^Z]T/Q*B7 MB&2S&81(ZLLU-24Y6>JG0 M&.*-@[L$]7OW7NE,N]]I'9]1V`^Y<`FQJ7!5.Z)]Y#-8R7:J[:I*%LG5;A&X M896I#0QTZ-.]5Y?&(P7+6!/OW7NBC]?_`#_Z:[#WQL[9M/M+O79F.[/KI,9T MYV5V=TCV!U]U7W)D5P,^ZJ;'=?;QW#21JU16XNDJLABXLI!1&OAB;[/S/93[ MKW3'N?\`F9_$O8>Z,%M#L/?%5U_FIQ\U2*/+Y;)UC>#'1"9XZ6GJ:^I,%#%YV]TZ(CT9RVV\+N3;>9 MW)@8J&?.;>Q&X\+D\UA*?**LV-K,QC*29IZ6&HB=)H))T7R(P*`W'OW370=X MWY,=(97>_;'6]'V1M$[VZ*Q>WLUV]A*C.4-`-@XS=-%/7X6LSV2R#14D<;QT M\GF83D4Y*+4&)I$5O=>Z5VZ.U]G;3ZPW/W%79.#)[`VEL/.=DY+-[:F@W%#5 M[2V]@I=QY#(X1\8SI6`TL$C0>%R)2`$)O?W[KW19ZW^85\;Z#HWXR?(B7/YZ M;K7Y>;[Z:ZWZ2GI=K9R7<&6W=WK7)0;+QNXMN-"M5B?MW,HS4E8BK0&&82DE M0#[KW0_X+O3KW,83%9FNS6/V@^;R<^'Q>#WMF=O[:W%59`;BK-KXVF3&5E99 MGR-5050QR)(S3JA"J)%D1/=>Z6;[\VI%N5-EU&X=OP;QDQ1SHVE+N##)N@X1 M)##+FDV^\XJVHU=74U(A\=U8%@1;W[KW3".Y.KC'1S?Z1.OQ#DL_!M3&2_WY MVJ8\INFII(,C3[:QT@J],U>]/4T\Z4:$S,DT3B/1(K'W7NA,5M2ABK+<7TM8 M,/\``@>_=>ZY>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K_U-_CW[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW2.[$W3D-D;!WKO+$;1W!V!E]J[4W# MN+$["VG_``_^].]\IAL3-D61/)(B78>Z M]U5_\?=U8KY#=V?/CO3;&PM^GJ_?'4?QMV#M+*=E]4;SZ]J-R;YZVV=OW([V MQ.!VMV7C<=E*K^$ON+%TDM:E`*:2>5XJ::8Q2A?=>Z-3\!MJMM7X'?#[;F6V MM)M[,4/Q/^/>(W3M[)X/^"Y6#,T73V'QN7QVX_=>ZJW[JV#N#%?#K^8_-B-FYG;&:J_YDVR-W[8RM+T]G-]5\>S<#WIT_ MFI]]X7KK#4HK=S8B@CQU7D9*.@5HJN.DGC6069E]U[ID[(;%_+7XY;GZ4W;V M96?*K`;E^4/P,&]L%B?@=W%\28,#UA6?*3`T6_*VJFWE&W\7C2DCJ*V:OHY1 M)AXJQ>VL_M#M&@W)5111SYYL'FL52[VQZ%GI,Y'6.IDI:FEFD]U[JX7 MW[KW71O8V^MC;_7]^Z]T3/LG)_/*#>F9AZ3V7\/T^T>[-O[W MF9L?&7R;VKM8]F+3X>/9VVXU^)N)J-XY?<%4'KSM_'9W)XO; M+TJ9&2K>3)ICTC]U[HE?QV[?^6.[OD=\0,QV+N#Y4[PW/O\`VKT!7=B[/KMM M=X],8OKO"'X_8Z+N"OW'UWD\+4]/;FVZN](\RV=RN5EV_OB@R+3TF*IJBDH\ M6]1[KW1P_F+O;O#&?(7OW;/6VZ.SH-N8[XK_``KW)OG']:-E*O?6UNJ=P_+W M?F!^2N_>H,/AHYJD;M79-'*E+48Z)JX)2H]"&KX*13[KW1"]\[I^55:_<]-T M+O/YE57QREZ4[*I_C!V#G3W5)WA5FJ[O^/%!O#(Y#/\`8]!_>F67&5U=OV/9 MU;N6)\G)CQFU$FS-Q[N^8V\N@NBOG/_+Q[IV? MFY.P_D'OC<>WL)OS)S4W>61Q.\=L256X,U@\55Q4-:M`):R#`5$\DM**&%E6 M'W7NC$_S+-I=FX7Y&_&;O7IG&=N9WN#9WQW^>.U^G*':%;VC6==U'>E9UQA= MP=/[;WYMS:8FPD(S,E'E]#YV&.CR$M#14LTD\M/00>_=>Z*MT"_RK[6SG4W7 M^VMOYSM[Y(;=VGO*+;LNX M\=LSS01T$6.Q>8E$&(KZ:>:&FH_=>Z[[(S?R-QFS>J^M=T;H^9.3Q6VNR/GO MUQM+>L6[OE-C=R[C'6?R"R^T?C)C=TY;XQ85MX;OW36[NWEFJ/;N1Q M@JZ=>D(_E+VCU1C?DEOKM#YGXOM:K^9?P?Z^J]AG-]J["V M3%U+VMU9TILGY2(_1ZTM)3PT0JL]OFOGR[4"/@LI3SU^,J,?)2S2/[KW16.K M*7O3HOJ_XL;"ZZRWS2%1M6OS^SATS'4_+3:N=B[6'REW'%V=DMF[SK,=GMG[ MIK(L`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`4WQ0Q]5-V?LKKN#K7>&T MT[2J8\KOE=W$3U6/RR[_`*&'&?PB&J9)Z:H6N6C@DBJ3[KW0=5_\OW=61D[& M[!@ZFV!B.ZLM_,I^/'>VT.VZ>39%/V3ANBMH8;K+:7865QV]Z?\`W(4SQ8S! M;EHI,$*M'JX-5/HDCJ@']U[HJ61_EW?)JKQ&"V5U?\>.N^BLUU7\.LG\?M\= M]8+=W160RGS(W'C._NHNP=PUF6Q%3BZ]Q#O?!;-W6M55;^Q,ZI6Y:HILG1RT MSO+5^Z]T87JC^7YVGF.O>AMI]P]:XC<6P\;_`#"Z7Y);@Z5[4'QJR&*V%U)C M/B]N3K:)IMB=`[>P&P4J)]W55%EWPF`I*Y!/4MD9:J>I>I\?NO='M^4W6_;& M+[>^+_R#Z7Z[A[;E^/=)W3M3<'3.)W-M/K[#I\SL;<.]:S'X* M.HPU=AJ-IZ+(5=/'+25$S02&H@A@F]U[HI/5GP$W+N[O/87;/RAZ0ZIWGM#< M]=_,,[2WEUWO&'9/:%%U1N'Y0]@=65G6O7T\&7%52Y7(QX#:667-Y/%0O1Q5 M+24]/+-`\,\WNO=%[^/7\M;O3`;:^/-/VWUAL&OW)UK\E/B9V)E\[G,QL+?E M=MW:/57\NBEZ`WAGL37UWG:6HQ^\,=BXZ>G4F2H%%35<0\,,4D?NO=)O<_\` M+M[^WITQ+U-C_CAUML'<>ROC]D.F>UNPZ3>_6=='_,'W7N;LG9.8K=\[G6D` MR9H]&W<[NJNJM\?;Y)6.K8-[KW1F>OOAGN+)_"_Y??$_.KBNL,+W/V/\SL5UG%MY<5DL!LOJGN;? M.:KNK'Q6W<,R4M#1TN/KJ9S@X5A,*:H=,4G(]U[H'-Q['^<_=7;OQRWSD^FM M[?'O-]1]N]4IW76XGYKS9#H/M+J7;6;RD.\/]&W06RZN7'YB2O%1!6+-O3#8 MK(0T`AAC:>LIHHT]U[HF59_*X[+'26WJ7/?&;I7>G:.T/@O_`"\^NHZ#+GJ& MIR^X^X_C5\C*W5GXI((GR&T(Z'"T.3K:A,?6QO!15$JTT$@C]T[X MOR_U4Z-9\6/B%W%U5\X-U=H3=.XC8'4CM\AG=[]>TF+W]4TJ)+50[@VYV@N1Q^)>**CVM4+14=(\WNFNF;Y`?"OL;)_*/ MOKN+:GQLZ[[1Z_WGNGXG]M9;;'\5ZKVVOR-I.G\#N;:G8G16\DW(],XKOXID M\%OK'RYS_<)7U6$H:6NJHB6T>Z]T8WJ[XZ]IX7X0?+?K!=CXKKS='?%'\E]Q M]2_'3%Y_;-1MOH?&=M['FPNSNFZ+<."D.$B+Y(5&=R:XZH?&T5=E:N"BFDH( M(9#[KW11*3X#?(UZO9&TJG9VW)>L_C_V-\4NU.C*-=Q;318MP;Y^2O6'='S! M8Z*R\+;539VZFPI-%`:^+<$D$,E6XD9O=>Z3&WOY8^_,YUM\C<1VGT-U3NG> M.:^`_9_372U7NBHV!N2?!]S[D^2O>':VW3@LQ5&5\-)]KNW:&1&;B,0AJ6.F M=)Z.;3[KW0F8_P"'7?,7:V'HLMTUMNIWM4?(SKWY$S_/RLWGU_5]A;4ZWPNW M,33;A^-<>(-1+N>IK&H:"LZ^BIHX7V[482J.6GJ5R32P>_=>Z+GOW^6'V9M_ MXR?#?8O4OQBZX7MK97Q8PG4?9KXG)_'W(]98?MC,8K;L>]]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__U=_C MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7B+\' MD'@@_GW[KW7K"][<_2_YM_2_OW7NO>_=>ZZL/K87'`]^Z]UW[]U[KWOW7NO> M_=>Z][]U[KJP/U`_VWOW7ND=O;L'8O6V*7/=A;QVCL7`25=+C5SF]-RX?:N( MDR5:S"CQJ9+.RP4[3RA)#%#Y=;:3I4V)'NO=`ULSY7=1]B?('MWXU;/KJ[.= MA]&;=V7G^S*BFCQS;8V]5[ZEF;"[6DR8J3,^6CIX15U=.E(8X(Y(EDF$[&)? M=>ZB[5H?C1MKN;N7M'";DV))W9F\3UILKNC)S=F+FLE+O[KW0P9WM'KW:L&4J-S;UV9MQ,+/ M14N=ESF[-OX>'#5M?C?XM14>7J,G/"*>6:D!J8$J-#20J94!07]^Z]TEMQ]] M]9;?ZY?M"@W!AMY[6?[F+`2[&W#M3./N^NI&D%7B=G5:HI\KMRE MGCF*R5](U)5+4T2$S1&&970-$X7W7NDW2]Y=/U^TCO\`H>T>M:W87W4M!_?> MEW]M2HVNZ8JIL>9X0CF2#[G6H!+*`/?NO=(7L7Y8=#=;[5W1NO) M;]VYN:EV;G^J=L[LP^Q,[M[>&X]OUO=&_,7UWU_+F\'C*LS4E-65V9HY1/4A M%^V,DZZE0CW[KW2D_P!F`ZOJ*S;28GLHH M)-T0;DW%#D`M.\1G,;!(Y%A>.5:EH"$U^Z]TO-I;_P!E;^HY,CLC=>U]X8N" MOK\34Y':VXL+N.AILKC)/#D,7/5X6>>):B!O3/`7UQGAU'OW7NFFM[?ZLQ^Z MW^K\AC=UY?'=@;#R&(V()UWSDZ/>6VJO&;,DI:-Z7.&[1 MZ\W!3;BK<'O39^8HMGU%12[OK,1NK;^5I-J55)1')5-/N6JQM1+'0/%3@5$B MU;QE(OW&`0:O?NO=$=[(@_EX=D?(CX_[QWKN;KW<_<7>---A.EY\'VGN"JV? MW'#TK5UF[**#<6U=G9H;4W6=N5U17S823<6.K325Q=*%DJ1I'NO='=S_`&;U MYLC/;:V?O#?VRMO[GWA*M'M#`[CW9MO`[AW=5R5*T:4.V\)DZB"HKY?(\46B MEC=BS(MBQY]U[J9B^R-B9O=>=V+A=X[1S&]-K&D;=>TL1N;"Y/<^V(^9'0'0>:VUMSL7/[CIY]P4&$S!R.U.NNQ>QL!M+;6XLZ- MM;:WAV5N78F*R5#MG#Y"N#TU%EL_4TM-,\4Y24K3S,GNO=>^('RNVO\`,+JJ MM[4VKLCL'8=#0]G=M]9U&#['V=NC9V9:KZK[!R.QI_=>Z]87O87^E[O?NO==:5L!I6PO86%A?ZV'OW7 MNN[#^@_K[]U[KVE?]2OX_`_'T]^Z]UT55KZE5KBQN`;C^AO[]U[KVE?II6WU MM8?GZ^_=>Z[TK]-*V_I8?TT_[UQ[]U[KVE?]2/\`;#^H/_$#W[KW7@JCZ*HM MP+`?0_4>_=>ZZTJ+`*H`^@L.+"PM[]U[KE:W`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`EOEL'FNZ\5EL:DL5/B8-O5>-W,N)DDH3&]+N><13/)$R MI[KW2G[K_EX=V]F]A?)O:6$EVUB>BJF;M#O[XU-5YN>"*O\`D!\D*#!XWO'8 M6]:'#NM7C<174^-WS05.1CHIG:C[`R,M/,U31B-?=>ZXU/PA[$[^<_P#%1<[UQNS:%)M/X\U.YJO?O<.?HMKQ';%1F,__`!?# M4"8K'I([TF$H)IQ]RSA/=>Z+]G/Y9_?>5R/:VR,-T9UWANIJS+8FFIL3NK=G M4&\L;NC&Y?YJ[([NS]/U3O/%87%[R_NW)MG"9H9[;G:D^5>">/&XW;<]/2I* MTONO=ZL_\`A?T7NG9?9';_`&[D>B-F M?$["=A;*Z@ZYQ70/7. MJ^RQ5,:OPF2.D@]U[JM+Y/?`?Y<[[["[>KMC=/[#K(Q:O/PU.Z,56[UAW7O%<.[T\_\`I?M4HJ&+W7N MAEWS_+CW)BMR;%W#UCTMU72;,V7\;?B;%V'T]@JK8VS]K_(/LSXY=M2;NR'5 M^^:8TIQU7%)C)6?%YG+4DE*:RGI(IIH8-4T/NO="QU/\6>WJ'X*_S$.I:CI3 M8O2V\_E)N/Y=;AZHZ7VUO#9V2VUMJE[JZ>IMJ;.PV4SFV*:'#TD\^269\HL$ M3P4\LDKK)41:9I?=>Z1._P#^7AN^ERF\(NENJ^J-F[0S'Q)^'^U-S;'PD^`V M-M;NCL'XZ_(.?M#?'4.^Z/;U,NK'[FVR!M>;.5,4J?;UCP2%J=9%]^Z]U!Z\ M^&W;4/RDZ+^4-1\6^LNM]MTWR&W-N6M^/^-W'U;75_QZV;G/C52=/OV7B,S@ MZ;^#U.2R6?QL66RF&VW5D)`F/JX_)D9,A[]U[K%_,E^'7R1[U['[AR/4_5^Q M]T4W87QTQ6SM@[RCW#TAL[*[8["VQ59;)?<=C[I[4VUN/=E-XFGI/[I'KVLQ M$(GEK#F9XW^UKZ;W7NE9\6OB3W5UQ\W'6?9 M>5KMQ]Y;X_OUBYNIMZ;8Q&.W_3$K4U$>Z<+V#EZ]U= MC[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z] M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7 MNO>_=>ZK[[Z_EU](_*SO'-=K?)?#4G:^V*3INCZ;ZTZZJ:W>.V*#8^,SFN`^-E7EH=G;CZO?<&X9<=M[*Y?%9:HQ.?? M,XW.P.#]W3Q0U0#^_=>Z,=T!\?NW.@]M;MV'C.SNO=P;+K>POD]V-LI:SK'< M-%N3!Y+O3MFI[AV?CMQY.'<\E-D*?`Y#-;CI<@:6CHGR--)CA$:"2DJ6KO=> MZ&.+"][*U/Y][]6SQK4=<-5(G76ZZ=I*;'QV[;CII#N:3QR99K';LCAUQ7_* M6F7O8>Z]U&JL#\@),5D(J7?_`%-'FI=L]ATV-K:CJ_=LV,I]XU^YDJ.J\O68 MR+=<'5Z3/8]*E)LE6$5=+68N$&D/NO=/M=B>W9,U628[=O7L&VI-P; M.FH\=6[%W'69F':M-3LO8>+JK-X38N'>U7N5*C8N:EQ?\`>Y9'Q=#AQ)29 M7&BJ6:MK&%7!6T,*_9GW7NE#6X?MML]538O=FP:7:[[HVK4TF-K=E[BKLY%L MJEQWCWIA*G,19Z&"3)5E7:;%Y)*)(:.$&&>BK7/G'NO=)Y\#\B?X1+%'V#T\ MZ]TG4P/R'BP[1#L'I\YT[4D@-=_HHWFV+_`+\_WC,\>;., M.\#,<4,/:D.,%6)S6`U0KA"?LQ[KW3E04G:+9NGJ:S=FPI]IC>.X*RHQ--LO M<-)G)-@OMC[;;V`I\S49Z2!,S1Y>];DZ]TY5..[H@KWE&\^M_X2VX-WRQ49Z]W0:X;6K,*E-L'&2UZ[B,9K MZ#)WJZ8I(\37XW538?%-,U105%JBHK\A'W7NI7\$[M6L MJ)(MZ]9"C?+;YEAAEZ[W1)5I@ZS'A.M**:K&Y@C56-J]4^Z]UBJ,'WHT,?VN^.K8JL;5Z]I999^MMUSP-O2@W(U5VIF(X4W0CKC,IB MBM+@<<9#-C:H?Z[EPO>GFE-/O?J](/NNQ&I1-UUNF2>"BKVO MU-#+)'N9%DEQ7_,0R:%&5X%(F(M<^Z]UV,'W@:+(1OO?K(UTG^C?^%SCKO=( MI:8X^H@?MPY"F&YM4_\`%HA4KM[QRP_PQWC:K_BHC9)/=>Z]5X/O&1*I*/>W M5L(*]G"@^XZVW5/X&R%2K=,&J\6Z(C)_!X=2;E"E/XN]FH_X,MT/NO==QX'N MO[Z.2;>O6CXX9G9,LU,O7FZ!6R;=H\.8NQ,=%6ON5D2LR&0T5&&K#`R4%.#! M4T^1D/W`]U[K%4X/O9J>J2BWSU=#4&C[42AEJNN=UU4,>0R=:'Z4J:N"/<\3 M218:FUQ;GA25#EY2LM%)A54PM[KW4P8;N@Y)'?>77#8?^\NV*F2D786Y8\C_ M`'1IMMK!O/$QY`;B,?\`$:W,!JO&5[4YAHZ/_))J2NF_ROW[KW4&JP'>C4E8 MM#OGJV"N?#]J04$T_6VZY:6GS63S*R])UE730[IC::DPN.#T^YZ9)(Y,Q4$3 MT4^%C!IS[KW2SV[C=[4F4S\NYRN(R&,HX=NP4^?@SE M;6Y.MCK9)\K]W5TDD,%.L-,\5-(D\L;54GNO=+7W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__7W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7C_K7_P`!^?\`#GW[KW1)>\/FCL3I#Y&]%=";OVAOU8^Y M-@]O]@57:E+M?NZJ&@FQ]-"\,TDM=/-7PKCT6F>I`6 MOI2WNK*I8$CRZ;Y?YB?QIQ^W<)F\G_ICP5?N3LFGZDV[U]F/CIWGBNV\WO3) M[+S?8>UJ7%]25.WUW#+0YO$[>R]5ALJN.^RJO!)&LXD1U7W7F4KQZXUO\Q#X MSP[)V)O7!_Z7-]4>_J3>M;1;5ZY^/O<^^^P]JT76&=.T>RI^RNN-LX.HS.V% MV[FA_`\LN=HZ5J>OO2E2ZM;W5>FRG_F8_$/(;DAVYAMU[XW'3U&]=J]=IO7; M73/;&?ZM?>_8>P,+V/U9ME>T\7AI=OO6[MQVXL-'MBFCR#29"KJX*&%3531Q M/[KW05]3?S8OCAOGI_K7M7<^V.YMA5W8F,[#W'+U]+TQVSN[=VPNNNK]YR[* MW?V]OZAP&!,V)V=2U`IUJ-SUU/#0)([P&9GI9]'NO=&:^3_RPZQ^,6"V!OCL MG<>!PG6^XE['S>XL[-0;TSN53:O6W2>X.YLQD=H8O96+R*UM1'0X.6>2&LGI M5DIEE%+)45IIJ2?W7NE7T=\G>H/D!FM^[6V)-O*CW;U?+@#NW:_9'5_8'4V[ M(<)NF.JDV5O;'[;[*QF*K:O!YH4.0_A67IH&IIWIJF-7$L$J+[KW2-W#\Y_C M9M+L_.=5[GW/N/;U7MR#=8RW8.7ZV[!H>CJ?-[!VI4;^WMLQ>\Y<8-IOGL1A M:.MR==AURQJHHJ>H4Q^:&2-?=>Z"FM_F:?$Y<+CAD*/NT9K=&Z,9LG`]2UGQ M@[X_TQ;KKMT[)SN_ML5V&Z8FVY_>"LP^9Q.VMP3X[,)CC0SF@JH?.)(F3W[K MW4ZE_F?_``VJ-K[UWU_?;>-%LW9'7V<[1EW5E>G.VL+A]W[)VAD:#!=AY3K& MKRN%A_O/)MC)93'8K__`(_=T[`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`[IZZVKD-P8"'8'35+@O[R;%J]U018_;U+$N7K,%W=%E,9GNL MLW1U#&?,!XZ^')_;LKT4]54U:CW7NLFQ-N_+3;^^MH[0JZ[NZNVC3Y[L#"[G MR.Y,U2Y6CFV9N?";FFQ^9HL]"8$ADAW%583[%YZBNR=+31EHXJ?$Z'A]U[I( MT>-^5^W^N=T8WLNHW,U%M7IS;N-V6F5J,KF\K4]KX&FV_2?'6MI-QM.%DSR; MGBF?<]3`TXJ9#KKM%/\`;%O=>ZN='OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO> M_=>Z][]U[KWOW7NO>_=>Z__0W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=$-^9WPBA^7M=L<5'8G]Q\!BNM?D=TOO[$1[43/U6[.M/DML M.CV?NJ/;N56OH3A\SCYL9CZN@KY8:VG*?<0343F6.6'W5T?1T7;X\_RJ\?T= MO_8?:#;\Z[7=FT>X]O=D9*CZNZ7K.MML;CV]LSI?L3J+;NVZFFSVZ-S905\T MG85;FZ_(RYB:D6:`4U!BZ**>1Q[KSOJH!Y=2M]?RQ<]NG^%'']W;=DIH.U?E M[O\`R.WNQNHJCLC9M/3_`"Q[4R78]1G=M;27%2297C]U3I]Z-_EL97J'X_4G1V3[OAW;4TGR1^(_?[;PINNAMU:J'XH M8GJG`X_:DFW3F:T(^KLSVQ2;-WO/T-50=F;!VGV)V0_8FW]U]4=C;5W=B<[@-^X*61HE MS'\3JMOUSQTM15;6,M+&??NO=&Y^;_PC?YD=>;+V(W:-9L639^+[=QQSU9MF M+=U=E9.U/CUN;HC[^JBCK<8BS49W%_%G*\3-`80(1+Y8_=>Z'G:_24NWODCV MK\@Y-R?>MV=T]TEU.VU3C1'_``4=-;JWMN9X]S?(+?>=Z9P'5NWZ'L:HW7\CJ MO,[@W50YGNK+5U>*C!XC<6:J=SX*BH]O4=6M8D%+69"KQD34RX=IMMR?EBR MU;EM]U.?RV::NDBD-#24='CZ&(SO)[KW2`S_`/*PESW2?7'3LO=QA_N#\?\` MY+=%MN/^X,4K9,?(;NO9_;PW0,6V4'B.(7:8Q_V:U-JG[HS&:$PK&_NO=#GV M%\%1V!NGN7<%7V,*.B[@^5WQ1^2]9AVVQ]TF*I/C-A=FX.JV(M7#74[S?Q^/ M:.ILE9'I/NR!#/X5U^Z]T7YOY6^\LW2=`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`VOZAP&^GU']??NO=9/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U__1W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=<))!$NI@Q%P#I%[7-KG_``]^Z]T5'IWYF]-]X]X_(SX_;(&[EWU\ M9,CM3&[XJA+/- M#(%]U[K#BOG+\8LYV7OGK3#]L;(RDG6/6%7VKV)OO'[WV'7=8[%PV-WG-L7+ M8+>&]J3*O3XO+T=9`SU=%7B(0Q%6>0-=![KW045O\T/XAXK:?;?9.8WY#BNI M>F9]S4VYNV9LQL:LV3FJC;>3V]BHEV*V(S-3DLW'E)=S8Y<358_'24]0_DA\ MJ5)AAF]U[HPE)\K>A4V'5]H[I[.Z_P"O>N8M[YK8F-WWOGLOJ_$[,W#D\5D9 M:"@J\'NZCS=3C)(\HL35.-IIJN*M>'F:D@<.B^Z]TK\MWWTC@-TX?8N>[>ZP MP6^=PY;$8+;^R-2\ M:,HO[]U[H-.T_F?\<>J-N=X9G)=G[0W;GOCMLK-;][8ZQZ]W;LW=O;6U\!@8 MH):]\EU]29)*ZDD'W-,J_?)`FJ6(,Z^1;^Z]T-V_>R^O.J]NUN\.SM\;0ZZV MCC&IDR6[-];FP>T-L8YZVI6BHDK\_N*HIJ2$SSR)#"LDP+R,$4$FWOW7N@%S MGS@^,>V>R=@=;;A[9V3A).T^K3VWUWOO+;SV3C>L=Z;>EW=0;+Q>+VMO>MR< M=-D^,+BNVNL>P"V(LB9,@YFMB1Y* M3%C_`"F959HXF4$^_=>Z=MT]]=6[5V9O3>\^\-LY3&[$R&X]NYFEQV\-D051 MWUMG'R5];ULE9GDY=W;6ZXJ M^U.N<3VEO+;M#NK;_5.3[`V1'V7DL'7XR7+Q9"@V539&6NJX5@IZF0U%%%-` MRPRR)*\:,X]U[H+^FOFY\=/D!6YL=0[^P.]]N;9@[+.XM\8;=&R*G;&$K>J- M]2;#W519)(\J2AVK-%3;GDQ^[/XE_#YAC9*BGCK_'4G[9I8A- MH\B7]U[I65?>?3-#NK96Q*SM;K>FWUV3AFW%UULB;?FTH]X;_P``E.]6V;V1 MMIJP5N6H_$CR_=8^&6+0K-KT@D>Z]UWOGO+IKK#)[?PG97:W6W7N:W94TE'M M?#[ZW[M'9^5W'65V0CQ%%28''[CK::6MDEJY8J6)*9'+S.D:@NP!]U[J!'\A MNB9=I;QW]'W)U6^Q.N\UD=M]@;V3L79;[/V)N+$5$5'E=O[SW0E<:#%5U-// M!!44=?4131R2(KHI=;^Z]UUB_D1T)F]O97=V&[JZERVT\#MG%[USNZ,;V3LF MOV[A=F9R:JIL-N_*YNDKWIJ?%5Z]T[=B=U=1 M]0;=IMX=M]F]?=5[0K*VBQE)NOLG>VUMB[;JLID8Y9Z#&4V/9FU,[O+$[7QW4W5'4?=&[^Q=T9G;N"ZL MI]A=UYO MZ<[W/U1A=K=IUN-QW6&YLOV1LC&[?[)K\S$D^%H]@9BMKTI\S+6)(CTL>-DF M:4,"@-Q?W7NF+NSY-]0?'>KZK3N+`ZV MSG:577;YW-N.LHZ;&T#0/*67W7NE?E.[NGL*W7R9;M/K MG''MJO@Q?5?WV^MIT1[,R=52)74N.Z\6KK$;-U$L,B21PXL3NRL&"E2"?=>Z M6%=NS;>+R&&Q&2S6,QV6W'65>.VYBJZOI*3)[AKZ#&39NNH<#05#K+63045/ M/6314Z.T<$;RN%C1F'NO=(+-?(#HW;9VJ-P]Q=6X+^_6Z MF]<-F&V]E]H;1DR5;$N3RE)D%:@JL?0F6>&I!@EC24%/?NO=/E/VQUG5[[RO M5M+O[9E3V?@L'3[HSG6M/NK;]1V#AMKUDPIZ'@GD94AJY:58G M8@*Q)'OW7N@JZ[^770_;G<&ZNE.K]\X/L/<^RM@XW?\`N?+[&S^U]X;2P]/D M=Y9'8K[6K\YMJOJO#G*6MQDYK<;-$KPQM$S-JO.OMX]';47>.]*??>[\MD8*:AII*0D8ZL4R15 M+I(%8(CN/=>Z-%EN^.E,!-U[3Y_MOK3`S]NSTU+U)#FM^[2Q4O:M16)!)1P] M:QU]9&V=:9:JE,2XP3%Q-"R765"WNO=*6D[&V%7_`,%-'O':]4NY,_FMJ[<> MGW!AYTW!N?;8KO[Q[=P3PSL*ROQQQ>3%?1TQ>:G-'5>9$^WET>Z]T7G?7SK^ M+&QDQY_TR;`WG-4=K;%Z>S5%U[OK8V[J_9&Z-^[PI]C4-;OZDH,F'Q&.HZ3V$^0O1&YL1O;/[9 M[FZHW)@NLX7J.RPQXTYEI-\Y6AKWI\0OV8:KU9"2(>%3+?0" MWOW7N@^RGS3^+F+W)\?]J_Z;>NLIE/E'F,_A.B)<#N_;F=Q78U;MG$SY;+/M MS-8JJEI:F%33O0QSPRNDMZ]TO\WWQUOM3=>Z-K[UW!AMBQ[6 MQ.Q,G4;EWGNS8NW=O9&;L&7-IAL/0?Q#*K7QU:+@:Z1Q6T-/%,O_``"EJC!6 M+3>Z]UFJ^_.F:7J/)=]1]F;'R/2^*VKD][5/:.&W7M_+[!EVMB(9):[-46[L M?4R8^HIU\3QB2&I93(-`.OCW[KW0!=&?S$/B3\A\@,=UWVWM9I\G4[`I-CIN M#<>U<#5=IU'8W4N+[EP]-UEB*O(??Y:HI<5EHH,G21TBU%+60U5-)%JIW;W[ MKW1H=O=G]<;LW7N[8FV=^[+W!OGKXXM=_P"R\)NS;V7W;L:3-TYJ\-%O';F, MJ9:S&-5Q*TM,*V&/RH"R:@+^_=>Z9]U=W].;$W?M+K[?/:G7&RM^[^JXZ+8> MR=W;[VGMK=N^*F6MCQL46SMMYFLAK,HS5$L<"K0PRDR,L8'D(7W[K8!/#H.N MB_EQT5\AX\O2]=;UP]1N[;N:WUAMR]99#.[73M';0V!V5E>K,CF-P[#QE?55 M]%CZS(X>IFQM741*E13/#(-+N8U]ULJ5X]+':WR*Z$WU]M_<7NGJ;>[UN[LE MU_0Q[/[)V3N:2MW]AL-)N++[&HUPM?-Y].F:++;4P%7VMUO39[?>>W#M;8^$J-];4@S&\]T;1G:EW7MK:6,FK%GR6 M0QDJM%D*&BCDGIG!2:-&!`]U[I#]U_)[K_HG,[2V_NO&[FR>8WMM#N?>6WZ? M")MJEHY:#HS9:[ZW=1Y'.[NR>*QU!+/2.L=#-75<-+Y+FJJ:6%6F'NO=/&Z? MDW\?MD56Z<5N_N7K#;FY=D=>5W;&[]FY??\`LZAWIMOKG&T'\2K=YYG:L]<* MVGQD<5KU\D0IR2MI"&4GW7NE5TUV_P!>=_\`56P.ZNI]R4.[>N>S=KXK=VT< M_02I)%6XG+4XGCCJ8T):"JIWUTU;22VEIJB.6GF1)8W1?=>Z$OW[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_2W^/?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=)K><^Y*7:.YJO9N+H\YNZBP.7K=JX3(UYQ6/S.Y*.@DJ M<%B:_)C_`(#P5-4D4$TW]A&9OQ;W[KW5(?6G\K#NCIRKZFRN%^0G9N]-R=A] M!?(?X[?*'*YK<^P*7%=;4?R)PV0[=SG8?1(V_M7"9BKFQ?:LC5F+I\QDYY8: M+)5Z1%'_+[^1>9WWBM[U_QH^.W7>.Z.Z7^-&Q=L[!VAVCB:K;O MRBSOQ>[CGWW2XG?IBV72Q8C"Y6BE2IV\N0HZV2AR,4#U*0)'K/NO=(RK_EE? M*#?&W/F-DLKU/T+UMEOD'U%\M:+8_6F,WU3;BVMMG>W<'9.P>P-AX#(9BAV[ M101F;^[>2DR64I\:5IZZ7RHM0K>9O=>Z'W;GPX^2'7M3M_MW_9>^ENY,Q2=N M_-[<$_QAW9V5B<7LO!8/Y8]H8GL':N^L)N[);>R&-.9V]18R?;=;"<6HEH,A M5"ED3_-R>Z]TC,3_`"KNTL#T#\F^N\IBNI]^=F[PZ5^&G7_478-=-$E;0YSX M_8=)LI1XK/97'R9+#8O`Y`F#:;L\E0E-!3RR,*H22-[KW0,=[?RU_FWV(-Z8 M/`;*ZF6C3>7R[&'R]%V?M#8NTOGKTOVUW!L'K<]/X+;FY,_L#MK%[WRF&K MJ_8NW=Z5F!&U,QM6J3K#?'9NV]W8'!Y3RY.$U]77;>J))\1_$J&CFH:VKIZV M#W7NJN]K?`;Y<;)RN-DS'QH^-W<5#7]=?.;I^HHMY=V4N2Q6PZ#Y6?*\]Y;. MW?B9L[L.]?18W#5U1C<]008JAFD>C04D MO.L\MU_3?+'XZ?)'%_,NK[!I*WOK)X+XW=/=;[(AV?F]F-M[[X9'=%7L[)XV MOJH]RM`,3DJ]9;F8TL_NO=`INS^5A\H<=T[T!M;8,6UZ>LQ'27=_3O:77VSM M_P#5O7N!I=Y=O=GR;Q/;63W+O_K'?HRU+54)%)N`XF@QV:]$#4U35DR)%[KW M0Y=I?RV>\=R9?NK8]%E=L;PZAW'T#OGLK8M7N7<%?%G0?PNKP8FW%-DYH:B7^*5]5,ZM($8>Z]TG^Q?@I\NJWLVER6VMD]:9;;N-[ M3^$'<>/RV.[(V9USCC3_`!VS&P'[!V[G,73[!R>Z,UO*N@VKD*6#-56[J?"2 MXHXRD6CI9J6I%9[KW36W\M3Y%Y7*?(?"0;?"]MT M'9_S]H/F/M/9?8FVL-B:6IQ>`S.WA/L#"6F$?NO="WU5\$ MNTMU_-+:?RO[CZ+Z2ZSZ_K<5VA1Y3XZXC/X+LK`[#SU1UUMOKS;_`&3'-_!* M''5NX]S4U%74.7J,?2P)38F@Q-,S3S/5$^Z]T7OJG^6A\H.NMR?&*BQ^R^K, M90[5@^/Q[9W'4[\PF\NNGP_0?8-5G\?MK,]/;RVQ7Y#^)4&*\<6QLYU_N+;B MTM8:-\S!608Y4F]U[H^7S,^&6\?D)V5V'O/$;6Z^W!'D?Y$U$ MV5PG1VA/1R5-'4-0TCQXV0UF3IW#QLD8\;\%?=>Z+_P!L?`+NVDI> MQ:_IC8W4N/2HZZ^`M+MW;6)DV+M[+5NZ_CG4]B1]HS['K]W[;SNV]OY\P;EP MR8C!*B`T\$B4U3![KW1+V^P]Z M_)GK_;>^O](U=1?"G9?8.V_D1UQN#>#8[";=%,U3N&AWKU?*U5B10U,F;JOL MR\)E>7W7NK@?F_T/W3VIN/X];PZEVOM/=B=>;QW/+O+$U>:V)LK?383>-#CJ M#_?N]A]A[4WG1T.$TT&L]U[JNW8W\M_Y1;;Z' M?:>\-E;&W3O39G3'PSV5MJ@VSWID\%65^]OB]WKW!N^KW5LK?F4V])24]1'C M=Y;?K\)#NK;=;BJF]5C\KBA&BE?=>Z5M!\#_`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`S$?R[/DUL[K MC>'7[.A9MP[IW['CH_B+2R]Y]E;UP>_=@T$F$JILI13XW>^ M)RQQ6'J,?54^4Q*Q"=H#3O3>Z]T(&W/AE\M<#CNE.C\]A]M)U'\?.]OF;VE7 M_)3!]GUV5[EW[A/DYUCW'187JJ#`Q&CW'B*0 MK'[KW1"_C[U1%\P>Y^BH.H.I_C=E>H_CIU5\1=E[ZWUUKNG$[LVKO[%]*?)[ M;_8&2HNR\:^U\.V"W/)B<369BFZ_SD4N6Q\KU"Y%*)Y('JO=>ZNLQ/Q1W[@N MD?YDG6N%P^SL/-\EM]=Z9[I+$8NOCH,#28GL/XR[9ZOP:96&EIDBQ+29S&Y& M2JB@BD`1_N27DF<>_=>Z*OV#_+?[$7-]7;AZSZ_Z=Q^-ZT^+OQ4VKN3K>GJ\ M9M':G=6_OC;WKC>TZCJ3>:XO#S1-A:RBI:A,5E*FGFBI:\4SRTK4OW,>=H**FH8:FKJI/MI%GB::7W7NA#^0?PD[$[?\`EI#VL^VN MO=P=7R]B_P`O_=&1QVYJZGJIJG'?&K)=R9/?;S;>K:.>&26FFWKMZ;%H[GRR M>=PT34ZE_=>Z&CI'XJ9S8/57S%ZNR6WMBXC"=W]]?(K>W7F#QL=-4[3H-F]L MX*DI\0V4PE/2QPTKRUZU5774<,+C6[RDO)*Q/NO=5V=-_P`M7O'#?&CM[;.\ M^J>F=N=S[JS7\O%-H2XG=.-SLM!B/B;M#K3:&_*B/?4.'I)J1:J;:NX+8.T^N]N[@H5IEC2NS7][][9UDR<<(H&JXR]D#M'^7;\CM[[3R'66[.O>KOC M37[;W-\]]^X'Y']7=C8[=?8G8.1^9-7V+C=O;4W%C:#:^*KJ.#$4V],?EL[- M)EYTGKB^.'SPZPJH]RYR3#Q/NCY"_'YNN.NJ?TP5&JEDR1T9 M">]Z>']P+(?3[]U[HON8^!_R`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`50%50%55``4`6``'T`]^Z]UW[]U[KWO MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KQ%P0?H>#_L? M?NO=1A1TH;4L$:$N\C!%"*TD@M)(Z+8,QXN2">!_0>_=>ZD^_=>Z][]U[KWO MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z] M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z__U-_CW[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7_U=_CW[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW71(4%F(`'))-@!_B??NO= M%CZZ^:_P\[?WK1];=4?*7X_=E=A9&+*ST&R-A]N[$W9NRMAP5,U;FI*3`8*N MGJI!20H\E3HB/C527L`??NO=&5^Z@\BQ:SY&-E70]SZ=9MQ]+6Y_Q']??NO= M6 MJ(\=B,1BZ]UFQFZFB MKIRH?R!5*EKL"OI`NQ]7]/S_`$]^Z]UP-;3"P:32Q*J$9)`]V;0HT$7Y/'T] M^Z]UR^\I]036=1=DL$_=>ZXRU])!#)433)%!"KO- M-)=(H4C4O,\LC<*$4%G)/I`)-O?NO=-.W=V;9W?@<)NK:F=Q>YML;FQF/S>W M-Q8&L@R^#SV&RU(E?BLOALK0&2"II:F"2.:GJ(7:.1&5D8J03[KW3L:ZE%_W M>`H/R M='69;;%3F\9'F\-!G\?`[2T;U='+%5TRU"J98661-2$'W[KW2C]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW2?W5NO;&Q=MYO>.]=PX7:>TMM8VJS&X=S;CR5'AL#@\31 M1F:LR>7RN0>."GIXD!:2:5U51R2![]U[IW^\IK$^3Z$!K)(=)(!`<`<<$'G\ M<_3W[KW77WM/Z@)-174"%!))0$LH'Y(L>/ZBWU]^Z]TQYS>>TML/@8]R[EP6 MWY-TYV@VMMF/-96BQC[BW-E*:>LQNW<&E:Z&KKZB&FJ98:2`-*ZQ2,J$(Q'N MO=/_`-S#8'40"VD75A=N;@7'/T)X]^Z]UT*NG-B)002%!`:Q8MI"@V^I/T'U M]^Z]UU]Y`1PY))(4!'+,0Q7T@#FY''OW7ND5MGM3K/>F;S.V]H=@;.W3N';J MU+Y_";>W'B_=>ZX_<1``EBMU#`%6#6*Z[Z;7X')] M^Z]UP6MI7"LLH(6QV0I&2-RKJRLI(( M/OW7NIC5=.A<-(+QFSV#'2;7.H@<6_-_I^??NO==&L@`8ZF(4H&TH[6\EM+' M2#QS;;)W;E=@;P_NKG\9N`;6WU@A$1%U"_NO=*\U<`N"YU:4<)I;6RR#]LK';4;\@.H7KZB.B6NR.1E,%!C:$U)7S5$SC1%!'=W;A5)X]^Z]TXK/&X!0E@6"W" MMP;E?5<<_=>Z][]U[KWOW7NO>_=>Z][]U[ MKWOW7NO>_=>Z_];?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]UAJ&*1,P.G2T9)T:_2)!K&GCZBXO^/K^/?NO=:[O1'3_`,VN MK_YWR(V#WOG>DZ'X.[LW+OC#[_`.P]WBBW[#LT]FTU-38:MW)50Y"6 MJ\U)'.M$N)9O=>Z-#\\6[_Z_[*ZTR_1.1[.EIOD'UCO;X:SR;=J=SY[`=,]H M]@9O$93J+Y(5^%IJA:6B;`4,.[!7YRI`;7_#X&F19#J]U[JK#>6;^1F/W7V5 MLBE@^86=7/3?-CH?LC`[\D^6O;--7=Z,Q!VGW9UYU]N+I>6@^2E%V3N+O_P#EC[BZ MAH\%UMW;D-O;?^-T>WN@=G]V'^_VWL:^#P."3*8_?]'N;$U63IZA6?(35=(* M:J,TONO=*'^7+OKYG;B^1VX*?O.'=-##5[&WW6_(G;6Y8_E5DL#M7N"#=.+I M^O\`&;!;N?"XK8NWX4HI,O%1XWK&OR6-KL;IJZIVDBIJVI]U[II^7]!\JZ+M M3YG=E=7YCORMP.UNQ/B;L+$[=I=__([!=5;?^/>[NML?DOD=O/KW9_1]/6Y2 MIR7W*QTV4S^U\3D,QBHC4SXW[*L6>H/NO=,^*WIWA4]"]`P?)O)?*C%?';*[ MA^28RV[OCE%\Q:3OZ>'$UN#I?B1B-R;JQM!3=M3XG)4T^[1#F]PX_'S9!Z7! M-F&*RN]7[KW2+P6_/G5)\J-BXO)+WK00TE=U)B-EXWL^+Y'MGLY\7INHL!7= MB[H[EV1UIB7Z/&ZVR<^X!FLY7[ECSN/SL$=/14_VJ4E)5>Z]T(/2$7RY>7XA M]09[/?(>GQ_RS^/?P9[3[$[&SV0WN:CIW/\`QUV(F6^6?6>3RE?-!-MK([\B MHMHT$]+*L-355&2SU1I:6-_MO=>Z`CI_>G\RS=U!WM_$'[3VWV+6]7YG,]_X MK&P?++)9/9N^J3M[:@R5'T;3=S;?HMFX?-IL67>]-MG%]3564H*]A0UDKRU4 M-+5U7NO='F_EV[DZMV/W7\N:W;V5^0K]<]W]W]';3Z(W9\DMN_(.3>G8-;MS MXFT^X\W0T.Y>^<=%N2HQE#'A"R&$[9K:NC$)EJML]$=W;QPZ9/]F)V'_SS7>W_I,7R0_^Q7W[KW7O]F)V'_SS7>W_`*3%\D/_`+%??NO= M>_V8G8?_`#S7>W_I,7R0_P#L5]^Z]U[_`&8G8?\`SS7>W_I,7R0_^Q7W[KW7 MO]F)V'_SS7>W_I,7R0_^Q7W[KW7O]F)V'_SS7>W_`*3%\D/_`+%??NO=>_V8 MG8?_`#S7>W_I,7R0_P#L5]^Z]U[_`&8G8?\`SS7>W_I,7R0_^Q7W[KW7O]F) MV'_SS7>W_I,7R0_^Q7W[KW7O]F)V'_SS7>W_`*3%\D/_`+%??NO=>_V8G8?_ M`#S7>W_I,7R0_P#L5]^Z]U[_`&8G8?\`SS7>W_I,7R0_^Q7W[KW7O]F)V'_S MS7>W_I,7R0_^Q7W[KW7O]F)V'_SS7>W_`*3%\D/_`+%??NO=>_V8G8?_`#S7 M>W_I,7R0_P#L5]^Z]U[_`&8G8?\`SS7>W_I,7R0_^Q7W[KW7O]F)V'_SS7>W M_I,7R0_^Q7W[KW7O]F)V'_SS7>W_`*3%\D/_`+%??NO=>_V8G8?_`#S7>W_I M,7R0_P#L5]^Z]U[_`&8G8?\`SS7>W_I,7R0_^Q7W[KW7O]F)V'_SS7>W_I,7 MR0_^Q7W[KW7O]F)V'_SS7>W_`*3%\D/_`+%??NO=>_V8G8?_`#S7>W_I,7R0 M_P#L5]^Z]U[_`&8G8?\`SS7>W_I,7R0_^Q7W[KW7O]F)V'_SS7>W_I,7R0_^ MQ7W[KW7O]F)V'_SS7>W_`*3%\D/_`+%??NO=>_V8G8?_`#S7>W_I,7R0_P#L M5]^Z]U[_`&8G8?\`SS7>W_I,7R0_^Q7W[KW7O]F)V'_SS7>W_I,7R0_^Q7W[ MKW7O]F)V'_SS7>W_`*3%\D/_`+%??NO=>_V8G8?_`#S7>W_I,7R0_P#L5]^Z M]U[_`&8G8?\`SS7>W_I,7R0_^Q7W[KW7O]F)V'_SS7>W_I,7R0_^Q7W[KW7O M]F)V'_SS7>W_`*3%\D/_`+%??NO=>_V8G8?_`#S7>W_I,7R0_P#L5]^Z]U[_ M`&8G8?\`SS7>W_I,7R0_^Q7W[KW7O]F)V'_SS7>W_I,7R0_^Q7W[KW7O]F)V M'_SS7>W_`*3%\D/_`+%??NO=>_V8G8?_`#S7>W_I,7R0_P#L5]^Z]U[_`&8G M8?\`SS7>W_I,7R0_^Q7W[KW7O]F)V'_SS7>W_I,7R0_^Q7W[KW7O]F)V'_SS M7>W_`*3%\D/_`+%??NO=>_V8G8?_`#S7>W_I,7R0_P#L5]^Z]U[_`&8G8?\` MSS7>W_I,7R0_^Q7W[KW7O]F)V'_SS7>W_I,7R0_^Q7W[KW7O]F)V'_SS7>W_ M`*3%\D/_`+%??NO=%-_F`[JB[L_E_?-C9G7VUNW:O<^1^.G8^+Q6)K^E^V]H M9S+Y+,;=JJ.@H]HT>\<%2-DZXNI,=-0QSR`Z"R!64GW7NB`?+&A^4?16[^XN MM.G<]\AM[?'S(/\`%3>/9>[]\]A?*G>NY-O8_>]%W%#W%7;"[5Z9HL_V%BJ> M;);>ZXI\OBMB4WCQ4%4)((,;39&JG/NO=.9Q_P`V.P]E?$"HR&8[S@WY@/C[ M_,%["Q&$V_N;NKJ_!=@=A]9[TVA+\(-O]_S9\83,Y)*ZC8%J#=JX^KS*?=OD MZ*TV2I3[KW1+:>I^06^MF;(J>\#\F:OI';'RE^*N^.QLQL#&?/?Q>PH< M+O\`I^]\UM[O=H;(?:^\?D#G,%\S*OY!_"'XTY+>NX^SXNR]C8OL'?=/O?XN=[;SQN\ M6H-QV#->QJ8Z@3>Z]T?/\`F54N_-G](]4TNP=X M]LX/![>W[14&^'VC'\BZR7>V#Q_7>6Q^WL?VGV?\37J.U-N4DV53'5BYS;&+ MR?W.0B@I,M2_85DTT7NO=5U5?8_\Q2I[-^-ZS[:[EVKG'ZV^*U5U'AM]97Y( M9_,9NOW#6P_[,K2]UT'1FW8>K]Q9&FC:II,W4]DU.%JZZCXAXZL[(J*Z=Y:L;?I**KH,$\R5!S MM4&7&J?=>ZJT'9'S.K]N?"'=6Z\I\MZDY7< MWRYH^SN_\#B`BD^=VPX]N[4S/4N]Z'(;'H( MX]FSYJGV_F.E=S24>0P=-D:W=5!2^:!:?W7ND_\`+G?W=^VZO-T.U>V?FQ'\ MO-U[[_F$X?+[=V%E/D%)\?LCUUBOC9W+NCXM8WIN"EHTV159FAH\;M&MQ-/M M667,?Q>FK?XC'+54L@@]U[JY7XQ;'WWU-\K>]^O%WSW]OOIW*?'[XX=GXBN[ MKWON[M&@H>Y=R[U["VSVA3;/WINX2FC,V.PNVJK(;;Q]0E%1221ST]%2+5Z7 M]U[JDGY`]F?,7"Y/O>JZYD^:6W.PLUEOF7UQNFGI_P#9M^PLAMK"U'2V\L:6>1:0TD&2RQJJC)QS>Z]T?3M/97>W4V^ MOD5UQL[LSY69KX\_9_![MCL+<5?O;M_LWM/";0WEV1V!A?EW!T#OG&TM=N.* MIEPV#VG5UV`VM+Y,=2O63X6DH*BMA#>Z]TN?@SUS0;K^,/STVEBHOD9%LSM+ MY(_(-^N<[VK4=P[![SW;L?<74VV,3M[<-)NO?BXS>3"IEADIL3F*^1:^6&*+ MRS/*KL?=>ZKUZAV-W%A?C909;;]=\[ZUP^*W] MN+=^^-D?+:IW?MJ/'5>Y:^+;U+1PT^8CV[BZW.8S!T]+)M."GK!A*E/=>Z$[ MXR;;[S[Z^0M-T=OOL/YR;1^.&`QGR$SVULW0;Q^8G31SNV]T=9]$9?KR4]R= MPBDWOF*6#=%;V3-M\YC+1UD9BJ::.&#%@X\^Z]TFZ??WS)KRL%0]Y=392FW35;MDQG>V^GR>R<77]:Y_,R8V2EGWO@NZ\ M7AQ04-.9MMUXK*P&F]U[H",=M/YA_'JCH^O^EJ+NW;^UY>R/DYO3H27.[G^< MN\:G=??E?\V.R,._][L7L#&9S%YN@GVKB-EY`8OLW)XW!U\.1KLRE0]5D,AD MHO=>ZOA^.VS-Z93Y>_-;LC?^Z.XIL5MSL7K;874FSF6V/US52I@ZRHEW3)EEJ,NL,\D$XJH89HG>L6;W7NJH/D9W/\`*>+XXT?3 MVQ:GYATGR0V#V-_,MD[+S>V=A]]13X[;&3ZE[OW1\8J>F[6I,:V'S(<56R)] MH08O)5J13P45/'X:NGBA7W7NE9\L>@-TX+MR@VWF-V_-+L/H?K?NO^6I\BQE MJGLOY#]B97:N[]V]P=@;&[\W!@,WLWRY0T5%C,7M'(5>#H'>BP4LPR-)1XZ. MMDD;W7NA[Z6W!WK/\J-A4E?F?DI4?(U_D/W91_*_96[(^XU^'NW_`(GTT6ZE MZDR?5L6_=>Z][]U[KWOW7 MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_]??X]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UQ=0ZE238VO8VN/RI_P/T/OW M7NN@BA='-CS^HZKWO?5];_X^_=>ZX>!`P>\MP^NQFE*DZ-`U*38BW-OI<`_4 M#W[KW7-HU;5?5Z@58:C8@BQX_'^P]^Z]U@%)"""/(+?33+(`"6#G@&WU`/\` ML/?NO==BDA74%\JAG9R!/,`&?]5@&MS_`$]^Z]UTU'3L`&5RH1H]/EETE&L2 MI&KZ<>_=>Z[^UBLH)E;2VL$S2WOJU_@CBX!M[]U[KHTUN+_`.]>_=>Z[2FC37;63(;L M6=B;7+6!^MKLS#_$D^_=>ZZ%+$&#'R%E!56::4E5(LP'/YMS_7Z^_=>ZA5.$ MQE9/155720U53C:B6JQU34Q15%105,U*U%+/133*S1.T+R1,\9#%&9"=+$'W M7NIZT\:&ZZ@;$`ZW-E:UU4$V`X'`_P")/OW7NN>@?ZI_^2C[]U[KV@?ZI_\` MDH^_=>Z]H'^J?_DH^_=>Z]H'^J?_`)*/OW7NO:!_JG_Y*/OW7NO:!_JG_P"2 MC[]U[KV@?ZI_^2C[]U[KV@?ZI_\`DH^_=>Z]H'^J?_DH^_=>Z]H'^J?_`)*/ MOW7NO:!_JG_Y*/OW7NO:!_JG_P"2C[]U[KV@?ZI_^2C[]U[KV@?ZI_\`DH^_ M=>Z]H'^J?_DH^_=>Z]H'^J?_`)*/OW7NO:!_JG_Y*/OW7NO:!_JG_P"2C[]U M[KV@?ZI_^2C[]U[KV@?ZI_\`DH^_=>Z]H'^J?_DH^_=>Z]H'^J?_`)*/OW7N MO:!_JG_Y*/OW7NO:!_JG_P"2C[]U[KV@?ZI_^2C[]U[KV@?ZI_\`DH^_=>Z] MH'^J?_DH^_=>Z]H'^J?_`)*/OW7NO:!_JG_Y*/OW7NO:!_JG_P"2C[]U[KV@ M?ZI_^2C[]U[KV@?ZI_\`DH^_=>Z]H'^J?_DH^_=>Z]H'^J?_`)*/OW7NO:!_ MJG_Y*/OW7NO:!_JG_P"2C[]U[KV@?ZI_^2C[]U[KV@?ZI_\`DH^_=>Z]H'^J M?_DH^_=>Z]H'^J?_`)*/OW7NO:!_JG_Y*/OW7NO:!_JG_P"2C[]U[KV@?ZI_ M^2C[]U[KV@?ZI_\`DH^_=>Z]H'^J?_DH^_=>Z]H'^J?_`)*/OW7NL?V\5]5F MOU[:OQ?^G'OW7NN!HX#;4'8J[.A\C@QLPTWC*D:;#@6_''T]^Z M]UR^VCLP8R,&))U2/?GFP8&]AZXFCI]1<+(KLB(72>HC;1&VI M5U(P/_%1P>/?NO=!GG.DNL=S=G['[CW!MMLSV#UK0YRBV'EZAU^#Q&5BC@RF M.H\E3PU%+51T^0IH:VG6IH*M*^@J!#4JRAX)XHIH7`!1T1E(*BWNO=3I:>*5 M@[A@P1X[H[H2CJ5*MH(N.21?Z'D>_=>ZZ%-$-8]9#\,&ED(*@6":;VL!Q:WO MW7NNA20KHMY/VF=H[RR-H,A);3J)M^H@6^@X'''OW7NBY;'^'WQTZW[8W3W= MLSKI,-V/O#);AS>4RAW3O7)8/'Y[>$Z56\]P;/V-E\E48';^1S4B>3,U^!QE M'45[-(U7),99"WNO=&0A@2`%8]5B1PS%@-(TJ%!^@```_P``/?NO=8S1074@ MSKHX54JJE$`_Y9HX4_UY'^/U]^Z]UVU)$S*Q,AT%"MY'8*8[V*ZB;$WY(L2+ M#Z`>_=>Z\U)`S%F75<6(8E@?5JYU7_/OW7NNWI8WTZC*2FDJ?-("K*X<,"#] M;BQ_J.#P2/?NO=<31PG5_G?6Y<_O2FS$:6*@FPN"5-OQ[]U[KLTD1\FK6?*5 M,@UM9]*A`'`^O``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`O;\L9]EY#,4]9MS:VZ=A M=/9O<^W]I15V7R=?XJ7(XJNPU-3;DD>>*$I44=3:CBK5,7NO=-DO?OR,JEVW ML6@B["IM^5':B;+KXNQ>P<-7U`P=;-79"***'&":"!_!H^[24HWNO=#YU#ENV)=_P#? M5)O/L^GWCM[KC=N/VM@,6VQL!ME8(/W6/P^ZC3[?S'8=9M:/!9G>>R=N/U]M_&;HDH))>Q. MLMT==[DKZ/=&T8#7QX^'^-Y'%905Z%6B[7[X=\; M>I-QX:?.U#=Y4>SJ">ES=/MS`8#,G9@V=5U[4$6Y->6JWRB)5!$HJ)YX*2%Z M@BA]U[I$[G^6G8]#M'>+8([*S>^3,;=Q]%AO[P/!24$BN\:SN/.5LZ4T6/P$ MW2?1_8E+B:K'5V,W%@=S;]S.\W9]#\ADV[5>>GZPDW_C>N)ECAA5JH"H6J]^Z]TA>K>[/D%FNM=I;WW;7YS%R M=OYS9.S]LYOK:39&UI]^5==)%O+;L.R]P9#)UM-`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`R.3[KW02U'QI^/M678.U&;/9 M89.7,C(YC_)+5%1]W/-4^>4&3RN\FK6S,?=>Z2G9FTNI^E.ENP:_"=2;$EVL MN+QYW#L>BVWM_#X#=5,CTVWZ2ES=)3T;13QT].4CACFB952-8@%2UO=>Z+%E MMU;4VWA.X]V;D^-G2=9LG>6[^\]E3'%0TE5N3L?=/2)W3G=?;N-K\+#224N8 M.UJ^KCEBGKFIJF2%VAD=F>/W7NLVR>],/LCK#9-%D.E>LL5U9V-V/4[)W9A- MA;?WYM?;VT]J97J;.]A[QWMGMH=I;6V_-E*.%<9305T5-1-')235,[R7I'IY M/=>Z7-#V1NO=65Z(_NOU-TS_`'6[8R_92>7<>;R\6:VUE<=-F*OL.OQU!B,) M/2U39>GAG>:9JJ&2IEJ)15%E9F;W7N@2VUO/8>_:KK;J/;GQEZ$H=H9W9O4_ M=4&U]Q;*WIE,#C=T]KP9S'SS4$NS=G5^"HJFDH\=-3_Q/*5=*\Z3O$5C@(:3 MW7NAJPG8NS+#=GX3)2-58.BQS8\19 M&DV1)0XXXK*Q$03R,GV+Q_:EO?NO=,_7?S3H-S;?VWF\?U`N$WWV/MG`9W.[ M/&X\?'7Q=D;FSNT]C;"PF;W'!0HD]#D,5G\1DX<_X'TXU$5*=Y4$`]U[I;=9 M97JFMZX[^W-1]<='S9W;4VZ8.W,;UI/MC.[0WUF\/M]MVS4>>K/L(:XEUJC% M/2YO&K+%*971*B%HIY?=>Z"[:/:W4V]]A;)ZVK/CQL;%;1KW^.T&7ZIR./VW M487K[>O:^\-R;8SVVIL!%CQCYZC;E3M\5$&0AC`R,-5'51!()(7E]U[IX/R/ MZWH^W,G0;AZHQ.+K]G[4[AR.%[)I8L/D,RE5U#O?=?7\NSZ!:BEAEIJC*X7` M9:MQYIJK2J"JHV70+R>Z]T"U'W/LW([RZFW-3_%+J*'=F>V5U7V75_?X_)'> M>U-R]R]L[HQN4Q.([%Q>U)<#2U&.S5%79BIK^;Q?9N$W#14]?W#%U%1U6Y>R=Q[0IJ5\ M;34\U36Y`X*OKC&B"&+7"WD/NO="!USG^DJ+JGMO?E)TATM]O29,;$W1+T]B M<'D-@=OR9^HH128;'Y?(8['--"V0R]-0Y1*^D,4-2)G#S*A]^Z]TGNVM^XOK MW9>-ZTW]\8G:6_NO,=7;9W!E*W*8["25.Z*J2HW'TWU[O_;F$J=M M4F1IZO"@2C<&5Q%%5RBB,+ND=1+2^Z]TXK\N4PVY>Z,(>O-KX.NV71;LW?D= ME-E,UM3LB:HP^2FP\>Z-QX_.8FCQ^7H,RF/O#E=KY#+)"&@%0QB;SQ^Z]THM MO[_ZT?L_(X;_`$9]*[=Q7=>>[`V/2UT^2VU0]I=K5>PZO(8/=&:W%LZ6@A3) M8:6JQM;2?:+D:JO)1*J6C,4TPIO=>Z#2A^9>.JMA?Z6<7U%@ML=E;GZVZ6W! MOO%9"MR%?DL1FMX=BX+9&#VSG\UL7#UF7S-'C:+=D>:Q-30T,TE333JE/3QM M4,![KW7:=JG9%;M/;.V.ENDL/5][X+?F[=UMC-D]V8_"9JFPFZ<;LJ"BS.`P MNPVRS/6#+3-5RY^AIJ55_P`R9DFE<>Z]U8D-F[9R-'4KD]N8*=\KC,1BLO#+ MA\?-3UM'M^>2JPE#4Q5,3"6"@GFFEHHY05B9V9%4L??NO=)BDZ*Z8H,[N'=% M%U5UW2;EW;'GX=T9^EV9MRFR^XHMU,S[EBSE?3TRR5:U[.[5HJ&?S,S-)J+$ MGW7NEQ2[7P%%F:O<-+B<=3YVNQF*PM;F8:"CARM;A\%/4U6&Q5;D8HQ--34D ME95O302.R1--*8PID]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_]/? MX]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW2(WIV9UQUO!CZKL M/?\`LK8=/EJF:BQ4^\MTX/;,63K*>G^ZJ*3'R9J>`3RQQ`RO'%J94]1`7GW[ MKW2`_P!FC^-'_>0O2/\`Z-38_P#]7>_=>Z]_LT?QH_[R%Z1_]&IL?_ZN]^Z] MTF=X]Z?$K?NVLKM'<_?72=?@FR"NMI(T)LW- MK&X)!]U[H'D?X)M5;NFK^_\`KS,T>\I]^5E9@DE30I')&E1,D+1K(X;W7NGG:^YOAIME,%'-\F]G;Q&U\Q_' M-N'L+Y(XS>S8:N;9^1V).M&<]EI?V9<7E:VGFIY-4;EQ(5UJK#W7NG;:F]?@ M[LC&];8?:_MU5=G=Y]+XI4VKL_9:@]Q[2JU&W=AI6IM:A"5F1<#[ M<9"J!<#4X90Y8(MO=>ZQCL;X7B-(O]./2WC3L9^V57_3%M,6W[)5&L?-`_Q' M@&1F8TX_9]1]'OW7ND=#+_+\IHL6E+VIT;2U.&ZXPO5&-RE-W/MR#-4FR]LY M"ES&UJ6/,1945/W>*K**FJ\;DC(:NFE37#,A)O[KW3WM'=_PLV=A=]X6D^0_ M7N<3LY5&_,GO'Y&4>\,YN)UVQ#L[R39?<.:J)JR?R_)TQ0R/;?2^8J,/DMJ9NEK\KW?@JS( MS[@V;NW);[Q6XLG6OE@]77RY?,96NKZJH+O5O52K4&2/2B^Z]UACC^!D64PV M0B[YZXBHL/@MN;;DVQ'\A\8FT-P8;9^>R>Y]K4>[=M+E_MNJ8C6(^ MIG42^1$51[KW6?!5?PFP$.0Q]/\`)S;5=@:[,4F?BVMF/D]3Y7;.(R]!ONF[ M(HZW!8BKS#1T;1Y:EBF00V`C+P6\,CHWNO=+O_21\,)*?L:AK.\^F,IC>ULY M_>'>V+RW>X8JS:U7)6[8H5SNZZ]T$D\/P,EKLM5P=^=? M8RFW'E,KD-UX/#?(ZCQ.V]W4>:K:C)Y':^YL!0YE*:KPK55;DJE<0\?VJ/75 MVF,)5SJ_NO=9JG_9#*Z3.KD>].LLEBLU29NDI]LUWR"Q-1M7:R;G5EW+-L;; MSY?[;#2U_DF%1)0)&=,LT::(I'0^Z]TYR9CX.R[RQ^]9/D!UX*O#[I??.%V[ M!\CJ6CV'B-Z5-)7T62W31;"H\U'B?O*Q5I_U*TC*[`^Z]UZLJOAQ6R[=KI?EY''GMLX_/8>AW33_+1:?<]7 MAMQY&CRV0P^8S,68$E73"HH*:2".?5XK,J%5=@?=>Z,/#\GOC-!$D2?(;I,J MBA07[6V0[M86U.[5UV8_5F/)/)Y]^Z]UD_V:/XT?]Y"](_\`HU-C_P#U=[]U M[KW^S1_&C_O(7I'FP_YFIL?ZG@#_`('>_=>Z%+:>\MH;\PT6XMC;JVYO+;\] M154D._=>Z4GOW7NO> M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[ MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_ M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_= M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=> MZ][]U[KWOW7NO>_=>Z__U-_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=%Q["B4_(CXY2']8QG=Y5N25!VYBHR`#QS8$V_I[]U[HQ>EO^.A_Y M)7W[KW7M+?\`'0_\DK[]U[KVEO\`CH?^25]^Z]U[2W_'0_\`)*^_=>Z]I;_C MH?\`DE??NO=>TM_QT/\`R2OOW7NO:6_XZ'_DE??NO=>TM_QT/_)*^_=>Z]I; M_CH?^25]^Z]U[2W_`!T/_)*^_=>Z]I;_`(Z'_DE??NO=>TM_QT/_`"2OOW7N MO:6_XZ'_`))7W[KW7M+?\=#_`,DK[]U[KVEO^.A_Y)7W[KW7M+?\=#_R2OOW M7NO:6_XZ'_DE??NO=>TM_P`=#_R2OOW7NO:6_P".A_Y)7W[KW7M+?\=#_P`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`LH;XY?\`:J[N_P#=#BO?NO=&)]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=='Z?[$?[W[]U[HO'QU_X!]R_^+$=O?\`N]7W[KW1B/?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U__UM_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M%V[!_P"RAOCE_P!JKN[_`-T.*]^Z]T8GW[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UT?I_L1_O?OW7N MB\?'7_@'W+_XL1V]_P"[U??NO=&(]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__7W^/? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T7;L'_`+*&^.7_`&JN M[O\`W0XKW[KW1B??NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW71^G^Q'^]^_=>Z+Q\=?^`?]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_]#?X]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW0/]C=*[8[.S.UL_FLQOC"979HSXP&0V-OG= M&QZZ`;FIZ:ES$574;;JJ?[B.2.EA"I.K!""RV+,3[KW27_V6[;__`#]#Y$?^ MC][._P#KA[]U[KW^RW;?_P"?H?(C_P!'[V=_]_P!ENV__`,_0^1'_ M`*/WL[_ZX>_=>Z]_LMVW_P#GZ'R(_P#1^]G?_7#W[KW7O]ENV_\`\_0^1'_H M_>SO_KA[]U[KW^RW;?\`^?H?(C_T?O9W_P!_V6[;_`/S]#Y$?^C][ M._\`KA[]U[KW^RW;?_Y^A\B/_1^]G?\`UP]^Z]U[_9;MO_\`/T/D1_Z/WL[_ M`.N'OW7NO?[+=M__`)^A\B/_`$?O9W_UP]^Z]U[_`&6[;_\`S]#Y$?\`H_>S MO_KA[]U[KW^RW;?_`.?H?(C_`-'[V=_]_V6[;_P#S]#Y$?^C][._^ MN'OW7NO?[+=M_P#Y^A\B/_1^]G?_`%P]^Z]U[_9;MO\`_/T/D1_Z/WL[_P"N M'OW7NO?[+=M__GZ'R(_]'[V=_P#7#W[KW7O]ENV__P`_0^1'_H_>SO\`ZX>_ M=>Z]_LMVW_\`GZ'R(_\`1^]G?_7#W[KW7O\`9;MO_P#/T/D1_P"C][._^N'O MW7NO?[+=M_\`Y^A\B/\`T?O9W_UP]^Z]U[_9;MO_`//T/D1_Z/WL[_ZX>_=> MZ]_LMVW_`/GZ'R(_]'[V=_\`7#W[KW7O]ENV_P#\_0^1'_H_>SO_`*X>_=>Z M]_LMVW_^?H?(C_T?O9W_`-_V6[`#D=H?(>X((OW[V:1P;\@UY'^\> M_=>Z:L5\4MC8-_=>Z=?\`9;MO_P#/T/D1_P"C][._^N'OW7NO?[+=M_\`Y^A\B/\`T?O9 MW_UP]^Z]U[_9;MO_`//T/D1_Z/WL[_ZX>_=>Z]_LMVW_`/GZ'R(_]'[V=_\` M7#W[KW7O]ENV_P#\_0^1'_H_>SO_`*X>_=>Z]_LMVW_^?H?(C_T?O9W_`-_V6[;__`#]#Y$?^C][._P#KA[]U[KW^RW;?_P"?H?(C_P!'[V=_]_P!ENV__`,_0^1'_`*/WL[_ZX>_=>Z]_LMVW_P#GZ'R(_P#1^]G?_7#W M[KW7O]ENV_\`\_0^1'_H_>SO_KA[]U[KW^RW;?\`^?H?(C_T?O9W_P!_V6[;_`/S]#Y$?^C][._\`KA[]U[KW^RW;?_Y^A\B/_1^]G?\`UP]^Z]U[ M_9;MO_\`/T/D1_Z/WL[_`.N'OW7NO?[+=M__`)^A\B/_`$?O9W_UP]^Z]U[_ M`&6[;_\`S]#Y$?\`H_>SO_KA[]U[KW^RW;?_`.?H?(C_`-'[V=_]_ MV6[;_P#S]#Y$?^C][._^N'OW7NO?[+=M_P#Y^A\B/_1^]G?_`%P]^Z]U[_9; MMO\`_/T/D1_Z/WL[_P"N'OW7NO?[+=M__GZ'R(_]'[V=_P#7#W[KW7O]ENV_ M_P`_0^1'_H_>SO\`ZX>_=>Z]_LMVW_\`GZ'R(_\`1^]G?_7#W[KW7O\`9;MO M_P#/T/D1_P"C][._^N'OW7NO?[+=M_\`Y^A\B/\`T?O9W_UP]^Z]U[_9;MO_ M`//T/D1_Z/WL[_ZX>_=>Z]_LMVW_`/GZ'R(_]'[V=_\`7#W[KW7O]ENV_P#\ M_0^1'_H_>SO_`*X>_=>Z]_LMVW_^?H?(C_T?O9W_`-_V6[;__`#]# MY$?^C][._P#KA[]U[KW^RW;?_P"?H?(C_P!'[V=_]_P!ENV__`,_0 M^1'_`*/WL[_ZX>_=>Z]_LMVW_P#GZ'R(_P#1^]G?_7#W[KW7O]ENV_\`\_0^ M1'_H_>SO_KA[]U[KW^RW;?\`^?H?(C_T?O9W_P!_V6[;_`/S]#Y$? M^C][._\`KA[]U[KW^RW;?_Y^A\B/_1^]G?\`UP]^Z]U[_9;MO_\`/T/D1_Z/ MWL[_`.N'OW7NO?[+=M__`)^A\B/_`$?O9W_UP]^Z]U[_`&6[;_\`S]#Y$?\` MH_>SO_KA[]U[KW^RW;?_`.?H?(C_`-'[V=_]_V6[;_P#S]#Y$?^C] M[._^N'OW7NO?[+=M_P#Y^A\B/_1^]G?_`%P]^Z]U[_9;MO\`_/T/D1_Z/WL[ M_P"N'OW7NO?[+=M__GZ'R(_]'[V=_P#7#W[KW7O]ENV__P`_0^1'_H_>SO\` MZX>_=>Z]_LMVW_\`GZ'R(_\`1^]G?_7#W[KW7O\`9;MO_P#/T/D1_P"C][._ M^N'OW7NO?[+=M_\`Y^A\B/\`T?O9W_UP]^Z]U[_9;MO_`//T/D1_Z/WL[_ZX M>_=>Z]_LMVW_`/GZ'R(_]'[V=_\`7#W[KW7O]ENV_P#\_0^1'_H_>SO_`*X> M_=>Z]_LMVW_^?H?(C_T?O9W_`-_V6[;__`#]#Y$?^C][._P#KA[]U M[KW^RW;?_P"?H?(C_P!'[V=_]_P!ENV__`,_0^1'_`*/WL[_ZX>_= M>Z]_LMVW_P#GZ'R(_P#1^]G?_7#W[KW7)/CAM])(I!V?\AB8IH9E5^^^S)(W M:&02A)8WR!5T8BSHP(87!!!]^Z]T8**/Q1K&&9@MP"Q)-KW`)/\`3Z>_=>ZR M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K__1W^/?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_2W^/?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=?_3W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=?_4W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T& M^_#VS$</ M?NO=!]]S\L/^=%\=O_0J[)_^LWOW7NO?<_+#_G1?';_T*NR?_K-[]U[KWW/R MP_YT7QV_]"KLG_ZS>_=>Z]]S\L/^=%\=O_0J[)_^LWOW7NO?<_+#_G1?';_T M*NR?_K-[]U[KWW/RP_YT7QV_]"KLG_ZS>_=>Z]]S\L/^=%\=O_0J[)_^LWOW M7NO?<_+#_G1?';_T*NR?_K-[]U[KWW/RP_YT7QV_]"KLG_ZS>_=>Z]]S\L/^ M=%\=O_0J[)_^LWOW7NO?<_+#_G1?';_T*NR?_K-[]U[KWW/RP_YT7QV_]"KL MG_ZS>_=>Z]]S\L/^=%\=O_0J[)_^LWOW7NO?<_+#_G1?';_T*NR?_K-[]U[K MWW/RP_YT7QV_]"KLG_ZS>_=>Z]]S\L/^=%\=O_0J[)_^LWOW7NO?<_+#_G1? M';_T*NR?_K-[]U[KWW/RP_YT7QV_]"KLG_ZS>_=>Z]]S\L/^=%\=O_0J[)_^ MLWOW7NO?<_+#_G1?';_T*NR?_K-[]U[KWW/RP_YT7QV_]"KLG_ZS>_=>Z]]S M\L/^=%\=O_0J[)_^LWOW7NO?<_+#_G1?';_T*NR?_K-[]U[KWW/RP_YT7QV_ M]"KLG_ZS>_=>Z]]S\L/^=%\=O_0J[)_^LWOW7NO?<_+#_G1?';_T*NR?_K-[ M]U[KWW/RP_YT7QV_]"KLG_ZS>_=>Z]]S\L/^=%\=O_0J[)_^LWOW7NO?<_+# M_G1?';_T*NR?_K-[]U[KWW/RP_YT7QV_]"KLG_ZS>_=>Z]]S\L/^=%\=O_0J M[)_^LWOW7NO?<_+#_G1?';_T*NR?_K-[]U[KWW/RP_YT7QV_]"KLG_ZS>_=> MZ]]S\L/^=%\=O_0J[)_^LWOW7NO?<_+#_G1?';_T*NR?_K-[]U[KWW/RP_YT M7QV_]"KLG_ZS>_=>Z]]S\L/^=%\=O_0J[)_^LWOW7NO?<_+#_G1?';_T*NR? M_K-[]U[KWW/RP_YT7QV_]"KLG_ZS>_=>Z]]S\L/^=%\=O_0J[)_^LWOW7NO? M<_+#_G1?';_T*NR?_K-[]U[KWW/RP_YT7QV_]"KLG_ZS>_=>Z]]S\L/^=%\= MO_0J[)_^LWOW7NO?<_+#_G1?';_T*NR?_K-[]U[KWW/RP_YT7QV_]"KLG_ZS M>_=>Z]]S\L/^=%\=O_0J[)_^LWOW7NO?<_+#_G1?';_T*NR?_K-[]U[KWW/R MP_YT7QV_]"KLG_ZS>_=>Z]]S\L/^=%\=O_0J[)_^LWOW7NO?<_+#_G1?';_T M*NR?_K-[]U[KWW/RP_YT7QV_]"KLG_ZS>_=>Z]]S\L/^=%\=O_0J[)_^LWOW M7NO?<_+#_G1?';_T*NR?_K-[]U[KWW/RP_YT7QV_]"KLG_ZS>_=>Z]]S\L/^ M=%\=O_0J[)_^LWOW7NO?<_+#_G1?';_T*NR?_K-[]U[KWW/RP_YT7QV_]"KL MG_ZS>_=>Z]]S\L/^=%\=O_0J[)_^LWOW7NO?<_+#_G1?';_T*NR?_K-[]U[K MWW/RP_YT7QV_]"KLG_ZS>_=>Z]]S\L/^=%\=O_0J[)_^LWOW7NO?<_+#_G1? M';_T*NR?_K-[]U[KWW/RP_YT7QV_]"KLG_ZS>_=>Z]]S\L/^=%\=O_0J[)_^ MLWOW7NO?<_+#_G1?';_T*NR?_K-[]U[KWW/RP_YT7QV_]"KLG_ZS>_=>Z]]S M\L/^=%\=O_0J[)_^LWOW7NO?<_+#_G1?';_T*NR?_K-[]U[KWW/RP_YT7QV_ M]"KLG_ZS>_=>Z]]S\L/^=%\=O_0J[)_^LWOW7NO?<_+#_G1?';_T*NR?_K-[ M]U[KWW/RP_YT7QV_]"KLG_ZS>_=>Z]]S\L/^=%\=O_0J[)_^LWOW7NO?<_+# M_G1?';_T*NR?_K-[]U[KWW/RP_YT7QV_]"KLG_ZS>_=>Z]]S\L/^=%\=O_0J M[)_^LWOW7NO?<_+#_G1?';_T*NR?_K-[]U[KWW/RP_YT7QV_]"KLG_ZS>_=> MZ]]S\L/^=%\=O_0J[)_^LWOW7NO?<_+#_G1?';_T*NR?_K-[]U[KWW/RP_YT M7QV_]"KLG_ZS>_=>Z]]S\L/^=%\=O_0J[)_^LWOW7NO?<_+#_G1?';_T*NR? M_K-[]U[KWW/RP_YT7QV_]"KLG_ZS>_=>Z[6?Y7,\8DP?QY6(RPB9H]U=D^58 M/*/.8A_!U!<)JT@L`38$@7/OW7NC!PK(L8$I!>[$Z22HN>%4D`V`L!?W[KW6 M7W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_5W^/?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW2>W9-44^VL]4TD\M+4TV'RE3!40KKFAFI\?+-# M)$EQJ8.%(%^?I[]U[JLGKO_LULW9>[]R=(C=2;Z[1K-_UI MJ,OU_EZW=VXMR;SW#248Q&-RE5)B(1A$9H8*F`O&T?G:-_=>Z<*+O?;%%W]W M%O;=?=6`'7NS\K0[CVGB:?Y"[GI\GD]D4OQPV[O`/LSH?$T)Q&XL=5UT^3GC MR`R32SSM-H5GIXH_?NO=)>D[=^0-+UGOG:?<>1RW679PW/L[LV.DWOO3";5P MYZM[$AEJ\YM.3MOI9MQOM7"8?<5+E-NT6X98):N"./&+6B./(B5/=>Z3&+[7 MW%FMU]046].V!LS;5;UY5300[R^4VYMBTN7KH^WJG;T61V+O?:.&@_TB0?8P M00XK)Y6&BDR%*:>IE59:N>3W[KW1I^^J+N?=7>NRMK=7Y?Z=NXZEJHMU14B,Y;`U?CAEB$L;-^_KC]U[HO68W MEWEMO/;WSS9?L#''/=F_*W:.W,_5]CY;GIJ1:/!-& MN#IY,=EZ:>29FI@I$OW\B#W7NEACNP^_*7L*E@K,YO?-=>[P[]Z%VM13Q8Z) M)MA^?X_[,W'NO!5E10TJU+X#<,]?E:UZ^K=_M(5=+#'[KW0T=2;=W MUM+;_P`GZ]T7?>W8N\H=E;ECZ?[7[4[+K\GU_-/VG]_EJK#9/8 M/9%3N[;N-P&.H\T,/#)M#)9&.?+XV?!TL`^UIA'DQ11.KU%5[KW1FNA\?NG< M^+[OZYWKFMZX:/:N]L1M6##GM3O_`(G$ MT`95>D>.JIDG>(".+W7N@5V)0]R83I3XSUF![0[!J\[WA0X+8W9.4W[G\UO; M,;=R6[]IR[ER'8NV9P\5U!U]V1LCLJH[,WB]?M+96Z=M;)^0.]N_ MH6W+W%UM5[4V!E]Z8O=6-@;"RQ;PFQC344-*8(-3U%544])3U,D?NO=*&/.? M(7>&1V_@)\KV=N+);6[HPOQYW%CL;V#G^DJ/>\O5/1V]-V;E['.XL72334XS M]=68*OE%)Y()?M:.F%5(RU"^_=>Z=:S=_9?8746X)HNP.T5W-A4II\KD<33T\6)KY90HRCT[5<]*K3:%]U[I M2+E9=K_)[&[!S_;^0Q^U,3L[I#([7QW8/RA["VMN?.9'1R"*B"*E`6)4#>Z]TJ/E;OSO#9.Z-_9OKK)[LJ]K[?^)^]\EE M-JX''QUU53[FRV0R-/@>RML?;T\E4^6P%524(DHTD=),?4U3_;S5$%.1[KW0 M0]V]\]X_WB[JSNW,EO?9O4&XMM=@=&=-[]Q<^PZS#47='7U.LU/NO!8..HJ] MQ')5N9I][83R9'&KCY(L-BS$LOWZ2-[KW3#V%WKW[G*'L;,U6XMP;`PFU^F< MKL:JIS+6[$Q'^ES8W;.QMO\`:W8"[GAH&K:*@=LUD,7C:^E$L45)355;1&=G M)A]U[HUV#[5&QOC1NC?6S=R8CM?=JY7(X'9.+VWW3F>\,3N3M/;" MI>Q]ZICI5%9F*K&PU*5"P04:RRR.XA627W[KW0`[:[.^2%#4=:[6KF0[\38_Q9JNO>ILENG(Q4&]*7=_66#RG M9N1S'6$S11543O49:IR>8EIHFH'C:3[BF:`D>Z]T-W>?>78NV.Z=L?W+IMTY M'J'H[^";E^1&;P]9LQ<'!B^Q9&PT&/W7!G*F'+5,&`P+U.\2FWZ6:M;NA^I<9LN3>476NX, M3CRY7;%?!E*'!X_&4M*8%JZ:>>4TU1]J*FE]U[I=;JSV[T-GTN-W70=YYS"5V;S%1U;V7N#L/9M-WC01UU?4XO&3XC:F1*&6915U$ MF/%4J)]I![KW0?;7[4W)G>P^LZ3L#MR/;6W1LC&K'B=X_(W>74&5_BM!\C-X M[-K\+C%P&.,>^,QCZ#%8W#UU3DZBE^]:&"=TA_B4Y'NO=*/;G97;3YWN/%TG M8N1R&;CV1O\`KY-QX3>>>W[/M?,T>6"X2/M'H#*8.GJ^M*ZAIY$CIXL%-E8: MU/O*@15`HZ>1_=>Z$/K;L;?E;\OV?L[?\VQ=P[8[7K/D-M)\O MC]B9"OH#R5? M2XVJW9O+^\7;/RKR'6JZ+MKINDWOO#>F4BRVWL%7;A MSF8H=YX3(]BY!HC2O,JXP97;G=&3J=U[KQ>SN MP):K_2%4?&#(]&4N$R5+7P[SP_ M/F?FNN,H,+1Y"#^&[0W5NG;^V>N,W1T=(B3-@'H\;DMMK*JODZ25:;R5,E'. M\ONO=&)^,79U%N;?_:NP\%O/V\C554N(@S`K:O&TE.J)##AZ>&H!5 MJ]XX/=>Z%'XC4O?$O7>#WQO:MS1CW5U)M'/08'>'9>3[(S.Y=^Y'"PYB3=<4 MN6IJ+^[=).I:FFV_`[P^22ZFG^W9ZCW7ND/MSL7?4FT/6:9 MCNK95?C7W=B^J^RVR^#H\[%08B8QG;V2Q5)/N$XK:--0SIDDIEJ9()#`KU_N MO=(G=78V'I=R;&PE'\C>PZWXV97?N)@WSVYE.R:O:;WRE1LI^UX( ML;-#!6UE/AZNNQD=1HQM;31X\)2I5I0Q^Z]UPWEV-O9]T=,T.]NT$VCLW*[> M[UEP^6WSWGNSX\/O3;NW^X\-@^K=W29/:6,F;,Y>KVQ(E8*"I%(LPJ&G,<;2 MMH]U[HSG=6ZVQN],!B=\=F[MZPZ?GV@^2QF]MGY)L54YSL^/-".BV]D-SPTU M8RF/'_;U>+Q#:%RL\CT[1Y$!J3W[KW04]34OR![)[=I,KO:OW#2XS:NR^EJW M.TLW:6_.MEAR505>B]U;JQ,>Q\OMY.W-^X@9''9VHVM6UR;CR- M=BLY+L[;N-AH:(43ME\HM3(?`&B]U[HO&)[7[5GV1NU!V315%+1UFSJC<&ZH M/D1O;*=69ZJEQ];/EL;NWNE=LQ;AZ:S%76HD=5@5Q=924;0TE-Y8!7R!O=>Z M$S`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`"`+`DL0";$L=3$C_$\G_'GW[KW7$00@@B*,$$L"%`(9D\ M;$$?U7@_X>_=>ZYA%4646Y)-N+D_5F/Y)_)/OW7NN!AB-B8UX%AQ]`/I;W[K MW7?BC%OVTXM_9']DZA_MB`?]?W[KW7O%%JUB-`VEDU!0#I=M;KZ[T+ MI*6`4@C2.!8_4`#W[KW7`0Q"UHU%B6%A:Q)N3Q^??NO=_=>Z]XH^?0!=BY`X4N?JQ4<$G\GW[KW7)45+A5"W-S;\FP%S_L`/ M?NO=3:Q%KG_7/OW7NN)AB*Z#& MFBZG3I&FZ/Y$-O\`!O4/\>??NO=??NO==>*/T^ MA1HY2PMHO]=-OI_L/?NO=="*,6]((73I!N0N@632IX%OQ;W[KW7C%&6+E06( MTDFYN+WMS[]U[KOQH`P"J`QNP`L&.G1ZK?7@`<_@#^GOW7NNO#%:WC2UP0"H M(!%K6!_I86_UA_3W[KW7(HA(8JI((()`)!'TL3_2YM[]U[KAX(-0;PQZ@`H. MA;Z5L56_]!I7C_`?T'OW7NN>A=0?2NH`@-87`8W8`_B_Y_K[]U[KK0AO=0=5 M]5^;W`!O?_6'OW7NNRB,%#*&"LK*"+@,OZ6`/Y'X]^Z]UQ\,5K>-+%0A&D6* MCZ*1_0>_=>ZR`6_V]_\`;^_=>ZXE$/U53>_Z@#]5T'Z_U'!]^Z]UQ$48OZ%] M1)-P#_=>ZZ6-$OI6VKZFY)/^N3S[]U[KPC0,7"*&;ZL!8G_`!)'OW7N MO!$#%PH#-]3^3[]U[KQC1CJ*J6*E;D--6O2-0&D-^0IL M2JG\#@<#W[KW7'PQ$@Z%NI!!_.H$MJO_`%N2;_X^_=>ZY/%'(&62-)%==+JZ MJP9>?2P/U')X/]3[]U[KKPQZ770-,FHNOU5]8L^L?0W_`#?Z^_=>ZY%%)#$7 M*FZ\G@VM<#W[KW7+W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__U]_C MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7_T-_CW[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=!UOWL-MB+C"NQ>Q-ZG)252%=A;=A MS[8X4J(_DR8EJ:?Q+)KTQ$:M15A8:??NO=!W_LPLO_/B/D3_`.BZH_\`ZY>_ M=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z] M_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPL MO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B M/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_ M`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZ MH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\` MZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_ M=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z] M_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPL MO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B M/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_ M`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZ MH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\` MZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_ M=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z] M_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPL MO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B M/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_ M`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZ MH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\` MZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_ M=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z] M_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPL MO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B M/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_ M`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZ MH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\` MZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_ M=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z] M_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPL MO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B M/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_ M`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZ MH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\` MZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_ M=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z] M_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPL MO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B M/D3_`.BZH_\`ZY>_=>Z]_LPLO_/B/D3_`.BZH_\`ZY>_=>ZY)\@Y7>-/]!7R M'3R21QEWZ[I`D8=PADD(R)(5;W8@'@'@^_=>Z,*C:U#6(O\`AA8C_7'OW7NN M7OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z__1W^/?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UB\,6MI-"ZV(+..&)"Z!\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=> M\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_ M`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5] M^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=> M\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_ M`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5] M^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=> M\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_ M`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5] M^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=> M\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_ M`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5] M^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=> M\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_ M`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5] M^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=> M\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_ M`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5] M^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=> M\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_ M`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5] M^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=> M\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_ M`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5] M^Z]U[QK_`$/_`"4W_%??NO=>\:_T/_)3?\5]^Z]U[QK_`$/_`"4W_%??NO=> M\:_T/_)3?\5]^Z]UT8D(L5N/R"6(/^N#[]U[KM$2-0D:A%!)"C@`LQ9O]N23 M[]U[KG[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_TM_CW[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7_T]_CW[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7_U-_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=0:O)XV@*"OR%%1&2_C%7504WDTB[!/,RWL.3;Z>_=>ZA M_P!Y-N_\[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\ M[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A M_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"OGOW7 MNO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"OGOW7NO?WDV[_ M`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_ M`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY M[]U[KW]Y-N_\[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y M-N_\[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_ M^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"O MGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"OGOW7NO?W MDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"OGOW7NO?WDV[_`,[_ M``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]* M'_KY[]U[KW]Y-N_\[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[ MKW]Y-N_\[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\ M[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A M_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"OGOW7 MNO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"OGOW7NO?WDV[_ M`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_ M`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY M[]U[KW]Y-N_\[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y M-N_\[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_ M^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"O MGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"OGOW7NO?W MDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"OGOW7NO?WDV[_`,[_ M``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]* M'_KY[]U[KW]Y-N_\[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[ MKW]Y-N_\[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\ M[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A M_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"OGOW7 MNO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"OGOW7NO?WDV[_ M`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_ M`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY M[]U[KW]Y-N_\[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y M-N_\[_"_^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_ M^?2A_P"OGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"O MGOW7NO?WDV[_`,[_``O_`)]*'_KY[]U[KW]Y-N_\[_"_^?2A_P"OGOW7NO?W MDV[_`,[_``O_`)]*'_KY[]U[KW]Y-O'@9["DD@`?Q2AY)-@/\Y[]U[IY5E90 MRD%2+@CZ$>_=>Z[]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 M_]7?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW2)W?UIUSV"* M%=_;!V7OA<9+-/C5WAM;![F7'35,2P5$M`N:@G$+2(JJYBTE@`#?W[KW2+_V M6SXZ_P#/@NE?_16;&_\`J#W[KW7O]EL^.O\`SX+I7_T5FQO_`*@]^Z]U[_9; M/CK_`,^"Z5_]%9L;_P"H/?NO=>_V6SXZ_P#/@NE?_16;&_\`J#W[KW7O]EL^ M.O\`SX+I7_T5FQO_`*@]^Z]U[_9;/CK_`,^"Z5_]%9L;_P"H/?NO=>_V6SXZ M_P#/@NE?_16;&_\`J#W[KW7O]EL^.O\`SX+I7_T5FQO_`*@]^Z]U[_9;/CK_ M`,^"Z5_]%9L;_P"H/?NO=>_V6SXZ_P#/@NE?_16;&_\`J#W[KW7O]EL^.O\` MSX+I7_T5FQO_`*@]^Z]U[_9;/CK_`,^"Z5_]%9L;_P"H/?NO=>_V6SXZ_P#/ M@NE?_16;&_\`J#W[KW7O]EL^.O\`SX+I7_T5FQO_`*@]^Z]U[_9;/CK_`,^" MZ5_]%9L;_P"H/?NO=>_V6SXZ_P#/@NE?_16;&_\`J#W[KW7O]EL^.O\`SX+I M7_T5FQO_`*@]^Z]U[_9;/CK_`,^"Z5_]%9L;_P"H/?NO=>_V6SXZ_P#/@NE? M_16;&_\`J#W[KW7O]EL^.O\`SX+I7_T5FQO_`*@]^Z]U[_9;/CK_`,^"Z5_] M%9L;_P"H/?NO=>_V6SXZ_P#/@NE?_16;&_\`J#W[KW7O]EL^.O\`SX+I7_T5 MFQO_`*@]^Z]U[_9;/CK_`,^"Z5_]%9L;_P"H/?NO=>_V6SXZ_P#/@NE?_16; M&_\`J#W[KW7O]EL^.O\`SX+I7_T5FQO_`*@]^Z]U[_9;/CK_`,^"Z5_]%9L; M_P"H/?NO=>_V6SXZ_P#/@NE?_16;&_\`J#W[KW7O]EL^.O\`SX+I7_T5FQO_ M`*@]^Z]U[_9;/CK_`,^"Z5_]%9L;_P"H/?NO=>_V6SXZ_P#/@NE?_16;&_\` MJ#W[KW7O]EL^.O\`SX+I7_T5FQO_`*@]^Z]U[_9;/CK_`,^"Z5_]%9L;_P"H M/?NO=>_V6SXZ_P#/@NE?_16;&_\`J#W[KW7O]EL^.O\`SX+I7_T5FQO_`*@] M^Z]U[_9;/CK_`,^"Z5_]%9L;_P"H/?NO=>_V6SXZ_P#/@NE?_16;&_\`J#W[ MKW7O]EL^.O\`SX+I7_T5FQO_`*@]^Z]U[_9;/CK_`,^"Z5_]%9L;_P"H/?NO M=>_V6SXZ_P#/@NE?_16;&_\`J#W[KW7O]EL^.O\`SX+I7_T5FQO_`*@]^Z]U M[_9;/CK_`,^"Z5_]%9L;_P"H/?NO=>_V6SXZ_P#/@NE?_16;&_\`J#W[KW7O M]EL^.O\`SX+I7_T5FQO_`*@]^Z]U[_9;/CK_`,^"Z5_]%9L;_P"H/?NO=>_V M6SXZ_P#/@NE?_16;&_\`J#W[KW7O]EL^.O\`SX+I7_T5FQO_`*@]^Z]U[_9; M/CK_`,^"Z5_]%9L;_P"H/?NO=>_V6SXZ_P#/@NE?_16;&_\`J#W[KW7O]EL^ M.O\`SX+I7_T5FQO_`*@]^Z]U[_9;/CK_`,^"Z5_]%9L;_P"H/?NO=>_V6SXZ M_P#/@NE?_16;&_\`J#W[KW7O]EL^.O\`SX+I7_T5FQO_`*@]^Z]U[_9;/CK_ M`,^"Z5_]%9L;_P"H/?NO=>_V6SXZ_P#/@NE?_16;&_\`J#W[KW7O]EL^.O\` MSX+I7_T5FQO_`*@]^Z]U[_9;/CK_`,^"Z5_]%9L;_P"H/?NO=>_V6SXZ_P#/ M@NE?_16;&_\`J#W[KW7O]EL^.O\`SX+I7_T5FQO_`*@]^Z]U[_9;/CK_`,^" MZ5_]%9L;_P"H/?NO=>_V6SXZ_P#/@NE?_16;&_\`J#W[KW7O]EL^.O\`SX+I M7_T5FQO_`*@]^Z]U[_9;/CK_`,^"Z5_]%9L;_P"H/?NO=>_V6SXZ_P#/@NE? M_16;&_\`J#W[KW7O]EL^.O\`SX+I7_T5FQO_`*@]^Z]U[_9;/CK_`,^"Z5_] M%9L;_P"H/?NO=>_V6SXZ_P#/@NE?_16;&_\`J#W[KW7O]EL^.O\`SX+I7_T5 MFQO_`*@]^Z]U[_9;/CK_`,^"Z5_]%9L;_P"H/?NO=>_V6SXZ_P#/@NE?_16; M&_\`J#W[KW7O]EL^.O\`SX+I7_T5FQO_`*@]^Z]U[_9;/CK_`,^"Z5_]%9L; M_P"H/?NO=>_V6SXZ_P#/@NE?_16;&_\`J#W[KW7O]EL^.O\`SX+I7_T5FQO_ M`*@]^Z]U[_9;/CK_`,^"Z5_]%9L;_P"H/?NO=>_V6SXZ_P#/@NE?_16;&_\` MJ#W[KW7O]EL^.O\`SX+I7_T5FQO_`*@]^Z]U[_9;/CK_`,^"Z5_]%9L;_P"H M/?NO=>_V6SXZ_P#/@NE?_16;&_\`J#W[KW7O]EL^.O\`SX+I7_T5FQO_`*@] M^Z]U[_9;/CK_`,^"Z5_]%9L;_P"H/?NO=>_V6SXZ_P#/@NE?_16;&_\`J#W[ MKW7O]EL^.O\`SX+I7_T5FQO_`*@]^Z]U[_9;/CK_`,^"Z5_]%9L;_P"H/?NO M=.6/H7I=)898IX9$ZMV,LD4T$@EAEC<4-U9&`96'((!'(]^Z]T, MJ(D:A$4*HO91P!ZY^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO M>_=>Z][]U[K_UM_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7_ MU]_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=8S-$I(:6,%?J"Z@CFW()]^Z]UVLL3DA)( MV(-B%=6(.D-8@?X$'_6]^Z]US]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?__0W^/?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]UQU+>VI;_6UQ?_`&WOW7NN[C^H_P!N/?NO=>N/ MZC_;CW[KW7KC^H_VX]^Z]UZX_J/]N/?NO=>N/ZC_`&X]^Z]UZX_J/]N/?NO= M>N/ZC_;CW[KW7KC^H_VX]^Z]UZX_J/\`;CW[KW7KC^H_VX]^Z]UZX_J/]N/? MNO=>N/ZC_;CW[KW7KC^H_P!N/?NO=>N/ZC_;CW[KW7KC^H_VX]^Z]UZX_J/] MN/?NO=>N/ZC_`&X]^Z]UZX_J/]N/?NO=>N/ZC_;CW[KW7KC^H_VX]^Z]UZX_ MJ/\`;CW[KW7KC^H_VX]^Z]UZX_J/]N/?NO=>N/ZC_;CW[KW7KC^H_P!N/?NO M=>N/ZC_;CW[KW7KC^H_VX]^Z]UZX_J/]N/?NO=>N/ZC_`&X]^Z]UZX_J/]N/ M?NO=>N/ZC_;CW[KW7KC^H_VX]^Z]UZX_J/\`;CW[KW7KC^H_VX]^Z]UZX_J/ M]N/?NO=>N/ZC_;CW[KW7KC^H_P!N/?NO=>N/ZC_;CW[KW7KC^H_VX]^Z]UZX M_J/]N/?NO=>N/ZC_`&X]^Z]UZX_J/]N/?NO=>N/ZC_;CW[KW7KC^H_VX]^Z] MUZX_J/\`;CW[KW7KC^H_VX]^Z]UZX_J/]N/?NO=>N/ZC_;CW[KW7KC^H_P!N M/?NO=>N/ZC_;CW[KW7KC^H_VX]^Z]UZX_J/]N/?NO=>N/ZC_`&X]^Z]UZX_J M/]N/?NO=>N/ZC_;CW[KW7KC^H_VX]^Z]UZX_J/\`;CW[KW7KC^H_VX]^Z]UZ MX_J/]N/?NO=>N/ZC_;CW[KW7KC^H_P!N/?NO=>N/ZC_;CW[KW7KC^H_VX]^Z M]UZX_J/]N/?NO=>N/ZC_`&X]^Z]UZX_J/]N/?NO=>N/ZC_;CW[KW7KC^H_VX M]^Z]UZX_J/\`;CW[KW7KC^H_VX]^Z]UZX_J/]N/?NO=>N/ZC_;CW[KW7KC^H M_P!N/?NO=>N/ZC_;CW[KW7KC^H_VX]^Z]UZX_J/]N/?NO=>N/ZC_`&X]^Z]U MZX_J/]N/?NO=>N/ZC_;CW[KW7KC^H_V_OW7NJM?G1V7\CME]C;.H]@YKNS8' M2<&P=T;AW5V3\;_CKM/Y6=@TO9E/EZ:FVWM/?O5^5QV8RE#M>IQOW=2E;A,3 M+45E3'-%)7XF.E5Z[W7NBZ=%_P`Q[NN9NR=_[NVELGNGX][;[6^(W7V8[KZZ MW;'LK#[/K?D!TAUCB*V'KOJS<>#3*VW4_(+;^WZK;_>FV]V]AMO3X^]59[N7 M(X3M7KO!XJ2BVE3YS`[9R=9BIEW+DZR-)L=][CZ:2HJ(J/W7N@W/\Y_;.V-Q M];[6[@ZMV!U9N'<>W.KM]=A;.J?D?M_R=C4&WX9=Y95:5 MFR.ZL9C*F"+&TNDT%;FJEC3+[KW1I.LOGW)V+\Q=X_%"?J>FVM)MC*;[Q--7 MYWLW#XKMZII-@1H:CLS*?'[<-!CZY=A9N5EAVUNS!9C,+5FHH6J*2C2>=J3W M7NK&??NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7_T=_C MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=![OC:&Y-RC'G;O:6 M[NM#23SRU;[6Q'7>5.6$\*PQ0UG]_P#"9D1B,@LAI1$Q+$.6%A[]U[H#M_X^ MMZJP<&YNROFUO38.WZK.;?VS2YK>5#\8MM8NJW%NK+18/;6`IJ[+[-BCDKW9C,EL/&Y+*;X^;&\MHT>%Q"[@S53N.B^,>' MIL5@OXC'B6S5=+7[,C\5(*F6.G^YD`C\K*A8,0/?NO=+&/JKLQD4O\I.WHW8 MA2C;1^/`(_=> MZY?Z)>S?I_LTG;]_Z?W1^.__`-A'OW7NNAU/V81_=>ZX_Z*>RN/^0"/]^E M\=>0?H1_OR/S[]U[KO\`T3]F7*_[-+V]J%@1_='X[7%Q<7']R/S[]U[KW^B? MLPFP^4O;Q/\`3^Z/QVO_`.\1[]U[J`_7F^(\G!A)/EOV>F9J:"HRE-B'V[\; MER=1C*.JAH:O(P4!V5Y7@BFJ*>&294**\L:,0SJ#[KW4\]4=EJ=+?*;MT'@V M.TOCL#8_0V.R/\#[]U[I,X/:VZ-Q9?=6!PWS$[$RN:V1DL?A=WX?&X/XW5F4 MVMFZ4W^BCLN]O]FF M[>O?3;^Z7QVO>Q-K?W(^M@3[]U[KO_1-V;]/]FE[?O\`T_NC\=OZ7_YXCW[K MW77^B?LR]O\`9I>WKWM;^Z/QVO?^G_'D>_=>Z[_T3=F_]Y2]O\_3_?H_';G\ M_P#/$>_=>ZZ_T4=EWM_LTW;U^3;^Z7QVOP+G_F"/Z<^_=>Z['4_9A^GRE[>/ M`;C:/QV_2?H?^/(^A_'OW7NH&/Z[WSEZ=ZS%?+;M#)TD59D,=+58_;OQNK:> M/(8FODQ>5H'GIME,HFI:J&6FJ(B=4Z:-V[7W)L7!U&Y=X?,?L M/:^`I*K$455FMPX7XUXC%4]5GLM!@<+2RU];LM(UEK*VIIZ2E1F!EGECB6[. MH/NO=8WVQNJ#=.*V15?,+L6DW?F<)F]RXS:]1@OCA%G\GM[;=718[<.:QN*E MV2LTU)0U.2Q\%74(A2-ZF!7(,J`^Z]TJCU-V8`2?E+V^``22=H_'8``?4DG9 M'OW7ND=N[$9+85')7;U^:^]=I4L5+%7/4;EQ_P`8\+$E%-FJ/;D=:S5^S8_V MCD,C040D_3YZF"'4'FC#>Z]TK(^JNS'6[?*7MT,"RD?W1^.XL58CD-LB_P"# M?_8^_=>ZR#J?LP\CY2]O$?X;1^.Q_P#E(_P/OW7NDONW;.Z-BX:LW+N[Y@=D M[;VUCHX'R6X,W@OC7C,5CC5U\6-HA65E9LM$033S)#&68`R%4Y9@/?NO=-L6 M/R\VYJ#9D?S1WLV[LHFZ),?M6.@^,M1N*JCV5-CXMW218JGV8TQ_A@R^(.07 M0&IOO:83!3-'J]U[J=0;;W9D]Q9C:%#\NNS*K=>VZ/!9+J.S%'_94G;Y)!*J-H_' M;4UEU64?W(Y-O?NO=`/L'L;8O:N]=S=;=7_S&(^Q^PMEU%;3;QV3L;._$;#U/V8/K\INWAP6 MYVE\=OTCZG_CR/I[]U[I'9;#9G"Y/%X;(_-'?-%ELSNB+8^,Q55B_C1%DJ_> M=3MJ7>=+M2DH_P"Y?D;(R8BGJ,HE'I\K4J-4!?$-7OW7NDWUIF,7W&V>7JKY M[YKLG^[%3]GN$[!E^+.[5PE5_%J_`K!E'PFSI5A8UV*RE(NHV,U)4QB[0R!? M=>Z%?_1+V;_WE)W!_P"@A\=__L(]^Z]TW4/7F]\H]?%C/EQV?D9,57S8K*1T M.WOC=5OC?[D>_=>ZXGJCLH?7Y M3]NC@MSM+XZC@&Q/.R/I<@>_=>Z3>$VMNG<>3W-B<'\PNQLS7[,S8VUNVCQ6 M"^-U?5[9W$^'I-QQX+/P4^RF-)5G'5]!7?;SZ7\%33RA2DR,?=>ZX-MG.T_F#V/N?:VZ\/C]Q;:W'M[`_&[*X+/X#+TJ5^ M)S.&R=)LIXJFFJ:>2.:&>)BCJP9200??NO=/_P#HF[-_[RE[?X%_^/1^.WT_ MK_QY'OW7NDWNS:NY-B;>R&Z]Y?,CL+:FVL4M,^2W!N/"_&O#87'I6UL>.I'K MS2A9_E)V^FDMJU;0^/"Z0#P6U[( M%N.?]]?W[KW2?W'M3=&T8:"KW/\`,/L;;U%DLUM[;=!5YO!?&[&T];N'=F9B MV]MG!TDU5LI4>KR%=/%244"DO-,Z1(I9A[]U[I2#J?LPVM\I>WCJ%UMM'X[& MX_J+;(]^Z]U[_1-V:?\`N:7M_P#/_,(_';\<'_F"/?NO==#J?LPG2/E+V\6L M&L-H_':^DFP:W]R/IQ]??NO=>_T3]F<_\Y3=O<,%/^_2^.W#&UE/^_(^O(X] M^Z]TF=U;6W1LNEQU;NGYB=B[;I,OGMO[5Q=9GL%\;L725^Y]VYJ#;FU=OTDU M5LI5DK,ED*FGHJ&F4ZYIY$BC#.P!]U[KE6[5W/0;FQ&RZGYB]B4^[\]A\WN+ M"[6GP?QM3<.7P&V:JAH=Q9K&X?\`N5YYJ6@ER>.CJZB-"D3U-.KE3,E_=>Z4 MG^B?LS@?[-+V]&K]/^_2^.WJ M_/I_WY'/OW7NN_\`1-V;_P!Y2=O\?7_?H_';^E_^>(]^Z]UQ?JGLJ.-I9/E/ MV['$B-(\C[3^.JQI&@U-(SMLBP4#DD\>_=>Z0-!#/E,R,%0?.+==9E&Q>TLU M%CJ6F^,,];48GL":NAV%E*:&/9I\E/FCC,D,7+'J%4::?P%_$]O=>Z6M?UKO M[%4-;E,I\L>U,;C,91U&0R61K]L_'&CH_=>ZZ_T3]F6O_LTO;UK M%K_W1^.UM(^K7_N1]/\`'W[KW28R.V=S8G3I\-E=PPXH[*\K45/55E'32U`70DLT:,0SK?W7NGJJZYWW0 MU&-HZ[Y:=I4=7F:N6@P]+5;;^-]/496O@H9LI-18V";90:>9*:GJ*AHX@S"* M*20C0C$>Z]U._P!$O9W_`'E)W!_Z"'QW_P#L(]^Z]U[_`$2]G?\`>4G<'_H( M?'?_`.PCW[KW7O\`1+V=_P!Y2=P?^@A\=_\`["/?NO=>_P!$O9W_`'E)W!_Z M"'QW_P#L(]^Z]U[_`$2]G?\`>4G<'_H(?'?_`.PCW[KW7O\`1+V=_P!Y2=P? M^@A\=_\`["/?NO=>_P!$O9W_`'E)W!_Z"'QW_P#L(]^Z]U[_`$2]G?\`>4G< M'_H(?'?_`.PCW[KW7O\`1+V=_P!Y2=P?^@A\=_\`["/?NO=>_P!$O9W_`'E) MW!_Z"'QW_P#L(]^Z]U[_`$2]G?\`>4G<'_H(?'?_`.PCW[KW2IV?L+>FW,Q_ M$L]W=V!O^@^SGIO[O[EP'4F-QGGE=&BR'W.RMM8JM\L05E1?N_&0[:T8A2ON MO=!-W1\0.NNZ=WT_84V\>Y^J>P%P=)M7*[WZ%[8W7T_N7=FT,965.3P6U-Z5 M^T98AEJ+&5=;7U6*6M1Y*.2KJS3R1BJJ!)[KW2>P_P`!/C-MO8&_>KML[.R> MV]C=C]A]-]H[DP>'W-FZ=6WET2VU)MB92CKI)7J8W:?9N%J\L[3-)D:G[NIK M'EGK*AW]U[I#9K^69\9<[FZO+5DO<<.-.[.S-Z8'8U!WAV90]9[)SG=>UMP[ M2[EDV;UU3Y$8BDCW/!NK/SY1'I9"*BLFFIC3EW#>Z]TK\Y\`?CUG=Q;-W$T7 M9>%.UMK];[-S>W]J=M]A;2V?VQMSIV,KU9CNZMJ[=KZ:CW.,(S,U/)D8F>=# M]K6-4T86F'NO=*#;OPJZ8VWWS'\A8JGL;,[LQF;WONS:&UMS=C[JW%UCUSO; MLVAEQO8^]NN-@92>2APV3SD-5D(Z^6D58R*VL$440J''OW7NC;^_=>Z][]U[ MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO__2W^/?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T5SYI5'<-)\8>V:CH==P-V7%A\4U`= MG04]5OR+:W]Y:+_274];4M6K12[IAVQ_&)=KQ2J5?*K1J>#[]U[JE/,]0UW= MF]>CY-C-\R-V_$?KWY\_&#<'3&:[4W5\K<'V/C\N.N-W3?(+,Y2J[4J*/>E1 MLJ@R$.UH<;DMV(T=/D*O/4E!,F/J(U?W7NG;^:7T/G-Q_(3N/=^W=K=^YW<' M:'\MC>G7FT:K8I[AW1LB7>&$[VP62RVW*7`X$5>WL>S,GV"NTNU>CH\_P!G4^+J-UXC8\65QNSF:#&^6%/#C\?7UKR>Z]T> M[;>X_F+2_P`K>JW$N-W+F?E93]9[L?%4K;V)VAV1OC?'S.VOVOU;T7\'!T_B]M[K[$V]'5S]A?(_?.U M-[[GWUUGM=O[M9_?/^CMMMOOBFJ\?74N-KRU4:>.1(9E]U[I?9_J+ONI^1/; M/2U/O?YNTW0?1>W/E_N/IC)8ON7Y"T]?N/<>.Z,Z`WMU?BMP]PID'SN[HZ?= MF1*_&1+)14,M$ONO=3L;0_+K9FP,Y%CMT?+'-8?LCXC?`; MO'O_`">2R78^[.S<)O/?_S'9GR=ZD[,SF9Q MU7T\(XM\[VWB]!O*:CH]PS[PEV&NYJE@]S[GW-W/M3N_+]5?&7.]W9;;6PNPINSJF5X\1/VUC][;;ZAJ,/OG!4E ML,FBJLIUU'N3.]=Q]P8BES&2R M%'@ESLE?E\=12K[KW1D1N/=M-C-W1];9CYQY;^774=M]0X[?F]MTP?+BH^46 M"PIZUWM7]UU75&1W;2GN`[1;<]/UI2Y"KH86J*=ZK^TOE7D=^YK&_,6B^%F;^4^#H\7+VIC^S,3\D,SO?+_`!0V3LSH/?\`\DAA MJ6?(;DZRQK4-?MZE.6G-3#7S8W(;R,CTDHI?=>ZLY^3VS>W-X?+/IH;'R7;L M.#Z_^*OR@[-V_MO:6_M_[!ZEWE\A-J=B]<'HS;?%R=4 M(*JF^^\L4U*LZ>_=>ZI7Q/:7RQQW5E/5]X;O^3&S>O=P=T?"7#]WU>QY?G71 M=PQ=K;L[=%#WIM78N9[6Q>)S48K,,):;/;7ZKH:G!TZ)2'"O3RR:*CW7NCU] M<;#[T[#[4^-6(DWG\MV^-4>^?F7O_J*3.[_[\ZZW=N/JW:N#ZYR'QVV]\E]P MYI\;NFJI7W&V[),#CMXU*5U9B1!'6FH1JN&7W7NBM=1;K^?FY.MN^SOW.]Z[ M(S%=TWM?-=_UF#V+\UM\YO:'>B]J[5FWAB]D4G9,&V5Q6,.V9]U8[-4/0=76 M?;8;1D\!Y,O28\5_NO=-.Z-]_-V;I7IR+&X'Y`[>ZSDR7R(FVKFZC1IJ0Q/(IAK*=JL^Z]T3[,;?^2/0VV*OJ/I MG"_(S;_7>!^1G\P3,OD5;+/1X=,7+ MBYE\*ZYQ/QT^5F!3>7Q*Q?R!_CM+V% MN3LSJVLZ]VMNK/JJFE3[Y)::*1??NO=`QUU'\ MPZ+Y%?'7XG]N[R[(K=T=U;<^,GS/[EWAA]W[BBH]F4/Q^ZO79'R#^0>6RV M[/BCO7K#"9;K2H[@SNT\9NZA^6/46\(Z+(83:GW6WL76G;L.YZ]TV?)^G^573>\>X.INO:WO_=W-N_?/87S;W M7N?$X7=O16=W3E:3;/<70=-N'M!\'5;VI\='D:7;DLM)CZC[6BE^QQ];50R^ MZ]U8UM_;/R8[+_EI_8;KW#O';'RKJ>E,MF,%GL*F6V#OB'L+:U3/N/JTYFFS MACJJ>OK!1XBGST&5@C^Y,M7%D**..>>B7W7NJB,EG_GKO/8_8V?J_P#9J]K/ MO#'S?/38>#PF,[CHI]LTW>O8>WNI-B?%FL&=1H M%;6TB-4T1IO=>Z7?2OP^3-?S`>RMF9J'Y=[1VI-W/_,+W?O'=>([(^2VPJ/) M8/L[&]%YOJUL!W535=,5HLVM+F9C'MK.Q/428I*>K9DQXI5]U[K+UW+\S>TY M?C?B>R]P?++!1[UH_P"651]N9W`3=D=;98QU.S.\_P#3RF2S.`@I&QK5M11; M4CWC)!X)HWEQ[U,E//)22K[KW5@?46P/D+G?AW\V>A\/O#M"CWW@M^_+[I?X MO;][?S>ZLGO6AVI5X.6@Z6SE1V3NHS9;,TE%59#30[AKZJJJ)((4U5,WAU>_ M=>Z#3"[GV;NS9/3^UOB_\+=UTW??Q?ZV[079B=@=4[UZ4VO\5>R:;H/);9I= MHTN\]T8W'X?>4V=SLM+MF>DVSE,G05L3U>6GK33TT4\ONO=$>ZEK_FSO[IOL M#;.8S7R/P6$W%V?\`\7NO-;>R7S.QG;NW>PMT_*["X3Y2Q[=WM\D,/BZE_(#.(V;'-T8O\`,CJ:3;WQ^[BWA\2JWM>?Y?Y[LC=G9^#WSNS*[)H*/8W25)?- M"G2@PE1'_LQ>4:2JV]58.&/%3.=P1S^Z]TA]PX7N_JK.=YTO5V(^26.ZJ[2^ M:'9':_;VXULUM M>>GK]\4E?08S(3TE:AI(ZNIJ<-E%R5!35#2TE3$R5$-,'@C/NO=4U[KW?\D< M/\K]SY7`Q?+"CR)SFRNW^KJ#NN7K-LM'7Y#:N_*G8N9WPIP6UTHZNM: MGDFIJ)LG2),/=>Z.)_+_`,#EZ+KKYZU_2D?=4=#NGY*[HS_Q_P!Q_*C#]N4. M\]U0K\3.N\%M;<&>K.]*:GW5D<'%G**>BIJ[*QRSO2TQBD>1D8^_=>ZK=QF* M[9H>QX]T["J_GMG]V8SX?;%V?\T=\;SQ'R*KMX[=W%/\IMA9#Y9X3XSY;?6, MC@3<3;;BS]534/6[FA6EABJMOPBMCIV?W7NK>OA/+N7([(^0)Q57W#G?CTF^ MZNF^+&5^0B]GR]RY#851U;BI-[Q9=NZ8H]X5&%CW@^<@V])N8'(O%YD4G'1X MYF]U[JK#:G7_`,P?CA\4?B=2?'%/DGE-Y]A?RW\?+W5M+L+[TPO9U M9M__`$@HPQU;N04ADJ`N-IYJBFCI&E]U[HG_`&'5?.[L7K7Y<[9[1VIV]DO.PYN^=A;-V_\`,'=M?0[BQ?>NWZGI]>E\1O\`Q0V%0U]/B4JGV]#U-49. M/)8]9*W*(]3!'6#W7NC=;O[,[1^.VW,[\N.J$[[^UW5E<53=F978U7MA<_A8^TDI@O MNO='KW7L7NWJ'X:_$3K^/=O9&^.VML=[?`O#=P;PQV:W/NO=&Y#4?(C:DG?] M;G]>])=S[P[:^/M=OKL#YL MTN)[*^7G\Q3(=OTVO-21XN3&14; M4T>9B%,LDM72F.`>Z]T6#K3-_P`Q+)5F_=Y[CI^W:3L#JC&0_(7O?KW$3?,: M6AW)V=T_W%MS>,'3VS(>UJ3$;&@H]P[0_O9@:+;_`%755^*S%*])/6D2T]-5 M3>Z]T9'=]1VJV-V'V!\F-R?-S!=1]Y[*[K[NV5B/CJ,A M457R'Q?SIA^>&WL1+2;3V3\6GW13?'+*=<4_Q>BK&S]?'V#"W3#SU^ZI\G33 MUF2%7F*3=#4,5-!_"J9*>/W7NBAUE;W!N39.W,W58/ M`_S!NQ-R;=WUL'YYTU%\AZ,I2]1=_=I[QRB]3[@^1L6QZKXX_/2'X3]H]F5G=6$[BVUC!7_`!YW M/U?MWL'?79D='NNGBRV^-O[K7%4FYYUR59M]95D:2$>1?=>Z._\`%'L_NOO3 MXP_)#YC;"QVX7WE\EZ?=_8GQ4ZHWWDLG4[=VEMG9?3M/U]TSAX,#D:G[7&TV MX]PXFKW#7?9R11U`R*SOXRWI]U[HJ6(R6ZY^F]YY#JG,_P`RBKVO69WXO/\` M,W,=LQ=]-NS`86HW/D(_D]'\6:/?J1[WQ^XZ2!8XMYTNP**+%4F'99]I@9I( M5/NO=(C8O7/>7VZOBCEZWLOY&]5]GYW(8K=VUY MMIUO8N;R\E#N7(Y"BSL6Y4V=3;KD?*UN!\8RM/5T;PJWNO=)[8=7\JNTN]^K M]O=IUWRUW%F>[.H=ETW:U#AY?D=T##UMLW=_P[I9]XM3TF$IZCJ*NP$N]9*R M2?*4E9MOL>ASE4:2EB:CH%%3[KW0%[#Z;W/D>I_@]0[AVY\RX^J_CMM3^4)E M\OA$?Y88^NZ^W]B=\]M[5^33MM>D$6:F.`RL.!H:A$I)H<5BQCVI!3X=Z65_ M=>Z%WN_(_(CN_P"-FUOBAD<#\O!O=>Z>NH-R?+&F^2W06" MV/0=QT'6V(K/C)M_J&AWQ3?.>K&5^([]4;4?N'*=DX#=&-BZ^.57+5&Z(*S) M[_R\.Z\=74]$D5/X$IJ6K]U[HWG\S:M[3/8'6.&VG!\D:7;V0ZN[7K?\M#.]<[1AK>V=E;+R2;PZ@ZCHOE!!5_' MA:>EQ&4HZVMR>[X-T4==AIJ:@J(ZJ6**AK*::?W[KW2UZ#VYOBM^>WQ-R?8$ MWRNW5WULH?,R#Y2UF]\+WY5_&?9>8SV*AINN*CJC)[RHDV/C:*OQ\<$.W8]G MU*_=8X@Y)9:]'9/=>ZS?-;=_?NW/E]O'.[)IOE%!7[$WG\4 M9NALKO")=GQ;AQ>?H]JT^V6V56_>QT=/D5R#LL*:?=>Z-3+5]@C![ERO6&[? MG7DO@?5[\^/-+W1FM]3?*.H^5N`6GH=[3_(NHZAEWQ31=D18"7)MUE#N%]L1 M7AICN$[>T!)%3W7N@KWG4_,')8&NH=AY[Y@T?5F6V+O;&=$[EDB[CQW=T74% M=_,'Z8Q.P<_O;([DICFH=R1[4FWLV)JMP0OFCM..&JS*F?\`B5_=>Z%#>70V MZ-M?-CJ.EW'D?F'O+I'H;^8CUAFNLL[F>P_DAV+2;3Q7>'PDW)_>.LJ=RT%3 M65V4VVW8PPF+JZS-5%7C\/%D\EBIIZ/#9/(4I]U[K8E]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7__T]_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=(+?W66QNT*?:U+OK;]+N .^]I]F[6CJIZ MZ`8??6QLD,OM/<,'V$T)>6BJ0)8XY2\3$>N-QQ[]U[I=J-*JI)8JH!8_5K"U MS_K^_=>ZY>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@GPO2/6FWNV=Y]XXG; M4,?:78.(P>W=U;NKLAF]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=-5)AZ*CR%=E(8:=:[)1P15M4E)31U55'2 M.[T<=15HHED2'RRB)']^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW03]E])=<=OU^Q:[L3`?WF'6V[]^Z]U[W[KW2([&Z^VWVILO<77^ M\(\I4;7W7BZC"YVEP^XMR[3R-3CJHJ9XZ/<>SZS'Y2BD.D!:BAK895YTN`2# M[KW4_9FS=M]?[9P.S-G87%;:VGM7"XS;FVMN8*@@Q>%P.`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`OR<^16Q/B?T=OSOWLB@W=F=J["HJ":?;O7VWI=W; M_P!U97-9BGV]M[:FQ]J4\D4F2RN2KZNFHZ*C213))(+LJ@L/=>Z!OL3^8O\` M#SJ/#]-9WL[NS9>Q\;WYU?F.X^L)]Q;@PF/7/[`PNSX-[SYE9)JD(HJ*.IBC MQZAV^\J#]M3&66RGW7NA5V9\L?CKO_&=/Y/;''3&&J=_;4 MH=T]CX*NHFKI:G:6UJFK%=7M2JK)614<$LD,J2Q2*LD3J/=>ZFY7Y2?'/!9+ M<6&SG?72&#R^T9:R'<^*S7;W7V+R>W6Q\-945PS^.K<@DU"88\=DI)EJHXRB MT=4S`"&0K[KW2BJ>]NGJ2GZZJJKM+K2EINX:B@HNHZBJ[`VG3T_:>0R=,M;0 MX_K>IEJA'GII872:*/$O4,Z,K*"&4GW7NG7']M]9Y63!1X_L'8E8=T;GW!LG M;?VF\MN59S^\MIBK_O1M#"BEJ7%5E<;_``^O_B&.@+STXIJ@RHO@ET^Z]T(O MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K__UM_CW[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=!SOO=N\]M_PX;0ZOS'9# M54U3%7+B=S;/VZ<4L,*R0RS?WMK*/S"4LR@4^LKI):P(]^Z]T'_^E3NG_O%[ M>7_HR^GO_KS[]U[KW^E3NG_O%[>7_HR^GO\`Z\^_=>Z]_I4[I_[Q>WE_Z,OI M[_Z\^_=>Z]_I4[I_[Q>WE_Z,OI[_`.O/OW7NO?Z5.Z?^\7MY?^C+Z>_^O/OW M7NO?Z5.Z?^\7MY?^C+Z>_P#KS[]U[KW^E3NG_O%[>7_HR^GO_KS[]U[KW^E3 MNG_O%[>7_HR^GO\`Z\^_=>Z]_I4[I_[Q>WE_Z,OI[_Z\^_=>Z]_I4[I_[Q>W ME_Z,OI[_`.O/OW7NO?Z5.Z?^\7MY?^C+Z>_^O/OW7NO?Z5.Z?^\7MY?^C+Z> M_P#KS[]U[KW^E3NG_O%[>7_HR^GO_KS[]U[KW^E3NG_O%[>7_HR^GO\`Z\^_ M=>Z]_I4[I_[Q>WE_Z,OI[_Z\^_=>Z]_I4[I_[Q>WE_Z,OI[_`.O/OW7NO?Z5 M.Z?^\7MY?^C+Z>_^O/OW7NO?Z5.Z?^\7MY?^C+Z>_P#KS[]U[KW^E3NG_O%[ M>7_HR^GO_KS[]U[KW^E3NG_O%[>7_HR^GO\`Z\^_=>Z]_I4[I_[Q>WE_Z,OI M[_Z\^_=>Z]_I4[I_[Q>WE_Z,OI[_`.O/OW7NO?Z5.Z?^\7MY?^C+Z>_^O/OW M7NO?Z5.Z?^\7MY?^C+Z>_P#KS[]U[KW^E3NG_O%[>7_HR^GO_KS[]U[KW^E3 MNG_O%[>7_HR^GO\`Z\^_=>Z]_I4[I_[Q>WE_Z,OI[_Z\^_=>Z]_I4[I_[Q>W ME_Z,OI[_`.O/OW7NO?Z5.Z?^\7MY?^C+Z>_^O/OW7NO?Z5.Z?^\7MY?^C+Z> M_P#KS[]U[KW^E3NG_O%[>7_HR^GO_KS[]U[KW^E3NG_O%[>7_HR^GO\`Z\^_ M=>Z]_I4[I_[Q>WE_Z,OI[_Z\^_=>Z]_I4[I_[Q>WE_Z,OI[_`.O/OW7NO?Z5 M.Z?^\7MY?^C+Z>_^O/OW7NO?Z5.Z?^\7MY?^C+Z>_P#KS[]U[KW^E3NG_O%[ M>7_HR^GO_KS[]U[KW^E3NG_O%[>7_HR^GO\`Z\^_=>Z]_I4[I_[Q>WE_Z,OI M[_Z\^_=>Z]_I4[I_[Q>WE_Z,OI[_`.O/OW7NO?Z5.Z?^\7MY?^C+Z>_^O/OW M7NO?Z5.Z?^\7MY?^C+Z>_P#KS[]U[KW^E3NG_O%[>7_HR^GO_KS[]U[KW^E3 MNG_O%[>7_HR^GO\`Z\^_=>Z]_I4[I_[Q>WE_Z,OI[_Z\^_=>Z]_I4[I_[Q>W ME_Z,OI[_`.O/OW7NO?Z5.Z?^\7MY?^C+Z>_^O/OW7NO?Z5.Z?^\7MY?^C+Z> M_P#KS[]U[KW^E3NG_O%[>7_HR^GO_KS[]U[KW^E3NG_O%[>7_HR^GO\`Z\^_ M=>Z]_I4[I_[Q>WE_Z,OI[_Z\^_=>Z]_I4[I_[Q>WE_Z,OI[_`.O/OW7NO?Z5 M.Z?^\7MY?^C+Z>_^O/OW7NO?Z5.Z?^\7MY?^C+Z>_P#KS[]U[KW^E3NG_O%[ M>7_HR^GO_KS[]U[KW^E3NG_O%[>7_HR^GO\`Z\^_=>Z]_I4[I_[Q>WE_Z,OI M[_Z\^_=>Z]_I4[I_[Q>WE_Z,OI[_`.O/OW7NO?Z5.Z?^\7MY?^C+Z>_^O/OW M7NO?Z5.Z?^\7MY?^C+Z>_P#KS[]U[KW^E3NG_O%[>7_HR^GO_KS[]U[KW^E3 MNG_O%[>7_HR^GO\`Z\^_=>Z]_I4[I_[Q>WE_Z,OI[_Z\^_=>Z]_I4[I_[Q>W ME_Z,OI[_`.O/OW7NO?Z5.Z?^\7MY?^C+Z>_^O/OW7NO?Z5.Z?^\7MY?^C+Z> M_P#KS[]U[KW^E3NG_O%[>7_HR^GO_KS[]U[KW^E3NG_O%[>7_HR^GO\`Z\^_ M=>Z]_I4[I_[Q>WE_Z,OI[_Z\^_=>Z]_I4[I_[Q>WE_Z,OI[_`.O/OW7NO?Z5 M.Z?^\7MY?^C+Z>_^O/OW7NO?Z5.Z?^\7MY?^C+Z>_P#KS[]U[KW^E3NG_O%[ M>7_HR^GO_KS[]U[KW^E3NG_O%[>7_HR^GO\`Z\^_=>Z]_I4[I_[Q>WE_Z,OI M[_Z\^_=>Z]_I4[I_[Q>WE_Z,OI[_`.O/OW7NO?Z5.Z?^\7MY?^C+Z>_^O/OW M7NO?Z5.Z?^\7MY?^C+Z>_P#KS[]U[J50=G]O5&0Q]+7_`!NW;B:&JKJ6FK,K M4=B]2U$&,I9YA'49":FI,N\TBPJ3(T<*,[`612UA[]U[HOORW^-W9/RA['^. M&`Q/8FY^F^K>JMY[H[PW/V!UOF-G0=EUG96VMMR;0Z>VW@<9O7";@QLU`ISF M0CT=$D1,DI,7NO=5[T'\N?O#;VP_CKTTVU>N^Q=G_&[,_-7H;:&\ M>Q-S;8J-X#XU]W;(K*+H;L+,4V+P"46#$U^!H*>B81P155,K$,OOW7 MNF?`?!+Y.#K].L,GTGTSB,EW%U_\3=N9KND]FXNOWS\+_/Y7WRKE7(8+9,^*Q^R=VQ_(G8>$VCLSLWJG8>W.D-N[_\` MF#V-WALC?5-#O'K7>>0^QJ-N[JP"U-#L2KP64H:W%0P12RJM)64'NO=&M^+W M6DFXOYC/?(P&Y\1O'X[?%_>>\NQ]GS8F=LE#B/F#\I]HT&V^]]L5E=&TE+'D MMM?P7=F4RE+$4J(*C?;+4ZI))-?NO=7=>_=>Z][]U[KWOW7NO>_=>Z][]U[K MWOW7NO>_=>Z][]U[KWOW7NO_U]_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=$9_F3]H]U])_"'Y#]L_'K*;1P7:NP]BU6X<%F]YTU76XO%4] M%51'*5M+04M+6+45J4YD^Q@J8#3O-I$Y$>H^_=>Z`O#?-WNVGWA1[AW'UIU; M_LON#^2FU_A5OG+8;>.[)>WAWWEMP4'6^4WGM39V3H8Z6;9T&[\DN+IX*R9, MI+BT.?9!1:5/NO=)WY1?*GY.]%_*+O*3!T_5^X?C[U%_+:[F^5%'L3(3[AH] MY;@[%ZSR.$V]M*>DWW0[0&S]O5N- MAW1BIJC%;UR^/KLC'3SUU+2QXZNQD\WNO=/'6W\Q#Y(9C!]3;VWQ\=.MLEMC MOOHGY*=F]-[8ZM[4W%7=@5F\OC=CFW`^R]X#L'#XO$4L&[*..&/'U"UI_AU2 MQCJWF0F<>Z]T5CM_^8G\F]U[6ZHS%3E>N>JL'UC\M\'3?)VEZ\K^[=B=GUO6 MFT/CGNWY25_6=5UCW'M+';IPLU3C]I5ZU<]7CXZ'-C[&+'UYH9S=&XJ7LGKO;/3._>O,%48+Y*=5==;CVYWGVE3]987:>X-X= MZ;&V[7G,X:2;[C(Y#`8^OQ]1'-#)3$,LT0]U[HR7RU[/^9G6/77P_J-FU?1> M![,W_P#*OH[J[N^E%5O7+['K,!O/,S8_*X#8E?D<8V0--4Z-,]95T\%1$@+0 M%6/OW7NB1]+_`,R7OGH_XL_'7L/Y3[1VUOO$=L_#VL[9Z^WAM#=6]]S]I[FW M?L7*[)V3)'W!A*;;RB.;ZLP^$GREW#\ ME-D]DQ[YVBVVNP.J-TTNU=S38[9'=VQ-E[FBS&TJ3=V%S>S<3\B=M[6W)'$( M*LT-;'78UE6JIY7BJ)H)8F'NO=$/P/\`-&[LKMK]NR;LZFZ?Z]["P.'ZSSVS M.MMY9GN_";QVC!V;V(NQ,5B]W[';:KY7L*5"VK&Y+IJ#/T.7K(CCJ*99*FDD MF]U[K@W\S#>^'K'W#V1UAEJ7X=_;2VMO7,?';ICKON3"- MB=C=I[?Q^?"Y&@WC34M-_&J2FFQ]3'53I%54T\9'NO=&W^+'8?RFSGS`^2O7 MGR3'76%3:_QX^*V\]F[.ZBW7NS=NP*#^_G87;%!F=P"IWOB,37Q9>ICPM!CL MB`LD$L>/IIXO"9)($]U[H@WR$_F5?+*BZ[^8&&V/LSJCI+LOKCIWM_LKJ:#? M;]C1;XPNUNHNQ:/957O,T^>VXVT-]Q9>@J8MCT> MZ]T;JG^;O=U!N2/=6YNMNK?]E^VS\D-K?#;LK-X3>F[9>VU[USNT?:.H;W7NBD?(;^9/\D.M]L?$_P"3 MN?V'MJB^,/;^Z\AW#L'`=+[NW!N?O???5-/\6=^=C;=ZX[AZWS.&0Q)EI$P& M9KZL]W3\D-R]3_#/_`&9;L;$;.W1NV'KO9VYI M=L]2;CR>;ZWS6[^Q:NCP^Q\1M3L7<-/%(^$GKLKCDJMQ55%'%'2M-D988H%T M+[KW10\E\V?F/A_D5L_X65?4'QIJ?DIN>@SNZ)]R0]G]H'HNAV&_7V6W5LK/ M4]7'@)L[_%!D<+D<5E,'54\+&$4V1IYUAG">_=>Z%_<_RK[@[(_E8]I?*WJW M![5ZQ[RPO0?=VZJ+%YO*5.YMH;2W[TZV:P&ZZ[%9*.A\F2I8*O"UU;@A68]% MJ;4B5T,2/.J^Z]T5;I+Y@?,?9E=V/O7NW$=2;\ZRQ/S0^/G0&^:G&;RWW2;P MVSD>_NF.F\)00=-;4[DZ7W)2[#^16!2/8F)R>)I$P/9&X^W=G[? MV[7YJLI\]0Y"CGV9E\K0LL=9%YF2"GJ:KW7ND)L;Y4?)G9?>_P`A)MV879O8 M7QL@_F*;7^*^'KJK>6Z(NY-C57:VS.O,+M'^[>T:7#?P67;&+SF?,M=#4Y7[ MLQU596))&E.M/-[KW35N7^9_O_8.P,-\C-]].[/G^-7<[]MX;XZ4FT=Y9Z;O M&?=G6N)SF1VS1]RX7)XX8S"T&YHZ]T!GRN_F3 M?(CXH]L];;5[XVGMFEWGU[C>P>S-T;-^/^=WSN;J'MO8&[^AM]'JZCWQNC/X M)LOMF';^Y]IU=?N/)RT#4U#CHDR_[D):G]^Z]T;?<'SG[XZ\^2/4O3'8G6_4 M^+VMN6HZ7V?G.P8LQVK!M#LOL+M7&05&:7H_LU,-6;2H8L)-4JE'M[?F8Q.< MW`42/#TTLM?0+-[KW1A?D+WYW9B.W-M=%?&G9/5^Z.S:SJ?=O>&YJONS=FYM MD;'I.O-I[IH=F18/`Y/:F/KZBIS64R&0-I)%6DQL%/Y:TAZNE23W7NBR_";O M[NWY0_+ON+L[*[@I\;\:JGXE_$CL#I;J^++YN'+[:?ORCSN\JC,[SV]4XZ*D MGS[_`,,JZ&LK8\C+#%30TD5)%HGJ''NO=%GZ@^2'\R?>GR9KME-E_CON6JIL M]_,BP&'V]G=Q]D;6ZVH=M]!]_=6;5VO7;A&WMO5&0R&2Q%/F,EBL-)!I=Z:L MJ*BMDEEB2-O=>Z$K9'\WP]C;YZ_JCLK8/;&'ZNI:W*9NFJ\[\F<#28[(=-]6UF,P%/5ULN- MW'!+FY*VMQU'45%%%CY*AHFC%C[KW5=W<'\Q?Y![WV9W/OKHK![>V-+M3X-? M*;MCJO=.=W=E:C"R[PZ:ZGZ:[-[)R.Z>L)L;5+_&-MUF^\C@\'3Y8Q20U^+J MXIITCI9(HW;W7ND5M'^ M8I\EJ#HO.=C;-ZCZUWKLSX__``YZ=^6_;]9VCW9O=>SMT;;WIN;LF'>>S-FU MN,VY+25F5IL;L0U.-RN5:FIS--]M40K&PJ(O=>ZLA^4'?W<>P=^?&+JCHK9' M6VYMZ?)+,]JX>ER?:VYMU[8VMLR/8'3^0[(ILQ6OLW'Y&KK1+/2Q43T2)$76 M4R+41F/GW7NJZ,]_-F[CH^OZ+L?%=*=:2T_6W4.[>T?D+L&CS7<_8^[D;K7M M7Z]T+,_S MB^6^6[,S6S-C]/?'J?!;D^7_`'%\*.G,KNCLGLW'9V7?_5/7V8[3;L[LW&X? M`S4U-M]L5M[+4+XW%U,E9+6R44DY>L12]/[AZUV7E]MP_:R[4R.:B;?.6Q*U-+-3 M4R^%UJ)X_=>Z$WL[Y5_)7>'='3G]P,5M'8'QSHOYCV-^*FZB9'9]9ACA4VOE,I0FGI8J?+?>-%#3UWD9)C1Q^Z]T/G;5-OOOSY9U MWQHINZNV.@.O>O.@]E=\2572>;PVT>P^XMS[\W_N7KZ;'/N[.4&1F@P.TZ?! MTT];0XR*)YZS,4+UDR1100U/NO=`[C/D_P#(C#8_$=*=-[UZ4^7_`&1U=U7V M;W!VYW3V/F:CI?;>[MA;.[>SO5>'V7@(=CT]=02[S%3@\EBMP9A$IL+1U>.> MJG@I?XI!!%[KW0=K_,I^1O84LF[>C^ENEZWJ_=OR$^-GQRZMK.T]]]E;3WSD MMQ?(KH39O?U-NO?&"PN!JX,=0X3';JEI:B"GFGJ*JHIE15IE8R+[KW0K8/YL M_)GL??QV&?,5T MNX9MW8J:ECK*-(\4(:R.MDF=:>2?W7N@UR/\R_M_=N-R78/575_3>+ZAQ'QN M^)G=%?DNY=_]BT&_5W1\M-P[JV;MG8V"VMU_M[*R9UL/DMOQ.:7#I493-K(* M'"4-365=(&]U[H-LG\]OF+NGLKJW;<.$ZTV1@]I[V^477_R'P]-C^W]H9+?4 MFP_A]@_E!LG.=Y,_UOD>NNR=Y[GW=M'DWYC]Q87'T3469H'6>C;'U+RT2IINT^@LE/N2/)[ER,^.^*O:.+RF M#[$[FRN,V_25;4-5MK=>'GQO^7B#'RTLJ3/4*T,P]^Z]T32+YS?,7L?-[(RO M6-!L+KJ??WRY^-6SMV[?WEOG/;[PB=0]V?$Z7N_:F$V@V#Q=1#C:F3%FGJ\U M48VHD63*()*:I^VFE4>Z]T:S^7S\G/DAO;:_PZV-\A\-L+)57R#^$V([[V1V M%MG>6YMQ;YR,W6^#V%C-\UOM)DJ<81WCIY(JN"<-:"5_= M>Z2O5_R$^2F"_F1]R=5=EY7;.YNI.P/D;B/CUUCM[%;KW.!U=M?9?P?J/E?# MGZ7;53BX*:?*9QZFEBS=6^0D;S2RP0JM+14KS>Z]T!^Z/FUWEV+V9B\Q@=U9 M7K?`2;B^/VT)MF[9R0K67[6[!WMLJ67"[`W MSCMKS[(VM'M'#96,UN3BK96BKZTK#2-&K215"MH'NO=`?N;^8[O[(;>WAW3U MCU+M.?X[]#=3]%=N?(O_`$C;ESV`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`'%L6HW'25VTMH_&CX] MG;)ZSW'NJ@W'LV?OCI?MGL#ZJ_)8D-N"CJ1M&2.LQ4LZQB2GQ<]-(K&J1 M_=>Z&C=O\S/OGKSIO"=W[AZ-ZJK=L]^=(9_O/XF[?PG9.\I]QU6#Q>Z]T?SXU]Y]M[^[7^1/ M1W>&R]@;9[`Z)R'7.5BR_5NYMQ;FV-NG8O<.$K\YM.19=W8['9"FRU`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`'\#_86]^Z]UZP_H/]L/?NO=>L/Z#_`&P]^Z]UZP_H/]L/?NO=>TJ? MJH/^P'OW7NN@B*;JJ@G\A0#S]>1[]U[KIHXW%G1''TLRAA8FY'/OW7NNRB$D ME5)(L25%R/Z$_P"Q/OW7NO%$-[HIU"S74&X^EC_7ZGW[KW7M"VTZ5T_TL+?[ M;W[KW7%(88[^.*..[M(="*MY'X>0Z1^H_D_4^_=>ZR>_=>Z][]U[KWOW7NO> M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO__0W^/?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]TA.S^MME=Q]>;SZJ['V]C]V[![!V[E-I;PVSE? MN!C\YM[-TK4.4QU1)1O%.@DB=@LL$L(WCDMM9K*U&*R&YX<+%#BANW(44 M^::E189*]T`'OW7NE)VI\5NC.Z=T5&\.R=@8_<^>J^J.Q.CJVOFRVYL4^2ZE M[7H!CM_[!S%-@:VE@KL=D(Q<1UD4CTTC//2/!,Q?W[KW2`[)^`_Q3[>W+4;J M[#Z?PNX,M6XG:V)R1_O%OS%8S*OL5Z:39.X\KMW`Y6DQM5GL,:&@7#[BJ*1\ MK0)30)2UL:0Q*GNO=*Y?B#\=QMO8&SI.I-I5>T^K-K=B;$V+MO)?Q/+8;$;( M[9Q?\"[)VQ44&5FFBK*3-4!>DKXJ]*@/&S*NFY]^Z]TG-F_!?XP["QV/Q6WN MJ<9-3XG>D?8E'6[KW-OO?VXI]WT^R7W5OW*9/)5U'1[?SF7Q-%BJV MJFH::GK*A*>FBUD^_=>ZB[6^!?Q8V9LS>G7^W^G]OP[4[#J-FS;OQ^0SN^<] M49*EZYSZ[HZ]V_39?<.4JZVCPV#KU%3A\'0U,./HBTB4],D-@T3O&WNO=!Y4?#7XW5NT=@[`KNH-GUVRNK^K=T=*[#VQD5R MN2PNW>K=\TN*I-X;-IJ*MG82TM:F#Q`9JDRRH:6)XI(Y`S-[KW2YZ4^/W5?Q M[VCE-F]4;4BVWB\WEZG<6>J:O.[HW=N'<^X:O'P8N;.;KWCOJLRF8RE5]M2T MU)'/D:ZH=*>&&!"(HD1?=>Z`S'?RZOAWB,#O?;6+Z5QE%AM^PX>DR%+#O'L@ M5&V,?M[.KN?;^*ZIRQRYJMD46.R*I78ZBV7+BH*:>.&6&-&BB*>Z]T^]>?!/ MXL=69N3<&R>E]IXK)U,^^:VOGJ*_=.=3*Y+LS:6&V+V)E,S2;DKJR&NJL_BM MOX>ES5361R2UAIA-4-)/+-(_NO=*CH+XA?'WXRY7>>=Z9Z^AVEG.P4RDZTF*.8R$>.I89$BIXI?#$B0I%''[KW M2(3^7Y\1EE[3D;I/;U1#W-M?>NSM^8>LSV]:W;C[=[+JQDNQ\3LW;53D6QNU MHL]5A:S,':U%CFK*A(:BH+RQ1LONO=/.)^$/QMP?9^VNX\?UK2'L/:%#AZ7! MYW(;IW[EH5KMO;2CV)@MW9;;^7RE1BLEN6FPL,6*3=>2Q]1FC2QQQ-D&"*1[ MKW3!LW^7K\/^O>P<9VOLSHG:&%[%V]GZO*JHFQTT\[5,E(]2LF1EGEE@RUNMJ*CV9%V5UOV]_#*_<^^=PU53V/U"NW5ZWWAD M,[N3)5F0J*S$_P!U-OB#SU;HPH(!*D@,@?W7NIW3GQ$^/O0F\MQ[\ZIZQP6S MMR;IHJG&5]?1Y'MR0S=;MK9V.S];5TF`Q$M:JUDV)P-/14M119#>F0VQ3;+?>] M9LNHR;8&3,Q8FD@QM-E#C/NX*8-!!/%')*']U[J/0_!_XP8K>_878E%T_MJI MW1VABM[X/>*9RNW'N':=;B>S=4G9U'BNO<]656W\0-SR$R;C?#8RD?)O)-)7 M-4/+*9/=>Z@]??!'XN=828R?:74V)%7A\SN+<-#E-S;DWUO[.297=>PZGK+- MKE\]O[*9.MR-(V!JZK$4^/KZB6DI::65*6"$R.3[KW4/:W\OWXD[-W)UQNO` M=04-)E^J<9M;$[,6?>/8V5P\%/L-V/7U9N#;67S$^-SE=MQ?$FV\EGJ2MJ\0 MD%+'CIZ:.CI%A]U[H1._?BOTA\FJ?;]'W-LB'=L.U6RC8"II]Q[QVAE:"'/Q M14^Y,,V;V'D,773XK*1T]*,KAZBJDH:TT].:FFE,$17W7NEEM7ICKW8VZ-R[ MQV9M3#[7W#O';FP=H;BKL*LU##5[7ZLIJZ@Z\V_38F&U%2TN+I\E6PTT5)3Q M!5F(.H)&J^Z]T@MH?$OHC8/:6[^ZMG]>8S!]G;YDWS/N+P.Q=M;!B@RV\4PV-QG5]##C.LI"./`Y+-T576 MX_2II*F$B_OW7NAV[.Z:Z[[@DV&W8FT\1NQ>LNQ-J]M[$_B_W1_NOV5LB::7 M:N\,8M*\=ZNB-1*\'F+Q!B&:)R%*^Z]T$6)^$WQEP.V_[HXCIG95)MA=I]]; M!_N\$R[X279'RAW53[S[^VS/CYJET>FW-D:2FJ:U9->GQK%3^"$>/W[KW3CA MOAW\>]O;)W!UYB^N*1MJ[KRW4F>W+1Y;=6^<_7Y_.=%X_;V'ZJS.8W#GLC4Y M*HJL/3;5P"0SRU;/,:*)JEIF:5I/=>ZBXSX8?'/#[)WOUOCNJMO4FQ>R.HL' MT)OC;<62W,:/AAIY5BD:IQT MTE(_W*2:48E-+V;W[KW15]U_RV_AAO>A;$;IZ(VUEL'/AMW[>R>`?<&_*3`[ MDPN^-SY7>^>Q^],%CLK#1YU5S.Z]T,N"^+G2 M&V:K;57@^O<525.T^WMR=\X*J?+[FJJJ@[=W;LW(;!W'OLS5M7*U175F)RE? M1SFJ9XRL\CB,2VD'NO=!K4?R_OB955FR:VHZ7VRS=?222[]-246\,!@FVUC=[?W-HLE'@GSB8Z23%O MF)<:]7+1%::69X$6(>Z]TK.Z?C!T[\A$VZ>V-JR9ZKVE5U57MO,83=6]^OMS M8N.O@BBRN*7=W7&2Q.3EQ]:T,,M;C)JIJ.=X:=YJ>22G@>/W7NDEV9\(OC%V MYMS8FT][=0;:J=M=98FNV_L;`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`-9XG9.$VAUY24M'U]V=4]S[:K,KNC?&Z-Q1=J5FR,AUQ4;\ MS6[MUY&NR^7R'\"R53A8I,Q7U2Q4/BIXECCIZ=8_=>ZY=A_#WX_]K=D[?[>W M_P!4FSFSH-\[9PU;38?Z]T'>Z/YI:>GV5G-RX?>4UM\]F2;QQFY]O0O1;=RNU^SIZQ[G^`O MQ7WCN7<6[<]U)C#G]V]B5':>X8HXUH\U28 M^@7<>'ACCQV8DIJ:?)TE7-!%(ONO=<]L_`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`Q%53T5(]3,T,*R2S/)[KW0M9?XA=`Y[NB@^0F7ZSP%5VW09#& M9I-RG(;G2AGW)A,2N`PF\LAL^*M7!5F?H:!%H:#/5>+DR%-3JL$%3'&H4>Z] MU*P?Q+Z"VUC-I83!=98+'8C8O6W:'4>TZ.');D,>%Z\[FS%!GNR]K4JRU;$P M9:JQE#-42R.TRM"@ADB4LI]U[H.LK_+R^(>8VM0[+GZ:QN-P.*S\FY\5+MC> M/8^S]Q8_+5FS,1UUEXZ3=^U,O19B.BK\)@<-C\CC$R(HJR.BIC5T\SQ*_OW7 MNE2/A)\8H^Q]J]KTG3NU,=O/95+MJFVT^*FSN)VMC9-DX=-M;'RIZ[Q57!MR M?)8/&10X_!Y6KQ,M9CZ:..GI)XH8T4>Z]U&V)\'/C)UA+N67K[K&':LFZ:O; ML];/C-Y]BB?#X[:>[X-\;>VAL=JC+.=M[<@R=-3U1VQMYJ+$2>-89:&2GO%[ M]U[HW`X`_/\`C_7W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=?_]'?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]+? MX]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]/?X]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]3?X]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW1>_E?WC4?&GXW]R]]TFU4WQ5=4;%S&\:;9\F>_N MO'N.?&1AH<3)N(4E>:)9F8*U2**?5.])]G?-OK;KW MX[PUW6V\^T=E[WV'W+ENZ]B;HP_7.2Q>(WQM:HGK]H;5R]+N*G;-8FJQ^+@Q M55_$(J@QTZ9NQOYH7QKV3A=@YO'MVSN:7>OR$ZW^/-?M.GZ,[ MJVUV%L+X,92XS=5 M#0Y+3BJRLVK59&&"N>*BE=:F:*)_=:((-#TP_&'YD;,^5>__`)";X>M]MC.[JV_O?8FXL]D]\]>0;[KJ;+]<=BXC#9G"O0I4PQ+%6TMZA&2H M2T;I?W6NCF>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][] MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO> M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[ MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_ M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_]7?X]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1OLW ML_$[JRN)JL[C,#D$F/8VW.U-H;O[%&_]^YO;LE3A\IM;$)48_9V!P%+E%21ZKQJ8::#W5&.H MUZ/S\9>@N^^K=\_)?N#NSL'JWL/L7Y!9CK/-Q8KJS8^Y^MMD[57K3K>'85+A M84W;FMS5TPK#`*F:NDG+*9&5:?3&BGW5>AF_O#\G"`3U%TD"0"0OR)WPH!(N M0`>L6^GT^OOW7NO?W@^3?_/H^D__`$HK>_\`]K#W[KW7O[P?)O\`Y]'TG_Z4 M5O?_`.UA[]U[KW]X/DW_`,^CZ3_]**WO_P#:P]^Z]U[^\'R;_P"?1])_^E%; MW_\`M8>_=>Z]_>#Y-_\`/H^D_P#THK>__P!K#W[KW7O[P?)O_GT?2?\`Z45O M?_[6'OW7NO?W@^3?_/H^D_\`THK>_P#]K#W[KW7O[P?)O_GT?2?_`*45O?\` M^UA[]U[KW]X/DW_SZ/I/_P!**WO_`/:P]^Z]U[^\'R;_`.?1])_^E%;W_P#M M8>_=>Z]_>#Y-_P#/H^D__2BM[_\`VL/?NO=>_O!\F_\`GT?2?_I16]__`+6' MOW7NO?W@^3?_`#Z/I/\`]**WO_\`:P]^Z]U[^\'R;_Y]'TG_`.E%;W_^UA[] MU[KW]X/DW_SZ/I/_`-**WO\`_:P]^Z]U[^\'R;_Y]'TG_P"E%;W_`/M8>_=> MZ]_>#Y-_\^CZ3_\`2BM[_P#VL/?NO=>_O!\F_P#GT?2?_I16]_\`[6'OW7NO M?W@^3?\`SZ/I/_THK>__`-K#W[KW7O[P?)O_`)]'TG_Z45O?_P"UA[]U[KW] MX/DW_P`^CZ3_`/2BM[__`&L/?NO=>_O!\F_^?1])_P#I16]__M8>_=>Z]_># MY-_\^CZ3_P#2BM[_`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`87X-N??NO=>\T7_'6/_DM?^*^_=>Z]YHO M^.L?_):_\5]^Z]U[S1?\=8_^2U_XK[]U[KWFB_XZQ_\`):_\5]^Z]U[S1?\` M'6/_`)+7_BOOW7NO>:+_`(ZQ_P#):_\`%??NO=>\T7_'6/\`Y+7_`(K[]U[K MWFB_XZQ_\EK_`,5]^Z]U[S1?\=8_^2U_XK[]U[KWFB_XZQ_\EK_Q7W[KW7O- M%_QUC_Y+7_BOOW7NO>:+_CK'_P`EK_Q7W[KW7O-%_P`=8_\`DM?^*^_=>Z]Y MHO\`CK'_`,EK_P`5]^Z]U[S1?\=8_P#DM?\`BOOW7NO>:+_CK'_R6O\`Q7W[ MKW7O-%_QUC_Y+7_BOOW7NO>:+_CK'_R6O_%??NO=>\T7_'6/_DM?^*^_=>Z] MYHO^.L?_`"6O_%??NO=>\T7_`!UC_P"2U_XK[]U[KWFB_P".L?\`R6O_`!7W M[KW7O-%_QUC_`.2U_P"*^_=>Z]YHO^.L?_):_P#%??NO=>\T7_'6/_DM?^*^ M_=>ZY@AA<$$_=>Z[]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7_U=_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M17OFCW]N#XN?%_N;OO:>R*/LK='6FSYL]MSK_(9\[4H]Y9Z7)4V(P^W9]T&" MJ7'K55-5%&:IZ:18[ZF4*"1[KW16,U_-`V%B(=N[B38>X7=C4:- M)B^Q:/M?:O?NVOC>OQQJMGYR*F2GSK[MW"=OU<]96014E?`4F_9+3)[KW2^I MODQ\H]J[PVQUMW9T/TML+>/>5'OG&?'#+;5[YW;OO85=VKM38];V#2]0=RY2 MNV1AZ]T`FTOGI\M(ML]Q;[[/^/_ M`,><9M+J'Y-;%^)];%U[WOV5NGU.R9] MQ[=ZQH]G9.*2!UW,V-Q@.4_RJJI)$+1W(3W7NK.=I[RQ&\X,A6X&>:LHL9G] MR[5KIIL7EL2\&?V?G)]M[AI!#F(H7D2*MIYXHYXE:"95$T$LL+HY]U[HA7R6 MRFW]L]G[WS6[_CK\>.T,#MWI#<';%1G-T;5ASO:N8@VE74VVZ7;,:5V'JH)` MU75H*4BJ9O"OB2(R,#[]U[H*-L[IZ3WKWT.I<-\,>D\#AJ#.?P_,5>[NAZ.D MW?'020T;P557@Z?""'%,YJ6:)LC,$D0(Z`JU_?NO="[WOMKHWJ+)[#BQ_P`4 M_C;DL'G7SV3W;GW=N5V(HJVH&+H<545H1DRKU,^6^UEH:%:;35 MLGWE._OW7NB_9GM;X[8?;F`WG4_$OXPP8/*;:V>7QE3L;;7\:R6]=_=34G:. MVTP<]'MZ6$8'56Q88Y*JC62>KBJUBB4TP67W7NH&3[?Z%DK,7MW"_##XZX_= M_P#??9^S-]8SZ]TOL+FNG*78&&W'O7XA?%J+PZ[:^1V_B9\S@(ZFHJ-NXR&DR%=+#3LI:8"1*>%HY&]U[H(MJ]J;#W#4]:8 M2M^$/QMPFX-^T6#W/4Q5/2E5*^.VIG]OPY:C\&W9-O0Y%[3--`F:=%Q\V@^, MAT=1[KW1S.[^INM=BKUXW7_QA^)^3_O9V5M[K[,#??6F!Q*T7]YY3!C\AB9, M#AJGS/&TN.J<9N7L#(1=@[4&\\?F*K;38)8C)34K MK'/34TTERKSZUB`7W[KW08[3[9Z&W7D=KS2?#;XS[9VM6[GI<7NO)9_:&R(\ MK@,56X_;-3&]5@H,(:VBGA_O#))455;2_81O2BBFJ8)ZF)_?NO=&7^2&$^,_ M0,/74B?%GH[-ST2=1[6+;6Z]H`)M[]@50PF!KC%38N.2F$M57BFQ M\3S1BLK:99$9O=>Z+YNG>'6.$SV\-N47PO\`BQ4Y*BWMGAP,M17XPY`)74`-#5>_=>ZR5W9WQK3"8K>% M)\5_B^FSZ:MJ*W=&3DV/M?)MD-J/W)G>H:3(=?'%;>)K9*L:J=?8.'.9#^^)@ZHSF-[IR5'FINM\4N_#%T_VA'U7- M%-@JG`0TL$]55SQS3T]1*DM(R2TLJ&9&*^Z]TP_*7?/QK^,VY'V[5_#7HW=) MR'5>4WIMS(C8W76&I:G>=/N3^#8G9F51\+.8X:FD2MRIP^`3:F1^[VSN.CP#Q8^)*7;.Y\_%A=CX&L;(>/^$0RU-)1U"U6+-4M/DJ=)878^Z]TX;\WOUEL7`U M&=J_@E\;I\Q0[CV)UC5]5U.!Z]Q_8'^DW>F$Q6X#6"H_@H MD$!R-0!O:_UT_CW[KW4GW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=?__6W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%S^6/ M2#_)'X_]C='IN3^Z![!QF.QO]YOX1)GOX1_#MP4>?,YQ"34WFUBD,6G[A+%K MBY&D^Z]T3+?W\KWK7??R![Y[@;>V\,#LKO\`ZAK-FYOJ_"4E##'L7NBI[2VW MV9_LR766?JWE_AV5ER.T]O9&LQ[T_]L=R/TG+N.OZ=VUL+I!NG,'1;KW/M:IV#E.S>P?XEN+,>V2$L8C%5YQ3OX/%)[KW3=!\/.TL%+N7 MK39/R#FV1\4]R[^W!V74=<[7Z_R>+[YP==O?L*3M3?\`L+9O?V-W+3T]!M?, M9BIR-XEVLV4IZ.MJ:*GR4:B">#W7ND!N;X+]SQ]X]\=K]==@_$&7$=V]IX7M M48WOCX89;N;?NTJ]K]7?PS"]A4/86`!H]&UX:^EB_A8-//43$&0GW[KW M5DNRZ7>%+13IO7.8+/Y5LGG9:6MV_MRNVU218"?,23;:QM11Y"OR+R55+1&* M"LJEJ%2IE#3QT].CB)?=>Z(S\B/EEG.J^V'EQ7; M>2'7O5N*DIXZ*H6H_BV_T3!F*.8*BE)98X4C:I]^Z]TE-U]T;O&0K.TWZOZ* MSU)LKJGY.=JT#UVR\ID>QILU\?-__P"CN@H\!O&:K$5,^;U4=2LJTY>(1M#= MP\FJR^Z+;5=M;KP.[V&_NF.MNS*S%]O[\Z4 MVB>KNOJ<;VP^W=K=4S]KSSPG?V9>%:>H9::GEI::I@CC"/($D:2-8O=>Z4GQ M-[^R'R+SV\9=Q;3Z\P-*NWL?2/CL+A,-/F'IOX71.M'GV:NGW'M7$;?PN.SOQYK<)B-SXF68_QN3/8C;GW, M2QP29&8R8MI:9XU/NO=&2^*WR3W5\C<]N2CW=A-CX>AV_18C(08C"Q4.0R&. MS#X?$Y*2NDR]=N"IK6"R9&=81+M>@T*(]%5*;>7W7NEEV+V=0]6?(#8&S=L] M=;=J:3L*F-3W+V'386KHLAAZ-S8>E:FB_BN5IJG'4S9N8M(;)1 MAI`X]^Z]U)^,/<]5W?@MR93=V*Z\I=UX/*;=R552[*K:',PTR9C!^;$25&7I M:K*TM344S15E#35L&1\LT4'EEH\87%*/=>Z*9NGY;Q4>^=X[2J/CYUSDHWA_>;/T]#6TF#7'5.0H:>NKH-3S01FKIQ M3R32^Z]U,VMW[%NO?O7/7V]>GNMZVER?9^V-M[&WC3X"BJ<6Y9,O49 M+*XN'[*IR.3'VV$-%4TM-3&7]]:B#W7NE3MCYA9BGWQ08"LZUVDE)E=Z]6]; MXOL/;M1D)<)N7='8_Z]T93N/)[TH=]=)8?;>.ZNK\-V+OO(;(W.V]]IYK<&9H**AV#G^Q%FPE5C M:^DA1'@PM50B.IBE4257F&J-)(I/=>Z(SNGY8R9S9F$K9OCSM#;*=J8_X];C MW6_:>T-E97![HR79&U=[YR3-_P`-K-R8BERT&/\`[E4--BZG,9FDJ`E07:)G MAAA;W7NCY]N;\RG4?06>[0V7MO!9;=U%MG95/BL/!C(8Z&MJ):N-7,X]U[HJ>:^2^X<3V3E:#=_5&S9L]B^M]J;? MI^TQ\[MBLB MV)2YK.83[2BEDQ(JJNFH,?N*$5KS)YYQ"E1)[KW0]_(C-8#"0;`VSDMK=*0X M_=F1R=&=U=WX'%UO5VUUVIBI,O3XZO1GIHQ6Y'S2P8M5JXUCM4S!)2I@E]U[ MI*?%3?\`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`/DE\B]X=5;@W_`$>#/7=-+M+8\&Y,%L?>N*W77;H[OFJ\5D\IE9-@ M5.W:M&2';8H4EKXUQE8A,A^ZJ\1"Z57OW7N@8R'RM[PDV)LC6;PVS=BYS;V-H]A97;=+1XRK;9W;>9I:6F<9FHER$^*R6=RCF)&7"( MRF.;W7NESFN^OD+M7:J3MCNO]X;TW%N;M3;V%;;?5^;P,;QT, M@HZ')78K[KW2%VM\D^ZL[V3GIJ79O6^RL!44O:F[L%2Y3I[=8WGV!U%L_;PR MG7NY<=O6DW%!')#F)Z>H@^Z?#N55(+44;M&TONO=&A^*O<51WKUCB-R[LR^R M*7'[4WIOM&2EJJQHGDJ_76&Q%+V!N:MQF/W)BL9N:HI9,)@N@8^U=P8VJJ M,AK2@R5)FJREBHXJBH>.LQ\LAA1:FBJ6]^Z]TU;<^462Q,O>G8F>QO6E/MWI MWM+,;;GJ::DH,;EI?X[MC!4_VZ M534Z3((WA]U[I#TORW[_`*O(]@;<_NQUS'V)@]Y]/[.I^O,=M?;.;W!0OOS+ M;0AR-56T&=[1P^:K7Q8W!5TZ293!X3'>>%)!DV*K!4>Z]T9/I_M+LO<&F*.JQB[A]U[I9[E^1/8D4-1BJNDZG.=II=RX6@ MV?N3;.\)ZKY$Y3!]Z[JZB.U.M<=35]144U;C:+`8_,5T7V6816RE/YVQU`KY M$>Z]TH-B_++`U'8&R]MY^IZOV?UUF]AQU5-N8UE'@Z4=JX+`X6LW3UUA6KJ@ M4[9#%ME9J6JQ<<;5T)`A*AX9PONO=`A-\P_D)GL0LO\`H7P^+R6W<7VOV=N? M;.Y>O:B:6DV!M/-[6SW4&2J4SF[,3-11U./S=735&9QM)F:R:NQ<]718*+C' MI[KW1K?D=W%NSKW;NQAU-LO`=KMVQN3/[#Q.-FCFRF#R6ZZS%U.=Q8RF0PIF M@BH9Z3&YT5U15QK"98T62HB=A'4>Z]T"^S?D1W+V3D.J9=H8SKW8VU-^UG55 M734VX>K]Z97*0;%[)QV]-U[2JZ6G7/X,8^HBPVV,4RQ5E([029!O)3TTL"TY M]U[K%B_EYV;GCM*ASNQ=N=)XS<6U,+F*_MWM*CQ63Z^VU-D3IRS.I\#>Z]T\4'R"WWV#AJ/;[[.Z]P.]L_N"DF MQV"W/L[*;KIXNIZ'I:HWB>X&V=+78ZMJL-/N:F.)H:O[B&G@2I@IWD>K_P`] M[KW2EWGWOV[L3XR=1[YHMDX7LKN#?M#LC-ML_9>QLW2XB/`U>%7?^\?X-LZ3 M+U5=&N.Q<ZYX?OC%DVG6[YRV)VU@I-ZY;:.;<8S:PNV(2_P#%J"19SDFJ(T,< M:TDWNO=%;P/RX[BW9L78V[MH;#ZLW1FJ?;_8V[V`<+VQ-/C$+9219ZBI2FS2K"OAVM*S.%]U[H7Z;Y(]Q]F;T.W<-M?86V=F9 MKMC8N&V3E=\]5;NW?0[\ZZKDJ,=F]W[?G;<.(AGDQN=QDM1%D/M(T%/EL?$U M,)*1JVO]U[K!E/ESV31X+/9V#$==09W'TVXDQ75-7A]Q2;^WA3TVV:S.?Z8L M75192*4[M\=C= MX]1U^T=IU.VIJ7-5M!2Y+/;'P&X]W9JHR=1&),C@3%0;/ZN[/ZVV%N?H_#3=U[2Z]I)=J;T7N+L"39U;N MO9V>K]\5-=BUQDB1XV$8?&;C2:OH:@5=7CZ7 M2/IKL!S_`+#_`%N+>_=>ZE>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=> MZ][]U[K_T-_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5Y=N?(#M#:W?7:&PMOU6'AQ6 MTNCLCOS:&%J-OX'(9'=>ZX-C[CW`52.7,TN;R$4%5BJ*&:EPV,E4H3%)/$[E ME]U[IKV%\LMX4O:>3V1W7MS$]<8_$[6RZ+X\'N*FBW)V#MO:NR,W7T6P,Q5) M)_&\?5C.9>IQBP4S3RPQPP-&M535$:^Z]T%V,^2OS$JVV_!N/K4;;RVV<)7[ M@[7V_/UY2,M-C\QO^AI]FTLLZ;BK)1"NW:\K*V!.2J9*BGFFFIJ*5I,?3>Z] MTU;T^9?<^#KOX-%/B,?75.2V57;IKZC9&&I,3TH^4BR4.Y>K\]F-R[AHZ"3* M8ZKCQZ??YF3'>96EGIDECGI4]^Z]UFW#\R/DQC-^0.Y<+ MOD;*W=7XW-[8V-TWF]S=2SZJ.M;&25V2W1AJVFK!35SK44D$/ABIXZ^DJI?= M>Z4&-^0WV/D7DMDY!JY.N\Q ME,35[=I<3C#-5K%D]5!D6H:FO44U3,U+[KW1@MF]H]M4?1F]]S[@S>"W]VKM M_+;A)PF+V5+MJ3`;1C[(R&Q-O;CS&SJ'(5E74PKC\769Y=$R&K2&:*GT*48> MZ]T`>1^1OR.7<-.VR(\+V-UYMG%P9:N[0P'74%)ANS,0VX<+CH\WCZ&HS8JJ M6E@>NR^**8*/(32SX]ZE(TBD6/W[KW0C=V=_]][1[-W9MWK+96(R&U:##;0V M?M#=VZMK[AR&V\EW=F]XXJJR>#S.X<+6KD$QZ;;R=1(\L&,-)2RT\C#(3U,; M8P>Z]TI.ON[NZ-^;EVQ22[2AVS@]T[Y[6PM32;DVKN2@W-LW$=/[IJZ1$GRN^3-1BMXYH=8PX/'X[JCMU<9D,ELG)YB@Q_R,V=F[6K^H.^^R\O04V[,]T_NJHJ)>O\`;NU**LS--LS;?962QNY< M?2[8VIELAGJK*/M^CEJZ"GK:*FJZFI512TLWF,0]U[IMH/E'\K::@R4.3Z*7 M.[OVVW:FV=R8#!T,^"H1O#KKKW&;M&ZMNY7?%=3)7X>>KRL-/"M)K>ITDTLC MNE1I]U[J-MONGY$YC+T.WMJX7$]2;%R>_.KJ#KO(ITHV0PN[=@[BJ_[J=H5^ M/A.;BDI!C\V@R4,];CZ%F@R,:QTU;2TIRE1[KW7NO/EOW75]+0=H9NAQ&^,T MVZJ/:&Y=H;?VOC?XAMS=6^-K2T/7.&;&;0S>4K:2.3=QQ6&KQFA!4Q0UIEFC M@6!I5]U[KABOD/\`)?.8K?.&QU7MK`VCL]_X/M^#L?<6U_P"/^^,YV#UOMS<.ZXH* M;>$E!)1[LH8*6KQPQN:H*Z6EDIWQ=4\H@>6-4J&$4TD3ZPT$DL'BD;W7NAP] M^Z]UU8`D@`$VN;"@7(`!)N;`"Y_J??NO==^_=>Z]87O;D7`/Y ML?J+^_=>Z][]U[KP````L!P`.``/H`/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=?_T=_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=-BXJC3(U&4CIZ:.MJDHXJFICI:=*FI MBH1+]HE35!?)((O-+XE9K)K?3;6U_=>Z<_?NO=>M_P`4]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]UZW^\_7W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=?_2W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=?_3W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=8Y#;\7&EKVO?\<"WO8'GZ=:8A$,GF.'00=G=W=3],8@[A[9[+V+UGA$4-]_ MOG=&&VS33`D`)2-F9H6G>[`".`.Y)50I9E!0W^][1M,:ONLZVXDKI+L%U4XT MKQI4Q,\4W]F^B3[?M]=.8UW&-#3%:Y->'#CTWOG]W]]\38X4GON0-Q ME1]68F@E*Z0"21',Y`(X&@&./1]^N>X^JNV\QM8[KMFYJ6VVX2<#CH8-3TK3A7R]WUV)M7:N:?%U,LD-+D4QF:JH93# M*T4BI+HTL48*3I:Q3?;WL>SSBVO[A(&85[W`_P`)KGY=#?EOVO\`=#G2R.\< MF\N7^Z6BG0TMK;33@-Z$Q(X'V'/2)_V??X4?]Y:_&[_T=/7G_P!_P!GW^%'_>6OQN_]'1UY_P#7 M#W[^N/*7_1RA_P"-U(Y!1C];CCV]^Z]TWY;)T&%Q63S&5K:7&XO$X^LR>2R-=/'2T6/H*"F:JK*VLJ9B$C MBBC1I))'("J"20![;E>*.)I)FT(H)9O10*D_D,]/6]O2MZ=6\QM]W3T_WR>N?^S\?"?\`[RU^ M-W_HZ>N__KA[U_7#E/\`Z.,/_.1?\_3G^L'[]_\`3$;W_P!RZ[_ZT]>_V??X M4?\`>6OQN_\`1T=>?_7#W[^N/*7_`$?_`%P]^_KCRE_T6OQN_]'1UY_\`7#W[^N/*7_1RA_YR+_GZ M]_K!^_?_`$Q&]_\`DJ<_1[`WS MMO=U1AZ7(R208^JR46#J)GBBF>*1(WD`#,K!22#[-[+=MKWA2^TW<;0+TD+]3!+!J`.2OBHFH"HJ5X5%>AT7Z"_UL M/]Z]K>@S0#`X==^_=>Z][]U[IDS&0HL70U-?DJRGQV.I5FFK:ZMG2DHJ2".[ M23U=3.52.-0.79@![T9H[:)I;D]H_P`'^3_)UM+>YN[J*TLUEDGD(5$A4NS$ M\`%`)+'R`!)].B%;\_FD_`#JR3+T6[?E?U-_$,'&S5V%VMFGWWF(VBJ6HY:6 MGHMF1U[S31R(RO#%J=;'4H]@Z[]P^0[`Z;G:MJ8J2*?)];]JXO'0O,^A9*W)U6%2""('EYII%11RQ`]EJ>['(`E-- MUAI7YXS3S'4@7']W7]]"U@9Y^0KV<<:(UJ3]@"SD]')Z@^8/Q@[WCC3IKOGJ MKL*JD=84Q6W=[X6IS@D=Y8TC?;\TL=>K,892@:F&H(Q6X!/L4;?S1L',(ILU M_',3_"0?.G`T/\NL=N=_8WW>]JI7AY_Y4W+:/#PQE@D\,5`;$H!B."":/BHZ M,W32&6%'(*EM5P?J"&(L?9V$>(:)&UD>8\^HTBE69!(H90?)A1A3&1Y=9_>^ MG.O>_=>Z1^]-Y[4Z]V[FMY;ZW%A-H;1V_1-DL_NCLRF5R3 MQP01AF5='V]*-NVS<-ZW6WV39;22]N M[QM"11*SNS<%554%F8^045/1:D^>_P`)]+,_RU^.(5CZ?^,T]?:](^FI37\' M_#V2-S;RK4-'N$!8G33Q$XCT&KY]26_L%[^1>(T_)6\PK%74XL+K2$&:DF&@ MQDUX>?1M<774V2HH:ZBGBJJ*I2.>CJJ>19:>JI9XEGIZF"5"0R2(RLK`V(/L M^`&D.KZPPJ#]O46N'25X)4>-XF*,KC2P9>.#^S]O62JO M=1&9I-+X0#[,D]5)55>60:A&NK2.).?\/1:]S_,KXH["W%F=F[X^2/1VS]W; M>JQ0Y_;.Z>TMDX+/X:N,"5`I,EBLE61SPOH=&TR(#8@_0@^R2YYHY:M)FMKB M]BB9,49P#CSH37_/U(NR>S_N_P`R[5!OO+O*6Z7EI_=>ZP3$C38`DZ@`;_FP]U+'6L?DW$^@&>O"C.$8X-:_.G0 M%=B?)7H'IK(X_$]N]S=7]897,4L]?AZ#L'?>V=HUF5Q]+4?:5-9CJ?.5,#2Q M)+9&9`0I-C8^RW<-WV'9I!#>W20%L]S`5^7<=.A1R=R![B^X%K+N?)/+F MX;G#"WALUK;33Z3Q&OPD?3J&16A/0;S_`#Y^$Z*K-\M/CAH#@,5[HZ\)`(-C M;^(?U]HXN;N59'$:;C#J;`_43_/T+V]@/?J0A6Y(WG3Q8M87:@``Y_L?]0ST M:K$9.BS-/29/&U,-=CJ^BAK:"OI9DJ*2MH:R)*JBK*2>(E9(I8W5XW7@@W!L M?9^@U1B9)1(C9%*?X>HD$;)=3V]U"T%Q;.8G1J@@BM01Z@BA\P<=<=QYW%[9 MPN1S^;R%)B<-AZ.JR>6RN0J8J+'8O&8^E>MR&1R-=.1'#3P0QO+++(P554DD M#WI]*H7=Q&JBI8\*#[>GH89;N\M]NMXY)9;J58HTB4LS.]=(H,Y(I]I`XGHK M*?/CX2NLZNO#J+`7/\`Q(G M^?/4KGV"]^#(P3DK>I`E`&&W7>0?^;/67_9]_A1_WEK\;O\`T=/7G_UP][_K MARG_`-'*'_G(O^?KW^L'[]_],1O?_6OQN M_P#1T=>?_7#W[^N/*7_1RA_YR+_GZ]_K!^_?_3$;W_W+KO\`ZT]>_P!GW^%' M_>6OQN_]'1UY_P#7#W[^N/*7_1RA_P"O!_O/\0][7FWE.5A&-QAS_PQ?\_56]@O?K30\D;V M1_TKKO\`ZT]"EUA\A.C>ZZC)P=/=N];]I38$T)ST?7^]MO;O;"QY+RB@?)C! M5$_@$QAE$?DMJTM:^D^S/;]UVS>-?[MNDF$?'0RM^1()Z!_-'(?/G()BCYYV M6_VEK@TB6ZMI8=5/,>*B$J/,BH'0U/\`H;_6/^^X]KV-`2.@OW'X>/ET"7:_ MR&Z+Z+GP=-W)V_UMU;-N;[K^[T6_]YX+:3YM:!XH\@V*_C<\/G$!FA\S1W$> MM=5M0]EE_NVS[(JON,ZP>*:`NP%3_MB!Y]"SE?V^Y_\`<`S1\D;+=[NUN-4P MM8)9V1:$U*Q*Q%0#0D4KTC-L_-#XE[RW!A-I[2^3/0VZ-R[CR=+A\!MW;_:^ MR,MG,UE*N00TN.Q6,H:V2:IGD9@$BB1F)/`]I8N9N7)YD@@W")Y'(55#J2S$ MT"@`UJ3T=[O[,>\6Q;<^Y[ORENUI:VZF26::RN8XXHT%7D=WB"JBC+$D`#HT M7L^ZCCKWOW7NO>_=>Z][]U[H!.ROD=T1TO5XK&]P]Q=:]89'/TM55X2A[`WW MMG:4^8I:.40555CHA3RE[>\_\_075WR%LVX;O]%\?TUK-.%)X:_"1M(/D6I7RZ:]B?*SX MS]L;B&T>LN_NG^P]U_PRNRZ[:V3V+M3=.;;&8S1]_7IC,-533F&'R1^671I7 M4MSR/;5IS!L>ZS_N_;+Z*20_P.K&GK0'I9S+[7^Y_(VUGF#G#8=RVNQ%`9+F MSGB0DUP&DC4,<&@%3CHQJ,&1&'T958?ZQ%Q[-J:>T^70(5UD4.O!A4?8>N7O MW5NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K_]3?X]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=1*ARC*=!86/(-B"3]?J/Q[^-/P_R>-'8.`-9@^U>X)J:GRT6PL_"Z MK-M/8='7)+1U.5IK.F2K:J&:&F=O!"CU"R208[>ZOO.G+T[\O\O`2W`UK*YJ M!&U0%`X=W$GR&//KLE]P#^[,B]Y=CM/>CWU$MILLK*]AM08QRWD5"6FN)!1H MX6;1X0'=(`QU*A&K4LW[V+V'V[NNLW?V3O3=G8F\LU4L:K.[MS5?N'-U]3,V MJ.GIY*MY)/4?3'3P*$'`1%&E1B9?;CNN_P`PFO7ENI&)TAG9Z$TK0$FE:#A3 M@.OH/Y1Y(]NO9?8SMO*EA9;)MD,48<0Q16RJL0.DR3`*9*!F-9&8KW$'N/0U M;&^$'S%[,I*G(;#^+W?6Y:*C%&U15T75F\8H!'D86J!\-J'[*TKT`]U^]O]V'8KCZ?=N?MBMB=0"G!(%/(UZX[]^$OS$ZKQD69[!^,/?.U,1.*LC)9'K#>)H8TQ],:VL MDJJBCI)1"D<0+L\NE0`3?CW2YY!YRLX_&N]KG5,Y\,^7'A\NG=D^]M]V+F&\ M&W['S[LEY.U`$3L;Q-'R[S(%1J`1R MU.R7?N]]W\2OLP;5>[42TTEDA0N]W% M(U7:!672T98M$'!6J*=.TS`S,JL0PUHK%6!5UNHX93]"/R/>2#/^H$4=I!-? MS_V>N,"5\-0W%10_;USF_1_L1[NOQ#KSY0_E_P`>'6BM_P`*,0!_,"P]@!?X MZ]9%K`"Y&Z-S6)_K]?>%'WBW<\X0(2:>`,5QQ].OIU_N9`?^!EWMHR%D.^7" MJQ'#_$[.@^P$DTX9/KU13C<-ELQ(8<3BLEEYD0R20XN@J);(TA]%76?V4/[:==7;_?[#9Q;VV\W,:7,@8JK2I$ M'H.X@R,JG2/G7IY_N)O7_GC-V?\`H.Y7_KW[4_N[=O\`E&E_YP'_`*`Z2_UP MV3_?\'_99;?];>O?W%WH/KLS=G_H.97_`*]>_?N[=#AK:4#_`)H'_H$=>_K; ML4G8]W!$/XOJ[8TIG@)2<\.'GTU93;^8QE9C8//*# MXD\]9&B`O9@H#%C8V'O4FW7R(2T4H`XZHBJC[33'R^?3*MLCC9WK::/;.X*J+"3RS0? M:LV2VQ5&;%5\3Q`(T5=13(5MQ<`@PV'FWF/E^[6?;+B4-'P76Y4T'PE*T*^H MIU'/NK]WOV6]Y-DFVWW`Y:L=Q6Y%!)]/%'<5P0T=TJK+&^*JRR*1P!H2#N._ MREOYP3?,C+4?0W?$&$VO\@*+&RU^!S>,J:?%;>[BH\<+<[3NZK%?#A3"R8-=(J2"*5(.,X.#U M\V_W^O[OF[^Z]+%[E>W%S/NO*5_,(3;.I:;:F<@J\\W^B0LU8U=J'655M3.I MZV"?@=^1`#?'_O-6`96Z=[-!4@$$'95:""#^/9;O(!VB[!_P!\R_\` M'&Z&7MRS+[A;"RFA&XV1!&"#]3%D'KY8U*H^VHP`HU01WX`!)N+GWS`<]\C- MFC?R].ONIM&*6D8%:#1@8QX()`IZ_P"'I3TNSMU5L,-13[5W'54L\:S05%/M M_*5--,C#4DD,\<11E/X96(/X/LR3:=X\,7D%G*8VP&\-F&?3M(/RZ);CFWED M3&QGW&V,RT/@&XBBD6GK^J#CS!I\^I/]Q-Z_\\9NS_T'O?W$WK_`,\9NS_T'_?OW=NW_* M-+_S@/\`T!U[^N&R?[_@_P"RRV_ZV]>_N)O7_GC-V?\`H.Y7_KW[]^[MV_Y1 MI?\`G`?^@.O?UPV3_?\`!_V66W_6WKW]Q-Z_\\9NS_T'_KALG^_X/^RRV_ZV];.'_":'`97"=D_+:3+X/*X=VV+U.89,@< M>N%W]]/N^P[KRGR&NWW,=S);WN[:]$T$KT$%J0K>$2U!4T5N'V];?2FZJ?I< M`V/^(O[RP'#K@0C:E##S%>N_?NK=4O\`\S#^;UU+\&:4]=[3HZ7MCY$Y*&:> M'8-%F88<#L*FL&H\KVCE:!I)J7[@.):3$PK]W4(`[?;T["VWK3!^37SF^4GR]RU;E.].W-Q[CQDMVIMB8RIGV_UMB*=) M/N!!BMCXIUHO2P#&IK1/4$*"]0Q'.'7,GN'S/S353U]*?L=]T#V*^[EMZ;;[?\NP23`*9+^]6.XNG<<&^HE4NM,D)'I52 M:]!+UQ\?^].X9Z"DZFZ>[/['.3J'I:.39>Q-T;AQTM0E.U5XSE<92R4:GQH6 M&N<$\`I*Y[]^/9_P!N@HYUYIVG M:25U!;F\MXB5!(.E2Y>@(I\'''''0P[C_E^?./:6&J=Q;G^)GR"Q&%H1`U97 MS]6[NGCI!43K30M)#1TLLIO(Z*=$9(O MK(W"2I68774Z/<\I^X>T,!%:;O92KI8,T-Q$014C\<3`@@U%:@BF.KZ/@)_/<[SZ M)S&%V!\I\MF^\^E'^QQD6Z*X15';'741K(X6RT6:4"3<-#3P>0RX^OU5C\&& ML+*(9)ZY"]]]UVRXM]JYA!FM?A\0YD`+$U9CEJ5I4FH`ZY+_`'N?[J/D/W`L M+KG3V%6/9-Y@#RR;=5A97KA6<+$:A;6&*@SFVMT8&MCR&)S.*J[M3U=)4Q_ZQ5XW`>-PT1RJ&4[M%4$`@_IS'(.#GK MYOZ^RV]`-E,A':8WJ/(_IGB.!Z M^K!U@JIUSL15554;-VK95`4#_?O4WT`]]0++_<&#_FFG^#KX->9&9N9-Q+&O M^-3\?^:C=+*H`T.?SI//_()]JT_M%'^KRZ(IL6\K#!T-_@Z^<3_-R55_F3_+ MS2H6_9=$QL`+L=E8JY-OS_C[YZ>[F?<7+%;&_^M[CE=49,R'3I\P: M$'UKY=9J7[D&./PQ(LA(<-E=`!)J#C.!GKZ)_P#)O^0K_(SX#]-YW)9'^([N MZZQ\O3>]'DJC5U;9CKM4QF+KJV:0L[2UF(?&5DC.QN\C6)^OOH9[5[Z-_P"1 MK&Y8EI(U,SK^RWWI^:-B@0)8;G/^]+/2*+X%]6 M5E7R"QS>+$%&%"4`'#JTCW(?6'G7O?NO=>]^Z]TWY`>F(Z"X$@U:7*,JW%R+ M?[S[>A4,2":'RZ9FD$*^.RU$8+#_`$W`#\ZG'RZ^=[_.*^18^1WSS[?RF/JH M:K:G5M:O2^SVIYC+32T&PJN>FW#DH2?^5O-2Y&;6ET9/&0Q^IP!]Y^9(^9.= MYO`Q%:#P%%:@E22S4X`DD_LX]?7E_=E>RS>S7W6MC3<4IN?,$9W:Z)30P^K( M-O&V-58[98@03ABV!6G5658`:*MN`;4DY%P#8V`N+_X$CW%,>)HZ8[AUGOO. M=NF!S^G)_P!6VZ^J7T<`.F>I+`#_`(QAU^.`!P-I4=AQ[Z?;6`-MM:8K"A_/ M2O7P>^Z`58`@@];Y.X(/M#S3 M_P`JSN!\Q;3$?(^&V1T/?N_*K>_/)*,*@[_LX(.00=QM@01Y@C!'GU\O",)9 M;Z0+*!Q]23I4`#_?#WS+4BO<"W'K[BY)$A[F!TJHX>7<17'D!_+I34^S]V5D M,=11[6W)64TR+)!54>"R=125,+C5'/35"1:71AZD=38BQ'!]F$6U;JR"XBM) M='\0C9AGA^$CH*_URYX1,Z5!B^KMEH>!U*7#`KZ$C[.L_]Q-Z_\\9N MS_T'O_/&;L_] M!W*_]>_?OW=NW_*-+_S@/_0'7OZX;)_O^#_LLMO^MO7O[B;U_P">,W9_Z#N5 M_P"O?OW[NW;_`)1I?^%':RLS8`$!%?S"5ZT><-A_P!$N;=5\R;RWH/F:2U_9UM* M?\)F<1D<'N'Y?19?#Y'#RU-#T>:8Y7%U>.:H\=5NA9HZ8UB)J9=2%PA-@REA MZA[R@^[A97$$.Y+>02(X*D%@P``!\B!Z]<#?[ZK<]NW2[]OYN7[F*XC"[H)3 M%(DH^*T[682,:BA('EFGGUMK-^D_ZQ]Y--\)^SKA6WPGK4<_X4](ARWPPD*J M9/L.^(S(0-93[G:+:"WUM?FWO%3[R+-XFSI4Z3',2*X)_3S3A7KOS_<@1H;3 MW)F*C6DNP*K4&I0XW/6`>(#:1J`PU!6M!UJN8K)9+#93&YG#9"KP^9Q-?1Y/ M$Y?'3R4F0Q>3H*A:N@R-#5PV>*:"5$EBD0W5E##D>\8K:>:SN$NK4E9(V5E( MXAE(*T_,#KO5OFU;9OFRWFS;S"MQ:7<,L,T;*&62*1&21""""&0D$$'CU]#O M^5?\[*+YQ?&K;NY\UD*)^Z>OI*;97=6#A`J.AOMQSO:<\SW+5*>!(:O;N1@RV^8V&30(Y^+JTWV/>L1^O>_=> MZ][]U[K3._X4TJ/].OQ6:PU'I[?]VL+G_?ZTGU/O$_[S``O]K`P"LG^%>OH3 M_N0<\M\^L5>S/V_/K(/^^,5?^!&+T%5W[:@#3(#)=5`/D#3(X'S MZWP4_0G_``5?]Z]YP+\(Z^6IL,0.N7O?6NO>_=>Z][]U[KWOW7NO>_=>Z][] MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO M>_=>Z][]U[K_U=_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T1G^ M8]\A*SXL_#CO+NS$5=/2[HV]LV7#;$-2(G1=^[PKX-J;5JQ32R1>;[6IK%K7 MB5[E(&LK?I(0Y]YF'*G*5YNHKJTZ$H:'6U0*$$$'S'V=9"?=0]G5]^/O$\J^ MVERC26M[>1R76D5T6EJ3@K%$4U>6NGGU\V*)9Y MJW(9?,96M!8NUF>2:HGEN6-V=R2>2![YTH]QN>X!927EN'(+$U+-(:`DGSKY M_/K[-PMAR?R_,DR):[=MJ.26PB6D*>(2H%`H055`!157%!CKZ!'\M'^5QTY\ M-NL]M9K_^Q,U20;CEP>8K':LFVQL!\E#HQU!0-I@\M-& ML]3(AEFE9/$B=`/;[VUVGDK8XXI8XY[N3,DI12P-!VJ34A230C(92XB!9(PH)+6 M[JBZB=(^@%["]OZ7]R,**H1<`>0P.L'5'ZC/Z]<9%'`MP0P(`%CQQ?W5E1U* MR4I\^G"S5"@'/G_#\^J6?YF?\IGIWY==<[GWOU_M7!=>_)?;^,J\KL_=^V<1 M38F#?=7C89:F+96^\90""GJ4R1TPQ91Q]S33>)O*T"O!)%_N![6[3SCM$J0J MD5W&"\4BJH9F"GL,R>-J_'4TSJUI()X)4(OPTKNRZUZIJBHJ=Y["E3'ME*\2.S"HR>.DQ^5FU`$ MO4-8:-#-T#]KN9OZT\E6UY(VJ:"D4A)JS,H^(FE<\Y`7XAUB M0_P_F/\`CPZT6/\`A1C_`-O`\-_XKIUG_P"]1N7WA=]X0`\XI7RMO\HZ^G7^ MYD57^[/O`8`C]_S\?^>.SZ'C_A,LB'Y%?))RBEQTQMY0Y4%@O]](/2&^MO\` M#V:_=O`;?-S+"NF"*E?*KFM/2OG3CU'G]]0J_P"M)RE+3N.^W2D^9463$+7C MI!-0.`/#KP>&SU$)HJA*+-XRBRE&M1&W[1&G",T!^[GM1M$VT3\S;&JVUS`A<)$HC#]P!!"#B%)(-!4X/78/^[L_ MO`?1H:J2CGAR.&KDK84^YA-Q'-H M,$R\J\;NK!E8@X?;5N5WM6YPW\!*/;N'JITMVG.10Y''UK3KZ(?<#D?8?1]WC66RW.RGLW615<$3H55J,""R$AD:E58!E(8`]?3VZ#[4Q7>G2_4_OAY]P>2MQ]N^?]Z]OMS/ZNS7L]FS5KJ>VGD5C6IPVG MA4XQY=9OD-_S(#O+_P`0]V9_[Q=;[9WC_DD77_-&7_CC=*O;O_IX&Q?]+"R_ M[28NOEBT_P#P%I/^H:/_`**]\OV)#RD?Q=?=5:`&WB!_H?\`5D=?2O\`Y:<< MQS0=8ST'7K# M^@_VWOU!UZ@Z]8?T'^V]^H.O4'7K#^@_VWOU!UZ@ZQF"!FUM#$S@$!S&A:Q- MR-1%_KS[VGZ51%VZLFF*GU-./7M*ZE>G^*GIZGMS?%34[(Z7PDW[L@%2Q^SK*[[E_W9=W^]%[ MTV7)(8Q;58_XWN]P*T6U1AIAC/`2SDB-0/Z3?A(Z^>SF,KO_`+OKUCL/;WVA]NOI1:V^TYNWZY<7F:#8>2BJLEUG MUK%)1)5G%5>'ETP9_*PSLRU%56QR42%%2G@8`SR9B^W?LKM&PP1[EOH2\NI$ M#,DB*\<;%Q%Y)RYRS'))$\@=D MO=QB$C@3"=:26J2+I*1PLK!20[D'2NQ+@\/B\%A\?AL/CL=BL7CZ6*EH\=BJ M&#'8ZE@C'IAI*&F`CC0?A%%A[F^&W@M5$=M&L2C`5%"J!Z`*``/D!URMN99+ MF=YIV=W=BS-(YD=B34EY&)9V)R68DL*X1T"'-/(FQSNDU5:%[9CX:X) M(G31*I9M+BIZT`?F=\2.R?A5WUNOI/L:*.5Z`G,[)W-1E/X7OO8-=734^WMU M4`B)$3RB%XJRD8ZZ>ICFB.I45WP0Y]Y/O.2=]FVMZR6ZD>%(:=RD`U!\B"2# M2E".OK2^ZI]Y;D?[S_MA9<[=Y3C5+K;FAMMW5$`,T#!8X+J4K0NT(T0$N&(C,0!"Q@=; MD-.YDB#G\L_]H,+!R`01?Z_4>\KF"@Z5-0,?LZ^>]7\0:_(Y%/-?PG\Q0]5Y M?S9?^W='RX_\1/7_`/NUI/<>^Z'_`$[[>O\`F@?^?>LNON%?^)D>W?\`TMXO M^K4W7S>I_P#,3_\`+)_]Z/OGQ;?[FVO^F3_CW7V67O\`N)+_`,TW_P"K9Z^K M!UE_S+O8O_AF[4_]YZF]]0++_<"#_FFG^#KX,^8O^5DW+_GJG_ZN-TLJC_-O M_P`%/_0I]JD_M%_U>G1'/_N-+_I&_P`'7SB?YNG_`&\G^7?_`(DJB_\`>*Q7 MOGI[M_\`3QMT_P":B_\`'%Z^Q;^[;_\`$*N1O^>:X_[3;GHM,/1M?4?%QODE M1//-C\3WQ+TON&!5>2''OF-@P[SVSD&TBR>;[;*4Y:2X+^)1I)P*5^(Y%:7R_\)N/D-+M_MCNCXRY/)&'']@[*JR`AJ`X7 M54$D<:9X`CDW_?4^SOU')G*?O+LJ5;;YSM%ZX523:W'Z\,KRCN_2EB>)*DT, MY5=-2&W)X1S(=1()4"[%OH/J/Z>\LE!5`K<03_AZ^?$Z14#C4D_(^G[!P^?6 M?WOK77O?NO=$U_F`?(&'XN_$3O+NP5*TV:VKL7+T6RR6(:;L'="KM?8L$:!E MU'^)UE.[#ZZ%8K[NYIX49IY'4<+0^M2.IO^[;[47WO?[Y\ ML^V5I&'BW&]B-R2*A+2`^-=.<&@6!'.<$T'GU\Z'J?JS=/>&1[4R,-155B]; M=0=E]Y;US=6YJYFH-H4/F\M;/4"0N]=E:ZC@9F-R9F?5JY//G9]GN>8(-PN2 M36V1KEVXD@G30GCER*G[>OL%]RO<+EWV>7E?;U0(W,F[;9LMH@;1&ID[-,:B M@4);QNZHN&*@4/0%5HM15P))/V<_ZK`DBU[@>PS%_;)\G'^7J8KQ73;KCQ6J MTB2.!6M!X(!`^0/IBIZ^J5T?_P`R:ZE_\1CL#_WDJ/WU"VS_`))MI_S13_CJ M]?"3S?\`\KEO'_/;<_\`5U^D5\N_^R4?DW_XKYW1_P"^WR?M!S5_RK&X_P#/ M--_U;;H?_=\_Z?WR1_TO]F_[N5MU\N]20O''[4G_`$(3[YDU*T*FAK_FZ^XB M7+4/`K_E;KZ:O\OH`_!GX@&PN?C9TPQ-ARS;`H2S'_$_D_GWTKY.CC7E?;F5 M0"T"5(`J>P/O#Y]_>=%.0N\[B!\A]7,*#TQC[.CA6']!_MO8HH.H>H M.O6']!_MO?J#KU!UZP_H/]M[]0=>H.O6']!_MA[]0=>H/3KAX8=2OXH]:&ZM MH74I(L2K6N/]A[K'%'#7P5":N-`!7[:<>JO%'(RM(H8IE20"5)XE:\*_+KDW MZ6_UC[LWPG[.MM\)ZU'O^%/7_%S^&'_4%WQ_UOVC[Q1^\C_;[-_S3F_ZQ]=_ M/[C_`#M_N6/^',<8JP8X`/7? M*:Y@A98)#E\#/KY*<+D,3(5)$B/!PE3(0/_`&SYZFY%YA\85:VG94F6N"FK MXM)QJ6I(-*\?7K#/[\?W5-O^]-[,7/*40CBW;;E>[VV;0/%6Y1&(B$@[UCN, M1NJD`DAC4J.OHY[!W]M?LS:&WM^;'S%+N+:6[<-C-Q;:SU!,DU!FL+EZ5:N@ MR%')&Q!1XV%QP5:ZD!E('0.&\M[RS6^L6$D;@%2#4$'S!^P]?'?OVR;URMOM MWROS#`]MN&WR-%-$ZE'21&*NKJ:$,K`@_P`L=+CVIZ+^O>_=>ZTS_P#A33_S M/3XJ_P#B'M_?^]K2>\4/O,_\E#:O]+)_A7KZ$_[D#_E6>??^>NS_`..S=%O_ M`.$\?_9?\W_B".R__=GA?8-^[[_T\,_\\\WU^$?9U\M3?$?MZY>[=5Z][]U[KWOW7NO>_=>Z][]U[KW MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=> MZ][]U[KWOW7NO__6W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5 M//\`/:VAF]W_`,MON88&E^]GVKE^NMZ92!8ZF69-OX/?E!%F*RG2FCD-Z>.H M^XD+:56&.5V950^XG]Z]O:^]O;LCA$4?_>37]IX?GUGW_=C^T=WO04M2 ME)/6Q;8SU/G9:"GGD5ECDG%.(TE8$*3<@^\%]ENCMVXVNZR#5'!,C,*5K0@@ M9^0-.OJN]T>5KSG7D3>^2K29(VW7;;VS5GKJ$]S$R1$\04%6U#C@`8KU]1/I M[M#8_=G76T.VNNLI3YS9O8.W<1NC;^5@EAF%1C\M2BL2"8PNX2>F=Y*>IA+7 MBF22)@'1A[Z:6&X6>ZVD6XV,@=)D1@1PH14?[/7PZ\W\E;][??=@%H:XH,'A2N,=,B%%)90`*&HI\51P M^>>M4WY)_P#">OLSNKY1]N=K;0[MZJV)UAVCV;G-]PX6IVQNG(;LVU2;IJ_X MUG*2GQN-2DQLK)6359IHA4Q`QF,/-K!8XR\S^P%UOG,TV[[?=I!#.QI")!$=,7=)% M263R+;Q(`/K[E?VVY&GY#V:?;+B<3&276-((%- M-,@BM<<:\/+K!7[Z7WJK#[VWN'MG/UKRY)R_):6`M)%>\6Z\0+,\JY6VMR*& M60@$-0LU#W'JSJ;]'_(0]R&OQ#K#I_A_,?\`'AUHL?\`"C'_`+>!X;_Q73K/ M_P!ZCS7[MW_`"7-T_YH0_\`'SU'O]]1_P!.AY2_Z7]W_P!H+=;F M7O+KKYS>O>_=>ZZ(#"Q`(_H1<<&X]^ZT5#"C"HZ1?8N-Q64V!OC&YBDHZO$9 M':&Y:#+4M8H%)4XNMP\U/D:>J(*6C>)G5_4.">1[1;E%%/8S)<*'4HP(85%* M=&VPS7EMS!8WFW$BYCN(&B8"K!Q*A73YU!I0>OEU\J(A8W"Q_M*GH0`E!&`2 MJ*&)O8"P'/TL.2.>8>X`)>W"1?#K88\P&/\`+Y=?=WM-6VR/ZK^&W-#3CX:X M]./^JO7T7OY/\\M1_+:^(LDLLLY3K_(TZ22R22N(:;>V6I*>%7D).B.)$2-? MHJ*JK90/?0?VP=WY$V=Y&)9H#4DY-*TK7C2E!Z=?'?\`?\MK*'[XW/D=FJHB M[F2%0`+J:UA9S04%69F8GS))-2>CI_(;_F0'>7_B'NS/_>+K?8PWC_DD77_- M&7_CC=8X>W?_`$\#8O\`I867_:3%U\L6G_X"TG_4-'_T5[Y?O\4O^FZ^ZNS_ M`+"+[8_^K(Z^EC_+6_[("^&?_BOG6G_O-0^^C7MI_P!._P!I_P">>/\`P'KX MOOOK?^)?>XG_`$OMT_[26Z/5[''6,G7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UH M,?SZ/D3D.Y/G5N;KNBR51-LSX\8:@ZZQ%`'_`,C&[,C31;CW[E8$%OW'J9Z? M'R-SQ1+S;@8-^^_,+[ISHVV1NQALU"A*G2LA%68#X03C(Z^I?^Z1]E;3V]^[ M-;\ZWL"+NG-=S+>NY4>(;.-V@MEJ>XQZ5:9?+5*?D>AW_P"$\7Q4Q_:G?V^_ MDKNBCIJ[$?'G'8S';+IJVCG\$_9N_J2I@H\C^UFV^R'* M\["[YJD=[PK(04M+1HS%$P!U>'=W+QJ_X9(X)D-5+#K=HIHECIX8]"+IBC4J MH&D$*!86'O,$2B7]9.#9_;GKYPC'$BB&-0$7"J!0`#``'``#@.I```L!8#Z` M>_=>``%!@=>]^ZWUB,$+,6:*,L18L44L1];$^]ZFTZ:X/EU3PT\0RT&HKIK3 M.GCIKQI7RX=4F?SF/Y=.[/G3UQUYDNF\?MU^[NL]WPT.(J<_EZ?;F.KNOMV: M*?=>(KLK+')J%)4)1Y2&/1JM'.L6IY/&\1^[/MWN?/&UPQ;5X2/$VH%A1B"> MZK`$TP*#U'SKUT)_N[/O=[7]U#W-W-^>1=R\M;M9DRQVT2R&.XB/Z#HA9*M3 MQ$8EE-'%3I7%:OQ+_P"$]O?W6O9'7/<78OR7V5L#<'76\L%N_$XOJ;"9[>&4 M-?MS*O7)356?W$<-!%#-XX4G5*24/!)-$UB=1`?*7L)N6QW]IO-S?E+FW;65 MBP!1C10UR:;AC2.G`CMXV>610-5@))"]AKYMSQ[R8(IB@!'& MGKYU]37B>)/'KAA%;?2)X`K12:`MJT@FH4'R5>"C@H``P.J]OYLO_;NCYZ^RR]_W$E_YIO_`-6SU]6#K+_F7>Q?_#-V MI_[SU-[Z@67^X$'_`#33_!U\&?,7_*R;E_SU3_\`5QNEE4?YM_\`@I_Z%/M4 MG]HO^KTZ(Y_]QI?](W^#KYQ/\W3_`+>3_+O_`,251?\`O%8KWST]V_\`IXVZ M?\U%_P".+U]BW]VW_P"(5<;24]%L;?V%KMS1IJAD MDV9ER<%O6B=6**6DQ-75V1V`#:22AN1#7)&]2\JT^V^_WW?N9O;VV"R#=-ND:S+=RK=*/JK21.-#XT:`,*D! MFH"#0_39V]E,?F<929'&5E-7T%?24F1HJVCFCJ:2MH*^'[BAKJ:HB++)'-$5 MD1U)!4@CCWT@#B=_J8R3'(JE?V$X\O,=?%2D-Y;A[7<8S%GSW;JW46J4LJ@-(#=O\`-R&,GT'ZD?7_`(K[V*Z33Y?X1TW( M,"3-4(8`&FHC\)]0:G'R'6J)_P`*3_D8:?"]#_%K"Y:H\F4JLMW'OZA@KM2' M'X]9-K;#H;+J9XV#)L?8%*)<[5T@+% M62MS[ MT/,O]XK[0>Q5G*9;3EO\/^>VY_ZNOTBOEW_V2C\F M_P#Q7SNC_P!]OD_:#FK_`)5C_=>Z M][]U[KWOW7NO>_=>ZXM^EO\`6/O3?"?LZJWPGK4>_P"%/7_%S^&'_4%WQ_UO MVC[Q1^\E_:[-_P`TI_\`K'UW\_N/\;?[ED_[_P"7O\&Z=5#?RB.F=B_(CYEX MOI#LK%IE-E=D]0]X[;S"6_RFC^XZ\JI:++XR2X,570U"0UE).I#)-$AOQ[C+ MV=VFTWWFZ3:;Y%DCGMITHP#:2R@!UKP93E3Q!`(ZSI_O*?<3FKVE^[K_`%^Y M.F>WW"PWO:9HI$=E)$=T',3Z2"T,P!BEC)TO&[(V":E7^67QE[`^(7?V_>A. MQH2V;V?7BHPV9CIFIL?O/9>4=I]K[RPZ/:\%=3J6=%8B&H2HI=1>!@`QSCRG M=\HM@7^0!_,+&$RT7P7[6W"8<1FJRLR_QVS&3K3"E M!G:EGR6X^JO/.]@E:3/7X:(&WF%13QJ#)"ON>_8+G\%GY*WAR%DJUNQ)X_[[ M7TJ`"H''(\\\=O[V3[HD$6G[TGM[9LC,X@WVVC334#L3<-(I6K42:0^11R:: MCUM_^\J.N$_7O?NO=:9__"FG_F>GQ5_\0]O[_P![6D]XH?>9_P"2AM7^ED_P MKU]"?]R!_P`JSS[_`,]=G_QV;HM__">/_LO^;_Q!'9?_`+L\+[!OW??^GAG_ M`)XY?^?.LA/[XS_Q$-O^E_M/_'+KK>^3]"?\%7_>O>;Z_"/LZ^6IOB/V]]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7_]??X]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW10OGQNWO/8WP\[\W3\9\]L+;'?.+V1) M_HOS?9>?VGM;:-'N:NRE-CH%GSV_63!4]?-'-+!AFS1^P.1>D6K#4[2*?=>Z MU>?D!_,$^7'0OQO^:.W\?\C?G%UAWKL_K[XF]C[&ZK^^]AQ9;Y/X M3I3N#??5O=75..DV/O;9F8CJUHZBF&+,M!65`:CJWA=DI_=/QJ#0D?ZOGT9/ MMWYH?)K=VPOGW\RH/E1\E>EMK_%'Y;=A_%?J_IGXT=#=7_(38?6&W^@,(N;W M#W7\N-H[RH*;-97';C=:RHR,M#N7&Q4-!48R.E=:ERWO75M"X%!_J].H/8?\ MTKY-["^2WS?W+E^Q7A^&6<^+'1.&ZHW,^"PN*JOC5\I.^/A@W=W1^[G26FJJ MF+#;QR\&1PLD>5JJR"CS+8F*1XXJDF3?6@@('K_DKT'O\PG^:K\C.E?C)_+% MH>M_E+LGJWO#.?"W9_SZ^0>>[+J]BX2M[^P^P>K-O5D706)AW#3&D_C79.:K M(WYL7K;8E?7;,JIGP^JX"DD"H/6/?_P`TOF+4?`7KKL39/;F\JKM_<'\\/<7Q9ERV`Q.U M,CN"OZ3B^<6Z.L*'JZ+&&@E@DIUV_2T6/B?P?>&%(Y?.TQ,C>ZT5773Y5Z*7 ME?G-\\J#Y`[HS6R_D5\S):__`(=SW+\4=JX3?W0/5%5_+8BZ>KOE=+U3CMA[ MA[RH-N_WE3-1X1UHX%@RC5:Y`Q11EGLX]U?2M>`X?GT:7H[M+YX][_-[OW'O MV5_,]K.H=A?S'NV.F,5G>E<5\"!\1]E=8=>]ET\$&V-]'L>@7L5Z6EHW-)G) M<;#/4?:NK474C-_*WYW]V=4])?(;8&[^_,ET]\AOD M'\P]W[RZ<^(V4^/%1\PNO>B.DMT)TITCMWI_8_>%%+'N'&451@Z[<78:X..L MRLN0R<45+.*-HJ;W[K>E`:'R_9TJ^D/D[OKNG%_`?KWL[N[='R=ZZ^5N]_FG M_+R^36V^S.H)>@]]P[GZSV-G.Q]F[F[*ZMF,\."W_MRCV]D=M;I_A$RT64_B M,-=%#`]-$D2/<;.TW7;Y=HO8EDCG!J6%>`I3[#7^71YRSS+OW)O,FW\U\L2F MUOMIN8KVWGC)62.>!@\9#`UT`@ZAP)H.!ZUE/G-\3L]\(ODIN?X][CW)AMS2 MT&)QV]-F9O&2,E3G^N-QU552[0-YY(W"6W*F2R=M2,`=)`P-0X!E!I_/SIU]?'W._O<>WOWJ?;FTYHL)TM=Y MATP7EG,R^(MRB][P5(,D+DEHV&:$JPJ*=3/B]\_/EE\.ZF%>BNX=P[>VS'EQ MF:_KC+&+T?*_N+S9RJ!^[;E MFAQ6)CJC`%30*3V@U-=-#T?_`'@?N:_=]^\/+)<\];#;KN;H0VYVY^FOE[0L M9,J+6X"!3I2;6JTPIJ>CPYC^>M\WLET#\E=@8_L3+X+N_N?M[#[RZD[IHZ7: M]9C?C1UQ4Y3&U.[.L-E[+KL>XR5/%3TE=#AJO*U4]2OWC?=3RF*-Q.>S?>51 ME\+F"P"E::6A\ZUKJ!R:8IGUZY/^X?\`'*S"F MG15['Z@_E^4WNX2%N53O%E0D7%E>+,H M`!-?#U1R'Y@P1C^$MD="SBOYHOR#Q?\`*5WSOO/_`"SQ&#[;[E^=&9^('Q*^ M1'>-+L#KKM'K'J7+=B4^.A[;^3FU,70P;=HN6-T?:-^M;BVN(S26-[=U:*N M.)%:4K1C0'YT-%%7_P`ROYK=M_`7^5SV=\5.R]N]D_*//?+S>7Q[[QQU%+LB MNVC\G\U\=^K=]9S>NSERD=.^-I8-^TVVJ+*8;(XR2F2*?(T4\4XIO6ZX,2HT MFJCSZ*?`5'.@,8B`0S-^61Y5(-#_`$2*=([OOYM?(GY"?'K^;7\V?BS\\^[^ ML^N?B%'UGV%\>]B[,VGU`-N5^*WA\5]E;TSO7G9-!O[:V0S$$V+W++FH\A3Q MU=-5T]9+5TTCE885CU05)]>MD#6-0!)\^EGW-O\`_F`;+W?_`"^NG=D?*+^8 MGW]6=Y?#OM[Y.=E5/QPP'PDB[PK<]-GNO?X%'51]RX/#;5AVM@!N"LH(Q`!D M6:KI@[U-G=+I3Q%KPKFO#JA"E3BE&'_'A_*G'Y5ZJC_F]X_?.,[OZ&@[.S7= M.X.P*CXC=5Y3=-=\BH>KZ;O"FRN9WMNS*O@NRH.E8HMJ+DL:DJT+G"!J9HXH MR'E8_LU=?3=_SOAOE]E=/4F[*O?\`UYM[JWK>U'* M1K@;]=_]H)K4?Y?7K:?_`):7RY^0?RM^,/PQ[9WYU;CL]CNXNCMZ[C[:[UV] MNW;F"VUC>Q=B;S79.W(L3UA+&N1J(-ZT\-=GZ>>@/V>.2,4[M()H&.7?7SI] M6D>_=>ZC59*T\C*Q0C0=0U<>L7_20;?UY]^\5(?U)/A''_!U5U5UTN&(]$)# MZW/FV\M;%-8V-T#>72, MJA35HZX+^J8K3YG`IUT(_N\ONC#]WMOYPW+;WM^4]EN8[BZN;D.D=WX- M7CMK9".Z1I54R,AHD:L7()53HJ;6VQGMY;CVSLW:6+JCCU MU>3S>9K4Q6(H*9.;L\TD:!F-N1J/U]X+V-A<;SN<=C:"LD\@4#YL:9_;U]6W M-?,G+O(?)]_S)S+,MOM^V6\D\TQ-%5($U%B?D%H./IGKZ>WQFZFI>A?C]TGT MI2U"U,?5W76S=E25A>%GKZ[!8.&CR==^P`MYZE99+CZWO?[SW/]TN8/<:_!$F\[C=7;`UJBW$CF)<^ M@(0>5`*`"@Z4'R&_YD!WE_XA[LS_`-XNM]ZWC_DD77_-&7_CC=)/;O\`Z>!L M7_2PLO\`M)BZ^6-3`FFHPHNQIX@`2`"3<`$MQ_M_?+Z0@&4GAJZ^ZBV8I:QL M!J(T&GK2#A^?6ZC\*_YS_P``NEOB9\;NJ.Q.T]X8;?/7'4&R=J;JQ5)U3V-F M:.BSV'P\=%7TD&5QN/DIZA$9"!+!(R-]0WU`S?Y,]V.0=EY2VW9[FX(DC@53 M5'JI49J:>M:?+'7S"?><_N__`+V'N1]XOG7GSD[EE[C;]TWB^G@D-S:@/%<. M)8V"O.C`:?4#N)&#Q-1_P_S_`"S/^?O;V_\`1+]I?_6WV??Z\WMS_P`IQ_WF M3_-U"?\`R;+^^I_TR1_[*K/_`+:.O?\`#_/\LS_G[V]O_1+]I?\`UM]^_P!> M;VY_Y3C_`+S)_FZ]_P`FR_OJ?],D?^RJS_[:.O?\/\_RS/\`G[V]O_1+]I?_ M`%M]^_UYO;G_`)3C_O,G^;KW_)LO[ZG_`$R1_P"RJS_[:.O?\/\`/\LW_G[V M]O\`T2_:7_UM]^_UYO;G_E./^\R?]`]>_P"39?WU/^F2/_959_\`;1U9CT+W MGL#Y)=5;2[KZKS%?F>O=^4577[:R=?B\E@:VII:+*U&%J6J,/E$CG@9:BFE4 M+)&K6`)'(]R/MFZ6N][5:[KMYK%-1@?XA4CSH:'T/6&W/_(/.7M;SGN?MUSY M"MMN.VD+,BE2T;E5;260E20&&5)%>!Z%^:JBIX6EGF=(XXWD=EU,0B)K8V7D MD#Z`L!LC^7UM_=E5CGHZSM?LOLC>K3S14(>LQU%D(-@ MXMX9J?\`=>#1A2\:SL61VDL%4B^97L/9)8^WPF1:27$K.QH,@$Z9_OC[AMJD>%L.VV-CI!)7Q0AO"Q'`.!=%KTT%E47O90+ M_P!>/]^Z]UC:*-BQ9%): MVHD"YM_7WJ@K7SZJ45JAA74*'YCT/72PPK^F-!_R"/>Q@DCSZWI%*4Q4'\P` M`?R``'V=+_JU M-U\WJ?\`S$__`"R?_>C[Y\6W^YMK_ID_X]U]EE[_`+B2_P#--_\`JV>OJP=9 M?\R[V+_X9NU/_>>IO?4"R_W`@_YII_@Z^#/F+_E9-R_YZI_^KC=+*H_S;_\` M!3_T*?:I/[1?]7IT1S_[C2_Z1O\`!U\XG^;I_P!O)_EW_P")*HO_`'BL5[YZ M>[?_`$\;=/\`FHO_`!Q>OL6_NV__`!"KD;_GFN/^TVYZV$?^$T(O\;OD@2BN M/]->'NK`$,/[@TUTL?KJ%UM_0GW/7W;%4\O[DI'Q7*@_,>$N#\N/7)C^^[>2 M/WBY.>(T?]R3:*&A+_7R$`'UJ,=:WO\`,E^/;_&+YL]]=4P4*T6VO[YU>]MD M1Q0>&D?8_89_O=@(*5/TF.C2J;&G0;!Z9EX8'WCY[I["VP<[W]D@T1L_BQXH M`K9P/*A)ZZX?<8]V8_>W[JW+7-NHO>P6\6WWJL?@N=O'@2ODX:5566M:]XKZ MG=&_DH_(+_9@?@)U7-D:\5V[>HQ5=);M>25Y:N2;82)#M>MJ&FNY\^"GQ;!K ME2P<"Q#*N8_M'S(.8N1;-I'+S6P,4A8DFJ_#D_T:=?-[_>&>S\GL_P#>NYFM M+>$1;?OLB[Q::5"JRWU7F*T[>VX66/'D@]03;1[DOK";IKRDD$,:3U$RT\>6014\4:J#))4.2+*%O_MJ&?*T.\^Q*'KCJ:B>..!9]LX M2>+8.Q*2D"@>JN:-:P*S'2U43<6XYW\[[M-SISM<7,+,WB3"*.I)(1310/E\ ML?EGK[$ONE^V>W_==^ZEL^S)86R6XTPZUFZ\S4!0-< ME;DI:JKDEL"S2&XX]Y='[OWN3N M?O%_>.;![G;JSN^Z\U0/$TE2X@$I$2:CQ6.(1QKY40]?/HJ_^`5;_P!04W^] M#W@+%_:Q?Z8=?7;N?^X4_P#S1;_JV_7U3.C_`/F374O_`(C'8'_O)4?OJ%MG M_)-M/^:*?\=7KX0^;_\`EVY_ZNOTBOEW_`-DH_)O_`,5\[H_]]OD_ M:#FK_E6-Q_YYIO\`JVW0_P#N^?\`3^^2/^E_LW_=RMNOEX)\O M]W1][_FWWAYIYNY?Y7,MAN.Z7L\#?56@U12W$LD;`/.K@%6'%0?(]&&_X?Y_ MEF?\_>WM_P"B7[2_^MOLZ_UYO;G_`)3C_O,G^;J./^39?WU/^F2/_959_P#; M1U[_`(?Y_EF?\_>WM_Z)?M+_`.MOOW^O-[<_\IQ_WF3_`#=>_P"39?WU/^F2 M/_959_\`;1U[_A_G^69_S][>W_HE^TO_`*V^_?Z\WMS_`,IQ_P!YD_S=>_Y- ME_?4_P"F2/\`V56?_;1UT?Y^_P#+08%8NW-\/)8E47ICM!6<@7TJ7QP%S^!? MD\?7WIO>?V\45CO:MY`K)3\^WK8_NR_OI5`;E/2#BINK.@KC_E(/^#JT3I#N M?8_R#ZNV1W+UGD:W+;"[$PT.X=K9'(8ZMPU968N::2G66HQ.05)Z=]<3J8I4 M5A;D#W*5G=VFY6$6XV;!XI5#(PX$'@__`%OVC[Q0^\G_`&NS_P#-*?\`ZQ]=^_[D``[=[F`\/&Y>_P`&Z=5P M?R$0&_F6]2*?H=D=Q@_['KFM%[^P)[`9]P5)/^@2Y_WGK+W^]TQ]SN_53I!W M+;>&/]'/^#K9$_G3?R]_]G#Z&_TC=;8..7OWHS&97.;5CIXE%?OW9Q9:[<_7 M;%C9YV6+[_#W!85<7@4HE7*?>2/N_P`@CG#8_&L54W<`9U8`:G`6I0L,T>E. M'&GSZXF_W<_WLI/NX>[,>Q3N99(X=PUDDVMP&TV]XJDB@#LJ3&H!A)8 M@F-!UH?X3.9S:^;P^X-MYBNP>X,!EL?FL'F,9-)39'#9O$5:5V+R=%*HND]/ M,B2QM:ZL+$?4>\%TFW';-PC>IAN+<@J1VLI7(R,CA\NOJ_WC;N7^?^6Y]JOH M8=PVO>N68 M]T!T7,`T3QCR?U(\P:5!\OR/7QP_?,^[7NOW7/?6\Y#E$LFRWX^KV>[:NF2! MS7P)6X&2$GPW7S*AZ`2+U9O[&O6+76F?_P`*:?\`F>GQ5_\`$/;^_P#>UI/> M*'WF?^2AM7^ED_PKU]"?]R!_RK//O_/79_\`'9NBW_\`">/_`++_`)O_`!!' M9?\`[L\+[!OW??\`IX9_YXY?^?.LA/[XS_Q$-O\`I?[3_P`O>;Z_"/LZ^6IOB/V]]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7_T-_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=!UVWU1UY MWGUKO/J'MK9FWNP^M>PL'5[:WILK=5",C@-Q8*N`%3C\A2$J2I(5T=6#(ZJZ M,KJI'NO=$8'\I#X%R[%["Z[RW1M;NG;G:6%ZWVWO:?>WF^-UY#:O3^XJ/ M=G6>SL?OC=^Y:[,X[$8C(T--64N+QN1IZ3RQ@O"ZDJ?=;#,!0'K+WC_*4^`O MR/WQOSL;N+X^T6YMV]HTF'I.S9<9V/V]LG;_`&5_=[!_WE_E/YG+9G\OOXB;$W%D]WX7X^]?5FYZ9V_+ MMGK?8M#0;ZGR5/34=#1RO#*:>)):LDRUDL\OK]^Z]J;UZP=8_P`O/XH=/[B^ M/&[>O^JHL+N/XI=?[^ZM^/V3J-[=D9RHZVZ][.G%1O+:6+_O#F*N.II)BJ14 MHR,=2U)"D<-(T$2!![KVHGCTBT%2N] M>R9-ATO<]=$R5/:5+U"^9_NE#G#*\E4F2BPBSQU+?=1LM0`P]3K>MCBO0E5O MP0^,5?L&LZSFZMCBV;7?).7Y?38VEWKORCJX_D:_8Z]M+V31YBER2UD%0NX1 M_$DI(J@4:N!&M,(?VO?NO:FK6O0,5'\HGX$5G4[6J=R+NZJW75[-P>Z:;",TM?&DLU)_#132*/$\+0DH?=>UL,5 MZ3&ROY3O0E)MW)[+[4IG[)VML_Y)]Q?(3XN5N&R>^.HNR_B_#WQD6W1V)USL M/M+JW.XW*+BGS%7EI*5:&2AC^PJ8Z&>FE6G1V]U[6_KTN-L?RYNJ]B]K?%G/ M;#QN&V7TO\/<7W%N'JCJ'#1YW(SY/OGO"G_@6Y^[-Z;QW+7U=9D*^CQ%1FZ6 MF-:U34U-1FJ^KJ:LO'"C>^77M;5)K\2E3\U)!(^PD#]G0A_+'^7O\/\`YI93 MK_+_`"1Z0PG8^=ZT7+)LC<0S>Z]I;BP-+F'CFR>)CSNR\AC:J:@J)8XYI:&I MDDIVD17,>H7]EV[[/L^_636&]QB:-N"L"1D4)QY\.A9R)[@<\>UV^P\S>W>Z M2;1?6]-#Q'2QIPIQ7'S4UKU29\BO^$U_6^=J:[-?&/NK.==UM9+5U5+L;M.@ M&]=HP%BTD>-H-R8=J;*TL0+JJ25:U[J$%]5R?`!^(>?KY==:_9[^^5]U^7HHMK]W]@@W^)`JF]MI!;72*H[C(A#13.YR#^ MD`0?7JE/N/\`DK?S%.F16U,G1_\`I0PE**V9\WT_N'$[U04M*TA65<%(:/,D M/'&9%48PD`A3ZR%]PYNWLIS_`+*&:&V2Z0FE4(8T%ZFM:\,\:$<.KKOY=W\P_P"/FT^XMKP?+_J#:T;57R%I M?D;AOD%LN?=&TH=C_(*JZVJ^G)>U-Z=5[=R$.WWBJ_P!X7W;YII+J$-(VQ2,&66$`LXLY&.KQE.425G+KVJRG!VN=M_R\OA)7]:?)GK MW:G2VTWZC^=F6K^P_D1C=M[MWFNVNWK4^/Y9/PO^2:]1GN7J&NW"_0VP9^K^J*O`]L=R[` MR6UMB5,6/2IV^N2Z]S^*J*J&3^%T(Y+R&DBD>1Z8+$#\U_P"/ M#K4"_GC],]=?'KY8=<]-]3XG(X'K_8_QKZ^H-M8;*[GW7O.OH*.NWUNO,3Q5 M&Z=[5V1RE9>HJ9G5JRLE=0VA66-$485_>'8KSE$`?B@S^;&OY=?3M_JJ5:V%Z:6LSD%),K15U%B=P9?"469I9D,-3C<[ M3XF:$5E+(C,LM-4ZXI%)5T921[B;EOFW?^4[B2YV*3+CH].WOYC' MS+V=GNK=P;-[LK]GU7276V9Z?ZJQNT]H;!PFT]F=:9UL6U;M3&[*H<7%B)(4 M_@N.6EFJ:"6>F2+1!+$LDJN,S[V^XY-1=?M5*?L"TZQ?3^Z^^YHJ&(\J8)K7 M]XW6H?(-XVH#U`(!],GH8S_.?_F;V/\`SE=N8?X_Z/\`J'_B,#[VOO;[AU_6 MN@%\Z(E?^.^O5A_=>?AQ[Z[742B7R!;A7%R"67?NUSS>./$W M.>-//PRJG_C('0WY2_N[_NB\H@FWY(LKMM:N'OO%NBI7AI$TCT%0.T4!.2": M=$-9\WN7-7EDRFXMR[DR%[,:W-[AW!EJQRFH<2U-952L`/J\CL1]2?8+87V[ MWGC1B6[FE;B:L68GSI4D\3UE/3EGE';P)HK?9[&P0E2KQV]ND:+2NGL72JG\ MJ=;;?\EO^45O?JO>F$^6WREVI%@-TXNG2?IKJS*F*;-;7K:T5%'6[YWYCG@9 M:7()3LAPM(E498!+)/4I%,L4:Y6^S'M'+L]>9>:8P)^,$;4)0BO

/54RLPTRT"I M5"^K::6BI4976",,K!U8#D,!8,#_`*W'O)3Q)*4KY4_+TZXN%58LQ%2VFOST M92O^E/#H*/D-_P`R`[R_\0]V9_[Q=;[*MX_Y)%U_S1E_XXW0S]N_^G@;%_TL M++_M)BZ^6+3_`/`:C_'^3Q\WM_7\^^7[_%+_`*;K[J+0/8VM.0.>K^RBW&SV^:>)Q1&"U!!QC-:'AUBSOOWS_NK\K[ MO<T_P`-#TKO^&JOYBO_`'B3W#_Y MZJ/_`.JO:C_6J]P/^C)/^P?Y^J?\'K]SC_PHFR_\YY/^@.O?\-5?S%?^\2>X M?_/51_\`U5[]_K5>X'_1DG_8/\_7O^#T^YQ_X439?^<\G_0'7O\`AJK^8K_W MB3W#_P">JC_^JO?O]:KW`_Z,D_[!_GZ]_P`'I]SC_P`*)LO_`#GD_P"@.O?\ M-5?S%?\`O$GN'_SU4?\`]5>_?ZU7N!_T9)_V#_/U[_@]?N=G;-S&Q-^;5VUN/'[BVMGZ:.DS&)J*CL',9*"&N@B M9P"\$T4RV8W5U/U-O>;OMI8W>U%$*J?X:@T'1]QR]/"DUYT9KZ<,_Y>L:+=$:\AN&;PUC*!?(`EJ'[*CCU\I[,6_B M^4((/^Y&ML5MI(^Y;E;<6_I[Y>[J2VZ7).:S2_\`'VZ^]'DN.([L@1Z@[-:'/\B>K5D-T0_2Z MKQ_L/_=>Z][]U[KWOW7 MNJZ_YLO_`&[H^7'_`(B>O_\`=K2>X^]T/^G?;U_S0/\`S[UEQ]PK_P`3(]N_ M^EO%_P!6INOF]3_YB?\`Y9/_`+T??/BV_P!S;7_3)_Q[K[++W_<27_FF_P#U M;/7U8.LO^9=[%_\`#-VI_P"\]3>^H%E_N!!_S33_``=?!GS%_P`K)N7_`#U3 M_P#5QNEE4?YM_P#@I_Z%/M4G]HO^KTZ(Y_\`<:7_`$C?X.OG$_S=/^WD_P`N M_P#Q)5%_[Q6*]\]/=O\`Z>-NG_-1?^.+U]BW]VW_`.(5CDEF_!L\K#Y,+Z6A'S'0)_P#"E'XW""/H/Y287'%8X1D^EM^U<$55 M+$BR^7/%=O[2H]];4HWJ5B0;SZY)AS$-%%)Z3+5X6J MEED"V)2@6X.D%";[N7,,=OO-WR],>VY59(U)[0R*P?'JU5\\T^74H?WTWLZD MWMURQ[V;+;AI]FN%VR\"C/T=UW12,:_#!-&50'\5P:')KN?TK:GDN\C62&ZR M6LA*WXM^3^?>76EEC`:E:MGY5_P#RZ^=A%(D:C$A*1Y\RN2WVL&%?L'5;G\W M+Y(/\8?@MW%O3%U4]-O+>&+/4NP#2SK!4INKL>&3!G)1.2#_`+CL<6R]QY#')7; M,Z`PV1[9W!Y84J*-@-0O@((<#_1`#UN`_P`S2-(_Y>/S`"*Z`=$[T!5FU`G[(>HWN;G_`%_> M5_NHRR>W^\28++`RUIF@IC[*]?/Y]Q+5'][GVZMV%-&^68IY"DA_X_74>OFS MU?\`P"K?^H*;_>A[YU1?VL7^F'7V=;G_`+A3_P#-%O\`JV_7U3.C_P#F374O M_B,=@?\`O)4?OJ%MG_)-M/\`FBG_`!U>OA#YO_Y7+>/^>VY_ZNOTBOEW_P!D MH_)O_P`5\[H_]]OD_:#FK_E6-Q_YYIO^K;=#_P"[Y_T_ODC_`*7^S?\`=RMN MOEX("0MA&QVX-LY_&XR@DQF:P>6I4KL7DZ"5:H: MH9X722)M(N"#['D?MUSSN,4<]KMDT\94%2%P0<@@U\^L3-P^^W]TWES?+KEW M>^>MLLKNQEDBGAF9ET3(Q1U+!#W*P(('F*=*?_AJK^8K_P!XD]P_^>JC_P#J MKVY_K5>X'_1DG_8/\_5?^#T^YQ_X439?^<\G_0'7O^&JOYBO_>)/_?ZU7N!_T9)_V#_/U[_@]/NUO>C[5>X!'_)&G7YT&/Y],W'W]_N<1 MP-)_KB;-VBO;,[-C.`4H3Z`];SW\MCK_`'?UE\'?C'L+?FWLEL_>>T>N,=B- MU;7R].*7+X/,05M1+44&0IU+!']>MUU&VKZ^\[N1+&ZVWDK;]MW*,QSP1*K* M>((\C\Q@=?*U][_FWE;GS[T'/'.')U^FX6&X[IXL$\']G)'X<=/]KZ_.O1\6 M_2W^L?8F;X3]G6/#?">M1_\`X4\_\73X7_\`4'WO_P!;]H^\4/O)_P!KL_\` MS2G_`.L?7?S^X_\`^2?[E_\`-;E[_!NG5=BF@TC`Z^426)7+2'XV4+J\Z#*_L.1\^M'+^>I_+U'QS[ M<'R&&WOOR'<;3N@YIL5_Q>=@&(`[7\B0/)N/H#]HK]*?]U#][B?W-Y%D]A>?I MQ^_N6(U>SD=QKO-O+!0H)^.6VJ%>G<8F0T.EB"`?RWOG#N'X*?)';O9:R5U; MUEN9Z3:'=6UJ/4PS>Q*JJU-EZ6ECX?(X69OXCCSI+-::G%A4N0`/;'GV;D;F M%IY6+VMQ19EX@BN'IZK4T^1(\^LQ/OV?=1M?O1>RL_+&W1Q)ONW%[K;9V`#I M,!W0A^*QSJ-#"M`VAZ50=?1EV;O;:_86V<)O'9>W]_[VM)[Q7^\S_R4-J_TLG^%>OH&_N0/^59Y]_YZ[/_`([-T6__`(3Q M_P#9?\W_`(@CLO\`]V>%]@W[OO\`T\,_\\N7NW5>O>_=>Z][]U[KWOW7NO>_=> MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO MW7NO>_=>Z][]U[K_T=_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=8)=8( M*L0/R./H+L3_`,1[<730ZAU4=KM(QJ`O#Y^O23R^^=J[?9H\_N?;^!E6G:JD MCS>9QN*\=*@+&J;[Z1"([*UY+:?2W/I-F&NK*,_JRJGIJ8*3ZD`D5`]>ENV[ M3S!ND"/M]A/<%ZBL4,LJ@UP&,:,`3@@')&>D%L;Y"=(=HY>JP?6W<75?8V7H M:+^)UF+V#V'M+>&1H\8*A*0Y"II,!5U$D<'EECC\C*%U,!>]A[]%?;9='P;2 MYC=SY*ZD_L!/Y=&6^\F<]1*OI?BOGP_U<.B!@'+J3J`.D_:./#[>N7VT% ME!B0A%"K<7TJ!8`7][!(&D<.MT`4(.`X?+I&[VZWZ^[%Q4F!W_L?:>]\)412 M0S8G=NW<5N/'/&T;+8TF7BF06#-8@7%S8W/M/_;WRMN"[ERW>W%A=C"S6\TL3BA!^.-E-*@>?5*7RL_D)?#SN_%Y?+=-X2J M^-O8LR3S8S(;$>>OZ^FKG0M%!G.OLG+)!'3/)RSXG[21`UU#@:#$W,_LARMO M\+BS@CLK@DL)(]0U$C@RU*D5SC33KH=['_WIOWFO:'<+>UYRNGYKV9!'')#= M%#<+$&RUO<(@D\0#XC.)M0&2"=0TN/D%T'VA\8>W-Y])]P8-=O;[V77QTF2I MJ>9:O&9*AJ85K<1G\%7*`*C'UU.T=32365BC:75)%=%PKYAY=O\`E?>9>7]Q M0>+"U0PK1A3!!X$$9X5Z^FCV8]XN0OO#WUX;BPG0LZ8#0SA0)+>X3 M)6:%FR*TQ4%E8$[:/_"<+Y2YOL/I[LSXP[OR7WM9T1-B-P=<"9)S51=>;UJZ M@Y/"/422R!HL9E(OV%"1A(JN.-0RIZ,L?N_/E]G7S[?WN_L1M_(_NEMGO-R_`L%KS8)H[E$&E4O;,(HDTC`-S"P=J<7C< M^=3LKS?H_P!<@>\A%^(=$N&V'UOB=UX)=F;B3;E:^6K]SQX>?[ZHEIZ@2Q"!R5C*BS6 M(-Q[*O9SD?8^=MSO[#?E"X%U`;FWDC6UU@-$&5M0DHR,K"E#6HZV'/^@>;^7U_RH=Y_ M^C/H?_K9[G[_`('GVY];G_G+_P!<^N2'_)WW[W7\6P_]RF3_`*W]='_A/-_+ MWM^Y0]ZJGY*]G418?TL%QE_>C]WKV[`JGU)/IXO^=.JM_>__`'NU&JNQG_2[ M3+J_*EQ_J'3K@?\`A/W_`"Z,76O-6;,[5W,DD?C2DW-VUN"GI(B&#^6!=I#& M2Z["UY)&6Q(TDF_M;9>QGM[8L9/I);@C@LLC%*_/3I/V9I7RZ#7-7]ZM]\7F M>&..SWBSVFAJ[V6W+'*10X#7#7"+FE:*"145%>K'NC_A'\2OCI4I5]-?'KJW M8>90!$W+B]M4M;N\JNLC7N[+_V,9 MS6O1K8J>&$$11J@+O(0O^KD8N[?[$DD^SZ11+IUYTT(^5.'#J(UHHHH`^P4K M\SZGYG/6;WOKW0/?(;_F0'>7_B'NS/\`WBZWV6[Q_P`DBZ_YHR_\<;H8^W?_ M`$\#8O\`I867_:3%U\L6GXIJ,_TIX_\`B??+]C1I2/XNONKL_P"PB^V/_JR. MOI5_RU::`?`+X9`1@`?'OK6P!8#U;;A+<`_DDDGWT>]M9I3[?[42?BMXZ\,X M/7Q;_?3MH$^][[AA5X;[NB\213ZDXH21_E_+H]'VM/\`\<_^3G_XK[&=/F?V MG_/UC5I3^%?]Y7_-U[[6G_XY_P#)S_\`%??J?,_M/^?KVE/X5_WE?\W7OM:? M_CG_`,G/_P`5]^I\S^T_Y^O:4_A7_>5_S=>^UI_^.?\`R<__`!7WZGS/[3_G MZ]I3^%?]Y7_-UU%1TT((BB5`Q8D`L1=OK]3[W)^JJH^0M*#TIPX=-P016VOP M136VMLDU;US7KD]-!*NB2)'2]]+"XN>#[W4D,#P;!^8^?6Y(DE31(*@$'\P: MC]ASU\PGYG]?U75?RV^2W7M72BBDVMWAV704D*438V(XJ7==3D,+-24#LVB" M6BGII:?D@Q.A%@;>^:_.FV/LW-^XV$@P)IBHI0`,Y*T_+AU]M?W8^>8_>FWQAJJ.GD%Z>GD_B-1'%$21>*5Q8,![S!^[[ MNB3^WZ0,`Q@E=14X%3J(QP^+U.>OG'_O<^2KKE?[W%WS*HT07IUS1/'A3KE[ M]UKKWOW7NO>_=>Z2N[]VX#9&W<]NS=>:H=M[7VSC*W-[BW%EJF"AQ.#PN-I& MK[:*GJ>H>[^K^S8I M8XYV_N/O?;VXJZGAFUF#[['8R>2HIRXCG#/#H2G:N==CW3:Y`Q6L]I+&H*X-9FC\,U/ MF":5H>AWII?+%JO?KZ'JO/^;+_`-NZ/EQ_XB>O_P#=K2>X\]T/^G?;U_S0/_/O677W"O\`Q,CV M[_Z6\7_5J;KYO4_^8G_Y9/\`[T??/BV_W-M?],G_`![K[++W_<27_FF__5L] M?5@ZR_YEWL7_`,,W:G_O/4WOJ!9?[@0?\TT_P=?!GS%_RLFY?\]4_P#U<;I9 M5'^;?_@I_P"A3[5)_:+_`*O3HCG_`-QI?](W^#KYQ/\`-T_[>3_+O_Q)5%_[ MQ6*]\]/=O_IXVZ?\U%_XXO7V+?W;?_B%7(W_`#S7'_:;<];#O_"947^.7R/_ M`/$V8;_WA*3W/7W;?^5?W'_GI7_JTO7)O^^X`/O)R97_`*,LW_:=+U<#_,5^ M.P^47PY[XZ@I:1*S/YK8F0S&R86B69AOW9\B[LV>(+LFAIJVCCI6<,+I*ZDZ M2;S+SULD?,O*%]L[*'=XRR5\F4$J1\P>'7,W[K/NQ_K&?>"Y5]S]12';[Z-; MH`D![2XK;W"M3BJQR-)3^)1U\]/XH]YY#XR_)/I;O*E6KA'6O8FW<_G*6)9H M:VLVP:D8[>6&:-A<-/BYZV!XG2^H@<,+^\!.3]XGY4YFL]T9C$T$NB0^>ACI M92#Z#5_JR/KF^\1[5;=]X'V)YD]O;>19CO6WN+:5CVB:GU%E.#PI'(H92`>W MB&&#].'`Y[%;CPN+W/MS()E<)N'$8S.X?(TX/VV1QF4H4R.-K8&<*Q2:"2-E MN`;'D`^^D44HO(([B$_IR!"I^1R?Y$5Z^*2[L;K;-VFV_<8F@FAE:":)A0I, MI(<,#D,I4*1Y$=:?'_"D/Y+U.[.V>G_BQBZF&7&=8X*7M+>RPSM(QWIO2.3% M;6HIX`NE#1X:&:JC.HL1D3J50$)Q/^\?S`DM_;_?+=1<;E*VT61((=8+8^-.ZFM"EV[11MBH-M@BI MZLM_X3P_'%NLOB!N#N?<&):FW+\AMZU&-_H5`D3V%Y8_&'^7I\ MP3%&$OT5O13:_P!!1`@<^QE[HD_ZWF[CU@<_F2.L9/N."OWP/;R0_$^^6-3Z MT>@_8.OFM5?_``"K?^H*;_>A[YUQ?VL7^F'7V9;G_N%/_P`T6_ZMOU]4SH__ M`)DUU+_XC'8'_O)4?OJ%MG_)-M/^:*?\=7KX0^;_`/EOZ?\`6C-0/]EKZ8-D&A06V%1,;*E@!TI_"O^\K_FZ]]K3_`/'/_DY_ M^*^_4^9_:?\`/U[2G\*_[RO^;KIJ.F8%6B#*18@EB"/Z$$^]J2C!E)J/F>FY MH(+B)H9HU96%"-(R/R'7*&F@IU"0QK&B_15O;ZWOS_O?N[RR2MJD-3TZ,5H` M*Y-`!7`'^`#K*WZ6_P!8^VV^$_9U5OA/6H__`,*>?^+I\+_^H/O?_K?M'WBA M]Y/^UV?_`)I3_P#6/KOY_"O_-"7_GWK+S^]T_\0]OO^EGMO_5\];_S?I;_`%C_`+U[ MSKH&[6X'KY2AQ'0&?(/HG8?R/Z?W[TKV1BDR.S^P-N5F#R18ZI<9-*%FQVXW*$SV^X[1.)K:5"002:21GB"DT9:)ZANQVI0]?-?^4/QQW] M\3^]-]]%]CTG@SVRLH:>BRL4.W;MRI)GV]O7"/)J#4>1I3'.FAF\ MTD3J.?=]][N5/O&>U>V>Z'* M-P2NYQF-EK66SNT!^KMI!\(,$@*H2.]-+"H=2=C+_A/_`/S#)8)A\%^UMQA8 MI3D`S5!7Y97C7AUQ;_O:/NBQVUI/:/[S7_)1VK_`$LG^%>I,_N/ M_P#E6>??^>NS_P".S=%P_P"$\?\`V7_-_P"(([+_`/=GA?8-^[[_`-/#/_/' M+_SYUD)_?&?^(AM_TO\`:?\`CEUUO?)^A/\`@J_[U[S?7X1]G7RU-\1^WKE[ MMU7KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z_]+?X]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW6&2Y)L"3HN"/K>_T'NXH5H>J2*1&7C^+A^76FW_P MI>ZN?%]S_&SMR/&Y`TF[NN-T=?560EFCGQT61V9N4[BH,;'"HO#,8LY/(68V ME5?3_FG]XG_>6L[F.3:]PMP5B5)8V()I74C"N?.ISPQ3KZ%/[D_G399^5.=^ M3KID%[%SZBKD9D0K_'*+'0`/?_.D@:@/<=>S.\V.S<]P MI>$K!)0NIS% M$&2=%I4BD,K2&@R(_E0_0BQ[1O&75&5F5&ZLJM M\76ZD`CUZAU(CB53I=KDV4,Q!('`.J_MU(PY!KIT^?I7!^W\^FHPJ2K"M1XE M1JJ30`5/&M*TIUI!?\*/DVB/FIUTV$-*-T2=`[=_OK%#45,M3',F],Y_=P5L M,S&./51,&C$8%U:[7)]X:?>/\"+FNT>WIXG@:G(X_%05_G2F.OI1_N6$W^;[ MO',4EY&\=F-Y;Z0$`*RBWB$^DC+%L5+$D$XIT]?\)JJ;(2?-3MRKC@J&QU/\ M9]P0UU1&CFGAGJNS-M-C(JN4<:I!%4F!6YLLA7^U[9^[A'/_`%MNY5!\(VCU M]-1EAI^=`>E_]]!-M$7W>MA@:1?K)^8+5HHSA_`BV[!WZX!^PV=F.AX_X3+*#\B?DHQ'/^A? M;RWY_3_?6G-O]O[-_NX_J;SNJ-P,$/RX.?,9ZCS^^G4?ZT/*!.=&^W:"I)HH MLFH,_P#%];F.A?Z?[R?>6G@1_/\`WIO\_7SGX]!^SKHHA%B+C^AO[LL2(=2U MK_IF_P`_7O\`5Z=<1#&#<*;CZ'4QM_K7/NVD:M6:_:?\%:=4"**@5S\S_GZY MZ%N#;Z?2Q(_W@>[ZCUXHK,&-:CAD_P"?KE[UU?KWOW7N@>^0W_,@.\O_`!#W M9G_O%UOLMWC_`))%U_S1E_XXW0Q]N_\`IX&Q?]+"R_[28NOEBT__``%I/^H: M/_HKWR_?XI?]-U]U=G_81?;'_P!61U]+'^6M_P!D!?#/_P`5\ZT_]YJ'WT:] MM/\`IW^T_P#//'_@/7Q???6_\2^]Q/\`I?;I_P!I+='J]CCK&3KWOW7NO>_= M>Z][]U[KWOW7NO>_=>ZT:?\`A0]\]\5CU@VK\AMGP3Y"JA")".Q M.NZ>';NXHW7]0:;%MAJMG('D=I6Y().&GW@^7&L>:(M\B2D-U&%)_P"&J!4\ M>)!'[#U]*_\`\]ISC[(;E[4;G,?KN5KB5H4)J6V^]9I!IQ4K'<^*//351 M4"@Z:/Y!'R[Q70GR=SW2&]6: M3TJ_=>Z][]U[JBC^?7\L678V,QMYFJJ;KND:";LG< M"BG*Z4-,\&*C,K!6DK6(+^,J(<][^:H-BY.DV^&73=WG:@''1^//D*>?SIUT M8_NO?8B_]V_O+V?.=U&\>SN]=SX?:>V$PZ5$==+G-RUBXBD2G:EM(?54%967@J7OP3[P MMY=M]UO]XM[792Z7,SJ%*LP;C0G!^TGKZ@_:N=$@EVS;;6>Y ME%U'')&`BM,%I,"O>**`>.!QZ^HKTSL5>L>I^N^N1E\MN`[&V=M[:LN>SN3K M\SF,W4X/%18^KR^1RN4EFJ9YJF6-YI))I&8EC?\`I[Z5V-J;*QAM&XQQHIJ: MDL%%22>))J3]O7Q!\U[[_6GFGZ^RR]_W$E_YIO_U; M/7U8.LO^9=[%_P##-VI_[SU-[Z@67^X$'_--/\'7P9\Q?\K)N7_/5/\`]7&Z M651_FW_X*?\`H4^U2?VB_P"KTZ(Y_P#<:7_2-_@Z^<3_`#=/^WD_R[_\251? M^\5BO?/3W;_Z>-NG_-1?^.+U]BW]VW_XA5R-_P`\UQ_VFW/6P]_PF4_[)R^1 M_P#XFS#?^\)2>YZ^[;_RKVX_\]*_]6EZY.?WV_\`T^3DS_I2S?\`:=+ULIU4 MWB:/]1))]*_D`7)_V'U]Y))&'KP!I2O7$XL1J:N(T9R/XJ"@'[?3KYO/\T;X M_'XV?.7OGK^CH10;6SFZ9^S-B1(JI2C9G98.YL?1T40](CH9Y:O&>GTWIF4! M=)`YZ^[/+IY>YZOK&%=$,A\:,9H`1G))_%7'EU]A7]W][NQ^]?W5^6>;Y"9K MVSLQMMW5N\W.W@0KJ"D4,D!5Q@$ALU(KUMW_`,E?Y-X[MG^7AM#(;MSL4&2^ M/$&9ZKWMD*RJ>5J#;FP*+^-;9RU9K!=(5V]+21^4`J6@E523&57+#VDYKCW7 MD.VGNY-3V*.DM>(T_P!F<<>T''[<]?/9_>.>S-[[;??`WS;=KM6:UYIECW.S M103XDU^6$\:TR6^K1L"A&I0!0@G3/[6W9OSY[_-;=.XG/CQQN96O9P MB5I_9H:+@4^%/]DGKZ.>2.6^5ON?_=1LH=Y"0VG*>TI=7IC8TN;R*+Q9Y<]V MNXN>[%,L%"A>WKZ0/376>#Z$4^VNN]F;:V5@HE18E&-VWB8L52N M84X5G6+R/^2[,Q))N>@UA9P[?86^WVJA(H(U0*/(J`/MZ^/'F_FS<^?><-WY MXWQS)>;Q>W5[(3^$W,SRZ!2F%U=N,+0"@`'17?YHG_;O/Y@?^(+WK_[@CV#O M=+_IWF[_`//.W^$=9%_<<_\`$O?;O_I>67_'^OFJ5?\`P"K?^H*;_>A[YUQ? MVL7^F'7V8[G_`+A3_P#-%O\`JV_7U3.C_P#F374O_B,=@?\`O)4?OJ%MG_)- MM/\`FBG_`!U>OA#YO_Y7+>/^>VY_ZNOTBOEW_P!DH_)O_P`5\[H_]]OD_:#F MK_E6-Q_YYIO^K;=#_P"[Y_T_ODC_`*7^S?\`=RMNOEW#])_Y92?]:S[YD'A^ M8_R=?<3)\0^P?X6Z^FM_+Y_[(9^'_P#XK5TM_P"\!0^^E_)__*J[;_S03_C@ MZ^'?[PW_`$_[G7_I<[C_`-IDW1P_8FZA_KWOW7NO>_=>Z][]U[KWOW7NN+?I M;_6/O3?"?LZJWPGK4?\`^%//_%T^%_\`U!][_P#6_:/O%#[R?]KL_P#S2G_Z MQ]=_/[C_`/Y)_N7_`,UN7O\`!NG5<7\@[_MYAU#_`.&5W#_[[NM]@3[O_P#T M\%?^:$O_`#[UEY_>Z?\`B'M]_P!+/;?^KYZW_P#WG7U\I)SCK&Z*58VN0I`Y MM^.!SQ[L">'6P:+IKI'KZ?/\NJ)OYV7\O2/Y7]'Q=O\`5VW%J>_^C,9697&T M6+@+9#L3KU&-?N;8TD4*_OU5.!+D<,H6YF$M.K(*MC[AKWE]NUYLV47=A'6\ MM]3!A\3+2K+2N2:8Q@_*O71O^[<^]UY-Q;*W%M[=^U,Q7;>W-MG,8KK3(XG)TDT?TDAF1'6]QQI8$$CW@]:WU]:7D,UL?!G@(*,,%2,CC_`)>O MJEYAV'EKGK8+KE7FFUBO]LW&)X)8VU,DD;BA1L@D,!A@>(!!K0]6C_S._FOC M_G3M3X:=J54%/0=AX#JO?VQNW,-3*D=/C-_8C=%#-5U^.B0DK0Y:"2+)42NH M*+(\7/B+&6_=+G6UYYVS9+]`%FB619QZ-5/V#!(-!\5/+KG?_=^?=NWW[K_/ M7N5R!?H[6%S?6EQMER0=,EFTN7NW5>O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K__3 MW^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UT0#]?Z6^I''^P][!(Z\!1M M7GU67_-?^&E1\TOB7N[8NVJ!:SM#9!?LCJ)3X@]5O7;M'*S[:\TS+I3-43U. M+]3:%DEBD>WC#`!>Y7*,7.7*D]@%U7"4>$U(HP^R@->!KZXSUEI]R7[Q=U]V MG[P>VP>3J**MI9TJ,;E\)FL35M2U5-.AT34]52U$15D.EXI4YLR\<\IX[_:KP MQ35BFMWI3@RLA_P@CK[%+27E_FW;8]RLVBO=MO;92&5M<4L$JAHSYJRNA/J" M.MO3^7+_`#[-A[AVQA.HOFEFH^OM]87$TV*Q?>,D$M7LC?:8^(P4U3O6GI(G MFPV5=!&LLZQR4=2X>9Y:0GQ-F'R%[[;7N-O'8)G4W<9J0(TF M66,*JI%+4L-E79?8FS.Q<+3;CV%N[;.]=OU<<;TV*55=36N*$5P&/2KEJQ"%9]:IR&JR_F;_`#6OB?\` M#_;&5GSG8V![*['@#T^#ZHR,B-HN( MHII2L9CGG#W*Y3Y2M'>XN?J)B2HA0J64TJ#@`CR^(TSY]97<[RUD@M(X=0#%)932X8UH(X59_,E0"1H/_)#O_??RB[L[ M#[W[+J8*C=G8.=.5JJ>D71083$TE/'B=O;Z;NEE?+D&5V)(J0H(`II`&X9_PGN^'V2Z/^/.Y?D)O?$28K>_R2 MDQ5=MRBK:98*_&=1;;60[4J2LH\J#,U-559,+PCTWV4@!+>\NO8KDJ3E_EL[ MQ?`BYNSYU[8C0J/3)757CFGEU\Z_][!]X:U]V/?>+VXY:=9MKY/C>WFF1JK) MN'6BQ_P`*,?\` MMX'AO_%=.L__`'J-R^\+_O!_\KBO_/+_`,_#KZ=O[F+_`,1HWC_I?S_]H=GT M/7_"97_LHCY)_P#B&=O?^]I![-?NW?\`)_WU'_`$Z'E+_I M?W?_`&@MUN9>\NNOG-Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@>^0W_,@.\O\` MQ#W9G_O%UOLMWC_DD77_`#1E_P".-T,?;O\`Z>!L7_2PLO\`M)BZ^6+3_P#` M6D_ZAH_^BO?+]_BE_P!-U]U%O(D-I'-)A4T$\3@05.!4G'D!7TZ^C7_+A[;Z MMQ7P+^(6/R_9_7N,R>/Z`ZVIJO&Y/>>VL?D*&HCV]"DD-;1U52LD4@_M1R(& M4\$7]]$_;J_VV/DC:K9ID5A;IC4*X&1GT_V>OC5^^/RSS/=?>Q]PKV"RN9XI M=]W%D<6LM"&N'-10"H(I^SH[?^F[IW_G[W5W_H?;4_\`JKV,_P!Y;7_RD)_O M:_Y^L;?ZJ\U_]&VY_P"R:;KW^F[IW_G[W5W_`*'VU/\`ZJ]^_>6U_P#*0G^] MK_GZ]_53FO\`Z-MU_P!DTW7O]-W3O_/WNKO_`$/MJ?\`U5[]^\MK_P"4A/\` M>U_S]>_JIS7_`-&VZ_[)INO?Z;NG?^?O=7?^A]M3_P"JO?OWEM?_`"D)_O:_ MY^O?U4YK_P"C;=?]DTW4_#]K=:Y^OBQ6`[)V)G\M.)#3XK"[LV_ELC.(HS-* M8:'&SRS/I16=M*&P!)X!]W@N[*5Q;QSK(Y]"I/\`+'22^V'F7:[1K_=-NN+> M!>+O;3!?VD="*#<`_P!0#^1]?\#[4\,=%@(8`CS_`"ZKM_F2?"?"?.?XR;NZ MG2''4/8V+J&WCT[N;-25,5'M_L>@@>&B6OJJ59'6AR-/)-BZT>.0+%/Y50O# M'8%>X?)EMSSRZ;!P/'C[H7J>QABI%:$'SJ#CK)7[I'WE]\^ZW[U67N#8LS;; M06>X6X53]7:3,&=%U#M>-@LB,I5M2Z2P1F!^=1N_:F\.LMZ;BV5NW%979N^= MD9ZLP>>P]4M5B\UM[/8>K,UE8*U-)#*WQ#`P2*CRIPZ^Q?EKF7E+W6Y'M.8.79H=VV[=;5":.'C>WN M(P61PI*:@KE&4Y!U#B#UMA_RYOY_NU:S!8#I[YR9"':>;PN/H,/M[OG&X^LJ M-M;@H>^EEN")LW.!6W MF10HN*'3(0*:F%**QX\`O'[.N`/WQ?[J'G/EW<;_`-P?NVI^\]I>66>;:6=1 M>6H+/(4M'?MN+=!14C8_5#"@S&K#9=V%V;L;L["TNY.N.PMF]A;>K(UDI15CN&VWUO'+:2K*C@%7#`ZP>!%*#/ M&G\NN,W,'+G,?+&XR;?S#87.WSPL5DBN(VA9&!R"DD7B+3^ED>9Z6DE9((FF M,T<,:6URN`(U!_M,S$J!_P`A>U;^'":R4H>&?]7^#HC5S=2*MEJEKY1D$_SC MZJW^9_\`-W^*'Q`P.7HI>P,-V]VW!!,F)ZGZOS&*S67.14.D$>[L]3_<4&"I M1*%6IEJFDJ50ZH*.=A;W&O.'N=RORA#+6=;FZ4T%N&!(-*T)%"!D?%ZXKPZS M/^[=]Q/[Q'WC-X@FV7:#M6P,09-SW%9(H?#K1C#&`DEU(*,1X`,=0%D9*UZT M:?E]\L.U/FGWKNKO'M6HI4R^<6FQN"VUBI*D[BJF+"*%27J M)VL]34-)42`/)I7"+G3G#=.#GIMI;/7*[=Z(HLG0Z(MS[LKJ1\5N3L2C>J%S28NGEDQV/GA! M66JEJ&4JU)=YV]A.0KE[M><=UC(4!O`J"*&I#/3%036E:^?RZY/_`-[O][2R M7;E^[)R#<+<3WICN=YDB<%8XX]+PV98<'=@LLH!!"B-3AVIN)4B*D.E00NN0 M@,VLV+FW/]/Z`_3Z>\KY*ZLFI^RG7`&/PR-<;:@Q+?83DC\CBGRZKT_FR_\` M;NCY3_`"[_`/$E47_O M%8KWST]V_P#IXVZ?\U%_XXO7V+?W;?\`XA5R-_SS7'_:;<];#W_"93_LG+Y' M_P#B;,-_[PE)[GK[MO\`RKVX_P#/2O\`U:7KDY_?;_\`3Y.3/^E+-_VG2];+ M;Q(Y!=;D`J.2.&%B./>1XP0PXCKB?09^?^>O6JA_PI;^.T$N!^/WR>PF.59\ M3D,KTMO>JA6:2:2@RZR;LV#42KJT::>H@S,)=K%C4QH=5DT8S_>+Y?DFL;;F MFW4ZHBT4S>6E].BOH:A@*4X]=Q?[F+W<&W;.*HJTL'^+7 MBI4?CCG@DI6GZ)H!W5H4^*OS8W3\;OCU\U.F,/4U$<7R7ZTVUM/#O!))&,/G MDSZX'-H1](O$B"#CW=PV\("B MHI(]1I+'H_G_``GO^-M5VG\N\UWID\='5;2^.&U):^F>4']SL3L*EJML[1AI MSI\;&"@7,5C'R*T;QP-_:`(]^[ORRVY^VY*]@[/VJVZ77>+<^\T&:H(!J-1].OFC$?A3RBM=1!'V!0H_P?ZCT1O^:)_V[S^8 M'_B"]Z_^X(]Q_P"Z7_3O-W_YYV_PCK*[[CG_`(E[[=_]+RR_X_U\U2K_`.`5 M;_U!3?[T/?.N+^UB_P!,.OLQW/\`W"G_`.:+?]6WZ^J9T?\`\R:ZE_\`$8[` M_P#>2H_?4+;/^2;:?\T4_P".KU\(?-__`"N6\?\`/;<_]77Z17R[_P"R4?DW M_P"*^=T?^^WR?M!S5_RK&X_\\TW_`%;;H?\`W?/^G]\D?]+_`&;_`+N5MU\N M]?T_0G]MAQ_M2Z1_O)'OF4HU8^=?\'7W$2_$":X`X>>6QU](SX&]O]5XGX5_ M$G%9'M#KK'9#'_''IVDR-#6[XVM35=#64^PJ&*>CK*2>J66*6-PR2(R`A@00 M+>^D?)NX;:O*&VF:=`3`E*L`<**_+KXE?O#\J\W'W]YSECV>]\&3>=Q*R-;R M4`^KF(%`HJ2",BH\^'1M_P#3=T[_`,_>ZN_]#[:G_P!5>Q)^\MK_`.4A/][7 M_/U#_P#53FO_`*-MU_V33=>_TW=._P#/WNKO_0^VI_\`57OW[RVO_E(3_>U_ MS]>_JIS7_P!&VZ_[)INO?Z;NG?\`G[W5W_H?;4_^JO?OWEM?_*0G^]K_`)^O M?U4YK_Z-MU_V33=='N[IZQMV[U<;`FW]_MJ?C_JJ][_>6UG'U"?[VO\`GZ]_ M53FLX_=UR*_\NTW3G@^T>O-SY.#$[;[`V3N+)SJ\B8W`;JP.7R$D40#RSI1X M^>65HT!N[A;*.21[R;]M<376[6=Q!$'$6 MI[>5%UMPJQ%%KZ&G0@M^EO\`6/MYOA/V=%K?">M1_P#X4\_\73X7_P#4'WO_ M`-;]H^\4/O)_VNS_`/-*?_K'UW\_N/\`_DG^Y?\`S6Y>_P`&Z=5Q?R#O^WF' M4/\`X97WW_`$L]M_ZOGK?_ M`/>=?7RD]>]^Z]QP>HSTT9NPUA]-A:64"XN1P#;\^[AVX>7V=-&%"[/P+KIX MF@`X4'`$>H`/SZT4?YX/\O-_C#W#%\A.L]OM1=']Z[@R,^6HJ&,&@Z\[;JG? M)9K#`*`(W4GLASM<$&?^>.7_GSKE/\`WQ>/ MNAL/^D_M/_'+KK>^3]"?\%7_`'KWF^OPC[.OEJ;XC]O7+W;JO7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U__U-_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]UBD75;Z\!K$$BQ(M?CWX``ZO/ATVX)(4_#Y^76OQ_,W_`)(N MTOEAF,WWA\>Z_"]7]^U\_3V]^NI$J:J*GS&8Q4TNT&.:?%5T:Q_N&2FJ MF*J?6%8,!B-OW)',W+D@CW>SDA)+:7"DJ^F@)!&`!CTK7KZ'O:C[S?L-[X;? M'OGMSS'8WBJJCPI)%M[F$R"NAH)"LJL:4;M(JN#QZ!G:V[=V;-JSD=E;IW/M M&N3[I_OMH;@S.VZQ?/&(*T_!_P!Q%6-QJ.H`+8\#V4V6\;QMC-]+/)$3 M@_J.AQ]C#\_EU)?-'(/M]S=;)#S/LUAN<-21]3;QW"$FF1J1P34#CY@4R.E7 MGNZ>Y-T47\-W+W!VKN7'">*J./W%V1O'.42U,#7@J?M,I6S1B1"3I?3<$\'V MHN.9^8;E/"GO9V4YIXTA!_(M3HEY=]EO:'EJ[-[R_P`J;/8RTIKM]OMHGTGB M-0A!(/H#3UZ9-A]>[^[4W+2[.ZUV3NKL#=V1F(IMN;,V]D]R9VJFMZW_`(?A MXI9B!I+.[+I'J9B.?:>UVW=-VE\"QBDGD2GI:/R>.0X>CEDDF`,=9)"FJ M"3*#VY]C6M#%N_-*AB:%(.RC=1)XE"=-TP7337&-04C;GP]#2T%)24E'2T]!2T-'3T5 M)0T<,5-14E-30)#%2T=-``D<42JJ1H@"JH`7@#WD\D`MD$2'M`X77! M\RWI1_MS^/=T!+"G34 MSA5%32I4#[=0ZT4O^%&%3`/Y@N'1I8PZ_'/K0Z&959E&Y]RDN@/)%B"3[PN^ M\"S'G")_";1X&@MG)+?Y*?GU]./]S8QA^[3NJM*B-^_[ERM5U,B6=IJP_=>Z][]U[KWOW7N@<^1+*GQ^[T=B%5.G.SF9B M;`*NR:XDD^RS>VT;-=O2M(930<<1MPZ&GMLC2>XFP1J*EMQL0``223]+1W<:Q20L=!L58H2#=3Z?KQ^??,28(#)13E_RIU]T5B&N;"*, M-1C%&Q.EP_- M=3OIJ[=HTBAI0#RQT_%M5E$"!%&VIF-+_&_^]'IS]W67^^(?^_=UE_OF'_G#_L=>^VI/^5:F_\`.>'_`*-]^\:7^-_]Z/7OW=9?[YA_YP_[ M'7OMJ3_E6IO_`#GA_P"C??O&E_C?_>CU[]W67^^8?^/"]O2*JI#&X<=19ID(*@$?X?@G\'CW,7L5)*.?XG:1D30]3DUX"GG@ MUSUS7_O7K>WA^YMO?TPTW$=UMVE8@`XU7,:M\*UH032N`:'C3KZ%:?H7F_I7 MDFY/'UO[SP/'KY1$!"`&O`<>/Y_/UZP?:0_T<^K5S(YL1_2YX^I]V:1FP?\` M-U5(DC1$`J$U$5S\5:UKQXXKP\NJ=/YEO\I#JGYY4\.^\%DX.J_D-A<<<7B^ MPZ>C2MP>\<717_ANW^R,5`%FJHX1KCH\A!(M53`A/WZ=!3^XN]Q_:S;>?(!/ M%^C=QBBR"OJ,,M0&`\CQ%<4ZSN^YE]^_W"^Z+N+;%!"=ZY5NY!)>64STFM_X MIK.0U*,1G2:QO054&K=:8/R4^!ORS^(^8J\?W)U!N7%8,RO%0;_VW05>Z>N, MU`DR0BHQ^]L2CTT8F=T\=)7K35?(U0+>WO#3F?VZYHY7G:/=[-],;E1*H9T; M34:A0$`&E:F@'7TD^R/WR?NY_>'VZ"_Y$YEL]3(KO97CBUO8G;(K%,RJ[AM0 M+1ZPWD2".BJ[>W3N+:];2YC:&Y@X=9";KR9R1S7M[)S M/MEGN5M(,BXM8[@,K9R&616!XX%#4'TZ66;[D[DW1CCB-R]O]J;CPYEIZE\3 MG>QMWYG%M/2R>2FG:@R-;+$S1MZD;3=3R+>S"7FSF&\3PI[V9U_I3R_MIJI7 M\N@ULOLG[-ZN$B!C%"QAC!1B/* MB@M44"GK8[^`G_"?GLC>&T:4>2I>D\+FX:O?F[:R.J24X[? MF0QJRTN)QSQ!TGIJ.KEK9"=#-2:6+Y'\@>Q5Y-=1;SSHFE:ZA!J((TFE)""# M0TX`UIUQI^]Q_>X[+;;5=\B_=B4;C`PVV=M8:AVYMW;M!2XC`X##4T6,Q&&Q&-C%-CL9CFL>0I7JN7^;3*R_ MRZ/EX.$"]25Q$KCT*YRU&%##BX-[?7V`?<\1'V^W==7<8#4#C2HI]E?]GK+# M[B;S1??&]O"@`!W2,ZFRJD)(,@%30@GS^?`=?-\J9X5@G+2(JF*102P_4J%F M`O\`4_7CWSRLDE>]@7-0R^7`:A0]?9#<7+IMUP]](JZ?%4%05!`C.`&+DG/$ M'/D!3/U8^L&5NN]CZ2"!M#:ZW!!'&WZ;Z6]]/[!E;;X-+:J1J*TID#KX1.8` MXYCW+Q`1_C4]*BE1XC9X#'^6O2QJ3Z9/5IM'<`VL2;@"_P#MO:Q3I=6/"M*= M$LJN\3I'W,ZL`O#-/7\^OG$?S<94D_F4?+T(RDIV91(XORK_`-R,0Y5A^."+ M7^HL??//W=\1?MF'WDAUQ3Z)7_,)^.,?RM^ M(_=/2L4*/G=P[/KEWSM61-S[0DB9V0+Y:ZDAII#J7]N63U#\A;G M388.9.6+S:KA]*O&S`"E2ZC4A'G@CRXUZG3[LGN[<^Q/OYRS[H0*6CV^Z5;E M0:![2<^#<(?EX;EQ\T!X]?,_>\,TU/4)]M5TTCQ5=)/JCJ:2HB8QSTU3"UF1 MT=65U8`J000""/?-N6+P$:"6-A(&(J:B@&"*>M>OMAL]PLMS^GW#;IEDCDCJ MK(WB+HE`D#55M`';VLP/#&">M^_^1%\;3T1\%-I[HRU/%'NGY!Y)NY7%*#. MA:>H4Y/F?EU\E/\`>7>]3>\7WH=TLK,,-MY9C&TVX8JP9H))&N95HBGOF=@" MS.=**`=(`ZNC5%7Z7^EN23_C^?OLDW>:YM[.X=VC$025M;U;]-8C1=*%*$5)K4U4$8) M!'U2NCG#=-]1$."K]6[!<+]6M_=*BL=0_P!?^GY]]/MJJ=JM"ZT;P4_XZ.OA M6YQTKSENZDU+WERPP1@3,#@U/'YXX=(CYA2K#\3ODVS$*#\?>Z!J9@H7_C&F M4;5S_2WM'S/H_JUN/B$@?33U#WES(JHSM1!116E!TS% ML^WPUTPQ$DEB3&6)9N))->N/VU)_RK4W_G/#_P!&^VO&E_C?_>CT]^[K+_?, M/_.'_8Z]]M2?\JU-_P"<\/\`T;[]XTO\;_[T>O?NZR_WS#_SA_V.O?;4G_*M M3?\`G/#_`-&^_>-+_&_^]'KW[NLO]\P_\X?]CKQIJ/\`--2VN#S3P6X-Q]5] MN17$B2!BSD?)C_GZ3W>TVD\!B6.)"2N?"`I1@>)%/*F>KK/^$_D=!_PY1UX\ M:TR2_P"C7MQH?&8XF=VVLZRV5+:O1R1;\7_%_O7RM3DB%BITFG&H%/S(('Y@CK49_X4[3* MF8^%L-1-")9:#OAX1J5#(HEVF28XR;\$6/U_WGWB[]Y>)#'MTD,3'PM:ELFB MM2H/EG2,TQUWV_N1KD1P>X\:%`)IMC,:L:F3PTW,D*P(%0:G@<9X=5R?R$:B M%/YF74$;2HCMLWN!%!87+'KNM*K8_P!?H/Z_CGW'7L`JCW`#D$#Z>6F#D]O_ M`!?67_\`>X-)+]SZ_CX.-RVUBJD-11.:D]N!GB:?;U]`7WG-U\J'7O?NO==' MZ'_6]^ZT>!Z+I\E_C]L;Y/\`2O8G2&_J(5&VNPMMU.&J*@Q^6?#99=-9MS=% M`EQ_EF,K8X*VE;_CI$`WI9@2OF#9+7F#;#M.Y1^+`U:BI!&*`@@AA0Y%#QZ' M/M5[E\R>S7N)LWNGR?=/:WVV2*\17(9?QQ2JP*R1R1EXV5PPTR-C)Z^;'\C^ M@]__`!=[JW]T5VA0)C]X;"SD^.DFC29*+<.&E8SX#=>$>-K5[SD[?9-EOB9-&0X4@%3\)'KCCDYJ.(Z^S[V%]]]B]__`&MV M[W/Y/;]+<$S;L8Y)+>5699(Y`C(=2L,UIC(6AZMB_P"$\LH'\P2>,.@8]"]H M-&KD*&T9##-ZB>;"PO;_`(W[D?[OY3_7$60L50P2*<5JI"XKY9`S_/K!?^^& M\<_=$9)#K=]^V]E51H.E(KJ@R'KD_%2E2,'AUOAQW\:7^NA;V^E]/-O><9`! MHO#RZ^7!6+*&(H3G_5P_P=<_>NM]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7__5W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7B+^_=:(! MP>L,D$#>W'O:G2XD'$`C]O6@B4*L`P-#0Y%1P_9TSY#;."RU+ M/097&4>4Q]5$T-509*F@KZ*JB8W:.JI:M720$\D.#<_6_NLRQW-?J463Y,H( M'K0<,XK]@ZM;OY2#VU.FE*5/KT5W>O\OWX0=BU M$E9O+XI=#YFMGR$^6J:\]:[8Q]?69*J0I45E=78JG@EG=P3J\SL";&UP#[#E M_P`G6A)%8EXGB<#SZG'E'[S/WAN1%9.5.==YLU=%0JM_<,NE*Z M0%D=E6E2`5`-"16AZ2N-_EC?R^L1D*/*4/Q`Z)CK*&85%,T^Q<76P+*%*@RT M=:LD,H`)],L;+?FUP/:*W]ON2;643VVUVZ.N01&!_L'\P>A7N7WT/O7[O8R; M;N'N!O;PS*5=1>RK4'B-2%6'Y$'HU&RNINL>ML;!ANO.O]F;$Q%-!#24^+V= MMC";:H(:6G9GAIDI<-!"@C5G=@MK`L3^3[$L&W;;:T^FMXHZ?PHJ_MH!7Y=8 M\[YS#S)S1*TW,VY7>XNQ+5N;F:ZE07\0\:4 MZ\!0DG)/KGKMT612K"X((_Q%Q:X/NZL5-1UZ@)!(K0@C[1TB\MUOL'/UZY3/ M[-VOGLDD7@7(9O;^(RU[^ZO%B8NBSW$TJHQ4H2JN[*#I)'"N M>E;[?Z+.O>_=>Z][]U[KWOW7NO>_=>Z][]U[J/5TM/74M315<23TM7!-2U,$ MJJ\4U//&8IH9$<$,K*2K`BQ!M[\*5R`?D14'[1YCY=5=2Z%0S+7S4E6'S5A0 MJ1Q!!!!R,]().H>J4O;K78'(M_QYNVP+`W`LM,!_O'LL&R;*H*K9P`,=1'A) MD^O#H6?UZYWUZQO-^"%"_P"YESP'#_1>LG^B7JS_`)]KL#_T#=N?_4WOW[EV M;_E#@_YQ)_T#U;^OO//_`$>K_P#[++C_`*V=>_T2]6?\^UV!_P"@;MS_`.IO M?OW+LW_*'!_SB3_H'KW]?>>?^CU?_P#99K/^?:[`_]`W;G_P!3 M>_?N79O^4.#_`)Q)_P!`]>_K[SS_`-'J_P#^RRX_ZV=>_P!$O5G_`#[78'_H M&[<_^IO?OW+LW_*'!_SB3_H'KW]?>>?^CU?_`/99L15N*VWA<=60B1/'((*NC@25`RDA@CC4"0;@^U-O8;=:2":VM MHD1#H(*]K2$8(!R.ETJA55 M1]%`4?ZP%A[5'/11]G7?OW7NL"T\:_ZHF[&Y8D^IRY'^MG%`CE$\79(IJK+VLOII(I2GE3(Z+#OOX)?##LVHJ M*W??Q:Z'W%DJRI@K*O+U/6.TJ?-U=331>""2JS5!2PU4FE/3I>8@@"X-A8/W MG*?+-^ABN["!U8U(\-0*_D!U,?)_WA??;D&=;GD_G#=[%T70/#O[B@7&-#.R M8H*=N/*G0=TO\KS^7E15M+D*?X>]%"KHZF&L@>79&/J8Q40.)(I)::IUQ268 M`Z9$93^0?97#[=/G7H=W?WT?O7W]M+:W7N!O3),"'_ M`,=D!(84-&6C*:<"I!'E3HU77_3O574^)7!=7==;)ZYQ"@AO4`;_`,V;=UO-VF)KXEY.1+@'2ZD?X>ZLD3H\YM+F*\LYI() MH7#H\;LCJP!`*LI##B>!Z19Z?ZH(`_T:[!X!'_'F[;-PPM9KTUC_`(7]H1M& MS@@BS@Q2GZ28IZ8QT(ASMSO5"^][@V@D@&]N""2*9_4STO**AI<=`*:CB6"! M3=8D`5$](6R*.`+`6`X'X]F)-:````4P*8'05BABA4K$ND$LQR35F)9B2222 M2?7K/)#'*-,@U`@@C\$'Z@CW6G<&\U-1]O5P*-K&"`17[>D35=8=<5]54U^2 MV'LW)Y&LE\U;DLGMC!U^0K9M`C$M96U4#22L%54#.Q.D`7L![27&W;;=S&>Y MMHG=N):-"?Y@_P#%]'VU\UI@PF*H,3#43*@C6::*@CC5V"@*&8$VX^GMRWL[2 MS4K:1)$&-2$55!/"IT@5-,=)=SWK>-ZD6;>;N:[=!I5II9)2HK6BF1F(%'S%/^*^>>@Y3 MISJE)*B7_1OL5Y:MFDJI)-H;=DDJ)I"3-43.U-=I)"=4CDW8\DW]I)-MVJ4` M26D!H21^DGG^70BM^<>=;:)88][W'2D:Q*/K;C"K6E*2#.:5]`!Y=+J@QE%C M(UAH85IJ>.**""FB`CIJ:G@&F&"F@2RQHHX55````'`]K%"1Q"&)515X!0`/ MY=!Z2LUTU[*2TK@!F))+4)-6))JQ+&K')\SU/]^Z]TU9C"8G<%%)C_'2\3P2*KI(-+*P!!'H0>MQ/)!= M07UL[Q36TBRQ21N\;I(O!E="K`Y(P>!Z1IZ>ZG86;K/8#_7]>S=MOQ_J?53' M@?@>RU]FVAT$?TL2@"@I&@H/V=">/GGGF,:?WYN##.#>W)&10C^TX4\NE]2T M=/10Q04T:Q0PQ)!#$BJD<44:Z8XXXT`"JH``50```![,:#MI@**`#`ICR_+H M+"H6C$L:DEF-6)8U)+')J?7K#D\90YBBFQV2IHJRAJ4:.HI9T26"HB="DD,\ M,@*NC*2&1@0P-B"./=U;2&4@,&!4@@$$'B"#Y'K16KQR`LKQ.DB,K,C))&X= M&5E(8%64$$'I$IU#U2G(ZTV!_07V;MPZ1_1?\FX'^`]EG[GV?0(_I(=*\!X2 M4_X[T*TYZYZ0L1OFX$,:T-[K/^?:[`_]`W;G_P!3>Z_N79O^ M4.#_`)Q)_P!`]7_K[SS_`-'J_P#^RRX_ZV=>_P!$O5G_`#[78'_H&[<_^IO? MOW+LW_*'!_SB3_H'KW]?>>?^CU?_`/99_T2]6?\^UV!_Z!NW/ M_J;W[]R[-_RAP?\`.)/^@>O?U]YY_P"CU?\`_99/5&VI3H9RI(;.1QZ6; MHLB,CC4K@JP/Y!X(]JE8J0R\1T4@T->DKG=B;,W1+2S;EVO@-PR4*21T)SF' MQN7^R29@TRTG\1BD\0JM_A!Z7[;O&^; M*TC[+?W-F92I;P)Y(02@<+41LHP';]O43&=:]?86MBR6%V1M+#Y""_AKL5MO M"XZMA!_4D-71P)(BGZ,%<`BX-P?;,%C86TPN;>WCCD`*AE15:A%"*@`\,=*- MSYCYDWJT>QWG12R$,ITLY&"`14'I;^U71/U[W[KW7O?NO=8 MFA1OZC@CTD@BXM<6]W#L.JZ%UHYSHX>G[.DAD>N-@YFL;(YO9FULYD'CCB>O MS6W\1E:YXXK^)&JZZ%Y"%N0H+6`X%A[17-AMUV_B7-O$[>K1J3^T@GH[V[F/ MF/9U,6T;C=6L1R(X;B6.,'S*HC@`GS(ZXX[K?8.&JX\AA-F[7P60B22*/(83 M;^(Q5>L4MA+"*RAA230UAJ358V%P;#WNULMOLI#+:VT4;'S6-0?Y`=>W/F+F M+>[9+/>=PNKN&-UD"37,TB:E#`$J[E30,>(Z6H%@`/H``/\`8>U/1-0#`Z[] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?__6W^/?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T&N_.PJG8IQ[1["[#WPN0FJ8638&!H M(2:M,977<@CCZ^_=>Z#_P#V8*L)M_H#^17_`*`F#`_V MYR_OW7NO?[,%67(_T!_(KC_LQ,';Z7X/\7]^Z]U[_9@JR]O]`?R*_P#0$P=O M]O\`Q>WOW7NNO]F"J[V_T!_(KZ:KC8>#(M_P89>U_P##Z^_=>Z[_`-F"K+`_ MZ`_D5S;_`)@3!WY_J/XO[]U[KW^S!5G_`#X/Y%?D<[$P0^GU)_W+_P"\^_=> MZ\/D#6'_`)H'\BN#;G8N"'T_U\O[]U[KC_LP=7Q_Q@+Y&)@S_O67_P!Y]^Z]UT?D'5CZ]!_(O\_3 M86$/T^OTRW^V_K^/?NO==_[,%6<_\8#^17'_`&8F#_U^/]R_OW7NNC\@JL$+ M_H#^1=S_`$V'@R/]BPR]O]Y]^Z]UW_LP59S_`,8#^17!M_QXF#_W@?Q?G_8> M_=>Z]_LP-9_SX/Y%?G_F!,$/I_Y%_?NO=>'R"K";?Z`_D5^/KL3!@_=>ZZ/R"K!]>@_D7];<;#P9_W MK+_[S[]U[KW^S!5?_/@_D7]+_P#'AX/^E_\`G;_[Q[]U[KQ^0=6#;_0'\B_Q M]-AX0CGZ/R"K!]>@_D5_L-B8,_07_&7]^Z]UU_LP578'_0'\B['G_CP\'? MZ7Y'\7O[]U[H4=A[WDWS05U=+LO?6R6H:T40H=^8:CPN0K`:9*G[NA@HZJJ5 MX?7HUEP=:L+<7]^Z]TNO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__]??X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW1;/D+T_0]K3]4RR4\%1)M#M/`;CR\SDSO9U#V!C\#-GLMF M]CKG\/A:JEPR[GS=53)6OFN^=H;P MW--T;G.O9;'93MNOVS@:+L?>&)E[1P>^]HTVQL%NF8X;(4%-@Y=O\`V-!G M9:=J.OICD6JHJ(X]&6IF]U[I:]P?&KNG+[-S75/6F?BVSM7+UO56X(=R-V'G MTCV;CMA86EPF\-@S4514KD*B/-OY5*MHY/%]Q[KW2#QGQ_[_VO MO.MSFVRF:#8Y//6XZ$T]% M%D^*9_,T83W[KW3[M'KKMK:'9&V]TX'';[I-I[BWOL?/19G>F_\`(U^8P^S8 MJJ'(YNDW?AZETEBI*;:/\;QM5%N6D+4&0-+#0Y&N:>.=?=>Z4_='2/R6[#[E MS^5ZM[8BP_5&X-S],G<>*H>P$&F)L@]=4S96A%53K5+ MCJ2*>.ICJW^W]U[I'[TZO[USV-V?G9 MVO\`2-4UK24DA_B-Z$W)="9;`?&GY";.V M'5XO';M[!WUO&?"UM+V3F:RD_A4F_4J-L[7CW%N*NT43QXM7QJT*5--&I*P. M(PQ9?=>Z0'Q[Z>[LZY[NAWCVY/0KM+^&U6-V?59/>FW,C+L_"4U5G(TVOD:: MHS+"EFAER-+CX8\/35T"TT=)#+4^:*5A[KW3ON_JSO>O[6W-7[4SF&AIX,UN MC<>\=WU/:3$#%1T=-MZJ>IH4I?"TU?Y9WEGA] M^Z]TC=Z="_)S>$G86^&[-PFVL1V#C-W[8P^Q*KL/+U']UMJ]HU_]_)=P2[FH M,E'AIJG&3Q4%`F.IJ;5)24LKT66IZ:6:"L]U[K-4_'SOM(X\5LGMC;\]'M2@ M[AH>O=OXWL7<6,D[%Q7;NVZK"'(T$&+RLD6"@VU,E-D*.*5,FS5$,IH:C%2, MTLGNO="1L[XY;ZK]];3WAOW*JFI?XE='DDID]U[H%.L/CUWACL?\=9,_CJ;*Q; M8ER1[`,.\=KYI=Q;CFCV13T>^:>5]S:,K#'+B,ZAK))!7!JC_@"?N9+>Z]T/ MG3?3_;6VNJ.U-JY)4VCG\UTFNS(<5)V95[M_C?="8+*4NX^Y$W$\LQQ<68:L MQ>F*Z3H*?SRP1D(6]U[I)]%]%]M[?Q>V\9O_`'C78##;8[!HLCO;;H["QR24 M'5\G7M-GWQN6QV&KLG2PP5>]\)CZQ&2N6:;'Y#.I-*L%?+`/=>Z4_=/1G>F_ M^RMS;NVUV&^VMF;QPNQ>M<;A]O[VSVWMPX3:VW]\8/LO(=H[>R]-52XK^)-] MIGJ*+'QXAYI*6HCDJLA/2_[C:?W7NFSL;JCN_-="8G9VXLQM[,=AU?R/S6[, MU08C>'V6.W1L#);PS-;M[%8.'<]?BP5GI*G'5"8&:N$5.5:&*2;[>,R>Z]U* MR'6_R.K=J9G9N*EFV3-M_M#:IJL8E# MDZJB@DAE+P4UOO:620TR,/=>Z`GH+"HF>G]^Z]TJLAU#\J, MOU-M/86]\))G\[LKNJIWCN7<2]GX+.4_86U\]L+<.`I,V&[[J.U%WKF*'>>Y*E- M@X/>/=]/OG9R8VNVWF*"JW'+_`8LAMS'U&-J\-/0)4.E+.JF\7NO==9+HOY# M;YQ&YX]P]BX7/8G/#L[/[HQD70VCUADX\%'EH]DT^V.R8NT,[- MBMO]208'$T6Z^EY-M25WGKVR-=#E,ZN3UE9TJQ>KC<*B^Z]T=GXT;)SW7_7^ M2V[F=P8_=%`F]MU5^T,SB<@];C*G9^1K5JL2E#3/-4BB2-VG3[-*N94(+"3U MZ%]U[HPOOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z] M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7 MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][ M]U[KWOW7NO>_=>Z__]#?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW10OE/TI!W/08?$U^Y,)A,2^+W3L_)4.9JZN@.;;L&LQ%%28^AJZ66-A M43)03T].L1\S231B&S@GW[KW17QM4*EV!U4A,Y+"#W[KW354="=;UBTFWNQ>R>AV-[IS&\=YT.Y'T4,^5I"<+`]*):*1)EJ'J#%5+30^Z]TPCXWT&1P MM7L_&]F_'S)56\<)N'>."WLF6IJCL+;>UIXJZE@V=U_3PQ.9ME9%'+9F>&LB MB`J,HB4T_G5T]U[I^@Z+GFV1V5L+8W:>T^U")U=Z&CJ/K#+=* M[CW3MO)5_4='M'N&6IP%)4X[=TD6<7/5%/E,MM]D@R\.-RE:Z1.W/A2@V;A]B[OKNG\+5[;W]7YW`5&$Q=)NC<6WZ+,= M&Y7K9JW%[AW)CL94#(?ZAU/2N+2NBHSF M?B$-QO31TE/T#-GQ!U+G*:CVUD,?/VSE<)34L==)N.6&IDJI#'BW`IJ84_\` M$-0%='[KW22W'\%]SKMN@PU+V!L+>=#B-^[@W3N*JWIE(\1DL%1YBIW4V/V/ MM;+Y?;V[8/(4YJH9F-;'4T_NO==8?X>T76LV!&Y.]N MMJ[L+*Y?X-O;QEVSMG$]GY:L[%V]V#MK9=<*:CASN0IU=U83;77N,R.UQN?8;XG;FVP>T,W1KD:?/TRT?\*D MPM,\CJDHE>03S^Z]T+75W7>0PO6_8W0^7#;S MQR;&E-53[?I]L9.LQ[M!3S1YS'4]*Y\Z0_=U==&U=-[KW0*9'XFS4,6#R'8' M>'4?6K;,J-V;:Z\P&)RNV(\?B8.SH9I=X/N#==7C-MS299:BDIZ4.?^$N\\Q5U.Y=P=K[)PG:FZ>MMY4<^8IH,W]E4]R= MC055/N_(08'(3P-D=MR',5.%AQZD9_XD[N5\KDYM]= M52[$IL'NF#V8Q'0U/6]C;#VQG_`(^+F#M;!X''Q5&#K]Y; MGR#M58++U$M'2U,2Q[1$F.-3A<=C:FH6MR+FFIL352XV3W7N@>R^DMX&LW5V/$=Q5,G5 M<^,E^UWU@(4EHZC:FZHZ>*ERN4%?=Z:NDB%-4AT$GNO=`IG_`(F-NW[C-/W1 MTMM=^RME=E[0V%UAMNNH9^J*7K7LS;,]+VA@MC95$H\E64D=2U%FG&*@I:&: M:C@GKZ02Q4?R,VO@O[_P#=T/9F&KJZ?;Q[+;;N MU.O\)@.KMLRX/F@KZ=H,FR55/[KW3'1_&+/\`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`S'W7NBA;F^,_46;V-D-Q[:^2G5U%FF[.Z=[]GH]OTDF*ZUI, M'F=AX]]HT>W-E;5J9*S'+GI,/45&#S$#S2O2:XQ%45"RR'W7NG/=>S^L^X,; M345+\A.GZ;!]D=3=<9%-TT&#WAF]W4L735;GJB/-8K=E>(`-L92]1%D*JM:$ MS4\59#$[K,77W7NCZ=1Y?I_!UF\=Y;6W9LR2A^0GZ]T1ZNZXZ7R4FQ\S5?)WK>CFZ M;Z8QE!UKO':6*KLI1X#J_8.P=V;9Z^[6S.56J;'R5C?Q3+2Y.F6H6@R%'#)2 MP1E*@GW[KW3?C.A>NH.C=L]/I\C^H'H-V?'[<&(KMVUF"K<5N?![7Z8W?7[C MS^]^L-?=>Z$')_$6AVOE,O%@.U>M@-M MYOKG:V(QV[\5FF_T7XG,X/;6U]H;,JH:7)FFS,4^2Q]*V&QF?I3]Q3S4-&*J M)J3SU7NO=9_D9UUTU\F=YC=^!^3VQ-HY7$]9;GP%!3S4]-E91N7KO)-GSV72 M1U==CWJ:#$;9S>[*"L6%9Z>HART6125?X5$)?=>ZS=D];=%;1D[!V[N_N7K? M9^?WAT_\FZ.BR>:P(AR&UMJ_)3Z4E?MWHG<'3O?'755\@*3,X+Y.[TJ\539W?.6R66W-BJN;K/:VR M\OM[.R9I(ZEA'#C8:N*JK:>&&&"MHD:Z&!I?=>Z+SMWIK8W5_9%7V=5?*'8> MZJS&;_RV+W\V2I]XX3,5NF6*1JF-RC(:A13 M.H]U[ILVI\4^M]M;;S--MCY6=89M]J[>^*6*H/XA75&!QVSMIT6[JG(=98ZL MR^)R4]30T^XZ$/J3X?4-=#O;KBF[ZV;OC&; M?[%ZTS.XUV3FLY_>G:&4Z\S.%^SV34T#U%93TLL/]VI\4F6E9JN5X7-5%]R* MH#W7NFFG^/\`UYN_>;CW309_P`6+;?I\SYB5Z?=L'DIZ*GDF$**558R2GNO=&;[ MLZYZ*[GQ?3TT/:&Q,/UCU?,]'%3Q95:RFK,-M9=J]PS4>%W/2U</=.VNV][Y?O'9LF,VM,F5Q\,^XC+3.#)C:NBK:6/(+3T0601P^Z]T@]I87I M_![SZ9[NE^2VTZ__`$C=C;:R5#54^U\\V*[SEV/\9XLM2U#5 MV9AKXVE%115M333"HAIZ6JI?=>Z?M]=.=9]O[S[7[F3Y)XM,4VX-@T?:%%C8 M*&GQNW=A=2]@;>WULVEVYG8PE>M>]=MV1:?(2356.DER->,72Q3RU4E5[KW2 M.SGQA^+"XSSIV]D(*?N;M[:'9_6$5+F<_E7?(;$R&T<'V)7P4E)"\S9^HJZ+ M(TU5DZJ...@JLLL3TJ24RH/=>Z4F4^.G7>*W3)T9G>X.OZD]K9`U.8P.[*6> MI[/HZ1&+ZAP M=1VC]EF/DMUKN;LY,+F^L>UV;^\VU\AEMPY7=--LW;T>)IDGFI*ZLHZ*;;V$ MFQ,LS`52E[1?<%%]U[HS/3E+L'IOKO?^4WKV=U8T-#D=K]0[R38.,JZ;8NV= MT;.V]#L2AVVNWVDGJWSN1-3!)D:=`LC$T\*IIC$K^Z]T7[!_&6GV+%M'=59V MKU!CH8]L9.OZMV55X3=TV%W;18#;N+W'7/F$SE7)N"MH8<+@HZE*"U5/C&I: M6=)Z@1F$^Z]TA^I_C'M+<4--CMD_+7:.=WGO_<_='8N=3![>N-M8?!S M[,[@ZTRE135FQ]D=*9[(83;A;,[A^.O:FZ>S\=LW*5FUA1Q5,=#3O+A,A3[? MAIHZ2FQ;O#3P1QBE3W7ND)C/AALWO+8.\]Z=>=V4>:P^?K*/`3315%2BY#<$U1C*U:HE:-8H]ZLEZ/V7G]@]?T&W M-SU>/KLS35V5GJ:G&5N]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U__2W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T!G<72 MH[3_`(+7X_=5;M'<6!CW%CJ/*PT)R=++@-YXI,'N[$5-!%44J@J MXI:>5%=2Z&6*7W7NB\P?`;:4FW]K;(S79W869V-MJIP.:EQHJX<+NG.[JH-M M4.W,[G^^- M]35%=D*JES>7->L-?D]B5G5%'TK4[*IZ>G*T5`\N`HH:>7-8^DAR'D,DT<\; M.??NO=/&W_@YL3;.ZMN;KQ.\]YPU6TM\;7W)AHY)J"LJ*O:>T*6LAP?6VZ\S MD(IJ[,8^FEJDJX*NNJ&KEJ*>*9ZF222J:I]U[J+F/A/CZ^*MQM54Y#)[?P6*RV*H-P4M1CZ] MUSS/PHQ.Z^G]F]4[G[$SBR[$W=5[UP&Z]L8^2AR%/GUVA6[6P5I,9U52T^0PU1 MELGC(-O464I-N9BFJH\I34,[0?Q",SQ5^,J'F$(`GB+ZD]U[IPW/\!L#O*HW MINK<':V]7[/WO0YJCR.[L734>,VY2KN?9-=L'<:P=<+))C9DGHJ MI6`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`3#2Q0&LA5XJIW M,CN?=>Z1E7\':N;`;^VS%W!6_P`)[`[6V_WSDXJK9E.*B'N"ARN*S&Y3V/EMK[A2OQ<2K0U.9K\CG_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_= M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=> MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW M7NO>_=>Z][]U[KWOW7NO_]/?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U_]3?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]7? MX]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_];?X]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]??X]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U_]#?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U_]'?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]+? MX]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]/?X]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]3?X]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U_]7?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U_];?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]?? MX]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]#?X]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]'?X]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U_]+?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U_]/?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]3? MX]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]7?X]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_];?X]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U_]??X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U_]#?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]'? MX]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]+?X]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]/?X]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U_]3?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U_]7?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_];? MX]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]??X]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]#?X]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U_]'?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U_]+?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]/? MX]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]3?X]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]7?X]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U_];?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U_]??X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]#? MX]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]'?X]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]+?X]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U_]/?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U_]3?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]7? MX]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_];?X]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]??X]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U_]#?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U_]'?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]+? MX]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]/?X]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]3?X]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U_]7?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U_];?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]?? MX]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]#?X]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]'?X]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U_]+?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U_]/?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]3? MX]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW3/N'<."VEM_.;KW1E\?M_;6VZZ_X>"_E7?][#/A]_Z/SKK_`.K_`'[KW7O^'@OY5W_>PSX??^C\ MZZ_^K_?NO=>_X>"_E7?][#/A]_Z/SKK_`.K_`'[KW7O^'@OY5W_>PSX??^C\ MZZ_^K_?NO=>_X>"_E7?][#/A]_Z/SKK_`.K_`'[KW7O^'@OY5W_>PSX??^C\ MZZ_^K_?NO=>_X>"_E7?][#/A]_Z/SKK_`.K_`'[KW7O^'@OY5W_>PSX??^C\ MZZ_^K_?NO=>_X>"_E7?][#/A]_Z/SKK_`.K_`'[KW7O^'@OY5W_>PSX??^C\ MZZ_^K_?NO=>_X>"_E7?][#/A]_Z/SKK_`.K_`'[KW7O^'@OY5W_>PSX??^C\ MZZ_^K_?NO=>_X>"_E7?][#/A]_Z/SKK_`.K_`'[KW7O^'@OY5W_>PSX??^C\ MZZ_^K_?NO=>_X>"_E7?][#/A]_Z/SKK_`.K_`'[KW7O^'@OY5W_>PSX??^C\ MZZ_^K_?NO=>_X>"_E7?][#/A]_Z/SKK_`.K_`'[KW7O^'@OY5W_>PSX??^C\ MZZ_^K_?NO=>_X>"_E7?][#/A]_Z/SKK_`.K_`'[KW7O^'@OY5W_>PSX??^C\ MZZ_^K_?NO=>_X>"_E7?][#/A]_Z/SKK_`.K_`'[KW7O^'@OY5W_>PSX??^C\ MZZ_^K_?NO=>_X>"_E7?][#/A]_Z/SKK_`.K_`'[KW7O^'@OY5W_>PSX??^C\ MZZ_^K_?NO=>_X>"_E7?][#/A]_Z/SKK_`.K_`'[KW7O^'@OY5W_>PSX??^C\ MZZ_^K_?NO=>_X>"_E7?][#/A]_Z/SKK_`.K_`'[KW7O^'@OY5W_>PSX??^C\ MZZ_^K_?NO=>_X>"_E7?][#/A]_Z/SKK_`.K_`'[KW7O^'@OY5W_>PSX??^C\ MZZ_^K_?NO=>_X>"_E7?][#/A]_Z/SKK_`.K_`'[KW7O^'@OY5W_>PSX??^C\ MZZ_^K_?NO=>_X>"_E7?][#/A]_Z/SKK_`.K_`'[KW7O^'@OY5W_>PSX??^C\ MZZ_^K_?NO=>_X>"_E7?][#/A]_Z/SKK_`.K_`'[KW7O^'@OY5W_>PSX??^C\ MZZ_^K_?NO=>_X>"_E76)_P"'#/A]9068_P"GSKK@`7)/^7^_=>Z7M;_,I^!= M-T/V'\G:/Y7=-;CZ#ZHSN#VQV/VGL;=,'86V-G;AW)645!@\-FIMC+D)8ZBI MDR-"$C$1(69':R'4/=;TD\!T44_\*$OY-`)4_/KJ8%20P.![+!!'U!'\#^H_ M/OW7B"#0]=?]!"?\FC_O/KJ;_P`\/9?_`-8_?NM=>_Z"$_Y-'_>?74W_`)X> MR_\`ZQ^_=>Z]_P!!"?\`)H_[SZZF_P#/#V7_`/6/W[KW7O\`H(3_`)-'_>?7 M4W_GA[+_`/K'[]U[KW_00G_)H_[SZZF_\\/9?_UC]^Z]U[_H(3_DT?\`>?74 MW_GA[+_^L?OW7NO?]!"?\FC_`+SZZF_\\/9?_P!8_?NO=>_Z"$_Y-'_>?74W M_GA[+_\`K'[]U[KW_00G_)H_[SZZF_\`/#V7_P#6/W[KW7O^@A/^31_WGUU- M_P">'LO_`.L?OW7NO?\`00G_`":/^\^NIO\`SP]E_P#UC]^Z]U[_`*"$_P"3 M1_WGUU-_YX>R_P#ZQ^_=>Z]_T$)_R:/^\^NIO_/#V7_]8_?NO=>_Z"$_Y-'_ M`'GUU-_YX>R__K'[]U[KW_00G_)H_P"\^NIO_/#V7_\`6/W[KW7O^@A/^31_ MWGUU-_YX>R__`*Q^_=>Z]_T$)_R:/^\^NIO_`#P]E_\`UC]^Z]U[_H(3_DT? M]Y]=3?\`GA[+_P#K'[]U[KW_`$$)_P`FC_O/KJ;_`,\/9?\`]8_?NO=>_P"@ MA/\`DT?]Y]=3?^>'LO\`^L?OW7NO?]!"?\FC_O/KJ;_SP]E__6/W[KW7O^@A M/^31_P!Y]=3?^>'LO_ZQ^_=>Z]_T$)_R:/\`O/KJ;_SP]E__`%C]^Z]U[_H( M3_DT?]Y]=3?^>'LO_P"L?OW7NO?]!"?\FC_O/KJ;_P`\/9?_`-8_?NO=>_Z" M$_Y-'_>?74W_`)X>R_\`ZQ^_=>Z]_P!!"?\`)H_[SZZF_P#/#V7_`/6/W[KW M7O\`H(3_`)-'_>?74W_GA[+_`/K'[]U[KW_00G_)H_[SZZF_\\/9?_UC]^Z] MU[_H(3_DT?\`>?74W_GA[+_^L?OW7NO?]!"?\FC_`+SZZF_\\/9?_P!8_?NO M=>_Z"$_Y-'_>?74W_GA[+_\`K'[]U[KW_00G_)H_[SZZF_\`/#V7_P#6/W[K MW7O^@A/^31_WGUU-_P">'LO_`.L?OW7NO?\`00G_`":/^\^NIO\`SP]E_P#U MC]^Z]U[_`*"$_P"31_WGUU-_YX>R_P#ZQ^_=>Z]_T$)_R:";#Y]=3DF]@,#V M62=*EC8#!W/`)X]^Z]U9ET%\@.I_D_U=M/O#HC>N+['ZAWU39.HV?OC$4V7H MZ#/IA\W4[>RDE)2YJFIJA5@K*.HIV,D2DO&U@5TL?=>Z&GW[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7_ MU=_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=%G^:AM\./EF?K;XS]\&QO8_\8LROUM8_P"\^_=>ZJK_`)-?PJ^&W8/\ MJWX$;VW[\2?C'O;>>Y_C-UIF-R;LW9T)U5N+7FGE=V^K,3[]U[JR_\`X;Y^!'_>$/Q"_P#2:^F?_K+[]U[KW_#?/P(_[PA^ M(7_I-?3/_P!9??NO=>_X;Y^!'_>$/Q"_])KZ9_\`K+[]U[KW_#?/P(_[PA^( M7_I-?3/_`-9??NO=>_X;Y^!'_>$/Q"_])KZ9_P#K+[]U[KW_``WS\"/^\(?B M%_Z37TS_`/67W[KW15N]-F?R=/C?VA\?.F^Y/CG\*=E=C_*7=V1V'T9MJM^+ M?6^0J=[[LQQI(I<;'587;=3!0(9JZDIDJ_=;`)X=,N6P_ M\FO"_(#LWXN9/XV_#O']Y=/='U'R.["V?6_$/8M/2X+IRC6FDJMXONB3;0Q, MD:?TMZ=/.\/D-_(4V#C>KLINKXT='T0[GV%GNS>O<-1_RS-Z9G=E?LC:^\:C M8&=SF:V7@^N:G+XA(Z]I;TZ%':.ZOY%^_N7Q7W'_)#^96\*EDVNLV8@BHZ6::EJ<-%4Q502U-)*2+>Z]I(XCI:[-VC_`"=^PJGXR0[( M^.?PHW9#\Q]K[VWG\<*_;_Q8ZWR6'[%VYUSMRGW5O6LAS$.W/#CY*"BJH6FI MLH::?S>2F6(S0R*ONO4(X]!!\DNQ/Y'OQ)[1J.FN\_C#\=L'V'1["PW:&1PN MTOY>U7VC3X?8&>R5?BL;NG.YCK'8N7I*&E>?%U\9:LFB*^%V8`"_OW6LGATO M^ZT_DH?'?K3I3N'MWI'X+;:ZS^1>Z]E[-Z4WG3?&#K3ZM@K=T["P.1GQ.=R^"S7]WSC:B>EGI:EI<>E9]T(( MI:D0F"-G'NO4-*TZ"/:>X_Y'N]J"ERV&Z-^%&/PU9TOVQ\A$SV[/B7L79^WJ M'J'HOM"3IKMG>&:SVY=LTM)118?<<38^:&IE29Q:>"*:!ED/NO4(XCI>P[*_ ME)R?%S.?,ZL^('QIP'QQP/7^2[4J]];H^#>"VSD9>N\9C(\R=W46Q<[M*GS\ M])44K&HHS'C"]1%I>!)`03[K7'J&,)_)D9^JM'0?PR]Q](=5XW&YK?W8;[P@V[_#Z*BQ]'F<;42I7SPSZ)3IB9HI53W6]+>G1 M=MD?(C^0=V"N<;;/Q^^-E4V#ZOW)W-2TU?\`RZ-R8"OW_P!9;3F@AS^[>G?>4-**B*>2#:\5?.T#I4+'X27]^Z]I/&G28VY\OO^$\N[<3VIG\'T7\ M=7P72&W*W=':^8R7\MS=>$Q^RJ#&[@Q>V*['9>HS77=.%RR5F9QL0PJZJ]Q- MY$IFCCE9?=:Z,W\9X/Y.GR\W!NS;'1GP\Z)RV6V3A\?G=PC?'\N[(=04-/C\ MID6Q=)]ED>W-B8.&ME,J.'AHI)7C4:Y%52"?=>Z#[N3M'^0[T!W!/T5V[TW\ M+-H]AXFKVACMXF/X<[>W%L'K3([ZG2#:]!VQVWM_9]1MC:DU7Y8)%BW%E:)T MBF@FE5(IXG;W7NN'>W:O\A_XU]A[KZM[>Z*^)F(W?U]C-JYCLO\`NQ\%$[&V MSU9B][4B9+;&0[1WOUYLC*8;;T552.M>K9>OI]-'_E4FB#]SW[KW0CI%_);/ M>N^_C8?CS\,9.W^M^B&^3F[\%3_$[KVHPV*Z(:FIZVG[!3><&VVPM53O#502 MB*DR$DVEU8QA2"?=;TGTZ`&J^2G\@.GZ:Z/[\I^A/C1F^LODCD^R,1TKE-K_ M`,O7([PSN]J[J2K%!V"E+L?:FPZS-TZXZ5AY)*S'PJR!G0L!?W[KVEO3H0-Q M]F?R&MJ=3=`]Y9SJCX+4G5WRD[!HNJ>C-SCXH[+J3NSL.KK9L94;:KL)1[4D MR.*DH:NGFI,J^7I:5:&<+%5F)W0-[K>EN%.C`UG4?\IC%_)7"?#[+?&/X4XS MY'[HZNF[IVSUC7_&+JNBR.X>MJ3/5.W,AG?RGE>IIO$9)(51D)]U[2WIT;/I#X MO_RTOD'U;L;N7K;X4_%ROZ_[(VYC]W[+RN?^('7^R:_-;7S"?<8/.+MK>6VZ M+)T\%=3E*JE-521F2%TD4:'4GW6NA8_X;Y^!'_>$/Q"_])KZ9_\`K+[]U[KW M_#?/P(_[PA^(7_I-?3/_`-9??NO=>_X;Y^!'_>$/Q"_])KZ9_P#K+[]U[KW_ M``WS\"/^\(?B%_Z37TS_`/67W[KW7O\`AOGX$?\`>$/Q"_\`2:^F?_K+[]U[ MKB_\OKX$A2!\(OB&-?[;6^-?3(NC^E@1_!;$?X'CW[KW6JB=I[6VC\>/YU^R M=J;9V[MG9N!_GQ?$K`8+:.`P6)Q.UL-@H?D3U%3PX7%[=HH4HH*1(V,:TT<` MC"FP6W'OW3Z,!2I\C_AZW(%Z9ZA;43U9UQ_ MT,=0_P#/K.N/_0%VK_\`4GOW7NO?Z&.H?^?6=_T,=0_ M\^LZX_\`0%VK_P#4GOW7NO?Z&.H?^?6=_P!#'4/_`#ZSKC_T M!=J__4GOW7NO?Z&.H?\`GUG7'_H"[5_^I/?NO=>_T,=0_P#/K.N/_0%VK_\` M4GOW7NO?Z&.H?^?6=_T,=0_\^LZX_\`0%VK_P#4GOW7 MNO?Z&.H?^?6=_P!#'4/_`#ZSKC_T!=J__4GOW7NO?Z&.H?\` MGUG7'_H"[5_^I/?NO=>_T,=0_P#/K.N/_0%VK_\`4GOW7NO?Z&.H?^?6=_T,=0_\^LZX_\`0%VK_P#4GOW7NO?Z&.H?^?6=_P!#'4/_`#ZSKC_T!=J__4GOW7NO?Z&.H?\`GUG7'_H"[5_^I/?NO=>_ MT,=0_P#/K.N/_0%VK_\`4GOW7NO?Z&.H?^?6=_T,=0_ M\^LZX_\`0%VK_P#4GOW7NO?Z&.H?^?6=_P!#'4/_`#ZSKC_T M!=J__4GOW7NO?Z&.H?\`GUG7'_H"[5_^I/?NO=>_T,=0_P#/K.N/_0%VK_\` M4GOW7NO?Z&.H?^?6=_P#=1)"H M`!<\V`M[]U[J[7W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7_UM_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%F^:G_9&_RT_P#%9N^/_?697W[K MW11OY'G_`&Z&_EU_^*J]6?\`NC7W[KW5J7OW7NO>_=>Z][]U[KWOW7NO>_=> MZZ8V4G^@)_/]/\/?NO=:JO\`,N_E_?S'/G#\H/D]VKUCL;I79NT.F.E>L.KO MB1E^Z,ME,AOO<^\MC;NHODYF.VN@9-@5+T^V\K7;IH,3M66HW8@$U-3/$T'V MLDK'W3L3!<'I&_)WX1?/#Y"_*G?GRMVC\:,AM3=G?W4'Q"^.F]:7<.Y^K,74 M;,ZB[VZ.WMU;\U<=553QGPG^3/4OQV[:VSBN\_G+3]H]& M+D=Y5^Y\33SX7+[6I!75.-I*@L'^U\\<,T'@]^Z\64@BHZ/7C/A%\J/D!\D/ MC)V;'N[YZ_"7;&QOYHMR;_K^Y^CNR?DE4=D47R,I:[!=9=R;\W!%O2DS MLV5Q-*=RR9:AC?48Z99:Z.8R0'W50RT(QQ_+JKS'?R>/FOV#U9L+JNBZ0I>E M*P?R4\]\:\_7[ARNU/[FUORAP_S?/?>1ZXWC3[>SLE54'?..HW?,9J)VH77( MS222#UTPUU;6H)SY_P`NKLLQWA_,0WYL+M_>6TOY6*=0]D=;_$'-;*ZMR6^N MS.ALGW=N;Y$;K*X3#;)Z8R6W,EDL4FQ,.ULUE:[/Y?&RS^***#'3R,PCWU3M MKQ_S?GU6;TO_`"Q_YA_Q#V-\E.GDZ[ZC[+V/\JOY4W9_QMK*SXXUM=MPT7R7 MZLV'FGZAW=W')VQEX&K-Q;U;=6/2*X= MZUJJ?"9;=.,3&Y< M+59["4\.J0!S,0/=4CIJS3\^@-[F_EE_S'OE1LCXE_&G=O7G MQ?V3LCXJ?RSQT?E-V=DUNX+K?>&5Z

G:4^-E_BE91I%-3WC@FE?[J!: M9_#KSL-+9\_\W5Z?R.I?E3\Q?Y//R)V%N3XW9WJGY==J_%WL?KVLZ%FSNS)H M7[9J=NR87['9.Y*?,5.*?"Y*I/W&%GKLI&ZT[JE8(9(Y5'NFD-'!/5/_`'7_ M`"C/E_N+LS>GQFZQVM2[?^'-?\`_E[M7XY[Y;T_E/)LO?.\/B]NO M&29"+)/MN3=VUV^^P>H=ST6[=_[OZ'J^@J#I_H_!]6Y MC,5?\`)K7S$N4R9I%,-)30FF,MB=]5.D*U#6O1;=Z_`[Y_<_P`==N8_=^R*/.=F]S^M?G'\2 M=X_//I38OP(V[\P<)\OOFCG_`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` MW]MVKJ<;DYI6>B..RZ2M**NF*1;ZUJ4#36HK_(_[/25D_E7]P]L?RS?Y8'4? M9O1^Z]E=\==]\T6R?DMA=L;QVI#NK9WQ![V[ES^;^4?7F;W72UTM'EL!D<+) MAWKJ"EJ*J25X8'AB,J./>NO:@&-#Q_P_ZJ];5>*Q&-P>/H,3AZ&EQF*Q5!28 MO%XR@@BI^DW3E[]U[KWOW7N MO>_=>Z][]U[KWOW7NN#_`$7_`(.O^]^_=>ZTM=Q?\R?_`)XO_C?GXG?_``1W M4/OW7NMTI/HW_!V_WOW[KW7/W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=8VFB7AI8UM]=3J+?G\GW[KW79EC'UD0>H)RZCUM^E>?R?P/?NO=> M\L7_`!TC_P"2U_WWX/OW7NN(FA)($L1*Z2P$B$KKX2]CQ>QM_7W[KW7,N@`8 MNH4D`$L`"3]`#[]U[KH21GD2(;`$V9>`3I!_V_'OW7NN0(/(((_J"#_O7OW7 MNNM:"_K7TW#>H>FPN;_TXY]^Z]UT)(R+AT(L6N&4BP^IO_3W[KW77EB#!#)& M&*ZPNM=13_5`?6W^/OW7NN_)'J">1-;`D)J740ILQ"_7C\^_=>Z]Y$^FM+BP M(U#B_P!/?NO=>,L8^LB#Z_5U'T;2?]L38_X^_=>Z\LD;?ID1N2/2RGD&Q''O MW7NO"1&_2Z-]!PP/ZN1]/Z_CW[KW7FEC4D-(BE>2&=01<7%[_P"`)]^Z]UY9 M(VMID1KVMI93?4NI;6_J.1_A[]U[KS21H0'=%)Y`9E4GFW`/^)'OW7NO"6,B MXD0C^H=2/I?W[KW71FB4V:6-3_0NH/\`MB??NO=9/?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]TG-W_P#'J[D_[4&:_P#=7-[]U[JFW_A.I_VY MN^%O_:D[?_\`?_;J]^Z]U=K[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K_]??X]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW19OFI_V1O\M/\`Q6;O MC_WUF5]^Z]T4;^1Y_P!NAOY=?_BJO5G_`+HU]^Z]U:E[]U[KWOW7NO>_=>Z] M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[J!D4G>G84KPQU&F40O4T\E M53I*T+"*2:&)XV*JUBP6121#&=*]=9KMGHS"_'GK2K^3D=+3;[[AIQD.FCN'.U^+V)@:S'XB>F METBOR]5-1M-3BD>J'NO="W-\J/F15],?RD.T>SO=77T>:R%!UULJBQS8''8^KJS)/6UTF12HIU(@HZ6+W`C MT4E!B=NX[),T,ZV>HFI8D*R2(R^Z]U7%VE_-&[K[7Z:^"W:O2F]OD1M"B[Y^ M'7=?:W9F-^)_Q)V!\O=X;5[TZAW'LS9^ZJ'>FQ-PK5'';=P.4RFX*.O-)D8) M)9Q1P+4J7$A]U=*:L_X:=%RV3_.#^;<.YUW!O?>G4NY]H[M_ES="978FU^OM MI;6K]HU'SP^1O56[M[=/9##[MD(KLE092LV;D<74[:CJ&CCJWJ(H6'VR0S^Z M<<+I)!ZY;4_F3_S&LA\;.H>^.SNU,OM#86,^*M%VIVIWGT5\;ND?D#MW"=GX M7OS=VT^P\W\K^DQDL=O+;G7J8#"T9Q>7+#!-B MXXX(*^21>!J/AUV;L(4E1V!@!D*\KF()J:26#!1ME#.) M)D2+W7NAC^7?SA^?OPIZ]KL74?+GJWY`;Q[E_ER;V^5>P>P8NE.N=JGI7M'K M+?>QL!693;NW=I"JQ^1JM4B1^Z]U![#_`)NW MRXQG8W9G2OR<^:'Q"[;[=W MGW+O?XO9W8F2HL]V+\:\;\>MX46T]^0UV#HIC5[2K#@-T8?)56'K,EM[-X[" M8QI**=/*E0HAF]^Z]T]_`WYKY'>/\M.@^77REWS@ZW-[4POR?WOV;F,9A<3A M#3[)Z4[BW?@Z6JAVI@510T.`PE(#X8M4SC7RTG/NO=4D;)_F^?-KL[X6=R46 MS^Z.C'^:]%\G?@]#UKFJ7;VSV"P6V^L=[XS&PRK+6;+RM=EMF M;JS$6/6HCJJ43HK/)$TGNO="IN7^;%\LNV\_W[%TXN_MNMLSY(_`OH\=+]8= M>]'[P[YZPW9O_J??=;\INGZ!NY?M-NY',T.Z]K)!#69NJ2*.CA>:C=$J8PWN MO=;`_P`)<_VANGX^[9W#W%4=P?W^RN3W+/E<3WSMGHW:':6VZ>#/U%!C<'N+ M!_'.2?:B*((8ZFCDHJF:62GFB:H<3:E7W7NC:>_=>Z][]U[KWOW7NO>_=>Z] M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZX/]%_X.O^]^_=>ZTM=Q?\R?_GB_ M^-^?B=_\$=U#[]U[K=*3Z-_P=O\`>_?NO=<_?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO==$`@@\@BQ!YX/^!]^Z]UK<8/O+YL_\-[5?RPQ6_P#MNDHX M?Y>7>':78._NRJ[IO-09?O`;8HLKU!N_H/";>-358W[.6+-5&0@S&/IZ%J9J M2)J>2H`>+W7NC#;Y^2_=_5/>E3TY09CLW9>T-R;;^,]5-E/D.O6>[]X[#C[; M^3:=1[U[9VWN3`5U;AY,11T$E)@8Z#,ULLL.8R6/KX\?-10UJU/NO="1V;WM MVUU1WK5?'?!=CY+/;$K]X?$3;V9[OW-'L#+;HZ3'>N=W_C=T;5SU?.(*>LRE M?_=7;]#MVKR.+DDHZC<--)+%D8(TA]^Z]T&GR&[R[UV3V9'\?=A]F;VW=@\# M\I/AIL2FW5BZ.5W+O?LOH#X@;IWY1-NC%[YQ^7VG2U.8[7W+MKLFIZ]PF] M>TL5LS/[\W!D\?)14%;C-KXBNJMR34BU,=X*5XFDU'W[KW11/FAW=W5T!3=E M];]9=Q;QW?&>G>H.R8-\Y.JZ[??O7.Y=X?,':/51P/\`'Z3'T]**7>V$S>9& M"6JQ)BQ[8RM>";P24\%+[KW5D'2N-[(V_CY_[RX/?,3UF7K(\C'VAV[AM_YO M$T$&.C;$U>".V*%J5XZFW5T7V_\`'NCBR>_JG;O7WQT[*ZKI&Q6_-G;RCB:G MQ^?S0I\F*3*HM345HQ52*"F]U[H)>O\`N;Y,R?RLNSOEGN#>_UDWWWYU?L3JCXP;J[6Z%J-_[RZSS7:J]U;$ZOW;N'>.7R M57LK^+X^;9DBQ[5?&XC+3M4?Q"GRDC0Q4DT"-[KW3GNS(]U8_P"2O0?3FT-] M]];^VUNSX@]K]T[HPN-[1V7M;ON M]H.B^MEW7M^JJJ>"%\[^_P!@4N_:D53%S#CN%ZXVI%O#XJ=3]D]D;DWWTIC\?'7[FCJ M'96Z_D#NW=67[=RNV]B?* MGY?;$VWGX.Q-B8_KK$[5ZP[`R^V=E;9EZWHZ2+(SQ4<<$='Y)=;R21B>61T- M_?NO=`[\,?D)W;F\A_+=.\]U]P5=-\IOC=DM_P#96:[I?K[/[;[6WEA^CL)O MREJ^E!UW-55.WZ@U=969::#+0XVDEQR2PB.2K6!$]U[HT?97;':FUOF[E-H9 MOM+#[:Z4_P!D#[G[HH-MCK]\I)L[>W7?9VT\1)V/NFII*N?(YTTM)E*L18K' MK1QB'7"4J*B5)H_=>ZG?$?LSL3\MK[-V3\?MZ]?Y+<5'M_( MY+Z]U`[I MW]WAF_D..N^C]^9#-;MP^3^/-;+L'";)U=8=9=<9/?,F7[TW'\D=_9F">CJ* M[<&UZ>JH]EX3%5:9."ICIZN*D^VGJJ]/=>Z!#X\_(_Y%]J1X*%-XT4&X>XOB M%VOW_DDW)L[!;EPWQ=[;VEVW1[!V[UE4[;VG)@JZJ@:CK\GC6Q^^4 M@PN[N]NPMLBB2KWC19>09"BIMK;36FJ:6>G:6G"5%30R0>Z]U?3[]U[KWOW7 MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NDYN__`(]7]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7_]#?X]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW19OFI_ MV1O\M/\`Q6;OC_WUF5]^Z]T4;^1Y_P!NAOY=?_BJO5G_`+HU]^Z]U:E[]U[K MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NH&1KX<;3O5U+PQ4L"2SU< M\\\-/%2TL$9EGJYI)V51'&!=V)LHY-E!(]U[HAW6O\T'X.=LSY6/9_?NWUIL M5UYO?M^',;NVSO[KC;6Z^I.MJR2D[`[3ZUW5V)B\7CMU;=PIA=LGF=N5-;2P M(8Y9)%BEC9O=>Z3V!_FS_`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`>'?>U/B7W7UGUM\?>ZNU-R9W<^(ZZ?Y+[5Z?CVWL;$9G M*3X3'[?8[E6#$+_":4@ZVCG5HU]UKI2]Z]X?REZ2KW]V#\@>N\6<_P#(7XZR M4/>\6]?B3WM4;\R/QDV/NZIVM09?Y'[/.U):R$&:AJL319S<(K/%7T4,86*:DA]^Z]T7397QU M_D>Y+S?B#AZ9LI0]\;2[;[!I?B?\G\)U;E<3UYGJW)=Z8+.]UU>"I]J MUE+%E-N5T=;&F8:*NJ:8TT'FE?Q/[KW1Q-G4?P#^=F_L/V;2=([GWYO7!;!Z MSRVV.Q.T_C'\B>H,7E-A[*[&I.V.J#MO=/:NW]OXO,1X[<1I-PXR&DDJ7AF( MJU41G4?=>Z+-V/N_^1KW3E_F5MKM"A^..Z:[;.7H>Y/F#)NG9NX<'A]X9GX\ MF38:]C29S[.FHMXUFU)\G)@:NKV[45\T%=4B@J-=9*L?OW7NAVZ8^3_\K[X8 M_"3+]R=-[@Z\Z(^&VQ>PLA@-R1839N^MKG9W;&Y=SP8G.[2SW5^7H!NBCW!) M7U=,:O&3XH5"*WF>)(%,GOW7NC'[:_F$?#[=_;>]NC-O=[[(K.S.N\9NC*;P MQ%6^7PN%PR;&@HZG?]`V]LU2P8.>NVW%D,?-N;'TN1DJ<3%54TM?#`DRM[]U M[H>>D^[>LOD3UUA^W.F]WXC?_6FY*W<=#MG>F`>:?`[B;:6Z*W9F=K,+6S(@ MJJ1,ECJR&GK8`T%3&BU%-)+3RQ2-[KW0L>_=>Z][]U[KWOW7NO>_=>Z][]U[ MKWOW7NO>_=>Z][]U[K@_T7_@Z_[W[]U[K2UW%_S)_P#GB_\`C?GXG?\`P1W4 M/OW7NMTI/HW_``=O][]^Z]US]^Z]U[W[KW7O?NO=>]^Z]T'/:W;'7W2'7^\. MUNU]W8+8/6VP,%4[FWIO3WK%UQAM]2T4,3R& M@J<]408F"958O4L$"&S1TQTX"_:?8N07.8G M;VRHQ3Q51?,5.6I(&11'/"VI(V'J`N#?W[KW0FX?Y#=-[AW?L7KW#]C[2RV\ M^T^L,CW/USM['5[5E;O/J?&3X^DK]_8(0JRS8R*7+8R-JD-I+5,0`NWOW7NB M/-_,!_E90[*W'TC-W/T12==[5V9G:'=?6%7M/*T.R]N]>X3'5E?FZ;/;4FQ$ M=#28B&BH:YW2>)*=D@G`U"-_?NO=&.WOVU\1,/O'^*]@;QZ7QV^ZGXU[M[1? M/;NCP,.7?XHXK.4%3O?8A0#:,5;6XZ3(12S"G,LD+-$7L3[KW2,Z5^0 M?P1[,Z>['R_1?8'0VX>F.NL%79KMF@VO2X6+;NU-KR[;?<]9F=];0FIX9H:* MMQ:/71UM90>*KIXR8I)E6R^Z]TTY+Y$_R_=A]#=']OU>^>B\3\=MZ;CPN?\` MCQNS%[?HZW9N9W@N%R&6Q.=Z_3"44\G\66@I\I4"JIX5GC1*HNX*R6]U[IWR M_P#,7^"7^CKK3L'(?)3J;)=;]T4^[6ZSW%B,C4[KP^_:38M32XO?$6(7!T]4 M[#%S5U+2Y*.>)6B>:-9%&M0?=>Z465W#\+NO_C5D^X,]%T3LOXK9+#X3L_/; MHW%M[;FU^L9\749ZESFW]UYC'Y*DIHFF-#P M>7S6Y-W[4QL]!NK$4^=Q-!+E!EZ"AQ]339)9TCJ::"G:&Z2.2[Z_ ME%]5]/;0[/7.`SN!V M]N3=&%S.U-\=5=FU9VAA,WEHRM1CTV[G9I_X;35&3>.EJ6=X=369??NO=)+Y M*_(G^69UWV1M[9GRMWQ\<-N=C[;VKMNBPM/VCA\8E7M':'9N87%;9QT>Y*ND MFIL5CU(GPD]?2O)5'%J*-2],!& M?=>Z+!L/Y/\`\GG(;CQ=3UYNSXKT.YJ#.;!V1C:W"]=TV(.*W-45^'ZKZPVR MU1+AZ>""O2>KP>#Q=%,5FB1J**$1I'$%]U[H4MJ=X?RRJ_Y+YGJO9V[?BW+\ MIEWOOIMQ8##T.VJ??M=V/AL6V8[,ICDJ*!(J_<5)23O/FZ6&IFK45I&J5OK] M^ZW0]+SK/OGX"=BXSXJ9[J[?'0.Y\!NW<.\MA_#>MVM2822A.X=@;/R6+WUM M;I7[:G44$N.V_C,E35]-1"!5HX)(R&BLH]UKJ;\A?EQ\&_CGVSMW'_(7NOH[ MJ[MO,;#:#!/O>NQM)O&FZYW'NZEQLLE?DQ&\V.V[6YNGH(VEKY8:*>LAC!9I M(AI]U[H.ZSO?^7;@^VL?\:*'LOJ_:7;6VNX>O,O6=6[`Q\F%R4/:^Z#M&@,(DKJ7*453%#452QRTTL2$FD9HV]U[H7N\X_A7T5E]N=M]]T'2'7V MX.Q^T]B;&VYV-OG"8'%YC=G<.;A3$=;85-SSQ>2;+/!BXJ;'R3R:DCI8T#JD M2@>Z]U!E^17PNZ_[.[ZZNJ.S.D]G]N=<=>2][_)':[?PK;^X=O=9OCX9Y^S. MT#'%#JH33Y".5ZJLE>_W%_U2-?W7N@?R_P`O/Y8&UMM?'S=&0[+^/\&V^$)[0P?2DOR8ZMH.U=S;@PVT=O;-RN4J\17Y;=^Y=O0;KV[M.DGRT- M/3-DZS'U=+508\U"U#K*@$88A??NO=2-[?S$OA7UUMC&[TWI\E>I]O;8R_8? M974^*R%;GYGERW8O3M3/1=J;4Q6.IH7JJBHV[-2529MH:=HZ+QL9W06/OW7N MA+W#\L_CCM6BZ0R6>[MZQHL7\E-SXO9?0.9CW9CJ[!=O;JSF.;)X;";#SN.: M6DKYJJ)2]/XIBL@!T$GT^_=>H>C%*254FUR`3;D7(YL??NO==^_=>Z][]U[K MWOW7NO>_=>Z3F[_^/5W)_P!J#-?^ZN;W[KW5-O\`PG4_[]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=?_]'?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW19OFI_V1O\M/\`Q6;OC_WUF5]^Z]T4 M;^1Y_P!NAOY=?_BJO5G_`+HU]^Z]U:E[]U[KWOW7NO>_=>Z][]U[KWOW7NO> M_=>Z][]U[KWOW7N@E[WZY7N+IGM;J%LO5;?7M?K/L#K-MP4-(:ZKV^F_-I5> MUWSM/2^6'R/2+5&=(S-&'90I=`=:^Z]U2'7?`GYN]\?#N#X4=^4WQ1ZJV1UK M\(MQ?%?:7;W7=5N?M/L#L/?E!'MW;W6^^L:F:P>&GV/M-Z';%)4[QVY#5Y.H MR4M2*>.>%*&*9_=>Z#;Y?9_8NS/B]T]VSM/XF;$^.G5/6V MU.V=W[VVMV!NRM^3_7_R$[4WMNGL2LVSCI]NX2%-A08[;F(I\5D:IC53R5=0 M/'&&]U[HUW8'4O\`,?[?W/\`%GY2;QZ6^+&S?D3\0^]-^9#`=-;7^1._=T=> M]M="]V=0R]:=F4D_9F5V1CY\%NBEJ9H:[$F3!U=&T5*T4CJ]3JA]U[JNGF2*7^(S12QTH`CGC]TY&0&J>E9L'^43\D?C]LO9&S>N]H[ M>WMM78/<7STR>WMI;)^9_;?P_P!PR]8_(H[`INII]P]G=,X`Y&5WI]I9'^\^ M"I8HJ?W[IGHV_P`4?CS\S/Y>/9V_=B;=PW6OR$^.O?GR#^/F4QF1VWCL[U1FNF\= MDNM9NO.]L_0=7XB'<5#18G'46VMHUU#%/G8*2HJ),JYDIZN>EI*KW7NK`\AT MKO?(_+#MSNN-\(NS=]_#KK[HK#4_\2FCW`N^=L=F;XW77R5N-E@,<5$U'N*@ M\-1Y6ZU^^N/Y2_S5Q?Q3WS\9=P=*=)[4J]R;.^)V(KM]9+^8 M/\GOD=MK>V2Z!^0^RNP]QTHZ5[GVY_=W:-#EL/A\W4B';\?C$GVV*T_9NTD? MNKH0&!/2XS'\DONJI^2N[S79+IGL7X>5WR2^%>Y^N^O]V93-4VY=K?%;H_(] MLYG?71V>PM?CZR"L&$D["BQ.U=-65FQ$-/3L]-)1K))[I_71?G_EZ8:W^3]\ MU=M[([!V_4Y?KOY.UP^?&#[OV9593Y0=W?%C>F]OCYL_X4U'Q7Z^FWWW)U'B MJG<>,WAC`,46><+6/"ONJNPTT^70N=O?R[/FGN[973^9ZWZJZ MUZ7[WV?\6=X]!X;MCK/^8?\`*G&]O]-[@I^QJS.=:2[R[AW)@^.X/D;U7WIVQU[MWN?#=6;Z1_1G\N[Y9]==S_(/)5W2_6M+M7N&K^=-/0]NTG\P+Y. M;HECQ_R(SFZ]V=/J_/EZ+!\COY:WS-^2N^_DGNS*;4^.&Q,7 MN_XR=Y?'7;>SJ'M_=VZNM.S\5OGOC;_86P,]LO9^Y=GSOTSEJK`XK)+O;*[? MFR'\3W!64F4-.\E#%(GNO=('LW^3A\O>S?A-W+U;CNU^OMB[WW/O'Y8[HZ\Z M,WME\[\A]N4>'^1F/VUB*&#?WR;WJN+W#E-W8W^$YZ2GWW78G(U5)19ZIQT$ M+"FIW3W7NC3=+?RW^\Z'Y1=69KO?$]#[HZ&Z-[!^=_:--N3#0UF0SG?]9\ZL M;C\?EMD]A=+YG&R4.,3!-+F:>JR#9FOAK:.''TT=+&K2,GNO=6Q_D1NOLS8V*Q-)!!31TXI<)F,=3 MRTL,"14\B-!%JCB5V]U[HW7OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7 MNO>_=>ZX/]%_X.O^]^_=>ZTM=Q?\R?\`YXO_`(WY^)W_`,$=U#[]U[K=*3Z- M_P`';_>_?NO=<_?NO=>]^Z]U[W[KW7O?NO=$%_FA])=D_)3^7]\M^@.G\'1[ MC[0[;Z1W9L[8N$R.;Q^W*#*;@R*1I1T=7G7\#TE+DV$D8EF/B/NGHR`,^O^3I=-\3?YAG<_0'5 M_P`6MU]4=A[)V9D_F#A>Y.\=W?.?Y=;)_F`PYOJ7J_;%)O\`V?USE8MKOMO+ M5.W\]OC%X:AFP%"X,$,59---]O6&,>ZH]*BG^"G2,Z%^-W\T'XA]F?%C=^.^ M*.W?E;_LJ/Q[^6OPPQU7C/DIUIU`NZNIMS=\;5WS\>>Q*9]]U69JZ8-MS`_P MJ;"U2FHI3#%Y9.=/OW5.C\_)'XX?)7O'JW^9[/C>L\5A]Z_+?^7=U%TWUCLJ MOW_MC(T:]T8W8?9]%O#8.2W%Y(::.DH,CNS%T8R]0D-+5J\D\7H1P/=>ZK6[ MP_DL?)O(9*LH>K^U.U.TJ7T<7C.ZMI?)OK'NN#X_;> M69&K,5M'POPZZ M)^+N9^4U1\8OC_OW>U=O3K?L/N7&_';:V;R>Y/D+E^X]Q[,RE-C\YMJFHJM] MK[-VUA*K^*^+)9&OD>C9TIXO=>Z0/7/\NWYN4&$V7\<-\9?<.S^MNKNUWW<,-0XK?VZJO:=/B*^BJ7&'J MA44NE(3*GNO=%ZW!_+B^?/7VR.G,5M3K_NS>V[=A]]_S(:[>G8_QF^;>P?AC MW5W%MWY#]M;-WCUCWQV9OB2GRU`]?N2BP-5+G=K8:@HZ6"J@H7^WI5@6)_=> MZM6^7_0OR,[Z^%OQ5BVSUW25?>/QZ[=^*?R0W3\>>V>X<;NH]J5?162CRNY. ME]X][14G\'K\MD"/N(=PU]`U!49*".>=(4D$\7NO=%_[$^.WR\WSVAU3\T\? M\0.F-I[WZA^9W^F:H^+V$W]L.A[5[QZQS/QNG^.,G9O='<9J*K9E9V)M>:NG MRVU*>.K6"'%4T5%_%8ZUV?W[KW08;/\`YIMT]E?'[86[?BD.@-H;,%\A^C?F1\:.J>C.M.R.S>Z-C[>R70U;MKJ: MIZ+W-1]P8K>%/_$Z]TX?)_P#E4?+? M?O7OR.VWUGWOOG$4Z_`;XK?'S9W56!J>J\?U%\S=\],;&W5M_>6S>]*/>%%/ MN3!X;)_>46,^^Q>XL3-!3Y&>:.HDFI@Z^ZO&:.#TR]E_!/\`F&;K^2=;\ZMF M;(Z;VYV#T-WC\7<+\=.A:_)XF;?-=\8.EMFR=?\`8FT=M=TXK&PN&W7%O MGL+*UF%S--/5S-18B.>0M#3W]TXQ`2@_U&O1M.]/AS\B-\]/=N;:V[M/%9#- M[K_F]_'GY=8&CDWAMRE2JZ'Z\[HZXWIN7//55,XBBK8*#;F5=,4[?<2/$J1H MS21@^Z:3XA7HLNT?@E\R8]A_%KX8YCI+9>,Z]^*WS\S_`,KLC\UI^U]C9A^U M-D[>[8W%W!ME<+U?2(=T46\MUON%-O;B.1\5+2+!4S'(5\,L<1]T_7NU>O0; M?"'^5%\NOC)V1_*1RQVYLS!]8=/T>^>P_F'UY3;XPU7D.N?DK5]!;MZ??LO9 M7V\\M%EJ3>-%EL'3[CAQ,C,M?C8,BT;&HJ9$]UYF!5O]6.C?_*SXP_+3#=V? MS%\GTQ\=-E_)G9O\QCXV]:]48?=.YNV-@=?4_P`?]V;+Z]RW3>0P>_\``[VA MFK,IM&2GRXW>G\`2KF^]CK*;^'++/'5-[I-UD^`'\M?O+X]]N]V9W?\`WCW# MM+:E+NCXCTW7]#U)OC8M#UUWYB.B_B!L'J3>.X.Q-F9C%9G+T8KLWMO(44E+ M+E*2HEHM#!E+++[]U[K-_-(^#OR@_F$]L;:V#M8];;$Z$ZN^.G;M9MS?'8F- M@WS49;Y+]P41V%A]P[&VOMG/XS)XG,;+P0GKL#N/(HU)#79!F2&5H%<^ZVO$ M=$)W9_+I_F*=]]J;T[N[-ZKVALS>'R@VK\-_C]\G(*'M_:566Z-FZ);:'S.3 M`2;>KF.26FW)A<))CL?4UD;5E!65HIP9G+P^Z4`J%H/GTVI_+P_F"]8=3_`' M#;1Z:[]K=T=+?!(]"=IXWXI_S"M@_$+/;>W_`$W9QW=38+-;SK*3*P;GQJTI MU40IH1##,7:20Z](]TFZ,QV5_+A^9'86ZMT=U+O'>4^/S_\`,=^-WR/K/@MN M7>'3V:^.VXNN=KY#KR;>G8N>WAB:''[E7.L$#TB>Z]T@ODK_+0^ M=_R&P.T1VEM#:5%GMR0M'4TU7F*N&F@@JFT>Z4A@/G7K9:ZKSF^=P]=;#R_9N MU:;8_8V2V7M?(=@;0H\M09VBVOO>LPL,VZMNT&:QDLU/604=<9X(:N&5DEC5 M74\^_=)NA!]^Z]U[W[KW7O?NO=>]^Z]TG-W_`/'J[D_[4&:_]UZ][]U[KWOW7NO>_=>Z][]U[KW MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z_]+?X]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW19OFI_V1O\ MM/\`Q6;OC_WUF5]^Z]T4;^1Y_P!NAOY=?_BJO5G_`+HU]^Z]U:E[]U[KWOW7 MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][ M]U[IEW'D:/#X++9G(-,E!A\=6Y>M>G#FH6EQ=*]?4&!492SZ(VLMQJ_2>#[] MU[K6#S?\Z/Y+;=H?BYV_GML=1X7IONWKCXQ]PQ;>GZM[IKLWVU@OEU\GJWJ: MGZVZU[BHI3MG!YWJ[:7\*SF?DSB3OFJRJ6.*EH()(5;W7NCF]>_-3YZTWRX^ M17Q?WIU#\=>P>R]O=%U'R`Z3ZTVYF^Q.CS38FN[-I=F;7V7D.Y^S*;*8W?U. MN+J%RVY-T[/P<=-A:P)AYH6JZA8X?=>Z%3X\_-7N7=%!_+$W7V;B-G/MCYU] M);JI]X1;6QAQ-/U[\A\)UHG<^"3"5^2R,E14X/)XC'[FQL="*&22.IIJ2=JH M+*T7OW7ND7\E/FS\KOC[\X^K.M@ MZ[M*KWYN'Y+YN:/86+R57G:.7`T?71H9Z]U7%L#^=%\UM MX_'.LW)7]=]94O=&?[7^&&!Q6(HOCYWFV^-F[`^5^WLWNS"FQ%0I]U[JPCJ;^:2_P`C_C-L#9_2.^/C M=_PXSOSHO:O;F8Z2GE[(WWM#KS;>1R]-2[_WS+M3:<`S.;;`T,M15C9E)DDR M-1D8Q@S5+4%I_?NO=$HJOYR/R\KOC7!WCMG97QQ>3I+HOY,_(+Y"U.4PW96' MKNQ<#\>/DC'T+C^O=H]6UF4AS776>W!2-4YO*4FZZO(5N`J(H*&JHI!4LT?N MO=#U7?S&_G/G^]\;UUL/K;XVR83Y$]D?-OH?XLXCV?NOX95%%%ENU M^W=PXZK=,S09B)L_,=J8?%452/X=114^28Y*6:G]U[JP#^5_\K>R/EW\>]V[ MT[:I]BIOOKGOCMGHW-9'8FUMY=:0;B?K'*0XV+]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=<'^B_P#!U_WOW[KW6EKN+_F3 M_P#/%_\`&_/Q._\`@CNH??NO=;I2?1O^#M_O?OW7NN?OW7NO>_=>Z][]U[KW MOW7NO>_=>Z][]U[KWOW7NO>_=>Z+[\J,[V[M?X\=V;FZ$3`S=T;9ZKWUN?JZ MBW7A,EN/:^5WQMO;M1G-OX3.X3"2P5U5!75$"4CQ46D@+Q,)B/=>ZY=`?S'/YDGS#IOBKT)U`GQ. MZS^2O:/Q!D^>'?O9F_-A[XW/U]U5TYV5V4^WOC3L#;75F"W.E;5;AS>%:GKL MO55.::*FTMHB1G\:>Z]U8K\&OG/OS>V$^1^POG%#T_TUWU\2_D!4?'OL?=&W ML\NS.D^SJK(;%H.T=B;XZT;L3(-D*:+*[?R5-5MC:^9IH[-(A:(G1[KW1O\` MY/[A^2-!U;C=P_$J'XZY;>(S-%D\U6_(_=6^]M]7TW6ZX6KKLUG*;/=9T>0J MS5QN*.2`O%]J:Z]U1-@/YR7RKI_C)\9N\NP]H?$7KR+Y7?*3LW MJ[J;><9^0>[]DYOXX]7=:9O<,W?]#L.CIZ?>.0&:S>%6EP-%!2>67'UU#52Q M1M4*@]U[H>/D)_,0^3^WOB;UE\G.F>R?Y?/^A^KZTWSV7V'\Q]]YKL>K^.>= MW?@=ZC;W7GQXZJZMIH:*G/NO=+2B_F. M?*C,]K_RJ-J5_P`4<=UGU;\[\'LO,=G]J;EWSB<[%M_>^<^,>XNZLWT?U]UY M355/FJ6OQ-7AX369_,41H9*:\-/'-/,\D'NO=&6_F[?+?M#X)?R_NWODQTW2 M[,K^P>O\KU1C\-!V)ALON#:+0;X[8PNQ,K-F,9A*W'U4BPTF2FFC,57'ID12 M;H"I]TY$`7H>B+?RZOYH?:?R)^579'1^\^Z/AS\HNH]D_&VN[[W!\C?BMLWM M7JS$=59K';YAVXG6>^]J]G9;,29"2NQYJLQ!D,?/'XEIY(YXE#Q^35>KN*)Y M_9TC_@[_`#J^P.W$^6F^/E?U?MKJ#JK;/QMW7\^_B%6X.+(4V=[$^%V$W=N# M9\U9N]LM4STE1N""IPE'4&6G^V1H,E3R&`1LLIWTQT/?Q7[]_F_=EX[XD?(G M??5'Q'WC\>?D[/LS<6^.D^KUW5M;N_XQ=2=H8-]Q[2[-K^R]\[EDPN[_`.%4 MTF/.%E'NO=$@^*_\YSY;?-7MBB^&/2F(^/6/^5%!\C?D M8W;O9&\L/F(^LNE?B1TAV2-D8+(XKK-=PT^6W9V!G8B&AH*'(P4E*G^6U4<< M!(A]U[K:CQ<1@H*6$L7,4*(SE%C+NJV=S&I(4LUV*@D`FP-@/?NO=5F?S;?E MUVI\(/BSBN[^G:'9F2WA7_(/XY=534N_DD^Y\:2A6DBD%U/NO=+;^9/\RC>A M=A;HRTF`V[O#N;N?>,&R]G8O.96`QF&@I5>IRF0\,B2-3TLH5D=A(/=>Z(!N M7OS^;OTOW]TI\5>VMW_!O>&[/F/B>RZ/X]]][(Z5[CQNQ>I.T^F*"+M;>.Q> MY>N\ENY*O,XO+;2BRM/MVOQ.5IZE:^&.6KA\"RF;W7NE?_+)^3_\QCY3]P?( M]N^=]?$=^H?BA\GNZOB=OC;'5O27:VU=_;_WIUIAZ&JQ._MI;IW3N_+4-%BZ MB>N5I,?/CYIVCB;]Z,LI/NO=&%^6?S.^0_2?S/\`@ST)M;X_XYNB_DOW-C^M M]V_)//[SP&2I/XDW6&[]_5'6^R^M<760YFFRT8V_%539_)0-CEIF>GBCFJI` M:?W7NK5_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW2_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO> M_=>Z][]U[K__T]_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=%F^:G_9&_RT_P#%9N^/_?697W[KW5=7\FKM>KVI_*J_ MEU;>CZH[;W7"?BETVYW)M';N%R6VD_B&$0,C5M9DZ:;53W_RD"G.GG3J]^Z] MU94G?M`42;,VT]8BPQ1R?=2*,WH6)]95&+W+*XMP+^Z]UW M4=_5T,IC3H+Y"52"*FE^XIMF;;:'_**9*EHP),TKEXM?CE4)PZLHO:Y]U[K, MG?%>]1CX!T-W^!7)1L\[;/VVM/CS5SF%DR#MFKJ8;:YM`<*I!!8\>_=>ZQKW MY7,M8QZ$^0:?:1ET5]F;=#US"L6D$5$!FCJ8AO,->D>,,Q((*^_=>ZXP]_5\ MOGU]`_(2G,-+45*B?9NVO\I:G36*.G\6;>\TGTC5M()^K#W[KW79[\R`I5J1 MT#\A&9JN>E-*-G;9%6BPP13"K=&S87Q.9#'&P:8L1K\K:]($89KW%O?NO=<(>_KPU=\>^_\ MGCZZA6GKXDV9MN6CJZ/+XJU902,^H`%@X=5)%G/NO=5H=*_"/H[K M_:W1^S-X=(_+C?\`!T&FU=I]8PU53N;9W64/7O57:];V5\<,'V=TYMK?)VQN M6LV$]310TF9RF'FDGEH8*V6(2HBQ^Z]T.O1/0?QT^._8.YNU^J?BC\G\1O:J MPNZ,+CJW=.1W'OV#:>W-_=C?W^WQM'I_";^WCDJ#:^,RV=H M87=&^WC0>Z]TS8;J?"[8[8^)FY-J=-_)/;O2WPRZS[%VET[TG2;-I:PQ[WW] M@J38--OK<6\,IO&=\A#A]JKEL/CZ&KI)9?+E*FK>K+)&GOW7NI6Z?CG\8-X= MR9GY$[H^'_R;SV_=R[EDW+G-OY/([HR/7=;ONFZK'3D/:D_34V\FVDN?CVG/ M)MZDSL6+6MC@\H1Q)^Y[]U[H.<)\#OAAM_;HV5B?BI\PZ(+D>I]RX;LD]K]Q M?Z4]G2]*[3R&(Z?PFSNYW[`_O7AL?MK'YK-8O&X;'9"*BA&0K8A"RU$C-[KW M0P/TM\=LI\<=M?$6+X??(G;/16`;9Z;;P^V*.LV-GMKY+:>]Z??^W]WT'8VU M=V4^YJ7+4^=ABS<^9CR7WKU8EJ99'EDHZ/.Y^BW=55U/62P M)),C-'H]^Z]UDWG\+/AEO?/=C;RW/\)_DE79GNM-]5.\:+$Y?=N!Q&(W!O?* MX3(;UWYLS:N"WM38O:FZ,Y4[=PE77;DVU3T>1JGHUDGJ"SN)/=>Z,WT/2=:_ M&39&4VGU)\9/DMC:+=>^=S[^W?5YZEG[`[!WKOO<$5*V>W[V#OS?6Z,EELQD M*R..FI5K\ED9IC%2QTZZ8J>)1[KW0\IWM6O7)1#HOOS0Z*XKSL[;ZT"EL=_$ M-#RMF-88$BF(\?$WI_2"P]U[J/2]^9&IJ::G/Q_^0M**FH@@-15;/VLE-3"> M41F>I=,XS+&E]4A"DA02`?I[]U[KR=_5SQU_=>ZZ;OZN%/3SIT%\A)6G-2KTZ;-VT*FD-/((P M*J.7-J!Y+ZHBA8,O-Q[]U[KL]^9`4J50Z!^0C%JJIIC2KL[;0JXQ3PQ2BJ>- MLV%\4AE*1,&)+1R`J``6]U[K*.^*TUJ4?^@KOX*T,;^ M,7#JW^3LNC_.^D77U^_=>ZCT_P`@*^::FBD^/_R'I$J9X(6J:G9FV13THGD$ M?GJVAS;LD:7U2-I.E03^/?NO=9!W[7>*KE?H/Y!Q_:^+QQ-LW;;35S2U(I]- M$D>:;45!\KZRH"`M?BWOW7NN+]_5Z0TLR]`_(65JE9V>"/9NVO/1F"7Q".L$ MF;50SCUQA&:Z\W'T]^Z]UX]_5XIXYQT#\A79ZBI@-,NS-MBIC6G2-UJ94?-A M1')Y"L1UDDH]U``)]U[J1_IVK17+1'HKOQ4,<4AKSL_;QQ\?DQHR!C>5Z@CY!Y(@'_9>?D8+B_.S-J@_P"Q!SOOW7NI$7?F0EBK M)?\`0#\A(FI(H)1#+L[;*RU?GJ5IC%1VS95FC#>60%A9`2"2+>_=>ZQS=^UZ M4]-/_H!^0TAF%1(U/%LO;CU%.:6;QB.H7^-A09`"\6EF!7\AB%/NO=:F>O^?G\2YF@<1B>'7\C.H&\4X9@JNI.F0!B`0;$@7/NO=;9N5^4 M72^"EF3);HR$*QY;)XK;^)8>=8,K3E:/#2"T;.@20,4DO=&(%_?NO M==5/RGZ4H)IJ6OW1D8:FF81U,<.QNR*I(Y&4.%66+#:6X8?3Z?3ZCW[KW6>' MY/=.3ST5)'N6N:JR,%%4T4?]S.Q!%-!D:=:NB=ZAL,$CUQLK%7(*WTL`P(]^ MZ]U!@^6'1]332UM/NO(R4E.*(5$IV'V9&Z29%RE&(H'PFIU;2UV4>FWJL#?W M[KW62+Y5=)U!J_!NG(.N/ITK*XOL7LJ+PTDE3'1)(FO"_N,9I8T\:$M8EOH# M;W7NO5'RLZ/I::"KGW7DDIZHUJP,-A]E2,S8X1&KUQ1X8N@7SQ69E`8M9=1# M6]U[KG4?*CI2BGJ:6KW1D8ZFDD,=1'%L;LFH1#H$B@3184JQTD$Z2;'B_OW7 MNN<7RBZ8DK:+&?WGKOO\@M"])$NR>QC%(F3IDK:$M5-AEC37#(C>MAI)TM9@ M0/=>ZP_[-7TFU+4UT>Z,BU)0BF^\D.Q.RQ)$:TNE'HI_X*7<.R,&*CTVN?J/ M?NO=<3\J>D9HZHKN>ODBI:0UE:)MB=DH$HONHJ&1U1\*?(?)/&OC6[&Y-M(8 MCW7NM:7+?R?_`(Y#XI?(/H3:7S`SVV:SNKYF5/R!Z\[/JOCWV7N3)],=68C' MY7;U/T9M[;E8\>MJ;"[OW/CSE3404\HRL[18^%@WOW7NCY_(OH_;E-W7U9\B M?A+\K,9\5^^NG>A1\3XX^O]I[EQB[4F3%;?4K)[ MKW1%]K?#')]`?'+8'3'QN_F-5NT-OY3:WR2Q'R#V_P!L?#K=G<'4?=6]._\` M/'=F]^R,-UG328BMVU686OKIJ?!4?\9K*84#""<5+&IEF]U[HU&S?B[\>.I] MJ?RQ^HNO^_=X2;:_EF;RSN[*/^^_6G8.Y-R=J8YN@=U]7Y"@J\]14--3XUXC MN&?*P"G@J(EBITH(80"DJ>Z]T*?\R';/4'\Q+X=]B_$K;_>%3U9E>S\KUQ5X MS?5?TQV;N^EQ%1L7L?%=@1+-MYJ7%"7[G^%_;:GKHA&9/(=>G0WNO=5W;_\` MA3N_Y"Y'N3N'O'^8KMW<'?69^)>__A]U3O'K'X/]@]0;)ZIZ^[XS-+_I&W-G M-FX_+U>1W5E*G'TE?C<7%5YB.AH3.*M:;SHK-[KW4B?^5)_+[Z_W]T)N+HSL MG>/7^U<+TSVQ\??D%M#?>-^4/=G^S`?&_M_K]^LAV>M!5PU>; MQ\=%C):5:](931>..._NO=")\;_CWV]TI4_&C8/:?\TS?N__`(C?%',8^OZE MZ\V'\<.V>I>W^S,5L>FJ,%UYL3Y&=N[>KJMMP;?PM-44@JL4F*@I\NU-`*R/ MQ1LK>Z]T$V`_E@=.;!ZTQ$?7ORVGZ[^9W3GS5[T^8_4'RCVY\=NQHI]M8;MW MBI8LA+CNO.TL3B:G+)3@Y*2@@RF,GDIZ=IA(T,514R.B:5>1V] M3>Z]T0'^9EL_JC^89\5:OHW;'?QZ?KZ'M/I3M&CW[E.C>T-_T5#E.M=[P[YP M^/GV@D.&DJH:UZ$Q2.ML MG6F^N@M_="?"[L3H_>?1':/5._9-V8/LN&7(Y7<@RL\>2Q]'$E#,*2T,4Z%V M6J#)[KW6'IGJ#.E@\K?;J[Q:V]U[HRWP>V=U'\-]Q?, MR*K[LG[`R/RA^9G=GRS-%!U%V3MJ/8=%V#BZ"HGV,U<]-71Y27'PXQY#71_; M^Z-RWRMZ2%)55Z[IR!HZ'[8 M5DK;%[+62)JY9#1::<80NXQM[KW7.3Y2=,15M9C7W/6BOQHR, ME?"-E=CM'#%B:9ZNO,52F%*2LD:,=$9):UDU$@'W7NL0^5W1O_/5Y3_T`.R_ M_K+[]U[K(?E3TB*6HK?[U9/[:EEI8)W_`+A]DZUEK1)]JJ0_P;6^KQ/_=>Z<)?D MYTY%656/_O+7&MH5K9*J([+[$T)%C('J\@T]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7_U-_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=%F^:G_9&_RT_P#%9N^/_?697W[KW11OY'G_`&Z%_EV? M^*J]6?\`NC7W[KW5J-A_0>_=>Z[M[]U[KJP_H/?NO==^_=>Z];W[KW76D?T' M^V'OW7NN[`_47]^Z]UT`!]`!_K"W^'OW7NN[`?06]^Z]U2CV5N?Y#+OK^;[' MU_F\0=M[7Z\V1/@WW?F^QH/RNFM;(4E;*L%'3P0>Z]UCW+WG54O\`+E_F M88C(=QQ47?6WM^_S'Y\)@\?V;+_I)VQ3[?[.W%481=E4SUG\Z]T.GRC_C.^NX.I8/CE\GJR@VG\R=PT7Q+[\DZUWV^ZAU]1 M[1V'N+O>E[8ZJKMN551!M?>5?MS;NXMC3UZ-&9!EL5E`7J M?GV$GQAVMDLGE-D_&O-]NG:'?N^\7N+/X9MJ[0Q75^6RG6>"W=O*A;[O&[=S M.YJ/#8?<&3GJJ:-XI$HZNLCBKY5G]U[JM.+>V1W]W'UAT=L+&Y[=^P=G?/C- M[9IMG;E^0'962Z5W'M'/?RZ-Z=CKM[9/:T>VZ;,5^U<1F:),C2T=;0Y:AI\T MDE-05PIH*5:'W7NA"^/&_-PYWM#=.P_DAN[.[<^/G7_9OS!V)4XBL[`W4>O= MG]K[3[*VC6=:]4Y#M>),?/5X;%;.K7R.R/XW48VHJJNIRT<6.E7%X_[?W7N@ MWZYWA\J<7\G\CW10[A[DWSBNC_CQ6Y^'IO_Q.SOS@[6P-'G*C:. MYX:02=A4>R,1MG/[9R'ACKZ#7X3[UI>Q).N,KVMV;U M;E=OY/X+_$#=V#J/DSVYV'M*IR$^Z.[NZWS6XMDT]=70?<5U9CJ3%C)/5DU( M2'&QS".-57W[KW0I;JW%V9M%?EQW33+78>DV9_-`Z_V8G=M#VIO"H[*V5U9E MNS.K=NY7:NU.ILS2#;];MVJARM3BJZ&;.P4Z4%=75RT[5$"P3^Z]T9OY^[U[ MNVGVG70=4YFMK]S2_'2LB^/NS_XCV%L[&X'Y)5_9LF#P&](*W`44U#O,UE/4 MT&,RNV4DEJZ"@CEJ:FF3$Y6KK8/=>Z>-J9C/Y?YM;*Q.Q]Y=L8[!YJ7Y;8[N M"BFSSY/?>`W1@,S'@]C9#LS:>[#58''[$I'DD?JR?'XQZFI5Z!I5FIILUY/= M>Z4'P?[`[QVY\%=@U>*V!OSY);SQE=\I8YT?D%N_%[0Q. M:SN]VIU\V5%-3P"M2.*DI8[-'%'`D4(]U[HD/5>\>^<+1=P8_O'=O9F5CQO\ MS#5W)C^P=VOLK;&Z=K;N^#6#W;D.K=G=B;)RN5H=C[9VUNJJIY]W[DIL]78K?N7CW%LSHSIZF_O[V-68#=.P,E M11QU>;E?"[:AGI7-92KF9*F(!J5WB]U[JKSM+OWY18B;N#*46)[9?M#/=U?( MKK7-TFS.XM^4`ZP/E MEMW,;5R?Q[H>GMYX:G@R>>VA)2Y')T^T\+F8ZV!:J#+8ZGFR5'CZZ5=A_0>_=>Z[L#]1?_`(W[]U[KUK_[[_8>_=>ZZ``^@`_UO?NO==V' M]/?NO==:1>]A<_FPO[]U[KOW[KW75@.0`#_K?['W[KW7%P/3Q_;7_H;W[KW6 MEKN+_F3_`//%_P#&_/Q/'_LQW4(]^Z]UNE(;ZK_ZMA_O/OW7NN?OW7NO>_=> MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K!- M-X?$2C.))4C)6WH#G2':_P"`2+_X<^_=>ZKIVE\Q-\YWKOH/Y%Y#;&T8>B_D M9V;UUUYM7"8^MW8W86U,-W'O7^Y'4G866RE3$:7(#+UD^+^_P)PU#)BXZPO+ MD*@4TR^_=>Z)OMG^9WWEE_CSE>\J':_5^_9J3XN_*WO+=&`V?MGLC#8[HG=' M0^`JLKL+`]C[LRV=KX_=>Z0^X_YC>\=N]>=W9':.R]C=\[[ZZ[TV=T9U=)M M;=&9ZSV=W5G\SU?2]U[Y!Q^4&Y,IMR;;>WX<]J6I>MBKYJ&(02QBI=8?=>Z$ M_._*;LFN[3Z(_N'V!U!6]`=^?&CN?Y4X3>%3U/V)F]T8SKSJM=@U^,HZ;^&[ MUHXLA+E\=O9ZH54=!3M":5$6DE:8E/=>Z-1NKK7,;KZ3S?=?7M)NO+5434^>BR%-AFHH^*]'N/_1SV'E/D+\;X>W.V<;\B?CWT M=UG/L+!1=P=;_(/L'.Y[?NU]S;MGQRMZ=A87HG8_4FT*#O3M>EZFV;UO%N_);R;J'8? M;.1W_P!L=>]ZUO:W9U%#3TLV#Q%5UA6G9&'HDH\WN>>1:2GA@+R5%'[KW1EX M_G+V%MWY`Y/IOLW&;.ZJK*?NC;G577N`[5V?V_L.B[RV?7U%!25_;G6WR$R4 M<^Q)ZK(25[Q[=V.9YZZ>H@_A\N0^_EC1?=>ZM1IYUJ(_(JLHU.NEK:@5:WJ` M^A_J/Q[]U[K/[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_= M>Z][]U[KWOW7NO>_=>Z3F[_^/5W)_P!J#-?^ZN;W[KW5-O\`PG4_[]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_]7?X]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW19OFI_V1O\M/\`Q6;OC_WU MF5]^Z]U7=_)HV%OS/?RI_P"77E\#W=O39.'_`-E1Z<4[2P^U^KLKB'>DPB&K MD:OW/@JW(_Y5])0*T!;_`+/CX]^Z]U91'U/VNIK-7R9[%/W"A:9QL?HP/CR* MQ:DR4P7:JAB4#4]I_(-#%K>4!Q[KW7*'J;M6-Y'F^3W9=6'IYXHTFV-T0BT\ M\L92&MC:GVJA+PDZT5RR$@:E8<>_=>ZZDZE[5>G2+_9GNRTJ%GFE>N&Q>AVJ M)8)(T2.C>)]J&$)&RLZL(PY+L&8J%`]U[KTW4_:\CEX?D[V31IXH$%-!L?HJ M2`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`0J3RJ\*0PT[H-IB+3%I=D<1"0F1@SLH15]U[J35= M2=IU,KLGR:['IH9*>"!Z>/8G1$T;&*DCI:B0M5;4=C]PR-/*I;2'8K&$C"H/ M=>ZXP]1=IQ2TSR_)OL>L@IY87:BJ-A]#QTU1#$X9J21Z;:B2(C`:28G5A]5( M(]^Z]UVG47:`CKHY/DOV)/\`=I&D,DFPNAPU$T=9'5>:%$VH%=BJ>`B8.H0Z M@!*%<>Z]UP/47;+?J^4O9Q_'.PN@3_O>TO\`'W[KW6&IZ8[*JJ>*&?Y)]@2S M13R2BNFZ]Z#FJ?`T,<45`(I=IF$1(RO(K"/R7<@N5"@>Z]TX#J;LG[A7/R,[ M`:C%-'!)BSL;H_[29THOMGJ9'&U_-J>6]4RK(%$A*A1%Z/?NO=1Z?J+M6&2F M>7Y/=E5D=//'.]-/L/H:.&H56_>@D:DVI'(BRH6C=HG5PK'2P//OW7NNHNH^ MU$^]U_)?L-GJD@CAG_N)T2):,057G4P!-J*K?MEZ<+.)`$8LH$EG]^Z]USEZ MD[3DBI(U^378\1(UAHI(9-J&$1Q-&SH5C#DNP9B`@7 MW7NI"=5]I"L2I;Y)=A&E55U8L;(Z1^TDE^Q^V>9ICMC[B[3_`.6&TW^=]/\` MFO1[]U[K%3=3=K03T\DOR>[*K(89X9I:2?8O1$<%8D<@>6GG>EVK'(JR@%': M)U<`DJRM8CW7NN$74?:<0K"/DSV,TU5%%##4'8G1*34(BJ/,LD/AVJJR,$+P M*LX=`C%@ODLWOW7NN0ZD[22EI*:#Y-]DT[4RRQO40[%Z'#U4;.#31R0G:AB0 M0*-$8A1`026#'GW[KW7AU-VL*1*=?D[V3',M1/.]9'L7HD2R12P11141B.U? M$(X3&[QL(_(3(P=F58U3W7NL@ZJ[4%:E1_LR?8)IEB1&H#LCI+[=Y5HOM&J& M<;8\X9I+U1`G"B3T!1#^W[]U[K%#U+VLDU-)4?*#LVMAAFADFI9MB]#QPUD< M<@>2FGDIMJ)(J2`%&,3JP!.D@V/OW7NLG^B?M0Q54;?)OLIWG\?VTS;&Z*#X MXI4"5VID7:H5]:`PD3*X"DD6ZBKU'VVH`_V:CM`V%O^/"Z" M'^\#:7OW7NLL/4W:T:5:M\G.R99:B.%(:AMB]$I+1-'4B>6:`1;557:5087$ MJNH4DJ%DLX]U[K'-U/VPT5-&GR=[(BDB$Z35:[$Z):>K:>;R0R3))M5HP85M M&@B5`0+N';GW[KW6I?G@U/TM_/"6:9IWA_GY_$M7GD4+)42+\C.GU>:18@%5 MG-W8(JH+G2JJ`![KW6VIE>\,[B6E6/X]=^9;1E,M07Q6)ZUE#PXZ=8HLLGW6 MZ(3]K5AB]*[`2%58R1Q&P/NO=>K.\MP4M1/#'\=>_P"N2%PJU5%BNL7IJ@%0 MQ>G,^ZHW(%['4@-P>/Z^Z]UGB[MSDM11PGX_][1154%)-+6RXWK04F/:HIUF MF@KV7ZA0=\;AGIIZ@_&[Y"T[PM1A:.HQ'5ZU5 M0*MV21X%3=;(1!8&?4ZV!&G7^/=>ZR0]Z;@E-6K?'/Y`T[4U(M3&L^*ZP'WS MM51TYHZ(Q[J8&95IO&'UTQGW5&Y`OINR+R#^.??NO=L#65GW4C1N:14W44/AT@RZY%X9=.HD@>Z]UR3O3<#+5,WQR^0,1IZ5 MJF-'Q/6&NL=:F*G^SI/'NI@9B)&E`='W4$"3%V$)5R28WU!;+J]U[KNH[TS\-54TT7QT M^0%9'3R&-*VEQ?6#456HM::D>;=2.R'\%D4_U'OW7NNZ;O3/SUE)2R_'3O\` MHHZJ7Q-75>*ZQ%%2`"YEJWI]U2.$_P`4C8_X>_=>ZX#O3<#44]6WQP^0:-`U M&%HFQ'6#5D_W+,'>GCCW4RD0:09=3@@$:`YN![KW19L!L38NV\U@LEC/C+\J M3@=I;MK^PMC]=U^4V/7=<[)["R]96Y'+;UV[MB?>1$=9//D:V58III*2F>:6 M2BIJ:661V]U[J/%L'8N(^*.1^(E#\:_E0_2^X^M=_=0U^"CJ.O:C=U-LS>%) M5X[<%.=QS;L$D<]5#DZI:"J1V:+3PNM^U]H5.ZZLZ_R,.+V3WOO?$;UWIMVFHZG=DBU%-0U6W<5#CDGE!HJ1$IX M2Z$A?=>ZSX+KCK_:4VRX,9\;OE77X+8.%RE%U;LRKS.S,GM#IBESNVZ_K_+T M&R\16;P`IIWPU554E,:J2L^RHJHT]`]+!)+`/=>Z;$ZRV+MW!_%NFV_\?/EW MB:GXF]?[BZJZ5J\'6]7S;AVSM#)=:T/550=QSY;CEKMH0#;V(^/^?SF[^J-T[:W`N\IG;.SJNCS&W>PJ_:#[P>**>CR>(Q>6K<=CJFCQ=1D(*>MEQT]3KE/NO='(' M=^X88*:4?'/Y`3-61254D4>(ZP66C?[N6F%-6(^ZP!*5C6:R%AHD0DABR+[K MW7=3WMN&FIJ:H'QO^0E0U2:P&EIL3U>]33&D,8C^Y#[K5!Y_(?#I&<7(5%#_`++WWR8H%JBF3&+ZT&-JVIZ5JB*.EE;=`D+3NH@@UQ*# M(RABJW<>Z]UBIN\]P5%934C_`!R^0-*M3(4:KJ<3UB*.E4*6\M5)!NIV"\!? M2C&Y'%KD>Z]UC/>^?6CJJMOCC\@UDIFI`E#_``GK!JVL%29`[4:)NLH1#H'E MUR*?6F@/ZYOWIN!8J25/CG\@)C54GW,D,>*ZP\M$_W,L'V58)-U*!-: M,2V1F71)&=6HLJ^Z]UU_IUW!]K!4+\<_D"TDTE4CT0Q75XK*5:&.@D M;=`D9JHJ(Z;R1H"[*'*`EA[KW4?_`$[[C_[QL^0W_GJZL_\`LL]^Z]UD/>>X M125%4?CE\@@U/+2QBD&)ZP:KJ%J?)KFIT3=14I#H'EU."-:Z0WJT^Z]UT_>N M?5*5T^.?R!F-33&H=(L5UAKHV%5)3"EJ]>ZE`E*QK,`A9?'(AU:B57W7NL$O M?>XXHV?_`&6GY%2D`VCBQ'5;2.=)(50=V@ZZ\[%65E* M?C]WLT5(E>..D8[G$A:H*B*`/$MW90Y078>Z]TQ5_<^9S MNW\G3U'0_=^VTKJ;,8R>LW#B^O(*3$0-@YIVS>5..W)52+1J;1LT,]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7__6W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]T6;YJ?]D;_+3_`,5F[X_]]9E??NO=%&_D>?\`;H;^77_X MJKU9_P"Z-??NO=6I>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[ MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_ M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NN#_1?^#K_`+W[]U[K2UW" M;=/_`,\6W_>_GXGC_P!F.ZA]^Z]UNCI%&6=S''K+\OH74=#$I=K7]-S;^GOW M7NN:11QJ%CC1%4654154#^@`]^Z]UUX80I411A3]5T+I/^N+>_=>Z]X8KJWB MCU(NA#H6ZK>^E3;@<#@>_=>Z\88F*EHHR5;4I**2K6TZE)'!MQ?W[KW7+0G/ MH7D6/I'(_H??NO=<5BB0:4CC47+65%478W8V'Y)Y/OW7NO+#$BZ4BC5?KI5% M5;WU7L!_7GW[KW7C#$Q5FBC++J"L44E0XTN%)'%QP?Z^_=>Z\T,36U11MI(9 M=2*;,#<$7'U'X]^Z]UWXX[EO&FIN6.E;L?ZD_GW[KW7A'&HTJB*MR;!5`N?J M;#W[KW7311."KQQLI%B&16!%P;$$?U`/OW7NN6A./0O'T](XXMQ[]U[KVA?] M2O\`MA[]U[KH11@LPC0,_+,$4%N+>HCZ_0?7W[KW7311,`K11L`00&12`5-U M(!'X/(]^Z]U5#\BOYD6*^.O\QCXT?"3?77#S=>?)3KBHSJ]XT^3E6FZ\['S/ M8_\^+L?;]'\;)H M.O\`X6]5-WCM?Y:[BR6Y?EA\IMU=$=>8#_9:?E=7_&S%;:P.[H-J9N2NRF:I MJ,9L44M'"8PM3&K,L.MO=>Z%K?G\Y'LWJ/;>[7WMU/\`'7=.^]R?"_IGY2_& MN3I_Y#9;='3O?>Y^V>_EZ!79&WNS,WAL=-445-693;>2ILA2X?54TU;/>*!( M(IYO=>Z.=\'OY@F1^:'<^4VOM/KK`8CJ_;'P^^)_R!W1OF+>/]X&FAAAJJ#`8S&S_>91@DIJV$;4T*E&D]U[JU588D4(L4:H!8(J*%` M_H%`M[]U[KLQHPLR(P/U!4$'\_0^_=>ZZ\4196,<995T*VA=2I]=*FW`_P`/ M?NO=3<^D?4_4^_=>Z]H3GT+R+'TCD?T/OW7NN(AA`"B*,*&+A0BV# M-R6`M]3^3[]U[KEH0\:5M];:1^#<>_=>ZXM#"Q!:*-B`R@LBDA7&EP"1]".# M_7W[KW78BB4LRQQJSMJ.,%CXTNQNQTK=C_`%8_ MGW[KW7$P0D*IAB*JVM08TLKGZLHMP?\`'W[KW7/0G^I7_DD>_=>Z]H3_`%*\ M?3TCBXL?]X]^Z]UQ$42EF6*,,]BS!%!:W`U$#G_8^_=>ZY:%_P!2O^V'OW7N MN+0Q,`&BC8`JP#(I`93=2`1]0>1[]U[I.[NBB7:^Y'6.-7_N]FUUA%#:3C9G M*ZAS:Y)M_7GW[KW5./\`PG4)/\F[X6DF_P#N$[>^O^'?VZ@/?NO=7:>_=>Z] M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7 MNO>_=>Z__]??X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW19OFI;_9-_EIZ] M_P`.G?RTO^\_OAS_`.E'=2__`%U]^Z]U[_AT[^6E_P!Y_?#G_P!*.ZE_^NOO MW7NO?\.G?RTO^\_OAS_Z4=U+_P#77W[KW7O^'3OY:7_>?WPY_P#2CNI?_KK[ M]U[KW_#IW\M+_O/[X<_^E'=2_P#UU]^Z]U[_`(=._EI?]Y_?#G_TH[J7_P"N MOOW7NO?\.G?RTO\`O/[X<_\`I1W4O_UU]^Z]U[_AT[^6E_WG]\.?_2CNI?\` MZZ^_=>Z]_P`.G?RTO^\_OAS_`.E'=2__`%U]^Z]U[_AT[^6E_P!Y_?#G_P!* M.ZE_^NOOW7NO?\.G?RTO^\_OAS_Z4=U+_P#77W[KW7O^'3OY:7_>?WPY_P#2 MCNI?_KK[]U[KW_#IW\M+_O/[X<_^E'=2_P#UU]^Z]U[_`(=._EI?]Y_?#G_T MH[J7_P"NOOW7NO?\.G?RTO\`O/[X<_\`I1W4O_UU]^Z]U[_AT[^6E_WG]\.? M_2CNI?\`ZZ^_=>Z]_P`.G?RTO^\_OAS_`.E'=2__`%U]^Z]U[_AT[^6E_P!Y M_?#G_P!*.ZE_^NOOW7NO?\.G?RTO^\_OAS_Z4=U+_P#77W[KW7O^'3OY:7_> M?WPY_P#2CNI?_KK[]U[KW_#IW\M+_O/[X<_^E'=2_P#UU]^Z]U[_`(=._EI? M]Y_?#G_TH[J7_P"NOOW7NO?\.G?RTO\`O/[X<_\`I1W4O_UU]^Z]U[_AT[^6 ME_WG]\.?_2CNI?\`ZZ^_=>Z]_P`.G?RTO^\_OAS_`.E'=2__`%U]^Z]U[_AT M[^6E_P!Y_?#G_P!*.ZE_^NOOW7NO?\.G?RTO^\_OAS_Z4=U+_P#77W[KW7O^ M'3OY:7_>?WPY_P#2CNI?_KK[]U[KW_#IW\M+_O/[X<_^E'=2_P#UU]^Z]U[_ M`(=._EI?]Y_?#G_TH[J7_P"NOOW7NO?\.G?RTO\`O/[X<_\`I1W4O_UU]^Z] MU[_AT[^6E_WG]\.?_2CNI?\`ZZ^_=>Z]_P`.G?RTO^\_OAS_`.E'=2__`%U] M^Z]UQ;^:9_+3(N/G[\.;)^XQ_P!F-ZF(5$Y9F(RO`']3[]U[K5HRG:_6.2^* M/\\/NO&;_P!I9;J!OYX_Q:[#B[+PN;HLWLNJV)0=^=2YFKW9C\[B&GAJJ%:2 M*2H$U,T@=5/CU&P/NGT`Q7T/^'K8.'\_7^3>NI6_F#]!`ZB2#E<\"+\BX./] M^Z:84-.'7?\`P_O_`";O^]@_0/\`Y]L]_P#4'OW5>O?\/[_R;O\`O8/T#_Y] ML]_]0>_=>Z]_P_O_`";O^]@_0/\`Y]L]_P#4'OW7NO?\/[_R;O\`O8/T#_Y] ML]_]0>_=>Z]_P_O_`";O^]@_0/\`Y]L]_P#4'OW7NO?\/[_R;O\`O8/T#_Y] ML]_]0>_=>Z]_P_O_`";O^]@_0/\`Y]L]_P#4'OW7NO?\/[_R;O\`O8/T#_Y] ML]_]0>_=>Z]_P_O_`";O^]@_0/\`Y]L]_P#4'OW7NO?\/[_R;O\`O8/T#_Y] ML]_]0>_=>Z]_P_O_`";O^]@_0/\`Y]L]_P#4'OW7NO?\/[_R;O\`O8/T#_Y] ML]_]0>_=>Z]_P_O_`";O^]@_0/\`Y]L]_P#4'OW7NO?\/[_R;O\`O8/T#_Y] ML]_]0>_=>Z]_P_O_`";O^]@_0/\`Y]L]_P#4'OW7NO?\/[_R;O\`O8/T#_Y] ML]_]0>_=>ZK@^2OS;_D;?*3N_?G:?8O\SCHQML=@_"?>OPUR>P:2GS"U..CW M3VUC>WY-R9#: M6[29/,^N)9WA]^Z=(K7MZ-7O\`^7/\G[NG=_\`+X[. M[M_G!?'O=W:'P@W=G-P;KW%M'K*+K/;WR$P>0S6/W?A-F9796`:6#;N.QF>P M&V,Q%3T51503RXZTT),H>+W6M)S1?\'0H?RZ_G5_)(_E[;-[@VG@/YIG37:- M3VWW?NKM:IW+N.FJ<'F,+M>IQU)MGK?K!?X31-'54FV,+0T]!2U;",R$R,L$ M$;+"GNO.,5TT_9U8M_P_O_)N_P"]@_0/_GVSW_U![]TQU[_A_?\`DW?][!^@ M?_/MGO\`Z@]^Z]U[_A_?^3=_WL'Z!_\`/MGO_J#W[KW7O^']_P"3=_WL'Z!_ M\^V>_P#J#W[KW7O^']_Y-W_>P?H'_P`^V>_^H/?NO=>_X?W_`)-W_>P?H'_S M[9[_`.H/?NO=>_X?W_DW?][!^@?_`#[9[_Z@]^Z]U[_A_?\`DW?][!^@?_/M MGO\`Z@]^Z]U[_A_?^3=_WL'Z!_\`/MGO_J#W[KW7O^']_P"3=_WL'Z!_\^V> M_P#J#W[KW7O^']_Y-W_>P?H'_P`^V>_^H/?NO=>_X?W_`)-W_>P?H'_S[9[_ M`.H/?NO=>_X?W_DW?][!^@?_`#[9[_Z@]^Z]U[_A_?\`DW?][!^@?_/MGO\` MZ@]^Z]U[_A_?^3=_WL'Z!_\`/MGO_J#W[KW7O^']_P"3=_WL'Z!_\^V>_P#J M#W[KW3+N3^?;_)TKMOYRCIOY@G0_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][ M]U[KWOW7NO>_=>Z][]U[K__0W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]T7CY.?) M[K/XE]<8[L[M2+>-9A,UV#U[U7@,3L+:&8WUNS<&_>U-TT^R]B;VQOG%[LHZ:3&9''3[KP;10R@K4Q5`EII)44GW[KW4O M9'\P+J3LKNS?/1^P.N?D=N[)=9]QYGH?L#L7"=%;SJ^F=H=D;=Q5+FL[BLYV M<(QCX8J2FKJ.2>I+&-?-&";L![]U[K))_,=^(=/NOY<[0K>SQ05WP=V[C]U_ M(K)56W\\-O[8P%9A*C,U=;@,W!3O!G'Q[TL^-RE-B&J)Z3(***:))V5#[KW0 M697^;'\:L%18>#-[(^3V&W_G^V]J]*8;I?+?&[LS&=RY/>V^.MLOVUM#^'[% MKJ2.6HH:_!X',5,5=!*\:O2RP2F.8",^Z]T8+<_S.ZJV%U!UIW1V1MWMKK3; M_:O;77'26W-M[]ZSW#MSL&AW_P!L=CQ]6[%H-R[*JE^\Q\%9DYH&^ZG41I32 MQU#D1M?W[KW1/Z_^:'`S+/!05<)7(P5$7V_ECF4M[KW10=Q=C_`,D?:>Z- M_P"T=P?RQL'C*SJSIS(_(3?-?/\`RUL`,#M[H?&T&7KJ?MJJRZX$PC!5HP.4 MAQM4#_E$L#11J6*@^Z]T8O'==?R3LGWET?\`'*E^&_Q'/;/R%Z@3N_K?`-\2 MNLOMIMC56)ESV*_O%F$P;4N*R.0H:7)U>.QM=+'/518^O:%'^UDM[KW2_P"B M/C/_`"D?DG\>L'\F^H?@3\8=R]:;FQF\LIM^-OB!UC0;NRZ;&W%D=J9BBH=I MU>%6K>IDKL750T<&G5/^V4N)%]^Z]T3C;/8W\D#<=?D**K_EI[4V9!A.^^O_ M`(O[CS._OY<.VMIX';7?O9FXL)MO:_6&=RV1P0B@R9EW%B*BICN5@IIQ42,( MU8CW7NE9OG,_R1]E=KY?HVD_EX=5=B=M8?MS?'24VQ.J_@#LW?F=K-]=<=4; M=[KWC#C:?$8,B>CH]N[IP]8]:C>(M))$I,D3J/=>Z-GD_B3_`"I]L]$Y7Y$; M^^`'Q?ZQV!MWKS*=G;JINQOB3U1M3=NT=M87$OFS-[=2[9ZO_`)>V MW]\=A5>$Z9HZ2K[63<.PL3MPY/&UF!-6L.0H*FG%0LT_ MD#9?UWKNZBVJXQ# M;B-1!30_?01BGGD6*K,!/OW7NI6UNU/Y!6=CH,QN;X3]"=0[`SI[E@VAV[W/ M\$-H===2;YR7Q^;+MVUA=G;\R^W_`+.MK<5#@,U4&F4AIXZ*?[;S.%1O=>Z= MJ_>7\C/;VPNW]\[[_E\]7]85/2FQ=A]I;LZ[[._EW878O:N3ZP[,WE#U[LOL M+9FPL_MJ*LR^+JLW,,9+)1AI*6=2E7'`2FOW7NFT[_\`Y(#93";0I/Y:NV:[ MM?-]K[LZ6_T'0?RT:&+N7%[\V9UO'W!EJ7*[&KMLPS)1OMB6/-TF2B>2EGI3 MKCE)NOOW7NA#ZXG_`)#G:<6X:K;'Q+^),&/V=\<<[\I-Z9/`2:BW5B8MLY MR;*82LCCFIXZ5W;BU_=>Z&#H?:G\H;Y(;ZK]E]6?RN]FY*@Q'8'8W5N:[,RO M\O'9^"ZBPF^NI\G6X'?.`RG8>1PB444M'DJ"HQG+$/5`0J2S>_=>Z==[;,_D MO["[QFZ%RWP$Z*R.X\/NKJ_8>^=X;7^!NV=T]6=7[[[J2GEZJV=V5V'@]MS4 M&)K\TE=BY8$F-V;OC_1WF:;;>X9\%IKZO^*B6G@I84,D@BE=1I0GW M[KW1COD/U'_*,^-N]>G>M]U?RWNG=]=@=\8WL/+]:[-Z;^"FPNT-PYC'=64> M,R&]ZNHQ^W,([4Z4<&8H9"TM@P=@I)5A[]U[H,M]R_R2^MLUC-O[L_E[=3TV M3I\'U3N#M2'%?R]<'N5/C=0]V9./%=;1?)67;>VJM=FU.0>1IC29,B:"FCDJ MYTCI@LK>Z]T&NZNT/Y(6Q,MWKB-\?RQL)M&3XS[9H=Y=YU^>_EK;?I,1USM? M.0UM1M'-9[*+@FA6'.ICJQL)H9FJ_&?&/?NO="W7P?R.\=VQ_HKF^#WQYFHX MNV\%\? M([%^.&U9-[=I[7WQ!7X"-L//38M(ZVC-4`E7'-`U.SB52?=>Z<:/&?R:,CV9 MVQUU0?RW>KZK&=#]B[GZO[K[B3X#[$BZ#ZJW)LK:M)OC=L^^>W:C#)BJ"@QN M(KZ/(5E?++X8HI078$,%]U[I(T&[_P"11-M'L?>V<^!W3>Q,+U[\?-U_*VE7 ML3^7QA=D9#LWXZ[*6)]Q]L=/T.?VS"VXL=3K54#O'1_Y2L=;1RM`L51&Y]U[ MI>==;9_D\]G1]EXW;_\`+-V!0]B=7];;0[BR72NY?Y>NU-O=S;GZNW[E*W![ M1WSL'8.0P*U.8H*VNQN1HHY*5BPFI9D=5T@GW7ND'TMN;^2)WIGNHL%M?^71 MUOMX=[]I;OZ8ZISO8/\`+UVILO;6[^QNO,'N;.=A;?Q^;RV!$6K!?W0SE'E) M7LD-5"D&HM*E_=>ZAKV'_(->HW/0K\,/CQ)E-L8WL"K.'I?@OM#(9G<.5Z\^ M3J_#NOV?M+%XW;TTV1S60[!>+!X;'4Z&2L\B5"6IR91[KW0_;8ZD_D[[DZ`[ MD^1L_P#+^Z!VALWX^4W9$_BMM;1^3&,RF3Z-SVR]KY#;4?\4QNX1A^`?36Z^QL_P!B=C=50_'?;'P%VIF?D?C-\=0XZFS7:6+S M_4%/M_\`B-!#@:&OQ=9D:^I"4J1Y#'JLSS5E/$_NO=8,GN3^1.NU.O-V;*^# M71G<2=B]>[H[:@VQTQ\`\#V-O_976&Q]S2;(WIOGM#86#VPV5V[1XS.05>$J M(\G2Q5#5]+5TL$$TM+.L?NO=3-N5/\E7L/L:7K?IG^7)UCWW4TF`Z1W9DMX] M+?R_MG;YZYQ&UOD/MF+>G56XLOO2EP<=+3TE=B9OOY9)"/MXTE$X22-T'NO= M6!8?^7-_+(W#1QY'`_![X2YK'2O4QQ9#$_'GI')4,LM'4M15D4=70XJ2-FBF M1X90&NKJR&S*0/=>Z=O^&R/Y<7_>!'PW_P#2:NG?_K/[]U[KW_#9'\N+_O`C MX;_^DU=._P#UG]^Z]TQ;G_EW_P`L#96W<[N_=WPC^$>VMK;7P^4W#N3<6;^. M_2F,PN!P&$H9,IFEI::*6>HGE<)'&C,Q`!/OW7NJT*CM'^0MB MMH[OWMNCX(=1;'P>V^JZ#O;;S[Y_EX8K:=7VYTGD=YXC8<':G3-'FML1/N'% M+7Y_">;[2U3%!74M1)3K#*K^_=>Z.9U+\7_Y2G>6YNS\!UA\#/BSNC$]2[IE MV)N3L2F^)'5<'664WU0*G]X]I;)WI4X9*;.U6&E<4F8EQ7GIJ2K66BDJ!64] M1!%[KW0"T\7\B&KP/RMW#!\3/B1-C/AKN^DV%W4T'P]V#4S_`-Z,OE3M;`XO M8$%+M]VW*>@N)HR#[KW1K?CUN+X#P="=^UG5GQ:S>;^0W2^X/BU0],9G';BV7L>CW]#F-V=5UN*I$R4\N#_A];BJ^**I66 M,1)'*)(RB>ZW4]!#L_Y=_P`L'?F7ZUH=H]!T.

24XENONM$DY/5CD M?QL^-LJZX^@.DF`9E/\`QBG8G#(=+`_Y!^#[]U[K)_LM'QQ_[Q_Z2_\`14[$ M_P#J#W[KW7O]EH^./_>/_27_`**G8G_U![]U[HM_R(R/P=^,]-L>'?7Q\V)N M/=_:.Y*G:?5W5W5_QVP/9':G8^=QF'FW)N"GV?L;;&+FK*F'%8NGJ,GEJUE2 MFHZ:,R3S(6C5_=>Z+12_-/\`E(3T-'D:S9'5^#AJ.I^T>V:VFW#\:Z;"YG!0 M=,]N4'0W8G6VCWADZ+;\&SEI'R=952QK14]0LD;/[KW0N[_[2 M^`O4N/Z_K>V?CCMGK.?LKJ?MWN#;>'WC\;MKT&:3"=(;4@WSOS;&8H*>BF-' MN&/$5'WU)A9V6HJ%CGCC!FADB'NO=`C6?-O^52F7V'M[!],;9WKN'LC%=)UV MU\!L?XNXCH MBC;W7NH_7OS6_EI=B9O;V%IOBEN3:?\`>;Y&XWXD8W,;_P#A0=H;?7Y%UN1R M.+K^K*S+Y+%>*+(XR7%5O\5#?MTP0%W]0]^Z]T:'9F[/Y>N]=I_(??E-U?TG MM[97Q7[-[7ZG[OW5O/IK9NU<'L[OQZV;MW%=F?";-=?93=4/REWG_ M`'!Z4WGMBDW3M^F^]P64RG^3SU\))HK@UL=/J6_NO=++L_Y.?RO^G=B_)SL7 M?O5/76+VW\1^WL'T5V\*;XY87*YH]E[BVS@]Y8K;^QMNXS%RUNX&?&;@H*TG M%02Z8A4,1:GET^Z]UA[-^5/\J;J+L#>G6&]=D].TN\=E_$?,?.$X_']!X'+0 M;L^.^WJ#)9;-[GV)7T.*>'+5M+1XNIK)<13O]YX"DJQ-&Q9?=>Z\?D[_`"T9 M-W4.V,9T%CMQXA:[K/!;R[-VI\/ZW='474^[NW\7CZ' MWXX;A^$_R=GWQB]G_%O'[%W1UV=KS;IV7W5\4:?J7=M+B-[XM\OM#<5'B=W8 M>'[J@R$4-2L,]/(Y62"6.58V4!O=>Z-'_LM'QQ_[Q_Z2_P#14[$_^H/?NO=> M_P!EH^./_>/_`$E_Z*G8G_U![]UL$CAU[_9:/CC_`-X_])?^BJV)_P#4'OW6 M];^I_;T4_P"0&_\`^7I\8^T_C+T]V_T]U=@MX_+GL>NZFZ53']`[>SV*R^^J M*&CD7$9O)XC%RIC5G:OI(8:FK"PEWLSH%9A[KVM_4_MZ+HGSK_E!R_'OM;Y1 M0[-ZMJ>F^GOD)F/C%N?/4GQQQE;D\IVKM_(TM'FZ/9VVJ/$25^6H:6"J;*35 M]'3O&M!3U=8?V:>1A[K19C@GH4^Q?D!_+/ZQWUO_`*QW!U+UO7=A;#P?1.9@ MV=M?X[8/=&X>Q:KY)UN:H.G-L=1XO"XN67!ZNK,%*C MS+[K747JOO/X,]S=K;DZEZ_^%F[,QD-D=J;FZ4W[O8?#.A3JO8G9>S<;#DMS M[;W3V,N/;&T[4:U-/').DKPM)(BQR.&!]^Z]UE[7^0/\MWIWMBNZ?W+T/M[- MYS;&7ZRP/:6YNO\`XGMV#U[TAFNY*V.AZRQ?=&]MI8.JHMO3Y8S4\\<=6]X* M::"JJA!33Q2O[KW4S:W>O\MW>%'TA783I;8,E/\`(7Y&=M_%;K0U/QSP%))7 M=P](U.ZJ3L'$Y:*;&AJ&CIWV;G1!D:@+!/XX_&Q\R7]U[H-]Q?-3^4?M?JCY M0]VY/9753];?#OMC$].=[;@QWQRQV37`[FS6Z:+9>/R^!IJ+#O)F<*V2JWIC MF,4L],&I:T:[TL@'NO=*+>_\`M6A[?K,/U1M7X,Y6K[4V[+T)N'$[5[:QV^=B MY+!TM;B9\17YO&1-]R@CJ4G2>CDJ*=TE;W7NEA+\A_Y==/VC@^IJOXT?:YRM MS_5FR-WYY_AU43;&Z@[.[HV]1;GZ[ZG[BWA2822CP&XJRER>)\M#4N5I7KJ1 M:J6'R@CW7NA8^36[/Y>OQ#INJ:KO3JSIK;,?<_:>W.H-C1T'2&U\_4U.Y]R. M4BR64H\/C)9:/#47H;*YF=%I*)9(FJ9(UD4GW7N@.W?\M/Y5&Q]^?)#J_<'7 MG5L'8?Q3WGT)LCN':%/\><'5YG&UOR4W#@MI]5YK`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`#0R=N[BP.S<'BGJ)MMX1LIC: M>IW&Q2B-15TU,DK3U$,;^Z]T]XC^:5\-MH4O0NUNH^LN]MR;2^0.,R55\?GZ M1^,6\ZS9>^,EC,;D-T[\V=MJ#$4=+'2YS`18_+3;EQ%33T]10RTU4E0@FC=? M?NO="56?S3_B'C^K^N^X:S<>]X-D=H[_`/D5UEM*JDZ\W,N2GWA\6-O[OW-W M%CZ_#&+[BF2CIMC;A^TFEC"5;PQ)`7,\6KW7NDU_P[%\>X>K-K=R9/JSY:X/ M8W8>Y.F]H=4UF;^,_8F-R';^Y.^VE'6.*ZOQ,T/GR\E>L:2-X$M$DL+.0)![ M]U[H3Z7^8U\9I?C;W[\HZ_)[[V]L'XMY'>."^06V]S==[GP?:75>Y-BXVBSN M=VUN?KFNA7()6_PW)8W)TT<2.LU+5P31N0QT^Z]T$-1_-]^*])5T^VJG:7R> MI^U*GMS;G2<71E7\:.U*'N>3>^\>L1)%*>_=>Z5T?\`-.^+&4VQLW,;-C[D[*W9O&J[3I&Z9ZVZ5W]O+O'9 MK=&;L.P.Z9^Q^L,32-D,##M?/^+"9.;(K&AKI8J:E:ID>P]U[K!NK^;#\-=O M[VMIYCI3$_)'<6X>E>I.PNT:'JOH+.M4C#]K=P0[7H)JG;F.J M!095XZ>O@6MTX_(,:0"CGT>Z]TK-F_S&>CNR^Y=P=+=6;.[[[3K]H[UV)L3= MW8O7G3.ZMT]-;7RW8^QL+V7M:NS?9V/4XZ+'RX#<&*RLM<',44$VIR"K`>Z] MT?GW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]'?X]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW1'_G_P##Q?G!TMM#IJHW33;4Q.&^07Q_[?W%43P9UI,YMGI_L_'[ M[W#M''U^V*_&9#'U>5I*26AIWP.S72?3S=4;!^2^TMQ[-[LV[V]W!3;_P!Q?)36=WSD^B>T*3NS9C;YZ[Q^S]Q[#ZWWX=WS4M'BDJ:*66C^[QL[B"JGCF,TA$ M@]U[H,=C?R6>S=AUD6[J+Y@5.Y>P.SNI/EOUQ\G8NQ>G=@]A]2[ZR?RRSDW: MF6SVS>K]Q4[ZJ7$;Y=,D,5O+)9Y*S'M+0B:DCD*^_=>Z"^;^1?V?-M7`8G_2 MA\:EP6W/D_L'Y%XKXVU'4G=F>^(>,GVEU#O+K?=6/P_7.[>PLCDG9_Q4^-G0%7F^E>K\QT3\C?C9W7 M-#T_UYN3"=3';7QY[NI.T:38FRMF[@S%?78X5U#11T(GJ,E4+#422U"QZ-$( M]U[JKC+_`/"=K,/U=U;L_;/R8PNW]Q;>^*GS`^/G:LZ];5TFS^R=[?(O8>;Z MZV)W1!@J?+Q3T64V]A\Q'BZL)[5_EH;M[&S?RH MRT';F`QD?R*_E@[9_E[XVEGVAD*L[6SV`7=RR]JY&1,A&*REE_O-';%1K%*H MIV'W9UKH]U[H"H/Y-W9478NW?D(GRRS&+[\Z[[;^+&[>MX,'M'&Q=04/6?Q= MZVI>G*+KWX)ZK<.W:[>\.0KJ'.TM%%/GY)?X74&G+3>Z]T:W^7G\2 M_E=\,NM=C?'?>?;/Q_[!Z&ZYI>Q/[NU6U>M>R]L=O5E=O+L&NW]COX[GLUNC M)862&FDR=933B+#H\B"%D>-E?7[KW0+=D_REZWL_9'R#V#N;LK:&7VSWY_-` MZR^?F9PN9V+69#$_W!V54;-_O#TCF*)J\"JERU-M>HIGR@*1JE7ZJ5_&WD]U M[HMF]?Y#^CMFJWUUCE/B[+UM2?)WNGOK;/QV[ZLB^0OPP["^1OP_P"N?B;E M>P-C]1X:7+]+T'=V0Z;VAE<5AZOJ_J_<='N?+[`Z5P>YZ_)?P49)\5C\;`^: MDRE/3T1G2:EK-03W[KW1)MK_`,DD0=L=:3=F=\YOMGX[=0]Q?+KMC9.P,H^Y MNONSX%^7FU]OUF\=L5G9O2^0VRJ4]+O+&YO<7^0T%-3U,&6>A>CCC@5G]U[H M=NNOY/'QPVK\C^VNX-S[4P6X.M,IC/B)BOC_`-)XK*=A[N M2QM?/5?,+'?('>>%@WAEF[!V=\DVW-7[,Q_7NQ=^YK+[%.N_C-UZ>I M^FMU;.ZYVAL[;?=^"[OW]O/<>-W!NG+YC(YSZ$OLG^3E\>-T=H?&K<6RL?5;(ZXZI[6[@[:[CVRG8?>%;V#W1N?L3H ME>F-MY(]TKNB/<]!-AHX*-E0Y.6&2EA-*(D21[^Z]T3_`!_\B[M9=L5_7^2^ M5>!CV9O#HS`?&+?53@>MJ_'[Q_T%8WYQ;A^5>6P&W<1U61R*U[U+TY]U[HR?7O\IW?/6V_NHZFA^1U5O'J[I/\`F#;D^=&R M,-OS:])5[ZB'9W0VXNO.VNN*[-[6&*Q'^7[MW#6[NHZ^CPU/%$*FII#1!B*A MO=>Z>OB#_+2[`^*_R1[([B+_`!)WCC^Q^^/DEVW7]BCI??V,^3]%MWOO>63W MO2[!@[(?=$V(:GQD]92T4C'"!)J6!@(XY7$B^Z]UR^17\L#?7=/S0VU\I=J] MH=5=9RX?=W2FZXM];?ZJW1MSY,[:H.J,G25.Z.N\7VOUKNC;]#N;;V\:"A7" MY&DW_A\S]C15M=!1`1&&)/=>Z*-M'^1SV?M;XJ=_?%BAWE\/<*W<_6/8>Q'^ M0>UOC_V+B^^S>]=V?`[?E9\>*?NC"X+K;IW7@\EOR2M.2Q4^$6>AGIZQ8K2L)(F<*X]U[H4<9\#_EKUOVCOWL[X\?( MWH_I+(?(O9GQ:VW\@Z>CZ`RV\EV57?&G;J[&2?XOT6Y=R-C<709C;Q?%IC]V M8_,"@=5JHY)G8H/=>ZQ_)C^6+NOOV3^9Y)C^W\!M@?S!.D_COU/MZ*LV?D,L MO5M7T?B\O0U^:S+1Y"'^+19-LFI2G@%*8EC(D>:ZZ/=>Z:%_EF=RXW*;RZOV MS\@]F83XE=F_,K`_-WL#:LW6.5RW?M9O>B["P?J<)V9-G(L'3[;R&[<# M35L5<^VFR=-12/1+-(RK4^_=>Z"GXN?R4ZKXV=T?!GNNA[RQU;F/C)0_)*+N M/;N&V+-AMM]YY[MZCW-@^N=\T=-)D)GQ6:V[A]QMA*^KF-4#-UMOKXZ=(]55_ M7>4R&^MZ9Z'LWJ[<6=R>?[%@[`[+S&:R,&-R=%E*.AI]NTDL5'3-2_<+&9I7 M?W[KW18<'_)MQU?UO\+NJ.WMX=>=L;#^,?RV^5_R4WWM7XMBXW>N(PG M;O2=5@,QU7WUUQMG8>\_COC^QNLJ6C[3^?/^SG;6P>Y=C[MR4E-4XC'8U(]H MR_:&GKX2%R>+K*"IAA">Z]T9/MW`5<_P`AL%W?@]A0 MX3%]DUW5?QPP?:_5,76^-V+UK@^T-T;ES\N!Q]7'/N"2EGSJ!ZJNK(X4IX=` M]^Z]T$FZ/Y(O2-?U#\<.NMI3P[8W'U[VW\2NP>_M_5&ZNY,[N/NG:_QCP.9Q MS;`VYG\IN:3+;4I:VJSF0K,9_!LC%%CGGE*0R,;GW7NN.POY47;/0G8>#[HZ M`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`I25E+O[&YNIQU#75U%22M#]N(O=>ZNPW3D.ZL=FS#L38/6VXMNFG@E6OW1V MYN39>12M9I!5TO\``\3LK.Q>$#QLDPK]3L6!BC`NWNO=,G]X/DO_`,^BZ0_] M*'WY_P#:S]^Z]UQ;<'R9(LO4?2`-UY_V8??GTU>K_FF?]/?NO=%Z^3/Q;[5[ MOW;\6?D%U_N[8O6'R/\`BMN3?VY-GX[>.,S_`&MTQFJ3N#KR?K#LG:FZ:;"U M&T\U4*,?,M7B,I1STCP5<*&:EFADDC7W7NJYMT?R,LKV9O7#]J]H?))Z_N;% M[!^36Y<)VSL79%=L3<75?S![[[]P?>6S^_.G:&ES%1'08[98PL.!HL+D9JN6 MNHVE:IJUEJ9B?=>Z.G\M?@9V+\S_`(__`!SV+VGVGM/`=T=/=K=:=C;YWULK M:^X*78/8N'HZ6JV5WUL"#9M;DVK:+%[WVID\OBY(9E?BYMFKK\ MM42T]+M'%;A*460=S$;3H*4"167W7NGCOL;UEV#OS8V\]FR_P`V M3?\`_,9WQ04\.*D@ MAKXL5C8U+Q4D\CNY]U[I`0_R0**/?NZ,+@NX\?U%\8,U\N]Z?+G%]3=+;#P^ M"W1A\_EOC%AOCELK8]-E=XKF]O+C,5X]S9BH,NW)VJ),C`D"T;TK3R^Z]T#^ MXOY!6]M^]2[_`.OM_?*;'9;>E/\`"?KOX==`]T4O6\T>^^N*3J7>_8$>TMX; MB5LFL603)=?[U7K_`')CHY$%71I5S";RSQ>#W7NA2WO_`">?D`^+WOLOISY7 M[=ZRV?V/VYT_\BCVQW#A.X-E]O[!ZMV?U/OVAV/NGK??6!Q=9MS=6+V; M34\E#N3#5YH8Z^M\2RSI3SK[KW2FZ,_E';^Z=K_D-C8\K\-:F@[ZRGS$FJNX MV^,>9W/\@Z+!_*'>6SMF=&==9G:\.17< MF]=G;1[-W=NML9DMT/7P#,4>%-!C8TQ]$L%("KN?=>Z.WELY\@X)R&5[UWIALG78Y92*2JR&(I.O:Z*EF=+-)3QUM0J-=5FD`U'W7N MF_\`O!\E_P#GT72'_I0^_/\`[6?OW7NNUSWR4DDA27J?I2&!IX%J)H?D'OJ6 M:*F,H%1+#"_6J+(ZIJ9(V=`Q`4N@.H>Z]T23^8K_`"\MW?-S[/)A\AC9D@VUN'#8[,5=(LMZV* M-J42PZS(/=>Z)=L[^1/D*.GI^M]W?)?+0]`4O?7??R*GVMU]M#`8;L#A>`R2^Z]U#VI_)$[ M=5 MVU\ANU^],YO2JZ5['B^0>R\=VUMN##9CKGK_`+*?=)Q\>/IY(I1$]9A9-4-1 M.C1ZG##W7NA:SGPI^3^S?D]WUW3\9/DSU]U1LSY8;WZ$WQWCCMW=)/V-V5MZ MKZ6VWC>O\QC>H-Q5V<@P5/!N;;F-BQ]0Z*%MG^2,> MLINFNS.J=X],8#Y,]3?+/Y8_)BK[DR/5.9FK-\8[OVB[%BZ\V!N.2AR\5;)# MM:HWGB:B64U)6K&*\<45+YE>'W7ND0?Y"V[MI=>KUCUU\O<]F=I;SZ<^,?7G MBS51DJG1G`\V2JD MI1#)[KW2XV__`"4=V=2]L[^[BZ.[^VUBLQB_E9M?Y%_&W9N_^O,QG=C=:[)H M/CKGOC;F_C[NJ/;6/IW%0(`_OW7N@LB_D M==XR9KK/=>^NYOCC\B:WK_/_`"BR-)UU\E^LN^.V^H\'M[Y%G8=5@]G[,IMU M]A5NXX*39TNT*V#$');@K#)#D9'<)/Y))/=>Z-!OO^5=VGOGY5=7_):E[3Z' MZVSVU\Q\>]S;BWEU-TKO/KONB@AZBQF*QV_^G-M;[V7N_&TN?V1NVGQ"XK[7 ML/'9^LQF,K*JCIIY(U@5/=>Z$OYX_P`L'*_/WLF;-]@_(#=?6_7.W_C1V=TK MUWM3K?#8&;-4.^NZ,M35F_\`L'=^5WC3Y&FJ*1*7"[>H\?0XFDH*Y1#4N,M" M)5C'NO=%!WQ_(Z[$[93?>_.Q_DMMIOD-OKY%_$GO#,]I[9ZUKZ"'<.WNBNO. MNMJ=O]8;MQ>:Z^Q^[*;Q-&,;D(:$HLP@G:I]U[HP?QD_ED][]2;S MZ0H.T/D1L/=O1/QC[X^2_P`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`/R?>\/B;N'`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`,H*;*1Z%D,N,GJ MY46H4*\;:H2PLZ'Z,"?=>ZBUO8VP,;656/R.]]HX^NHI1!64==N;!T=723%0 MPAJJ6HJ%DC?D>EU!Y''OW7NO5G8NP<=5R4&0WMM&AKHC"LM%6[FP=)61O.H: M&.2EJ*A9%9@RE0RBX86O?W[KW2AR>9Q.$H),IFDR.]-IXZJI93!4TV M0W'AJ*IIYEB$S15%-4S+)&P0ARKJ#I(-K&_OW7NG&AW5MO)T,^4QN>P^0Q=- MYON,G0Y.@K,;!]M$)JCSUU-(T2>-#JDU,-*^IK`@GW7NHV'WKM'<33IM_/?NO=1Z#L+865K(.GH:#S*@TU+45U2(-U8"8T]%2#54UDXBJ&T11BS/(?2H-V(]^Z]T['=FVA M2U]?_'<2U!BAKRMZ<(MZ[0GRQP$.Z-O39X2R0G!PYO&39D310?QTKJN;&WT/O MW7NFM=^;+>''U";KVY)39:KFQ^)J8\YBG@RV0IV"38_%RI,143JQ"F&'4X/! M'OW7NG2+<.$J,C58BGRE!496@2GEK\9#64SY&@BJ[_:RUV/#^:%9`&,;2(`P M!TWM[]U[IM;?>R5QTN7;=^UUQ,-8<=+E&W!B!C8\@/K025YF\2S\C]HN'Y'' MOW7NLV2WEM3"RT4.9W%A,/-D6=O,;!)!105\D;S6=E0^)6LQ`_ M/OW7NNJ_>>T<3D(,3E=S[>Q>5J?!]MB\EFL90Y.H%3*:>F,&/JI4F;R2`I'I M0ZF!"W/OW7NN&6WOLW`5*T6>W7MO!ULD(J(Z/,YS%XJKDIBYC%0E-7RQN4U* MRZ]-K@C\>_=>ZS1;PVM//'2T^X<)454V-3,P4M/E:">JGPS@,N7@IHI#(]*0 M014*I0CD,01?W7NI&-W)@+7]^Z]U$HMY[3R64K<'C=R8/(YO&"0Y/"T&5H*W,8P12_;R'(XJFD:H M@TR$1-Y8ULY"&S$#W[KW6*CWWLO(U[XG'[LVWD,M&]1&^*HZ;O[^[(%%1Y([NVR,;D:ML?C\B<]B?X?7Y!6*MCZ M*N$QBEJ`5;]A'+\'T\&WNO=/7\9Q7\1&(_B%)_%FI#7C%?<0_P`2_AXE\!R' MV%_-X-=D\VC1J.F]^/?NO=0J7=FUZ[[?[+<6"J_N\E/AJ7[;+X^?[C+TL3S5 M6*@\,QU'&9JNOR%5!14 M5+$#8RU%55,D:+?>6TZ6NQN*J-R8&#*YF(3X?%S9C&Q9++0- M(8HYL7022B6H1V5@C0HP:QL;^_=>Z<:G-8NB2E>NKJ:A%=54]#1"LFBIC69" MK!--CZ03$>6>2Q"0QZF8@A0;>_=>ZQ/N'!Q25\4F5Q\6.LR$;L&@A9(I)%EF"H41F#%5)'NO=,D?8_7TU`N5BWQM"3$O6/C4RR;E MPKXM\C%'YI<7Q3R4$DBJVGU:2;VY]^Z]U!QF]]GYJ2>+"[HV]F9:2`557' MBY`/NO=98=Y;4J,I48.GW)@ZC.T:3 M25>"@RM#-FZ5*<`S&IQ$;S&8N0@BT:RQ``)-O?NO=CTV):P!/OW7NL478>PJBN_A=/O7:51E3 M5_8#%T^Y,+-DC7F7P"@%#'.9#,7]`B"ZM7IM?CW[KW3TF>PTM=58N+)T,N4H M8::HKL7'50-DZ*FK)/'25-7CPWFCCE(/CD9`K6.DGW[KW3?C][;.R]=4XO#[ MJVYF,I1I+)5XO$YK&Y+)4R03"GG>HH**5Y45)&".S(`I-F(]^Z]UF?=FVHYL ME3RYS$PU.%I!7YBFFR-%%4XBA:%JA*[*P22!Z:!D5G6:<*A4%@UN??NO=9HM MR8&:M&-CR^.;)-1G(ICQ6TIK9,:KB,Y..E#ZVI=1T_ MZYX_>^SLK2UU;B]T[=R5%BHA-EJS'YO%UU)BHFC:59&DD9=<<=7-CI)5B+@'0'(O M8V]^Z]U&S&^=E[=JC1;@W=MG!U:Q13-39G/XG%U`AF8K%-X*Z:-]#$$*VFQ( M(!)!M[KW66JWAM2AKZ+%UNY,#1Y/)QP2XW'569QD%?D4JI_MJ5J"BEE$LPED M'CC,2,&;TJ2>/?NO=1\GOS9.$K!CLSN[;.'R31I,F.RV>Q6,KWBD)6.5*.OF MCD*L5(5M-B00#P??NO=.53N'"T531T==DZ*@K,E+)!C:.NJJ>CJ\E-#'Y98< M?35#*\[JMBR1*S`$7`O[]U[J/-NW;%/$)JG/X>F@;)_P19ZC)T,,+9LN8EPJ MS22!36%@5%)?RW!&B_OW7NN--O':=;EJK`4>YL!5YZA6H:NPE+E\?49>B%)H M^Z^\QL,AFB,?D36)$!74+_7W[KW6''[YV9EZ]\5B=V;:RN4C$S-C<9G<5D,B M$IB%J)#0T]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__U-_CW[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UIH_.>3M#I+YD?SN_EW MLE-Y;IZWQ?2O1'QD^3'5V`I9JYZN!J^@L/\6J!>RMK_`!OI:#&RI3[SBWRM1-F(*>9,@[/C)8A'!%(X]UN1 M5`!4>O4?:OP$Z>S_`&A_PG1I?E-\6-D;B[9^2VR/DC-\PI.S]@XW,;S[P=F9?&T&%QK% M*BAH(JFBK/%D8IJEP4_;;W7NMK9-J]4?*?>^NN_E/UABM\=587=' MQKW5U3C(Q_P"33\M^S:+J'IG8FZZ[^;O3]/;F[!W=UE/EL!3=#['^>FVJO;FU M>Q\/A%AR&5V+A88EJ:W#03()***5(G5R&]^Z]T9Z:H^#C_RY_DULWIK._!?L M/Y.;P^0/QKQWQ6IOY9/0F_OBCNM/EPN6,WQ8R7Q@2IW?NS M)XZB11+DH?BMT!1]Q_ M`;O3>.V\M\/*;?6W-W]\/0=*;$J8J;YBP;RI**EK\E#29B3-T=%B!/IROWD[ M.(H5)]U[HB'P#HMATGQVHX?CCNO^7)+\_9/C3\FZ?H#9&R/BEOW;?\Q/$_(& MJZ\W0VWIX_DIN#.+MY\]2T1JY'JEQ,!F@T0P,DVEV]U[JU#XPK_*2JNL]N0_ M##8'8]%\MH_YHJJI;-+45-&L:.96]U[JHSJ+'_`!/A_EE?)6DVKNW^6IN+O>7^51V##2[4 M^.OQ)[0ZO^7^$SR=>8*;?D/:G'\9_P"6Y_>W+87&21Q[9R?QNQ6' MP7S$3-52T[1Q097J>EHHYC5RPR2U#A(Q5%Y8$]TYI4J33A7H*_D=M_XD8+^: M5\]L?WMN7^69L'!8?NWXYXS#;4^:/Q![*[OW_5=<83XP[%HZK'=+[NV+F,;C M<#B8X8VH*:FGH:CPUL32E3&HB/NF>H/RVB^#\^[_`.<5A*K8U!N/^:OFOG`& M^!$W7.S-ZR?)JGW%4=2=:4_668V)O3;%,%IL)C\V,I791*FNCIOLH<@*J-XG MTR>Z]U=!_P`*`Z/&U'P6^.$/9]3UM2XV'YN_$.3L/*=U;/R78G3V-IX:C(?W MCRW:FRMLRP5&7V[$WE?*4-!40F:`.D4B:@??NO=5??![XR=;?*;XS?S2NN]J M5/7)VQU=W9TS\G/B+\BOBWU%N_I3XL;*[VZMZ0QN[.S MN%DQ^_Q#6S+7FLG6.>*215A]U[J]S^3%U;7CXD8CY>]G2XW?LW#T]9UKUCBVJD6JAPVT-LIB\+CZ&0^..6.JE109W)]U[K3 M"R&SLY-_+R[;^*#XC=E1M+-Y3N3^;+4F.DST6"HGV+O?=GQD_NG5S4>)I*=W MEWIC]OYE:>LKZFRQTRK'JFD,6L]*_#3TZNJ^3$W\O[;_`,HOYL>0ROQDCZ4I:78^`^);8C&RO3;GI-Y&J.<7&U25RY)J M:JE:.)!/[WTDZ+CEHOA?M[LS%4W\Y796/WAW1_PR?\`L5M3%]@[.W7NONG)? M(6CI^Q!OW"]993:5++6T6]IIGQ$`J(*B"J%;$8G$[%S&%GQNYZ3 M&''_`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`J/[KW M6K5U%LK*>JH=QIA/NOFQVUTCL_8>$*X_ M&T5'-44&:W!VQ5A:BHJ6AC6:-2#$&772A$4KJ/\`JX]68;H^1&_ZW^:U6_S7 M:/ISY`3]!==_,G;OPDA^1,F&PT/QIQ?PIHL=5_'CLVNRINO^M>O/^%'O M\P_<&\=Y9K'Y2;'X#$9#HWL+#TV5K/X93U$YBJ*JLI:>*9(V5C*AU:"2/=,N M`&QU=]_-;^0_2GRS_D9_/CMGX[[[Q?;?768Z)[$P.+W+MNERRT=;F]OYF#%Y M6AAILE3T]0STU4A1QX;$CTDCGW[JO5`'R5QW76Q=P=D[P:AZ*[X[&.U_@MO, M?'#Y%;"[@Z@^=D>Y=O\`36S:;K7_`(;#^576#5E1D\'424=2E!C*/'P08_*5 M&2BRKI&=-5[KW5_'\\3JN7Y!?%'XF]/5>:W=UY7=L_S!_AALV7=FW)A+O?KC M*;JW-54$.Z<;D*:Z&NPU7**E)U*QF6(Z&0$,/=>ZH=[8[`[D[A[!^>&0^2VP M=T8K;W4?<_\`)YZ=_FK8C:F&S,T6_P#I/I+=78>)[?[`VI2X.CFR%=L;/U$F MV-UY"EQB-41X.JJ*=W9(7D?W7NC+Y'H/^7)\GNX/YC59\2.A^J=^?"?J;^73 MD=WYM-N=8B@^/.*^?F&Q^ZZ[8V_>K<3DJ.GH'W?0;'J)*;*YC!P:D1J>"KE: M40`>Z]U<1_(?Z3ZJZG_E0_$_U-@[K[D^/W7G8O;N4V]MZEP>6[![!J M]H1T-7N[>4D*1R5F1ECC5))Y_60`.``/?NO=4E?RE/Y;?<4_3OQ!^:^+V7\/ M^D.M=C=%_(SW98*>JE&9:5): MJ2.:DI4A$8>8^_=>Z+_\"/C!V_U1N'^2UV=M/J7XG=";H[K^,7R,S?2O9/Q[ MCWIM?M_N?LBB^&U1F-C8;YKR;SH(<564]=65-/75-#C)JKR9$R!`D2ZO?NO= M"+\;U^&+]<_RI-H_'?9>0QO\XC$?+?IJN^3.1I]E[DHODYBJW$[IJ9?G?7?) M7?5300))MNMQ+Y0!,O4RTE2CT0QZR-%')'[KW21GIOC1#\5,ML?N[/WG_+0QO:< M'\Q/Y3U]%LGL;XE=H9[YSQ;H;Y+[H/7=1MKY$4^6@P=)6BK_`(=D,'4-@W6F MQYB@=C(C2K[JTBA14#CTK_BG\A>Q(_YI6R_YHF?Z8^0NVNC_`)R_)GM#XJU? M?6Z\3MG'_'[+?%_=./Q?7/PHI,"9,H,W0Y!-W[/%77U%=@Z:C=,P=%5)(H-9 M[IKH*NC:?X>5>%^.^!^->RJ.H_F^4O\`-MW[D=S;@ZFVAN[%=J['+5,]-JJ<;IB%0BO%[KW5G/\`.2Z/W3D/F1TG M@=BXBDJ-I_S3>J-M_P`N[N5EP.:R6-IZ?8GR$VYW/CMV[A;"5M$OCAV)4[]H M(YY98WAB5XXA4/,HA]U[JM'`;"[S[7^#7S:[RJMI;^-1\=ML_"7^5GV3BMK8 MS=.+[2K?BQ\*NRXJSYQ?Z+\-6QU60C3/TF5054-**B:I&/K9HI/-424B^Z]T M*OR(G^#F>KOG9E?Y56U]M8WX[8C^2E\L<=\MN@I6$57)8RQI[KW0>4OQ:W7\=MW?)/'[AZ?^+' MQYRF_O\`A/W\T=Z[0VG\&J7>>`V'W"*K%XK$Q9#OK&;[HJ27)[JHA4I58N+& M1RI$5J)FG*@1M[KW1R/Y:8^&65^=WP+JOY8FRJ#"X;`?"CLJF_F,[HZ6VGN/ M9_2^1S=7M';5/U/M[LN*M@H\36[RCW7'DZN&:"!\A]L9"\QI05'NO=#?\KOA MKC?E]_.5[VQF8Z4^'?;]%LKX$_$[)/'\P>I-V]HX?#09?NCLZCJ9.O8]L9#' M?:5LRQ,E>\KRAD6F`50&U>Z]U7A\@L3\&-G;7_F];+^=JDP0"HI\>89%B9R/=>ZL#[[VV^VOY)?\` M+U^4^S M3BLAD]L[CPNT9?D-V9\3LU8K19J9XJR9J+^%J=%,Z^Z3]`5\5?B]N/;> M7_EG?)'+]+?%/K39F_/YN.]=LT?R(Z@Q^]L!\ZMV92A[H[5FAV;W9F\W21;? M.S\A5XI<37Q4U9+-44,>/ACB\LK%?=>Z=^FH?AQ6TO1^!^.6QL?4?S@8OYP? M8.2S>>ZBV;N?$]M;;Z4C^=^Y\KV'F^[=W4=-3XV;9C=:GD/CTEE)1F6Q/NO=##[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_ M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z_]7?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=16H:1KW@CN5*L;"-WB(,4CJ'DB(^AB=KE?\`8$>_=:ZQ/C*"1F9Z6!F8HQ9HT8ZXSJ5P6!]5 M[$M]387^@]^Z]UD^RI1JM"BZRID*C29"AU)Y".6L?I?Z<^_=>ZZ%!1"X6E@5 M3+YF58D5&F`"B5D`L6L+:K7M_K^_=>ZQ#%8V^K[&E+!S(&,$997:UV4D<'@' MC\\_7W[KW7-<=0(Y=*.F5VC6)F$*`O&GZ4?CD#^A]^Z]U),49C\11?%;3X[> MG3_J0/Z?X>_=>ZPFAI&(9J>(E050E%O&"--HC_9XX]-N+?T]^Z]UTM!1+^BE M@C()8-'&L;AB=1*NEB#?^A]^Z]UTN/HD,C+31`S/Y)SH%YY+%=J_ MU/\`7W[KW7!<90(0RTD(9590WC4L59M15F(N1_@3^![]U[K.*2G&FT2@*+`` M6%K!=-AQ:P`M_@/Z>_=6U,>/6-L?0NQD>DIWD)+>1HD:0,5*EE=A<&Q(N#]. M/?NJ]=B@HUD$JT\2RJ7(E1`DH,@TN?*EFY''U]^Z]UR>CI91:2")Q>]F0,-0 MM8D'ZD6XO[]U[KI:*D1$B2GA6.-_)'&$71&_^JC7Z*?K]/?NO=988(:=!%!& MD42BRQQ@)&@^MD0<#_8#W[KW6`8^A5`BTL*H%T!`@"!->LH%^EB3ZY-14CMKDIH97L1KEC65PK'4RAY`2`3S:]K\ M^_=>ZZ-#2D`>!``VK2HTJUBS@,!]0&8L`>`UB.0/?NO==?8TH1XUA5(Y&+RH MA9%E=A9FE"$:B?R3R??NO==_8T@9G%/$KO?7(JZ9)";$M)(MF8W`-R2;@'Z@ M'W[KW7!\=1/'X7IHFCU%M+(&]9%O)S_:YOJ^M^;WY]^Z]UR>AHY55)::&5%# M`+*BR+9Q9[A[WO\`F_U]^Z]UVE%2QW\<$:`D'2BZ4%A861>!_L/?NO=<#CJ, MW!@2WHL`+*GCL8Q&HX4`^H`"P8EOJ2??NMZB!3KM\?0NC1/2PO$ZLCPL@:%T M?EHVB/I*DFY4BU^;7]^ZWJ;UZ\N/H$18UHZ81HP=4\,94.`0'L1]>3S]??NM M$DY/64TU.86IS!%X'!#0B-!&;FYN@%O]X]^ZUUC%#2!D<0J'C5TC?G7&DFK6 ML37NM]1OIM_O`]^Z]UV:*D98T>".186UQ+*/*L3:2@,8DOIL"0+?CW[KW7$4 M%(&9Q"NIU",Q+,S(H*A&9B218E;'^SZ?IQ[]U[KL4-(H"I!&D8U6BC4)#=@` M28ELI/`L2/?NO=9XXHHET1QHB?ZE5"KS^-(X_P!A[]U[KJ.&*%=,4:1K8#2B MA5`46`"C@#_`#W[KW48XV@*PK]I`%IV+TZB-0*=R=6NG`_0;\W2WOW7NN?V- M+J=_"NN16263GRRHY#%9)?U$<"USP.!Q[]U[KIL?1,Q M-Z2!H_,:CQF-='G+%S.$^@>YOK'-_P`^_=;!(R.NCC,>26:BI2YL3(8(S*6% M[2&6VK5R3JO>_-_?NO%B<'KTF-H)D>.6D@DBD`5XGC5HF4((POC/IMI`'T^G MOW6NN8H:-6=TIH8Y)559)8HUBFD56UA7ECLQ%^;$V_K[]U[KBV.H7`#TT;Z6 M1QK&LZT8NCW:_J!9C?Z\G^OOW7NN:45+$VN*!(VU,P,8*69^9&`6W+'EC^3R M;GW[KW7!,;01V$=)!$@O^U%&L<)NI0ZH4LIX)'(]^Z]UYL=0NZ224T4C1JR1 MF1?)XT==$B('O8,.&'T/Y]^Z]URBH:6`H8HO'H)(",ZAF(TZI5!LY'X+W(N? M?NO=97IX'9G:--;!0S@:78+?2"Z\FUS:YX]^Z]U@..H3*L_VT0F0$)*J@2*# M(9K*XY'K):P_))^I/OW7NN7V-)J9OMXM;QF)WTC4\3?JB9OJ5/Y4\?X<^_=> MZ]%0TD*>**GCCCT&/QHNF,1LVIHUC7@*33[:)9)#>65%\O28^BE`62GC9%=91':T8E5_(DH0&GAIUT01I&O\`1!8'DFY_QY// MOW7NLWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7 MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][ M]U[K_];?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]??X]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]#?X]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]'?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U_]+?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] %^Z]U_]D_ ` end XML 15 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
Liquidity and Financial Condition (Details Textual) (USD $)
6 Months Ended 12 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Dec. 31, 2012
Dec. 31, 2011
Liquidity and Financial Condition [Line Items]        
Working Capital Deficit $ 3,640,546   $ 4,564,045  
Stockholders' Equity Attributable To Parent (8,281,522)   (3,951,169) 2,824,234
Net Income (Loss) Attributable To Parent (14,066,292) (2,495,461) (7,575,965)  
Net Cash Provided by (Used in) Operating Activities, Continuing Operations, Total $ 4,784,185   $ 7,921,407  

XML 16 R54.htm IDEA: XBRL DOCUMENT v2.4.0.8
Bridge Notes (Details Textual) (USD $)
1 Months Ended 6 Months Ended
Sep. 12, 2012
Jun. 30, 2013
Dec. 31, 2012
Disclosure Of Bridge Notes [Line Items]      
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants   $ 296,250  
Stock Issued During Period, Value, Conversion of Convertible Securities   3,159,624  
Preferred Stock, Value, Issued   0 2,362,517
Debt Instrument, Unamortized Discount   7,728,486  
Loan Processing Fee 673,229    
Series C Common Stock [Member]
     
Disclosure Of Bridge Notes [Line Items]      
Debt Instrument, Annual Principal Payment 3,025,000    
Bridge Financing [Member]
     
Disclosure Of Bridge Notes [Line Items]      
Fair Value Of Warrant Liability 82,726    
Preferred Stock, Value, Issued 2,362,517    
Notes Payable, Fair Value Disclosure 3,479,757    
Debt Instrument, Unamortized Discount 2,445,242    
Bridge Financing [Member] | Series C Common Stock [Member]
     
Disclosure Of Bridge Notes [Line Items]      
Stock Issued During Period, Value, Conversion of Convertible Securities 3,159,592    
Stock Issued During Period, Shares, Conversion of Convertible Securities 315,959    
Healthcare Corporation Of America [Member]
     
Disclosure Of Bridge Notes [Line Items]      
Bridge Financing, Units Issued 59.25    
Healthcare Corporation Of America [Member] | Series C Common Stock [Member]
     
Disclosure Of Bridge Notes [Line Items]      
Stock Issued During Period, Shares, Conversion Of Redeemable Preferred Stock And Warrants 592,500    
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 296,250    
Healthcare Corporation Of America [Member] | Bridge Financing [Member]
     
Disclosure Of Bridge Notes [Line Items]      
Bridge Financing, Units Issued, Preferred Shares 10,000    
Bridge Financing, Promissory Note Face Value $ 100,000    
Bridge Financing Units Issued Warrants 5,000    
XML 17 R48.htm IDEA: XBRL DOCUMENT v2.4.0.8
Software, net (Details) (USD $)
Jun. 30, 2013
Dec. 31, 2012
Capitalized Computer Software, Net [Line Items]    
Software costs $ 294,109 $ 0
Accumulated amortization (31,967) 0
Net software costs $ 262,142 $ 0
EXCEL 18 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0!=*R&J20(``.PH```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,VLUNVD`4!>!]I;Z#Y6V% M!\]?TPK(HC_+-E+3!YC:%VQASU@SDQ3>OF.31%%$B5"1>C988,^]!R^^U5E< M[_HNNR7>5G,\XQLY>K6;I;YS]NOLZL\"]'8VG3.TC+?4\BO5V_?+&[W M`X4LG;9AF3Q/35[]A@ZFV9D.,S^>:5WOYS;%J>' M'$GIUNNVHMI5=WUZ`T48/)DZ-$2Q[XKI6O2FM8^Y3^R?'@YLNI07#C+^OVGP MF3DX2`X!DD."Y%`@.31(CO<@.:Y`1E:/(RE%DY2BR"A19!8JL M`D56@2*K0)%5H,@J4&05*+(*%%D%BJP215:)(JM$D56BR"I19)4HLDH4626* MK!)%5HDBJT*15:'(JE!D52BR*A19%8JL"D56A2*K0I%5H(#GLT_E2)VT&^^&D-IYGLY_"X_UN_'T;$B#R,>6G@IXQXIL M3QM3L^_\A2^:=#1V!VNJC^QF4U=Q]0<``/__`P!02P,$%``&``@````A`+55 M,"/U````3`(```L`"`)?]=J>*V?5@^@8B)G:13'&HX< M85?=WFQ?>*24FV+7^ZBRBXL:NI3\(V(T'4\4"_'L)MI<3_3_MCAQ(DN)T$C@\SS?BG-`Z^N!+I]H MJ?B]SCSBIX3A363X8<'%#U1?````__\#`%!+`P04``8`"````"$`;[UJ"Z`" M``"I*```&@`(`7AL+U]R96QS+W=O!CZ2NG56A6A;X;VT.\K]>7YX\VM*F*J^[8^#GVHU#E$];!]_^[^ M4SC6*7\I=HA M-.NUE-/U&&K[9LSBJ:W4]-0:4<7S>-"HS_E_3,I_Z;00-$6P<>W8K8O/?2EL*DLD,KLZ,#D")O)`IFLV<;2V%AL16BH",-6A(&* M,&Q%&*@(RU:$A8JP[#ZWL-$=6Q$.*L*Q%>&@(CQ;$1XJ0MC<$<@=85-9()79 MT<')80O40X%N%E5$[.HIM)_3E-\J7C^57Y]&^U(V&]C1L71FH*TN/#LR.93/'0N@XMJX+4T/I2GL[`C,CK`E(5`2].B@%P1L!D($:K8^-=2G9NM38WVRU\K"Q;+L M'%N,0#9S/&2.9S/'S\PIW_S!&PO=V]R:V)O;VLN>&ULE)A?;^(Z$,7?KW2_`\K[7<@_ M6JJV*PI41>JVJ,G=?;34R53>6_:UG=82*TEBJQ8WU?WC_WZ75R357,4]2)6ZL=Y%;WV___>=Z MDV9OKVGZUB$!E=]82ZW75]UN'BW%BN??TK50],T\S59<4Y@MNODZ$SS.ET+H M5=)U>KU^=\6ELO8*5]DY&NE\+B,Q3J-B)93>BV0BX9K2SY=RG5NWUW.9B)_[ M'77X>OW$5Y3W-K$Z"<_U))9:Q#>63V&Z$;4/LF)]5\B$OAVX/=?JWE:;G&6= M6,QYD>B0MG=0IWHYGN/TR[\L2_%3BDU^7%2&G>TOJ>)T4_XIE?:]BEQ*8+/[ MZI>,]9*^[_5ZU6L[N9T?MMG>H"!NJF$V4EOJ=3=6^ M^C*E%I95G]+.;*N374GZ)9O&=IDXJHR>GX+GQ^EX&$[&[&[X.'P:35CP,)F$ M`4@X(.%\08+-.*BXH+*K]:>)!"'E\V/R%`;L^9X]SR:@XH&*UYI+724(GT'E M@EI35<7_F@P5M"IN'V1V5)RYI]$0ZWL!*A?-9,8BCS*Y+GEGZ9S=%;E4(L\A MB0ML\65S_:/\74CRP#LC3[-[J;B*)$_8*%7T*T)U6#=S`.;9QM$!NE<;W@FF!*U[+%9MD'@5/VA39=/RMF#2&(F M%0NS(J])T(0])F[0-Q9SD66BZA5M?I3FNM;Q`2H8X%'9LH($)EN:R3G-[R.P MEPB^;<#V2&R5E(WH^34X+I$QVX#L+I/Q0K"G5->?ADC9!E./J5J$(ENQL7C% M`ETB5C1%&T/K1<2"CIS71+!`1$4FM:P_%0%S3,!T&KTMTR2F$X.58.AW+!!2 MY1A43>FH7`D6\FW]D1/23@L M'2!7CL%5NZEQH@X0-,<`#48*-8$0J"6!N#D&;NU)T-IJK`\00-<`\/1H.9$/ M@NB:(,*$.;$8070-$#^;$GLAW`NBZ1IH-F?%B4002M>`LF;B$ZL11;H#-;R, M?CJQ&(%TC3G7:BL&-:"K%@Q,U\2SU5B(I]U#/EV#S_;3%I70>,\`%=WRH0*K/=P*!8W6M-N%'%*EX=6R,%!M%R*/ M'(70=Y[!:KL0^>4HA,[S#&;;A<@P1R%TH6?@^\DD.%%K=*%GD-RN@]AXZ$8* MFDW#F7(B#72C9]"+=YX6[#Q$EX)&#I_>@7:24%P?74E!0^?3$;?;%^H@R+X! M,HVXHKQ/':Y#AYVA`A+L&P37KT6']:4AZW[TD5\*&AO"6Q**-%SM([P4-%3J M`]?LL8_(4G#.; MIW(?Z:6@(6-&PO=V]R:W-H M965T&ULE%=-CZ,X$+VOM/\!<4^P^29*,FK2ZMV1=J35:G?F M3(B3H`8<8=+I_O=;IAS`SG2&7$*`Q^/YE:N*6GYYKTKKC36BX/7*IG-B6ZS. M^:ZH#RO[OW]?9K%MB3:K=UG):[:R/YBPOZQ__VUYXJDK')21TJJRH;618-%,X^'Y? MY.R9Y^>*U2V2-*S,6M`OCL5)7-FJ?`I=E36OY],LY]4)*+9%6;0?':EM5?GB MZZ'F3;8M8=WOU,_R*W=WP,^EZPBQC]M\217_YHBMU?1(H%CE>6<#*+@^OJ;'K.VFR];/C%@KT'RL4IDSN9+H#Y MZ@^NIG?L,\/`*4GR)%E6-B0->"$@RF_K.%@Z;Q"87$%2A,!O#Z$Z8G.+B,,> MXH#>7C08.1;]\V!>M4FPU":#*\6F>&&LQ.U?TR$VMPC/ZR&:$K!LNA()7ME` MWEL01STM:D-(U%GH^IX;QR'1(1L-$GDDB)+!:TV<_X@X"3;$Q?J;4X0$*,[S M2!*YPYO1.0T24C^F=Q$'Z3'=.@@UQB2$.(2B.$II0S]2F(6@0A='@OB8M M?$2:!$-5&`4U,2*6(@2LZ>-N2KN'T*1%CTB38-VUQ,BY%"%7UV(:N-&PTS&D M8T@4$L\//HFH[)FC4G(_*R78T&9D88H0U#9+HB2DWO!FU*9!0M^7);7?%YIQ MR2/B)-B(J>%*BI![,;V'T*11Z&K3C>O0AG-^OV:L(@JCK/,]S_7HL-?1.AU# MJ4=H//#H`F5E'D56-@D/1-^/,,5Z/BYWHT*EA"(&A88N#0V;-XK$[VK.D%>Z M/%FN1_)^(0N+NR9K:#-*%F*N_KD1H<'@C?)/P]SW3Y;LZ0*QP&L"C>"E%#%* M(/5)&+J)D3\;'10%49"$0^'1+91U>[I"K/*:0B,S4XH8,W#*NY_?U"4]U"#D M-YU93\P.H3"_,&W<)6;W33/ZQ,2TP%H_-H^286>K#8@@)=4+X$-@5'65B=>F M(3^W!@+=1*-?3)1XVSB@HYHU!D'XJ3*CL+D2&@PRE$8-=-_-A]H'QG'A)0DRA.*CA!%*QYL`V MK"R%E?.S',(H.-!?[0?$)[<;\?H;,)^=L@/[EC6'HA96R?;P*)E'D+D-3GAX MTO)3-]]L>0N36??W"),X@QF`S`&\Y[R]GL@9LI_MU_\#``#__P,`4$L#!!0` M!@`(````(0!&PO=V]R:W-H965T/W,W:6MR]U93U3(1EO4N39+K)H0WC&FB)%OW\]W,R1)15N M,ESQAJ;HE4ITN_K\:;GGXDF6E"H+'!J9HE*I=N$XDI2TQM+F+6W@3.[;NS4F#7(."S$-1X\SQFA]YSL:MHH8R)HA17PRY*ULG>K MR35V-19/N_:&\+H%BRVKF'KM3)%5D\5CT7"!MQ6,^\4+,>F]NYLW]C4C@DN> M*QOL'`/Z=LR)DSC@M%IF#$:@8[<$S5-TYRTV<^2LEET^?QC=RY-K2Y9\_T6P M[!MK*(0-9=(%V'+^I*6/F7X$C9TWK1^Z`OP05D9SO*O43[[_2EE1*JAV!`/2 MXUIDK_=4$@@4;&P_TDZ$5P``1ZMF>F9`(/BE.^]9ILH4!;$=S=S``[FUI5(] M,&V)++*3BM=_C<@[6!D3_V`"YX.)%]FA'\WF_^,2'%S@W+OXMA>Z\<8:ZD(-F;31P/&K"V5BSZ36ZH``X4$)NIY3G:]?#:+&&T;74=&OS8-1S MXD]Z/J<)!LT(!F*Z'D:+838M3!",_ M5B29]+PVFEE74]^-7?V;P!D)'`>;H\D(#KZ7Z^&T>`H7CWM>&\WYGKMH-T81 M=?B>!_C!.VSQF$U_!P&L-9=GFFXT99Q,Z;717&(TBIXQ">>G$8\"G(TA+\-I M\11N/@G0:"[!&86I_SR.8.\ZEG_$IK?+R4+R<8"ZT90QF3`:S25&HS`!SH,D MB:N'W8'8,3X<]Z<[OMI7A!>P)+2[H=RP*UDBK MHCDT=>T9S#!A=A5SHWC;K:I;KF`WZ"Y+V/PI+$2N#>*<<]7?Z&5N^#NQ^@<` M`/__`P!02P,$%``&``@````A`"@R1!KA`@``]@<``!D```!X;"]W;W)K&ULG%5=;YLP%'V?M/^`_%X^`R112-6FZE9IDZ9I'\^. M,6`58V0[3?OO=XT3`J2+LKT`AN/#N>?8UZO;5UX[+U0J)IH,!:Z/'-H0D;.F MS-#/'X\W<^0HC9LIXB%>58 MN:*E#7PIA.18PU"6GFHEQ7DWB==>Z/N)QS%KD&58RFLX1%$P0A\$V7'::$LB M:8TUZ%<5:]61C9-KZ#B6S[OVA@C>`L66U4R_=:3(X63Y5#9"XFT-=;\&,TR. MW-W@C)XS(H42A7:!SK-"SVM>>`L/F-:KG$$%QG9'TB)#=\%RDR)OO>K\^<7H M7@V>'56)_2?)\B^LH6`VQ&0"V`KQ;*!/N7D%D[VSV8]=`-^DD],"[VK]7>P_ M4U96&M*.H2!3US)_>Z"*@*%`XX:Q82*B!@%P=3@S*P,,P:_=?<]R764H2MPX M]:,`X,Z6*OW(#"5RR$YIP7];4'"@LB3A@03N!Y(@=F=AG,[_A24ZL,#]R))< MS>+9NCJ;'K#&ZY44>P>6'BA7+38+.5@"\]$?6TWOV-\,`Z<,R9UAR1#L&?!" M0<@OZ]3W5]X+)$,.F'N+@6N/"<:(S3EBGO00#P3WJL')H>KWTSR*,V`CSJ1K MU-[;%T,E8?^;#K$Y1T!)#Z$Q?N+68VP)S^;-5=0HRT M``+86`!([(L[F3J2F/R/1#-I*O'$;ZVS&"OQ)DFC9.K?$!#& ML\7B9/Y(83I6>-D\`YXJ.^TIJ\QB;*CQ;!XMIN99P"7S;/^UC8536=(-K6OE M$+$SO36`7/JW?=N_"[O.W7^`MMOBDG[%LF2-&ULG%== M;ZLX$'U?:?\#XKU@O@)$2:X*H;M7NE=:K>[',P$G006,L-.T_W['=J"VT\_M M0PG.F<,Y,V,\67UY[%KK`8^T(?W:]AQD6[BO2-WTA[7]\\?=36);E)5]7;:D MQVO["5/[R^;//U9G,M[3(\;,`H:>KNTC8\/2=6EUQ%U)'3+@'K[9D[$K&=R. M!Y<.(RYK$=2UKH_0PNW*IK6U<0M;J[HNZ8: M"25[Y@"=*X5>>T[=U`6FS:INP`%/NS7B_=J^]9:%Y]GN9B42]*O!9ZI\MNB1 MG/\:F_I;TV/(-M2)5V!'R#V'?JWY$@2[5]%WH@+_C%:-]^6I9?^2\]^X.1P9 ME#L"1]S8LG[:8EI!1H'&\2/.5)$6!,!_JVMX:T!&RD=Q/3$Y)`ATUF*"\/X"2[,OJ*+JZ^56FN1S,#2-(@W*KC\HDQBHU"P_TA'YA)CE M3PNOAA03PE0/4E3UHBHQ;_Y7]L1DA,>M;6"=1<8HU&5F$A/+*D4(_G1`+@&I M6JD8&6:W*HM!4+Q#H-4)$JHZ?;M.'*S;"Q*CB3*)B82]8!%ZZ<*P)P&A>(^( M+E,CXCCP4SV@4`(TZ5`-5?J'B\3C=!>E9H,I$9IV/M\H[^:WT\[!NO88 M)7H_9!(CM[X?^@DR7Z>Y1"CBU9!HD42^P5DH$9KX]#/B.1C.#W_>E-G52GZU MLKU:*=0538T'0XF:R_][SG$:,\MFAXAG@1MX#?TAW<40#R/GMRRP-4/S(,K1D,?Z(^NB.CC?-GU+.C.7!:XH/DA6L^].1@ M*,>2#H\'G..VI59%3GSHXUMM7I4#:>8M85B`>&-]RP?5%]9OTR6TQC4^\Q`$ MB.'48`++T\SKSE_!S#F4!_R]'`]-3ZT6[T$>V*>V_W[$-@<"&Z$!*XN3U MD_><8Y_,'EY%C5Z8TEPV&8Z#""/64)GSILSPSQ]/=_<8:4.:G-2R81E^8QH_ MS#]^F.VDVNB*,8.`T.@,5\:T:1AJ6C%!="!;UL"30BI!#`Q5&>I6,9*[2:(. M!U$T#@7A#?:$5-W"D$7!*7N4="M88SQ$L9H8\*\KWNH#3=!;<(*HS;:]HU*T M@%CSFILW!\5(T/2Y;*0BZQKB?HU'A![8;G"!%YPJJ65A`L"%WNAES--P&@)I M/LLY1CA0K,KR(T]48A_.9R\\OSG;ZY!KI2NX^*9Y_X0V#9$.9;`'64FZL M]#FWMV!R>#'[R17@FT(Y*\BV-M_E[C/C966@V@D$9.-*\[='IBDD%##!(+$D M*FLP`$Y2' M#/80..\A<1*,!LGD_CV4X9X"YP,%@-S$>N=^=>QSU'2R]YM3!>'*V!E>7FG^X'/^/2SOIW.61[ZOM-:&ULG)E=CZI($(;O-]G_0+@_*LV7&O5D MH#.[)]E--IO]N&:P53(B!IAQSK_?:JKE4`W;X-PXHSZ4]797U]O0FZ\?^=EZ M%V65%9>M[M_?=?SU^6ME75R66?G(N+V-K?165_W?W\T^96 ME*_528C:@@B7:FN?ZOJZGL^K]"3RI)H55W&!;PY%F25*^ MOEV_I$5^A1`OV3FKOS=!;2M/U]^.EZ),7LZ@^\/QDO0>NWG3"Y]G:5E4Q:&> M0;@Y)MK7O)JOYA!IM]EGH$`.NU6*P]9^WY;M,,T#^9N%6=_ZWJ5-Q^ M*;/];]E%P&C#/,D9>"F*5XE^V\N/X.)Y[^KG9@;^**V]."1OY_K/XO:KR(ZG M&J;;!T52V'K_G8LJA1&%,#/FRTAI<88$X-7*,UD:,"+)1_/WENWKT]9V@YD? M+EP'<.M%5/5S)D/:5OI6U47^+T*."H5!F`KB0O;J>W_F,3]"YSU-4,$T_J9+95]=$5K*SALC#XP(#(MDG"6]M6!L@ MN8+)?-^%3K"9O\,$I(J)D('7E@F\D#)QGW$HP>^$G%O(M$T7AG)ZNA*6Z6H'UZ=$ M/$IP$T&RAY_I9B^7CO>_2^=>(O*BK0U#U&88A-KD1LB85"`1-B7&5E#?"RJ3 MFT(0$9"P+L*%+F*NSBDC>();B)(-D[L%:GCWU#C_50!9D$C"/&WMK&_*CLE1FW85CR/N`I]?6^JD.'\E`2,,HQ0"=+_.A(F M]B5TS:Z4OCL[7?-EGN2HIDPW:D6[XN!3TT*Z44-^B14UHV/AV M.H"^Y1Y'N!&ALR*ML2-EI,6BD8[T)Y/;-D,=.Z,(-R)$`M,\>UIA-5=I?:IG M>`I2A@=[:G^E%Y9"#!/&C0B5\BGO9GWO#IE6-9&"NE*H-<:*,"K!7QI&J!(H M\VY=39P4>16=%#_4NE+$$!I.`NMK'.%&A$J1?CMYB3!T9_,249!1`L8Q(-P8 MA4J`,`](D#2=A9Y#1PPAK[G=]%?P.$LOISOP8R^C(;R-,810`9J%RW(:?S@@ MGU/UA/3*:=2G8Q4'!+7;LIX44Q0JY2$K9^BO(^5D,F&U(D81KGYJ6"65,&#E M$V:C;^5PGTRK)F)=*X=N"[<8E(@5,9PF.KD1H4H&G'R"DKZ3]Y\Z,834%G'@ MH5*L"*,2##*,4"6:D4]<(6C$=$^B/1V(V*A;Q^,(-R)$BGQD,[U;-?383;B" MAL<15\@XPHT(E?`I(W?[1AXL]'ZE(*PK!^[`]06B`(-6;D2HD$_YN-OW\6"A M+W4%X5/71DA/R:C3-A$YZBY*(\BEB(I%;ZIBVMS1O-2U'"ZU/Q[@M-$`:<9BQG`AZ*H[V_D M64E[/KG[#P``__\#`%!+`P04``8`"````"$`*;[T:$X#```&#```&0```'AL M+W=O?U^/JWN7\O">J&-8+R* M;6_BVA:M$IZR:A_;?WX_WJ-BM MAF:Q_>`MM][4=M8K'=!?1H_B[-D2.3]^:5CZG544TH8ZJ0KL.']6Z+=4_02- MG8O63[H"/QLKI1DY%/(7/WZE;)]+*'<(/5(=6Z9OCU0DD"C(3/Q0*26\``-P MM4JFA@8D0E[U_TE$00GQ`%?)W,0SGAS"H:J MV-:9.>^DJSNP069ZQH0FL1TB#&_PH?'>%!S;H'WFK1/+!IE(Q^JYH:O^.N80 MZ;=OF`-DO#D%F^:F[L+\\@:94)N[BR)_/IW/3&2+"%Q/??S(UC`'\V6\.06; MYJ*ST8)510;-^5'DA=ZTXPV)J;;_$:KA:G:+*P5W776^N4&F/P_M>SM$&-ZB M6[PI^-H\0&;(VQ!A>%,;Y.@%1,'=W+KS`!FL9M0[#9#H=V]X6]SB3<%=;Q\C M&$<:,OU?QIH.$88W#[:P\<%I^EI56VC(WB!B^KMM9\!%?7B%\Q#"TO96MB7Z M>V#:4POUV;A3^WD`D5[9P'!Y-VUV%K*-VI-A)/2;P"H/(J;/F_8)#U=XN)X6 MT2CH;F(M-.AO]$X!9RXCQROY*;H[2;H36$O&-NYD?G^=4:>_"Y@?GN3PK%*3 M/?U!FCVKA%70#+)Q)Q&LZ0V>X_!%\EJ?379#7_P$``/__`P!02P,$%``&``@````A`!`9=DFD`@``3`<``!D```!X M;"]W;W)K&ULE%5=;]HP%'V?M/]@^;UQ$C[2($)5 M5'6KM$G3M(]GXSC$(HXCVY3VW^_:AC2%@>@+B;G'Y]QS?7TSOWN1#7KFV@C5 M%CB)8HQXRU0IVG6!?_]ZO+G%R%C:EK11+2_P*S?X;O'YTWRG],;4G%L$#*TI M<&UM-R/$L)I+:B+5\18BE=*26ECJ-3&=YK3TFV1#TCB>$DE%BP/#3%_#H:I* M,/Z@V%;RU@82S1MJ(7]3B\X@/X(=& M):_HMK$_U>XK%^O:PFE/P)#S-2M?'[AA4%"@B=*)8V*J@03@%TGA.@,*0E_\ M*I"D>Q)X[DD2>+V\F81$ MO*\':NEBKM4.0:^`E.FHZ[QD!BS_-P(.'/;>@?T6R-%`\9\7V2B;DV>H&-MC MEJ>8M$<0$.V506VH[$HY@@.YG(';!#B,!AG<]OP^RV7`C`>828]XEP'0##.X MK.S`!4Z]ZS1.QCUE$`WAS(?C/O9.#C*Z7LZ!!W)O#H)<"(\OR4%#72_GP`.Y M:>\@R(7PQ,N-\CR.SUB:QXT4PD$SR6[/BV8?$77@@>AQ[X3PWN@T MA>EZQJD;Z%??&P=VHF]=.T[>;D4H<<`$Y?'4N3VCG']$V8'?*V>C_.AP`R:T M;A)/G/*Q=!B(87!T=,V_4[T6K4$-K^`BQE$&#:+#.`P+JSH_*%;*PACSKS5\ MM3A,D3@"<*64/2S1;J'!/X4VBCMX=!%(05LM#@H:%P@,5!SA_7;2K;VRJ;$(W2*F_VA?1):M4BQD[5TKQTI M)4HL7LI&&[ZK4?X6=_1*"J.M+ER$="P4>J]YSN8,F99I+E&!;SLQ M4&1TE2S6(\J6:=>?WQ).]N:;V$J?/AN9?Y4-8+-Q3'X`.ZWW'OJ2^RT,9G?1 MVVX`WPW)H>"'VOW0IR\@R\KAM,3:#R-APG"R0ZLVTI/28DX6*?5GP!*+E2!9'`AP?>%)!E' MH\%X.GN`A86*.H$;[O@R-?I$T#28T[;<6S!9(//[BE"*QZX\.*-H:BS6XA2. MR\ELGK(CMDY<,.N`P6>/27H$PZ1]9LSV>&8/]IE];WTIZ[!QFV;P?IKAVS1^ M=$,TP/^%^B#$W8B8S&8]?Z@@8$8WF'&/>",4(8\+]>",HKJ^?9-YW/.&S`$S M[08PQ)O@W_^0-_@XC%F!*>$3U+4E0A^\1Q.,ZW?[X[,:=">@_X'V;7D)W[@I M96-)#06&QM$4_6K"`0@+I]O.1#OMT+C=9X7W%.",X@C!A=;NNO!'K+_YEG\! M``#__P,`4$L#!!0`!@`(````(0#\]&PO=V]R:W-H M965T:WR)G8OB5$VJ;I56:9IV M>288QZC&6$":]MOO`(F7R];E)4#\.W__SSF`Y[>OLD4O7!NANA(G48P1[YBJ M1+$&-9P M24VD>M[!DUII22TL]8:87G-:^2#9DC2."R*IZ'!0F.EK-%1="\;O%=M*WMD@ MHGE++?@WC>C-04VR:^0DU<_;_H8IV8/$6K3"OGE1C"2;/6XZI>FZA;Q?DQ%E M!VV_N)"7@FEE5&TCD"/!Z&7.4S(EH+285P(R<&5'FMT^ M<[%I+'0[AX1<7K/J[9X;!@4%F2CU-IAJP0#\(BG($X_PHF./[WMS<(E!>_"6%!&?ORIM-1$D]/@=4Q$`_/3DQ! M9M>;+0.3>U,W63(MSMJ^"L#(`_\P!>?D>E,./C?U9Y>$+@9F7ZDB M349GKN$^<2(!.#<5;HIP%GJZX4]4;T1G4,MK:$X&ULE)1=;]HP M%(;O)^T_6+YOG`0(%!&J0M6MTB9-TSZNC7.26,1Q9)O2_OL=QQ#QL57=#<3. MZ\?O^S"BQCK<%;W0+.7T%2^^6 M'S\L]MIL;0W@"!):F]/:N6[.F!4U*&XCW4&+;TIM%'>X-!6SG0%>](=4P](X MSICBLJ6!,#?O8>BRE`(>M-@I:%V`&&BX0_^VEIT]TI1X#TYQL]UU-T*K#A$; MV4CWVD,I46+^5+7:\$V#<;\D8RZ.['YQA5=2&&UUZ2+$L6#T.N9;=LN0M%P4 M$B/P:2<&RIS>)_/UF++EHL_/+PE[>_),;*WWGXPLOL@6,-E8)E^`C=9;+WTJ M_!8>9E>G'_L"?#.D@)+O&O==[S^#K&J'U9Y@0#ZN>?'Z`%9@0A$3I1-/$KI! M`_A+E/2=@0GA+_W_7A:NSNDHBR;3>)2@G&S`ND?ID92(G75:_0ZBY(`*D/0` M&:'[PWO<>OLP"T;ZN!ZXX\N%T7N"O8)7V8[[SDOF"#P&%*X?0OQ7A!B:A]Q[ M2DZQR=&\Q:H\+[/99,&>,97BH%E=:Y)SQ?JH\!5`>X-'C.[4X]^3?;3BQ=Z* M3[[WM@H;R!Z\I1?W7BLFD]F@.;."*3JUXM,UPBYZVY(_A+H3!]EL-/"#RZ`9 MGV@N\K=^2W'F$2'_[]$?RBEF8LA2-LLN/`;-M*]ODHZG<7PNP,GSD"!(XRP^ M$02'8;!"`RHP%:RA:2P1>N>')D7RL#O,\WWJ:WFQO\(Y[Z>"#2]PSCI>P5=N M*ME:TD")R#B:XF"9,*EAX737M_U&.YRP_K'&#RI@K\01BDNMW7'A.W'X1"__ M````__\#`%!+`P04``8`"````"$`M&=I5S_O3ZWK^YW^_WN7S67W9GIZWA^I4KN>_RGK^V^/?__;P M49V_U6]E>9F!PJE>S]\NE_?[Y;+>O97';;VHWLL3_.6E.A^W%_CQ_+JLW\_E M]MD]Z'A8RBA*E\?M_C1'A?OS&(WJY66_*W6U^WXL3Q<4.9>'[07&7[_MW^NK MVG$W1NZX/7_[_GZWJX[O(/&T/^POOYSH?';JK.VZ<#^/XIDNWNJNU^ M&,@?][MS55+_OYL?P4/7@X>_=55X-_G MV7/YLOU^N/RG^OAGN7]]NT"Y%3BRQNZ??^FRWL&,@LQ"NF'LJ@,,`/Z?'?=V M:<",;'^ZKQ_[Y\O;>AZG"Y5%L0!\]E36EZ][*SF?[;[7E^KX/X2$'50C(DD$ MOI*(4(M$JBR?HA*32M*J@.#((AU".GH(2YP4-\=Z>]D^/IRKCQDL M7+!=OV_M-A#WH'R=7)R*9KIOS3;,D!7Y8E76<]AQ,)$U+)$?CVF2/BQ_0%EW MQ&R0@?\[3.8SQ5!'^(2^$K8X]JG-4#9OGWD)+ANK,-5=JY^OGZLC"UM'U^?9 MX"_\X>?^X(HA(WU"#PFE>BIFR,1Q(^,Y@O74=62+%\/^"CNS#P+.J\.JT7>3 MND$&EFE3*^43!4MHEC`APO,)`^GZ#/NS\'H.D]B,/>[;0R1D#XG,+678X4)E M/0W-:AA/0\@T[VP)SQ[LN_'V+.S;2R*_-AM$0O:04&A/94FJ^O98#>-IQ#). MLJ09AV&\+:S<,]> M;TUM$`G90P+MR43F4>?D39C5,5T.EN9+M^>H5;S7%G85]=S+M79HVR(3L M70F[+'N+6E__=GM1(D&+4JSD2MW8<`*N`>,+YVC?F^AL9;P@$!0RUR"?N6O^ M>-L>(53\.(53]\:V$_::/WIA.MKW)]/>=7E#4-`?)@T<'^R[EP,6"\20P-W:N>3-O40$5$*&CRBKB3<]4_7-R@UO.`@B'D MNDPSE:L;QXNPU__Q#C$M^`[;#4`.0Y'"(85[UO6<"I`F<.'JK#.J(RMC?!D5 MP;_/KWX")FN"2TO[BS5O=P&91"90A,(]Z=6D3&*9Y_VKJ"8F(&-\F2R.(`:U M2\)?KC8.C"\FAH=N,?N;:6-?X\%4!,97$(*UE'$).:)K4W8NME3.;MA($R&2WN%4""0",Z%YQ!""DY6E49QT7GGX M)FU"&&\2\T37Y&JP+]E44@@6T3QB"$&3=T+$DE&IRO M;#@I1#>=W,DDBU0>MP.D)H;EI/SC:/_( M33L7931,4&`+%CRB><0$$=]E+P6->_4O,<7`!:YY>9PF[3R26X2";EE$TU,% M5$P0\=W"@AR_B*6E_9H.F@#$!(97\(CF$4,(GDDJ@US6;@7?HXT=HS>JQ)#2 MW:B#3@`Q08]LUM&\BB$$/8I0-T#"8":8M+1?R&$_P$F&DP*/:!XQA*#+0%_` M-I8G>!R&H?YAN7&*C$4VZ&A>Q1!"%I6,I&PO<_YJG12%Y#`*]7M.&V*"JY6/ M0KR*(>1JTN;:YN+D>YR4A.0P"0V[!`0%3?)1B%.\-^@60C3,$CFD<,(==2YOFMUV'2QHWQ)C&<=$T.FP9.DMF4J!.HMN95 M#"%H4HE<=5X3>NO5=O_'FW1T_W!MUPAF`8("#@H>T3QB"$&3T%])HUN-@[B7 M?,*-24?W7?8B]X:@H$L^\?`JID'\+IE?19M>1B_5V-*^O\[RH"(B$[3'(IJ> M*:!B",$BRCQ-H?70SK7O@8$!.L)1]X M>!5#")I,DP@6[0V/D_)._$G>:2>/=B4;9@J2"4R#YA%#"'J\RU=QUFT'^KMR M4N*)/TL\;98BFVR<*4@G:)-5,:1"+8=H$;6O:WV/D_)./,P[J>J_]T-0P$#! M(YI'3!#Q7?8"S[C^0(R!!4[;0'^`H*!;/OCP*B:(>&Z32,,DL4%D=/IQM%_)88.`H*!+/O[P*H80=!EH$"23LH^C?8^=%ZQXR!(3M(@1 M*H!H7L400H54\&9)9RS^:H5GFE!(2_=,MN#HOLOV12L=/6R>*4@G,!&:1TR#!!H$:E+8<;3O;]`@("8P M]H)'-(\80JB(>1+!^]TW@H":E'855)-BCN.]ET.&P0$!6WR<8=7,82@S6"#0$T*/([V70X:!,0$3?*!AUAX`T2Q_+\6A;EX5#/=M5W>X.) MA,\R-+]M;G[Y(NU-`KW?%^)>NSM(ELT?X)Z4]^UK^:_M^75_JF>'\@4DHT4& M8SKC72WXPZ5Z=[=E/%47N!O%??L&=Q^5<+-#M`#XI:HNUQ_@B9?-_4R/_P<` M`/__`P!02P,$%``&``@````A`',34C8B!```>Q(``!D```!X;"]W;W)K&ULG)A=;ZLX$(;O5]K_@+@_(89`FBC)T4FK[AYIC[1: M[<F;Q^QYX);+Z^%[GSQFN9B7+KLMG< M=7B9B#0K3UOWG[^?OSRXCE1QF<:Y*/G6_>#2_;K[]9?-1=0O\LRY*]`OSUDEK]F*9$JZ(JY?7JLOB2@J2''(\DQ]-$E= MITC6WT^EJ.-##NM^9XLXN>9N+@;IBRRIA11'-8-T'@H=KGGEK3S(M-ND&:Q` MV^[4_+AUO['UH[]PO=VF,>C?C%]D[[TCS^+R6YVE?V0E![>A3KH"!R%>-/H] MU?^"8&\0_=Q4X,_:2?DQ?LW57^+R.\].9P7E#F%%>F'K]..)RP0&N!(_-Z\7K)4G;=N$,W"Y3Q@@#L'+M5SIE.Z3O(JE2C^0XBU MJ3")WR:!US8)@[<3@X,V&%Z[X)G_$+(P&I?@X7(:=YYB%>\VM;@XL.5`L*QB MO8'9&C)K6P(P][8MX(>.^::#FE"@)=3R;1>%_L9[`_^3EMD/&8MX'!)!T"7Q M0%\G$DRZ7Z0.@L6X3D_D9_YF(7MD%CTF[!0TQ"-%&!KAB_H::0,UO'4A=ZHTB[OD:9A4UH4 M+KHM@R<"&D"ZVD\J/#`Q^M(T'//+G&;P:Z_J4GW[>F:L,OW9T44V@V9(41Z M1B&F/DC3US>M)S,=-79R6XC4B7EN(Z9.:W:,U!;;?=_'X>G5OPAA$51G-A"J M-3-K;$RT<3@_HG!I->DF]=:][1'V&A(Q;;1FR$2=.`9@4U%'F9H5K4X*,75: M\V2DW#@"S'(/CC)"9+G["%GNNT8)&\Z2*+1^W^U;B"SS=:9\EN%SD89]_D]- MEB9J[%2W$*631$R=UF2AR^SC)##+;'?'%K*;,F[`[L-Q!^%;[N^+OHZR9_/* M.M`M1#J(>6XCIH.ZT_?FR[0#[>-\H`]T"]T6T?J)>6XCIDY@^CI'*JUIT\?A M#VMX@J`AO&FR9W/[(:4,'Q_@#7(5G_B/N#YEI71R?H0V-Y\M83[4^/``+Y2H MFAOA@U!PT]^\/<-#'@YWR?,9P$&ULG%9=;YLP%'V?M/^`>"^?X2L*J9JP;I4V:9KV\>R`"58!(]MIVG^_:QPH M)EN:+0\0S/'Q/>=>^[*Z?6YJXPDS3FB;FJ[EF`9N82P,8&AY:E9"=$O;YGF%&\0MVN$6WI24-4C` M(]O;O&,8%?VDIK8]QPGM!I'65`Q+=@T'+4N2XXSFAP:W0I$P7",!\?.*='Q@ M:_)KZ!K$'@_=34Z;#BAVI";BI2T>-' M1HK/I,5@-J1))F!'Z:.$/A1R"";;9[/O^P1\94:!2W2HQ3=Z_(3)OA*0[0`$ M25W+XB7#/`=#@<;R`LF4TQH"@*O1$%D98`AZ[N]'4H@J-?W0"B+'=P%N[#`7 M]T12FD9^X((VOQ3(/5$I$N]$`O<3B>O],XE_(H'[2')U!(O39+@/DT-KX051 M?(4.6WG26YPA@=8K1H\&E"VHYAV2F\!=`O/@K7)B=/MO9H/+DN1.LJ0F[#?P MD4.!/*W#T%G93Y#5_(39G&-<';$=$#*%DC93`W`=:>-PG&.#@E$&I&4JX\^E M,40KP3+:89V-&IBNXXW+])%LSQ%!$.N8[!SC^R-$BQ;R?WVT$@PE.S'!7\R< MVR@,Y&\T*AA75@+>1&27$%KTL,SUT4MP:H(U8V1)HH>V49"H+YL;=^&$H9?, M_5<8N(XT,X&9QA(%49"$KQ`M?MCTT_AER?MP*%VN&3E)U^$Z\PI7F$`)\0/? MB^Y:+G@@=:V*+$J2: MK^H,#69[O,5US8V<'F1C]2"0<73L^7>>/$%GXQMW">%?E^-?/QYLY1DJ3KB"-Z%B.7YG"=ZN/'Y9[(9]4S9A&P-"I'-=:]PO?5[1F M+5&>Z%D',Z60+='0E96O>LE(81>UC1\%0>:WA'?8,2SD-1RB+#EE#X+N6M9I M1R)90S3H5S7OU9&MI=?0M40^[?H;*MH>*+:\X?K5DF+4TL67JA.2;!N(^R5, M"#URV\X%?2E3F^#Q>;#/NKI?7G M-V=[-?I&JA;[3Y(77WG'P&Q(DTG`5H@G`_U2F"%8[%^L?K0)^"Y1P4JR:_0/ ML?_,>%5KR'8*`9FX%L7K`U,4#`4:+TH-$Q4-"(`W:KDY&6`(>;'MGA>ZSG&< M>>DLB$.`HRU3^I$;2HSH3FG1_G&@\$#E2*(#";0'DC#UDBB=S=_#$A]8H#VR M9%>S^"XN:],#T62UE&*/X.B!7:_$@.$$C2R(DW2Z]=IADA'F#+'Y'V*B M#4BNUV;`.8;`A_3$T=G.:X>9V03'<9@$T;MQ<:N=F:71[2O?$K^P]F@SX7--LNN_:89Q?YYK&U8"LT5#'[6<-/B\%U"3P`ET+H8\?4V^$WN/H+``#_ M_P,`4$L#!!0`!@`(````(0`X$`1"B@4``#`:```9````>&PO=V]R:W-H965T MK-0&=V;[(WV6SVXYG! M5LD(;8#Y^O=;12'2#;?!F0=FE-,UYU15U\%V\^TC.QMOO"A3D6]->S8W#9XG M8I_FQZWYS]]/#TO3**LXW\=GD?.M^:JJ MR]JRRN3$L[BE%VMISYW+>R.,U-BK`NIL00 MAT.:<":2UXSG%04I^#FN@']Y2B_E-5J63`F7Q<7+Z^4A$=D%0CRGY[3ZK(.: M1I:LOQ]S4<3/9]#]8;MQI$_1ORM_+SM]&>1+OOQ7I_H\TYY!MJ!-6X%F(%X1^ MW^-;L-CJK7ZJ*_!G8>SY(7X]5W^)]]]Y>CQ54&X/%*&P]?Z3\3*!C$*8F>-A MI$2<@0!<%\80/<>.9E]91B2--(7LM*9/\1 MR&Y"41"G"0*_FR"V-W,=+UC>$V711'%O49R9L_1LSQ_G8I&N.DTLKN+=IA#O M!O0>,"\O,7:RO8;(U_R0FC9C/TL89`J#/&*4K0F;!G)10I7?=K[O;JPWJ$S2 M8$+"P+7%V#(BZD=9^C*$72%8&U(E,?=EYOJ.0;#*.)#S&1+&JQD_^,'"5Q/>!3B> MNUHI/<<(,%P1B7L@FK8/;'*^[N#T5FHS-2":/\%,F8Q1>WMHS%`S:2&R#+2[ MCHR10I`Y=NG[@6*RH4T@OQY&KN,OE4I%#4!;!XHQ#)$%H-%-%T"V*`EPE5$8 MV@1:-=8UZ_'7>6M3`#7$+4DR>U#893^QBW"5NA]Z*@C4JEC<*)`'VP2`ZT]- MN(&T,=R;4\HRT/FF%X%\4BI"H`S[$!_O0:.&730.85J(+`$-L"-A8B7(-J': M;0[[CW.VSEN;6HQ"F#:*+`5]L"-E9$^3:TK5Z&\)`K6-8+OD%-=K;XOHK+C9 M(I-#RN+0**>+(UN5Q`7*0`WM47>.QB%,"Y$EH%UV)$QL-3+9D5;3.7'3:J,0 M9NL@DA1GP,_'/P/5J]3Y=1LM-<^P`74'@!\HS[W1`$BI+M-"9#%?LG2G;^E^ MH#[;-J"N&(5G-`YA6H@L!3K^_A9S<-78A],&I)5"<300IHTB2T$KO7NW.&3` M\L;OM1B!NCS]0'D:BYI(79!2.J:%R&(@S!?$X"IEOZ@??D*'0!J>T3B$:2&R M%,7SITTQ/.,:;[%Q[V_B:-0R+426\B7O=\BS1UJL;^P#4ZP/ZK68#B*+05^] M?[^0&TMBU`?WT!EU]6@/0Y@6(DM!2[V_*F3$ M4E6"WA3KN_7`%.N#>BVF@Y`8.J"GD^>,%T<>\?.Y-!+QBH?O#GSB:]]MOQAX M=/"$5GD_@B\,ZM-UJ[T!Y_67^,A_Q,4QS4OCS`\0&PO=V]R:W-H965TT]<:6%;#.$_1!YO,UE(=I=AGY\O[N:(4\;UA:L MEBW/T`O7Z'KU\\89I7W:\A2>E5`TS,%2[ M0'>*LZ(O:NH@"D,:-$RTR#DLU"4>LBQ%SF]EOF]X:YR)XC4SP*\KT>E7MR:_ MQ*YAZG'?7>6RZ\SR8!^"T6A8".K"Q>XJ7&;K!BTV*@M6RS^>GX`=]UNNS9VP MELC+]]K(YI<3X:.5,XF.)G`]FF"XO;"8'(OA.A3[T2S!"?TW0N#:Z=.Y98:M MEDH>/%AQ`*P[9MVJ"\%M8:I?%K16;0,GB#__*A9 MGVLFBLVY@I#!)`"^`1)"^G](6P3-(.\$\LV_;V3M-/&))AD(>L7F/<6($5YT MROA^@%:<(?`>V$@R97.:M(\7TY#&83QA&RE(&N.(#HH1&S1X.9L53]DF;UX[ M3=*S14E$P^&]+K73YSC$]&WJ1URPT'ISFNN8C0E$SS&RDPCL.3_EQ^[@AVATS'=OR!J9UHM5?S$E9[Z*

\ZQS>K^3;3HE2G-95?@*`@Q8ETI*][M"_SSQ]/= M'"-M:%?15G:LP.],X_OUQP^KHU0ONF',(%#H=($;8_HE(;ILF*`ZD#WKX)=: M*D$-+-6>Z%XQ6KD@T9(X#&=$4-YAK[!44S1D7?.2/\ MUV)':\Y>;=B6(DRN7SOI.*[EK(^RU*:7G6=HL;><%+ M);6L30!RQ!N]S7E!%@24UJN*0P:V[$BQNL`/T7*;8;)>N?K\XNRH+^9(-_+X M2?'J"^\8%!O:9!NPD_+%HL^5_0J"R4WTDVO`-X4J5M-#:[[+XV?&]XV!;F>0 MD,UK6;T_,EU"04$FB)V-4K9@`#Z1X/9D0$'HFQN/O#)-@9,XB.=9E,V`1SNF MS1.WFAB5!VVD^.VIR+H:5.*3"HPGE0BF$X.34S",0_!D"\3GX\KS2`U=KY0\ M(CAR8%CWU![@:`G*_ZX'I !PN[$,A40P]?UWD:KL@K%+X\,9M;)AX3VULB M20:$@*_!'!1GNCD+0ULPNC`7#;HN@8UGT@LF&Q/;_Q$C;[#1=&\6+C!H#][2 MZ&KGC6=R5]8H#/,\N2*VET0V3V?)?#`_L@;Y3;=FX6MKLT'7E\TSF;-V%V?A M/+XJ['9$1%FR2/)!8^0-+LMT;Q8>>\O3J].T\8PO6Y[-%E$Z;.S,PZMB13R0 M)F$>_O7NG?E'P]^*GN[95ZKVO-.H936T*PQR4%#^R?`+(WMW"W;2P$UWTP9> M=@97)`P`KJ4TYX5]E(;_BO4?````__\#`%!+`P04``8`"````"$`QRWAN5T# M``!)"P``&0```'AL+W=O.\LD%RT:U=LO!=AW65J'FW7[O___=TE[F.5+2K:2,ZMG;?F73O M-W_^L3J*X5D>&%,..'1R[1Z4ZI>>)ZL#:ZEW3OR((Y_#;S^FW<, MH@UYTAG8"O&LI5]K_1=,]FYF/XT9^&=P:K:C+XWZ5QR_,+X_*$AW#"O2"UO6 M[X],5A!1L%D$L7:J1`,`\.NT7&\-B`A]&Z]'7JO#V@V319SZ(0&YLV52/7%M MZ3K5BU2B_8$B,EFA23"9P'4R(7!K.3F<)L/U/'D19#&)D]\C>+B<,3J/5-'- M:A!'![8<`,N>Z@U,EN#\<3@@#EK[H,7C%%BIA!R^;M(H7'FO$/=JTA2WFF"N M*&\5X<7$`ZXS'`3''DZ+(2NN*YHOR58L8&+[)GT^*U&XPA M"WP2S5]:X'"*PSJ=Z5Q0HN!C[AD52.RIM/B*R@A%@<,Q4D6!'_D&%0K@]QSQ MB\6,"KX0>RHMOJ)*YB\M<'BB\O,\S.:"$@465,EGJ+3XBLI(4('#2$7B+#-3 M7*+`@BK]#)467U$9H2AP>*+RDX08V"4*+*AT&[0N$UJLJ2[[(B)&$2A0@VBQ MG]SL+1RW(,L_0Z;%!EE@[.H"-:>@!5'H&UNP1(4%&X$V91^V46W2F15L$B'> M'4F3(+A\=&.5+B>)#9]1_753#('Y-UT`"_@LOX&97X(BY,RBS,^,E923P@93 M%V7KW:=;ZDV2+PUFC%$QB4YAS/(\RXTZ8DC"%)K]63(K;W!N^0S?J1E;G1H#U84DO\U?AP\,0MON>[MDW.NQY)YV&[2#1_B*%4CG@ M40@?E.C']KX5"HXPX^T!CJP,>K^_`/%."'5ZT(>M\R%X\Q,``/__`P!02P,$ M%``&``@````A`&W51!```>!$``!D```!X;"]W;W)K&ULG%A=;[,V&+V?M/^`N'\#A@!-E.150]7ME39IFO9Q38B3H`*.,&W: M?[_'?AR"#:7.>M&$<'QR?)XOG-7W]ZITWFC#"U:O73+S78?6.=L7]7'M_OW7 M\[<'U^%M5N^SDM5T[7Y0[G[?_/S3ZL*:%WZBM'6`H>9K]]2VYZ7G\?Q$JXS/ MV)G6<.?`FBIKX;(Y>OS6O%:U; M)&EHF;6@GY^*,[^R5;D-794U+Z_G;SFKSD"Q*\JB_9"DKE/ERQ_'FC79KH1] MOY-YEE^YY<6`OBKRAG%V:&=`YZ'0X9X7WL(#ILUJ7\`.A.U.0P]K]Y$LTR!P MO!/3'7GP$B[W!ZF<9@3\: M9T\/V6O9_LDNO]+B>&HAW!'L2&QLN?]XHCP'1X%F%D2"*6BGV[6GMAO$L2OR0`-S94=X^%X+2=?)7WK+J7P01184D@2*!5T5"HMD\ MB)*'>UA"Q0*O5Y;8FL7#?4F;GK(VVZP:=G$@]T`Y/VU"T8`7'*+\MDGFT(B:6VN9ALC#NIWC?0IF8H+W& M,JU,@`UED>')%C'H&O&C,=L08B%N<8\X`3;%F56+&!0W*@T!%M((5&C?.+NJ ME:MTD3&YM2PL6P7J2L._)3[6K@+8J!2]NA=>2Y78X;7F$IK-A2!H7(32.071 M:IB(3M[3.9V&$OU5@U:@27TX/\8ANC[1S.WU8>O7_(MN_55%&4&JO03!/#$Z M9$JL)PB!+=PA3Z#U)$RB01(B".6%BR@B<[T%I?)+UZZ->\80^2*Z(]-CT&7$ MPR'L0;DW6LH*8J//&"%?Z!O.CB@V9P>9&@VJ.J8@>O;=-3X(]GY(GFYR#A]? M%&C<'*7/>H808XA8=IFQ:6(DV5927^,])B):/@3%5OM"'4V`Z'R7E9\T$\W$2 MHNN[:YK`N7;8#LUIIT#XM/K)8XW"C'N,`O$`C">[BC9'FM*RY$[.7L7AEL#C M7/=I=_!^E.=NK[L!Y]YS=J2_9\VQJ+E3T@,L]6<)=,0&3\YXT;*S/#?N6`LG M7OGV!+]P4#A:^3,`'QAKKQ?B;-[]9K+Y#P``__\#`%!+`P04``8`"````"$` M!6B+RSX%``".&```&0```'AL+W=O?O\F7V'7:+J_W M^9G5=.O^H*W[=??K+YLK:Y[:$Z6=`PIUNW5/77=9^WY;G&B5MQZ[T!J^.;"F MRCOXV!S]]M+0?-\/JLY^&`0+O\K+VA4*ZV:*!CL0?K M;T_EI;VI5<44N2IOGIXO7PI674#BL3R7W8]>U'6J8OWM6+,F?SQ#W*]HGA+A8YC7ODK'Y1VFWT)$7#;G88>MNX#6I,PV\'?3GMBU]^:)WX%'QIXX^FW/+\%@?S2:]'?@S\;9TT/^ M?.[^8M??:7D\=7"[(XB(![;>_\"T+G*GEJ@"/Y:_]^ M+??=:>O.%EZT#&8(<.>1MATIN:3K%,]MQZK_!(2DE!`)I0B\2Q$4>V@>+#ZA M,9,:\[M&N/RL!JRX#P;>;\$@;XF"U6PY/9B%%('WF\AD1WSA;G^S<-[ENTW# MK@[L`/"OO>1\/Z$U"+]_=^"VQBM-CX+Y`&A602P<#K MG4$JD8X)<$)E\)B)M8FR,3*2(6-F(..#!7@ M0S6@=$S$:*DR>,S,PTAELC$3HUAER)@9ZBAA0W)/#YO#2MCBPC#L:#E3%Y.^ MPRRT6XDG,-D$AI@9)7#8S=,#Y[`2N+@@:@U/@%2_@/4+V>W"6XK$:*5Z1<9, MM'QCE/5#V9B^?@Y#_1RD9QQJ.RX1#*S@GL):ZJ56`EN)S$H0$Z$X`-5JZ`!_ MOLS@*66N8'S0UH4-A$,(;X4D$LA45@T,@C;-7(K`0Q$8H#O&<U$,"8GK`2V$ID@1,+%L]5JH>T\8I)0C%C]C!%\D&Z$5L43P9B,L!+82F2" MD$8L^,[3MAXQ:2A.("@%G\^)?I3NA5X?)&0RPXY@B8A@0P1=K1YL9E&",AHB!7!<%JO%EI3G_226]=H M@]`Q(-BNDMD1(A&177UY?:NO:EKP+DQ+BY6UN>(_[T=^:#].$@D9@DWM"+8C MF1TA[R!Q^%%J\'YL8(DE-43WINR0V9O9XE;R-3H21^L"+:K9':$2$04BG`61O!@_L`(WI5- M-T+T<*H1>KN)3(V>-,**8*DB0M`:NI,E(5/= MM"-8(M*0.5I&6E'*["+\V)C7^?>7(OP0Q\+BI+&BS9&F]'QNG8(]\R-?!#W> M_>K]./IAWA\HW[^`T^!+?J1_Y,VQK%OG3`\P-/#XB6DCSI/%AXY=^G/,1];! M.7#_YPG._2FP`?&NML'?F)]_T_"[G\```#__P,`4$L#!!0`!@`(```` M(0#[8J5ME`8``*<;```3````>&PO=&AE;64O=&AE;64Q+GAM;.Q93V_;-A2_ M#]AW('1O;2>V&P=UBMBQFZU-&\1NAQYIF9984Z)`TDE]&]KC@`'#NF&7`;OM M,&PKT`*[=)\F6X>M`_H5]DA*LAC+2](&&];5AT0B?WS_W^,C=?7:@XBA0R(D MY7';JUVN>HC$/A_3.&A[=X;]2QL>D@K'8\QX3-K>G$COVM;[[UW%FRHD$4&P M/I:;N.V%2B6;E8KT81C+RSPA,S*A/D%#3=+;RHCW&+S&2NH!GXF!)DV<%08[GM8T0LYEEPETB%G;`SYC M?C0D#Y2'&)8*)MI>U?R\RM;5"MY,%S&U8FUA7=_\TG7I@O%TS?`4P2AG6NO7 M6U=VJ^>?__J^5/TZOF3XX?/CA_^=/SHT?'#'RTM9^$NCH/BPI???O;GUQ^C M/YY^\_+Q%^5X6<3_^L,GO_S\>3D0,F@AT8LOG_SV[,F+KS[]_;O')?!M@4=% M^)!&1*);Y`@=\`AT,X9Q)2"M.69EN`YQC7=7 M0/$H`UZ?W7=D'81BIF@)YQMAY`#W.&<=+DH-<$/S*EAX.(N#UO5D"53,+2L?VW9`X8NXS'"LY1ZMAUC_J"2SY1 MZ!Y%'4Q+33*D(R>0%HMV:01^F9?I#*YV;+-W%W4X*]-ZAQRZ2$@(S$J$'Q+F MF/$ZGBD".S1P1%H$B)Z9B1)?7B?-AOZ'&(KA\1JCX_M\+H>SHX;.1DC56#.M!FC=4W@K,S6KZ1$0;?785;3 M0IV96\V(9HJBPRU769O8G,O!Y+EJ,)A;$SH;!/T06+D)QW[-&LX[F)&QMKOU M4>86XX6+=)$,\9BD/M)Z+_NH9IR4Q>Q,O91&\\!)0.YF.+"XF)XO14=MK-=8:'O)QTO8F<%2&QR@!KTO= M3&(6P'V3KX0-^U.3V63YPINM3#$W"6IP^V'MOJ2P4P<2(=4.EJ$-#3.5A@"+ M-2[\JIB4OR!5BF'\/U-%[R=P!;$^UA[PX798 M8*0SI>UQH4(.52@)J=\7T#B8V@'1`E>\,`U!!7?4YK\@A_J_S3E+PZ0UG"35 M`0V0H+`?J5`0L@]ER43?*<1JZ=YE2;*4D(FH@K@RL6*/R"%A0UT#FWIO]U`( MH6ZJ25H&#.YD_+GO:0:-`MWD%//-J63YWFMSX)_N?&PR@U)N'38-36;_7,2\ M/5CLJG:]69[MO45%],2BS:IG60',"EM!*TW[UQ3AG%NMK5A+&J\U,N'`B\L: MPV#>$"5PD83T']C_J/"9_>"A-]0A/X#:BN#[A28&80-1?F#R`Y+<< MS=*MOP```/__`P!02P,$%``&``@````A`'\HQ@."#0``\X0```T```!X;"]S M='EL97,N>&UL[%U[;^/&$?^_0+\#P;1%`]36B[(EQW)PUIGM`==KD'/1`DU1 MT!1E,\>'0E)W=HI^]\[P.6N*Y))<<14@$7*6*''F-^_9X>OZVV?743Y;06C[ MWDJ=G(]5Q?),?V-[CROU[_?ZV4)5PLCP-H;C>]9*?;%"]=N;W_[F.HQ>'.OC MDV5%"I#PPI7Z%$6[J]$H-)\LUPC/_9WEP3=;/W"-"#X&CZ-P%UC&)L2=7&VI"X8BX1O!IOSLS?7=G1/:#[=C12TQ+55SSZMVCYP?&@P-0 MGR>:86:TXP\E\JYM!G[H;Z-S(#?RMUO;M,HHEZ/E""C=7'M[5W>C4#']O1>M MU&F^24F^>;=9J1>JDHB\]C<`X@\_[?WHF]\E?[[ZTU=?C?_S]3?_^M[:_/N' M/Y:_^^%K=92Q(33!!O4TS\>U9.'KA/(HE>#F>NM[1!``'2OHZI/G?_%T_`Z< M`<3#G]UH5FJP(S%;KL?` M;S!F%_/!))OI,_U2J&2,+Y;MA@QGNDA5-C#4WUR^'4R=XIE529>FX:$B``-. MK!9M"-V:^+[4\36$GPQ*I44M M_C53DQG'$T\^-STAG:?VLJ^UAK^G[D5X'+9V:_*,]XHG7Z7\(30DD@U@N-_!BL,,[%V$#IC[`"D3A^W3M;V,/3H$5[<=)V_?9W-L<&'+S36L M)"(K\'3XH*3O[U]VT-YZL.A!B*/D=PV_?@R,E\DT;O+X=@A]Q]X@BL=UW%2G M.E]?W.GKNY@O0<:+HH*HKJ\OCT#T[G:Y%H]TO5R*)CK5X268Z)LYO@03U>&_ MM3"=IH&DB0*9TU,B&Q?!X_/+Y7*YF%PL%HNE-IMH6JSDA]2C;6]C/5NX+A:F MIC*".2!8SA;+BRD`&6N+F-6@"&8`X'(^7\PGRZD&_\>9[/@(1.MTKLJV*D$@ MR:H$@22KQNNPD8#,GT8*3'C^=6;7C%JT98IS[XP096R-F!IHD&:\1DV\VU8VTC6)$&]N,3_HW\ M'?S[X$<1',&ZN=[8QJ/O&0Z\'65[9']K]H1C?'`X;Z5&3[;Y"9@Q(Z1$-PF+ M8W'(LYZ&JPGM4AM?:O/I1;)@$\3:M3;VWBU+E_,^Z)>@1M1ML^!$AU[.)'6' M8HPY0BNDYN/<(S9U;&G.'<`G,I?@W$.$C,5(GU=&L@>?C&0'3AG)'KPR0N@< M"JY,DQM_#X>77QM8UQ?C<3(]Y>533Y``/^`QAT&0?"N.R8M/MW&O4GR.Y_RN%<\&U83,=X$?6684GV(4'R2I MPC.KP#-)"?'@Z<-?J^`/>N+61Q_^,'LZ:$30BU3^X%S<_$7Z`TQM,GV`":A3 MU^$1B0`F#!D",((,!'CR5QK8X)XR$,#*+4,`#EH@`#@U7M$G#B8DFX$/%"R! M_[%80H[)I&18'E'*JO0+_&NDU)GTVTO-)-^"HQ=JA@\U`'JQK$JQLE(,,3M$ M6J$"^%"C`AVJKIB2-ZG*^=(40I(N8"@T`FF@3B/BO)+D7.!9`*C7R*W`/H0X M!:8BV1``CA0(Q!`32?5W0C%(JL#4&R258`J!J<$#Q@2U!%,A)6$`/%*BHN@3 M)DS%&%`-!(*L#$F\82HK15(,LG)D88JIK!1)(,C*D-02LE(DQ2`K1Q)3R$J1 M!`)H1$J&I):0E2(I!EDYLC#%3%:*)!!D94ABB=F14^2(CDV3(2J9G\(YI=6C M4#!0MOQ_;:OG;>,@=5*U:`):V>[)ZBE9.8(MXK4464KCY78&GB.-LU/ER0_L MGV&1B9?=F;#!"E2\3#.R3;KE2V#L[JUG6(HFAYZ>M[T$;,!4\(L;0YF8 MIC^W/K9`/TV/10`0IK?L5.7:2(Z+;:',J2/@B0=L15/PRH7D*G\X@#JJJZS" MD9V2B:B61(2+<&51@(D93U5]-4Z6G$8\J)-1O64=II!XQ(EY73:X30?UC2W. M\1`"ZY-#.'L]NZE#J,='6UIIL.Q];?+:,.B*R.7V2-)JXQPRJQ`->`\W3SJT MB;B42GN;]CJ.ST9CZT@K);\>G9V6"PR"KH,+H-G3!I]Q@2/C[6!L!MZ1X_W$ MX?5+1T*ZS^/5EU\K(.]4BK:#;,YN:B/8$MBIJ>CG@X/#Y8UH4A+;J+=]3>RD M=%XI2%9GI&"R.MR1K+:3D^\D0\/MJUZF*N%9'_P]2"=W$!J#QX?+JUZ^&"SA M/=T8K&Y=!DC4J=;[]892LX@0"6IL4/*DNK5,IT`5(@&=YK+ULZ%E8A-YY2B5 MMG1",\O)UQDV;Q\?+F\BY"KC0Q@_'^A6'"JMRMA,`2\!;9^PN7RWKW89;RB! MKLL-7/#*H25$N^5NKKUZ^^2VQO%GE8_4J[N]$%Q&Z.`C3`&I=VP)/B(I5?34 M(Z!^B"?:Z:5W=?TREUVY1Y]$7U/TS/3(W.G55<;MF%@I1WR=WW6*[7*N:AK) M2H7;TQMG@T?U06V21,EHLQ[=B29*QF-/H9C2P,?W(@_)TPZZ4R:J`M2T3.P4 MW)T00G,L5&6-;0.Q%UT`P>;^E:,5`^AX+-84U^PZX,.WD19XD@ M2:UFE@!695N`]EFMDQ"\A:-*"B;+E>ORB4E!0XIX]2O7.?Y41*CKE.#^,I0N M)(_1NL.IU"H?8#RY%(YU#297?\X;:%7PF!YH@.PF%F_)1^OT>=1$5J%?V-R_ MJM9[8S[L2.Z_*^VTK7*[;Q(COVDK%+FU9=8L6'=!=\4XCCK(T\MO[* MACZXZJJ(B.'1=75#)C6*-W-9C;\\H,F-TNH"&Z]#S1Q32#)LL\1@5OM'+L2) M.3L<%"0M<`N\[9NQ-NU$!S%(N#-B#!)%'?!6J;T>[Z]J3ZX"3-NX8^F]W(BV M5_Q0[=[PWDY38(N:40UT@#-K>O;]3.F80.RR4PVV[>]D^2Y=%^T*680-A[P[ M(>Q<8:I2,U,1RR''*E7`9$NH#QQ/PS2\#G:VJ*KM"5U("@]Y.GZ/%5_-#M>O MD[N!LO<"S:]V5_`!;_!`VO'OE3/EC8F!E1L+)\X/>]N!QPK@$4J\$X$)ESWZ M[FVR,;UVO(Y6ON;'PXR4%E3NMK3R1#+%NU,07##%:TL+V"=):0;2$EIPH]36 MM,"@*2V\=TB!2X-+F-OB@EU26JSNYYRZUP[9$6L)P84B\^"BM`H[8LM5R`A/ M0FM-J[`C&([2`I';XBKL"`@)+0V8M*55V!&L0&F!N[6EE=M18W4_Y]3]Q4$[ MLKZ*M\3@P45I%79D?77&Z:N45F%'UE=1Y+:X"CL"5:I[^*(MK<*.;)[0./,$ ME;&P(ZO[.:?N7V=4UN.GG!Z?4"EL!^^(CG!(PZ.CA$IA-=;+9YQ>GE`I[,7Z MM\;IWPF5PE)`CTBDP1?\$N4VFK':U3BU>VMLLJS+.@S6&1X8\&Q)<^_`(^5] M?"!]?,L7/`I&!,+!"A>E)\O\I*SA#MXY(38>L(SR$+I[WCF&9T1^\*+@!34Y M.=;HHPV9/!98]>`]']N0 M@;T3-*S_X5*A#1G8.R'#)E7LGWC(O/-V^]Q";"[%TLU#XKWM?;(VK.>P&L:A M,P^E#]8^"HS<_]B0FG(JY@/>]SVGP::(Y%FWV4WJT_[S`]SF/5,BWGZ&Q`XV M\#S`_[:/B!IQ+T)DRIF7[NT(GM"1!3%#`F'QX+CWX=9+.8E7&863QC^,P,-H M84+WE8]62%3@^_W*E%N__ M&C_[!IPI_=5W]F<_BDFLU.+]>WRH$$0QK,$@W;P/X4$U\%?9!_9*_>_=[>7R M[9T^/5N,;Q=GVLR:GRWGMV_/YMKZ]NU;?3F>CM?_`Y6YCA=>/4^TE?H41;NK MT2@TGRS7",]=VPS\T-]&YR8\J\C?;FW3&H6[`))*^&19D>N,IN/Q8=P@(*E@&DK2X::FRW:`IJ]ZDGF1^_^\[Y\2))9-4E:MG@%ZL M9,19OO7_+>?$EW_W<3HI?JP6R_%\]M6#O=W'#XIJ-IR/QK.KKQY\?_YJY]F# M8KDJ9Z-R,I]57SVXK98/_N[K__I?OEPN5P7OSI9?/;A>K6Y^_<47R^%U-2V7 MN_.;:L9?+N>+:;GBGXNK+Y8WBZH<+:^K:C6=?+'_^/&3+Z;E>/:@&,[7L]57 M#P[WGSY_4*QGXW]=5R?^T[.#HP=??[D??_G%ZNLOO]`K_MJ3XKOY;'6]Y)51-6K_]>_7L]WB MX/&@V'^\=]#^XW?E8K?8\S\>MO^8EI.OX?>OQ[.J.%U5T^4_MU_XK/U#V,/[ MZFJ\7"U*=O:FG%;MIS[[MBHGJ^MAN:B*D_GBIIA?%L?3:C$>ENU'PX`G$&E1 M3B#.J/I8_$-UVW[NL\>/'^\=[1T^>;;?_M/)>K'@]>+5>#EDB'^JRH4(5[PH M5]V5[>SL[>\<[+7'",MX-9Y4B^*$%Z_FB^X:SJ;E1`^\KV[FBQ62QNZF-^6L M\^3YHI0@%F>WTXOYI#W99V>_.SEN_Q@),9].$8RSU7SXPZ`XNX:$R^+M>F6B MS)#MUQ)+SV]ONKO=>[SS#^?M5^#$;&12^6I2=@;\[+*<+#LCI6G>P<6Y9+F? MONFYP(SP^"OT8-E>QV>O_JG]4_MUXV7_RWW"'VCXNVHRV?EA-O\`':MRB?J/ MBM/E_BF,\8_SR7JV*A>WB!4L[R[^GZK.;Y&%01YK*3E;E:ON M_L/C[]87D_&P>#69EZOV8D[>OCE[^_KTQ?'YRQ?%-\>OC]^L^^&Y1W93C M45%]Q%(N$4R]-%]=HQ+#L.FR=X;S^0K-W/[,Z>Q'YNQ1N^.A&=MEL:B&%4N[ MF'3$\WUU@^+=`NN^P/QJR=KBC31@4,RJ#M&UD.7*%.2ZFHR*\:Q8+=;+ MSG,OJLL*RS,J+L>S7J`\K<^\>W1L)MI.O_V^MQ>3&> MC%?CBDG?5Z,*-P9UD'I(;3_;=LV87,\G(^3X__S'G__M?_WYO_U'P>K'PW%G M4\ZI23UP6R1[!QOY8+]N/XS`!!HM5V;0'N[*CACY_N"H M?[[6G_HG_4TQP=V/1^5*+OS&M@CTJ.3E'NX-#I_M#?:/'FMIZ&(UO4`[-NDC M[D/6?B-Q\/);J/-L\/SH8'#X_/`O(5)SZA:%ZFES;AS&GY_?/>&=6S\>C9#0 M^0R[()NR@Y8-RYLQ=J(M1.C_>KJ>H."C(@A:^Q&76B-C6\ZWOI')^0#SDA1H MV52@3QDXHI%LZ(Y:)(MV4][VF;.FNMI;^8%L.5'%)91MTSM:]SR@)1F;*[!?=\0 MF([=1_LQP>TY/_OYIY]_:O^86>E:R#H"DCTU[)B(AOE\=O!\\/S)T7:%;"_" MY:M7WMN/;D,@OW^'0R-.J58`^\D_;T(D'7.<;''Q"*T?S2>3Q_L)T?OH%BID8AI>-6H4O__.W%XGG&P(T]DYJ/:[EV^`LF]?%6_?O7Q_ M?'X*WMTD1GO[6Z/B,R!K1P5/P&.R#LN^/_YV,5\B=HOY9=>\O44:,1=`NFA: M.SIZ1I3!`X,"]>?AB4&/%P*CAA\Z2W0:-265, MJ^)1F/WSSNRGLU5%:+B*ZVM/=7)=8I>$72_+<0!;H@08\!Z&T`W$W&!I>RGM MF6Q3%Q5)C4K$_'&LC$S!/YG<-K$J/W8Y`QZ_YY-OJE4Q@7"=>:OE\M=`K&HJ M7##^<3PBK"U60+TFZ`R`H/UZ'!:;_(/W[Y]_>+E^[//BAG)X7QV]>%.]?OGCY\KOC;UX3 M=+X\^?[]Z?GIRXWZ:3+3IG)MNK=;!OMKH#9K\'!BLQUQ%FT?,@.8[P+`C-AA MDWUZ7ZU([D'MQ.!-3YZ3%ERNR0YL7\,WY,EF$I7BHIP0(U8A*D@1>B<1U7U# M/C(P]3@A35C*-VV0X2V/;I,CO68;00*)9Y4"[&BFW,+TQJ(CGLKU MJ2,>Y:WB[*46>X9E(H0_+K[U2+7]+"FG+83LI#I:CV^A8N?5]\HSW+CC$`5E M47X7U="V M0P;%X?/XCS9ZL<.&L"S+JB`]>P4"^S!>7<.*R8?RECRHQ6/%\9!P=VG1FJ5S MVVOZIP-&5PE,Q9%4/L*G+17M.FY[:-?9)9_L(14K&^P9D!\T4D^34$ M^F)+T/07#/&I*U*@W%A/AN,1U!#PF>J;_]E__L3R$9NTM6_)?^TU[3/G;%S"V24H)=*%%;2\?W<)G_;^MK6X'@/<=R??$'J3^32%+<,+>WYE/T/KIMAI8[0GR]*BY`V>H$VWV;-G-R?'9 MM\6KUV]_MQ$@6IEA+0?'$@/>:DVF!MV3M M'4]+8U6T^*1A7U38223)$(H@>CE5.<]=8GO+;V3_-07F86O$92JT<[<'?T-6 MZQZ/];$1>^9LR#=D;6X%'8'*+[+U;+X;7 MP#'9*L+:GN)1>PX/FAM+ZYNI_9HMS9("=1UIV[H6\V%5C4(>P69#F*F+H5?8 ML>\,QK7G>.[=Q<5M5D>L^=]^56D+H)+"3])#H\K_ MZW,IK62A_;B$:X#OC&&HA!DO/1_U/UAA##<^=-"#M,@M<+_[E(R7#Y_^"P2]G%BDZ^&^/_C(6=8N;H+I+ M1U5W<"B9FUK]+BL"4:BLF@*<6:\DI%:F:D^**DP!<52M@QS+G21/X4!%Z1OY MJ2WZ`4:B+@\^"XH,-YMQ68?&GB;T%_I*2&_P,F&\OC^[!&Y^_74&UG`&!N#N M7E3/6VV"6=JM.WC[L:")11SQ=F,N**\.WI4W$E&6!P7U7*X(+<00LEOUL2NY#';V\\?>WM9O%U+^?KJ.J9">#9D2T)&K?H((B"KOEN\K>?>/_)&O`'@ MIRBO%LI'TXPF+MV0\M.20VKED5;&UMU%IZWS-+C2K,8<2[WZ4%7T+4$L&Z/5 M21<)RJBAH!*[`@]"CD#0NE>\;%.]P(4DGU"W8L\=O+/AC'`G2.\:-/Q@51>O[ MC!)>UCMP"RFH9E?DU"T><3^L_7N@R5S37%;0<2AA,HM_@][R#^@/)A^;=!NY9P0P048)F_2U1R%PPF$J8090MB5R&E+XD:+7JB%=:0:@"\=RLI)[$3_<0J"&\ M(F,`I&3!EA#41$VN20K@!5$*6[PUV6L+`&MWP=MW]3P8V-;3*_^^+"[FY<(0 MQVB,+Z+YB_W1J)J2G^NB5I*Z:XJ&&$'JZ*9P\XGZBZ!" M`"7\3`L';R$OS+%#/:NI9I MT(M_R9AZ)S!6[P-/+[%J/_]4;#417C2W1"[SOO(V.K8*&/3FH+9(W?G"%B]X M][OFYR[DY[;ZO/-LKT2(15E\F"]^$!.CNQB%^I6H60;6WHKT"#F84H^J&HC2 MZHE9=85QI3/%@KG+R1Q'EQ>)>;J.!W:+8V-BM^LM$T&3;Y0NY\KVE;*VAP># M)W1X'1T^L54]/!P'&:W>+$V0FB-R_%'W+)UO+MAZ^XN*CTJ<<=&$VZ/22*W MC0_WV,P34N'/P\*>#HZ>'JEWIKDP^?%/Y(EM^W#P]-GA8._9D6_[Z>#Y/KV` MC[$U.?5V?_[I)+.NQB)PRB4,EO%;E&/^)4O+R8656N&WAJ1J/V9/%[-31I)EE6+6<<>Y?([7L:N7$S]M#0IKBXIWF,X,&N^ MGBC6!`#BEHXO:,LC1=P0ZPN`DH=DN[1L*7>TIBPXE#S/\*;%%;*M-\E.Z/7N M:_%!FPV-@?[C2RK>.%P#ZN,57F@RT5AR:]5BRMZ'P^HFU>PU;C`_O=MMF%H! MFNWV=32W@`])FJQ'T'1&I2GETF1^:484A:&09D:K<2V+R`ZM?SB!#&/RU0DV M\6]"=XY$+&[U*BG'M4PYM-,0_D_;>O?5+`7G9)RJ*4!RA8&G-CQ?TZ6KQ\[!4K#U`LI-#1^I"41S*/S`UBU+4GN_7MEP+-OV-"G"0JPN<$Q"O]MBK("([QDV"=:%V*41/QPW MXH=W(7Z(:%O<`7.EAPS\*GJ"!5D(X3WN2)0DM%8,3I-X63<,=[:^&'#>9KB+ MQ2O>5!^*OU<=^!8ZUA!B&S.N1'6,+:0#P]7\T4H(MYNYJ M+**_94-9>-7")3%V.O%JKYWM\3GT8IA7XWA^G#B8^CD05DR3`E#V\@9BTFQZ M(]$P1$D=R2#]JT8'3);K>'IA$&>#?A[902(5S36[E1!]UZZ=4G4$UB"7";OI M_CUINBO2V;AYR"-VC71$C<7!>-"37(Q.I6T85@$(NJTU=+89>BWT=X)O_3]1 M)Y0EC9YU#V3J.&KF>N/8Q7A*F8^JBJ(&`AY9-J?=:DSH$88.K+HN:5HNA]?A M9SK4EJ&=:_QG,*S, M?C3@^%Y^T""L*/@-\ZBA!^4$F:F;P(P##-I,]`6>$_*CLP`X<^*5GVK0KAZ" M+\)\C_*`RE&90J<@RB&7+&G^#2F#-4'N>-L^UC?:\_[@V9V[R3>!B83%,V0E MJI)ZG'8$*\("BC/C@!D5"8#YCY0%"%3"[UZ/:89!K,$69HP;[O3*>BI#MSFR MA!:H_PA_33RMQ`NQ,N(QLI#_`FY>5.#=>M]LO(^UF[FJI^%-5H_0+]7':C$4 ME((1<9VA_D70:4F/NO3>RF%))=C?261=_[!TF'H@R7\M19::`/,O@2$SE59 M,7('I42LU'2TO%02CDZ!609@.*.F*"4+(7<+[_M1Y)(@.?NR8ZDNY;X,N+R= M'CP\OZK@6V@_8LFNOY%^P3;4+),M,Y9X@MF M'&E+C+)5L_F,4S+R]*2-+DB"F"]A+N(%\E("*0Y[9,G)#L@"&]AF[U(*S`%( MAD?XCQMAVC"7CH:L1&K\2G59"E."VF#&=?*YH=>)L M]$[ILM8B### M8IX<8EA'OY4D25Z\.%Z#/T2Z-&BC?6>N;&W(['@*`E" MR_>LK9\E2P6@E1<$4=9DKB<"@H&).3?EY%634U3!0TIJ$V3,Y"U=8)1/9S&7 M(;,79UXK1I0=#T^YYHZ_ZKD[%@EB%>C`ZM;^*M`YVXH/8#=Y3%(",9UJ)IM2] M4*:YK@22S_&,H-NSN'4I($]$'.T68+XEH0<+F.!)HV=ID:"1.!:@A_'$(F80 M.F1XZD8\PA\*%PEV(IKX,.LZ+&-II'N(^84 M$$5L;YY/\'XETBI1F)5WVK$S"SC[(O37+=WR!:243UD8M=!R5488'1-(GFWO MF0'M-+BYGX!WTZ[U8UJE$CO\.^[8F=IA_3F/;,"M-<"-SB+`!3;L:(?3(@H0 ME)5KH"^`L::.OL81+N9T"[`5S_93=">1BZ3IBS<0#@!?%CP M9$-U?F-\-\C_2ZWLP/?W:2L[:J\,'0#RV4T>0COZ*SNY(XR#J)_ M4[5&X:A@E=(#=*MZ42ND6@E+PI165O..#(15SZ>ZDND?!HR=6ZAGD%@JRB_R M)T(`1YQQKP_Z&/RXUVY$SYOZI('=M*#XK+7+_CC;L%J&;D2+@8R=+[\.VRIR M%6"[+IM:2J"J.=0J696>CV5R$7RJ_4)5''.I)9NP['585FB4]!#3+")0 M+4`M/1IKGUD]\?!S3/XL#SWW#L0F?%_`@8QMA2H;KQOI"24B%.N%8B*V((8$ M\K#&R7+>&=[86UC>R0NDS"BY>0`=Q M4EWTW\D40;ZCY[O[1X2-6(.!)_;TWQ%W\0"\X%8J7?-QXID\Z]%_E\ZKG%GR MB?@M0@+3D2-[HV8GZ\*W!JY*90>A])!(4Q]?,M07*"I%HM,<\T?]!HV0P=E MS-X;$X/N82QE48G(L>V6W0O9"1D`C=VBB_.J;O;"W')%B?>*^CEHO40\3X6; ML#IB6OW8MD)N4=IN,3MF%,2TS,*8MN;["%@7:$G&P^]0\44,_H_38'D+>-YR%MJWL M%M_?\#?)N`(S)T_C_%JP,2,LT8)S]3+3T!#J*)*#5WC4;8>"()2>SU1+_VQO M)<#_0*F&7$2N,A#@A`:)HP/R[D?/S*&DF,>@`Y9:Z3/@0?,P>L^,<3TIMSX, MD5'@@*^D%P,D?0B&`?F$&@U3KPG#T23/7$<55:GWA$4HEG^^-*H]FPM&,[K'@J"8?$&^/4 M("NL3'Y)?JU!++?)+OPNL&DE%QQYI?R4[]M\68`^]:XWJ=(Y!&V%[(D6#O]- MP1W?!A&5:^EE8%N[:#_#EZ;@,S]I#`K^LUYQOQ50G:>1Y^P5 M:6W!5-_9*:D!FTW&0'THNV6`188#0M\MV2?#`@C8G(:'0`-/<*;\GV6(-4T\ M+Z+_-L`0`L>@K1&2DU)O7%P1&>J"!B0HP,7,F6QBEOR5.@0]I&=U!E+<8/,6* M/3Y$<;WJ(./+KTK:/#LR7Z,!.(7Y1X_K:;](*VNN&G$5%[.PTYU=<)NA\$2/ MB*;(LQY18K:O].G>P6#O^1-G"&0)RT@QM^9N+BA,O*U9K-?K)("'DU1/LHGS M+^UVTB1"D4SBCD<-%PUTE>NW'<.7R"9"U2$'QARN[3W;'QSLPTL)4!V.=#A? M.QN;+9YE%PE;ZH"LGZ)(-*]ELQ\QE8T`XK6&`0EDXS M@")E"((TFC35!77X3:[9E`=!.'H^>+)_J-/(ZLJ21)'=X#CH#59`)$I;9NEV M*1I:),M,?30SIX@1#\[)Q]'[=Y0NL@N;P@?<$/!O!I$VTX;E9LO)%_Z8#A_% M/2%1:FD=MBI`Y):@1Y M4Q#^8+J+'NP:Z*(=8P*=@\(>)ACAC^WUN0,.I$1!,_"&#)3WQV_51W+V+"R5 MT,1T4_JQTNZZ8"L*3:.:9M7+B;79!8)(/O1B[:'\A>!S6AR(8*,)RS+J-7>8 MK*7/(>C#0N^&IPV]KE7Y+DT.:E(;5RC4M*U?MJZ3/NU'B5V^F=D#ZPSMPB*Y M.[_FV0!72'ND4A0$A9TI%T6T#S7]C>"I`O$S=H@'[6F#'6QX$4DX$NPY"->2 M>MXTI2V723E\`6N;JZTS1I)T:/;D,=;@U@)LK2*,GB')C+\YG#2-MYJ87FM0 MI)YC5(%<=8B'WEEOE+8AF'9OW^?=L`F*MN644R:VKKU?6=K8J@?1P[>I15:# M$Q+,!.U)_PTL36*=5/Z:%IE4+V;I;;/A*(?OPA*(2F7V`ILLX897,=NJ0E[H M`&E*/^)N7;)U"I4@%86ZL!`CSZAN9Y.F,3(G6@;&:<%!V!/G]7`$BO7$5OC! M):P=*$W+C^/I>IHH[$T-&B[)DG,ETBLYV8?Q'EB$*[F5",1BK>>3%?`/U-KK ME)S6,?4[=["C(?JDONSN2:+=.?/Y\_]N:_9YQFV8B4T,[BT>5:NWRADLY<94 ME2%`K./F&(VR"$WJ^72_X<;CQVMR9W*@7`NN&"T%W-F+5*=QM*)Z.2OZ6T!" MK'(LQ4LI/!H,3I:K3$7#568/EV[.#H,,N.:<3`W-RE-QK;__\&]9T^? MZ>KDOQGWS(ZAX7Y3PL.#W:.#ND@G:]LKH4D@*>V0)FR+'"FAO<>$3@?/.CPZ M;DGGPSU:@PZ?#0Z>[!F`:W:.M070+APW$+Y62C+V[03\T[T$L%'"WB;K\ME] M>+B]@)1;R/45&M`S86U-#_#-,&-3(K&RXR\F-,[:%#,HJ$KEU\ M'V^9:-IB,^,R9UY^M(L=(,/$TPNNL;G'7NF&>>'#AT?T7SU^\CSRV_L2+AA& M6DYQR(>2!]'"_%\;-Z"HBFE':[?<[+%UK:!BI1,_[]`1@7/&MS8DZT^,"8S" MZF2AP)E;ITNBG9%J`)OXLZ'AN25HH1"1*5+.PJS=("V(7:7D>EO".]>S(P'Y M>%8*5]-*:+C%DH'*>>CAWN-&'=S9"S#8TJHKAD1;6E=A8C^'F.0M'$_Q,4'< MHEM@1L!]1$UWUDT:6^!=@Y+W:F!WGYV1<=\7,^SOAR/)%D\1.P6Z^U.#CH5S M>8Y2*$--@+0M4!HG_E)Z-%+9,K`$4OR=D[\4EE49(,)&IJ=K:P[-'@W!7TPR M.X,BB($.>1>A1[X-XK!>NV[FX=Y^@Y\&/`&W**$%XP:N`;RJEQ\\W@D_[_!S M0&]VK"-U,O6>":Z+FD%7DXAJ:Y&I')C\$*5#8I!D=Z^8 MI`.?P.V[JV);J8FD,$]^2XZM/#5L6'K7]P']'N[1T.;DSIA%L-,\6*=)L`CA M(F#>,[[9!C(J!8MA\!6Y10']N4SU37W1F+:R!3(`?;$-#N^5@*#6?)52!YQ9 MXUR)G2C'W72)TO*]C4S#E.]-I4-^K%\;"N3I>(,X!DT(J&KX`_F\$ M\/@'VY3M6CTVFSK=J\4@0&[9/^`IB?'0!J(=.]RQC-$'Q@YKM![Y2JT8EN;# M;Y)-RN0FZMK!P=8*?",Q4^/^AOTPS4T]NU:E#LE*W>U6@:O2*N.>,'_S#4CG/0KL721UL;PAQ@4ZU^=UM/OFBR;@+C1.N[+V!1V/"2ID!:[LM"0=(45:.+:!=3\8A84#UJ97X$'_0O,!J\] M92X'^:X=CI+]$;RR^UNBGMJ[P0JK!5_IO[`)A//)8VL)R(8UCL0)LW.%.>ZR M>R/BGKRGEWG#2YE;]#2`E3&0'QT<:*QY5=D)%HLMD+05I<(Z7R[)2O'-(QVK MP>R&;R=]GM!M;$A"]9[4MBUHY,:M.`S=NMZ1.\&0R&@L)KPG=9]S`37K#,91 MQIG2),Z2,_DKAWZF.`OA/6(ZD3GO*]I(#8YMP4L=-C'PDC1%K%TLK\)H]EG;)0<4]5>.A#%AM<,,L<<1:(;$E M\P^ZHSI4Y>S!Z/H_V)EOETU+'A[M;1.Z!E$^J%[L!EOF:,LVQ0ZE1,.BPY/Z MU>RZ&3.$M!:B.-AF%CM8/SJ\]VI5U;]+$?X?"U;;^+R'9(B9(,Z6/VVYL24; MX,X+60+$I1:8)E7?_T*G$?=__LF$P_IOU6"M:A>ZA8=#O5886X"7#G54BX4$ M5%&,^UBQ-H9*#C51O!^W0MBL+=;O&H<>[7V#"R+>=D?.4_)%?\=87)VJ$^HX`][D?>N5GM\0@L5YY]"LJ9A[,D\P:,Y0*\VX-PF`4INT(K96U M,)'00,;'$E_W(H:UJ>]([:`G,WBA`@%X90-E)L>V1#^A\"."]=E;"*!S(R+8G?3 MPJ:V9&"**WAQP?'UCAH>YXWB!"*^O"9]XFUWW.;(M4"8.P6+G/;EQ!?@7%## MMB2>U.WX!$7\]6(^_P%5Y"\>#_E_>VHV)67S.S?TJ.[?\(N]DR&V(5P567&S MGRI;=28_K#&$5$:-6$\D&5;?"C,,E>*FKFB:7MX,BA!=D`:R0Z[+]:5NEI?Y M78(DB9-&X;O-^3Y=O"P\JW?Q(?T>4L3FOYC* M0B@EMY.EZ!/*CM2<(X:9&IL_21#>`S8O:*<\5Y9S$HL]$94FS?28P`K5[]CB M3NQVEHYYM#&"F8#VC\%X=:XO?DMN'%O6^79D7,#//Y'D^ODGD;4]Y,/V#V^E M9!)T=VUC?*0P1WWG[Y=R$Y%L]8=F]9S^J?[9>/WYV>M'_;:?\0'+ZI M4O-S8R1].2S5\^W%UXU/3[4'/!O3ZZ-&A`4:1- MU&@F%$5?3X!;_%T'8J+R-2_RE/`?DV"!JH9HOC\K!+_L@&Y[!]^CMSS^,H9E M[;]KA[[0E!OJTVX9`?:N#*D2!Y8X_,7V$#HO!(]B.4,N@QOCJ$K$A;M(DFSS M;XR$QHS26F(,,GE#G[R3#HK4I-NP'1E^@5C95'JQUJJ3^-4,_"IK;7>JN8V. M^F8GN$,\/`(SZ0WTN=^6RH3ICVD]<8&\A#?4%U-]]*A8>`Y$P9O0_"7]RP&6 M[SZ7Q)G:&CW=&,"#I0VX[-;OC02Q0K*C&>"0[J,`300"G"[W`UL!POB!.DOGDV+5RTB3MSV[*W)(F4M MQ>RWWN=:L:)OJ:V$F\1*$9T23HB04][QI8B+7XE]\'`X3=EQS%G8QKY/DD6# ME'W6X6Z3%P"DL3J(7?+I08A,6`3V-M[53+E`*8C,75ASE(1#5;_PB;NEMW%9 ML$V(P[D="UW<.@7+S#XZ>SYV>[LLWB?/V]YK>J1VSM)=]P[AJB^VE14ZXMX4 MQ),\4QV?0]^,$ZY104U%T>&:N@?>H/46;"-(7_N'Y6B*&ML=H!(KP(55 MAK`LLN>QV[8QEFP`WEY6<4A8J[9#Y,3VI6^03M6^C]4$#NSF=X&DH_L7BC]1 M;[,S.5/#VG4%##&U>G!A_)T$H90`L`.W94&,'G3/;+"&C5)."X* M'>B-']K2.?$-L0C)*1S,1KX=BHYV-W(BB\PQYW=0>;.NL@2ZCN`NGBE/VNB4 MM1DC1(Q7-.QW)/.4_GQZQNW$D%2-Y4A(,+AC2B4$V*2*L^O`DYQ9$,3BD-9T M.X:XBV!A"!C!4T4J6^I[/>&&$#UA?\@ZI[&VI8-M;H"BYU.!O-W=%@[2G?-. M%'7W1@`/Y80\IG,H+SV-%T0SN6(\[C=QA6P MWITI55I<':I@4=\'7:ZFS+FR7!8WD*29(FFGEST_FU=C0-0-<@6O"V'DW8QM M%I#BK+&VGK43$=("FQ%6LY9KG48[([+7T@>I+P6G"=]*T"?`O%8;K3_ MC^B`GEU.J,FXVW.J$SIEC6%V_J5[>]?[Z@)SU@D)WC5%`(U=R]&@G/@KKT(L M_$V+A9=<&V8)\`L,!P<&%^NKIFWX^2?L2'!M;NP@#$2!ZG&<>(,W9[6NQ]RB M+E?,%1;U!XCGU'$:S]3E\ M-_E@M+#60`>[1T(\9>R\B2H(X\\_D0T2+SEL,D`AE)NQ*_EW0(*P-2Q:][;IJ.X=(TW]48 MN)+H2"`2E3/7%`0-.Z;5J(8AA12$:Z-&2[:ZEH9#+Z'K`-(&I"6OG6*<^#59 MS`\2OT'PW6JG/*ZV:SV\=@,%[]Q%'M%*&7)=>YCN.)6$Q8^R,0);-)@GZ50& MR1E8TZ!M2XN/T\FOES?TWWSUX$9^&XOPX&L.S;==_;O\DULOP:DW?76$QE,Z MPVU/F32&-!\+-#'!_[!]NE_@M^$1Z*S3=AY2F1)F7X7;+5[KZF"5F02Z]4$" MA[V2\_`FK/%;UD1'?7E%UY'NF$F9,.3&LQ"3*)M4LG^*P((+.J M42(@U,B5T,8$_&VJJ+]ZM$,2FQLKQC(M9DDOQQ_UWVR.'[@M!=KK#M;[+^X^ MDTI^CSS+OFN.A@,B?F@^$!P!60+QJ0RZ5?];+41E9KM5S[YN;ECZ0)(7%]<4 MH\777ZX0+O^1?^A_WO%_EG^4R?_JP=[C!U]\_27HR>D_12CW],OB%JZZ^7)6UF7*]@(^B'+VS05;]L%]G\7RS'3,[_KKX^5;<^":N= M[S'I9Y%T+S`2D[G3]*3O6V;GR$%T]*G5@P6&X,=D'5'@BU1!"D+3/]:9Q":7 MT)C0Z,;V4385W#4DK_4@>8F5^0E1BPPJ/MRBDV"IZ`1ZB]EDZ5`<):R#J,.O M12,=:(A7HNC4LTHXQ^K+#YU;(D.H[+IB`;U+#26_O"K\AM+2V.*+IVK1-7%(PIG_HI$2UYVPGQ9K@1KTX1J4'92G1D.T"2=*E<&^9@WG5@SC'#MY50 MQ`Q;L5ZV.B'DH/K=QGG&B82P^$U8A&^Q*]*'>\=G)\7Y_(;8^6#_\0X71`0< ME?FZ,0[J;^/OLDWR68+_3K''OP=2"*ZM0N$C6\G?:!6PB\C?DT>N^QGMK9]( M`:!H'ZV0Q(GL!A9*AZ@AHY[:813L$OE=HJCZ!CO:C_R/.SU_-,SEV=KZC3A+ MKDNZ_UN41G1`$3_YA<@9M7L0[?%YY=P'VK1?+V(]NV&0# MH;]_WL/^@:@WO_K)7:I>KFF6 M8'J.RZ.]M?LENCC?%^'*P9ZC@X?[1X>#Y\P-M2UN]QU>2Y/KTZ!;S=J"&Z_IS3NZN M\BL^8FRI7N"'1SJQ]OS0UW-TQ%T3S[BH]EYIM-8\;2?^@G3,CP`J,I!!3LB8 MGW('\V)M9K/Y_"]G*)_M'>WPF:O_5$-Y0CBA+W.:A+Y$T5=^T.8M6:O_5&/9 M[VNL0EF[$J>02I7P,E@G%6X;2(QRF0CMH1&X\>S]G$(J53`#WBN M%:@D7<=EP=O(DW!&&)-QN\@,-1_R=6/E!RQ]'#P>Z\DP%R=$U%H3ADG"%#R! M&1'UGDN8T%!,GN0^U+:`SG'%9L-K8ZKG8BT1BRA#X=B2/(\;V_I6("F"%AT3 M/%RRRAS-_(Z%ZSRTP$202W5ZCFK9KY?KL*.QK'!DR/*XC10RU;5Z&0FYU3]% M!)5&BZ>XM-SFQ87Z)3=VO@P]3\*$J*-)&D?.LDC99-$^Q2XNS5Y_="DFL'0* MPT(CE64#8&H[#@#$BP!8.RE6@Q?)\QA;:AM>6^CZ!@8+1D%AZIA65WXS)[/) MV+M!=%'!`^IK)_"]'K\WTP.=9G3U*:Y1(RD,\VH?LH>$E++?*NFZ'L4&,@O4 MZH%[%A[\2],4KKX^4VOZ#MT1+.R=5XHZU/)G'&"':A)Z2,4H)7@EUP&8(^0N MR1E3X:%$0]_:33G(6%"W%]-E4W:XU#"/GXIF\N-U4P=.A*M_8!Y)*ZEWGA`>QD\-U MO,Z:RR&%J<$Z[GFEI"GWBFFC,A(^SVE91H?Y#:'O!`2;^*$:2LT3^>]N4=(M M4&T`PA7.KLN8@A2:ZI?.Z]3>'11L8.XRV&R+D:&H#!5:SZE.B7&XO:>.;._% M%A*Z5M,RI./5K3H;^M"0+.';WWFH-R/6W-.X?`)RX* MQ>J6N,MT'2U7F0=[0R`RXY/4*OUS[M$J#NFND7`!1Z>&:Q'=B,C.2TBZ!UMW M;,B:I%8;99T`DQ]1>/>-)B>32ZJ!"JRYNTFM4JY$<7UNN&7`;5O4MKB3UKI/ M?0E67E+R*T`3RQ36Q1'_DE.(6^*8AF'XC46$F[>:(7QJKXY'M8H]_Z!3'$"! M$`?,U'4EHQQG=Y)-3/'M#$HZ]E@O2+ZX_GE2CO452&H1EK&1B'-/R34[E!+$ MZ;!\'G@Y_`ZVX`:3DKXX;?4L+82V)1&2\#ZOV/L]R=SNPW3@C_WF=F+6Q5[1 M,XT5F7FRCT899I*I(P-G1E2;GU\;P,_:$YQ8:WMVE16E[]TQ(9K M.CBR>91YC@UBVG68G@XKF+D#XVW/60,*NS5$L#,,"AS7N$O^O?Y`711)99UR M#$N*CO*65S.#>/W\DYJ6ZN1[B/90_ZLU\HU5X(_Z.)P=GD!I,K$S0D`K[Q3* M^SR0&EMAR'=I;VDXA,93:4B-?:M>WP?0$\'9&;5U>@0>-GDNO=.EJ9>"U$AB MV'R\?"OM""?!JSPP56511L)>\Q'J0J[%I#+8UO*Q_8/V+^ MX1ZIBBTI"NZ61U72%Z<[]#V=H2!5<:[C46UQ.X??09AC4M`[2B"?7EKII0S. MU[%>3.9\;R&OG4CVGS@O$/,YO.W9;FG3*`6*^HI"M+"A6R%2(B3=]:)\##5J MM2WQ^(KCA'P7)78EZ)S(?%$NZLA!3UU4?%&&ODG);:V)B7E4Q]J?$Z;/0!U; M$GU+G_#)'2=W=L-L4.'L)0]W)`STCR[6H=JS&^4MC8 M3C2P_&A;#NP(H:.?W^(?'B%YM-1/DJ@C,7JX$%BUV@K>VV#1:J7/[EGK2^P= MG=V+A:BX70Y!M7B3 MOW?4YGL$SS_96>N"3DW3CIVK*JE9X=W3-;690$2&N%R'<-!DBD^4055=QH'A M,U&#:<\@.6+,J_GPQ(0R1HX M.O+?3&A;;I[E"IM+>S<=MJ\?LC#WK;4_`(?(*G541HN+WB30]X]8MCJS5%]( M1HD]:-?_I>[,EJ/*LC3]*GZA+$290Z,1L`I+,R$@@S1`:E!D6%M87P@-H$HA MJ>12$%'6%_T@=<&S\"C])/W]:ZT]G'W.<7=%1%9U7V05(3][6GO-TZZQV/`Q M?Q[RM*MN5_.B#Q_B(V&%Y)\Z=."->FOJ[IO?K2S51_YN_'E<,Q[XH5`Z5NM9&SNCO6MU\%#?^! MX5I:B[\U%)/ER#?`E:V8C4B% M4/:@7"*-]W3Q5)&1V/#9Q16-/I+J+4>5RT$B`9\NSE"&8'@0F6W'OJ0*3=PU M^9\\:5BT*=^_`0#,(1$&74D)#BQ>LGQN+\KG3J.0$RPR4IW$GFP[E(B8[S0+ MMS3L3/DQ2;[%U@&5J=R4LJB*[ MWO#7^&W.)VN]BDG`51,>/'ADN>Y2,9W$:D(Z]H!D)O9G&9W\U[_=$J*18\(` M+>PP9@>Y6IS._Q[JM.6)X_\2VNGULPISQ,",'^O`D+I,,:5CASBM6(5K2"W/ M\JVN_[$G7^^??/"X4MS)"CY#2(XT$_DA,#C< MDB+1\J.0XY94A[-_%^>IZTY:.!3"MN3=/DMPE]>EM/A4.NQ$;WWU7Z+%,+.^ M?F&'A;#>%6/B+<"9@DM!O]Y[P+NG@?4HWYVGAM[;"[0&THA4MCU=O9O''1ZJ M]4Y"LF*4'0F/!'?Z;+.Z!,RK_.J%WF2VQF/1\"T]%)9O=>`,`E?;8SWMC/_2D?@.WJ\_)Q2T,T^[QA+JUA.C(N^#W;A52QX>>6I09]TVR:'#1 M9U'GJ%T%#TA>AX'O1;.%^[C,*H3`CUV4/R0#7O)G/7D7NGX^MQ"G^"E1D73=;:A*N M:(P(+7Z3HT].P>XZJ`BVUCR#'+D8\@8*E5ITI6BU%DL127-UG8OJ<5$#T;>O M:RU1QM][K0;B[QOM]S]ZTX"^,TM-C6OQ7B%^.\?_D+KC&)^P?*@(!K84T.(D]*]"2&**9@UR+'\P]Q87'WS3Z MV]?\<1B#KFE[LK(T7.RH[&XS^D:1*ET*K<3C@3C%!*<',;E$NA7^.9]HMG^N M;&<;9ZEF8GCXYB_/?Y9X5`=^.(]4_I0U/;23:B,6#B8'0?I6MCO-B]6NK@VJ MQ"ZEJ792)1.W&,]HL)!7J-%&,*>*A[/3=/8([*N_WU09=3$CYN+?=3"4JE M-7%_RY8AZ"F2^#=;@.P4)$%\KJW_*2%@S38M)S+%O;RQH[%*9)7%Y/1&;XJX MJAZOCAP;+-*//G;MD:VBT%R>-(F@'`)(L2FRI%BFPU`??OOZEI"YN:&B[7D5 MR91,PJ>(EP9-O%5ST(Q[#,8LZE3V0-H#AP$)(!AV-R/MX^3:=)4T*=?N_$&G M9[Z*S`3!S4$(QCES`':98TJ6\#"\3*7?MLB\6`D*4,!O!'2Y0)YC;H`6HJW- M;3M<9GDU+VPAK>][H%X0H2'_X]O7?H;%;F+5]@]E/@:K;I%9;#Y1=W)S`SM` M:$P>ROQP>/%W7`+Z'"19[J*`5H)KUW05([W!09Q=R51JT6Z(SGP4,LG0\'(3(AG( MCI\)$_![IV>(3'^1QDM:GU[#K9X'C!"^,<-NW0!8Y7#>($]=1B7Z/ M';V@NAC>2]JO6I<,90O*`_!/U?+@OOB&:%!B@L0L*?@T+P5 MQY1>J3[+@B/AME[U,8<_$[LVP<=)&X0CJ^BLY*Q M%L8/R%"/[[R]7!W<8PQ$S.)5V_%#2!6N;#Z3+(@:7@GE`C&JY&JP')XYD+"$ M!SH.<6MP0UU=;]_`"I!@*$>#2_Y#[:CQKU.6%@_`DM8%NLE:+KT82Q*BVC5S M_U1`6")NBHD^JTR-1)=,'L%INPO=@?!;1.J`49J0J>]J\FU_7K`-,S<]JX/; M*?DL=OTNDT7,`6U;L.!)4CX$F!3VDX)3Y8A\=E%_<_8@`:&'MN_/?OGV]8T1 M_K>O+R2Q6GS]']SRR$^2;30:>S2U1F,]+=\QW=BI'Z&G$/_88J;C8[L%GRB? M/Z&J#*[V4S'2ML,;B4YP3-J#N%G5PZ(6^]M0]2)LJE\JEURUU\F85#>3,,,# MHO;@WQ04< MTSVCM`4?.JAE0TB;OF!FY9A8I*C]\)T>@#/'+D*'K;>_[T9L"(HHG2BO5!4. M&PKY76I5$,?%36S,S-IZ)0X>9.4PNBW^Z:YR-90PT/=_72R3W+5C8E/ M">8K4UM_VOF@?.>CF__9'FC^."5Q@Y\R@WXZH$)X\HR7@?\^.HFM*LO-5Y5" MWOK&BS`+EZ74AH,IB(:VH6T`Y\2U`& M&0MFJ_W&O(V@J.59[,O..CIU1X?GQ97-Z6->#M6D*^N/MN^:8B-MO\?AZN)? ML7*KY$\%Z%,JW6_F=/.#;&!_1[Q*4U6JP]S98&\NR^1?`@G*VLIWF'_WZ5O$ M,^75[4W45PA195BWW^F,W;KG]HO.345HU;IUVKE(I:J:&B M@@?6U7V<^*HA\\CK94['%>N=YZ+%FVD-E^'2X3J$&V=O'7BTQB7#?N2.XAN0 M\>%V?FQ'A6)FMUJ<3$^'8[4EVPK]QE5C&!WZ5_1$A"V;?G&`KCH[1?WYI\// M5_\2YQ8F48[(B@@HS75"4?7;RIIS13_[*SB;+VGZ`^P2=1V;W;6@K$5T=H5Q M"$@4N,3RSVX2E`6,39XC!C\DKY0JII*=&_)?!4%0/SV0OGJFAP*4,XP%$:)* M3H0CF)@GU!A1K)[Q'0DZJE2*KWB>*QN6T3<_M$X26U*DT=S+Y%+$9>`R4AMM MEP2^)M&T[G(`5ZVHUS;-M;K1H_N]BRB?5)4P-[HQ3;.+4VMV3ECO'PB8,SWE M..OW-_Y@Y>H,\^BMR4,O5=RXCQGJ2JG,`X->_GR:2[Z8DA>KMQ_Q8-Y6"C3P M-P'HY+-I[EQ`5MO1F(_,<+D@:,;9_3/M$R=7P,R8LR43R-$#_VTXJ+^Y9\\O M@TU]K%!&[N47-@\*&SY@.!7C4><04I2'4/B#WXD[@OP=$9DCJ6J2#P2H#K9I MFF9C3Z;;%%.F?9D,[YR0K8IP-/.3C:?3I]M;0U!*H1I+!1:!RL>BSF(B*5>Q MXG*18SNW'T67J;VX&["N>W#(V+%'&[]]=<<@6&$ETOS\`YE%_.?[&[.I_\__ M_H^/*KBY".<6EH#E=,%$S,C6?$`!?[L=P:!&#)E=K*\>WE]=VZ:CE`.J8F5! M]\J)UJ]K3SSWG"KQ1`V>_'5_\N;R^B.S[%KW M%?_(_4Y^!*SA@LPG8E:(I MUT5W,P?)&M2ZTJ_<75.;CIPSJN=+@;P.;C1IC@C+W'JY\_Z9=2O84)8/Z%/N M?3;4/``J2SCU4$C5*\(OAFK^T`*%J,XJ50!4B"#7`?@/S^MVI-36W:(XH_#Z*_TK%/^,:)>XJ%54WS+V>@7=)H"_02P[!(E MP[7O\VWGW:D4M;XBA<6UQ!SY"!C@/#XX?`"T0WMFX\5(1OZ^6W;N0;2/540Q M?D=\HMJ;F4HP378)>](BKXG`*)M(R0%+&D-I:*B;[`/K:]G>.FOE53N MU_W//0#'N2/N-?YS_ZWWG(_XSZ.S8OF<*K_GD@0%J\(8FS\?RS2O]JO>_`FH M2$6*4/S5/R+-O$PO*S^$1S"Q'H/K;_<%;E:8**P@GTG:`$0-F;`&_Y+26(&` M)4+'X%]PC**6B*TVF1#BR?4+S[T=O5:G22;:18DY:YK`W/S92IMK-!DUNWM? MSK&NB\87)(U?2AL=[>^K#4KEP]-HS2FDC1K\H_),"!Y>0S0MGHVVIGA&M*KI M@V$#7QP<$;R,490">EZ="0($83)$1>0HO'[1H M*7N-!E*2Z:X!>7\0&2MPL&V]\V!.:M>$='1[T1R4]2=-16"<#W/!%##T;^7/ MBXU]N;S^NS`CFH8TNY!PUQZ4WLZ)P8=.UY&-*AR;Y&PDR3A3P/$>]572-5'S M*E>-W/947,%63!@I@:1Z*2W$E3H-2]&S(PFSS/(AT,,+N;[7>A`"##ZE_(O\ MO5#:,%$,AO_H1.5,=UC9VMB<;FSV[8BZX4I+Q14*[YVFM)JW9B>,\]%Y@^9C M=X'Z&B5#7#G_5T?,N@UR7BUL4082=1;9N*HO443:Y!^S@RWF!,L`!8#.UM.' MZUN`'`4)TE#NK?XM)J!6P/$19I74^2L:=WKO%^<>/,X9:OXUMFZZ5CF,].Z- MNN]>`)^(3)':`!OW8#KK\H2R33IH6^&6HU+^2$JUGSH/T\%LL^ZQH.)$@3"` M4'0`O:@0VW1#7"C=49VJ7=#T97M]NK5&THZFSLD_@71)WP)CTV\EAUC@6WFR M/GV\OIV55QTXHKUC2VY,-Q\_G3[>8LGJ^552[,B'R-V';.[UZ>;FUG1]<[T) M_M9XD)46&VZE@DX3P?Q7MA]O3-?7GSKI).S)>\O^@>0(PM';:Z_8U1+=MNGN M5O2L795-)+:EOX9EK>+@GO!8SK(NR68XT6:6?L:*-2,H\JS"4O/#<$O.^/$B M_'QV?4->"W\J^\*$)Y6P4%(-)N5SH+S!E%637WO4S9@'>T%4D` M8Y[ZCX:>,?YRUJ1^;ID,OJUQ;XG3!U)!(XN0+*!9V9BN;3V=`J')*K@=KV20 M,!@U^0)!1MK#4/\`A9#KOLN*YFHV\`H\W7KZFX`]LMUJ.R%_X`14B?).G+D] MT%FA;2O9E0"\/3_OX;TU@CQ02I74GN^:RA;[59=@OQIW"=\VJ8N'LY/)'K5U M'\UL@VWO*E:)%!R70\U\\QRK/UPA3,7^:_>?;HM4E8_(Y>P?FVS0,^![_'K> M!KQ*"$T(HKL:IM&.SAD$2NM!FA2HOR^*"A!&50G"ZKO=YI+LX.0-4NA`=Z#7 MZ;I+J]^$1#WZ2,[7Y$[0:IQ7$RN1?Z"I"D+EPA.Y'[VA@. M3BO>8^,6C>^J("W+JO;6@]L!>[=7!G'1SNBD\0'MPMG`PFM#34KW9O%.?V]` MZ7+.3P4W0(61A$"`;J6CJT=.YF%M4[GV MF8UP!3?7EQ;LJ:`WB`@!&^?G21DTZ8:2<%+L;L\%<;URJF073A$V2?DJL3$[ MFSF7CTL#VV!U79^=:4Q619JNV("E`_"VBAEX%,NF/OU&SVDY0"X7K>#\SHM503^^B3O9"7QIE"5-N=QUU]3%*;428TMFL M!1;@J+F[MK&R\70+Q7M3=Y<*;7,9.IA4,2:8`;L4FBVL-R)-@&B_>.DM MB\/Y+VTOR+EEMQUT"D0P.DSGYEZA@H M([5AQ4157JQ#LH\U@W:?`;J114<#UXLU`T+G]Q$ZN0FLW'41"#M34JB]K6CF M]R(8Y]0-([)\S!:N>#8'M]'[KG8=BVG50)4\@[E:`IR`#J)!RNJ*CV!130HT MTC>UWN"<^GS[.?7*-C`EBDE>E\XR%.)E+7/0F;(`[91.-GG1<9.WQSRP8$\T M$L'I9!OL[JP=8I05!@.LU%F8I&82H^V`_9;+B4/=82U\?Z9>AR773O^N1'A+ M8*?]"'QZF!YAZH4?!F>8H\UWO4HCH^>XEZH1,-3L_$VII+I5\5NU&G%9K!"V MZ_>$B.J.!JY1>*@6-!S2`VN&E;RCSY24*09I.1+)T0,?29I$J!'U6&691=ZS M&"5,LH2N40U"8ZKW;<:P^K40P:#SF=N!U704N58#EW;]E^I*>7Q)>)0;N M+$400X66!N>KA@U*OQNI63C-K/>-,T.8HEISATA48H4E7J1,NRDV+G]+B,L_ MF-UR,=1J)!2(SHXGJTVP?>W1PPWK7>&FR7W;$[,RK;D?[/S^6Y(OW0ESWD!H M(`%S9];R!YK,U-6&OT-Z*$[A\$_XKU9MSM[EDA0+XH(.)T.W;-D(_-KAN$F+ M,Z=;2@FPVS.9&&L]D_3/R-HQ+$O&)1JS/:]A*F1*33%]$\$04X9O3T@-E(>3 M:`3\)JF@)6ES+@;-W.NT.B[QQ_J;^,1LJ#G$/3JDHOIY]GL]'BUA9&.U`)=> MZ*UK)$D),8::GN`EZ5-!?@KVIKZ<*P_YEI"$7T#`E[1]=&#(08SDPKJW(/2O MF?OFDA]$9BJ-1LJ;WY;9S%K)25"R+F:&7U/$'B^3*$,UD(#X3?NG9X;R&2%] M$VYB)(XF=,2\2:=P?L6'_(WB"5I0``'^_?.ET?N5/6$GCF).09M0L.`+,^NT M43[M"]BT1POZ?U\\([XE$47^8M:B2'M%AZW@!/S=?%;#K!B M?,MU`E1M`4>U6)W)-+S/8QZAXSKM?3=MQZ#169A+-JHRBC:&J\=Z`1P(QA-# M5CL&+P8'.OPDEGLFG5(4;F`99!4R6\`JQZP.#QC<RT>,M&HM5G!.0-R'9**SB.-.U5&X,&)1>WV+#T+/;_WP4[" M@,B$?$V'%/4+15PLNNDY(J$#V`I@B269ANK)#.+U;`S@!CT.RHHD=3N&^!@: M[2ZD]-T.2O]&-.I?6#-M8K0U$UFE.^UO822&AH$7S3(#;`5RG'30H([NRZ`4.%9CW$$'T- M4J@R4DUE:AB+Q,PPM)-?K,LZ(?+2)`[%D>:QB*.9SXV$Z1"$6?;FZ=&PUJ'? M(]'?1\,Z>MF=M$``"1N#S_'O0^WS`03X0/MU;Q3;%?[P/S3&*A.@7(`+X'RX MHTH-X?&!3@IX!E-W$V1#VT,XXT"JX*SV?>A`B7FD7W(\&6C#/N2`K^34U!)# M[0FP2XQ[;$74&KE4NDIN#U7VZQ!'!%<$#N:^(D7/]6JC2W9IZUHU[ MU`Y]LT@Y+()?)X\?;C]=W_`ERLW55^5A.3S!9*2K=9ZA[5JPAD""^M3UV![8 MGM^:B[R?$1'"='VZ1AHF\9J*CNL)2SH"^I+G%<"SJ)1D(RN/'CY:DV;#/S;6 M&K-!3$*>;_07M*=C::7+;XXV4F9.DTO$^U%I#P8NY^ZNWN6`;HHC%(!:\6T' M_P^L:U=\$4:-G+;"/S2(*/Z22A89^A)_*>_"E&9=9C.>MA%V0]3.?J#5,O>K MA$D+%'?^8JRSL:E*9*ET_4=F*-D@-6\$R/"JG_4$"JYI-B03S(SW[+>RB]A\ MXO&O3NY&Q]NCO2<':-4V0Z.K8_F6>O>THV(W-SOTL2/G2;8<:F@A1)#FE1X;YKCBNW0BI`6SXQH&ME8R2.?-6%?,"*!$ZEPLTG<2I M[>%DLQN"5)L)W505-!4<-6')K]='_,D]J;7-O64WJH\]0H##ASC3QR[+\NT% M9=HU.G)UKVI]^A2"PPXT]2H?2!Y<.75]F\$YZG,YT.WR5]:?;$R?/'DZ.L/( M&;YKO/=R"N$_.:#5:FTMCV8]DP>"3O<_(8]BO=GB=/%8M`[=:ESG3=D@?5`N>U MBIBMRPM;(HODN.?5?T6=_\5';V=G4[93O+17&GRY]C=SRPJ_W0F-Y+_\HMSK M]COW^,HCEKUMY0R]CT'0@3DM^0LH*X4?&B"Q9V5SNK7]6(E.*3&R@;G,DZ9# M1Z#>=.OQUO3)^I.,?-75]"_"HG&+MQ3=T@+BBG48NV,[I(=, M,[S35*".OVS?@GW'B)V,&WHR)7]>&41P)MC4#P_?/R0Q^MB:+*AS-S8>$H/= M6&Q2)XUA*;U,OJ9Q%.U4J$,EW[[.J4BWQ5.'A^[B[7G^U/[!2GW2WHQ.LY,V M'2D5).+;[4>[INC(4A[`E/;C%YC,I#H2W10="';M%P?C M&',W7&!#$6H1CBO&:KZ8JE$ARHUE*DNRR&,D?:)4NNA",],+WZQE:4XV*,L) MR0L7L=>?)^^\Q0[(?DSAX8=N`Z4C`Y'%YB^_T"3"7D8QB>$^MM"D7836Y/)V M[W7:]^GM-3M2K0:YU>R8IDRWE!GJ;VJT#.J3\1S?#*UG?@>HPI(7."[A&\/V MQ8<1())<).4)]"0?1=!XCQ$380.-L+=5K#%MVE*;@4\;'B'WKTXZ24LLGCB,OX^Z/)X6 M\RAUW*1)B'4*/9M#TN1VY,G;5Q>H5A`7=@FY^X+ZR]P2+OP@8N#PI8MCB>;) MLTN]3:;3O:2\S$X76J?Z23_>_,]_$?<'A+EE](.MP.%5UK42__O'MY5.AKG3 MK#1,24&(0S:4R>^P-:S_JGX-+NZY%8>_/.#-U]MKFD/GEP'B1H.L2-4RQ%-V MCDDJX$\@OM>07B8_6`&/F=TRP!@(6HCM9_`Q`.1>GACG[DP93A84(7?BEZMS M9+T$2FXL$3_&-C[@'(%KU%RPJUA8M0\,T+4+[-HBK/-1ZUBG$L/8M>*[)$)1 MV^3*@OB69%`&FO?Y-ZY\[+Y_;POKA20#,#.](6P]&J`=<`.)3=(NSI(%CZ2A MFZ2SJS`)(+AU=(E_QPBJ#6 M\CZ#].]$]86QN#'/BUH09&25I(V*EZ/&35)E^&C6>(,[EM:*@@Q/+".)=<"Y(I7)(X@4E,W M8U[,L"@2P_MB86F#*P"C*S\J6VGVKR5-0)^B)^)4"3J4B\[;JV]R/ES-4EY]BCNVZE^T$RR'O M[;-"(U-HDF]#*:K$K(Y`$45B*WDL\\OQ(:K8#*K`(Z<_<3?8"B$]<\+>A=KF MG*JUHM&MWI&%+:.Q1`)08)Y/O6CYKMDK?:FEPEY'I/[MZ_[( M2Z/Z/>53D1,;!#F_"-CH*GTZ%V_E1EAYNCW=W'YB@U;6>"'[\<;&@@:$+^R9 M4TL@W4F%BKW+W.F#H:]P<3I803ADW6=GT^;Z1W3!LYM/*><8]0\?%7:#^*C; ME'/\7M4D>N_J[%1UE2G#NWKU+5Z5G%&J;0$2;F]E_>%F;L$B4%HDT*7F)NLW!O:297-<2V\S2*2.`RIO6#YS4`%+OQ!&!HA:`TL)/ZX0#0^5(;2#N=*$)_ MS/L0&]0X>?!%V:!&?O$S*?`:Y!,W6N[-GU_JM^5P!FO22V)I/^&4K]8F9,:+->PM[YE#P87VX/WI9,VE:8&%0=^+S@[3L)T8C`0Q.\C3L5.]+KH8#R^SN7#36;E1Z M="VQ[7"MNQ?]TEH&8;>^O_T0=JLA4-WCH(M!G=.FPA;4]>I4>4^Z,F!O]A)` MSW4P?/YD<\U00[CMU8%I)P<54SB^1*R)V"/UDSLVKT2*J?CV_P8R3(!*_$Q';<$*W00?9>\'[8' M_A;GA(583,_4Z1%0!`0M;P&(G.M57$WK4V++@#+Z(S>).F.G%"*2[./&87"& MWFV^RMF&XJ5=S$^A0T.:'#S4?Z6ERD/!!&ES\7Q'&/DD)MQK4!EC,Y$B<3`\ MIZ3QXP1XO_PU+@(11`-A<0%IO=P6G+8K$L2PA=.E:U"Y%?Y<%5)S8>!;3[&7 MR6H^R%M9X^E^6GS?R["+_F!-I7R7'OV=`+F+D5D. M`>JT(+R3KNX]15-=-BGV"B[(NE>2(MCG\IZK"OFD8ZX$)^1LYY2[>6>1E`(U M`(/ZON0E$U\"D!ZHU8\+]JE,3(VSBCU]7W"A*U+K2<7._-ALLQ/X9:,7236CO1GJ1T^.7:^Z0'&7Y8@%<\9,_)X9ZL\I@3#V+SR_UVR'\G M4`VZPS++F%?65M1-YJ6"@8LFF9MTJ]:Z3A+?OIJ9VFY1)FWIG]M[/2-\Y>TH MB]E].`'54V'.C-V!]47.,_"O8'?O+S5B\?N@Y#&9?J0JF@M4)@; M[O!GJ7?TK9!7$=_V%Q+ZP=)2L#A<_-A/5%(#`?&SF%&\L/`8V+\Y/-!6O96[ M_V7A)=OY"X0MJP)4*L;*CA(16=+0*\:N;6 M7J>/>%:Y2LQI4BENON!FQQ:P4.D''C?G3"::,'ZZ=^@MX[UO4KG&9.0D&5N[ MQ>0+*[J<-P`T]4F:(FSIZ.R:LBS4+6RA5`J5.^L47MCNF)'UKGOL-))Q]&PH MJI.P"_&^+N\(;)\;-VZ",U8.QJ,%T)C`#,VL1K]3PIN&EVD1B*`H+D M]UU/_D('RYM/W[Z^>O5J\GK?XB'[+_^B<`A5J1>3O:.;RP]@?EIWPH\2D/X( MH<";Z`'!"SY)CS!-P\JB;8I65#7:EWBJ)FW.`!6I6-M#HX?$X.0N7WUHFE0%:;$SCN MM._>#H%X4Q33O6CT(U4`B6Q9*R6SZ1MW3'2[>&))G.8.H.\]R?-94COXB:N3 MMO7>[#0_IKT)[3)=?*QK8JX\>4@K45XW/!?TV!#"'8X^AI"V;"\913*;C68#O%+H3U):^HFX#A[1>8*V(< MVE7U\]`I&QJ-=F[R22=4K'A-ZI'U?G_'HJO&>W2M&,7Y>PZU:K['0V7][M_* M"$8"*OPG#!ELSI&_\ICTQ:%2'`'$]0D3:]0N')^D"IY$N3I3T^DW]L3+;#IY M_7K7.-P.W-^:>ECP_UA><76JMQR1M*SR!QB+?:RGZUBS@ZHAXSV[\+E47XGBI)3(+"U7UA[Z,]T^O4O;`FV= M*+;D\=4PD7+#I'20'^-%.KMV-GL5UVJ.PIG$L=GTB`M\JKYHGCI]:[JDE4KD M#72E/^>L6&$ZHCH62P%D/E5GZ@5I^*2]@Q_YI5VXM/9P9;721J.[D93WC+F7%X*Z;'VE?E-#K.WGGVM6(=^\YV! MQ@YG%.W0.FUCKH`>ZTCF)D7GHC35FAF70@3[F?D,=BU8[(9Z8&FWJPNJ*0]K M^-3+=KE,3J!CB5H#O/L)O+KO'E=Y-2P^>X-K5N9KR[38QDN5.49K9S M5=S:3_^DR]:6.%?J896;VNCO#LNK\UO?.>Z!\%[GMS^CK9K<91KP6@;F]13O M`<)A93WR^.7MA;PWU,XNM5C1;F2:ITY4&HW<_&SX5Z;W':P:!ZR*AHLUF$A( MI?;--"<%4"V;65H9/Z&H66V2G=LM;6MY:^$K$PT[<"G@,X.,CS MTN;MNA*IF]J)?F;MAIAP;;HE.#[9J%A7AU55S<@&)UQ#=R=]/`T/?@N&".:. M'0*0?*TRK&"BSOSBA5%##Y@=6UG9H*A6\02?:Y+8UHM?\#B>88R`FTM/*P7B.8!`'AT7O[QB28H;28EP M5FJUO`K=NF/Y<^\^WE-A;0HJ^FN58+:OU!!I1*OI7SUGFGQ)IG2683R@XRDE M/\7_G^.#^0$,!8M?1+X):LWR8]%`0@M&_-]EX+O\WBGK'>AY94/"/6[K.AU_ M-BE?32<[*3_=9/WSR]L/-_3IR]_>97&U>T?IN:;J??FCOHN76IEJ^=ME'"(FIX(=_G-O"+">4;Q#OL`1W'/D5&'"L?%6ZO! MUU9%M&-%!'?96NF:;K_(/D9<)+2">!)6&R'^;3TFW_%U3#)=FMQA2QH5E MX)DD35?$3,:N-'T.JO0%TS+7=WEZ@TX-FBIH-;9*1AS`&IX3Z_PFV37TSMM" MK,E2(SA`8F%+[>`E.MZG!V`I1:0[UE#1^,82IT6KZCS5L=1R:5#]],9BK.GV M&%YJH7$Y!15X,A$V97+YA6]VA]O#2\[EHU>1L_WS&4KLXNW5-_K>"29LK] M]MH56^+I/`Y0T5QRJUF2*Z^6>''DW;83^:B1)XK%C>!.W78]*[6SRC)$5:2= MM.\1CE2#)./G`4GF<0II"7?#@7K&4FE6-C-Y)W^-](:JW&\QL*"Z\03HI8[7 M@-@S<;LP;A.6E\"I_^1$XB5R%98"QN+<@T44X.UT1'C"D:+4H)V@B4@S67UN M-1\TW2-CE@#D_=L_!1&0,>7+1&_H6^1*H M'T]W+S_.5#)$G;\WCMF]BJ6+(7]Q'Q4^%>`&]X.-H0.Z*U9:1'R`=8MUJH!> M>R9Y3Z(>?NEKJA0HB]!.?GIS\IE@:`^NG!A8R*SP4-K8=Q&"VY4Y6`)O"[[> M6>[K]I&`T68N MA/A/^/P(C.-\%N$=^^;[$TIM/E&!+X,[1PO57'F''@]G1^-[>D$CG!%>U^]#MIHTHVYS1FN9NP'S]3!M4>"=1C:^>/#DC?&/T(_70@XC5Y?7XT M.J9JM5PAL!3=\1U')-%B@YNC,]=?;8U^A2F"M]7B4-DW.;YR[G59-<.:IHZ/ MK\(G.)N\\I^7;A6I="PL/V/VT^&#C=Z MKWO5O<8-`,X@LUT%+Y2&UBXQIG-/=O2L4F3L(W#J[Q()F^J=G$A(E[]A0*N! MU:+[#V&3,9OV9$Y:FD`BZX``<.^F[^U&?+PJ%5#66J=;.[:RYZ8.Q%AZ&;6J M`4M&K.5Y6+1C#NWGZ//,]VLI65=>UH'+74@&IY0.1/2AM(+UEM(6O1+>*.\= M[[S;;"D[I<,7>@[U7SVAT@Z_I][':].FAQ&O0"->I4%<*<9!MV$E M_2FK/,4!8$(?K]75A*?W3E3Q!*Q6UB+D6?<M,/>JDML?R$-8M& M3>WMVS0,/TV.F#O5+Q[?JA@O]9B;H4P[=@[:5TQ)_C3/]-R%#KDK^%LZS3P: M2)Y^UV2?JTZ/NX;QA5J?_88312B.>A;`*!4GFC29G'>REZC11=_P6:&"&#!) MWS.;7C7HL?H>22;5P,QPF+![/Z%"J>R$9MH5VWO`R,B9-\QUV='&V\$[S9L" MMANE5EL;SE6PXO/9[>>>/9CWR*'TL,"4!)3^DU6]H_U`YI/>/E-3Z;1(NZ-F M$*XT-U8/S[G0"*3&J@N&XGFR5 M[(.NPZH=9:?TFY(^:::A;@W`U.Q9GIAV:!EENIQ$9!;5=MUR%,FQYY=,UST#+>R4E(H:`P M?<<^-7F44GP2(;9K_7:F]$(M\!-Y(T%,@K?3%WJUI.7OH_5W:/L*;R`AT3B\ M6'B8YS9SN)TYDSI>M*%VW4JGMH4SWPH%0\RL'7.OHVY)33XY)HUH;;V;=2*1 MM?[(.EU*';0L+J4T(*8W'CT@VG7,GQ_P9V6J0#[+ZTO@O.?[-5I08:,]5%G( MM2,I1M#*,"AN^18$#:C!W2JO&%>HJZ][J@\$AXEQDG73>R#'<3RN.&HNF1A0 M)`(-YC!G]0XB"TTJ2U>DW@XM/[^5G3^L=U:G`QQ+#6GQ:-#HJ>D5\:^,WW9_ M9LA]/OQ7BL_1,B_)\G,EG7_5>AZY`CBJ4KR2S[T5;5N@(M@);XHD3Z<5?A.G0662G;`Z;MT#F6 MV.RQM^CQ[7=W$C-J06J7M:6T7F3/BO3,4_TCJVOB2N`M3RD*.M(Q&6-8F;]Q.?2$[M=T]Q1SC\9<< MSZO<_SL@U)S\B3DAEV;4F/]VCPI]>X1ZW:7M3+7T` MGK<8.<#24RR*Q>[,3U.%K4E;'=+SZPS-@:S,R?>(67N/X7;6LQ%:1T&3(=,R MK'WT.633*0FAE@0G!\&I5V0L&%GG#X[8^5F?'U*UVYVX4BX!.W<8?G(E$'8< M8<;PZY'MW'E&\^UXMM^0([7("!(X\7\0>G]%W:0_=E(G(;<+[*)RD=]U/4ZJ MM*X\4Y,4TQQIQJU_C\>D\!6!Y#=*2^[G9>$2G)THX_GUV6GO_N]M>6.VW@Y3 MKI52$RWO&*\+R7J1P)4W#K]8%,>]M_'[EU@0"L[;TJWF_ZBSGRUE->^Z/6V" MGT&[G#CQKU'B3^,&X3Z9)\GFCIQ.3).YXRX79GO0Q`Q;P/M\BW!5M2:<%=!J M/J"(WL75]:7>'S$GUJ"[)H$Y@SXY2R MB0[,)DK7OW`52FBS&M?+E-FYNGXXX;UPJ]5MKW1\\7G(4X_2Y5G"BKB\V(_M MO5WG@(2^RVMUCA-VBU&$PEMYJ]HQD8H`GJB%KAR['RC0B53=U,'C`"/85>=W M9OT.1GT=G,$7)\]H88>*WR[7;C'-6^T0&9@L[/BUG61,&BU6U$='SKL(C@1? M)GKN[G*R_1:104KOS",63&\)I-;\CMY+*H:<]9L]_+362P1*RU#V%@7%T#FJ MO6*8^]8(EL2E%G@_K8_.4X7/1_*:C';Q!D0^?`*$:&=>!MJCN?:1TXY']3;: M[38KXJCB$0.<4?,@.C)&`5-/-GIV26NS+S+,85C,V&]X,SI%I2R@&.`=7'+# MQ#/CLT@H-O+7.BANW<]#XS+RG:%.OII_>5'M38PYT%YD'0]:XA#2VK M6I6E+82HXE91`SB`>_LE3NF1CU#;AAV?EGR%"*6%BQ6DO#SIL9-BI56NXF+= MM0!VR!)'DH(]G52C%="BEALZ;\?T(K;)8D0IRI[!CN,W?=#.-`^HSEX[P9RE MH=KNL!L=;G>Q?-;:/_J`(&3%ZAO<,$4TJ>B_ZPPM>$;UPS:]?A&7;X.=\PBJ M&U`F]A^BIJFZA4&G,9^ZZ$III`P[A5 M,@(UGJD;-:;[R?UG_QZ&9O?P\[D\+4P?$(BDY^1`^'IL6^,V?DI3;NH,3!(, M)S@/CAA1Z\?VPT.9(SZ'SNR3/9SGWA^T)]''IE[DBYC'CX(QJTV_,>?>H@WR MRU,7\7V%O4F)RJ_@%/NYQ=_>')448<+3!S@A(JYN^Y'2_H(`I_?0&0WJ>W5' M):B'K/HNHK4[Z_XZW219,7XY[T^L M$8S!MT*<4<[7NPC4++HZVQ-!I7S'6/IF%5K M&0]RX[NIT&ZVELO)&B*,6P**[8"0Z,\Z.0GCS,^N*4)-N79A:AFT/6/W\WT>!"7-*3*5G,[N",]A].,G5\K8E61Z5PY^MY1-CY,$V+%M1"F'=Q:,![//#$7OOE\(R+I'HI7K)" MX5W"\+\B;X2&B*BTLKE0%>!L%YTSW),@QQWE]_2"5CN?&(H/R:&/*IR02R&Q M?/(;>\.4++H??:)E\3TZ,*R$*YYUF:M<+K?:0FE'=T7<@IO#MKG]&-G,`WZ/ MU`]^%)%?E+<`T;8.1_A/SQN];R)ASM;]2X;OWVR*C%U MWH0-UN!1?7[H/>SW*6<)7TB[B]+*GT/IF6@EJ23_3^]C)3.@]ZI(`^>??+9Y M3&FBA,$X6+^1&[>WT_JAYCIPS-ILQ[VV#N929]M?JFUAN(L^X,>^S#/*!=[2 MQ3REVK5#YVIPIG&T(T)1]M)LE1*W'RQ5J+O(@,^Y%XBZA16[<^Q`CU6+H(ZC M`\10M^XEH]7)YXY>AILS"Y)%;+\[K,[MFR>T(L=:'_R0=#T=DHA M?F&MO8)CIM8`QE@(=A@'C*GAI:-+\&+Z]-:R9.U,?^;'5168&A#%_2[O%N3))&&&-E,TQFN^A)8U< MW0=6=\C484Z#.&_>>T"A!783,J"?##LZA]L'RTQ!:0G`X)WI=FEG< M6H`6?UN5X/C_0YO)%LH5M!R\P\I9N.K/HE)C^*,.,G:3Q=MEJV++7F71LZJR MB,#DLY0W[;V@84KH&RD!<,R!7.;WZZX\&5&_]/M6^6^SVF]U;=GG[4N3&,ZT%X^7*=":V:=`RY@DK=ROS M]Z^'F\`TA"1E0G)>TI7Y2H5YN_[X8;GG]:/(*)4&,)1B96925@O+$G%&"R(F MO*(EK*2\+HB$QWIGB:JF)&F"BMR:VO;,*@@K3618U)=P\#1E,;WG\5-!2XDD M-&U#2*>/%U5_*:;'/8]XOC MD?B-NWDXHB]87'/!4SD!.@N%'N\YM$(+F-;+A,$.E.U&3=.5>>@/HWO1NS=$QO>?:Y9\8R4%MR%/*@-;SA\5]&NB?H)@ZRCZH MRIBTGH&^^,6LCF&3(>(Z!CANAW$`GF=1O#H>HTJ:&7"]T&CW]$W MV]@@)&PVX'RZT;80X?*\6;:[T($R<*RO;-PU!=84S3I:5(00'Q79S6>(B/H( M/YSZ]@EEWC7*%%A3-A_^[P8AGF9&HSK"-50]I@D.RN5N*;"F*=`T(>1]3;AV M7M-LJ.FR^E=!FK90TX80<*8K/ZWZ(D1@>3E>`'WD1"KG_R-1!0TE!@=Z+#:$ MG"Q_7!XM?_5R[#6/\?)78$V1HYF&$$R:B^6OB8[Z$"C^X1$9G,WP&G$*K(G3 M^M4&(2@N"'W7"_6&T4=X*.U0%@-M#K38RYUKT)JZ0ZO$9+:8,7D#R!E]VFMA M/+,.MO)^KPTT;S8M9NQ`C$*&]JG6W"N\RTZM>M?J2=;*:]-BND.AV1R=7A\* MO.K%X!R_&0*]^EI,FU\W#&=Z/QE##,6I?MUS[TQRL;L/DJNYLH'!33D[)FX$ M@>)P.7N/,W9^(QB&PNX7/+M.\OLP>Y@8Y.38OONQ_!G9F?^ MBWG\^/UX6'PKZJ:L3NN`+<-@49PVU;8\O:R#?_[^\B$.%DV;G[;YH3H5Z^!' MT00?GW[^Z?&MJK\V^Z)H%Q#AU*R#?=N>'U:K9K,OCGFSK,[%"?ZRJ^ICWL+' M^F75G.LBWW8''0\K'H9Z=;UV-Q:C%(71SR%O0W M^_+(80S^6A;']T08/%'K>J^FK0W[;F5W#P:G3TEZX" M?]:+;;'+7P_M7]7;KT7YLF^AW`JNR%S8P_;'YZ+90$8AS)(K$VE3'4``_+\X MEF9I0$;R[]WK6[EM]^M`Z*6*0L$`7SP73?NE-"&#Q>:U::OC?P@Q&PJ#=SWN9/CW7UMH`E!X*;D@RB>R*<*3!N>Y7YJ!UP'$'J21$Z>(1%U. M693PD&LBC1",B>'R/&EP?:ZT^RIK#B(2B8`4$67+SK6(B4(7T"SA$>L!3R#T MC2MPNJP&)L*B/BR6%1$4ID0L8DF(S"-D*".>]#$\:7J.-`,3:20E*2(H34J> M2%+WS`64E&%XI:C1'&$&)L*&Z\6<(8+"8)(Q%1$B\PC&=2R'!>'ES#BE,TFF MRVE@7YH,^U*@-$2L-!5)K:@TCQ!0&=":AG4):6`]O1;)/.(6.CX2FLRX@4W:CDV`:?G;2W=(<]@D>E8 M#0O)5M-EM`ZYC`;$7VO$"N[S*K-]@]I")GL_I1,_M0PHZ9FA$:U,#',9\67. ML@4V]@5)?<$R6&*F82L7.9L@J\_U!@:#1&@Q3$)?X"Q[8#C:O?P-@6V=D;F< M'*MO"O'E$8OH]N#\]FYS;!9TK:4,&=JA5J%K%%S`=ID-.P-?(7&*3F$("^1& MQXP]@_9JRI!!A7$R6H6N8T@6J5A=:6:3L/L'8$?[CJ'(>$LM\[X*)3BIDR#, MH<^H$/[UP\A+(9_E&QU-Y%'?L`S*^V"FB(I'ANM#+(0>4,E]\Y"//<79=6`_6^:]U!?GML=,SFUN M)OS=7MS1_KQVUKC59R*N@ZEY8\-<1OPT$EN9;F)S$TVV"FH8$U8>,I@^!3L% M03.5C=-GOH%"B/2QZ'([.S86R"85/!AVOT:TN\Y$9MQQ:BA_EEU;DN(1,X\U"W MCLBX2\!]+^=#=GUQQ$9NB!N[AR8[O92[[D&49_:/=LG!'3>,OLO#V7RUK]P7-\LNQ-@N]%`-7&J6L>(T%S$9-)DEII-&7&)ZE8FQ.VBR"4DM@[IX M%#'%B/3,(M/"9MF"P)$/:>NWZ,[$M`E#!H5I%8<)68>9C8*$2!+HSBO5G&4* M8FP*FM0JM8P]M5()BX>A97O`]0W&F7`VL/Y:F^4)8NP)FIPZM0RJ,X9%[^4R MC]"2.4/9US;+$`0.>Z^LI`53R[A6[MPBVM1AG"N,+W"6)PB M_@<``/__`P!02P,$%``&``@````A`#5Y#)L&`P``!@D``!D```!X;"]W;W)K M&ULG););MLP$(;O!?H.`N_1OL6P',06T@9H@*+H MPJE%T46*Q;WNY8+O&T@ M[FT$%SR2MD@YQBCYS%?.]<.**V6)84(=-HM0:H,W7J+/$'. M:MGGYSXM252W5$MB:QB+Q5G?PSD':6,B'\4@>M1Q(OLT(^2]",J MP5$%KB>5^.,JX5$%KB<5L#4?B&.2TNL6161L&O@8.N"<`PL%!#=J,QL7F7R.>(D7N8YG+W&LX09&9P!EMC[&UMF#GW[Q*Y(9*^ M^H+8A<\PR<@\[.W+S6MX:GZRZ&O#S)E_E\@-$??F0S\)_FV,D?=X[%V?>`&< MF_.;4P^:QA`.N3'E8YBHG]]WXQ0ZV9C8&&(FRGR.&$61_$\4>M`TBDF)KPUC M2B`./2^FMJYY4*R7B[=+&'7(>V):]8NU^Z?__U/,M<1RK25J3F+5VZ[U2Z MGU:__K(XKRC+;S9<=$0!8]B[\M.4%+U MG9K:#Q!*_(:PUC4,<_$(!]_M6$D+7AX;VBI#(FA-%.B7!];)"UM3/D+7$/%R M[&8E;SJ@V+*:J?>>U'6:L^L):"F'# M-.D)V'+^HJ&?*]T$G?V;WL_]!'P33D5WY%BK/_GI#\KV!P6S'8,A[6M>O1=4 MEA`HT'A!K)E*7H,`^'<:IBL#`B%O_?7$*G58NF'BQ2D*,<"=+97JF6E*URF/ M4O'F'P/"9RI#$IQ)X'HFP<&'2<(S"5P'DH<51.?.<+UT3KPHB-/L`1^^R:2/ MN""*K!:"GQPH6W`M.Z(7`9X#\R5;D\20]H_"AI0UR9-F6;JPWB!'"07RNLI0 MNO!?85;+,V9]B\$V8G-!Z"G4M(5I@/\K;3+T\<'!8`.F96SCOTOCHE:#M=K+ M.&O3,!XG&(;IE6QN$7&M.P%N'`::2%@; M#,SC$%@\*#!&?HHH[B$L%S#,V,5]]1J\="&B05F47=/IM:T-YIYZ@TC["L,( MQ4D:3@P6]T@L^;#V'Y>OP;;\++>371M(?-:&T:;&N/LL@>>6TP]Z(W"&-O%D0Y"K/)^BWND5CRTX_(UV!;?CZ- MWD!,6P[F0;R=#4 MB<'D?1'-]`9CS]/&>I]ZR/ZEO\TFM@NK`_+P=4#+4/Y_#.E.MB&,IH5E,*9L MDBS&V4B!^2*-$6&:Y6D^304.%WH@0Q)F>9B/(<:'.3V8K:VA8D\WM*ZE4_*C M/AD$$.C0.AQ:G@*]!4S:UW@.&Q&T^\,+.$QT9$^_$K%GK71JN@-*Y*6P7(4Y MCI@'Q;M^0]UR!<>(_O8`IT8*6QGR`+SC7%T>]`##.73U+P```/__`P!02P,$ M%``&``@````A``K3UFSU!0``VQ\``!D```!X;"]W;W)K&ULG)G;CJI(%(;O)YEW(-QO$0^@1GNGE6.R)YE,YG!-8ZFD10S0A_WV MLXI5*E78M7#W1:/EQT_57ZL.BUI^_\R/QCLKJZPXK4Q[,#0-=DJ+;7;:K\Q_ M_@Z^S4RCJI/3-CD6)[8R?[+*_/[T^V_+CZ)\K0Z,U08HG*J5>:CK\\*RJO3` M\J0:%&=V@E]V19DG-7PM]U9U+EFR;6[*C]9H.'2L/,E.)BHLRCX:Q6Z7IU/.TCER?EZ]OY6UKD9Y!XR8Y9_;,1-8T\7<3[ M4U$F+T=H]Z<]2=*+=O.E(Y]G:5E4Q:X>@)R%%>VV>6[-+5!Z6FXS:`&WW2C9 M;F4^VXO8GIO6T[(QZ-^,?52MST9U*#[",MO^R$X,W(9^XCWP4A2O'(VWO`AN MMCIW!TT/_%D:6[9+WH[U7\5'Q++]H8;NGD*+>,,6VY\>JU)P%&0&HRE72HLC M5`#^&WG&0P,<23Z;ZT>VK0\K<^P,INYP;`-NO+"J#C(N:1KI6U47^7\(V4(* M149"9`RU%[]/!Y/1U)T]HC(1*G"]J#B/JT"MFP;!5:B,W($]&3H/M,<1&G"] MU&3^J(8K-.#ZR_6`0=JT!:X7C##**+L\\<7IE0=XB?"D;&^Y,[FRVM=XCF5#!K9.#_ MC;&',K/I,K9,>%UBYLB(WT6@RJDS8 M15Q5)KK#J&V*N\RM39*],&/UMY?#DKUJP48M\-0"'PO:1DT=)5:#+N/.;^'1 M]&S8@XEZ,/$]Y@NO8-KH[Q6'):_4@HU:X*D%/A;@4L/#.5`+PDO!+>PZ;D9= MQAXJ8R"^,'RE;8\^6$3Z-YG#L'RVQ\!,F6+6R,#CKN-D*H^D#4EX).&31$`2 M(4E$)!'K",EG6&C;/O--S!BV0OKUA=^T,F&H7[UTY\J\M$9&YS=)>"3ADT1` M$B%)1"01(^$V:^UH,N1_U^B2_(9-R>-^\YM4OR=7?5QPD-'Y31(>2?@D$9!$ M2!(12<1(3!N_[<;N+_SFV5;O?1.'59^566*-C,YGDO!(PB>)@"1"DHA((D9" M^`P)YE=A#5O2MLW]IA%^DVJWLB*OD='9C016T9E*56Q&AD=*^"01D$1($A%) MQ#I"FD5LF*(?][NY2S5<72<%I'-<(&CY;,+'GSP9>;2(3R,!C80T$M%(K$5D MXWGZT'L^L3'9D!?*3B*&D-9P$O'$HS0J/HT$`L&>;<:2VK4AK1+12*Q%9,=Y M1M'?<5/>?:1DCCU89&/!KQ:22@D5`@V"DCE\]PRGB+:)58B\B.\\RD MY7B_R=S&?*;M_$RMYUI`6N=11X-XM(I_!YD-E4PNN`,IJWU((Q&-Q%I$]A[: M_0O>\[ODB=T9=R9VA#3&;FP2\6C$IY&`1D(:B032GJWD=2C6BLC&\XSI\:#' M/$L.^EL2CSMS_E(8>D=K/")BB,_EC1;N8F@5GT8"&@EI)!((5A>WWZKQNC;+ MQO/4J66\/O.T,=&2#5=33P&UXD*NW48`FA[Q:,2GD8!&0AJ):"36(K+?/'5J M^=US=L>$2_9=34%M,F_;T(A'(SZ-!`)IQ8"R9H:T2$0CL1:1C>>Y5,MX(M`Q M\Y(-5U:GM4TFI12`]XMYL$-(B M$8W$6D2VFB=2_:W&M$NV6LU#X221G,01P9=`&RW@I35_9WP5@J/5<[)G?R3E/CM5QI'MH`K#@0L+ M48F'L_BE+L[-:=I+4<.A:O/Q`(?H#-YR#P<`[XJBOGSA#[@>RS_]#P``__\# M`%!+`P04``8`"````"$`?L^'8JP"``"W!P``&0```'AL+W=O,)F+9IOA M/[_OKF88:4.;G%:RX1E^X1I?+[]^6>RE>M0EYP:!0Z,S7!K3S@G1K.0UU8%L M>0-W"JEJ:N!2;8EN%:>Y*ZHK,@K#":FI:+!WF*M+/&11",9O)=O5O#'>1/&* M&N#7I6CUJUO-+K&KJ7K= M"G0CDOZ*XRO^3^.Q?; MTL"T$VC(]C7/7VZY9A`HV`2CQ#HQ60$`?*-:V)4!@=!G=]R+W)09CB=!,@WC M".1HP[6Y$]82([;31M;_O"@Z6'F3T<$$C@>3"$XO+(X/Q7`\%@>C61(EDX\1 MB&_'I7-+#5TNE-PC6'$`K%MJUV\T!V<;2PSAOA\+Y&%K;FR1*P6UAE$^+:?) M=$&>(']VT*Q.-:.^8GVJB..CA`#?$1)"ZD*>A[-B:`*C#MSLZ.L:6'G-N*-) M^HKU.46/#1[49;LL0%N487A&AS'M$ZR\)G7Q1F'P%HUK8>UOO]]"#Q`D7<#S MX5GQ`&P2#L"\)G%@LS2)Q^FXKUAW%>/0?=ZZZ\'!?^=R."L>PD7]1Z^\!@". MR0XG>T[18YM\ALV*/UIU7G..[9RBQS;]#)L5#W,;#M5K#D.-TW0RC,T+WH?W M:'[O];M+2[?\@:JM:#2J>`'#"(,I)*_\SNLOC&S=+K*1!G9,=UK""Y+#%A,& M("ZD-*\7=F\_OG*7_P$``/__`P!02P,$%``&``@````A`#\0S3>Y!0``Q1L` M`!D```!X;"]W;W)K&ULG%E=CZ,V%'VOU/^`>)\0 M8(`D2K(:H-.NM)6JJA_/#'$2-`%'P'SLO^\UUR'8L-=)YR&:)(?#.;[7/@Y> M?_DL3]8[JYN"5QO;G-_67[ M\T_K#UZ_-D?&6@L8JF9C']OVO'*<)C^R,FMF_,PJ^&;/ZS)KX6U]<)ISS;)= M=U%Y7D&BI?B5+3?.U+;*O/5UT/%Z^SE!+X_W<UXZ2P>8MNM=`0[$L%LUVV_L)W>5^I[M;-?=`/U3L(]F\+_5'/G' MKW6Q^U94#$8;ZB0J\,+YJX!^W8F/X&)G=/5S5X$_:FO']MG;J?V3?_S&BL.Q MA7('X$@86^V^IZS)842!9N8%@BGG)Q``KU99B-:`$_HL@5U(AB2])'GL2UYMYB\`-0C.+@XHZ@VG6 M9MMUS3\LZ!JX9W/.1`^Z*V"^.$,=O=BI\MPT2;`0MN%-<8/AD(T MJPQ&*0H?U5O'B(%J]2,9J(C$B$@IA*(> M;G.[>@'NVKQ7%H6:MA@Q0=>1B-)AR2!3J+HAPDVU"\:W(<% M@.X9<9'N(U1%QHA9=C[<7QZT(B7X->4!$5%',._)%?&A*IX6+<"ZZ"MO-Z-B MQ.#@+Y:!_[C4=2."TCWD>,2Q7T[+C^Z1+\"Z_*CG1?F(H>0C@I(_Y*#EB_C6 MUD9SZXB+=!L+S09B")&)$9$B`H<"9T!_$Z6%EJH)NH4$6!=_K2W6`#&4>$1@ M8[M=@_32<%VG*!3Q+LS4^TO07:79B/29($&4#PG!,7Y<"">:$9)$=2*R[.YF M)MIB"I?)-]`O@B$T!@(+N;ET$:PU$(IEB#9+Q.-GTC$ MM$R<&R1$=0(T_\.)N$J?'-J(QRZ"T(FWA)\;>NLG$D):099IB&I%9*%6%/-2 M*[;@FI4@TB-#@J9%R/XR9S7)HEH1\3BP8I@>&*;07=<)/MKON<9,3LR0E(2H M%D1$WFX!`W4X-<:;/G>8NJ,-FRP#8HA*I9)F&J)Z$/DX\'#;OL_%5%6]Z!L_ M"=(W;M*$.;GE];>8$$&IF;AAK<)X54Q$VC8O=L<9'$7:@I9,@#1(2D*4BG@3 M66XVTUUE6JXD""OB+?S%0MNT)!(Q/>:X\)(0U8F6Y?04]\89'D1Z`DH0H2\Q M0U(2HEJ`[AAVEL&"0)M^E7H((BT8(2G)HEJ8"')S9GCC((]"?89+$&D%>0A( M*EEP5S.?^==]F^H#..XHA4"K\R$8[0@]!!'B$C,D)2&J!2V^#=V$<4MGGGBD M!3Y)"T9(2K*H%K38OBTO/$QF:.M!?(^ZR1S?DH=PFTK(I9OF/^JFN[+;F\CN M:*3?F,N)Y"'U4RQJ*;3H-G03!JZAFXRIG'A&2$I"5`M:$D3H2\R0E(2H%NZ* M:1]CFNXC"2(M(`\!24D6U8((S,$&D.XC.`+1LR$:]9$$R3Z:?`0H(:0%*LG1 M`IZFX&%#R>H#2]CIU%@Y?Q,G)2X\]NP_[4]QGKI#'*?_`@Y1SMF!_9[5AZ)J MK!/;PZ7S600K?XW',/BFY>?N*..%MW!\TOU[A.,R!H<(\QF`]YRWES?BH*<_ M@-O^!P``__\#`%!+`P04``8`"````"$`,`N"&_,"``#("```&0```'AL+W=O M/^?8V*RNGIK:>:1",MZN7>PA MUZ%MS@O6[M?NKY^WL[GK2$7:@M2\I6OWF4KW:O/YT^K(Q8.L*%4..+1R[59* M=4O?EWE%&R(]WM$61DHN&J*@*_:^[`0E11_4U'Z`4.(WA+6N<5B**1Z\+%E. M;WA^:&BKC(F@-5'`+RO6R1>W)I]BUQ#Q<.AF.6\ZL-BQFJGGWM1UFGQYMV^Y M(+L:\G["$I2#9T=6_/A%L.(;:RD4&Y9)+\".\P0D,YK63S?4)E#0<'&"V+ME/,:`.#7:9C>&5`0 M\M2W1U:H:NT&`J&]ASL!?,8Q\G_$7R33E^=&Z+(9B7XT8$=!\"R(WK_XB4X_[L<4`>MO=;B M/@0RE;"$CYLT35?^(]0]/VFVEYK`5F27BC`\2WS@.L-!<:;#:?':A1P& MF24)<1QA],;N7WR$3HM'=/%KUN;4,!KS9H[&X,K2\>,QLXKF,C+';4?V])Z( M/6NE4].ROVA2V)W"7$7(TQW%N_YXW7$%5TC_6,$7`X6S%WDP7G*N7CKZLCM_ M@VS^`@``__\#`%!+`P04``8`"````"$`<3(^NAD#``!0"0``&0```'AL+W=O MB]?BH@1)^K,[$ZR MFVPV^W%=H4@S0$E;QYE_OZ<4T,+&*!0D+KY;(F>G+YRFWVA%(-E0)E6`/6.O"GU)U2U8[(Q6/S<%^,&M ME&3X6,B?[/25T$,NH=H!!*3B6J8?CT0DD%"0L?U`*26L``/P:954=08D!+\W MYQ--91ZCZ=P.0G?J`6[MB9#/5$DB*SD*RP12Z=J9CJ'@;V(C"-\F@Q+?<\*(X:Y&<-U[PH>>@_-Y&TUTWGWGR;GEM-= M:0#&<\-8>(\Q!9O&HD%1MQII?85VY!J'-TZIL>#<0X9)-49O?KTHV#0Y"X;[ M1C.M2VA-'^;IQ3%\UPSQ*+R`7??<)8;KZ![7"AZZ'KX4-=.Y-AL"QI\2&#W4 MCO1DTZ_LDO`#V9&B$%;"CFIJ>;!%^[O]0-WXS4SL'\!`J_&!?,?\0"MA%22# MI:X=PI[@>B3J"\GJ9B#LF811UGS-X9\+@9>I:P.<,2:["S5T^_]"ZW\```#_ M_P,`4$L#!!0`!@`(````(0"V#1,&P`(``%L'```9````>&PO=V]R:W-H965T MT8H)H M3[:L@6]*J00Q\*BVOFX5(T6W2-1^%`2)+PAOL"/,U34,69:<_/:03$2=/ZX;:0BFQKJ?@FGA![9 MW<,%7G"JI):E\0#G.Z.7-<_\F0^DY:+@4(&-'2E6YG@5SM<)]I>++I]?G.WU MX#/2E=Q_4KSXPAL&84.;;`,V4CY9Z6-A7\%B_V+U0]>`;PH5K"2[VGR7^\^, M;RL#W8ZA(%O7O'B]9YI"H(#QHMB2J*S!`%R1X'9G0"#DI;OO>6&J'$\2+TZ# M20ARM&':/'"+Q(CNM)'BMQ.%!Y2#1`<(W`^0,/:F49QF[Z%,#A2X'RG)U13? MU=7%=$\,62Z4W"/8>N!:<9CK0Q.>*]5N*,V\`&7JS6WP"!^7M5MI% M.88`^C:EV2B>.Z=)NT:'\2RP?R.33@+7'G,JX\PDG);WF[2+QB9/#7)!.LW0 M09I-1RXO-?]PF?R/2[MH[/+$=RZ=QD4YC9,TBF8CCT,%C(8XBTY;QB7IAIP[ MO8*I+5NSNM:(RIT=8"&TJ7_;S]95U(W'_@N8;2W9LJ]$;7FC4"`NI33'!SM_^Y_%Y1\```#__P,`4$L# M!!0`!@`(````(0#,I=K;?@(``&0&```9````>&PO=V]R:W-H965T[QI30IJO2EX!SSSWGGGMML[IZ5`UZ$,9*W18XB6*,1,MU*=MM@7__NKM8 M8&0=:TO6Z%84^$E8?+7^_&EUT&9G:R$<`H;6%KAVKEL28GDM%+.1[D0+D4H; MQ1PLS9;8S@A6]DFJ(6D+`L#3G<.BJDES<:KY7HG6!Q(B&.:C?UK*S MSVR*GT.GF-GMNPNN50<4&]E(]]238J3X\G[;:L,V#?A^3.:,/W/WBQ-Z);G1 M5E&+ MD>4WV0IH-HS)#V"C]932>)0!'&V'= MG?24&/&]=5K]#:!DH`HDZ4`"SX$D@=?WDTDHI/=URQQ;KXP^(-@K(&4[YG=> ML@06;V@&;7G;$#CQ.=<^J4\%M(4A/*SI(E^1!^@<'S`WIYAT1!`0'RL`U6D% M[RM[,%2(T429CKQ]=3:4-;YFAX\T3S:")HAG`V:>9HE8U$O-&%KG:_IP1/-UV,-X4$SH70>OZV9 M?T33@R>:KP<:PD$SF>=9^A]-^A%-#_::QYV4Q*_-!DP8*J6+E!XG$!H<+HIP MH#JV%=^9V/>O-=SF`DY5'`&XTMH] M+_Q%-'X?UO\```#__P,`4$L#!!0`!@`(````(0!NVNNR^0,``.H.```8```` M>&PO=V]R:W-H965T&ULE)==CZ,V%(;O*_4_(-]OP.0["ED- MC*9=J96J=K>]=L!)T`"FMC.9^?=[C`G8)AF17"0A>7G/XW-\;+S]^EX6WAOE M(F=5A/`D0!ZM4I;EU3%"/[Z_?%DA3TA29:1@%8W0!Q7HZ^[77[87QE_%B5+I M@4,E(G22LM[XODA/M"1BPFI:P3\'QDLBX9(??5%S2K+FIK+PPR!8^"7)*Z0= M-GR,!SL<\I0^L_1Y/*C M,45>F6Z^'2O&R;Z`<;_C&4FOWLW%P+[,4\X$.\@)V/D:=#CFM;_VP6FWS7(8 M@4J[Q^DA0D]XD^`5\G?;)D'_YO0BC.^>.+'+;SS/_L@K"MF&.DFR_X<6-)4T M@\HA3U5DS]BKNO4;_!1`$-$(5!#Q_S7,4ZBB^%T8\_LUY$M3MK^XE]$#.1?R M;W;YG>;'DX1(N*2O``MZ],E?S"=)(WC5=GLE3 MA*:+R7P93#'(O3T5\B57ELA+ST*R\C\MPJV5-@E;$_B\Z/_#QTVFK0E\MB8X M'$OBZU$U"7LFDNRVG%T\F*[`+6JB)C_>@/$U.WHL7;[NI0ORI$R>E$N$H,\@ M$P)J]K8+MOX;5"5M%;%6P'NGP+8BN2I480&N(X2L:#*#%,%6.\L\Y5DVG%S%#,;47RF<(B`Y/Q9$H<(1AU M5XF%'3?6"I-L:2N2H:)GM\B@1<:3*;%-MK+CQEIADJUM13)4W"%;/$*FQ#89 M=B>XEIAHV)WA0\D=MN4C;$KLL#E3/-82BZV?X\UL3(:2.VQJ,S46C,_;48D= M-K<-M,1BZR-KMJ&D5UBS;6VSJ<5L"KO,YXSJ)H?1;0@M,1E[`(VH%?-FZ5NM MIN%BW=?`0L3`,SY_C=J!'1]L5ZTS<4$.QT9 MMQJ3+W2:)[FAN<>GENOQ?'IQ-_E"IRMCK#6+IG8S/)OWD75M6X$Y@%YB)T^M MV./A]/INP?6SIHD=X^$>$+JM>T-SCP_&\`"?4MN3+W2[%VN-F9NP#][F;ZCI M)7;^'MHNU%.[AQ3IS'C5F/Q#?(W>N^`P\$C\V^X>TP'S:LURZ9YPV`6J)?S2-!$C9`Y M!C=_^B2A'XQ+RH\TH44AO)2=UKFL7O/)!P7FJ\G.%-2>%H-)B`^,":O%^I9N#NE[GX" M``#__P,`4$L#!!0`!@`(````(0`V%EA>@A@``*3R```9````>&PO=V]R:W-H M965TA5@@I8*VU][<_+4L"NFWT-YQ<)*3YN2W;>A^WI!?S\=__N?UY]/?F_N'F M[M>GX\G)V?'1YM>7NZ\WO[Y_.LXSXU^7QT_OE[_O/NU^73\W\W#\;\_ M_^__?/SG[O[/AQ^;S>.1F.'7PZ?C'X^/OS^[KX]GHCI M3KL-W7W,5Z=7IV*FSQ^_WHA'T#[M1_>;;Y^.EY,/2VUQ<7SZ^>/V&2IN-O\\ MO/CZZ.''W3_F_O/P13RE8IJ3Z:*=ZEX=GZRN#B;300_^F/S\&C'WWY MZ^'Q[K;LT*2?JIMDUD\B_NTGF9R?S*>+B\NWS#+O9Q'WV\\RO3B9S,_.W[`E MY_TV\0T;WYB)\/^UGXQ;,[E6W>5R;"_M5\,LUR\?6=IJZU[5,\[[CMJ:#+L MNNT7_>9,)V]^4,.N._G_[;N38>>=/N^`AS^HTRYDMIFUOGZ\_OSQ_NZ?(_%. M(':?A]_7[?O*Y$,[\Y!67;8\Y==K\25RJYUEV4[SZ5ALHDBF!Q&Z?W]>G"\^ MGOXM2Z3]4#:W&SO65<'C&[@Y:8H=V,.8IC#4N>P M!_'JICJ#&.9PU0%/'?#5@:`;Z(*[?2SA(%Z]VV@0P]W&ZD"B#J3J0*8.Y-W` M\W84@WAU.\I!#-M1J0.U.M"H`\NGG6:89-GO(I?;M[+M?M7O$MN14['+/NVW M(J^D_7;_N^NP>[:ZW3V'>UH-`\^/<"KO:-JNF,UDLNZ(>%Q/.[1XAY6-OFN4 M.S)0F"@L%#8*!X6+PD/AHPA0A"@B%#&*!$6*(D.1HRA0E"@J%#6*!L5RR:0O MO)^:B775>!:TMY*R0!W0U(%U-_!RBQ;GRAN3 M?H`Q]ID+.3#,?>92-M8^X^Y.).-]V&,NE=>T/,!4!YAZGU%> MKV:?45ZOY?(0M#H$]74IE>'E\]U)T2`.(-X1#>VMI&A0!S1U8-T-/*^=='7` M4`=,=DP\.)&:A9E^XQ2U_D^H]1C<8`I#S#5`:8^P#2#&9Z,Y7(8>?%L7"J/=+G: MAY0(6_9[HUP0S\^'5!#B2%@JB/'WR%9+A:`.:.K`NAMX40CJ@*$.F.J`I0[8 MZH"C#KCJ@*<.^.I`H`Z$ZD"D#L3J0*(.I.I`I@[DP\"+E_U">=,N!C/L+.4P M\.)&E\J[;[7/*.^^]6"&B1MU8+G<&5GMC/2O^O9%EO8N<8)$VKL.6XFUMQ(K MMA?'3XM+)=56G1'5\'2,I92*AF*-0D=AH#!16"AL%`X*%X6'PD<1H`A11"AB M%`F*%$6&(D=1H"A15"AJ%`V*Y9()5]URM.RD;!"G/=^1#>VMMM=`GNO^4DG+ M56?&L@'%&H6.PD!AHK!0V"@<%"X*#X6/(D`1HHA0Q"B23BRZT]'B,JCX(Q], MII*XFBY4D.&=Y"B*EW5+(2ZO[6YHA:)^*<1EL;,S90G0O`03\4C% M'_G96"X[,E)02ZZYI38VBY0,XAS].Y*AO962#%?*(UEU9N2!:"C6*'04!@H3 MA87"1N&@<%%X*'P4`8H0180B1I&@2%%D*/).7&SSYV)?Q14X1XFB0E&C:%`L METRXZI:C92=E@[@4N9,-%B\)#X:,(4(0H(A0QBF2/N%+>2],]1GXOS5#D*`H4)8H*18VB0;%<,N&Z M6VICLTCIT';/2/$P'@M;KN:"Q8,]&9&$Q, M)A83FXG#Q&7B,?&9!$S"GG0OX^3JXD*TSLFU&?$L,9.$2WJ7D(.C;6I1.R3/LA,#"8F$XN)S<1AXC+QF/A,`B8ADXA)S"1ADC+) MF.1,"B8EDXI)S:1A(G*CJ\?72TW$QDLRVYZO>8J$KLMYO!SEV&@[6M38F)SA M&8RV@7XG-Y0+_ZL>C:2"QF3-1&=B,#&96$QL)@X3EXG'Q&<2,`F91$QB)@F3 ME$G&)&=2,"F95$QJ)LT^D'!ZBLJ7P@-,;+5=/ M;ZB-%.W/U`C4!6!W,4PY+M9Z,A(K:R8Z$X.)R<1B8C-QF+A,/"8^DX!)R"1B M$C-)F*1,,B8YDX))R:1B4C-IF(C%1E=K(X4D5AMLQ@M23HRV5TM=;G`O?/N3 M)R\1CXC,)GDC[ M8W<7ZNL3/GW[U=;/]^'$C8Z$X.)R<1B8C-QF+A,/"8^DX!)R"1B$C-)F*1,,B8YDX))R:1B M4C-IF(BH&(KLU2H1BPLV0SWNCQPY*MJ.KC=$1=<`)D>%VH71_C3\-BI>?10: MDS43G8G!Q&1B,;&9.$Q<)AX3OR?GVU7=?'JN_B!9P'.$3"(F,9.$2=G2G-2M15CO00IIF(CTP&(2Z<%FO"BE])B^K1%TR^4K)>=GZM75'NT_,.I2@\F:B<[$ M8&(RL9C83!PF+A./B<\D8!(RB9C$3)(GLOW8LROQJ8[R>:WT";QZK)LQR9D4 M3$HF%9.:2<-$?%X0MWBN#C#:J)'S8E\;*%\GF>ZV@9Z?*1>*5ST:S0WL3%OS M+#H3@XG)Q&)B,W&8N$P\)CZ3@$G()&(2,TF8I#WISIE/=G]D,^,Y&.-#8.4HY(#?:FZGK#;4S8]JAT=Q`LN99 M="8&$Y.)Q<1FXC!QF7A,?"8!DY!)Q"1FDC!)>_(B-Y1K;1E/DC,IF)1,*B8U MDX:)"`ZL(Q$<;+11(P?'OC[0`X)CMPWT_$QMS)AV:#0XD*QY%IV)P<1D8C&Q MF3A,7"8>$Y])P"1D$C&)F21,TI[T78)7XH/>=X(#]ZB<[Z=@4C*IF-1,&B8B M./!1B^!@HXT:.3A$6;]GQ='>3%EQ3)37<#7M4-^*L9A-+Q?*HD3KR=Y6CO73 M-U\]H-69&$Q,)A83FXG#Q&7B,?&9!$Q")A&3F$G").W)R,Z4\2PYDX))R:1B M4C-IF(C,Z*I,_/W4,J6<&1*9P>:Y%/?-(V?&^[I`V]_FL9,9:L-&CT8>C<9D MS41G8C`QF5A,;"8.$Y>)Q\1G$C`)F40]N=K?[QOS#`F3E$G&)&=2,"F95$QJ M)@T3D1K.F.=(F*1,,B8YDX))R:1B M4C-IF(B\P#(2JPPVVJB1\Z)M%GN9%X=]VN^TZS&3WPF3A,7"8>$Y])P"1D$C&)F21,4B89DYQ) MP:1D4C&IF31,1&IPP^?J`#->CG)JM%UC[TB-KME,3@VEQV4UQ8XTC;EAP.(Y;":.=#>SR>)*_3PSER?QF/A,`B8ADXA)S"1ADC+)F.1, M"B8EDXI)S:1A(F(#"TTL-MB,5Z,<&VV[V#MBH^LRDV-#64NLVM]W"#WE3-9, M="8&$Y.)Q<1FXC!QF7A,?"8!DY!)Q"1FDO1DR.W)Y>5".=A)>9:,259,B8YDX))R:1B4C-IF(CD&.OJ[#[3:ZC'D6);CA>DG!RB M^-^3'.W-U"6'<@YQ->M0O^287$[%)Y/+IPNTGHP\F#43G8G!Q&1B,;&9.$Q< M)AX3GTG`)&02,8F9)$Q2)AF3G$G!I&12,:F9-$Q$Q\QX0(Q\9D$3$(F$9.X)_U3=];^JC.E*S#A65(F&9.<2<&D9%(Q MJ9DT3$1R8*V)Y&`S7I!RD]RM#=3UAQ394]8S3HTDG$:DS43G8G!Q&1B M,;%[,E(A#L_B,O&8^$P")B&3B$G,)&&2,LF8Y$P*)B63BDG-I&$BD@-K320' MF_&"E)/C?5VBLSU=HE/E_/>J1UT1+?;\1DVM%R/9LF:B,S&8F$PL)C83AXG+ MQ&/B,PF8A$PB)C&3A$G*)&.2,RF8E$PJ)C63AHD(C@,:10\PXP4I!T?;1O:. M@Y6N^TPZ6)DJ9[-6LPX]]U(I%VNU'HSF!K:YZ3R+P<1D8C&QF3A,7"8>$Y]) MP"1D$C&)>_+JKI#P'"F3C$G.I&!2,JF8U$P:)B(UL$;$#G*J:&VB\)U MV#UMHE.U3736H6Z9<7DAKJ8H"Q&M%Z-Q@3UP.L]B,#&96$QL)@X3EXG'Q&<2 M,`F91$SBGG3[PO1RLE@H)WP2GB1EDC')F11,2B85DYI)PT3D!1:)R`LVX_4H MYT7;/_:.54;7=B:O,I0]837#WC2-R;HGW0](3=0/W-=Y!H.)*=W)[&2A1*#% M4]A,'"8N$X^)SR1@$C*)F,1,$B8IDXQ)SJ1@4C*IF-1,&B8B,K#(1&2P&:]$ M.3+:QK%W1$;7;R9'AG+!J; MB(Q\9D$3$(F$9.82<(D99(QR9D43$HF%9.:2<-$1`<6FX@.-N,5*47' M_&U=HENN7CY1&CQ7/>I7I+.+,_6C`K5>C!V=,-&9&$Q,)A83FXG#Q&7B,?&9 M!$Q")A&3F$G")&62,Q6!B,K&8V$P<)BX3CXG/)&`2,HF8 MQ$P2)BF3C$G.I&!2,JF8U$P:)B(XL$J60SF.5))8:8S-(P='VR^FGM68BZN^ ML.+HVLS$W3SWADZ5]<1JWJ&7P;&3'-BNMNYG&7F\.M^1P;.83"PF-A.'B1H M?U@.DJ.]F;+DF"FQL)IWZ.GJ_(5RPE3KP4@HK)GH3`PF)A.+B(R\9CX M3`(F(9.(26BPZI'3[FA_I88,8+4LZ-MF'L'4D')VM,UC:G8<<*S2]9S)V:&V>\T[ M],HG66O]MT=7'-C:IO,L!A.3B<7$9N(P<9EX3'PF`9.02<0D9I(P29ED3'(F M!9.22<6D9M(P$:F!52)2@\UX0)VY-7.F,]Z=L7:N.LSW<0,`F91$QB)@F3E$G&)&=2,"F95$QJ M)@T3D1A88R(QV(P7HIP8;=O8.Q*CZS:3$V.GX:M#3^SW<^',7D2 MBXG-Q&'B,O&8^$P")B&3B$G,)&&2,LF8Y$P*)B63BDG-I&&R7!Y@#BC'Y7@] MRL&A-HH>&!Q[&D;53[E:+3KT^H*C!R/)LF:B,S&8F$PL)C83AXG+Q&/B,PF8 MA$PB)C&3A$G*)&.2,RF8E$PJ)C63AHG(C0/Z10\PVJB1Q61B,;&9.$Q<)AX3GTG`)&02,8F9)$Q2 M)AF3G$G!I&12,:F9-$Q$7F`)B+Q@HXT:.2]$14IYT1Z8S,^N3K"U?-'>4EEK MS-5&KQZ]+/MS]\K76+K'HP\#3H3@XG)Q&)B,W&8N$P\)CZ3@$G()&(2,TEZ M\MJNDO(4&9.<2<&D9%(QJ9DT3$12=#4V4B(B*=@,M;A_'CDIVD:Q-QR8='UE M\H&)VM*UP.8SCBA+H=4"F]`T)FLF.A.#B<7ORP=\W'DX^9/O&"S&_MN\;J^F'U;X[UJ8?M.WXZ=.6/GS^^/OZ M^\:_OO]^\^OAZ.?FFW@L9R<78L5V?_.]SA_^(1WSZS]W]G]OGZ_/_"0```/__`P!02P,$%``&``@` M```A`"YT4&UL MK%==CZ,V%'VOU/^`>`_?!(*2K$(([4I;J:JZ[3-#G`0-X`C(9.;?]]K&C#_8 M*)5V'F:2,\?']_A>7]OK+^]-;;RAKJ]PNS%=RS$-U);X6+7GC?G][WP1FT8_ M%.VQJ'&+-N8'ZLTOVU]_6=]Q]]I?$!H,4&C[C7D9AFMBVWUY04W16_B*6OC/ M"7=-,<#7[FSWUPX51SJHJ6W/<99V4U2MR122[AD-?#I5)6M0.S"1#M7% M`/'WE^K:<[6F?$:N*;K7VW51XN8*$B]570T?5-0TFC+Y>FYQ5[S4X/O=#8J2 M:],OFGQ3E1WN\6FP0,YF@>J>5_;*!J7M^EB!`[+L1H=.&W/G)KD;F/9V31?H MGPK=>^&ST5_P_;>N.GZK6@2K#7DB&7C!^)50OQX)!(-M;71.,_!G9QS1J;C5 MPU_X_CNJSI\XT'6M.`R#91P!IH^T6?AT-;)B*+;K#M\-*#$(L+\6I&#=9&D: M?!F8PK0P/UH76!`BLB,J&Q/V!ECN(9EOVS`,U_8;)*`<.:G.<67&GC/(:A/9 M3`4.*I`+@`V.)EN0EI]@BZ@06SR@E`.?/CW%`V?P(9D*'%0@%P#)@Z][\*'. MYRN49X(,@EH4,A%$*SG&E'%H4 M9OF,.US*D::>YP?0J8>^-PI0SS:KFC9[S4D M8X@/U3XY#V)E^QPF$I?.12$I9-CI8LALUUND=0R7JGQ-,4P#D\U8\6%WLSU/ M-&0G#!&=:$C&$%],3Q`KF^@PD28GHI#D))*=S$0,_9B'3,ARR`P10]:0;$2\ MJ0T<-"071TGQD?N"T%\?QT?(U'3C2M>S8S2K?%2,&* MV@H\,.7(ZY6+PI(I%]KK\]FB;-G6""GY"N3Y]YPE)(Q#8J)U:R-K3-G""U:. MK[:!G$M1==D>.2V?+D:7G:W0;ODN3$=(2MM*31LG"7GCD)CN&7=LPC%SQ!W< M9Y0FEW,IJBZ[(^?H\^X(6TD>@Y3D*3MB3XY-&.B)R9L9.&./L2+20=^VB\AR MY)_HL%#Z8"[-)9LE1ZU@EG1P;TFNJG--6VB!Y/14?3-(RFH0*^?J?ASHB6F= M!O(*.8RL,8=^%*^BE:-42"Y)R;;((2O8>MPNX7V@>6&04/OL!<#NO`WJSFB/ MZKHW2GPCM_L8DC&A[.61A0D!(Q9<)'$PZ#B^5'3T;%'Y*7C`S_-1+X,JG MZZ1^`AH?7BGX`'>)O3C!=ZB""[=C@4U=,)XX%_(!-/K=OL?````__\#`%!+ M`P04``8`"````"$`]9\#1=`%```'%@``&0```'AL+W=O;H;I+U6%_W+9+KS^\KT^:^]EVU7-9:.;L[FNE9>BV5>7 MXT;__5O\M-2UKL\O^_S<7,J-_J/L]"_;GW]:?S3M:WZO+2TR!M>:5L3(@TG:]KT`! M2;O6EH>-_FSZF;G0C>UZ2-`?5?G1"?_7NE/SD;35_FMU*2';,$]D!EZ:YI68 M9GN"P-E`WO$P`[^VVKX\Y&_G_K?F(RVKXZF'Z79!$1'F[W^$95=`1B',S')) MI*(YPP#@7ZVN2&E`1O+OP_.CVO>GC6Y[,WN;^H_ MJ9')0M$@%@L"3Q;$F,_=(C#M^-O.#)_,S[4?\'.8'3_Z^F;5T3?>S%\)P M!K7P9([+F6.YB^6@]LY(/>8(3S[2^6SINHZW7-S7N&">\.2OO)L36)C#$.') M[+W'7K1BCO!\;(@&+86ALL*\S[?KMOG08+G"9'?7G"Q^TX=HO*1H>L8B^[L: M@^(B09Y)E(T.,J!\.E@8[UO'61OO4,L%,PFPB2E;[+@%*5P2-51!I()8!8D* M4A5D`C`@!V,BH)[_AT20*"017$/`P9092Y'-+;A+J()(!;$*$A6D*L@$(,F& MY:C*MF%CNKVE\.DF3K!Y"--MNTM95D!M3'CO6!.N;+(;34;IB$2(Q(@DB*2( M9"*1$@#[BIH`LJ?^PP5`HL`2@K>,:FUW)>L-F-&]E(PF8TH0B1")$4D021') M1"*E!.2+*;E?"\1X4,Y''#`R'_:!A9R#'?L15N&8*&&KD(8!^^_CPR#&\C`8 M<<:UN$,D1"1")$8D021%)!.)I`K.AL=5$6-9%2,P=V/^;&^N)'DTXG,2(A(A M$B.2()(BDHE$$DJZ3N%DN5]%Q%@6RH@P?8B$B$2(Q(@DB*2(9"*15,$9*:JB MY^6,]`7]J2I>@P:F!8K[AEH;U@,]+4D,62PEUM#^#38[1$)*;''WL!UEYJ/1 MB,]\C`(EH\U40I:Z?:>C$0^4B8&DE)AP7H@YN:$=>D,N?K"6U3,DRLK!5]M.>PI-/!0^T/LYHJ/F2Q M)$=+/58B9N5:PX9KK1QSKIP\,0\TQ4XX$@>%8J?,:B%9>3N7ZT7TD0H"X8A"[9981]46RMN-7R3L9Z2QO(F%#$K;SGD[\DV5YYR:L4X M4,*]ID`I0PMQ<[9PLN@(K,%13A9D64S6)PN)6"N%1A'4"U^U.]*2@)4US7S( MD..-5A%'DY@8.R;<:G),.9H<,\E1UDW#YR#FSX[_3*_OU!, M5[C;OP```/__`P!02P,$%``&``@````A`.%?,Q]W`P``$0L``!D```!X;"]W M;W)K&ULK%9=;]HP%'V?M/\0Y;TD@1!*!%20JENE M39JF?3R;Q!"K21S9IK3_?O9*U;'GR32G)9$C7M,*ONRX*(F"5['W9"THR?2@LO#&OA]Y)6&5VS#$XAH. MOMNQE-[S]%#22C4D@A9$@7Z9LUIV;&5Z#5U)Q-.AODEY60/%EA5,O6I2URG3 M^'%?<4&V!:S[)0A)VG'KEQ/ZDJ6"2[Y3(Z#S&J&G:YY[OE.US!>F>PHIP87'V>D]E"HX"S6@\1::4%R``?IV2 M86F`(^1%/X\L4_G2G8Q'TYD_"0#N;*E4#PPI72<]2,7+OPTH:*D:DG%+`L^6 M)!P%H1\AQ85ADW88/+NYH[>Y3P=ZC79MQ3U19+40_.A`?8$Z61.LUB`&LLZ# MAJ%WY7^F@!M(LD:6I0L;`]8K(9//J_'<7WC/X'[:8C:GF,!$)!T"DP;R>HW@ MS0=H1!;4B(E$T9LN,!!M">H0MB`PZ@,$(0O4S,"T230U%6P:#.R"-Y$6).DA MMLKP0U0B"Q2'*3.R9+:@2S)[B"T3"GUHYOG=UQ4:@K6:/HMMQ-=5=VOJ2MJ/ M4%AG"].HLN@].A!LZF@C85]?R3!BS#0S9])[+M2'3+OEK]YWR&3*:"/@=K_B M232S;.E!=B[P:ANF[T,`&(V3X$."A-[!<%X,/&^F=+F@>2T=SG@:F M#W.K%KJ!6JTI#8^_@;3+U8!GE)6'-C1@;N[BY@(JJ=C3A!:%=%)^P'L6\*M% M'VZ:@$W@0Q>@+_*3+]@?Z-O4^@*-PUKW#59\@P-P?]KQ<9RLP M7H/6TP^;,$[T:NT)HAA.@S/X69S,SL5OXT1?5#;//$[FB/?Z#]"0U&1/OQ.Q M9Y5T"KH#(WV]CT33TC0OBM=@,+0E7$$KHO_FT'I2N`C]$6RZ'>>J>\$)^F9V M]0\``/__`P!02P,$%``&``@````A`,3@8F)T!```6P\``!D```!X;"]W;W)K M&ULK%?;;N)($'U?:?_!\GLPOH,%C`#;NR/M2JO5 MS.RS,0U8L=W(=D+R]UM],WTA$4AYB>-#]7&=NG1U+[Z]-;7UBKJ^PNW2=B=3 MVT)MB?=5>US:/W_D3S/;ZH>BW1]_6WU^V^+"^Z>^Q-"@P4,;;^T M3\-P3ARG+T^H*?H)/J,6?CG@KBD&>.V.3G_N4+&GBYK:\:;3R&F*JK490]+= MPX$/AZI$*2Y?&M0.C*1#=3&`__VI.O>"K2GOH6N*[OGE_%3BY@P4NZJNAG=* M:EM-F7P_MK@K=C7H?G.#HA3<],6@;ZJRPST^#!.@`:;785Z"` MA-WJT&%IK]TD=P/;62UH@'Y5Z-)+_UO]"5_^Z*K]7U6+(-J0)Y*!'<;/Q/3[ MGD"PV#%6YS0#_W36'AV*EWKX%U_^1-7Q-$"Z0U!$A"7[]Q3U)404:"9>2)A* M7(,#\-=J*E(:$)'BC3XOU7XX+6W?G\S",(AF,=#L4#_D%>&TK?*E'W#S'[-R M.1=C\3@+/`5+-`GCJ>_"1^\E\3D)/#F)YSY,$G`2>'(2]W$YX#,-"CPYR=UJ M'!9?FJZT&(K5HL,7"WH``MB?"])1;A+9EL@3"^J8N8\2!QDC)&O"LK2A>2$E M/53;Z\J;>POG%2JDY#8;T\95+;;"@I0#H4UU(-.!7`(<4#3*@HQ_@2S"0F0) MAS8"D'1J&H2%6)+J0*8#N00H&J#@OD`#88'ND5+CQU/5Z0VS<<&1,7^A:K(= M349A!I(92"XCBC;H@R_01EB@<.$KH]]^K%75AAM])FXT&<492&8@N8PHXJ`_ M97&W]SS1.L28:A#?WG!D2OMHKN6!_PAU/TJ66TWQ`_KY?C^(L>H'1^B4H/VX M-9#40#(#R65$\2]^Q#]BK/K'$4C#&`H_UG:=[6@DPIL:2&8@N8PH+I/SB;1= M?IY:8JRZS)"(33RRQ6T-)#60S$!R&5'\FS_B'S%6_6.(IS:4KY4@-[K617IC MF1=JE9LQHUCF]B)MF\EE;D68"T<0.?)D4'D1.3Q\<*80_447JBHYY$%A2I43 M:#*%53QN_ZF`HA'*.!3,:;=&;AB'&E$N5E$B51097U(Y45%0>\.I*I\W&)P# M@QLUYL/'^.!E`Q"V0%'?&Y=!6A*U0&^%E91%#OE7*!-01-4]1;$?:;,C5XA4 M=62P2>IN"('TC4K8&%24,`CR),1MR8R"FO7DI##(OT(9M_*ODSM7%JINDB$E MN@IV2>`9W+*^`24BX]!5`W[(KLBL#-G@[HCVJ*Z[JT2OY#C M/VF;$1VO)FN/9%S#-^3*<@OW$CA"W;#W$SA_F/@Z2-;LZJ-_($A@IIL+-E$" M,^P&'B!QWV' M![C3T!2H`8``&@:```9````>&PO=V]R:W-H965T;#=B6-;]:5J=\WE\&#_\S7]-+>M M?B@ON_+47NH'^T?=VY_7O_^V>FF[I_Y8UX,%"I?^P3X.PW4YG?;5L3Z7_:2] MUA?XS;[MSN4`/W:':7_MZG)'!YU/4\]Q9M-SV5QLIK#L[M%H]_NFJN.V>C[7 MEX&)=/6I'&#^_;&Y]D+M7-TC=RZ[I^?KIZH]7T'BL3DUPP\J:EOG:ED<+FU7 M/IX@[^]N4%9"F_Z`Y,]-U;5]NQ\F(#=E$\4Y+Z:+*2BM5[L&,B"V6UV]?["_ MN,O"\^SI>D4-^K>I7WKEWU9_;%^RKMG]T5QJ!3B+CO%O&Y"'QR$3><>//0#6?OF$K`5>!33.7]^4#FU!3XY"+19!Z&P6P> MW6]*Q$7@4\Q$2><5-V%KTF^'3V&$XB8>.&5+2BLD+H=RO>K:%PNV'2Q:?RW) M)G:7"]L2I<$4QF+Y6:U`D1"1+T3EP8;)0!GT4.#?UGX4K:;?H"@K'K/!,:X> ML141I`*);&R"Q`2I"3(3Y"8H%#`%$T8GH#`_P`FB0IP0.6P$D-9X1MHB0@R) M39"8(#5!9H+])HE8\AH"2()(BDB&2(Y M(H5*-$O@1%,MN?W@$(`ZN@E;_EO8EXI3\O30)C)[ST1( ML#X13H)Q>VX1B1%)$$D1R1#)$2E4HF4%Q__]]I)@/2M.8/6D@7/3Y3%(K$J, M2()(BDB&2(Y(H1(M4=)1*D^;U^N(!.N)P)RC1T)-EQ*.M'8W9(A(SXJOGAQ\8 M*Y^,06+E4R24C3&RA+S0.,#S,4@(%:J09HD+3:KJR8WY870 MHO)Z;9!6Y'[O2+3A'4,>G*>*=V9;11H-&.A%XV$?"S0;4<)1L*!&^;/`7*(7/%8(%]Q MA$7QT@D7\+*.2@<)95@HY^BM.E&U=%=(.W)_G?#F16:R<1DRZB0P7>%1:IV, M`\5)EW`M7B?>PHG,%YQ4?)T4R@22!9?K0C\Z,U0^_.ODJ$R,DB@7B`L%KKM` M.TH5TFN']%J*4V\\?WAGIM8.0U`[H@2V+D=R?6..?(D2@>0K8(H'9B)*#LP% MD@,+;:">'VFQE/Q^K1)XGZ:FS1!4@DR;([DTL[-C4KH4W MA-*KC.$$-M8;6X:U M?G#&BQPV+D?JEAF1],.?&P_86`Y4HW[R!@@=H3;AUZ=)H_5G)4>1W'I;C&*, M$HQ2C#*,LS)OV14D)OK`CKIM3"@;MO\D2B!PQ39E?9[*+R7'>'>EN?3KU5M<_D MFAK&KEMO3$F7BSAI0F/R!9+>`?" M'.[OO]`7"4-G`_?Z]!+&ULK%;;;J,P M$'U?:?\!^;U<0Y*BD"JAZFZE76FUVLNS`R98!8QLIVG_?F?,90-)JU;J"Y?A M^/C,F;'-ZN:I*JU')A47=4P\VR46JU.1\7H?D]^_[JZ6Q%*:UADM148UD-#.# MJM+Q77?N5)37I&6(Y%LX1)[SE-V*]%"Q6K3]Y,UHVG.;ES/ZBJ=2*)%K&^B<5NAY MSM?.M0-,ZU7&(0.TW9(LC\G&BY(E<=8KX\\?SH[JY-E2A3A^D3S[QFL&9D.9 ML``[(1X0>I]A"`8[9Z/O3`%^2"MC.3V4^J&-$TB.P<"!OT`CV?(!&9$&-6$P4O>T#_T7[$T$]8BH(C/H`0<@2 M$[B>F#:Q9-MB/!`R@,*)R`$R53G[$)7(`LTQECDQ:MN!7I,Y0*8RH=%/S;R\ M`OM&0[!1,U2QB[BFZ[R)?TGW%3IK\.^T,T=M-G^/$`2/A721V=!@R6ED---B M/)-9=/["!K'O7'=(-%;11<#MDX2#2KP6"QY.W$>-`FV^[ M_[8;3L7DGB6L+)65B@/NK4NHV1`=MOV-CPY.XELX#LS>.8W[47(1'T1)<(%G M,XLV9@N8\LRBQ.B>QN<1E/&"GD64+##N#`/@>&CHGGVGP%5 ME>T!T[YHT8!K<$8(#>>">2S@/X#!EN1B"^1"Z/X%)QC^+-;_````__\#`%!+ M`P04``8`"````"$``JXS*"T#``#-"0``&0```'AL+W=OL.FSLW[_N M;U:V)16I4E+PBF[L%RKMV^CSI_#$Q:/,*546,%1R8^=*U8'CR"2G)9$37M,* MWF1RM%\2>:SM1J`WZP^A) M#NXMF?/3%\'2;ZRBX#;4"2NPY_P1H0\IAF"Q<[;Z7E?@A[!2FI%CH7[RTU?* M#KF"$%"(!?JV38&N`(>=;7$TM5OK&GBXF_ MFGOS!>"M/97JGB&G;25'J7CYMT%Y+5?#XK1K5VX(XI$H>`G"UH+=,F:8*-Z`9!UVV\8>D/^YP<8@21;9-G8\$W` M3B44\2F:KF>A\P3&)RUF=X[Q3$3<(;!>(*_7"%9\@$9D08U80Q2]ZP*OHOV1 MH`XQ%@1&?8`@9(%V,4R;FPIV#0:;H7=V!(E[R%CE[$-4(@LTARES,9+9@MZ2 MV4/&,J%?AV9>_O"Z1D.P5M-7L8VXNNN\<07;M]!9O7_#SC3:;'&-$`2;0MK( MK&^P>!@Q,BW-3,U'!PY?^=4AC:FAC8#7@^TNS6+%/6A<"9QI@[/@[4H@V$S> M1@8&#".&`6LSDS9@,9\LH5Q7>H!,IHPV8GJP&GG0@\8>P*RYP@2--M.W(>U" ML^=F]C2G;DG%@<:T**25\"/.%&ULK)A;C^(V%,??*_4[1'D?<@\0`:N!7*56 MJJIM^YP)`:(A!"69G=UOW^/83FP?RK"CODR&'\?_^%QL'[SZ\KT^:]_*MJN: MRUJW9J:NE9>BV5>7XUK_ZVO\M-"UKL\O^_S<7,JU_J/L]"^;7W]9O3?M:W0\?VZ/17=LRWP^#ZK-AFZ9O MU'EUT:E"T#ZBT1P.55&&3?%6EY>>BK3E.>]A_MVING9D:OS]O7M^E0T M]14D7JISU?\81'6M+H+L>&G:_.4,?G^WW+S@VL,')%]71=MTS:&?@9Q!)XI] M7AI+`Y0VJWT%'I"P:VUY6.O/5I#9IFYL5D.`_J[*]T[X7^M.S7O25OO?JDL) MT88\D0R\-,TK,TK(ZG'M+M@4?$L6#_ M(RR[`B(*,C/;(TI%*MZYOZ'VID,2DJ8C,1>'(1;V8O/,OSB)[K+SX8"`MK>"$\V4`+PH)# M8-!$#'D-\S[?K-KF78/%`J'NKCE9>E:PU#6>4*HPIOB_,@RI)2+/1&6MPR0@ M>1V4Y;>-O7!6QCE!"1")$8D021%)%,))*CI.L3 MSI;[942,94<9$=*'2(A(A$B,2()(BD@F$LDK."5%K^B).2/G='^JBM=M`VF! MZK[AK0,+@IZ71$-VEA+:NPTV.T1"2AQQ^W!<9=N-1B.>^1@)):/-5$*VMY!+ M*!V-N%`F"DDAL>#`$&-RPW?HS+CS@[7L/4.B^QB%'-GC@HXPBCD:.MDAE`E' MT\`4HXPCV@*+K8%%>H:'*WFP5ORC30/>RXEF_ZKNG*-C%7FL03CNZ*IXJX,W6(*=ESTW:4_2"3YB3'BG110JP^ MJ!;6+1S7H],:04W=CY204M$./^T>;)]C^>#NUM2B:2_V< M-Y?/[=UDQ0>&&$48Q1@E&*4891*27":W98^[/%C+AQ1#0K'0JT9Z)567[;'< ME>=SIQ7-&[E&A'!M5B.F=YS;10#-.01#Y19\`>FZ]^"9FDCT;GC!#?NM#?>QM[@3P(7$#7T7](?^4WV!&\#/=3Q@ZP?P M0_,&GP?PNPRX,0K!/>PU/Y:_Y^VQNG3:N3Q`@,WAATM+;W+IAY[M!"]-#S>P MPZ9P@AOW$B[DS!D<"(>FZ?D'\H+Q#G_S+P```/__`P!02P,$%``&``@````A M`/;:&ULK-U; M?!VR@ MYD[N;K]?C7 ML=/7K[Y]>M?\^OWV[OKGKWK<_]R<7G]R?1__![K_]N73W>W][2\/;]3=V_F. M\C%?OKU\JYX^O/_\18_`Q/[J[N:7'U__M'DW;?:7K]]^>'],Z/]^N?GK/OCO M5_>_W?Y5W7WYW'_Y?J.X-5!F"'Z^O?W=-&T^&]+);W%V>1R"_W7WZO/-+]?_ M^/KPOV__JF^^_/K;@\9[KX=D'MF[S_\ZW-Q_4J3JYLUV;WKZ=/M5=T#__]6W M+V9N*)+K?_[X>JL;_O+YX;J'\S)S[SUG4_CP]!_]I.-I?^(3QRZV?V M1/WK3]Q>[#?[,_/@'SGSW)ZI?]W]?G.QWY^>79P_?J*NN^-]U;_N)B_>G&[W MYQ?'O!^YR4M[IOYU9UZ^>=:=W6A2'6_4_,>ZN[MQT\/\QW+J\VY5,VJ^53^U M-"[/.]=-J$TPHYX7\,9-*?,?+JA@1C^2L+ELYGL;7R[4O[M.=8&:7GXRW?SX6I-%E^"] M5I<_/VS/+MZ__5,+PB?;YB/;;.(65ZZ%N?I-MX<4BA3*%*H4ZA2:%-H4NA3Z M%(84QA2F`-XJZR5P3;+_1."F&Q.XB^JC@V`$DG1="W?*(84BA3*%*H4ZA2:% M-H4NA3Z%(84QA2F`*%U=AO^)=$TW>H*)IO-E'.?'NKI=$R,2$%I(14D!K20%I(!^DA`V2$3*%$J9J:9T6L MQ^9QKHZ"N4DZD`I22:I(-:DAM:2.U),&TDB:(HHC-7OPYU_LIG1,IJJE9!'= M)7/5MUHF*ZD@E:2*5),:4DOJ2#UI((VD*:(X9;,77Y'RO'77YLZ%]='LH4WP MX<0%'=BJ()6DBE23&E)+ZD@]:2"-I"FB.%*SP0XC-57Y[L*\,&9?['E^86[W MZF':9D@4XK%_/"EH9'K?Q6KD3#_Y$1P6I)%6DFM206E)'ZDD#:21-$<4I MFQ)D1$;^4N@`.I()6DBE23&E)+ZD@]:2"- MI"FB..5U-6[8%O6-H[B=3YY:^S*M_)S&A50P58EJ2+5I(;4DCI23QI((VF**!X` M4U<\?S'>VC(D6(P=A7,:Q8MTLC/V]!Q194DBI236I(+:DC]:2!-)*FB.*0S99[1M)`&DE31'&D::WR\K689DO794KQRI&\FNA/]F!Q(!:DD5:2:U)!:4D?J20-I M)$T1Q0.PKD[._%IP13J0"E))JD@UJ2&UI([4DP;22)HBBB--B\%_8P/-0G%G M*5Z@TS=5?"L_J9<3'15L59(J4DUJ2"VI(_6D@322IHCB$3"E6?@,^<3282NY MH%#<+<5=L$#C10_?RD5Z(!6DDE21:E)#:DD=J2<-I)$T112E?)H6BH^G?&P> M;S8L)0MT^J*T;[6D3"I():DBU:2&U)(Z4D\:2"-IBBA.>5TQ>,IBT%&P0),. MI()4DBI236I(+:DC]:2!-)*FB.)(T\KOQ1OH4Q:%CN+U.7U1VK?R<]KVY8>I M8*N25)%J4D-J21VI)PVDD31%%`_`NJ+PE$6AI6-6<=>F?GG^TG]JFB>+DB4_ M#E>NE:<#J2"5I(I4DQI22^I(/6D@C:0IHCC2=>7.*M)`&DE31/$`I)70$SM$5CNG*%JN2`=202I)%:DF-:26U)%ZTD`:25-$ M<:3K2IM3EC:6DL4X?6_`MW*S]$`J2"6I(M6DAM22.E)/&D@C:8HH2GF_KK0Y M-H]W$8Z"Q9AT(!6DDE21:E)#:DD=J2<-I)$T111'FM8Q+UZ,]RQQ',6+I8VC*&6\*.);^919 MVK!52:I(-:DAM:2.U),&TDB:(HI37E?:[%G:6$K6Y_0=&-_*ISSWI1,=%6Q5 MDBI236I(+:DC]:2!-)*FB.*438WV_"IO;YHGZ[,E']:5:^7I0"I():DBU:2& MU)(Z4D\:2"-IBBB.-*WR7OZJ]9X5H*-HZ;A,W_#RK=P,/I`*4DFJ2#6I(;6D MCM23!M)(FB**1V!=!;AG!>C(S^`KTH%4D$I21:I)#:DE=:2>-)!&TA11'&E: M`3[QG,<=/W M"=V)/O@#J2"5I(I4DQI22^I(/6D@C:0IHBCELW5EWK%YO(UP%*6,+;%OY=:" M`ZD@E:2*5),:4DOJ2#UI((VD*:(XY;3R>WP1/F-Y9RE9A-/W"7TKG_+<5[@E M9JN25)%J4D-J21VI)PVDD31%%*>\KKP[8WGGR*\%5Z0#J2"5I(I4DQI22^I( M/6D@C:0IHCC2M)9[\4L69RSS'$4KQV7Z/J%OY>>T[`(6SHLPSZT-2YCGR85V1#J2"5)(J4DUJ2"VI(_6D@322IHCB M2'-EWHO^.-9\>#%-VU(XIW/(#\T5Z4`J2"6I(M6DAM22.E)/&D@C:8HH MCG1=:7/&TL:2N2*7C_KN3M+W"7TKO\[/?>E$1P5;E:2*5),:4DOJ2#UI((VD M*:(XY775SAFK'4<^K"O2@5202E)%JDD-J25UI)XTD$;2%%$4Z7E:VIB]BWES M8.57(!S[B6L>1_&,3M]`]*W<]#V0"E))JD@UJ2&UI([4DP;22)HBBN-?5_.< ML^9Q%*:\167I6_F4;5_^4BC8JB15I)K4D%I21^I)`VDD31'%*:^K>M)`&DE31'&DNJI7%#;GIGFR"%L*EX?=2?HNH3O1 M!W\@%:225)%J4D-J21VI)PVDD31%%*>-)!&TA11'.FZZN6G`5@6I)%6DFM206E)'ZDD#:21- M$<61KBODSEG(.8I7W/2=0-_*3US;EP^^8*N25)%J4D-J21VI)PVDD31%%*>\ MKI`[9R'GR(=U13J0"E))JD@UJ2&UI([4DP;22)HBBB*]2`NYQY_$CLWCK8*E M9,5-WPGTK9:)2RI():DBU:2&U)(Z4D\:2"-IBBA.>5V]=L%ZS5$P<4D'4D$J M216I)C6DEM21>M)`&DE31'&D:7'V\@\47;!PM)` M&DE31'&DINP*/WCX;TQJTU6R4EN*)W7ZGN#%TLI/:E#!5B6I(M6DAM22.E)/ M&D@C:8HH'H%U1=T%BSI'X:1&G7=@JX)4DBI236I(+:DC]:2!-)*FB.)(UQ5U M%RSJ'$43=Y.^\>=;^8EK^_)C4;!52:I(-:DAM:2.U),&TDB:(HI37E?47;"H M<^3#NB(=2`6I)%6DFM206E)'ZDD#:21-$<61KBOJ+EC468KWQIOTW3G?RD_< MN:_PU0BV*DD5J28UI);4D7K20!I)4T1QRNN*N@L6=8["B6M;>3JP54$J216I M)C6DEM21>M)`&DE31%&DEVE1]^)/%AU[BG<1CN+%.'U_SK=:YC2I()6DBE23 M&E)+ZD@]:2"-I"FB>`#6U7N7K/=OW'5:]SQ>L%^RMG'DKXTKTH%4D$I2 M1:I)#:DE=:2>-)!&TA11'&E:R)C+Y6SWQKQ._42ZK&DN+9TOGZNXV*D@EJ2+5I(;4DCI23QI((VF**(XT MW4:;67!^9G[=XXE+C!OJ2TOA)+`43X+DQ=*#/S&FZWBBJ7`-$^> MT6<*1OSJ$G0@%:225)%J4D-J21VI)PVDD31%%$>Z;DMZR2VIHWB3E+[4XENY M-?A`*D@EJ2+5I(;4DCI23QI((VF**$IY=L8?H]6YA^T!:F7[0- M+8DXW8B:Y>R%/PUZPEWJQEDTS[?I*S-!LV6B9TPC8F_"CY)&!*81@6E$8!H1 MF$8$IA&!:41@&A&81@2F$0DM&9%U^_?-"3?PB_F8KC*F26_/]>T4,4P1PQ0Q M3!'#%#%,$<,4,4P1PQ0Q3!'#%'%H2<3I?OZI=86[^,V)M7ABIZ_6I&X*BN?O0S8GIGVZFEOS M$U83&Z:)#5/$,$4,4\0P10Q3Q#!%#%/$,$4,4\0P10Q3Q*$E$9OB((S8K.:; M_;%0??CMRZ??/]X:R&Y5=Z\_O#_^[N1/FQ-;8P3UBC/]DJ";M$I^;A>8DI_- M?"._;NI>G?[Y8;=-7OW18"S-7'<:#'2GP5C:A=TEI;'&9VGFNM/XH#N-S](N M[,[7T,<`-&1+,]>=A@S=:G,R6W(-)NNR!L,VBZ[!V@(7O.+6@4[2UL'KT&T;^&]3G]:Z1M_X\^`@T^;D&#_YQ;T'RPM_#((]`$ M"?N/)\C&E*V/[6;^^_:/O]O-Z$7993MS["?92#J+5B#\>=/&-W.7YB%C1<;* MC%49JS/69*S-6)>Q/F-#QL:,3;$EHV%*UG`TGBB:-K;$#3>1SL(GN-TV>77S M:N.;!:F'%?/Q&4BIPY0Z3*G#E#I,J<.4.DRIPY0Z3*G#E#I,J8>6I&ZJV#6I MVZHW2CVLA(_1*6*8)C9,$<,4,4P1PQ0Q3!'#%#%,$<,4,4P1PQ0Q3!&'ED1L M2M8PXI<]#^EW>%&N6HMVX30E/Y_[5-'DF[GK0H,QGQK=A@S=:<@RW6FO_O[MGQ_>O_UD5VV-XM+,=:=1#+M+1M%4 MQ>$H/K4\V2HZNE!F"[+4A0+3<%D+BR::Q@;G:FQPKBX4F`8"YVH@T$X7"DRI MXURECG:*&*:(PW.3B$W)&D;\P@O%=),^'<^6;-B2DD:#89N%&S9K3Q5-KIEZ M>&S#QEO0D,VW^O@M:!1ML[GDV&PWNWWR.K=&%0]`H_J<[C70@Z1%VGTP/4VZ'T^.I*W`NSW5-NPO\XV9C2_:P9'+F MRR-=@7.[J&1R%I9,/%?#B7,U=M;\N1HK>U_\[6JL<*X&9C;])(A['!H%G*M1 MP+F*W)J_744(!:%2?T[T&VG:O%7*):)O6 M?!I[W(+&_CFWH.E@;^'O'X"F1]A],CU,L?W8]'ANP307[?'\L.:77DT&F"8# M3)M(F)X;81IFF,84IBL3IC&$:FH8`I^M"2Z$T9&T;_U.(WE[UQ MQ+/%'P;>)J^[*?6EF5MOE#I,J<.4.DRIPY0Z3*G#E#I,J<.4.DRIPY0Z3*F' M%J>NG=JJU(_MDZV'LW!BTPX;6I&Q,F-5QNJ,-1EK,]9EK,_8D+$Q8U-L2<2F M-@TGMGG*>=$7MFD]5E=I^DOIZ]?4W39YR?MJ.=4/D@9D.=5=!QH0F`8$I@&! M:4!@&A"8!@2F`8%I0&`:$)@&!*8!"2T9$%/)A@/RQ$JSM96OWYY\W#CS<2KB ML$*VS^PT18QVBABFB&&*&*:(88H8IHAABABFB&&*&*:(0TLB-F7FFHCGLC1: MS$TIH\D>+^:[I"!0ZDLS-XDUL6%*':;484H=IM1A2AVFU&%*':;484H=IM1A M2CVT)'53>:Y)?:Y4X]2M11,;IHAABABFB&&*&*:(88H8IHAABABFB&&*&*:( M88HXM"1B4[VMB7BN]N*(K>E6EEWP;H_6 M_&!I98)I`&$:0)@&$*8!A&D`81I`F`80I@&$:0!A&D"8!A"F`0PMB=CL^\.( M_XT]D"TAHF?CI:P(KZCD(S,:D*59\%0!TX#`-"`P#0A,`P+3@,`T(#`-"$P# M`M.`P#0@,`U(:,F`F)(@')"G]D!S"1'/>6OQ.I:\2*[4EV9!ZC"E#E/J,*4. M4^HPI0Y3ZC"E#E/J,*4.4^HPI1Y:G/IN9;5U;)_L]ZTEVZ+DO82KC6_F4Z<5 MF79EQJJ,U1EK,M9FK,M8G[$A8V/&IMB2U$TIL&*N[VSI$*XPSL+UG7;8T!1Q M6(HVEP=!ZG#E#I,J<.4 M.DRIPY0Z3*G#E#I,J<.4.DRIPY1Z:$GJIG!8,]=MH1&M[V'Q<5PF]!0*T_H. M4\0P10Q3Q#!%#%/$,$4,4\0P10Q3Q#!%#%/$H241IP78O[&^9VJSG36-<5`1 MXU--OEDPYY=3G6E`8!H0F`8$I@&!:4!@&A"8!@2F`8%I0&`:$)@&)+1D0$RM MM6;.V]HLFO-AO>;F/$QS'J:(88H8IHAABABFB&&*&*:(88H8IHAABABFB$-+ M(C;5TYJ(;;4513R;WOEPLU/+"DP1SV9V6,$%D+QQI=279JX[I8[NE/K2+NPN M>4]``[$T<]UI(,+NDD!,81,&8A:!]1_Y-^]RXTEOMC@GF'*:S6Q\?$ZGR6O" MRFEIYAZ8L'3W[+!QI_I/@!2+^4]BE,Z"C%_;N-L/C=Y]*9* M"&?)4X_>5A7A9://'Y@IE)JU<-KC`R**+>PNBF!'$+ M2O`YMZ!0XUOXNZD8WD"2J=E[AYD^=4G/>_6HF#R=+9IVN]/DBM.TFYL%$T73 MSII?(33M;'?;8VIG%_O-Q29Y?E-FZ$R9H3,%%'6VN[C<75ZF?\F@21?VE@1D M=LYK`K([;?^(/F[,4J]KU?QD^C)==J=X-=4VBV?:?.J3BYZ]A=-YIFW?[),= MMA*S/44+WG-Z5XAQ[R=OTO%0@F'O28)FJ[LF0;LUCA(,M\MV/ZMGLN,U[98YA-,8<`T?6!ZY#`]5%B;L2YC?<:&C(T9FV)+(C9;W341VZUQ%+$U70K! M),6+SZ=+,_=$H=1A2AVFU&%*':;484H=IM1A2AVFU&%*':;484H]M"1ULY]> MD_J\_X[73FM^$FNAA"EBF"*&*6*8(H8I8I@BABEBF"*&*6*8(H8I8I@B#BV) MV&S%UT0\;]WCB&?;[Y>MC2(.M_C']401SV9^:ZTT"$W<6!F"?9*)"7%6K';I*ZQ%J4D[6@>#MH`Z.[8+[B M+\R)A9IOYAY8Z4X-NJN<1=UE"C5VU[A3Y^Z2G,SN>\7$,;^^EVZGK>VUWOL) M<8JW)FRS:%_C3O5/ML7&F?\XNP*Q18*__!7(;'M_;KV8/U>//CPW>?1F$[WF MT<^;[NBRV<\6;UJV?/1SLVC3XD[5-%Z"RVR/;3/]./GQ>S!V*M6VR:9(":%_ M)63OVJ/]*[2YF>U_LU?QLDOZ5XIA_TF*9MN\)L5YFQVG.)OY:?`EBMTI7O(W M*6OZQ7-H-KVSZRX@S2';+GKD:>VIT-"=0D-W2LBV,W\/_.>'\SWJ9.43=I7D M8W;-:_*9=]EQ/K.96PGR23:O5YO]W"R>9?;4RS`?VT[/*$MW*#*5#[I3/NA. M^9FBU9JF&80 M3''`%`=,<<#TZ&%MQKJ,]1D;,C9F;(HM2=ULT->D;C?TX6[8+/KF22Y,?7>: M;`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`8K>@ MWN:_CL,1]:;O6?W,F8KD]_):."R8ZVNLE?( M1CWIJ_)RMZX1T->;Y8YH!/YF;Z81F%\?2I(Q+\R_4T&6NR757R?O5'#ECOVT M>?=3]EHT=RYWW\SDR+FY##/^T^F[GS;Y5=]<[)DS/FH@L^.H8,Y\Y,^?E1LU\@,R=G5U;SOH_.RQ\SW/^L\?;DQ M1US??+G7>=EC^M;*_3M])V7N/'W?Y/Z=ODTR=TS??+'3[65GB[[98J?;RQ[3 M-U?L='O98_IFBIUN+WM,WU!DIOK?S?7C9#_.J+?+U+W_\/Z/ZU]OANN[7[]\ MOW_U]>87%;\GQZ_DOOORJWEO:_X?#_;++'^^?7BX_:;Z^/6KWVZN/]_.7V]L']S\4[MN_;N]^/Q;8'_Z_`````/__`P!02P,$%``&``@````A`//Y M%JMX#@``.4H``!D```!X;"]W;W)K&ULK)Q;;]M( M$H7?%]C_8.@]%J^ZP?8@%N_D`HO%7IX568Z%V)8A*9/)O]]JLH^*W45WS,&\ M1/''4T=D]1'535&Z^>V/E^>KWW?'T_[P>COQK[W)U>YU>WC8OWZ]G?SGW]FG MQ>3J=-Z\/FR>#Z^[V\G/W6GRV]W?_W;SXW#\=GK:[WW2MM>3P<7S9G^O/X=7IZ.^XV#VW1R_,T\+S9]&6S?YUT#JOC M1SP.CX_[[2XY;+^_[%[/G'DC MBR_[Y_WY9VLZN7K9KLJOKX?CYLLS'?+XFNVFW MH_*8E]/EE)SN;A[V=`2J[5?'W>/MY+._:N)P,KV[:1OTW_WNQZGW_ZO3T^%' M?MP_-/O7'76;QDF-P)?#X9N2E@\*4?%45&?M"/SS>/6P>]Q\?S[_Z_"CV.V_ M/IUIN&,Z(G5@JX>?R>ZTI8Z2S740*Z?MX9EV@/Z]>MFK:%!'-G^TCS_V#^>G MVTD07L]];QG.R>7+[G3.]LIRM4DXNX[G7NC3 M<[H*0UU(CRCTKA=Q',T6ZND=3QGI2GK4E?%UL(C]>/:+IR3;]H#I41<&,SY@ MQS/.="$]H8E[J.'E$WN_[0 MKOH4P"X/*HG=6'^PL?XE2O0?/.V'=M='?M1_4.G>X6D7X_95D6S.F[N;X^'' M%9UJZ+E/;QMUXO)7R@ZOAVY@+Z^0]UX@],I0+I^5S>V$^D[9/]&K^O>[()K= M3'^G5^)6:^ZEQC<5:RC4RT[9)C9(;9#9(+=!88/2!I4-:ALT/3"EQEVZ1PW[ M*[JG;%3W<-SW`+UV6JV"`B6)#5(;9#;(;5#8H+1!98/:!DT/&*VB4]9?T2IE M\T*LT746Q*UA?)I7^"I()D@N2"%(*4@E2"U((T?6(TDL[@ M?T4CE0V]Z.EI+DT*HH79IGLM$Y`$YQ2MTV#`=ZKXG7GN\BLW5KO9'.'+W^\BG1V!%ZBQRQ(TIM[H@F MT>4$LA8D$205)!,D%Z00I!2D$J06I.D3HQGTKF\T0[TC!?$U]7/D>Y(R,OND M"06B-R9+:^`N(HQS(D@J2"9(+D@A2"E()4@M2-,G1NO4(J7_9NX.M%*;_=&D MER-!$D%203)!PW32,S88%UYE*30K.UB42I1)E$N42%1*5$ ME42U1(V!S#[2,1I]_$7"E-PZAW6H#9AIK>9V_2'ZA;6>"O;'0:-^>`5*U'4I MB,G@/V.].AH+T8K#LC4.)W*#06:;&UDDM9A;!E M&O7LE5254O4&(5F_]3,;D3_]$2PW[\.]0YP[0N4:&3V MS[[NE[(*QYQ)KYQ5_?[Q@KD=Q()5\"JE5\6JOI=UF:AF%;P:P\MH*77";*EZ M6_;C:W79_?RTWWZ[/R@P>)TTI`L$[>Y_;EW,=QF-^IV6*-$H[%^)"6+KW'PQOHZ7`OO!K14^#I MUA(E0,%%E4J4`;%7#L2%A40E$!=6&H6\J[5$C5%H=F;N"V"I,H8K;"V*^'\P6]LD@@X;-0%59Q[/@UEHO:!+ M2-B[`G)ZUU#I'0_49[+6F;N!IC4WAX7,QP16R:US0(>"V26*:S5$I`KF%Y0` ML2H%XH\.,B`NS(&XL`#BPA*("RL@+JR!N+`!:@O-SHR;@P=R#JZ1>HI+8"/[ M2@M$/.X)4+]N(+#=$](GH.H3*S\,PFANO?MG<&+S',AI7D#E,"^A8?,*R&E> M0Z7-9^'"\ZRV--`,)%8M+$:<8O4ZA,];]^I#8Q5/3L8:B/.3`+$J!>+\9$!< MF`-Q80'$A240%U9`7%@#<6$#-)!8M8H8T1F]Z.AWID-&8H.9-39K:ES;/Q[X M!,@Y\"E4WU6.W3)!&VX#_2:J#]ZL16H-40\Z@E0OV[@]*K=]:A'H1_.K`E]!B0TKZ'JS/W8CQ9V6QIH!A([;OD5R.671KTL MKH$X/PD0YR<%XOQD0%R8`W%A`<2%)1`75D!<6`-Q80,D$QO:JRCWE;-6;DZ5 M-#).K_9$=`T1CWL"Y!SW%*INW./9(@ZL=5$&"7OG0$[O`BH$-O3L2)60L'<% MY/2NH7K?NX%$QE4MWT><1EJY-2C=&JP?5ZVBDQ=.-@D0AR<%XO!D0%R8`W%A M`<2%)1`75D!<6`-Q80,T$-=Q"RZU.K=F]AH9<0UF]D0&5-E]&\YEOGV&A8?,*R&E>0^4P;Z`9B"R9CXFLDEN1 M[9`168TX0`DMU=MI&@(`94!:4/&X)T#.<4^A MZL;=#_S0OM4C@X2]K7?6-50\[@F0<]Q3J/1YRI_'B]A>=4'#YCF0T[R`JC,/XWCFV>8E-&Q> M`3G-:Z@UKJ)SV#50RM=&XQ5DS)ER`]%`:,E]Q/(K4G(KM!WJGVJUR@BM4*50<80R(,Y>#L39 M*X"XL`3BP@J("VL@+FR`!D([;OD5R>671F9HK8M0:XAXX!,@:AF?Y^PK8RE4 M.E8SNK#I^Y9[!A&[YT!.]P(J[4Y?O%LL/6ON44+$[A60T[V&2H?6G\5>$%K3 M_`:B@=".6X)%<@FFD1%:N023JA2((Y0!`<2%)1`75D!<6`-Q80,T M$-IQ2[!(+L$T,D(;V-?ZUU#QR"=`SI%/H>I&?C[SPLB^]R6#ALUS(*=Y`94V M#Y9+\C=/A24T;%X!.?;;]\91.R>`SG="Z@Z]UGD!0MQENV.N+?G%:JGT]7V\-W M]4LH%.&[FPON?J:%OGZU4E]BHK=%L26D+>T])F)+3%O:'U416V:TI0VIV#*G M+6TP[2U4,EA!!8/ZQ8J^*SJPO\L5?1%R@/L>/7-[]Z[]S#[]1@U]M4W6T&W: M*W43MMQ"-UVOU"W5<@O=0KU2-T@/;?%IR]#ST(_D?![N/>W8@-,]#=:@GH9J M:*0^1ZO/W8_PV(<>K>CK]')7Z9L4*_4]";F%OA>Q4M]ZD%OH6PXK];4&N86^ M5T!N0X-"WQ(@MZ$M=,\_N;5;II>=IA_N>=M\W?UC<_RZ?SU=/>\>*>\_^ ML?OIG^Z/\^&-SN?T\SV',_UD3_O?)_J)IAW]!(FGOGC^>#B<\0?M[O3RHT]W M_P<``/__`P!02P,$%``&``@````A``1O+(V-"@``BS@``!@```!X;"]W;W)K MFFG.(44=41*9Q@]__-I_3'[6Q].N M.3Q.Q=UB.JD/V^9E=WA[G/[[7\4LGDY.Y\WA9?/1'.K'Z>_Z-/WCZ:]_>?AJ MCM]/[W5]GH"'P^EQ^GX^?][/YZ?M>[W?G.Z:S_H`R&MSW&_.\.OQ;7[Z/-:; ME]9H_S$/%HOE?+_9':;HX?XXQD?S^KK;UEFS_;&O#V=T(__2^^SQU MWO;;,>[VF^/W'Y^S;;/_!!?/NX_=^7?K=#K9;^__?#LTQ\WS!\S[EP@WV\YW M^\N5^_UN>VQ.S>OY#MS-,=#K.:_GZSEX>GIXV<$,E.R38_WZ./TF[JLPF,Z? M'EJ!_K.KOTZ]_T].[\U7>=R]_&UWJ$%M6">U`L]-\UU1_WQ1;X'Q_,JZ:%?@ M'\?)2_VZ^?%Q_F?S5=6[M_X'@M9=@?1<&T2J^94)+[05>NUC` M\4@U5MH87O^/$&"#M@L#KYT7>;<2B[5<#2[,'!>YS9EL<]X\/1R;KPEL1%C& MT^=&;6MQ#XY5LDA(.5Q:DSZN[(&T44Z^*2^/4[`'\Q.D_,\GL8@>YC\A3;>: MD]@X2\I)KSEQ2"D94N!G;Z@5Y>0VSIIR"@M'+"BGM'$$Y53((5,7@>',06:C M-6R&OM;V#=E)JLA*4K5!E<8)?R/E;V3X!@34DR8VH;1>\A&<8@2G',&ID--. M@>@`^WF\#HK\.`57ETD)22>5(&?5)EX0!V$@6=:D?09;Y:R/!1*.%L'SJ<^0 M41`%:^:_Z#.8_[*/S>1B*:,5&Z#J4R[F1#0X;?JB=1O5GT3*B(O'0D^0`S^- MP&SGIAU#[>M+=&T^91XL1RQJET6NXM4Z7O!=V)D[!R\'&57'H.$1\>!\[(OG M%TV1N6A,D@0Y.+5EM(`+B:9DBH2PG3O7S(/E0XX+CW'IP2H[1E2"NVV\2HK, M56+'>8(<6!]G:G4,NG:86AXL1PSU#T2P@!J3+D#163O'+@<95<>@T1'-X$H? MKYDB<\W849`@1\\L6L`_.K$4"?;,\F!YASD%*8:&+CL75(]VM2H[1K2"2W*\ M5HK,M6*768(4R4PY3*4&B,5$55 M"_=4'$A%K)RI>FSQ$H$D:YJE/C#S@;D/+#2(HMJNIM)G7A%S?K51O53YV]-K M9-9AT4QUXVV50)(WZSH*75$LX(R]!5JF/W.!BUKLJMM0FFF%-R\P'YCZP(`-+R\"ES[PBYBQQ MJ6:J.AZO&=;25#-VA2:B*[B=:YH:BB6G,A^8^\#"@,Z1RV%*I2FXYMY\4]5R M3SNU:4-(F(&\PQJ;:L@NO$0@22>]]=Y,-<>1><,.)->=VWEP1E":")R4RE!H M'%1&55KW9!Q(0RS$B7SB:BMWU3H=MKT84N$!,Q^8$S#B16=!X-D57A+\S-0;)9Q`6N[$DWR9ASZ<6CF`7/M7*\(NP3;C58,CU\. M4RI#\64<:R;&%<>!I:F0;.T23<)Y2@$?"`2L!$PUQ2&BIRG)B:5D_4QQ-72T M9I22.&"A5PZ0IITJKWM7PDCEL"B'_#"?^`K)F]D`2=[TZRAT;;&M,/86,-?@ M95DBEOV%,;_$R"ZOAPXB=RB5Q<)5]]J&I0O*D-AGL,0Z%KJ[.O ML[>`N;9$;6!7PO'';]O.W)-]@Y3*$2'54-7?M^]@K-KI#F8'6Q+T2_M@W985 M=)ZIIE@3+/.!.0%7;&L6;&BQ!I'IT"5QP/2O'"!53A7>MRN'Y3I5CL66!(,U M?6HHE@3+?&"N07]86@MY53![NH<9MB*V%TNBE_K2S>TYUUJQMH=`5 MQ1//!^8:Q)QC'Q=AM6?,G0E5#E,J0Z$14@UOZB^DI;^0["9+-,EZC*4^,/.! M.0'Y%540=,;ADL"7=&K5KAP@U4G5[S>?;U)9\5QCQ56B2=Y<0S]623-C3Y>Y MG5NN0:3<89V6\ MT"BH@JJ$'J\@%MQ40=8P)K)?U<]B$2Y6[-Y--<6:6)D/S'U@,3QRZ;.O'"`5 M3)74XP7#`IP()MA.3"22]&$D%F+!+X]44QR"=54^76>=;1ZP("//I&WHTC=T MY0"I8JQ[&-BDEJXAY)V7['<-LZ4,I`C9?9MJCD,R=&`%,C_W61:#`Y<^\\H!$KE" MUD+XMVS+IN7>-`?5FL&=L%Q"M\]*$DVR"^8#QE'W+`R*R=@O&8A%`062_5]>/Z= M]I)P9D&X6D0Q_]I\14B7(*B$L./ZNW1?F#`^!M?]]AX?^:GA497$'Y->F M.7>_J,?5S&.$3_\#``#__P,`4$L#!!0`!@`(````(0""VL1P30(``-X$```8 M````>&PO=V]R:W-H965T&ULC)1O;YLP$,;?3]IWL/R^&$AH M$A12M:NZ55JE:=J?UXXYP"K&R'9*\NUWQ@G-E&[J&XCA[G?/<56S$D;=:E1`>^[<1`5=#;)+^; M4;99C_WY)6&P9[^);?3PV5]Y>;@'*["AB(G2S).$;E$`7HF2?C.P(7P_W@=9 MNJ:@L^LH6\2S!,/)%JQ[D!Y)B=A9I]7O$)0<40&2'B%X/T*2+)JGV6+Y#@H+ MBD:#]]SQS=KH@>#28$W;<[^"28YD[VR.FH*.R>N_K*)'#[GUE(+BMF.ZQ?&\ M;)+Y8LU>L*?B&',78O#Z&C-%,%0S24(9YY+>;O*IL@_VE7W3O92[\."\3/IV MF=G?94[._U_.)Q44:[R:F"\G?E`08A9C&]+5=9K%4T#P&?8LC$&!J>$3M*TE M0N_\#B68.#V=UOLV'3=T>H'KU?,:GKBI96=)"Q6FQM$"9V?"@H:#T_TXY*UV MN%CCSP:_(X"MBB,,KK1VIX/_"TQ?ILT?````__\#`%!+`P04``8`"````"$` MM:@M&[<)```_,P``&````'AL+W=OEN(V62[JPZ9YWAY>'Y9__.?; M3;Y_SK7^X_F^/W]JVN3PL;X=`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`I/T<4$<,'K$&$I4 M>%^>@E<0D*RK[XW029K*@F>.,)G)3)$.^HDZVS]C=6[E M*=O?\[5T+^(9%#0_)3!62'\E@P(H[QQ!-*94X[PV!],,"L/24P)CH$5,FJ:: MBJ_&@$Q,460]0)1E,5LGBN.IK+8@4J$>*GA>KA01"=:B'TL#9)#84;PZ,BAC5F]RHN<%B[L,80`@TW MJ10I6X45$OP2J$`WG4<"YU>9@%E.AV[>-Q4*`VAN9F`X0F#R?3;`*EF+L$]+D16'8[*DH4AB37)I_478A/'Z13EID;!AVYR0+ M-9$W1E*52SF,1E)<&>4;'4T;.!U6#2P]9+!!C$HRIK]"8K:ZDMG&?.-V--4E M4K;B2X3X:6'@X4%4G>J+MPINM`XAW["Q"];GI'9Y!F/4T@\.PQPQ2 M0TATD;/B5Y(@VC;T:.%2?5&6X>[;F:6)T2T*ZB..(+SZ"#*KCYG&EQ MBM&B06ECJ[A1;D,P\M&.J20P\]*B;$+Z;(*[&$(X,W(W,5CA*T1FE;F[Z/!^ M[6@VB;D!E`CQTT*V\"#(+K0Y&E1R,(,4XD*=>,]>-XI,`,R[S+N&`B!0*.T_F1O6X2F#T4Z5#<6`/E4`\=-B,>$@R)8JM7<=PPBB M.8LR!^4QAXPY9XG0!65C6U"94*,_\%%A4:Z@8)J3E`F^D4/H@C"(@)46MD%& M+4*51?F!\O@!'ULE0N>32[O[9N(K1+AXJBS*#I3'#K)AF>`R\X]Z7&9P$&0+ MNP$9VH?J8EX0.-H\GI"QM)0*()"@\R))#$,J@J2Y4<6HAXE.'>4,'Z,YZE[(TRJ;*OVHX^*8_XP[_4:QCEIB)S-_!*A<_T*(10;,Q5! ME#):C?YZ0?79I\C9XBH1XC,-ALN%@U03,XFPP:(]9C%:U9B[L1](E:0F&1H3%0+"Y5.% MS"P"%7I,8W0#CPH!PM&GK$"6WTH#X5^?5"9SCD"9'@?)N8/HL4GD>:;8%*H0 M"%'Y?_F(]OA(SDRB1`B2J81]6VYD$EANB!.@TT3Y2$>S-^WXVS@E0OZ3@[Y9 MA%3;1%E)1[-17;`BE@BASTW^NHB'<:TF^>B.F"J+,A'C,9&"=6F)$%;6C.YJ M,&T0Q)]9*B[*00PX")G0W/]+A#`O]EVGWOM1'`0)$6>9^RC8>"L1@N39G5-F)F]=(!*BCUG)_/;*>"RD8-Y?(M3K M4T*SL5,A$J*/&,5U_`&'S)B(?WS*BOF#/2*,\HZ/93$[XO0="<_F;14C^TBC/ MZ.AK\P6A67UP&^-'J+XHYTA]SL'G"T)\?P>5[0_Z]OY4691MI![;$-QM$?*G M!?4%.T=JPX0[1T=?K:P+^;"'T/Q%.4<:XAP(7:@L1/"+I\JB/"/U>0;? M+2/D/SE6%N+X$:HORC-2F/7S,QDA_\E17[!GI%&>T=%LYDUF,D(7*AOL%FF4 M6W0T5\:LOD1H-G/!;I%%N45'7^M9A.;TS2)DY651;M'1/']\&B,$;BN*S'YX MDHW%"A'_)5!]46Z1^=R"NRU"_I-#9\PB5%^49V0PZ^<[%Z%9?1#'CU!]E@GW MC,S15^L+$-8W5].WO#%,B+PHR\BFEF$?0Z!W8B5"_I-C>8.-(XLRCHZ^VKYS MKH#ZYA!:WBCCL`\H!)07(/ATM+T1LA_AHAEVSSE%^_UO]<'U^WAW:QJU_L2Y-; M5]\C/``!/YR:]^[C_T_-R3ZXT/WWS3ZH4MM/R">W%GYIFM/Y!_>(1?_HR^/_ M````__\#`%!+`P04``8`"````"$`UIR'/1($``#/#@``&````'AL+W=O:DP>67RI2BPZD)64F@#\_TX;W:%7^'K@J:Y\OS<><50U`/-&2BC<)ZGM5 MGGP^U:S-GDK8]VLTR_(>6[X,X"N:MXRSHY@`7-`1'>YY':P#0-IM"@H[0-F] MEARW_CY*TFCE![N-%.@G)5=N_._Q,[O^WM+B"ZT)J`UUP@H\,?:,H9\+-,'B M8+#Z45;@6^L5Y)A=2O&=7?\@]'064.XY[`@WEA1O#X3GH"C`3*9S1,I9"03@ MKU=1;`U0)'N5SRLMQ'GKQXO)?!G&$81[3X2+1XJ0OI=?N9UU0I*`ZD*D" M@:<"F?V#<6-=K-;!;S)LUR@!L%Z$#D'+ M\F^J@!P(LD>4K0\G`S;,H90ONVD8;8(7D#]7,8=AC!.1]A%8-:"G.8(XOX`C MHB!'K"22/O0&@[1-.>TC7$(@E$LHAOX;[YQ>(UP$/6)I-+43'KJ8"/)J(>=V M2*I#7%*S(2ELYSLKB2C0"S;-V.9P4$&W:.H0ER90,K6[K1D&2S:Z:,H2RB9S M&T@YH8^T?&8?6DVUN(<'!ML\E&6FVRDU+5:FI9U)'K&9'"KW%@>1;!K*`FH; M.Y[9Y4IUD%L+_"DS#O_M6F"PG5Q9#`U,BZ7!VLZ$&JS6.%?OE0"!;!;*8DO@ MGAH=Y$H0P;E]OP8RVD[?FPP5+),E0X0CSE`<=9B#[U>P`GEE*$WF3JHJ)%L.,6,;*A#O/H__8"3RF6B3+842U<* M'35H"5AHDOL/*3#:J84RF5*8)EMX'%J_1@HU_F(]DP[X`X#DX&',AY4KA8X: M2''7E(R&8[(WV036+@&U4%ZS;'5&AND1Z,ACI1Z)+340-U M[IJ?<)<=-$IG,LY'=UOM;F@5:4\D)67)O9Q=\"8*$+N--G?7Y$.T@'OR`FL^ M\"S!LQSUA."1U^/!&KQURSOJP#,%SW04+0:/[+K!FAEXY/8&GCEX9+T=#US[ M]^-98,%8=J`U&@^DQCCM9\F^^ZQP$A^`ZRA5T'=47E!W5-Q5DLI;IHN_3M(U M;B#0#OB<:+(3^9JU)UISKR1'*'(HN[OM/DBZ%\$:*#Y\5#`!'Q+RWS-\.!*X MQ883.`I'QD3_@@GTI^CN;P```/__`P!02P,$%``&``@````A`.;+=T':E(F9"4BX(H>!4'3U:"DD0/*G)O[/MS MKR"L=&N&4%S#P=.4Q?2!Q\>"EJHF$30G"O3+C%6R92OB:^@*(IZ/U5W,BPHH MGEC.U)LF=9TB#K\<2B[(4P[K?@VF)&ZY]C)]G[[\B,GSX)EGQE)06W(4^8@2?. MGQ'Z)<$0#/8&HQ]U!KX+)Z$I.>;J!S]]INR0*4CW#%:$"PN3MPK5Z;<8#462[%OSD0(6! M/ED1K-<@!++6A9JA\^5?MH`?2+)#EHT+6P-6+"&7+]MQ$*R]%_`_;C#[(<9" M1"T"TP;R.HW@SG_0B"RH$5.)HO=MH"?:E!RU"%L0&&4+FD`!GB^=UB,#0V)]S7&"C[=TTS$Q)U$%O4="@*Z_G&3"(+U((I@2S([B"T3)/6] MN^P9@K6:+FE-Q*^+S-05-1^ACL[6H5%4\UMT(-C4T42F73E%_8@QT\*<26^Q M58!=Y=;D(),IHXF`V[T53RU;.I"="SS+>IO_1'H>]".&!RMS)O1@ M/AF]-[FK.PT2F2J:B&F!O6LZD&U!`/OV>@\TVIR^#?5<,$*�&VN)[C=;N% MS7;C+M4\EHZZ>P:F#W.K%-J!6JTI#9M=3]KE8L`69>6A"?68Z[.W/FX**@XT MHGDNG9@?\5P%_';=A>M#?Q_X<.KK@WOP!>\#^O2TOL!%8:?O"59\CP-P>]KQ M<0B-_4Q\$D)S'<9WTW`'6HA^)^@I3ORA>@<%P#>$*KA[Z;P9730K' MGC^"OI-RKMH7G*"[O&[_`@``__\#`%!+`P04``8`"````"$`!!=!/OQVW8S^EJU7=WL[L;)Q70\JG:K9EWOGN[&__S]Z-3UY6Y=;II= M=3?^7G7CC_<__W3[VK1?NN>JZD?(L.ONQL]]O[^93+K5<[4MNXMF7^TP\MBT MV[+'Q_9ITNW;JERK2=O-))U.YY-M6>_&0X:;]I0-CO:J*9O6RK7;]D*2M M-F4/_MUSO>],MNWJE'3;LOWRLO^P:K9[I/A<;^K^NTHZ'FU7-[\][9JV_+S! MNK\E>;DRN=6'(/VV7K5-USSV%T@W&8B&:[Z>7$^0Z?YV76,%)/NHK1[OQ@_) M33'+QI/[6R70OW7UVK'_C[KGYO67ME[_7N\JJ(TZ404^-\T7"OUM31`F3X+9 MGU0%_FQ'Z^JQ?-GT?S6OOU;UTW./U7O?/=^,LN4BO9LELCOC1YZKK/]64)CU9)!`*5J4 M?7E_VS:O([0IUMCM2VKZY`:)C90#?RON6]I"5$KR0%GNQKB^H%J'AOAZGR:7 MMY.O*.)*QRS"F$1&+$T$58S2%@R8@*\E#B4I+8:8!$2L]C,9LK0AEC9'!&^TP`_@35G04)+XM62U MT$&'B-L02YPC@CBN.4X\;@6F72E8\3-Y%QJ9JM[-)-.E'D0W6HEY>PL>\W-X M4+#DH9'<-N4R0`J.B.^^E-]-U_+5-5F@MJ.3+V=*)'EI!/(["=*IIY,-,K(6 M'!%4:2MFMG.X7!0LZ6B$R10@!4?$=U_+[R:99JCMF99'620IC4B-?(^S058C MC@B>"3;&TT52T9*0AI1*,C,9Z\GR)X,-XW(VG!<&8@4(H4)`D@#Y)B-`-4CG MEQ>7Y_M[HHLZQ"0)(P.28C?+AAR?E\3AKBB@50829&2D;. MQPBHC3I7!YQS.S>A5%ZG:$@JYON@F>C64`A(*D:NR0@?44Q[+.\Q#0E.4V\7 M6=*YCQ;#.7%(?4GVH0Y7^O+W"-SO^MLE.LZ#DF^Y)^, M[Q$-M=MR3M:`&:=00QOE.'%((AMJ-.2=KT(Q3J*&-G[]FJ52IY,1M(7#CI MW&M$%V4)"T@2/FO#2,,-PT""4R"BBW*<=*[0$=/('I),`9YY*:L\GH)Z3Q%L M4^^&9FDFLC84D%3PK`TD#3<0#45T`,O3&SRE:&^U&G+K6)HH!Q4"DDLCOV57 MF.KFJ^D[7)6.JCXY:^;LZDN]FZ"EFCT*@%D%9Q" M#;FM#\\$W,2@KN2WGH;Y%!G.-03MVUQ!:^6LXIE__Y/:**<@AT3%,V\/.*R@ MBI9=:*##"KHHRTE`DI-G\]2%R7SVGF-Y%NX!!A*$,_\&R44YPF_N`9FW!QP1 M4=LZ*ZQ*H-K0?-LRA`H!2<7.LO4LM'4#25'\>Q4796@6`I*"#\Q@-:\U0F"]W?0'-[Z[ET$+\4O5N5PD3!P-## M^I%DY@[CDN]9&T*F39QWT0`IO61FS]:/E"*T[HP[L#+`90@5`I($/)]65[2^ M;3Q")O3L3$.\&A;B.@?5T%&R&NY8+RF393(;/T)3&RRO!O=^!H(BK#%]P4R4%,P=X25?S[4/"Y:'QFP@*.(X!7NQ MB[(>)"#)R3-FTC"?7M.9\`B]T*-S#7$5-71$13N1K2MSQWC)^"PGST,G-]`U M*[:.?R1JH;6GFM( M<`J;SD8Y3AR2G#P?)P7GV7M.+WGH\082?#/_$.VB'%^=*Z(AF?O)3I?KK8`Y MG8$$IU!#/9%W(8>DAF35C!-IF%VI)Q-'2JP]GM/3$-LO<@NQ2S+W#M*%B0)+ M9TBY.RE*QE@]9WR$)D5[+JTA]+K[ME!%&^4JRR'!:1;90DY244V4]`S$5'00 M8YQ[A\;"1$D5W58C&9^UB=#O)9Z*!CJLHHNR*@I(<)DK*^,;AA8X)G/+A9E317K6'+8,=)8?7((8?[;=5 M^U0MJ\VF&ZV:%WK%`?O)_:V%A_"/ M9)B#TU(L&^;@#!`;R3"BU/>SY3E&U/*"D1E&U/L:P<@<(ZK__9%L"F[J;9%@ M!-QP+QGAEJ482:,C8(W[JM@6<5&L%(\ M<8J-X'OPB"8V+/I(?[]F!")7]`B8S@U6@1_R&\>8`KA%R_HJHGA8!HCND!] MH^5%=:/%16U5:2=6);PQM2^?JC_*]JG>=:--]0B[F:K35#N\#@41)5IO+MBNU4E7U\NR`DU@+&-G.9O?O.\:! M`$FS:5\`FS.'.6?&-I/[UR*W7JB0C)=3VW<\VZ)ERC-6;J?VSQ^/=XEM247* MC.2\I%/[C4K[?O;QP^3`Q;/<4:HL8"CEU-XI58U=5Z8[6A#I\(J6\&;#14$4 M#,76E96@)*N#BMQ%GA>Y!6&E;1C&XA8.OMFPE"YYNB]HJ0R)H#E1D+_A!=IXMN>.' M3X)E7UA)P6PHDR[`FO-G#7W*]!0$NV?1CW4!O@DKHQNRS]5W?OA,V7:GH-H8 M!&E=X^QM264*A@*-@[!F2GD."<#5*ICN##"$O-;W`\O4;FH'D8-C+_`!;JVI M5(],4]I6NI>*%[\-R#]2&1)T)`D@^^-[F+HQ.#P&P[T)CIP0X3CYEQ0@V5H' MW!L6Y*`$^SAZ7XAK3*D]7A)%9A/!#Q;T+!I%875*>KZW*S-.EKL$Z_^?#<3'0_C/K?79PC,$[ZF.4Y)@CZD-4Y!.-1 MB^DI@M;K*M*5"F`Q75>F@P#7<1!'7LM?NSPW&&C.UF7<1RS>12S?1:RN(7HZ M(9&NSNOZ-'AJ@XNGW*-!6\T-)J[;,HA"#X>#)EH8!%Q/+'T'EEV.$`-)./!H M=8VCIP]665??;77404.=@Y:<&PRN==XE*/$Q&D`6!G)-:(\D&&'?CT[]6/?+ MJ@M!"0I1$+9N]91&_Z-4!PV5#E;-W&".2OW0BR(T&DKM85`X@JH/&F/9@\0X MQJ-H6%4#N6Q83VM\KC4$HZYWKPX::CUY:5:GP9CN#>,D])-!C@N#N)RCV4>[ M'/$(@6.#S1G.;YW)90ZCTYS/YNPHJ-C2!!%W7SK:_!0](;ZF# M^;D_AIU>[]?M"SBN*[*E7XG8LE):.=T`I>?$8*`P![X9*%[5)]::*SBHZ\<= M_)=1."L\!\`;SE4ST!]H__1F?P```/__`P!02P,$%``&``@````A`,D3<&L$ M#@``C44``!D```!X;"]W;W)K&ULK)Q?;^,X#L#? M#[CO$.1]&MNQG:1HNYC:EFW@#C@<]NZ>,VDZ#:9IBB0SL_OMC[)(BQ0]^5/L M/FRF/Y&,*$HB)2>Y^^V/[>OHQWI_V.S>[L?Q330>K=]6NZ?-V]?[\7]^-Y_F MX]'AN'Q[6K[NWM;WXS_7A_%O#W__V]W/W?[;X66]/H[`PMOA?OQR/+[?3B:' MUK[]OUV]$9V:]?ET?H_^%E\WX@:]O5)>:VR_VW[^^?5KOM.YCX MLGG='/_LC(Y'V]5M^_5MMU]^>06__XC3Y8IL=W\H\]O-:K\[[)Z/-V!NXCJJ M?5Y,%A.P]'#WM`$/[+"/]NOG^_'G^+:=Q>/)PUTW0/_=K'\>V+]'AY?=SWJ_ M>?K'YFT-HPUQLA'XLMM]LZ+MDT6@/%':IHO`O_:CI_7S\OOK\=^[G\UZ\_7E M".'.P"/KV.W3G^7ZL((1!3,W268MK7:OT`'X_VB[L5,#1F3Y1_?Z<_-T?+D? M3_.;;!9-8Q`??5D?CF9C38Y'J^^'XV[[/R?4>=0;2=`(O`X8.:$X145X)<7D M)DVRV;Q[^Q.:*6K"*VJF-\D\B[/<]ON$(K1V#L,K*B;139Q&Y_1RU(-7THLO MT9NA'KQ>UU%8H5U'X145X_RRL5F@)KQ>TM6)FQ+=#"N7Q^7#W7[W%_:32"^!5LTM=S@]I/M5W,-)IDU\ME:N1^#%S"-#K!`?CQ,%XN[R0^8U"N4 M>=0RL90H2,+.8&NV#$$5`A.".@1-"%H&)C`(_4C`Q/X+1L):L2-!/CP2\$.3 M!&Z3!*F4(:A"8$)0AZ`)0CV%':HX;V%XFV58!=A\4ZC2+KUZ&1B M>-]^4F12I.A%>M<5J10QBM2*-(JTG(@!@-TE'`"[N5ZY`JP56$/P+KVW:11, M\$<4.C4DO4@_)(I4BAA%:D4:15I.Q)"`^WQ(3L\%*]QY3CU^1!)U&T$\#8*. MK;`,^Y'BFX7H"&S$EW?$"LN.($G[U5@H4BI2*6(4J15I%&DY$5Y!FKC<*RLL MO7)D#M'K!S`/5U8O0T$I%:D4,8K4BC2*M)P(/VW]R7++Z6EDA:6?2%CT%"D5 MJ10QBM2*-(JTG`BO($MRKVS&G,YMX77MEF$-28^1\,BF49@N>J$^M(I4BAA% M:D4:15I.Q"#$D"+X*)R.;2K!#9W;923 M[.;Z(,>NW(#$0.%Z)"3#'&Z37HH42XTJC8Q&M4:-1JU`FQE$ MY?BR67U[W$'L8.<>&(HI5+5XZ'6%#ZPC2DR;X0MZ9`M5YA#`QV'"J7O.18WO.<.B9XK5,:(DM[E2B-#R-UJ\3-V M;`N*R[N)Y0?OID,)[(/]T,&]3KB9HI3??\KNG2&'<\4D"^9HA5)9TAU=9EED M_Y/GJC(L@P.!=X5TG+?=-1`DL"^;=3':@(*E9'X224-ZC"E&ZZ%P9](2T M.D/2DX'R)\ZN7!^)+GT0B2BDT3QTT"DF+'RH./6H(I1W#B;#'G)+TD-;:UP\ M$Q.L3-A,1`2QHN59$.*!<8I3CRJ4FOH[(B,493=MPK^\FU@>\&XZ!"/NNXG( MCV5I`P+IB$E5B'`IQ-'P^')3LN,VW[..?VB'A1D0EA:(@B42K.."I/RPEXAR MCRI"\VX&?9K-DGDZ#_82(TQ)%VT.9RZ>WG/M`3$HDQ"Q42\(\=@XQ=1/M`JE M4N^+$8JRFS;)LFY^+!*8J?TT>K0AL'/&]ZL@Y/M5(IK!UMAO:7K?):G8K>79 M+,[BH$(VPKCT\$PV_WWW_JML#L-&23'1Z9R0CT:A4:E1I9'1J-:HT:@52/IM MLS&+[)D)Z'(W+U<21*)6C8.$5W@IVD)*C2J-C$:U1HU&K4#2Y:L*B$07$(1X M2%'*HU)+51H9C6J-&HU:@81_]NJ=A_1#B[4S(BL+1#9G]LLPC8/[Z8*D?/E: M:E1I9`22#MD,?/$!`I!.R(^2$"31/BAZ;R3+0BJ\\#5DJS,O7;,Y^O((N(PN(N#0 MS%62X%IXF)TZ`=BHO&N(?'*H4"KCFTVB_>"VI!]!17%ZMX-*487((1^B(-47 MJ"-"Y'18BJY0"@LC>'2ACPC"D'3BJIIAJFL&1#X8X>D`!40PG!E(H!2?"J7P M=!#/YD->H%H75NE%4%*<"86N':8.^5"$1P`4$*'`>L.7(!5*42CR!#Z8$F0O M(RQ)+\Z4#1==`D!EK^:90Q`BOZS3.+S&1T41)Z?(2U24RMVVDN8V3,I#I^8L M20^O*A#@1*)<<0CB1#.G0"D1&2?%*U24XA6J4)3=#)+ZQY*>SO53AR`0OO<. MB5%'J=,5*MER%>HOCD,H-!")]$Q>OZQ$[:S(Q$X(]BF?0]3=FY>BD2@UJC0R M&M4:-1JU`HEHIU=5!)UTX#(6"=SE5#UF)D66;S6J-#(:U1HU&K4"29>OJBY2 M75T0\LX4&I4:51H9C6J-&HU:@:1_-FFS$L,NX`\]+4M=]N?5!R$9[>!P6'@I M/\'1EA^S2DL9C6J-&HU:@>1HV)J!C<;I[)A:Z6""(_(]+TC*HU*C2B.C4:U1 MHU$KD/0OJ&$^M%VGNK1!!+>2%,-"HQ*1K7?[#4]?GGLILF6TK=I+>5M)%M0B MC9+ MC6C:[14H?L]1@;T/!L0U+LC(:(EYN$ M\$84+M7G27!)8+2EFM2\\8806HJSZ6(:'%5:84F.E:W)+I]EKH(3LPSK/']8 M*."LHZ:40S#;:657*`5A)&2T8DU27K$AY!5;H2C\R\Z4@Q<=/3HC,G,@8B>] M@I#O5XGHS)TL2;F*=Y;EB_!.PVC;-6F=K*8;DG*VTVDT"S\KV0K;!S(K'2P(1'ZK+TC*HU*C2B.C4:U1HU$K MD/3OJE+17IV%_O6E(M_\@Z14D")WN5>D*%=:RFA4:]1HU`HD70ZJQ]/5<:;+ M1$+>F4*C4J-*(Z-1K5&C42N0],\6:Y=/65?:\=25.33G.V@:AT\X48K=S)0: M51H9@63/KRKM,EW:(1+9QTFQ*Y@2I1BJ-#("R6X&==29":0+ILRA.3YLU%?U M*,"+3T(GZ\,*I6`_LU^!2>SWE(+=U9"A;O9*OVPQ&/2TC*/FC_\1!'>1X'HV%(9"`2 M0?X/2[V+ZN1)I'(R?"99.XS"YNX,RZ/H+A21\?D52/%A. MD7_8#:7@4&-=@8]71?/P/D$8DI[P3`^]^5BL=`$`2[5S4,8J_`(&2?G`E(A$ MK)RM/E;SQ6(>U&I&6)(>\IQ_/E8ZY^>8TOWZ*`CQP#@I$1A$_LF>$8JBF_:F MH"]-/AJ(SHA,]HCX[D6(C3HB^W"MGX_ZX@^EX"&,G6EY-H\6P90UPK9TD&?\ M`0(.F_<.[IO^;OO8&_7^Z_K8OWZ>ABM=M_M-_CA0Q(/=SUV M/R\`]Q*W]EH`]@?5DD!+=Y6K6J;0TA5$JB6%EJY#JB6#ENX'!,*69'%K/[0T MT(,TNK7/^H9:H-<0C:$6Z#4\3!IJ@5[#@Y6A%N@U/)(8:(E!Q^W$8:]CT(%O M@0SI@*?PA8BAEAQ:NM446DMF,`;=HE(M\?W-IO%PRTI-EM!<\V=`L\*KFU#T)T"_SX MQ>>A=WFT'1N0?X1N#Q^7",<7#LCAMX`(M@%<-(KP(]AO"^_ MKO^YW'_=O!U&K^MG6&I1]W'VO?LY#??'$3\H^F5WA)_!@+T*<@[\[,D:?HL@ MLM_]>][MCO0'C,2D_R&5A_\#``#__P,`4$L#!!0`!@`(````(0#%,&PO=V]R:W-H965T%TNG+Z6%[>WEY M[>V5.//OKWGFO+!2I+Q8N,'`=QU6)'R3%KN%^_=?C]_N7$=4<;&),UZPA?O& MA/M]^?-/\Q,OG\6>LY;$8\`,K,++E91Y7^%GN/'$H M6;R1D_+,"WU_[.5Q6K@UPJS\"`;?;M.$/?#DF+.BJD%*EL45^(M]>A`M6IY\ M!"Z/R^?CX5O"\P,@GM(LK=XDJ.ODR>S'KN!E_)1AWZ]!%"F$B@*&`&-8V$9R"`?YT\I=:`(O&K_'M*-]5^X0['@]'$'P9( M=YZ8J!Y3@G2=Y"@JGO];)P5$J@,)&Q#\;4`F9XP+\X;-//RU+-Z?Z-7DI18/ M<14OYR4_.6@PT!.'F-HUF`&L%:%&Z&1Y3Q7LA$#N"67AXF1@PP*E?%E&X73N MO4#^I,E9]7,"/6/=9E#50*_C"'&^@".A$$>2GTBOVL"9=&@0:C-,0A#J"P@1 M"II&%6WHZPQ6=4X`(IVR(SUEW:68+*,O84DH:`Z=IE&Y59-TB6:78M+$85'% MM!^_MM$H6;+IJMA$?-EU@2E.,XK.ZO2+ANM$FDC4-=A:C6@K M3?25Z-!-X!VM4WSXV!&.3J*)0&QEOT.C8[HDLQ3T:%/,X'(I*%E?O(DH"J@1 M38&IOI*T'1_ME2C(VN:"=:R&&B2NZ*%)1MU*(.69#)H)1M7T%N M[&S8>:)@> M*3&\HY?>6UU((NF=WX9T*8QWP_4YRVR*T/#(RU+(;(-`9X.`KINBS>H?Q]#P M/'E`/O%][ZW:BA9IAD%>$Z)M@V)G@60@UI)V.D`Q+\24I M1!`-)I]HBMK[X*[MNBN)+MM3U<)XJ5R?LWI-00ZGL+NB1>.'*H$ZI*A<7Q/K MJU'.RAU;LRP33L*/=`4$E>6\"]?WTU4XQ`55@O9&(HQ(<',DF,S(D["AWL@= M1N3MI#NNIK+2^J:RTN:BM+ZW5:X!O#(=ZQW^-REQ;"R=@6#>C+DU?67RGJ M'Q4_X`CA2P.O\'5!_G>/KTD,5UN?7INVG%?M#]3'Z[Y/+?\#``#__P,`4$L# M!!0`!@`(````(0#)$A"+]00``-@1```9````>&PO=V]R:W-H965T`^9J&]E>Q>8J;:6JVK;/!(]M%&`L(''V MV_<,P\!<7"N[VI<0?CGG/YS+W++Y\E%7VCMJNQ(W6]TR%KJ&F@(?R^:\U?_^ M%C^M=*WK\^:85[A!6_T[ZO0ON]]_V]QP^]I=$.HU4&BZK7[I^VM@FEUQ077> M&?B*&OC+";=UWL-K>S:[:XORX^!45Z:]6/AFG9>-3A6"]C,:^'0J"Q3BXJU& M34]%6E3E/7Q_=RFO'5.KB\_(U7G[^G9]*G!]!8F7LBK[[X.HKM5%D)T;W.8O M%<3]8;EYP;2'%T6^+HL6=_C4&R!GT@]58UZ;:Q.4=IMC"1&0M&LM.FWU9RO( M+$!L*M[Q4($_ M6^V(3OE;U?^%;RDJSY<>RNU!1"2PX/@]1%T!&049P_:(4H$K^`#XJ=4E:0W( M2/XQ/&_EL;]L=<T%='Y=$4M>*MZ['];_4R!JEJ(@]BL!S%+$M MPW(7_@]HN*,&/)F&8:\\RQM$'@P.GSE$`,_1<66XMK=<#1$\<%R.CO!DC@^C MA"DS#`3/T=XW5I[G^JLEC*T.9-)4#Y4+\S[?;5I\TV`Z0#*[:TXFEQ6L=8V5 MC"I,1?R_&D+QB,@S4=GJ\#%0G@X:[WWG.:N-^0[-4HPV>]7&$BT.S()T!I$- M91#)()9!(H-4!AD'3$C"E`EHF%^0":)",L%BV#,PI\:6PF86S"64022#6`:) M#%(99!P0PG;4L!V8^??G+*LW<8+9R=7;\>1Z4QL+QIV;0HI\,IE"5TBDD%@A MB4)2A60\$1(`D_P7U)VHP!R"4>9HG;48[WXT>I22R61*B4(BA<0*2122*B3C MB9`26$+XE#SN!6(\1,Z^>#\2D)]RX?@+,1>'R8BYA0J)%!(K)%%(JI",)T*@ M_H\$2HS%0$?B3K/]H)!0(9%"8H4D"DD5DO%$B`HV$;Y\=$TWR,;07\KB=8^A M++`*WBFK`VLW7=&)AA@L)?9P!!AL#@H)*7'X!G=\E1`4;]N>C(L9B5)38_)KE^/*F/!K-/1[><;,]::F+J)%G#X^U:"\DB M5H23SPBGU&C)?[3M>^+BDO':0L8LV-KXE/W4W!A$Q%2.R(8YR:UY\D[/K)93 MCX0C\F<4,;0:K"B M%XQA@=B/"#J,S=`#0UP_C7OM`S_Z6)*R3'K04J_X2ODZN[>PRW`Y!@EYY2BH6WHB/0:2B\S M-6K/Z("JJM,*_$:NF-#5N\V$Z?TW7`:P^4`K2CQ9!K"7J!SNR\_#"^`LG'@KS@'F[40VTN\!\4!->OA0%=<,*X M9R]D@.E_,KO_````__\#`%!+`P04``8`"````"$`T[-@WA0$``""#0``&0`` M`'AL+W=OK3:U,; M+Z@C%6[7ICV;FP9JRHE_4U)8SGP=6 MDU6MR16B[A$-?#Q6.8IQ?FE02[E(A^J,0ORDK,Y$J#7Y(W)-UCU?SD\Y;LX@ M<:CJBK[UHJ;1Y-'74XN[[%"#[U?;RW*AW3],Y)LJ[S#!1SH#.8L'.O6\M)86 M*&U6104.6-J-#AW7YM:.4MLQK-G1OU:,`@66Y/5:5^!'YU1H&-VJ>D_^/H%5:>20KE]<,2,1<5;C$@.&069 MF>,SI1S7$`#\-9J*M09D)'M=FPZ\N"IHN3;=8.:'<]<&NG%`A*85DS2-_$(H M;GYSDCU(<1%O$('/0<2>+7S?"Q;AXR+`[".!ST'DX4`L;JK/49S1;+/J\-6` MQH.PR3EC;6Q'@6F(Y'`K8[K>RQ:DB8ELF-[\U7U@N4)1\X MNRG'5AE[P6`U8+*Q#B0ZD$J`!8Y&6U"L#[#%5)@M$=!.`#>?CN9!,,226`<2 M'4@E0/'@?H@'I@(M*Y7&#?72<`YLPILO7_,U4D9C$R29(*F,*-Y@'WQ`?9@* M-"Z\1>H[K:MV`^E/YD;*:&Z")!,DE1'%'.Q/V=S]@T9L'4;N/8AW[P8$Y$=7 M;JCWV4@2R^()DDR05$:4D&'K/QXR(ZLA6.?Y2799P4BAK.X&V?5)96S'&I@SM_'4" M=A&]/([+1",E'/&6_3D>V'[H:RJIK**X M6=YQ`]9I6>7/.PQQP7E]9SNX\"I^D3`!U19'M-)IZ=T/)*ET''%O2#(@06_K M*0C=0#L&4UE%L67#T"%7Z8X%J)CPT+-5$P,$Q1%9W@M(*L4`N3+P"-K]2X5`5H>X&2*M!H+668-U2'@^0"XD=>W*Z@0:6 M9_>5\;V%N]0;3M%6/;/;\P^>?^+S>UTGEXS?P8II#O5N^!OYA,FGIP9U)[1' M=4V,'%_8]+B`Z$=TG&RW_6"KX3LV\;+TZK@3P3!P!WZGC,S1_H$-^ M#YC"[-NGNH3?.@CN@/D,&N^(,14/[`7CKZ?-?P```/__`P!02P,$%``&``@` M```A`(S-NK92!@``TQ@``!D```!X;"]W;W)K&UL MK)G;CMI($(;O5]IWL'P??,:`@"@^6\I*JU5V]]IC#%B#,;(]F>3MM_KD/K$S M)$HNXO!1]=-57=U=[FP_?NLNQM=F&-O^NC.=A6T:S;7N#^WUM#/__I)]6)G& M.%770W7IK\W._-Z,YL?][[]M7_OA>3PWS62`PG7=INFTL:ZS/35>-B_[6 M7.&;8S]TU00?AY,UWH:F.F"G[F*YMKVTNJJ]FD1A,SRBT1^/;=TD??W2-=>) MB`S-I9I@_..YO8U,K:L?D>NJX?GE]J'NNQM(/+67=OJ.14VCJS?EZ=H/U=,% MXO[F^%7-M/$'3;YKZZ$?^^.T`#F+#%2/>6VM+5#:;P\M1(#2;@S-<6=^LM%$-J>`^;&4S-.68LD3:-^&:>^^Y<8.52*B+A4!)Y, MQ/EA$8^*P).)/#P`G_K"D_G^>!00+TX%/*E(N%@%@;]%)'1\BA[FB1B<1UD513M=\._:L!BPVF:KQ5:.DZF[5I ML((@"G.)_%^%0&D@D4](96?"8&#R1RCKK_O`=[?65RC%FMI$NHTC6\3,`M4= MDDU4D*H@4T&N@D(%I0`L2,*<"2C'7Y`)I((RP6*(&."I41(3,POFDJ@@54&F M@EP%A0I*`4AAPP+Z!6$C%=@,A`+PPI4\O1&Q<6`@O$IDDW@VF7.AD50CF49R MC10:*44B902VA5^0$:0"BPI^A4?K>W*\$35Z*R6SR9P2C:0:R322:Z302"D2 M*26P&8DIN7]/(V8@C2D!^SH6WLN5H MAVF!;?'.M'JPF9,M'FG(P1)"VA5L$VLD(<03"]SSE9E/9R,V\YDFE,\VO(3< M0-EABMF("96BD)02U-$*Y]Z=T.$$9K$C8SEV0L38-9)0XL[%D&HDT[QRS:;0 M2"EZ25'!"?YX5,A8CHH0#]I*89VJIS0QVR#3A_!'A@AB%TJ\O`UF[%+6EC#D0[.,IP]9RSBAR8?$)25//>&85SL60 M,+2<44J1O\9)\I:^LU[*@63,BPOE#'&A0A8*0\]5IJ-D3EA'S@AJD!Y>&@YI MI^"<8VLNHD@I(^7HBZF56$<,<:V4(EHVP1K>%]6R85Z\('.&N%!!T3MEPARQ MEIP5U#\]GA5DK=0)04J=^/+TQJ@[`D>73V_"$)_>E"):)^[:#L-0%LJ8%Q?* M&>)"A2QT9U&6S.E.G:`&2LC(3YTJJ#]2$T60*RYH;Z4LZ)@Z2N5#'#U>""FU M\I9X0?F>8R^U\J$_Q[URYL51P1`5\AUGK:TH44BN'=17"9EZ^[!Q:!?&BS>B M"&J'+;*8(3Z_"44>1RE#_'TDTQUS9L4="X:X8RDYRO&A=DJ([^#*YME*V,;=B24YT ME.HHTU&NHT)'I83D5*!V34F%&RQ@@M]9,J3-@T7*8H@*-Y*.6`3 M[BA:\>U5'C#JQ(0!OS-,TK=)PR0HY$LO=C24Z"C54::C7$>%CDH)R?&AODF( M#ZUL;X7N!M^;$=)P2:%2),[(C,1<*TLG<>Y:\3J61@PMN33BMV<$6\OG-$5X M@R'*Y#:5W)IUS7!JXN9R&8VZ?T$WI7!`[KXL/0VJ,RA&K5O5O`-WE65 M;Y)P`R]"ND<>;N"]1N=P5?P)OUHH.A%<(>/[5I6[<+5\1R?R-G`5!*^5:=FC^JX=1>1^/2'"&1-GXA'8\'"8?5>6Z=%=];N/[/W[NMH,?]>&X:?8/P_`N&`[J M_;IYWNQ?'X;_^5-]F0P'Q]-J_[S:-OOZ8?BK/@[_>/S[W^X_FL.WXUM=GP9@ M87]\&+Z=3N^ST>BX?JMWJ^-=\U[OX9N7YK!;G>#/P^OH^'ZH5\^MTFX[BH)@ M/-JM-ONAL3`[7&.C>7G9K.NB67_?U?N3,7*HMZL3^']\V[P?R=IN?8VYW>KP M[?O[EW6S>P<37S?;S>E7:W0XV*UGU>N^.:R^;B'NGV&R6I/M]@]A?K=9'YIC M\W*Z`W,CXZB,>3J:CL#2X_WS!B+0:1\'X5,XJ]+)W!\:SX6A\WS/S;[&K(-==(5^-HTW[1H]:PA4!X);=56X%^'P7/]LOJ^/?V[ M^5C6F]>W$Y0[A8AT8+/G7T5]7$-&PQC&X[LT"^(0Q`=?Z^-);;3)X6#]_7AJ=O\S0B&:,D8B-`*?/4;.*,:H M")^H&$5W61A,XPRN?D8Q047X1,7$>GU&#ZRVX<(G73"\ZH)C5(1/4KS.TPP5 MX?,F3V&#MI[")^J%V56>3E$1/J_R=&161+O`BM5I]7A_:#X&L&NAYL?WE>X! MX0R,TW6VE\M-5ACVLB3MO(PA"A@%1UA?_QX3)/D?O0#UO0:9>92)N02 M.4GH!:S-%CY0^H#R@84/+'V@Z0$J!*($L!+(42.4B+`'07?P$Z-YZXP[05F`/P55LM$G*XYVCT+F4 M=")=2@12"D0)9"&0I4`J%V$I@?!E2NYTMSZ];=;?YHT9%CUK)(;-;UJ"MM$F MA`*9&R1J1UTKDPND,$CL9BA.O)55=D)D6KF&6"30R=U(>CR&"4@N:V'NLD%< MEP52(!)U6[X4B'*UF'\P,*[W3PMS_PP2N:LN"<9\U>4HE'0.%CUJ43KE:J41 M2J.VG6=IH/_C(LJUS,+2Q-.9*N?3KH5Y6`:)(&O=9DJ"C%\\1Z',AM6IT;HH M#9),S4CJ"\&UPD*`8>B&8`;CC7M`V^"1&<0KV,2+#(6<@ADDMDB)R+B-+.JM MCFN&A19"?W=C.U^>5II'@1`4B#*=$^24`Z'80B5!=CXJILC=U)/ZZE44FKD. M'9A\FB,$V28H)\AFLB#(2I4(X=H/@][TDEYKBCNN9ZWC^*?6CAZ8>]>XG.:\/B+S4`].=7#3%SQ M9L(4FIFH:]*PJMS*TS0L)E1)2$EI(:"FABD&\''HD.LFY ML"_,`(4^S_40,XQ9V#B?87,ZE1;WQ"AE M67,1"JB4D&(0"PCH+`OH_!IMI?GX1RBRE#-_TB.?X0R M,^*BP.^J.0I$=N$5!+E=2;9LLLRDQEY?4F1+ME#(W"T5D$R@-?`PS`RQA="\ M:^7@%H M@ELBH^,PAQ*ED*_%TZF\56&&^#K34]K9WQ>",#/=WBEFB=>BEUO<>->E^;&_S@P$)7)[K3B(,U*L3@9RF3.:'YM$)6-=)A&A M:XE'>!-!`%=$*`:".M'HSU&*5<9(N<09I5SBS!2YF]Y0_]30B^2L1P@*8;TW M4N`+005)G2?.)&6(\U_\ MF3FW9MH^:A=SFGA-9TY2YYBSE>E2+Z%20DI""PDM)50QB)4C]L:]+D>4WD$[ MN?$DMC7$QPQ!T#T=JN7=9.56RF8#684=/Z644A):2&@IH8I!/!LW,01]7NIU M/(*LY[F$"@F5$E(26DAH*:&*03P^CSGXF^^J(^98$@J$@%52#7,)%0AI][KU M((^9K1394M+6PDI96U'J#<^EE2);%;/%DZ.GO-.9SC,2.!44Q4>:X&9!0`4J M`@DDGTH)*8*LK05!5G$IH8J@5I''ISG"]?$91N%VV-A`FM-U]4L$!R8INP4* M@EQ%2>]1JCO^"[(L]@BV(DO6^(*@L\:7W'@Z2<:QMU@J,M3:YIG3O,+)W.>V MC2$G+*'(5^##2:A/QF.4A)Y=[5*6EJ0FC6^)`@MA6D, M/QG@9^45L\1S=1/3@E-JL8L,Y+#;'*5;R%_L21_",FMF_P>\M>:$>3/ZR!SDG('G-?!XZ0<]];2*B4D&(0=_,F M%I5(%H70!!\\R?-1%'"G'4&0]6Z?20*%4DB@HG0DWT,3\#_$$615CL7>7%N(A]P)B-6 MOX%L<7PRACJL.(*PE"A%E0BF4Y]M*F:(!^$QC`M;6%*)Q$"V$MXJR%&`5<+H M./2C1"DZ&4TG$\$BF"$>A#OIH?`7@I`3'2ZKBV,K(::*$6"50,@^V"O1#)Q] MZI]'AL%X''K94"0B]T3JD@<(XE.\OS7">RQ"$W<[)Z%_+HI2;I40?_Q2*UTEX@9HR[7!VEW+(@!-N6YG])D*6VBBER-]V9?=E- M.;-A'[:=!W2[]@F-A=_3Y"1E?2H(LM\"3-XFN"Q6,4L\6*Y M8_QRL>08UX_%])C@Q1*;`Z7<8AD(;MUL*`:"I:5#@9_:!!,O)XHNUU,K=])_ MNE:2`*0&XL

RO1I2RA2E0D=7*2'6UFDRG$X^K*;I>3W^#J-S5>+Y)IUK: MV_\&=G%O(NPJP^O M=5YOM\?!NOFN7V2!9^>/]QV,;]DDP>S)O&;C?0/WNS-]=PG;37P#K^9`+OJ^ MB>";]@C3UPG',_T3GQZ=,(-OV@TJ=";P3;N(O&^>8O`::M9C#;[1#T3ZO@&O MX>%`WS?@-9Q;RV^*=`8_C.[!XWA6PEFS_`:.KF?Z8%I^`^\S/?5=8PYN]7H% M3O7*Q^!LG_UD]@0_.9,7GB=0DQ[\"4KR!(_:0&/4Y1?><'I?O=;_7!U>-_OC M8%N_P,()VH?%!_..E/GCA#^!^]J%=MAK>,`GT\Z67ICG1'_H" MW=MQC_\'``#__P,`4$L#!!0`!@`(````(0"6@9\280@``-TC```9````>&PO M=V]R:W-H965TFZNQ4>(JW)%: MJ:I.VV=BXQC%-A:0Y)Q_WUEVE[V,DY#TG(=#_#'S[!V]^^GXZSEZKM MZN9\9UASTYA5YVVSJ\^/=\;?W]*;E3'K^O*\*X_-N;HS?E2=\=OFUU]N7YOV MJ3M453\#AG-W9QSZ_A(L%MWV4)W*;MYSA9_NXZ"YM5>X&I=-Q M89OFSW]?;*FZVSZ?JW%.2MCJ6/Z_S&0&K/3-B@>STU;/AS![N^66VXY]_`#T9_J;=MTS;Z? M`]V"3A3;O%ZL%\"TN=W58`%Q^ZRM]G?&O144CFDL-K>#@_ZIJ]=.^GO6'9K7 MK*UWO]?G"KP-<2(1>&B:)R):[`@$R@NDG0X1^+.=[:I]^7SL_VI>\ZI^//00 M;@\L(H8%NQ]QU6W!HT`SMSW"M&V.,`'X?W:J26J`1\KOP_6UWO6'.\-9SCW? M="P0GSU479_6A-*8;9^[OCG]2X4L1D5);$8"5TYBS^V59WG+3["XC`6NC,6" M82=.`28[V`%7IKR:N[;GKSYCA\](X,IGX,TMU_R,%;"PAHG`]=,36=#@#+&. MR[[.[Z=O$"Z;5E,B&6L52)B$N07"*TL0XD.I#J0*8#N0X4$K``)XR>@!3["9X@ M+,03W(:0`\(UMF8VE^`JL0XD.I#J0*8#N0X4$J"8[?P4LPD++'`I`5Q7LS.D M,A9,1&2)YHI19/0%0A*$I`C)$)(CI)`1Q2-0)7Y"(A`66%0PBK#6,U5[0R;T MGDM&D=$E"$D0DB(D0TB.D$)&%)=`[9-=NZZF^ MB$8AKA8C)$%(BI`,(3E""AE1#%U^QE`BK!K*$-E0V]0*830*C88B)$%(BI`, M(3E""AE1#(6-2(XHK?MS'QS3'^KM4]A`I*!27HFT`_6=5GW"H=I/$7MH+`:9 M""$Q11PYYQU76QC)*,1]E"*B;)01665[*S6K\E&($Q4RD>(2TKA*6^$5TZ'E MX+838=5VBLBV(R1FB#UN#PE"4J25(9D<(86LI5@%F_ITJXBP:A5%H,\43G;= MI>KDB`K9[FA6S!"Y^MF>MA`2)D2<^K)9.DO'M+3PI8@YF\*<*\RVN71M6]N- M"IE9<9@%MD[WV""MNHQ!'HP@E3M?\QF3LGWA-`XM1RAAT-(Q/]22(6)"6[>I)0J64 M)$%00EHJH%^M!J?`AK,V-:*4B4A$&89R3B1GKKW4-NI"452]0GJJZ5YA'9@S MIGM(VB6P1"LW6E&(F)04X)A#@BOA$"TOOJOOPRD7$&4KXY"@R3E$:6XLU[*U MA"NXR$"D.H1T5))#OK3-6JPM$Y,*&:25&+2DJ*(4])@I+D6U2!BTIB7FQO=M MRW&THUG*A"2J#%/E&I5C>:YEZH57H5*]1=HRR5OO[\#D682^J"A$GXK0_H-) M*;E"I5Q1'A,FY8ES6XH5,P9)BCE6+!1%U3[2C4GV?2T;6$LG9P.%UE#WQEKB MZF>-R*)24@AC!OGR[HZW:2:UABHSTJ.JD&+Z;!)]/HF^4.A5KY*&[AVO?FLN M4'JOMK)2/V?1MA"6,F\40P9=6=6DV4(C\N=8TQ^:T)Z-5(_1KYZGK;S08E*R M][6*'`D9/OD80PF&4@QE&,HQ5"B0&@[26$G.^6`1TS9,<3N#Y$.4ZVE5)+)& M*6$R@A(LE6(HPU".H4*!%).AY_^$R8.TV@QP2.Q$$89B#"482C&482C'4*%` MJGVDH9)"^J6Z9=.N3(XT@V!@'L,(0S&#E`.CZSEJIY0(*/"1V7.15\+*(]& M25LF>>+]-6W3)DXQF4+DSECJ7$]K4B.F*._5#'+]H;6]<325A*NHQ%I]3+F4 M[!(ZH[>(QH8M6O*/?LSF4J)YBQGDN=0_WESK M`1.N(YJ=E$.")ON()N:-O+21FO:&$0<+MFN'Y>YE`AAS""?/)!Z MV=S`:RB])M#!@%DL#@8)FDRE02PY'WE@44TG'=7T94'[+V59L)9,#OM:2_&( M)`7)#1&NF$$LZCX.^L@K#$/J.*AV,"DQ3J:-LY[[XQCD#VV$8L8@23'G M4E,,`>:;A]]8JN(%.`\

P&\I0)\,+0$```H$```&0```'AL+W=O"90@L#S(7(A.>(A.AF8?\<-F__T&F)S+A*3*]YQ*A MH%XQ/&6QP<,:X:]]`CR?J]'A/>XMV^==OEVWY&;!/H`NTFO.=I4;`9OTBJL< MW/N>>=!P1K)C+!L;-C#X0F'%O6U]'ZV=-U@EA8B)S1A7CTAD!/.1T>ZG0#H% M,@5P0-$@"VS_'V0Q%B9+%A1+8-0Y49G(")FRGP+I%,@40-,`"W"J80&;\?XV MDDZP)-@PBA->X.E]CGF,"^\=[=)#DB%DT&$@J8%D*J))@1TQE<).A!]<98P% MUBF\9:S;7^B5QR+HD;@A9!!G(*F!9"JBB0,AJKC'_K#@7H-\=RP0H%=432Q+ MAB"9MC>0U$`R%=%*AIW^?,DL6"]9(-ZP,1(#V1M(:B"9BFCUA7I]_%2:L8.[ MNY3%2TR@5;#U[[1Z`:"]?HX@EC7 MW[9H[D[7K?C[N%+V0\:XW)&_TDU(>9"/!&T83L^P3"76EHX+1^3S'>^C=4D" M0H'4Y.O%)3(@'"V0T.A3*B!O)6@"Y$_F72:S>B)=!)MK3R\;ET]!.!CEFHT% M-!H33$7P'*0X,^9(FE1`T@@W#+VY3I3)K)Y(%\$&FR+BIW8QFU*3-2>@T:!0 M+RF1`:I!G"88H51$!(-<+?&1HXUGHCD%LU"G:'N]K-K*F(C@$!LEF)R)* MLX1'>>JZ$M"H)-,2=0O8T%+*_#D+Q.0;2XU=#H$%8_4"&NO:BZ@0=N0PVLR] M+J/&PO=V]R:W-H M965T=/FQ,73[*@5!G`4,O(+)1J0MN6 M24$K(BW>T!J>9%Q41,&MR&W9"$K2=E%5VI[C!'9%6&UJAE"\A8-G&4OH/4^. M%:V5)A&T)`KTRX(ULF>KDK?0540\'9N;A%<-4!Q8R=1K2VH:51(^YC47Y%!" MWB^N3Y*>N[TYHZ]8(KCDF;*`SM9"SW.^M6]M8-IN4@89H.V&H%ED[MPP7IOV M=M/Z\X?1DQS]-V3!3U\$2[^QFH+94"8LP('S)X0^IAB"Q?;9ZH>V`#^$D=*, M'$OUDY^^4I87"JJ]A(0PKS!]O:&B6PC7"[N?+[2U^M:,>Z+(=B/XR8`&`WVR(=BN;@ADO0N:8?#E?[:`'TBR M0Y;(A#<#,I90RN>M[_D;^QG\3SK,_ASC3A%QC\"R@;Q!([CS`1J1!35B*5'T MO@^,12]GDGK,7!)8]0&2D`7Z9F);,%6PUQ@7A`S>SD4.D+E*_T-4(@NTQU3F M:B:S`UV3.4#F,J'5QV9>?@/[5D-PJV:H8Q=QVKYS9VT7=T^AMP;_QKTY:;3@ M/4(0/!721?RAQ>)Q9++3:KH3OG:>`P:]\[U#FJF&+@)4HW37TV+%`VA>"3S; M1M/@>B40/-U<1]K\=;9Z^NJ!4U&1TYB6I302?L3)NH:*#=%AZ.\\]&\6W\-A MT([.>=P+XXOX11@O+O#L_'#7CH`YCQ_&K>YY/`BAB!?TK$)P$>T;%L#AT)"< M?B&ULK)A;C^(V%,??*_4[1'D?<@\0`:L)(1>I ME:IJVSYG@H%H"$9)YK+?OL>QG?A"$1WMR[+\YIQ_?&Z.\>K;9W,VWE';U?BR M-IV9;1KH4N%]?3FNS;^^IT\+T^CZ\K(OS_B"UN8/U)G?-K_^LOK`[6MW0J@W M0.'2K"V*7OXVAZM[MJBW0:LKZ M8E*%J'U$`Q\.=8427+TUZ-)3D1:=RQ[6WYWJ:\?5FNH1N:9L7]^N3Q5NKB#Q M4I_K_L<@:AI-%17'"V[+ES/$_>GX9<6UAR^:?%-7+>[PH9^!G$47JL>\M)86 M*&U6^QHB(&DW6G18F\].5#B!:6U60X+^KM%')_S?Z$[X(VOK_6_U!4&VH4ZD M`B\8OQ+38D\0.%N:=SI4X(_6V*-#^7;N_\0?.:J/IQ[*'4!$)+!H_R-!7049 M!9F9.RRCPF=8`/QK-#5I# MNAXW_U`CARQJ%'&9"'QR$7^V"`(_7,P?5_&9"GPR%="[\U10'I8.G\Q^,9L[ M]M(CS[SC-V=^\,F?(RSVCB/,S/!`^&2.SLT56C3'0\F2LB\WJQ9_&#`'D,7N M6I*I.U?NOXD'"B<@S45F;L`BH2P<=][X)O'!EO4.75,PFUFT< MV6+++4@=B6RB@IT*4A5D*LA54`C`@B2,F8"\_81,$!62"1Y#S,&4&E<)FUMP MET0%.Q6D*LA4D*N@$(`4MJ>'[<'(WQY67F_B!&,IU-L+;#FLF-J0=IR:0C;9 MCB9CZ!K9:2352*:17".%2*0$P&S_A+H3%9@A>,H4K3>7XXV9T;V4C"9C2C2R MTTBJD4PCN48*D4@I@&*#>[ZR,>Q&(U[Y M5!/*1INIA=Q@(8]3/AIQH4(4DE)"SI;":^Y&Z'"VX+$38SEV2L38-9(PXH[- ML--(JGEEFDVND4+TDJ*"%_;C41%C.2I*R&XOS*DG)WE+C=RIQQ-&Q*W.#9:R MVXX:!>YP&'!"._1M7S9)->7L$>5<5O;FON,J1XU"5)82YD"L8L:^-!J#B)Q) MAEP822&52L!;;C4?6R1A*)S0CJ/%D#HW<$-E@%)=)^-.DT[.$=5Q;"=4MN!" MTI'S1`Y)#\^+0X]4\/+C@Q@SY$YHRY'020SYX>BX8RA4G(P-*G*V$7-W?7,ZMF+CC^':@ M=''!;&@7RQDE)[([&?V.KS`V-X\HPGN:7"JHG431T#7TB?2:@O[F;5![1%MT M/G=&A=_(%01L@9O5B.G]2#*/X(P"6YG"LWD$1PZ=PWW*\_#65^QC=XB#"(Z\-W@8P:$1N#4*P;W+M3RB MW\OV6%\ZXXP.D!1[."NV].:&?NE905YP#SZ/8.<'S#N^1?R M@/'.;O,O````__\#`%!+`P04``8`"````"$`%\U::G\,``#2/```&0```'AL M+W=O3M'W^> M7F??Z_/EV+S=S=T;9SZKWP[-X_'M^6[^GW\GG];SV>6Z?WO+R^&E/NTO-\U[_49_>6K.I_V5 M?CT_+R[OYWK_V!:=7A>>XX2+T_[X-I<.V_-'/)JGI^.ACIK#MU/]=I4FY_IU M?Z7G?WDYOE_@=CI\Q.ZT/W_]]O[IT)S>R>++\?5X_=F:SF>GPS9_?FO.^R^O M]+K_=)?[`[S;7RS[T_%P;B[-T_6&[!;RB=JO>;/8+,CI_O;Q2*]`M'UVKI_N MYI_=;;7TYHO[V[9!_SW6/RZ]_\\N+\V/]'Q\K(YO-76;UDFLP)>F^2JD^:-` M5+RPJI-V!?YYGCW63_MOK]=_-3^R^OC\V??P9U9<#=91L;KQ` M.!V:5WH"]._L=!31H([L_VQ__C@^7E_NYGYX$ZPQRI7JI)^=@_9O?211Z1CIWU$^LF/Z*T#-VA?\$BE2^LKVRT66K;2XW:/ M578+1?_YV*,NY%*WR8GVU_W][;GY,:/#D1PN[WMQ<+M;E]8,F9$/WZ7H5R&B M]`B7S\+F;DY-H'Q<*/G?[P-O<[OX3FD]*,V#K7%UQ0X*$4UA&YD@-D%B@M0$ MF0ER$Q0F*$U0]<""&M=UCQKV.[HG;$3W\+H?`+B=GM$J*%`2F2`V06*"U`29 M"7(3%"8H35#U@-8J__>T2MC0>:D7-&^YTGOS(#4BS9Q&7;+K)%W_+!);)+%( M:I',(KE%"HN4%JGZ1&LDG11_1^:$#1WT]##<)-_1V_2@1&.=["1=)RT26R2Q M2&J1S"*Y10J+E!:I^D3K)+U+:)T197=>VUDDLDALD<0BJ44R MB^06*2Q26J3J$ZT9M#&8$!:AUILAB=?NX-HWMYU%(DE\>K?I!6JI!RKN1`A4 M8AFEG:9O%.A&62>"46X9%9:FM$C5K]):)N:*_MYB_/@2:KUEDO1;9I%($KUE MRU!_I7$GPBM-+*.TT_1;9AAEG0A&N654=)J^D?$6578B&%5](ZV+&Z.+2?G,M$DGB]T__7K`VFMN)\%(2 MRRCM-/V>&$99)X)1;AD5G6;$J.Q$,*KZ1EISQ29\0D9;N=Y'A?J-M%$$U$Y_ M[9+$-DJ`^"21`G%A9J,?TMAF\,!3N(^$TB`NK7>8%1&$,5M-.&ZWKAVCSN$VC8/`4:-<^@DN;!R@M] MXPC.(6'O`FC4NX1*/7%/?$ABG)HK:%IS?5G$_GK"L@BY$5B)O+!;J9W8*I/* M6W4H`F)5#,1S2@+$A2D0%V9`7)@#<6$!Q(4E$!=60&VAWAEJ^Y3."+G1&8FT MP"Z-+?%.[)A%KWC=(R#Z2^]]VPJL*E3K[GO^& MS0N@4?,2*F4>^FO',=I203.06+'_GI!8M5WOGT@DTA*K$.`9F2' M"NUSK%+)A5\ZZ]`X"R:V=0HTFJD,JE]:YU#TX_J19UVB\)?6%10#817[_PE+ MHL:%_I)(I(55(8Y.Y%JJ&(BCDP!Q80K$F,>CGT+!Y`31J7D(ES=W`7:[-ME30#"16#`X3UD7.&=JZJ-&# MD[%S%>+\1$"LBH$X/PD0%Z9`7)@!<6$.Q(4%$!>60%Q8`0TD5NSZ)W1&#@E: M9]3!="H=PG5K[TK2.RXTIPT95%:N;Y+4ZA_@@7B\$1`')X8B,.3`'%A"L2% M&1`7YD!<6`!Q80G$A160'5=OVL#5RHW.R!G,V`V87[*HPOX&%FATW6.HU+J[ M&V\3F!M8:#A4*="H>0:5,M\L5Z%KGF&A8?,":-2\A&K$O()F(++31B[/'KD4 MTB)KCURV*@;B`"5`G+P4B).7`7%A#L2%!1`7ED!<6`$-1);:/N$,*X)IC%P* M:9%US;%H!Q4O?`0TNO`Q5'+A/9^^DW6-'4<"#9NG0*/F&50J5<&:QB+]L[$< M$O8N@$:]2ZA^[5U!,A!8,0E]_(V/S@36LEBSU$ZI^I\1`'%\8B".3P+$N4N! MN#`#XL(ZNY_J!D:D$$O9.@;0G97IG4$GOP%T':^-8R"%A[P)HU+N$ZM?> M%20#>17#T(15D;.3MBK6.+6CDVV[4)R>"(C3$P-Q>A(@+DR!N#`#XL(0X-FQ=`H^8E5"/F%30#D9TV=7GVU*40 MK3T&Y!T0!R@"8E4,Q`%*@+@P!>+"#(@+#>@SS*M4ZSEG7[(.X.*ZOF38//3 M_1PJ?NH%T.A3+Z$:M:^@LE/K3QN^6KD^8BC43RT09R@"X@S%0)RA!(@+4R`N MS("X,`?BP@*("TL@+JR`[-2*+Y`GI+:5&YT9&+[,]]>=JJ,-"@[Z"&ATY6.H M9&B]E9CG-\:W1@E$[)X"C;IG4"GW=1CZWMHXX'*(V+T`&G4OH5)GVO72<>EZ M4'VG7$$T$-IIXY?XMMH8,A320FN/7[8J!N(()4"6 M0%Q8`0V$EOH^);1";H16(FTWNS8^A-K15\CFY@"(_L+G.>M,"Y6*54@?;+JN MX9Y`Q+%*@4;=,ZB4.UUAO-XXQMXCAXC="Z!1]Q(J%5HW#!S/-[;Y%40#H9TV M@OGV"*:0%EHUE7&$(EL5`W&$$B`N3($X>QD0%^9`7%@`<6$)Q(45T$!HIXU@ MOCV"*:2%UC,_Z]]!Q2L?`8VN?`R57/E5Z/A+\YJ7!!HV3X%&S3.HE+FWV9"_ M?BK,H6'S`FC4O(1JQ+R"9B"RTZ8PWY["%-(B:T]AMBH&X@`E0)R\%(B3EP%Q M80[$A040%Y9`7%@!#41VVA3FVU.80F+_T9TO-\8;[$Z)M,W!T/1FGV>52J[[ M)]?U'==\^TYL]Q1H-%495-(]7#K>VCK+JB?03^Q'GGGY_[TK2`8".VT&\^T9 M3"$ML%)%DQ_OT!3B^,0HY/@D0%R8`G%A!L2%.1`7%D!<6`)Q804T$%@QOWQ\ M!O/EN-.?P132SK'6IR]IE2LMI,U@KUS=M"O53"\09 MBH`X0S$09R@!XL(4B`LS("[,@;BP`.+"$H@+*R`[M3PDW/C&M=X)5!PJ%*@4>L,JL[:,:QS*-BZ`!JU+J%B M:^-`JZ!HK?6P3IN]Z.9&<\)0J&)WFQ?K+5W+3GS1/5&Z MH_1]_US_8W]^/KY=9J_U$RVKTUZO?I;WI,I?KLT[+3?=5]ITZW]JFBM^$0_0W8U\_Q<```#__P,`4$L#!!0`!@`(````(0`XLECQ M50H``!0P```9````>&PO=V]R:W-H965T7-\V.R;8WTW_E&WXS_N__ZWV_?F]*U]KNOS"!2.[=WX^7Q^64VG[?:Y/FS: M2?-2'^'*8W,Z;,[PY^EIVKZ/C;EOG MS?;U4!_/6N14[S=G&'_[O'MI4>VP'2)WV)R^O;[<;)O#"TA\W>UWYQ^=Z'AT MV*ZJIV-SVGS=0]S?PV2S1>WN#R9_V&U/3=L\GB<@-]4#Y3$OI\LI*-W?/NP@ M`I7VT:E^O!M_"5=5$HVG][==@OZSJ]];Y[]'[7/S+DZ[AS]WQQJR#?.D9N!K MTWQ3IM6#0N`\9=YE-P/_/(T>ZL?-Z_[\K^9=UKNGYS-,=PH1JS M&R3\XCVO.RR-`_RBP_5!3G45=$65;\Z;^]M3\SZ")Q4FNGW9J.<^7($:5I,. MLZ^OGY47U)42^:)4[L8P?"B=%IZ)M_LXF-].WZ".M\9FS6U":I&AA2I:)9O[ MH/!!Z0/A`^F#R@%32$*?"2CFWY`)I:(R@3&L$=C41%[8:($NN0\*'Y0^$#Z0 M/J@<0,*&1_$WA*U48"5Q"B!)O#C7VB:$@?15DGJIZ$WZ7#!2,%(R(AB1C%0N M(1F!->8W9$2IP$,%=^FC39*8QKLV1M=2TIOT*6&D8*1D1#`B&:E<0E("JY&; MDLM[#2X&RKB+'$>\-B3H5H9P1I.0F:OP7/:9D8*1D1#`B&:E<0J*"?7-X5,J81F4( MG3Y_9>R-^NECI&"D9$0P(AFI7$("#:%;'1YI9TU#1>3&&@5+KU2M51\L1P5' M)4>"(\E111`-6;4+3LGJ!FFB&KKS\V[[;=W`,PZYX#-``-: MAQI%7;/?664[]B?A,1^'.LD8Q/#?.TNQO@-UM(#Z[KN6(W/8A2KT'I4`KE>.W^UD\BX/0 MF]`2;:RX0'157**5%H^"61)%7DM7H4TG3DM#]1+#2T-9>Z6A40J+D9,Z[Z4B M"[55-.^?K!S1K$>%03/=@"S"(/`>H1*=K(Y`9'4DU4D2IE.A4Z=#$Z+:G.$) M,4V16TL:+=3*@V]9?D5DZDN`>E3L;.<<%08M9KHA"V80",L(4Q)<20Y0JH@; MS8GJB(;GQ/1/;DXT6D##T>`)E5Q(<"11 MR*W<:.9MZ!5QI%E1[=/PK)AFR\V*1MZJXRT,6:BM2*D89+4*M-*KP#SQ-^L2 M#6S%"4161B+2,C=A$D9>P55HHFYF<^C,(Z]#QPEEQ(&.5+2DXK#-`D#MO+J(>A1T?)1[9N3 MK0\V9=/LN6G1",H'6X`LU(C4BD:)71X+8Y7:KQ\E=Q0&.8Z2.U;$D<0'S0*) M[Y>JH1.A&XY!2VC,^K4D2;TJS8R56PT&S=U-GN_5*`^]3"_/5H62RXM!\G*0 M?$7D:595/^I4C9_5OYJ7G_6Y3HL7\487$6S4-FY_%ODH.^!L#>P98% MTW@Y6ZZQ@A4;GZ3<(/(U($F];\J%M4+'DB/!D31(WY&&K9J-_SMLW;&0V39- MC(TQBQC*#5JZKZO\(P@ZVG?]$AUM,0E$KA;_"():W;AH)E37XV3B@]50]T@D M9--)N0-(4N]%(XN,E1UY;E`R[UY/;F+/I4`7*NR]=91H987%!\(277XF3/*C MWCF&YZ>SIEV80>H1[-N%)/6_F*"5;=>'U\@3ZV82T161GQD8Q$ MGTZ&QNZU4-=K(^:MDD%JPW1B]S]YH)6=PMR@N?KB^'9_`__R3[_J%>ACM^42 MD9415(:I2'3I5&CH7LOT0>B\+U)KFOINX4[[TBOQ#(WL=.4&F5F?\TGO=?O% MD*L(JV(3SWISB8X79AYFS*WZ7]H68B7B/0P:>07AO\@;1VA$,,;Q]:4Y]J#V/> M'AH$-85YR1"Y%:0=8_O26J"5=2P164=AD.,HT>I"A:B.S-DW?JU"3%MGG^)U MK)%7(=[2EZ&5G;G#)*7'\G3>E!]X)44#GM#C4TW MZ>;0(#O\#*TLRCDJ."HY$AQ)CBJ":-P7>LX4-H]/OHS&O.M$1-XO9OX7#VN% MCU'.4<%1R9'@2')4$41SX36B'^PSO..$I]6\+-D5B/\#I+6R(?>.B`IN57(D M.)(<5031D#_5<<:\XT1$9]G_Y&"M,+Z2H(HB$K!8E]TF_/LN= M-=TW$=G'-^,HYZC@J.1(<"0YJ@BB\7F-HMH,YG"`\M//=,)[2$1TMKU^,+-6 M_6QS5'!4QK\"+A<]P.&B/23F M8EY"R`NPOURZRQH&=DEIK89U06<=0Q(O\"_)ZHL^X^V%L89YOSCM,(.Z*>P= MX$SVR^:I_L?F]+0[MJ-]_0BE&70'2T[Z5+?^XVP^O']MSG`<&]8Y.*0+I^]K M.!\+1Z?'H\>F.>,?D(EI?Y[__G\```#__P,`4$L#!!0`!@`(````(0#BNZWY MT`<``*DB```9````>&PO=V]R:W-H965T1PM$X<]&6] M.1R.Y\P,>4C)MY^_'?:3KU7;U3ZKAN-O7QZ6[Z]Q?QZ7HZZ?KR MN"GWS;&ZFWZONNGG^Y]_NGUMVN=N5U7]!#P_BS?9IUI[8J-W+283\+Y_-D=BCKXU1YN&G?XZ/9;NMUE3?KET-U M[)63MMJ7/<3?[>I39[P=UN]Q=RC;YY?3IW5S.(&+QWI?]]^ET^GDL+[Y[>G8 MM.7C'GA_"^)R;7S+/YC[0[UNFZ[9]E?@;J8"Y9R7L^4,/-W?;FI@@&F?M-7V M;OH0W(CH>CJ[OY4)^J>N7COG_Y-NU[S^TM:;W^MC!=F&.F$%'IOF&4U_VR`$ MDV=LMI`5^+.=;*IM^;+O_VI>?ZWJIUT/Y5X`(R1VL_F>5]T:,@INKL(%>EHW M>P@`_IT<:FP-R$CY37Z^UIM^=S>-DJM%.H\",)\\5ETO:G0YG:Q?NKXY_*N, M`NU*.0FU$_C43@+X[YD)D9X`GR/?>F9BK"?"IYX(49ZQAU%)#SY-9.E5&LR7 M47I^8J(GPJ>>&,;G)LY47F69\K(O[V_;YG4"O0^9ZTXEKJ3@!IR9^JB8AXK] MJ&!0*73R@%[NIK!HH18==-G7^SB);F=?H3/6VF;%;0)JD1D+;`-TF_M`X0/" M`6;`:*`%]?T?:*$7I&4"6AG`\@P]#L;"3,E]H/`!X0"$`W2?SR&"!3B^=$PE MA3YW M.-NE10*!]?O^0-"8!J*1>&CWC"$Y0PJ&"!XW]Z9;6-&@#.0GG4,ZA@D."0#1, M5!VG*Y1H7J%D][MZ_;QJH`Q@,](M$:QR+9E*NF`W,[E;!0J*W+TK3JZ]#K=6 M9F+.H8)#0D.A.K&Y:HE2X!(:"1R.6T/D:.WE74'+9""329_0C>$`Y1PJ."0, M-!(FZHN3]S?"U&KD)EA!(5;AZWTX#SQES%!;@%IH^R3\O+40N+P6%B>'EB6(6:(/4*<8PQ[11H:WBI7:3 MA`OOB":((TH"E>K])+2NN2049(OC;^UX8O"+,\RQ)!1D*A&D:3RGQ1+$$26! MVN60^-C*U@+H]**O8;@6%MHHM$T$FTC!1ZYPP/U8"+9@VU%6@ M("B!C5Y#-JY<6Z4@1.=6NYJ8!K(.:7H=IMZ*$^;KI&]*$.7O#,$OS>E'ZN%N MPEI$788*BM3E%R]06<"@G$,%AP2!2/@@'RS\#QTYI",J(P:"K6G(?IQX>VUF MK4PESMFZ'*Q,C^3XD`Z/BI9,P2%!(!HYJID3.=8CNL9'A9=><&#?9_70 MD,LJ3MD#G<'*LF)08=Q;HH)`E-5%2AQR)=:0_#+J&87)R=<;E58R1BJM(\&E%DK&[GRY>H* MMQ($HI%?I(AXL_9NK@9R&IY#.8<*#@D"T3`]^<-];`'4+Q25B.NB@=R>B?W3 M:&:M;.:9H!;<2A"(4H)OO*#;T=KK=@VYD8]T^V!E(V=0$3%($(A&CJ+D;)(? M%Y5(RYMS"#>0RRI._:NLM;*LN%1R*T$@R@I%R6%U?NN/M(2YD3-5RXR571PY MAPH."0+1,#WM^^A*X*(8:8AFWK]H6RN;^6&B@0IN)0A$*5TDNO"VE:T$!3ER MKMZGJA=UAZI]JK)JO^\FZ^8%WY7"1GY_.\#J1>XJ2N!-KKS&XE@1#84&XEA1-)C(PL8D2]^_9$0O,%!'4K" M1L`;'';'1L`;G`W'1B`[ZNK/O%W#B'S%QT:6,+(<\P8#HW@`^83'QB/?'\`4 MN%./C(0P!RZF8R-0`[@+CHU`#>"N-3(2!#?XZ)>/P(O^A_$9$-B(_0J_8@S' M(H_@#_'-@_HA@9]&J-9HL:`BH^T*W3K:K%`G6:;9\`7P0X%3^53]4;9/];&; M[*LM+(ZYO*VUZJ<&ZH]>/U%Y;'KXB0"H$+SGAI^$5/"$9([O2K9-TYL_('.S MX4&PO M=V]R:W-H965TK[=OUVK$3V MZ]?ED:[_\+)Y/[#:=G6.W':Y__;]_.&[D"%O;5? M/]VU'[SAHN>W._>W98#^NUG_/%A_MPXONY_I?O,XV[RM*=HT3FH$ONYVWY1I M_J@0.7?`.RE'X%_[UN/Z:?G]]?COW<]LO7E^.=)PAW1'ZL:&CW]%Z\.*(DHR M5WZHE%:[5[H`^G]KNU&I01%9_KIK^W3BS>/QY:X=]*_"ZV[@D7GKZ_IP3#9* MLMU:?3\<=]O_54:>EJI$`BU"GUK$ZUU=>]U!<$TB)QQ[VI$^M:-O3G["CU3+ MJZ9/<\*;,.SU;SXX8U][TJ?Q/.=2K[4C?5YTJ331RDNE3W-"K]?MJ_B>N,6! M]J-/XW?.A7J40^49U1_:-;CJ^>'U33FF)\[I<3:H/^J[/"NN'B50=5:326+ M5C>*U>%]J=9*;ZAD>0I6%UY/RM_-29J,2N5!R=RU*4UHNAUH(?EQ'P;>;><' M3?Z5MAFAC6,Q9@LUTY5LY(+8!8D+4A=D+LA=,''!U`4S%Q0NF+M@88$.Q;H. M.&78WQ%P):,"SJ$:,3`CX,OXC]F"72(7Q"Y(7)"Z('-![H*)"Z8NF+F@<,'< M!0L+B.C2)/P[HJMD:#.QTMGO#V0X1Y6-6CI,SDN3<6U2AQQ(#"0!D@+)@.1` M)D"F0&9`"B!S(`N;B/#32O9WA%_)T()$IS&A#9QT'FFC4_&O3>KX`XF!)$!2 M(!F0',@$R!3(#$@!9`YD81,1?UK`1?R;"RE>M)5U&68.ST@3TJ\#'_CN*ET; ML5L$)`:2`$F!9$!R(!,@4R`S(`60.9"%3414J=RZ(*K*6D95DUZ]6(^!1$!B M(`F0%$@&)`)P'<6D[@VXIQ.0"BM;>S)$<@E/ZN- M6"@'H4EM8POUI-"T-F*A&0@5M8T1\KI]*32OC5AH80N)45)]M5T,-HP&%?X\ M',I:#D=%[.$`$FE2=I7ED,5`$O!*P28#DH/7!&RF0&;@58#-',C"]A(AI(Y' MA/!3B:Y$9&0KXML[8N"'WT M'.U,&_7+EB`(PX%WN>F$KBP10C:O( M@-.3J#278ZV1WS?[!:/K&D4:!0;%C$Q7D*!CRE;&,6-D''-TG+"5<9PR,HXS M="S8RCC.&1G'A7"4(56]E+TN?6I2J<<"SJS2R)E6S@(Z9BMK7FD44!:8.0,3 M2UOU*".,%6$M8&IWLW-"(W$LM)U5LPQ.U;/)*LG%;4C;[,Q6B6(4D09 MHAS1!-$4T0Q1@6B.:"&0C+YJ_^SH?[#"Z6XQJ->ND>KL5.#M?2GPK^7&,#96 M'-((48PH090BRA#EB":(IHAFB`I$!5X M$U)`,5HEB%)$&:(;$6/%6CEJ38R5K>7V(\:*M6:H51@KHX4M MB;%BK870DJ.FFLH+)H+N0>WEID+66(P]0!$CJS-!E#`R+6?*R#AFB')&QG'" MR#A.$"D7&<(UHP*AUE2%4':(?T-1''FZM3S=I["569@B MC3[H5-B*YM:I@DI?A)%/V9'6.N/HUFL96U5UO^=[0=B5>U*N37RC/6&OD]I3 M;45O4ZTK<&O!&KWE[X0VC(=5#=KI\,'&WK5_(IQU_VPW;)H9(K^ MR*N0:%DT,GU`HJU\XYBB8\;(..;H.&$KHS75J&>R=H:.!3K.&9DS+H2C#*GJ M#^V0?FZ&55VFB+1N/.4,@Y9%6YDTC;P*?=2R5%8?M2P@GYXEGVFK7E7V-\\P MT)Z MLKEIYM?V9[_9]>NVV2Q<8>!4&B.VLIDZ=-C96)LI:RZP&,5HE MB%)$&:(?)3F:L6"L76C(,JL>SD^U3F[SZ*I4;'6@>Q]K* M"EBDD>PG>T[%&ALKOJ,$M5)C9:+CATZD,V/%6KG0DM&YK&^CQ]T0A@KU['(_ MZ+FOH[4C#1-?5*11SY2C,2-3"2;HF+*5<Q.36+&V"JHVZTL0!OZ-.TL2E$K9STAEC.SDAM=NN="2P5*%+`2KK[XHV_06 MG3"_M_6K$EC$J$(BZ[PNS#1=.YN\B+06M70GTZYR#*O:^8M':3'PW-XZT5HT MX#R1T[/D,VW%\K])._OB120#MS@_/6E+<[F;:212+.@YTVJLK>P48V3JCYBU M_'**]F]"[\9SYG_";B:=4D9&*9-*PH>2"'Q*UNJX+CXIXNJ,M>,VO#P.G71FQ%%UAO M*8[-V-CPJ$>(8D0)HA11ABA'-$$T131#5"":(UH(),?CLCI8/=UT*CU&=*2. M,?9TQLI$66N9)2!&JP11BBA#E".:()HBFB$J$,T1+02245;5L+W3?3"AE+FS M/FMD@C4.`$6(8D0)HA11ABA'-$$T131#5"":(UH()$-*R]\E(57F3D@K%)I7 MX&.JBI25W:)HU+>7$&S@C!6G=X):J;&RIDK@;(V9L6*M7&C),*ABV\ZL3S5P MJOAQHU,A$9T*B>A4J$^KL37YG4:&1II<;*:&$#9ZQ8*Q=:,CIN M.?[!O,/2.ZA02(EAW2#L(965J(NTH]FX8]8RC]\3C2S'E*V,8\;(..;"4=ZS MJA+MC/C@GJNBTBZEU0-VRH90#"I\54];B:)'.])''2SLX+1COUL6/4%`+9S[ MVC=!\92OZJ1X)L6]D'H;]TEO+L1%[-1+@PMB5YK+146COGC>TW-?;F@K:]@C MC:B8Y;R.V4KOKH;7:?5<_(J7M\/ZVQM4O7$=>;ZB^ M,4)IXQQY\+WA`U7B>(1>=@S5@_ZF(SX=:?8)Z$BYA+OG"8+A`]U*@QH=4<5G MTQ&Z:BJ8FHZ$=*3T/U?!B/T//@H7K:BT?H MN2KY-)V%GI*23].1*.A3<)NN@,H6"F[3D8C&HW$X:#2:^.1Z2#\*P.LMKH?T M'7_D]'VC84Q?J\$C].VA8=9XA+X+-)PV'J%O]@SGC4=&'B4]?5L0ST/?\Z,C MY&UL MK%C;CJ-&$'V/E']`O(^YVF!D>S482%9*I"C*Y9G!;1L-T!8PE_W[5-'=3%_( MQ"ME'];C,Z<.=;JJJ^G9?7EO&^N5]$--N[WMK5S;(EU%3W5WV=M__E$\Q+8U MC&5W*AO:D;W]C0SVE\.//^S>:/\\7`D9+5#HAKU]'<=;XCA#=25M.:SHC73P MFS/MVW*$K_W%&6X]*4]34-LXONMNG+:L.YLI)/T]&O1\KBN2T>JE)=W(1'K2 ME"/D/USKVR#4VNH>N;;LGU]N#Q5M;R#Q5#?U^&T2M:VV2KY>.MJ73PWX?O?" MLA+:TQ=#OJVKG@[T/*Y`SF&)FIZWSM8!I]_>@EA;>QG<-N M6J"_:O(V2#];PY6^_=37IU_JCL!J0YVP`D^4/B/UZPDA"':,Z&*JP&^]=2+G M\J49?Z=O/Y/Z,#!6L*,BL_#4J5;2!!.!_JZVQ-6!%RO>] M[<.#Z]-XW=O!9K6.W,`#NO5$AK&H4=*VJI=AI.W?C.1Q*282A?XZBJ<,/GDJY#>E#I\\T/-6\7H=;N((,#/28=ZGIOIF M07^"N^%68K=[R<:VQ!HRA7E5_VU18351Y!%5]C9L+%BO`3KA]1!&\I5 MG).:'$]E'`4#2X6RF0[D.E!(@`..9EM0T__!%JJ@+9%0*H`/G[[F03!$2*8# MN0X4$J!X@);2/02P29;;6U0"@Z"1E4ILU1Q3QO'@N7.YUBKE.%-F'P:2&T@A M(XH5:'#="N[4[^PR5($^A:?,>8>QJV:>0 M0D:4_*+OR0_):GX,\:=#89H/1P/)&!(HRQ5K1($V-@LA-:FK]O"DDCKI\_7WD*W98Y`/ MNVN>!+&6Y)''^=%<@DQ`;B=WH0_>M,%:"*%)6_6&)]C]WI"M>6.0 M5KI0+QUGR:5;"%PPQUB\=`]^N'4#?2@4>!Q"6OY"Z?!8N]\>LC5[#%)*MS5* MQTERZ1;B%MPQ%B\=NH/70&WD%7AHHKN%XN&Y=K\[?@H&#U8&N'20,2W M%;VJ#%*J&L8;O6DY2R[K'"BF=L[E>0V#*-Y&6U?KD(*3EFJ(1ZYDZS^&"S^@ MY1HR2.I]=NMB5X66]!=R)$TS6!5]P1L5CHD99;>]+$K@8`5'.AXG<$R9.-P. M'Z>30N.G>&M:>*/8?+(;I_Z`\($WN7,@'23P*L+X,X< M`+?%6WDAOY;]I>X&JR%G\.Y.QW_/[IOLRTAOL./AVD='N"=./U[A[P($[C#N M"JI]IG047_`!\U\:#O\```#__P,`4$L#!!0`!@`(````(0!H+C62L00``(82 M```9````>&PO=V]R:W-H965T&9F2-2 MJ^\O9>$]LUKDO%K[T2CT/59E?)=7A[7_]U_WW^:^)YJTVJ4%K]C:?V7"_[[Y M^:?5F=>/XLA8XR%")=;^L6E.RR`0V9&5J1CQ$ZLPLN=UF3;X6Q\"<:I9NI.3 MRB*(PW`:E&E>^6V$9?V1&'R_SS-VQ[.GDE5-&Z1F1=H`OSCF)]%%*[./A"O3 M^O'I]"WCY0DA'O(B;UYE4-\KL^6/0\7K]*'`OE^B29IUL>4?)WR99S47?-^, M$"YH@;I[7@2+`)$VJUV.'1#M7LWV:_\F6F[CB1]L5I*@?W)V%MIO3QSY^9,9&!4809Q0E%RG@!`/CTRIQ*`XRD+_+[G.^:X]J/%Z-XGD3)%/[> M`Q/-?4XQ?2][$@TO_VV](A6KC1*K*/A64>:C610NQC/$N#!OK.;A6\T;3T?) M+!Q'M+@[,6C12S+NTB;=K&I^]E!A@"=.*=5KM$2PCH4V0L_+>[2`#PIR0U'6 M/EH#&Q;(Y?-FLHA7P3/XSY3/K>L3F1[;SH/2!G@]1I#S!1@I"F&D5!+HV\[P M!MJ"O.T\;$`@Z@L`492UCT^-M+%)R6WK$P%([Y28+MO>Q48Y^1*4%`7%8<*< MF!ANE=,EF+V+#1/UJI,YW']=H9&S1--G45E"675Q:`+;JE%45L^?7IE&F4VO M`4+.)A!ED9(E"VRK6XR59N9*U'0SM&_7N!]N.XIC@E`6D*WMUZZ8WLE.!3W; M-#&XG`IR-A=7%HT!W6(PL#!7(@;&Y?&?26#!,!@T129[&N)3?$&UTK?ZVTHDN[?M"A@8TDX>9Q<.;ET,$ MB9\&[7(QD$)9>>A,.A'*2YI,(DC%M-6(B#CY1$N04-E`E,ED8FXST7LY3&"B MCNU_F"!OJR2426="-YE,D&193'RN->@T8R-1)JRNZADG`#Q=Q8RO4DSI;;9'9]*H,$Q&>\1?I)@RCH5#B:C>'$GH MG`E[+[LFXJL44WI;`'1Y;(\0G9?DQB1B0#$_5Q.Q*YF=R:3".IQNW[P<*DC> M-!&[+)FXYME"I4S:MMN+7'MW*5E]8%M6%,++^!-=TN"_6?7F]@9Y&\>X0L;T M2'1&QAB1#TM[))HNMQ"I@3G1#".SP9$Y1N3%PHFVP,AB:$X<`H&\H=IS8KKX MRENB/1)A#LX20]@P!X_RH1%P@"?QT`@X:`\,SCH3C$CJG9$$(_(V;(W@MGXS MO`HF#*U.J1FR`]107FXFB#\("5@'[#*40&90*#?L=X"W!* M#^SWM#[DE?`*MDX3V3\-/Z&^\"N`-KO_RYQ'O>QCNGB&=;/:< M-]T?Y"?HWR!M_@,``/__`P!02P,$%``&``@````A`"^GM>$-*```*_@``!D` M``!X;"]W;W)K&ULK)W90:;[EIB9 M3"ZR*AUC+MB7L;$S,]=J%:M*UB6Q3&1W]7G[^2,1@5B^4%+@45\T55]X!(#? M'1'N`!+XZ3_^_?F/5_^Z__KXZ>'+SZ]7;RY>O[K_\O'AET]??OOY]?_YS^)O M-Z]?/3Y]^/++AS\>OMS__/J_[A]?_\?[__D_?OKKX>L_'G^_OW]ZI1&^//[\ M^O>GIS_?O7W[^/'W^\\?'M\\_'G_12V_/GS]_.%)__GUM[>/?WZ]__#+J=/G M/]ZN+RZNWG[^\.G+ZVF$=U^_9XR'7W_]]/'^\/#QGY_OOSQ-@WR]_^/#D_;_ M\?=/?SZZT3Y__)[A/G_X^H]__OFWCP^?_]00?__TQZ>G_SH-^OK5YX_OZM^^ M/'S]\/<_=-S_7EU^^.C&/OT'AO_\Z>/7A\>'7Y_>:+BWTX[RF&_?WK[52.]_ M^N63CL#(_NKK_:\_O[Y;O1M7US>OW[[_Z:30__UT_]=C\.]7C[\__%5^_?1+ M]^G+O>26HXP+_O[P\`]C6O]BD#J_1>_BY(+_]?75+_>_?OCG'T__^^&OZO[3 M;[\_R=];'9(YLG>__-?A_O&C)-4P;]9;,]+'AS^T`_K_5Y\_F=B0)!_^_?/K MM3;\Z9>GWW]^O;EZL[V^V*QD_NKO]X]/Q2BO'62]?G.YWE[?G([AS.:O;$_]]3U7 MEQ=7YMC/]+NV_?37]KO\O@WJM#OMJOZZ#9Y7]M9VT%_78?WF._9PI4`Z;5E6"J)IHSZ:Y(KOV5T702L?0M\IZ2NM9<`76CQ#< M#&,$=U+M'/`>6"?J.@O7Y9""8PJ*%)0IJ%)0IZ!)09N"+@5]"H84C`&(U-7) M]R/4-<-H'0G">7UU&\NYFVS,C.%C/C;9SR:SY"!'D`*D!*E`:I`&I`7I0'J0 M`60,222_)K`?(;\91A.2-N.EO=C&XNZLT3G]9Y-9?Y`C2`%2@E0@-4@#TH)T M(#W(`#*&)-)?$WBD?SZ'1*X\_"KZ_367HV0`J0$ MJ4!JD`:D!>E`>I`!9`Q)I*J2JP6J&NM854LNY\EZ#W(`.8(4("5(!5*#-"`M M2`?2@PP@8T@B"95G+I#06,<26A('9KK`S49S8((<00J0$J0"J4$:D!:D`^E! M!I`Q))&JI@8.D[?SI[NQCE6=R"DNHW&5?$;COC`I-,.<-NAGD^W%53*-6Z-S MT_AL,OL5Y`A2@)0@%4@-TH"T(!U(#S*`C"&)]#>M2B9R3>Q M]GMO-2M+="0JB$JBBJ@F:HA:HHZH)QJ(Q@C%*IL4_?M/'U-,)N>/0\',3G0@ M.A(51"511503-40M44?4$PU$8X1B24U>'DIJ9H[-C;EP8\O9[Z\HS5!)4%L4 MKP))F;DW&;GIZ)UR(#H2%40E4454$S5$+5%'U!,-1&.$8@^8W#STP#-3ATWE M-W-NLC-IM_3CJF`N3T1#OW!9.(V#=>$ZGIMVSDK>G'/1I`38>QL_?YF=U.#K M^8".M"J(2J**J"9JB%JBCJ@G&HC&",6N-@GK`E=/^:W']7626NY7 MLY6+T@/1D:@@*HDJHIJH(6J).J*>:"#2K9G3*:Q90L<8J[RL.EBQ/+`H,[3) M7$,'OG0EL!EP?*'G)ET)YCS9.QMSU&SC70UT-%?5X\6A("J)*J*:J"%JB3JB MGF@@&B,4N7J]K%XXF<>IE47)2I"LR7MO-:M,="0JB$JBBJ@F:HA:HHZH)QJ( MQ@C%*B^K%]:L%QSRJ>F>Z$!T)"J(2J**J"9JB%JBCJ@G&HC&",62FEP]G4C6 MVS?*.!;>@%K;K#]8)!R*RX5D=ME[*Q_3J"".M"J(2J**J"9JB%JBCJ@G&HC& M",4.6%8NK%DN6,1%8OV#RH73."@7TKLQSNI!MO*M9+M"J("J)*J*:J"%J MB3JBGF@@&B,4N]JD\>&Y=KXR-"6[62O#$VHN!/Q"O,'Y-!MYD8&.=G2M-\ZJ M("J)*J*:J"%JB3JBGF@@&B,4B[RL6EBS6G#(*[,G.A`=B0JBDJ@BJHD:HI:H M(^J)!J(Q0K&D)L,-X]8DFR];(VRN'(;TG#[[D%Y?)Y/+?CU;N6@]$!V)"J*2 MJ"*JB1JBEJ@CZHD&HC%"L0.6%1)K%A(69=8(DY"GOC6U^-+5WR;V42&QND@* MB?6<_GMGIX6$M_&NGKLY=*150502540U44/4$G5$/=%`-$8H6SE)#T1'HH*H)*J(:J*&J"7JB'JB@6B,4*SRLD)BPT+"H2BU MO4BG+6_E5;9C^=7E2*N"J"2JB&JBAJ@EZHAZHH%HC%"L-F]B`V+"XT*HA*HHJH)FJ(6J*.J"<:B,8(Q1Y85EQL6%Q8Q(5C\X.* MB],X:7&Q2MRXB@J@DJHAJHH:H)>J(>J*!:(Q0Y.K+9=7%R3RN M+BQ*%HGTOI^WB(Y$!5%)5!'51`U12]01]40#T1BA6.5EU<4EJPN'@D6" MZ$!T)"J(2J**J"9JB%JBCJ@G&HC&",62FIP]S&Y>_EC3I4W_@VM0#L6K1'KO MS5OYH+9C>3\=:540E40544W4$+5$'5%/-!"-$8H]L*R4N&0I81%7B2L?TRPE:%40 ME40544W4$+5$'5%/-!"-$8H=L*R4N&0I85%FD?A!I<1EMI1(*L*=LSJ[2+"4 M\-V<]X]$!5%)5!'51`U12]01]40#T1BAR-7;9:7$R3PN)2R*%XG;]$:%MW*2 M'HB.1`512501U40-44O4$?5$`]$8H5CE9:7$EJ6$0\$B070@.A(51"511503 M-40M44?4$PU$8X1B24W.GI82+[J;O;79?U!).!0M$K?)U>R]M_(Q;)[0^J)$[CH))([E3OG-6Y M1<+;>%>SDJ!50502540U44/4$G5$/=%`-$8H=O6R2F++2L*B9)%(KOSMO957 MF94$K0JBDJ@BJHD:HI:H(^J)!J(Q0K'*RRJ)+2L)A_SLLRV_E8YJ5!*T*HI*H(JJ)&J*6 MJ"/JB0:B,4*Q`Y95$EM6$A9E%HD?5$ELLY5$5Q(6)8M$4M/MO963]$!T)"J(2J** MJ"9JB%JBCJ@G&HC&",4J+ZLDKEA).!0L$D0'HB-10502540U44/4$G5$/=%` M-$8HEM3D[&DE\;+GFZYL^A^4$@[%JT22@^Z]E0]J.Y;WTY%6!5%)5!'51`U1 M2]01]40#T1BAV`/+2HDKEA(6<94PDPF<^X('8T_CH)1([BWMG-6Y5<+;>%>S ME*!50502540U44/4$G5$/=%`-$8H=O6R4N**I81%9A/S[]G7M\EZO?=67F66 M$K0JB$JBBJ@F:HA:HHZH)QJ(Q@C%*B\K):Y82CCD9Y\]T8'H2%00E40544W4 M$+5$'5%/-!"-$8HE34N)\P_F7;%><"@.W&0*V7LK'[BL%VA5$)5$%5%-U!"U M1!U13S00C1&*55Y6+URQ7K`HLQ+\H'KA*ELO)#=%=\[J[$K`>L%W<]X_$A5$ M)5%%5!,U1"U11]03#41CA")77R^K%T[F<;U@4;(2))[8>RLGZ8'H2%00E405 M44W4$+5$'5%/-!"-$8I57E8O7+-><"A8"8@.1$>B@J@DJHAJHH:H)>J(>J*! M:(Q0+*E)S--ZX45W'JYMBA^4"P[%BT1Z>]I;^9BV8WDW'6E5$)5$%5%-U!"U M1!U13S00C1&*';"L7+AFN>"0%VM/="`Z$A5$)5%%5!,U1"U11]03#41CA&)) M307R8V+:C)3,TQ:%,;VY2.\07\]6/J:!CK0JB$JBBJ@F:HA:HHZH)QJ(Q@C% M#EA6%YG7KZU+4&"UXW1JB`J MB2JBFJ@A:HDZHIYH(!HC%+MZ625QS4K"HBCQV5RDMZ>]E5=Y&DL='3K2JB`J MB2JBFJ@A:HDZHIYH(!HC%*N\K)+0ASEP0EGDQ=H[*X\.1$>B@J@DJHAJHH:H M)>J(>J*!:(Q0+&FN@C)/:"S\D?GU7$&Y*-PY%"\1Z?UA;^4Z'HB.1`512501 MU40-44O4$?5$`]$8H4C^FV4%T\D\7H@MXA)QDU8)+UPB3N.D2\0Z6>EWSNK< M$N%M9E<3'8D*HI*H(JJ)&J*6J"/JB0:B,4*QJTTR'Z9CYR\VW=CJ' M`ZV.1`512501U40-44O4$?5$`]$8H5C2M%AX)H5A37!CD>;U^4;O)OWLQ=Y; M^<"=.SITI%5!5!)51#510]02=40]T4`T1BA2^79937`RCVL"B[@2W/Z@FN`T M#FJ"I+3;.:MS*X&W<7X]$!V)"J*2J"*JB1JBEJ@CZHD&HC%"L:M-8O[]J=7M ME,>';X:Q*%D)TAO0WLJK/(T5U@2T*HA*HHJH)FJ(6J*.J"<:B,8(Q2HOJPEN M61,X%*P$1`>B(U%!5!)51#510]02=40]T4`T1BB6U"3F8>"^_$?_MS;'#^H% MA^)5(KT)[*U\4-NQO)^.M"J(2J**J"9JB%JBCJ@G&HC&",4>6%8OW+)>L"BS M2J3UPOEE_G8N"YP?=@YY/^R)#D1'HH*H)*J(:J*&J"7JB'JB@6B,4.RM-.7_ M;YPO+`=N+8K/E^0NSMY;.3\=B(Y$!5%)5!'51`U12]01]40#T1BAV`/+RH%; ME@,.A4'-72RK!R;[N"!PC'/]ZN('E033 M0*@)DJO3N]GL7%$0&,T>SS!]?,_LO+;I[S#KZWM@^OP>F+Z_!Z8/\('I"WQ@ M^@0?F+[!!Z:/\('I*WQ@^@Q?R!+O+RL15A>L$1R+BX3T19[ZX"%*@D.&2778 M274PJ0XFU<&D.IA4!Y/J8%(=3*J#274PJ1ZR1/5E)WK M[20QF"0&D\1@DAA,$H-)8C!)#":)P20QF"0&D\0A2R0VN7I:0KSHD;O5A4W[ M@Q)B9O'2DERB4,S;KEY\.01,#@&30\#D$#`Y!$P.`9-#P.00,#D$3`X!DT/` MY)"0)0Y95E&L+EA2S,S+*8FMG6>2&$P2@TEB,$D,)HG!)#&8)`:3Q&"2&$P2 M@TEB,$DV4F?HKK*MD&98# MK)DJA\#,_RXSV>^T?'EN9UFCK"XFIE]CN#5=.PNF/0-3:(`I-,`4&F`*#3"% M!IA"`TRA`:;0`%-H@"DTP!0:(4LD3NL3$QHWMZ>OPSZG-FN5U85E46A8IC^! MSY.[1G+`W#4T\S_&2O9[61&PNF`5X%@<&I-=P+1G8`H-,(4&F$(#3*$!IM`` M4VB`*33`%!I@"@TPA0:80B-DL<2GKS2G*^7UE?D0V#.18;_O'%XP7CD61H9C M<60D5Y'UK693B2C=5A0'`>2ORR6[;9+:<+>?VUF;!(>KN/V:+!,B4'@U/3BT2KZJO+I0ZU2?>[JIG2I#B;5P:0ZF%0'D^I@ M4AU,JH-)=3"I#B;5P:1ZR!+535*[1'6;!$>!'2;&]KNW01,'@&31\#D$3!Y!$P>`9-'0I9X MQ&2UH4>>F\UM%ARI;ID/<$D,)HG!)#&8)`:3Q&"2&$P2@TEB,$D,)HG!)#&8 M)`:3Q"%+)$ZK@^T*J@TEU,*D.)M7!I#J85`>3 MZF!2'4RJ@TEU,*D.)M5#EJANV+F>TP^RUDGEX/DC-G, M#2=G8#@Y8[8+ATNJ;/EG-G/#R3\83OZ9[<+A?#5^$D`NF\W<<'(9AI/+9CL_ MG"K^^(M_\N)LYH:3%\/A$B^:"B7TXG/3TU31Q"?*Q`+7R%U@=)`:3Q&'?6.+3][5#B5]VHIR&T0D5 M3E&6F2\2!R=`4OSO5\XLG+4L,Q^XFKNNMTF%<'1=S1>:O-E5LH7"F>E;O"[J M2L?.;Z&:S:XT)_SK_6:[O5W=^.KS=)+4SB@8OW'L_/CM;';V"#IG%FRA=^S\ M%H;9[,P1C,YH&C\)$%,+A@'RS#GHOBX>1<)43^JCLLX!3G;XJY)@4]])6ST%?.0E]Y!GWE!O25&]!7FJ.O)`[[)A*; MPB^4^(7GH*T?(^4GEIR#R;PL9U@S?X;(&1,SWP_R)U?F')S,S`=PO%GF',06 MY++OV8*\:+>P.GL.8GRY]7O&EZ?M^&>/0,['%N3\[]F"XL%NX1[,#D:3*"R6-@\AB8W`,F;X0L\88I64-O/#? M-9MU3ZF!2'4RJ@TEU,*D.)M7!I#J85`]9HKJI M8I>H;NS3C,0R/\U)8C`%-I@D!I/$8)(83!*#26(P20PFB<$D,9@D!I/$8)(X M9(G$IF0-)7[A.F0KWRC>)Z:\S@6RE`>3\A-[KFCR9FXX.0/#R1G9X5`T>3,W MG/R#X>2?['`HFKR9&TXNPW!R66:X3-'DS=QP\F(X7.)%4Q6'7GQN>K)5=.2N MB<7N`I.[+`N+)C+Y!GWE&_35B0(F1Z"O'`$[G2A@4AU]I3KL=**`2>*P;R*Q M*5E#B5]XHDR5;UPTV6I8R\^<3FW624FC<\>:^9E,SIC8^8)`$YDUTSPP;V&= M2=BP!;GL>[8@+UJSJ>10YKO9)C_>EUD3FN:R1?X, MY/"-ZW?^`%IG9CX:.$N$*:1S9DKJ7#STCIW?PN#,SAS`Z&RFX9/P,,5V>`:F MX?&=!=-F*MJC,].RTT$E6S45'+>Z^,TV*Y/^3+FKUW>[3O*,W6P63H18*=Q8 M?HD^!!V=8XX95F28(M#NFQ]/X0969YC""W:*)3`%#I@"!TQ1`J:H"%GB'U/3 MA?YY9E[>V!K0SV?2?&+Q@\WKY)+@/C!S"DOUN:MC4AU,JH-)=3"I#B;5P:0Z MF%0'D^I@4AU,JH-)]9`EJIN:;HGJM@:,5`_K0GNWR^0YYB3QLXLD!I/$8)(8 M3!*#26(P20PFB<$D,9@D!I/$8)(83!*'+)'8U'2AQ&:Z>]F#S>9:>EHV.Z8= MF*?[S3JY&J^8#RO+DY/D$#`Y!$P.`9-#P.00,#D$3`X!DT/`Y!`P.01,#@&3 M0T*6.,249Z%#GIMIIG(N7F9V7\J)6+O3RQ>9S9)&:5S;C8+5`>3ZF!2'4RJ@TEU,*D.)M7!I#J8 M5`>3ZF!2'4RJARQ1W50+2U2?JHM8=*0Q1*;BF6)Q"?[I+QR+%I,-GA%C//3"ZMD+?6A:?4` MR2%@<@B8'`(FAX0L<8A)I4.'/'=&&?MT'IM8[HPR>6$X^DO3LTN;8.I`?-Z5 M7HG:K9R9`M";Q4]>R?MV+%^VZW0$D_?!Y'TP>1],W@>3]\'D?3!Y'TS>!Y/W MP>1],'D_9(GW%R;GEYGDW+(D/4NNT$CUJ:O,@G,.3*J#274PJ0XFU<&D.IA4 M!Y/J8%(=3*J#274PJ1ZR1'63+X=GQ7/GG,VOHW7&,B^G)`938(-)8C!)#":) MP20QF"0&D\1@DAA,$H-)8C!)#":)0Y9(;)+C4.+_QCHSY=E1I=Q3S$\NL,]LT&W_I.G,:Z+2\!0M(^C#*;N7,SJXSWLAY^A!T=.R8846& ME1E695B=84V&M1G695B?84.&C3&+O6_>:;_$^R?[),NP+%EG<#/*FSF%I?I4 M!@1KCU0'D^I@4AU,JH-)=3"I#B;5P:0ZF%0'D^I@4CUDB>HF#U]PSFUMWAZ> M3A*#26(P20PFB<$D M,9@D!I/$8)(83!*#26(P21RR1&)33X0Q_\Q2OK7U1Q38$XN>JK)V`9/$DYVY MT3P7=)M-[<+CD]HT<,9NYX>2(<+A$$)/JAX),V!,S-2TP8'BFNEV,@N>MY!&MJM_CDB" M6.:?(Y(@Z"M!T%='C[XZ^K!OEIF;_I6NS5U?HVN8`FB;`%2?0]6Y!JDYG;PO7V M>GN;/G(G'<,-)#JFE<1IR97N"W[,N,U4%Y:9K'U62*_N2Z\>6;,XLJ;A=%O: M":[(LFQZ<.YOF^UF?9.>01)RL@I&DY`83:I9%H8]'C.2;.%PL6Q7N1)I??4] MK[@Y=4VR<$;H1AM(-'4Y-X+3NFK*5>/9GC+HK#;7"9GW'YES8)`.YO^'J9V5M-H MB4`FLWVR3# MEF(878I]S^@2<3)30G6*XXLWJ3^D8#AZHJ!)=9AAIF@?2#)%>OI`$IFB%7:2&DQ2@TE7,`D)UF18FV%=AO49-F38&+-$ M8I,W+I%XRC/C.<(R'5UP"N`2^]5LYI8AS1%@4AU,JH-)=3"I#B;5P:0ZF%0' MD^I@4AU,JH-)]9`EJILL=(GJ4]8:JVZ97]4URX!)8C!)#":)P20QF"0&D\1@ MDAA,$H-)8C!)#":)P21QR!*)3:J[1.(I-8XEGIAJ*Q>QDGAB47ECF9DG_0G` M,M";N>&D.H:3ZA-+ADN623EB-G/#R1'A<(D@)F<-!7E9&7@UI;ZQ3A.+=;(I MLO\=F4)Q8E?Q6IGD3(K.VNJ'9R%RR3?UDRYKTE:-AL5 M@NLDY2HRXY>.F4+DV^-7SLR.KW)O>[-)QJ^=T;3_B8HF,UT00]=3)AO%D&4F MR9UW=7.)&PK6+(B#P\HR_6[$1?S1,?-+G7DXE&@2;=J38#B)-K%@."ED[`^G-&WZ8\L=BMGIN.=Q<5LZ(U`&LR MK,VP+L/Z#!LR;(Q9XGV3.H;^>6X6MJEF6/B8]T:KR#$UQZSYYC*Y2*KS8S8+ M5`>3ZF!2'4RJ@TEU,*D.)M7!I#J85`>3ZF!2'4RJARQ1W6232U2WV6>D>IB1 MVG+S&DR!#2:)P20QF"0&D\1@DAA,$H-)8C!)#":)P20QF"0.62*QR4^72#SE ML_'$;YD<&01VDAXKL&>S(+#!I#J85`>3ZF!2'4RJ@TEU,*D.)M7!I#J85`>3 MZB%+5#?9[A+5I^PX5GUBP6+R]O'W^_NGPX>G#^]_^GS_];?[_?T??SR^^OCP MSR_RBRE_`_[JZ_VO/[^^TZ3W3O]W2F3G/E.;627>G69%^8MM6]-V*L38=F7: M3O=-V'9MVD[)=-)VIZNU9E].9V_29AZA43]=]>A,ZVF?W40[ELN]/3 MFM),=T?89AYO-?WR^W)I]D4/'6;[&1_I:;ELVXUIR\7+G7Y`JGW9Y,=4FWX@ MD3^^C3D^_0XRM[V-T7JZ4P+_;^HADKD7>U@<+E-]DAO=*0WV2.]T9'>Y([T[N;J MW9T^B9S;`VF@[[3G6J2!OBV>:Y$&^D1VKD4:Z+/.F99K[75^$3+KH8H3]KF[ MUE[?9/=:+6-^*;S67F<7PMVU]CJ_)%]KKZ]S>WVG->E.%]&X;SNS6N47JRN= M8_FEZDI[G5^HKK37NJC)[=Q=W;Z[RR<$:AEUB8M]=M>:-77M*->B>-,%BUR+ MXDV%.EONMM)`3P*P9:>6,;^8;Z7!=)TTG7ZWTD`7#'.C20,]N<&6NZTTT-54 MMNS4,NHJ5Z;E2AKHLD2N11KHD4TC[I0IW&43MIW)(?(IQ*4TR"<0E])`/T.DMWF$;^6!GK)7:Z/--"+TW(MTF"ZEI>,=K>6!OFD M3BVCKGMF1MM(@^FR9C+:;B,-\JF)R2RSB:7R/RW<60U.65=N)E>AH3P@J\%* M&GPCX9(&V73K;B4-LLG63BVC7BZ=T6`M#::[6:D&:VF@E^'F^D@#O04UTZ)= MR\Y4VK%\1JK]RN[62KNE;PIE-C&E5=D6[58VIS*WGMZ=;BQQ/',?Z9WND^0< M=Z?\)'N84B8OC'3)[9G6^-PT?:>(R6UW9^;.W#B*EFRP*%9RIXMY0E7'G5UP M]"375L>=;3-/;)I^N3'5[\KTR[5)YVNC^BU/:R;>;%DMI>MLV\)5+; MR[;M]+Y4$YI9G^I%GZ;MY->W\SGX^/ZG/S_\=M]_^/K;IR^/K_ZX_U4752Y. M#^U^_?2;N5X__<>3?:'PWQ^>GAX^Z[K+ZU>_WW_XY?ZK,=`ELE\?'I[&ULK%;;;J,P$'U?:?\!\=X` MN8,(54+5W4J[TFJUEV<'#%@%C&RG:?]^9[@50S9JI;X$/!P?'Y\9>^+?/A>Y M\42%9+S$5+^))P41`%0Y%:LA*4Q/6D(K?FMKVV"L)* MLV'PQ%LX>)*PB-[QZ%304C4D@N9$@7Z9L4IV;$7T%KJ"B,=3=1/QH@**(\N9 M>JE)3:.(O(>TY((<<]CWL[,D4<==#R;T!8L$ESQ1,Z"S&J'3/;N6:P%3X,<, M=H"V&X(F.W/O>*%CFU;@UP;]8?0L!^^&S/CYBV#Q-U92)O`W):JH9D MWI+`LR5QX/7*A$4[`9X75IU.M!K5M0EW1)'`%_QL0&6!+ED1K%/'`[)N]PU# M[\?_[``?D&2/+#L3C@3L5$(.GX+E=N-;3^![U&(.4XRC(\(.@>D">;U&L.(# M-"(+:L04HNA#%W@5/1\)ZA!C06#4!PA"%J@6S;2MKN#08+`8>F=7.B3L(6.5 MRP]1B2Q0'+I,5]=P:$'79/:0L4PX)4,S+Y^[KM`07*OIL]A&[+KJG)&PL/T* ME=7[-ZQ,K?+<#R*.+:".Z M`^.KI@>-'8!6\PX+:K2^?!NJ/6AVW+2>YM8MJ$AI2/-<&A$_85L!?.#WX;[G M[>=81Z/X`7OAI?C<"R_B%QY<#U.>_=+;P[K3#X>E%];*QPNO/:CF"_B-!\5T M(;[UPOJF'?.X7N@BWNH_0"^M2$J_$Y&R4AHY3<`4>[:!4A!--VX&BE=@%G14 MKJ"+UJ\9_&NB<)/;6#<)YZH;X`+]_[#@'P```/__`P!02P,$%``&``@````A M`$7;N,(R`0``0`(``!$`"`%D;V-07B^CW+9Z3KY!.=58RI$ MLAPE8$0CE=E5Z&FS2AO&0(5Z\&C)+B]*8:EH'#RXQH(+"GP22<93 M82NT#\%2C+W8@^8^BPT3PVWC-`_QZ';87Z--00N>>#X`$SM1$0C M4HH):3]`*PP?OGG[,O````__\#`%!+`P04``8`"````"$`Y)>Z[.4#``!)#P`` M$``(`61O8U!R;W!S+V%P<"YX;6P@H@0!**```0`````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````"<5]]OHS@0?C]I_X>(]RUIMU?=5H152JA:*6VBPNX] M6BY,$JO$9FV32^^OOR'D!]P.7C5O@+\9/L]\,V,'W[;K8K`!;822(^_R8N@- M0&8J%W(Y\KZG]Y__\@;&>]@O&_AIS^"N58E:"O`#-"%-"-O96UY MZ_LF6\&:FPM?RZ-!K M/-YN[+E."W%P-DET!6 M:6'?PV'@MU^#).,%1.@X7/#"0."?/@0/P.N@S;G0)@PV]G8#F55Z8,2_&+8K M;_#*#=1T1MZ&:\&E15HUK'G9/1>EL3K\6^DWLP*P)O`1T'S;'/42SYV0V?9R,TWC"[L;3\7,4L^0ACM/DHW@VY[\W25+\TU/\G"9L M=L]F\_BC)DDZ.\/D\J,VT9C>_P1,ID59BY:I!;NKC)!@.JHXQG8J?E8BKY.` MM0R$[Q@D9+XE624KH`]@5Z")I=?`.O>0EVIY'HBEE)@/:.2V3C+5(4: MD$LV5UAH`FOC2*U6>:.9?<]H.,9(N.SWCO7Y#]?`)-"_?Y0;)%C;&_8`1P`*TAF-DD&BD3+?"CC1Q-[I";+S%%F:@+^`2ZJQ$Z+4GP'=:Y$M@ MS\KV^5!RF8)>LPF\TKQ?(`?LIJ\%L'U7PH9+QC:Q*GM;J2+'7L[JV-IW$O>( MW7T-+.7;'D>16J_%/K"UEE!!=6)Q*O3^&@KL=:?@HNPFW')625[E@F3Q`@5J M*\P[BP7A6$IGD(J MCD>!8P\X-:VV7/9X$N>6XIRB=*+<-G3!WXZ5M.@.\%4`[KIP_!`][`=%$[B58<3S7Y`?/K0GUI_-'!UO?`G_?[_!<%/X'``#__P,`4$L!`BT`%``&``@````A`%TK(:I)`@`` M["@``!,``````````````````````%M#;VYT96YT7U1Y<&5S72YX;6Q02P$" M+0`4``8`"````"$`M54P(_4```!,`@``"P````````````````""!```7W)E M;',O+G)E;'-02P$"+0`4``8`"````"$`;[UJ"Z`"``"I*```&@`````````` M``````"H!P``>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"+0`4``8` M"````"$`?PD9O3$%``#F$P``#P````````````````"("P``>&PO=V]R:V)O M;VLN>&UL4$L!`BT`%``&``@````A`%L_62A]!```(!```!@````````````` M````YA```'AL+W=O&UL4$L!`BT`%``&``@````A`"@R1!KA`@``]@<``!D````` M````````````SA@``'AL+W=O"_T#``#T#```&0````````````````#F&P``>&PO=V]R M:W-H965T+N`(``$$' M```9`````````````````!H@``!X;"]W;W)K&UL M4$L!`BT`%``&``@````A`(,$-ECO!0``Y!P``!D`````````````````"2,` M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`"/_:E!9`@``/@4``!D`````````````````CR\``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*.8@_+"`@``2P<``!D````````` M````````)TD``'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`';*6FB'`@``<`8``!D`````````````````Y50``'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M``5HB\L^!0``CA@``!D`````````````````OU\``'AL+W=O&PO=&AE;64O=&AE;64Q+GAM;%!+`0(M`!0`!@`(```` M(0!_*,8#@@T``/.$```-`````````````````/EK``!X;"]S='EL97,N>&UL M4$L!`BT`%``&``@````A`%"!.($:=@``]X$!`!0`````````````````IGD` M`'AL+W-H87)E9%-T&UL4$L!`BT`%``&``@````A`#%@EP-C`P`` M]@L``!@`````````````````\N\``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A``K3UFSU!0``VQ\``!D`````````````````5`$!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`#`+@AOS`@`` MR`@``!D`````````````````4Q`!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`,REVMM^`@``9`8``!D````````` M````````Q!D!`'AL+W=O&PO=V]R:W-H M965T&UL4$L!`BT`%``&``@````A`#866%Z"&```I/(``!D` M````````````````J"`!`'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`.%?,Q]W`P``$0L``!D````````````````` M+T0!`'AL+W=O&PO=V]R:W-H965TH`8``&@:```9```````` M`````````(A,`0!X;"]W;W)K&UL4$L!`BT`%``& M``@````A``@HXH@!`P``G@@``!D`````````````````7U,!`'AL+W=O&PO=V]R:W-H965T!```&``````` M```````````7GP$`>&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`+6H+1NW"0``/S,``!@`````````````````FJ$!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`,4QR&;'!```Y!(``!D````````` M````````#,X!`'AL+W=O&PO=V]R:W-H M965T%`0``((-```9 M`````````````````#;8`0!X;"]W;W)K&UL4$L! M`BT`%``&``@````A`(S-NK92!@``TQ@``!D`````````````````@=P!`'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`).:A'BT!```*!```!D`````````````````I/&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`!?-6FI_#```TCP` M`!D`````````````````8`4"`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`%E0`FT/#0``0$```!D````````````` M````J20"`'AL+W=O&PO=V]R:W-H965T M&UL4$L!`BT` M%``&``@````A`"^GM>$-*```*_@``!D`````````````````XCL"`'AL+W=O M&PO=V]R:W-H965T&UL4$L%!@````!. -`$X`5!4```UO`@`````` ` end XML 19 R55.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-Term Debt (Details) (USD $)
Jun. 30, 2013
Dec. 31, 2012
Debt Instrument [Line Items]    
Long-term Debt, Total $ 10,500,000  
Less debt discount (7,728,486)  
Other Long-term Debt, Noncurrent 2,771,514 0
Shareholder Notes [Member]
   
Debt Instrument [Line Items]    
Long-term Debt, Total 7,500,000  
Placement Notes [Member]
   
Debt Instrument [Line Items]    
Long-term Debt, Total 500,000  
Management Incentive Notes [Member]
   
Debt Instrument [Line Items]    
Long-term Debt, Total $ 2,500,000  

XML 20 R46.htm IDEA: XBRL DOCUMENT v2.4.0.8
Property and Equipment (Details) (USD $)
Jun. 30, 2013
Dec. 31, 2012
Property, Plant and Equipment [Line Items]    
Furniture, fixtures and equipment $ 1,606,404 $ 1,374,126
Leasehold improvements 25,260 10,162
Property, Plant and Equipment, Gross 1,631,664 1,384,288
Accumulated depreciation and amortization (394,930) (270,233)
Net property and equipment $ 1,236,734 $ 1,114,055
XML 21 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
Deferred Financing Costs (Tables)
6 Months Ended
Jun. 30, 2013
Deferred Finance Costs [Abstract]  
Schedule of Fresh-Start Adjustments [Table Text Block]
Deferred financing costs are as follows:
 
Balance January 1, 2013
 
$
-
 
Costs incurred for line of credit for the six months ended June 30, 2013
 
 
615,754
 
Amortization for the six monthes ended June 30, 2013
 
 
(67,360)
 
 
 
 
 
 
Balance June 30, 2013
 
$
548,394
 
XML 22 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 23 R57.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-Term Debt (Details 2) (USD $)
Jun. 30, 2013
Dec. 31, 2012
Capital Leased Assets [Line Items]    
Furniture and equipment $ 1,007,735 $ 584,638
Accumulated depreciation (250,821) (153,937)
Capital Leased Assets, Gross $ 756,914 $ 430,701
XML 24 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Selected Financial Data (unaudited)
6 Months Ended
Jun. 30, 2013
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Information [Text Block]
18.
Selected Financial Data (unaudited)
 
 
 
Six months ended
 
 
 
June 30, 2012
 
 
 
 
 
 
Revenue
 
$
10,056,735
 
Gross profit
 
$
426,730
 
Loss before income taxes
 
$
(2,490,381)
 
Net loss
 
$
(2,495,461)
 
Basic and diluted net income per share
 
$
(0.07)
 
Weighted average number of shares outstanding
 
 
37,897,909
 
XML 25 R50.htm IDEA: XBRL DOCUMENT v2.4.0.8
Investments Held in Trust (Details Textual) (USD $)
1 Months Ended
Nov. 30, 2011
Apr. 10, 2013
Investments Held in Trust [Line Items]    
Investments and Cash Held In Trust $ 20,600,000  
Temporary Equity, Shares Outstanding   1,160,035
Escrow Deposit Disbursements Related To Shares Redeemption   11,948,000
Trust Account Balance   $ 8,652,000
Temporary Equity Shares Outstanding Redeemable Shares   839,965
XML 26 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
Significant Accounting Policies (Details) (USD $)
Jun. 30, 2013
Dec. 31, 2012
Significant Accounting Policies [Line Items]    
Total derivative liabilities $ 3,559,188 $ 121,350
Warrant Liability [Member]
   
Significant Accounting Policies [Line Items]    
Warrants 3,559,188 121,350
Fair Value, Inputs, Level 1 [Member]
   
Significant Accounting Policies [Line Items]    
Total derivative liabilities 0 0
Fair Value, Inputs, Level 1 [Member] | Warrant Liability [Member]
   
Significant Accounting Policies [Line Items]    
Warrants 0 0
Fair Value, Inputs, Level 2 [Member]
   
Significant Accounting Policies [Line Items]    
Total derivative liabilities 3,559,188 121,350
Fair Value, Inputs, Level 2 [Member] | Warrant Liability [Member]
   
Significant Accounting Policies [Line Items]    
Warrants 3,559,188 121,350
Fair Value, Inputs, Level 3 [Member]
   
Significant Accounting Policies [Line Items]    
Total derivative liabilities 0  
Fair Value, Inputs, Level 3 [Member] | Warrant Liability [Member]
   
Significant Accounting Policies [Line Items]    
Warrants $ 0  
XML 27 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies (Tables)
6 Months Ended
Jun. 30, 2013
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]
Future minimum payments for non-cancelable operating leases are as follows as of June 30, 2013:
 
Minimum Rental Payments
 
 
 
 
 
 
2014
 
$
207,764
 
2015
 
 
206,251
 
2016
 
 
217,740
 
2017
 
 
146,520
 
 
 
 
 
 
 
 
$
778,275
 
XML 28 R52.htm IDEA: XBRL DOCUMENT v2.4.0.8
Accured Expenses (Details) (USD $)
Jun. 30, 2013
Dec. 31, 2012
Accrued Expenses [Line Items]    
Accrued severence costs $ 750,000 [1] $ 0 [1]
Accrued rebates 364,196 77,329
Accrued registration rights Penalties 592,000 [2] 0 [2]
Accrued professional fees 290,777 50,000
Accrued expenses other 431,060 441,199
Accrued Liabilities, Total $ 2,428,033 $ 568,528
[1] Payable to a former executive of the Company.
[2] Estimated penalties relating to late registration of shares of common stock in connection with the bridge notes.
XML 29 R67.htm IDEA: XBRL DOCUMENT v2.4.0.8
Selected Financial Data (unaudited) (Details) (USD $)
6 Months Ended 12 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Dec. 31, 2012
Schedule of Quarterly Financial Information [Line Items]      
Revenue   $ 10,056,735  
Gross profit 1,019,135 426,730 1,157,677
Loss before income taxes   (2,490,381)  
Net loss $ (14,066,292) $ (2,495,461) $ (7,575,965)
Basic and diluted net income per share (in dollars per share) $ (2.57) $ (0.07) $ (0.19)
Weighted average number of shares outstanding (in shares) 6,851,819 37,897,909 38,939,909
XML 30 R61.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Details Textual) (USD $)
6 Months Ended
Jun. 30, 2013
Feb. 28, 2013
Dec. 31, 2012
Class of Stock [Line Items]      
Common Stock, Shares Authorized 30,000,000   50,000,000
Common Stock, Par Or Stated Value Per Share $ 0.0001   $ 0
Common Stock, Shares, Outstanding 8,953,494   40,000,009
Common Stock, Shares, Issued 8,953,494   40,000,009
Stock Repurchase Program, Number of Shares Authorized to be Repurchased     500,000
Common Stock Redemption Amount   $ 100,000  
Equity Issued in Business Combination, Fair Value Disclosure   480,000  
Stock Issued During Period, Shares, Restricted Stock Award, Gross 750,000    
Share Price $ 7.30    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 400,000    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 2,920,000    
Healthcare Corporation Of America [Member]
     
Class of Stock [Line Items]      
Common Stock, Shares Authorized 50,000,000    
Common Stock, Par Or Stated Value Per Share $ 0    
Conversion of Stock, Description Upon the merger, every 7.6923 HCCA shares of common stock were exchanged into 1 share of the Company's common stock.    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value $ 283,889    
Maximum [Member]
     
Class of Stock [Line Items]      
Common Stock, Par Or Stated Value Per Share     $ 0.31
Minimum [Member]
     
Class of Stock [Line Items]      
Common Stock, Par Or Stated Value Per Share     $ 0.01
Series B Common Stock [Member]
     
Class of Stock [Line Items]      
Common Stock, Shares, Outstanding 839,965    
Series C Common Stock [Member]
     
Class of Stock [Line Items]      
Common Stock, Shares, Outstanding 8,953,494    
XML 31 R47.htm IDEA: XBRL DOCUMENT v2.4.0.8
Property and Equipment (Details Textual) (USD $)
6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Property, Plant and Equipment [Line Items]    
Depreciation, Depletion and Amortization, Nonproduction, Total $ 124,700 $ 206,000
XML 32 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Liquidity and Financial Condition
6 Months Ended
Jun. 30, 2013
Liquidity and Financial Condition [Abstract]  
Liquidity and Financial Condition Text block [Text Block]
2.
Liquidity and Financial Condition
 
The Company has a working capital deficit and a history of recurring losses and negative cash flows from operating activities. As of June 30, 2013 and December 31, 2012, the Company has a working capital deficit of $3,640,546 and $4,564,045, respectively and stockholders’ deficit of $8,281,522 and $3,951,169, respectively. During the six months ended June 30, 2013 and year ended December 31, 2012, the Company incurred net losses of $14,066,292 and $7,575,965, respectively, and negative cash flows from operating activities of $4,784,185 and $7,921,407, respectively. Collectively, these factors raise substantial doubt about the Company’s ability to continue as a going concern.
 
The Company is currently making efforts to raise capital in the form of debt and/or equity. No assurance can be given that the debt and/or equity can be raised and if available it will be on terms acceptable to the Company.
 
The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.
XML 33 R62.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Details) (USD $)
Jun. 30, 2013
Dec. 31, 2012
Income Taxes [Line Items]    
Loss carryforwards $ 6,363,018 $ 2,064,222
Intangible assets 81,000 44,000
Accrued expenses 1,060,000 1,060,000
Stock based compensation 209,904 0
Fixed assets 7,409 (14,120)
Less valuation allowance (7,721,331) (3,154,102)
Total net deferred tax assets $ 0 $ 0
EXCEL 34 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\Y838S8S(U85\Y93@T7S1C-S-?.#$T8E\Q8C4W M93=F,#4T964B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3E-/3$E$051%1%]35$%414U%3E137T]&7T-! M4SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O M#I%>&-E;%=O#I%>&-E;%=O#I.86UE/E-O9G1W M87)E7VYE=#PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/DEN=F5S=&UE;G1S7TAE;&1?:6Y?5')U#I7 M;W)K#I7;W)K#I%>&-E M;%=O#I7;W)K#I7;W)K M#I%>&-E;%=O#I%>&-E;%=O3PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN8V]M95]487AE#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;6UI=&UE;G1S7V%N9%]#;VYT:6YG96YC:65S/"]X M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O3PO>#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E-U8G-E<75E;G1?179E;G1S/"]X.DYA M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)E#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/E-I9VYI9FEC86YT7T%C8V]U;G1I M;F=?4&]L:6-I93(\+W@Z3F%M93X-"B`@("`\>#I7;W)K5]A;F1?17%U:7!M96YT7U1A8FQE#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/E-O9G1W87)E7VYE=%]486)L M97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7 M;W)K#I.86UE/@T*("`@(#QX.E=O#I% M>&-E;%=O&5S7U1A8FQE#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/D-O;6UI=&UE;G1S7V%N9%]#;VYT:6YG96YC M:65S7SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-E M;&5C=&5D7T9I;F%N8VEA;%]$871A7W5N875D:3$\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K#I%>&-E M;%=O'1U86P\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-I9VYI9FEC86YT7T%C8V]U;G1I;F=?4&]L:6-I M930\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E!R;W!E#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/E!R;W!E#I7;W)K#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/E-O9G1W87)E7VYE=%]$971A:6QS7U1E>'1U M86P\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7 M;W)K#I7;W)K#I7;W)K M'5A M;#PO>#I.86UE/@T*("`@(#QX.E=O#I7;W)K M#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/DQO;F=497)M7T1E8G1?1&5T86EL#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)E9&5E;6%B;&5?4V5C=7)I=&EE#I.86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/DEN8V]M95]487AE#I%>&-E;%=O&5S M7T1E=&%I;'-?,3PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/DEN8V]M95]487AE'1U86P\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I% M>&-E;%=O#I%>&-E;%=O#I.86UE/E-E;&5C=&5D7T9I;F%N M8VEA;%]$871A7W5N875D:3(\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I. M86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O6QE#I!8W1I=F53:&5E=#X-"B`@ M/'@Z4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T* M/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@ M;W!E;F5D('=I=&@@36EC'1087)T7SEA-C-C M,C5A7SEE.#1?-&,W,U\X,31B7S%B-3=E-V8P-31E90T*0V]N=&5N="U,;V-A M=&EO;CH@9FEL93HO+R]#.B\Y838S8S(U85\Y93@T7S1C-S-?.#$T8E\Q8C4W M93=F,#4T964O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO2!296=I2!#96YT3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)S`P,#$U,30V.#(\2!&:6QE3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)U-M86QL97(@4F5P;W)T:6YG($-O;7!A;GD\ M'0^)U-70T$\2!796QL+6MN;W=N(%-E87-O;F5D($ES'0^)TYO/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO2!&:6QE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y838S M8S(U85\Y93@T7S1C-S-?.#$T8E\Q8C4W93=F,#4T964-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO.6$V,V,R-6%?.64X-%\T8S'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPOF5D.R`U.3(L-3`P('-H87)E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879AF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`P,"PP,#`\ M'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'!E;G-E'0^)SQS<&%N/CPO'!E;G-E*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M/B@Q-"PP-C8L,CDR*3QS<&%N/CPO&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y838S M8S(U85\Y93@T7S1C-S-?.#$T8E\Q8C4W93=F,#4T964-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO.6$V,V,R-6%?.64X-%\T8S'0O:'1M;#L@8VAA2!3=&]C:R!;365M8F5R73QB'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N("T@ M'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO2!A="!C;&]S:6YG("AI;B!S:&%R97,I/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y838S8S(U85\Y93@T7S1C-S-? M.#$T8E\Q8C4W93=F,#4T964-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO.6$V,V,R-6%?.64X-%\T8S'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E2!A;F0@97%U:7!M96YT/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M/B@Q,#0L.3@Q*3QS<&%N/CPO6UE;G1S(&]F*2!N;W1E&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^ M)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4@6TUE M;6)E'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&IU6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE.+51/4#H@,'!T.R!&3TY4.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E#L@1D].5#H@,3!P="!4:6UE2!#87!I M=&%L($%C<75I28C.#(R,3LI('=A&-H86YG92X@3VX@2F%N=6%R>2`R-2P@,C`Q M,RP@86X@86=R965M96YT(&%N9"!P;&%N(&]F(&UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M3X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B<[ M($9/3E0M4TE:13H@,3!P="<^2$-#02!A;F0@:71S('=H;VQL>2UO=VYE9"!S M=6)S:61I87)I97,L(%!R97-C#L@1D].5#H@ M,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4 M+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE28C.#(Q-SMS(&)O87)D(&]F(&1I65A6QE/3-$)T-,14%2 M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E3Y/;B!.;W9E;6)E6QE/3-$)T-,14%2 M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[5$585"U)3D1%3E0Z("TP+C(U:6X[($U!4D=)3CH@,'!T(#!P>"`P M<'0@,"XR-6EN.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E3Y4:&4@86-C;VUP86YY:6YG(&AI M6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)SL@1D].5"U325I%.B`Q M,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2 M;VUA;B6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE M9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\ M+W1D/CPO='(^/"]T86)L93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!A;F0@ M1FEN86YC:6%L($-O;F1I=&EO;B!497AT(&)L;V-K(%M497AT($)L;V-K73PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQD:78@6QE/3-$)U=)1%1(.B`P+C(U:6XG/B`\9&EV M/CQB/C(N/"]B/CPO9&EV/B`\+W1D/B`\=&0@2<^(#QD:78^/&(^3&EQ=6ED:71Y(&%N9"!&:6YA;F-I86P@ M0V]N9&ET:6]N/"]B/CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\9&EV M('-T>6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE.+51/4#H@,'!T.R!&3TY4.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3Y4:&4@0V]M<&%N>2!H87,@82!W;W)K:6YG M(&-A<&ET86P@9&5F:6-I="!A;F0@82!H:7-T;W)Y(&]F(')E8W5R6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG2!I;F-U6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG2P@86YD(&YE9V%T:79E M(&-A6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)RPG2XF(S$V,#M#;VQL96-T:79E;'DL('1H97-E(&9A8W1O M3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!& M3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE2!M86MI;F<@969F;W)T2X@/&9O;G0@6QE/3-$)T-,14%2.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E3Y4:&4@86-C;VUP86YY:6YG(&-O;G-O;&ED871E9"!F:6YA;F-I86P@2!B92!U;F%B;&4@=&\@8V]N=&EN=64@87,@ M82!G;VEN9R!C;VYC97)N+B!4:&4@86)I;&ET>2!O9B!T:&4@0V]M<&%N>2!T M;R!C;VYT:6YU92!A2!I M3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y838S8S(U85\Y93@T7S1C-S-?.#$T M8E\Q8C4W93=F,#4T964-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M.6$V,V,R-6%?.64X-%\T8S'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO'0@0FQO8VM=/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=-05)'24XZ M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)TU!4D=)3BU43U`Z(#!P=#L@1D]. M5#H@,3!P="!4:6UE6QE/3-$)U9%4E1)0T%,+4%,24=..B!T M;W`G/B`\=&0@6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE.+51/ M4#H@,'!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M#L@1D].5#H@,3!P M="!4:6UE2!O=VYE9"!S=6)S:61I87)Y(&]F('1H92!#;VUP86YY("@F M(S@R,C`[365R9V5R(%-U8B8C.#(R,3LI+"!(0T-!+"!00T$L(&%N9"!R97!R M97-E;G1A=&EV97,@;V8@2$-#02!A;F0@=&AE($-O;7!A;GDN($]N($%P6QE/3-$ M)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E3Y0=7)S=6%N="!T;R!T:&4@06=R965M96YT M+"!-97)G97(@4W5B(&UE6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4 M:6UE6QE/3-$ M)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG28C.#(Q-SMS(%-E2!N;W1E6UE;G0@4VAA2!A8VAI979I;F<@8V5R=&%I;B!C;VYS;VQI9&%T960@9W)O M2!D97-C2!N;W1E6UE;G0L('1O9V5T:&5R('=I=&@@82!P M;W)T:6]N(&]F('1H92!S:&%R97,@:7-S=65D('1O(#QF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)SL@1D].5"U325I%.B`Q M,'!T)SY(0T-!)B,X,C$W.W,@:6YV97-T;65N="!B86YK:6YG(&%D=FES;W(\ M+V9O;G0^("AA;B!A9V=R96=A=&4@;V8@/&9O;G0@6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3Y4:&4@<')O M;6ES2!N;W1E2!V86QU960@ M=&AE(&YO=&5S(&%T("0\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I M;65S($YE=R!2;VUA;B2!T:&4@8V]M8FEN960@8V]M<&%N:65S(&1I2!A;F0@8W)E9&ET(')I6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!& M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG3XF(S$V M,#LF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4 M+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE2!O9B!W87)R86YT(&QI86)I;&ET:65S+"!W97)E(&%S6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM M97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@ M,3!P="!4:6UE6QE/3-$)T-,14%2 M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E6UE;G0@4VAA6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@ M3F5W(%)O;6%N)RPG6UE;G0@4VAA6UE;G0@4VAA2!P&-H86YG92!F;W(@:71S(&5Q=6ET>2!O2!T:&4@:6YD97!E;F1E;G0@;65M8F5R28C.#(Q-SMS(&)O87)D(&]F(&1I6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)SL@1D].5"U325I%.B`Q,'!T)SY4:&4@0V]M M<&%N>2!E2!O M9B!T:&4@86)O=F5M96YT:6]N960@#L@1D].5#H@,3!P="!4 M:6UE6QE/3-$)T-,14%2.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E2!#87!I=&%L($AO;&1I;F=S+"!,3$,@87,@<&%R="!O9B!T M:&4@;65R9V5R('=E6QE/3-$)TU!4D=)3CH@,'!T(#!P M>#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!& M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)RPG2!)4$\@=V%R2!.;W1E('=I=&@@82!F M86-E('9A;'5E(&]F("0\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I M;65S($YE=R!2;VUA;B6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@ M3F5W(%)O;6%N)SL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B2!. M;W1E2!V:7)T M=64@;V8@=&AE($UE2!O2X@268@ M6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM M97,@3F5W(%)O;6%N)RPG6QE/3-$)T-, M14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E3Y4:&4@=V%R6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG'!I6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@,3!P="!4 M:6UE6QE/3-$)T-,14%2.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-EF5D('1O(&EN=&5R97-T(&5X<&5N2!.;W1E+B!(0T-!(')E8V]R9&5D(&EN=&5R M97-T(&5X<&5N6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPGF4@=&AE('5N M86UOF5D(&1E8G0@9&ES8V]U;G0@870@=&AE('1R86YS86-T:6]N(&1A M=&4@:6X@=&AE('!E65A2!A;F0@2!N;W1E2!N;W1E28C.#(Q-SMS(%-E M2!C;&]S M960@8F5F;W)E('1H92!M871U2!O9B!T:&4@;F]T92X@070@=&AE(&ES M2!D M971E6EN9R!S:&%R97,@86YD M('1H92!A;&QO8V%T960@=F%L=64@=&\@=&AE('!R;VUI6QE/3-$)T-,14%2.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E3Y);B!C;VYN96-T:6]N('=I=&@@=&AE($)R:61G92!&:6YA M;F-I;F2!A;F0@:&%V92!T:&4@2!D;V5S(&YO="!C;VUP;'D@=VET:"!T:&4@ M6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@,3!P="!4:6UE M6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)U=)1%1(.B`P+C5I;B<^/"]T9#X@ M/'1D('-T>6QE/3-$)U=)1%1(.B`P+C(U:6XG/B`\9&EV/CQF;VYT/B8C,3@S M.SPO9F]N=#X\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&IU&-H M86YG92!A9W)E96UE;G1S('=I=&@@=&AR964@8F5N969I8VEA;"!H;VQD97)S M(&]F($A#0T$F(S@R,3<[28C.#(Q-SMS(%-E28C.#(Q-SMS(%-E6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P M="!4:6UE28C.#(Q-SMS(%-E M28C.#(Q-SMS(%-E M6QE M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)RPG3L@5D525$E#04PM04Q)1TXZ('1O<"<^(#QT9"!S='EL93TS1"=7 M24142#H@,"XU:6XG/CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T.R!724142#H@,"XR-6EN)SX@/&1I=CX\9F]N=#XF(S$X,SL\+V9O;G0^ M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y M)SX@/&1I=CY!;B!A9V=R96=A=&4@;V8@)#QF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG28C.#(Q-SMS(%-E M6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T-,14%2.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[34%21TE..B`P<'0@,'!X(#!P="`P+C3XF M(S$V,#LF(S$V,#L\+V1I=CX@/'1A8FQE('-T>6QE/3-$)TU!4D=)3BU43U`Z M(#!P=#L@5TE$5$@Z(#$P,"4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&IU2<^(#QD:78^5&AE('!L86-E;65N="!W87)R86YT6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG&5R8VES92!O9B!T:&4@97AC:&%N9V4@=V%R2!P2!N;W0@8F4@97AE7,@:6X@86YY(#,P+71R861I M;F2!C86YC96QL960@=&AE6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T-, M14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X(#!P="`P+C3Y0=7)S=6%N="!T;R!A;B!E;F=A9V5M96YT(&QE='1E2!T:&4@0V]M<&%N>2!I2!(0T-! M(&%N9"!I6QE M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG"`P<'0@,"XW-6EN.R!&3TY4.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2!A;F0@2$-#02!W M87,@86-C;W5N=&5D(&9O"`P<'0@,"XW M-6EN.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$ M)U=)1%1(.B`Q:6XG/CPO=&0^(#QT9"!S='EL93TS1"=724142#H@,"XS:6XG M/B`\9&EV/C$I/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=. M.B!J=7-T:69Y)SX@/&1I=CY(0T-!)B,X,C$W.W,@;6%N86=E;65N="!P2!P;W-T+6-L;W-I;F<[/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^ M(#QD:78@2<^(#QD:78^5&AE(&UE;6)E6QE M/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE.+51/4#H@,'!T.R!&3TY4.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)TU!4D=) M3BU43U`Z(#!P=#L@5TE$5$@Z(#$P,"4[($9/3E0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&IU6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%=)1%1(.B`P+C-I;B<^(#QD:78^,RD\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG M2!O9B!S:&%R97,@ M;V8@=&AE($-O;7!A;GD@<&]S="UC;&]S:6YG('=E6EN9R!W87)R86YT6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG M/3-$,#X\='(^/'1D/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^)SQD:78@6QE/3-$)U=)1%1(.B`P+C(U:6XG/B`\9&EV/CQS=')O;F<^-"X\+W-T6QE/3-$)U1%6%0M04Q)1TXZ(&IU3Y4:&4@9FEN86YC:6%L('-T871E;65N=',@9F]R(#(P M,3(F(S$V,#MH879E(&)E96X@28C.#(Q-SMS M('-A;&5S+"!A8V-O=6YT&5S+B!);B!A8V-O2X\+V1I=CX@/&1I=B!S='EL93TS M1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE M6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M2!O9B!V87)I;W5S(&UA=&5R:6%L(&5R2!I;F9O M2`Y+"`R,#$S('1H870@=&AE#L@1D].5#H@,3!P="!4:6UE6QE/3-$ M)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!& M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3Y!2!E;F=A9V5D(&5X=&5R;F%L(&-O M;G-U;'1A;G1S('1O(')E=FEE=R!A;F0@:6YV97-T:6=A=&4@:71S(&)O;VMS M(&%N9"!R96-O2!D:7-C;W9E6QE/3-$)W=I9'1H M.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C M96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\9&EV M('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE3X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B#L@1D].5#H@,3!P="!4:6UE6QE/3-$ M)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[5$585"U!3$E'3CI,969T.R!415A4+4E.1$5.5#H@,&EN M.R!724142#H@,3`P)2<^(#QT86)L92!S='EL93TS1"="3U)$15(M0D]45$]- M.B`C.65B-F-E(#!P>"!S;VQI9#L@0D]21$52+4Q%1E0Z(",Y96(V8V4@,'!X M('-O;&ED.R!-05)'24XZ(#!I;CL@5TE$5$@Z(#$P,"4[($)/4D1%4BU#3TQ, M05!313H@8V]L;&%P"!S;VQI9#L@0D]21$52+5))1TA4.B`C.65B-F-E(#!P M>"!S;VQI9"<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!A;&EG M;CTS1&QE9G0^(#QT6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"!S M;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`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`P,#`[($9/3E0M4TE:13H@,3!P=#L@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED M=&@],T0Q,B4^(#QD:78^,2PQ,C8L.#0V/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@ M(V-C9F9C8SL@0T],3U(Z(",P,#`P,#`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`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^ M,2PS,C,L-#6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-4 M64Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@0T],3U(Z M(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O M='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^,2PS M,C,L-#6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q% M.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@0T],3U(Z(",P M,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^,2PV,S@L M,#`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`P,#`[($9/3E0M M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E' M2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^-#4S+#`U-SPO9&EV/B`\+W1D M/B`\=&0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@ M(V-C9F9C8SL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D52 M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@] M,T0Q,B4^(#QD:78^-"PQ.3(L.34T/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C M9F9C8SL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q M,B4^(#QD:78^-"PY-#6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C M8SL@0T],3U(Z(",P,#`P,#`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`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1) M3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M0D%#2T=23U5.1#H@(V-C9F9C8SL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE: M13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z M(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^-3$X+#4X-SPO9&EV/B`\+W1D/B`\ M=&0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C M9F9C8SL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q M,B4^(#QD:78^-"PQ-S4L.#4V/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C M8SL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM M04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^ M(#QD:78^,RPU-38L,#4V/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!& M3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M0T],3U(Z(",P,#`P,#`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`P,#`[($9/3E0M M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E' M2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^,34P+#`P,#PO9&EV/B`\+W1D M/B`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`P,#`[($9/3E0M4TE: M13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z M(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^,S@L-#`Q+#$T,#PO9&EV/B`\+W1D M/B`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`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q M,B4^(#QD:78^,S$L-C4P+#(S,CPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO'!E;G-E/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4 M+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@0T], M3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^ M-C0P+#(X-CPO9&EV/B`\+W1D/B`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`^/'1R/CQT9#X\+W1D/CPO='(^/"]T M86)L93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^ M)SQS<&%N/CPO6QE M/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE3X\=3X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I M;65S($YE=R!2;VUA;B#L@1D].5#H@,3!P="!4 M:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E6EN9R!C;VYS M;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@:&%V92!B965N('!R97!A M6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!& M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E28C.#(Q-SMS(&9I;F%N8VEA;"!C;VYD M:71I;VX@86YD(')E6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4 M+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA M>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^ M/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\9&EV('-T>6QE/3-$)TU!4D=) M3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE3X\=3Y!8V-O=6YT6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3Y!8V-O=6YT M6UE;G0@<&5R9F]R;6%N8V4@;V8@:71S(&-U2!T6UE;G0@97AP97)I96YC92X@5&AE6QE/3-$)T-,14%2.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E3PO=3X\ M+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4 M:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E2!I;B!O2!O M8G-O;&5T92P@2!W:6QL(')E8V]R9"!A('=R:71E+61O=VX@=&\@ M;F5T(')E86QI>F%B;&4@=F%L=64@:6X@=&AE('!E3XF M(S$V,#LF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!& M3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG3XF(S$V,#LF M(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49! M34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE65E2!T M:&4@=&AIF5D(&%S(&$@2!R96-O9VYI>F5D M(&%S(&$@6EN9R!B86QA;F-E('-H965T('1O(&YE="!R M96%L:7IA8FQE('9A;'5E+B!!;B!A9&IU6%B;&4@=&\@8W5S=&]M97)S('1O(&-O3XF(S$V,#L\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)T-,14%2.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE/3-$)T-,14%2.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E3Y02!A;F0@97%U:7!M96YT(&%R92!S=&%T960@870@8V]S="!L M97-S(&%C8W5M=6QA=&5D(&%M;W)T:7IA=&EO;B!A;F0@9&5P6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM M97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG6QE M/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3X\=3X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2 M;VUA;B6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T-,14%2.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E3Y4:&4@0V]M<&%N>2!C87!I=&%L:7IE'!E M;G-E9"!A6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG6QE M/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3X\=3X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3Y,;VYG+6QI M=F5D(&%S6EN9R!V86QU92!O9B!A;B!A2!A2!B>2!D971E6EN9R!V86QU92!O9B!T:&4@87-S970@;6%Y(&YO M="!B92!R96-O=F5R86)L92P@:70@;65A6EN9R!V86QU92X@1'5R:6YG('1H92!S:7@@;6]N M=&AS(&5N9&5D($IU;F4@,S`L(#(P,3,@86YD('1H92!Y96%R(&5N9&5D($1E M8V5M8F5R(#,Q+"`R,#$R+"!T:&4@0V]M<&%N>2!D:60@;F]T(')E8V]R9"!A M;GD@:6UP86ER;65N="!C:&%R9V5S+CPO9&EV/B`\+V1I=CX\=&%B;&4@8F]R M9&5R/3-$,"!S='EL93TS1"=W:61T:#HQ,#`E.R!T86)L92UL87EO=70Z9FEX M960[)R!C96QL6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@ M1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4 M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E#L@ M1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2 M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E2!S96-U2!A M;F0@:6YT96YT('1O(&AO;&0@=6YT:6P@;6%T=7)I='DN($AE;&0M=&\M;6%T M=7)I='D@F5D(&-O M6EN9R!B86QA;F-E('-H965T2!A;6]R=&EZ871I;VX@;W(@86-C6QE/3-$)T-,14%2.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E3X\=3X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE M=R!2;VUA;B#L@1D].5#H@,3!P="!4:6UE M6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E MF5D(&]V97(@=&AE('1E2X@5&AE('5N86UOF5D M(&)A;&%N8V4@=V%S("0\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I M;65S($YE=R!2;VUA;B6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@,3!P="!4:6UE6QE/3-$ M)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2 M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E2!R96-O3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=# M3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6UE;G1S/"]U/CPO9&EV/B`\9&EV('-T>6QE/3-$)T-,14%2.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E3Y3:&%R92UB87-E9"!P87EM96YT2!E>'!E8W1E9"!T M;R!V97-T+B!4:&4@8V]M<&5N#L@1D].5#H@ M,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E&5D.R<@ M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^ M/"]T#L@1D].5#H@,3!P M="!4:6UE3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4 M+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE2!E;G1E7,@=&AE(&-O2!A6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4 M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)T-,14%2 M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E3Y#;W-T(&]F('-A;&5S(&EN8VQU9&5S(&-L86EM('!A M>6UE;G1S(&9O&5D+2!P6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@,3!P="!4:6UE6QE M/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'!E;G-E#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!& M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)T-,14%2.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E3X\=3X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE M=R!2;VUA;B6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG M3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS M1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE M2!M971H;V0N(%5N9&5R('1H:7,@;65T:&]D+"!D969E2!D:69F97)E;F-E"!A6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H M.R!&3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$ M)T9/3E0M1D%-24Q9.B`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`P<'0@,'!X.R!&3TY4.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG M#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4 M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2!O9B!T:&4@:6YP=71S('5S960@:6X@=&AE M6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE6QE/3-$)U=) M1%1(.B`P+C5I;B<^(#QD:78^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%=)1%1(.B`P+C8U:6XG/B`\9&EV/DQE=F5L(#$Z/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y)SX@/&1I=CY4 M:&4@9F%I3XF(S$V M,#L\+V1I=CX@/'1A8FQE('-T>6QE/3-$)TU!4D=)3BU43U`Z(#!P>#L@1D]. M5#H@,3!P="!4:6UE3L@5D525$E#04PM M04Q)1TXZ('1O<"<^(#QT9"!S='EL93TS1"=724142#H@,"XU:6XG/CPO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,"XV-6EN M)SX@/&1I=CY,979E;"`R.CPO9&EV/B`\+W1D/B`\=&0@2<^(#QD:78^5&AE(&9A:7(@=F%L=64@;V8@9&5R M:79A=&EV92!I;G-T2!Q=6]T960@;6%R:V5T('!R:6-E"`P<'0@,2XP-6EN.R!& M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E"<@8V5L;'-P86-I;F<],T0P M(&-E;&QP861D:6YG/3-$,#X@/'1R('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU M6QE/3-$)U1%6%0M04Q)1TXZ(&IU2UD979E M;&]P960@;6]D96QS(&%N9"!M971H;V1O;&]G:65S('5T:6QI>FEN9R!S:6=N M:69I8V%N="!I;G!U=',@=&AA="!A2!O8G-E"`P<'0@,2XP-6EN.R!&3TY4.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3Y4:&4@0V]M<&%N>28C.#(Q-SMS M('9A;'5A=&EO;B!M971H;V1O;&]G>2!F;W(@=V%R3XF(S$V,#L\+V1I=CX@/&1I=B!S M='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P M="!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG28C.#(Q-SMS(&EN M:71I86P@<'5B;&EC(&]F9F5R:6YG("@F(S@R,C`[4V5L=V%Y($E03R!787)R M86YT2!H87,@=F%L M=65D(&%L;"!O9B!T:&5S92!W87)R86YT&5R8VES86)L92!A="`D/&9O;G0@3X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4 M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X M('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXF(S$V,#L\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E"!S M;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXF(S$V M,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q M)3X@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"!S;VQI9#L@1D].5"U714E'2%0Z(#0P M,"<@=VED=&@],T0Q)3X@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@ M1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9% M4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H M/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C M8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!& M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXM/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE"!S;VQI9#L@5$585"U!3$E'3CH@"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@ M1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9% M4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H M/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C M8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!& M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXM/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE"!S;VQI9#L@5$585"U!3$E'3CH@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED M=&@],T0Q,"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO"!S;VQI9#L@ M1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXF(S$V,#L\+V1I M=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^ M)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-4 M64Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U3 M25I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=( M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXM/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@ M;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/ M54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=. M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^ M)#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!" M04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%, M+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^ M(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T-, M14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E#L@1D].5#H@,3!P="!4:6UE6QE M/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CIC96YT97([(%1%6%0M24Y$14Y4 M.B`P:6X[(%=)1%1(.B`Q,#`E)R!A;&EG;CTS1&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(",Y96(V8V4@,'!X('-O;&ED.R!"3U)$ M15(M3$5&5#H@(SEE8C9C92`P<'@@"!S;VQI9#L@ M0D]21$52+5))1TA4.B`C.65B-F-E(#!P>"!S;VQI9"<@8V5L;'-P86-I;F<] M,T0P(&-E;&QP861D:6YG/3-$,"!A;&EG;CTS1&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`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`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%, M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD M:78^)#PO9&EV/B`\+W1D/B`\=&0@#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U3 M25I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=( M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXM/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E, M13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H M=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@ M=VED=&@],T0Q,"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO"!S;VQI M9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXF(S$V,#L\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!& M3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$58 M5"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E' M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I M=CXQ,C$L,S4P/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$58 M5"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4 M+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5) M1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@ M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N M;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q M,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P M)R!W:61T:#TS1#$P)3X@/&1I=CXQ,C$L,S4P/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T-,14%2.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E3X\=3X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I M;65S($YE=R!2;VUA;B6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3Y4:&4@9F%I M6%B;&4@87!P6EN9R!V M86QU92!B96-A=7-E(&]F('1H92!S:&]R="UT97)M(&YA='5R92!O9B!T:&4@ M:6YV97-T;65N=',N/"]D:78^(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@,3!P="!4:6UE6QE/3-$ M)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4 M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2!U=&EL:7IE6QE/3-$)TU!4D=)3CH@,'!T M(#!P>#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@ M3F5W(%)O;6%N)RPG"!M;VYT:"!P97)I;V0@ M96YD960@2G5N92`S,"P@,C`Q,RXF(S$V,#L\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@)U1I;65S($YE=R!2;VUA;B<[($9/3E0M4TE:13H@,3!P="<^ M3F\@86UO=6YT6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG"!M;VYT:"!P97)I;V0@96YD960@2G5N92`S,"P@,C`Q M,R!A&EM871E;'D@/&9O;G0@65A6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG M#L@1D].5#H@,3!P="!4:6UE#L@1D].5#H@,3!P="!4:6UE2!M87)K970@9G5N M9',@86YD(&-E2!O9B!L97-S('1H86X@=&AR964@;6]N=&AS('1O M(&)E(&-A#L@1D].5#H@,3!P="!4:6UE M6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E2!D:79I9&EN9R!N970@ M:6YC;VUE("AL;W-S*2!A=F%I;&%B;&4@=&\@8V]M;6]N('-T;V-K:&]L9&5R M2!T:&4@=V5I9VAT960@879E&-E<'0@=&AA="!T:&4@;G5M8F5R(&]F('-H87)E M2!D:6QU=&EV M92!S96-U2!S=&]C:R!M971H;V0N M($)E8V%U2!D:6QU=&EV M92!S96-U#L@1D]. M5#H@,3!P="!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@ M3F5W(%)O;6%N)RPG6QE/3-$)T)/4D1%4BU"3U143TTZ(",Y96(V8V4@,'!X('-O;&ED M.R!"3U)$15(M3$5&5#H@(SEE8C9C92`P<'@@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@ M=VED=&@],T0Q-"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H M=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[ M(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I M9'1H/3-$,30E/B`\9&EV/B@S+#4S,BPX-3@I/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@] M,T0Q)3X@/&1I=CXD/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-) M6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU43U`Z M(",P,#`P,#`@,7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS M1#$T)3X@/&1I=CXH,36QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@0T], M3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0U,B4^(#QD:78^ M0F%S:6,@;&]S6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2 M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-EF5S('1H92!N=6UB97(@;V8@ M"!S;VQI9#L@34%21TE..B`P:6X[(%=)1%1( M.B`X-24[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P"!S;VQI9#L@0D]21$52 M+5))1TA4.B`C.65B-F-E(#!P>"!S;VQI9"<@8V5L;'-P86-I;F<],T0P(&-E M;&QP861D:6YG/3-$,"!A;&EG;CTS1&QE9G0^(#QT6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED M.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q M-"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M"!S;VQI9#L@1D].5"U714E'2%0Z(#0P M,"<@=VED=&@],T0Q-"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@0T],3U(Z(",P,#`P,#`[ M($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D]. M5"U714E'2%0Z(#0P,"<@=VED=&@],T0U,B4^(#QD:78^4F5S=')I8W1E9"!S M=&]C:R!A=V%R9',\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[ M(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@0T],3U(Z(",P,#`P,#`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`P,#`[($9/3E0M4TE:13H@ M,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P M,"<@=VED=&@],T0Q-"4^(#QD:78^,BPV-C8L-C8W/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M3Y#97)T86EN('!R979I;W5S;'D@3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\Y838S8S(U85\Y93@T7S1C-S-?.#$T8E\Q8C4W93=F,#4T M964-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.6$V,V,R-6%?.64X M-%\T8S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2P@4&QA;G0@86YD($5Q=6EP M;65N="!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2P@4&QA;G0@86YD($5Q=6EP;65N="!$ M:7-C;&]S=7)E(%M497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQD:78@6QE M/3-$)U=)1%1(.B`P+C(U:6XG/B`\9&EV/CQS=')O;F<^-BX\+W-T6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)T-, M14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE.+51/4#H@,'!T.R!&3TY4.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M"!S;VQI9#L@34%21TE..B`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`Q,'!T.R!615)424-!3"U!3$E'3CH@ M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXQ M+#8P-BPT,#0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%, M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y' M+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!4 M15A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O M;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0 M041$24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X M('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@ M;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/ M54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=. M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,3(E/B`\9&EV M/B@R-S`L,C,S*3PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^)B,Q-C`[/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@ M/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@ M6QE/3-$)TU! M4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-EF%T:6]N(&%N9"!D97!R96-I M871I;VX@:7,@87!P2`D/&9O;G0@"!M;VYT:',@96YD M960@2G5N92`S,"P@,C`Q,R!A;F0@,C`Q,BX\+V1I=CX@/"]D:78^/'1A8FQE M(&)O&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^ M/'1D/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQD:78@6QE/3-$)U=)1%1(.B`P+C(U:6XG/B`\9&EV/CQS M=')O;F<^/&9O;G0@2<^(#QD:78^/'-T6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB M;W1H.R!&3TY4+49!34E,63I4:6UE#IA=71O.R!724142#H@.#`E.R!"3U)$15(M0T],3$%04T4Z(&-O M;&QA<'-E.R!/5D521DQ/5SH@=FES:6)L92<@8V5L;'-P86-I;F<],T0P(&-E M;&QP861D:6YG/3-$,"!A;&EG;CTS1&-E;G1E"!S;VQI9#L@1D].5"U714E'2%0Z M(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO M"!S;VQI9#L@ M1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^)B,Q-C`[/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YOF%T M:6]N/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=. M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4 M+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4 M+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5) M1TA4.B`T,#`G('=I9'1H/3-$,3(E/B`\9&EV/B@S,2PY-C6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H M=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@] M,T0Q,B4^(#QD:78^)B,Q-C`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`Q,'!T.R!615)424-! M3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R M)3X@/&1I=CXR-C(L,30R/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L M93L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F M.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/ M3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D M/B`\=&0@6QE/3-$ M)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-EF%T:6]N(&5X<&5N M&EM871E;'D@)#QF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D M/CPO='(^/"]T86)L93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQD:78@6QE/3-$)U=)1%1(.B`P+C(U:6XG/B`\9&EV/CQB/C@N/"]B M/CPO9&EV/B`\+W1D/B`\=&0@2<^(#QD:78^/&(^26YV97-T;65N=',@2&5L9"!I;B!43X@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!& M3TY4+49!34E,63I4:6UE2!F86EL960@=&\@8V]N2!-87D@,30L(#(P,3,N/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$ M)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV M('-T>6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^3VX@07!R:6P@,3`L(#(P M,3,L(%-E;'=A>2!C;&]S960@=&AE(&%C<75I6QE M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2!!8W0@;V8@,3DT,"!H879I;F<@82!M871U2!O M9B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA M;B6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)RPG6QE/3-$)T-, M14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E3Y4:&4@0V]M<&%N>2!C;&%S2!I;B!A8V-O6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE M9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\ M+W1D/CPO='(^/"]T86)L93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE M/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE.+51/ M4#H@,'!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M#L@1D].5#H@,3!P M="!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)RPG6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4Z M,3!P=#LG(&%L:6=N/3-$:G5S=&EF>3X\6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CI, M969T.R!415A4+4E.1$5.5#H@,&EN.R!724142#H@,3`P)2<^(#QT86)L92!S M='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,&EN(#`N-6EN.R!724142#H@-S`E M.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R!/5D521DQ/5SH@=FES:6)L M92<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!A;&EG;CTS1&QE M9G0^(#QT6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!4 M15A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O M;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F M9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[ M($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,3(E/B`\9&EV/B@V-RPS-C`I M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!& M3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F M=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[ M(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I M9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)W=I9'1H.C$P,"4[('1A M8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN M9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA6%B;&5S(&%N9"!! M8V-R=6%L'0@0FQO8VM=/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=-05)'24XZ M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)TU!4D=)3BU43U`Z(#!P=#L@1D]. M5#H@,3!P="!4:6UE6QE/3-$)U9%4E1)0T%,+4%,24=..B!T M;W`G/B`\=&0@3X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@ M3F5W(%)O;6%N)RPG6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E"!S;VQI9#L@34%21TE..B`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`Q,'!T M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W M:61T:#TS1#$T)3X@/&1I=CXW-3`L,#`P/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@ M(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$T)3X@/&1I=CXM/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4 M+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D]. M5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=% M24=(5#H@-#`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`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!& M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$T)3X@/&1I=CXT,S$L,#8P/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T M.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=. M.B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U M<'@[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z M(#0P,"<@=VED=&@],T0Q-"4^(#QD:78^)B,Q-C`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`Q,'!T.R!615)424-! M3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$T M)3X@/&1I=CXR+#0R."PP,S,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!D M;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[ M(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!6 M15)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T M:#TS1#$T)3X@/&1I=CXU-C@L-3(X/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T-, M14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X(#!P="`P+C5I;CL@1D].5#H@,3!P M="!4:6UE6QE M/3-$)T9/3E0M4TE:13H@,3!P="<^*CPO9F]N=#X\+V1I=CX@/"]T9#X@/'1D M('-T>6QE/3-$)U=/4D0M5U)!4#H@8G)E86LM=V]R9#L@5D525$E#04PM04Q) M1TXZ('1O<"<^(#QD:78^/&9O;G0@2X\+V9O;G0^/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#QD:78@6QE/3-$)T9/3E0M4TE:13H@,3!P="<^*BH\+V9O;G0^/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=73U)$+5=205`Z(&)R96%K+7=O6QE/3-$)T9/3E0M4TE:13H@ M,3!P="<^17-T:6UA=&5D('!E;F%L=&EE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y838S8S(U M85\Y93@T7S1C-S-?.#$T8E\Q8C4W93=F,#4T964-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO.6$V,V,R-6%?.64X-%\T8S'0O:'1M;#L@8VAA6QE M/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE3Y/;B!!<')I;"`Q,2P@,C`Q,RPF(S$V,#MT M:&4@=VAO;&QY+6]W;F5D('-U8G-I9&EA6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2!H M87,@82!T97)M(&]F(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM M97,@3F5W(%)O;6%N)RPG2!W87,@=&5R;6EN871E M9"!I;B!397!T96UB97(@,C`Q,R!D=64@=&\@=&AE($-O;7!A;GDF(S@R,3<[ M6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y838S8S(U85\Y93@T7S1C M-S-?.#$T8E\Q8C4W93=F,#4T964-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO.6$V,V,R-6%?.64X-%\T8S'0O:'1M M;#L@8VAA'0^ M)SQD:78@6QE/3-$)U=)1%1( M.B`P+C(U:6XG/B`\9&EV/CQB/C$R+CPO8CX\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&IU3Y/;B!397!T96UB97(@,3(L M(#(P,3(L('1H92!#;VUP86YY(&-O;7!L971E9"!A(&)R:61G92!F:6YA;F-I M;F<@*'1H92`F(S@R,C`[0G)I9&=E($9I;F%N8VEN9R8C.#(R,3LI(&-O;G-I M6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@ M3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG M6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)RPG3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5! M4CIB;W1H.R!&3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE28C.#(Q-SMS(%-E6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE M9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\ M+W1D/CPO='(^/"]T86)L93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4 M:6UE6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)RPG6QE/3-$)U1%6%0M04Q)1TXZ(&IU M3X\:3Y);F-E;G1I=F4@3F]T97,\+VD^/"]D M:78^(#QD:78@3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5! M4CIB;W1H.R!&3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE2!P6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2P@=&AE("8C.#(R,#M#;&]S:6YG(%!A>6UE;G0F(S@R,C$[*2X\ M+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4 M:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-, M14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!& M3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG&-E6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)RPG2X\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H M.R!&3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z(#!I;CL@34%2 M1TE..B`P:6X[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3X@/&1I=B!S='EL93TS1"=#3$5!4CIB M;W1H.R!&3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6UE;G0@<&5R:6]D#L@1D].5#H@,3!P="!4:6UE6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P:6X@,"XU:6X[(%=)1%1(.B`V-24[($)/4D1%4BU#3TQ, M05!313H@8V]L;&%P6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5. M1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@ M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$T)3X@/&1I=CXW M+#4P,"PP,#`\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I% M.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@ M-#`P)R!W:61T:#TS1#$T)3X@/&1I=CXR+#4P,"PP,#`\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I M=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P M,"<@=VED=&@],T0Q)3X@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4 M+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D]. M5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=% M24=(5#H@-#`P)R!W:61T:#TS1#$T)3X@/&1I=CXR+#6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE M/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@)U1I;65S($YE=R!2;VUA;B3XF(S$V,#L\+V1I M=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE M#IA=71O.R!724142#H@ M-3`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`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXM/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N M;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q M,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P M)R!W:61T:#TS1#$R)3X@/&1I=CXM/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5. M1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@ M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXS M.3DL,#`P/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4 M+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D]. M5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=% M24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXQ+#6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@ M1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4 M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXT+#8Y,"PP,#`\+V1I M=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@ M=VED=&@],T0Q,B4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@ M;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/ M54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=. M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^ M)#PO9&EV/B`\+W1D/B`\=&0@3XF(S$V M,#LF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4 M+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB M;W1H.R!&3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE6QE M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL M93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE#IA=71O.R!724142#H@.3`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`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@ M-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXU.#0L-C,X/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E' M2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT M.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F M9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!& M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXT,S`L-S`Q/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)RPG"`P<'0@,"XU:6X[ M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE#L@1D].5#H@,3!P="!4:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=# M3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE#IA=71O.R!72414 M2#H@.#4E.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R!/5D521DQ/5SH@ M=FES:6)L93L@0D]21$52+51/4#H@(SEE8C9C92`P<'@@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F M9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!& M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L M969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%, M24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4 M.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E, M13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+ M1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%, M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD M:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@ M;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P M<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G M('=I9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$ M)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG M/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L M93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQD:78@6QE/3-$)U=)1%1(.B`P+C(U:6XG/B`\9&EV/CQB M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)RPG2<^ M(#QD:78^/&(^4F5D965M86)L92!396-U6QE/3-$)T-,14%2.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE.+51/4#H@,'!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E#L@1D]. M5#H@,3!P="!4:6UE&5S('!A>6%B;&4L("AI:2D@:6YT97)E&5D M.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO M=&0^/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A3QB6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE M3PO8CX\+V1I=CX@/"]T9#X@/"]T3Y4:&4@ M0V]M<&%N>2!IF5D(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM M97,@3F5W(%)O;6%N)RPG2P@8G5T(&%R92!N;W0@3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4 M+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE#L@1D].5#H@,3!P="!4:6UE M6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)RPG6QE/3-$)T-,14%2 M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E3Y397)I97,@0R`F(S$U,#L@2&]L9&5R2!I;B!T:&4@5')U6QE M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE M+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS M1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\9&EV('-T>6QE/3-$)TU! M4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE3Y4:&4@4V5R:65S($$@0V]M;6]N(%-T;V-K M+"!397)I97,@0B!#;VUM;VX@4W1O8VL@86YD(%-E3XF(S$V,#L\ M+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4 M:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM M97,@3F5W(%)O;6%N)RPG3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB M;W1H.R!&3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE2!I6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2!T M#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2`R,#$S+B!);B!&96)R=6%R>2`R,#$S+"!T:&5S92!S M:&%R97,@=V5R92!I'!E;G-E(&]F("0\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)T-,14%2 M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E3Y!6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2!A;F0@=&AE(')E;6%I;FEN9R!V97-T('1H&5D.R<@8V5L;'-P M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO"!$ M:7-C;&]S=7)E(%M497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQD:78@6QE M/3-$)U=)1%1(.B`P+C(U:6XG/B`\9&EV/CQS=')O;F<^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E"!M;VYT:',@86YD('EE87(@96YD960@2G5N M92`S,"P@,C`Q,R!A;F0@1&5C96UB97(@,S$L(#(P,3(N/"]D:78^(#QD:78@ M3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!& M3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG"!A3XF(S$V,#LF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS M1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE#IA=71O.R!7 M24142#H@.#0E.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R!/5D521DQ/ M5SH@=FES:6)L93L@0D]21$52+51/4#H@(SEE8C9C92`P<'@@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%, M24=..B!C96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`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`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM M04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^ M(#QD:78^,2PP-C`L,#`P/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4 M+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@0T], M3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ M(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^ M,C`Y+#DP-#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4 M+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@0T], M3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ M(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^ M+3PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L M969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%, M24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!#3TQ/4CH@ M(S`P,#`P,#L@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXH,RPQ M-30L,3`R*3PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO"!S;VQI M9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXF(S$V,#L\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!& M3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@ M;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P M<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G M('=I9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO3XF M(S$V,#LF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!& M3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG65A28C.#(Q-SMS(&%B:6QI='D@=&\@9V5N97)A=&4@6QE M/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C M:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T M86)L93X\9&EV('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P M="!4:6UE3X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-, M14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[5$585"U!3$E'3CI,969T.R!415A4+4E.1$5.5#H@,&EN.R!7 M24142#H@,3`P)2<^(#QT86)L92!S='EL93TS1"="3U)$15(M0D]45$]-.B`C M.65B-F-E(#!P>"!S;VQI9#L@0D]21$52+4Q%1E0Z(",Y96(V8V4@,'!X('-O M;&ED.R!-05)'24XZ(#!I;CL@5TE$5$@Z(#@R)3L@0D]21$52+4-/3$Q!4%-% M.B!C;VQL87!S93L@3U9%4D9,3U"8C,38P.TUO M;G1H"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q-"4^(#QD:78^ M*#,T+C`I/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N M;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q M,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P M)R!W:61T:#TS1#$T)3X@/&1I=CXM/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R M:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@0T],3U(Z(",P,#`P M,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q-"4^(#QD:78^,SDN-SPO9&EV M/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!R871E/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE M/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0G/CPO9&EV/B`\9&EV('-T>6QE/3-$)T-,14%2.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0G/CPO9&EV/B`\+V1I=CX@/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG#L@1D].5#H@ M,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-EF4@=&AE(&YE="!O<&5R871I;F<@;&]S M2!F;W)W87)D65A2!W:&\@:&%S('5N9&5R9V]N92P@;W(@;6%Y('5N9&5R9V\@:6X@=&AE(&9U M='5R92P@82!G6QE/3-$)T-,14%2.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E3Y!="!*=6YE(#,P+"`R,#$S+"!T:&4@0V]M<&%N M>2!H860@9F5D97)A;"!A;F0@&EM M871E;'D@)#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG'!I"UR971U2!T:&4@=&%X:6YG M(&%U=&AO28C.#(Q-SMS('5N8V5R=&%I;G1I97,@"!R971U28C.#(Q-SMS('1A>"!Y96%R2!H87,@;F\@86UO=6YT(')E8V]R9&5D(&9OF5D('1A>"!B96YE9FET2!R96QA=&5D('1O('1H92!U M;F1E6UE;G0@;V8@:6YC;VUE('1A>&5S(&9O65A2!D:60@;F]T(')E8V]G;FEZ92!A;GD@:6YT97)E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y838S M8S(U85\Y93@T7S1C-S-?.#$T8E\Q8C4W93=F,#4T964-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO.6$V,V,R-6%?.64X-%\T8S'0O:'1M;#L@8VAA'0^)SQD:78@6QE/3-$)U=)1%1(.B`P+C(U:6XG/B`\9&EV/CQS=')O;F<^,36QE/3-$)T-,14%2.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0@9F]U6UE;G1S(&9O3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!& M3TY4+49!34E,63I4:6UE#IA=71O.R!724142#H@-3`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`Q,'!T.R!615)424-!3"U!3$E' M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I M=CXR,#6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S M;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F M9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[ M($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)B,Q-C`[/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`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`Q,'!T.R!615)424-!3"U! M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@ M/&1I=CXW-S@L,C6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@,3!P="!4:6UE3Y296YT M(&5X<&5N"!M;VYT:',@96YD960@2G5N92`S M,"P@,C`Q,R!A;F0@9F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+"`R M,#$R('=A6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3X\=3Y%;7!L M;WEM96YT($%G3XF(S$V,#L\ M+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4 M:6UE#L@1D].5#H@,3!P="!4:6UE65A'1E;F1E9"!T:')O=6=H($UA>2`R,#$W+B!4:&4@ M86=R965M96YT2!S979E2!O;F4@>65A3XF(S$V,#LF(S$V,#L\+V1I=CX@ M/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE#L@1D]. M5#H@,3!P="!4:6UE2`R,#$T M+"!T:&4@0V]M<&%N>2!T97)M:6YA=&5D(&%G6UE;G1S(&]F("0\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P M="!4:6UE6QE M/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6UE;G0@8V]N=')A8W1S(&]R(&5M<&QO>6UE;G0@87)R86YG96UE M;G0@;&5T=&5R2!T;R!I&EM871E;'D@/&9O;G0@3XF(S$V,#LF(S$V,#L\+V1I M=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE M#L@ M1D].5#H@,3!P="!4:6UE3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4 M+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE2!F:6QE9"!A(&QA=W-U:70@86=A:6YS="!I=',@<&%S="!A9&IU9&EC M871O6UE;G0@ M;VX@8VQA:6US+"!E6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG2!H87,@3XF(S$V,#LF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB M;W1H.R!&3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE2!S971T;&5D('1H92!S=6ET('=I=&@@=&AE(&-L M86EM2!A6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)SL@1D].5"U325I%.B`Q M,'!T)SXL(&EN(&%C8V]U;G1S('!A>6%B;&4N/"]F;VYT/CPO9&EV/B`\9&EV M('-T>6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3Y/;B!!=6=U2!B86-K(#QF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2!H860@;F]T(')E8V5I=F5D('1H92`\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B2`R,#$S+B!!('-T M;V-K(')E9&5M<'1I;VX@=V%S(')E8V]R9&5D(&]N($1E8V5M8F5R(#,Q+"`R M,#$R(&EN('1H92!A;6]U;G0@;V8@)#QF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\Y838S8S(U85\Y93@T7S1C-S-?.#$T8E\Q8C4W93=F,#4T M964-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.6$V,V,R-6%?.64X M-%\T8S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!&:6YA;F-I86P@26YF;W)M871I;VX@6U1E>'0@0FQO8VM=/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=-05)' M24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)TU!4D=)3BU43U`Z(#!P=#L@ M1D].5#H@,3!P="!4:6UE6QE/3-$)U9%4E1)0T%,+4%,24=. M.B!T;W`G/B`\=&0@6QE/3-$)U1% M6%0M04Q)1TXZ(&IU6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE.+51/4#H@,'!T M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)T-,14%2.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[5$585"U!3$E'3CI,969T.R!415A4+4E.1$5.5#H@,&EN.R!724142#H@ M,3`P)2<^(#QT86)L92!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,&EN(#`N M-6EN.R!724142#H@-C`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`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=( M5#H@-#`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`G5&EM97,@3F5W(%)O;6%N)RPG&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D M/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M2!4'0^)SQS<&%N/CPO2!46QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE M6QE M/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE.+51/4#H@,'!T.R!&3TY4.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2X@5&AE($-O;7!A;GD@:7,@8W5R'!E;G-E+CPO M9F]N=#X\+V1I=CX@/"]D:78^/'1A8FQE(&)O&5D.R<@8V5L;'-P86-I;F<] M,T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^ M)SQD:78@6QE/3-$)U9%4E1)0T%,+4%,24=..B!T;W`G/B`\=&0@2<^(#QD:78^ M/&(^4W5B6QE M/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2`Q-2P@,C`Q M,RP@=&AE($-O;7!A;GD@96YT97)E9"!I;G1O(&$@)#QF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$ M)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E2!I#L@1D].5#H@,3!P="!4:6UE2`D/&9O;G0@28C.#(Q-SMS(&-E#L@1D].5#H@,3!P="!4 M:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4 M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2!T97)M:6YA=&5D(&ET#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-, M14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E65A6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2P@=&AE("8C.#(R,#M0=7)C:&%S97)S)B,X,C(Q.RD@;F%M M960@=&AE2!I6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG28C.#(Q-SMS M(&-O;6UO;B!S=&]C:R!A="!A;B!I;FET:6%L(&9I>&5D(&-O;G9E2`D,2XU,"!O9B!.;W1E2!R969E6QE M/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\ M9&EV('-T>6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^ M(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^26X@8V]N;F5C=&EO M;B!W:71H('1H92!02!A9W)E M960@=&\@<&%Y('1H92!!9V5N="!A(&9E92!R97!R97-E;G1I;F<@.24@;V8@ M=&AE('!R:6YC:7!A;"!A;6]U;G0@;V8@=&AE($YO=&5S('!L=7,@=&AE("0U M,#`L,#`P(&%D9&ET:6]N86P@;&]A;B!F6QE/3-$)T-, M14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T M>6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^26X@8V]N;F5C=&EO;B!W:71H M('1H92!I28C.#(Q-SMS(&%N9"!I=',@2!N;W<@;W=N960@;W(@870@86YY M('1I;64@:&5R96%F=&5R(&%C<75I3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y838S8S(U85\Y93@T M7S1C-S-?.#$T8E\Q8C4W93=F,#4T964-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO.6$V,V,R-6%?.64X-%\T8S'0O M:'1M;#L@8VAA2!497AT($)L M;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQD:78@3X\=3Y"87-I3XF(S$V,#L\+V1I=CX@ M/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE#L@1D]. M5#H@,3!P="!4:6UE2!A8V-E M<'1E9"!I;B!T:&4@56YI=&5D(%-T871E2!497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)SQD:78@3X\=3Y5 M6QE/3-$)T-,14%2 M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E3Y4:&4@<')E<&%R871I;VX@;V8@9FEN86YC:6%L('-T M871E;65N=',@:6X@8V]N9F]R;6ET>2!W:71H(&%C8V]U;G1I;F<@<')I;F-I M<&QE'!E M;G-E6EN9R!N;W1E&5D.R<@ M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^ M/"]T6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE M6QE/3-$)T-, M14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E6QE M/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3Y4:&4@8V]N2!B86QA;F-E2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/ M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE#L@1D].5#H@ M,3!P="!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@ M3F5W(%)O;6%N)RPG3XF(S$V,#L\+V1I=CX@/&1I M=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE#L@1D].5#H@ M,3!P="!4:6UE2!F;W(@<')O9'5C=',@2!M;VYI=&]RF4@;&]S M'!E2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[ M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE#L@1D]. M5#H@,3!P="!4:6UE3PO=3X\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!& M3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2 M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E2!I;B!O2!O8G-O;&5T92P@2!W:6QL(')E8V]R9"!A('=R M:71E+61O=VX@=&\@;F5T(')E86QI>F%B;&4@=F%L=64@:6X@=&AE('!E2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=-05)'24XZ M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE#L@1D].5#H@,3!P="!4:6UE3XF(S$V,#LF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB M;W1H.R!&3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE65E2!T:&4@=&AIF5D(&%S(&$@2!R96-O9VYI>F5D(&%S(&$@6%B;&4@=&\@8W5S=&]M97)S M('1O(&-O2P@4&QA;G0@86YD($5Q M=6EP;65N="P@4&]L:6-Y(%M0;VQI8WD@5&5X="!";&]C:UT\+W1D/@T*("`@ M("`@("`\=&0@8VQA6QE/3-$)TU!4D=)3CH@ M,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@ M,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E#L@1D].5#H@,3!P="!4:6UE6QE/3-$ M)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-EF5D('5S:6YG('1H92!S M=')A:6=H="UL:6YE(&UE=&AO9"!O=F5R('1H92!S:&]R=&5R(&]F('1H92!T M97)M(&]F('1H92!L96%S92!O'1U6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)RPG#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T-,14%2.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E3Y4:&4@0V]M<&%N>2!C87!I=&%L:7IE'!E;G-E M9"!A6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)RPG2!497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQD:78@3X\=3Y,;VYG+4QI=F5D($%S#L@1D].5#H@,3!P M="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E2!N;W0@8F4@2!I;7!A:7)M96YT(&)A6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG M/3-$,#X\='(^/'1D/CPO=&0^/"]T6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@ M1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4 M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2!S M96-U2!H87,@=&AE(&%B:6QI='D@86YD(&EN=&5N="!T;R!H;VQD('5N=&EL M(&UA='5R:71Y+B!(96QD+71O+6UA='5R:71Y('-E8W5R:71I97,@87)E(')E M8V]R9&5D(&%T(&%M;W)T:7IE9"!C;W-T(&]N('1H92!A8V-O;7!A;GEI;F<@ M8F%L86YC92!S:&5E=',@86YD(&%D:G5S=&5D(&9OF%T M:6]N(&]R(&%C8W)E=&EO;B!O9B!P6QE/3-$)W=I9'1H.C$P M,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL M<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=-05)' M24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M#L@1D].5#H@,3!P="!4:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF5D(&]V97(@=&AE('1E2X@5&AE('5N86UOF5D(&)A;&%N8V4@=V%S("0\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG M6QE/3-$)W=I M9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$ M,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\ M2!497AT($)L;V-K73PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQD:78@#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E2!N;W0@ M8F4@97AE;7!T(&9R;VT@9&5R:79A=&EV92!A8V-O=6YT:6YG('1R96%T;65N M="X@07,@82!R97-U;'0L('-U8V@@=V%R&5D.R<@8V5L;'-P86-I;F<],T0P(&-E M;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T6QE/3-$)TU!4D=)3CH@,'!T(#!P M>#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!& M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E#L@1D].5#H@,3!P="!4:6UE M2!;4&]L:6-Y(%1E>'0@0FQO8VM= M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS M1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=# M3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE6UE;G1S('1O(&5M<&QO>65E6EN9R!C;VYS;VQI9&%T960@6QE/3-$)T-,14%2 M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E3Y3:&%R92UB87-E9"!P87EM96YT2!D971E'!E;G-E(')E M6QE M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)SL@1D].5"U325I% M.B`Q,'!T)SYM87)K960@=&\@;6%R:V5T(&]V97(@=&AE('9E6QE/3-$)W=I9'1H.C$P,"4[('1A M8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN M9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=-05)'24XZ M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG3XF(S$V M,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E, M63I4:6UE#L@1D].5#H@,3!P="!4:6UE2!E;G1E M2!R96-O2!A8W1S(&%S('!R:6YC:7!A;"!B87-E9"!O;B!T:&4@9F]L;&]W:6YG M(&9A8W1O7,@=&AE(&-O6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS M<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^ M/"]T86)L93X\2!;4&]L:6-Y(%1E>'0@ M0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S M='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE#L@1D].5#H@,3!P="!4:6UE3XF(S$V,#L\+V1I=CX@/&1I=B!S M='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P M="!4:6UE6QE/3-$ M)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG M/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L M93X\2!497AT($)L M;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQD:78@3X\=3Y!9'9E'!E;G-E#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4 M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E&5D.R<@ M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^ M/"]T"P@4&]L:6-Y(%M0;VQI8WD@5&5X M="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2 M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E&5S/"]U/CPO9&EV/B`\9&EV('-T>6QE/3-$)T-,14%2.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E3Y4:&4@0V]M<&%N>2!A8V-O=6YT&5S('5S M:6YG('1H92!L:6%B:6QI='D@;65T:&]D+B!5;F1E&ES=&EN M9R!A"!B87-E&%B;&4@:6YC;VUE(&EN('1H92!Y96%R"!A"!R871EF5D(&EN('1H92!P97)I;V0@ M=&AA="!I;F-L=61EF%T:6]N(&]F M(&YE="!D969E6QE M/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C M:6YG/3-$,"!C96QL<&%D9&EN9STS1#`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`P<'0@,'!X.R!&3TY4.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!& M3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P="!4:6UE28C.#(Q-SMS(&1E6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@,3!P="!4:6UE6QE/3-$ M)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z(#!I;CL@34%21TE..B`P:6X[($9/ M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S M($YE=R!2;VUA;B6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)RPG6QE/3-$)TU!4D=)3BU43U`Z(#!P>#L@1D].5#H@,3!P="!4:6UE3L@5D525$E#04PM04Q)1TXZ('1O<"<^(#QT9"!S M='EL93TS1"=724142#H@,"XU:6XG/B`\9&EV/CQF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2<^(#QD:78^5&AE(&9A:7(@=F%L=64@;V8@9&5R:79A=&EV92!I;G-T2!U M;F%D:G5S=&5D('%U;W1E9"!M87)K970@<')I8V5S(&EN(&%C=&EV92!M87)K M971S(&9O"`P<'0@,2XP-6EN.R!&3TY4.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E"<@8V5L;'-P86-I;F<],T0P(&-E;&QP M861D:6YG/3-$,#X@/'1R('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&IU2!O8G-E6QE/3-$)U=)1%1(.B`P+C5I;B<^/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%=)1%1(.B`P+C8U:6XG/B`\9&EV/DQE=F5L(#,Z/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y)SX@ M/&1I=CY4:&4@9F%I2!L M97-S(')E861I;'D@;V)S97)V86)L92!F6QE/3-$)T-, M14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[0D%#2T=23U5.1"U#3TQ/4CH@=')A;G-P87)E;G0[(%1%6%0M M24Y$14Y4.B`M,"XU-6EN.R!-05)'24XZ(#!P="`P<'@@,'!T(#$N,#5I;CL@ M1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2 M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E6QE/3-$)T-,14%2 M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E3Y!="!*=6YE(#,P+"`R,#$S('1H92!#;VUP86YY(&AA M9"`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA M;B&5R8VES86)L92!I;G1O(&ET2!)4$\@5V%R2P@2$-#02!I6QE M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E28C.#(Q-SMS(&9A:7(@=F%L=64@:&EE#L@1D].5#H@,3!P="!4:6UE6QE/3-$ M)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[5$585"U!3$E'3CIC96YT97([(%1%6%0M24Y$14Y4.B`P M:6X[(%=)1%1(.B`Q,#`E)R!A;&EG;CTS1&-E;G1E6QE M/3-$)TU!4D=)3CH@,'!X.F%U=&\[(%=)1%1(.B`X-"4[($)/4D1%4BU#3TQ, M05!313H@8V]L;&%P6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([ M($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z M(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO M"!S;VQI9#L@ M1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^)B,Q-C`[/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($9/ M3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD M:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=. M.B!C96YT97([($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED M=&@],T0Q,"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%, M24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4 M.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE"!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P M<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G M('=I9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@ M(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXS+#4U M.2PQ.#@\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%, M24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4 M.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE"!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P M<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G M('=I9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@ M(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXS+#4U M.2PQ.#@\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P M,"<@=VED=&@],T0Q)3X@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@ M/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F=#L@ M1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9% M4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H M/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I M9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C M9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXS+#4U.2PQ M.#@\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG M3XF(S$V,#LF(S$V,#L\+V1I=CX@/&1I=B!S M='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE#L@1D].5#H@,3!P M="!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)RPG28C.#(Q-SMS(&9A:7(@=F%L=64@:&EE3XF(S$V,#L\+V1I=CX@ M/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE#IA=71O.R!724142#H@.#0E.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA M<'-E.R!/5D521DQ/5SH@=FES:6)L93L@0D]21$52+51/4#H@(SEE8C9C92`P M<'@@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O M;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U19 M3$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED M=&@],T0Q,"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E' M2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z M(&YO"!S;VQI M9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^)B,Q-C`[ M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([ M($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^ M(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!C96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H M=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/ M3E0M1D%-24Q9.B!4:6UE"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D]. M5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1) M0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$ M,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4 M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ,C$L,S4P/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!& M3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE"!S;VQI9#L@5$585"U!3$E'3CH@6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`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`[/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!D M;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[ M(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!6 M15)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T M:#TS1#$P)3X@/&1I=CXM/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L M93L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C M.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/ M3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D M/B`\=&0@"!D M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X M(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!" M04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%, M+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^ M(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@&5D M.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO M=&0^/"]T2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=-05)'24XZ M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E3Y4:&4@9F%I6%B;&4@87!P6EN9R!V86QU92!B96-A=7-E(&]F('1H92!S:&]R="UT M97)M(&YA='5R92!O9B!T:&4@:6YV97-T;65N=',N/"]D:78^(#PO9&EV/CQT M86)L92!B;W)D97(],T0P('-T>6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA M>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^ M/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=- M05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE#L@1D].5#H@,3!P="!4:6UE#L@ M1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)W=I9'1H.C$P M,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL M<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\9&EV('-T M>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE3Y!<'!R;WAI;6%T96QY(#QF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG M6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)RPG"!M;VYT:"!P97)I;V0@96YD960@ M2G5N92`S,"P@,C`Q,RXF(S$V,#L\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@)U1I;65S($YE=R!2;VUA;B<[($9/3E0M4TE:13H@,3!P="<^3F\@86UO M=6YT6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPG"!M;VYT:"!P97)I;V0@96YD960@2G5N92`S,"P@,C`Q,R!A&EM871E;'D@/&9O;G0@65A6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2!497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQD:78@#L@ M1D].5#H@,3!P="!4:6UE#L@1D]. M5#H@,3!P="!4:6UE2!M87)K970@9G5N9',@86YD(&-E2!O9B!L97-S M('1H86X@=&AR964@;6]N=&AS('1O(&)E(&-A2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=- M05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE#L@1D].5#H@,3!P="!4:6UE#L@1D].5#H@,3!P="!4:6UE3X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA M;B6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CI,969T M.R!415A4+4E.1$5.5#H@,&EN.R!724142#H@,3`P)2<^(#QT86)L92!S='EL M93TS1"="3U)$15(M0D]45$]-.B`C.65B-F-E(#!P>"!S;VQI9#L@0D]21$52 M+4Q%1E0Z(",Y96(V8V4@,'!X('-O;&ED.R!-05)'24XZ(#!I;CL@5TE$5$@Z M(#@U)3L@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S93L@3U9%4D9,3U6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4 M+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO M6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Q-"4^(#QD:78^)B,Q-C`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`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=( M5#H@-#`P)R!W:61T:#TS1#4R)3X@/&1I=CY,97-S.B!$965M960@9&EV:61E M;F0@=&\@<')E9F5R"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@ M;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/ M54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=. M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^ M)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@"!S M;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F M9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[ M($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)B,Q-C`[/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P M(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F M9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!& M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#4R)3X@/&1I=CY.970@;&]S"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q-"4^(#QD M:78^*#$W+#4Y.2PQ-3`I/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXD/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R M;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$ M.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B M;W1T;VT[($)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED.R!&3TY4+5=% M24=(5#H@-#`P)R!W:61T:#TS1#$T)3X@/&1I=CXH-RPU-S4L.38U*3PO9&EV M/B`\+W1D/B`\=&0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@ M(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$T)3X@/&1I=CXS."PY M,SDL.3`Y/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P M="!4:6UE6QE M/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF5S('1H92!N=6UB97(@;V8@"!S;VQI9#L@34%21TE..B`P:6X[(%=)1%1(.B`X-24[($)/4D1%4BU# M3TQ,05!313H@8V]L;&%P"!S;VQI9#L@0D]21$52+5))1TA4.B`C.65B-F-E M(#!P>"!S;VQI9"<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!A M;&EG;CTS1&QE9G0^(#QT6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C M96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO"!S;VQI M9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q-"4^(#QD:78^)B,Q-C`[ M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!& M3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q-"4^ M(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4 M:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P M=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@ M=VED=&@],T0U,B4^(#QD:78^4F5S=')I8W1E9"!S=&]C:R!A=V%R9',\+V1I M=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5. M1#H@(V-C9F9C8SL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED M=&@],T0Q-"4^(#QD:78^-S4L,CDR/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M M1D%-24Q9.B!4:6UE6%B;&4\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F M9CL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM M04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q-"4^ M(#QD:78^,BPV-C8L-C8W/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)W=I M9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$ M,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\ M2!;4&]L:6-Y(%1E>'0@0FQO8VM= M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS M1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE#L@1D].5#H@,3!P="!4:6UE2!R97!O6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y M838S8S(U85\Y93@T7S1C-S-?.#$T8E\Q8C4W93=F,#4T964-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.6$V,V,R-6%?.64X-%\T8S'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE/3-$)T-,14%2.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",Y96(V8V4@,'!X('-O;&ED.R!"3U)$15(M3$5&5#H@ M(SEE8C9C92`P<'@@6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U19 M3$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^)B,Q-C`[/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($9/3E0M4U19 M3$4Z(&YO"!S M;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^)B,Q M-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT M97([($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P M=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@ M=VED=&@],T0Q,B4^(#QD:78^,2PR,C`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`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O M='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^-#`L M.#8W/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N M;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@0T],3U(Z(",P,#`P M,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^-#`L.#8W/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[ M(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@0T],3U(Z(",P,#`P,#`[($9/ M3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^-#`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`P,#`[($9/3E0M4TE:13H@,3!P M=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@ M=VED=&@],T0Q,B4^(#QD:78^-"PT,S$L,S8V/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5. M1#H@(V-C9F9C8SL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED M=&@],T0Q,B4^(#QD:78^-"PU,C`L,C(S/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@ M(V-C9F9C8SL@0T],3U(Z(",P,#`P,#`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`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD M:78^-38X+#4R.#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6%B;&4\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P M=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@ M=VED=&@],T0Q,B4^(#QD:78^,BPS-C(L-3$W/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5. M1#H@(V-C9F9C8SL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED M=&@],T0Q,B4^(#QD:78^-#4X+#@P,#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4 M+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@0T], M3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^ M,3(Q+#,U,#PO9&EV/B`\+W1D/B`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`P,#`[ M($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D]. M5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^+3PO9&EV/B`\+W1D M/B`\=&0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q% M.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@0T],3U(Z(",P M,#`P,#`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`P,#`[($9/3E0M4TE: M13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z M(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^,C8L,30X+#$Q.#PO9&EV/B`\+W1D M/B`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`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM M04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^ M(#QD:78^-C0P+#(X-CPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA M>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^ M/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^)SQS<&%N/CPO'0^ M)SQD:78@3Y4:&4@ M=&%B;&4@8F5L;W<@<')E2!F;W(@=&AO3XF(S$V M,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E, M63I4:6UE#IA=71O.R!7 M24142#H@.#0E.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R!&3TY4+5-) M6D4Z(#$P<'0[($]615)&3$]7.B!V:7-I8FQE)R!C96QL6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!4 M15A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE"!S;VQI9#L@5$585"U!3$E'3CH@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R M;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE"!S;VQI9#L@5$585"U!3$E'3CH@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R M;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E' M2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I M=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O M=6)L93L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)4 M24-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS M1#$P)3X@/&1I=CXS+#4U.2PQ.#@\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W M:61T:#TS1#$P)3X@/&1I=CXM/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O M=6)L93L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F M9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[ M($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\ M+W1D/B`\=&0@6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z("TP+C(U:6X[ M($U!4D=)3CH@,'!T(#!P>"`P<'0@,"XR-6EN.R!&3TY4.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E3X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPG2!F;W(@=&AO6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4 M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E"!S;VQI9#L@34%21TE..B`P<'@Z875T;SL@5TE$5$@Z(#@T)3L@ M0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S93L@3U9%4D9,3U6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R M.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=. M.B!C96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O M;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE"!S M;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED M.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$ M24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@0T],3U(Z(",P,#`P,#`[($9/3E0M M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E' M2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^+3PO9&EV/B`\+W1D/B`\=&0@ M"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@ M;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/ M54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=. M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^ M)#PO9&EV/B`\+W1D/B`\=&0@#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I% M.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@ M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ,C$L,S4P/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@ M/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5. M1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@ M;6ED9&QE.R!"3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@ M/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F=#L@ M1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9% M4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H M/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I M9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C M9F9C8SL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E# M04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q M,"4^(#QD:78^+3PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@ M5$585"U!3$E'3CH@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0G/CPO9&EV M/B`\9&EV('-T>6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0G/CPO9&EV/B`\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF M:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT M9#X\+W1D/CPO='(^/"]T86)L93X\'0@0FQO8VM= M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS M1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2 M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`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`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#4R)3X@/&1I=CY.970@ M;&]S6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D]. M5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=% M24=(5#H@-#`P)R!W:61T:#TS1#$T)3X@/&1I=CXM/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE"!S;VQI M9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q-"4^(#QD:78^*#6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q M,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P M)R!W:61T:#TS1#4R)3X@/&1I=CY796EG:'1E9"!A=F5R86=E('-H87)E6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N M;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q M,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P M)R!W:61T:#TS1#$T)3X@/&1I=CXV+#@U,2PX,3D\+V1I=CX@/"]T9#X@/'1D M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D]. M5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E#L@1D].5#H@,3!P="!4:6UE6QE/3-$ M)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[5$585"U!3$E'3CI,969T.R!415A4+4E.1$5.5#H@,&EN M.R!724142#H@,3`P)2<^(#QT86)L92!S='EL93TS1"="3U)$15(M0D]45$]- M.B`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`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0U,B4^(#QD:78^5V%R6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F M9CL@0T],3U(Z(",P,#`P,#`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`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0U,B4^(#QD M:78^0V]N=F5R=&EB;&4@;F]T97,@<&%Y86)L93PO9&EV/B`\+W1D/B`\=&0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0G/CPO9&EV/B`\ M+V1I=CX@/&9O;G0@3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y838S8S(U85\Y93@T7S1C-S-? M.#$T8E\Q8C4W93=F,#4T964-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO.6$V,V,R-6%?.64X-%\T8S'0O:'1M;#L@ M8VAA2P@4&QA;G0@86YD($5Q=6EP;65N="!;06)S=')A8W1=/"]S=')O M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2P@4&QA;G0@86YD($5Q=6EP;65N="!;5&%B;&4@5&5X="!";&]C:UT\+W1D M/@T*("`@("`@("`\=&0@8VQA6QE/3-$)TU! M4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E"!S;VQI9#L@34%21TE. M.B`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`Q,'!T.R!615)4 M24-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS M1#$R)3X@/&1I=CXQ+#8P-BPT,#0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O M;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R M;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E, M13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@ M1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9% M4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H M/3-$,3(E/B`\9&EV/B@R-S`L,C,S*3PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S M;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^)B,Q M-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@ M=VED=&@],T0Q)3X@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U! M3$E'3CH@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@ M5$585"U!3$E'3CH@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y838S M8S(U85\Y93@T7S1C-S-?.#$T8E\Q8C4W93=F,#4T964-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO.6$V,V,R-6%?.64X-%\T8S'0O:'1M;#L@8VAAF5D($-O;7!U=&5R(%-O9G1W87)E M+"!.970@6U1A8FQE(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/ M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE#L@1D].5#H@ M,3!P="!4:6UE#L@1D].5#H@ M,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M5$585"U!3$E'3CIC96YT97([(%1%6%0M24Y$14Y4.B`P:6X[(%=)1%1(.B`Q M,#`E)R!A;&EG;CTS1&-E;G1E6QE/3-$)TU!4D=)3CH@ M,'!X.F%U=&\[(%=)1%1(.B`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`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4 M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXM/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D]. M5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^)B,Q-C`[/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$58 M5"U!3$E'3CH@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-! M3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R M)3X@/&1I=CXM/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE M6QE M/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C M:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T M86)L93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P M="!4:6UE6QE M/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!& M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4Z,3!P=#LG(&%L:6=N/3-$:G5S=&EF>3X\6QE/3-$)T-,14%2.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U! M3$E'3CI,969T.R!415A4+4E.1$5.5#H@,&EN.R!724142#H@,3`P)2<^(#QT M86)L92!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,&EN(#`N-6EN.R!72414 M2#H@-S`E.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R!/5D521DQ/5SH@ M=FES:6)L92<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!A;&EG M;CTS1&QE9G0^(#QT6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O M;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R M;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$ M.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B M;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,3(E/B`\9&EV/B@V M-RPS-C`I/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E' M3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z M(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T M,#`G('=I9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y M838S8S(U85\Y93@T7S1C-S-?.#$T8E\Q8C4W93=F,#4T964-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.6$V,V,R-6%?.64X-%\T8S'0O:'1M;#L@8VAA'0^)SQS<&%N M/CPO6QE M/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'!E;G-E M#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CIC96YT97([ M(%1%6%0M24Y$14Y4.B`P:6X[(%=)1%1(.B`Q,#`E)R!A;&EG;CTS1&-E;G1E M6QE/3-$)T)/4D1%4BU"3U143TTZ(",Y96(V8V4@,'!X M('-O;&ED.R!"3U)$15(M3$5&5#H@(SEE8C9C92`P<'@@"!S;VQI9#L@0D]21$52+5))1TA4.B`C.65B-F-E(#!P>"!S;VQI9"<@ M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!A;&EG;CTS1&-E;G1E M"!S M;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q-"4^(#QD:78^)B,Q M-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT M97([($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q M-"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5. M1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@ M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$T)3X@/&1I=CXW M-RPS,CD\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!& M3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4 M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$T)3X@/&1I=CXU.3(L,#`P/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[ M(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!6 M15)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T M:#TS1#$T)3X@/&1I=CXR.3`L-S6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X M('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@ M;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE M"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@ M;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/ M54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=. M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^ M)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@ M/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F M=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[ M(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I M9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E' M3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z M(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T M,#`G('=I9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG"`P<'0@,"XU:6X[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$ M)U=)1%1(.B`P+C1I;CL@5T]21"U74D%0.B!B6QE/3-$)T9/3E0M4TE:13H@,3!P="<^4&%Y86)L92!T;R!A M(&9O&5C=71I=F4@;V8@=&AE($-O;7!A;GDN/"]F;VYT/CPO9&EV M/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\9&EV('-T>6QE/3-$)T-,14%2.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[5$585"U)3D1%3E0Z("TP+C1I;CL@34%21TE..B`P:6X@,&EN(#!P="`P M+C1I;B<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[ M/"]F;VYT/CPO9&EV/B`\=&%B;&4@6QE/3-$)U!!1$1)3D6QE M/3-$)U=)1%1(.B`P+C1I;CL@5T]21"U74D%0.B!B6QE/3-$)W=I9'1H.C$P M,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL M<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/ M3E0M4U193$4Z(&YO"!S;VQI M9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q-"4^(#QD:78^)B,Q-C`[ M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!" M04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%, M+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^ M(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@ M=VED=&@],T0Q-"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E' M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$T)3X@/&1I M=CXQ,"PU,#`L,#`P/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4 M:6UE"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R M;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$ M.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B M;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)B,Q M-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C M,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@ M1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q-"4^(#QD:78^)B,Q-C`[/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@ M'0^)SQD:78@3Y& M=71U6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"!S;VQI9#L@1D].5"U714E' M2%0Z(#0P,"<@=VED=&@],T0S-24^(#QD:78^)B,Q-C`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`Q,'!T.R!615)424-!3"U!3$E' M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I M=CXS+#8R,BPP,#`\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O M;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R M;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXF M(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L M93L@5$585"U!3$E'3CH@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO&5D M.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO M=&0^/"]T'0^)SQD:78@3Y4:&4@0V]M<&%N>2!H87,@96YT97)E9"!I;G1O(&-A<&ET86P@ M;&5A'!I6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPGF5D('5N9&5R('1H97-E(&QE87-E#L@1D].5#H@ M,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M5$585"U!3$E'3CIC96YT97([(%1%6%0M24Y$14Y4.B`P:6X[(%=)1%1(.B`Q M,#`E)R!A;&EG;CTS1&-E;G1E6QE/3-$)TU!4D=)3CH@ M,'!X.F%U=&\[(%=)1%1(.B`Y,"4[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P M6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED M.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U19 M3$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-4 M64Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U3 M25I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=( M5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXQ+#`P-RPW,S4\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@ M1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9% M4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H M/3-$,3(E/B`\9&EV/B@R-3`L.#(Q*3PO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C M9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T M;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)B,Q-C`[ M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P M,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E' M2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O M=6)L93L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F M9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[ M($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\ M+W1D/B`\=&0@"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,W!X(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^ M/'1D/CPO=&0^/"]T'0^ M)SQD:78@3Y-:6YI M;75M(&9U='5R92!L96%S92!P87EM96YT3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS M1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE#IA=71O.R!7 M24142#H@.#4E.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R!/5D521DQ/ M5SH@=FES:6)L93L@0D]21$52+51/4#H@(SEE8C9C92`P<'@@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F M9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=. M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4 M+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5)) M1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!" M04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%, M+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^ M(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E' M3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z M(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T M,#`G('=I9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA M>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^ M/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA"!$:7-C M;&]S=7)E(%M!8G-T"!!'0^)SQD:78@3Y$969E6QE/3-$)T-,14%2.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E"!S;VQI9#L@34%21TE. M.B`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`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D52 M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@] M,T0Q,B4^(#QD:78^-BPS-C,L,#$X/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C M9F9C8SL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q M,B4^(#QD:78^,BPP-C0L,C(R/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q% M.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@0T],3U(Z(",P M,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^.#$L,#`P M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!& M3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%# M2T=23U5.1#H@(V-C9F9C8SL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@ M,3!P=#L@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P M,"<@=VED=&@],T0Q,B4^(#QD:78^,2PP-C`L,#`P/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO&5D(&%S6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[ M(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@0T],3U(Z(",P,#`P,#`[($9/ M3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^-RPT,#D\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%, M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!# M3TQ/4CH@(S`P,#`P,#L@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E' M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I M=CXH-RPW,C$L,S,Q*3PO9&EV/B`\+W1D/B`\=&0@"!S M;VQI9#L@5$585"U!3$E'3CH@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E' M2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I M=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5. M1#H@(V9F9F9F9CL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED M=&@],T0U-24^(#QD:78^5&]T86P@;F5T(&1E9F5R"!A6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO"!D;W5B;&4[(%1%6%0M04Q)1TXZ M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@ M(V9F9F9F9CL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D52 M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@] M,T0Q,B4^(#QD:78^+3PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L M93L@5$585"U!3$E'3CH@6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U M=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R M/CQT9#X\+W1D/CPO='(^/"]T86)L93X\'0@ M0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S M='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE#L@1D].5#H@,3!P="!4:6UE&5S(&%T('1H92!5+E,N(&9E9&5R86P@'!E;G-E(&ES(&%S(&9O;&QO M=W,Z/"]D:78^(#QD:78@3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS M1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE"!S;VQI9#L@34%21TE..B`P:6X[(%=)1%1(.B`X,B4[($)/4D1%4BU#3TQ, M05!313H@8V]L;&%P"!S;VQI9#L@0D]21$52+5))1TA4.B`C.65B-F-E(#!P M>"!S;VQI9"<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!A;&EG M;CTS1&QE9G0^(#QT6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z M(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@] M,T0Q,B4^(#QD:78^2G5N928C,38P.S,P+"8C,38P.S(P,3,\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED M=&@],T0Q,B4^(#QD:78^*#,T+C`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`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@ M-#`P)R!W:61T:#TS1#$T)3X@/&1I=CXP+C(P/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E, M13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E' M2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P M,"<@=VED=&@],T0Q-"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT M.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C M8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!& M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXM/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E' M3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E M;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO M='(^/"]T86)L93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)TU!4D=)3CH@,'!T(#!P M>#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!& M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CIC96YT97([ M(%1%6%0M24Y$14Y4.B`P:6X[(%=)1%1(.B`Q,#`E)R!A;&EG;CTS1&-E;G1E M6QE/3-$)TU!4D=)3CH@,'!X.F%U=&\[(%=)1%1(.B`U M,"4[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C M96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0S-R4^(#QD:78^)B,Q-C`[/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($9/3E0M4U19 M3$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED M=&@],T0Q)3X@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[ M(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!6 M15)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T M:#TS1#$P)3X@/&1I=CXR,#8L,C4Q/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=. M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4 M+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5)) M1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP M861D:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA2!&:6YA;F-I86P@26YF;W)M M871I;VX@1&ES8VQO'0^)SQD:78@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P:6X@,"XU:6X[(%=) M1%1(.B`V,"4[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X M('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z M(#0P,"<@=VED=&@],T0Q-"4^(#QD:78^)B,Q-C`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`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@X+#(X,2PU,C(I/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M2`H57-E9"!I;BD@3W!E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)RAI*2`Q+#0P M,"PP,#`@'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!.;W1E($-O;G9E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G0L(%!R:6YC:7!A;#PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)U1H92!M86IO2!O9B!S:&%R97,@;V8@ M=&AE($-O;7!A;GD@<&]S="UC;&]S:6YG('=E2!A9G1E M2!C M;VYV97)T('1O(%-E7,@6EN9R!W87)R86YT2!M86YA9V5M96YT+B!(;W=E=F5R+"!(0T-!('-H87)E:&]L M9&5R7,@6EN9R!W87)R86YT7,@'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y838S M8S(U85\Y93@T7S1C-S-?.#$T8E\Q8C4W93=F,#4T964-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO.6$V,V,R-6%?.64X-%\T8S'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N M/CPO'!E;G-E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^)SQS<&%N/CPO'!E;G-E M'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y838S8S(U85\Y93@T M7S1C-S-?.#$T8E\Q8C4W93=F,#4T964-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO.6$V,V,R-6%?.64X-%\T8S'0O M:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO&5R8VES92!0'!I'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'1U'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)S,@>65A M'0^)SQS<&%N/CPO&EM=6T@6TUE;6)E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2P@4&QA;G0@86YD($5Q=6EP M;65N="P@57-E9G5L($QI9F4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S,@>65A'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)SQS M<&%N/CPOF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M/B@S.30L.3,P*3QS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2P@4&QA;G0@86YD($5Q=6EP;65N="!;3&EN92!)=&5MF%T:6]N+"!.;VYP M3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\Y838S8S(U85\Y93@T7S1C-S-?.#$T8E\Q8C4W M93=F,#4T964-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.6$V,V,R M-6%?.64X-%\T8S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\Y838S8S(U85\Y93@T7S1C-S-?.#$T8E\Q8C4W93=F,#4T964-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.6$V,V,R-6%?.64X-%\T8S'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO2!%<75I='DL(%-H M87)E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\Y838S8S(U85\Y93@T7S1C-S-?.#$T8E\Q8C4W M93=F,#4T964-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.6$V,V,R M-6%?.64X-%\T8S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'!E;G-E'!E;G-E M&5C=71I=F4@;V8@=&AE($-O;7!A;GDN/"]T9#X-"B`@ M("`@(#PO='(^#0H@("`@("`\='(@8VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y838S8S(U85\Y93@T M7S1C-S-?.#$T8E\Q8C4W93=F,#4T964-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO.6$V,V,R-6%?.64X-%\T8S'0O M:'1M;#L@8VAA'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D($1I'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D($1I'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`@ M("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO2!%<75I='DL(%)E9&5M M<'1I;VX@4')I8V4@4&5R(%-H87)E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XD(#$P+C,\3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\Y838S8S(U85\Y93@T7S1C-S-?.#$T8E\Q8C4W93=F,#4T M964-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.6$V,V,R-6%?.64X M-%\T8S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G0@07=A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M&-H86YG960@:6YT M;R`Q('-H87)E(&]F('1H92!#;VUP86YY)W,@8V]M;6]N('-T;V-K+CQS<&%N M/CPO'0^)SQS<&%N/CPO&EM=6T@6TUE;6)E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y838S8S(U85\Y93@T7S1C-S-? M.#$T8E\Q8C4W93=F,#4T964-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO.6$V,V,R-6%?.64X-%\T8S'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO"!R871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP+C`P M)3QS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\Y838S8S(U85\Y93@T7S1C-S-?.#$T8E\Q8C4W93=F,#4T964-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.6$V,V,R-6%?.64X-%\T8S'0O:'1M;#L@8VAA&5S M("A$971A:6QS(%1E>'1U86PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X- M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L69O M'0^)SQS<&%N/CPO'0^)S(P,S4\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2P@4V5T=&QE;65N="!!9W)E96UE;G0L(%1E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO2P@4F5D96UP=&EO;B!686QU M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y838S8S(U85\Y M93@T7S1C-S-?.#$T8E\Q8C4W93=F,#4T964-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO.6$V,V,R-6%?.64X-%\T8S'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5S/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'1U86PI("A5 M4T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$ M=&@@8V]L2!4'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0O:F%V87-C3X-"B`@("`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` end XML 35 R43.htm IDEA: XBRL DOCUMENT v2.4.0.8
Significant Accounting Policies (Details 1) (USD $)
6 Months Ended 12 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Dec. 31, 2012
Basic and Diluted:      
Net loss $ (14,066,292)   $ (7,575,965)
Less: Deemed dividend to preferred stockholders (3,532,858)   0
Net loss attributable to common stockholders $ (17,599,150)   $ (7,575,965)
Weighted average shares (in shares) 6,851,819 37,897,909 38,939,909
Basic income (loss) per common share (in dollars per share) $ (2.57) $ (0.07) $ (0.19)
XML 36 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Restatement (Tables)
6 Months Ended
Jun. 30, 2013
Restatement [Abstract]  
Schedule Subsequent And First Restated Statements [Table Text Block]
The following table represents the effects of the subsequent and first restated statements as of December 31, 2012:
 
 
 
Subsequent
 
First
 
 
 
 
 
Restatement
 
Restated
 
Original
 
 
 
December 31, 2012
 
December 31, 2012
 
December 31, 2012
 
 
 
 
 
 
 
 
 
 
 
Accounts receivable
 
$
1,126,846
 
$
572,637
 
$
1,220,065
 
 
 
 
 
 
 
 
 
 
 
 
Rebates receivable
 
$
1,323,474
 
$
1,323,474
 
$
1,638,000
 
 
 
 
 
 
 
 
 
 
 
 
Other receivables
 
$
40,867
 
$
40,867
 
$
40,867
 
 
 
 
 
 
 
 
 
 
 
 
Accounts payable
 
$
4,431,366
 
$
4,520,223
 
$
1,514,857
 
 
 
 
 
 
 
 
 
 
 
 
Accrued expenses
 
$
568,528
 
$
453,057
 
$
453,057
 
 
 
 
 
 
 
 
 
 
 
 
Note payable
 
$
4,192,954
 
$
4,947,613
 
$
4,947,613
 
 
 
 
 
 
 
 
 
 
 
 
Redeemable preferred stock
 
$
2,362,517
 
$
458,800
 
$
458,800
 
 
 
 
 
 
 
 
 
 
 
 
Warrant liability
 
$
121,350
 
$
518,587
 
$
518,587
 
 
 
 
 
 
 
 
 
 
 
 
Common stock
 
$
4,175,856
 
$
3,556,056
 
$
3,556,056
 
 
 
 
 
 
 
 
 
 
 
 
APIC
 
$
150,000
 
$
-
 
$
-
 
 
 
 
 
 
 
 
 
 
 
 
Sales
 
$
27,305,795
 
$
28,663,284
 
$
38,401,140
 
 
 
 
 
 
 
 
 
 
 
 
Cost of sales
 
$
26,148,118
 
$
24,068,906
 
$
31,650,232
 
 
 
 
 
 
 
 
 
 
 
 
General and administrative expenses
 
$
7,603,458
 
$
7,299,603
 
$
7,299,603
 
 
 
 
 
 
 
 
 
 
 
 
Interest expense
 
$
(1,130,184)
 
$
640,286
 
$
640,286
 
 
 
 
 
 
 
 
 
 
 
 
Accumulated deficit
 
$
(10,639,542)
 
$
(8,937,860)
 
$
(4,970,540)
 
 
 
 
 
 
 
 
 
 
 
 
Loss per share
 
$
(0.19)
 
$
(0.09)
 
$
(0.02)
 
XML 37 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2013
Accounting Policies [Abstract]  
Basis of Accounting, Policy [Policy Text Block]
Basis of Presentation
 
The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
 
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements including disclosure of contingent assets and liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period and accompanying notes. The Company’s critical accounting policies are those that are both most important to the Company’s financial condition and results of operations and require the most difficult, subjective or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of the uncertainty of factors surrounding the estimates or judgments used in the preparation of the financial statements, actual results could differ from these estimates.
Consolidation, Policy [Policy Text Block]
Principles of Consolidation
 
The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances have been eliminated in consolidation.
Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]
Accounts Receivable
 
Accounts receivable represent amounts owed to the Company for products sold and services rendered net of an allowance for doubtful accounts. The Company grants unsecured credit to its customers. The Company continuously monitors the payment performance of its customers to ensure collections and minimize losses. Management does not believe that significant credit risks exist. An allowance for doubtful accounts is based upon the credit profiles of specific customers, economic and industry trends and historic payment experience. There is no allowance for doubtful accounts at June 30, 2013 and December 31, 2012.
Inventory, Policy [Policy Text Block]
Inventory
 
Inventories consist of finished pharmaceutical products and are recorded at the lower of cost or market, with the cost determined on a first-in, first-out basis. The Company periodically reviews the composition of inventory in order to identify obsolete, slow-moving or otherwise non-saleable items. If non-saleable items are observed and there are no alternate uses for the inventory, the Company will record a write-down to net realizable value in the period that the decline in values is first recognized.
Rebates Policy [Policy Text Block]
Rebates
  
Pharmaceutical manufacturers offer rebates for selected brand drugs. The Company currently receives these rebates through a third party administrator. The rebates are considered earned when members (employees of customers) order the drugs. Rebates earned are paid to the Company by the third party administrator quarterly. Rebates earned are recognized as a reduction to cost of revenue. The portion of the rebate payable to customers is simultaneously recognized as a reduction of revenue. Management evaluates rebates receivable at the end of every reporting period and adjusts the amount reflected on the accompanying balance sheet to net realizable value. An adjustment is also made to the rebate payable to customers to correspond with any adjustment that applies to rebates receivable.
Property, Plant and Equipment, Policy [Policy Text Block]
Property and Equipment
 
Property and equipment are stated at cost less accumulated amortization and depreciation. Leasehold improvements are amortized using the straight-line method over the shorter of the term of the lease or the estimated useful lives of the assets. Furniture and fixtures are depreciated using the straight-line method over the estimated useful lives of the assets of 5 years. Computer equipment and software are depreciated using the straight-line method over the estimated useful lives of the assets, which range from 3 to 5 years.
Development Stage Company Policy [Policy Text Block]
Internal-Use Software Development Costs
 
The Company capitalizes certain costs associated with the purchase and/or development of internal-use software, including its website. Generally, external and internal costs incurred during the application development stage of a project are capitalized. The application development stage of a project generally includes software design and configuration, coding, testing and installation activities. Training and maintenance costs are expensed as incurred. Upgrades and enhancements are capitalized if it is probable that such expenditures will result in additional functionality. Capitalized software costs are amortized using the straight-line method over the estimated useful life of the asst, which approximates 3 years.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]
Long-Lived Assets
 
Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. The Company assesses recoverability by determining whether the net book value of the related asset will be recovered through the projected undiscounted future cash flows of the asset. If the Company determines that the carrying value of the asset may not be recoverable, it measures any impairment based on the fair value of the asset as compared to its carrying value. During the six months ended June 30, 2013 and the year ended December 31, 2012, the Company did not record any impairment charges.
Investment, Policy [Policy Text Block]
Investments Held in Trust
 
The Company applies the provisions of ASC Topic 320-10, Investment – Debt and Equity, to account for investments held in trust, which comprise only of held-to maturity securities. Held-to-maturity securities are those securities, which the Company has the ability and intent to hold until maturity. Held-to-maturity securities are recorded at amortized cost on the accompanying balance sheets and adjusted for any amortization or accretion of premiums or discounts.
Deferred Charges, Policy [Policy Text Block]
Deferred Financing Costs
 
Costs relating to obtaining the line of credit in April 2013 and the Bridge Notes in September 2012 have been capitalized and amortized over the term of the related debt using the straight line method. Amortization of deferred financing costs charged to interest expense was $686,631 and $254,993 in the six months ended June 30, 2013 and for the year ended December 31, 2013, respectively. The unamortized balance was $548,394 and $552,380 at June 30, 2013 and December 31, 2012, respectively.
Derivatives, Policy [Policy Text Block]
Derivative Financial Instruments
 
The Company applies the provisions of ASC Topic 815-40, Contracts in Entity’s Own Equity (“ASC Topic 815-40”), under which convertible instruments and warrants, which contain terms that protect holders from declines in the stock price (reset provisions), may not be exempt from derivative accounting treatment. As a result, such warrants are recorded as a liability and are revalued at fair value at the end of each reporting period. Furthermore, under derivative accounting, the warrants are initially recorded at their fair value. If the fair value of the warrants exceeds the face value of the related debt, the excess is recorded as a change in fair value in the statement of operations on the issuance date.
Debt, Policy [Policy Text Block]
Debt Discounts
 
Debt discounts are amortized using the effective interest rate method over the term of the related debt. The result achieved using the straight-line method is not materially different than those which would result using the effective interest method.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
Share-Based Payments
 
Share-based payments to employees are measured at the fair value of the award on the date of grant based on the estimated number of awards that are ultimately expected to vest. The compensation expense resulting from such awards is recorded over the vesting period of the award in selling, general and administrative expenses on the accompanying consolidated statements of operations.
 
Share-based payments to non-employees for services rendered are recorded at either the fair value of the services rendered, or the fair value of the awards, whichever is more readily determinable. The expense resulting from such awards is  marked to market over the vesting period of the award in selling, general and administration expenses on the accompanying consolidated statements of operations. 
Revenue Recognition, Policy [Policy Text Block]
Revenue Recognition
 
The Company typically enters into annual renewable agreements with its customers to provide pharmacy benefit management on a fixed price or self-insured basis. The Company records revenues from all its current contracts with customers gross as the Company acts as principal based on the following factors: 1) the Company has a separate contractual relationship with its customers and with its claims adjudicator to whom the Company pays the costs of the prescription drugs consumed by its customers (the claims), 2) the Company through its claim adjudicator is responsible to validate and manage the claims, and 3) the Company bears the credit risk for the amount due from the customers. Revenues are recorded monthly as earned. The Company also operates a mail order pharmacy that services plan members. All revenues and associated costs from dispensing drugs by the mail order pharmacy to our plan members, excluding the members’ co-pay are eliminated as inter-company revenues. Some of the contracts contain terms whereby the Company makes certain financial guarantees regarding prescription costs. Actual performance is compared to the guaranteed measure throughout the period and accruals are recorded as an offset to revenue if the Company fails to meet a financial guarantee.
Cost of Sales, Policy [Policy Text Block]
Cost of Sales
 
Cost of sales includes claim payments for both fixed- price and self-insured programs, administrative fees paid for processing the claims to the claims adjudicator and, the cost of prescription drugs of the mail order pharmacy.
Advertising Costs, Policy [Policy Text Block]
Advertising Expenses
 
Advertising expenses are expensed as incurred and included in selling, general and administrative expenses on the accompanying statements of operations. Advertising expenses were approximately $68,000 and $143,000 for the six months ended June 30, 2013 and year ended December 31, 2012, respectively.
Income Tax, Policy [Policy Text Block]
Income Taxes
 
The Company accounts for income taxes using the liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. A valuation allowance is established when realization of net deferred tax assets is not considered more likely than not.
 
Uncertain income tax positions are determined based upon the likelihood of the positions being sustained upon examination by taxing authorities. The benefit of a tax position is recognized in the consolidated financial statements in the period during which management believes it is more likely than not that the position will not be sustained. Income tax positions taken are not offset or aggregated with other positions. Income tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of income tax benefit that is more than 50 percent likely of being realized if challenged by the applicable taxing authority. The portion of the benefits associated with income tax positions taken that exceeds the amount measured is reflected as income taxes payable.
 
The Company recognizes interest related to uncertain tax positions in interest expense. The Company recognizes penalties related to uncertain tax positions in income tax expense.
Fair Value Measurement, Policy [Policy Text Block]
Fair Value Measurements
 
The Company applies recurring fair value measurements to its derivative instruments in accordance with ASC 820, Fair Value Measurements. In determining fair value, the Company uses a market approach and incorporates assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and/or the risks inherent in the inputs to the valuation techniques. These inputs can be readily observable, market corroborated or generally unobservable internally-developed inputs. Based upon the observability of the inputs used in these valuation techniques, the Company’s derivative instruments are classified as follows:
 
Level 1:
The fair value of derivative instruments classified as Level 1 is determined by unadjusted quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.
 
Level 2:
The fair value of derivative instruments classified as Level 2 is determined by quoted market prices for similar assets or liabilities in active markets, quoted market prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data.
 
Level 3:
The fair value of derivative instruments classified as Level 3 is determined by internally-developed models and methodologies utilizing significant inputs that are generally less readily observable from objective sources.
 
The Company’s valuation methodology for warrants classified as derivative liabilities qualifies as a level 2 fair value measurement since it is determined using internally developed models and analysis.
 
At June 30, 2013 the Company had 2,000,000 warrants exercisable into its Class C shares that were issued in connection with Selway’s initial public offering (“Selway IPO Warrants”). These warrants are publicly traded and are classified as liabilities. Additionally, HCCA issued 296,250 warrants in connection with the Bridge Financing with identical terms as the Selway IPO Warrants. The Company has valued all of these warrants as June 30, 2013 based on the closing price of the Selway IPO Warrants. Because the market for the Selway IPO Warrants is not active, the valuation is classified as a Level 2 measurement. These warrants are exercisable at $7.50 a share and expire on November 7, 2016.
 
The table below presents the Company’s fair value hierarchy for those derivative instruments measured at fair value on a recurring basis as of June 30, 2013:
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Warrants
 
$
-
 
$
3,559,188
 
$
-
 
$
3,559,188
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total derivative liabilities
 
$
-
 
$
3,559,188
 
$
-
 
$
3,559,188
 
  
The table below presents the Company’s fair value hierarchy for those derivative instruments measured at fair value on a recurring basis as of December 31, 2012:
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Warrants
 
$
-
 
$
121,350
 
$
-
 
$
121,350
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total derivative liabilities
 
$
-
 
$
121,350
 
$
-
 
$
121,350
 
Fair Value of Financial Instruments, Policy [Policy Text Block]
Fair Value of Financial Instruments
 
The fair values of cash and cash equivalents, accounts receivable, rebates receivable and accounts payable approximate their carrying values due to the short-term nature of the instruments. The fair values of long-term debt and revolving loans approximates their carrying value due to their variable interest rates. The fair value of investments held in trust is not materially different than its carrying value because of the short-term nature of the investments.
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Risks and Concentrations
 
The Company utilizes the services of a single claims adjudicator. If there is an adverse situation in this relationship, the Company’s mail order pharmaceutical fulfillment services would be ineffective until a replacement claims adjudicator was obtained.
 
Approximately 12% of the Company’s 2012 revenues were derived from one customer. Revenues from this customer were 10% of our revenues for the six month period ended June 30, 2013. No amounts were due from this customer at June 30, 2013 or December 31, 2012. In addition, one of the reseller’s customers accounted for approximately 14% of the Company’s revenue for the six month period ended June 30, 2013 as well as approximately 14% of the Company’s revenue for the year ended December 31, 2012. Amounts due from this customer represented 32% and 46% of accounts receivable at June 30, 2013 and December 31, 2012, respectively.
Cash and Cash Equivalents, Policy [Policy Text Block]
Cash and Cash Equivalents
 
The Company considers all cash in bank, money market funds and certificates of deposit with an original maturity of less than three months to be cash equivalents. The Company maintains its cash and cash equivalents in one financial institution. Cash balances on hand at this financial institution may exceed the insurance coverage provided to the Company by the Federal Deposit Insurance Corporation at various times during the year.
Earnings Per Share, Policy [Policy Text Block]
Earnings (Loss) Per Share
 
Basic earnings (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted earnings (loss) per share are determined in the same manner as basic earnings (loss) per share, except that the number of shares is increased to include potentially dilutive securities using the treasury stock method. Because the Company incurred a net loss in all periods presented, all potentially dilutive securities were excluded from the computation of diluted loss per share because the effect of including them is anti-dilutive.
 
 
 
Six Months Ended
 
Year Ended
 
 
 
June 30, 2013
 
December 31, 2012
 
Basic and Diluted:
 
 
 
 
 
 
 
Net loss
 
$
(14,066,292)
 
$
(7,575,965)
 
Less: Deemed dividend to preferred stockholders
 
 
(3,532,858)
 
 
-
 
Net loss attributable to common stockholders
 
$
(17,599,150)
 
$
(7,575,965)
 
Weighted average shares
 
 
6,851,819
 
 
38,939,909
 
Basic loss per common share
 
$
(2.57)
 
$
(0.19)
 
 
The following table summarizes the number of shares of common stock attributable to potentially dilutive securities outstanding for each of the periods which are excluded in the calculation of diluted loss per share:
 
 
 
Six Months Ended
 
Year Ended
 
 
 
June 30, 2013
 
December 31, 2012
 
Dilutive Potential Common Shares
 
 
 
 
 
 
 
Warrants
 
$
3,314,023
 
$
1,585,833
 
Restricted stock awards
 
 
-
 
 
75,292
 
Convertible notes payable
 
 
-
 
 
2,666,667
 
Reclassification, Policy [Policy Text Block]
Reclassification
 
Certain previously reported amounts have been reclassified to conform to the presentation used in the June 30, 2013 financial statements.
XML 38 R56.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-Term Debt (Details 1) (USD $)
Jun. 30, 2013
Schedule of Capitalization, Long-term Debt [Line Items]  
2014 $ 0
2015 0
2016 399,000
2017 1,789,000
2018 3,622,000
Thereafter 4,690,000
Long-term debt $ 10,500,000
XML 39 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8
Significant Accounting Policies (Details 2) (USD $)
6 Months Ended 12 Months Ended
Jun. 30, 2013
Dec. 31, 2012
Dilutive Potential Common Shares    
Warrants $ 3,314,023 $ 1,585,833
Restricted stock awards 0 75,292
Convertible notes payable $ 0 $ 2,666,667
XML 40 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2013
Accounting Policies [Abstract]  
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]
The table below presents the Company’s fair value hierarchy for those derivative instruments measured at fair value on a recurring basis as of June 30, 2013:
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Warrants
 
$
-
 
$
3,559,188
 
$
-
 
$
3,559,188
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total derivative liabilities
 
$
-
 
$
3,559,188
 
$
-
 
$
3,559,188
 
  
The table below presents the Company’s fair value hierarchy for those derivative instruments measured at fair value on a recurring basis as of December 31, 2012:
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Warrants
 
$
-
 
$
121,350
 
$
-
 
$
121,350
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total derivative liabilities
 
$
-
 
$
121,350
 
$
-
 
$
121,350
 
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
The following table summarizes the number of shares of common stock attributable to potentially dilutive securities outstanding for each of the periods which are excluded in the calculation of diluted loss per share:
  
 
 
Six Months Ended
 
Year Ended
 
 
 
June 30, 2013
 
December 31, 2012
 
Basic and Diluted:
 
 
 
 
 
 
 
Net loss
 
$
(14,066,292)
 
$
(7,575,965)
 
Less: Deemed dividend to preferred stockholders
 
 
(3,532,858)
 
 
-
 
Net loss attributable to common stockholders
 
$
(17,599,150)
 
$
(7,575,965)
 
Weighted average shares
 
 
6,851,819
 
 
38,939,909
 
Basic income (loss) per common share
 
$
(2.57)
 
$
(0.19)
 
Diluted Loss Per Shares [Table Text Block]
The following table summarizes the number of shares of common stock attributable to potentially dilutive securities outstanding for each of the periods which are excluded in the calculation of diluted loss per share:
 
 
 
Six Months Ended
 
Year Ended
 
 
 
June 30, 2013
 
December 31, 2012
 
Dilutive Potential Common Shares
 
 
 
 
 
 
 
Warrants
 
$
3,314,023
 
$
1,585,833
 
Restricted stock awards
 
 
-
 
 
75,292
 
Convertible notes payable
 
 
-
 
 
2,666,667
 
XML 41 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Property and Equipment (Tables)
6 Months Ended
Jun. 30, 2013
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment [Table Text Block]
Property and equipment is as follows:
 
 
 
June 30, 2013
 
December 31, 2012
 
 
 
 
 
 
 
 
 
Furniture, fixtures and equipment
 
$
1,606,404
 
$
1,374,126
 
Leasehold improvements
 
 
25,260
 
 
10,162
 
 
 
 
1,631,664
 
 
1,384,288
 
Accumulated depreciation and amortization
 
 
(394,930)
 
 
(270,233)
 
 
 
 
 
 
 
 
 
Net property and equipment
 
$
1,236,734
 
$
1,114,055
 
XML 42 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Description of Business
6 Months Ended
Jun. 30, 2013
Description Of Organization and Business Operations [Abstract]  
Description of Organization and Business Operations Disclosure [Text Block]
1.
Description of Business
 
Selway Capital Acquisition Corporation (“SCAC” or “Selway”) was originally incorporated under the laws of Delaware on January 12, 2011 for the purpose of acquiring one or more operating businesses through merger or capital stock exchange. On January 25, 2013, an agreement and plan of merger (the “Merger”) was entered into between SCAC and Healthcare Corporation of America (“HCCA”). The Merger closed on April 10, 2013 with SCAC being the surviving entity upon the consummation of the Merger (see Note 3).
 
HCCA and its wholly-owned subsidiaries, Prescription Corporation of America Benefits (“PCA Benefits”) and Prescription Corporation of America (“PCA”), are engaged in providing benefits management and mail order pharmaceutical fulfillment services to companies primarily in the northeast United States.
 
On June 3, 2013, SCAC amended its articles of incorporation to change its name to Healthcare Corporation of America (collectively with its subsidiaries, the “Company”).
 
On April 22, 2013, the Company’s board of directors approved the change of its fiscal year end from December 31 to June 30.
 
On November 7, 2013, the board of directors approved the change of its fiscal year end back to December 31.
  
The accompanying historical consolidated financial statements represent the financial position and results of operations of HCCA through April 10, 2013 and the financial position and results of operations of the Company thereafter  (see Note 3).
XML 43 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Software, net (Tables)
6 Months Ended
Jun. 30, 2013
Capitalized Computer Software, Net [Abstract]  
Schedule of Capitalized Computer Software, Net [Table Text Block]
Software, net is as follows:
 
 
 
June 30, 2013
 
December 31, 2012
 
 
 
 
 
 
 
 
 
Software costs
 
$
294,109
 
$
-
 
Accumulated amortization
 
 
(31,967)
 
 
-
 
 
 
 
 
 
 
 
 
Net software costs
 
$
262,142
 
$
-
 
XML 44 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
The Merger (Details Textual) (USD $)
6 Months Ended 12 Months Ended 6 Months Ended 6 Months Ended 6 Months Ended 6 Months Ended
Jun. 30, 2013
Dec. 31, 2012
Dec. 31, 2013
Subsequent Event [Member]
Jun. 30, 2013
Subsequent Event [Member]
Jun. 30, 2013
Incentive Stock [Member]
Jun. 30, 2013
Series C Common Stock [Member]
Jun. 30, 2013
Series A Common Stock [Member]
Jun. 30, 2013
Bridge Financing [Member]
Jun. 30, 2013
Bridge Financing [Member]
Series C Common Stock [Member]
Jun. 30, 2013
Minimum [Member]
Jun. 30, 2013
Maximum [Member]
Jun. 30, 2013
Warrant [Member]
Jun. 30, 2013
Criteria [Member]
Jun. 30, 2013
Notes Payable, Other Payables [Member]
Jun. 30, 2013
Bridge Loan [Member]
Jun. 30, 2013
Bridge Loan [Member]
Series C Common Stock [Member]
Jun. 30, 2013
Healthcare Corporation Of America [Member]
Jun. 30, 2013
Healthcare Corporation Of America [Member]
Bridge Financing [Member]
Jun. 30, 2013
Healthcare Corporation Of America [Member]
Notes Payable, Other Payables [Member]
Jun. 30, 2013
Escrow [Member]
Healthcare Corporation Of America [Member]
Promissory Note [Member]
Jun. 30, 2013
Earnout Payment Shares [Member]
Healthcare Corporation Of America [Member]
Jun. 30, 2013
Earnout Payment Shares [Member]
Healthcare Corporation Of America [Member]
Criteria One [Member]
Jun. 30, 2013
Earnout Payment Shares [Member]
Healthcare Corporation Of America [Member]
Criteria Two [Member]
Jun. 30, 2013
Chardan Capital Markets Llc [Member]
Healthcare Corporation Of America [Member]
Jun. 30, 2013
Management Incentive Shares [Member]
Jun. 30, 2013
Management Incentive Shares [Member]
June 30, 2014 [Member]
Jun. 30, 2013
Management Incentive Shares [Member]
June 30, 2015 [Member]
Jun. 30, 2013
Management Incentive Shares [Member]
Rescission Agreements [Member]
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                                                        
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares                                 5,200,000 592,500     2,800,000 1,400,000 1,400,000 546,002 1,500,000      
Business Acquisition Cost Of Acquired Entity Purchase Prices                                       $ 7,500,000                
Business Acquisition, Notes Repayment Description                                 The notes will be repaid from 18.5% of the Companys free cash-flow (as defined) in excess of $2,000,000.                      
Liabilities Assumed 6,327,559                         1,977,570         1,977,570                  
Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Cancelled                                                       750,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 400,000                                                 400,000 350,000  
Merger Agreement, Shares Vesting Terms                                                 Certain members of HCCAs management received an aggregate of 1,500,000 shares of our common stock (the Management Incentive Shares), which shares were placed in escrow and subject to release in three installments through June 30, 2015.      
Class Of Warrant Or Rights Issued 2,000,000                                                      
Class of Warrant or Right, Exercise Price of Warrants or Rights 7.50                       7.50                              
Proceeds from Issuance of Warrants 0 371,350                                                    
Debt Instrument, Maturity Date                       Nov. 06, 2016                                
Value Per Share                                 $ 15.00                      
Criteria For Payment Of Earn Out Payment Shares                                           (i) 1,400,000 shares if the Company achieves consolidated gross revenue of $150,000,000 for the twelve months ended March 31, 2014 or June 30, 2014 (ii) 1,400,000 shares if the Company achieves consolidated gross revenue of $300,000,000 for the twelve months ended March 31, 2015          
Bridge Financing Units Issued Warrants                                 59.25                      
Bridge Financing, Units Issued, Preferred Shares                                   10,000                    
Bridge Financing, Promissory Note Face Value                                   100,000                    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                                   296,250                    
Preferred Stock Dividends, Income Statement Impact 3,532,858 0                               3,532,858                    
Class Of Warrant Or Right Exercisable Warrants Or Rights Price                             $ 7.50                          
Class Of Warrant Or Right Expired                             Nov. 07, 2016                          
Debt Instrument, Interest Rate, Stated Percentage 5.00%         8.00%                                            
Promissory Note Convertible Into Common Stock           10,000     315,959                                      
Amortization of Debt Discount (Premium)                                 1,018,851                      
Interest Expense, Debt 1,732,047 713,196                                                    
Debt Instrument, Unamortized Discount 7,728,486                               2,445,242                      
Debt Instrument Additional Interest Expense 1,182,327                                                      
Debt Instrument, Annual Principal Payment             3,101,038 3,159,624               3,025,000                        
Debt Instrument, Periodic Payment, Principal               3,025,000                                        
Interest Expense, Other Long-term Debt 592,500                                                      
Debt Conversion, Converted Instrument, Rate 5.00%                             5.00%                        
Conversion of Stock, Shares Converted 878,481                             281,554                        
Debt Instrument, Convertible, Conversion Price     $ 1.50     $ 3.53                                            
Conversion of Stock, Amount Converted           11,948,361                                            
Conversion Of Stock To Underwriters 237,007                                                      
Transaction Cost Total 577,069                                                      
Aggregate Shares Of Common Stock For Placement Warrant 100,000                                                      
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right 1,000,000     1,000,000                                                
Percentage For Holders Issued And Outstanding Shares 75.00%                                                      
Percentage For Members Of Management 25.00%                                                      
Description For Warrants Exercisable common stock exceeds $12.00 per share for 20 trading days in any 30-trading-day period.                                                      
Class Of Warrant Or Right Initial Exercise Price Of Warrants $ 7.50                                                      
Class Of Warrant Or Right Exercise Price Of Warrants Adjustment                   $ 1.50 $ 7.50                                  
Percentage For Consideration Received Owed To Adviser 5.00%                                                      
Stock Issued During Period, Shares, Other         335,000                                              
Percentage Common Stock And Incentive Stock 5.00%                                                      
Incentive Note Issued 500,000                                                      
Percentage Of Incentive Note Issued 5.00%                                                      
Description For Business Acquisition Transaction Factors The majority of shares of the Company post-closing were still owned by HCCA shareholders, who represented 60% of the Companys shares outstanding immediately after closing, if all shares subject to conversion in our post-closing tender offer actually convert to Series C (non-redeemable) common shares, and 65% of the Companys shares outstanding if all shares subject to conversion do not convert to Series C shares and opt to receive their pro rata cash in trust at the time of the post-closing tender offer. Estimates of HCCAs ownership do not include shares underlying warrants held by public investors and the Companys sponsors restricted incentive shares held by management. However, HCCA shareholders would still have 51% of the Companys shares post-closing when including shares underlying warrants and restricted shares and assuming all redeemable shares convert to Series C shares, and 54% of the Companys shares post-closing if all shares subject to conversion do not convert to Series C shares and opt to receive their pro rata cash in trust at the time of the post-closing tender offer.                                                      
Concentration Risk, Percentage 10.00% 12.00%                             10.00%                      
Consolidated Gross Revenue                                           $ 150,000,000 $ 300,000,000          
Conversion Of Preferred Stock Shares Converted Percentage                                 3.70%                      
XML 45 R53.htm IDEA: XBRL DOCUMENT v2.4.0.8
Line of Credit (Details Texual) (USD $)
0 Months Ended
Apr. 11, 2013
Jun. 30, 2013
Line of Credit Facility [Line Items]    
Line of Credit Facility, Maximum Borrowing Capacity $ 5,000,000  
Line of Credit Facility, Expiration Period 3 years  
Line of Credit Facility, Amount Outstanding   $ 534,343
XML 46 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED BALANCE SHEETS (USD $)
Jun. 30, 2013
Dec. 31, 2012
Assets    
Cash and cash equivalents $ 1,792,026 $ 1,791,134
Prepaid expenses and other current assets 322,638 619,271
Total current assets 5,383,847 5,404,729
Inventory 442,945 544,004
Accounts receivable 1,251,579 1,126,846
Rebates receivable 1,574,659 1,323,474
Property and equipment, net 1,236,734 1,114,055
Investment held in trust 8,652,482 0
Deferred financing costs, net 548,394 0
Software, net 262,142 0
Other assets 443,251 83,686
Total assets 16,526,850 6,602,470
Liabilities, Redeemable Securities and Stockholders’ Deficit    
Total liabilities 16,156,733 10,553,639
Stockholders’ deficit:    
Preferred stock, $.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding at June 30, 2013 and Preferred stock, no par value; 592,500 shares authorized; 592,500 shares issued and outstanding; liquidation preference of $1,481,250 at December 31, 2012 0 2,362,517
Common stock, $.0001 par value; 30,000,000 shares authorized; 8,953,494 shares issued and outstanding at June 30, 2013 and Common stock, no par value; 50,000,000 authorized; 40,000,009 shares issued and outstanding at December 31, 2012 895 4,175,856
Additional paid-in capital 16,423,417 150,000
Accumulated deficit (24,705,834) (10,639,542)
Total stockholders’ deficit (8,281,522) (3,951,169)
Total liabilities, redeemable securities and stockholders’ deficit 16,526,850 6,602,470
Current liabilities:    
Accounts payable 5,214,355 4,431,366
Total current liabilities 9,024,393 9,968,774
Accrued expenses 2,428,033 568,528
Deferred revenue 495,286 638,223
Bridge notes 0 4,192,954
Line of credit 534,343 0
Current portion of capital leases 189,989 137,703
Other current liabilities 162,387 0
Incentive Notes 2,771,514 0
Capital leases, net of current portion 658,092 399,382
Derivative liabilities 3,559,188 121,350
Other liabilities 143,546 64,133
Commitments and contingencies      
Redeemable securities:    
Redeemable common stock, $.001 par value; 839,965 shares issued and outstanding 8,651,639 0
Total redeemable securities $ 8,651,639 $ 0
XML 47 R45.htm IDEA: XBRL DOCUMENT v2.4.0.8
Significant Accounting Policies (Details Textual) (USD $)
6 Months Ended 12 Months Ended
Jun. 30, 2013
Dec. 31, 2013
Dec. 31, 2012
Significant Accounting Policies [Line Items]      
Allowance for Doubtful Accounts Receivable $ 0   $ 0
Impairment of Long-Lived Assets Held-for-use 0 0  
Amortization of Financing Costs (67,360) 254,993  
Postconfirmation, Deferred Financing Costs 548,394 552,380  
Advertising Expense 68,000   143,000
Warrants Issued During Period 2,000,000    
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants $ 296,250    
Class of Warrant or Right, Exercise Price of Warrants or Rights 7.50    
Warrants Expiration Date Nov. 07, 2016    
Concentration Risk, Percentage 10.00%   12.00%
Percentage Portion In Accounts Receivable 32.00%   46.00%
Customer [Member]
     
Significant Accounting Policies [Line Items]      
Concentration Risk, Percentage 14.00%   14.00%
Furniture and Fixtures [Member]
     
Significant Accounting Policies [Line Items]      
Property, Plant and Equipment, Useful Life 5 years    
Computer Equipment And Software [Member] | Minimum [Member]
     
Significant Accounting Policies [Line Items]      
Property, Plant and Equipment, Useful Life 3 years    
Computer Equipment And Software [Member] | Maximum [Member]
     
Significant Accounting Policies [Line Items]      
Property, Plant and Equipment, Useful Life 5 years    
Software and Software Development Costs [Member]
     
Significant Accounting Policies [Line Items]      
Property, Plant and Equipment, Useful Life 3 years    
XML 48 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT AND REDEEMABLE SECURITIES [Parenthetical] (USD $)
6 Months Ended
Jun. 30, 2013
Common stock issued in conversion of redeemable preferred stock and warrants $ 296,250
XML 49 R59.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-Term Debt (Details Textual) (USD $)
6 Months Ended 12 Months Ended
Jun. 30, 2013
Dec. 31, 2012
Debt Instrument [Line Items]    
Stock Issued During Period, Value, New Issues $ 0 $ 650,562
Debt Instrument, Interest Rate, Effective Percentage 25.00%  
Debt Instrument, Convertible, If-converted Value in Excess of Principal 2,000,000  
Lease Expiration Date Nov. 30, 2019  
Long-term Debt 10,500,000  
Long-term Debt, Gross 500,000  
Debt Instrument, Interest Rate, Stated Percentage 5.00%  
Management Incentive Notes [Member]
   
Debt Instrument [Line Items]    
Management Fees, Incentive Revenue 222,477  
Payment for Management Fee 395,514  
Long-term Debt 2,500,000  
Series C Common Stock [Member]
   
Debt Instrument [Line Items]    
Stock Issued During Period, Shares, New Issues 5,200,000  
Stock Issued During Period, Value, New Issues 7,500,000  
Senior Debt Obligations [Member]
   
Debt Instrument [Line Items]    
Debt Instrument, Face Amount $ 10,500,000  
XML 50 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-Term Debt (Tables)
6 Months Ended
Jun. 30, 2013
Long-term Debt and Capital Lease Obligations, Current [Abstract]  
Schedule of Share-based Compensation, Nonemployee Director Stock Award Plan, Activity [Table Text Block]
 
 
June 30, 2013
 
 
 
 
 
 
Shareholder notes
 
$
7,500,000
 
Placement notes
 
 
500,000
 
Management incentive notes
 
 
2,500,000
 
 
 
 
 
 
 
 
 
10,500,000
 
Less debt discount
 
 
(7,728,486)
 
 
 
 
 
 
 
 
$
2,771,514
 
Schedule of Maturities of Long-term Debt [Table Text Block]
Future maturities of the Incentive Notes based on the Company’s estimates are as follows:
 
June 30,
 
 
 
 
 
 
 
 
 
2014
 
$
-
 
2015
 
 
-
 
2016
 
 
399,000
 
2017
 
 
1,789,000
 
2018
 
 
3,622,000
 
Thereafter
 
 
4,690,000
 
 
 
 
 
 
 
 
$
10,500,000
 
Schedule of Capital Leased Assets [Table Text Block]
The Company has entered into capital lease agreements for equipment, which expire at various dates through November 2019. The assets capitalized under these leases and associated accumulated depreciation at June 30, 2013 and December 31, 2012 are as follows:
 
 
 
June 30, 2013
 
December 31, 2012
 
 
 
 
 
 
 
 
 
Furniture and equipment
 
$
1,007,735
 
$
584,638
 
Accumulated depreciation
 
 
(250,821)
 
 
(153,937)
 
 
 
 
 
 
 
 
 
 
 
$
756,914
 
$
430,701
 
Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block]
Minimum future lease payments under capital lease obligations as of June 30, 2013 are as follows:
 
Year Ended June 30,
 
 
 
 
 
 
 
 
 
2014
 
$
256,257
 
2015
 
 
242,040
 
2016
 
 
209,938
 
2017
 
 
158,814
 
2018
 
 
106,617
 
Thereafter
 
 
50,640
 
 
 
 
 
 
Total future minimum lease payments
 
 
1,024,306
 
Less amount representing interest
 
 
(176,225)
 
Present value of net minimum lease payments
 
 
848,081
 
Less current portion
 
 
(189,989)
 
 
 
 
 
 
 
 
$
658,092
 
XML 51 R65.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies (Details) (USD $)
Jun. 30, 2013
Loss Contingencies [Line Items]  
2014 $ 207,764
2015 206,251
2016 217,740
2017 146,520
Total $ 778,275
ZIP 52 0001144204-14-015509-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-14-015509-xbrl.zip M4$L#!!0````(`"Z*;407C#ZXARX!`$^^$0`1`!P`+FZ MW6Q5F+$Q,##/RQ;SELQFWFIFDB>YJRM*V`*4&)O(]LRP5_?=KR7;((-MS#L& M;643QI;4K>Y?M[K;DOWY'Q\#2WG#U"6._:6DG:@E!=N&8Q*[]Z7T\^M-N5%2 M_O'UW__M\U_*9>4';&.*/&PJG9%RA3ST2I'QAQOU5[03[:2FL!]Z^1[14_]'^=^G^_]3KE]>E;+R_OY^8L(('A_AQ'`&2KD+Y3*B=:>.^C0RURSOZM`-NV>^Z^&^A+J>]YP_/34S8DN^"ST4Z!MJ[6 M=9A/T-0B]A^QIFR8$X?VH*6JG[+;'2`;-6=W33+N(#:NGP8WQTUGAG[7>5NM MV6R>\KOCIBY):@B#:J>_WM^]&'T\0&5BNQZRC1@O)(/WZ?;$=:H5[2RK1]`B MZF#B(<4&4VQJG^8IH@9U+'S:1897QA]#"]G(<^CH!OZ.!C(?M-+S)-5-6M;*NC;OYE`+JTOJ%=UG'2KRCB4ER'[B10`=_&/WD]NQ.0@=B MOV'72^X2W$OH9"-BN,E]^"W618MW<8F1W`%N)#7WAC2E/=Q)Z."[Y1Y"PW&? M+G([7+/AC819?%@9^/GU3@"U[]$,V,#=$MBNHGQFAG#N/<&PWQ MEY)+!D.+X9=?ZU/\23!7.-HZ[ MFE#DE[<_E;ZJ8,$UK5IO5#Z?3G>.2)U.T8IQ,,24..8T!V#7U`-'B[]&V%>U M:)S)O6@H83JFT*E>UM4)<3/L(K(D$(\NA3(,QYXG6*W2UK5C$RS\HVN;%*PN M(%8OHF#U902K;QZQNH#88Q+LIA#;))IEI6`3;J!B2C5@4O5VUKA3;&ZC)>KEK6-F:,U1!R11%HW!BK MFX%<))E"06U&,MJF)%.T4",N&3%F6*>;.CN@F.%LCV(&M2'D98VV5BUR^M!8 M)B]KE+7J9@2KZ9%@FVT`;:$%J^D+"[8)H-V$8)L"8IL%KR0TET%L$>S-D;TPMOF,#(Q]`B!@FGH)B1;+Z4P@<(YZD3 M2FD0C/3Y-)'`9,:G29SM*A2&3EIM:P7?]C=$*9J"C0.+>?H$QL'L!`APX]HOG&'^X@5C8P[26S_W8 M/:)_8`^=W*\<:J8M@>JK10O$M%Q*4Q;@B,-'+-2 M.C!LI"PZUX.AY8S8!-@C=HH,SQ47H!MB$P_?D3=LWMK`2H]T+-QR7>RY%Z-[ M]+M#+RWD%A0KT3JST"2C3JF"DPM5^FZ!]AT88@]QXQ10-KG*(@._X'!*G@WW M-=/3WQ%6]FT#1$-P38TH25\`*T>5>:T%7L>0\BU>I.>=MOCTHST3=.1(^Z0/ MW2C(\Z6F.XP6]_E95+P`+9&ZJ]5^:S5U(9/X$2/+ZQN(XDN'#AW*)_[8;0U@ M;`--,L][3'N8%E/I7*WB!/B%/#,_L&QRRM#O(8,:^`/1RI\ACRIXI"5,(;H4 MF^@!VK.H4_1Q)#H5)WI@.DVI^DA?O1^^>I\K./$'P^UG;&(\0!T++Y.T%`\^ M.1,"#JH,V>S$GZSCF7@N4#Q1W,648G/!%/:E#P;8=RP3W$S0(-9WYNX!%)ES M)I9)$EUSAILEW?1&QP#GI(VH3N^=*9*^.[&292DAO"=*O%"/7IR.96,7` MD""6`\-!RE8)F7#O><*]UULJDC$E\W69KTMKB*Q!IOLRW9=V4)'5`EDMD/:1 M&8G+8H,L-DB+F%B$K%7L7ZVB$#"*;T.1)8XBE3CV;']*"J9DB4.6.*0U1-8@ M2QRRQ"'M0)8ECSV`T=7I*EC;VO+2Q MBR-ULC8A:Q,'!&=97)#%A8,`LJP.;`S4LCJP#P"7Z;U,[P\,TC(_W[_\?!>O M'9*)=G$2[:V]^5@FVC+1/B`XRT1;)MH'`629:&\,U#+1W@>`RT1;)MH'!FF9 M:.]UHKWU+X:T#,/Q01Q/:,0R2Q$1UQ\>&*A/W#Z;WV/W"G>\8H,A?4;C=3=) M'')+1`:`KL),\F<;'.D[^S2/W;O!V#U6)/%23;90))XR\/3@>#@ROT>OCVGX M.QY\]1WJO6(Z8'(O_D=`4J83W9XC$@FG^9]AO".H0ZSI,/PH0Q[NH)+%(I&T MYL,W!PNB??MR2C$@M&K![.#AM&392T)K^5+5P6-JT8+3,8%IJC@D@Z6]#)9V M42>\083^@BP?W]I#WW/O\!NV-!$/XP87H_'/'T$]B!K]$6_."^%'"*E\DIDX MJ`Q1K[DL+K&>&^L5B?5M8;TBL;Y;K.L2Z]O"NBZQ7K@8YK@1.S<2.52D+!$! M'#=2YJ[CAXJ4)=;/XT;*W%6PL$@1CK3(#'J_UZTCB+2V=GQ+9M#[O?)*K*\/ MZT>(40F%C2[QQ05&T1/,HBV0QXV472:8FT-*R@/]>V2C'G>ZM[;!F'[#?!^@ M")H[Q^YY![,+,GDV?'')%H9\EI^!HQ<8"[N7,QNUF%Q;OL%VV]PC^@?V7K#A MLYW*V.6M@G[%1!3'3-[)\<9I4I+02JB!O6";.)29Z6/'(CW$Q!S?[P]72"PE2X#UST,7+=SQ+31!OT'GQ=3FVU(>WGN>T&)V<,W MQ$:V0>Q>+.N-+CYC`Y,W=J@)?CG4Q.:M_89=CTW[(CB]_=A-:,VKQC]B9'E] M`_SKI4.'#N4KZV.W-8!)&&@2[MYCVL.TF%@+T"1,@%_(,_/U5H77HK&0^T1@ M["CBKI351EG3%XNXH5.SK%4FQ-<;<6_/A(IG#P>(QUBU*0:L=2_6$V#)ZD`Q MJ@-;P4;*^BV7U^665[E>R9!OWS`IE]@"N='C79UWB/HB1@?[O#+LJBAPM+:S M8>P>^0JRSZ8VO>>$4-=[!NG"\.8$_.$5)H<"HWQF%OQJPI0/;+?(E(X?*>F! M*5C'H=[X;`],L^/]&[!02BO>F15/._C%]V%,06036WSB$)%.0`(C<>_7C4]M MXOD4MVSSAGRP7[''L$_4`7+>Z,D"'P9MV/;N81"+%?^I;*[)C2/45$G)'6#9 M[\0;^AZF8]F"^%Z0Y@8G*'>\BZYJ(H)L1@#N%HV?+!5?%0OJ3KG2,UB;AM(:[]C%T#,B)V3+Y',1\V-M"%[Q(;NV[+ M@!%=<@"O#-@24I?A+578T8/X%%5)>\FPEW_Z-M95^%D5VX9@KI"\M-JE3:0QP9JT@8.T09JT@92GSA<4@+:),+9GNA*,:$:U"YB4XA= M.J:J=C3G1QLGJU?6O8M'UWY((E%ZP=+UAC%,H%*\-F$\^Z,CE.W9!6MXN7!"0H80_/ M*.\9TJ=29(EPB?"]S?SC641PVE*7V<`*V<"F/=V2KH[!]D'N.4D MYW:/:1DC^0(%0VDOXYE3GRHP:'(5>O;DO9M;]QL2#GL'AP(Y MDT4RJ^)!1J8G:ZD921>SLHLY'-3NLW-;`]B+!UH)E]UE8M(U;M" M(NBL.&T>=R0)5:(P(5:1&Y'VZRUT6XM7QR]=E_'JWL:K6_GRAK[0R_TD6+9\ M@J0(K^';^'=$=.$C$=)?[9._6D>HLXU/24AW)]W=$P<6BP_=ALFW.9'/Z>H MF.0-L#6M!=;U`188R/4=.@VLW*R)`I\>,8'@%;9A!;.S2"2Y";=SB5;4IPZ,^`+ZY4UB`7PC__I5R^MOA35>4%\R_@ELM! MT\BO72*WW[)-]A]V6OH-6=#8;7F7,.\1L7N_(,O'2FCRS[@[4_G5%CENNBSWWTJ>4*2*O+/5,SFIZ0V]4SR:%#'-;"17M*I>JPD\ M)%);EJ<4N6AJ)E/5JJ[I]?JB3-T1U"$6_[CYHD+2LKUW$Q2E-_4)0[.DEF$F M33K9CKG9K#?.SJI+,I-?)-E.6*MKM?J9GBR3A>BG22';!6MJK:;7]68N^D\4 M=S%(QN0/,A=M*+7*S7M;"%VA"UE"PHEVYTVFH)' MF2:R.!-I`LEVKU7MK-:HU?,STC)-_J)C]BB5ZM7*WI5 M5-9\VNO@-BT0S';'6DV%_ZW"ZS/V$+&QR=XR!)&B"_[<'_@6I-SF%>ZR6D%N MR5:R/769K:BUAABWSB>^#G;31)OMR\N:"CZL5JVLPBX7>=^Q3$S=X+5/^:69 M[>3+C4I#JU4$[F9I+<--FK"R77X9)*5I]>8BW`B+`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``9'88$DSN2&N@:S?,*(W<&5Q9UG32WR7 M6WQ.4Z.F$W[BFYJ6)`T)P\UO282%4472KQ0Q_;Z,!AW'6IQJ7>K`1,S:<]R^DS[O%%U?8>T&`)4)^5 MODY.6RGLN)7B=)7PI)7(5IQ0@LA`?;#2W]HF_O@)CQ;GI!'?A9@ZLD@Z?$(Y MP>MUL/=N<>I-6!RB;7Q9(\]._!M$.C_9SKO]@I'KV-CDP2]=F(4Z!`$/CCCQ ME)%G6?C%L7S;0W1T0RQ,%S?%.KBVW]CNMM0A$_0=".@9#QW*@A26*"_A!>J5 MZ5DG#SS+`&?L$E32<^CB<*N#XWL!0X0QE#$IP/]@B.R1R$Z,S"P73W['(L:- MY:#\3YWJV;%T1:V&*70BF>DU^P%[;)O+$W78WCCS8O2S"TBQ)^_T`IIO"4_+ M\P@I.Y2N-IJJ*@;]^5E9^R32@XWZG"<8C9K>K%37,0G>C:]=$+%3L%E\A8/_ M+B[Y>8_$A:=HZ6179C!#JMF/R\M:K:Y7:MJR7.;?%#;GV7C2OL,%"6KQK5_9 MC[=UO5;5&[5E"*;M-5MB+VA$D.^\O<*N0,W#J?[6\3R9Y4UQO9.$OI?O6\P^W#^>* M.O3@_Q^?E)O'A]=S16-_OY(!V/4#?E>>G0&ROP\N?*^P-Q5UE=)?>]XGA0WG ML>U:\0'+KX]/?-#\`WY2PJX7CZ^OC_>\=TDQ8*UUAX@9.!,K_WN(3#/Z^YV8 M7O]+25/5_Q08HA$WOUP_O]Y>MN[*K;O;'V":GC,4FIE1LV^W5Z\_`L632HW8 MDP8@)_:;_>RP']H)^WG:B2Z>A@UXXU//3!CY]?K7UXCX[[[KD>XH?7P!$2S: MBT"0D^BI1X7?3"[G]K^M` M=Y_6J]>`,S08?OH/K:[.SFMM#"^![)*"+-*SOY1$?;U@ZQV-E'`7C")\,5T1 MWH6@?!?,J5&IJ)]>+EN7XS^U3XI#%?$N'U"X_W?E';G0B/1@1;.LD4)L(QP9 M4GD?HFRJ>'VL6.C=9>BXPO"+)0=`]I_(]B$F5+3*]PKSC$K7"1H/?1@!EA%H MCQC+E$53$+(R9@8.ZQP5LY1.B#80C->GCM_K*Y!M](`JM#7">;M\RQ'^,/KL M/38GRN.$=J7&:>O?*\A64/3%>/C#5(86XH`.Q_N.<2:(XIY?GA$%YI\U,T$. MGJ-TL/>.L:TPH?(QI[*C2`&3)"FFBQ\O+ULB@1/E%7@(""O,KP(=Z-T:4F(! M1(*9@'/Q^@'%#F8B8GR#!WZ#.`/^"@XS*?X0.K([X(U=?S`8\^%-*'SG8JRP MPYB*_O>3_0=[D0R3,=6%=3#B2N1$^=O4>'\+.9UPP\=@Z."@(IZKO/<=L+XR MI'>`"=?ON,0DB+V:[WOEB0H..@5U%]C&73:."+\G&#^Z$<,Y(YIGU*G!Q#'` MWL`&L-U#/6XLRI!'R-RD(UX&X^^&,.B>>T8V0-Q`IAQ[F+;''._^2[=@2`C6K$HEP@+3P93@ MM;-/KM)Q$#691DU"08\.!90,F:\`R/#E*T`%`PSHM0?#?\-ZJ.G\`K7%%G(E: M7TW#'021'6A54/)&-+ME:0FJWQX(.&+7"V$6KR(C6(?904RE3R`8IWS59I&G M8Q&39PK=H"#&@_7PC<.N0O$0H@RVJC,@3)I`V_:W#AR M+(K^%<1X?-T3`,.^!NUCR*G(&6=*3.'/+C'F M8.ZW8P?_%P]IONY=69Z)S)F,09_Y9/7(_#7EY;-(R2,UO6CX(@211C$^ M8Q#C"T>?.;&,=R?P/\_--S+[4AD&B=_OQC_-8K,K_:.;_!@%"/[O7]N)1M4K M8[X%/IV^;Q'"DCL)8?6JL59894`@!?@3C8OB::8_I':3`AT,S\#?N_#20TH: MHC0WL3(#'@39CB0'5^O1L/_-+R&.6_P!29L;)KUAM*4913A3^GO M"0CBN'EF%4"9*1[@=`B8JCW&&$PWDC]%C+CV9\K MP'@E&`Q]HS"'40L6F\?MCX-:LY#:=,&$Q(\I$,E\#CYT&#^#MX78+9!`!D!P M$JV^#^&/%CTB+AO7[=ZG9I>GUV0.[\TZV1@;"&]N<_>_Z0OIKS=WYQ=W\>WC MG\;D40,ECT$&ZC1_X<(GKB\N'PH_CS\LP@?_ M"&%2A.0J7Y7^G%'C%6Q6?>W>)S+B1\)%_?-/R.'`@S9F[><1NS??$MR^41\B M^?T"KR;V#>$#VCQ,I3W4W4HGSASEY9YN8H)+7N&SHD-.3%3M8+"M.)1XP9:@ M+PM\\@OZT<>]W>.]C:[94OLK9O=7.IC]W5X`6]0]:([UU\G9__YZ=_/[]W-@ MINET/I].-R7%J$(FLR`%!C9#7__S!ON[6SP7YFR&GLO.+*1^MC'CF*U*E)UA M[V),:8_05_9Z]X_,?63N(W,/2UG?3L[/K[[_&H;B1#F*?-8DSYS^UY53]3V, M4/>U^;6QVT_)UM[F%:#WL*[=S=JMTY37QO,_<.=:`S=A].Z88^PY>Y[)VB9EK]4.VIS8- M;@T@Y-$O`7KR*)K)09E798G75;TW.7CD\8_)XY'\#Q,&U-[D?Q'?GQPRMP]8 MZ^_&0^8,WW?-Q\`OR:0[9+-P".AU$!_<(V>FS;#@)Q&&';-<-`;V=)RWNJP>B@=,M\KHX'OR6'CGV MR+'XLZSS8WG,CX6#9MD!*]S('CF[N;ZYBRVLKA0PRQ>+*Y0B%SHN'#Q0@VP( MZ!UO^E)^`DZ<.&@780CH'3DRQ9$X3.2@.;+33K!Q16EAUX/,+Y34`VR!D"/$ MEOT&BC>EW35:VKMMFP)@ZX^Y8UG.*RV'9F6VV/,4Q\9YQ07E^4+X_-U`545W MNG`>V]H28_H<-9"*BL1?GTWXHY$N_0[KXZ>&-<6YRJ6%WZN9^/V3^EA9?:RL MSFB9W7@=!UTY.-2-.E9>']!F'BNQC_+U0VWJ[JMW=W]HCY7:A[/7Q\KMP59N MM\,,597ANYKAP;#LG:^AWOR`>ZR1^S%';WY#B6QAZ9_\C\0^2.H5PZ M'/3%_1^&B^.8CQGNW:+7@>'?^1WIEOE'':)>E(_$RUA=+FWBO1X9^:SG?`)MU' M\4T&*NQVZZ3TIK:/G'SDY%8Y6>(U38-_H[ZW?"B:^YB"G_RX.H6P8J!@?O[@ MI6&Z_S"L@-S,+Z/!D%V'P*H?KQIA"NFP1&)PXB&3E*1TR+CRG) MI4A)-VR`XPEW/^"]_5FO] M)G_#;R=$B+\46LEL#OR;N8!O85D$+#XU7)?.$0^AF`4D&I3J/3NN?X*3!CD; MQ\22J-S"3)B#C8'-H6$Y]A/[WHP\^N'\[Q?'>L%U+,>PO30@7B$D*4#HNUV3 M(F!B=A3Q?,[%;^979V/Z7N!S-N[\F5BL`L0%NN/$/O`9.%S3C>I,YG-X'1V' M;MCA[-H,%-$HP!#S$I+$J^[S*-A:4C4OBN^#1P]X%1ZX>,&GMA@"JW4B?C/5 M*E.+&"X[_.S=[/*?&@9UWQU5K,1IC:B,*\M'(F,B6TD3N_-YJ\1WED5>?5@> M(YQ*JFFOFB7PXR.UO@3&AX_%-D*E!9:65(4+)+O.L6VON5RG%E'+6\H@&ZA. MH5#)SXS%Q5FDM*B^!`DAH/WQJN;^/4W$O'Y7YUG5?_.2'JU=45=WW+?6)_T25)^')[ M^6O\F_CEEU/$\F;J.UA0&"'*P4,HSLVY&8[^CI`&B4PH0^)/YV1N!)9/7Q$E M['*R6$0L5%/XTAS1YH[["!*#3@1_-#Q_B&JC-+A7T8 M#3MD)D]/FC<]+Z"#@GW'!SL5MKA-IN945>7!)\[R]FN8R8.[BQP"%@5H-IM, MZ>93%L=-M[*LCUSBTT+9!@PT,%;9"P$X"9[0O"L6@3CQV2)^*".6@3M]-CR" MS[A.\/2,C$3L&:U4!E.0;YVA=&SEH^6$)<(/+_F:JHV.,L?I531C,,\$N!A_ M8,%SRF0&@=^J+-=/\Q!&XOR31PCWG4;:=E8\?SM(&Z854UG?J= MHB;]`I#<"XQ$-(8;$PEXC,L>'TC/@@ M-2W3IMLZ!:UJ'B7H\*R)TY25\=PYU1P\=T03\Y8'3-R-3$3@C8 M?QF\W">R]LMSTYN"3GT';<7AG(:YZRPX+&GC9`&_GC*@CKO8?!<+[,]F0KQ8 M>)<8_*GV&9'F2QDHG_";*;/[_G:2-KN988.BV0!]%'T?&.H3;;UAI+]Z&WV: M>@$+9#F6A7;2"^@LQK5%W_(RZ]K&@JEKE\#"5*R#FIR!<75F+$VT^KX9[K\) M1L6NK\\RGL/D"1#+O,SP.&,&TLCT?-0G+R0&"\-`\"X#OW+*W>;4%!"#SZI$ M?]4*;54)2[PH2KR:-S[A+,,1-,$`N,?=A%73E^`/&(IB^KD0EMP:^2VGWTS3 MBP][J+!7&DR7QJM1MDILEK7J/-OGAN8`#_;4C*/N"XB'I]`.^UE#7PC_H47*H,P!QGZ>M2);P?;?1^S+QA.P!:UL_`*GH MOV6J24S5N%7N^*^3.!E90X["I3\"M^`D5TQA;`9O>)4L0 M)U@_"\PP_G/X!U&]/?P2%H!V_.?U9!!,:`?O(HQ4PZM(&/T2O23!X&<)1+PFJ=PGE#8LA%&$*5LCD8H`J:3RHJ3F MF'=P#++GC(QZG09J,MR6$45\D2&0CA`EEE9.G+8:5Q!Y%5E9E[/";$VSM4_` M8E9`>Z<5@BHJ(C\"G1=^/<0J-(78:46&16\.3HD'9@)3Z^2-N%/3(Z$:1PZ7 M3X64`E]1R!?1-V[Q&UG3@[X3)`10`E4>+`BOI>=D1?WIM30].]>Q4D5E2>V& M1Q)#/L.5#'KA2B7$H^&9W@"D=$V+V9CX0O[)4HD2H4\.<6-`GD0V%02+GT3*?:-`H?6;9 M&0;3[0FY`(\`#4M99/9$NQ.3BX M"_._A/:6Q12E;X9M/#$U.',(RT%Z))9)7D*?V0-:T]L/>"*$W36]?X-Z?3,] M_Y2;5!($W>Y'&J$(XIL9]B*@^]RTF$7H+JN.P9?.*" MML$]8>@\`P@.F&HQ6<@;=MLE``LEJ$M87E4EB(!H&$H.+_#Q[7FS3MIGM=:F MMLIKPBL;-:7CON?28IMK-?WC:;48BH"Y=B&IAJH)!GU9423Z(XJB'4[OI3TJ MJ.<857\&H;,$3V]A3$G@FU,:T`AE/9YP]`%!8^"1G:$,8(D2KRQ2,G7P32XX M9AC/YQ,W@7XP(^PB,?+1YJ;K^2NFL9RE7("WV_,PJAH# MF`TYO)K@@C"2`E%>P4,A)S-P)1!Z5*'@/ECF?^GB+(A9G"P!G;"U?QQ]/OI9Z#;C1=,EB,_D7YEO&?P%PB'VTK#W7AX.1A&.'#LQ63\2@* MNX$U0VT249L:5E044IN36I,TN@]R,%C@'!C\8.&X/AA*+`$7OC[#:`9(42JJ MN&L"#C4.J>?,!5BT+Z%4Q3>'WT1WFUYAT\H@WS6P$VE0+XC^#K>6\A#%H M6C?$;%Z6),EN%:DQ3&@:`GN.`&8+"AU8@N@^6^9+DFN!R8\8_;@,7-NDU4<( M-L@4_)F!%N/0`+@ZB[:?:)V5K)AS!IBA7@J04*FMQ%B1,_=?C=!@[@K%*/7% MI3ER]/ZX38QS%W5@K+?Y]D)R[D;=[IE6K*OI5B(P8/&8+CYXXYZ;'GB2AG4S MOW;LIVM,09I0'MI:6XH'IBV1?B>4@!RCX%%1=@,K);1%"1U*=!:9P?`(>A!X MNQ]S.$A"8F,N7%Q)Y8:YPQXUZDT7U"A.8YO2/\Q8YGX<63BAV0`.S?'W6%DS>\*T\!KV\3T."=%$AF>"410V;0Y>_>@X_TY6 MQ+^Z)-3T=&D:-TG6I5EZK`:$Y1LY_R*T&V``^'C474*Z!%3/TGKLN>6\9G4& M#?>D_:DX9.6542/^_AIR\)B7MP"[@*EU3#-)MH;%^<,H?[;T.7FO09,PET:8 M(+=:V'S*G0=NK#O--[P"\9_Q1A_C=*N!>GPLR@LG!7'[;(AJ9LXH6E&4*HL! M<)(+G'3T!G<;#=M`?Q7=0K`J]ZT5G71@BFX/+]>O4IT4?@L[*3Q@)X6CCNXN MKA72,HD7Z2:<<8DWS"#E)_=GW(.S-*><+`DGHL"J2,SLCD7W2ZKP!81U MV(0#35V?78O1QWF:/,U"@\P"6-<[(_*-4*FX)DV;MVBE-3YU0O/.?98KE92< MG%*F@0]/"CZDU@?X:%YZQBM?D`SV'"9W1T8`NZ?VPUIKZI^S5/9HD>IET]=1 MB2O/[J+L.%Q*ET<-&<8XP8MTH'"R)NA/956`U]<*O!URDTR`FD.7PHY:1YSTI0BRXQQYB5$::Z8 MXF-[K!BBU1(W3==X31:S9C2BWFXAG:KPXW$NWA9>@M=P=:+K]Q)W1\;66YA. MQ8J1F/L:V,D&1CJC=0JJBL[+8Z5C"JJJQ,MZKA"Q7@)7CC)[K.7*E=>JJJ,U M4!A6WEK-*1]/S653M!)B[5?+P;W+W&KJ4>BB>J*D/8HSX%W7F-)T`NX"#&T_ M6^]P\VJON!79BNSJRGR(%P).*QY$WL@":AZ^)^35TEZCV M=8E!K6!0MP`F"K[``E>)EKG&9599CP.?L\RT,Q.&83$H1SV25$@O#"!B*P9L M:H55]RY9HHZ!U5DZ%[T,Q#`HJ!X2T;,07!:ARX`5EN+2-+E,AAY`D(`1!SE7 M@XWQV\C;E)"9%SXV)<5Q6+1<&!CXO$<3SK*D"1M4P&ZE%HOW+DQMP=?B'4Y8 MZ1/Z;''I'J;$[+?>6:=)5G7.X_:!N`_8\3:O;,!>/H_\[J-J:4FU4++&X8RU M>1%D/F?&8+9UZ\H-_3I/A]G63+2"-'O&LHG*>__*3J\L\L1TR:L36+-HA5+` M0^?J>*U>*+569-%J-=\+L0-RQY*+VTBVU;OI%SNXL[;/MPCAKG.I;1^J#-[W M\%7:VO??EV$)!"W2]L(:;=O&EA(@",DK:P@>E6A[K/ABIAJ['ZP950S9D^M@.I^7S6:F12=>JJ-&]K+!SD!``1SFR:4AYV%<'^YY/VLX9"<70([FWKI@D.L7(Q#:&%#$VSE'O=C M2=5CWD5[G_&1:'C.PC00<'E/F8XZ8)[GA.F$;!^8RV=Z&`1%;F%[P(KPBY<#@`(WLPZ/+D[8 M<8-^C?TYW0I@ZIQ@/QS$/94S;WC,WCB9Q@>%P7K*W3N+V*5*#D;6%7[%NJ(0 MU$Q_`I1@V!S*BSNZ)44#3P&VI_4)3;EY,EP*=88-*6&`=NPLI"MCS6RF":X; MOVX6);%$G(@56ZE2)$K]Z=2%=Q;XR1BWGJ.'[CL1$3BSH/,"8@;>HD7%U8(0 MVEAH%;=]=@DK+:>\J;5:3TC-4*>2-K(UFID1']W[-`0;D3&%HNFEKH2J7_\+&&X:V*IE=A_`;2W9RA6#JNFJI&\`6G1XHTA0?6*5*P1E#/!HJT(B M7*A0TA;F")BN8R61B-1%94\;(6+;@7?6JJ5"^\5 MJM6";`U#;D2_//.S;5K_\Y,/ M9O-/W%^W6G8M35:41-6R#V2!H[;<=Y;&=T=FF/<&)Y5-A:Z/<+DBT#55U.24 MY5&^[K90KJ5/;76P%7QG8;'MA%Z`37S?-1\#&MA_<&Z-AF>P7$-4$;8:E`YP M64O^VA&?C;&@0=UHXBC.X4RZD&?32T:I])+1#U&E/__(]:;^1N_M`@]ARGWT M\+XDDS?3RV%8HGM.-/!'!/I?&'PNA'-EOC(FK5[1EORL:/N67I_=TU[]W\DK M_2@G(XJ39WZ$K?`S6$5IE2&AL4FB3870"FYR6E^Q40%I]*Z^7P)^JDK1:P9\ M9O.P;U5@H?2+21*E(5^\+4VWB1B61;!!!7%T(H@G@A12O7J!##P3FC1Q28AW MZ;CWT:UR?1#*U92LI?BA<*D\/_P_@8'-A*SWU(AN>A^+TFGS9"K0EMU/W_Z@ M([<]WP7'`7\3=7;1G/QE]=YYJ^';V1=WDPQV3RS6"R.ISCC'&3>?`ML(9B9\ M\DL3)#_2R._NG)[#Q#0F7I+CWSA;N!<75[?_/&9P\H*>'7U M00VSV2R`NNB@_G9Q]>MON*G2\JWHA*8/SY0FO$54?_CG-X;PAMO7EI:'T_@GFYB@DLHIR,=]R?F?W#B\HVC MW6%#)3$$;"O.*%8?)^C+`I_\@I[FP>SM\8`.!ID]5)&A/*#FU0+Q(PJ\H&K\2%8' MOY4=51/J5EK;1P6U^7YM=&\/]%$OM;>#@Q5*+J!:()45"F20, M?A\_ODSJUDJZ1I'T2.8.[1HSQ4)$WW@CWB$KHR&@-P#Y-!@3Z9/$*V.!EW7Q ME\'OV\>71]W:2%@.@O-U#UGQ#`&]_9(_W=I"5/ZHO*+U)W^&P)8#D3_=VD-? M#2^'EM&2`-J8WW3(:F@(Z.V7=.K8.A).A='1,.I?,'5K&/U! MD!>Q@PK.$GHBG!W0]LS.G(DDCW,"'R;-(:NI(:"W\^O%?0TSR2->'X_X ML3`>_)[N2(#ETBB/8[1VU8JI7O+U2@J_86&+&7K5N-+*(,[-EE*YV;G"";F\ M^!.HHFHC.=5[)+=B'B!ZR7!+[Q@V`*:B+E\"4%(E`*FU5KL9=_"ZAB^T5ZMZ1%6S=$L MKQ4ZD92Q(.NI/AL[Q&:EEI_XR?^DK-P@<8#A9<@LQET#:H,L4>VY6"_OBV*2)1NYKT?6!') M:&=%)"E^H/&,#$(C%7D,KK,O`D4;)H>JQ'YB\^D'V\[^([52QJ[`4=-4 MV[%/IMB"S*("R8FWPZ+;03O?SD&46.&X03A1R2A[VI:6T`K#I/&]#>(5OA:X MJ:'MW1C:EVR6,8Y/7@0+[#[,CCW"7(47;>_OA2V4:9-E9YX=!_5Y^)O:+0.F M9&^4[UE>?A6!R)ZNJL9:OGTV`M^)7Z%6%&&M>*J;5V6M`%@[>K8_Q0?*.%U\ MH*QHS6_LU"0L=`?`&E;R^VUXG#;0U,?TX($E@,NC_4L`/^;U'U%-.RO[A^N' MDE$=7>T522:POI1#OM@;`GH#N&H>3OU"@>R1A!$_T@Z:30*]<62AHOJ>+@-_3C"Z7.#23MD#7/$-#[0$*I8TM)!$M)Z:VD M:@C\.A"AU+FE-#IDS;-ID'A@6[M[`NRKM24J&J]*QUK1_@5;M];6'ADE!V)S M#25>WE.=Q&!BZ!^&N0+[ M:I^-1CHOC0XZ>MMKA44$;_\Y4ZE\GWW*V<.,'$ROPSFUJ='@X2QZSWQCH^4] MCO;SS6:OT4R]Z%%,Q`L?.B=3.BN!DT7ZH,2]&A[W\UCC%4VG7_I9U+$'CLQS M+O&69(KS>:SWU6GC@R/7/FTM`D6S7"\62\NAB59Z+=..4S!3;T$SQ8`!G^"OST9/N&>`@.'F1"L=J5S,SC/L`P7\V[A53^W M*:BE4R4KJQ>F99F.344&,:;/3&;`LFD*8/+OF\\$B?_L.L'3,_?->$="CE;P M,S"SECZ8T!"/Z\!&SIIKS'!,#7.&`CP2(672T"*88#<*#?(UCH8D\) M\-S[TIP"@=X!%Q*3FKUXOR3M'IU^K#Z#CY<^4X!42\*6_MV`H^92)E:RTB!F MU5F:KUVR!,5(:%5)NX=2+#Z2IAV)@RD`!L8`969VWB)0%\:,)`R6I,*W+3=$ M2>#!5\@"BH<5@$16GAH>'IZE94RI%`-Y87J44C$%F?0T4DA%PXM2S]#*`I?8 M!'/SZ7-P5G"=)>X)(+96JA@HI^!O@!9;:2QP,^/=0W$"@GKU=`V]5#=WEK8L M/BL^L.VN,?0 M&8'>*9=,BZ-2LR8=\0S@"^"@I^@58XMXA2@2*A.2QUM%4%?$5011Y69Q3(O4 MF4.HT.#"J9H6FHL]D=K0,NO;&KH'YV%C?HPO6#:QL9B*-/&2EQMRT M\(!PEO$*X@[=+1"AGL^ALE\:\(,Q^UL00_L'/07V',\1UW5"+VV!=>&&YYES?!T>5)[^W26/<.9`7J/;,D=K<>8& M3RB[@SG(_\!%84[?ARC,C`6(="K=Z9JMVEEJH2EXFNST)!:4UGO>AT4;=8HV M3&B!T0!2'`PRZ,31$$ETKQ@A@61H<81N7#&MPRV:X@N`Y/A7^@KV2H_#WAOL M42RO9-Z?@W]]?$^#>)1C'4%]97.3X`G^4*"5/;!0K-"XH`>,FBK43PVW+-GS M4^YW\/'=52^;O20T8Y)W4[M]%OG'Q>]L.WXQ*G:6Z%$4U2@RBF8&EO[#>06# M+.O\(:NCNF7GX35S;#R41.%L[?>P.G@E=-H,H6)$>.K>3:?L`$6',(/;\/EN MG\[(37Q&T-U?U4-9Z]5>\5M9V[EGQZ('Q.$>@W?NT0`KKE5[516*#/*PX=V< MLC4P.S,?YVT?+K%@<:87J&,,5/4<#L-70"868WLFB)0Y)G`D;'($_@( M]NPQ\"E$2\.K'M#,60=NQHB(VVKOP2]*OJ%FGH7R?HEL7 M>U#X[[?@Y6%7K(NHB\8VO8G$3GH3#4YF1[3+M1\QO50+CV.[CD[:=>1S1<;D M49L2)$:4;A8^<7UQ^5#X^=J&'R.UX=3E7.;;6E#";)25!W;0'V0H%>:*=BR7 MKY/S-,#&+:*\S=18^;BW>[RWD8F6VE_Q.!7X*(#W=A/WK\_,`:$J[1^NQWT[ M+%2/+-J.*FRU4@>".[TI:7@6N;>.G&61PHO20?>4&8B.;7&:5H%.I3W6\>Z2 M,Q=+UWDAFW;X_3`5N'1^Y:T>!L)-47M(.NFG'D>4/C.5%@1>U30+''X;E M!Z+<6YSAVW9X^PNN']G]R.Z[9'=15'A!/;8+CW_.M`O?OD`Y:1">6;[H%TKJ0?<"J*[FS]?_ MWT^?R2RPR,W\,L!D]F^F;2Z"!?;X-JS;L%_GI>/>P'L-["Q`<_6\!UQ[FQ8! MTF&T"&!$A<-!J9HT0,7F*+9CGTRQ+ZI%>`3NH]=^?LF-EG"X[5E;40RB+$A9B4BGY/9)/ M&RC'8\75P&KJ6A\--.3ZP2.J'Q'5MN>8'674(.[*UDR5/:;W#7WC#JE^KFC" MM3#B1X>=A3H06=3M`$6010<='AH">CMO!+(7`8J/V12ZP+!)NH:+PJ M'71;@8$(MFZMK3TR2@[$YAI*O'S?LEO;CJ%_&.8>B!SKUD#K?ZN'H+*.Z7T? M,KVO0+2-1CHOC0XZ>EN2W+>G27BMI-3E\_3BMK,3>W89]IW]U74\+YM[-_%N M[+4Y=_![`"^A3_Y^?_X3-R-3$WC&0]S_!CNE*8*2X+%VR2U@$Z4?,LT-E'*P M*>6PR2-%E+0-8(M;"UZE.@LV)9Q:"IRD2IJ0@+9^Q6U@6TLXK9QP@JA)F\"V M-I.T*>U&%4PGBYJFU,A@;07*M534*]A/5R1=WQ3*5)N,\U27#/C9(O@#O&"2 M:I:Q]N4-J#XNQ4<>*V,YQ;)M`;@[Q-=MI"J4']61(,ER]XCG1'M&#T0:X#P@ M9VR$=_U]5<5R](31*'V8FH&Q(1)7]L.K\T]BN`VD@BI5X*%)JM@8CP22S5%Y M=@EIBDRY7I7$T4@1-D$FAF5C="Z=P&V*384F5C15V@2;&)0-D6F`0;FZ!IL; M3.[&&.3!/B=S`L=F]F"\33R/^%[R'E`!9X;KOL\=]]5P9TV(7Z[--5F3!3&E MAQH`T2K\:\5ON;:'&5:%\3?N&3/"VVFNB"MHY=6KBE/1/`GA*V! M^H=A!92L$ZS1P5J>!D0KUX&CD23*LE@"XNKBK<"[EJ+E:DX&S2$*96=[`WBO MPUGG)O&P\+T^;#&?$UCB!53NU%D0^-8=F+=W M!"";PK?8!OB79`:"UKKW#3_P'?<]\W#S6H#_3Z,APW(13.6T#M0#D M[O"6'IRUNSC:"[SQ31@IN7:FAA4_1[P--EJO1%A0Q\T07@?=#C`MV]KQ[C&E MZCMZT86Y_D6WQ%T8-EBFYR8\#<[;E'A_@+4$;FDL99MO[D@H05EA*`M29&:T M!>,KS]D*.,*>1* M^,_TWQL^) MZV'PSW__[OCDW/2FEN/!FEMT1!AIG71$*"AL9UD9])ZO[@N_<.%7HPM9;)Q1 M67WRF;SZ3W(7\):/O+(M2&,+:>^%44DU[]981?GRDJ6[J*;V0>XROYII= MJ*:;%A0ND-Y[=K>I2^+H"\?XH.;:G;8R^=+N_C+(.NW?T&ZOB8=GPITYBZ5A MOW.FQQF!_^RXYG_)C(([AQ,9P9NY(_]+;J6_\'_Q<(V_K%R,,Y+(`B\(]!\E M";Z7_MU[-G`8J#.'P[]8@`WB(F\$I?UN#,BK,*GGXT70@&%1\GI\#ESGTY1M,/1T5>%+]QO MR08F7!X_>,;VDPI(RFQ@])J^11D-V"3P"'`3'DUWZ3#%BA\`(Q*RH!ONP#;# M=KOT(\I[Q'2CE4QJS-NHL>'35]-_!I[@C"GPLF>REX%-[1GT\U/NBGX]S7+% M<,X<>B:(!2]&<"A+919F`)(9CW^V\?^]P_(`+O:$60`>>`+>\2`!?"_$]1G" M\7%(+W?*35;;]^`KL<#]R.K%\(\I'/N^#SKW7Y/+NA,;]PGK$@ M+`&-]F@JW#J>(V]3`F`6OVMJV,B+P$FFYP7`1@$<((OS`A![/N"![Z7G),4B M=.+;4%N84W.)83,XH09WZWC^R21U*A^(#2_E;M#YQ1.^ M\L`D.D;<@PO[PEV;\-G,8,>X_+BTJL\S.K3--W?V8ET>\V--76=^%.]ABGDB M0X%V&)M.'6`WX!'L269XL5H.'O\5BD84A(LE$\Y4#G*/AD4=:N^9$/\HE[J0 M2V=UY=)9&W)I50*)E"I0]OCLC5Q)MSW.?I%]" MPQ!6!FOT'=^`WV`B9<*8&R'X)/_2A]#BNY):.C]695X9*Q52X&RM%%@]MT// ML6TW/E(L%#J(P0Q.Q*#.7R,/BG5'QK/+?$(-8C!S+Y_[<-CPT.+7@L7"2/D!;1_1AW`9!IW)W%"&`LXM0SA/0!&>(+R/ MAF=Z$1S4!R@VP)A[&B.7]OY/N4O:OA._@&^)R90%@H=U@6PE1$K1.0QJ1$H\ M^L0-`\HH?$'>1R$J2?B2V>'X[^*78H&4$S1L$6C+V69E1-SIBITS;`6[ M3\;`K6L"B\..(O,LB/L4GI0PS)6*0WI1`UF,GK\29OW/@JE/W8E9^+W?SLXF M\`'3U*&C_LY]NB>$PT@V)_YRRIYY-F:=!=#4A@$TVTEB:*?<[\O0"&7D`!,& M?)QW;G2JC269`5_\(D85,'CH#4PHE\30?`A/>1%=,^=Y^"RS3^Q]'K@H&?$V MAT_3/_*#6V4[B1B3!']I^[A(`"\EUCAL;6D\:DS98!/9/H1S]%]81X9\Z26@0M" MRVO9@U#+9;#IYT1?EFNH,'7)%!T$>G]@A`>Z2/+J!`2J"&BO<5>XO=$=R>(7B!X@/J%C..V%Q:$3WR39C/Y:X+^:4 M<*!W`=,%D@'GWMJ@8Y;$]MJ7%8I>@/ZKX27[X&(5BX=J/30X"7#A`E5]2I"% MNBZ*KU-^55@GR7T:DOI;:*JT>GY':@$WP([ZKDFMON0HI\R?A+.GQ/4- M8.H%63R&H1]8U'BB18',44H?".W,? MD"+?B;_M_)O1^##FWT0D`R>>^#0I)QYHL]OA-7K%\)H^9M4,9=J!NH=C M*OIH/#3`(4*BG!XB)*V@CA9!@CZ8!LDO*):/>[O'>WL.7CXZ+ZG]%;/[*QW, M_F[?'^XH@'O?Q/V;>71`J+8]>/W(HD<6/;+H(%7AP%H^%VG'R+,&^\C;:`+F MA^F,.P3TCK/(RJ60-%9X41@/?A^/;'K0;'HR^!T\=AC?3FVF.CYR1NH6H*^- M'T(+YN-8F/;'PO1#@0*1]DD6^;$V^N7(X$<&_YASCX:DQX?`[0/1X]VZOWMD M=!^(3S&4^-R^33QJ.V9W9.XA[>Z1N?=X]S^^DN[6V<:.N-X@XM1#L,N.8[T^ MY%BOHFBW)O&BLDGNR9'9C\R^9\Q^]+7CG_=Y>MT6Z>_Y''_6;X!6,-S30HV; M5-N$DB*$'ZS%Q-?4][UOK#H)@)L$M.?+-\/]-_'OR31P:0M\M@S]XN3-]+)I M]GJZHS4K&DE7"5Q]O_SI;[H\'FNI>3!ET+>,Z5GJ^ULB*M9`=*S*REAIABEE MBP?B+DS:*'+RY!):(#:Q[<"PD#6([=4NX/AQ0V0#)$^:AL_;(7]^_&?]RW#/+\(KP+QFF<:+A'+RP8J4^/MF^Y&$9 MZ#TK^:3D>C0\=CBB;US1VCI*SYOE*DG**FYTN7K_-#6%PF8`-<=I`N(%_Q?' M$6R"EU*#+Q6Q(5Z%0*U.5WPRK$NLW,TRII[TDH:?1:6@E[1>/IQ#S18_Q0NM M=(LV+`./ZQ_&$YQ9>W8SGP-*KC><4U,R;NI$_>EODI*K\ZJ#T0H5L#\'=HNC MHX?$?A&N*&R3)H24W M0.O'??#HD?\$\/Z+%_A_Z>=S'SV\+TD!)4HF8U$F'N4IL1:UPG;O3(BR%@ZW MM'PW5);8V*V.;/FQHN5#['`:""[.ZCOQ##DX+X*195/&&-

=3\L:[$LR9E M*"L-E3#E$\'$>C1),,S6C<:'=@NMA!9$:OSJ:K4Z0^+B^PEQ19TG4M:QX6K;P=@"4S7\;E M0S&ED2RHH[':&$`T]V[FOSK.S+MWK%ECRDE"Q1AJ61;&(RD3=,BLN!E`ZRD% M?R@'2!,574Q/EJT`B`J#6]>9F\WY2A+*598H@*Z64\1)+=89<6JX13A1PMD0UQ19KU]X6R#**EFN%DQ7>K0TD^Q#W MX-)U%D4#P[Z2N>.2U&C'BS??-1QW9MI@GUZ!6^/!:HB2ZU@678^=F^9[(9;K MF!-1$31-&DOI,]H9^/U3JH0AQ(I9T"-UI&:N`'9.*'A%R')?B4TV4JIBN5(5 M\MBM++D=9&7D+U>SS2&[C5I=4^_UW'PQ9\2>>>S;M64I=0$F@XP*2-\;;=O$QQH1('U5@>G>V+/+H'W[:F)MR@VB\]OWB`+M/9Q M'.(VXQ"ECJU]S^>-`Q`S`28(#]NBZN?O,AILMP?NW_0BH M+N8E/M,.OJ^.^V]Z=2].FQA8=W$>? ML,D3-4KAZ]XS-\IU=/.()7Q-U]>%DD2_HF5P.:=L] M,F5>4P1>532ZVYF>P^VV]N553>$%)3O4B<=^KDLVK#9L.>JM&4/:%0%T7M)% M7I6DC@D@\V-5Y$5M7$*`4R[LI$U[@)IOW`(>>_:PG2J9%7#2.S'<\,,*IC+M M<+X%MBD,6;IM2HJPOYK&@TG>,2E'/!BT*P/"LJ3DFY_8]MM9\R-=X45=[9P> M8TGD%6%4QEJ)7#\#BSTA$VL./@J7[\JP.BAMX_-6U+7X M;'"]8>.(GR?@29MU/:9MF%>6CAZD$+-V]&#^&B^&R4;UTAD#\;0C\$@7'@X` M)$MF%X=S9D*R'.?Z=,M].'F1$CJ4`C^#.SN6I M^"H>Y!E9HL8'N`,<%&3,X&1@N_+H^,(;Y@%@E&BX4-VSF:LFCF%%K]?CEC32 M3\>A1%.%4P(CP<5YI'WT\ROQ'`V6(!D>J;B81GWW<9)',JQI'[N4-_']HWB! M:6.G]L]7]'^09[>)#HR.T8%MH@-ZQ]&!9),][C=BT3$L=!C?,2K0O^YI'2K8 M7/HO/5"Y:JQ@=BPBYG.BNEL&CY8Y!:$_)]3/^Y2:8GAU>Y.:7?@+&W%JO1IT MY.MWT'74O0-9`0Z>`><#A7WK$S.$TUP@8`'F%!U5"]IH:1E3-G((UJ>C)\/A MRAQ."$$E`9\^OG.3!2R!EAH;[4@'VN(P2XH>_@L'5X;:AD=-1]]'0!-]QR&1 MH59$1>9QS^$!HU,JZ1?IP!90-70JI(7Z9L;2$&;JI;4FS*?Q`8G\U*34<.HV#S.'X2:!%^2U@]39#&MJ%&1F`^(U"@:5T!Y/1ET# MR*8;#]7#B.ET2F\$GS!TMP1S\HV.XH+?VHTKB?Q8T=<-!LL??^)-7>>51E^7 MT=A=XOK,MJ>DQ].?C/*.Q2R?FW84S8"/YN-F!!Y*@>XPUGE-E8H1#CPF'Y(] M28'<*O?H\G@EQE;$,=&H(G8,0#.P^<54QX4C?,,C1&<7/R$913447LP78GX8 M2D1*9.;D9^5%+$:8F4W?QJ:A_XZU$C..WN)EQ@(_H7]HHY'&>7&567H\,(XC M-*-9JP:E(.4&-IQ=^F3\\DG4?HD8(+'Y8C=I,J6<((X5`>?24Q<3=*&/:[VW M?YSU'#_,C'?JRUK$\QJ$CAFC9\E62*MPHIK--!!C?'"$_T!+G[LTW">'^VK8 M_Z:#FBW"CAK&6`@*KJT>A`!,\1CO7<[3.-XGPSY=`@S"M"@_0E.5Y9A'EQ0`H'+ MHD`8*7PQK!SW&,R.//&=D_B`FG:HPBCOT.&DEY/[K]SD_HR3)3@M:>L\Y?&% M-%2%+]QY&*+D6&H^EY2SGJ8ES6_YI?T(XC2(F8&C?M2^D]95`(^'L^DR4;6( M[[UG0L);3!HR0X68!+F2?&[X&WS?)9'F6X+N,(,%E2(STZ,G,1/TI\VR#FIR!!H&HQ)VD)JFWFV)$'W@+AZ8?.LZ3ZZQ^!Y@;.!F MS@K:)O%8^P?G*TD>+JW/RJ$E;5ADMREHF:2K%"V26J>BXDQ:72/]D/0B7JM7 M8U6U8'X#F)QG=7-7]M?`,VV"A:>+1RRXAZ]=&J9+Z[*2698-@*[(DM>S)-\$ MF$8UH'?QM%WZV`1'7A;49M4Z^VHU2XW4!G6;:V%;P1`?OZ6C=NO69DE2+NO^ M!_B2/^B+TD!+`/*IG`8X7JH0B-5"?]W+UNYLN=&I-I9D%LI/`N.9:#B-@I$W,%1A]_'B MQGB5PGAM^9P$FBJ&`U0 MTFMLEDQ@/,$KGFA&%GO2,A<=),BK>!&U$G_WP M;M6R."?5;#&,]&)>WBR\UK10*S0DD3<6-!>0KB MV2[SR`HO*]D]W,?X

SH2O_F"L%#8ZJ1]SD"OZP6B*H"I:&++*+M)H_75! M/[F\4E]1`0!%+5T_:4%F8X]5RFB7X2$*G9JOCNO2Q"CX*GR".=TK!%)^B&(1 M@#;";8EEQ!*N7<[&DNB(HRZPC9]9Q'>@JX7.6(. M\O(@O:0#;K*2"PAGUMH.FA]W<3[+)KWZTVT^N?%K<=E12R@OQ0;-):KJY3^OX;]1HL2WD*]2V*JG2N$L>3KH%8[?3*SO4 MR;LG1.U./QT<8Y9]?&&XF,;E[1[WBK0`6=!D==3E$8AR8+:28.7Y!,UVL+I? M?$=R6*W1(39_@U/6!+\9)CV+8K5&H_SND.]3#JLU`=HX MA6J-7OE-MG!M^UAZ45WGHB$'GU+SSDD4,I?C]>!HTHGY.WFEGVQ@,ZOE)HNF M"JHF568B9*'H#/1VQ6.YO5*S1?0.D.Y;DC8S9_JC4Z]"M]SN&=@Q&HJEK#:S ML_J4.SW;U5IY<&HXE&I#\6OE4:N.D&7V0W_Z2*MAM]7-"=P%[CVK):VA==@W MN?K43EJ-Z4R2*`E2[:3375"L%5%2(]MV:YPG27N6!V>-;OW#P*PIG[V[N9FN ME1NK4BYAN#%$.T&I77%9VRP=*#'ZEI_E%NOPZ3<4(U:K&$ZQ+T>S9PMW5-O" M'2@%VU!7H]J6[TZ(4#3AJX:R&I7?PY[DYSK5!J53'%K53J/:O=`'@GS/VFA4 M^\YX(/3JTYP?U>[W/A!B#455C\JMZ.$*IKYUD:O;:EV3+>?>H,O;9EV3+20Y']99/C.R5`[]);+[=%.VC5 MT;XPUFO;A^WV&6E5X%:,F^\.B;X%;NV;]I;Q[E7@UK:96D9Z,`*WMOW4^I'M M6^!VV(ZH%@7:D+CC=JRD1MF;[=JW%8/@N\O#[=W"K9@5WW4>>K^6;L50>44< MJ;JJ=8C\4`1PQ=AZL:C)4)MTZ%T.C\OMK1-1T.2QJN3SLMJD02N2N%FBXM;@ M=V3]CLL-(EU31=B.#I'I6RC7MH=:Q[Q7<5QN#.ECM4/$!R**9:'=E0:U8A+)@K;S+>S&*I*%&ITH=7FDJ"?20KF;+I=O%OXS2*;1>:1@V(8?W9C7MF6%9!?G_C;ABRV"P@ M5`E!=W"W*F+$9B9+GVCW+(K$VEE;O5.J3[DE-FOPT2>9AN(`BN6AJ'SB4>]T M:T4M-,RVZ@AIIFYV+W5K&'9-D&=H=(E]W\*WH1W8/\%ZE<$U;,=A4:L-D2+5 ML#1/U@SDJ(L[;>M75EA*'U_IBGU/W!=S2CQX$$?&KRT:*+%/*X:H1%,OV@*P M#X1;%;%2I6&[UZ3J61Y7#([9=^KV*;PKQMOL.VF'8G1+Y4:W_#'D:<_W.OD) M01^,EUNQ6LIOOC,CN-JFTWFH0RY9?VW[ZPG M_&W,6G\G?VAYH$+RXFC[N7C_.60`K\GZQR$+7-SW@%GJ"%Z3.;R7 M_N'J^_D%(BB8]A;(JX.CCR;]3-?7E$;;W_WIS=WYQ=W)V_?SS]S?YI.Y_/I=(63 MOW!Y@0N;Y#N+\,$_0C`5(9'+[,*< MS2Q2@JRXBFN)O!L:>I5[68#>SQM@Y9I/SVO0NIV#'X'.V30M*'1HV":T_^Z$DS4_.),>QHPY>RX^8$TT<1RSWSC%J`-GSV. MV#@+/3.CIB]&J4V=_91D[6U^V^AU)]):Q+E`I&FBRH]49?`;^O$%6[<6UV3A MN+[Y7QJ36)5A9%!";`C:+D$OM/,C/_9/+`.3$Y=O.)G-G(5.QC!98?<$*!&$ M@['C/FDC7M:$7PZ9P078CN)E1_.LIG4BPZ&:.<$CKC_@S=XBH-80\7V-N:F*SLOCWAS4(3![R15? MYCMMW51E+JKV9/1QC>OT.AD*]!)_L!EU];)*V\*O%WKUG%8GURN6VFL2]YE; M)]<;_+?7]&TC*4FN,6Y&K9&9M#&Q+N9S,O5OYG=DRO(#P]@A2M0-"_SDBDZ' M<>.C>@"T#VZKPEJNET7:!YI]R]B*QC_]\T&O$K*B+BOND-4;=8:20"R7)V[V M3ZC>LW_ERJ9&O=&F%259V2*[1?1Z*E14&ABDY:"WC67/6D1I8$GNEC!]:@^E MAMUXDC21Z8$Z;1Q\I5Z#I`;8M3%JL\3T59K5Y.]R0&B'HJMV0^V>D>Y;D@UW MU/6`!%NYL:=*PR'34.QCI=SZ.QD2S7HWE97A#KMN7W^JOYRP.RBUI`Y^XO5PM)-:PR`%<5O0^:)/BK4B2AJVZ]PVW=&GE=-?HZ7Z5ABN<8W/'/L%W@%:[F;.?O:Q#<`]F<*3 MOKE)"%DK-^UD41UK4GX^PZ;@[1S7=H5B,\MO?XC4MSQM-B-G?^C:JR@N-T/E M_/RK_:'J4`S]4;E-BY)3'>\OF7OW&4;-3.S]H6P;%LBH67O_CHG#+)GA:>S1 M!I;ZQMCU0*N>%?>HQ2#M$,G;I_X>U7`QF(K98P*W(@D;3H5JA4:573O3;THD M6O:\3NS9'X;K&H!6<[]M5.Z,9).=6X2T3PJTJQOJ);%^%-+UK2KJY=1^%&KW MJ3GTK=A,>G;SWCH@&2K M%M@0K0:]GLO3.J+]4K!GXT&O=]WRP8C>JPU1PZE2QWB5]^'(WHJ$K3<&KC/* MU8G];9CJIE=D_8RE6MF("0B=P-RNS&\EA[M#9'L6S^-6TKX[I$^?DG1<[A6, MU-ZI,Q3_:5QNR4MC<0P:IW=R]>[QC)O-*]X]A=K0H.-6*AN;(,D4;C\:9KQ! M/E$I!AWAW+>B:3'4WR69>M4W-4S/D=J@8J1+0K4B*3:8(%P+5VJ=IPWP>X#! M<]S(V+ZR?2>UTQMV+QK7"XPWA*-K'-J4?K29X1Z2H%]AJ`B5Z3&#I%J/LE$1 MRBU,<:@T&XB%K@@5G=8&2\"^;79%J->U;6AT:T$_*T)ENXX=HMY/.8TBU#-< M-T*F>TKTK>@:!%.'1[Q>]5T-TS@SAWAXY&M%`C7H;[P5!Q:5XO;)$+NC59^242RW9&5Y4)0: MBOTOEENQ)P,C6^]6OUC/]!T&M=K0M&)EGY`.$&:*N&\MU=:-_P[Q[UM9U0O< M#HIDO>JL&F:L+*OU>O?ODFAM2!:II0$::_".;@>N05]X-_,S.I/Y#(Z/!YK54R]+NRW M':H]ZX;&X\EV1I@^542=H6(G/3)-&^>^SD"P9CL?6;>3V;\"STH]A2 M-=;GY-'_P_2?DP#\)3'\P-W`SJT8"":*NB1+H\0.;PO2/BG0JK"LGC'VH4C7 MM_"M/<_B0U"[5XE>NX_QAR#U4-R)BHEJG0MDJKWJO/3B#<=88E#F9@XB`1R, M#;1/Q7@,752$430^;C.@=H17NSJE7I[KL`G2LZ90ZN4`#)N&?BR9(L*GH#Q%:AVA%BK1H$U>/I]H`@?1L$]8+1PZ9AKP9!O;#WL`DX&(.@ MW,1O5=+%KN+"`2>0C5Z]F5^:MF%/0=+C#.8-9'7%`+L3;21KZ2!!R>(K%9/3 M9S(++`+/N<1[A@UQ_30)`,ZO%AR!#8`6?_K;_['\+S/SA?/\=XO\ST_?)G>_ M7GW_S`E+'_Z]?>$N;[X_?.9$_/W!7`!??2>OW)VS,&R>_8'G[D%%SKF?_L^3 M_X7+O>[L^F)R]_G1\9_9FTXN)]^NKO_Y.?>J+_2S^ZO_[X(M]65C,'[B#,M\ MLO_G)Z2/.7^G4)V'HI:;1X0&6N$V`WMRAL?-'[CX?Q].)M=7OW[_ M?$WF\%[ZAZOOYQ>(H&#:7[@_KLX??L/'A3\G[.&C%;#";Z:=_#M54U\>"7_^ MPGV]N3N_N#LYN[F^GMS>`P13V#)CZ9$OW,T_+NXNKV_^^,R]F!X&=7[BIL2R MO*6!&XVGC_Z^-$!0A+^'=+0`ZA18;@33;Q=7O_Z&>R0MWU*?SZ+/4XAS%L6< MD>;AG]<`F>VX<.RSI,SO-"`T.?O?7^]N?O]^_IG[TW0ZGT^GT6L2"G.`VL/5 MV>0Z6@TVR7<6X8-_A*MA7<^8__\]/JOKGS#G$G[\:%C`]X?YNV('AOG,B MSZ$H6&&)O_JS02&[,&56D5UY/![V"'#/I7WQV"8)K3_[H23,S4,NUIP)2SXW*6 M:1/.F7-3FME(_^0_@[(PWSBP]/UGCR/V#)[]>P#/R4*_DJPV=?93DK6W^6VC MUYU(:Q'G`I&FB2H_4I7!;^C'%VS=6EQI[VY5AI%!";$A:+L$O=#._WKS\'#S M#:"C)<8")R[?.,^QS%GH9`R3%79/@!)!.!@[[I,VXF5-^.60&7P@4J];[__'EV([B94?SK*9U(L.AFCG!(ZX_ MX,W>(J#6$/%]C;FIBL[+X]XUK$_95>522_9KX3O3:^T7ATW!EQZ05# M2"`*S&>\_?C"T6=.+./="?S/<_.-S+Y47E3$[W?CGV;Q;4[Z1S?Y,8(XU;>T MYOUA_M[QG"Q=,C6I%PL_6P1_F-BSC'?;_,ZQHI.BJFE:JM*Y#A`M`BX].*+T M0V8_YP`O3[22!'4\'FT'.+TO_VIX9(;7[,3V-J5Q>2J4K.FRKJ>G/Q:NNQ5T M982L7;50#A?-!?CN^*U0K#RE2!$E78K*>@N7W!BH,D+5R]&IAB?5UF#".A6' M&6X;$*KQ[,/LBEO!54:K\@P231%%1:H+7,1_EX;ITOK41%S>S#<>O*EH53DB MDJC)"?>7KMX&J"7DU&I/T&X$Y;5C/ST0=X%U%]^PT()FYMR1I?%.=='-_-8U M[:FY-*PK^SM`_/!*K!?RC5W]U.ZFH=4><;T50%MA]T]BN`^O3@.D:@]OV`2. M[7%Y=@EI@$V%BAJ/,WWF-P-G:Z0NG8^<3=`JURU*MI8V!2M#$1EF#6`MESIBH(JK`/Z5/;6"&9E=V=$G#5`I5\OB"/2RV@23]4`U M1_`67@3_R^9HS;\3/_=Y`S3+U;2NZ((N-D&S"K0R9&\>+?.).M=-,"A7W9JJ M"V.I&(/4>GFP$'[ZR003U_&V(DIQ?S#>)IY'_+-GPWX""3%9.$%>C]?Q54?E M^EQ1M9$DI4)(32'J"*,2E[9BN#V8)ZHNZ=MC1$,,-TOBPI?MIVO'\\[`&WZ? M.^ZKX>*]8JM^N>?D*F!2X$1I174\:H]05\6^.27#2_? M]W-OM\^O.![0WC>Q-UR&DNXU9%25_<-UD')F8*D]1:(G57T.P/G$.^2TEB&@ M=ZQX+!=$(UX5!!Y$V>!W\N.GF+:7*E\DFL"%GM*F&OT*IB&D%`\!O6,!8TT) MU;-\&@*_#D0^=6LZ?3-LXXD)*--&$QW\>^8><2LYQZ8?XI8:]CMC5.)OZ^47RY`#W^(C+49!\ M:$'240R\2'R`]W+0;6.'@-ZQON8X46SX! M]2:0AL"I@Q%(G1M&VB'KG2&@]X$$4K<6DCP>'Q,Q!R*6.K>31H>L?8:`W@<2 M2]W:22(_TGL53$/@V,$(IL[M)?V0]<\0T/M`@JEC>XG7).EH,0U$,'5K,25M MJ@]9"QV+5@;7`Z%;VTOAM?&QZF2@'8H$="UD^T`3G(3#W8"19 MM\9:_YL]!+5U+&7YD*4L11&RWILH#('?/W(M2[TBD_5%*NG),K.)A_-+O*T+ M5)3#*%!Y2,I-N&?#XZ@&)#/.M'V'FS+"PBD"RG+&DTL(FW(T=UR._"A7_V76"IV>*_QSV(2)`Y@3^)0?Z7_B_ M>`CT7U:.'07[N_-"%H_$Y6#GQI3#\,WXR2F'*!F4"2($S/\"1H&-W;+]9P*H M4(0\SK!G^*2#LZSA"6,Z#1:!17^>I69<(TI8D\#)`H\+RO2+YV1*04A5*HCT M8^E8H9.%=<<5.N-]J-`92O:O]J'RL@]K\HQ\G#QSJ'M;J'PR^RL=S/[N13W3 M40`/%)>AA"&'C.JQW&D_]^V`4#VR:#NJ< .$7:\3)P;9.VU4`W/`Y#'/+5 MQQ#0.Y;H565Z"L*('\F]U7`=&?7(J'485=457I,/.E-U('JTO8NU(CTZ61/N M/N1KMF,.X$=I7%T@V#Y)JL#KDGC0;:N/'/Z1.5Q497XLCPZ:PP>BO+MU@O?( MWCX0=V(H4;IC/NN1N8>SNT?FWN/=__A*NEL/N_^M'H(]=DS5/I14[9&J\>/# MGCEP9/9#879%%OB1(!XRLW_DHH3JHH+U!0ELZL,WTS87P8*^X=9XIYGSEXZ; M?O'V90KJ890IA+3DYFR>!BM(6(9$#5/[L]4*SB.\A=YG>)B+[\SS*?S''/WN M<_3SJF!,'K4I06)$KE/XQ/7%Y4/AYVNS_'6U/,M_):D_Y\6M!254-BL/[+@H MH%5/#PATKXBTT8L@5YQ=G-W>3AZL;>)0>/LNT2:Q01L*J1ODG,5SN`AZ= MQ>=P`\TYN%8#PTFQ.R*X][W\![>%'RY(4R29AK#9P[H7/2(XM'O=#X;A(`52 M%&Q@IJ@\[BTGKTA('6>0](_>,6^T7$A)JL9+:F^MEX?`I@.63]T:4H MCE-,CA;5?EA4HJKS^F$G_@Q84'5N41VTAAH">A](4+5^95W17%;CM?X4[1#X M=W>"2](&96$=IYYDT3O6@Q[$U!-5X+5C\*LKB3<8LVR/K)<#,']2[X=6'?3P'51_"T=M\^NJ4-0=T>#[D,;=/J8'^OCHT'7OU@;<"7D MA]%@0T!OC^RU0:(_R"N#(3#W0.38\>IS`$99IYW(!E%5.9A.9-U::)H*;N=X MDX&/'X;92SJ1S;9NCA3W%BML:D9_:6NN-7UQ-,HZLPS=Q#WIG;9I_[-\1[6K M\++DUC!G&_1&TW[B`MMDW_C]_OPG;D:F)G"WASC_[4065%G4$_C3JVT`B?3@ MB-(/F?V<@V14#HFN2M)(JPO)U%F0!^.->!N212\%1DB#D5EJ,TC*R#+>$A+O M=6I\/G/L%^)ZIF/?S.]]X*)GQX+SX5T[ANT].!?_"4S_O3F9QD(I<)(L:*H@ M_M^_UH>A-:A+2#H6JTC:'-YH$](']R;IK@=[@Y&P#3AQ+)4"J\A`825A@HKU M\^#>^,_$O2-38KZ@D/&R\$V\&WLM7'(I7+HZ2H#*KY+9Y.^.3Y+/&@"@E`(@ MJZH2;F1VAD/PW4-VX^^ M_I[!Q#=\@CO#I/69LU@Z-MI8*QBI0KDN4P01-FDW&`&8"\>F.F=39"I5W"Y$ M`=C.J'T,"^V1*SO439NB5*X(=X/2'?$-TR:S"\.UX=Q[F^)2KCSKX4*UR^KG MWXG?6(&`"5&E0&004J%&*UPS`]6MZRR)Z[_?6G`P)_;L(IH_#`_F>T83O[[5 MH0KE:A>\N]%(5D,X&T+1+@9KC$]5*%?5JJYHLKX=`A'O7%H8JXF_E!IE>9Z: M9-F`^.6:65(%74IIYGK+MP7T6GI7J%Y5'LNC;8$NV(Q?7<=KPMCE^G2D:F-Q MC9F?7G!SP-;13ZQ0B[(P$L3F@*5DR*5ANO_`]*ASTYM:CA>X:*V#NX*IH"4$ M;$OQB^6Z$AR)L:@76V=EH'>!2&6F$8[?N#K>_SC;R9Q#7?Z M_$X?1_Q;H]PF*GD(-)-ZI%FYZA\ZM\D]4J[<1NF:V^K+U!V9;X MR&%;;M#4WI:.\=S@R.?P++=^AK6K&QS3'+:U`^!MXEDBEQ+[9'!:L':$?M>R MO()F/6I!J=RJ%"515H=!N+80+C(KV_/=`,]#=#=[!^?C8CXG`,`+N24N=MDWGAJ84E+:E%K" MNFF@)=B<4TE-0&X$1#D&[/+/QYE(5_/P%S(+]^3B;4H\[V9^"V=P:BX-JWG` M32JWFB26A;,.M6;0Y3']9MB`/[X';S.N;"0(D.8.V,8.2*TX:/**^.OT9B'- MH]>._>2772*H4D5`29*442HV4PYW'LLPF^+2<3/?VR5ZY3:4/%;5=$QG#<`K M$_3P6N#*\P(R.P]0"0!+F\[L_MD`9O].7NE'7BTT<8X:\K[Y4]_4Z4<9]?#IR85Z!'HEPAR MN6DS4NOAG\6D7%C!TF3"ZJC+'(5[8IN.BU]-909D+C/AKU2F@%5SX_[J.L$2 MN#&6_C=+_$8!QA6VC9!'>1WT*QH4HX@7;TO3I;">@R!O?CFNRA+*4W%\(HHG M"8-UL8@WUI`>'J;L`'`Y;9$ M)_"V(Y3E\N",U`3T+!__;AL++'/[+QQDL).JCF,.K')[8#22=$77UAVA@J4K MS!OP:MY!UE1+C1R8Y1J[_*!G%ZUO05(W:[:)^2CK5>:C4,M\S$.0N2J<3*!-JM9ZPD M=F+/OCMV5!];GSSEFD(:"Z.TR=P`AE;!7TO=&GJC%>AI;E/X_90GNR7Q*Y+^ M9%'04N`W@*%5\-<2OUS'8,[B>-P*^*T3OL)15"1=D.45QMD1U&OI7>[_J9H. M+N*F0%,!E,1C;N9?77/VQ"RBS6>EJ\JXDUGIF8'7[(6L8I'6P-1]833I.BY6 MPHJ0RHG34=V,D*Z"2^KZ\@4XOK,L*N\+)VICP,FT5RMPX,='_$&43FGIQV-Q M.4QEL5%ZF'GA`FR;.;K/-5?JM.[G2[N[R2#K=(I[NQ/G;VSX<.E3'X03)9Y# M.Z=$>:[$F#[3G[M<7A1X4/W9]9=NF(#- ML5@2WS+&JRN^LLL>CS-LW*REZRQ,SW/<=\Z&\P:2Q'^&/\_!;TX:.OW<)E`@ MI%:@.N4F/N4G'UZ%*]*?`4[/H-$IQFPQ//@+W3G`!A"Q0`\8E/<\;N[`;Z_> M9^XVIBR-/M$G73+%FCEXT`<#T&9SEW MB\(,[>^3HJ@\F%4Y1KRR.2-,ZLZ*.#.J;Z)PS<%(#QL[(K2^TRYTVDCF)6F< M@^TA!4Z\35$G28Z\+8GM$6`GS\$D3OB,GF9$(HR=L,32\`1EZ1MQ0H*=_^PZ MP1/[_C?B/H'PG\%;3X>OL/9)N18(/D9LG@N+\?#/(..B3TT:1Z?[Y02^Y\,/ MR(%,?^!#*9U")1_\Z;>SLPG//;YS+Z;K!ZL+&3.F`MG?3;?Z;:@HV94<,J!# M7T?KYO$HN+04C##U$O;%,JRH#VK[:AWD;5[-)0BDSG!D:(BC+Q['+C>X,[1= M%G`J&'I(UEA,`RK+P)T^8PO#5D&6QC@BN1V0F MB]C(M.G'>9.,1^F_CB_#%[!O&D]/+GD"N9#:WI9UA:B.>76<%=3<)Y#'5D!9 M?QG?4>/NQ?+08,XF[B+*K5^8>LOQ;:O;*HLJ/U;'[7'B&DJG$.Z*YH)49#LR M^V")5=X`U#RPK%5M,/Q&!;7B"OG(R7?BL^KS:\?S)K[OFH\!?>>#IA[E7I-).HK^F%0SWX6&UA7(#<_' M:Y.O[V>6@>DG!4_3#,+?B&'YSU/`X\QQ0?]1L^MF/EG`D9L:R=T[$ZBK%WBJ M5"/)(+DQJ29+AHK)9?<\G_E7$*[<'=ER-*@HOI?`EPGQ+T%HY02D:H/K)2'W MAG]%[3\X4*-T`X(*S%:OI`W[UG4PC8J5?-(690Z4;U'::BUI^F2`+DEIR%5R,0$UY5DN.;2UF1C7$S)BF'U:` M6Q.K.";#,I\^B+#6JZDH"G6D=8X\942]C87D3/>Z_R:WM*5C1<$-93 M<0T]5A(F8PKCN>^?9%G\M:I60YJDBBF17X!-&^D[O:%?;D-*BJ)*BK1!?A!E MF-(.48N%IZI-(A6FLZ8^7Y,/ MNO]$KTI?@5.?>#1;,J%"^!=J]Z^B6]$/ M!3Q9.9O0MA:VUO"X<#8:'M' MY59CE^`VW.!119O+9I#FFA!V);M&Y=8,F.2"),FK!S\+5@O`-R5V126H*BJ9 M_IVUX2[.7VR?[A5YN*HLJ*M)T*N`M8-!4^)79.%N"GPZQMD9X*DVQ+Z')]IZBZG@ZNU@AV-(6Z(9WU"L78'.!S,&%? M#*SR2O%^O33LC4BNE^M*5=15?90.L)2"UR8V3;>B7)5NB4C*S^F&]?7*!EF: MH*8JX?(`;05P4U)7]J!N!NN:CJFIK[5/[G)=FJ[&J02N972:;D;M1E3-,;DW M+'0H:*,!<-Q?S"G6IJ]KM)K)!=AL5RH*7G1-DR4]U3Q@#8!MXM%T.RJZ'^B* M((J*T!@%+#6\F?_J.#/OWK%JI6-LM@7E*EA2!$T?"YG#G0&L#;@;DKQB'(,L M:JH@R5)MD'\E-G$-:V+/)C.<6>SY+E44%V$R;>-,F(K)"R--D,%22."K`*`# M>#=BE8H9#2-I/`;,>D6K*2=5-"38$B/JO]\L"3YD/[%7$5\,SIR`U&N16 M;K97.67^`_B*]6S)=80X$4Z%U,5*!;Q=H-=LT[3\V(I2S*2-,5O;BOYWC\P# MZ]JV,]%$\2?_G:K_C,=6JB$M"OD M,'\=B./MV;TS]U^!O@V1_!$.ADM_[?Z6_*YLO]N35,%;ZF*[H%5,&LE81LDYB*HZ*BGC4C-J949K+$FSR-N`UJQ>L?I9'6PJ_H%)Q_*(QRO)1] M^]OUE7(#?Z%>WWW*3@#3;F_V?O6IO;MK'V M]\[T/V#R[LXD,[27HJR;W>V,8R=M]G7BC.-V9S]E(!*2L*5(E2!]Z:_?"`$6?*6:VB$+S=="S)/N8;UPKD6PH!0LF0<&2/G$.,A,"++$J/HO_PZ?P==MKFP0E)@9DDO%/6 M177W@_!3.`)WQS2)PV43PZ._GY"WEU?G[ZX.SBXO+DX_?X&>N*'OTX5@6\7` M)^3R]W=7[R\N_WU,;B!D@%<\#D:UJX-+.*I?TR/?.\[BK@B'*@\6E0W*T\^F M?_08>F!6',X?.(:^VWOV.?3Z$=,I@994<#(PJ_]3H1OI+.Z("'WNI;*K`[5` M+HHUR&F`@D(KYM_6@U?&L7J49$Z\FW%I%J1+2>?&L1J49$RTDH?#:) MGT/UV].S___EZO*W3^?`.->=3%RWJAPC6Z9[!E=?EKHY]SR?5:R@3\O]-6-O MP0#\K1*Z)=)P,>&?3\_//WSZY>!*=:^7K?^\_&`4V+`#(^1&R)LNY%VKUQM9 MG>'0"+L1]J8+N['H1L@;+^3&HNN3C$WD?UHN^+PL?2]BU_;//EUFBQZP75J2 M7_8,DA%NG;AKA+O&W#?";83;"'<]R3/";82[R>E5M6M=+>(G$W5MV(>0O$ MW%CUC41M=:JR_%C6\=.RZ>S4Z:W.5/:62AK.1K@4H(`,%>#`/G1ZB`RP`76@ M_DU_PQ;*0#VH%/^@9*R&$KE(7D8^M,7I.&>N!'$CW8[$ZG`,5DO;\N_/W9:!];X!X;$YL[NY)ZYZT;##A(VTH4FEBU;L!! MFLM,`P[2(&8:<)`Z,].`@YAHIV9,K%\A;8M(-37#]>1;BT@U(EI/OK6(5".B M]>1;BT@U(EI.0J'9^K,!!S%5MFVNLC6;:(R0-U[(.T['ZO9L(^I&U/41];/+ MB\NK93]*D0YCWXW0ZRWTQKXWNY+-`(68BEQ3D6LJ_(\#$J1`L%J>!=['*53^F4!27P54&/`$W?`J#)0[%6X2AN,9FK]E=_-8/ MW3]^_O&''W\@Y*?L#5_<&?,2GUU.WM$H@&?$9Q9]F=&(X<,N-'C._21FWGHS MQ(7!A0]7;/+/5Y_MSE?XX]B=[G5H][]V;7G]BG`/V$C=F'M?^YW!JY\W1.?9 MF!7D58F26#)T!N*03$+?#V\1""1%J$CFE(!"02Q'3`&5/(I@P MZLZP47S9`GH:>H+0D)YC2A7T MI*7W<&WZ%WZWHNTC^(R96'U^%X`5JAO!+6+>?QB-VLJM>L,,&'OY;=FPCF@? MCRCEOY*`Y9!;;"N'R0-!M^%MC7F;007F^-M9YV][8)<:L10]>,0FRQR;0.9& MTBQ[.\UJT426#N0U3K>J+;//2JH^ ML5A.E.Z+^3IL&M2!O"I74C78Z?HDD_2ZP-]V8'C8PW4\;UV:I7(/>MWI&JL==_ MF0QY:U-3?L?3GEV^#F&A#N15,#]8HV2FS&G!UQU(=D8CJ].S6YWLZ$">D>K2 MI-ID\)K[\FHS^'\SE&$\_/"&173*TOW+;8[K="#OQ3P-6IT;Z$">D0+]9GX'/KZN9A.ZJ;L5,)7N#@8;6P'#[)J&3)LI+K;2NK$M:^K]D@ M"QQD#`.Q;EL0UZ=\3A;T?LZ"6,B*;^PID4IX0!81=YDL*A#,GQSP0*($P-?A M-*)S>"'UYCS@(HX4_-V$09L+RCW9$MSF,B%D\3H6A^.[!*[7Y#Y1[[^)QUT: MP_WP'DO]EG9V$3'A1GPAZ\F]*)F*K!1]3KE/I$TA"]#6.77O#VMLAG;;CTU+ M<^K=L"CF.*CX4`GF9M0R-(B4Q:PB/KRA@V+LVPU5`@4U(6$=D&#>WREB&G,E&4# MNQ%"NBNA*<0A*>S8+8.>T068K3L^AR?]>R)CV;*@9/I#R[85OE`&*"-)*O4E MG:/N]EO0&N/H"'Y'YK)TGC"LP298`DJZMD70,,C.W#,:I3]F-82DVY$W.!8! M@[Q@+HZ\7VN#^X@9W;2Z%V$PO6;1_)R-X^^PM8Y=B:TM0`-1BW0R/_C6!D]( M^FBV=P@EZE%4D"6>UAH\R7)B;3,YB<-%T?Q:BEIB'SH]'FQG)W`)"@\\R#Z5 MI2QD34W*;/EE&NYTE1*NC\X3T].\P=X][*@"!Z@#!)7@*6^M%%3LI%QY5SVK MD8?%3G&\^!!@<3:ZQ$]AG$8TW$0T9??UMP4$&F#X)0Y7AG,E,Q(63<%5/DW5 MBU7\M6"*BZ3[9DW=+?*KVMV&+Z6^G[V;"Y&D\5,>OVL')!A\_O7L[)3P^9QY M7,4YD.AAB*!2LQAZF37]49$UHUX>"HQ'CS4.0X0>5@9R:;-RC@_?$4%<@8)* M,4-AT!B=""@'<<;8! MJ!;(_'<.8QY&]R1`90,O"#DS#0B=3B,VA2$E$PJ)\PWB[>$K2HWP!E:OB*#7 MB.Z5Q68JC\[(<>R3,S^4P>YGE>HO?^F=G* MM!04@$-"`HW1J4Q.RI4.IU@Z0`@_KMZXX2R44,MI&R9GAU!]`Y0E$'LIV](L M1#005'TY5N2@1&TIPXS>X/=KZ@#V)7#Y8DW+2R6[B&@K12J,V`050Y1K5R8P M?.MC#/DE#FMFG+<&)A6`%"LQ-YQ&`TO'S:3C$*3;D_.'8QCT/=CICEVLBJ`? MX+(]5$`7%"*&F%II("B=LALXL1HQZ'-PP!%PAXF8C"$O5VKER1]%@KDU#VBL M;`I*G&`!NG$/`O0-QY8)';O)!!3NFM#$CTD2X"RJ2$!1GB0S2@I<%3L_1O\ MQ.YP(KIT#CO(W"T&JZ'+!CX;O'`,@IHQ"T?R7HUY:AHF%EI&X"_H#K!#\DE( M_Q%A?`?\RIO?>$9CG(L!_DEJ*7%G-)@R%8X%D)?Y&T/7>A.SC:RZAIOZ73W7 MG*A!0V#-(06&5.P3%^D,,%*I$(GS_5/AW<'?6L7N=HW0/!0(X9.A.4B6G`_U)F,Q>2 M\N7PX'0Z`\.C.V" MP'-,0*:-P:LV(*M1L-*26$R7R:P&X(#5B/O-MV/5!F[[9[4.+DL'\AJ44U8; M9&ULX=.9I\VW3M5&67BD@-HYF>W/:;-#VFLZJ=?6$RQO=KS.'OV$SQ1,+K MNIKI6(-!9[ESOZ7B_JUX@UIOUJ]3D53YV!35(+6\3^(D0A0X^(?'?%7'OUG8 MO%;)5%1%N"HWPJ)*BA!XOA_>BN,:#&_U]7)*Q;-]I`]7F61=5'<_5G2RN#NF M21PNF^C9+U9KLM7!;XZ9ZE/4T.UM&]WM0H:GNY9Z;BDVM%1*2P':?'V):79] MS'.S[R)[TD(>&UJ,(6FT(:EH9KK(?#CV_I);':;M="#/5+T\;'W,.<,ZV*'R M9MIVV*%>FR?9=""O01N22J19)X.D@Z1J8Y`J#XSZ;?8[.I#7((-4;834'8W, M]DA-S%+E<=*@S=Y'!_(:9):JC9,ZUF"X5\.D@\1J8Y@JCY>&;?8_.I#7(,-4 M<;QD]1W'1$R:&*9J(Z9K!&^F$^AHF[V0*271#IF@VMCKR.J/#!2++B:NVMBK M1B%*2R(P4U[R//++WGO0&.'6QI)5&ZSMG]DZN"U38-+(`I.B&;*]0QOH(.^F MPN1YQV-HU^LSNN`Q]TFT*F];Z^<"'3J`Z%3+ILDNXW M:OMZNX[-Z9IC<]K*VT+GL\9?IS7\K479ES'`FM*BRVRMSJ2:JK!Z\JU%I!H1 M+<<5:K9IJ<@[OD^B@$OT$4S#E],0;5XATH$\4\GXV(98VQY8@^[>2MV,H!I! M_19![0V/K'ZWU1MZ-?&CY:T_%OG1TQW3W6U>C31;)9N"NEU@V%X[/=L:.IU6 M8VX;"6^RA'=Z76O4';1:PC5QWM4FP36*MUN23N@R2V>V_1KAUH>[1KAKS/WF M.^EJ,^S]LUJ'>,SL:&_+CO9!KV^-VGU@@A'VM@C[4=>V!G:GS<+>Q-H-]>]A MCZ=+^=^TIUKUI_I-U&L[II<=?T97*QFZ)_2B:!/ZZ3R,8OZ7VG(?3M:K#P3A M\"=P_<23U0GK&_39W8(%@AU6,?!UVFE?EZJ3CSS@\V1.)NH4&55?LJ#WJKI$ M56JL%Y^$8^B?9+;`T@H0CXV*#%-R47W)Q:9G'[%QWV72:J:9<'K'Q;OWUX6_ M[RS:&/8>+MK8JM'82,IW=B6-';9N>.$:CU(3=QB@RZME9/4=`4XJ%>?OSBZO M3J\_7,*M4OE\'K!E?#"PMP.$_S`:D7L,H M-'-N#UDF'9BMUS*W(5"W9?J&4:BE0.91\9$"T]#57E@90Y MJ:>&@92FAJKBB,H>62-36*6IH:H\HC)G]YB(JAX15:EL:&J/*)J MM8?2@;P&&:K2EZP?@53N6_W].5H=Y/?E#)?3URK",F?]K)-GRGM;<=9/S[;Z M9O*K*HNG35A6H^BE)<&9*8DT)9%-M&,51VDA[NE.]WW/TVW@Z_N_V^S+=""O M0=EGQ=-DENT<65U[;RM0.DBL)E:KVNCK@@E!Z#Q,@IA$6'@DP%#Q8(K'I$#6 M*0SXZ+Y23KWFU/:!*%7MFN7KSJ!O.4YO;XA2.DBX)C:NVLCLL[)JY(;Z"<," MNX#%)D+3DKP:I:`O'<"5F98.CX:6/305_ONW?"\0W;E)%*'Y6V`1^OY`<'5P M=R:@:W1`-QQ9H^'(!'3[-VL:5T(VQH/I0%Z-XC4MR==RR4`'X=;$CIFE3PV" MLDJ!Y;2HJM0&6*[:"*W?@[1S])SS.QLC[`\`RWG?#8ZT@I);>_W3/D@F2&RD M<1AY+)*(06F_)/G'"*MT0N0]!SZ]#Y/X>,+OF'?R*/+0LOUH>>4M^YR_C%:7 MV1C]](]$'$PI71Q?A,'TFD7SCS85@^X'&<7U4"O=8X42MZX6`L> MM3%Y#+/"KJ\DB:Q$Z1M?6:G>GY0K,*IGFL+YR5[D..&&\WD80']`FV>A#P9+ M2,@\7,:,?>:!N))(WDZH[Y,P(C2;"<.E`)&X,R)F\`2",*(Y")@K?[SE\8S$ M,T;.POF"!O=J0(9.9W""MP+SJ4_>)H('.,EV'=%`4/FDA7!]'IO`#QYYFK@7 MBSGT:U<_SAA0,N$NC>7"QH?`#2.@3L()6FO:(8^4W!P823B!VV$H[TGZGC@" M12#4=7%1V$JA*7%)&'\$NE@$XZG0U&Y1!^`7#^PMWBWD6Y`E7`B%:(AO==TH M@4?&28R/<1%''*XEVJ5:9+;DD@P0\)J_`<=R!X.RH/?(7PN^@N^R&[$WX1R( MH!&.;EC08_*:+A91>,?G,"A`U=_*M#@=^[!KKX_K@D5J'-](8J&[T%^0L2B4 M`YN.,="VW=.(R=4GR8HDVO*2%+X96;O&O4FWSL#NR1OW>^F"EF@:]2*EXNZ;`!&() M$<,PHE#=SC@,`9(HDO%_02LS59XO%#G7,R98UJ0D0"DZ#-0D"N<%`P[O.4VF M^$VGI^BO81CTM`AG/2YB-\P/Y:&R7V(Z9:G`?0Y][J9_[PJ-.JO0R.Y_[=I% MH9%326BT5W>S"STVJ3:6^8#V+J#^P6\@X5_"27R+>I!C']@*D2Y7)X7!AWZC MIFE`4=37ZYPQ3M%Z^5_0A@MFF,HP0:"O$R)$G&:P-\M@89%$[@QW%(`1^P>8 M<2_',K!Z/.-K@I8KY6O>Q_(83=E8\)@=DE]8P"*(6NXM`HHH'Y0^)FLE[0<\ MG4B?[('RIWX:?*"/80%ZA'P?!*J]\A'@H:15E2YF2:0G[>I3GI]FO\.G9:T07-^[YZ*QJ5&VG+#M&+0<25WC6G M2']``Y=EC,"P1@%E>QA\90-R2'Y;3".*/9(':@#\Y:\X4G,I;B`]D\0G/I\L(PL0 M1@BC4I^Y"H!$J4Z]N^[-[R$,$]O0Y'5QH4]PAID7S:8@WE,>_8[;B3Y"``=B M@8V4Y46[+?.B.)9$#B;)C:;Q;2_@VZ25A^8W8)]OF#364:)^13L((7;D2:,LG>'IES,R="#+P$'@C_%9WG`(^2N\`7S; M7%G[56>LM?PHP5,3*#B"Z`](&Z6UPVQ)N9`L`V;202+1(TG?D+BE+N+F3L+^)^)='DV1G M+B;M4"+4.16Q[&41!=;.^8H=\B,]HP]#RB=3^&'E^Z0YF&N-"(/'>$P#=HMW-^ MGWC@4PH"_!=;V%BMWQZD."LQ3FB"`X?>;9S\<@`RV5LS-[ESKSJ']M,.OGJB MW6RP@I>M;8XVVN9L:UNABJ%""3[G/HUVJ-.6$EH[E373TJ4&!F&&V5M!?:E17Z.^9:IO5QOU[6ZK;V&.,P\]YJLI M0#6E%OKA%+4VB4%__\)L#FS$X2"2/V/O:?M M;1M'^OL!]Q^$8`]H`<GNQX"6Z)A;6?+J)8GOU]\, M2;U:LF5'CNV8P.W5L25RWCB<&0YGQ$:4'WYS(*1Q0Q0SF/*8X1OPJ>: M^GOQFG9U/=3^E"!%OS;>OPUC61&XJ%#%>""U/I[-F%%F2GK])!9-71M$IRQX M&/;Y_'P0HE(ML?O8&:2(U`7Y01]=9MY3[1/#(RF>N("_Q`X8KEJ^VO'A''J) M`[=8@(2N02)@OM)8QMEB"GH9\1OQT)T,W&%2`,+`[1X54&RHUC+!2Y95?B2RL!/:+%<8DO(+4EIIMDZOGN5EF([#CP.? M9@Q-:[M2&?KF/-#I"$SX'F=/-S6_TL0'TL;W\"+-J$/D82M8`H^:+.7B%8;B M$Q;'A(&!ZQJ3N=0`CD>+['"YG$U2OOBXN;# M[>7-AQ>N0BQT(W[A;L*;]P!\_I655F=O&AINY3;2EN^([Q1;0!?%&N041+&9 M'[J(\=^D\H5BYIXR\K,G(1LQRE]0&_?HD6'5DE]+\MK*^%6PJV$6PFW M$FXEW(>)GA)N)=ROV;W:[EF7Z`F??Q/XF'UKU?+E5;9\4?%2)>;'*>8J8JK$ M_8C$76EU)>9'(.9*JV</_P=8JR.[=_;IJ&M0OIIE-%$^\>7RTVWN M[QM7^U@H[I$);!:"(G?GA0=4<9!CNZ+P&F^MJ^(@KY>9JCC(*V*F*@YRR,Q4 MQ4&4M7-@3#R\B[1'A*JZ,WR8?#LB5)6('B;?C@A5):*'R;JH_&=Z-/9@1F\J,;?PS)_>N_`^_TGI#9NT^$N7]@48BOHE0$UHVX M=BQFS,7_W](G_Z/E&#\__/,?__R'IOWJ/1KDW07U#)?-?.;8GQSW8^`QFWK> MP/@[8![#;V]=8GO$X`_`/X[K:89C^S#8#1W_=G*M-^[@?TV]T;IU].Y=2^>? M3S1F_G:"+S#SKMMLGWS`.AE3\I?C,G^.Y2F\"7$I+U21*)2AS1S//S4LQ\-J M%H_4Q2H+S+(TY]&FIC:::Y_/SP?BW8EC`1^\FO8X<327RKH;\%17_U=F6"^: M+?`]G]A(>(U-I]1DQ*?67"-CG[J:G+>FL;%&8%+YDA>,_J*&K_D.8OX`V,[]JE+34JGR,FW\-!T M"J.**6L:P*AU.^7P*`&LZ8"2\7,AD>_AA,Z,_^12@V)X`B9F@*`+WQ"?:`;Q M)HBU[P:>CV5($#`?5EL(9"$IZMHE<'$*I.;\1A9ZG*.N-V&S$#AF&U9@TA"@ M`-^WYEP.9!*Q-J$6%X(9["/,@#<>J,DS*OM![8EV"D/KSP1/S,EJTQ)KOR<6A'?)X[KWU)WBGHCI'N&@/VE&J/1 M[_4ZO80(YZ"Y2O]R4&_H3*S;Q-;X8IM32Q4&<,^)EOT3Z@3Z`0N=7X2[,&"QW_JQG(W6#;O#C7.U\C\O0HMY,TU M?X9&S=4T:G1V8K*L->0YL=%GWP5![VY`BL%4`9`'][!8>#G(Y$`YN.4PHK6: M$<)T*5Y25!E$XBS6*<]KJ_$#S!&>$%\6DJ2Y/`IH\R'EW$P(1[(,,=&O9F#=0]W MZ4;WM-$XU;LQ8L5`[=(WD,P;VC2?H_OEP+5*>`Z-K-;;PNX?NM?#\3F/LG[W M'>.G>/IVXCK!_>26!YB&/&Z;9L19@A%G=XV.8(0(>'U,#),+'$-=]J7PZR$6]'IUYNA.EH->DE,KUT* M"]"EYAHF9V:T>-UD?JA.ZDL8_8VDSU46W65$2D>V`13*)6FIF?CRE.DL#XGI MQ50IP"\=X)&*\)/C2OTW'*,^'&;TX6LTNMK=DP]OV%NM46N+<%EX*,?2)^W$ MF##Z(&C`+RX0/'&\=QT/#TUA.PWX6=POC8X>!MYDEPJJ^8_4>J`:;(_^Q--P M0S2UK]C((NPUT=;@273QM)8NO@A#8"4YD]U:;ZA'<8(++"#MS+AS97-/+(#Q MOCMC'UPM>L$\/#(,7!HE.ZR?K-`&CR"3:[)QDPNMH&>$&%#<(.%I.V4'#)M% M1/E5F-*RLFE#E,>43&2*[UEDW,T4+-?KO6T/M[STSVZPUVIODGBAA5\)^8,*N?.WH^=0#!(1?XT^8L\\7J*UES[I4J6M7B1G33CPDL_'GL2 M-WZT&8S@F/+>3_*63ZN^*(`'4S]UXRM&"U4<'%ZO0MS>NF'>SVOJXA?DGFZS M7E7F%E/R[OTL2%\U;9Q\T.N-1!6')1"G+]8E[HK]CE?%;N1-L==X9WEYV:Z6 MKJ>+.Q60IGKZ'_=Z5/9I3?IMXV+G@5$L_`V:I8&T>U`H&I\#P63:*V M,?].?=_B932B6F%8FS"['M(%.@1E6\\NM-%IXZJ6LI,H9U@.Q"QFX:JZ%)8/ MUN/9@.XK[IGW6DV]W8MAS9ET<[B6R>V*(K*-5J/?+066K(6?$Z!YTRM5/[S<[V*]CF%NJ*7J0&EK=B M6+8/:_9]G*]59>SER5JB#%*SWVVNK%16G@!9>L85.;!`T`5[8";LEMZ5;3A3 M&A4SNH(=V2BEMUZ>B-WE]EFKTVJ>=IRJ[)&'(IOEM2\;%P)@?OB M$'O-4KS=1LE*/*+*W>;@ER'`#`N`KR$;F^#;3%2WZRU'B(.SO#9?J(%N@-F< MXV9LFBQEF*C]=;YN[:\,,LN,*&[LZ6=%!?R609XN>Y8J+W,N>AS@#7,8P4G` M7XIOU:"]9A6ALA@L9_7`M@-B@2R#TIG!!V'35[8-9%!<;J:U&AU0YNTBWN:# MNL)NXP6]OSCV?;B`UC>.NLN-N.R^O@J`/'Z<1UTW)!^I&>-]4[)"9@;JWLI5 MU$E3>B40.;Z3?$$*M2P)'+Z]@0/5+6%(G?7.VF=I/VHY&-G03/KI6^<'5OI[ MY([N!DV/NLOC1\U63X]5\O+)4X`F^II@+PG157AMZ'K+=_].KZ=W^Q*ZO!FW MIS37,H0JT;"]$M4)40=U^I6JV&L>1F>&5%B1`JN<2AELFROBFJBV]")E6P3T MUK37.L9/1>*PVL[8"PVY`\J4,$6:9XU.I[V!%J[8#GE)LJPP7Y:OJ'+F2_J= MA,J)ZME!XD1/5JG=:15@OP:!R@9!8/P_IY9&P5D-OZ*U"]Z,< MCQ>6RF#J!!&IRFJ%:GA\MB+PUV^?M;K+C*TL["F#87!_[])[],6X,D@56\83 M!8L8'$CIHVY@WI2($*6JC*X)T3/#:Y?$F*2?+=]WYDPOB]KFT:]%^-+V7N0[ M`VD^B_:((NPXL,UAW)NR_&%=DE#1B%5S M`4)CWXN8@32L,.Q9"M6TXDIB'/URP;!5\BA`)?V5F/36X1MH%`\9NK]3&Y0X M&-RN#Q]RJ%0F]--*NV^K\5O283TD7^(`:7VUU@>VA0W#^<:";1*IZ6F_-)IU M7<<$39$;Q/-ZFKKFNX2WGC;)W,.VBI@FU-)/Y=>G\+5,ZLSOKIP#],(I/O&8 MAWUM#33[D2AYK>Y&)G"UK'>`'3DC,S[IV>4/[N.)'$&6O[DVB M\LL7HJX65NQ82D!D>>(<+I!4RMQ8!%&)!4!+K]D3G=]'E-K:#+N;NKRQ/!\$ MV_8:5'MD_H3_+=8!/,:]?@M`NQ?:R,('O3[@+^Z=<^[+HWSM MC2#G6;.IO__Q7?M],+B.OFF\?WO("=?E5$96T?S`WDR7P,(I)]7Z"J5]9`H% M"(8"%9%,Z9+MZ1*A$L25#:!YK@)AO"DS;,Q3YL\KUA8NY6WE/6T:1S%\!_[Z M234:K1EBFQK!SM*B,R4,27R-C,?4\/GPA(?N,%EXYKB):0O0,:Q`&!?1U0@$ MR0A3/GV ME41T4=T"1Z>.YVMLBE,3P0._8/@88Z"82)GD(`(7`TO@Z,QD(,*3OW`F\Q'Y M/"8;CYD!3]T%*1W`2A-3'D1-B(GC,7+Q> M!,CQ^6KPC`\['5XZD@"%C++!WLP3K1%L(_P!*N2)3^+S$_2(0LP&&QGF!,FN M\O*2EKJW%,!>#,1G=EW[2`T2>)&,1;_`\L-%"AN#`^"!X+K`7S,4G!@IH&1, M01@H6A"9Y5XDP"#IAA_`5R%/08XLD[,-#'7>'!U>]1)3'O*VGMZ@?U('$6P[':KZ<'>]YP=I8G#Y4ZAN M3,WF83Y\C+^;T-6@K\*;IKB[&KY0^P_PKM@RC<0RCJZI"D6'FI1K-R\P)N'( M#.T*=)80C@UQPHP)1?$#>9PZ?#IB,I!RDX*Q`I*%&YN0\%)"'7-F M39LF7PE/B?LS-+#@DU_=4I'!I.AZ=Q7KIE@JMU=+X'`,H@U,GL7D9;QD<4N> MGA]/[1Z9:21(IP'M5.ACFZ&/^/:Q(9QSU.Q,$-]'XFMXKTVX5F$48`[&#'C/ M9EWCV<[P&VIC_E4-%+&X;H1O%X00HGWBWF;_Q8!MJ/<#'Z,0^")J,'YPB\RDAX[PX?[HU;6+DLA&QI\@)K6)L,C@+9?[JDDC#3WY.<>3/'&4)3ND M]SJGQ.7A*+X9AF&,7)+@U,F11X+L#WRSYCLX7NHUY7XI/7^[%`O1YM2,"1YB MMQBU^/FJ8@\44_8LD@)SA[$1JB5`?(S!V26Q7\"C1BA6]>N M\LCIDY\82X5Q\05G//;0KGFN(TP.&^3O1>T6@(RY127\:!P=<2X)XB MN*D3`A$R1"A=21I.DPY/-4#S M-205O"EX+[0JLFF,VMVR*"AXD_,=G0P18^;;<%H,YD((>,P^CJI*$+`EL^<` M?R-:YG],90<']R2SA]M73%%!LOU5\V!?^ M%%/>L3=\!F3QK_SM62KE7"[FF4L?F!-XUGSQG#C.V7$C/@EE($_BPP/:62+G M*G72EZIRF&MFU+=F[*N!4P,?J#9>5\MFM?0@=&(_.>Z%$XS\<6#)U"E/7%!8 MS"5==HVHO_R&5R+?M=S,5<%;5#*KO_PZ_<;P\G372QZR8`\TVC/QUBX\[,`R MMQCGTC<'J^$%!K^S*(LX/+?`5D_7EUQ0:/,+"KU^F)Y=$90OB'EQ";2>ONR. MEV#H-I`V*7MWX1B)N^R7MGFQ226-GBZ*Z[1.]>YI"\`M''K!X"+,O++_GV'L M7UJRZT_>6EY=HMUN-9,EY!;GW!BJ94QMEUVDQ?!PKM_0$08!JTDB[^G'E@\B MR;>O5N@*-_:`'-KK"7&GQ*"!2!&$EP+,)P-UYF)H&_.[7,$+>=(MPPTC%^/@ MIAO(NY&X,H<.5=!^@D&R"7--GM,W3Q[U.JX8.GQ! M-#:)PM>4N'88`Y^*"ZC:F_A@'E,X`5%0N:[W5N-&E<@G$3!+"0M'P;%GL*1S M,QT1'1GX*015^SN`+ZEKS7/'3L3]9#(B5_<8V')XMY9$+FAN!$D0(0SK\+=" M[#`0Y+%I8/G$IJ$'431=BC9--2 MN2&8BE;%$:J\\_D1L?BYAC?A@4"'GU[(`PV<^U+6!+8<6F9Z`D>5A9H%) M0WXM(P^GL(OG5K#-RH1E/.B+1Q390AC3H_SQ11H<8AQEY4:TD-MH3$!.+#H< M_R<4YD^AIWC%_4QNK=SB%,_9S?;V"#_1-N,+[YJ1B@7HZ.O_>75Q^QD?UQ-] M+`3_L[B`ZQW]5^\D7NZB/,B.)>?#+U\&U]\!`L.Q+#+SZ'MM^,?ES:@OL4G'D.?W/&FW*NYAMDMDJNY'MU-<.O\Z M00D%&;3QUFT6L>_L?^V]Z7+C1M(N_'\BYAYP^AV'VR<@F0"X=GL-X%<\;4ZNP%=GXKZ'.(N\1C$&G)%O=-3L#_2$CX:WLQH2@;QV2:>&K2/,9):&T>L+IF8-HS\(8A'3YAY) M@*>"9IVE^&'U?G8FQS&K*1'(>_'MQ;:&F8R!.AP-U%%G)#Q/7TB`97F2RO(] MPF=V?E/"9N5Q![]@=[WB>0#_B[FWM/?3N-S[B878=T_\7'\&F3XTAL-1Z9R" M/0;VD@1^N24V(3.3'@.W_L"RCW_%3K3`M_@>%EPN'>8PZ&Q=TM:*J2D>N+[U MG+!#/J;L*"QV0?$?U/7'`[<-J_R^!:]HJVO MM6QJ2IAJ)/9UP,[<6GI@2P"U=4WH=E0O'P_+M"2SW`B>4!YB?'[;RO*!MO[X MWL+!O96OVGM$JPP];<.9>MVA,>KN,:S\D;2_>^8,*]#^ABEV0EH=O_9(NE^) MZ493"YA^[@?8(I`V,9WPDR<8,FSB7)$'T_WH18"'"BAL,&"[W9[>U5<=HELQ MXJ6F`^P"/C:\/;D2C*F9$\^V6C*UD+KA`-V.-ASV58UZV!OMS`OXW(IIC8:Y;(HI"^F]/5V3]+JIGJT M=1'TRN$D?6-P[@7FX#6#0/K&>-H+3(`HH1MC?43LQ``#N6,,7V1.7MU#-M;' ML5X&&74$2HR-L:,M",FU+\4AD0O"_GWI;6H?M\T>BK$^EJ/I7;BDT$-UXR!J M'/B:UEK&^C#*25G66D=]"1ZO%_FX(/:8Y?4&Q@E*T]YHW8!SKZ]CK.LF=[TAH/>&A<9U MWSC4&SRBT;&3$!GO!GCFV91#9^QLA]WG>[TN/S$ZG:&FK2-BFW$U2MT:#G77 M*^=^QS!0-3=-'+N82ZT;UID*G@'?!.!K7N7.$-F9?]T-.T>]X6C4&VQ1W\A,A,T\(KG/9BV7G6?:%U]9*QE6FD(=8UY'0/6:^V^ M,=3UM>;&AB'?18&)25578,#>DG((?ZM9W7KWH_RN/<>R;K;6Z]T3K=\=]KMF?+TR/AF,=*W;&=1!1G)Z[+U_9M$#K.$9<%>TP'/O(A`JZ%_,9_N!>+T^ MUCK=T3"GCK'N,?PW75V!OG. MW.FMU[8G9?9\V_A>A-IU;%ROY;K:W[SB]S^AP7P/WU*\GN=#A'E.YM9+=^/*Z1KMN M3M>KX5%7KVO`MR0Y&?AZ\MG'/JN\`>WN,[Q!'QL=O=?IK!CWJF'4./1UT[U> M!W>U$=CIW?I&CN827'X.5J6SAZ[MK=>U/:,+_ZT>;>'-WSK$-3/:WSK?KW-T;'"(&H<^+H9WCI+L/XQ?Y/GW]^@U'I&9[#U MZ'=W\[OJ@HW>KQKGT[F\?YKJ9W+H48Y<15IH:V49]<8=[ MC[G=NN)AMY$T0L>:R1^L5W^ZT==[VJ!9:OXP`TR#W@/A@XV[H=N]N99QKIOE M]2K0&&A&;^?!LOW1#?SX)E=DL#&9?=JK[R MO8=[$LQXIL05ZM'KL>L\[!L-&:S7AIK>ZW5RX8$=QE(_&>MXL;6N_`8*\CQ, M%,4G/Z!6#*_4_+8P[F!C9M:>0VF&DG7\V)!P#BIYA5>V`S7?F&12&O%Z==ML M"M":F1QN]!ZW'5&Q,`-F]!,A(1CE:'_;'^((//;_D@@SL7:?O>%Z-3D<#HQD MI-L/HS#Z1#>=S9:+0[8:X08%:8#=CYM?%2_;?1SK^+G)Y1OVAL;Z<10JE%BN M\U)=TBT)H\#!HYKH56=/9F#O6>@]W*UD:MUPK$;*UWMHP(B8@6!,I[+*9%&"$WWI* MU7`HZBE5-9SY7=?AQJQ?1G*Z,1Y;-_'Q]%HL'>"'8L6SF1G0T^SQG+;E=CH3 M8`T:LC`.Y%CNFZ"]8KS'F$AQ*0_C?>@Y:^>"<$1GW+4(/3^<'2/`KKCY^NJ_\/7>26OK"86_'L]-*QUBL M'`5OW+-T04O.7H.YN+Y-C^FHHY%03Y>G>+2"43N=S?9;Z6RVCT=U-EO[F?E? M8@;'RKW7/+A+RM>#.6GOY1?M^I/W#,GK`^+U!;%H\5F.WYH\:5&(7M;U@&&P M089?)%[J3>*Z*FRK1F&!B6/N(2PRDT4YV+'>;M@O/QUU'_XHP2\RMR7X)?A? MVQ1(>F^S0*)F[-E[^V50T8_FTYJK`!TJMZRJN&UE4[^C[> MJP2R!+(P0-;4WK"G#HVC!K+`ZKE>[WV3>LY2,Y(-:4S.D$Z[H'Z+"(Y)30>? MOXRT.WEM5DLD2R37@N1!3]5'^\32#P;.`BOME_6I`UEHI"')VY9,5!9"'5O/K..#[R!(.\,&>Y0^+"ITUOA0:K29/U[JS+,_$(],G"BD7/I0/G\* M*^VWG_[1AL:9G=&H4W$R49V#?9T)6ZF\;:[>\SU@W%:/FS3S[YP1T)'AUK MJ7AWE)7&P6XZW;*S!QS'=`AJ=4BMA7&TY;;1+_XS#R)DL5K^`@JZ[P,=#&Y7Q`K[' M`[1)@%^'L1N97J0J3U-?\9^\$`L(R3.()5K!V/LN*3D\9X]B4S'4M<'[8HDB MDXVJ,C5#^F+Z9/S!?`@(/:6"%CVR7IK*S`R^$O:S!\`S\3"`,!'2<-VOY^=G MIPJ67=*A@S10GN#!=DQ+)\GSW`F(XGNUFOS*?TPO-H.%HJL*2*)!P078U;NH M?L74?R*/,/&Y"54B$H"4I8L(O\ZF"XL^+3,&B0\LN2/SB&9?X]",T\+8,GCB MA)D>4.$J$P+C"?CJA#F#9X"R,[;72]P+30?_(E MNTO4K//K7FA=[S/.RQ++`9.U8EU7P6A1]1*_DMIEB@Z'G7:'V'F"-8>'2V)= M\IBX#H"8_C`F)=$234'Z+$F7D@QA"SO!/]Q@L;9W+OS!>NL^T([5K)#9":QX MAF(&80MR#9[,RIXYHJM'#'?F1UU\94`L=-UM%%1P^P-=83C)"OD+UPY_0%;( M7>M"`7M+!8.K./$@W!Z8W44EHEFPO#*<$F:#E=;_JHB(N*&*/8S'55WQP)+> MK[_^:'U?GE&_6]74F[]NR0\!1>Q,'`L;?#.G!0&K60<5)Q\:*9GR`]4_`A@8W&!LBI:$K_YHMX'CCPD#FZ*EQ5@\$"OZ.9EO9= M^1T4"OQ%C^:CW.SL)OU&>__#LJ7 M0'(TQOW?P5X&2'X$:F:(3RF-FI-&3*BD#9@J11#(#)!3Z"XYT:)F>1,0>O1, MJ,"0S8X'N=>N M(`=[4.'0[=1\9VVP*$$X`I-UMM07"?.8N4K\$;\,1U/,D"X M*6`'<;&+2+(W:-,`?.XF.K4T'L^HSVL-FF)5\!4+\2X+6W-9Z*+EN,1-.]J% M*YKZ(>&3&*#7!1R=X:Z5,\-7FXP'J\)I&<4P8^PT8#I$X"+XT91&/SO^AOU" MF4R?2-]C.Q.P/N%J50GC\9_$HO7:&$B"][GD&9SEZ$U!F^27D`8GNA+H@@[?Z8SY'A3 MPEW_YN1I#-H\P).$3Y4/A$74^-#37V#YX2(%IPO/N@'@!L!?.P%.1A3,9#:# M\*!T0926^RH``]*M"$,,"4\!1ZY-V48"91+X,Q[62%\I#0,F]%LD_E_`1+C) M=`.@[3PU=J6+T:A2W^Q5,!W()#+7$F$I_$DEMQ-A]T8?5/J)_^1A34X\#AW; M,0,:K3QSX:FY6(*#35*2W9RQZ;)H:.;"$-=)-A&849'A85F`B!X>K#?>58VQ M!F)JPB$VE4-)&H62Y5%(*=',6-.I#K)D&3`-6`@HLU:?LFV*1"K@=M\\\.W8 M@@M@^3+S--VP`RL)EBC7'( MQQXXX=<03'TGC$!D;IP0W&H:8[*6$L^Y]?$PO=D9*@*@7GP M9_`=%=V>#;\$"R5"GC!RIC`$'_RN=%K0_P!1#F.A$THWIX"FC4,$0K&GFF)T MZ":T09^>=-Y2#(U^JTNC4$!QD(ZB8=L/SQ_U`&T+465XZW8#DAGEQWN$L)AY MS,8)IR`NYE,3))Q%8N;]IU*:Q@\"DMM/9@XO+''6"MQ"GQS6.4MW45F(A\H= MZJP3EOL!-Z*G#^\+PNC$@1&S3^@_CW$7H2B36?`"1^+B5O:C0YY"_M#9W`^= MQ`=U$IR@24@-/"KL;=P3GX"_.P8E`R-0E1#&>S+S']'=A<'Z>-3(DQ-BQ9EW M@KDY5(LY8.+"2"XG%5_368`'@K(B=A*D@:_P:RKT@%"T3M%EIOD!=+SI`-6" M(GQR7)=/*4S*4P!O.+'!2,;1H_(+"+#P;_KR1SQS('7!65"'*@L:3"*6"Y.+ M/]/KJ/RG,TN?#MKD;V)+22K=ZQ>,P-^2<8L#[RT"R4U19,--,4;WP!0-T,K# M:%O`>$'%44C0.L4<@N>5XT#?SX80JR*YHZ M(,,PPKK(9_3X`7MT(Q15=P9R:%)6V3U4)6_8OB2!.ZB\MF9)$U"PZ@: M40/!"YGZ2R/SC.HY2^Y/@B)L$I*R9GI7ZCZ`O`Z=&+P=,S,7*S8);,16F-L2@>LF'#+6+A*MQXRIBH<^/?\7.'.'94BTH_%@+LTV2V:;BFD:JJ9]" M9;.+:?X@N.)9S!+%0;B!\/O;3/<>;8Q=60Z+)"OT5,@IQJ:<&:;R)[NR`4GN MQ.!*F.R;H0K!XNX3:H?/2#0%>>HG"?#A%+=P@T01H"^4?';Q/0IW$Y*M,'PR MP6")2Y4NOY3M*)\JG^+`PND4`78#J[/A--]'QXJ=F; MVX-.MV;80Q4*5>HBBV^>Z(`TXSN/`FJ)2!=7Q(^X\Y%A&8X6KR3AT(G!;?DG2T52%/+,;^9SL'(I184QA%CW M3?>U,+R*B4O,+4Z)M)GWN,/]6=(Y:MX4;\ILJ1S5BH-[:N@:`EECY@/2W;`8M#)]MNTP2X>'36EF%B8R MVRR##$L!8\]B'YT(O/CSW-/3"6RCB:==X%M! MVB]XC@(-2L(K:#BML%.'5^+_LBLPX7F!A;+)WA\^',:(VV4\F18>Z?M?LS>R M*"!WS^FKJ:3/WDL+QUG(F66B4O6'TMC#/&R,5N*\Q-0YMLQPJDQ<_ZGHZ-%] MO?PF7+HW&:Z;C?3^%=.AHNZ:@3//?'&L]LU8PU(Q>/1T`M]6/=<,61.#@"7, MT/22PC!.E8O,N@B=9\Q2B:8A!G7AEN5<"KP,]0._8"FUHK@7:3LV)2O9CBQ2 MP(J'*S2-S+`[L@R[2UJWSBRX7XE+LS#O`[A2:H'F/:%T@X-)/SP>&]/,L!CF M[ERY]^>.I1AZYT3KL"8*9%9D61*6Z'7>@SP81VF4FG>T8=>K*']XGA;3,CF> M3SG/(^1Y8NZBX`HPC\+W7%I?@%>=T$J)"$]Y7^2.>S^EL($?3RI^S-669%^J M61N$=":P^0J5G5S1)$X9JSNA@5LL6W'3$6Q^;3ZW)7,-V,[>IHVO,+=YQE4S MY5<^R(S?659`DDV\>4!F#NAD_"%17[((HBW+\@4,[:0SG_*)Y=\#Z&3,J<&Q MTLEE%B@ULWS%'T<\[$'W:C`D@$D)+)46A.`92#VW:'%]"!S[@2B?:0OS(D/'%N"ZLY2=E; M8SD;*D:?YJSDT.5-?F(O8V"B&FJ?P5YWJ!JC;L,SV.OIJC$L]4O:+EV[-#/' MHLS*6SZ""KUT%(TKKL!YI/V<$M5ENLJE![(JID:DJ`JL=3MWN_H&0ZUWTBWX M!N>\Z2#551^QAUBQ4OOZR5MV$`HM/LI/S_?Z4`MMS*S<$1].A@8J29[XD9J9 M1^'1?1Y4@3PP`T1%N-N!QCTFA=$]>I[Z'*82GA[X!6H9Q.];K$6*DB,U5O$/`WA4-\B M%P`JI>69F']0RLJC^1X8-`/M0I+YK!PNB^<4A@6V"QY>[BZ44N(^C"`;1AH2 M6PY-I4_#1IG$#OEE%JF.VJ%QPH;!&VLZ86EJ6$@2N95[6(R2VU2$ZSHM*:1B)5;I*S)!U&4(<"^A MO%FZRGM)4L+I_BV(/-9C<\,6K,/J)'%#-6`2C762X+F_'@\:,>7Q1%M-\#>L M'3AWF.0&JMQ`E)[92TFZ*U\<7]R"RGQ8NI+X][O_3`W*QY$38XQVM` M[&)TR.*=MG%7(.E=GAT*D@:0F`!&Z4MM;&HU\R?G[<)483SR1"1>CE*@`TS$ MD+@N-7-7MP_.FF%51>P+/4URG4P*UF:SC;PEFCF:L;(V0S0K3"OW?RAORA`G M31Y8AOO2[6J25;]B:22N)LV9`#RB?X6%2[;C9DD!6:;#5J#..%-+$WU:3,T[ MCF%9=7U+A3=/2@V(.M;-FF/39)+`<24)W++Z1.S"@T6,LEG7RX0`H\6<-TL@ M'NT^"'Z.GQR3`7*1/+%BT.3@C9!E32]ULDG.+N'=(!;*F)T"EF^=R/LX/*-< MI]$V5EL\.7$\9IA4]'-@PCS,^E=2$0H#YD.@Y<;I.2A\=-G('@(?B[C"8HLQ MVIXB3'J(`J'%;"L?V]!0<2[=I[]*\=J>;M*>-D)`("ERV>-[&C"/"S8$RM= M*&RLI\H=3%L"DFQA%*/C3]B!A`]UJ>H=>Y5F91-9)[^'V$1?@)V=\P!V`VO$ MFX,AG1B8.[86\MVOG&*J(KXW?9R=N"8)$I/>J,5.M`$\LR)TCKO5DY`5DO-) MP+J`2LK`KG.IN)IAY;E919N,$LOXRW+\Y9PW:[C#P[BD7=)<,@UM,D=//$OK MDIA*2CU!5!JT=S2U)$ZX*<':`>9L"3!('@*3JJ.BOT_/_J)=/WA30=QU2@]4 M8AJ92Z@*_6SBV7&)+N8I>64US&5OA0HX;32.)S9WVX3$%Y`H9S;=V*;(2PY- MEH*EH;ZCN;E.PQ:KZ@]Y7C`5/O4$$5?&/Y3*@='3VG+5@&#CUIQ3MW048?T) M85K76'Y+8N]OD5.WO@KE*#/&VKX*V[Q-=NE9Z%7=F\]22K](9EK2\I?5DM#) MCW#R*`U;*K=H2*<6+`O%&#*R0OV)" M*R'-*`J<<1PE/<=`ML_]`,_&3?(+\*HQB9XP9YL^:;D9?E:HESNDA39KIM^M M&"A+&'>"G`"DX\/X%:B3BRV)37<"V602SV3;L,XIOE,Y68,\B?( M'6J<[$)0^9`?4+5@V.8(D[P$X;U;F.C+[73PWOPA[TY2M<:SRO%T2+1TW6.9 MQBFYI\IEU71&YE<\<(JVD(Z2""C&)QX>,#:;MK>A_:JS^U8]#<="8Z(T<`'# M/6'#/<'AGGA^VA6:=2^=@OZA!9/%O!(F1%U:]YV^ZQ'M(CM1.N]Y0;5R$P:*RJ2H?PG(KH$K< MLHFFP\TG-'/B4MHIG)*FI\R;S&P6WJ!4YHDT9B^F2SG,99CR!%*P--*CS$K, MI<*J6,.VO/W(GPN_FBXU-K9]<(JFPL'DTE,]YEEHL0_>68LXG/]`*T M3@K-?[+!%#O/T),RS"3%C<9*L1"*1V[]`)U/NNU?/KV5WX&MW!U,_:`)+33U M'WO[.1[=34K;\87AX\SA* MMY@R_S(BUM1S_HJYZ1JF5UI@'(VS/$-VD@AK(,3)P4;G_IC23!WIK+E?[&67 MIQT(P:SCW0&IY8LO.54^%`WRY#868.&6$Q]0[FC/L)J"`K<*Q8$K\$.[[+DP MI<[$8084R\()W\G,P)?)#&1367C@R?WUS;O='OA>X;=^N+Z_O_Z-WKW5;+,Q M!,D`[C_^?_7OP!57':]5_[WX^W]Y?G95?)#Y,]S]]K)O7]<7MS_"F\^ M[3E>(?.Q>;U;!"H#2FET>UCF-]00G_GD=UZ5E+],!HWC`\ M*(3TTDH"/-4[9,EGW&/.*:85E9WYR>&K5"DNT[IT\X>S\__WR^WU[Y\O3LZO MKZYO`9:!Z868Z>3!6R@_+C]??,3UG7'AM M\M\+KE7FB&488B*Q2MVK5%71<=$K^5DKUP?&!)83IB$ M(%@CUW' M8D<7(N[RS8;8;E#ABK">';=Q7S5=P3 MP>JGI#61Z_+84&$&PQ+\"N55ENN'K'#$L=(ZE:.4$VUI88=#D+(ZI`P9N M8$T77`)@DMD*.SS?YB)ON'NT&UNRS4%+35$.@``J"*MEWT$\4#6Z`').D45K M@DO&>`>-;>Z&880]'2*[>FU$F?J;[\PX\M-'#+O?O5<^7-]>?+Q%1^#J[.8. M1F+YKFO.0[($J_?*-;B9GZZN_WBG8(L^>,5&_W7E`%-W]M>/E[_\B@S1P1W> MX"@FD\(&=O_?*QB9AV6.;G&>RXRM(*7L,`.S(G_&+_R#CZG;`0KHAL:_WQB] M[Y8CVFN:*&ST>E^3&*T&6CAPDFC&_W3H?Q0-?$.:R,6Q*P*U0"["&G`*4-2K M0Q<9_9IDYN$P4Y?,/!QF&I*9+6;FO1^9[M%P,!_"E=9.2YGX:K3P54]WF2J6 MO"052.VTCU;)M^,B54*TG7P[(E(E1-O)MR,B54*T'H>"I?'L3G66+P*,LZS) MQ+*:\C'2;>+=N?JRU,TQ&Y]OKL$R5:M$9V"4E^W1$D"6Z1N"O!W6+N2W!+<$MP MMY,\"6X)[D-VKYK=ZZ+YD"LJ@8_9M]X84#%@;=E^/,;W"\SS^B-)JPAO:RA) MQDLES(\`YC)B*N%^1'"74EW"_`A@+J5ZR5$K-:IZF;,6V]6'(9GA6AH%Y%IT MZ2M;="6_X1/JZ'H@&X`TB0]A^W0L'00H>W4TTJNCK#M'9-RW"%W-/)K(K[CZ M^.F^\O>]NWTL-?1UD[+F-B^0MHC(E76#+>3;T=$JH1H._EV1*1*B+:3;T=$JH1H/0Z% M8/O/LCF(K+(]YBI;F40C07[P(-=T337X*2P2ZA+J0D"='XG'QU$+.J1\EZ`7 M&_12OA]V)9ML%"(K-%O*O;^JY[6I)\C+#KVG"6]4AHOYN)G'=2%`*3/J$K4#^E[4"F2B?',_T M+,=TES3Z0OV('?D,>J(II67Z, MC5P"8A'X&J2E"I_'9D3RW^'=V22D-\W-!?MU/@_\9V<&=V%_&7BY90;!`EN_ M\%'8@(3(I\UGPJD?1"<1"6:*9T9Q0"&"/^3ZRIPJ%62XOO?`[K/).*($!>31 M=Q_Q/:YO>F%^(&'E2'(#H<\.'$J`@YGZ)(R4`.\LOQU?[GB/\#MK>C,EK@U? M*#!:N,4)05-&"KX3GN:Z"\5V)A-X'"RL:&IZB@.WE$8Q)I89ARGE:Z8D?>NI M%*_B+N$7T.ZE,Y]#PM68`$XOB>L=&:C$!D-]UE_+26.'-?Y MFXDB!7CRZ%A,E)E*",(`!(_EFLX,&&#_&=N.949^<*I_)CD&YCE#T$Q)A%MP1`VL-#L*77W(7[Z1W+0U>>L,77.#+A5OLE MY57R&NK=L*9GE&#:&HJ_D?H5[[!_UGO6&.W$-1=^'+V;.,_$?K^QQ53Z_"#] M9*>CR7\,LH^)\U%"YMX(4]8(PWK?(`^ M^XHY8T8HFS0PJBHFQ8R*HP`YN-R`$"0N2EG;05FJTBGG',.>B:Y+@@++DH>' MB?&,O(+GF@TBJKL]HCAW=F(.MF9\`DKQWX*2L2!FP(=>P<`SCH45,`"UQ=I? MPMVU4F24ESI:4K6^H=M?GK,*IVT9Z3B2I9E"WRZ<,Z7N+DZ/,GRS!WVK%$I1 M$6& MI,"A&9O>5Q45%5F`QQ)\)1&X)Y[-?%.+!/`H=#*8^V23N0_ND/+D1,@XT.K. M@^.9N19^,PRC.-&"QHU(&+)(3#0-"&':,,0H$'@YY9#8:<&!`]_)0W!&]>*.39(J"Q M>&PL#O!^F#YP!\T'HH":?G10'_*X6C+F\8+^^8G`',-#+_A<7:9/./>#N<_\ M?!P$!L'\&.:#3=1)"NX"0SZ:@07;I/(.-KH0XSQC\L6!%QVBSCC&F#(L=5Z8'DM'QX">2 MW&,^FHY+C4"0!/`#R#<@U;>^3GV7REDN$9X(;FICKW8N0;R8&H<@(NDKV5Y! M[G[P]J(P`EF%[\T)!N9(G"H7CDN'MYH(D_JS&-C&D!`+7(%+8L+@898\]-!" MVAU^S4RH5`[.:3`]HONN;1=\YSQEMOU''(/O[(X:;VD;P$3'OOV`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`@G5] M'^]5`ED"61@@:VIOV%.'QE$#66#U7*_WODD]WY(P"APK2JK:%?/)#&SIM`OJ MMXC@F-24B?PRTNZHJWDED@\(R8,>MDIZ;7Y+I2V`3WWN>X]X%A9F'WD^GH;% MCV`_9I/N4'P3087=RSHIKZ:V)9(EDFM%LJ[V^WWX9_#:+!=%8V%7/Z3SJG>P_3ZTI#9O_EO M6X^^ZL"Z*"JN\!SQ_V`]J/@YY-/S4<\L8]X>'0WYQ,[LM#R MO0F(^.0P5WZ"("O8B,.LD*-XR'=V=FP(UY(9/<%VI42D^H96+HS]P"8!3>KG MDTPE_3NLTLF_WYST]&^P/\P&^W>U_0O!OO\1G%L6'6F%3GVER&J MNMASV!V_WUV\46QB.:!O0R3M9VW8'QA&-LK2^\K#N2#CZ-(+HR#&JW(N&_L8 M`DMO`L@JLA*6-$H=T[WR36\]#U^6 MYNY:AO<*_"X2L8)`.A?"L;:WEDQ=T_MZ;XG,'"D%8I%\<5'<7T^JH?>TE-8* M2@J4?J8%E]>3LP=XWUU:-WENNBZQ/RR2;)1[_P.Y#,.8V+_/?2\3:M>3Y(H5 MZL/(J8\:I-<@1SJK$,U3?_GY$PCFKC;H)8BNC;S"I+%\W3O<__OX#(+""0F5 M[LU*[N&6FLDX31?TJH&6=>\E/1G[WGR^<$++]4,0C:G9L)JQG?X7HT,_ET8Z M>O-SR1C=V^)55E2/L@>R##SJG6_[P,2436L+T!_86,.9>/3%],ZS-;M_BN'4,M>1-^-1$,5PH`B^>U;_G. M1N,?[^O%S@NX9/4>$7X_Q8/3G\Q0\;!)OX^%T.`NO1T3CTR>59FM$"4'FZW(&:@$"PQ+/E7].0[7N>B&!K]5F_#X>DMXF(+HS<7 MR7D0@"H%O'@"5@-V73!#WA8B%*R5P@:,O%2/A:2X:WV7A62P[.KFFR[,G]^9 M<>1GG1>ZHG9>6)J1]AW\W).UP`5:6G0XL"%K?X^5M[+65XSF#%(`"]H?96M: M1*D_%)E4V2^DG7P[(E(E1.M1A8*GI%=IRROLF6B90;"8^(&LF1&`O/87`C98 M4%`AJ?JJT3?4CC84GK,2N!*X.=IUM=/OJKHNBV%>7^DV6/A2H70OOY\0+96_'HR-/0!=B\QQ4R"_0OOW.:XHP<5E\X.1)!!\0BP51 MPGO;7GLI89K^K(Q-+`>S_!EJXJS&[TBML:,D3T!G8B]1IG?PZ-BN9/"1D7PVVD#M'O=Y[2*0)Q)ZA47J M6ZVK:GKGU0Y&%@&L@NC9E]WOO2)AJ#R:;LPZH)A85&5ZENQSN$=AP0'NK.TV M`?4>`/]"DF^@#G1--0SMJ$^%EY@_)LP;JM8#A=_1CQKS@BC\EW6L6V2Y'XEC M(DH9B"!^BS"E(A+L$NP2[&T#^\L=86",A$D@K%+T]WYDNHI'(L5>[J)RS&;? M1DO?@`5H^S%M.-(N7V?;FI4="1=P&W$OO^>HMQ$E["7LCQ#V:QH#BGRTP&L= MN5#3\%O:0JWVMHE56RNTD:+C60&A"8;CA?*O.MG957O]@:KKHR)?[3APO(=R M4\95O1AK'9&N]@8]=:@/BR-*>D3FFD(NMX!4MIM$.R;8T3^&7^CA`-BR%[L$ M\B[_Y_YL;GH+!IZAK@W>PZ]CQW6B!5[R0#P2F!',3#R98`M\H!ML9=H&+VEK M"0^/X(:_"7T@FM7^'&_"27733@5*TJJ`SB+@#VA)S>^L0Z;B1&36P@,$2LOL M&WOT5J_E>M\AIF1H3'R?X7D7OFN@CXFN&W\4(DQ0E;VW6S@;'F3*4K:BFM[[29&5L-M=;,O7"HB]I5$VW* M5O?4E,V(OF6G]#6IU8?YOHO=Y8H/YSFC_C=J&V5_@RK/_O@O6"O97Q_1;#D: MSK>\(Z-4W;%]HS];!WI>D]##@7W%8:BR@;"P^3W-:##J MR7VJ].2.>1OX)7;]7T6OO36ZIRW(T]]G67\G/%42L+MKI*,%K"#JI[Z=URKU MJ8-R&;7-PU[JQ7J9O>Z4C\)/$7K_&3R'Q9]E7I ME6-'IB#ZI5GWYH;`@#S)G:!^^HFG6CSF?FMX#!LI$:K8BEM%86]^%5O4(,_13\4_9D;LY$M4[*31C M=#IX;?XW0*G<`A*R[KR5!FF3_#NLM@(B&*DBD"?1NWOV08O8*UVL;]-#'R<3 M8D7.(ZNPDPEPPE6]-[N]]&HQ%.E%20RW/0XH2)I`@$V)/2M,X(PS`9X" M_[`T)C$Z$I?F/)#R%P7@A^2LFR$F5SP"? M)3H[=)L`.,=&8L[\V(L2&E?,<@B4.=8T>0Q'G(WH\R>3$$#',57J;X'X@6F! MB:!H6VY-(=QZ:V=/F+.HV&VEB,JI::=IT]A`)*39U9M%Q=L$!GKG/8(@_5-[ M_P,"QIR#('AV9O`TM^9V,UI/'76R8Q(3?<)$04++9@J>'!$$ M)%F"M$%,G6.&F3=ZQ>&V3V._F%53YQH"CM)_YKE&$$NSLY;JEUGK^XSSTH.E M#!KT MV=VY,NAV3C20&C@4!]_W>]KL:($KY9()\GNLP:!S0R]2N3Y@"C.DPXJFH)FF M/BA=;,&$#6/`HO@[Z0[%RS6HP0!*XB0@H"\\9>Z'#E-'B6),B:-2:@9:C+:( MR9$S\P-RXCI?0>BW5[9\6]>& MK3"=.+T(X'1X=&93FF'HC&3:@HT?9[^6H-/U>DWTIF@__1B')P^F.7_'1#!( MX(M4#MV3Y^B#ZUM??_[G/_[Y#T7Y*7RRS'=G#\"X3X1/N7?Q$;R@*']UZ:?[Q9S@+6\4QP;=9H*0L+\,M)/S,' MG%K.'$5)P<]!0F&]N3'37?_J,6-30=[AH.`&UT>'#$4.7G&%&`Y4Q<63K?ZE M]^CEU+O[EZX:?5V%)YS^].,J/B1\2GAZ9TV)';OD>G+!^_@!?\]H$^TSS[YR MF'L/6+]'/*3L7LW.3O^+T:&?2].MO?FY9,8<9.^[B^5NY%1GM+6[W$OUF4MZ M<*SO-)<,EEW=?..Y^?,[L-/\K/M<5]3NCN1@QEW(V_:\I=97-E5(JKYJ]`VUHPV%YZP$K@1NCG9= M[?2[JJZ+7VW:TM-!=YB*EST)]-*+3.\!@ZWR]$\AR'MQQ^=03C(<:FFBF0*Z$)OGH$)^@?;M M=UY3A(G+X@,G3R+X@%@LB!+>V_;:2PG?19B5-Z:G!6/N+&ABFO1[S-;849(G MH#.QERC3.R-UU.E*!A\9>8>"7_%[GAZ^"G[9S=]/6(OQRB%H$>PO$<@[H!C> MRVZC#=1N9R0\>R5Z1>R$][)(?:MU5:T-)ZX*ZQ\$ZC-N`@&U[Z% M!0>XLU9;1VHA%D"EY!NH`UU3#4,3_X`XB7F)^5HP;ZA:#Q1^1S]JS`NB\%_6 ML6Z1Y7XDCHDH92""^"W"E(I(L$NP2["W#>Q-*O4D^,A:71@C81((JQ3]O1_Q M;HKV58S;[]NX4+KZOLVW-BC`MTE_6[SGJ;40)>PG[(X3]FB,#6MHY<,\N M!3=&?CFCG7Z<72L.Z.M+K-Y6VK7:4;+_5:Q M&6H<^<&"GD24=/WDM_%*`.P?VM:V=PV,-2>KKJBH6M_J+I-V#?6VR[UPJ(O: MU@Z%>JN;VLEN(-^R5?&:U.K#?..S[G+*M?.<4?\;:)=IF/UM>G;VQW^)F6N/ M]A&;$!\-YUO>$DTN7\&7;YWAR%:VJ10E/+VO^[6UI_6:A!X.["N.Y9,=/(7= M8&]&@U%/[E.E)W?,^S`OL>WV*GKMK=$];4&BK#Q`]B@!6Z&1CA:P@JB?^K8^ MJM3/'3U(*1]B5-D1>I,TO,C/SCGF78`F%W>-6UM5ZJ9W.A(_2_/%BVPD,E^6 M?55ZY=B1*8A^:=:]N2$P('IVG.U,)B0@GB6[4@EC)^ZF2CJG;2CQ:Z#U^9_`Y3*+2`A"S];:9`VR;_#JNL5P4@5@3R)WMVS#UK$7NEB?9L>2NO( M:*&Y3(`3KNRTV>VE5XNA2"]*8KCM<4!!TN1*%=+?7JB9UCS77`!:_=S65W3O M7HJ=E'6'3Y;YCI\>=DL>G#`*Z-6WN!+#&^*9+M:$%RNWS\)K;V7%-OP=>PZ[ M\O>[BS>*32P'X^PH0K MYS#GQ$NO#;^>!\2&]\"G/>K?>X=7_YZ.(L9/."^A8GJV4I@XEBL4-R0&OGGT MC1:I?^/@[J<$YG(V-[V%$D>P_/^&.[`S0$B"1\>"/_R)8BHAR"(0;I9K.C-@ M@/UG;#N6&?G!J7(YP>L#UCS`@]\>21#"_4[$=T`<#RZ`'P/B,FY-G;E*W\%? MS"9HJ&N#]Z$R,QU7H3)4F4]-T'$6@7%9IJM,8G?BN.X,\\32T3WYL6LK8]QT M(:EK$'M`"8PZ(',7[J=W+`]=>3*!NG%DPJWV:>M$>[TKO1JDAR9-*KMIS.>! M_PS"/"+N@@YQXB/"V!@+YM7WI:=_KWX?XG._7[*I&+V\#`^?1TTD7$NK<(]* M!P#[2+P888T+"L`&:+:52>#/%-^#Y0?#!HT-B^XVN9#^1I=7\B.[MUXZ.LMT M^'&0#7<"JXD*#>=9F6%AO3*'Y_FV0K!T7L$R7<7HJ$BD<5J$VO:#K![<9U\Q M9SZL^&328E(U*694'`6(&"4IHU0,C7ZI@S!#`08*&,242J><@9"R(&?"A5S#PC&-A M!0Q`(R`K*:MJI<@H+W4T4FI]0[>_/&<<=SA)%G$>J99:0CJ.9&FF5(3TG.E+ M=W%:>'3K5&'FY:RQIPO.P:7W2,((#0/L9W5NAM-?B6M?>O6N)Y:W= M^_"96=Y:R?+NK_8/3L`JUSM]&LO@?L+:MY==A#/.XQMS@?3"#=S-R'7ANG!" MR_7#./BF]EF#1MR'0CAAVT?F+1!2J-#N"XV]B1*PA7%]DQI;+P< M]XC\>56(G/=,<%&DSWFJGK,)?TW MUG>92X;(KFZ^Z=S\^9T91W[6>:XG:N>YI1F1S:O:V=)%X"X^JZGMY7O/Z8?1 MJ4KR=BO>RG9,LGN@@,34G2@F(#A%$;A_]V#ZP>8X=:NE*YMCSPYA*2\0:^CPK(0GH\2ID<-4_%S1UMZ M[-X.4]%LH5VB0`,R-J/7ZX(E;KV28#R4W2UX,7"_JVJCOO`,E7B5>*4&WT`U M])'P_#Q\=?HZ_FF0R]%G&`Z5>9*E_W^EN]I"/T!0,=:L0]`;Z=)O?7WR)%ZE M`]L:C?LR#NP\\"#56EM)O$J\[F8# MONK6A0AP%42Q-MOZ9BF5VL>ZVV.VI_9-)A2,V8?8@;(92=$/4N.ZP>E^,A2JJG[-`IP2T.=R6X6\S]PU?2S?K@K\]J M$>RQO5MV"L;A;T@F/9)>I;K:U8=JQ]BG0%7"7<*]97#O]8=J3Q\>,]A?H5-O MX8_&.N>TZ\$U37BY%PK[]VG/X;5QV_7.P4&=A,[?Y!U]YE+CG-7(VMS\:?72 M6.[8`T+F[,/5QY.KL_]>_PYC9ZW%EI>+'473=ZP+V:^F]^!X#]_<*BH16X71 M5/2/R@0<(S/?,&JYHQ1M[@*B]>2/VS.X>AP0\^O)DQ_8E<]^LT$>I7VJNOL^ M-Q$55:@NH?7_+JV#+21FPV/B+=+@?L7$?H'8\8\\$RNF76&+/08WM;Q[L9Y6 MA78_)YQYZ;)U//8/7;;=/)HV349I5:ZD5"[1@UVB(J[1CV%$6XK:6;HU[PSM M/>#"A4^DF)T-ZS:G&A*5_@X<.P' M`@981,)ZEGES*KX]K37W[$-9;F=Y3V9S/S"#Q<>_8B=:W%'.7L=1&)D>#KCB M\(#N%ZVR7^4PUW23(23?=_/R\Z'UZ^_LL.V[`$H>P#*'H"O%'5N9_.40^P3)WL`'BYO90]`V0-00&*.J>O8 M$9$J&ZRUDV]'1*J$:#VJL,4]%F0/0+'(D\W59`]`"=/6PU2V4'A]A2I[`+9? M(,E"=-D#4.+UF/$J>P`*HDYE#T#!S"P1R#L@,29[`$J\2KQ*!U8P!*/%ZS'B5/0`%4:RR!^!K22G9#^TX^J')'H`2\\>&>=D#4!#U+GL` M'I?C(4JJIVR3)L$M#GP"*\>":)ESV`)0-QF0/0-D#4/8`/,8E*N(:;64/P/9TZMN^9UW2[2Y\LLQW M'T,K\)\NR-P/G>C""<=Q$)(9\:+P%GE#['N?MF=7+>^ MW^\N\JWZ.MBH;]0=@COQTX][CZ5`S'T0AQ%O6?C!=$U6A;[M6+6U8QWV>WHV MU(HW%4>RH>,@HP#9PG[:89CZY@:(0V,TZO>2H>XXE'(SQ'/?PS8,;$W>.N'7 M&Q+@%^8#T;9I?_CE'*;*!XW\&^V5%(?XU-_,/_T@^2$\>W;"$I5&CLIY')`\ MC?J;GSNG6C?#_KHAUD".?N]K^A>#?=Z/G&[=Y%#6_D:"!Q)4]-_5F&V,[1V39WOAFJV&M7JM0W'HO;R_D],(8/QA,WXQWT+?Y*$*^[V3E\^]! MO3%V;_F>9FW7>EE9=BO+=-7O#F\_X,K6H->>\A_3BT&H*GI/57`YJ8KI*6_Z`\F:%"N]Z`H>1X8!>- M%_1A)E@_#WD_!L?G/IF+Y/%W\5A5+CWK%$9"B?D/B"*R`%$0H/RGBAL?]#3U M77>A^$\>=FN)QZ%C.TA(T4M2WN9&FKTA/U15^?7\_$Q5;O#_\,D!F8/^0$&% M;A>UVO`*^EO>`5-@^L[F@>/"]+/)6YJ;@-HOOC-*%P)]+DV%5$!6 M>J%)K4&N2F=S:C'@[.$=&6-05!+[5'R,M6D]W("E%ILPNX#7PG2K.70J,_QH M,W,=>4?AS3`$N(E=Z@F`:4]!,R9@\>,7YI:(/44@LG4'__Y`/#)QHA`7@XT! M61@`CI34):4@[(R*W7A.QK@W>AY05<,5YD4J<:1CV#";>A_5._?I$?"CF M`PB9!PP:3$SP\QY--Z;3^:\Z*1JHO2J"WF+;:XP^/`)7F4ZJ4%XWYJ*LWM\K M":R)A&2%N9(%PP97 M#Q69\1P>F#:3'``"631;]G3*Z(2W^ZTAWA6-F:.,N"EQ4)AO#`+89+9;HGF5 MCY,)6U]*TF09#,7$TJ;LH,/`:.+:^8"+_0="C41&=/EZ/DT9ZW9;=]7K#6DH ML-8U M6S4<*?A@"R-D(#*EX5WO6.^9J"HRS?$L-[:I35`I(O`D#L_W3ASJ9H8`20)V M+T+2HX8PF+2.1T4O[J>!_0,^'=HM-AFG\A'TPMA!P]GB0IR_"Z4TO0C,;C(Q MP:A78ECO8,C$8-;D'G1:*[1Q'A+$PH#'",6YZ7`@:L/3WG?KM-P$W!7`:#@] MF8#H@E48XNB1OA^HR'NV2$B%T[]HTPW\I[B_H-SG]%DR!"[8V#SB>!9L%CB7 M)BIWZID/2V^!J2,81>"[2PY1?E!T MR3(_G+T?'E>KJ:2IHP&82X.BB:&"F^4`S6EL@(^!_Y5)$B;3DRVB21S%`6.) M@BP)<0IA2A_`K0ORCGT)AVA$VDY(X_+P91PR6"LIU`.VRS3AUEORYMCC*CUB MT18K`)L=KG;"K\DEN5TEH47"5ND9XHVZYGP:$9^EG'.S<48-FM3:*8@B>(SY MP$)5W%"UE;)1H"5>2E=BIM:1VBLF7ZJAG&$"DQZ`7PL#HX_;S'JGI3Y31T1!TO$#%*3DGF* ME=ZQ1R+%S?(95!H@<$(:,)X'8#,$CDOCP=PA+UY,99@)#MX,_`\E]U8'EN"E M!U>!BWX3@[5FPPYFA,IVIE)=$$-76[TI@#$&DU$-TZ[96& M0'>:\+USAV\9V0U(S<_^(W/I^W2%]4L^<$YI<29J-OB@DL7(W`/B`L*GX?X MB(?X_\T,P%`T-*[CL07*ON$Y+]/=.0;?D8B+Y M8=D^#`D)$X"M0A)`I8%NE=I7]);\Y2&((<^NO!Y^]O(;5RM`BG.6 M!R<,N#A[N4D#1-/MVQ#)I'&)"=K?N&T:H10U,5K-7XEJ%40PPVG"1DU![0X?ASB)A[&E?"RTO15[_31 MB$\ND(.3K&8_9WL?Q&%AH"5^E@#]5^RPN#X+&XTQQH'1*1:G8C$AA#!R@="4 M/R6)W0%DXH`;18QX>&+F9"R_&MW1!5)HVBCXLK`+QO#GN"1@EG*^V*KXVM@W M`[I+8,/8K<@/:/B)[W#Z+J$QFX"P^:DC`)^/?"51I9#%T)R(R>3\\L/+^/#- M,1HGZ&'Y'FT7S;>=3`!_1+=3>(@.YA@PY!70Y6,P%H^_!5!/ZD\%+(UA;;.LQ)$3Y#&-2NC^H M^+;1072Y7*%B)O4I$\<#@*#&+<=H/[`+/B47 M%!(H<(?#)5P)L]0B#T8PC])%H*O\^P9B%KW1J5XR>#&C'2:!)BSAYR0J0^S: MPZQ:1;CDG.4^X5'SR@WH8Q*@9$_\+S.-!:&PZY7$;D&JHEF@LK04,UW'R#&V M_M5"NU?ZM"#/5 M85[5NL-27:Y8"`.59JX8`RK>=A:M2*Y3E>E^67WS%%N%W#L5E^&C$T3Q\HO6 MI/'ED+IK)M]+)?&-=-Q?JB^%+UT&0,H\!@<:]XKJ#:B.^JI>CF7N.63J!9M) MWE).#J`!A_8C+%6:6)0E"23)#R7>,KQE^SU@`EK@@`4TFPO=!V8X8-`1O;0D M:A=5Y'2HR:9Y`8D99JCHTG""-8P7.B%#44K@.2,PA1RCB))*'51.K0V>+?I% M=)R)CQ@5A\E'6%Z2:M4,E%%=[][/Z6#9[J[,DJ6SPQ/J,-B+#,!).E5^1Z&/ M$B!)5RM-,5>H-D'Q3EG-#7O<>J#97#3/W,(=!$9KF(LD)Y9K3O!439)3R`$N M("[!"[/B:]4-AMHS='78&R[O`*01;NHPFR%-Y@$(VS!]C^#1>*E-7HGX,$OQ M3,+5!0$IG=T&G=VR&[.^5-KU38_Y+`[;!X,EPITCZIS4O<6QO.-$Y<*&+'?$ M)-V28I*ND:VH0<56%-L(2F<4E[W)DHTJ]X_H:K',.&1B8L97[H:@*M6_5D4_-_Q?7(KYU75K[.K_+@,K=7F"NZD%5(A*S4D MPI?:*-E>*3$#UX%UY*]]0)#SH= ADX3.ZXKF^92WDQW3+M/MB>2(?B5-F!%_*RP M8PRO9%TV'DEN`&%EI(^_C$8KZ01D6]UL`R%)K:S=4=75;K>GZEV]0OX6WXPS M`XX/(/1O-BGI^N#'8R@@T?D&'MAL*\S5TQ)]RP^IVQ-7!V!M=;I%DU7EN=IH M(M7\.DPE&/:TXE)COJ3_X,'D<;QF&Q8\*8\#'RZTFDY\*!-S'A?E#07TWXW!K/774&]47&%HQTSF"FYKS MCMZKR+]CNTYT?Q\&A0$#IH'*^K5<8%.&%U52ON$[%Z$)N]HH4ICIO1Z%<$*+_2F7= M)NFVI"+A[J*&%-\?::<75;'K5HU_JJM9ATAJW5:="I[&;15>>\5S!QP>D\<[ MN*7)09R#=:58J%KE9IAM[#%I8RZG*]#APDLG#L9DBJ/-]M^17L!>OP,*89&* MY.7PPBHI@W"G:?UT\Z'Z'3:Q7!.'1-("7?Y:36?O74%$"#_.S`CNRKLMLI\.DKL(N,\?SD.I-+CR:4OA%R]YI(= MBE($D$7%?I9'Y&""FS]F\9=<6M%Z-J73G,XEG\&I0)*3P8V5R\<_8*PE&OMF= M]:C"-CUI6YYWXA/V31VH6]-Z+ND\ETO@V;E+W:I%?K>8C7TW/YE#8T/CX/W; MV172,O.U;VGF:JXXCJ,4ZPES9EK.0UZJG2QL:DQ]7OB#V6+5#X!WF4R%F_7N M*A039=:6GG/OZ*RT!UWNJ%4Q02K;NDWHR3R_1@L>]:&F]GK=/9W`(IFES+ZM M]N972+)D?DJ3DG?I\MV!A7$Z*S($#Z,S<4L3":76.'2M(87^'EN%@Z':'6JO M(_23,`S;=JM7)I_VC")1:7E0;C^R-/Z$*S9-Z2_/>]W!X8ZF=HSB5NW>.J-U MC7_72V,NOIA^:U0T5TCC"L&UX:R$O43T\E%3+1':9TVN"TU31]VA:O1+(@FC M:<4>9*LD380-_.F^4HR)F4E'(!ZY\V*Z_>=/]A=R&*FIVI'92?2I-%&`]F.I M=[O=&(`E.EB>/&HH\U'2*-)3X$2H:-9.)L\=4^:LAX+/>R@48TXT7$6S,R*L M6[3\,`K37=JD)6J^X94?@<-?]\9X;P"4]TM[6(4X/\I$7JO$QIAL3;"_5LZ0 MR:*+=IP,7SG+]@AN\"[P77@IT>M+\/+!8(.=3@;;?\M`2O362G2Z$XJ=H-AF M0Y*+2$L+>5EP96\]GRZ3<*4T7-&PN$E[MJHN9L76+),.M-E`91U#L^.L;A2S M8A,9]VX;[QFC=5:7U*>[Y6O*+0M^3:Z6BE72HW1E_*]U'@=EWVPYW>9E^GRS M@'L.4_7&YBK(W-PQ+*2$ M$)54-3952U6RJ&>P,.GV927XD]S5);7`+?&DC*18CLWS:RQN"RDWN7S-U-1. M'I2KGLI]76E^EB0?#J'AXH5<,Y%<.T36+(-.1YKHQE*"$)@MFH5_N4W\`0F%L8H6+[ M5"[Q)*TD?8AWY4A2L,JSQ546C1[R`T3I=:7M)HSXE"5GH>TOPSSKS@NB/MEG M^"LV`PPZ5N>7&F7_LY`L-?/MK%DZURF-]\50GBB<*."=:W2$>,U(;CE*CZ5/H59)%6VDBXU/FH/,AG2IG-",71ND6 M+/]&6@\81D6RY@IKK)")^`+1_:5`M9.V9^41G)S(5;.)3?B?U^]>[F::9UJW M[5YYELE+SUB1QGR[%7;R`W,A*KJ#ER9G>PN#3W(A;3??%C)I#=HJ/XC-5ZLI+4[;6'$0FZ8MDL+LQB[<\4>K$]#B,@I M^F0\\2G_'OIX$"N$2L/I)XW6F!+\=H[K+2,IS[893<=K@GCTJ8;H*I7B=,[ZDH M+K2/K&@5F?A>1>`F-@*#[9]^4@U3N&\)P4F\B8;@)(P/;/]E,[;7[+Y4H=VH M$^VU.D5+NSRU]>/*/_B^M+@JM\,+NH%M\\`$8#R='JV:N#KY>(I*\W/SAP+U M.VLSII(7Y^+Q^8"[.4$/FP^!-=_&0(*%%;4#ZDCF#M-K;_^T*DJDK88-P]O50TJ M5TOGSPN=PR+:"&`>^'@`$HO04]N394$LU\*NG)53Y6-:C5*5@HTL#\*I,R^' MX99+I)9V$'GZ`(N$T![!Q8.CJPY,#&D)3^!8;$LQ];WY(27\R?F0W:_^$WH, MZC(HE2<_=FV.75JAT].VX6`1_MBU(2O>74,VRSI(!Y]C'G5(J9]`(XH)R))+ M5K.>X:[7W7G4+0!>8S*NT0@$[HOTYNB63?[^YZ6A?X'\8!K_W._TO1H=^?J,X M-O`"?6+[RU#OO_FY9'G);._M4KA!P/C>`_[591&N[(N:;9OLP3FF[_+*-IO< MS<=E:HBW\5U%TU5R9:]L`7\%@N3>YD5]#V%T%2 M4IOVPS"?5W0-,>=SL"_HDO^%GB.)QMV996'[)YON:'`B;E@M$(Q$>?O+V=G- M#^7->M>*>7<9GCG(NPMD.[\A?SO=(9'5K+6.]=KCY[#HO:I<"JR^MK/*L+OT MT`O*K316BSW&^(E\A1.G/IX7CRU'5H(M1V/.JY8/O@?[!X6K&@C15\,'[53Y M5#@>FW8A`GN*>E>/9H!GC"PML<(&FT>WIYEA#(/%M(#?S(4R4I,N^\RJ"E>L M=HO:N#QQ)R`NMB7$)`)F.O*':7QB^5PZ49A4RMO;308]1>,D.T:#I<7`8FX=/A"ED_?HJH$SSN\!%@;^9 M2Y-,$/646-1QTUQD50#IWB,FOQ/'DP!O[BA))^3,+:*+961@DU-@F\W^,:>L^M&2H9<;ZQQ3E-+ZF$MEJLL/HFBQ]-8PG6":)KPO] M.`!SR?:M..N)PNADB]/D9UAYJ5`H-9/BBX0V<&+:;!_I02>K>2TXM MTK0/5T@JA$/N7GD:R[&>QM)I M1_\_(S+N@^##]`=ZY.%[A5]Q]?'3?>7OZ9257IC>>7Y]=75VUP,81/Z,7_@''U.W MD\7)>H/OEH-.JW&V.9+UFL1HAT2+\=T;1#A@$&"F+Q%VE\J[MA%V1$RBWEK; M:#HB_K27L+V9E-\,D.JJI4P4D)8-*ZV\==4BRHZ/2^LS^`0DZXA8=!TX#XYG MNFTC2RJL`\!F#;24(P0=^A]%RUQS8:C=L!*3$%(V!8:F9G_0O7_)7\E?R5_) M7]'Y*Y6L,,2TT)@MQ-J7!8(D%4C5VT>KY-MQD2HAVDZ^R2!W_>8,*V+H/ M9^?_[Y?;Z]\_7P`3+6LRL:RF+)RSY83O/1C\LH3.'-O&W?D76[>"\;&"O'_M M017M[5E-ULW9Q<7EYU^2S(9>DG6R(ZGGUU?7MZD5X?=OO"< ME<"5P,W1WAOH:M\8",]7"5L)VX*\U?6.VNGWA.=L@\`5Q#BDC%M(B5C M@J*0)WW477U40S?4[J`K/&H*!R)P]?.M01@5; M+:.DWRK]5@E7"5?1^2GA*N':(GX>OMW7;%3PFK=42V*"X3%;^B*0)UW4W615 MMZ,.^S+=2J)6HE:B5J)6HO88;$(9"VRU@)+>JO16)5PE7$7GIX2KA&N+^'GX M=M\+E0WS,Z".V=`7@3SIGN[HGJI=0U.-OJP9EL!M&7![>D?5=4-XSDK@2N#F M:-?4GM95AST9$WQ]VU#&!%LMHZ37*KU6"5<)5]'Y*>$JX=HB?AZ^W==X3)`> M\DZ>Y\0+97K@:Y,G/=3=1%6O/U1[^E!XODK82MCF(X(]0^T<=UA%!/(D;"5L MVVD5RFA@JR64]%>EORKA*N$J.C\E7"5<6\3/P[?[FHT&?O8C(K,#Q2!/^J8[ M^J:J-M+544\V89/`;1EP1]V!VM=D=J`$K@1NVX`KB%THXX&MEE'28Y4>JX2K MA*OH_)1PE7!M$3\/W^YK^DP1FY`91@.5>4`F)`@(DN);7X_9Y!>!/.FK[B:T M=-7HZVI/.^K<%1'(D\#=,\J MX2KA*CH_)5PE7%O$S\.W^YJ-#/YA!H'I18KKF&/'=:+%,5OZ(I`G'=3=9)6F M:ZK1.VH'503R)&QW@VU/&ZJ]H8QB2]A*V+8+MH*8A3(?^;.9[,C50!/*D;[J;F.JJVJ"G#GOR6!$)W%8! MUU![O;[:DQ'(DU[I;N))ZW74SG&7K(E`GH3M;K`]$9ZC$K`2L!*P0EE_ M,NK7:MDD_5+IETJX2KB*SD\)5PG7%O'S\.V^9J-^=Z8K3Q!^;?*D.[J;?-(' MJM'IJ8-13WC62N1*Y.:1.U3[?4/5A_+(&XG<5B'7&*K=CJ9JW:/>;1'$)I2Q MP%8+*>FM2F]5PE7"571^2KA*N+:(GX=O]S5=$1Q&BC]10AD3?'WRI'^Z8V2E M#[[I4-6TH?"LE,R&OPCD">"Q"H'5*C'U5E,UHZ-JP^X/PO-1PE0&5G*T][L=51_*O$$) M6PG;=L%6$*M01@-;+:&DORK]50E7"5?1^2GA*N':(GX>OMW7\%$BEA7/8M>, MB*W89.)83G3,MKX(Y`G@H@KKCK[5.FK?&*F]KBXC@!*GXN)TJ(Z,@3KL=R1, M)4S%A6E7'0TZ($V/&Z:"6'HRPM=JB21]4.F#2KA*N(K.3PE7"=<6\?/P[;YF M(WQ7?A@J)SL)C]D8[I]KHJ!U1$E+RE,'7? MEY[]O?I]2`)G\OW2?&5OP8AW_/3=OF?Z?/#])/=CJ:_,<@^YC, M\4\_AD^6^>Z6A)$9D1GQHGOR''UP?>OKS__\QS__H2@_Q>')@VG.WUV0>4`L MQXP+8 M,+NF%3GVEZ$^>*/$GL/N^/WNXHUBP[,!NR%2]+.F=P>=SD\_;O'N;Q^FGANF M7AKF<.TP]4Z_L^,PZ73?65-BQRZYB\K/SE!&'%&V'<).\)[9%7* ME#UF>O3FY])"^NWL]I=+6-$`6_B'IS(S&)>%A^Z_A,L"[:.E`#Y$>(L*A'\3"838L%G?T+_ M#-/9I_V7)CC_2L`9H*0+(E1,>LL%L__,/U[<7'VY,/U_?WU[^! M/AJ1<=\B2+L2^JYC@[IB5UQ]_'1?^7LZ9:47IG>"&K\ZN[F#85L`$',>@A:[ M!O7VZ>KZCW?*HQ,Z8U1L_.K[ZYMUP^`E`$L7;!33"7]0:^?F8J\8AD6P`G`? MW2_@1M5K$E.W5?VJM!C?O4&$`P8!9OH289FV:1MA1\0D:@6TC:8CXD]["7O% MD+M45Z_.1`%IV;#2Z;2-+*JP#P&8-M)0C M!"P:KVB9:RX,M1M68A)"RJ;`T-3L#PPJ2?Y*_DK^2OX*SU^I9(4AIH7&;"'6 MOBP0)*D-Y(!*B$J(2HA*OLD@=R/FC&`)=2LZ1_@Q9C0$8,@ZCS0):'<&'TS: MF0CD"9`8V:KFAIJJZ7UUV#WJ]H8BD">!NQMP>P-=[1L#X?DJ82MA6Y"WNMY1 M._V>\)P]_*)#V6RBU3)*ED/+VHP[Y,MY*HE:B5J)6HE:@]!IM0Q@);+:"DMRJ]50E7"5?1^2GA*N':(GX> MOMWW0F7#D?5=4-XSDK@2N#F M:-?4GM95AST9$WQ]VU#&!%LMHZ37*KU6"5<)5]'Y*>$JX=HB?AZ^W==X3#"( MB:V0YSGQ0ID>^-KD20]U-U'5ZP_5GCX4GJ\2MA*V^8A@SU`[QQU6$8$\"5L) MVW9:A3(:V&H))?U5Z:]*N$JXBLY/"5<)UQ;Q\_#MOF:C@9_]B,CL0#'(D[[I MCKZIJHUT==233=@D<%L&W%%WH/8UF1TH@2N!VS;@"F(7RGA@JV64]%BEQRKA M*N$J.C\E7"5<6\3/P[?[FCY3Q"9DAM%`91Z0"0D"@J3XUM=C-OE%($_ZJKL) M+5TU^KK:TXXZ=T4$\B1P=PRR](;J\+@/:!"!/`E;"=MV6H@R,MAJ"25]5^F[ M2KA*N(K.3PE7"=<6\?/P[;YF(X-_F$%@>I'B.N;8<9UH</%9$`K=5 MP#747J^O=B1P7YL\"5P)W+;:A3(>V&H9)3U6Z;%*N$JXBLY/"5<)UQ;Q\_#M MOH:/%;FY/#]FXUX$\J17NIMXTGH=M7/<)6LBD"=ANQML3X3GJ`2L!*P$K%#6 MGXSZM5HV2;]4^J42KA*NHO-3PE7"M47\/'R[K]FHWYWIRA.$7YL\Z8[N)I_T M@6IT>NI@U!.>M1*Y$KEYY`[5?M]0]:$\\D8BMU7(-89JMZ.I6O>H=UL$L0EE M++#50DIZJ]);E7"5)/E%#&!%^?/.F?[AA9 MZ8-O.E0U;2@\:R5R)7+SR.VJG?Y0'76.NK92!/(D,"6IJO]=1=4,7GK6' M;QO*F&"KA93T6J77*N$JX2HZ/R5<)5Q;Q,_#M_N:C0G^0CP2F*YB>K9BVC/' M<\(H,"/GD2CD>4Z\4$8*7YL\Z;7N)KT&:K]CJ-V>#!1*X+8,N/IHA.`5GK,2 MN!*X$KA"FHLR3-AJ&24=6>G(2KA*N(K.3PE7"=<6\?/P[;[F+/XJ._#2BTA` MPB@)$AZSX2\">0)XK$)@M4I,O=54S>BHVK#[@_!\E#"5@94<[?UN1]6',F]0 MPE;"MEVP%<0JE-'`5DLHZ:]*?U7"5<)5='Y*N$JXMHB?AV_W-7R4B&7%L]@U M(V(K-IDXEA,=LZTO`GD"N*C"NJ-OM8[:-T9JKZO+"*#$J;@X':HC8Z`.^QT) M4PE3<6':54>##DC3XX:I():>C/"U6B))'U3ZH!*N$JZB\U/"5<*U1?P\?+NO MV0C?E1^&RIP`>5,SD-E]HK/PF+W1SJDV.FI'5`3R)$+7(K0C$?K:Y$F$KD?H M<6^-Y(VZ'R-S[)+\@Q+2SZ\^GMV^@RF>%@DLTU>BA`YJ^?55?]"IQM<#(P.; M!/]^`]3QMU,BWVF=SG?O%7K-B6LN_#AZ-W&>B?W^C6(1UPWGIN5X#_0^_'MN MVC;_.WU^D'ZRTY'E/P;9QV0F?OHQ?++,=W?6E-BQ2^[B<4C^BHD7G7GV)R<( MHUL21K@??(?_/X,?PGN\]YX\1Q]]1Q)$#ES]V8](>!F&,;$5R__W' M1_B_W\AL3((X?##->>FG^\6&CN]=3Y(KBM1WM"\=1OF]7^N(I360=R(#>@U!$M"\W(GU?Y MHW]<7MS_"F\\U7N.MRPUX6,8!;[W@'_U3ZDPR+[80U/\&8>1,UEL>%,"!MJ. M*D7"+F]O5)"_KY?5;&2K%51M`]X#[&\4TW4>O'^_R3,.!S6!)9B,JJ#DOR\] M[WOU^Q"?]/V29L]`\",^;8GQ)&&\XH2*&2H3WW7]I_!="R:H46;FUI-%L`#S MO4*_NOQ\\1$'W7'`M.(+FXJ'9(CLZA7BZ\/U[<7'VQ28_S,BX[Y%<#*4T'<= M&ZPU=L75QT_WE;]G<_C\SHPC/QW$H/==>C=8LE=G-W=`BP7L-.G5=(6M'@JO@EFZ8+/T7#4C>P7R$B[L;@!_NQW?[=?LCKTF M,76XEF4<,Y=)T3+P"$.M`4L35@'@%*"H+Y$.%B?)R#XZ]6Y.\^O?;;R=]OWTF1`OC5F?AJM!0LA66!($EM8!-70E1"5$)42%4H M>!.A*FWY*0X\)XH#HBH3YQD_A$7__YAW)$0@3X`]LYKZ7C2S;Z:I_4Y?[7:Z MPG-2`O7(@6H,NJJFRY8LKZ]CZ\M)K=*I5\0,R=1W;<69S0/_D>W%OA;;1*)!BS7WX"FA-V-2/!O):1]7ZKW9(JPB0%T2YUV?& MU1Y>/A@[3@3R1(OP">28U!D)!`<;SZ#N2P=;XOTX\&X,NZH^/.JCZP11Y,'-]C!W/._"!R_J9?'+.1)_V:^OT:87R8M\:HJXZ,UVLJ M(Q$N$=XLPO5!1]4-XZ@1+HAVEXZZ=%P$(' M2C0E2N@\*S/X/0EF:SK?9"U>OOQF>N8#?<"EA_4^SB-A3\KW MP,$Q18ODH&K6E.8ZP'\C/1\6*YKB&&]^/@?23,=39O1IH>)/E%_/S\]"99:^ M5P$\$WBM#>Q4S`>@YP'`C%=J:J_307"PUIGT;C\.@*X9@`+8B'ULWB).,BJ4 ME`R%T?&#JCQ-'6N:/.,):%#FKFG!"V%@)+0"_XDB*8S'?Q(K4B(?AN1B\B]> M$$UA@N%#&)FN2S.`\2L_?I@6P-@[Y8U]-K*%,O&G_W-R\LGWH\\^D'H';\7E M#(PZ.4EX[#K>UW<3N,2#2Z[@#^69?A7XB-UI%,W?_?CCT]/3Z?,X<$_]X.%' MO=,Q?L2??\0+W_#K(^#-O]\`#.@">O,S/CQY/&"*7P5$`DC^A[.N9XR*M\.% M9N0'R9>N.28N_?:+]D;YD0^Y/.@=!IS<`B^8N?!X7&#$._G]KC@,F$G@OT5* MX_CT&8;Q\XVYH`L=V&>B`)F10"'/Q(HI&``Z")1S?S8WO04PJS#4%12#/TKEA7\%]&V:!7_'C!!APDLU&>6I7,JS;V99A MQFJ&?2.YQHN1.]2,;'#"*&#J'3";";Z"T`.Y!,+=XW+CR8FF%-WCP+$?B((C#1N`>'>9Y]T7Y'EW M6Y[WZX%X!;G]6LB%015Y@^(=OO_I1WR$\P[_GX[__P=02P,$%`````@`+HIM M1!A$<.`^#P``"_0``!4`'`!S=V-A+3(P,3,P-C,P7V-A;"YX;6Q55`D``V@@ M(E-H(")3=7@+``$$)0X```0Y`0``[5UM<]NX$?[>F?X'U?=9EF5?TB23]$:) MXZNF3NRQE;Y,IY.!2,A&0Q$ZD)3L=/K?"Y"41(H$L)2I<$GWT_D4['(?/$M@ M%UB`;W]YF'N])14!X_Z[H^'QR5&/^@YWF7_W[NC+Y*+_ZJCWRY]^_[NW?^CW M>[]2GPH24KR=DY!,!'&^!6OYWO!X>/RBI_XXZW\BHG]Z,ORY]\^3LS>G MK]Z\./E7[S_7G_[;^W@[Z?5[J]7JV)4:PEC#LG)R-E@W/$I:OGD(6*[UZFS==CCX^Z?+6^>> MSDF?^4%(?&.NLMK5T[90_]=?-^NK MG_K#T_[9\/@A<(]D'_1Z;P7WZ`V=]6(#WH2/"_KN*&#SA:<,CW^[%W0F?ULY M1'7SVTK#X*BGE'ZY&>=L5PHBU?T#]:\# M@_1`6E:C;;>2>SJG?AA4R9X((NJ$&F4/RRC M5>*V=GU1WA(\BZ,K$ZK.&S<$4$_4QA3I9K7^_SJW!5)E:# M-9?,IW(.D*,O@W5'7J`."[A_%U(Q/Z=3H`4Y@1HL&#F.B*C[\6%!_0`X)A9D MZK$C$EN=5;Q#)UHS/ZG>866>MH*'L>AL7XO.#F71Z;X6G1[*HGT-RMCC$,^) MO#BTE>/`MYQ=]"&DODO=M65*W7X1?IQYR*=YW,D]P5,Y#Q=YZ.D#XL1F1H)I MG-U$0?^.D,5`=F&P_B7NI/[),$UR?DI__CH*@CBW2#1[9$J]^'E?=QNL MNZ()\SY$,DI6$8[%RDV[C+$9YD8B;S<1SEJE_+-`6SYE3%L,@F@^C[7UF?E_98^D!OMC0+Y:+Y0:HEWU.-"3OWOCH8G1[T597?WH?R[*094EJ1B M)/D?%8LLB1='3>$'(L2CC)K^2KR(&I@!RJ-A;,?7=HD#PD%,J,PZ%X2M9TS[ MJZ5IWQ;"-.:7$W2*@:"QOY0FVSJ[ MR_OW!8:W8KV^J\QB:'C2SR$F\Q%/)3"`7BB>@\W22X8+Y*%3_P(`P^<]])3#>_=P!9]/P!,!QD0JHK M?5JPD'CLNW0_/E]$(16Y=55#WF061,^;#0#B62X!MG4RZ\)#MBEZ8HHFEU/Q MLDB%Q#3860KK_`K9)2-3YK&04;575+8WHW4.NV@S_IVQ"V8]"J^&$K'K[SD< MB!=F,G;:8[.RQK@X`M#1AO7/=2I\31Y5=@9?`=@5P,4.<`%@%P1NHM3&9*6W MR"#3-KIT.!!GI^O(_H8NJ6_<1"BT;!4[!>L19YN?>4CA8UUIZU9Q4XH`<3YY MF:M",80'9<4JK6`D;SKB+#%-<"\I">C5U&-W2>6K_:VQ";:*+AL8<&[YXPF\ M"N^IJ!0O:"5:19D613E7?\3#%??O)FF-#FAUQBB%BS,S61H(B(,[S;@`H@T@ MVP[R`$`0QX+G5+"EM'A),U!!!%HEVT&?%0;B0'%WD*\P7K:9,A,"Q+%DI65E MRT(R`G8JK<^6M40\L>5/;=G*'TM;(R`+3D\I`L3K@.IL#_=!Y!2;MHJ9HOF( M7YN1*_/YV*YKPMRQGX9&&0RF=5J`<*NH@P!"'!G>J`,2/G4_$N$S_RY0IW#F MJL>I>TYGS#&N34&$6T4F!!#B2-%XRM4X=EK/QK:"/B,2Q#'CA,X77!#QF,!; MGT`8S=7.W2@,!9M&H5K7GO!K8@G\]]"%@.-](\X]T"(>C'?0W%!7_J`,M84_ M-D$$#._MXQ;*"UC!`6T#)5":&S8:J(5*G^[?)1U'F7 M7)_CR<%BY,Z9SX)0Q,L[Z>D@4\X-5(#@G3&05$B]@:CL;T>_L>'O5R$!7@L^ M,P:=N5;M(BEG.N(,[Y9XZAQ+7.-P2\62.30PUSAK)1`05.)6A;='9S[JU9$@ MO)K]RKD;W,I0R1C@[[1L!RD%L^UO3/__4[LJA/%Y?DRR3XH&F::.SH94T""T MFUYHB<"[K104#]/N@$`]3Q/FJVGNRM]NJXU]&6I$L?_+@?-:T)`\F"9QL(HV ML@E'!PX"GO>(1L-M<#5:$N8EB6)FD35=+7A/`N:8QKFJFAJJW&.(P;&OFA>R,9,TQD@/%]HUY3V=Q[,YX M;UM*RI[VXC$FF0R,D]X!GXK-C?23Y@$[`;W+23SI-/1>)OWFG%DKT2ZJ2P#` MC7O;=T=S+D+V/?[= M6&<,$>\$IS"HB+<'DD*GOS!U`8\U4REKW`D:RX`AKBW8G33&?O%J.',&`1#O M!+$PJ/8RL.82C]M[(JB,K9/[>F2^9!M]=0*=X%,'[B`%89K+#]7A9`@AIL:M M)L,$["`'2S5$Q+GD.`@BZHZ"^(B)?H?))M!^0@S@$)\@O2!,Q,5>(_??47+_ MW]7L;T0(XALO0+?(M9I.(,9R5E]A8+4X[<8.N9US3=1"A#O!+P1H.X M"(ZR$Q]:2#LW$:G5KT*%YY5]P&8UBZ[!JP' M-!Z#='T*?JD<0+:CY`,OI!NB.)YH'M:>-`*4Z>@HY5J\&NI1G'"\#051)EPR MG]Z8#S`6FW:"R"(L#5\O4%*$#A`/2]'<4,1W@F8CP=H>B?YZL<3BW-*E2#P MB-J&A%*`B+>5I?T.I6Y:@>M))KE0SS)Q:Y!!0&5U]RWYR)0.WT$*>#1;7>EX M,N&W5"T@_CDIN=3M<^E:MYH1(S+4I5?=$T;D: M5_+GBBI/NGI%W:"](FC$%47E4`"%8C;!#A-M*Q5[?9A4U>)TYB"YNHI6$U@= M+J!RJ,$+:+?1W_KC&)J/+1C>V$I:6LW^7HA1UP5E77D==%QP$>]S5ELTKJRI M$YY0&36@<*C51Z4UD\R$RW?#>-BIO%F#7_V`%3^C*G4V=77I)SX`I5GBY5#5AEA:WE<^QSGL/V!>)^P`#B^#;F*QZ0"'>(\181XRZ]@LCIGFW2X M)Y-4M0)7A<(RZ0[Q60;/O@OX@^]H6U=89HLK&\Q(M`6?YG3$+-;8HEZY3;:A MSB:(X!6!T%2R2&>$A?AFKXM(^"R,A#I5=L$>U%_6"P1FYS",SO5U M`,)K:+7?1&PPTMDNMJF7,KB(U&CZB?EL'FWVL,Z-9W[!&AK:OH&9]\'^(?>* MBA"\@17)+>P*542,>/(%0AG[DQ7_!R7&4S-[Z'HVOI`%C7@JAZ.13Z7U.41& MVW-RB0QLQ(O/8#P7/!*U^41&V3-RB0QJ\/+P#XK3;ODL7!%!993:8%R65I"Q M[\F*>A12D3',X'@VP8:^D:BWRI8"VT41O#DAP3>73-07E8,F.$&-`B/E$?6J_^HPT#8+8P@NZ[S@,T]):PO="B[B&9GWM MY=/FX$I:6L]]);3@2IP?%/FI0TXR9)VKT\AIV#=L(NY;'[92=IBV4'/-&MK[ MS=CPB821B.G.GAR[%LQWV()X8_^S)&2RHMZ2?N)^>&_<'GZ:7@3O41F)A?WB MIZ%$G$-70J;6RR8K7I<[;-1UT0LVX!!O0E0'I-;1:Z4_4=A9!TC@(=YRJ`Q) MK9O7Z0&)OJXZ0((.<>Q<'1%;UCH")/HZRW^,#G$E>P5$HYF,N>MU@1V5W?." M'8#@NZ^:2Z3.&MQK-.S97@L:R/_&WS.[FGVFX\R%47#-:20YO4ML)!#I=@ MFKH&755ER9+0:=-+0B[L:A2]2'UW$VO/DY8\7%=-5ED-LO>GC([=&XFK`42< M?U]XRH`-`LWQ8(-70A6TB.2JT-HPR#5R]%D5865W$^"%:CJIYG>1]BF$:NRP MF9T`T^8/ZH$K_E2''X0B4N_F%Y\DISGDN\F"^`OA!J(`LNUD#P#LJ8/5VX%Z M\E0.H7$/_0]02P,$%`````@`+HIM1%T.-L?18```U`H&`!4`'`!S=V-A+3(P M,3,P-C,P7V1E9BYX;6Q55`D``V@@(E-H(")3=7@+``$$)0X```0Y`0``[;U9 M<^0XLB[X/F;S'W+J/E=E:I?:NL^U2"W5.D>9TDBJKCDV-D:C2"C$+@:IYB*E M>FS^^SC(6!@1<"PD$/"(NB^5*@D`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`R^\L")V7#EU6G&";=[/C2M63"[84V6T M8(LKNI'HH*]$!ZXDVN\KT;X5B;X623QFW_.JUZ"4U':CK;[*@-1LRW]Q0W]:;2#5; MFLL<%M%,[.F/W0_,KS:3K/H<)Y//TS*?PS3]28D3N62=W9'RV]6C!G[3VE"1 MX&=8\V'_^7/,GL,ZK2P**&C;HKCY)$PR-]).FQXL;-/.SQ,V>6*%34F7VQTJ MY@M(5$3U$_MYK@*+P@I;'RIREEP_*I`5.7/X_#\/4SGQ<_L[0J M9[]I9LJ?O^Q-G3#^Q_37P7SNYL>[:_BQG'TE#9]8VGP[P`L'^YTMKR?)'_FZ MHB-U4S#8_[(D\8+84;$L.W2N6:O3?F8THS\7^41+?=-OYDJIZQ(DR)L;<+YB MY@4LLG_["?98;>_]2Y1G%73&R[2I!R.`C?D/B[^G>[Y6[1;SY>[-&P= M&6?N+_))2E8M.#QV:?5QL5%6PT%X\V8XX/=M1<)=.J?[Q1:U(LO'H;(N]%Z7YCL7/&IB0FCT9E4X#U^3 M*DR3?T/_RR>O=<6*CG.<]`PKJPA@G5KU'!"H`PAASYLAHEW4%]U,>49:%`5` M!UO&D!@"PHDW@T(KI9*)X&#;9KB.W(C.O1D*;I+P*4D;GQ%80==]N#6LIKI- M!`?;-K$9(4.8]69^Z`BO1UYP0&`':*1R)6L-)(08;T:)7H-,HHE#`M.A!=H4 M")&+W!YF"FO6[\X34M6]A:!T<$AB.I0J';6""\$@%'FS=73>(ROOE5:*!HT[G#"]"Q,XMT]/$!W99;M`9>7@D,3-;0_V-+$A?'HS M:=QSK]V,Q9=AD279N.1O7"9U$[5@ZJ'!"YT>_&IB0WATYMM8QVK MT=8$CI?^^7*R)6F0(6QYLV6HD`XXNP6'!"Z[[)X)<)P(K][L(1VAI_9LL]/X M2B7HNP261;MD"B$B//ISQIC>P=Z%'_QB4/_^>;E"<$!K5A7J7GX++0"$D$7! M;*(F:KUP<$!KPC0@"0&#$.33IZ.H66S$$UH']$%@:]E[4,E`(7[4W@PFLVN^ M>_;&,NEA?*4DP-G:B4\(!6'&FYVD>3RNO3@)2@.LK9WU4#@(2]YL)C>=$"'2 M)6E1#(`0<"?LNQJMXD`(\6;TF-IF;EA8LMNG-!FW,4;5(TA>$<#2NH%A##FS=[1"IMGX\=I*`\M-PY)+8"Y M&W=H2HP(E=Y,',B$H46HLBY`)G#%9H%63:0(N=[L'A>L2-Y`U#?6T8$6M8J: M`)?`]9P%8K5P(K1ZLY"LKA4&LR\"#"F2^*>*FW*D%L"D94SI M/=^J,"(/G+W95A[9Y#4OPN*CA?B]YBJZ?7YX"0O^)"6&/W-9&X<`0-3TU(ND MY#$K:BBA<:U@Z0N@/EJVG+Y=Q*H^D.[DS2"T`FX%CGXO6:D(8`F8B:PRI]4Y MA&I`./=F7EJ1>?;Z?#3A%S>CJBJ2I[KB1K+'O`TNI]\-U&V!2@@8JC;?,W0U M@W26Z288]/5Y.836)@-K+8<:W,(H6WO[_AX1]8VS=40ISE:K0'&'%\C]OR)M MS>+L'%&-M'5D&&GK:-3-<=HS>E15"\X9:D5,Y\(3E^4[`J07(?*)$]2_F30:+ M6/@M>XP1G2BM4:>:+GMFG!& M=?62%SQ,A3:9JQ4#"L&_!I$H1&0O!I@[]J[+LC9FKJT44(BJ9X&U#AIZ<<76 MQ;VMJ[(*LSC)QH:T=6H&%$+`6>!N%1*U`&/+,K?I\QHWD_8/+(N8V2-WO`FN M.P+^&X-(5:*C%G6LLQGKL<71J!T0C0(HXU07%KG88PNY#;8VDEH!T:AQFN0) MX5`+.;8FKW)'@]0(B$:(,R*K`X5:'+(U6?4V,K)J`=&0<4:4K>*1QS+;^*UT M-U/>[2LK6B?9;;R1/O88FZK??;33%WJF]]%J!Y M`8+SH\!"[`KY@:70YOA7EH'4Z2B+1_$$%,PEYH_[IAAD"X]6`P&%9\H*9I#E M2!\?L8OD.=SK+,HG[`:F#9TAN"@=4'B$W(LT#`RUV^+O>98OBSI%J3%G*NL& M)U]HWFO@\X*UY1[#'ZR\_`%*`,&3+"P^FB6& M!S"`FJ#CM$'=3E'2>=G95X-C"L&5C)9AY]J@=L$]!S(=&E]AMR^W(2`U`!Z! M@TX/LA$DU"ZX8>W1.LTLE0/PVT:*0'YJ^;>6ON@I:@84 M`M[(N=#C3X2+6KJOWUDR?@'A1F^POQZSI?`M'=4`].<]HAN#B#76DJ]U$_FAH6VDY0$A`9.DSJ`2\R,F+:I:@A4-4'=%$Y0&9RYV_ MHS,:CH2:3^&:J.H=O[@&P"/R6@M7OB9;74#4G`>M\D5KAV&3.-7&PI]S83%D7(;Z':)$,? M\K.9N#2(3,#E0S(0!$QCM*X\:"4P(CTLQGI"=( M:HYR_=S_3PF,QYX$H&RNP).[L?E8"O]9EVT>TL?\GD5Y%B4I6Y+[,;3O*B2?S>_E_0FG>K! MZ3Z!1<`9H^(.I*\8I$=XLP^UF]#_2K)8XS'H>F$`16`RV##;F!H0;KU9DF9N M_BSFVUV6E:KQ+:X0G!X0>*>[88YEJD!XMF=NXM<$.KSAA4%0`O:,#7&F4@/" ME[T<48T!IHU^/2J;>QT\LH*\`@C\YYE/=52!<.?-E'45)D6;+7JNH]OGJ9E4 M=O"2U@.H!.XS-SS#:F@$(=^;(0P443"88RY8^V\'^M2,IW$DTV\D."40,&?# MO<)0.\BS`F\&N'7Q9YZ%H#J6O"D>7NE4AW,L@:7=D"==LC&X",\>`YNMP>=+ MUT)LV5J@K@R@"1RB'7$L!HLP[,U0MR[W=?8&LV!>)(;D=NH!5`(F5T>\KN%$ M*/5F_5H7^:Y@KW"8GWDA&F?0'FVR@JX%PZ_.VCF;SYC M\DELT+A?;X//A@3,/!N8_==!(\3[B^X/`'EH'.XC%1;% MT!"NO%G=]*_ZK3@S!6<$CMX;MKH9:@>)!$'-[8T?2$M;;F^2Q@*BX1C-W=Y4 M(!'B_:6H#S^F8V04_:M."@:`H,]6'W=I"(>0+.;>GJ\3^02OWTAP>D3`A;\G M=Y@O@QEXI`?X>V.HK0Q1M&XKTX"H85`6@2.=U9YB0R%([_&7$D&,Z2K)0EAP M[2P-:&C?#MS;&*+A86'IS%??M=J\=5HYSA5 MPD5H]6?Q$BXF]RQF;,+GEN6T.L8K,=80]/%=V4H/40#2&[Q9O\08--S1Y14! M["X?:#'`"+L]K%/8J5;1Y>1[:-,F`!2!>PF+QU]3Z`B?WHQ.W?W@39Z->>RX MZ67M#;_#O7U*D['2,&W0"JB!@*>AU7%LC![I!-Z+;]N,J+QGU"H!+- M.5RC);ZAH7M[-7Q6UU-5OQX)XW@E`$G`S=CL8DF%!J',FWF,RZL@!P0G8,LTIZ&5&U&XOQCK]>MK MFZ8K3&<9X*ZSY[R8-,N]Q@6M9@O!GMMHIRYH,X*&Y!7Q^&BRC:+!XVI('6T7 MQ8)3"F]CC;0N)FX=%,*.SZ>.LUSV2H*62@(<"M.?#8X$N!":>IB"$&/!>9Z] ML8('UYW>#4X3)-_D858^YFT<0\Q,H%4Y."61_KT_0:90$1HF=^GN#I:&8R?*VK[WGUWPQ;O@Q;X&=4 M`L;7H:/2&#!"HK_@68NX-!=U`0#:PTD3L:0[Y;0_5\E3RAX8P%.=TP>URW5% MP*9K86#;4`/29>S%X6I?L;:A"K@]@;]E*TKVC15C5D@.'/J580(C<*\V=+`; M0$4X\V9Y,0C;L1ZWPN=+(5/%BX>A&!-"DKV<=]P;1AH01U`*1/,X]0U3-PH' MT70/(PNBZ<<K5A]*!"O(B@TA#%[1I+U+W]G!J,+ M"H.@'JU4PSE0(4,HF.XZ`>_G!>`;:'BJB+\N_W9)#^Q'Q;)X89]8TL3[^_LO M7*;ZERB??&YT`'OX,D^3.*RX,]74K,W=)Z=31GD7\J@!+ZQ*(I#Q/SRFN)L; MVZ4GN#7+_)Z_E!_+R>MTQ&ZSW.WMN5Q`PC0UNMIH%(B=%-?E1C+D0!,@4%S] M)S!QM-'P-._IWG)XK_]5!4\@HMGXAXBEH5P^-5-I]@M#^IP MN8(,2:/8$*6@=!T*$O+5&TE3`7_+RE<6)<\)B]59:+$Z@-#I4F.>1G%=_PAA MTV_N%X].MV"_T9$]SO^"/Q;N"O25Y7:8?]^PU M+RH6*_.5JJH";@J>3/)!)>=2#@WQ]=S@UN_V^9GQ:V#93N\1&JVWU$!TYLU* MW7O#=T+*0'0F<258E]OOA@_SZ"N2"CIYB&SC^17'&UF\$=.#2U]KR7-X7 M'^+.0H%CY8ENO3!@:L&RY[+WP-+W M\&/FCY]&\H5+7!HD)N#MBHT#P3HF@R%6N,?GD4\E^U<-L_HE3\/U"-]3&8C% M-0"=2[=61RN5%`QR&O1W![,NK-K@B-4!B$[]8O6MQ#(*M%GK@D)X\V=*LKN@0<36FD65=0$RC;M237*,F%V%B3#K MS9;BG%E:ZZ1[BI4KI[TWCN\LC:^SQZ(NJR&WU4A?$'_H1G(7K5,MV.^3>=-(1.S.654%1'-I*1+>/NNK M3-!3E5CHN""6+/IEG+_!\$C:)1Y^6%W9X5?!#1N'Z24,7?0:1%`J.';J-J"U MH]8C9)E$%(H3!T-="EIAT#W4:A&0V.\F&-7BNK+7Y7;B%>A0TS0VI0-4OKG; M[HK\4Z#.MZR(C=W%=5D4252P6"R[^K=*,.:19T!.-:P85E=CUZ5#HY*[)2781 M&HNBW[[BX%+>3I_Y[>&11U2NBX]%+"UEC\`K`58"%R##1[:X%ZAP6[O_5Q^H MI^)W%CR-(_5Z)9#;=[@1"\=K#!>U2_Y'-GG-B[#X:".0/KR$!2MOZZJLPBQ. MLK%DR*FJ!GO[/M-+]V72$)Z]VW]DA%V6`/?]@KWF95)=).53791M;)*IB]!C MWLK6YIAI),$&7I^V.$[?$>3Z#L@!>.TY`V`QSSB$413E=59]#5.>)PBC35"4 M2^D[T%Q?5G`X]J[U,:4K!O4B3U/[)Y01PW8X/M^QZGK3U0^K_&)_(S@UY\'LQ1$DC(X93/):3$;L'F3O/M"?H\AP-U MIG'3+:T7N+4H;&IOK8&1V/W4BJ#*C9.P/"!S&AK?/&H:KG\Q<1)8Q!Z=6B., MUH[6/G-*AWY[22A^#XLBY*&3VI#P'W*_*W%I$)E`>DW).!`8F61(J#TD[<3K MGZ^X%TG)[5>P>M_S^^9"?D6HV4)PMN\Q3\A`VV$OK-2>FLJ%[\TP@/5]E^^: MV!:B_.**S&6'S=<>&[GSV-OOD_?4RZ6'T^";@R\]6D7VO/7`@V]NUZV'G>#4 M^R%-P5.9+.9GG5<.6RNPA49M0._RIG!3DZDV4F(7!ZC<6D$1 M-&H'>U\.:42\T*;(D.$UK,3N$C9#,:W9>4-H?#*0A_E?S@ M/ZE?4."5.%@"D3+TAR!R:Z0"Z#HX);<1UA4KYH*#(`_Y<_4>%DP1R$19$R`X M];ISS)$92F+W"S,9.^)>\"O)O`%QGI<:+]JTVP`5.,UQM:'!:(J7VKN9^S`; MJ_:_\S)<$S3B30S;YJX"HG9ATBJNJE1"P)#JUBX1^%-#: M/O;C0GEYZLT6\PW4.*DG2E:6RO%YEX`/V'J/%[,ADIU::,EOX0\]'KKE.!8" MOEO:/`ADIQ8(\EOXS[PXK\LJG[!"Y8.U7ICCWYY7#?AJCB*S%\W1#E_?PPF[ M?5X25VFX0.OPUVDT+%*H_L5TJ1#9"_5(E35:NP2K]"DW#Q:M$-.O*RP.2Z6X MC`0L0*HA(+(IB'`@.O9F0!BE:?[.GT%?Y0"H?JJ>ZW0ZH9?W+&+)FR(IHEX# M//NZ[S?C`]P5>H%%[K*]V0U0N\EO)0,<-\FSC&>-VGS/M27.=#*2]9$B#'LS M0EQ/7L.DX*+>/M_DV?@F>6/QJ"Q9^^P>.BU`D'"L59]CWQ+/.AG+)E@1GKU9 M.D:3O*B2?S=!HF^?KY(,IB100&.ZE$W5DFH+O6)'DL8`'10TNL^^P M.D,=<)7H$$:\F6,>JCSZ`[9DN."-B_Q=,9T55LM+'6Z'-1J6Y>WS5,K;XCX9OU27/U@1)26`22(V_V,Y_:LT#G2/YD`S9[Z#V5GH M(`.@(YW"GGUI]EU85I(VA:*T3X-M",'&0;VA_L+KP6U`.M\@'4;@28\/ZN MT`+SXJYDJ@9B3Q"7YFK5)?9Z821%9,+]E1IO)T5E@=DWO.;.=LB2!`3>UZW)JGZ9;NX M!J"CD:U,HGM-LKJ`B,7KLTH7K1V!3=Y4.P![.:/^LX;#)[_2N,T4[Q[72X*D M!%Z_2;N_8'W"<#@/LS?_\.-[KJGJ>4D0T>-=VF!5K^!PGJ=I\6$HIMNO.V5! M3`+1#/NK>Q6)\P1*HRRKP_2*L?(J+QY8\99$>,(>8>'@D,)DTL=$I\+D/)'2 M.6SP8+%(LO%H#,2WCW;Y-4E4-1=>.!/JF@"!P$CH38LN0&K/TQHO@G57@S:I M4_M[^4#KUQ#WR2<0N6"0H;P/8&JOXGYE&2O"=)3%HW@"^B^;.\\WIG:24]3D M>#TZ/=H@6`^A_-W<1BX5S_/)),]6_8'\7R_.XZ7I7"BN%PX.OOB[0IQ)H[P; M7"H8[)^Y7,2DEWZ8`K'9:UWN7;B_F^.:>DNUHT(SXN=J'5"+RSM<,].;@#`% MM6(XQ&[9ND(J;33KA:&/.]U'F(?V%&M=3!6&A]BEF@6.B)G0[)%%-HQGNRMH MA#Y71I]8+PS8".S?L`&",(2@<'W9=EXD%6S^0V2=62L#4GD/@*J_KB#B6[MK M4R@5G7`$I4`RIW>8RM4`T95$H5W!K5UY658IC)9KMR$PO,.*J;(_ZWL/B#58O7,CP52Y/.HUE+'@`$4T4!,FP) MM.'R8M?1::$72&J!&0U`/"95JKX,[M<@*,?IU8+V8:07J8/[QYHFJ(6*)-1- M:"RII/J+,AR2OV0D+7)U/-]N.8!$X"9]R/!%S$OK(*G%OFQ%_*K)U]<.AJB%)2N0R%V/V$WI]7!OM,'MP,3D37Z1PB30R)V86&=-%K;=;OL M:=Y@;&1;\%`_E>Q?-<]O_<9H.#$L2Z2U/4"J!(>G_D;$LDS*K8*@."S1+JV4 M\@V#5*5(IT*ZLM?E=O*DV*&F:2P5`U2^.;>+O[,PK5ZBL&#G>?&:%],X MU*,)*Y)(X8RA4S5W?A1V.*;MX]RA=:O`:(3B#XD-DX$RR_*H#. M7VA?E@#X7<%"IPR(12#?YW"]KT&R]\X:T?2W,`O'C7WXNHD5G+PQG2&@J`;" M$\C[.9@/+93VWD+K4_0]KWHPU*D%HA.('N&"H#60]C*"6GLVXS^ANNG&'0%A M+V^GU:<>AWZ3I"+*DFBT*[C[))H]=4IC1SI$NSWB/8R_JD!+5 M=N6VEZU2H5)EY+6U@L&!SR@M?12[(KJ]/)$*W2I#K:T5!`%]9X4SU.V*Z-1R M,_+@9==9614UW]YAF9!#`VUC(O+-C9!]XE3;(XN)%.\`1E*6>?'!SVOR)4=4%L0E8/"1CP+! M$H1#H9J;VY[1S_/):YYQ5U9=YWY1/8"Z=?X.!L"HY2QF*E/$`C MYNN/$R"[=Q#"LI=0D!ACM)8H^]0IERI[)_G+']%+F(W9+""AXE9"6#HX."80 M)E0R$$27$1(DSK,&GM=EE4]8,3?KZFE?40V$)Q`,RHP&+4CRE(`6^+BM7EC1 MDQ2=N@##J9^#"V;T<2'T>#,Q3&54.@\OE0,H9.ZV-2B28$#H\.>;;S78Y\$Q MG3P[???88E`(;_Y"$PZ-)WE,)(..7.UBKC`\"$G>0H-;((GH9GHX6ZI=]($W M\\/@J)_'!-P;L"&"4(2@0*BQ=\<^C:S2";^N2FLH+A\<4DALJ*=T#2"(WKW9 M!K[699*QLAQ%L`4J6[7*]PA(#=#'UOF?:$%"&//V&$`D+/^Q8.K[!V5=@.S7 MRT6+$GT6!>"0IY?>_/Z=\TEKH^&*6.7;6GMFBWD2(Z7/R'I)$-6C-X[A4!&L M;A@B1.GV'.KG'U8ZDZR7#`Y."!A*+2A]!1&B='^I$`H6)]55&"4I_F(9+PR@ MMO;M&88&HA+A2$(W_&!3LOB79>%ETI9E!6@\@$[".XR-'3)X&)(0]>^:'_ZRSA"<8C&J0X3S/ MWEA1)3"'-P\Y9&\JE!4!P-:9PDV0(=38>RD@E4/^?$"C:G!XZM2'2^^=AJ:N M35GJ0D1XLIJ4W#%/-%:HS1"F6KF.K*8XQR52IN%6504P'E]AFHT14[JZ"!&: MO$4*D*;4_<[>FS_U3D(\;R`X/"%@H.@5TM(`'T*N/7,%3ZJ;L:*\R<-L?GS' M1IVP,$`E8+0P(4*%!5&ZO0?^=W41O80ENWWNW+ZT_#^^%'D]?GGD`7>+V^=G MB6.X22,`C(#OESE)YA@1\NS%#!#*](\PK=E`[I`V@KT]"HT MV^`ZV+*!V!YM51))QIA82XI@5>O`WKX.AA$[?:.]WQ0:<[N@J)< M2@*1S(Q5CD-!%&[O:-\YZUS^@$4E*5FSL\*TCI4/#DZW<1V5PT&T;^]L_KWF M>&Z?%ZD6S\,T9?'7C]G#I,?\*VN/-+^]YMEB^WO[/"N!,66C[>#@;!O'DSWH M2`^P=\*?B=HL=2Z[P>`/\!EI&X\OMA6`=(FI:CYM(F$92%?F:1+#F2R>/S"9 MN=&_Y"E(5%[`YZ*D&F7Q/8L9F_`K[`7Z;KJ#C@(G`369%J<*0$+F8,!Z/N=+V$T5Z"-8LLEK=U M559A%L.6345?MVQPXC:9@.9]FN$U@1B%O;1J%A_U+/4CJ:E_M3"`HO!&Q/0& M1PS#7DHUB]RT-CF>0*Z]B.V^+&IF$15?R@:"$[?A%-QQJ`G-7CJW#?':SAU# MB&U;`/@$;-"VF>UBO8G!"XDFM`6N:D)QG\L/D0)=*C5H@.H'+"AML M=/%02_PGF_$'1`U8K@\;^.V9#GL@HY8J<%.Q($XH9#:Q0ZL0&K64@J/XGW59 M-5ZRCSER*SIU\T5?5?=N"U2R?0?1GBCMI2+<'/%-9IB!A#=M@`HH//BR3W0' M';W,AZM&+Q6=2`W896S?*)5BH9;@$!%6SRJ$U0.HVS?F-!!1RW4HV]1U'\MT M8C5T7IOTVP8KVP55[=;V6!.QO2R*&]@V.^@=F@T')V<[MLW6A.P\X:-N'UYX M7B][]HZR6/5NT>(G0"G;LT:X`>\\Y:1VM[7?)7I]`]1"P$/4EJ&Y'WIJB2YE MO5YK5R^K&YQ^V1X;M2$J>BDR)5VU)Y.=R@!Z"QUG-&'92YN)1OQ83!4/K_PE M>3&;%JZS*E\-?HA-QH;-`#@"/FHF\VTO@/;R:0YF3WZ%9-H.P-N>H]8`A/92 M:_;8.C_FO_$0H^^PEP?)^^R,EUL(3O>VYP#4"YO[=)NR:7L07Z(F`-3V&"'[ M@;.7J%/&V$/]]$\658\YWPQ/FJ])5S-I)1!\>_8;NG#LI=\TY$&^+LEK@>C; M>))7X+&7.1,-9JB^X[G\P1V48"OZW$2X%ONR#V@-H&[9@7L(3N>Y,N_"C^;] M6]ZF1?Y[>YF`428N#=#WML>15@W$?:Y,C1XQ@K5PPN*;)'SBV;G$]NT!K4'_ MVC+?V"$XJ67BU,'2,*F_(>C3)6=B>N=\26FH)2;^SZCJ+\@F[D9.\5"XX.=Z> MC90$@3S1Z$;B:%[D49-@8I3%EUF55!_7&??(;_I-_PB9)8M^&>=O('[2=@7X M8;4'P*^"V=<['YTK4]`95%6"PSX7O)8$Q\)BRHH'AT[#(`F#8^HI<;D/JS'0 MB9.I2^$-&\/AI>GS2$000:E@;^_,Y9JA%0)$S<8Z>V(<3F)=ZA+02H/&=U@M MPD5VNNU7ANK`];BN;X'D3N)4NE0VC6`9@[3N(,9D?^W?LW%25GSK]CV<8$N% MJ"A,R1XWJGT7#!R)DV"39ER<`Y@B3*]AK_3COY@H-`):%C!X-#\,8T,(Q4E@ M25TZSNNB`*&NDC(*T_]F87&9Q1>PL488P8H#$H]'_;ZDR-$X"2MI-DRNDI05 MYR#1."_D@V2I9'#H,]G2L"$B`.(D0J0N$8]%R(/,/'Q,GO(4H6"I#,#S>#KN MJWP!!"?Q'@V7B547"7F@([V*@,ZC(]#`!42)RTT42-.#^2,TJSB,\R(@LD?W MD*%'\04"-R$<=94^`F%B+M!5&F+#8JD,".W1R:.OV@40W,13-.WLK058OG$2 MEN4&RRUV!AF6_I&G=5:%17M*PL:.L"R`V,*ME@2*F^"#AN>3UH!PSU[SHN+' MIRJLT"E-5@4@;>&.3(W(7AC!_B3=U4]I$EVE>2C*Y"LL!\)OX?*/P)`']-O( M-?<#2UE4L?@JR<(L2L(4=HSA;UE8QPGWH^!))U+#C)"8SV_TPN(Z9;?/_V<= M%A4KTH_Y1S6ON7NU$QR>670@U_LX=N5MW`8([_*"0W@//D#+RSV_)]H_RXWY MD=,$"UH7YCT96I_@A-BVZA+]R.T;Q%YWZ$?KP?#%*CE@NQ\;]]*[(GQ,93YU2T/,\ MGN"M<[2&C%@BQX57ZA4HX1RV'4E6PS'J%E;6!F7YE0%BUI9[#'^P\EN2Y47C M+`JJ827W'EUN99:XI'K)X2]O;.K0+N%_@U(`"QXM$=;[U\8U1RS=93\7\J,O M'NT=UON``!NQM):SA(YWTR!_7\,RB:#?721I74FCS2IJ`EJ/%GGK3&JA)98) M\W>6C%]`N-$;S#AC]KWFNKI];N3O^`?H4]ZO0="-1Z.9]9XP1`ER)XR-F-PZ MRXU-^UJG6:4-350V.+*82:3S`:DM;+4<".'R&([;NW"-"&Q:8JG_-':K?9>' M$'V[E9@%#=O4/IZ]@ZC%9-_IMKR?;6H]KZY8[NVR3>WO$;9-Z:FUC$LM.*02N@#=]G&=UUI3L'>_J'' M%SP6"!$#(F:769,:?IC];BIY-TH!'&&^L@R(J,K9P7283IH7/<<5N M_=1J3P_$3$IK2%610L058#+S;388S'$'"#';T)JH/%!)V_/2-'\/LT@6"4BC M-J#V^-S)#GT8*C=O:2R2V8E6);^&5=0$N!Z?1-DA481(_BYG(W:XNR*'O36< MK;*8W^J\Z&P4F<9TB\GKP6^5NSP"GYPRL!1@+!+H<1J$)'S+$.!:MB45X1L!(( M?SR,21V$Q,R9HRBJ)W4:-N^%7@L6);XI,;-C9A3>`"IA42E6&1W M(\'QI[&#''E_+*A#AX;5XVCK7@8>$7P9>*3Q3.UHZUX&'E%^&:BG6N@%0(G;M==8`4N,0.- M-HZKO"ZL]8%Y8\'1,8$#N.,NL(*6F%E%$\9PV@$]@:S"3KEN(?JWMZP_(]LC M\H[LV)ZG<_]W9,<;-W(H-++73LD+&A8,HZWSG_#;7:X?I:, M8PUG`CPG'%5+QC%E_PT]E9.U9%P^/[.H2MX6@3ONPXK=,Y@8HR1MK\-&U14# M*<.TB7D)@GPL%9;L="RT#MKS:/,P6H>LHR9F_]#!U>2K'&7Q#8B1=A0WL)-@ MS8*>:#ZR&M8[Y'!=/XF;27B9X!+>L6(29MS+.^$)V>%HP,K?PX*GX)J_,\`V MF+;:#XY.?(?P,MJBVL5MS3"BZ`6R?OH]YZ>L.FJ21$_??T%.#@",9O4SDV/T&0-XNV"C].IM\%CS/TRGZ M:%*&@XY!<,";"ZY^=@.#/H9=`F%Z6-LS>#QAT!A^_$5+JEG8&& M&=9_KZ!KS9V\IGESN\JGR"*,`,/2;E.T/<;J`%("'D>]!BVR5Y8C)69MO0%- MC^?6P%JUG(N*`RZ7[K:.UVT<$3''L%5!E5.ON`)L:9V&"-)>;G'%ZQ'5A4/, M?PG`%C*@BY2P7'!\0,$)3M+K!79?,0AB]K;FWHDOD&UJ M!AZA+<\:0XU\\9'6`Y6XM*HY7H4TH%$+H+4BJ7*.$Y8':#0.?QH$(-L]'):; M3/8$&*.U*-FG3K4X[7FSTG"K-E\*\N@/Y9%KK2Q`(W#4D@P8,4T(#H0:;S:3 MA_JI9/^J>3]\XX&EX'NJ]4Q<`^!M\7E*"@KAS%_NO75AE;,B6B(!)XPJ(80EJT=?$@ M5'DS:CR$:5@DW$]LS/B5^NWSUA",*?4Y@J'L0=6O,$@;I()/*TF$[@NRYK% MS;'D]E7JB-RK->B$6S<7#H:+,-O#8C*$V5$<)ZT(MM@5M@B0MVY<6H&,L.S- MJ+*L@H^+<,+7\+LPB;D#J[XOVUI-F*X\IN.PZ=Z&0$.8]&:#Z=R6L*IJO>M& MD[R61L?!*P%(C_DX!O*G0(501R16WD='Z-E&C>_=]/UCT18`/H'PSU8&I1PB MPK`_HPU?!]J%_Z(N`,(=*Y(\;I:/\K9ZD1_\E94!-/&P59)MKB8ZA%)_YANQ MW,T*T9/115V`3."ZPBJAJ^`0/OTYKO!WYU=,^I!V7@8@$`\4)9E(ET$@/-@S MR2QFZMOGSGW6U[KZGE?W+&+<\Q`[8FA5AJWUUBUKIN@0FKR99![9Y#4OPN*C MO=.\9S'\@DNG.C?(*P)8"IY'O0:6#C+$V=V;)\LL5-157MS+`VFNE`SV]H^V MSD@CQX)PL\DL;^MALGJ]U',5+.NXCP./[6!9QU]<;HT,@V4U&A',[&*IZ;R- M=5BZB6?%T/B^+C.2_>PR+6"_*Z6@FPDLP)+5@U=,%8>T.%+,OH]R]_O"9M MH(,+<4@RD^K!Z2G);,_8U6L'Q_L8C_6IH%S'DJG#X/K'EA4%TTN]P;" M`^-N:LA!QJ`VP'=YW](ST3/"DF`Y,T%I[1C4FR]T;VY4']`XO5)1'I&,-=^+ MN"Y8:^>-E:PXR.SQ7JS'$!%>RDB@N3Y^M1__ MVODZ'E]$7B$X/O`=:L\2%2@XUV%ZISW!=%`(NLZ![].NK5&!8",6A.*>G]`4 M+Q#G90"!RXV!R\T<@H58S-I&.N7SIDZIX-AS$DM$KQ+E=P4G%G*BE_II;+>& M\*!\^.?MSOU;^(-G:5)2LE0.(!%P\5OKZV(J!))3"P@Q396E)J%;#J`0<,O3 M)6%=]C&BK"*Q%Y1!JESYD;I;)CCV'.Y, MJ"94DUVA[05+L*A+&FMB7Z4JUT-[A]B_LS"M7J*P8.=YP5WB^*=NGT<3.$-$ MH?P,I5,7X/@^3ZUW60$%^EB(QR88$-#E^-3EA<.S%+K`>4*Y] M;3:JJY>\2/XM?(ZB42LX/B#P*LCXGE^)R%YH`NO$W87%;=%$06P?F-VQHL&@ M1R!6.S@^)/`*90B1&"MM[7/=DV&7%LC.'::P7YC MHZV+AF0,@7OV6A?12UBRNR(?%^'D>\UU`J!75N['_"M;%)91.JC=X-BGAV]_ MU\;AF.W%(T"L:)W.N7A*BKIHJZJ`T`2>:VH3I0>'6@R!UO&ZG42NLZ]U"1#Y M^]3)$P^\!U)>A4G1[,2E/_="G05`.@?A;_2;FGF"IA4AHA+X#@:6/!>:%``2!*!;F MC*T`H!;A``G1QQ.^CYMW"5\_%D6F@0&:GM6&[2O_`9V.QNLG>SF2YTTT*VC3X*"M_'L[58=2'_;W^#[/CBBO+*B M^AAE,=\KO7(`_E_XS:2Z2T,>37HAVHW&#8XXW<_+88E5/_(:"\"8#I M#.@2*.P&.D5B> M[U5!U;DIA14`F],E4C^-**IX/:*Z<(AEX;9(%2U/"'N26L'>_C$![H;M=-3XI*\1-Q,#)'^NX$S#OK-!1P/L/J+MR?Q"A)^Q:A@' MG0_*-OPFU8/C`XM7*-)O2L,.:E0%45V:6/%(A$:J%-VKZ&*CLV%W'*_PT&5* M)_UXA=K$+).*0MJN$(:'3B\H^X4P/%P+%"66>[M"&![NT]@4#U`YV=WO*/YG M759\&KS*"\W-$UH'1KM'R__0Q483GG3_ZVGCM%4[IB-[;PQ=[YB,Y3$S(@2H4=15$_JM$E%K+=!-F\,=.([$IU;YJ6X MB86@EFNB'^]0$68UW^&EW7(\Q^@_OO1-\J\ZB9/&`>4JR<(L2GCF\*S-=.O` MW"S_H/+PI%D]./G2PUN\E\C2PY-&51#5C[G92)6"PY,VMC_+X>GDB_?`1V;$ MJ`]/#:2M.CR=N,T9V.OPU&A1L9,_P;,!$CT\@<1T#T^:*M]<(.;?\^*/)!M/ M=P78>K%<*CAQF_Y)8R,T=)$0`2)VHEE/L2'9N:X7!DR^`S(/($F%B]B)`W;. M;>:7&[D!8:D<(/%]9K3`D``2L?#,(.%Y6+[<%?E;`D>0KQ^_E=SW?IYD:115 MR5L3G[I-[5G#[Z9_S#,%FP,:#DZ<)F?9'/V#=2`-(+VAXV;&;I_/"P;(%X=+ M3Z\"DCZ.3.T"JQPQH'>@R&S^7&FA8/$H4:/XT)]$# M,M$9%8QH'$$/\-?@1`]&3OT'>QY!#]8,E6*YM^L(>D`D>N\`E9.]OQ.-W&D$ M^*]Y4>3O[;D._B(],9DT`_H@\"+:ZNHCATKL*"P"L$B%VCZB-:1ZM3K@)A`# MTRK%8HC$3LXBP=N8.WI!^;3J`W("K\RMDHM@]']SQT,GL0G?22WR/CFXKQ-] M1G9(4E<*3H[LQ:07?4EZ(X=6"$X.7?9=_!Y.0UD"PZH"QY\WA^O)$0T71@5! M`DI-`.Y,^M83IZ[#=M.W-IKO15P7[,ZD;P4T-$Y?F^9PT^E;K>0-/?'N,FDV M3`0<*<`1.TP]L@E/#E-\M/=IBU"7350UC8CF>@T`=H_QY?KM8/H@)':>5Q25`M.SGH$N]02 MD35?DAZ8T`K!B=-T7?B!24M=@N5#@83.Y=`07Y:P:L3K1MI3I?C"ZH!:7*XL M^D_O>O3%[K'QZJ(@=G3BB$1E9O4$!$W#]G?> MM/+H@Y4/SHXM6D27/R(][HC*@C!^XEO(M2.R8J+2TSG=N'5].SMV:>;4/[/@ M3"S3AF+8*I>WLV.G3AV]7-X:+:XK>UWNK7)Y`XEI'"(&J'QS]R?34?C`WAAL MH:;;7L74OUPX.#OQ_;RG[RH@`F)MHR]7^#U[@J.E2M/34B"9[P<:?56\A,#: MUEREVW%25JW#V7TR?JG*.P8?Y*9ZI;[1FH#`^_5@;PX4J(@]DYJ*?5?DSZPL M&Z&N&"NGI[Q1%G_/LTAYYC5H!;3@^RALPFUOA-+G39OG^;9Z8<44Q$T2/G%W MPL289X-60`N^;X+[\&R,4,RSMWQP@RG6QN[1<7KH*-8"AYQ1OVSR@6(G$\#4 M+K+GXVWB(H'+/(Y0L\!UY9,95WJU$YQZS*JH(:A^8B9%&P!TXU?7`QA!+CC- MT-(Q``VYS'FJKC/8[-5-HC?YO?9Z85`$P0Q-6NQAESIBB,0NMY?%_!Y.U'E_ ML"J`SZ^E2:5Z':)6X1"[Y[9,%PUSE7W>R%YY\RGD<3J%?`NKJ1O?/7MM\V.6 M/"E9]]ASG]\9^D;^P8+P(LJZ5WO=H/3`Y?O,C2?AEE;?"WH@MJ= MNPFB_V9A\?B>V^HLT^9`+QYMK7[[R)(*B%WRFP.!KTN#CO1J$'3CT49)H'LL ME$#,I&D,Y2JO92D#>[4'FO%HYO3?/18Z(&8(-4>2O%F=/7A[H!D"H24\]HZY M#HB93PV0C)Y!1W8[R%*3H!\"L2E\]!&!&N3&6+_]1)/[X/200()2)WRVT!". M]OP:S`]\&,R["7GC45DR^;LKG6K!Z;&W-7.MT\PEY"(:&\+7:P>G1R[G.JD) M7*UT38LW!FL7;-UH7N.O'X\?;8)Q20_0J`V:=GG:'F8-QY@5=PQMM,0,XZC< M7&JET56C-J"F\2Y,FR%#@E>A$C.E;X1@6@;VS3!-UOC>G;_*JQIVW>P;$#&I M)W?3;?=%S=1/FDR:`7T0B+K6=U$W1TK,<*X%X#I[?,_Y`4MW,ZK14G!Z0N!X MXY3W5;#$#..Z&+CAUA;Y\[9`(P1NU%S3OP*7F.%;$P4WS5KB?]X4Z(/`99EC M^E?0$C-LZX)(WFR-_GE3H`^/;R8VQ?XR6F*&:RT0CR^L8"&WK@XE?]$2:(/` M/:A3[E?!4C-&:X$8RCA`)W"AZ93G%J+L,NB8K>4:FM(YY(I[97P:1 MCC<+BO+XML-]7U`A1[J(OWA-2D1W``?^_4>8UNSV^3NK5OX^J*.H&@>E$;CM M=M==]/`CG<9?`*D.KMNG-!FWR;G,K$'K%0$L@6MK&V1CV!`B21CY.C*;,PCP M=L1TMP8*X>S([]WT_J[<39_M>]L>N;^;/OOB\G#;_VZZ47K_N^D&UO^ZF]:Y M(3ISFK+5^MUTPVS_N^DS/)OK#M]-G[F-\V;U;KIAJ/^-Y1D>^&V'[Z8!]?;= M30]G>G/AC5"!FFS!:PN9@,X^S0!&ZC,R^YY63Q'L72^SUY MDK5NF>#LC$`.O%4MH8KL"NTZEUT?5=(X8.#W]G85J]1&'!SO."I^'B M7[I]'DU8D42A/,V<3EV8,?=]QZ-;[[$""@S`4#L*S,++W[.()6]\%H2?N%3Q M=?;&RJH]VTY3=@A**RQU5MH'O7N/NM1K\7"@!6)'#2UD."ZEDKT=@_;&&?4VU=>OCI(EN7=O:>2R/?JP@+^'/I=S\V5WXN\);CV M?%PIT$=CC=P\CZHEKH]#JC3U^WDGL;).YO?U\EQN[QE,S,:*@"4%.GN>GA@; M_)/795FS^`*DS\9W(%`>M[FNSW-8JXNRL1HL,FC?%=,LXLVNISU_6NHJF@US;?F^ M$7#15\S@(YVEAV5.SSKR&RAX.@5JFD@Z-;BQP'?RJ/[[""4NA`MGEJJ.!(O5 MI^D]YM2L-,`1;>7@Z@43(^6I%H#L`FI1E7GQP1%=AQ)H%0I,UI#;'XO&9 MGEW*Y!@1GPM[UJNK,"FFSP&GV[A9RJD/C"1)%2ZU[VQ;_9E1`T/H\/:D:'DK MC@TM26F.R^-+NN%;"QP3PI6WAR$-J+OP@Y^ZYSUM@5W"FZ(F]['82IN%&3Z$ M3R+I?G[+PDD..]=_PQ87),]KZ<-D95V.>:MM";H($58])@$*,UB2(YXZ-1M? M*=)QK)3EF+;Z4(\A0EBRE_\:W\>JK+_JFAS#+I[%5O`A''DSIJQD#,NR.DSG M@?.G`2>TITAQ=4!^L-6[%P.0"+V;?+@AB`O@(RS`LM)N-"("(#6"LR-O,?"6 M15(]_A>4!N%=7D]*'_M+]:G3TSL(=N%=_U+R4?5#?E%Q4(;+_9[1RWV4*VS3 M@,$A]C1_55"E0K--GL;A4.-L#1(3"`HHVP$"/;>,BC6GK1@,0K2,&J6/`V5B\J"E`0B'QHJ M'`=B[04(]F(NS,)Q\^GK+(+_)F],0_'R6B`Y@6B"AA3H0"+V1J)/BK.S(P(! MY'KLH]=!$`ON[=8L>G9,('7#X.,/BHQ8J.[;ZH45W1[W/<\B9=1-22U`22#W M0@_^E)CDSPQ\F6=Z!=8@9Z4Y]C8`=')0&@=NQ-H(S@Y<#HY^%IUC-*J7(:Y= ML/--VH:4"C%J`EL!$V&YK(-D`%TK6A;",/IL\.O,=BL;(6&V-V;7?;V//; MLP.GCJE6'T\WFN]%7!>L-2L=`>IH+(R;YG!SD4&LO9H^\^Z08S9(1+<^4FS$ M3'167`^B0<:KN.=.%0RVYGD2L:JYE]TC88 MYL/-?2V%S-"R,='COA;/_NPOH9OT/?!W]M[\J?=[ZGD#T(D)A.+O8UHW@$2P@7AG6`: MU[/(&JR=:JZSRQ_\D=?M\_RUB3;_9LV"H@CXP`WN#GU`VPN28:=W+':*5XR5 M\]WB/7MCF?3=N+PB@"601K<'PSJP[,7+L/3@OWT3=I472])+R$-J`#S*#I`X M:U(\]L)E6+(9\!Q,ES]>DS8YP@4L)GL2KD3%@[,CRBZ/.%$X&&I1-'KY#Q]O MYPYV'02U.!DK"V]8%!]P3C(\:RQ7`Z"[L"<5@:(=%:.[BWZH>!K!@0>.U49` M";NPO51#E,?)V(A_\4,RSI+G)`J;O)"\"W+[19XF43+/Y+=G)8>?]$LW$E=B M@]K!V8$]+P;I)Z5)_=0U05"72PV>VL]$CZ)K5$UD=!R#2Q;],L[?8"0E[80' M/ZS.<_`KV-F,P_02\%0?R'6KH%2PM^\TLK1^S@5=8I8YQ2$Y<=35Y:*5!KV+ M6RW"178:U5UY58KK<5W?`LF=^,>Z5#:-N\Y!6B?KEGH9%AF,W1(V"\W=T->P M3*)1%E\D:0U[B-$3["_"2+9KUFPA.#OQ[=;3?S7JA958QL+OC%_OYA-VDY?E MJ*J*Y*FN^%3]F-^%_!7:%(2$:MTF@K,S`K?@1F2)^38#3"S%X')6C%\XWC=6A&/VO>9:NWUN5');5V459C&H M:44[DL[0KT'0#0'CF84^,00^,:]?A3;Z;_@`+8'+/`MD:^$D\&C_GI6S!:E7 M2$7,(#7UHWZHGTKVK[H)+AE?)45933\8S]=!#8-:G\9XW$N+><0,1)#;VTP; MXME'/-G?!JA=9(_KB?Q/8Y_[\L7[&[]!1&G8ZQJ(VV6O^_+%[[L]7(\JRU$C M^7;9ZT!DPO8Z7:UO+C)B9_66/3)>*<835+CTZ=CT5"/!Z/KQ=W?[)'ULNE:0 M+Y1^P[A*U";7[Q(`UP^T!VJ8QG1B0]6J6<7>P^JE`2A_T"0HRH7UG>X`ZZP" M9>,(7+]YOBV2<0)-RS6\7(J+YCM;G(%RA<(3LV5,;W/*>Q:QY(TO,M]9=:Z, M,BBKQH>VTUM>G?LJ:ZCJ\$3"-T1`5\-5@IR"7UG-+)\HL8P4GNY MW`2O7$@I>WVW6I3GEO'H?NQH)"$H[3U:MCLS3E.CZ<^)RQ4XNMV=#858J3UX M!F&+FL6S=)(\O(@.F>(Z'*/O]*=.^)3"I?;.N9NT4$VFH#3'Y3M7JGT:<:#4 MWC/;R)VZ[]TKRCJ!.%!ZSYL+6+_YD[W.I*$5H5Q1DV=6E;)E4U&3 MX_5]G6"?5#W0U)Y&-W:KVU?&9 M^P!F+)ZY+XZBJ)[4*<=_`9Q$B8QE=66.>O=,1]JXY8^H=\F-%_#NGFU)#S1" M\M$&G7J_L6+,"O\YN+[6)2BVA`'QKSHI&VR7\%/U,8LW4+:A"&\+_B\WV=U( M?($MM!KL[9UZV]-=M@FO-I?VZ9^!WBQT"64;,]$,L#YD"O4Y@Y%V*W#"RL/N\U>@ZG M94HP4*[]Q?D1(J^K:1#)-J"Z0O-H#2ZRQSL(BSRH(+KV,3^'3\;A[+JCS=Q3 MWJ21G!EY+2XZA7`&@]G1@NG:)5V094)G\"BJ<>$IQ!L8S)$>3B?Q!5P_BG2: ML)W:$0%7@1.G>6?O^/;FZ7*I;1J[Y4%J5R9OZG&W MB:PF?V=A6KU$,$&>Y\5KW@:(OGT>35B11*%\2=&IR_%XO.9`>K5@W3``0\TY M?3F`K<(DM5Z8HW)YK4QM95%J@IK+^K*@W\.)VKZ`5>$(G3K*:MN14.WKD+4& MB)I+NFW*:"QJ+KA3KG7V+`YW`"0IR[SXX*[Q\K5-5!;D/227`&)M*`C6-@D8 M:I[D#R]Y43WJ9]$5EN>:<'E/1W5%DRF#FC?YFJS*"1*IP3NRWSC2.NK7)&P) M$C5'L5&!JG!E?%G,OOJJ8.:-[A(6OYC MP=1KI+(NQ^S4[5][@R,G19]($3QJ[M_N*:6U`7+'K6HSU,?I&X^0%L%!E\LQ M!B$:AV;Y.1^OP64G$&U;=_P(COU*;'+_[,V/N7_`4L&3ZLE7RDXICL/EK375 MU7%=!0B5WNPX4PF54^52.8[%;XA97,%2(I;$1ZCP9FGI3P6M%:H_)\H5R%XD MP_^L,W;P!7Y_*%]W5LMQ.0ED@1;U9\'*@DB/:+>'L4.EW2--[1[-Y3LAX!]H MJMUEZ1$O:'L1!<^+!!:D))3%3^Z6X0B\QVG?X.J+*0`AQIZ3QNR;\JB_RZ5` MMB.GKLEZ094%ZI(H=4ET1*T]#OFVU4IC71RF7]6:>-#CY*W0L\*'>*D4E]%W M5!EAKY1H=TER1*OVSKJSK]YFBJOLM8)\/?$=',14MZO"(^JUYRPP^_#C>ZZG MWGE!+J'O,!VFZET5'E&O/[>`V?OT=NT^SR>O><;M&2KW`%D]KA;OR1]\N`EH M*`7I`-X.L2NB:CZP6RG/L?E--&%"@9@\&3"$-&\.`_9(H['C.8/"Z".J-%S)`(!?+LU-O5_WV8C56.+V9#)#O"@[<7#-_"'WH\=,MQ+`1N,;1Y$,B. M\&#/L-!ZL%TE69A%^&4W5I1+Z=(K@=IJKM`#PI:]>`@KGY:;BH6%N8`("JW%^#`DLII+-,V=:]`"@MSB7T;\&7=6*WY)1R( MQOV%>9^9(,[3L"QOGYN0]+K&T-4Z'..?VA"**`0)@>0O''Q'3*4Q;;TP1T7# MD5BE>#%=*"*$)V]'>QL\T5B^G!"F6L>.>A@$D'7L@14\?5DG;8=\*WJW_]/N&FA=)2^!DWT/Q"!)$[][.^?,H61<\\T+R5'/) MOH4Q>\R;4%KSC=!M,5&RY[19A%L4;W4 MB\IR>0E$TC4898*57P(,(4_^,H>OEZD#H]F,ZG&D19S2X@0MBA%=5!DW/E>-QNZYS;B=/M7";UV/L#CRA+H#Z[R M$UE5$M+%[%F]!-*V64NGC_;C-AKM75U$+V')[@J>@!:]6.O3&$=*(+B/[>XP M6"$(]?8>Y`B$:R)+W;/7-IW#!2NC(FDD,&`<;0-PN;5ZT"):I0>$7V]VKYLD M?$I2$)V5(P`^8?&>9"D0E.:X=GA>QQ$C3%ITZAFXI)R'<-!/4^':;O<#7",$ MTG)L:HP/4A+2;3Q&.`4IGV`9BOG[`S@.A2UK!?=.Y'/8UX]%D6G&G]%[6,2W M#8:21PM@\3)FV5G!P>>X9@F\XG"6^M*=RI#.:,]#JTUL.P_LU'Y\&F""QU1$ M-Y7*BAP!@2M7)W..+GB$/GN13*87RM/71K?%?3)^J?`3H[(.EYN`Y[43TC1P M(TFW?'MJ+8M\^8,543(]ELS_6,X`J7V$C)H#S9SNX/'`@DJ0SN+-*GA7Y!%C M<7D%RFN4D'6%EW0+>46.EL"5FJL.H`4>H9I(JIYO8547/#=16,F2F..5.,H= M/B(J@2/TVC/G_2-,:W;'BF:C@*W+2X6X9#NX94:!(A38CW-SE1?3+?CM,T^3 M>KN2)A7=-6G6YWAHQGNUL(,RTP'"J;,W<+^!EJ>P)*N>9DV.85>/+]KH$0:= MO8OK2'('U5A1L%@^++4;X(AV]61CJ@2$5F=O[Y831UV%$6N6`$U.D=J`Y6P' M#R;F&D#8].83)CQ2S:U;+.*[+^[9'G*CZ]>/H>=7_9:YOG;X)&-'.TAO\N9R MMIC!FD<3R5L2LRPNK[,HG[#Y>Z+KR6L859*N8](,U\0.'X=ZJ`+)R9MI;WIN=Y]L:* M*@%`(%S>>;V(#67=^AP/@:>S3H:UH0X03KV]_1Q-R>-81M==E05W0T9<=--*8XD;VXKT65:'*9SBLBAYY0^"F[L9[7$LKLZ1[[!5Q$`% M"/G>3&3+HL,1(,GC))K*/,>@33_6`$>_@Q:27DH0=X$S;XYB*[-4DW[\)F^= M$(=]!TWA(\0[LW9BXO6'A3+YO52SVD+N:3BIZ6.&&0C9(R%E78YYAXUHNO@1SKW%-%]>H3IFH@6@QG(O MXUZ[#:Z#';2W]=4#TA>\V=S6^O!HPL^;_<;_:EV.>8=M;KKX$0Q M_RV#C[PW?G:X*Z*\&DB_MZNG=#WH"''VW-8>BS`KPVCV>4MMXVU]D.'[!MZ0?I4_;>4B[NSJ%C_SU/H?TIY%$6 MW]956859G&1CN4.R62LL/MK0LSRZB62-9K;P%'0/9M8F@PQDVO5`P#[ MN[KMTL2.D6?/6:P3KP4DF?FM=5S9\!LN144.85>W9+K@,?[L!=(7+@;77,MA MBKRZ-?(!E#?%8>[J1JV_.C#6[?F(F3RR'L7_K,M*-A'W:XV#W<%=UG"-8/3; M>WJYM'K`";Y,X!.-Q],]BUCR!FC?6?R8C^(WD!>-]VS8#(?WI]A:::L"8]J; M$UESBFSA7\`Q(!NWMZ[3HR:_B9.P=OL;05@#&NSU[V*(_=LP#L,M? MCF2N'MBRVAS,#EY(F&L`H]-!%'[NCBP/)B0HRL7=I$O/75[\6>5G> MLS>6X<$-L/)Y_B7*)Y\;S74[ MYOSE^RQ!XTM[97$!GXN2"G;C]RQF;,(5L[BVN@.0&9RUJB0"%/_AXPP]%7M. MEO3,O%H8F/7GQ#@7YQ$QW8L+&D2G?T_SDL5_^ZDJ^#HSA+N21;^,\S<8:4E+&_RPRA;\ M*KAAXS!MLR(@^;T$I3A:.NDW140LN MQW5]"R07*WN@UZU+9=-(A#5(ZZI<5][\7&>6L-GUQ;J]LXTFN;3UZ)17&9`' M-,T51^`VT7A!LH(:R4RXP;W;0S+.$MB:@5"CJ'ELRQ'`;BZ";=D%J\(D+??- M=F18"G+9EV3;+H/:L"G>MV=PDGX3VVQIUN22NC3O"G=?YIH4G%6TL='9GUG8 M6W=SSJMRLV)U0"].38A:.SDS#A7;<02ADXW>8+_5-E";*EOG>F$.BDB&587> M$0,?ALC)%M$O330VD4[X<4O>\)T>IW:F*)&3V55B*-$ MZE<&0(<>O3RMK(,F0*7[/`N,S=V2)DBH&4$IWJD\NG(9ZU!`@1`0DBV(F'=. M?T^/&V>RC:I-._" M#X7Q%JG!X7F\\++$K!P<$BE&A[)O0_'$1K$*39;57=5&59-#7]QW/[S5*]ZKJ@'0SQ^V M."0R"PG\,@$D$IG__C^_['?@":(J+XO_^,V[K[_]#8!%6F9Y\?`?O_GY[O+M M'WX#_N?_^#__CW__O]Z^!3_!`J*DAAFX?P$729W_`+]^^__&[/_SX_;?_"_R_-Q__/_#A\QUX"YZ?G[_.,(>: M_'J?5!#@CA75?_SFL:X//W[S#6G_Y1[MOB[1PS????OM M^V^:AK]A+7_\4N6#UL_OF[;OOOE_/EY_3A_A/GF;%U6=%&E'1=C(Z-[]\,,/ MW]"_XJ95_F-%Z:_+-*GI4!G[!90MR+_>-LW>DE^]???=V_?OOOY29;_!8P#` MOZ-R!V_A%M`._%B_'.!__*;*]X<=Z3C]W2."6WDO=@A]0^B_*>`#F2SRA1_( M%][]GGSAM_S7U\D]W/T&D)8_WUXI!?IAP(L3?8-[Z:N?-Q#E9?:AF-;A,;7_ MGG^N$U3/Z'N?WF?O[\HZV4WJ=Y_29X\_P6GCW-%Y'5]L-.&T\>U1+MWC6NRM M\Z`*H[DC_[[&?1CT#GZI89'!K.D?H=;85UC4F^UE M7N`%)$]V-V65D[5@?5^15:QNODNEI;WY;S?R9KR:$1L(AV!5'E$*G4:+S<.P M6\F]8[?P0HF)R7X`%F]__OR;_]&2@("1RR`5=B1#W:'J'"^_!S41U@FF]SF%V4^R0O='!1T_B'C*;_*MBL0*\U M^(6UCP%%IKD0D&0W$0$,#][9P2O\HY75Z34.9W+Z/=8L1Z09H.UB`(QRN)4V M1S'6_B"RKBI85Q8;Y'%#[]`0>CJ&!6M@W-O.[FC=.]S-[6UXT,H!,`:L;O;] M@?4\J1[714;^\^'OQ_PIV6$5JM;U>8+02UX\_"79'74[;4MZ[]"VE6N,(4(` MDB(#](<>Z0HD-6BH`25?`>KT.9%./$%T7YJU8K:@*?D!=J3A]<<)DV.UF@!( M?]IV@^`AR;,/7PZPJ.#Y$2'<.8UV*=I[UR95O\>@XNT`;[@"O&E8%7'M/60- M*ZH>9?T($4@9$4@B66*T0!JKA`6*?.^.S-`?M0NT-U*#A?W]U`BO>[<*D[M* M5ZGH("P%@GR3%!BR-Z@\0%2_W.!1K?':0M:5`SEJ?()ZXZTC"V##M5*(QI`U M7P%*0&UA2[("F"B*[<]$J:@XL!.G@$$UV%$*_%MPD$H27JUME$5 MX2X#>0%J=*PBT",'_(W5R1E\_K2*]*3`O%_T2^>PF7<]&?52!AKZYWB60=L> MA\>U#`%C`*NGW^,Y)4W+(U:8F^2%7'1:'%@4!/Y/+JJ>"T<8WA#PEI%8RQMZ!+NWQ&"2]1E$:+(1X0XVW)-3TG?SFV7)/,EF^ M?_WM'[Y[]V]_!!G_QA>)ZHI:U#W*%) M^BRY@V*M`&VV:FZ:KZKJ"+/0OE8W"2HFP;]\_>VWW[[#FW0$G@C-'\&[%?X- M^1^H'K&>5R`YUH\ERO\!LS^"HFQ^FU.9V2W` MX(,V$+Z*V?2^^/T/WZV^EW]O]"?Y1_^(ES6,_(R^@P('^C&(U0V46_`O[U:_ M^\.[U7???TNZ=@%3N+^'"+Q_1[OW70_#80QOK32:+KGF MU*NYQZB:-.B4E(AHDBKH1X]DEE&7^$D MNYLDSZZ*\^20XP-7KWLZ[Z0%L7]/I8U$@M>O)0*$"EP5@-.M0-],G4@7R$:^ MH!WXB>P'BE0P[@L*2,)VWN8%2!E=T.C;2:+<7)V'5W1[Q1$\M(Y:X_-ZND[R M`F8?$E3@U:!:I^EQ?]R1E[(7[*BIO9TV$P>XG+:02-RZ,B+04($W/3K`";\Z M[1V=E?Y,$J\O"_<@A+YE/Z44?N_7;15(O%YWTYZ0?D0G_V$4?D.C/^W]#W_4 M.PU#.LBMY&%^\DKM)3R1!`?V#' M)VV7P_IC[?VP$5RHK8O,R>R824->O:FDT=S'M9&QM2*ZQOO5G*T0PGW="J#. M%5C!](@Z"9W-5:!K/BT>-7=_%F"TT:_J.4VHUGS[^_??4ITAO_GO,V9M/C]" M6+-5ZA'6>9KL-!=]MH3>],5:$F&A8#2`$H$!511Y4]RFJ`'1E/D)\%"=(1D? M60]E09_"66;*D-.%>[ZND$-8WMG6L&L77PH-W8PHG[6;IR/4]2N&_0;1?F;4 M/WH#T6?BN;:^D54S"'Q)JY',>&^+:<$&`4;-;DP`I@>404SWN).$Y#<:[74& M>),7("MWNP15`._7V=W%5^&5S@VJ^BM%.YR&4D/:E6K=7B59JY](&%CM))(8 MU8W1@(XH)A5S$HBKEG`5&<-]Q@GFJ6\YHK,7*IW2VPF]0H6U#^S.WM$V-$11 MV(56`ENLQ1"F,%&0H2W(-8*$UI$AKFST0P:JL+JQZ:(K'!5D0!F%E@QEL565 M'E5\^F(KTE!I2I-(H35'@CH;]5%"+I0.77 M->C(>2!=;+`T3Z0>G[:S&"0<UQR<$EJJD.IE<#!74H37 M#>5)5J87T;T;L),ASJ.X`49&10A["+\JTG(/VRLNBT>O2HH`.6)4?1>3KY"6 MH)=B.X(K;\LI$#.S6(R_QTMNN,,\'UB)MMVZR-;9/B]RTJDZ?X(\XZ7NMMN2 M@?]K;UO)A&!)1KCB=>MV-'AG2-RE9PT>%3U?S(>>F,F`.+QRN<%3N/J?@$U_ MJK[,L M0A!5\YJF]0:M`*6B9I;3Q7`A[2Y:)T;&VH`=49O6*^3D*_)U6G$7DZ2('0H6 MF?M;(RV7C>6'(>'#4+!A*+>2:W9JH=BO3V66 MG/8(IQL%+KM17I\F;)[2CRW;$AH?I&`QR7Q]N2N?;>JPZ%\;WM.H2?R?`]6]%PZ`@Z;$ MSI/&T3RE,1N%3#3S`5A))1$Y,"MI\A9KC]$!!--O[S:]TD!1C,N@2H'OE2AK[?_4EZ['POHNEY7U+FH&F7=`\_S:]_E06;%'+>9NF MT'EX_*MQ(CPU,X#$:_`R@DD%+R#[[U71U'/#BR/,G\B)68-V._(08CV6&0`!G=#>2MN M5/Z*Z=BVO!NR!G9P?;[,BZ1(%])G+;-8]%DOL:,^M\Q>D3Z[#0`5GK[FV+:R MO@9EM@"VI3);H]IGRILRA3"K+O%HG),@[/L2D6_I+GTU-`&2VJC[+V:Q86T9 M"`>M0R>'FBH$=7^P,QP)XZS!1X@>(`JO2T9=!/G$GM7P_F=][PW1EO"J80:6D.7`$E5^ ME<.@!H$`KX!V^`HTFLZMP'U;>:;8Y^]X M..QHS'>R:V*^KXIMB?;4(V,3RF_+P;]OT%HVP9SL]WB MDT;Q,&G%MR3V:P9M)1)R.7&Z^!=OISD;X&["A,W`%KMA(R;H3W"7715WZ%CI M,C?:$/G%DDD",;:I:0\(`3YX`4H2#W:LYF2`&8<)<3W^5S#]^J%\^H9=0;/# M/_MY?.QGO^WU1;=]TS7VAA]MCS6X";]E.EW/?:#9H4M=@Y MG1%U9>#?2VHKF>`_[`B!%(+!+7`$(GKUFCIA5'":3@"H/_V[A3L2;'Z3H/KE M#B5%1>)R]$U+O.F=W8.T$EQ_T?).HUJ=E4"(\"%X0 M(AY3Z_W]F-6F:`M8V*LB8ID&,<[&9@W`PLO*+J&F"`TGK&A"1%,T6 M]]1RA-0)LQ_##E#^M()D:JXVVY%3Y87]OXV*V#+PKB_6DLFJ+E0D'SYPKO6C]4=;['>U7=JZIQ0^]X$WHZQA5N0$XH M;1-W4/DRT5:BE+-$\:D?<@R-]4`'()]U8(L*#R$OEVYMA?5D`2K":J402ZKV MFL>-)9OY$:NLVDZ.3]=QD]:END-)!M=%MJD?(1+3OJQWN_*9I(B]+-%%>;RO MM\==TXH)H_4M+_F9`,[G14=)]->V[%>`?H#&I=%/R'(EK4#[&1IIV7RH;1NW M[IP"3!,@8INR]+*Z(-HT;MZ;Y$)-IV4S&C)C+ M6WA/]BBV1S4+&K\1EX;^BV:2-H]NN_RJ9+%Z*#!+F-!1_#9:,0AZM5<)KPE% M#A#5+S<[$NI29,0%?R#S9K\6V+,(D6[$5CI)X@Y*BI<*0DPW2BUYW.N'ZYQ* M;N&A1#7,/D)2'T[G8#>2^O>SFZ41W-2< M!,.P)0(-%?B%T44`1-N)$KS63K,T8V-SCO(:HCQ1U%"3M/&[<1GU3_!C\#\' MKXNF',S!^J<>R06F\*+<)[DL2ZNT59AI;/NHGDC6)):I'`ZJ=#)E([K`="HM MN;15F.E4VN=N.H.;8LV@2J=SJH$];8#IV4O_+X:*ERY,H@DOE4IH'V^Y(MDI MAW\.O29,GU/;>$O3A(;!K7(ATC4.BD/ELC0"5/"UR3S<.N@LO%)]AKOGY.4\ M.>0D)=XNU:]8JM9^5RYEGX43!FT(>$N`FQK6,B^^K\G=OSZ/92G6HV:P)-M` M)E@XVQW^GF$=5E*$#F7K]=T4``9(VVB64L,<&(*_Y!,0%$'&M5)#$P.*E"NG M`D?1K*#&N;#`TM3U]"1H,GO^Y.U#HTB]A(T1%'X!LQIZ`W#"+F+G)8TXQ/T@ M,3)YQK/4G+U8+&<6M"'BGHSR2(*?.`T8$('[E[A6.^O)DL0_N6Z)NS8JI\I8\)RI*"GQ`^)NA76%?&DZB)RK,OU22# M@!]&T)[M.(G%$=6?N]5J7H;N5X=)F8&8-7S(*_Z1\Q(=]$A1M?:+$&6?AW46L8HESLO;Q'F4 M)#0J+.9"D3//,!%3,^9E,&=[&?S#>`N#?_7?U_`AV7W`JYOR"D;:RAM&Y'T< MPX*V`*Q)\+VN9EB;N3>.J<]KCJI&>4H>\2?5X[J@_R'104_)CL!2_EOCT7P> MVP!7)[-&05IGC427T1]Z%!%MAI>8>/%J9JE9]_@Z\/,=J>-S1"^?87I$M"2< M$=XZ(O^O!G42B,_N0-,:=,TCV%79SX?PZLYR,OS69A)Q;G)&:8B"U'%22N!@ M[F+Q.QDG1%:SR&8VEMFX\R_U]H`66W<94;#-NU0"W?:]Q$1)ME5''92_OCGW*(\*`\OES#)SRV^LV6+0/O M&R]KR<;X)*T!;;X"+4$T&S"W"1MOQJ;,5@`P?J2G$%J7KQ+[:;P.=.03#IJ6 MQ`MU?^M"-QE4R:8*5&':?W0!0OBH.Q[JBJO7.Z`W14H6#J50&'2@9 MP0I0$O`N(J>(Q;PH\6::E+#H^FX2NKZ+"EW?34#7=Y&CZSMW=$DG)2RZWD]" MU_NHT/5^`KK>1XZN]^[HDDZ*[US2)/=U6>"5V[B94[0/E%E:[+,^P[OSUP0A?!J^SI/[?(>_HP^V4;7VZ\51]GD,`=X0M"TC,"(6 MHSYP6=@,^:F\>]=Y`:]JN%>F';"ECLC+UY?)V=-'B`&ECM?=IQ/PG];E)R#5 MWNVG@&D$V8VL(OZMJ./)::2-^C>D,XHJ\-]AUJQ3%X4/_O^28Q@9 MWKP/&WG>J8QZ*,")_3V6;:MT0(7O_1DC1 M;P$5I-U;TA"0EI$MC-K1%PR$>>@#XL;\\EM%$1X[ZE??#JCK"30'U*XFLI=_E1-K7\?R31H"V`KA9+$N+>I@'ZXMIC)>8Z+OG MTG*B>RT#372_KYJ)QLVBFVAAF.43K1CC128:-[/5Z4';4),]Z*]NNDG#^"9< M'&[%E*O&.GB./YU#U)XTEGQ^.D^A\O!JX03U^^C';J(LT_4%=P9^KG&WB"_H M?)=4U6;[N2[37TWG%S6-_WVHIO_"*PO2A%3_HHWB.<"8ID#8@MJ-O\?7.KU^ MF'-V2!K[?YTCZ[$)+]$<6=3C+3S",0RVSS0O^WU9T/Z<&V-*9(T#)'*1]%C, MW$(:`0:5&!(JFL=;S,VB'VQ_&%D?Z:+(,GW<8,80(9AU;Q(IC#]#A'\T+%'. MG+RCRUU6(;4'X\"3O8"61^]5ZHJ;+L8GFA5OXCR/@3MKDJ-$]5U>[\Q>P*D, M8\;X4/+94%\!RC"B-7L>"F9`7PD!CX<,IH/F=)3#=OX/$Z-^BAF4D?FI_^Q> MVI9PM^OL.J(]B10'PNE�+?B#VS1.Q98,2>F4!P%AT(SFQ`(!W7<+F93;$G MTN:A<^DJ(T>$5+K11(1HAMV4@=E?WB^6>$JY5Q.;>,WX->J=$*O.$WT%WQVI M1K*?YTL]C#,N9?X$DUW]F"8(DH2")4M'NMFN]]CPI(9"2W:T?B]M+.49`Z$C M`STZXO/BE!$L',[S-;CE<9\LWT]BKHH:8CS4]"XJVR#R7V+'K,)Q[5D$>CAC M)9WB+4U#&U?`D>NLR1_8N$Y9+*BTBE.R9Q$9*K613&-4,F*P0:`ACRZXR74N MW;!Z@O"G#PDJRF-]D[R0"Z[/C]ANJY,)&BG\KL':O@M@8HT!;PU8\UB66_,T M#!99VSF8`XP*]_[9`(5!&\^3/^R?,-WTS]%,KV0PAQ.J',D94_@Q*9('>G%] MA;N(=_5/T$;!C61^)]HLQ7CN.PK0DD2F[Y93,\"(T[PL"YM/93T!-0.JX*`9 MRF"%&4H2,60DTV)"C').%BB7;(R@EC0,4S19%S_=UDV.*'I:.<+2\LG+QTXW MG(VATY*&8698%SC=SG!$8=/*$9;.\(R@Z67.K.0QQE51U8@^9C?X3&2-O9]# MI3T>(X,T`EVK:%P@ZN$>'R!-8QT*(I^2O=F-H28)#)=![PV@60'2.B*?A&DB M]!!2S<*,U>0&=S&OJA*]D-V(?D&1M_6[IBCZ*\ENP)O1C6,L*XMNM`>+BWFH MY[@3OJ2/>+`@3W=C\C$I6GMV,:CZ+#@;>$/0M(QE[O6C/O1`6`SYG!WDL:K+ M/43M0<0."$8RS[M+HQ3"7I-3]$Z5L8'$9D!FTW]"-%$[-C1^@60 MI3QC%%$R\`JPY#)?`T"Y3Y:_G2SOA3$X;=3.^YYUW$]5NKSP6-&.['@_JAE6 M?Q@X.U9Y`:MJG?[]F%[[&"%-2]!K<AV#`%8]A8C7]8 M`)$?$32?BRUHHP#56!X;>*U`0Q;1D=EZLFQ`IYFI.564'S!/MUE+3U7 M3Y;U57ASTC2*R?&N'N5AP63#$"\QST;?NZQEH'G6>=^[>8[(_:X>9?D\!W?` MGR.8Y?5EDM*DP:9"C9+&_I_WRGHL7LV01J!I%0SWPUB'@H@Y3X"T M>6"8J',%C($2S=Y!-^QZL(1]-'@+G\K=4UX\##ME//4:Z`(DP]'+(6;"X>V! M@*G@:Y/3W(@I<*PG9EZVK;Q$]"4LS,[+X@FB.K_?L4`3Q;ID2^@]#Y=1$DE2 M+DP#.!'H437!0X$7,+9FQ8+A/\)G^ M29]0R8Y!@.Q*EI()KPOI6WP>(,](`:-=\),7H**__BKP^_%_&H%KB$XH+DMQ6%&AZY+]\%CN,OQ1LVQ>W\TZ MF2$QJ9B[#9H3%TF17N*509=R!M[CKI0]%@(N^#MP`XW!$G3,F!= M=N>>DX9@?>*>6U6>./ MJ#P^/-[!`ANTS7:KB7QR8^)9.1TE%/##Z4D=C92E=&,6GS_3J!D34%,NN!5F M$U*C%Q279[#[W!>7,P&,"]B<4%P[,Q#-]/JS'5-T=FA3IBOL#%MSP>>3U!FB MB1NNBFV)]G1ZU_=5C9)4N<[;T?JU+);R"$&XG`RL24TIEFZC1XG/X9PV]%G< M9;X&\'*?K%.E8FEZTNN`*E>/OKG7%"V:7BO!-$!0Z'P]-D/?S^-B-^ZGS==S M"Q]R`DT61ZX`B+QI@/P]0F\5>7RZ=C36/X9T/O*!%M/ZZ$;YM%`XQU!$R>X* M+X%?_A.^:+$@M`T`!K&_"C3PAH"V!+AI#'A0C+8(".U0GPH1YT>$\'5AXF(:^CQ"[<3^M MV;C,=Q"=XX\^E$AO-$8M`YB,<5\5!H,V`TV[&*R%=)!%6Z$9X5.!X`XE65X\ M?'[9WY?"X',91FV\3ORX?^,IYW\'K$'8N9:.97^6-0-YXKW!^,"\.=95G12D M-_J-@I8PQ*Y!+XEJ"]'S"367.J!'&8.-L)DCR?;">H).?5HER;,,)U36),BI ME/=.>1(E?X_CZ-D?1]EQ4QS$4\WL&G\N(Y^\W"4J,S%JXW5NQ_T3(F&;OP/2 M(.SL2L>R/[V:@3RUYK*;4?T10=$VB"Z/^ZM4:M8PDH.!=K1EBJX9ZE,C@IU( M6`]DP3Z&]D&0(>NW$AW\[,A!0IO'@1#EZ,M08AAZ/T@A9U=[G/1:!T1) MO\\FC%#_0G0($49=C0_%D)_VU/%7N-O]9U$^%Y]A4I4%S&C,C>Q"WH(FP%E# MW7_%,8,0O/V54("&A$6-!;Q\M9X.\6QA-1>GA=!?RMVQJ!/$7",J\Z)H&P`R M8G\54&D;,F]58+NB'6P1&-J1/K$G@[E,;^&A1#7QI=1)K5QV]"0AO!>JWJO\ M%MS-W1(`1A$#6O0S(?%46$S#G#@-^`1WY8'F:ZZ3!WA>[@])\7)3[O*4__\= M_%*?89Z_*N,UG'AXCMMPDT],HM:2`TH/.`/`:,$O_+^$":!<`M4#^R>3UBH> M;*ZX>(^W*ZLCH@%A29J6V#P3:W%@4FY+!++>D%1T2%CL&/G.UZ%C=B;H[C!V M9[+B^GM5+30L@$8RPTC`F'"ZBWE!1BSE;..^WS4,`<%XR<.\R'@$?W%$ZQJZM:RA[B: MQC^.-?T7P-JVC1R+ICD1`&>/"7J`#M;31!@@'ZY!$G&+PTL& M$^#41`'`II%`!%K;.':,F>9%Q)?=I/A- MZNT"*DGK(*F\;6!T'_ERJ!E[60KO2!!#HS[.DHJD$-@?8%&Q@I`'^FRAR-I4 MGS=X-CC*-8B:Q,W_,_Y),@OOO@F7M_>$#>CS60'&"21%UDL%2YE%#>`94!!> M3\_%@=>\.K`XPEN8E@\L.X*]`;6@#9%?QRB/),<.H0$]HKAMK?6D29+NN,R8 MQVQ@955OMI^3G1;'KQ=2CR_1"6D#+H^FF5VW57A+`O,G\@#X M$ZSY9;?.+FO)_!MEO12"1>;-0=>>),G")WQ.LP)W99TH'N3XTI:I0J&V?7CU ML(&7L))88\N_J_XR+TCF.KK"?<)#P'J%^V?AK=?0!G/8Z^11^NPY4;.9Z>BH M$H55FEF";2D1V:>E3+1")4Z(VPAPZZ$BI<8/((H.Z>?0O M)8<<;ZCR?S"7[!$#Z7.YK9\3!/6+IXG0OY_))(G@:^H(0$,!&A*^[8Q@M^DL M5R>"<_Q;4/$6;*4/O\C;*8C@ZG/0#H]G2AJZU>TT=.=(H:G_ MLZ/86^%HQ4/S^CO="%36HN>L-&1"&X8'N0H8P@E0BPK?0#;"-QAHE5`-:8Z5 M7:,:$QD6]0@,A;OK/+DGU3AR6*V+[',OQ_F'OQ])W2!UYDYW%MZQZR#=&$(] M4AK?P`B,Z3M]&>1E)%OA@V<&X9[LUUGMD$[@/L]__>T?OGOW;W\$^)B?IWD$ MC@I7V(Z5;AIF@Z@E=T>Z*:)`%%+U1`FTD&S>\D6H:F9)FL[O.J(?HU(7!9PT M"J+%DM?K(W2$F=@Q_=V1BB;$Q9&R_Y(+%M(6R/0B^$V1LQ3P"PF,4U7[\7Q' MI,>0Y(+(!D#^;X=X>)?%75#;,MC-3]=7Y74(;Q+'A8Y%?Y&NOR%N;$9X4-W/ M2,'@#[VT8MM-\D+VFV;K+6WM'<7R/@N./EIDCS>+ZW+?3H`SE&U5335;_'`Q$)XH%`!0/O5WO7D!2WN=_E#_2VU>(<8"(, M=;6GED1QM0B11'(N('Y1IDINRH.K`9=P1)HLO0C\P>0J(NX9W]$O+ MI"$FDTWE)\]W"(L6=T^TG=50!$F[H9!`S;K2M:2#;H'W@ MO>,L05*S('[3A1B1)>8+L825/_VX@WN\_4[0"PO\^W3LRASFBF'LF>AJ>P# M@'Z!Z@!;)7H?B29,\'2#U8O1K=H8W0BB"A=6G;&Q.(G>!#,LHP[;VPN!,+09 M$"4Q:_=8EZ-25;-`/0U,6874BE5(_9>OO_WV'3@D"#P1TC^"/[S_8?7#[[\' M%2N=FI-"0!FU7&4,553=P&G02"TR@RG:.3Y?O^!!7N]):H]U7:/\_EB3N;LK M;Q+#,7`"K]#J:"6O64,;-H#Q68$^)U"7@/$*>6VQB.#T91B2K:C1::4]D@V* MZ@KC&>DY;O#,/Q(G\+97<)F:A[M'5!X?'N]@D9%E?"NM;S>!A]^D'H[RC>'7 MD--`M5ZM;;[#Y3P`8P(HEY`)*V9*RX1BY7/:11,(/NDC#_8+FC&1Y+XSM"JSWBD8'76T^./D)Q*5:JD;N]7 M?S3]%G*MT*;@K%F>F,W>T^;@%T86LN#=;%'T,GB#NPE*`XS;X60BO[WY!&M.UHI7'>=OS"2$-;((>YLE]P91-U*CSIUUXK MTHCPI%S&S'B*8T5SF"M[/$U=YQ1X6A?%,=E=0EA=DD^BISR5WH/K&OO%C*K' MPF-[V@YL<4-:QK9I&O)TP.T%BP#"%L@909HL4Y4QQTYJJT?$(1DV,G5 M.;G<^O#ED",U@FTH_<+92A8Q$*(A`DE#1:,A"!E)+T'H`IY)Y@K54H&&#'PX MJ5!6VNM[JKSIM;T^#93<59G\'KLK<8M8 M%6=.W@]O[K*.(=IR`"T+T./1"RXQQI;X/.M-G.3Q$7#6#$<":9O2.K8,X@*P MKDZ-";>_1%6MQFT"G5`:O)+-Y_019L<=W&SU_:0WK!98G3MI+FT#%N;WTJ4D2;(ZU M2`E,W[55KW$_+K$$[.'0,2\>-@>(V%/S,XB7)MC6O(35Q[PH45Z_7!486;"J M637V'A<6&_D1UH\E_LL3;D(?)FDTU&LO`E6`]37&BBJL;PCE5X#@%'1=`%T? MP#WM1)./G[$&/=XKT!5T)<^(/GRI45*B#.]AT`N[N6\ZAC"@63,\Y="GF-X`-=:=;C6T5.$JK5O=5G2+F)+ M668]GLL329=LW-!ZLACT1.=45H#+Z#@.J"JG$">PMAC=W?8@"W&?T]1)P/UC M==GPAJV7SF7"C8XCQX!W.JZRZ_9/;:$,@E_&C3Z"[E=5L[W9\:6@\8]$F#NN M23JAON6:H1`A+,*'[1:F),=9:[ANDQK>0C*,N,M3+WJGL`UH&R:-@DXM6H8] M;PT@/,&0:<16(OXQ"6,OIFN,VFC,51>O^=8.94%\.#)39SZK6M*'R,%F)9P$0TF:-E<,SG!1]MREVC`3L9U?%Z.DG^I# M6[NK"^T>5(WNP/VG']IEYM;H8I:W#3;'.E?Q<)[C\07KAELUX<%]NH*%X?DY0IKN;=>(2K!2FG8S*%:9;-5>@Y0#HI=V`1]B,V'-$I;*D M9EG\IL=V!JBJ_J8S.F?87O&;Z"$I\G_0S?)Y64E#':PI_=IE*UDLU`;TZ0`E M#/AN;))45T6-_TF?_^HVF[,%L'HC-DD"EH:L"3-(=A34O`8<2:/(_D%^_YQ@ M!:4'ATS89(-DE*`NPV?%E+V+KMOT=EE.TBI!RH8&E91]`*2DAZ$3W]CKZ6`) M=U72)2T)+XO]@1?VMK8C`EU@*R+*86-#FKKF'[1US<-8$+-$=E79`YD/B^Z' M-![CF8_.="@44V\XM%H9\!Q`+@GY[WC?B&,"_Y?.\;K(SF`!MWE=T9309TE% MTD=T#8@-=#DP+/*Y\">+94;-Z@A"+Z>;/_"/K4"?&[WJ:CZX8JG=W]Z3;PZ; MD:^&+D;D91Q9MD\V`FFO>82GG`75SW@<6ESW`IHM&B[O8G@X07C3T?3<2OEI MXP@"IJVEN,R_D%3LD3CH];`Q*HP$,U'4%'**RW3D$U/=(:MX1VTEHEA#("=- MKD.AGWC")*TZ:1/6XH/$!4O]S@B2/O M3,C+D@/IM(4AMJ#UCED;>83T^IQF!2@5A6I+%Y65M9ZM,1@=IRH"_+G94CH^*J(1W5D$--A&Z:;`,P),NLZ? MVI*Z3%X$QO+:HMB$\QO):$VEI0.-U#*&7[E-F;285\^4/AI='5.1DIX%[ M=9E_(3\9+S@T--Y!I^N_<$'0M*4H:UKSFXZPMY.3Q%B!+6]*!8(-J,)KBA%5 M8P6QA)0_O:#[ZL=REUWM#ZA\HMG`C8JA(_*N&5H)A+#^Y@BK1 M.DV/^^,NJ6%V0:I\INQM*_YY!WDHS'I/ZG:R.%^E$!IU6^X3WA5SP=&1A,4V MK$&?]PJTW"G\^_Q78*0@JZ&&+*WK/[!1*N`#Z:9)VST-5M;C3<5/>DS#&X>E M%6IL1DZC31XWLN3]4?]*V^3U4A'XW\"J>BY]4S:,6(C&C:4??F'39S'V`:%C MXYK2$86'D,X5)8-15/XG\WP8\13'Y$2+_+<67D'7O. MDH[Q.+X-78VO4-N[TPM67.!+#>Z>X>X)M\!S_ACXW#Y;?HR@WX57NFF`'2OB M'+1&IYQ7Q=US^5\P0;IU8`*O6%5T(.]D+5T1-05Y@76T!)3;J]!/K?`81]^_ M&A4583M12U68C5%1\5?A"-7V$F-H,:WM,8M7:?L2S]=9PNU5J:Q.?`RF?WM%&BM@=[+"*H`;G;[. M5])X-7/^N33XK=AT235=CU#U9NI;*"6S2?VZKB]AAJ78?:Z3^H@[\C)HK%'` M1;A[5\YEQF0,9]O\PRN0U(`S!RWW,=$*W$`L]O*W8&Y+[&F&ZN>O/[NER)QI/]1LHS0A[-9;"86R8Q/TB>BM0P)H\==IRRW'/DIJ\#I-A4HXIML).,V9DKFLZ M\2%7=P*#;Y\4]"%BF^[KKPE"25'_I4DH)K$`"_/WFPEOP7%1V00`#54,6OZ@ M]P'`OP#:3P3,KG?"4>J$[R69"YF*[X2R/D)P(!$P+$E?C?_9R8QM8/T,80'H M4:UG+IO\A*!$C9T$2040)*Q@1KPXA!/'D]$D(66+('PAYRAKJ6-:/>"^; M5T(^P(-L?E@2P&>.T#;;8.@L@$L;N4&VP--8N`5,NFY=^50674)'GE"L*<'* M_VFRZ+/9AS'H\T=E^AYOP+_+!]A\HOE-!`9]^5%JA80G%=+)E)\2"SVK2DZ] MV"X/L5`,L``;+.2C88K%="YD3*268!?")<( MH@0GS*OP&F_JI'J,3'74EO\$B4-\D.5WV$^WN(-`#6T/AW5VOZ+^Q-V[:@;0Q^8,_^0%.SDY31$%7E^5;]\*FN;=,4F0O]9 M?DR22+//4](V M2$[T<7]E:<\I3DC1EGCV8,JAEF4NUXRSQW4PV24H)[="#Y`D4=]LMWF*C6"_ MB(MN";0B][_ZV4DE+'R<;`4H(;VR;$@'99&TP;%>%SZ'Z1/6/.>YFW$Y>`?1 M/B](,H;V\+0NBF.R,P#-A=COQ9ZM1$)L:@#9";R,US],14 MF>7>.P@!Y\0K'IZ)%0\9-[ZU9/R"Q@PL/@(5'X&J5_.Q;YQ!SD:@HB-0'F(P MV/.P/[S]7P#XI];B=9;EY+\D5G\9359PC%";5;)/U^B.X^O2:N>1,&IVTHW$ MJ]-NK4ZX:[B%0H1*V/5RD>S)F>PFR3,2IFF?]$U"&3AUETP60_ZNEQ7@1(!0 MK6C$>03/MRPG29_*RS!#01S*L*YW["1#2[C;.94%HI".95$"G7.Y;;T"K'T$ MV#+.AL;'K)V*8$:LUZWFI$P.S_8I"#4<0ALUC6QFX]81=PZ@%:#T$0#1;1(- MQLYN!CW?^K*]_<41X4[>0)27&=TA5)OZ47LW8D,Y`7;+%=?A:R4/DE0?@7&]O'\R)Y4 M)/X?:QEY"<`$,\OH_:+>2@&E-_0.VA?-Q:0,Y'&Q*)0P9H.B MEX2:M,\]-H$*-33]4^L9X/_!L@?PR-#&$>Q M9(UT$&=X.;N-WV;;BW4X.]:?ROH6II`$:*L`46#W'JT%Y&)TP.'(H3`!DBUQTY M>R4(O6Q+])R@S"X'I4@4,*.=1`)-$CMZLNXWCR5GY$PQ5FT&*Q*`1#,HA%]$ MS#!3IZ_38\RGAZIXP`>R_06\K^_PQTQO#Z7-`_B>I+T6'4W%PUO2#I"&*T": MQO/\4#/RH@_)-.SA$&,.NU80!$>-.NQ:BIMX(J^U,V#"3N#(Z^20DSRG)'WG MYG['_?7FEWX&.O\1V08YA#,S:\_2S((>14RAVC9S(X1MVT^,1_]36S"=[4I? MZ!M74[4P+95_GY-6!N%,Q5N3(P<[2MV_-,D<8JD?9C$K@B/&=DIF',S7)*5) M67Q,T*^P_@S3(\KK'%;T@Y\A"0=7;(JS:UE$JHE,D+`*$%'RE'%B(-O MHB9,W.#X.F763@HQY2[*D3XVF"GW6+9`"[[KFC2!CF";NB=3NAH)4YM';OKF MOMV)JEZ+#D2*C?70=QA^(V4S^",OFL7(SP!"%Q&C1X#8SN_42_JIB58Z<:(, M*^>P6X_WM$UH;Z\*#0-(ZJ$PVRB=]<"N/O69"$(8)GG/%:;I;&":0N=V64:* MN`RL!D@2$VM$D7)ZV0-C)SS M3,T_7+B>+F(Y7CB<+\XC7O[4XR\[8$236V.=_>U8U61W?5FB]9YDVO^'*:&& MAL;[$J?KO^#AZ/TYFNP8Q@D8+U>6H^\/0K=XC$W7U+TVWB'2[]\8$O1OP9VG MRI$/Q)E"< MC0C!FBX#ASE;]_8VU>+`H$/X+&Z>M_U39=;=L%L?*($1TG['9:@'\!TEYR1^('>NJQC8Y+QYTSD8M6^\X.YJPX='3I*F8-/PM8VD2QJMGU`)DFKR?!H1%X:/_"965[NAI)HW)+]]( MXW@NH62!=<==J';/F<:1/,\690XW"!*(S=@O?H3H`2)=]%N_A=]]W:!OXYEF M?PSN:%$,XF`7H1I!SPXU8P#VH%48IYK27\_=:L%#Q30C*G6MA?7%?TR^Y/OC MWCCSHW;>YW[<3T'9V=\CN)_1CNP8`9IA]8B!O+##P+"=?PR,^BE@@/T])@S( M1E;`@'I8H]CLKM/TN#_N:&YGN\NZ*5^TQ"A:)#MJ`Y0=]MA6./;IV"GPD:G"/>"/9"Y@E:)@*:9JW#Y[(;4-+$@$4+:9%=(78SHG7:BBPNH5/L#@VV6.K3U!;>DY% M$:+FB:+ODC(GL`*\Z:K)GUQ15[XV=L.7N\-1E/#X-^!&4GG%#!J?1K6J-]N? MRC*K/I<[65H>9%54-:)WWF2)N$&P3KYHT&W/PCOL':0;`XN0 M@C>$^"N`=\$=/>@QX/L7QB0*FS]#XO-'ZN;%8F^3'($GDHR1+`Y9)_HN3^[S M'7U=&U[17*$[UL!IN`V098V;B,KB[9*&)ER.-4G_U;G)FL;&%TF^-&J:&'PY MJGX,KR=&'"FSJ.E!Y$\3/I5%V?3IJDC+/>0]L]`("UKOFF$CSQA:?1K`B,`; M3O95-,HR13*:\)=D-Z8B<<7Y*@+%L8;=6($<,1>!(DU1H)@4QU5A3KM7JPGO MR:HBD85V%I1218E83YSU(]Q1GG2";`8OL72LFL@1=XZOA&51G<%MB2!K=Y=\ M@=6'+UB32Y3E18)>Z-,*+!4>L!J/W([*Q%!;T6WC26=GA!5>%4^0/2FM_@1WV55QAXZ5^?&?D0,8AB=9F;6^Z4D-20;Z+7P_O6N0C."L+V=^/>9;7+^LBN\16IDAS4AR^8-5&-6=D)VK?&,UN0Q84SW2L\,,OHB[WY' M\YI$\D9QNKB]-\1D$[@;2+]MI4\;7E7X3'Q.>'50K>4?#;,'"OK\M,,V(1Z" M*//,-D]!@C\.4`ZFY#E(X!S]),,#3^IA4\`:5#RC9?SJ2O23N(WW;N3[6CR4B4;5WY1GL M&NLBK&;R#5,L5*)([AHT0&A.;J_N(?\MS.">AJVO]^6Q4)[MM22>Z]++`&Z M]H`1A#Q%NO=#&<$^3NO0K M6WY-+C!VQPRO08RJPBT/6$A("]^#+'_*,UAD%2U_V;'+8+K#%CH#^,.'),]H MA6L$/R0C]W+#*\UM7##F]A4A]I&@Q$%921'G=UOD]J2DOK M<.85J/`(X@\^Y_5C7E`VW,5-Y"/_I(6,@^=HMU"B85HU6PWRM[A]P.?3^H55 M3[XJSHX5WIA6I,C!/3ZMDNY=)CFBI92[<[MFY9O&SONR.%'JL4(R-DW9<(S4 MAA/HL5H!PHQ5$>\E4`N_(LV9^O%R-7_>@]>[9[O/6UC5*$]KF-%F:U+OTY1% M9BK#,(>=*9++3SD<]XP58+RZQ$T=/[[R4H[:=#3>SS>346!9@]X)`AXU@'3K M!G=)6V"OU\@_4OL]%-!'_@CH7R/`D3"6`C84`^EYON_)&9H\C\;'"6J2UPB1 M&'VRYSI[Z9KF&[E"JOV``PVQX3#XUWEK_ M""[PT1Y+W!S6B0_YT(X#/><_ECM\"E\\]=]0UCO\!:,++P:!?5J[*5H[MF+3 M5?:U;2RN"K9;;L^([TZ^N9!]\I5N,*2C=_I-!G%W-$>^SL$17O5.#/3XJ@?675CR^BG)J7_YKNSY+KF9/4NJ/-5HJC,G_R^`G&45W@7!&@Q?#[1L MR/K4OWG@G%:`\HKAS=`BTN](>']2URB_/]:-W/W;AA/M0AR?$D8@J]=75-.T M6'A;-4>%/5YB)*C(BX<*VU!J:RU>\JI)_%]&J'LO7#CPIF3E96MU-(]UITAQ M("4H2.,(WN>:,"3<>%@!Z'1ATKI:H%:D485'*VJ!6L3?1U$*U&&N7,*#%RT% MJO_6M>E!ES5Y3+BZU@266F#K.H98TRF3YP`RQYD'CFHQ])J%,7<32:+!!QB0` M2=7$^]PGF#R%>+<`\3X\2VH8.O9'CO*!XND@[C/<@;L*>>@YW["SB`V+G;(E M?8!@!CNYQ-B%YBJ@>53`*0$/YXGA2=^DR1.#$IQGSA\L+^!]W<4"6>!01>`= M>,J>"R_=<,-!R*.HR6LZ!'D#! MZRN23>]F>XX@W@-?)BG)0FFS%.K)O&/)((5XX"E8/51*`!J*J,R2S<2,L64_ M*UYO4=IDB.NTSI]HZE-9UA?]I25/YZ2]@_'LK5\`+1+G_6)0"6N:5U&>PTI+X]6CJ>R\4X>Q>!@Y>1T:2]LIB M*@:>-NMY"!6X:ZS9*&\>.!!7"9]QP&UXV-@,NS[",BQ4%E-SAA=#C/CL7PTK!.\1BTL;:PC:,!,]D$Y]B>K%;DJ6MO>->WF?A/I6WBFX]U@SY&"O&\0[KA+BV2*YFH(O"&7&MC8E1 M."2N8XB$<9H=&\^$8FK"XHR7FC\K$2J?6?@`_DO]X@@[-9LH4*B1TA*4*\!Y M@)8):+B$7>ECD3>T3IJ0;*.B=C`.J[$?OAQRYC5GCW@<-54DCT)#)5)9([6C MY6_$X@2H:N)L@*F?M^IGS&:/#7&LLX!B2*LLV)2?U9`&B=;12B"$[W"O*VP-*$%6`A$;V7-E6;T-.$NG^1]E]S`=.UCP(IUK.AN($Q3<4,C'01 M9)NM[(/&VA$.#/RBQT4R34&%S18H@!5)V8B%Y"P'*-Q'2"UMJ[7-$#4%X&ZV*S5'I M40S/#8TS8#3-X6-R*KOCB:1MF/B;2G_L:+)>]EJMP!E\R`MR[P'.V/NE$YG> M`TLV62>H-OFF;&3INMT\NWJ3%]Q8GBH7/!/A0V',G64CP`?Z!_O>>P]^DH%? M&O*D1O["!ESPG]L8<87_/(PAO];<:RB,^74,MQKV4V*TZL'O,^[@'F^O$O3" M8O2Z).$NW%[%D$*J(D5DR5;4B1DG.1XQVG--;D]O- MUZ7:9!EO80KS`WWM2W,TD:213WEYK-H"&1&56[($IZ*NDA,R(U(\C?$HI;;0OL@VZ&UJ=57%J/FE5F6UYY0&J\/+L++ M,%F7CO4PNVK#'+3<`R:2.>78,-G3'FU( M+_,I)_E)ASF9A$:FE MFP6V37C]FX4I%L1FLS#=?,RPDA^V6YC6Y`J=)R',_T&_2&RRRB]H2^C7PME( M(ER841H65C&D8KN'@/Z_!61"8YG>XE\]D;HU8`_1`T2TT"RVQ;OGY*5]?KI. M_W[,JYP/`CJ$M%$+RT]V3.S,$MBR6&O=P&XXJMP)K(+286E%%8<]4+KL-,8@ MI"]RKC#+6(%8=BU+#D05N$:@@ZI9V8&P%?MT+I!/\)G^94(UX3%]+,6#!;E< M:@53XA7`Y*Q!#-<<$T2D?^#W&W4962D8)SQ:UC76@=%GSI2_':N:F,KJKE2D MV_AK0BIQU4P$C=9-X!4@MXJ[O&*^E98'@>HH_0KHTJ^L`&?%5?=4E:ILRDH`YR*9KT34D19A,J[;MTVSE,@QF!UCCT MGYU#(4O@F=2`W()%\6C9@!_I%M($GN#HMPM!4]/%H@GZ<#.I/IS6JS-'+=3" M*)0CPD@R$]0LU25>G\9Y61`O&E[D-EOVVR(WE\K'`[W)Z0_$/REMB/A(O=;)XGO]K5Y)]V6.:L)],'9<*"$N'>>K8= ML32IDXS(B=YT]'O1O0$>IK)?%QGW]2IC%!;]1!0AG!-'9_;NL_>V?%P6`7^I MN44)&31QV@&3F9)\;$A0-TB'=I`8"=G#???#[U????^MX6+&3V2%#WC)XD)7 M+")KY39RX:^R3F6QK-^5S#)7B[TO86GQM'F0-`0A7Y4,>VZ;TS"*1$C&*=`\ MN%"._XG>6E2G7;DG?B.*I7OJ^,S\>*]U)"=8O6.)4;2"]KD2WF#MG^B MM7R6$;-^]S'/@GE,NUT6#W<0[4EA:]P=?J]_#9,*;NYW^0,KHGI^Q'TN:IO2 MTM/X^4_+/5%N(4TWYO.VQHP`K7-.X-^$7%-FH,<-&VW&+XK\N(L@0,CE/7_Z MPV!?]Y[:T#XH=G5/CD?8-#^=#@4[Y?MBAY&?L=OMF^K/!XS/$C5F^:JHRUXI M3NT+.FL[E**>ZS^EI/S:/>6@'`95F$-_=QN49%)YA\NH]G3E!1$HY`X@5XRF+AV93-Q(,20+P&"I5,GF7-$&\DB M2)ZDS1.MR)X45:IHR[DQIQJ:DRYZ]HE`_X+>G4^L9P)E"+/SH2#XV_MEA;;; M*$?B20XA>A2O\JZ[OM4=(,2V-3"%33@5!%DL_:L50 MO*"$HTULU4YF_+M8G6;:1SW-WU]O($H@,702""' M%2<`=V6_VEKH:_5ILE1<%E[*F)$$U_MEQ(CB(MQ*2415MM.0$RBOWG5NHHI# M?0U5L>3Z&]P#/E$:.?1C6L67DBD*G[6=WE@I],+^:)O48!^^D&SWL-IL-UM\ MU)!7QY[%S:\%F"SSY.1XH&%'_$TE9QC0:BPV`A[ELC(=IYK:I)O:`Y]:GN`9 M0.LA\&9NYBGUP`PMH=$SS---\D*^?5=^QGQA]2>6A$IE?E2M_9H799\E$7&D M(=E2L*9@#?ZDR]'LQ3:X=I_JQZG[_P/K?P$?DAHJ/8#3AM]#]UU,F'7_;^$! M=X+-P",$R9[$9Q$K=.""[9.,WKM53+H$-+GVN&^#4"%X*%'=>3I"%_;1*_S` M--EH^XEW1NNJPA/:OT:9LS.2<8MO9R25>?K.B+/KW[Y%OC&R&P`NUJYWJ8A5 MDV6)C'V'-&6*-3ND1!R+5[!!4NNV\P;)I-AQI3KO)1(BC[3^FM>/7;C4)4SJ M(Y(Y:I?_1)2)TBU'9T8>]7ZN+_K:CQ8!Z@7K\:_$GFI]XDC=PK1\8/D<62KV M@FQ/R'[F'A9PFZ(_8MXP3PCV1#D_9&SYQ\,K8T[BZZ-R7+N[OB>7S# MFQ?D#'F.(.XZ?U>LL3/RYOY?\,I[+3S@)<'Z))$?;=<^'S]5K`0[&"2625$M M96#O#O(B/;)RQR7"2SH3*Z6D]%=$":O\"]ACQ7VL`"PRW#:R"`L=U(0'RT:< M>4Y5^A,)4[8N9OX3*BMCDM))+,.D)YTFO?S&@/-JL^A1'F_%FL@K0/E$D(5T M2>G%0K_A%7,NP*79,V>C.T38[B6&TB,-V.NOZTY!NR86`4-VC=+I`G8I\5M* M#?K[ZKB#=NTF5!VRZS*;_@#[D6P9Z9%VLQUDC#$_9C>3>@>HA31C8'8D!)KC M/"T1O6ZWG:DQ`MVF:8;#]1,^IIV-K;'*GZIH[-==JNKQ&".D'3@3MA4!_9PN M/7]KNU'PX\!T&O28]CAFD`\ESA-YC+/$-85+4#%XPY42X2&(-@3`Z'GV@<%ZXJ7 M0^/M0\<96LH@2^":X.T1%06>5!375P*6\^$D1(CP?[E&J(+]=>H0UYIRK8>J M28XQ-$E[GIVAHR`X/7&6@(535:4-H9!$V[D;;B$/9*LVVQN4%VE^2'97Q2?XI;Y[AKLG^)'>,.FN M".?Q#9H->,HXZ+,&KT#'2;V0CA.&6,?+5Z39ZC'`N/K^E2GT M",:S]%B*X9C5%W]=YRBO49'[@)ZORB*: M(U;F2PRJ)769\8M?E;G<2VHR8?G*%%DQ"AA<__8*];B/Y=EJ+`(Y9BW.GQ9= MD1F_5Z#%3.Y%M1BS#.GV6FH,,+3^\!IUN(?D^3HLP#A*'5YO,3*65>,1RY@U M>2S]$LJ<$)XGU^?E5V736-P]0@2I<*]*M:4`GZ'=&G3[4_"K(D6DFMX%9/^] M*C8'B!+RVJEY-V@.HG1AXEV)G20<0[4A!F\:\J_`50%:#NT+8E.0I2\UG27M M^2/^%R2O:\AS65BS,DF]%[,_AE=8=\".570J6L.LNI8K:>#5T;CBG6HS6I)R MH$MU-#M=1R>LLA:[B#LB?GB=E.%5MS"&TJM/L#Y/JL<;5#[E&,W[JK?H=5Q"JO4L6:GF M@)1(>ZQ8;?>RE2\QR.=3M]PQ.]:\J8`-N@DEH8&W,(7Y$RUMZ+;Y%(ACV'2* M$MEL-C$N6?1MCS1,7JM9HMW">\R[`JAM%5ZS[%%GL8/40BZD)ET53_C<62+] MHF:@BT!_AG)8JDZ/2+M9"J<[)K'87R,(]+-"EEE1E+`*J2,W"))T44T-"QZ2 MOBXRJM9K>A1V4AX[AA%HE:7DENK&N34O1:CW@*U>C%.D.CAQ$!IIV]RK1%SV M-"-E&3JX%R5&Y76!O%FKW?$>?'/)DZA,4&X9>02J+)7*:8O)B;FRQJ:E5O(Q M0>)5.S7T+/>8&MP%5RF;ZMSNFF;'-18%M!P#VWL&MGA:EH&/[N9AQH"T,A]Z M,B=E)94<:"/0;5$>RY6UK;+(*6/3 M4;-@K02(-8E2ZQ1X,^N6%FS!5U2^VL]:/V4\(M`HM7R3]JRQ+X-6DC*1HLA0 M/1F8;OO8"!:OSS5*\H='^G[[5I_M56P:(/VDT%LQ6P1K`D@;<'N"!*]N1SF+ M+O?6&%5O_2:`E$-"3.RHPX,_"#=%4.[*=?KW8X[@#2*7F?7+#1[E&F\5/^#? M'O9Z<+LP\0Y[)PEU-6(X.6CH5X!R6-'S1`\P8=\Q.I^P+!+--'1Q+@DKE<0LBQ"=SY\:4!+0HXDJ MP[/E'(WAYC1!`=,#T@YFZXK>OSDGFY51AT\%*)7)(@$@0V+&[XLCSBNKGC1C MHC_3C'G<&Z`RA3"K+K&\C37&W:1I3JF)UFT0S+3^=PD6\H@A-XP&D$GOM@D$ MDBS=*R4,^?!YOE15PI0L[26P#:]3UN@3]A%NT`NC3_WWF23E>7/+:JE2:O*@ M6J612@_!-X,7R5\!2MQ$'\2B7=.EN^G+1NOR-5$&<>F9"94Z5;.#9!AMN^X7 M,[-4L1%-4+T:]U\/-]JZJ[H7B_J8A+A`R3,^O%8D[^QN4&`O+B61@DFG&1HD MA7#TD/>0[GX>"55`-X],!IV7AZ8)C]/)8R,*[7ZJ[G48UXX22&K/C@%%H<\V MMS"#<$]6K1O$+XBG'734C"(Y]6@DM3\"=4Q`RR76`Y&#P#VQ#JU849^*3+BU M.R+9@3:TCEK4%S`11J*#FJ3\:IT[<8D!RYBSF0+E/8&>(ZB9X"Q.\R?PAKU# M^NH;7BPG5@MA*I#@HC)>+8`\N.(.?_FBW">YK%*B$W4(6V`ADT1_^M%#0O`0 MI@6_,.H(_.$.\R8!HMNDA;D,S-@5Q+5%H28]6=!K0(D4VCO`[N;E.J:*2S83 MH[O^T\]*&(!5E\?ZB.#'O,CWQWUS@KHX0A[';`DX,YN@`+204@O(:@48!\!9 M@/;4?T%*V\=6TV6F['&4<)D"4YWZN6$T,G6\*NZ>2Y)3TW8)L.(4IU(.9)VA MER0T$'.BB69?@T)JY8ZC"LM$K$Y22Q50X]-,4E)B*=WL\8I6._ORSM5/PNLU M::A.]C@*K$Q&[50M54`V.CTE-2,64M,>JUBUM"_M3"4EK%Z1CNHDCZ-VRE3` M3M10!5KC4]#\::EUM,GNF)%7N,U?9NFB MCFV$*JH=A8F:NP(-5]"PI6EXM;"?/A9N,94+#\DUK"J0[$D./(#@`=/!@KYE MSSF7UZ#D9E5PUWU;/8C))-RPZ?M+LCO"S?83K$=_GV48S,PC-`\6(S+92'#> M@#(G05XD?EGB09H1W[5!9P?]B5 M+Q!>Y`BFN!LT2GS]G*",1.WQ1#O=KGPFK^V;BB2X:W0[>?Z(QQI>%6MZ`ZW!MCLK[^"?(.T8;"T+T/)8 M=;7.,!NV"5\!QHE$)3!>8;4H/LE]ZN14E(^5=A[$9_BCSLL"3W2%O\RSDC^6 MNPS_XKI,BNJN),D)ZA>5-\J2V*\ORE8BX;ZMI0,;GC6?4P)*BC=8@!&'4;BE MA,/GFJI'^:^__<-W[_[MCV!'9:Q+6LWF9#):.=N6%])..F^.-B>E&[C9)FA< M\+`"O"$AS]QUNU9:!"7+8S5ADF[7\,B_PTIX7#Y<0ME\Y.]:?ROJ_H,H9X4$BKM7>6E&TT M9&8K;C.OH:^^W#5TL"Q/54]_:S.M$'L+4Y@_$0^L+M9/;.I]]97T5E[8M]@3/6,A)VO^.KVJQ'K?RNR`+?12*/.(& M/<4)N*3:=?7D.F.U,"[35V\+FARI@T5+!],9.D+OH?)?;ZCP8KKJL)SD;W3[..DK;UO MY>1]%IXB=JT`;Q9V@^3>[437;9^[)`U*QALE(T1FK`,B[T]0=LNG:^QW35#U MV`*LY/U?P(V4;<_)*\6=+6;]K!=3!IUWF[P[#+QX:$$^6$(L$![H.3%Y!@[A M6;(CUXZ?'R&L':O_:CF$?1BLE< MS^1=&//E*^%@117F1DXI@_)RJD_!+N+"@\1A6J17,C9SXL_*].O&4B\U_UD- M,&M*[Y;'+(O,1=H:H!5@-PP-E0%KO@[^,Z6*0&,?QT-8W:R6C&90&0549<7)@1J$#(R9JZ6`IGJ6B_M;FRUW^\%BWG<,; MS>/^N"-Y^2Y(F]56W`%:/-8T@(N+D(H#Z@, M219%$24P"G*C>YGDB`907N15NBLKO/VYA22"$!]<[6YY]1Q"WOP:9-/<]:P` MH>5Y-COJ%6CIH[DG=A127^-366S;7]BH6`09!9Q%9L%%&43Y$][B/,'^=7?LFC9-P8)=S^$M9GZ_HP6% M-PBOHL?#98G:#FX.]#GKEURWJW/@X?_2SD$^X?Z.T]("TJ!$@)+3C#$]76,L MP"^$203^0N<)%2[VILVFQQ/^L"N2_AKOENU9^#_EVTLG+!0M*%<$7[#(2T1NQWMO$XWW1%HJ_RFZM#((N;=H:Y9]M/^`-IX[ M%8LY$;)DV4Z(/V21SEP558VHW_LR2:$Q!XN:Q#NF-+T7;[;O21V7IBW9Z:8P MBK0I)Q7"IT:8L#16!SL@A=*%)NG7;5+##]LM)*FNX0W$&"CJY$%W6G3D$UAK MS'(:4=BFGR,\\':AX0(Z-K&ATW)V]9!UFMI0.&9Y0FJZG]GR?\",[G:NB@]? M4EA5F^T-RHLT/R0";)0#Z,HV,,J=1\$(^AY'K`';MVG#E!_I\@(POB1FL^4< MFQY,0X=>+>9`PY^6?$P*K*-TY6$O]$G%LR=X"Y]@H2UD:2+TCG2C)&,L=P0T MM(\8<$X#.%%XF-I-SQB(+G/C#VH\`^YEB0;]TV!,2>$=7.J^"U$MK"5U;0T1 M%AY-AAD8P\AJ^#W>6Y`[RF'V?.UK3VES_W<4\EZ+I2=)DBRK`@]>_?.:,1>\ M\L8!#[7YNU.\N]>V#KQ5NU,\%N^G8Q_5I^F(F\3K$3B(-#.AWS])IF%&<"TM M[<1R`])X7OW[!55KOZ&RRCX+F.@:`A9\'=Y!:#'J@YA(FR&?$UR]2U*Z@%G, MOKRMYS!I>7^%W4;3+*YYUXWV,!+6.-2AUHSKO*`W'[K;6B5%X+6CWW?#"1[\ M0AK3*ZT8KEP-`$I_L$*6U@5,GE,7J(>F2@ MH0L;'#U%+%H:/B.R95H9PBF+!FYZM3%B;<:RNTY3=(2DYADLFF(WJF57WM;O MLJOHKR1*GC0#3;OPVVWC:`^67?-0+S?GNH74T#[HW.L647'^HUA%K89?!X3( M5E!:-C$O'APOX\=DH2]=QE((:\O@&!_-4P*;N3!<@6@F(H8+[<\UV2[,O,T6 MF41TE2V1T/4>F[%X)9?8JAFUO\'63^?\9?$S?,+?PF*>EY7Z$;>B<9`%4>BQ M:C5L&P+:,LPF?U+/J[;GZ2EZ[O*NVKKKU*82+W`B%2+T.VDMW&5[$!W6YZO= M+;S'J#'I6]LJB*)U?53AE+<(KUGFKJ+3='6"*FGZ*N@0[W4DRC,"K4QKI(A= M0ET>NH`",#+5T,"CA%*-07 M"IU8J$FJZB251'U%^N?$)4S1(VL9Y>5Z&J!>FUX]^]*[>4(UXL#&\5P2 M=N&5;@(/.!S$*(!A&=)E:>X9Q?Y[HA/TA9U&ZPY^,^W82V;D&V#4Y)+ M&T!I5X!2T\,PIS=:>E\[HNER"C+]&%[;'!$II`R9`L?E=T!W\$M]AOG\ZK@% MZM%%L0?JR^&R"2)T@!*>2CGLB@_/DJK<@GLF55%&X-2VA9K-CDZ!LQ,H@BYB M34\3AP(H(MBTX(\AELUF/JR0LFALVRVL2'P`32%K."1*F_K%A+RW8RCT6L5S M^M,,]C:.\S&0;UT-YVV#3K5LA!O,=R4+GWO70JYD.'"J$SEBU%JJV`NNK M(BWW\+JLJG5=H_S^6!,#>5?>).09FO.2/0O_]5?LI9/5@62TX`VA_@KT MZ4%=`L9AU9PTHD@&.E/@711AIJZ8%,JS3`*DQQR++,5L\="52\8_E2B#V57Q MA(T#L0QG+^>[A"0$D;0VI`Q=B+__[(P+C8N0GYT0D+-/2]*K61Y-;M%%42$D M$G.>7O,7ZY^/]Q7\^Y&Y#B]S5-5\:@X\J,*'"<7O-&CB?M?]$L/-' M0U`)TH0J0=,(,*Z`L06,[ZI);-SR!B)EV(WM"0;GO-SORP+;`R)ISH8E+P#+ M5T=B?,B6`;."<$]MYJ$=G*H=G.=H*E0LI4M";MY%%;N9_+O+F:&LY_0.*H!@8]MT$!))^+6_]0&&<.J]$"JM=DY,8GXX$ MQ&0-.-+N=UXG'I:W;?B$WA.9]4.GK$KE.(G&=KXG$A^K/(8X,(A%GT7)W!1C MX-&E+*)4^%2)PHJ;M%7=N6]D1)'=28J&4RJUA'2^.`65$U2AZ/%7E5\DTQ'_8"TNX_ MT1I+U'ZTPM%8_]=C-@QJJ+,95CHXPV!T]5"W_'ZK>07WHK(26A*_ID'?>W7! M6_(>@!.TSQE?0JJ(FR!-SDFN&PGUP=2/$-PGN!W6F>H1PAID24T5)P$53(\( M\\*-DAH\Y$]8>TA[7D^!_$@SR9`@T`,6\)$4:N&K-&:0#NZ5"Y**ID09_=)S M7C]2>I+;L^U'WDNU>*R.R6[W`HX'S.+`*P>Q7AU@FF]SK,()S7+S=7>GC[\, M4OP/^L<:;,G,46%#:[:%O@S4V5I9/`9($^-YD[P0[Y.F(+W$_VFD]!\.;91% MV(_2I8.3K/J5V3NR\!Y+RSD2XH1=)LAC5:LR*?!"1LH!8JNEKXN_GI6D MOV)"XZ0`7:,XBI\I!UJH8Z4?Y9,X-30Q;M:4L;@Q-$%8@I^Z?ZX_=>S9S..\ M1JP[O*P7[5F^B1)K]N!X"Y*0B]#CKNX]R8UU/ZX!I>7Y?7HLV#(6]2=80)3L MUD6VSO9YP3/F/4&>Y%YC7XV4WJVM698Q%CD%O8,?TC35"J)XNC1/L&0H6),- M*_PB8XF]\9+C!#S/2>8V!T@Z4SRP5U:\2Y^@,:^--^'/H,[X&&D./O`D7,^"Y0?E#7B0[ M/3+'K?R"4NBC<"S@#:)`HG5O0\-//O4#Y.GFW6.0_!$5>8W78AK(_X7\I*X5 M;D/D/YQ=)X%@I)K&U*G2-(\@>-A^/H2(<\O)F&'(SLO]X8A/TA_^?LP/;-^? M?2ZW]7."H-ZXV5#Z-7A6LDB>4E,BT%+1-T\-703X<9RG@25RG21_UNEC\K<2 MG1^KNMQ#5!G2`LD:>[=&TAX+<.)_#_X.TSS.8VMC&F1_V#@[5OC$6%48O?=X M'27;!ET9`SLR[W@Q2"%<)_+FH-\^BAR6+M,R!I7]G,Q8Q#Y"]`!1YWPPYES2 M$/A=LG0]'P.$M>U%KT23\'*"%%G;./1^W@B>P8)JB1R/B8CXN]W-ME&U=8H7 M^RJGJG;VTOL7V034+\W%";O?WB#R7YI229%XY%0?\I^D:.F14KX>+[>@M>;] M;X#[E_Z_5X!]IRM2S6-'2@2:;X5/8'U:H`DY>TZ(,O\;&&5OJW%WV>N9S98] M$U$^YUSZ`\$V1;-'1KE]@>+H5\9_;J!RC$3G09_5+M69=4KCF!EF)W M2%7QS9;^`L'L0U'CSMWP:EZ33F'D.QYPHL0WD`>%$+EX;7H`Q`PTW MP-@%C=M<6OZD)W]*Y*=EAKG\D,G?/@8_;>>ZT?Z;?;A._#POPEWD$_87S<^V:3OH.V14]V.R>7O/)O"=GC:5'JL M!KG;E<_D@=AEB2[*XWV]/>[6:4I>>55=[AL-6&T9^*\&:2N94#ZQ(01;O(UJ M2$%#V\N<%!Z@;M,GE%.<,'?^H'F#R@-$V+#CV2'W'NT=R,\5Q!V]SKP>EG4QC1#94*T#IJ/UL*5>`T0)"'!Z1#K,VAJ/SE/G#XM7^D.2(]&6SO2Z+ MA^O\"6;KJH)U]2>XR[#^_*Q]S&%)[QV/MG()T=LM'=F*$LJWE!0P6D"(WV+S M^?880V2WT^R-43EAZI8]+-(0S%O(7V1?P"I%^4%V_-!LO34\@A\-=?+9.4%8 M\&W+`O1XA$P7\L\AZM03KXNL[*_W/-E!FZ$`P5X:@BC*ADY13]-AUE(W/9X) M]B6J\W_0">^EPJ2G%=U)0$OF?_^OET+8]?>:#S.E4HI3*1?`?*P"+#*_8?SX6$+S_=@4(&L*OU3;@$\XQULCS>'K! M'\WTR2@7>X#P;>;DT?&ZG9B=!_7II/8]$("^'W\@,'Y'J MG"2M,:>ZD#7VOU^4]5C84W6-F@P6X=3])3)1:6;2KT="2:^@*-,Q8K&.O M3=4VBL)CO>A(2&R5,!*;WDAT!NU-7H"LW.T2Q&I94%_"5V'CQ&,&B<_#ZQP3 M,3[>SK!L;",)C#G8FO:`$(2'H7DZ].G6U',Q M8TO*RIM#1'>]JCWHJ)'?3>>XA^-I9PG;<0-VN@IX1HRCIU:[7U-7;^$!?YL6 M\*6G/-KS=ET+O7&5@G:P4]4@=L[Y#:L?1'ER62*>['"S_9"@8G.L^;_U-=KL MZ3V?Z^SE$C8'G!1@VB;')=DB$7*`Z=O?!2_0=B(A2U\RVIUJIPLY].NDC<@D MJJ,7(@7)O!*9V659:$O@JI'#X^PD=0Q\M&TOX5@9GYQ9_O[2`\YYP7^=@$/_^YZY'547"J$BWM5>9'4G)M M/_XP/:4ZN9O-S"+P0UM(;.WT`3UF,F\/91B=]WKR"'0>[=:A#6!O!"3N;OH" M./CJ/P?Y9L^V&^R7U^`#>7GLJ*B<)@I];/KOHG:4)D+-TLLB4:`5J3I!B")5 MD@&X;'1!@JP9D!_6,CTO"QHUA#7MJJC+X!!/,\E8 M1]YEWR"XSX][S?'1@C;P6QRY/*8'.?0&H2$#;SAAX%N\*8*-*Q^])55U!Z)F MG$?XTYDU$/5/:+KSY=IM`?92$W>P%VPS06HXDQP>)+';;&4A(0V\39-*8]PRLUBC- MZ$+"QN/<0R@GRK"A,,R27ZO(CIT536=(#Z`PZS3EUAP(9D$?Q";:R"4UB1WA M"K2D`T-Y&TVLF/7DR0RBX\QYO-1N.[;94@<(?TW:]/*=[MK:3.O_8MI"'K&@ M4$-#[U$)5?LVJ"4,#T+KJ1)N1MWF*=1.L>>4ZWI,;W9T('3@$7B_J)?/N&7L MD:]ZAE-W^1ENTV@QE_I]H_5$!C25ZSWQ;DTSE2)M>%,IDTP(:NTM(I/^:_%.4I1DPH88D_`E@@.6=)C%>U`BU;FKJUSYC7AP'& M2E`^%>9T\!(J9)X86R'J.)$H5=RWJHEP)YU,<<K/3"RH:RK-`,*L&K.C9?"N_+G(('JF(=KJ!Q4F M,M_594U2:+8W&[Z]`7$5_A>P)73-67(7#:U7$Q$]4+E9 M<([V;=F')'TN0"\VS"Q%=0]@2.XVGT-"0/8]AGP#B`I[KG$+TI M=WGZPO[?R0%MYA'.KVPAGYV[>`48)?B%_SFJ#8J6. MVD/8Z\4[6?<0W534U^TE^YJZE"7+9K9)"X;;O6@#1:`4;`_Q&K M]@46TW.,@0F5DN@".TAZU*VD>L2[1_(?4F[B*=EU^FZS4[.D]Z]OEG()D,0$ M]`1!?^B11JQSX47UJGRX2/H?M6[*H_'<:Q*D]=D:XS7KJW-:0Q5]JTB/U,B:I%,*" MT/?S9K,D\ER9E(;J1)LBK$<6]D7S/)F(4K1)OWJ9P$+KA#7J1L^7G2"W="*O M*U++(-DIDL0K0]NFL(H@[9=16OML8)R5I@!#=(G")DHO2\"7<^EA(_VAJ;'0 M:&9H;9R!=G/",1>HGRAYYOBCZ^QOQZK6[?:F8;97;G.GG!_ MD$J%G=D$/+]926DXS@UX@(8)(%Q()#KG$\WY;J[(9&>;#D1&C<@E$;DNL7)2 M/J$UU<=!5S`OHHN]Z,=UD5W1ZPC\77UN3TOJ4)IGD$F#OD'8+XF3:HDC MR.JY@'R#$%_BZ<];^>+(Z.F$2X4JV8-RA@:U;$GV4'V%4&E3O[HA[ZV8":@! M`\UO&[X&J&NW:/A@$QVJ M9PE4]@6*".^66%.8;`N@+>8+/SM6>0&K:IW^_9A7-%-B[QG6)?Y/J7[0.HE5 M2'^YK;0F#WK#!_08@?[K.\XJ'J_Z$I*3T\A](WG2D[SN2;YEK$)KX`R4:[SQ M$R#N+SZ"%X%??\EUQ;0&K;S'/0S[*)2<9'\%OY"_1W#++QG1\8V^NS`<685ED`WK#-OPYV,!WW^+?_\[ MO440V_FU`Y)^CN>5-`'OOUT!TBH6K5>-[T#7]8,[8W;/4)X]0/[$0+F4JYOZ MG6-Y;\?3S%J!MEGPU=TTTH.I-@[S)C$ M2'`ZP`F#KV&+0D"L$;#8_`=6AEN8YH<<_]YX"+(CCP/:HE3J2Z`^'4V[RB@C M6)"G3)P54K6SML0E)[T[U1^_Y&T#77,.^ZO&"KOH#[\>&T=;?F>H'.HECMO? M6QZWOP]\W/[>ZKC]?2RSK!I?^7%;.K@!']IW5W:&Y/8:LO!/[8=2V#Q"[RC" M+Q\VDV)\:*Z^]I@57]EF"C;0IH M6\`;AWE_&GW_;=,8VPIP"P^X&_36I'ZD]:D[>1ZH/(C1AKZ.-2G#.'VQA2;, M4,WN4=4A9T;@0EY=3-O:KUHJ^SS&1.]U7],27"C+A/F!](DZ[PV^>L`,P&N# MEB72&+/**YLMB1!27A*H6@=*2CSNLSH/+Z^9L]G2,+6@<336O1\9XX2)4&Y! MTHK%?W<\U"5X?LS31QJT5H$$0?!0$I<3_@,-80MML/4XD^<0UH#,HZ]<#-$A MJ4SJEZ;R)<\)N4'DO^0][35N?U7#O!D7_*? M=&KQL1+2.#5?`.P3`)/3&L5@^)458-\!.=[>\R_1MNQ;H/T8:+_6>IT"I[8Z M^1AV(_/4CD+2M`]O8$ZD<$*FK%-J6VCS=%X6=5X<\7Y_<^`O7'6;3Q]G.18,GMXDX M%7H^8-C6+S?'>[R_O]R5B2R#CJ*=5YS(^BG8&]H&L$:`M@H+!^7@]C%@&-D` MQ0_.7FC&3EY,A9WR:0X98VB1/8MP)1#,TFD*`MR_@#YUXQIBN8;B"31RG4IE M$0"G>?18<%GHE#%:6$WBOV2RNO="360)V/3Q++YVABY"D&@EWO1??_O^AS^2 M@W">YG4$H3FVB!+J,EO!::'"RS>('_OH2+*B3NSO-Y+-E98SM\18#L:SHY18<6M%9QA]>ZS-M13^TO$+?OLW`N;(0 M]"20S\FW@LH4PJRZQ*+1VX^"I-2[A1F$>W(3TDM,I-)1)Q:>\[`X22>D,.'4 M@)"#AI[H9\>A2;]5G3#5EDT\U3Q)2;L]2Q\Q*JH;-.G,,K-'M)9>U]/9P_*A M;O;,HOK+1N.NB]Q8>DA?ZYGZSO2Z+ASN(]N?)(:^3W35,*KC! M!\D'HZ/5B8OW';*;C)+H%$Y-@$KHW]:8`>`<`&4!>CR6UL\?F)0%#17)3#OI M><+>]$1-N8`[0J:0RN>F>@)4Q_OLR3CU&6;0V8QF-BY+M*D?(>I>4Q.7,:V5 MK(TR<.04(,C`55;]BO*FA>^V1%\!RJ?WEKKC%/:P.U]LVC2\1D[$JA@R,0.H M_C3S$ZQ)?2_I>(%$DM[:*2]?P';5L;$(*-/+77'[5A!IX)V3K@V MC4=HTE=?%>0E`ZK@1X@>(%K?5S7"0ZPZ_EH2>P[FMI1(B.UFD3UMRO:K`G!2 MP&C!+PUU("?N$N*UZ=GS@CZ](>+M*>V/H0.Z79`XC.]VA^$,C;G.D_M\1[40 M?Q@?Y5VUQH&!7\UQD6P,KQXMX,2Q:M!28B9%8&6DK\XBB,3MHMDHU=' MAQ)19VMWEX$5"2M.4AT1V]V1)PL/I,H/%YRFS68/DT)?>S@@554XQ`ZF>"M>9E(O8GR9IYW:4(OA0U+VX*FX0K[Q,[8V_';NJ[S.T+!_"8[6-"0 M``QXK`'X'\3]1Y6"OF,(C6X%7=LN'=V#U:[R&__5L:[JI,C(PI$=$7VGB@D0I*L-64VB4#`YR*6O MLZ>")4'0A7%-X^<_QFNB MW-+8J>;!*>,$&*L5"TDDFB+R$E:D=02>NEGP M%F+*YF-[5KH%;![QIE+_(%;=U'>B!5EOQ2P+Y*T`.0;UVH7-L[7XE$KZO M2Z@D6RP)OP\%97OS&7HQTB!GE#W!`!NO^)46( MK&:*OLN#`FG+Q@G`VH9=%:8)P-*'''0">$[&ID.0)`^;&3Z+G-4I>_WA1]$X MU+E]V&/-Z9UA.+S[RK;KRE,'L^,Y=5*1H#IZ`=G)R3/ET+,](8SX?"]!F^*4 MKX3:G!N4,BDL_;O2IIYO1:2]%2X&2*;XF)RU=MT>89W>Z/=CO%#`O2TZ]Z-"9;_%@R8S MMM2YV#0&M'70_,X1"V#YN-%:@M$&$C8R'$C[\8NJT'M#DTJ,GB;:Z,,,!?UT MI"5JMI]A>D0TWN8<6SD2]ME<`MV59[RX]L^'LNB_E6Q:J)1Y&=Y^%7^A\1#B MI2E;\G2Q8PP89Q(YW=[9WI7@K*DW#PA_,'R8?.(;4QO+\K_W"%F9KM,.$;9G MU0&F^3;'(U!TO^N&K7Y,ZNYZNG]F?J`IM;"-9/D'V`5U_O!8@_MC39Q']#?= M_0#)M'S`8_1(GKW1\!'R=YI[&:W('^_YOS)P)'.1#MZ2-UT(;7*7-'(#\[R\ MA5O`E-.[DE/:\P4^$,:H+S$R:KO%;@S_>:S7*49+ZNKKV3#FC^$695LB=GE9 M4:]WRH;S/@F_AUMF#MR"46R.M.DSEI'HH$R M@!?1)(O4R8;!1ZA($$WK.:24YN36?C1WDFBXP7&7()#E5;HK20`TT<2,"]S; M5?3W$?!+NCN2AW!T3X`U,\4\FJ"#AG9'!NN`!XNJ=-;C M)MSX84\G*W7[]:LRHKSZ%<"JSO>T\EO]B,KCPR-(FH%`[7="+T=.V%6\\;$& M;O"`;K9NLM]?EN@S1$]YJLVKX,HHEA!NM:0NL=N,RZKY*SDE-9S"KPK3YM@R MG-EJ@CUF[^G2E]Q":?B0LJ7_[#M"7Y79H`B@;I4E1+RFG)$/L)!21C>Z_N!P M!_?X5).@%Y;4E8%UTQV:-/@PDWH'C(4TPH:U(>'IAAM3!7IDX4%E.TUCE+G- MT8R=ZX<*R_-\@8_(55Y?Y-7]$560`OP6[LC6Y:YD'V>Y!;7/+:;Q\KNOG2BO MD,*?L@&<#Q@P`IP3\;]R3/:8A=SW+B2\.ESX6#0)TR`;(&+>N9\5=3QY-"5S MQY"`RM![X#E:,-@2SU>!&;I\AXY5S7?@9\E.$1:F;NI7$^6]%F0Z4=LCDL-O@9*8`37'(P;%L8N!2[[DU(! MG/EXU@YW.4T[),D&J9_;6A?`ZTFUYLML=^7'0@G8@@3#J]5$2`]U;A:>/::Z M3/9PL_V8_*U$Y]A*E'N(C-5Z-#3^$UEJ^B_$.O(&$17<,0Z_D*#1;NSG1.UR MMLK*.-)6GB-TQWU43W7P2C&:01U&>VI&U.?=(3;8*2LIN2ZR]9[L>/XA728& MUT$:J@!WACH9Q/O"KO6*G"!WD)V)B@ST25?@4UD<4)D=4_9/39E-OU=QQAD3 MK^$,TX7E8')=8W+\;_PO_,-]4D$JZ/\/4$L#!!0````(`"Z*;42L]9+/8&X` M`#PH!P`5`!P`&UL550)``-H(")3:"`B4W5X M"P`!!"4.```$.0$``.V]6W/C.+(N^GXB]G_HT_NYNTMV^38QLW;X4N[V6JZ2 ME^U:?5:<.,&@*4CF-$5J2,I5GAWGO^\$J0M)(7$A(2')GI?IFBH`PI=?`@02 M>?GK__H^CWYX8VD6)O'??AS]_.'''U@<)),PGOWMQZ_/MS^=__C#__JW__%_ M_?7__NFG'WYE,4O]G$U^>'G_X<;/_>?4#_[(UOU_&/T\^OGD!_Z'XY\^^^E/ M1Q]&'W_X?S\<_^7H_"\G'_Z_'_[WP^?__X=/3\\__/3#MV_??I[`"'DQPL]! M,O_AIY_X[T1A_,>+G[$?8&)Q]KQ;66G\[7K<=_?+_?+Y_"E[9W/\IC+/T!?]_/ZV;_<3_ZJ?1T4_'HY^_9Y,?008__/#7 M-(G8(YO^4$S@+_G[@OWMQRR<+R(^\>+O7E,VA;_[%OA0,_,+_]1?Y`+_`_#K. M\#[\QS*DJ$=;4P*U#*=,DFG[XO6)QIZO1.'RN[8,S&TVL` M&>HQ5>]@80:P7V:P+B?\@W[E1_RK^/3*F"9%DMX6YG:5AI,9^Y+DF@S5VMM@ M)XEG.4OG-^Q%DYU:!RM?@@F#`\=+Q)Y8L$SAPZ8I"G%'&[M_`)[]K]KBJ76WLKJF<_#&P?Q8VF!K2T_+)RV!"HFYV M3QD&DQ'TVN^)PV!N&J/L_?1ALC2U!K+\)7M:[_/9>#I><)-G"/]J_!7#AMF[ M#>V&Y7X89<_L>[[4_/J:#6C-OM9BIN*.=D\%J]%-CP6;;OL^%YC,3V^@`\UX M9&W*HX/-^3!64TWIY.D"8*+>V_W_F9B%5G&+LG7J-=0=!MCU_1 MJA$(CK6@6OQ]J;6-R\;/[$7V1NL.[[VW-X$6T]0;:&_W)1.E5HQ@Y\:T3+?W M'I/)85TMOR5LB=$_^J&][5KR6RB?I+?ENZ8)E<)^^YF/WH%)W'$_,]([#HD[ M[F=&QVUG=$SDF]?-6&KE-_?#C-$-5-)]3^]I+6:I,\Q>WMK:'#"4@]BUD)EL MH:)N>YF-W@8J[+>7^9@=O=#>^[4GFC"I,\Q!9FLB68/1]FX--;JVZ8UD^66V MU3Z)=]_C-_?:SUYOH^1;MVMD990]O#"WVZRK%7O1ZMI9C*YI&ZIWL7)[SH(T7'!A MCZ?C=.;'X3\+T0OI,'J%;#.P50M&Q>Y@]`HGZ7]PB9O9,5J-O.]=H,7&933> MOG3&[%PJ&V!O>UC+(XQZH$-\:^U=7[$AK>_2K>SYL@%L[R?KU6*^7VQ[;N:T M2%D&XBQ6W3U,H38Y0,#B"??G*_^6C]@Z/J2(7H%?C)*@]B,1CYM)4I4(^-]X MLA^X?,EXQ%"^'BCR7UA4#.]I]_4^'IUOA:,[V95`BDB>C`4_SY*W7R8L_(7/ MG_^A`/+3A]$JCN=_PE]M9E.91/']$UAPF?%&;<)7/R[0^>3\-UL/#'W?( MK$F$I7_[$>[? MB_6*NR_EA,(H,!3"/`RO]VSF1Z44+K^'&4)GHY4W&EVA1MRZ4WN!'".^LC@ M+@:$*\J6F$M`,.$H;B,?6X2U-H#TJ(]L"4`@=%$VPZR1/[`T3";R(ZBPK3RU>RT!WE][#.?"""$4LJFFCHB?D?2)W33 M&M#W>GD*X2!DTC?:_,ZBZ#_BY%O\Q/PLB=GD+LN6+)4>5I$^<-&B:%#5/*=* M02'T4K;FE*C^*XF6P$!:7HFQE2IL"\A[>6B5@$%HI&_%6=FF'MDB2;D;*G>( M0/==61>00R_/MFI,"+>4+3PEJ(?E2Q0&MU'BBUP6A.T`<2]/1`@0A+HNYAZ0 MR2]-EY:]N+HHTHS:<':1_X3*W46OMW=Z/C)7^E83YOY05U'AT]IFQION,&6G M6YFQ=.OKP1RJ?2>8@ZV25?I;H]50W5&G?O92P%AF/\U\?U%NJRS*L_7?-/?7 MU5][:U>WZV3^`@(NG$HE2T:GFS?Z<')B;;&LJQ^E=3,-OX(E3&4VW_@J;>Q7D+YT;U5)2:*VKK75PXO33*A210 M4QQ$CQ54GI';P;:].PN-31OOY(T:)OT#0I%G792L&;,!`*)3LYHN"?4EU0:C MI77VQM*7)&/W#I:;,,N\@U6VGL=#Y)=>V^O):"PV95_OY+C%E6+/P/3.66V& M`;A.KR.&O(B7H3G@/G_T*B46'"R^:W\1YGX4_I--X*"\6.8LK"= M-FQ%!X0(9R4&VOMZP]Y8E"Q6L2'-R9JMR=9C@B"UH4V\2CN*H,=+%BE% M8N-.)8SJ5-VNI)V\42,FJ[4A.2Q^IEQWY9^;*Z[\V\I\9$L);PP'+/>W,0VA MUM>%"D__#XQ(L1L'7ZWZ3%@Q#XUOE:R;=_;1GNU9*"FE94+>RSL[)7&U4@M1 M8*_0@=;C+T*S[I*+6Y3_7F2,@&]P,1L_TED1DE[>V<6IJR/;ZO:=K::WGAUH M0.B_A%&9S,SHP-9R1!""T[@N;9[$9[1.J'N\'N^K)*I=5K2^3J(-W M-G*V!.LSTEEB2`\`X32J3D?$XM4C!=3CU8%7Q'.P5#995<;3S=OS0Y*IO`I, MNGNCCC<@"^BP=!KBAMZ1TPN0L7`1<_HN)CHI-"QP^A2PV$_#!$FM(6WO'3EU M:Y10I.!R!P2='!L=*%V!^AIG"Q:$TY!-T!0$0D3/,X8PK`4#YU$'186 M[KTD80?>V#LBX70264G/D M+*W9$5T\/F6O_,T`_L/?^-[\B-O4+_-K/TW?PWCV7WZTE!V:M/I[1R0>7`0\ MB@G7!V4IN<>N1=G%4SE;^.':@+;RL)>^B0O:>T9]/.D7?;N3MY3Z M@\0"7-F`'UG`X&L"9T9`J;$>)=U`1OW::=5@;*7_Z,8XZM[\`B?&RNQQW^9& M0P#G-`V6-E.RZ=M*]T%A-:*^;?+M5=;-^WA*RUJHBC5Z>VX3+[=2`5U8MK*.4%`$D?/$ER0.2KCR/4#9%]8-+:.R MCA9HHK*5IX2"$LA]+UO[VH*@:!F>=>C7@60KK0D%[LN#T%;!E3?B;5,0!BT# MM+[YL@G"5B83.HPJ>?3<)M_K0)XG2;EG;))R;]"HN#[!F6.W]*3&JX+N$!Z- M8!PCSHVPV4IW0F$=5X#K4>^YS3#=BC`EYQZ>9MH\%8K[Q=YJ>4MDZ#89E47* M%1@1IXX#F\.LO2U5ZF&IWA0%K3VWV:HT*4/?F(1P$()[:5.K)'=6OA@WFGIN M$\QWHE:(!>&UEU:SRTF9@O[HH5W+)3M[*SYS9]62?N-=$AVF!L M.INP:1@7/_CK,IQP.XT[2VKNPREV\LE/XS">99=!L)POBQ+.-S#)()0;4E6= M/1K1N:UT0A,=HA/&EC3W[D.[4C(ZU'D?2>2IVLMAKL"&,&WN*.;\&*^248>[ MNO>1Q%.VW5LLM93% M?4"2)([QK9>S#!82B=-+T]SZ\?^1O;%8:KAIM`11]'C#%H)!>.VE1>Y+DC/] M3[*@-8BDQ[LU"@CAN)?6N?MJC@79AWC;#(1`PC&\[3>XB02ALY>>:2L+XCWS M,S9^B<)9F3%;O7KE'4%0U%Y)#2C7P88H02\]T\;Y*TN-SF!(#^_C&0F?Y':T M2T$A?/?2&ZT$FL2S9Y;.>;H3+<R)4H$47HI1,;LM%IJ8.R+XB+ MQ`.Z!:70Q(JH1B\M;#FF+:WXA M#;X;B("&8GQ7@42TH)>AI=S=("P#=HK4ST6]!!8'LOA0HE MDH>EEW:\9S9?)*F?OI?B^;*?`5AQSCL4"<)(RBA]I5&DYFK'@5L%(E8BOV\;0RMJI.A**;=]'8X/8P174.?$4_[^+P M/0"@8:]K+WWD!0]'V^-%Q[_-;,X_FT\L6*9E!*.-SXQH8'6E5[R/=_;17L7B MZEXJ^E&C+XUT`)BVTSNCIEP5WQL-B#U>`P*7<">Y[)NSX-_W5A&GU8[>R;FS M&I;BF9D5AM`>`X"2>!'0H4/\A3&$VN,5=Q?#']FS_]U-N:/-SQN569'T\DX^ MM*A'OCN)@14FF8[3&C,;Q3KI6I]PS M8)UU:#:0=^*VNF4'GHQ?NE#X/?[P/;&(\:2%FXHX-W[N?XW]Y22$OW6QD-O=$+"9-V.91$62_4\*?AU;0L=`QC]!2[KYGVD\?ELQ[<: MV1#J?&[KQV1PV)YLO-5VJP!=1E'RC:>SNTW2FV3YDD^7T2:;2B$>Z1W&WL^` M\$E<4>0$`FO_';$ZV"S5>?5,?OK5!!&S&.=0#(] MMB^J<-FJ\>J8\1>#C5W0&F31XY<"%)"MNJU.R2W"7Z_\K"Q/R>*L(&5&!&U@MLK#.N7\KWJSCB_\JBL7DWB_NXHWZ?$:4HQI2%=E;/TR+%"F? MF<_].K>F#GT=T![#^]A'>W)+F+:*TCK=$3:8Q].*]SW(:EG$SR@O$%K]857U MV%9L`'%(56JOD^(JE!8D/8;9'V6B>?XGN:L2U@M$U&-#L1+8H`K8^MEKD>`D M>^6OJ&]P,HY-#HQ:_4%L/;8?&T`<4@G<=2W/!Y86EA1]G5#T!%GW^`ZA!O"0ADD*:,-D\LB"R,^R(DR@(&OR]V7YI';#LB`-"\!2[Q2SH>!"=M3C MXT1+N+:JY+J(?-QZ^;+)E1]Q=\NG5\9?V`LYO[(XI70%ZFN<+5@`^SF;W"1S/Y1]]M`^'HUC,M+7C3F$N"Q`.6^<[;Q.`VE,&6/6$UU4)9X:8P3@N\D\+R MOC:K2*T(.@-X-!Q44"HQDX$VM@$%.=11EV4?+I?Y:Y*&_]S:'I2JT.SHG9#P M7NND`D),EB(3J%)_EV5+8]K+3MX)B5=I"Y17\-@*3:#*]WB99[D?3\)X9DAZ MI:=W0N)1P0+S35"V8A/HT7\?PG%WE1&B^`<6!TQ5*DMW""YW6A?N-BJAQ#>( M.(;*[:7%@5"CMW=*XAW)4!5T@=D*=Z"P0U0P&QP$);V\4UKV*>T[.DMJ:Z`L16"0))FO7.?K)MWVL)A'YG*4_#*)LN(;1.#7L:3VS#-\M4O3S9:D1424*;S M:#^B-_KPP;T#`"IQ@>&Z,]8>9P>79EIMLUB(YEEM?(Q=N+J7V3U`M2I%KU>2&A9R6+"]TFVP:)Y M72P,\$ZHUTUF9V[HP":7T_C1*#LZYTTBFI0`-8I MMV*UP!2)YR=-#C#[LQ[,/I_`DVG^#23YA3E<9*N:TMRBQ_U]8(M+*_/2J7:G M-8!WVJ;>@>+2.Y[*?]SLPFLV&@`BL/EQP;CRU,'S"YSPYH;NUQF?QO)I%$;Q>G#'N MF9^Q\4L4S@JLV?4R3?6N=:W&\\[/G=F`MQHGS@/X)8G9?!$E[XS=A"D+8!K% MB]PEG+LF_.YS&>3A6YB_MUC,5G\1A$CBD;.#!JCVA#W(:UBVXL]^ODR+S;), M7?YGEG8P(W%_7!A28HNC%OL4*-AH1A$#" M:U/)DVIQMD"]M[+13AT;IE/&3^9L(]%'/R^2;<5D$_C/I9_F+(W>*YF"ITDZ+U`;;0.&(WD?+X[=;P322;=8^`;C M@0!(V*9:\:9:ZL9RZ/'2KB:+W+K[CZ>K#0W^U=TM;S,?[1O>3@_OU-T'NV4: MR5,2YCJ9/)'ULPMC$`\`5O)'GI(X%@DH4G"Y`V(85GB;^2-/27C"X8QA7SL9 MGD%8RCMF+#LE$?YCOF3K"(:0'K(H%;:J%_?$TK%1N13@&QU8>2/<[_)H]OM(3C#@F3EB9G8L*%F#HG<[PH MZ8W9C!O5W9["_3#F6]Y_EQW1-8<`X9$XXW52 M"#.P0TKYB(JMS5<`Q$/">-9)%Q3H;"5_='\0V)YP;D&"I;/$$D!OGP"OV#1) M6<7_\]-W$!]`#F,_?2\^JR"M`'H"I*B05[FQ*A_L]O*KWNE9_PX?>Y?'D-)8 M;H2P6I)7<"^36YJ0'B`:$I?2%JJ"8-E?WDH''R66:]T]:^U`WAD)`Y:<23WV1<@0'3"V4D[@:!F'?)A? M>1&4.&"N-.%W%LY>`=XEJ*4_8U^6O,3B*G%!)7N[OH*T&]`[(_%.W49O.@!& MU*E/<4QE&9^P2/"Y\>R&B_:DT.X;EL-'M$@YM02$-C+ERW]0E3Q?KS?0W2(2 MH=6$,3]FW:XP5:?>5\92K2\B,YAT7)\S%OP\2]Y@(P_+O1;^T-QBX:^\>[@# M1)_BG(,3NS@+6@%8IV=G,U+JA*)PZ/@XZW)7(D"=F)M-`*;3;Q@J^5V"=J?M MUC>YU"-"#OXZK%I"P`+XT6:#8&>3@U(G2E6(5L""7LV[TFG(V?X"1!;"U;!XR[IYHP\G+6H2 MV$YAL)[B90"ZFH6EG\-[Y?^5'Z&U)T-9E7.<\O\6[QVJT&JK/\1E1L+'38-8 MY/.^#WG0,75T>&60HKUZ?X8)*`*_=8?@4B/A';<794`>+,QD0\<`LR^-XH"5 M,>>Z0X#4:)16-Z2YC:[LH"9I#OJ4@=B^?6;\?06S$53;>*/1,0FG)4/A"^P$ M`E@D#3G\_2Q9YJL<7F5%.P5A:`^.DX0/@07Z5"`MV7SLDGD-\YSX\$JDKNY.J!=2MB05%$K91C@HSQVYC+@H:#M2',VB@4K`5'$Y((;[X<[6M`NO"Q4+"VH4RID/P M#I[.0>)[V<,?`'6894GZ_B7)F7S/%K4%;`>TW2 M?%,>2VV-%K;GXB/Q@''`G5HF"%LQW+0T0YW+5-R#+Q<25BP999HDUQ#9BGQV MZ^D`VUJVJOPZSE]9NJX"BV[SFCVYD$C8N>0D(@X*6MALQ40[58"K-)S,V'WB MQTK&FTU!#*>]I1@!8RL\VBVGNU\_Q7<=Z<$E^&>Q?.F)HG-H-%7]X'],F?HK MK^S+!47BWBXG4I]\$3I;(<]V+VJ/+`O@ML(G/8,9%\FEY-U-B*I MS61/-$DYV8"BD>['E)3Z_!%2'#M*7:]TJBJ)^7)8DGJD/^8RI(1`D%*)? M1I(&/LT@F49[+A`:AA,-VL2$RW`A1/?+(O*[GZ9^G"L?LVKMN`!(V*QE](@) M%>%`B.Q7I-NC'\]4[BB;-APXC:?(P^W=3?`(Z_UR2"I`*1=OI14'3\(NT*1# M0EIMY@AM_?(6^AS&X7PY5Q)7:\<%0,(.O4N*F#S1[!'Z^N4%]-G_KD=?M1T7 M``F;M39]@MDC]#FVXY3.*:OL*NC3'M:40R/Q='LH4RDN`X1>QY:AQGSEAE-A M8^ZMY-Y^BLM=35(-!T*38U-18\9R6H^N(S_+ MQM,B.YVNY:C9APOF3VLU0H2!9&;HE\6HBDUI+MIMS$5!PJ2@(DM,,0H(X?90 M1B)DJWYB*<\65RE3(M^ML?8<)(G;)"I_P8:M`(,PYMA39C5I0\)$$$E<(5OP MA6!!Z.J7&6>3->*&%S,/7Y8%2BB(1Q:$BU#G/4BG.W]A)7$4M$&Z@3J)Q8!HC6-G MI6TZ&_4W1]26@R,1$6/`A.`3)(&&\-:OJ+:GY4O&_K'D+Z1O\#\ZD_8P]I&'`\-?D-H-Q\9!POK*M19U%@FB,8].K`%&1\.21+B/#XX940#'(9E=/Y;7O(QW%`G/+79_@(N1A"7_4#M*)S$AVM8O%\4" MV@M\8"?<.Y[%V8KJE#O_\6WVZGW;9%5GX/*;GT[&!?",QU"S25U0,@O`'GZ. MTT'")6!?&]X>A8;HL.LZ`D4EMTURF7+&JVA]GH\,/6I6 MN/G';"T%M4>9T7`@3AH&QWU]8#H(!=&Q?IFX'](D8&R2W8+$"\G%5<02;9)W MY"(B\8"U+[W1@H]4*NJ7X;F>XORSGR]37IK"SV7U3/%.7#2#OJ,KH2-:X=CH M^U]^M&0/+"U.3MB9H]:(PQGDY0.%BC#GV/BZSLMQFZ2K&]!XRJOCC1O5\="# MI&9_+@0206#[.52:20%1!<=YZ1J!-E_C<"T+R1==LR<'/MS[HS9^A'C7AE9T M^@_K6T!N!B&>[4T%0.B#8Y=4ALHZB5G;OV`%1\W355`>H,`+@9Y,S27 M`:($_?)O%5Z$-X93%O!3+(\Q\?DSP-5[5[N#_LAX;HE=1$)HC&.JU<@B!;]E$#*6`J$*_\DI>SA/`^,]5]6V^'&["+$B6<0YG MKWFXG$OV$65?+JA!FMU,)8"H2K]<7->R@L\JBS/&T4J40]":"V.0YC^A',@7/`T&\7;I/:N(>[.Q35H(YB! M$!"=Z9E M$[79<76G*Q?3(&-L#`6`Z$F_'$Y\(*+ MMN7@!FD#42%&Z'1L++VEE;L"QK3A,%PD M@S1H=!`&HA_],J(:.EE^\H/7>EM[#JZ[8W-!#]HP8DM"B"HZCM[?.KC`(OHM MB6!2*SE=QI/Q,L]R/YZ$\4P>@6$V"A?(("TC[66!*(=CK]4:E#)%*JR$(FDZ M0UYNM/H!Z*/A'D0UT2.4.W8[K:1G@]FOW68KGK3X"Z^B(X<]W#.J+GPQZQ>' M,H2:.!O?Q2`;/T(22ACY(,N'XJ(9[L&UO4`077'L:VJ2=>1R\O=EELL^%>U& MXP(:Y*&SNTP0I7$0T#4XN)V^`$:U!8C@, M%\F?Y*"I+0Q$/_KEBEK<^DN1W<#]*YZ5W@TKTP!_NI9<>=6=N:@&_1:G+0)$ M6QR;2[>:7S$"P>VJ7L='O8G(>G,!#/)1S5P&B!)0J5W%@S7DZ08%33FT03Z` M*0`C7#K.'+I5Q_'4@%=%-PYYD/$&!N`1OAU;'>NW98%X*D\^M_"?!'_S;#$4 MB.9XD*$&'06"Z$J_?$#A(,S7PNH@'&9_;->)PF,"[<9+`0[Z.*@!'M$-UT'R M<.M)HG#"0W5_39,L>V1O+,;3`V'M.U2T%PBF+%V,DB#<7ZK2!0!_K.3^U^;?U\3.ONVV M]0WA5G<;IEF^^NG))FU.]BQ[SS$>B.-P:FQ3"%BP#-IB1!:!@W-2QH*?9\G; M+Q,6EDGKXT24/Q+FZI<-DX][<`FT<\"M7R@\?G;KJV/Z` M=9$"XL'7*W/I95#DGLE*EX&B>B++KY=I*O;9T>G&OTQ.32>=B15;234P(U92 M4XUX8^E+DK%[R^>?%[\HQ+N>/7[^:33DX/JUZ.6$2E%B!BY3#GG,65L&[2SM MPH]CBT^6YKS9%&1QU*][BMX21G`BG!L;=+JM6[L;^H/_SB'J;^7U#EPR0][$ MA6@1/3"V!1'1@W0)\]U6W=92!7$?+I]^60*UM4$*&%$(8]L3!87@KB'ZNX*@ M-9>)4SOBGI0`AXK0;VS(U(*/=B(@AB;[-PK2,4'6+4U-)MR63@- MY=R3"B`X$0WR_J"+'-$48^N@ M>TUY\B.V=AE[8NE;&,!FR&2?#:0'E\R0[$AZZL%&5,38DKE(>`C"&WMN MW$H.YL+_%,[B$)3?!\F53SD\>CV)8#FPK)53O]5GM\ID)*$`ZD[>T<<+:R__ M4IG)@P"4/;VC$Q*AE"I1BEQ_-,'1\?9OKYZW?I@6=JRK]\T??POA")(&K^_W M<'6-$"]FLP%`8`2,@9J\BO=3$Z!T0@HEK-$+1$,B!5P+/A6*@6%U&R2Q/S4X M:J4&1QO1D,CKMEQ`'B40<&IPA M]A@9>'>HE;`SP2N=0DLA?<_V58+`5R6`[_DNU"]\IX M+ZW>WM$I`;>-5MNM,4I;H1Y.=]V*A]KFD,$KBD<)/[`\\OH4/,&G9!_6',&[ MH.`";D"O>'\V0CNDP!`Y\-;Z`8(B\*RR9[4H0>XO/(34\\EH".\G%PUW([+O M)Q=NG6!T1=GN_>0"=W498+:DHP^]>/PH2*GSB<.A\\2QM^Q(1Q^]R M))@XR>Q(![FI7%#P#FNUW(Q1#N&M0.&HHO&YUQS!NS@C$*EFP"YB2#)!:^D5 M@<(]Y0O+2Y_(^R3++O,\#5^6.5])S\E#(7>U*YCN$-[%!8DR=$94B[7%#+*E MUP8*ZE(/X+P)W\()W(BR4A@;*^[=?"'?6TR&`1F2>*NVH#;FL+N^5%R4JA,7 MM7PG33]"U]O-&UR`RU53B>AZ+8MX%N+5WG64(X$X23QU6]]\-)%;>@VAL`?] MSGB%-I`53,:?L4UQ8"[.2L57?5_F=@."7$F4*;"@45T$8.GM9L*F85S$>OZZ M#"=^'#"B)^<./O$7%S3>[;HKC!926P\^53'5E8.4(?=H"(;I M0TP8$!`HA#0@*RQ24+IPH^&1S6D8Y"LCX^4W/RW+T$F/6RW&XV)UGU&DO:;8 M`&_)D9R"3JV*T(4\T7HE1:?LU";NP47CWG6QNU[(X>W-GDK*IO$,@RX!WP`L M&T>GY_TP;!R=DJBBK1)E.[-&`6Y05HVG@,4^?#!T+1K5]M[162^,&05K"EO& M+JXAF#'6J+[&V8(%("8X)*BL&6@?$`LMF\8N9PC)9XI$B\8 MVK0::L4.U$$$WR_3.,R7*2LRB7WG?\K4L?=H)RX9$L<]?1;%6J"$2++B(@]> M7>8LW:"%V3\ETQSN^4P>FJON";AI).MJ2ZT9SB'$U*^!53#>\-P128&<9Q]6 MKW7M,4!NIR0?=5V7``D(G>UZ1/,WE9$NV/Z_IZDU\LL3^8L5>6:VFW,A4;<0T#Y+411 MV2I@Z)3@+_Z*P<.$PY3C&T_ODWAV'[ZQR666L3S[C4436"!?I07#M/IS M@?4FX9A,.4S0VJHAZ/;+,D_2//QGP=-X>AO&L&N"U`ISK.Q[(NG&Q4/11"/,'1%F$+]3PSE?:J&)`.0W,Q#^(:84D0MFH`4HCB74$;IX\\ M3\BG[RP-P@PD$`9L\X_9ZE]E.M9F.!"GV\P]MO2J`WA$EQR;-->3A0]FF);G M)3]'(Q_$K0'@>:\/$&IL"'G]LE->)W$`4BS!/8;9'[`3\K_P9VPD6_"2;MYH M=#8(TX(&2$0'#F6)1!;P=IX/_#ZQENU9OS,/L.NUQ<`8*L)T%]/BP2(" MUP;4JNW489%?U)ZK$0BH[.N=?/S@[!2_*DL]GN*NEXIG']TA`":)D"--/I`3 MN1%8.M&%^TV`?_*1A#^;&3EU@E%8=$(']Y4'_^2CT_=85/*[!.U.>]#Q?O<2 M7PS]SB`H$H["75:G*=HA1/V)PIA4V5/0/B`6V@$>#0+%]"O@D4B`9(?\>^9G MC*=.OILOTN2MK#^K8A_O!/(A45RS&_TJ?`-*JX0*2J4#\HX@)Q(NL-WT0`>C MI1C`/,G]R*DFP/5^.5]&/&?^#8/)!^'J/7@1L8*U>%+U(4!E(WM,M?03('D2 M[KO=M,NN-+I&&-:K)M#T+P9U/CI:Y0JP=*QR'>X'23S+63J_82^Y1E(@47,0!HD[ M@1EYR,T`Q4?'?&>/;&4,G+@#"(3$\0PG2X_<*IHAV/^N_47(O^O\=CM^B<)9 M08@ZO8>TGW=Z1.)D)2,/><-6PQJ">6_?5M_3$8F;OHW=71?M$))Z5:^K7$5P7W3HY+#:>,-_LLDZU59E8AIW M*KT!O--&UH4N?D/RGY3F/];H"E,E\71F(EB!TY`V4CHWH_WZ*YR>NH\1TB9% M[:=0P*%ST=F7G\+IJ=/%B$I>X:=03)MDL26Y"LK.H2;=08O=NU6W7&WF.(=P M-9$`5CT_JKJ"D-Q'4!@1*KVD*G`.R"%!`KCR8*9Y73$?#.3IWGE[OWHC1=[U MZ[UTF<)5$X\8MJ5JL*$.LBE:N" M\3=L&@8A-Q0\L@EC<_Z)?F+!,@WSD#FY'V]F6I\HMV/`<5!]/=;J[YTY?'9< M3U#YN%AKZ)W1,#4;R!=Y1A3`HG,EML!K*0J^K20Q7W&ZA8)$_4`\)&PC(M(4 M].)PZ%RBV[/=0*=\+!2V!W&0<`O0X$Q,M@05R;OX]B.WJ@[(=S!Y\DQ)%P!* MXFU?PH+@HJT$-(3+=3U9@_*15]0.>1/\#&;/+) M3^,PGJG=<,0=0"`DB@08TRR#,X1R.<\I\[-E^JZW3PM:@RA(7'R,F46Q#*&` M3E%-NW;C+Y("^0)(D%;'"_58$91,F=6S],BZQG5^\(8.6-5W<(;W3T M@88.J)@5*X0ASD&4]-D%JBZ3AW3A8B%A!#'D47=WJ*&T51"(PEOE9LN4N3#@ MC;E$:.0S,3=M-D$,H@Q0H;K9>)EGN1]/X%"J6LS5MMZ96_<3)462Y;J+PU:Q MGT61/13FE.:.EVKSH4:Z5)N-02BTGIXTR46`V*H71(K=TJK+)N/TVH\B0?I: M%>/*`;PSM_7LNVB!)CA;%89H?)X5N,N]KXM:E".`Z$B\@MC6BRHZ6X6%NBD& M5FF,(T&25A<@7ORL='-A<5:P\L32MS!@&32<)NE\ZU+2?/RR,#0(D,0SBJ9Z MV(5MJ^[0(?6F`+@?O3$9&@1(XJG&@MZ8P[95D&@O>O-I.F5!/IX^LF#M15=@ MX;52L*.&7D?O[+Q/!TT34+;*"QV44?2(H-$+8)-X@;/!9161K2I`9,Z(R'?N M"_M6_(ORA*CJ#Y>N/FWD+;#9*AE$6"7*%=!!)QH#>&=N@P/M*H40G*WZ0SE+ M'>O$Y>3ORRPOO,>?$\1!8541HY2-U&O#<"P09A_-#BUQVBHBU`^E&>>O"A+3>$NPI206?K:I`[I5CUS2K4@6D!YS)^K@[2-'8JA]$EF8]RR/6#X34 MQ[6N@==;NPJ$<%X0\M(N()F9;-8K( M*E:YBO:@69H#>V<7@[O.:()&=,L\ZVX'W6KQ,%)%MXV(J8=.R.NHVOX)$&>? MOFO[@8]$C=$PDVHO%_L*U>HW0*0T'"LM/:&TPX^HU.`,MEHW*%E?[_Q#GUY? M#'$A:C`\(VU+/:AT!H'UTIE/$QBB"0IC^"=C_IT76V%#B'[P+Z<;6X2G=@6#0$"Z9.1O!T\ MA&]"+II/RY>_LR!_3OC595[,5/H5EW8"T'TZH^D"0E@DY#`IF+_\>RSO!;#[ M:?51($*(I.'!J//N^ND[=]*$B\-T/(7YBN.A.HP&8NJ=<:8+4B2K$`W+WH/_ M7D0`)D\P8Y;]5C[3882+6X/8B)1Z,F!4"@6A[,"6LPYK^!+.#W.89.B_A!'V M`M1A--#LWL4V=$&**$0O;6@Z_'*2K^'^>OVYGG+?%X:NZ/[DLY/@/#[ M=$/?#WQ$]WKH3ED>P0/?!*LH=']M[[-IS1;EC$D8U$\&*7KET MD=))G[_GBG(?>U)1[GAG5T3AT$F&O[>*;PTNMTFJ620,[0-B<6H9,*=09842`K2?$O]@A]"[^(VM[&N_L6AR M%S^G@+3+>139;[8_5/D=R;E2WPH'MVL]>+^,)_P^W?;[Y$5/7B\,[P;[BONROX;ZGBVH(I8L> M03!I&.1L(D8K_EN-TBCMAP7ADG@(4M$O5IKNR(=00.GKTZ;FR"8V5ZDT>"<0 M#(EHD.[DBI5&A=QM>26C.X[2U*/H!H![=U#6Q^6VCI*:R)7R5@!HT+C;"<`Z M/3_K$R(G$D-FJ6X2!5^-9S9?)*F?OI>D!%1&K2\0HVSKL;APJ![]U9M` M!\2.JRDAZE":ZX(@6<;YE1_Y<8!:(@5-.32GA_).9.*`;!4_LLR58M_9YIF0 MA_F8CL.%XOY]K37+[=#NH5#2P9Y;;E83O`UC4&K`R#-\9ZOG%A=^/_4)L6(Z M&MX^LF[>V=G(VLH2_9#T50;MX)V=D[!2J$4G6"H*5'3>9"R4@BO*Y(VG92(> M15%0K`^(Q?V^J"!-?(150*+SDM/!8EU!IJP`NML8!$$KW$#,%&*B1N"0?`,2 M?ZV4!B-%-^_LPNEKD?G:U$1,O5CDN2Z]) M5"H`D:-? MQ8UM/*U+2^;K)^GFG1_U>KVKL5EZUYFP:1B'%+3`ZF;OWK%^/YL]ZF%O_`[D M-.#H,@B6,-%U<@V'5H<'_YV?M?AS#4PJ7?J1CM%!TLL[;YPTNAQ[B\&WF/OPFTE M=@W)XU2)H'2]CE^4/,6PJ'/6-M)?3MX&Q53RM6@$J;9`X/)2K-]*7L">G)'"0,&%;BZ7H6ML&K)%%)"?DB3*9)[D('N]]>I>%DQKXD^<:;Q&;*L)LP"Z(D6Z8@R+J54H!?(G3;>Q87[1^RF9%'A5^=,T@7D-^9'^6L`D*^3E(=FEHZP MEW,XP@2^/!N83E]O].'(_?:V2X:`,0,X0[@0;OQE'UG`PC>^D\"?.)3)-KKW MZGT5O21HK0C4LS(^D.4^TXSIYKL'"0SA7JDE#EP8RK!!*^/#`J=1X]BB\G30 M3DUQN;WD(I^V[W>@-]M@?OV!W\C@"33G:D1R&\,NOU!!@1J@QCQU8KO&EI+ MKC=V&2_G>7V=S.=)7,QKIE;HQX\KN?\H*;\CKW MEGZ#;Y'NMW--RD6+WKXL'&=/LY4HJ(YM5T1%!5<3W;,U-!>S^Z"-5BIG601[ M2-+F2-,0`5078*4`]?;SKE*SMN-R`;L/*^FN8QWQ(PK6+[.K]A9O2<,T!^8B M=F^GWX>*F0D`T;%#65KU3%E?XW"]2VO:LRH]N%W'?212^S.2$AE"(2UK9&7: MV^^J-%&L]@!<##U=RJV`(GP[-E$V4#R`=,(L2])W+H9;/V#%IT^3;*0W%P#9 MYS%SIN4H$9H=&RIO_3`M9CF>KH[#ZS`GD1>MJ@N'ZC[&JSVA:F@(BX:0M'A;@9'\KLXR],E?V']&OMEND"X80!<[MHK401E7RZHGIN.=#$B MRM`O*^1]XL=P1@EX&H1X=LND8:?-MEP0/;?A8)@05],H*M@M0IZP@OD9&[]$X:P`N\F3H9&RHK]>?L_P8PHGBO)9,^"(G&PD8DIE?'R(_**H.:3`E:@O0:*3G,.,)A^(V&@8+9/1C M?U;,]RX.X'_#-Z;!E[P7P*610<.,.1U00\B+4#\!W$N\7!4]0"0D\F$8'FFD M:-P&CMB_I6E>O@`\B3064F[P0TP=QH!2N>[7DG]QZM0]O0/IFMBZQHP02OU< MI*JMZKI^$E]Q+Y`0B9#1%NPK4?4_'^NNO6_DPN#WV<]7GH;C:.*CTO"UJJ56.S$JC'O:8P!0$A=./4+$*\X0[!!L?HV7 M!;G%;["':TJ5#;A/-$-+' MZJP!G7NPT3@@/A)7*BL;0`OD0\@V5/U,;C^?CVQ1/BS#AW3SUGP7?X%#WO,W M%KVQSTFB%J/ZYT?DSBXM]`)]0V^I30LV58I7/F-I/'?S$^?OR6V5&TU M',B4Q".U&PVK"<&2P;>?B@6_+O<6;#,@R)7$8ZE#Y=J*P9*YN9?J=9LL10], MG<8#J9*X:[M3KJT4!F0&-Y="^&9UY^+C@51[8(WL4'9Z[7.XI83'9RF<%D<[20@4%O`$?" M0]>("TUS'89V"`\U#VFR8&G^_@`RXK[LG_ZQ#!=EGF$-7VV-WMZ%V[!G8U;% M2J&-=`BO.BA8+3=OC=[>Q1&)[[,VJX9*T40ZA'>@YK*!5:/S["/K!L*A:8PW MVQO4$&GZF&/:^X7E`DBH^[G9,"`0$N9Q-6EULMMC'=#SRFT4SE[S#>K+(%C. MEQ%W[[MA@"8("Q8ENX'>`"`W.=HJP%R7)8>+BA=W8]=7]TK@;>&5W9!3^^\$80SJ*OZ.8W($RT.VE_1S_&( ME']=T>M7G/-3$D(/W7%5U\R#D_ M)?&QZ+@WJ"$.P>.R9OR^7>;+E'T.8UZ[?I7,)[M9LFMEW)/),"`\$N9=-<%J MQ=##.J#KO!;XN_CY6\)?EW6W$(V1O/,S$O;?O6I-$^Z`O"%U\7-?/5NJLQD+ MI$G":KQOY6D`'I"WHZ8$N#>>)>W9#`6R)''7V;/R-/`.R)M15P#AFZV=9S,4 MR)*^6=J"[M3Q6O)6[(WN/+^RE/GJ3" MWKD")M%75;$T'DIZ5U58OK"\\>^=U$PU.`BMX(QV2JZJ*CQ5*;,S6[8-`Q"_GRV+4*]+:/Y4$C_E>5A`")PX`:RF79] MUORI+W_7<`;1ZN^-1AH=/^H->1S)F$J-9$PXO$A`D;'NR-CP<^S MY.V7"0M+5N$/33+AK[Q[V-BC3W'.88O]-@2M.%H2Y@,A"76^\.G3\;K0):N$ M@#I3-)MPG$[O[[CL=SD23'P('A`;#=7Q>]AMS"5!XGE`8Z4I40S!HZ'X6L"Y M8UVC"BDG7Z],66DO9;_;T%S*))X#4`7`],4*[KVY0;CT8GZ&,99N#K%$JD,= MNSOC'C2M[`6--'`=6$)6MYD$Z)R@VRO.)Y!3"(CXUC=.?TV3Y>(V2;=UJ0MT M"B]I[3%`;#0."&8\BY7%$#6=$WR'"+8Z.($$E,[3ND-X%S22D!BR+%85,]"# MN$JP.$Q2OHXJ.S%:V4>C%XB&Q#?'C$KD,Z."23+B^7(9\`E]]M,_6+XU8!8G MW"QNJWD MA=4W+*9Y?9W,YTE<3%Q1X1!I#Q#=UW4VXT-`J!S=4"IU=:XK^W$XIWDNG9WX_W4QJ01^2$C0[`5ZX"RY2SK=(U:+(Y) M(ZK0RKXLQ6C+$=;]*\WN.T)1=3G[PKX5_Z1\BU$.`/LCB0<7*:&21Q=-@)V= M5PFK1&%WZ*`1]?X@+Q)^$?840H3/EF;2"MOMX%=F$@_C5]M@%>^VGZ#K=;P\M>O1M(9QBG>Q$LA/1^ M&0#Q2TSAG#SI>.-K#@*2&\9!70T248\NQL"#.5B+@@6[.%HC+TVBGY$X2"O[ M>&>-T[[MR6%>S/(.,"WW;@EJN0G>OQ20W/H@NW05.SMQ^IRI0XZ`3A-P;EV& M7?N%G9TX]2XQ9JL5V56L;OU^I7YA5Q5/*(43`MH!0#I];VK!B(!2!3R2GKNB M7>I>XE^@[@1@G=X<6VZ^&IC<^N+:N5`\L_DB2?WTO4P1P%'/"T0/:1CP!Y'B MY5QRF=`;``3F]&:I2ZGX+F&"T:W'KJ6,--L=JW2<&"_S+/?C"5RI):H@ZP;" M<7J3[*8`:F3V_7P/=GO<313B/DAW=T[F(7+RLE.#^O#?6TR,2ACU]?2H-^%, M!5M=KJT%5L+75M-HIIUPG],C]U9#,S;0*RL"CN2%U:+1X=1MQ@&;#*+P2!35 MV7=FQ>XN#K:6(H!O"-?/1CV>J8,)-&X!-PC7,\$2$X!A"6&@!29FGH=+* M.W5K!$*XD!!6G?<08CL_^]]Y0FTE:;5V`)_$762'$3%Q@KF[C=NT1%V9"UU- M7;4=P">Q:>I2MSMWQ^&:6,PM2V7RFJ000; M"A`J\X*@?4`N)`Z44MJTF:YB&D3`8`.C.A.?J#W(@\3)4T&8%LM51(.(WBMV MM=4>=Z^1/$38'N1!XC;?.;2_OU&VV M-@WB$*95F`81L%=!^>"GX[2,Z7O@!I$)&"9>"`KKIH%V!N6!6E8H))2CG<#J?9ULU>!&D0WP`)J1*LF934^6%O.197D:!OFZ!-DW/YW\FB99ZT2BZ(`@41)Y)-M]/5K"112H7R;# M`FD1[B13BDTC0$[".&A.=`,"0EZ_;($%J!=^D($-;\'B;$5#RMTR>'J,J_=M MDU5NJT*+R\(UV7^!@K-)_:RD4@/+/P=LD'@S:J=0>Q$&HIK],EO:$<]=7.[' MFX^X+%?9OGX26.FGS62_`D'4M(M5]6"AD70*"J$?G+DU$`D8:!.%3IW.M4W=8GZ5*DQC[!4;0(PG:9#0B6_2]#N MM$F&$%;T[5Z5+$74%O33??"@SJ)1('`;(6@KQ6)COQ\O&'?DC&?W<*4O,DM. MDY0??^3U=K1'`;UV'W>(K`D3729:C2UG= M$[`[M9<:<6N$R5(`XEX"27>/;$&0+MGDTW=^NQ':+K3Z>:,CM_GI+=`IAF0I M'K$;FWO:O^$/Z[];H:Y=<^/)%8O9-,RSXI)[U;P'@M_!PG90"?!'N2 ML!1[25(]52\MX@ZP";N/8>JL(14HEF(TNYP/]D0P-X:5M$11\LV/I4\H&KU! M7N[#H3I3C^'J'/!Y42I"#!?,?-66C"K(RGTZQ"LJY:1E%<8] M%0=H%3XE=5RI,*!A%3[%O3@($V5L%79;X0>5O,HJC%?TZ;U5V&TY'NU%HT`P M!*OPID;H!B8O)?/(@B0.X`Q34I+?,H#F1SS":`D3>:\UEKEB=A\=1.T^P3*N M`^(CH37<)-+:'4[3BA"VRWAR#].(*D+OJ&+8L"!CJF;/;KHE!TS9Q+U&]RG$ MT3VP=.YS+X:;$%J#@`.6_>YSMYY\<_O&OD>VQO=.SDBY`TA59P_(21C6%3HD M6R%?$G[YY;DLX=N_LN*NBZFM_J]*A3H.[XU&;E-)M%U0WKG;'#BM%GT[D'LS7Q[L-L=3PX0Y#UG-+N-)>7&= ML3@(78=THK,RN>@9C>.=G#BK?EEL2]7IJ0I?BCL`!!(.0"WD+EZ6,IA_ECOE M"8T"&3(JU)?+$[P^QI`NER=N2SBADE=<+D_P"D[]*KFPHZ2R&ZFZ$PB&1$(F M_;6GBVE8EU7F9RR[7>;P55D525KEXC0R@._RNRISV8T MD"B)'$K[5J`&8!)>0@=6H=MDF5K3H,U@WLDIB?S$>U:@!MX!N0AIBJ"[TH#D MG+[*'$132I"V8FM=Q=2I;7@./30&%^[L MU6WT%G:7G-V';SS78^[',^ZY6CH+7KU_]O^>I$7F244%2(-10'2D#8-GZ.YL M#)*.X7`O^K&%_,6?JRM'&HX$(B1AKS!FW5AY&N)DN/W"H:MVXYB,/5=L+R0N[-=AZ,0I&@JL#K M%$E@6++/.5UX1:PK_WB4I7"V*:Y5)=ME_4".),I%F>^R&K`L6=7))RL%85HL5Q$A#/?+>F7=,X]&!>X6]@L%)H3M?KGF/?F1GX8\Z\N, M\7>C\70:!BS-J@FL9SV*]CLB;VQE,=,%04PI,4%ZRU! MPTG$J[1: M!S^<%(5.M<_W.SUA1Z7QBM7J\Z`%#O%LZ9#E9V#]JSTZ`LB,IH&VS18@!XDH1L\,>?P+5YZ$ M;I8IX"ZK7I>%V"F:=75V^WK,!#Z'!ONMM^@\;3R1'RU MS+\D^2,+&'?%Q.YX6IWA9M/#3[8I/H3=?AGNGME\D:1^^EYZ%SRR"?P%AZ2Z MN,D[@H1(/+:V6\8ZV!#V^^7RM@Z$NTW21R:]JS5:>J.CDQZ:\N1H$$J[V.D. M%@'XQ"(6Y&QR&\8^R,&/;OS<_QK[RTD(?^LPD==_+OTT9VGTOIG973Q-TGF9 M<<\D_L]P).]CX][8Z9L9O++),F+CJ706TAS/)F/`Y$G<=J+V]I?MR>])%);]+T.ZT2>:2UM3%>U6>:=-Q0*_= M%]'INA`[(!]".K`G/V+9(WMC\9+)RT>^@ORO M*9SZ'])D&LHXKK2"_P)=I9:P?$*XZF^?4CS,_*(X%&C9@55?OJ)'4YI"WSXV^8K.\>J_]BR(K7*OQ M0``DWL_UB$(NK^V!T[$:VU\>=="*:&?]0;RC"&;+;_OH2[/?>2'L=, MON/NM@18))Q0I5(7[+T8$K?)UE0$/7]+-`G:M`18)'R<6A/40.(V49J2(%Y1 M19>B;5N`1B+,HCU)32R#2'^&?/+O-3+JJ+J"E$A8D`YE#V@`=YPX#5G&9?(0 M'EERFZ2K4'/4]4G8V/M(XW.HQX)@14M0.4Z`AG!V#2JZC+AG^B;67$B4K;U:>J&'<0\9U`Y8VRO. MDBB<1LDW)U$]FXE4YJ'Q?"OKYC4>+EV@43[)UAIZ1![. M5$+%=M0=+$-X/=W`>@I8[,,W0C=[?[6]1^,93$"1@LL=$$-XU%R#^AIG"Q:$ MTQ#.`$K;+=;'H_%$AC.&^43(\`RBN-5W?AM8AMEKN9=Q0X]B[6)=/!H/;MK+ M5XIC"($Y(H!:3S#RCMZ%6S=%+?[T*6\"&\*3ZV40\,1GV8/_SA>!,JV[L#V( M@\2+FPYI8KHEL$@6M;I9_?17N*FDW]*0X^:F-_D#@KP7P"5A@31G41O<(,I@ M67&2N*"1Z5?_!(VC&$*5*WO.#Q)7R9.3\4>(90X^I+DK/U]Z5((;?Z ML[I$K*(GB(C&@Z",03'I6LCV%]\QE!J&%Q]H.&H8FT-P-(.HCV6G=N'%B):Q M"R<-N4KAJ&@^#/_NIZD?Y_>A_Q)&15BS[%`M;@WX2!RP),(7G*%E6`91XZI; MH'[=EF[@>?OOXE6H@MJ0(>L'\J%AN#)E6@.5XVI5MOSK M6?BV660AV^P?3$=5P7SP3PB<4$(Q<@- MN1U,6R6M*.P![;+NT(@!:DD?J@L-@+:*4[E/K'(Y^?MRE33J.7ED01('8<1J MB)\3>[O'/G[.H^'`;57E]B8G6U6U*&Q0-PSF'(1ESF6VB%C!>#RYG"=I'OY3 M54I7I[MW?D3BX[4W?1"KG[YH;-7LHJ!/Y=7M/T*>9*_,MR?1GMW&(!`2&]&! M=043A*VB7>Z_D>O\:O7:E=(W0E$'[_R8Q*7HP/HA$X:MV&[$DAS65:L/*_%:&M MG@LT+M#Z@W@T(F$/K%&&\K%5K8S"QK0+?>U=6];G4\1PZ73WSC^2.-`8LJRK M*AC@S@70+DHMB=F,1RL2TY+B<[V%K$C_K^@,`B-A,-F3AHCA(OJA;PXFK1^\ MKD`,OQ8:JD:E'XB)Q+/`GK1B!RD2=Z9O926M$`\I6_CA9.WXOSKI7\:38G5< M9AE3U1!I,2`(EL2M:D\JI"\"1+?T+:ZD=:N`>[U,.14M-&FWNS*:O+-IK"&AJ,#8G`(T_KV74+'%'T7("L.EMX%"5/+ M@2V\AO)!],N\"F+""S$0U*ZR[*,E-U[)8-X%"1..%3=>%4Q$:7KIQ@OG]]7: MO`S^L0Q3!L*`M9*_/T1^S"N*\B"(Q5S^8=(?Q#L_(1&`UY)YS,?)##ZB/[TT M".L+4E32ULH6)!H8!$WB"FY5SVR(!,F+9>SA2_:#MRIV:>>#)QG,NR!Q6[?R MP5/!1)2FGVZ\:1(P-EE5V8Y`%Y*4_Y9L+T+[P)HB<Z.C(\H?#S-6U4`10O4MM(2.(^NCV'BZ M\3GD!WKX`$-:(DQJ98]PZ85<"/;+%9']5L6)I:@G7WSD\'N)-H`T=TI8?. MNE7,_.#-"PO`[$.ID03K`\(AD4IJ;UHA0(NH@KG=U;TJ;!2>)]@S/W#L].)? MWP'J@Q(PHA*]=*,5?SP?V82Q.=\/']:(VIT]L(%@;0WGXM)%!(@N]3`#@QB] M1D"1O".(:=B&"PPRDAW>W/[903,PVX5"T>6W%=,A0!PD7NPL&CE,P2.ZT$NS M9O7D?9_$,Y[Q=^5\<<]],L8O43A3/KH8C`(B).%Q;74',<:/J%`OW6BKZV=] M7+M-TL(52R!.S6^/QDC\`$CY5;C[UTA?"(A"]=)=5E^<5E[FO!&-A-M6M<@4 M/J(_QAZU[M]W"]A%N=*F?Z%$6_!.(!X2@1YF#[8J/`C=YN97$G0KB`7().SL MYA26,T?(,K9_+LHBOKF?YO0I(Y;JU8`R/,/KB;&=LJ3L4^SVA/>T7"RB0@Q^ MM"YZ>A=/DW1>\J%1BE9O!!`>"1.F&>U&X!#-Z*43Z#HU&T_6)HU.V3;SSFDD M$#'B3$S[+BR$6V/S(0UNN9O]L_^=/\8IZ*VU!%'0^-K:8%B`#*D@>.!.]EW+I!7KC=M&AN0Y--:1-O!&)4 M",4']7&49*R6YGH4M`)03C?N;E2A@!"6#IS8$^'IF=OBU40UF@$PI^_Q%I@2 M(D*H,K:S=7GA0(BJ)"8!X,NY\7=2>P`0!8FGS:[?2D/`"/>]M,/M0A])/IF" MUB`2IQ;7-@2*OYPH.#'?9S1,$W/*'N&<9:`Z=])!R@;TJ(MI$![_'"]`;\+OJ`2(A8BG"Z-*CMP8'R0#>=X;+@LAF'*^**!_3 M*((C94V;Z"HF)+=/GZE65O$6M@=Q$+FR2/G2(KF*"`DM2&?R!VD)O>;\R/\M<`4%\GZ2(I\V>-IY=SEH:!CVZ'VGV] MXX].G2+%5`AN>OI@D(M?KSY[I:O(VANL?.(;IT4D&6PZ5^\:AUK=(4!H1)QO MS$ZY9OC$2F%LN26L%%JG8-TA0&@D/&_,2&ZC*$W,8D4Q-O/:_0I\\M,X6>:K MT*VB3FTFW_OQ'@"3Q%NW&2V"+X(*(F++,+;@6J8R`R%]4Y!7:0-82-B9NM.U M`PHAZ%#6)H2@SW[LSXIWI;LX@/\-WYC.@E-T`\0D;$F=:=3"B3![*"N3/K-% M8BAC8BN]`"\)Z]$^>-V!B=!Z*(L2YI^>AH`Z])'S\$X;P$+2&H0=>!$`"!F' MLOXHR$!/HH)6@,?]:_*N@"4L5.>-\'`HJXZ"!_G>5F\%>-R_"8M$+&&B.G.$ M"<<6G/5,QS'3(V/3T#L^<6J;:<-'8_(()8?Z6Z%&R:0BHG!I+VE#2 MF#Q"2;],(47BOCC+TR4_L2@L8;N-01(DS!NF-B\,"<+IH:P6^^#TBS]7F[.P M+B`5$C8.C"\==IMHD(=[Q^:,!\`<9EF2OO/;@GPW%;4%;"3,&W+9"W97'`Q" M5,^<:-;9"LJ+Y74R7R1QX5^D<*61]0/Y].HAUP`40GJ__&H:\#1?$QKM01XT M8O75I,G>"X2H$)8=&T`^?0]>_7C&UME%%<9E86OOF$8Z>(GP139E"1:$*]?V MD666)W.6;HQL>J0IN@%B$F^X9NQI@4)H=&Q>6=4$;L6E3E_`3N*"8D:H/C*$ MU4.9:NQ\+E?`E#Z)M7:`G\351)M9"0J$Q7ZYVFS."=>1GZUK$.F>V]C^CJ91ZP MJV7&JRME1>7IK,@%H_B.(CU`EKUZH=>"@S#=+PN1"&%99UQMK%?V!3F1,`]* M:=1G7H`-T0'']J/+&4R3GRB43]2[+0$7"6N?)@&"_1G#A'#EV'ZTF:WR[7JW MI7=\1L+&9X&K!B:$*Q>151V.L45-PEL_X`D-L/`XO#%(@H0-T/2CB2%!..V7 MB:@.3GWK%#0':=`X\B(\Z;!:18+PVB^CT2-[2Z*W,)[5<2IOG])^(!\2ID&< M.S'7&J`0T@]E0$(^IO^^C,,D+5)BLDDE26;A^"QS)U9V!-2]L@.:H$*X=!PB M)9V\W!M9HRMA9E_8M^*?6B0) M;PS@?3PC8;Z0,XJ]V>DC1'3"L>'IP4_S>%4?8W.U1[U'18U!/B1,&B;\J=`@ M7!D;GO:2>?)AF0:OO(;%M/*@4:K<\VN:+&>OSSS%83J>3B6.P":#@%`HVC4T M*#9'B5!_X*3L)M07M08Z,H^,X8U&-.[#=IB7HT28=QR[)CU9EI^>5@?OLJLW M.CHF8=HR)E@?',)KOZQ=]>"("MYMD9&'-`R8+(NT]AA<<+U;]FU1(NKAV"YV M.8,3"2\"?SE/EG$^GA9ZC3\TB5IS@"3<:HP7MQ0/0IACXQ><_+FSK3]CMXR- MXV+"H&=Q$"[\J(2!?I'573ET$@_SYA]B;7!(:D;'AJ_+R20LIU24$$178+T9 MA]2[6ZT$",*-XSQ!ES.`!&IUP[(@#8O9X3OD3E.`1B,-5XOM$0.#\.0XZ\]6 MITH[N70W%#;F\"B^YIBLIUTX"%N.34)\W6M^N01-.30:3MJF3.%@$)Y\=4:G<;$B8'A)!&PY#S9;`4M+K@HXWXU9%MOZ(W66>(/)JO* M!7,\':[;HH7V7%;^M;$;F/VP:GMH-YHW.CGT?G$''X\LYROD-Q9- M[N+G=)GE%L4J'%\E/6DG$-(%::5<%>P;D%8V8J`/ZA&TBGM65NNK-80INZ]% MW$7:XH#HU//S\(&?J_CF+W3V!O1B%%ML74W,-@O]D?#X-*E"+5# M\\O9J?,587IP/7-ZB#$5KMXY]0RO7$$C)[QV%9'1&:U32$7`HN>JG:F[/5,W(9BH!*6$%&=^1`.7RN[-P\N>7]. M_3B#W9GOU%?OU7]17*GU!P'!T0C-4.Z!;;'1J=AL1RF4M^[=QB`($D[ZIM2I M%:"*CV3QYR<6??/?K_U%F/O1?12HQ`'13^E)E]:)%<1.:[!;"N_<)R',7?$@C]EX61E_]A6'Y>PK>P+@)?$.Y4F,2+KB`8^FJ6@+]DLS%;SOD[2A2)#JK"U-[H@\0+5GC\9 M+L=5HXF\,5[TS&R%8=A#[6FW[H8V'>;VX&]X='1$PHF[RQOLL%VZCR[.G.]* MAN^\1Q,/I&INWUIMNF. M<_S!Z8,C(E\)"=5YDWP';N6.<_S!?<9RD80E1%1G;NFAU^EGYG)9N"B4%K1M MZ.#'4/DRV`CB$EV(#X,]A'JF?'=H-"`(E\0#9 M2@\ZJ]2.(`;Q,%U*2?T@76T'\$D\1W8A#[FN[L*T]3I-PINH+#.JR?;51@PD M;$_[8KL&;Z/D M6_90"/&5Y6'@QKR_F55E4AK&>UDW;S3J7PC6B,3'4"U6+<-[@690AO=N20)& M)+Y](I(4=.["&(*QW7*2@!&M#]TN9PC)0`M&_CB$@O6.*QQ"=A=O`T.-C2"VQWCI#R8#2+1X= M6WM$-LQZJXAGJ[6"33`P3U'M_*FZ"T.")VU+0K%T3-I]H$!6Z%]_ MX5"XAV?!QO\!4$L#!!0````(`"Z*;42_)",O\1@```%!`0`1`!P`SZXG,W>,64D##X>#8Y/CAP< MN*%'@L7'H\^SF]Z/1\X?__#[WWWXAU[/^0D'F*((>\[3QKE&$9I1Y/[*LOS. MX'AP?.[P/\YZ=XCV3D\&WSM_/CE[?_KC^_.3OSC__7#W/\YH.G-ZSLO+R[$' M)42BA&,W7#F]'O\.C912MW_?[/!][<5',L_3A M`V)IXC]B22 MIB]$Q?5.!KVS09;%#>,@HINBC`R[QXOPN9^^E&6+*86FI\J7ON493XL9/4SD M>>"%Y#OXU5W*T_,WD@PD>,8LDF=)WDDR!8BX3)Y'O.)9!L4LC+CR#/!"DAP( MB#9KS*34B#<26"Q:4\5'X(WD*QY>4^SR/J]L7Q=]1%T:^A@0N%$/OZY]%*`H MI)L;^+VMD#`(XI6\$"^B?8ZX#XEZD`I3XF[SU6=*,X#V<)P/*`A"4"N@CL1O M_F2])L$\3'_"`]Z^WW/`,\CN\#\^/XX5>D'(=1VZ,=@-)&7JXPT?YI$GW?WD:8Y7>2[L:_\:)JM7R`B5V1SAJ["@(4^ M\7A#O40^5W;3)<812^A1O]9S1^.KD=7P]GHVOGL0>!IOVR<=3#)86B(AK2&U0CI[TCQZG M__2/9Q?_ZER/;L97XYDSO+]V'D?7H]'=\/(6NO?H"JIG-AYUK>-KM8X:]7V( M0O7MYAVWE0AS_9#%%!^\X71CPUX-Z0JQY8T?OM1HD5TR/=D_F"N)J^'TDW-S M._FEZ_LM*6O0M15Y]&3^V(;,KC^:S50Q8+C!-&$G_UM?\H%SSLR5VDIQ=%4NK^!&S3.DG]9Q_ MH*_LTW)EY[)VM2VM[2E9!`1L;11$0U(`QW-U.[?1)](R;L M2G.RXCJ6I"P]T'"-J=#](U#O8") M>8]3!O(/]!5_7ND,:=9_<0+\OL=BY4S,(SYAWQL',QJSM.H5[_0L5!P" MN5(<7HQ#`D<4U#&BF#O,,:4XLT*#Q57(HNWD0?I.S\@/U=E#4HJS+<81Y72$ M2`F!<93&V!N]KG'`LE&[_%!/P8]E"M+L3I:_JWK%S"W`D_D5M%429?.TW!-] MI5=FS3POGRXGN;LJEU;Y)27>`M^'4=;2\P^T%7Y:F08G61V1MZMN>0L/@T6$ M>;344];"\T_T%5Z9_?*\O1ED=GCNKLH5,V#5*EOS=;-3R9PX*\/9%=(Q(3?V M*E/C-*\C,GL,#C?97]U"JMV`6[&IPFLL@R7/M82#L3,R3T/UL9Z%RMP^[YCL.&CMH.V+)AC)BGUU%4=`_4NS([`?0+5KW&$B,]F^#6*LQTAC7)H"?V^ M>1"[\UWZ`2?]0L>K+JQ=QI_TC9XG3CE'JFFH;*=^P=@+V!.7V#&OXJ;@=3_IQ!QV![!D_-&3RM8;`:GV_* MX&G'8'L&"_9&DPQZ-JLA#*9L=K9)XQ6.PF"H2Z#GK.(24:UQ=$-?6XH*O[W4V5:72L]9Q1N@VGK?T=8\_K5@ M1DN>ZZFI>`.*$;"=#=V0AH&*AQH+^IWVC(3.?FY!1*??]N2MT,G,D^M9K'@3S%CL>N$^L?_%Q6ZCI'H6 MJ\EZ9/HF:IX*B8W-Z/'\?U/XBJCR\_3\?UH.NWN M1S,Q0L)`N`R`AE\0I2B(<@:CY)V>F(H[XFIR=S>Y3^Z>$N3\,GQ\'-YW-T4J M8QO3:`Y1\5D<8^&9GH&*U^'A<01]XU'<*@0D=/5>?V70A"Y00/XN/B]53\6S M'%KDU'-8/>-A-+UZ'#]P52;N?7S\:7@__B^AVE0:K]OL:1IEEPN=*VYX5R?0 MTU=U;-S_/)K.^'U>SJ?1[37\=F:/GZ>SCJ-#=LI2A%V;K'I>*QZ05MVRFX6U MMQQE)G^3#'I^*[Z1.JNRFP[LHVQ+JRN:%'K:*LX0M;KM^EZ+Z8#*'5F;4D]; MQ2NBG"ITW:S5Y$&^)4J30LO7CQ7O2&EB\?^:)?[/$V+X$<^=5_$D@F0?CQA9 MK7U\E#Y;0NW#,R"M=WHR.#MY=W;R5Q#Z^'7E9TGX%PH4OSY1_SBDB_[IR3D390PN+B[Z(A44(K:R$DV">2A^PZ\@"),&GPK^`<0*:>0$ M:(79&KDZR"1@$0I<*)ZY2[Q"MZ$KBM)DX;]Z6;X>?]0;G/;.!L>OS-O5?A,0 M.QF;@R0!`*S\L M/BK-V,=^Q+(GO5U1C>1GV#U>A,_0"+B!:0Q(DBW]>U\@8FL^W31&DL^7_=@; M2PRV0."*0D\;@_NLO&];+-)/[:MT8"1%S&BQLTP;#+E?S9 MVQ70"@4C;F,,61[^Q][?C]:T.8`LD_BK!82R"KI(!IL`+Y"X]\-$<_F4%G)Q M]77!U>;@W=XP#)5G#D)TD,^GXREH5S?JX=>UCP(4A71S`[_-(>5+&>T*:8&P MP+J'2>,NF^7A?[3HL`71O(CVN:73#^(5IL0UJY!RKGUYVI47!KV62,+@OC68 M_/C)2V,'&GE%66J*L)\2@--7'HXC&W&(5JOQI`5`C7S*%LC\1M<1^D&G;^`NX3 MN/3%DF92(]# M0JA'_`0F0W(USR;YU[9FJX>HD.N*0BF4H.$K86_.C1>]]PB`8?!X7!2FB*L& M_'6X0B0HT>")AV_;MLJ`:G#?X=43IA;AS@`I<$^Q_X(V5VA-(N3?^JXU^%7` M5/6_1-1#09K^#M%?<<1LDJ<.H$*N(5X0EF:Z"NG:&GE4P&I'$%:.K_@6.FH) M.:D;/^&Q:B21P*P7C"0IP%)CO4(`6XL$8[`U0S\_8,B)J$9I+)DXCLUFP`L":6:E-@XL$ M4PUZFX86"28%^@<:K@@#"V##F;)&`#DLE99Z=9[G:(FI_>*9P53Y0!9@`_'?-JDQ&:@Z_#8I,ADHM8U,0BJ. MA,+\+()G'L<%GQ0CD&U>9@.P*H6-:!1@RFY#%&QKYRW]-QY^:N*^4>!521=3 M4)F,GZ>["^9.C".88X3Q8CG#@8>I6"@J$2I2O?'21T.\JO7+T(WY3WXG!*B< M:#,.YB%=)4M_UJQ?F:%4+M$^8S\4-U-,(S`2H;K6*-C8O*S5#+)^^>X1NY@\ M5]V.K;IJ$@(:';JG2J`VZ:4_(U\X`K2=U"[5U$B,-L..<(YX;TAY4^>Z$7KE MHAPEF%WFZLX:LT$-K0V+UJSR&J%L(Z$UQ!FA5!FP@!KY-QBS&UX$?28N9O:J M6P5&YH@%"E2=PE]F(?%/%_ MQ&`N8NIOMD=&Y8P,^Y;M&N'>3WB;EL`:(U:N26\/:;2.VRJV>B$LXDB.2FF< M)_LO(?F0,1RQ?.RAN+;'7C5J@MU4[*'K`J+M_3J_(:$KR%6N4K!EW8@\CTC6 M/AYAH`"3/X3>ZQ-1:0\8.G``>:X)MWPQ`&2I#XP;QVG#3$T%L!-X_^$N_[>= MG1U.DIJJPF/U!^Y#F"!XL2MLE+3RQP%H1,RB]*<]-;6W((J*XH?G@_J/L+<= M^!/;AD^8(6>AP5@X#33$KVHFJ[4?;C!.+3CA^^%;([U\[F0F)28BDW6U.EJX MKO8VU]KBWJ<:AIXG-E(C_[=7%0KLRKEQ%"4/"LZ%RSB"F4SB87E3OT##+F$( M7S41XWHD#)+HT=T=#8EO5,S,;7/'FR)N+;`U+@1SJ%JOC[U.'W.?SRU(OA#? MM$:$*B1CWYL]/AP--I5S(PG0)G]/5&X,=D?NNE_KIH9&MN6L=J"5P6A8;K`U+8!/(^JT=X.BUII+4!EZT3V;"#*@U&. MNU]B`L;T9ACL[ANX@@DHL6N]VQ1G*S%MTQ+&:+5JP1HSMPA'N::R'>GXI7(K M,:4;KOB>#HN7;+6HV[5%VPPL([BM1+5(W1L#56W\"NFO`#H=U.WU)91Q*@-E MLFL=;;2-M>AJ)=K-L^T9W?3H5"LFVR,G)G-9`;:-:@WP-B#1.GVI`=E`+(MT M8PT\E2',.V7BLKZ..>@'`4I$=,F=NEG8!23DR]8'<PA1Y,8NJX!R4_(A9/X"[FI"5F><1"%Y1!RFWM.8U&:6`TVV9&U`/?FVIJQHCGD%J/' M+/S,=T2\B.W%O]G!H2Q%&R6IJPG[=&`3B:?QT]_`ZIB%.^^B]0JM!GA#<:WI MTW4`5>$HWM_B="%I%N[BEAX0\<;9T6Y9I.ADGIVY:3._;252[J$51Z#,PF3) M^U/H>Y:K,Q7B/5K`$'0%3`JS\[G(0>*=OVD+D$FDJ""^G^BR/&&V.$95@;=^ MY!HR<:A!*1C90@DUF%6'2B0G`P>+VY"Q*[!U-O.0OB#JB>U&`N0UBHQG:E]1 MCQLC-3%'>3TMD_[/]]1#=QA]B4FTL9A;0_RFLPR^9VXGD M3;VW+7=LF`BAT5F_A7WD99RJ;0,AJ.S?@CP5H,J5Y^VXDXY$]]CJDU45@&NZ MX78FD39B:]9HZP"J3\`"'-'FP4?)V1:@C<2A#U`9V<'.F`^]R4XK>]MI8T%4 MU@.?720:VJ[-X2I@*F)]Y(K?=DDAAZ4RY(O[^JQS/QIF4+A^$N>IRLF0$I<)E)\3D@D?174R*+0N0 M#;":25L\U_L&9L*'6EO^6MMM3`50R'^#"!4I)O/RA3@6"ZU%W;A=6Q0I9@*R MF5ENT>A1C[!^P+=F!Y\$DZJ+Y<=':P8Y*2K52B8E"VB2OC7@RX#4&RC%+O*M MIQFLE6Q'N36RF(#4;VJU]KY@#3Z5DDYOU1VZ4!N,9''RD[EX`*/$2)SLG9V, M_$#M/D.UI3CFE2,4Z"->)^$WN?N9+8@J:`;77.9D.3X[_2T='B>4_\]AWL>\ MSTSF:70UY\WW[3#&#R>+_K)%5HVSM$!\'3C]81[9L7=)-?P,-059^;%XQD;- M5U=R6HRJXL74)8P#RGII1K@8D_9F\NNTQGK8 MS2J!GP)>ZGF-SRD_`,5:<$;WI.5.IB]MKK!@'#"'JHST>8K&T*!H+Q93#5=YL!L;# M`A1-HKH+1YIR/9\%Y*0:P8(NW!BQ2FLE!TZC!89H@E7GD4C.[9W, MQ<*=Q0%!*L`&_K/B24OY,YF`\YTILJ]9=(C[*YMC5GN+78P]=D/#E5AK#-S" M":1*A[%53K9&4JA:NMAKF$V!Q@'OWY3A=%'/FAT`AC"-=_Y:*V@#J/4SG9*L%XG@"FY5R&6G-F'FPH^V_FCE01JH< M/N%O8-:N>!PIJMI&ENQYL_W2`05>E3Z$YJA0"1;*)D6K#`+V8SZ7>(!:"")Q M8+\8`X6%8(^6-X19?R]&P8%K092"$IGJS)0LP&M[C/@5XA%>EYM,UN'$:.FCH3^^C]240>01:P@I M_\XX&+HN5XRL>F"/!4:>%J7J\&\8I,.7:[P.&8FN"7N*P006/M-'['-WQ"Q, MZBR9[TB,#)L"H=M)HXP%B5F45N5E`LCBX5N*5B49B!Y20)[$!:?1%;NX@MR] M$X?9@K=W(V^.6#6H0RV%*TRM\6N6`7'<'_K,78(X0H3_!5!+`0(>`Q0````( M`"Z*;407C#ZXARX!`$^^$0`1`!@```````$```"D@0````!S=V-A+3(P,3,P M-C,P+GAM;%54!0`#:"`B4W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`"Z* M;4081'#@/@\```OT```5`!@```````$```"D@=(N`0!S=V-A+3(P,3,P-C,P M7V-A;"YX;6Q55`4``V@@(E-U>`L``00E#@``!#D!``!02P$"'@,4````"``N MBFU$70XVQ]%@``#4"@8`%0`8```````!````I(%?/@$`&UL550%``-H(")3=7@+``$$)0X```0Y`0``4$L!`AX#%`````@` M+HIM1'7(^\JZA```'4L'`!4`&````````0```*2!?Y\!`'-W8V$M,C`Q,S`V M,S!?;&%B+GAM;%54!0`#:"`B4W5X"P`!!"4.```$.0$``%!+`0(>`Q0````( M`"Z*;42L]9+/8&X``#PH!P`5`!@```````$```"D@8@D`@!S=V-A+3(P,3,P M-C,P7W!R92YX;6Q55`4``V@@(E-U>`L``00E#@``!#D!``!02P$"'@,4```` M"``NBFU$OR0C+_$8```!00$`$0`8```````!````I($WDP(``L``00E#@``!#D!``!02P4&``````8`!@`: )`@`` XML 53 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity
6 Months Ended
Jun. 30, 2013
Stockholders Equity Note [Abstract]  
Stockholders Equity Note Disclosure [Text Block]
15.
Stockholders’ Equity
 
The Company is authorized 30,000,000 shares of common stock, par value $.0001, which shares may, but are not required to, be designated as part of one of three series, callable Series A, callable Series B and Series C shares. The holders of all common shares shall possess all voting power and each share shall have one vote.
 
Series A – Holders of shares of Series A Common Stock are entitled to cause the Corporation to redeem all or a portion of their shares in connection with an acquisition transaction. If the holders of Series A Common Stock do not elect to have their shares redeemed, then they will automatically be converted to Series B Common Stock. As of June 30, 2013 there are no outstanding Series A Common Stock.
 
Series B – Holders of shares of Series B Common Stock have the same rights as Series A Common Stock, except Series B Common Stock cannot be issued until such time as all outstanding shares of Series A Common Stock are converted to Series B Common Stock. The holders of Series B Common Stock have the right to participate in a Post-Acquisition Tender Offer or Post-Acquisition Automatic Trust Liquidation. As of June 30, 2013 there are 839,965 shares of Series B Common Stock outstanding, which are accounted for as shares subject to redemption on the balance sheet.
 
Series C – Holders of shares of Series C Common Stock have the same rights as Series A Common Stock, except holders of Series C Common Stock are not entitled to (1) cause the Corporation to redeem all or a portion of such Series C Common Stock in connection with the Acquisition Transaction, (2) share ratably in the Trust Account or (3) participate in a Post-Acquisition Tender Offer or Post-Acquisition Automatic Trust Liquidation. As of June 30, 2013, there are 8,953,494 shares of Series C Common Stock outstanding.
 
The Series A Common Stock, Series B Common Stock and Series C Common Stock will be automatically consolidated into one series of Common Stock after the consummation of the Post-Acquisition Tender Offer or Post-Acquisition Automatic Trust Liquidation. The consolidation shall be on a one-for-one basis of the then outstanding shares of each series of common stock. Following the automatic consolidation, only one series of Common Stock will be authorized, which will be referred to as “Common Stock,” which occurred after June 30, 2013.
 
Prior to the merger the Company’s operations were conducted under the HCCA corporate entity (See Note 1). HCCA had authorized 50,000,000 shares of common stock, no par value. Upon the merger, every 7.6923 HCCA shares of common stock were exchanged into 1 share of the Company’s common stock.
 
During 2012, the Company issued 2,120,200 shares of common stock with a fair value range of $0.01 to $0.31. These shares are freely tradable.
 
During 2012, the Company settled a suit with a shareholder to repurchase 500,000 shares of its common stock. These shares were recorded as a stock redemption for $100,000 and the shares were received in February 2013. In February 2013, these shares were issued to employees in recognition of service performed and an expense of $480,000 was recorded representing the estimate fair value of the shares issued.
 
As part of the Merger, 750,000 restricted shares of stock were issued to certain members of management. The shares were valued at $7.30, the share price at the date of the merger. 400,000 shares vested immediately and the remaining vest through June 30, 2015. In the period ending June 30, 2013, the Company recorded an expense of $2,920,000 for the shares that vested on the date of the Merger and $283,889 for the shares that vest through June 30, 2015.
XML 54 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Tables)
6 Months Ended
Jun. 30, 2013
Income Tax Disclosure [Abstract]  
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
Deferred tax assets are as follows:
  
 
 
June 30, 2013
 
December 31, 2012
 
 
 
 
 
 
 
 
 
Loss carryforwards
 
$
6,363,018
 
$
2,064,222
 
Intangible assets
 
 
81,000
 
 
44,000
 
Accrued expenses
 
 
1,060,000
 
 
1,060,000
 
Stock based compensation
 
 
209,904
 
 
-
 
Fixed assets
 
 
7,409
 
 
(14,120)
 
Less valuation allowance
 
 
(7,721,331)
 
 
(3,154,102)
 
 
 
 
 
 
 
 
 
Total net deferred tax assets
 
$
-
 
$
-
 
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
A reconciliation of income taxes at the U.S. federal statutory rate to the income expense is as follows:
 
 
 
Six Months and Year Ended
 
 
 
June 30, 2013
 
 
December 31, 2012
 
U.S. Federal statutory rate
 
(34.0)
%
 
(34.0)
%
State income taxes, net of federal benefit
 
(5.9)
 
 
(5.9)
 
Permanent differences
 
(0.20)
 
 
0.20
 
Interest expense
 
7.90
 
 
-
 
Change in valuation allowance
 
32.2
%
 
39.7
%
 
 
 
 
 
 
 
Effective tax rate
 
-
%
 
-
%
XML 55 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies
6 Months Ended
Jun. 30, 2013
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Disclosure [Text Block]
17.
Commitments and Contingencies
 
Operating Leases
 
The Company has certain non-cancelable operating leases for facilities and equipment that expire over the next four years. Future minimum payments for non-cancelable operating leases are as follows as of June 30, 2013:
 
Minimum Rental Payments
 
 
 
 
 
 
2014
 
$
207,764
 
2015
 
 
206,251
 
2016
 
 
217,740
 
2017
 
 
146,520
 
 
 
 
 
 
 
 
$
778,275
 
 
Rent expense for the six months ended June 30, 2013 and for the year ended December 31, 2012 was $96,468 and $186,733, respectively.
 
Employment Agreements
 
As of June 30, 2013, the Company had entered into employment agreements with senior officers and other members of management. The agreements specify aggregate guaranteed annual salaries of $2.4 million for each year of employment and extended through May 2017. The agreements allowed the Company to terminate these individuals for cause and not for cause. Depending on the terms of the individual contract upon termination without cause the Company would either be required to continue to pay salary through the original term of the contract or pay severance, typically one year of salary.
  
From September 2013 to January 2014, the Company terminated agreements representing $1 million in annual compensation. The Company made severance payments of $120,000 and in one case replaced an existing agreement with an annual consulting agreement that renews annually and permits the Company to terminate at any time with 90 days notice.
 
As of June 30, 2013, the Company entered into employment contracts or employment arrangement letters with certain members of management that among other things committed the Company to issuing approximately 650,000 stock options. Subsequent to June 30, 2013, the Company entered into additional arrangements committing to issue an additional 841,000 of stock options. The Company does not currently have a stock option plan and these stock options will be granted at the time the stock option plan is appropriately established.
  
Litigation
 
During 2012, the Company filed a lawsuit against its past adjudicator of claims for overcharges, over payment on claims, errors and misclassifications, and rebates owed from drug manufacturers claiming damages of over $5 million. Additionally, the Company has recorded an expense for the amount owed for claims payable. The adjudicator of claims filed a counterclaim for amounts it claims are owed to it by the Company.
  
In August 2013, the Company settled the suit with the claims adjudicator. Under the terms of the settlement the Company agreed to pay the claims adjudicator $2.7 million over 15 months commencing in September 2013. This amount was recorded as a liability as of December 31, 2012, in accounts payable.
 
On August 14, 2012, the Company entered into an agreement with a shareholder to buy back 500,000 shares of common stock for $100,000. The order also called upon the payment of $50,000 in legal fees. As of December 31, 2012, the Company had not received the 500,000 shares of common stock but had paid the settlement. The Company received these shares in February 2013. A stock redemption was recorded on December 31, 2012 in the amount of $100,000.
XML 56 R68.htm IDEA: XBRL DOCUMENT v2.4.0.8
Related Party (Details Textual) (USD $)
1 Months Ended 12 Months Ended
Sep. 30, 2012
Dec. 31, 2012
Jun. 30, 2013
Related Party Transaction [Line Items]      
Annual fees for Services     $ 360,000
Consulting Agreement Contract Expires     Jan. 02, 2017
Stock Issued During Period, Shares, Issued for Services 2,068,200    
General and Administrative Expense, Total $ 641,142 $ 7,603,458  
XML 57 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 58 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
6 Months Ended 12 Months Ended
Jun. 30, 2013
Dec. 31, 2012
Cash used in operating activities:    
Net loss $ (14,066,292) $ (7,575,965)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation and amortization 156,664 205,997
Non cash interest expense 2,443,296 0
Stock-based compensation 3,683,889 0
Note-based compensation 412,824 0
Common stock issued as other expense 0 641,142
Mark to market adjustment on warrant liability (62,163) 0
Changes in assets and liabilities:    
Accounts receivable (124,733) 42,316
Rebates receivable (251,185) (1,323,474)
Inventory 101,059 (258,296)
Prepaid expenses and other current assets 300,811 (603,338)
Other assets 21,555 0
Accounts payable and accrued expenses 2,589,957 295,502
Deferred revenues (142,937) 638,223
Other liabilities 153,070 0
Deferred rent 0 16,486
Total cash used in operating activities (4,784,185) (7,921,407)
Cash used in investing activities:    
Purchase of property and equipment (104,981) (495,768)
Total cash used in investing activities (104,981) (495,768)
Cash from financing activities:    
Proceeds from cash received at Merger 11,948,361 0
Payment to Series A Holders (3,101,038) 0
Expense of offering (814,076) 0
Proceeds from sale of common stock 0 9,420
Proceeds from (Payments of) notes payable (3,025,000) 4,192,954
Drawings on line of credit 534,343 0
Debt costs (527,024) 0
Redeemable preferred stock 0 2,362,517
Warrants (repaid)/ issued 0 371,350
Redemption of common stock 0 (100,000)
Payments of capital leases (125,508) 0
Other 0 17,683
Total cash provided by financing activities 4,890,058 6,853,924
Net increase (decrease) in cash 892 (1,563,251)
Cash, beginning of period 1,791,134 3,354,385
Cash, end of period 1,792,026 1,791,134
Supplemental disclosures:    
Interest (305,318) (852,276)
Income taxes 0 0
Conversion of stockholders’ loans to equity 2,306,501 0
Equipment purchases under capital leases 436,504  
Deferred financing fees incurred but not paid 88,730  
Promissory notes and interest converted to common stock 3,159,624  
Assets received in reverse merger:    
Other receivable 857 40,867
Note receivable 3,554  
Total receivable 4,411  
Liabilities assumed in reverse merger:    
Liabilities assumed 6,327,559  
Net liabilities assumed 6,323,148  
Warrant Liability [Member]
   
Liabilities assumed in reverse merger:    
Liabilities assumed 4,018,000  
Common Stock [Member]
   
Liabilities assumed in reverse merger:    
Liabilities assumed 0  
Additional Paid-in Capital [Member]
   
Liabilities assumed in reverse merger:    
Liabilities assumed 0  
Accumulated Deficit [Member]
   
Liabilities assumed in reverse merger:    
Liabilities assumed 0  
Notes Payable [Member]
   
Liabilities assumed in reverse merger:    
Liabilities assumed 1,977,570  
Accounts Payable [Member]
   
Liabilities assumed in reverse merger:    
Liabilities assumed 183,981  
Deferred Underwriting Fees [Member]
   
Liabilities assumed in reverse merger:    
Liabilities assumed $ 148,008  
XML 59 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED BALANCE SHEETS [Parenthetical] (USD $)
Jun. 30, 2013
Dec. 31, 2012
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0
Preferred stock, shares authorized 1,000,000 592,500
Preferred stock, shares issued 0 592,500
Preferred stock, shares outstanding 0 592,500
Preferred Stock, Liquidation Preference, Value   $ 1,481,250
Common stock, par value (in dollars per share) $ 0.0001 $ 0
Common stock, shares authorized 30,000,000 50,000,000
Common stock, shares issued 8,953,494 40,000,009
Common stock, shares outstanding 8,953,494 40,000,009
Redeemable Common Stock [Member]
   
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares issued 839,965 839,965
Common stock, shares outstanding 839,965 839,965
XML 60 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Accrued Expenses
6 Months Ended
Jun. 30, 2013
Payables and Accruals [Abstract]  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
10.
Accrued Expenses
 
Accrued expenses are as follows:
 
 
 
June 30, 2013
 
December 31, 2012
 
 
 
 
 
 
 
 
 
Accrued severence costs*
 
$
750,000
 
$
-
 
Accrued rebates
 
 
364,196
 
 
77,329
 
Accrued registration rights penalties**
 
 
592,000
 
 
-
 
Accrued professional fees
 
 
290,777
 
 
50,000
 
Accrued expenses other
 
 
431,060
 
 
441,199
 
 
 
 
 
 
 
 
 
 
 
$
2,428,033
 
$
568,528
 
  
*
Payable to a former executive of the Company.
 
**
Estimated penalties relating to late registration of shares of common stock in connection with the bridge notes.
XML 61 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document And Entity Information (USD $)
6 Months Ended
Jun. 30, 2013
Mar. 10, 2014
Document Information [Line Items]    
Entity Registrant Name Healthcare Corp of America  
Entity Central Index Key 0001514682  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Trading Symbol SWCA  
Entity Common Stock, Shares Outstanding   8,832,692
Document Type 10-KT  
Amendment Flag false  
Document Period End Date Jun. 30, 2013  
Document Fiscal Period Focus FY  
Document Fiscal Year Focus 2013  
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filers Yes  
Entity Current Reporting Status No  
Entity Public Float $ 20,400,000  
XML 62 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Line of Credit
6 Months Ended
Jun. 30, 2013
Debt Disclosure [Abstract]  
Debt Disclosure [Text Block]
11.
Line of Credit
 
On April 11, 2013, the wholly-owned subsidiaries of HCCA, entered into a credit and security agreement for a secured revolving credit facility with an initial aggregate credit limit of $5,000,000. The facility has a term of 3 years, through April 11, 2016, during which the loan proceeds are to be used solely for working capital. The facility was terminated in September 2013 due to the Company’s inability to meet certain financial covenants and all outstanding balances under the line were repaid. The outstanding amount on the line of credit as of June 30, 2013 was $534,343.
XML 63 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
6 Months Ended 12 Months Ended
Jun. 30, 2013
Dec. 31, 2012
Sales $ 24,328,860 $ 27,305,795
Cost of sales 23,309,725 26,148,118
Gross profit 1,019,135 1,157,677
Operating expenses:    
Selling, general and administrative 10,815,273 7,603,458
Loss from operations (9,796,138) (6,445,781)
Other income (expense):    
Interest expense (4,332,317) (1,130,184)
Change in fair value of derivative liabilities 62,163 0
Total other income (expense) (4,270,154) (1,130,184)
Loss before provision for income taxes (14,066,292) (7,575,965)
Provision for income taxes 0 0
Net loss (14,066,292) (7,575,965)
Less: Deemed dividend to preferred stockholders (3,532,858) 0
Net loss attributable to common stockholders $ (17,599,150) $ (7,575,965)
Earnings per share:    
Basic and diluted loss per share (in dollars per share) $ (2.57) $ (0.19)
Weighted average number of shares outstanding (in shares) 6,851,819 38,939,909
XML 64 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Significant Accounting Policies
6 Months Ended
Jun. 30, 2013
Accounting Policies [Abstract]  
Significant Accounting Policies [Text Block]
5.
Significant Accounting Policies
 
Basis of Presentation
 
The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).
 
Use of Estimates
 
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements including disclosure of contingent assets and liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period and accompanying notes. The Company’s critical accounting policies are those that are both most important to the Company’s financial condition and results of operations and require the most difficult, subjective or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of the uncertainty of factors surrounding the estimates or judgments used in the preparation of the financial statements, actual results could differ from these estimates.
  
Principles of Consolidation
 
The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances have been eliminated in consolidation.
 
Accounts Receivable
 
Accounts receivable represent amounts owed to the Company for products sold and services rendered net of an allowance for doubtful accounts. The Company grants unsecured credit to its customers. The Company continuously monitors the payment performance of its customers to ensure collections and minimize losses. Management does not believe that significant credit risks exist. An allowance for doubtful accounts is based upon the credit profiles of specific customers, economic and industry trends and historic payment experience. There is no allowance for doubtful accounts at June 30, 2013 and December 31, 2012.
 
Inventory
 
Inventories consist of finished pharmaceutical products and are recorded at the lower of cost or market, with the cost determined on a first-in, first-out basis. The Company periodically reviews the composition of inventory in order to identify obsolete, slow-moving or otherwise non-saleable items. If non-saleable items are observed and there are no alternate uses for the inventory, the Company will record a write-down to net realizable value in the period that the decline in values is first recognized.
  
Rebates
  
Pharmaceutical manufacturers offer rebates for selected brand drugs. The Company currently receives these rebates through a third party administrator. The rebates are considered earned when members (employees of customers) order the drugs. Rebates earned are paid to the Company by the third party administrator quarterly. Rebates earned are recognized as a reduction to cost of revenue. The portion of the rebate payable to customers is simultaneously recognized as a reduction of revenue. Management evaluates rebates receivable at the end of every reporting period and adjusts the amount reflected on the accompanying balance sheet to net realizable value. An adjustment is also made to the rebate payable to customers to correspond with any adjustment that applies to rebates receivable.
 
Property and Equipment
 
Property and equipment are stated at cost less accumulated amortization and depreciation. Leasehold improvements are amortized using the straight-line method over the shorter of the term of the lease or the estimated useful lives of the assets. Furniture and fixtures are depreciated using the straight-line method over the estimated useful lives of the assets of 5 years. Computer equipment and software are depreciated using the straight-line method over the estimated useful lives of the assets, which range from 3 to 5 years.
   
Internal-Use Software Development Costs
 
The Company capitalizes certain costs associated with the purchase and/or development of internal-use software, including its website. Generally, external and internal costs incurred during the application development stage of a project are capitalized. The application development stage of a project generally includes software design and configuration, coding, testing and installation activities. Training and maintenance costs are expensed as incurred. Upgrades and enhancements are capitalized if it is probable that such expenditures will result in additional functionality. Capitalized software costs are amortized using the straight-line method over the estimated useful life of the asst, which approximates 3 years.
  
Long-Lived Assets
 
Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. The Company assesses recoverability by determining whether the net book value of the related asset will be recovered through the projected undiscounted future cash flows of the asset. If the Company determines that the carrying value of the asset may not be recoverable, it measures any impairment based on the fair value of the asset as compared to its carrying value. During the six months ended June 30, 2013 and the year ended December 31, 2012, the Company did not record any impairment charges.
 
Investments Held in Trust
 
The Company applies the provisions of ASC Topic 320-10, Investment – Debt and Equity, to account for investments held in trust, which comprise only of held-to maturity securities. Held-to-maturity securities are those securities, which the Company has the ability and intent to hold until maturity. Held-to-maturity securities are recorded at amortized cost on the accompanying balance sheets and adjusted for any amortization or accretion of premiums or discounts.
 
Deferred Financing Costs
 
Costs relating to obtaining the line of credit in April 2013 and the Bridge Notes in September 2012 have been capitalized and amortized over the term of the related debt using the straight line method. Amortization of deferred financing costs charged to interest expense was $686,631 and $254,993 in the six months ended June 30, 2013 and for the year ended December 31, 2013, respectively. The unamortized balance was $548,394 and $552,380 at June 30, 2013 and December 31, 2012, respectively.
  
Derivative Financial Instruments
 
The Company applies the provisions of ASC Topic 815-40, Contracts in Entity’s Own Equity (“ASC Topic 815-40”), under which convertible instruments and warrants, which contain terms that protect holders from declines in the stock price (reset provisions), may not be exempt from derivative accounting treatment. As a result, such warrants are recorded as a liability and are revalued at fair value at the end of each reporting period. Furthermore, under derivative accounting, the warrants are initially recorded at their fair value. If the fair value of the warrants exceeds the face value of the related debt, the excess is recorded as a change in fair value in the statement of operations on the issuance date.
 
Debt Discounts
 
Debt discounts are amortized using the effective interest rate method over the term of the related debt. The result achieved using the straight-line method is not materially different than those which would result using the effective interest method.
  
Share-Based Payments
 
Share-based payments to employees are measured at the fair value of the award on the date of grant based on the estimated number of awards that are ultimately expected to vest. The compensation expense resulting from such awards is recorded over the vesting period of the award in selling, general and administrative expenses on the accompanying consolidated statements of operations.
 
Share-based payments to non-employees for services rendered are recorded at either the fair value of the services rendered, or the fair value of the awards, whichever is more readily determinable. The expense resulting from such awards is  marked to market over the vesting period of the award in selling, general and administration expenses on the accompanying consolidated statements of operations. 
 
Revenue Recognition
 
The Company typically enters into annual renewable agreements with its customers to provide pharmacy benefit management on a fixed price or self-insured basis. The Company records revenues from all its current contracts with customers gross as the Company acts as principal based on the following factors: 1) the Company has a separate contractual relationship with its customers and with its claims adjudicator to whom the Company pays the costs of the prescription drugs consumed by its customers (the claims), 2) the Company through its claim adjudicator is responsible to validate and manage the claims, and 3) the Company bears the credit risk for the amount due from the customers. Revenues are recorded monthly as earned. The Company also operates a mail order pharmacy that services plan members. All revenues and associated costs from dispensing drugs by the mail order pharmacy to our plan members, excluding the members’ co-pay are eliminated as inter-company revenues. Some of the contracts contain terms whereby the Company makes certain financial guarantees regarding prescription costs. Actual performance is compared to the guaranteed measure throughout the period and accruals are recorded as an offset to revenue if the Company fails to meet a financial guarantee.
  
Cost of Sales
 
Cost of sales includes claim payments for both fixed- price and self-insured programs, administrative fees paid for processing the claims to the claims adjudicator and, the cost of prescription drugs of the mail order pharmacy.
 
Advertising Expenses
 
Advertising expenses are expensed as incurred and included in selling, general and administrative expenses on the accompanying statements of operations. Advertising expenses were approximately $68,000 and $143,000 for the six months ended June 30, 2013 and year ended December 31, 2012, respectively.
 
Income Taxes
 
The Company accounts for income taxes using the liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. A valuation allowance is established when realization of net deferred tax assets is not considered more likely than not.
 
Uncertain income tax positions are determined based upon the likelihood of the positions being sustained upon examination by taxing authorities. The benefit of a tax position is recognized in the consolidated financial statements in the period during which management believes it is more likely than not that the position will not be sustained. Income tax positions taken are not offset or aggregated with other positions. Income tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of income tax benefit that is more than 50 percent likely of being realized if challenged by the applicable taxing authority. The portion of the benefits associated with income tax positions taken that exceeds the amount measured is reflected as income taxes payable.
 
The Company recognizes interest related to uncertain tax positions in interest expense. The Company recognizes penalties related to uncertain tax positions in income tax expense.
 
Fair Value Measurements
 
The Company applies recurring fair value measurements to its derivative instruments in accordance with ASC 820, Fair Value Measurements. In determining fair value, the Company uses a market approach and incorporates assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and/or the risks inherent in the inputs to the valuation techniques. These inputs can be readily observable, market corroborated or generally unobservable internally-developed inputs. Based upon the observability of the inputs used in these valuation techniques, the Company’s derivative instruments are classified as follows:
 
Level 1:
The fair value of derivative instruments classified as Level 1 is determined by unadjusted quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.
 
Level 2:
The fair value of derivative instruments classified as Level 2 is determined by quoted market prices for similar assets or liabilities in active markets, quoted market prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data.
 
Level 3:
The fair value of derivative instruments classified as Level 3 is determined by internally-developed models and methodologies utilizing significant inputs that are generally less readily observable from objective sources.
 
The Company’s valuation methodology for warrants classified as derivative liabilities qualifies as a level 2 fair value measurement since it is determined using internally developed models and analysis.
 
At June 30, 2013 the Company had 2,000,000 warrants exercisable into its Class C shares that were issued in connection with Selway’s initial public offering (“Selway IPO Warrants”). These warrants are publicly traded and are classified as liabilities. Additionally, HCCA issued 296,250 warrants in connection with the Bridge Financing with identical terms as the Selway IPO Warrants. The Company has valued all of these warrants as June 30, 2013 based on the closing price of the Selway IPO Warrants. Because the market for the Selway IPO Warrants is not active, the valuation is classified as a Level 2 measurement. These warrants are exercisable at $7.50 a share and expire on November 7, 2016.
 
The table below presents the Company’s fair value hierarchy for those derivative instruments measured at fair value on a recurring basis as of June 30, 2013:
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Warrants
 
$
-
 
$
3,559,188
 
$
-
 
$
3,559,188
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total derivative liabilities
 
$
-
 
$
3,559,188
 
$
-
 
$
3,559,188
 
  
The table below presents the Company’s fair value hierarchy for those derivative instruments measured at fair value on a recurring basis as of December 31, 2012:
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Warrants
 
$
-
 
$
121,350
 
$
-
 
$
121,350
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total derivative liabilities
 
$
-
 
$
121,350
 
$
-
 
$
121,350
 
 
Fair Value of Financial Instruments
 
The fair values of cash and cash equivalents, accounts receivable, rebates receivable and accounts payable approximate their carrying values due to the short-term nature of the instruments. The fair values of long-term debt and revolving loans approximates their carrying value due to their variable interest rates. The fair value of investments held in trust is not materially different than its carrying value because of the short-term nature of the investments.
 
Risks and Concentrations
 
The Company utilizes the services of a single claims adjudicator. If there is an adverse situation in this relationship, the Company’s mail order pharmaceutical fulfillment services would be ineffective until a replacement claims adjudicator was obtained.
 
Approximately 12% of the Company’s 2012 revenues were derived from one customer. Revenues from this customer were 10% of our revenues for the six month period ended June 30, 2013. No amounts were due from this customer at June 30, 2013 or December 31, 2012. In addition, one of the reseller’s customers accounted for approximately 14% of the Company’s revenue for the six month period ended June 30, 2013 as well as approximately 14% of the Company’s revenue for the year ended December 31, 2012. Amounts due from this customer represented 32% and 46% of accounts receivable at June 30, 2013 and December 31, 2012, respectively.
    
Cash and Cash Equivalents
 
The Company considers all cash in bank, money market funds and certificates of deposit with an original maturity of less than three months to be cash equivalents. The Company maintains its cash and cash equivalents in one financial institution. Cash balances on hand at this financial institution may exceed the insurance coverage provided to the Company by the Federal Deposit Insurance Corporation at various times during the year.
  
Earnings (Loss) Per Share
 
Basic earnings (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted earnings (loss) per share are determined in the same manner as basic earnings (loss) per share, except that the number of shares is increased to include potentially dilutive securities using the treasury stock method. Because the Company incurred a net loss in all periods presented, all potentially dilutive securities were excluded from the computation of diluted loss per share because the effect of including them is anti-dilutive.
 
 
 
Six Months Ended
 
Year Ended
 
 
 
June 30, 2013
 
December 31, 2012
 
Basic and Diluted:
 
 
 
 
 
 
 
Net loss
 
$
(14,066,292)
 
$
(7,575,965)
 
Less: Deemed dividend to preferred stockholders
 
 
(3,532,858)
 
 
-
 
Net loss attributable to common stockholders
 
$
(17,599,150)
 
$
(7,575,965)
 
Weighted average shares
 
 
6,851,819
 
 
38,939,909
 
Basic loss per common share
 
$
(2.57)
 
$
(0.19)
 
 
The following table summarizes the number of shares of common stock attributable to potentially dilutive securities outstanding for each of the periods which are excluded in the calculation of diluted loss per share:
 
 
 
Six Months Ended
 
Year Ended
 
 
 
June 30, 2013
 
December 31, 2012
 
Dilutive Potential Common Shares
 
 
 
 
 
 
 
Warrants
 
$
3,314,023
 
$
1,585,833
 
Restricted stock awards
 
 
-
 
 
75,292
 
Convertible notes payable
 
 
-
 
 
2,666,667
 
  
Reclassification
 
Certain previously reported amounts have been reclassified to conform to the presentation used in the June 30, 2013 financial statements.
XML 65 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Restatement
6 Months Ended
Jun. 30, 2013
Restatement [Abstract]  
Restatement [Text Block]
4.
Restatement
 
The financial statements for 2012 have been revised to correct material errors in accounting for the Company’s sales, accounts receivable, cost of sales, accounts payable, capital leases, accrued rent and accrued taxes. In accordance with applicable Generally Accepted Accounting Principles (GAAP), the Company calculated and recognized adjustments accordingly.
 
On March 25, 2013, the Company filed with the Securities and Exchange Commission (“SEC”) its audited financial statements for the years ended December 31, 2012 and 2011. Following the discovery of various material errors the Company informed the SEC on May 9, 2013 that these financial statements could not be relied upon, and on May 15, 2013 filed its restated audited financial statements for the above-mentioned periods (First Restatement Financial Statements).
 
On September 19, 2013 following the discovery by management of additional material errors and misstatements in the First Restatement Financial Statements, the Company informed the SEC that the previously restated financials could not be relied upon and that the Company would review its financial statements in an attempt to discover all the material errors and misstatements that were included therein.
 
As part of this review, the Company engaged external consultants to review and investigate its books and records and other related transactions and activities for 2012 and 2011. As a result of this review, management concluded that it will be unable to complete its restated 2011 financial statements, due to lack of sufficient source documents and other information. In addition, the Company discovered various additional material errors and misstatements in the 2012 financial statements which were corrected in these restated financial statements.
 
The following table represents the effects of the subsequent and first restated statements as of December 31, 2012:
 
 
 
Subsequent
 
First
 
 
 
 
 
Restatement
 
Restated
 
Original
 
 
 
December 31, 2012
 
December 31, 2012
 
December 31, 2012
 
 
 
 
 
 
 
 
 
 
 
Accounts receivable
 
$
1,126,846
 
$
572,637
 
$
1,220,065
 
 
 
 
 
 
 
 
 
 
 
 
Rebates receivable
 
$
1,323,474
 
$
1,323,474
 
$
1,638,000
 
 
 
 
 
 
 
 
 
 
 
 
Other receivables
 
$
40,867
 
$
40,867
 
$
40,867
 
 
 
 
 
 
 
 
 
 
 
 
Accounts payable
 
$
4,431,366
 
$
4,520,223
 
$
1,514,857
 
 
 
 
 
 
 
 
 
 
 
 
Accrued expenses
 
$
568,528
 
$
453,057
 
$
453,057
 
 
 
 
 
 
 
 
 
 
 
 
Note payable
 
$
4,192,954
 
$
4,947,613
 
$
4,947,613
 
 
 
 
 
 
 
 
 
 
 
 
Redeemable preferred stock
 
$
2,362,517
 
$
458,800
 
$
458,800
 
 
 
 
 
 
 
 
 
 
 
 
Warrant liability
 
$
121,350
 
$
518,587
 
$
518,587
 
 
 
 
 
 
 
 
 
 
 
 
Common stock
 
$
4,175,856
 
$
3,556,056
 
$
3,556,056
 
 
 
 
 
 
 
 
 
 
 
 
APIC
 
$
150,000
 
$
-
 
$
-
 
 
 
 
 
 
 
 
 
 
 
 
Sales
 
$
27,305,795
 
$
28,663,284
 
$
38,401,140
 
 
 
 
 
 
 
 
 
 
 
 
Cost of sales
 
$
26,148,118
 
$
24,068,906
 
$
31,650,232
 
 
 
 
 
 
 
 
 
 
 
 
General and administrative expenses
 
$
7,603,458
 
$
7,299,603
 
$
7,299,603
 
 
 
 
 
 
 
 
 
 
 
 
Interest expense
 
$
(1,130,184)
 
$
640,286
 
$
640,286
 
 
 
 
 
 
 
 
 
 
 
 
Accumulated deficit
 
$
(10,639,542)
 
$
(8,937,860)
 
$
(4,970,540)
 
 
 
 
 
 
 
 
 
 
 
 
Loss per share
 
$
(0.19)
 
$
(0.09)
 
$
(0.02)
 
XML 66 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes
6 Months Ended
Jun. 30, 2013
Income Tax Disclosure [Abstract]  
Income Tax Disclosure [Text Block]
16.
Income Taxes
 
There was no provision (benefit) for income taxes for the six months and year ended June 30, 2013 and December 31, 2012.
 
Deferred tax assets are as follows:
  
 
 
June 30, 2013
 
December 31, 2012
 
 
 
 
 
 
 
 
 
Loss carryforwards
 
$
6,363,018
 
$
2,064,222
 
Intangible assets
 
 
81,000
 
 
44,000
 
Accrued expenses
 
 
1,060,000
 
 
1,060,000
 
Stock based compensation
 
 
209,904
 
 
-
 
Fixed assets
 
 
7,409
 
 
(14,120)
 
Less valuation allowance
 
 
(7,721,331)
 
 
(3,154,102)
 
 
 
 
 
 
 
 
 
Total net deferred tax assets
 
$
-
 
$
-
 
  
The valuation allowance was increased by $4,567,229 during the six months ended June 30, 2013 and $2,575,828 for the year ended December 31, 2012. The valuation allowance was increased due to uncertainties as to the Company’s ability to generate sufficient taxable income to utilize the net operating loss carry forwards and other deferred income tax items.
 
A reconciliation of income taxes at the U.S. federal statutory rate to the income expense is as follows:
 
 
 
Six Months and Year Ended
 
 
 
June 30, 2013
 
 
December 31, 2012
 
U.S. Federal statutory rate
 
(34.0)
%
 
(34.0)
%
State income taxes, net of federal benefit
 
(5.9)
 
 
(5.9)
 
Permanent differences
 
(0.20)
 
 
0.20
 
Interest expense
 
7.90
 
 
-
 
Change in valuation allowance
 
32.2
%
 
39.7
%
 
 
 
 
 
 
 
Effective tax rate
 
-
%
 
-
%
 
The Company’s ability to utilize the net operating loss carry forwards in future years may be significantly limited in accordance with the provisions of Section 382 of the Internal Revenue Code, because of the changes in ownership that have occurred. The Company’s NOL may be further limited should there be any further changes in ownership. As defined in Section 382 of the Internal Revenue Code, the Company who has undergone, or may undergo in the future, a greater than fifty percent ownership change as a result of financing initiatives. Consequently, there may be limitations on the amount of the Company’s NOLs which may be utilized to offset future taxable income in any one year.
  
At June 30, 2013, the Company had federal and state net operating loss carry forwards (“NOLs”) of approximately $15,900,000. The federal net operating loss carry forwards will begin to expire in the year 2035.
 
In July 2006, the Financial Accounting Standards Board (“FASB”) issued ASC 740-10, Uncertainty in Income Taxes, which defines the threshold for recognizing the benefits of tax-return positions in the financial statements as “more-likely-than-not” to be sustained by the taxing authorities. This statement also requires explicit disclosure requirements about a Company’s uncertainties related to their income tax position, including a detailed roll forward or tax benefits taken that do not qualify for financial statement recognition. The Company files income tax returns in the U.S. federal jurisdiction and New Jersey. The Company’s tax years open to examination for federal and state are from 2009. The Company has no amount recorded for any unrecognized tax benefits as of June 30, 2013 and December 31, 2012 nor did the Company record any amount for the implementation of ASC 740-10-25. The Company’s policy is to record estimated interest and penalty related to the underpayment of income taxes for unrecognized tax benefits as a component of its income tax provision. During the period ended June 30, 2013 and year ended December 31, 2012 the Company did not recognize any interest or penalties accrued for unrecognized tax benefits.
XML 67 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Bridge Notes
6 Months Ended
Jun. 30, 2013
Disclosure Of Bridge Notes [Abstract]  
Disclosure Of Bridge Notes [Text Block]
12.
Bridge Notes
 
On September 12, 2012, the Company completed a bridge financing (the “Bridge Financing”) consisting of 59.25 units, each unit consisting of 10,000 preferred shares, 5,000 warrants and a promissory note with a face value of $100,000. At the time of the transaction, the value of the units was allocated as follows: Preferred Stock was recorded at a value of $2,362,517, the warrants were recorded as a warrant liability of $82,726 and the notes were recorded at a value of $3,479,757, reflecting a loan discount of $2,445,242. In addition, the Company incurred loan fees amounting to $673,229. The Company recorded interest expense associated with the amortization of the loan discount and the loan fees through the Merger date.
 
At the time of the Merger, holders of all of the issued and outstanding shares of preferred stock of HCCA, by virtue of the Merger, had each of their shares of preferred stock of HCCA converted into the right to receive a proportional amount of 592,500 shares of the Company’s Series C common stock and warrants to purchase 296,250 shares of the Company’s Series C common stock. In accordance with the terms of the promissory notes issued in the Bridge Financing, at the time of the Merger, notes in the aggregate amount of $3,159,592 (including principal and interest accrued to date) were converted into 315,959 shares of the Company’s Series C common stock and notes in the aggregate principal amount of $3,025,000 were repaid in full.
XML 68 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Investments Held in Trust
6 Months Ended
Jun. 30, 2013
Investment Held In Trust [Abstract]  
Investment [Text Block]
8.
Investments Held in Trust
 
Following the initial public offering (“IPO”) of Selway in November 2011, a total of $20.6 million was placed in a trust account maintained by American Stock Transfer & Trust Company, as trustee. None of the funds held in the trust were to be released from the trust account, other than interest income, net of taxes, until the earlier of (i) consummation of an acquisition and (ii) redemption of 100% of the public shares sold in the IPO if Selway failed to consummate an acquisition by May 14, 2013.
 
On April 10, 2013, Selway closed the acquisition of HCCA through the Merger (see Notes 1 and 3). At the time of the Merger, holders of 1,160,035 shares of redeemable common stock decided not to redeem their shares and accordingly approximately $11,948,000 was released from the escrow. As per the certificate of incorporation of Selway, the remaining balance of the trust account of approximately $8,652,000 was used to redeem the remaining 839,965 redeemable common shares through a tender offer which closed on August 15, 2013. The amount in trust can be invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940 having a maturity of 180 days or less. During the six months ended June 30, 2013, the United States government securities were in an account at Wells Fargo Bank, while the cash amount was in a JP Morgan Chase cash account. The United States government securities matured and the total trust balance of $8,652,482 was in cash.
 
The Company classified its United States Treasury and equivalent securities as held-to-maturity in accordance with FASB ASC 320, “Investments – Debt and Equity Securities.” Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheet and adjusted for the amortization or accretion of premiums or discounts.
XML 69 R60.htm IDEA: XBRL DOCUMENT v2.4.0.8
Redeemable Securities (Details Textual) (USD $)
Jun. 30, 2013
Dec. 31, 2012
Redeemable Securities [Line Items]    
Temporary Equity, Redemption Price Per Share $ 10.30  
Common Stock, Shares, Outstanding 8,953,494 40,000,009
Series B Common Stocks [Member]
   
Redeemable Securities [Line Items]    
Common Stock, Shares, Outstanding 839,965  
XML 70 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Property and Equipment
6 Months Ended
Jun. 30, 2013
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment Disclosure [Text Block]
6.
Property and Equipment
 
Property and equipment is as follows:
 
 
 
June 30, 2013
 
December 31, 2012
 
 
 
 
 
 
 
 
 
Furniture, fixtures and equipment
 
$
1,606,404
 
$
1,374,126
 
Leasehold improvements
 
 
25,260
 
 
10,162
 
 
 
 
1,631,664
 
 
1,384,288
 
Accumulated depreciation and amortization
 
 
(394,930)
 
 
(270,233)
 
 
 
 
 
 
 
 
 
Net property and equipment
 
$
1,236,734
 
$
1,114,055
 
 
Amortization and depreciation is approximately $124,700 and $206,000 for the six months ended June 30, 2013 and 2012.
XML 71 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Software, net
6 Months Ended
Jun. 30, 2013
Capitalized Computer Software, Net [Abstract]  
Research, Development, and Computer Software Disclosure [Text Block]
7.
Software, net
 
Software, net is as follows:
 
 
 
June 30, 2013
 
December 31, 2012
 
 
 
 
 
 
 
 
 
Software costs
 
$
294,109
 
$
-
 
Accumulated amortization
 
 
(31,967)
 
 
-
 
 
 
 
 
 
 
 
 
Net software costs
 
$
262,142
 
$
-
 
 
Amortization expense was approximately $32,000 for the six month period ended June 30, 2013.
XML 72 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Deferred Financing Costs
6 Months Ended
Jun. 30, 2013
Deferred Finance Costs [Abstract]  
Deferred Financing Cost [Text Block]
9.
Deferred Financing Costs
 
Deferred financing costs are as follows:
 
Balance January 1, 2013
 
$
-
 
Costs incurred for line of credit for the six months ended June 30, 2013
 
 
615,754
 
Amortization for the six monthes ended June 30, 2013
 
 
(67,360)
 
 
 
 
 
 
Balance June 30, 2013
 
$
548,394
 
XML 73 R64.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Details Textual) (USD $)
6 Months Ended 12 Months Ended
Jun. 30, 2013
Dec. 31, 2012
Income Taxes [Line Items]    
Operating Loss Carryforwards, Federal and State $ 15,900,000  
Operating Loss Carryforward Expiration Date 2035  
Valuation Allowance, Deferred Tax Asset, Change in Amount $ 4,567,229 $ 2,575,828
XML 74 R66.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies (Details Textual) (USD $)
0 Months Ended 6 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 1 Months Ended 0 Months Ended 6 Months Ended
Aug. 14, 2012
Jun. 30, 2013
Dec. 31, 2012
Aug. 31, 2013
Subsequent Event [Member]
Dec. 31, 2012
Litigation [Member]
Aug. 31, 2013
Litigation [Member]
Subsequent Event [Member]
Aug. 14, 2012
Litigation [Member]
Common Stock [Member]
Jun. 30, 2013
Employment Agreements [Member]
Loss Contingencies [Line Items]                
Salaries, Wages and Officers Compensation, Total               $ 2,400,000
Terminated Agreement Annual Compensation               1,000,000
Severance Costs               120,000
Employee Service Share-Based Compensation Issued Stock Option   650,000            
Employee Service Share-Based Compensation Additional Stock Option   841,000            
Loss Contingency, Damages Paid, Value         5,000,000      
Litigation Settlement, Amount           2,700,000    
Loss Contingency, Settlement Agreement, Terms       15 months        
Stock Issued During Period, Shares, Other             500,000  
Stock Issued During Period, Value, Other   2,920,000         100,000  
Legal Fees 50,000              
Settlement Of Common Stock But Not Received         500,000      
Temporary Equity, Redemption Value   8,651,639 0   100,000      
Payments for Rent   $ 96,468 $ 186,733          
XML 75 R63.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Details 1)
6 Months Ended 12 Months Ended
Jun. 30, 2013
Dec. 31, 2012
Income Taxes [Line Items]    
U.S Federal statutory rate (34.00%) (34.00%)
State income taxes, net of federal benefit (5.90%) (5.90%)
Permanent differences (0.20%) 0.20%
Interest expense 7.90% 0.00%
Change in valuation allowance 32.20% 39.70%
Effective tax rate 0.00% 0.00%
XML 76 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
Accrued Expenses (Tables)
6 Months Ended
Jun. 30, 2013
Payables and Accruals [Abstract]  
Schedule of Accrued Liabilities [Table Text Block]
Accrued expenses are as follows:
 
 
 
June 30, 2013
 
December 31, 2012
 
 
 
 
 
 
 
 
 
Accrued severence costs*
 
$
750,000
 
$
-
 
Accrued rebates
 
 
364,196
 
 
77,329
 
Accrued registration rights penalties**
 
 
592,000
 
 
-
 
Accrued professional fees
 
 
290,777
 
 
50,000
 
Accrued expenses other
 
 
431,060
 
 
441,199
 
 
 
 
 
 
 
 
 
 
 
$
2,428,033
 
$
568,528
 
  
*
Payable to a former executive of the Company.
 
**
Estimated penalties relating to late registration of shares of common stock in connection with the bridge notes.
XML 77 R51.htm IDEA: XBRL DOCUMENT v2.4.0.8
Deferred Financing Costs (Details) (USD $)
6 Months Ended 12 Months Ended
Jun. 30, 2013
Dec. 31, 2013
Deferred Financing Costs [Line Items]    
Balance January 1, 2013 $ 0 $ 0
Costs incurred for line of credit for the six months ended June 30, 2013 615,754  
Amortization for the six monthes ended June 30, 2013 (67,360) 254,993
Balance June 30, 2013 $ 548,394  
XML 78 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Redeemable Securities
6 Months Ended
Dec. 31, 2013
Redeemable Securities [Abstract]  
Disclosure Of Redeemable Securities [Text Block]
14.
Redeemable Securities
 
Redeemable common stockholders are entitled to redeem all or a portion of such shares in connection with the Company’s initial Business Transaction, as defined in the Company’s Certificate of Incorporation, and are entitled to share ratably in the trust account, including the deferred underwriting discounts and commissions and accrued but undistributed interest, net of (i) taxes payable, (ii) interest income earned on the trust account (approximately $10.30 per share) and (iii) a pro rata share of the trust account released to the Company for each Share converted to a Series C Share upon completion of a Business Transaction. As of June 30, 2013, there were 839,965 shares of Series B common stock outstanding which are subject to redemption. These shares were redeemed from the trust account on August 15, 2013
XML 79 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Related Party
6 Months Ended
Jun. 30, 2013
Related Party Transactions [Abstract]  
Related Party Transactions Disclosure [Text Block]
19.
Related Party
 
Otis Fund, a company controlled by a former consultant, who owns in excess of 5% of the Company’s outstanding shares, has a consulting agreement to provide marketing and sales services to HCCA. The contract was due to expire on January 2, 2017; however the Company terminated the agreement for cause in September 2013. The annual fees related to these services were $360,000.
 
In September 2012, 2,068,200 shares were issued to two entities believed to be controlled by this former consultant of the Company. The Company is currently investigating the circumstances under which these shares were issued to the two entities. The Company recorded a charge in 2012 equal to the shares of $641,142 as general and administrative expense.
XML 80 R49.htm IDEA: XBRL DOCUMENT v2.4.0.8
Software, net (Details Textual) (USD $)
6 Months Ended
Jun. 30, 2013
Capitalized Computer Software, Net [Line Items]  
Amortization, Total $ 32,000
XML 81 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
Restatement (Details) (USD $)
1 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Dec. 31, 2012
Schedule Subsequent And First Restated Statements [Line Items]        
Accounts receivable   $ 1,251,579   $ 1,126,846
Rebates receivable   1,574,659   1,323,474
Other receivables   857   40,867
Accounts payable   5,214,355   4,431,366
Accrued expenses   2,428,033   568,528
Note payable   0   4,192,954
Redeemable preferred stock   0   2,362,517
Warrant liability   3,559,188   121,350
Common stock   895   4,175,856
APIC   16,423,417   150,000
Sales   24,328,860   27,305,795
Cost of sales   23,309,725   26,148,118
General and administrative expenses 641,142     7,603,458
Interest expense       (1,130,184)
Accumulated deficit   (24,705,834)   (10,639,542)
Loss per share   $ (2.57) $ (0.07) $ (0.19)
First Restated [Member]
       
Schedule Subsequent And First Restated Statements [Line Items]        
Accounts receivable       572,637
Rebates receivable       1,323,474
Other receivables       40,867
Accounts payable       4,520,223
Accrued expenses       453,057
Note payable       4,947,613
Redeemable preferred stock       458,800
Warrant liability       518,587
Common stock       3,556,056
APIC       0
Sales       28,663,284
Cost of sales       24,068,906
General and administrative expenses       7,299,603
Interest expense       640,286
Accumulated deficit       (8,937,860)
Loss per share       $ (0.09)
Original [Member]
       
Schedule Subsequent And First Restated Statements [Line Items]        
Accounts receivable       1,220,065
Rebates receivable       1,638,000
Other receivables       40,867
Accounts payable       1,514,857
Accrued expenses       453,057
Note payable       4,947,613
Redeemable preferred stock       458,800
Warrant liability       518,587
Common stock       3,556,056
APIC       0
Sales       38,401,140
Cost of sales       31,650,232
General and administrative expenses       7,299,603
Interest expense       640,286
Accumulated deficit       $ (4,970,540)
Loss per share       $ (0.02)
XML 82 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT AND REDEEMABLE SECURITIES (USD $)
Total
Redeemable Common Stock [Member]
Preferred Stock [Member]
Stockholders' Deficit [Member]
Common Stock [Member]
Stockholders' Deficit [Member]
Additional Paid-in Capital [Member]
Stockholders' Deficit [Member]
Retained Earnings [Member]
Stockholders' Deficit [Member]
Treasury Stock [Member]
Beginning balance at Dec. 31, 2011 $ 2,824,234 $ 0 $ 2,362,517 $ 3,525,294 $ 0 $ (3,063,577) $ 0
Beginning balance (in shares) at Dec. 31, 2011   0 0 37,879,809     0
Issue stock to stockholders 650,562 0 0 650,562 0 0 0
Issue stock to stockholders (in shares)   0 0 2,120,200     0
Issuance of warrants 250,000 0 0   250,000 0 0
Redemption of common stock (100,000) 0 0 0 (100,000) 0 0
Payments to Series A Holders 0            
Net loss (7,575,965) 0 0 0 0 (7,575,965) 0
Ending balance at Dec. 31, 2012 (3,951,169) 0 2,362,517 4,175,856 150,000 (10,639,542) 0
Ending balance (in shares) at Dec. 31, 2012   0 0 40,000,009     0
Receipt of stock previously redeemed 0 0 0 0 100,000 0 (100,000)
Receipt of stock previously redeemed (in shares)   0 0 0     (500,000)
Stock based compensation 480,000 0 0 0 380,000 0 100,000
Stock based compensation (in shares)   0 0 0     500,000
Effect of recapitalization - reverse merger with Selway Capital Acquisition Corp (2,362,517) 0 (2,362,517) (4,175,856) 4,175,856 0 0
Effect of recapitalization - reverse merger with Selway Capital Acquisition Corp (in shares)   0 0 (40,000,009)     0
Issue stock to stockholders 0 0 0 520 (520) 0 0
Issue stock to stockholders (in shares)   0 0 5,200,000     0
Selway equity at closing 20,600,000 0 0 250 20,599,750 0 0
Selway equity at closing (in shares)   0 0 2,500,000     0
Common stock issued upon conversion of bridge notes 3,159,624 0 0 32 3,159,592 0 0
Common stock issued upon conversion of bridge notes (in shares)   0 0 315,959     0
Common stock issued in conversion of redeemable preferred stock and 296,250 warrants 2,362,517 0 0 59 2,362,458 0 0
Common stock issued in conversion of redeemable preferred stock and 296,250 warrants (in shares)   0 0 592,500     0
Common stock issued as incentive shares 2,920,000 0 0 75 2,919,925 0 0
Common stock issued as incentive shares (in shares)   0 0 750,000     0
Conversion of sponsor warrants into common stock 0 0 0 10 (10) 0 0
Conversion of sponsor warrants into common stock (in shares)   0 0 100,000     0
Stock issued to underwriters 0 0 0 33 (33) 0 0
Stock issued to underwriters (in shares)   0 0 335,000     0
Stock subject to redemption (8,651,639) 8,651,639 0 (84) (8,651,555) 0 0
Stock subject to redemption (in shares)   839,965 0 (839,965)     0
Expenses of offering (814,076) 0 0 0 (814,076) 0 0
Payments to Series A Holders 3,101,038 0 0 0 (3,101,038) 0 0
Assumed liabilities of Selway (6,323,148) 0 0 0 (6,323,148)    
Recognition of contingent beneficial conversion feature on the convertible bridge notes 1,182,327 0 0 0 1,182,327    
Stock based compensation 283,889 0 0 0 283,889 0 0
Net loss (14,066,292) 0 0 0 0 (14,066,292) 0
Ending balance at Jun. 30, 2013 $ (8,281,522) $ 8,651,639 $ 0 $ 895 $ 16,423,417 $ (24,705,834) $ 0
Ending balance (in shares) at Jun. 30, 2013   839,965 0 8,953,494     0
XML 83 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
The Merger
6 Months Ended
Jun. 30, 2013
Business Combinations [Abstract]  
Merger Disclosure [Text Block]
3.
The Merger
 
On January 25, 2013, an Agreement and Plan of Merger (the “Agreement”) was entered into by and among the Company, Selway Merger Sub, Inc., a New Jersey corporation and wholly owned subsidiary of the Company (“Merger Sub”), HCCA, PCA, and representatives of HCCA and the Company. On April 10, 2013 (the “Closing Date”), the Merger and other transactions contemplated by the Agreement closed.
 
Pursuant to the Agreement, Merger Sub merged with and into HCCA, resulting in HCCA becoming a wholly owned subsidiary of the Company. PCA and PCA Benefits, a dormant entity, remain wholly owned subsidiaries of HCCA.
 
Holders of all of the issued and outstanding shares of common stock of HCCA immediately prior to the time of the Merger had each of their shares of common stock of HCCA converted into the right to receive: (i) a proportional amount of 5,200,000 shares of the Company’s Series C common stock and promissory notes with an aggregate face value of $7,500,000 (collectively, the “Closing Payment”); plus (ii) a proportional amount of up to 2,800,000 shares of the Company’s common stock, if any, (the “Earn-out Payment Shares”) issuable upon the Company achieving certain consolidated gross revenue thresholds as more fully described below; plus (iii) the right to receive a proportional amount of the proceeds from the exercise of certain warrants being issued to Selway Capital Holdings, LLC, Selway’s sponsor, as more fully described below. A portion of the Closing Payment (520,000 shares and promissory notes with an aggregate face value of $750,000) was being held in escrow for a period of 12 months following the Merger to satisfy indemnification obligations of HCCA. Effective December 20, 2013, the escrowed portion of the Closing Payment, together with a portion of the shares issued to HCCA’s investment banking advisor (an aggregate of 546,002 shares, and promissory notes with an aggregate face value of $750,000) were released from escrow and cancelled.
 
The promissory notes included in the Closing Payment are non-interest bearing and subordinated to all senior debt of the combined company in the event of a default under such senior debt. The notes will be repaid from 18.5% of the Company’s free cash-flow (as defined) in excess of $2,000,000. The Company will be obligated to repay such notes if, among other events, there is a transaction that results in a change of control of the Company. The Company valued the notes at $1,977,570, which represented the present value of the estimated future cash flows to be generated by the combined companies discounted using an interest rate reflective of the uncertainty and credit risk of the notes.
  
Certain members of HCCA’s management received an aggregate of 1,500,000 shares of our common stock (the “Management Incentive Shares”), which shares were placed in escrow and subject to release in three installments through June 30, 2015. Subsequently, certain members of HCCA management agreed to cancel an aggregate of 750,000 shares pursuant to rescission agreements entered into June 2013. Of the remaining Management Incentive Shares outstanding, 400,000 shares have vested but remain in escrow until June 30, 2014 and 350,000 shares will vest on June 30, 2015 and will remain in escrow until June 30, 2015.
  
As part of the Merger, Selway’s net liabilities, consisting primarily of warrant liabilities, were assumed. As part of its Initial Public Offering, Selway issued 2,000,000 warrants, with an exercise price of $7.50 and an expiration date of November 6, 2016 (“Selway IPO Warrants”). These warrants are classified as liabilities based on certain anti-dilution features. The Selway IPO Warrants were recorded at $4,018,000 based on the closing price of the warrants on the date of Merger.
  
The Earn-out Payment Shares, if any, will be issued as follows: (i) 1,400,000 shares if the Company achieves consolidated gross revenue of $150,000,000 for the twelve months ended March 31, 2014 or June 30, 2014; and (ii) 1,400,000 shares if the Company achieves consolidated gross revenue of $300,000,000 for the twelve months ended March 31, 2015 or June 30, 2015. In the event the Company does not achieve the first earn-out threshold, but does achieve the second earn-out threshold, then all of the Earn-out Payment Shares shall be issued. If the Company consolidates, merges or transfers substantially all of its assets prior to June 30, 2015 at a valuation of at least $15.00 per share, then all of the Earn-out Payment Shares not previously paid out shall be issued immediately prior to such transaction. If, prior to achieving either earn-out threshold the Company acquires another business in exchange for its equity or debt securities, then any remaining earn-out thresholds may be adjusted by the independent members of the Company’s board of directors at their sole discretion. The Company estimates that it will not achieve any of the abovementioned revenue targets and, therefore, no provision has been made for the Earn-out Payment Shares.
  
The Agreement required 10% of the consideration, or 520,000 shares of the Company’s Series C common stock and promissory notes with a face value of $750,000 to be held in escrow for a period of one year. As a result of the investigation and subsequent restatement (see Note 4), in December 2013 these shares of stock and promissory notes were returned to the Company. Also in December 2013, the rights to additional proceeds from the exercise of certain warrants issued to Selway Capital Holdings, LLC as part of the merger were cancelled.
 
In connection with a bridge financing (the “Bridge Financing”) completed by HCCA in September 2012, HCCA issued 59.25 units, each unit consisted of 10,000 Convertible Preferred Shares, a warrant for 5,000 shares of common stock that, upon a merger with Selway, converted to warrants with the same terms as Selway IPO warrants and a Promissory Note with a face value of $100,000  (“Promissory Notes”). At the time of the Merger, holders of all of the issued and outstanding shares of preferred stock of HCCA, by virtue of the Merger, had each of their shares of Preferred Stock of HCCA converted into the right to receive a proportional amount of 592,500 shares of the Company’s Series C common stock and warrants to purchase 296,250 shares of the Company’s Series C common stock. If a Merger with Selway or equivalent, as defined in the Preferred Stockholder agreement, occurred before the maturity date of the promissory notes, the preferred stock converted on a 1 to 1 basis into Series C Common Stock of Selway. If such Merger did not occur, then at the maturity of the Promissory Notes, the Preferred Stock converted into 3.7% of common stock of HCCA on a fully diluted basis. Upon issuing the preferred stock, HCCA determined the contingent beneficial conversion feature to the holders of the Preferred Stock if the Merger with Selway occurred to be $3,532,858 and recorded that as a deemed dividend to the Preferred Stockholders upon the closing of the Merger.
  
The warrants issued in connection with the bridge loan were initially exercisable at $7.50 into shares of common stock of HCCA and expired on November 7, 2016. The warrants contained certain anti-dilution that caused them to be classified as liabilities. Upon completion of the Merger with Selway, the warrants became exercisable in Series C shares of Common Stock of Selway. The exercise price and expiration date remained the same.
  
The Promissory Notes bore interest at 8%, were convertible into 10,000 shares of Series C Common Stock if a transaction with Selway occurred and matured on the earlier of a transaction with Selway or September 12, 2013. HCCA allocated the value received from the sale of the units first to the estimated fair value of warrants. The residual value was then allocated to the preferred stock and promissory note based on their relative fair values. As a result of the allocation, HCCA recorded a debt discount of $2,445,242. The debt discount was amortized to interest expense over the term of the Promissory Note. HCCA recorded interest expense of $1,732,047, including $1,018,851 to recognize the unamortized debt discount at the transaction date in the period ending June 30, 2013. HCCA recorded interest expense of $713,196 related amortization of the debt discount in the year ended December 31, 2012. Upon issuing the promissory notes, HCCA determined the contingent beneficial conversion feature to the holders of the Promissory Notes, if they converted into shares of Selway and recorded additionally $1,182,327, as additional interest expense upon the conversion of the promissory notes. In accordance with the terms of the promissory notes issued in the Bridge Financing, at the time of the Merger, notes in the aggregate amount of $3,159,624 (including principal and interest accrued to date) were converted into 315,959 shares of the Company’s Series C common stock and notes in the aggregate principal amount of $3,025,000 were repaid in full. The promissory note included in the Bridge Financing was only convertible into shares of common stock if the transaction with Selway closed before the maturity of the note. At the issuance of the Bridge Financing, the Company determined that a contingent beneficial conversion feature existed representing the difference in the value of the underlying shares and the allocated value to the promissory note. Upon closing of the transaction, the Company recognized the contingent beneficial conversion feature and recorded $1,182,327 as additional interest expense in the period ended June 30, 2013.
  
In connection with the Bridge Financing, HCCA executed a registration rights agreement that required it to register the shares underlying the Bridge Financing if the transaction was completed. The agreement required HCCA to file a registration statement within 60 days of the completion of the transaction with Selway and have the registration statement declared effective within 120 days. The agreement requires damages of 1% per month of the Bridge Financing, capped at 10%, for each month the Company does not comply with the requirement. As a result of the restatements and investigation, the Company concludes that it is probable it will not file a registration statement and have declared within the period required and estimates that it will incur the maximum damages under the agreement. The Company recorded $592,500 to interest expense for the period ended June 30, 2013.
 
In conjunction with the merger of Merger Sub into HCCA:
 
·
The Company entered into exchange agreements with three beneficial holders of HCCA’s bridge loan who were also beneficial holders of greater than 5% of the Company’s Series A common stock. Pursuant to the exchange agreements, such holders converted an aggregate of 281,554 shares of the Company’s Series A common stock to the Company’s Series C common stock. In conjunction with the exchange, such holders were repaid bridge notes in the aggregate principal amount of $3,025,000.
 
·
The Company entered into exchange agreements with three beneficial holders of greater than 5% of the Company’s Series A common stock. Pursuant to the exchange agreements, such holders converted an aggregate of 878,481 shares of the Company’s Series A common stock to the Company’s Series C common stock and received $3.53 per share of Series A common stock exchanged, or an aggregate of $3,101,038.
 
·
An aggregate of $11,948,361 was released from the Company’s trust account, reflecting the number of shares of the Company’s Series A common stock that were converted into the Company’s Series C common stock, of which $237,007 was paid to the underwriters from the Company’s initial public offering. The Company incurred other costs related to the transaction totaling $577,069 and recorded both these costs and the costs paid to the underwriters as a reduction to Additional Paid In Capital.
  
·
The placement warrants held by the Company’s founders were converted into the right to receive: (i) an aggregate of 100,000 shares of common stock; and (ii) warrants to purchase an aggregate of 1,000,000 shares of common stock at an exercise price of $10.00 per share. The proceeds from the exercise of the exchange warrants will be paid: (i) 75% to the holders of all of the issued and outstanding shares of common stock of HCCA immediately prior to the time of the merger; and (ii) 25% to certain members of HCCA management. The exchange warrants are only exercisable for cash, may not be exercised on a cashless basis, and must be exercised if the closing price for the combined company’s common stock exceeds $12.00 per share for 20 trading days in any 30-trading-day period. On November 22, 2013, the Company cancelled these warrants and issued a new warrant to purchase 1 million shares of common stock. The replacement warrant was recorded to additional paid in capital. Per the terms of the warrant agreement, the warrant’s initial exercise price was $7.50 per share, subject to adjustment upon the first subsequent financing of the Company. This financing occurred on December 31, 2013 upon which the exercise price of this warrant was adjusted from $7.50 to $1.50. The new warrants do not include the provision to share the exercise proceeds with former shareholders of HCCA or management. The Company will record a charge in the quarter ended December 31, 2013 reflecting the value of the modification to the warrant.
 
Pursuant to an engagement letter entered into by HCCA with its investment banking adviser, 5% of all consideration received was owed to the adviser. Accordingly the Company issued 335,000 shares of common stock representing 5% of the common stock and incentive stock, as adjusted, received by HCCA and issued an incentive note of $500,000 representing 5% of the incentive notes issued to HCCA. The present value of the incentive note was recorded to additional paid in capital and is included in liabilities assumed.
  
The business combination of the Company and HCCA was accounted for as a reverse recapitalization of HCCA, since prior to the merger the Company was a shell corporation as defined under Rule 12b-2 of the Exchange Act. HCCA was treated as the accounting acquirer in this transaction due to the following factors:
  
1)
HCCA’s management pre-closing remained as the management of the Company post-closing;
  
2)
The members of the board of directors of HCCA pre-closing represent the majority of directors of the Company post- closing; and
  
3)
The majority of shares of the Company post-closing were still owned by HCCA shareholders, who represented 60% of the Company’s shares outstanding immediately after closing, if all shares subject to conversion in our post-closing tender offer actually convert to Series C (non-redeemable) common shares, and 65% of the Company’s shares outstanding if all shares subject to conversion do not convert to Series C shares and opt to receive their pro rata cash in trust at the time of the post-closing tender offer. Estimates of HCCA’s ownership do not include shares underlying warrants held by public investors and the Company’s sponsors restricted incentive shares held by management. However, HCCA shareholders would still have 51% of the Company’s shares post-closing when including shares underlying warrants and restricted shares and assuming all redeemable shares convert to Series C shares, and 54% of the Company’s shares post-closing if all shares subject to conversion do not convert to Series C shares and opt to receive their pro rata cash in trust at the time of the post-closing tender offer.
XML 84 R58.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-Term Debt (Details 3) (USD $)
Jun. 30, 2013
Dec. 31, 2012
Capital Leased Assets [Line Items]    
2014 $ 256,257  
2015 242,040  
2016 209,938  
2017 158,814  
2018 106,617  
Thereafter 50,640  
Total future minimum lease payments 1,024,306  
Less amount representing interest (176,225)  
Present value of net minimum lease payments 848,081  
Less current portion (189,989) (137,703)
Capital Lease Obligations $ 658,092  
XML 85 R69.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Events (Details Textual) (USD $)
6 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended
Jun. 30, 2013
Warrant [Member]
Jul. 15, 2013
Subsequent Event [Member]
Dec. 31, 2013
Subsequent Event [Member]
Aug. 15, 2013
Subsequent Event [Member]
Series B Common stock [Member]
Dec. 31, 2013
Subsequent Event [Member]
Promissory Note [Member]
Subsequent Event [Line Items]          
Stock Issued During Period, Shares, New Issues 555,000        
Partners Loan Agreement   $ 5,000,000      
Purchase of Common Stock Shares Through Tender Offer       839,965  
Purchase of Common Stock Value Through Tender Offer       8,650,000  
Junior Secured Convertible Notes Issued     2,112,500    
Debt Instrument, Convertible, Conversion Price     $ 1.50    
Aggregate Amount Of Notes     6,000,000    
Percentage Fee On Notes Principal Amount         9.00%
Additional Loans         500,000
Agent Fee Description         In connection with the Private Placement the Company agreed to pay the Agent a fee representing 9% of the principal amount of the Notes plus the $500,000 additional loan from the Lender, less $250,000, or $2,362,500.
Additional Notes Amount         212,625
Loan Principal Amount         $ 2,325,125
Common Stock Exercise Price     $ 3.00    
Number Of Securities Called By Warrants To Be Issued Upon Conversion Of Warrants     1,550,083    
Number Of Agent Securities Called By Warrants To Be Issued Upon Conversion Of Warrants     141,750    
XML 86 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Events
6 Months Ended
Jun. 30, 2013
Subsequent Events [Abstract]  
Subsequent Events [Text Block]
20.
Subsequent Events
 
On July 15, 2013, the Company entered into a $5 million Loan agreement with Partners For Growth III LP (“PFG”). On October 15, 2013 PFG notified the Company of events of Default. On December 31, 2013, the Company and PFG entered into a forbearance waiver and modification agreement to the Loan agreement.
 
The Company issued a total of 555,000 warrants to PFG in connection with the loan agreement and the forbearance waiver and modification agreement.
 
On August 15, 2013, the Company completed the purchase, through a tender offer, of 839,965 Series B shares of Common Stock in consideration for approximately $8.65 million (see Notes 8 and 14). Upon the completion of the tender offer and pursuant to the Company’s certificate of incorporation, all three classes of common stock A, B and C were consolidated into one class of common stock.
 
On September 26, 2013, the Company terminated its line of credit.
 
On November 7, 2013, the Company’s Board of Directors decided to change the Company’s fiscal year end from June 30 to December 31.
 
On December 31, 2013, the Company entered into a securities purchase agreement (the “SPA”) with certain purchasers (each a “Purchaser” and collectively, the “Purchasers”) named therein and Chardan Capital Markets, LLC (“Agent”) as administrative and collateral agent. Pursuant to the SPA, the Company issued $2,112,500 of Junior Secured Convertible Term Notes (the “Notes”), which Notes are convertible into shares of the Company’s common stock at an initial fixed conversion price equal to $1.50 per share. The Purchasers of Notes also received warrants (the “Warrants”) to purchase one share for every $1.50 of Notes purchased by such Purchaser. The Company completed the initial closing of a private placement of Notes and Warrants under the SPA on December 31, 2013, and may continue to make subsequent placements under the SPA until it has placed an aggregate of $6,000,000 in Notes under the SPA or the date that is 30 days after the date of such initial closing (the private placements under the SPA are collectively referred to as the “Private Placement”).
 
In connection with the Private Placement the Company agreed to pay the Agent a fee representing 9% of the principal amount of the Notes plus the $500,000 additional loan from the Lender, less $250,000, or $2,362,500. The fee was paid in the form of additional Notes (with a pro rata number of warrants) in the amount of $212,625 (for total principal amount of Notes equal to $2,325,125).
 
In connection with the issuance of the Notes under the SPA, the Company issued warrants to purchase an aggregate of 1,550,083 shares of common stock (including warrants to purchase 141,750 shares issued to the Agent for its fees), at an exercise price of $3.00 per share (the “Exercise Price”), at any time on or prior to December 31, 2018 (the “Warrants”). The Warrants may also be exercised on a cashless basis.
 
The Company and its subsidiaries entered into a Master Security Agreement with the Agent pursuant to which the Company and its subsidiaries agreed to secure the payment of all obligations under the Notes by granting and pledging to the Agent a continuing security interest in all of the Company’s and its subsidiaries’ property now owned or at any time hereafter acquired by them.
XML 87 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 138 385 1 true 52 0 false 5 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.swcau.com/role/DocumentAndEntityInformation Document And Entity Information true false R2.htm 102 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.swcau.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS false false R3.htm 103 - Statement - CONSOLIDATED BALANCE SHEETS [Parenthetical] Sheet http://www.swcau.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS [Parenthetical] false false R4.htm 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.swcau.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 105 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT AND REDEEMABLE SECURITIES Sheet http://www.swcau.com/role/ConsolidatedStatementsOfStockholdersDeficitAndRedeemableSecurities CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT AND REDEEMABLE SECURITIES false false R6.htm 106 - Disclosure - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT AND REDEEMABLE SECURITIES [Parenthetical] Sheet http://www.swcau.com/role/ConsolidatedStatementsOfStockholdersDeficitAndRedeemableSecuritiesParenthetical CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT AND REDEEMABLE SECURITIES [Parenthetical] false false R7.htm 107 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.swcau.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS false false R8.htm 109 - Disclosure - Description of Business Sheet http://www.swcau.com/role/DescriptionOfBusiness Description of Business false false R9.htm 110 - Disclosure - Liquidity and Financial Condition Sheet http://www.swcau.com/role/LiquidityAndFinancialCondition Liquidity and Financial Condition false false R10.htm 111 - Disclosure - The Merger Sheet http://www.swcau.com/role/Merger The Merger false false R11.htm 112 - Disclosure - Restatement Sheet http://www.swcau.com/role/Restatement Restatement false false R12.htm 113 - Disclosure - Significant Accounting Policies Sheet http://www.swcau.com/role/SignificantAccountingPolicies Significant Accounting Policies false false R13.htm 114 - Disclosure - Property and Equipment Sheet http://www.swcau.com/role/PropertyAndEquipment Property and Equipment false false R14.htm 115 - Disclosure - Software, net Sheet http://www.swcau.com/role/SoftwareNet Software, net false false R15.htm 116 - Disclosure - Investments Held in Trust Sheet http://www.swcau.com/role/InvestmentsHeldInTrust Investments Held in Trust false false R16.htm 117 - Disclosure - Deferred Financing Costs Sheet http://www.swcau.com/role/DeferredFinancingCosts Deferred Financing Costs false false R17.htm 118 - Disclosure - Accrued Expenses Sheet http://www.swcau.com/role/AccruedExpenses Accrued Expenses false false R18.htm 119 - Disclosure - Line of Credit Sheet http://www.swcau.com/role/LineOfCredit Line of Credit false false R19.htm 120 - Disclosure - Bridge Notes Notes http://www.swcau.com/role/BridgeNotes Bridge Notes false false R20.htm 121 - Disclosure - Long-Term Debt Sheet http://www.swcau.com/role/LongtermDebt Long-Term Debt false false R21.htm 122 - Disclosure - Redeemable Securities Sheet http://www.swcau.com/role/RedeemableSecurities Redeemable Securities false false R22.htm 123 - Disclosure - Stockholders' Equity Sheet http://www.swcau.com/role/StockholdersEquity Stockholders' Equity false false R23.htm 124 - Disclosure - Income Taxes Sheet http://www.swcau.com/role/IncomeTaxes Income Taxes false false R24.htm 125 - Disclosure - Commitments and Contingencies Sheet http://www.swcau.com/role/CommitmentsAndContingencies Commitments and Contingencies false false R25.htm 126 - Disclosure - Selected Financial Data (unaudited) Sheet http://www.swcau.com/role/SelectedFinancialDataUnaudited Selected Financial Data (unaudited) false false R26.htm 127 - Disclosure - Related Party Sheet http://www.swcau.com/role/RelatedParty Related Party false false R27.htm 128 - Disclosure - Subsequent Events Sheet http://www.swcau.com/role/SubsequentEvents Subsequent Events false false R28.htm 129 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.swcau.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) false false R29.htm 130 - Disclosure - Restatement (Tables) Sheet http://www.swcau.com/role/RestatementTables Restatement (Tables) false false R30.htm 131 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.swcau.com/role/SignificantAccountingPoliciesTables Significant Accounting Policies (Tables) false false R31.htm 132 - Disclosure - Property and Equipment (Tables) Sheet http://www.swcau.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) false false R32.htm 133 - Disclosure - Software, net (Tables) Sheet http://www.swcau.com/role/SoftwareNetTables Software, net (Tables) false false R33.htm 134 - Disclosure - Deferred Financing Costs (Tables) Sheet http://www.swcau.com/role/DeferredFinancingCostsTables Deferred Financing Costs (Tables) false false R34.htm 135 - Disclosure - Accrued Expenses (Tables) Sheet http://www.swcau.com/role/AccruedExpensesTables Accrued Expenses (Tables) false false R35.htm 136 - Disclosure - Long-Term Debt (Tables) Sheet http://www.swcau.com/role/LongtermDebtTables Long-Term Debt (Tables) false false R36.htm 137 - Disclosure - Income Taxes (Tables) Sheet http://www.swcau.com/role/IncomeTaxesTables Income Taxes (Tables) false false R37.htm 138 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.swcau.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) false false R38.htm 139 - Disclosure - Selected Financial Data (unaudited) (Tables) Sheet http://www.swcau.com/role/SelectedFinancialDataUnauditedTables Selected Financial Data (unaudited) (Tables) false false R39.htm 140 - Disclosure - Liquidity and Financial Condition (Details Textual) Sheet http://www.swcau.com/role/LiquidityAndFinancialConditionDetailsTextual Liquidity and Financial Condition (Details Textual) false false R40.htm 141 - Disclosure - The Merger (Details Textual) Sheet http://www.swcau.com/role/MergerDetailsTextual The Merger (Details Textual) false false R41.htm 142 - Disclosure - Restatement (Details) Sheet http://www.swcau.com/role/RestatementDetails Restatement (Details) false false R42.htm 143 - Disclosure - Significant Accounting Policies (Details) Sheet http://www.swcau.com/role/SignificantAccountingPoliciesDetails Significant Accounting Policies (Details) false false R43.htm 144 - Disclosure - Significant Accounting Policies (Details 1) Sheet http://www.swcau.com/role/SignificantAccountingPoliciesDetails1 Significant Accounting Policies (Details 1) false false R44.htm 145 - Disclosure - Significant Accounting Policies (Details 2) Sheet http://www.swcau.com/role/SignificantAccountingPoliciesDetails2 Significant Accounting Policies (Details 2) false false R45.htm 146 - Disclosure - Significant Accounting Policies (Details Textual) Sheet http://www.swcau.com/role/SignificantAccountingPoliciesDetailsTextual Significant Accounting Policies (Details Textual) false false R46.htm 147 - Disclosure - Property and Equipment (Details) Sheet http://www.swcau.com/role/PropertyAndEquipmentDetails Property and Equipment (Details) false false R47.htm 148 - Disclosure - Property and Equipment (Details Textual) Sheet http://www.swcau.com/role/PropertyAndEquipmentDetailsTextual Property and Equipment (Details Textual) false false R48.htm 149 - Disclosure - Software, net (Details) Sheet http://www.swcau.com/role/SoftwareNetDetails Software, net (Details) false false R49.htm 150 - Disclosure - Software, net (Details Textual) Sheet http://www.swcau.com/role/SoftwareNetDetailsTextual Software, net (Details Textual) false false R50.htm 151 - Disclosure - Investments Held in Trust (Details Textual) Sheet http://www.swcau.com/role/InvestmentsHeldInTrustDetailsTextual Investments Held in Trust (Details Textual) false false R51.htm 152 - Disclosure - Deferred Financing Costs (Details) Sheet http://www.swcau.com/role/DeferredFinancingCostsDetails Deferred Financing Costs (Details) false false R52.htm 153 - Disclosure - Accured Expenses (Details) Sheet http://www.swcau.com/role/AccuredExpensesDetails Accured Expenses (Details) false false R53.htm 154 - Disclosure - Line of Credit (Details Texual) Sheet http://www.swcau.com/role/LineOfCreditDetailsTexual Line of Credit (Details Texual) false false R54.htm 155 - Disclosure - Bridge Notes (Details Textual) Notes http://www.swcau.com/role/BridgeNotesDetailsTextual Bridge Notes (Details Textual) false false R55.htm 156 - Disclosure - Long-Term Debt (Details) Sheet http://www.swcau.com/role/LongtermDebtDetails Long-Term Debt (Details) false false R56.htm 157 - Disclosure - Long-Term Debt (Details 1) Sheet http://www.swcau.com/role/LongtermDebtDetails1 Long-Term Debt (Details 1) false false R57.htm 158 - Disclosure - Long-Term Debt (Details 2) Sheet http://www.swcau.com/role/LongtermDebtDetails2 Long-Term Debt (Details 2) false false R58.htm 159 - Disclosure - Long-Term Debt (Details 3) Sheet http://www.swcau.com/role/LongtermDebtDetails3 Long-Term Debt (Details 3) false false R59.htm 160 - Disclosure - Long-Term Debt (Details Textual) Sheet http://www.swcau.com/role/LongtermDebtDetailsTextual Long-Term Debt (Details Textual) false false R60.htm 161 - Disclosure - Redeemable Securities (Details Textual) Sheet http://www.swcau.com/role/RedeemableSecuritiesDetailsTextual Redeemable Securities (Details Textual) false false R61.htm 162 - Disclosure - Stockholders' Equity (Details Textual) Sheet http://www.swcau.com/role/StockholdersEquityDetailsTextual Stockholders' Equity (Details Textual) false false R62.htm 163 - Disclosure - Income Taxes (Details) Sheet http://www.swcau.com/role/IncomeTaxesDetails Income Taxes (Details) false false R63.htm 164 - Disclosure - Income Taxes (Details 1) Sheet http://www.swcau.com/role/IncomeTaxesDetails1 Income Taxes (Details 1) false false R64.htm 165 - Disclosure - Income Taxes (Details Textual) Sheet http://www.swcau.com/role/IncomeTaxesDetailsTextual Income Taxes (Details Textual) false false R65.htm 166 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.swcau.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) false false R66.htm 167 - Disclosure - Commitments and Contingencies (Details Textual) Sheet http://www.swcau.com/role/CommitmentsAndContingenciesDetailsTextual Commitments and Contingencies (Details Textual) false false R67.htm 168 - Disclosure - Selected Financial Data (unaudited) (Details) Sheet http://www.swcau.com/role/SelectedFinancialDataUnauditedDetails Selected Financial Data (unaudited) (Details) false false R68.htm 169 - Disclosure - Related Party (Details Textual) Sheet http://www.swcau.com/role/RelatedPartyDetailsTextual Related Party (Details Textual) false false R69.htm 170 - Disclosure - Subsequent Events (Details Textual) Sheet http://www.swcau.com/role/SubsequentEventsDetailsTextual Subsequent Events (Details Textual) false false All Reports Book All Reports Element swca_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpense had a mix of decimals attribute values: 0 4. Element us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight had a mix of decimals attribute values: -6 0. Element us-gaap_CommonStockParOrStatedValuePerShare had a mix of decimals attribute values: 0 3 4. Element us-gaap_PreferredStockParOrStatedValuePerShare had a mix of decimals attribute values: 0 4. 'Monetary' elements on report '151 - Disclosure - Investments Held in Trust (Details Textual)' had a mix of different decimal attribute values. 'Monetary' elements on report '167 - Disclosure - Commitments and Contingencies (Details Textual)' had a mix of different decimal attribute values. 'Monetary' elements on report '170 - Disclosure - Subsequent Events (Details Textual)' had a mix of different decimal attribute values. Process Flow-Through: 102 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: 103 - Statement - CONSOLIDATED BALANCE SHEETS [Parenthetical] Process Flow-Through: 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: Removing column '6 Months Ended Jun. 30, 2012' Process Flow-Through: 107 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS swca-20130630.xml swca-20130630.xsd swca-20130630_cal.xml swca-20130630_def.xml swca-20130630_lab.xml swca-20130630_pre.xml true true XML 88 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
Selected Financial Data (unaudited) (Tables)
6 Months Ended
Jun. 30, 2013
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Information [Table Text Block]
 
 
Six months ended
 
 
 
June 30, 2012
 
 
 
 
 
 
Revenue
 
$
10,056,735
 
Gross profit
 
$
426,730
 
Loss before income taxes
 
$
(2,490,381)
 
Net loss
 
$
(2,495,461)
 
Basic and diluted net income per share
 
$
(0.07)
 
Weighted average number of shares outstanding
 
 
37,897,909
 
XML 89 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-Term Debt
6 Months Ended
Jun. 30, 2013
Long-term Debt and Capital Lease Obligations, Current [Abstract]  
Long-term Debt [Text Block]
13.
Long-Term Debt
 
Incentive Notes
 
Upon consummation of the merger (see Note 3), Holders of all of the issued and outstanding shares of common stock of HCCA immediately prior to the time of the Merger had each of their shares of common stock of HCCA converted into the right to receive a proportional amount of 5,200,000 shares of the Company’s Series C common stock and promissory notes with an aggregate face value of $7,500,000 (collectively, the “Closing Payment”).
 
In addition, the Company issued to its management $2,500,000 of Management Incentive Notes and paid fees in connection with the transaction by issuing promissory notes having an aggregate principal amount of $500,000, which reflects five percent of all promissory notes issued in the transaction.
 
The above described notes with an aggregate face value of $10,500,000 have identical terms and conditions, are non-interest bearing and are subordinated to all senior debt of the Company in the event of a default under such senior debt. The notes will be repaid from 25% of the Company’s free cash-flow (defined as in the notes) in excess of $2,000,000. The Company will be obligated to repay such notes if, among other events, there is a transaction that results in a change of control of the Company.
 
The notes were recorded at their estimated present value, based on the estimated time of repayment discounted to the balance sheet date. The Company will continue to re-evaluate its estimates on a periodic basis and adjust the present value of the notes accordingly. Of the Management Incentive Notes, $222,477, net of discount vested immediately and $395,514 is being recognized as management incentive compensation over the estimated payment periods.
  
 
 
June 30, 2013
 
 
 
 
 
 
Shareholder notes
 
$
7,500,000
 
Placement notes
 
 
500,000
 
Management incentive notes
 
 
2,500,000
 
 
 
 
 
 
 
 
 
10,500,000
 
Less debt discount
 
 
(7,728,486)
 
 
 
 
 
 
 
 
$
2,771,514
 
 
Future maturities of the Incentive Notes based on the Company’s estimates are as follows:
 
June 30,
 
 
 
 
 
 
 
 
 
2014
 
$
-
 
2015
 
 
-
 
2016
 
 
399,000
 
2017
 
 
1,789,000
 
2018
 
 
3,622,000
 
Thereafter
 
 
4,690,000
 
 
 
 
 
 
 
 
$
10,500,000
 
  
Capital Leases
 
The Company has entered into capital lease agreements for equipment, which expire at various dates through November 2019. The assets capitalized under these leases and associated accumulated depreciation at June 30, 2013 and December 31, 2012 are as follows:
 
 
 
June 30, 2013
 
December 31, 2012
 
 
 
 
 
 
 
 
 
Furniture and equipment
 
$
1,007,735
 
$
584,638
 
Accumulated depreciation
 
 
(250,821)
 
 
(153,937)
 
 
 
 
 
 
 
 
 
 
 
$
756,914
 
$
430,701
 
 
Amortization of capital leases is included in depreciation expense.
 
Minimum future lease payments under capital lease obligations as of June 30, 2013 are as follows:
 
Year Ended June 30,
 
 
 
 
 
 
 
 
 
2014
 
$
256,257
 
2015
 
 
242,040
 
2016
 
 
209,938
 
2017
 
 
158,814
 
2018
 
 
106,617
 
Thereafter
 
 
50,640
 
 
 
 
 
 
Total future minimum lease payments
 
 
1,024,306
 
Less amount representing interest
 
 
(176,225)
 
Present value of net minimum lease payments
 
 
848,081
 
Less current portion
 
 
(189,989)
 
 
 
 
 
 
 
 
$
658,092